Citrus Sinensis ID: 005206

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------71
Protein Sequence
MSSTGLSQIKITLKCFVIERRETSAKNMIMNDITSHPCYTNLFLIIFILFPTIAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT
Secondary Structure (PSIPRED)
ccccccccHHEEEEEEEEEEccccccHHHHHHHccccHHHHHHHHHHHHHccccEEccccccccccccccEEEccccEEEEEcccccccccEEEEEEEcccccccEEEEccccccccccccEEEEEEccEEEEcccccEEEEEccccccccEEEEEEcccEEEEEcccccEEEEEccccccccccccEEccccccccEEEEEEcccccccccccEEEEEEcccccEEEEEEccEEEEEEEcccccEEEccccccccccEEEEEEEEcccEEEEEEEEccccEEEEEEEcccccEEEEEEEcccccEEEEEEccccccccccccccccccccccccccccccccccccccccccccccccEEEccccccccccEEEEccccccccccccEEccccHHHHHHHHHccccEEEEEcccccccccEEEEcccccHHHHcccccEEEEEEEEccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHcccccccccccccccccccccHHHHHHHHccccccccccccccccEEEEEcccccEEEEEEcccccccHHHHHHHHHHHHHHHcccccEEEEccccccccEEEEEEEcccccccEEEEccccccccccHHHHHHHHHHHHHHHHHccccccEEEEcccccccccccccccccccccccEEEcccccccccccEEEcc
Secondary Structure Prediction (SSPRO)
cccccccEEEEEEEEEEEEcccccHHHHHHccHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccEEEccccEEEEEEEcccccccEEEEEEEEcccccEEEEEEccccccccccEEEEEEccEEEEEEccccEEEEcccccccccEEEEEccccEEEEEcccccEEEEEccccccccccccEccccccccccEEEEEcccccccccccEEEEEccccccEEEEEcccEEEEEccccccEEEccccccccccEEEEEEEEEcccEEEEEEEEEcccEEEEEEEccccEEEEEEEEcccccEEEEEEccccccccHcccccccEcccccccccccccccccccHHHHHccccccccEEccccccccccEEEEccccccccccEEEcccccHHHHHHHHHHcccEEEEEEEccccccEEEEEcccHHHHHHcccccccEEEEEccHHccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccEEEccccccccccccccccccEcHHHHHHHHcccccccccccccccccEccEcccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEEcccccccEEEEccHccccccHHHHHHHHHHHHHHHHHHHHccHccEEcccccHHHEEEcccccEEEccHHHcEEccHHcccccccEEccc
Coil and Loop (DISEMBL)
MSSTGLSQIKITLKCFVIERRETSAKNMimnditshpcytnLFLIIFILFPTIAISVDTLTATQnltygktlvssddvfelgffspgssgkwyigiWYKNIAQRTYVWVAnrddplanssgVLRIINQRiglfdgsqnlvwssnqtkatnpvaqlqdsgnfvlkeagsdeilwqsfdyptdtllpqmkigwdlkTGFEWYLTswkstddpstgdnsfkldfhgfpegflwnkqerkyrsgpwngvrfsgvpemkpieginfeffidqdhdVYYSFFIENKNLFSRlivspdgflqRFTWIEAnkiwnpfwyapkdqcdnygecgpfgicdtnaspvcqcmrgfepkdpqawslrdgsggcvrktelqcSEDKFLQlknmklpdtttsFVDYNMTLKECEAfcsrncsctayantnitggtgcvtwtgeLKDIRKYAEGGQDLYVRLAAsdigdganatpIIIGVTVGSAILILGLVACFLWRRKTLLgrqirkteprghpersqdLLLNQVVIsskrdysadktddlelplfdfETIVRatdnftdynklgqggfgivykgrlleGQEIAVKRLSrnsgqgieEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNilldkemtpkisdfgmarifggdqteqntkrvvgt
Flexible Loop (DISEMBL)
msstglsqikitlkCFVIERRETSAKNMIMNDITSHPCYTNLFLIIFILFPTIAISVDTLTATQNLTYGKTLVSSDDVFELGFfspgssgkwYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSEDKFlqlknmklpdtTTSFVDYNMTLKECEAFCSRNCSCTAYantnitggtgcVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIIIGVTVGSAILILGLVACFLWRRKTLLgrqirkteprghpersqdlllnQVVISSkrdysadktddlelplFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRlsrnsgqgieEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKasnilldkeMTPKISDFGMArifggdqteqntkrvvgt
Low Complexity Region (SEG)
MSSTGLSQIKITLKCFVIERRETSAKNMIMNDITSHPCYTNlfliifilfPTIAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT
Disordered region (IsUnstruct)
*******QIKITLKCFVIERRETSAKNMIMNDITSHPCYTNLFLIIFILFPTIAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSN*******VAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKST*******NSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQI**************LLLNQVVISS***YSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF***************
Disordered Region (DISOPRED)
******S*IKITLKCFVIERRETSAKNMIMNDITSHPCYTNLFLIIFILFPTIAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDI***ANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQIR************************************LPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT
Disordered Region (DISEMBL)
MSSTGLSQIKITLKCFVIERRETSAKNMIMNDITSHPCYTNLFLIIFILFPTIAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQIR*********RSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE*********
Disordered Region (DISPRO)
*****LSQIKITLKCFVIERRETSAKNMIMNDITSHPCYTNLFLIIFILFPTIAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQI*************DLLLNQVVIS********KTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT**********
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSSTGLSQIKITLKCFVIERRETSAKNMIMNDITSHPCYTNLFLIIFILFPTIAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	709	2.2.26 [Sep-21-2011]
O81905	850	Receptor-like serine/thre	yes	no	0.925	0.771	0.626	0.0
Q9S972	847	Receptor-like serine/thre	no	no	0.918	0.768	0.574	0.0
Q09092	857	Putative serine/threonine	N/A	no	0.943	0.780	0.529	0.0
Q39086	843	Receptor-like serine/thre	no	no	0.918	0.772	0.572	0.0
P0DH86	853	G-type lectin S-receptor-	no	no	0.921	0.765	0.546	0.0
O81832	783	G-type lectin S-receptor-	no	no	0.861	0.780	0.478	1e-178
Q9ZT07	833	G-type lectin S-receptor-	no	no	0.909	0.774	0.476	1e-175
O81906	849	G-type lectin S-receptor-	no	no	0.918	0.766	0.448	1e-160
Q9LPZ3	845	G-type lectin S-receptor-	no	no	0.913	0.766	0.443	1e-154
Q9SY89	842	Putative G-type lectin S-	no	no	0.916	0.771	0.432	1e-153

>sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1

 Score =  846 bits (2186), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 421/672 (62%), Positives = 519/672 (77%), Gaps = 16/672 (2%)

Query: 51  PTIAISVDTLTATQNLTYGK--TLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVW 108
           P  +IS +TL+A+++LT     T+VS  +VFELGFF PG   +WY+GIWYK I++RTYVW
Sbjct: 23  PAYSISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVW 82

Query: 109 VANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQT--KATNP-VAQLQDSGNFVL-- 163
           VANRD PL++S G L+I +  + + D S   VWS+N T     +P VA+L D+GNFVL  
Sbjct: 83  VANRDTPLSSSIGTLKISDSNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD 142

Query: 164 -KEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFH 222
            K +  D +LWQSFD+PTDTLLP+MK+GWD KTGF  ++ SWKS DDPS+GD SFKL+  
Sbjct: 143 SKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETE 202

Query: 223 GFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNL 282
           GFPE FLWN++ R YRSGPWNG+RFSGVPEM+P E + F F   ++ +V YSF I   ++
Sbjct: 203 GFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKE-EVTYSFRITKSDV 261

Query: 283 FSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRG 342
           +SRL +S  G LQRFTWIE  + WN FWYAPKDQCD Y ECG +G CD+N SPVC C++G
Sbjct: 262 YSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKG 321

Query: 343 FEPKDPQAWSLRDGSGGCVRKTELQCSE-DKFLQLKNMKLPDTTTSFVDYNMTLKECEAF 401
           F+P++PQ W LRDGS GCVRKT L C   D F++LK MKLPDTTT+ VD  + +KECE  
Sbjct: 322 FKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQK 381

Query: 402 CSRNCSCTAYANTNITG-GTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPI 460
           C R+C+CTA+ANT+I G G+GCVTWTGEL DIR YA+GGQDLYVRLAA+D+ D  N +  
Sbjct: 382 CLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLEDKRNRSAK 441

Query: 461 IIGVTVG-SAILILGLVACFLWRRKTLLGRQIRKTEP-RGHPERSQDLLLNQVVISSKRD 518
           IIG ++G S +L+L  +  FLW+RK    R I    P   H  RS+DLL+N+VVISS+R 
Sbjct: 442 IIGSSIGVSVLLLLSFIIFFLWKRKQ--KRSILIETPIVDHQLRSRDLLMNEVVISSRRH 499

Query: 519 YS-ADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN 577
            S  + TDDLELPL +FE +  AT+NF++ NKLGQGGFGIVYKG+LL+GQE+AVKRLS+ 
Sbjct: 500 ISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKT 559

Query: 578 SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI 637
           S QG +EFKNEV+LIA+LQH NLVRLL CCV+  EKML+YEY+EN SLDS +FDK+R+S 
Sbjct: 560 SVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSK 619

Query: 638 LNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
           LNWQ RF+II GIARGLLYLHQDSRFRIIHRDLKASNILLDK MTPKISDFGMARIFG D
Sbjct: 620 LNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRD 679

Query: 698 QTEQNTKRVVGT 709
           +TE NT++VVGT
Sbjct: 680 ETEANTRKVVGT 691

Involved in the regulation of cellular expansion and differentiation.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2

 Score =  748 bits (1930), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 385/670 (57%), Positives = 491/670 (73%), Gaps = 19/670 (2%)

Query: 54  AISVDTLTATQNLTYG--KTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVAN 111
           ++     +AT++LT    KT++S   +FELGFF+P SS +WY+GIWYK I  RTYVWVAN
Sbjct: 24  SVYASNFSATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVAN 83

Query: 112 RDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQT--KATNPVA-QLQDSGNFVLKEAGS 168
           RD+PL++S+G L+I +  + +FD S   VWS+N T     +PVA +L D GNFVL+++ +
Sbjct: 84  RDNPLSSSNGTLKISDNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRDSKN 143

Query: 169 DE---ILWQSFDYPTDTLLPQMKIGWDLKTG-FEWYLTSWKSTDDPSTGDNSFKLDFHGF 224
           ++    LWQSFD+PTDTLL  MK+GWD K+G F   L SWK+TDDPS+GD S KL   GF
Sbjct: 144 NKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGF 203

Query: 225 PEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFS 284
           PE +++NK+   YRSGPW G RFS VP MKP++ I+   F + +  V YS+ +   N++S
Sbjct: 204 PEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYID-NSFTENNQQVVYSYRVNKTNIYS 262

Query: 285 RLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFE 344
            L +S  G LQR TW+EA + W   WY+PKD CDNY ECG +G CD N SP+C C++GFE
Sbjct: 263 ILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIKGFE 322

Query: 345 PKDPQAWSLRDGSGGCVRKTELQC-SEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCS 403
           P + QA +LRD S GCVRKT+L C   D F++LK M+LPDTT + VD  + LKECE  C 
Sbjct: 323 PMNEQA-ALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCL 381

Query: 404 RNCSCTAYANTNI-TGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIII 462
           + C+CTA+ANT+I  GG+GCV W+G L DIR YA+GGQDLYVR+AA D+ D    +  II
Sbjct: 382 KGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDLEDKRIKSKKII 441

Query: 463 GVTVG-SAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDYSA 521
           G ++G S +L+L  +    W+RK    R I    P     RSQD L+N++V +S R Y++
Sbjct: 442 GSSIGVSILLLLSFIIFHFWKRKQ--KRSITIQTPIVDLVRSQDSLMNELVKAS-RSYTS 498

Query: 522 --DKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG 579
             +KTD LELPL +++ +  AT+NF+  NKLGQGGFGIVYKG LL+G+EIAVKRLS+ S 
Sbjct: 499 KENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSS 558

Query: 580 QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILN 639
           QG +EF NEVRLIAKLQH NLVRLLGCCV+  EKML+YEY+EN SLDS +FD+ RSS LN
Sbjct: 559 QGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLN 618

Query: 640 WQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
           WQ+RF+II GIARGLLYLHQDSR RIIHRDLKASN+LLDK MTPKISDFGMARIFG ++T
Sbjct: 619 WQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREET 678

Query: 700 EQNTKRVVGT 709
           E NT+RVVGT
Sbjct: 679 EANTRRVVGT 688

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2

 Score =  741 bits (1913), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 365/689 (52%), Positives = 501/689 (72%), Gaps = 20/689 (2%)

Query: 35  SHPCYTNLFLIIFILFPTIAISVDTLTATQNLTYG--KTLVSSDDVFELGFFSPGSSGKW 92
           S+  +  +F+++ ++ P ++I ++TL++T++LT    KTLVS   +FE+GFF   S  +W
Sbjct: 11  SYMSFLLVFVVMILIHPALSIYINTLSSTESLTISSNKTLVSPGSIFEVGFFRTNS--RW 68

Query: 93  YIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATN-- 150
           Y+G+WYK ++ RTYVWVANRD+PL+N+ G L+I    + L D S   VW +N T+     
Sbjct: 69  YLGMWYKKVSDRTYVWVANRDNPLSNAIGTLKISGNNLVLLDHSNKPVWWTNLTRGNERS 128

Query: 151 -PVAQLQDSGNFVLKEAGSD---EILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKS 206
             VA+L  +GNFV++++ ++   E LWQSFDYPTDTLLP+MK+G++LKTG   +LTSW+S
Sbjct: 129 PVVAELLANGNFVMRDSSNNDASEYLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRS 188

Query: 207 TDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFID 266
           +DDPS+G+ S+KL+    PE +L  +    +RSGPWNG+RFSG+PE + +  + + F I+
Sbjct: 189 SDDPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNF-IE 247

Query: 267 QDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKD-QCDNYGECGP 325
            + +V Y+F + N + +SRL +  +G+ QR TW  + +IWN FW +P D QCD Y  CGP
Sbjct: 248 NNEEVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRFWSSPVDPQCDTYIMCGP 307

Query: 326 FGICDTNASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSEDKFLQLKNMKLPDTT 385
           +  CD N SPVC C++GF P++ Q W  R  +GGC+R+T+L CS D F ++K MKLP+TT
Sbjct: 308 YAYCDVNTSPVCNCIQGFNPRNIQQWDQRVWAGGCIRRTQLSCSGDGFTRMKKMKLPETT 367

Query: 386 TSFVDYNMTLKECEAFCSRNCSCTAYANTNI-TGGTGCVTWTGELKDIRKYAEG---GQD 441
            + VD ++ +KEC+  C  +C+CTA+AN +I  GG+GCV WT  L+DIR YA     GQD
Sbjct: 368 MATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLEDIRNYATDAIDGQD 427

Query: 442 LYVRLAASDIGDGANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPRGHPE 501
           LYVRLAA+DI    NA+  II +TVG ++L+L ++ C LW+RK    R         + +
Sbjct: 428 LYVRLAAADIAKKRNASGKIISLTVGVSVLLLLIMFC-LWKRKQ--KRAKASAISIANTQ 484

Query: 502 RSQDLLLNQVVISSKRDYSAD-KTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYK 560
           R+Q+L +N++V+SSKR++S + K ++LELPL + ET+V+AT+NF+  NKLGQGGFGIVYK
Sbjct: 485 RNQNLPMNEMVLSSKREFSGEYKFEELELPLIEMETVVKATENFSSCNKLGQGGFGIVYK 544

Query: 561 GRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM 620
           GRLL+G+EIAVKRLS+ S QG +EF NEV LIA+LQH NLV++LGCC+E DEKML+YEY+
Sbjct: 545 GRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDEKMLIYEYL 604

Query: 621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE 680
           EN SLDS +F K R S LNW  RF+I  G+ARGLLYLHQDSRFRIIHRDLK SNILLDK 
Sbjct: 605 ENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKVSNILLDKN 664

Query: 681 MTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           M PKISDFGMARIF  D+TE NT +VVGT
Sbjct: 665 MIPKISDFGMARIFERDETEANTMKVVGT 693

Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain.

Brassica oleracea var. acephala (taxid: 3713)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1

 Score =  734 bits (1896), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 381/666 (57%), Positives = 490/666 (73%), Gaps = 15/666 (2%)

Query: 54  AISVDTLTATQNLTYG--KTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVAN 111
           ++S +TL+AT++LT    KT++S   +FELGFF+P SS +WY+GIWYK I  RTYVWVAN
Sbjct: 24  SVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVAN 83

Query: 112 RDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQT--KATNPVA-QLQDSGNFVLKEAGS 168
           RD+PL++S+G L+I    + +FD S   VWS+N T     +PVA +L D+GNF+L+++ +
Sbjct: 84  RDNPLSSSNGTLKISGNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRDS-N 142

Query: 169 DEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGF 228
           + +LWQSFD+PTDTLL +MK+GWD KTGF   L SWK+TDDPS+G+ S KL+   FPE +
Sbjct: 143 NRLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFY 202

Query: 229 LWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIV 288
           + +K+   YRSGPWNG+RFS VP    ++ + + F   ++ +V YS+ I   NL+SRL +
Sbjct: 203 ICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKE-EVTYSYRINKTNLYSRLYL 261

Query: 289 SPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDP 348
           +  G LQR TW E  + W   WY+PKD CDNY  CG FG CD+N+ P C C++GF+P + 
Sbjct: 262 NSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGFKPVNE 321

Query: 349 QAWSLRDGSGGCVRKTELQC-SEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCS 407
           QAW LRDGS GC+RKT L C   D F +LK MKLPDTT + VD  + LK C+  C  +C+
Sbjct: 322 QAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCN 381

Query: 408 CTAYANTNI-TGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIIIGVTV 466
           CTA+AN +I  GG+GCV WT E+ D+R YA+GGQDLYVRLAA+++ D       IIG ++
Sbjct: 382 CTAFANADIRNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAAELEDKRIKNEKIIGSSI 441

Query: 467 G-SAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDYSAD--K 523
           G S +L+L  V    W+RK    R I    P     RSQD L+N VV+S +R Y++   K
Sbjct: 442 GVSILLLLSFVIFHFWKRKQ--KRSITIQTPNVDQVRSQDSLINDVVVS-RRGYTSKEKK 498

Query: 524 TDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIE 583
           ++ LELPL + E +  AT+NF++ NKLGQGGFGIVYKGRLL+G+EIAVKRLS+ S QG +
Sbjct: 499 SEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTD 558

Query: 584 EFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRR 643
           EF NEVRLIAKLQH NLVRLLGCCV+  EKML+YEY+EN SLDS +FD+ RSS LNWQ+R
Sbjct: 559 EFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKR 618

Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
           F+II GIARGLLYLHQDSR RIIHRDLKASN+LLDK MTPKISDFGMARIFG ++TE NT
Sbjct: 619 FDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANT 678

Query: 704 KRVVGT 709
           +RVVGT
Sbjct: 679 RRVVGT 684

Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1

 Score =  698 bits (1801), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 367/671 (54%), Positives = 471/671 (70%), Gaps = 18/671 (2%)

Query: 51  PTIAISVDTLTATQNLTYG--KTLVSSDDVFELGFFSP-GSSGKWYIGIWYKNIAQRTYV 107
           P ++ISV+TL+AT++LT    KT+VS   VFELGFF   G S  WY+GIWYK I+QRTYV
Sbjct: 26  PDLSISVNTLSATESLTISSNKTIVSPGGVFELGFFRILGDS--WYLGIWYKKISQRTYV 83

Query: 108 WVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKA--TNPVAQLQDSGNFVLKE 165
           WVANRD PL+N  G+L+I N  + + D S   VWS+N T A  ++ VA+L D+GNFVL+ 
Sbjct: 84  WVANRDTPLSNPIGILKISNANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVLRG 143

Query: 166 AG---SDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFH 222
           +    SDE LWQSFD+PTDTLLPQMK+G D K G   ++TSWKS+ DPS+G   FKL+  
Sbjct: 144 SKINESDEFLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLETL 203

Query: 223 GFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNL 282
           G PE F +      YRSGPW+G+RFSG+ EM+  + I + F  +   +V Y+F + + N 
Sbjct: 204 GLPEFFGFTSFLEVYRSGPWDGLRFSGILEMQQWDDIIYNF-TENREEVAYTFRVTDHNS 262

Query: 283 FSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRG 342
           +SRL ++  G L+ F W    + WN FW+ PKD CD YG CGP+  CD + SP C C++G
Sbjct: 263 YSRLTINTVGRLEGFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTSPTCNCIKG 322

Query: 343 FEPKDPQAWSLRDGSGGCVRKTELQCSEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFC 402
           F+P  PQ W+  D +G C RKT+L C ED+F +L NMK+P TT + VD  + LKECE  C
Sbjct: 323 FQPLSPQDWASGDVTGRCRRKTQLTCGEDRFFRLMNMKIPATTAAIVDKRIGLKECEEKC 382

Query: 403 SRNCSCTAYANTNI-TGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDG-ANATPI 460
             +C+CTAYAN++I  GG+GC+ W GE +DIR YA  GQDL+VRLAA++ G+       I
Sbjct: 383 KTHCNCTAYANSDIRNGGSGCIIWIGEFRDIRNYAADGQDLFVRLAAAEFGERRTIRGKI 442

Query: 461 IIGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLL-NQVVISSKRDY 519
           I  +   S +L+L  +    W++K    R      P G+ +R Q+L++ N VV+SS R  
Sbjct: 443 IGLIIGISLMLVLSFIIYCFWKKKQKRARAT--AAPIGYRDRIQELIITNGVVMSSGRRL 500

Query: 520 SADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG 579
             ++ D       +FET+V AT+NF+D N LG+GGFGIVYKGRLL+GQEIAVKRLS  S 
Sbjct: 501 LGEEEDLELPLT-EFETVVMATENFSDSNILGRGGFGIVYKGRLLDGQEIAVKRLSEMSS 559

Query: 580 QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSS-IL 638
           QG  EFKNEVRLIA+LQH NLVRLL CC+  DEK+L+YEY+EN SLDS +F+  +SS  L
Sbjct: 560 QGTNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEYLENGSLDSHLFETTQSSNKL 619

Query: 639 NWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           NWQ RF+II GIARGLLYLHQDSRF+IIHRDLKASN+LLDK MTPKISDFGMARIF  D+
Sbjct: 620 NWQTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNMTPKISDFGMARIFERDE 679

Query: 699 TEQNTKRVVGT 709
           TE NT++VVGT
Sbjct: 680 TEANTRKVVGT 690

Female specificity determinant of self-incompatibility.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4

 Score =  627 bits (1616), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 326/681 (47%), Positives = 431/681 (63%), Gaps = 70/681 (10%)

Query: 42  LFLIIFILFPTI--AISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYK 99
           L L+I  LF TI  A + D L A Q L  G T+VS    FE+GFFSPG S   Y+GIWYK
Sbjct: 7   LHLLIISLFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYK 66

Query: 100 NIAQRTYVWVANRDDPLANSSGVLRII-NQRIGLFDGSQNLVWSS------NQTKATNPV 152
            I+ +T VWVANRD PL + SG L++  N  + LF+   +++WSS       +    NP+
Sbjct: 67  KISLQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPI 126

Query: 153 AQLQDSGNFVLKEAGSDE-ILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPS 211
            Q+ D+GN V++ +G D+  +WQS DYP D  LP MK G +  TG   +LTSW++ DDPS
Sbjct: 127 VQILDTGNLVVRNSGDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPS 186

Query: 212 TGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDV 271
           TG+ + K+D +G P+ FL       +R+GPWNG+RF+G+P +KP     +E+   ++ +V
Sbjct: 187 TGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEE-EV 245

Query: 272 YYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDT 331
           YY++ +EN ++ +R+ ++P+G LQR+TW++  + WN +  A  D CD Y  CG +G C+ 
Sbjct: 246 YYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNI 305

Query: 332 NASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQC--SEDKFLQLKNMKLPDTTTSFV 389
           N SP C+C++GF  K PQAW   D S GCVR+ +L C   ED FL++  +KLPDT TS+ 
Sbjct: 306 NESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWY 365

Query: 390 DYNMTLKECEAFCSRNCSCTAYANTNIT-GGTGCVTWTGELKDIRKYAEGGQDLYVRLAA 448
           D NM L EC+  C RNC+C+AY+  +I  GG GC+ W G+L DIR+Y E GQDLYVRLA+
Sbjct: 366 DKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNENGQDLYVRLAS 425

Query: 449 SDIGDGANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLL 508
           S+I                                   L R+  +   R   E       
Sbjct: 426 SEI---------------------------------ETLQRESSRVSSRKQEE------- 445

Query: 509 NQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQE 568
                           +DLELP  D +T+  AT  F+  NKLGQGGFG VYKG L  GQE
Sbjct: 446 ----------------EDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQE 489

Query: 569 IAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSV 628
           +AVKRLSR S QG+EEFKNE++LIAKLQHRNLV++LG CV+ +E+ML+YEY  N+SLDS 
Sbjct: 490 VAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSF 549

Query: 629 IFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDF 688
           IFDK R   L+W +R  II GIARG+LYLH+DSR RIIHRDLKASN+LLD +M  KISDF
Sbjct: 550 IFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDF 609

Query: 689 GMARIFGGDQTEQNTKRVVGT 709
           G+AR  GGD+TE NT RVVGT
Sbjct: 610 GLARTLGGDETEANTTRVVGT 630

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3

 Score =  614 bits (1584), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 321/674 (47%), Positives = 430/674 (63%), Gaps = 29/674 (4%)

Query: 55  ISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDD 114
           ISVDT+   Q+L  G+ ++S+   F  GFFS G S   Y+GIWY  I+Q+T VWVANRD 
Sbjct: 17  ISVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDH 76

Query: 115 PLANSSGVLRIINQ---RIGLFDGSQNLVWSSNQTKAT---NPVAQLQDSGNFVLKEAGS 168
           P+ ++SG+++  N+    +   D    L+WS+N + +      VA L D GN VL +  +
Sbjct: 77  PINDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVT 136

Query: 169 DEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGF 228
               W+SFD+PTDT LP M++G+  K G +  LTSWKS  DP +GD   +++  GFP+  
Sbjct: 137 GRSFWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQLI 196

Query: 229 LWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIV 288
           L+      +R G W G R+SGVPEM PI  I    F++ + +V +++ + + ++ +R +V
Sbjct: 197 LYKGVTPWWRMGSWTGHRWSGVPEM-PIGYIFNNSFVNNEDEVSFTYGVTDASVITRTMV 255

Query: 289 SPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPV--CQCMRGFEPK 346
           +  G + RFTWI  +K WN FW  PK+QCDNY  CGP G CD+ +S    C C+ GFEPK
Sbjct: 256 NETGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGFEPK 315

Query: 347 DPQAWSLRDGSGGCVRKTELQ-CSE-DKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSR 404
            P+ W LRD SGGC +K     CSE D F++LK MK+PDT+ + VD N+TLKEC+  C +
Sbjct: 316 FPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQRCLK 375

Query: 405 NCSCTAYANT---NITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDI------GDGA 455
           NCSC AYA+    +  G  GC+ W G + D R Y   GQD Y+R+   ++      G   
Sbjct: 376 NCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDFYIRVDKEELARWNRNGLSG 435

Query: 456 NATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISS 515
               ++I +++ +A+++L ++   + R +    R         H   S +          
Sbjct: 436 KRRVLLILISLIAAVMLLTVILFCVVRERRKSNR---------HRSSSANFAPVPFDFDE 486

Query: 516 KRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLS 575
              +  DK  + ELPLFD  TIV AT+NF+  NKLG GGFG VYKG L    EIAVKRLS
Sbjct: 487 SFRFEQDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLS 546

Query: 576 RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARS 635
           RNSGQG+EEFKNEV+LI+KLQHRNLVR+LGCCVE++EKMLVYEY+ N+SLD  IF + + 
Sbjct: 547 RNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQR 606

Query: 636 SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           + L+W +R  I+ GIARG+LYLHQDSR RIIHRDLKASNILLD EM PKISDFGMARIFG
Sbjct: 607 AELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFG 666

Query: 696 GDQTEQNTKRVVGT 709
           G+Q E  T RVVGT
Sbjct: 667 GNQMEGCTSRVVGT 680

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  565 bits (1456), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 316/705 (44%), Positives = 424/705 (60%), Gaps = 54/705 (7%)

Query: 39  YTNLFLIIFILFPTIAISVDTLTATQNLTYG---KTLVSSDDVFELGFFSPGSSGKWYIG 95
           Y +LFL  F+   ++A   +T+   ++L  G   K LVS    FELGFFSPGSS   ++G
Sbjct: 10  YLSLFLYFFLYESSMA--ANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLG 67

Query: 96  IWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ-RIGLFDGSQNLVWSSNQTKAT----N 150
           IWY NI  +  VWVANR  P+++ SGVL I N   + L DG    VWSSN   +T    N
Sbjct: 68  IWYGNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNN 127

Query: 151 PVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDP 210
            V  + D+GNFVL E  +D  +W+SF++PTDT LPQM++  + +TG      SW+S  DP
Sbjct: 128 RVVSIHDTGNFVLSETDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDP 187

Query: 211 STGDNSFKLDFHGFPEGFLWN-KQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFI---- 265
           S G+ S  +D  G PE  LW   + RK+RSG WN   F+G+P M  +    + F +    
Sbjct: 188 SPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPP 247

Query: 266 DQDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGP 325
           D+   VY+++   + ++  R  V  +G  +   W E  K W  F   P  +CD Y  CG 
Sbjct: 248 DETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGK 307

Query: 326 FGICDTNASP-VCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCS------EDKFLQLKN 378
           FGICD   S  +C C+ G+E      WS      GC R+T L+C       ED+FL LK+
Sbjct: 308 FGICDMKGSNGICSCIHGYEQVSVGNWSR-----GCRRRTPLKCERNISVGEDEFLTLKS 362

Query: 379 MKLPDTTTSFVDYNMTLKE-CEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAE 437
           +KLPD      ++N+   E C   C RNCSC AY+   + GG GC+ W  +L D++++  
Sbjct: 363 VKLPDF--EIPEHNLVDPEDCRERCLRNCSCNAYS---LVGGIGCMIWNQDLVDLQQFEA 417

Query: 438 GGQDLYVRLAASDIGDGANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPR 497
           GG  L++RLA S++G+    T I + V V   ++++G+ A  LWR K       RK +  
Sbjct: 418 GGSSLHIRLADSEVGEN-RKTKIAVIVAVLVGVILIGIFALLLWRFK-------RKKDVS 469

Query: 498 GH--PERSQDLLLNQVVISSKRDYSA-----------DKTDDLELPLFDFETIVRATDNF 544
           G    + +   ++   +  SK   SA              +  ELP+F    I  AT++F
Sbjct: 470 GAYCGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDF 529

Query: 545 TDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
              N+LG+GGFG VYKG L +G+EIAVKRLS  SGQG++EFKNE+ LIAKLQHRNLVRLL
Sbjct: 530 CKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLL 589

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           GCC E +EKMLVYEYM N+SLD  +FD+ + ++++W+ RF+II GIARGLLYLH+DSR R
Sbjct: 590 GCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLR 649

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IIHRDLK SN+LLD EM PKISDFGMARIFGG+Q E NT RVVGT
Sbjct: 650 IIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGT 694

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3

 Score =  546 bits (1408), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 299/674 (44%), Positives = 431/674 (63%), Gaps = 26/674 (3%)

Query: 56  SVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDP 115
           S +T+  +Q+L  G  + S    F  GFFS G+S   Y+GIWY  ++++T VWVANRD P
Sbjct: 21  SDNTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHP 80

Query: 116 LANSSGVLRIINQRIGLFDGSQN---LVWSSN---QTKATNPVAQLQDSGNFVLKEAGSD 169
           + ++SG+++   +       S N    +WS++     +    VA+L D GN VL +  + 
Sbjct: 81  INDTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLDPVTG 140

Query: 170 EILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFL 229
           +  W+SF++PT+TLLP MK G+  ++G +  +TSW+S  DP +G+ +++++  GFP+  +
Sbjct: 141 KSFWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFPQMMM 200

Query: 230 WNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVS 289
           +      +R+G W G R+SGVPEM      N  F  + D +V  ++ + + ++ +R++++
Sbjct: 201 YKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPD-EVSITYGVLDASVTTRMVLN 259

Query: 290 PDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPV--CQCMRGFEPKD 347
             G LQRF W   +K W  FW AP+D+CD Y  CG  G CD+ ++    C C+ G+EPK 
Sbjct: 260 ETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYEPKT 319

Query: 348 PQAWSLRDGSGGCVR-KTELQCS-EDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRN 405
           P+ W LRD S GC R K +  C+ ++ F +LK +K+P+T+   VD N+TLKECE  C +N
Sbjct: 320 PRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQRCLKN 379

Query: 406 CSCTAYANT---NITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDI----GDGANAT 458
           CSC AYA+    +  G  GC+TW G + D R Y   GQD Y+R+  S++    G+GA+  
Sbjct: 380 CSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLSSGQDFYLRVDKSELARWNGNGASGK 439

Query: 459 PIIIGVTVG-SAILILGLVA--CFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISS 515
             ++ + +   A+++L L++  C+L +R+        +  P      S DL  + ++   
Sbjct: 440 KRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDSFIL--- 496

Query: 516 KRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLS 575
             +   DK+   ELPLF+  TI  AT+NF   NKLG GGFG VYKG L  G EIAVKRLS
Sbjct: 497 --EELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVKRLS 554

Query: 576 RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARS 635
           ++SGQG+EEFKNEV+LI+KLQHRNLVR+LGCCVE +EKMLVYEY+ N+SLD  IF + + 
Sbjct: 555 KSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHEEQR 614

Query: 636 SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           + L+W +R  II GI RG+LYLHQDSR RIIHRDLKASN+LLD EM PKI+DFG+ARIFG
Sbjct: 615 AELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLARIFG 674

Query: 696 GDQTEQNTKRVVGT 709
           G+Q E +T RVVGT
Sbjct: 675 GNQIEGSTNRVVGT 688

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1

 Score =  543 bits (1399), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 300/694 (43%), Positives = 417/694 (60%), Gaps = 44/694 (6%)

Query: 43  FLIIFILFPTIAISV-DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNI 101
            LI   L   ++ S  ++ T    +  G +L+S D+ FELGFF+P +S   Y+GIWYKNI
Sbjct: 14  LLIFHQLCSNVSCSTSNSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIWYKNI 73

Query: 102 AQRTYVWVANRDDPLANSSGVLRIINQ-RIGLFDGSQNLVWSSN-QTKATNPVAQLQDSG 159
             +T VWVANR+ PL +  G L+I +   + + +G    +WS+N + ++ N VA L  +G
Sbjct: 74  EPQTVVWVANREKPLLDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNNTVAVLFKTG 133

Query: 160 NFVL-KEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFK 218
           + VL  ++   +  W+SF+ PTDT LP M++  +   G       WKS  DPS G  S  
Sbjct: 134 DLVLCSDSDRRKWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPSPGKYSMG 193

Query: 219 LDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEM----KPIEGINFEFFIDQDHDVYYS 274
           +D  G  E  +W  ++RK+RSGPWN   F+G+P+M      I G       D+D  VY++
Sbjct: 194 IDPVGALEIVIWEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVYFT 253

Query: 275 FFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNA- 333
           +   + + F R  + PDG  ++F W +  + WN   + P  +C+ Y  CG + +CD +  
Sbjct: 254 YVASDSSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYSVCDDSKE 313

Query: 334 --SPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCS-------EDKFLQLKNMKLPDT 384
             S  C C+ GFEP     W+ RD SGGC R+  L C+       ED F  LK +K+PD 
Sbjct: 314 FDSGKCSCIDGFEPVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVLKGIKVPDF 373

Query: 385 TTSFVDYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEGGQDLYV 444
            +  +  N   + C+  C+R+CSC AYA   +  G GC+ WT +L D+  +  GG  + +
Sbjct: 374 GSVVLHNNS--ETCKDVCARDCSCKAYA---LVVGIGCMIWTRDLIDMEHFERGGNSINI 428

Query: 445 RLAASDIGDGA-NATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERS 503
           RLA S +G G  N+T  II  +V  A L LGL    LW+ K  L         +    + 
Sbjct: 429 RLAGSKLGGGKENSTLWIIVFSVIGAFL-LGLCIWILWKFKKSL---------KAFLWKK 478

Query: 504 QDLLLNQVVISSKRDYSA--------DKTDDLELPLFDFETIVRATDNFTDYNKLGQGGF 555
           +D+ ++ ++    RDYS+        D+ D  +LP+F F+++  AT +F + NKLGQGGF
Sbjct: 479 KDITVSDII--ENRDYSSSPIKVLVGDQVDTPDLPIFSFDSVASATGDFAEENKLGQGGF 536

Query: 556 GIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML 615
           G VYKG   EG+EIAVKRLS  S QG+EEFKNE+ LIAKLQHRNLVRLLGCC+E +EKML
Sbjct: 537 GTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKML 596

Query: 616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNI 675
           +YEYM N+SLD  +FD+++   L+W++R+ +I GIARGLLYLH+DSR +IIHRDLKASNI
Sbjct: 597 LYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNI 656

Query: 676 LLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           LLD EM PKISDFGMARIF   Q   NT RVVGT
Sbjct: 657 LLDTEMNPKISDFGMARIFNYRQDHANTIRVVGT 690

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	709
224076591	834	predicted protein [Populus trichocarpa]	0.921	0.782	0.711	0.0
255555127	834	S-locus-specific glycoprotein S6 precurs	0.949	0.806	0.685	0.0
224114151	831	predicted protein [Populus trichocarpa]	0.937	0.800	0.677	0.0
359496546	866	PREDICTED: receptor-like serine/threonin	0.952	0.779	0.654	0.0
16040952	838	receptor kinase 5 [Brassica rapa]	0.929	0.786	0.618	0.0
1783312	847	receptor-like kinase [Brassica oleracea	0.933	0.781	0.614	0.0
2181188	847	serine /threonine kinase [Brassica olera	0.933	0.781	0.614	0.0
157086542	850	At4g21380 [Arabidopsis thaliana]	0.925	0.771	0.627	0.0
913141	851	ARK3 product/receptor-like serine/threon	0.925	0.770	0.626	0.0
15234427	850	receptor kinase 3 [Arabidopsis thaliana]	0.925	0.771	0.626	0.0

>gi|224076591|ref|XP_002304966.1| predicted protein [Populus trichocarpa] gi|222847930|gb|EEE85477.1| predicted protein [Populus trichocarpa]

 Score =  975 bits (2521), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 470/661 (71%), Positives = 547/661 (82%), Gaps = 8/661 (1%)

Query: 53  IAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANR 112
            A S+DTLTATQ+L  G+TL+S+   FELGFF+PG+S  WY+GIWYKNI  RTYVWVANR
Sbjct: 24  FASSLDTLTATQSLINGQTLISTSQGFELGFFTPGNSRNWYVGIWYKNIP-RTYVWVANR 82

Query: 113 DDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKE--AGSDE 170
           D PL+NSSG  +I NQ I LFD +  +VWSSNQT A NPV QL DSGN VLKE  + S +
Sbjct: 83  DKPLSNSSGTFKIFNQSIALFDLAGKVVWSSNQTNARNPVMQLLDSGNLVLKEQVSESGQ 142

Query: 171 ILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLW 230
            LWQSFDYPTDTLLP MK+GWDL TG + YL+SWKS++DP TGD SFKL++HGFPE FLW
Sbjct: 143 FLWQSFDYPTDTLLPDMKLGWDLNTGLDRYLSSWKSSEDPGTGDFSFKLEYHGFPEVFLW 202

Query: 231 NKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVSP 290
              E +YRSGPWNG RFSGVPEMKP++ ++F F  +QD +VYYSF I  KNL+SRL V+ 
Sbjct: 203 KDNEIEYRSGPWNGQRFSGVPEMKPVDYLSFNFITEQD-EVYYSFHIATKNLYSRLTVTS 261

Query: 291 DGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDPQA 350
            G LQRF WI   + WN FWYAPKDQCDNY ECG +GICD+NASPVC+C++GF+PK+ QA
Sbjct: 262 SGLLQRFAWIPETQQWNKFWYAPKDQCDNYKECGAYGICDSNASPVCKCLKGFQPKNHQA 321

Query: 351 WSLRDGSGGCVRKTELQCSEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTA 410
           W LRDGSGGCVRKT L+C +DKFL +KNMKLP +TTSFVD +M+LK CE  CSRNCSCTA
Sbjct: 322 WDLRDGSGGCVRKTNLECLKDKFLHMKNMKLPQSTTSFVDRSMSLKNCELLCSRNCSCTA 381

Query: 411 YANTNIT-GGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIIIGVTVGSA 469
           YAN+NI+ GG+GCV WTGEL D+R+Y EGGQDLYVRLAASDIGDG +A  III + VG  
Sbjct: 382 YANSNISNGGSGCVIWTGELFDLRQYPEGGQDLYVRLAASDIGDGGSADTIIICIAVGIG 441

Query: 470 ILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDYSADK-TDDLE 528
           ILIL L    +W+RK LL      T+ +G  ERSQDLLLN+VVI+ K+DYS +K TD+LE
Sbjct: 442 ILILSLTGFSIWKRKRLLS-VCNGTQQKGPQERSQDLLLNEVVIN-KKDYSGEKSTDELE 499

Query: 529 LPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNE 588
           LPLFDF TI  AT NF D NKLG+GGFG V+KGRL+EGQE+AVKRLS+ SGQG EEFKNE
Sbjct: 500 LPLFDFSTIAAATGNFCDENKLGEGGFGCVHKGRLVEGQEVAVKRLSKKSGQGTEEFKNE 559

Query: 589 VRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC 648
           VRLIA+LQHRNLVRLLGCC+EMDEK+L+YE+MENRSLDSV+F+KA+SS+LNWQRRFNIIC
Sbjct: 560 VRLIARLQHRNLVRLLGCCIEMDEKILIYEFMENRSLDSVLFNKAKSSLLNWQRRFNIIC 619

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
           G ARGLLYLHQDSRFRIIHRDLKASNILLD E TPKISDFGMARIFGGDQT+ NT+R+VG
Sbjct: 620 GTARGLLYLHQDSRFRIIHRDLKASNILLDGEWTPKISDFGMARIFGGDQTQANTRRIVG 679

Query: 709 T 709
           T
Sbjct: 680 T 680

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255555127|ref|XP_002518601.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223542446|gb|EEF43988.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis]

 Score =  971 bits (2511), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 471/687 (68%), Positives = 558/687 (81%), Gaps = 14/687 (2%)

Query: 30  MNDITSHPCYTNLFLII-FILF--PTIAISVDTLTATQNLTYGKTLVSSDDVFELGFFSP 86
           M  IT    +  +FL   F+ F  P  + S DTLT+TQ+L  G+TL+S+   FELGFF+P
Sbjct: 1   MKGITRRNHFNPIFLFFTFLSFYAPRFSFSSDTLTSTQSLINGQTLLSTRQKFELGFFTP 60

Query: 87  GSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQT 146
           G+S  WY+GIWYKNI+ RTYVWVANRD+PL NSSG+ +I NQ I LFD   NL+WSSNQ 
Sbjct: 61  GNSKNWYVGIWYKNISDRTYVWVANRDNPLTNSSGIFKIFNQSIVLFDQGNNLIWSSNQI 120

Query: 147 KATNPVAQLQDSGNFVLKEAG-SDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWK 205
           KATNPV QL D+G+ VL+EA  +++ LWQSFDYPTDTLLP MK+GWDL      YL+SWK
Sbjct: 121 KATNPVMQLLDTGDLVLREANVNNQYLWQSFDYPTDTLLPDMKLGWDLNKSLHRYLSSWK 180

Query: 206 STDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFI 265
           S DDP  GD SFKLD+HGFPE FLWN   + YRSGPWNG+RFSGVPEMKP++ I+F+F  
Sbjct: 181 SKDDPGAGDYSFKLDYHGFPEIFLWNDGRKIYRSGPWNGLRFSGVPEMKPLDYISFDFVT 240

Query: 266 DQDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGP 325
           +Q  +V+YSF I + + +SRL V+  G LQR+TWI   + WN FWYAPKDQCD+Y ECGP
Sbjct: 241 NQS-EVFYSFHISSNSTYSRLTVTSSGELQRYTWIPERQDWNSFWYAPKDQCDDYKECGP 299

Query: 326 FGICDTNASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSEDKFLQLKNMKLPDTT 385
           +GICD+NASPVC+CMRGFEPK+ QAW+LRDGSGGCVRKT+LQC  DKFL LKN+KLP+++
Sbjct: 300 YGICDSNASPVCKCMRGFEPKNLQAWNLRDGSGGCVRKTDLQCMNDKFLHLKNIKLPESS 359

Query: 386 TSFVDYNMTLKECEAFCSRNCSCTAYANTNIT-GGTGCVTWTGELKDIRKYAEGG-QDLY 443
           TSFVD  ++LK CE  C RNCSCTAYAN++I+ GGTGCV W GEL D+R+Y EGG QDLY
Sbjct: 360 TSFVDRIISLKICEELCLRNCSCTAYANSDISNGGTGCVLWFGELLDMRQYTEGGGQDLY 419

Query: 444 VRLAASDIGDGANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERS 503
           VRLAASDIGDG N   +IIG++VG   L+LGL ACF+W+R     R +RK E +G  ERS
Sbjct: 420 VRLAASDIGDGKNVAALIIGISVGIGTLLLGLAACFIWKR-----RSVRK-EQKGVQERS 473

Query: 504 QDLLLNQVVISSKRDYSADK-TDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGR 562
           Q+LLLN+VVISSKRDYS +K  D+LELPLFDF TI  ATDNF+D NKLGQGGFG VYKGR
Sbjct: 474 QNLLLNEVVISSKRDYSGEKDKDELELPLFDFGTIATATDNFSDENKLGQGGFGCVYKGR 533

Query: 563 LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN 622
           L+EGQ +AVKRLS+ S QGIEEFKNEV LIA+LQHRNLVRLLGCC+E +EK+L+YEYME+
Sbjct: 534 LVEGQVVAVKRLSKTSVQGIEEFKNEVNLIARLQHRNLVRLLGCCIETNEKVLIYEYMEH 593

Query: 623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT 682
           RSLDSVIF+ A+ S+LNWQRRFNI+CGIARGLLY+HQDSRFRIIHRDLKASNILLD E  
Sbjct: 594 RSLDSVIFNNAKRSLLNWQRRFNIVCGIARGLLYMHQDSRFRIIHRDLKASNILLDGEWN 653

Query: 683 PKISDFGMARIFGGDQTEQNTKRVVGT 709
           PKISDFGMARIFGGDQTE +TKRVVGT
Sbjct: 654 PKISDFGMARIFGGDQTEASTKRVVGT 680

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224114151|ref|XP_002316682.1| predicted protein [Populus trichocarpa] gi|222859747|gb|EEE97294.1| predicted protein [Populus trichocarpa]

 Score =  930 bits (2404), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 463/683 (67%), Positives = 554/683 (81%), Gaps = 18/683 (2%)

Query: 34  TSHPC--YTNLFLIIFILFPT-IAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSG 90
           T H C   T LF  I   F +  A S+DTLTAT++L  G+TL+S+   FELGFF+PG+S 
Sbjct: 6   TRHHCSITTLLFFTILSFFTSKFASSLDTLTATESLVNGQTLISTSQDFELGFFTPGNSR 65

Query: 91  KWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATN 150
            WY+GIWYKNI  RTYVWVANRD+PL NSSG  +I+NQ I LFD ++NL+WSSNQT A N
Sbjct: 66  NWYVGIWYKNIP-RTYVWVANRDNPLTNSSGTFKILNQSIVLFDRAENLIWSSNQTNARN 124

Query: 151 PVAQLQDSGNFVLKEAGSD--EILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTD 208
           PV QL DSGN VL++  SD  + LWQSFDYPTDTLLP MK GWDL TG   +L SWKS+D
Sbjct: 125 PVMQLLDSGNLVLRDQESDSGQFLWQSFDYPTDTLLPDMKFGWDLNTGVNRFLRSWKSSD 184

Query: 209 DPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQD 268
           DP TGD SFKL++HGFPE FL   QE KYRSGPWNG RFSGVPEM+P++ ++F F  +QD
Sbjct: 185 DPGTGDFSFKLEYHGFPEAFLLKDQEIKYRSGPWNGQRFSGVPEMEPVDYMSFNFITNQD 244

Query: 269 HDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGI 328
            +VYYSF I NK+L+SRL V+  G LQRF W+   + W+ FWYAPKDQCD+Y ECGP+GI
Sbjct: 245 -EVYYSFHISNKSLYSRLSVTSSGLLQRFAWVPETQQWSQFWYAPKDQCDDYRECGPYGI 303

Query: 329 CDTNASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSEDKFLQLKNMKLPDTTTSF 388
           CD+NASPVC+CM+GF+PK+ QAW+LRDGS GCVR+T+L C +DKFL ++NMKLP++ T++
Sbjct: 304 CDSNASPVCKCMKGFQPKNIQAWNLRDGSSGCVRRTDLNCLKDKFLHMRNMKLPESETTY 363

Query: 389 VDYNMTLKECEAFCSRNCSCTAYANTNIT-GGTGCVTWTGELKDIRKYAEGGQDLYVRLA 447
           VD NM+LK+CE  CSRNCSCTAYAN+NI+ GG+GCV WTGEL D+R+Y +GGQDLYVRLA
Sbjct: 364 VDRNMSLKDCELMCSRNCSCTAYANSNISNGGSGCVFWTGELFDMRQYPKGGQDLYVRLA 423

Query: 448 ASDIGDGANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLL 507
           ASDIGDG++A  IIIG+ VG  ILIL L    +W+RK LL        P+   +RSQD L
Sbjct: 424 ASDIGDGSSAGTIIIGIAVGIGILILALSGFSIWKRKRLLS-----VCPQ---DRSQDFL 475

Query: 508 LNQVVISSKRDYSADKT-DDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEG 566
           LN VVIS K+DY+ +++ D+LELPL DF TI  AT+NF D NKLG+GGFG V+KGRL+EG
Sbjct: 476 LNGVVIS-KKDYTGERSPDELELPLLDFSTIATATNNFADENKLGEGGFGRVHKGRLVEG 534

Query: 567 QEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLD 626
           QE+AVKRLS+NS QG EEFKNEVRLIA++QHRNLVRLLGCCVE DEK+L+YE+MENRSLD
Sbjct: 535 QEVAVKRLSKNSVQGTEEFKNEVRLIARVQHRNLVRLLGCCVEKDEKILIYEFMENRSLD 594

Query: 627 SVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKIS 686
            V+F+KA+SS+LNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD E TPKIS
Sbjct: 595 FVLFNKAKSSLLNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDHEWTPKIS 654

Query: 687 DFGMARIFGGDQTEQNTKRVVGT 709
           DFGMAR+FGGDQ + NT RVVGT
Sbjct: 655 DFGMARMFGGDQIQANTVRVVGT 677

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496546|ref|XP_002270295.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera]

 Score =  907 bits (2343), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 453/692 (65%), Positives = 540/692 (78%), Gaps = 17/692 (2%)

Query: 33  ITSHPCYTNLFLIIFILFPTIAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKW 92
           IT   CY  L      LFP I IS DT+TA Q++T G+TLVS+   FELGFFSPG S KW
Sbjct: 23  ITGFLCYNVLCFCFLTLFPIIVISGDTITANQSITNGQTLVSAGGDFELGFFSPGDS-KW 81

Query: 93  YIGIWYKNIAQRTYVWVANRDDP-LANSSGVLRIINQR--IGLFDGSQNLVWSSNQTKAT 149
           Y+GIWYKNI +   VWVANRD+P L NSSG +  I  R  I + D   ++ WS+N++ A 
Sbjct: 82  YVGIWYKNIPKERVVWVANRDNPILTNSSGSVVKIGDRGNIVIMDEDLHVFWSTNESTAV 141

Query: 150 NPVAQLQDSGNFVLKE---AGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKS 206
           NPVAQL D+GN V++E   A  +  LWQSFDY TDTLLP MK+GWD KTG   YLTSWKS
Sbjct: 142 NPVAQLLDTGNLVVREDKDADPENYLWQSFDYLTDTLLPGMKLGWDQKTGSNRYLTSWKS 201

Query: 207 TDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFID 266
            +DPS+GD SFKLD  GFPE F+WNKQE+KYRSGPWNGVRFSGVPEMK      F+F  +
Sbjct: 202 KEDPSSGDYSFKLDPRGFPEIFIWNKQEKKYRSGPWNGVRFSGVPEMKSSSVFTFDFEWN 261

Query: 267 QDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPF 326
           QD   YYS+ + NK++ SRL+VS  G LQR+TWIE  ++WN +W+APKDQCD+Y ECGP+
Sbjct: 262 QD-GAYYSYELTNKSITSRLMVSSAGSLQRYTWIETRQVWNLYWFAPKDQCDDYRECGPY 320

Query: 327 GICDTNASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSE-DKFLQLKNMKLPDTT 385
           GICDTN+SPVC+C RGFEPK+PQAW+LRDGS GC RKTE  C+  D FL LK MKLP+T 
Sbjct: 321 GICDTNSSPVCKCPRGFEPKNPQAWNLRDGSDGCSRKTEFDCNNGDGFLALKRMKLPETG 380

Query: 386 TSFVDYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEG--GQDLY 443
           +SFVD +M+LK+CE  C +NCSCT YAN  IT   GC+ WT +L D+R+YAEG  GQDLY
Sbjct: 381 SSFVDKSMSLKDCEMTCRKNCSCTGYANPEITSDKGCIIWTTDLLDMREYAEGEGGQDLY 440

Query: 444 VRLAASDIG--DGANATPIIIGVT---VGSAILILGLVACFLWRRKTLLGRQIRKTEPRG 498
           +R+AAS++G  +G+N T  II VT   VGSA+L+LGL  C+LW+RK +           G
Sbjct: 441 IRVAASELGSENGSNKTVKIIKVTCITVGSAVLLLGLGICYLWKRKKMKIIVAHIVSKPG 500

Query: 499 HPERSQDLLLNQVVISSKRDYSAD-KTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGI 557
             ERS D +LN+ VI SKRDY+ + KTD+LELPLFDF TIV AT+NF+D NKLGQGGFG 
Sbjct: 501 LSERSHDYILNEAVIPSKRDYTDEVKTDELELPLFDFGTIVLATNNFSDTNKLGQGGFGC 560

Query: 558 VYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY 617
           VYKG LLEG+EIAVKRL++NSGQGIEEF NEVRLIA+LQHRNLV+LLGCCVEM+EKML+Y
Sbjct: 561 VYKGMLLEGEEIAVKRLAKNSGQGIEEFMNEVRLIARLQHRNLVQLLGCCVEMEEKMLIY 620

Query: 618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL 677
           EYM+NRSLDS++FD+ +SS+L+W RRFNIICG+ARGLLYLHQDSRFRIIHRDLKASN+LL
Sbjct: 621 EYMQNRSLDSILFDEKKSSLLDWGRRFNIICGVARGLLYLHQDSRFRIIHRDLKASNVLL 680

Query: 678 DKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           D EM PKISDFGMARIFG DQTE NTKRVVGT
Sbjct: 681 DGEMNPKISDFGMARIFGRDQTEANTKRVVGT 712

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|16040952|dbj|BAB69683.1| receptor kinase 5 [Brassica rapa]

 Score =  855 bits (2208), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 423/684 (61%), Positives = 517/684 (75%), Gaps = 25/684 (3%)

Query: 42  LFLIIFILFPTIAISVDTLTATQNLTYG--KTLVSSDDVFELGFFSPGSSGKWYIGIWYK 99
           +   + +LFP  + S +TL+AT++LT    KT+ S  ++FELGFF P SS +WY+GIWYK
Sbjct: 4   VLFSVLLLFPAFSFSANTLSATESLTISSNKTISSPGNIFELGFFKPSSSSRWYLGIWYK 63

Query: 100 NIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNP----VAQL 155
            I++RTYVWVANRD PL+ S+G L+I +  + + DGS   VWS+N T   +     VA+L
Sbjct: 64  AISKRTYVWVANRDHPLSTSTGTLKISDSNLVVVDGSDTAVWSTNLTGGGDVRSPVVAEL 123

Query: 156 QDSGNFVLKEAGS---DEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPST 212
            D+GN VL+++ +   D +LWQSFD+PTDTLLP+MK+GWDLKTGF  +L SWKS DDPS+
Sbjct: 124 LDNGNLVLRDSNNNDPDGVLWQSFDFPTDTLLPEMKLGWDLKTGFNRFLRSWKSPDDPSS 183

Query: 213 GDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVY 272
           GD SFKL+  GFPE FLWNK  + YRSGPWNG+RFSGVPEM+P + I F F    + +V 
Sbjct: 184 GDYSFKLETRGFPEAFLWNKASQVYRSGPWNGIRFSGVPEMQPFDYIEFNF-TTSNQEVT 242

Query: 273 YSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTN 332
           YSF I   N++SRL +S  G LQRFTWIEA + WN FWYAPKDQCD Y ECG FG CD+N
Sbjct: 243 YSFHITKDNMYSRLSLSSTGSLQRFTWIEAIQNWNQFWYAPKDQCDEYKECGTFGYCDSN 302

Query: 333 ASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSE-DKFLQLKNMKLPDTTTSFVDY 391
             PVC CMRGFEP++PQAW+LRDGS GCVRKT L C+  D F++LK MKLPDT  + VD 
Sbjct: 303 TYPVCNCMRGFEPRNPQAWALRDGSDGCVRKTALSCNGGDGFVRLKKMKLPDTAATSVDR 362

Query: 392 NMTLKECEAFCSRNCSCTAYANTNITGG-TGCVTWTGELKDIRKYAEGGQDLYVRLAASD 450
            + +KECE  C  +C+CTA+ANT+I GG +GCV WTG++ D R YA+GGQDLYVRLAA+D
Sbjct: 363 GIGIKECEEKCKSDCNCTAFANTDIRGGGSGCVVWTGDILDTRNYAKGGQDLYVRLAATD 422

Query: 451 IGDGANATPIIIGVTVGSAILILGLVACFL----WRRKTLLGRQIRKTEPRGHPERSQDL 506
           + D  N    IIG  +G ++L+L    CF+    W+RK     Q R         RSQDL
Sbjct: 423 LEDTTNRNAKIIGSCIGVSVLLL---LCFIFYRFWKRK-----QKRSIAIETSFVRSQDL 474

Query: 507 LLNQVVISSKRDYS-ADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE 565
           L+N+VVI S+R  S  +KTDD ELPL DFE +  ATDNFT+ NKLGQGGFGIVYKGRLL+
Sbjct: 475 LMNEVVIPSRRHISRENKTDDFELPLMDFEAVAIATDNFTNANKLGQGGFGIVYKGRLLD 534

Query: 566 GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL 625
           GQEIAVKRLS+ S QG +EFKNEV+LIA+LQH NLVRLLGCCV+  EKML+YEY+EN SL
Sbjct: 535 GQEIAVKRLSKMSVQGTDEFKNEVKLIARLQHINLVRLLGCCVDEGEKMLIYEYLENLSL 594

Query: 626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKI 685
           DS +FDK RS  LNWQ+RF+I  GIARGLLYLHQDSRFRIIHRDLKASN+LLDK+MTPKI
Sbjct: 595 DSHLFDKTRSCKLNWQKRFDITNGIARGLLYLHQDSRFRIIHRDLKASNVLLDKDMTPKI 654

Query: 686 SDFGMARIFGGDQTEQNTKRVVGT 709
           SDFGMARIFG D+TE NT++VVGT
Sbjct: 655 SDFGMARIFGRDETEANTRKVVGT 678

Source: Brassica rapa

Species: Brassica rapa

Genus: Brassica

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|1783312|emb|CAA67145.1| receptor-like kinase [Brassica oleracea var. acephala]

 Score =  853 bits (2204), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 421/685 (61%), Positives = 519/685 (75%), Gaps = 23/685 (3%)

Query: 42  LFLIIFILFPTIAISVDTLTATQNLTYG--KTLVSSDDVFELGFFSPGSSGKWYIGIWYK 99
           +   + +LFP  + S +TL+AT++LT    KT+ S  ++FELGFF P SS +WY+GIWYK
Sbjct: 9   VLFSVLLLFPAFSFSANTLSATESLTISSNKTISSPGNIFELGFFKPSSSSRWYLGIWYK 68

Query: 100 NIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNP----VAQL 155
            I++RTYVWVANRD PL+ S+G L+I +  + + DGS   VWS+N T   +     VA+L
Sbjct: 69  AISKRTYVWVANRDHPLSTSTGTLKISDSNLVVVDGSDTAVWSTNLTGGGDVRSPVVAEL 128

Query: 156 QDSGNFVLKEAGSDE---ILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPST 212
            D+GNFVL+++ +++   +LWQSFD+PTDTLLP+MK+GWDLKTGF W+L SWKS DDPS+
Sbjct: 129 LDNGNFVLRDSNNNDPDIVLWQSFDFPTDTLLPEMKLGWDLKTGFNWFLRSWKSPDDPSS 188

Query: 213 GDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVY 272
           GD SFKL   GFPE FLWNK  + YRSGPWNG+RFSGVPEM+P + I F F    + +V 
Sbjct: 189 GDYSFKLKTRGFPEAFLWNKASQVYRSGPWNGIRFSGVPEMQPFDYIEFNF-TTSNQEVT 247

Query: 273 YSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTN 332
           YSF I   N++SRL +S  G LQRFTWIEA + WN FWYAPKDQCD+Y ECG +G CD+N
Sbjct: 248 YSFHITKDNMYSRLSLSSTGSLQRFTWIEAIQNWNQFWYAPKDQCDDYKECGTYGYCDSN 307

Query: 333 ASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSE-DKFLQLKNMKLPDTTTSFVDY 391
             PVC CMRGFEP++PQAW LRDGS GCVRKT L C+  D F++LK MKLPDT  + VD 
Sbjct: 308 TYPVCNCMRGFEPRNPQAWGLRDGSDGCVRKTALSCNGGDGFVRLKKMKLPDTAATSVDR 367

Query: 392 NMTLKECEAFCSRNCSCTAYANTNITGG-TGCVTWTGELKDIRKYAEGGQDLYVRLAASD 450
            + +KECE  C  +C+CTA+ANT+I GG +GCV WTG++ D R YA+GGQDLYVRLAA+D
Sbjct: 368 GIGIKECEEKCKSDCNCTAFANTDIRGGGSGCVVWTGDILDTRNYAKGGQDLYVRLAATD 427

Query: 451 IGDGANATPIIIGVTVGSAILILGLVACFL----WRRKTLLGRQIRKTEPRGHPERSQDL 506
           + D  N    IIG  +G ++L+L    CF+    W+RK    R I          RSQDL
Sbjct: 428 LEDTTNRNAKIIGSCIGVSVLLL---LCFIFYRFWKRKQ--KRSIAIETSFVDQVRSQDL 482

Query: 507 LLNQVVISSKRDYSA--DKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLL 564
           L+N+VVI   R + +  +KTDDLELPL DFE +  ATDNF++ NKLGQGGFGIVYKGRLL
Sbjct: 483 LMNEVVIPPNRRHISRENKTDDLELPLMDFEAVAIATDNFSNANKLGQGGFGIVYKGRLL 542

Query: 565 EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRS 624
           +GQEIAVKRLS+ S QG +EFKNEV+LIA+LQH NLVRLLGCCV+  EKML+YEY+EN S
Sbjct: 543 DGQEIAVKRLSKMSVQGTDEFKNEVKLIARLQHINLVRLLGCCVDEGEKMLIYEYLENLS 602

Query: 625 LDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK 684
           LDS +FDK RS  LNWQ+RF+I  GIARGLLYLHQDSRFRIIHRDLKASN+LLDK+MTPK
Sbjct: 603 LDSHLFDKTRSCKLNWQKRFDITNGIARGLLYLHQDSRFRIIHRDLKASNVLLDKDMTPK 662

Query: 685 ISDFGMARIFGGDQTEQNTKRVVGT 709
           ISDFGMARIFG D+TE NT++VVGT
Sbjct: 663 ISDFGMARIFGRDETEANTRKVVGT 687

Source: Brassica oleracea var. acephala

Species: Brassica oleracea

Genus: Brassica

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|2181188|emb|CAA73133.1| serine /threonine kinase [Brassica oleracea]

 Score =  852 bits (2200), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 421/685 (61%), Positives = 518/685 (75%), Gaps = 23/685 (3%)

Query: 42  LFLIIFILFPTIAISVDTLTATQNLTYG--KTLVSSDDVFELGFFSPGSSGKWYIGIWYK 99
           +   + +LFP  + S +TL+AT++LT    KT+ S  ++FELGFF P SS +WY+GIWYK
Sbjct: 9   VLFSVLLLFPAFSFSSNTLSATESLTISSNKTISSPGNIFELGFFKPSSSSRWYLGIWYK 68

Query: 100 NIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNP----VAQL 155
            I++RTYVWVANRD PL+ S+G L+I +  + + DGS   VWS+N T   +     VA+L
Sbjct: 69  AISKRTYVWVANRDHPLSTSTGTLKISDSNLVVVDGSDTAVWSTNLTGGGDVRSPVVAEL 128

Query: 156 QDSGNFVLKEAGSDE---ILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPST 212
            D+GNFVL+++ +++   +LWQSFD+PTDTLLP+MK+GWDLKTGF W+L SWKS DDPS+
Sbjct: 129 LDNGNFVLRDSNNNDPDIVLWQSFDFPTDTLLPEMKLGWDLKTGFNWFLRSWKSPDDPSS 188

Query: 213 GDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVY 272
           GD SFKL   GFPE FLWNK  + YRSGPWNG+RFSGVPEM+P + I F F    + +V 
Sbjct: 189 GDYSFKLKTRGFPEAFLWNKASQVYRSGPWNGIRFSGVPEMQPFDYIEFNF-TTSNQEVT 247

Query: 273 YSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTN 332
           YSF I   N++SRL +S  G LQRFTWIEA + WN FWYAPKDQCD+Y ECG +G CD+N
Sbjct: 248 YSFHITKDNMYSRLSLSSTGSLQRFTWIEAIQNWNQFWYAPKDQCDDYKECGTYGYCDSN 307

Query: 333 ASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSE-DKFLQLKNMKLPDTTTSFVDY 391
             PVC CMRGFEP++PQAW LRDGS GCVRKT L C+  D F++LK MKLPDT  + VD 
Sbjct: 308 TYPVCNCMRGFEPRNPQAWGLRDGSDGCVRKTALSCNGGDGFVRLKKMKLPDTAATSVDR 367

Query: 392 NMTLKECEAFCSRNCSCTAYANTNITGG-TGCVTWTGELKDIRKYAEGGQDLYVRLAASD 450
            + +KECE  C  +C+CTA+ANT+I GG +GCV WTG++ D R YA+GGQDLYVRLAA+D
Sbjct: 368 GIGIKECEEKCKSDCNCTAFANTDIRGGGSGCVVWTGDILDTRNYAKGGQDLYVRLAATD 427

Query: 451 IGDGANATPIIIGVTVGSAILILGLVACFL----WRRKTLLGRQIRKTEPRGHPERSQDL 506
           + D  N    IIG  +G ++L+L    CF+    W+RK    R I          RSQDL
Sbjct: 428 LEDTTNRNAKIIGSCIGVSVLLL---LCFIFYRFWKRKQ--KRSIAIETSFVDQVRSQDL 482

Query: 507 LLNQVVISSKRDYSA--DKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLL 564
           L+N+VVI   R + +  +KTDDLELPL DFE +  ATDNF++ NKLGQGGFGIVYKGRLL
Sbjct: 483 LMNEVVIPPNRRHISRENKTDDLELPLMDFEAVAIATDNFSNANKLGQGGFGIVYKGRLL 542

Query: 565 EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRS 624
           +GQEIAVKRLS+ S QG +EFKNEV+LIA+LQH NLVRLLGCCV+  EKML+YEY+EN S
Sbjct: 543 DGQEIAVKRLSKMSVQGTDEFKNEVKLIARLQHINLVRLLGCCVDEGEKMLIYEYLENLS 602

Query: 625 LDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK 684
           LDS +FDK RS  LNWQ+RF I  GIARGLLYLHQDSRFRIIHRDLKASN+LLDK+MTPK
Sbjct: 603 LDSHLFDKTRSCKLNWQKRFVITNGIARGLLYLHQDSRFRIIHRDLKASNVLLDKDMTPK 662

Query: 685 ISDFGMARIFGGDQTEQNTKRVVGT 709
           ISDFGMARIFG D+TE NT++VVGT
Sbjct: 663 ISDFGMARIFGRDETEANTRKVVGT 687

Source: Brassica oleracea

Species: Brassica oleracea

Genus: Brassica

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|157086542|gb|ABV21214.1| At4g21380 [Arabidopsis thaliana]

 Score =  849 bits (2194), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 422/672 (62%), Positives = 521/672 (77%), Gaps = 16/672 (2%)

Query: 51  PTIAISVDTLTATQNLTYGK--TLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVW 108
           P  +IS +TL+A+++LT     T+VS  +VFELGFF PG   +WY+GIWYK I++RTYVW
Sbjct: 23  PAYSISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVW 82

Query: 109 VANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQT--KATNP-VAQLQDSGNFVLKE 165
           VANRD PL++S G L+I +  + + D S   VWS+N T     +P VA+L D+GNFVL++
Sbjct: 83  VANRDTPLSSSIGTLKIFDSNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD 142

Query: 166 A---GSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFH 222
           +    SD  LWQSFD+PTDTLLP+MK+GWD KTGF  ++ SWKS DDPS+GD SFKL+  
Sbjct: 143 SKNNDSDGFLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETE 202

Query: 223 GFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNL 282
           GFPE FLWN++ R YRSGPWNG+RFSGVPEM+P E + F F   ++ +V YSF +   ++
Sbjct: 203 GFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKE-EVTYSFRVTKSDV 261

Query: 283 FSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRG 342
           +SRL +S  G LQRFTWIE  + WN FWYAPKDQCD Y ECG +G CD+N SPVC C++G
Sbjct: 262 YSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKG 321

Query: 343 FEPKDPQAWSLRDGSGGCVRKTELQCSE-DKFLQLKNMKLPDTTTSFVDYNMTLKECEAF 401
           F+P++PQ W LRDGS GCVRKT L C   D F++LK MKLPDTTT+ VD  + +KECE  
Sbjct: 322 FKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQK 381

Query: 402 CSRNCSCTAYANTNITG-GTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPI 460
           C R+C+CTA+ANT+I G G+GCVTWTGEL DIR YA+GGQDLYVRLAA+D+ D  N +  
Sbjct: 382 CLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLEDKRNRSAK 441

Query: 461 IIGVTVG-SAILILGLVACFLWRRKTLLGRQIRKTEP-RGHPERSQDLLLNQVVISSKRD 518
           IIG ++G S +L+LG +  FLW+RK    R I    P   H  RS+DLL+N+VVISS+R 
Sbjct: 442 IIGSSIGVSVLLLLGFIIFFLWKRKQ--KRSILIETPIVDHQVRSRDLLMNEVVISSRRH 499

Query: 519 YS-ADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN 577
            S  + TDDLELPL +FE +  AT+NF++ NKLGQGGFGIVYKG+LL+GQE+AVKRLS+ 
Sbjct: 500 ISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKT 559

Query: 578 SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI 637
           S QG +EFKNEV+LIA+LQH NLVRLL CCV+  EKML+YEY+EN SLDS +FDK+RSS 
Sbjct: 560 SVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRSSK 619

Query: 638 LNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
           LNWQ RF+II GIARGLLYLHQDSRFRIIHRDLKASNILLDK MTPKISDFGMARIFG D
Sbjct: 620 LNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRD 679

Query: 698 QTEQNTKRVVGT 709
           +TE NT++VVGT
Sbjct: 680 ETEANTRKVVGT 691

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|913141|gb|AAB33487.1| ARK3 product/receptor-like serine/threonine protein kinase ARK3 [Arabidopsis thaliana, Columbia, Peptide, 851 aa]

 Score =  847 bits (2187), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 421/672 (62%), Positives = 519/672 (77%), Gaps = 16/672 (2%)

Query: 51  PTIAISVDTLTATQNLTYGK--TLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVW 108
           P  +IS +TL+A+++LT     T+VS  +VFELGFF PG   +WY+GIWYK I++RTYVW
Sbjct: 23  PAYSISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVW 82

Query: 109 VANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQT--KATNP-VAQLQDSGNFVL-- 163
           VANRD PL++S G L+I +  + + D S   VWS+N T     +P VA+L D+GNFVL  
Sbjct: 83  VANRDTPLSSSIGTLKISDSNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD 142

Query: 164 -KEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFH 222
            K +  D +LWQSFD+PTDTLLP+MK+GWD KTGF  ++ SWKS DDPS+GD SFKL+  
Sbjct: 143 SKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETE 202

Query: 223 GFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNL 282
           GFPE FLWN++ R YRSGPWNG+RFSGVPEM+P E + F F   ++ +V YSF I   ++
Sbjct: 203 GFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKE-EVTYSFRITKSDV 261

Query: 283 FSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRG 342
           +SRL +S  G LQRFTWIE  + WN FWYAPKDQCD Y ECG +G CD+N SPVC C++G
Sbjct: 262 YSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKG 321

Query: 343 FEPKDPQAWSLRDGSGGCVRKTELQCSE-DKFLQLKNMKLPDTTTSFVDYNMTLKECEAF 401
           F+P++PQ W LRDGS GCVRKT L C   D F++LK MKLPDTTT+ VD  + +KECE  
Sbjct: 322 FKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQK 381

Query: 402 CSRNCSCTAYANTNITG-GTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPI 460
           C R+C+CTA+ANT+I G G+GCVTWTGEL DIR YA+GGQDLYVRLAA+D+ D  N +  
Sbjct: 382 CLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLEDKRNRSAK 441

Query: 461 IIGVTVG-SAILILGLVACFLWRRKTLLGRQIRKTEP-RGHPERSQDLLLNQVVISSKRD 518
           IIG ++G S +L+L  +  FLW+RK    R I    P   H  RS+DLL+N+VVISS+R 
Sbjct: 442 IIGSSIGVSVLLLLSFIIFFLWKRKQ--KRSILIETPIVDHQLRSRDLLMNEVVISSRRH 499

Query: 519 YS-ADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN 577
            S  + TDDLELPL +FE +  AT+NF++ NKLGQGGFGIVYKG+LL+GQE+AVKRLS+ 
Sbjct: 500 ISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKT 559

Query: 578 SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI 637
           S QG +EFKNEV+LIA+LQH NLVRLL CCV+  EKML+YEY+EN SLDS +FDK+R+S 
Sbjct: 560 SVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSK 619

Query: 638 LNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
           LNWQ RF+II GIARGLLYLHQDSRFRIIHRDLKASNILLDK MTPKISDFGMARIFG D
Sbjct: 620 LNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRD 679

Query: 698 QTEQNTKRVVGT 709
           +TE NT++VVGT
Sbjct: 680 ETEANTRKVVGT 691

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Class: N/A

Phylum: Streptophyta

>gi|15234427|ref|NP_193869.1| receptor kinase 3 [Arabidopsis thaliana] gi|75318808|sp|O81905.1|SD18_ARATH RecName: Full=Receptor-like serine/threonine-protein kinase SD1-8; AltName: Full=Arabidopsis thaliana receptor kinase 3; AltName: Full=S-domain-1 (SD1) receptor kinase 8; Short=SD1-8; Flags: Precursor gi|3402757|emb|CAA20203.1| receptor-like serine/threonine protein kinase ARK3 [Arabidopsis thaliana] gi|7268935|emb|CAB81245.1| receptor-like serine/threonine protein kinase ARK3 [Arabidopsis thaliana] gi|26452798|dbj|BAC43479.1| putative receptor-like serine/threonine protein kinase ARK3 [Arabidopsis thaliana] gi|29824117|gb|AAP04019.1| putative receptor serine/threonine protein kinase ARK3 [Arabidopsis thaliana] gi|332659046|gb|AEE84446.1| receptor kinase 3 [Arabidopsis thaliana]

 Score =  846 bits (2186), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 421/672 (62%), Positives = 519/672 (77%), Gaps = 16/672 (2%)

Query: 51  PTIAISVDTLTATQNLTYGK--TLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVW 108
           P  +IS +TL+A+++LT     T+VS  +VFELGFF PG   +WY+GIWYK I++RTYVW
Sbjct: 23  PAYSISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVW 82

Query: 109 VANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQT--KATNP-VAQLQDSGNFVL-- 163
           VANRD PL++S G L+I +  + + D S   VWS+N T     +P VA+L D+GNFVL  
Sbjct: 83  VANRDTPLSSSIGTLKISDSNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD 142

Query: 164 -KEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFH 222
            K +  D +LWQSFD+PTDTLLP+MK+GWD KTGF  ++ SWKS DDPS+GD SFKL+  
Sbjct: 143 SKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETE 202

Query: 223 GFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNL 282
           GFPE FLWN++ R YRSGPWNG+RFSGVPEM+P E + F F   ++ +V YSF I   ++
Sbjct: 203 GFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKE-EVTYSFRITKSDV 261

Query: 283 FSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRG 342
           +SRL +S  G LQRFTWIE  + WN FWYAPKDQCD Y ECG +G CD+N SPVC C++G
Sbjct: 262 YSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKG 321

Query: 343 FEPKDPQAWSLRDGSGGCVRKTELQCSE-DKFLQLKNMKLPDTTTSFVDYNMTLKECEAF 401
           F+P++PQ W LRDGS GCVRKT L C   D F++LK MKLPDTTT+ VD  + +KECE  
Sbjct: 322 FKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQK 381

Query: 402 CSRNCSCTAYANTNITG-GTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPI 460
           C R+C+CTA+ANT+I G G+GCVTWTGEL DIR YA+GGQDLYVRLAA+D+ D  N +  
Sbjct: 382 CLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLEDKRNRSAK 441

Query: 461 IIGVTVG-SAILILGLVACFLWRRKTLLGRQIRKTEP-RGHPERSQDLLLNQVVISSKRD 518
           IIG ++G S +L+L  +  FLW+RK    R I    P   H  RS+DLL+N+VVISS+R 
Sbjct: 442 IIGSSIGVSVLLLLSFIIFFLWKRKQ--KRSILIETPIVDHQLRSRDLLMNEVVISSRRH 499

Query: 519 YS-ADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN 577
            S  + TDDLELPL +FE +  AT+NF++ NKLGQGGFGIVYKG+LL+GQE+AVKRLS+ 
Sbjct: 500 ISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKT 559

Query: 578 SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI 637
           S QG +EFKNEV+LIA+LQH NLVRLL CCV+  EKML+YEY+EN SLDS +FDK+R+S 
Sbjct: 560 SVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSK 619

Query: 638 LNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
           LNWQ RF+II GIARGLLYLHQDSRFRIIHRDLKASNILLDK MTPKISDFGMARIFG D
Sbjct: 620 LNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRD 679

Query: 698 QTEQNTKRVVGT 709
           +TE NT++VVGT
Sbjct: 680 ETEANTRKVVGT 691

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	709
TAIR|locus:2141181	850	RK3 "receptor kinase 3" [Arabi	0.926	0.772	0.625	1.1e-227
TAIR|locus:2018546	843	RK1 "receptor kinase 1" [Arabi	0.918	0.772	0.572	3.4e-203
TAIR|locus:2018506	847	RK2 "receptor kinase 2" [Arabi	0.919	0.769	0.576	1.7e-201
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.561	0.508	0.465	8.8e-171
TAIR|locus:2131694	815	AT4G27300 [Arabidopsis thalian	0.645	0.561	0.375	4.4e-154
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.905	0.756	0.450	3.9e-147
TAIR|locus:2200908	842	AT1G61610 [Arabidopsis thalian	0.905	0.762	0.442	9.6e-144
TAIR|locus:2200888	804	AT1G61500 [Arabidopsis thalian	0.582	0.513	0.366	2.2e-135
TAIR|locus:2200923	802	AT1G61550 [Arabidopsis thalian	0.614	0.543	0.361	1.6e-132
TAIR|locus:2197664	804	AT1G61490 [Arabidopsis thalian	0.581	0.512	0.363	2.6e-132

TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 2197 (778.4 bits), Expect = 1.1e-227, P = 1.1e-227
 Identities = 420/671 (62%), Positives = 519/671 (77%)

Query:    51 PTIAISVDTLTATQNLTYGK--TLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVW 108
             P  +IS +TL+A+++LT     T+VS  +VFELGFF PG   +WY+GIWYK I++RTYVW
Sbjct:    23 PAYSISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVW 82

Query:   109 VANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQT--KATNP-VAQLQDSGNFVL-- 163
             VANRD PL++S G L+I +  + + D S   VWS+N T     +P VA+L D+GNFVL  
Sbjct:    83 VANRDTPLSSSIGTLKISDSNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD 142

Query:   164 -KEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFH 222
              K +  D +LWQSFD+PTDTLLP+MK+GWD KTGF  ++ SWKS DDPS+GD SFKL+  
Sbjct:   143 SKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETE 202

Query:   223 GFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNL 282
             GFPE FLWN++ R YRSGPWNG+RFSGVPEM+P E + F F   ++ +V YSF I   ++
Sbjct:   203 GFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKE-EVTYSFRITKSDV 261

Query:   283 FSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRG 342
             +SRL +S  G LQRFTWIE  + WN FWYAPKDQCD Y ECG +G CD+N SPVC C++G
Sbjct:   262 YSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKG 321

Query:   343 FEPKDPQAWSLRDGSGGCVRKTELQCSE-DKFLQLKNMKLPDTTTSFVDYNMTLKECEAF 401
             F+P++PQ W LRDGS GCVRKT L C   D F++LK MKLPDTTT+ VD  + +KECE  
Sbjct:   322 FKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQK 381

Query:   402 CSRNCSCTAYANTNITG-GTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPI 460
             C R+C+CTA+ANT+I G G+GCVTWTGEL DIR YA+GGQDLYVRLAA+D+ D  N +  
Sbjct:   382 CLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLEDKRNRSAK 441

Query:   461 IIGVTVG-SAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDY 519
             IIG ++G S +L+L  +  FLW+RK      I +T    H  RS+DLL+N+VVISS+R  
Sbjct:   442 IIGSSIGVSVLLLLSFIIFFLWKRKQKRSILI-ETPIVDHQLRSRDLLMNEVVISSRRHI 500

Query:   520 SADK-TDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS 578
             S +  TDDLELPL +FE +  AT+NF++ NKLGQGGFGIVYKG+LL+GQE+AVKRLS+ S
Sbjct:   501 SRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTS 560

Query:   579 GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSIL 638
              QG +EFKNEV+LIA+LQH NLVRLL CCV+  EKML+YEY+EN SLDS +FDK+R+S L
Sbjct:   561 VQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKL 620

Query:   639 NWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
             NWQ RF+II GIARGLLYLHQDSRFRIIHRDLKASNILLDK MTPKISDFGMARIFG D+
Sbjct:   621 NWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDE 680

Query:   699 TEQNTKRVVGT 709
             TE NT++VVGT
Sbjct:   681 TEANTRKVVGT 691

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1966 (697.1 bits), Expect = 3.4e-203, P = 3.4e-203
 Identities = 381/666 (57%), Positives = 490/666 (73%)

Query:    54 AISVDTLTATQNLTYG--KTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVAN 111
             ++S +TL+AT++LT    KT++S   +FELGFF+P SS +WY+GIWYK I  RTYVWVAN
Sbjct:    24 SVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVAN 83

Query:   112 RDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQT--KATNPVA-QLQDSGNFVLKEAGS 168
             RD+PL++S+G L+I    + +FD S   VWS+N T     +PVA +L D+GNF+L+++ +
Sbjct:    84 RDNPLSSSNGTLKISGNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRDS-N 142

Query:   169 DEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGF 228
             + +LWQSFD+PTDTLL +MK+GWD KTGF   L SWK+TDDPS+G+ S KL+   FPE +
Sbjct:   143 NRLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFY 202

Query:   229 LWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIV 288
             + +K+   YRSGPWNG+RFS VP    ++ + + F   ++ +V YS+ I   NL+SRL +
Sbjct:   203 ICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKE-EVTYSYRINKTNLYSRLYL 261

Query:   289 SPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDP 348
             +  G LQR TW E  + W   WY+PKD CDNY  CG FG CD+N+ P C C++GF+P + 
Sbjct:   262 NSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGFKPVNE 321

Query:   349 QAWSLRDGSGGCVRKTELQCS-EDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCS 407
             QAW LRDGS GC+RKT L C   D F +LK MKLPDTT + VD  + LK C+  C  +C+
Sbjct:   322 QAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCN 381

Query:   408 CTAYANTNI-TGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIIIGVTV 466
             CTA+AN +I  GG+GCV WT E+ D+R YA+GGQDLYVRLAA+++ D       IIG ++
Sbjct:   382 CTAFANADIRNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAAELEDKRIKNEKIIGSSI 441

Query:   467 G-SAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDYSAD--K 523
             G S +L+L  V    W+RK    R I    P     RSQD L+N VV+S +R Y++   K
Sbjct:   442 GVSILLLLSFVIFHFWKRKQK--RSITIQTPNVDQVRSQDSLINDVVVS-RRGYTSKEKK 498

Query:   524 TDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIE 583
             ++ LELPL + E +  AT+NF++ NKLGQGGFGIVYKGRLL+G+EIAVKRLS+ S QG +
Sbjct:   499 SEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTD 558

Query:   584 EFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRR 643
             EF NEVRLIAKLQH NLVRLLGCCV+  EKML+YEY+EN SLDS +FD+ RSS LNWQ+R
Sbjct:   559 EFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKR 618

Query:   644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
             F+II GIARGLLYLHQDSR RIIHRDLKASN+LLDK MTPKISDFGMARIFG ++TE NT
Sbjct:   619 FDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANT 678

Query:   704 KRVVGT 709
             +RVVGT
Sbjct:   679 RRVVGT 684

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009875 "pollen-pistil interaction" evidence=TAS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1950 (691.5 bits), Expect = 1.7e-201, P = 1.7e-201
 Identities = 388/673 (57%), Positives = 493/673 (73%)

Query:    53 IAISV--DTLTATQNLTYG--KTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVW 108
             +A SV     +AT++LT    KT++S   +FELGFF+P SS +WY+GIWYK I  RTYVW
Sbjct:    21 LAFSVYASNFSATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVW 80

Query:   109 VANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQT--KATNPVA-QLQDSGNFVLKE 165
             VANRD+PL++S+G L+I +  + +FD S   VWS+N T     +PVA +L D GNFVL++
Sbjct:    81 VANRDNPLSSSNGTLKISDNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRD 140

Query:   166 AGSDE---ILWQSFDYPTDTLLPQMKIGWDLKTG-FEWYLTSWKSTDDPSTGDNSFKLDF 221
             + +++    LWQSFD+PTDTLL  MK+GWD K+G F   L SWK+TDDPS+GD S KL  
Sbjct:   141 SKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRT 200

Query:   222 HGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKN 281
              GFPE +++NK+   YRSGPW G RFS VP MKP++ I+   F + +  V YS+ +   N
Sbjct:   201 SGFPEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYID-NSFTENNQQVVYSYRVNKTN 259

Query:   282 LFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMR 341
             ++S L +S  G LQR TW+EA + W   WY+PKD CDNY ECG +G CD N SP+C C++
Sbjct:   260 IYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIK 319

Query:   342 GFEPKDPQAWSLRDGSGGCVRKTELQCS-EDKFLQLKNMKLPDTTTSFVDYNMTLKECEA 400
             GFEP + QA +LRD S GCVRKT+L C   D F++LK M+LPDTT + VD  + LKECE 
Sbjct:   320 GFEPMNEQA-ALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEE 378

Query:   401 FCSRNCSCTAYANTNI-TGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATP 459
              C + C+CTA+ANT+I  GG+GCV W+G L DIR YA+GGQDLYVR+AA D+ D    + 
Sbjct:   379 RCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDLEDKRIKSK 438

Query:   460 IIIGVTVG-SAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRD 518
              IIG ++G S +L+L  +    W+RK    R I    P     RSQD L+N++V +S R 
Sbjct:   439 KIIGSSIGVSILLLLSFIIFHFWKRKQK--RSITIQTPIVDLVRSQDSLMNELVKAS-RS 495

Query:   519 YSA--DKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSR 576
             Y++  +KTD LELPL +++ +  AT+NF+  NKLGQGGFGIVYKG LL+G+EIAVKRLS+
Sbjct:   496 YTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSK 555

Query:   577 NSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSS 636
              S QG +EF NEVRLIAKLQH NLVRLLGCCV+  EKML+YEY+EN SLDS +FD+ RSS
Sbjct:   556 MSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSS 615

Query:   637 ILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
              LNWQ+RF+II GIARGLLYLHQDSR RIIHRDLKASN+LLDK MTPKISDFGMARIFG 
Sbjct:   616 NLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGR 675

Query:   697 DQTEQNTKRVVGT 709
             ++TE NT+RVVGT
Sbjct:   676 EETEANTRRVVGT 688

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0034613 "cellular protein localization" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 1019 (363.8 bits), Expect = 8.8e-171, Sum P(2) = 8.8e-171
 Identities = 191/410 (46%), Positives = 273/410 (66%)

Query:    53 IAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANR 112
             +A + D L A Q L  G T+VS    FE+GFFSPG S   Y+GIWYK I+ +T VWVANR
Sbjct:    20 LAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISLQTVVWVANR 79

Query:   113 DDPLANSSGVLRII-NQRIGLFDGSQNLVWSSNQT----KAT--NPVAQLQDSGNFVLKE 165
             D PL + SG L++  N  + LF+   +++WSS+ +    KA+  NP+ Q+ D+GN V++ 
Sbjct:    80 DSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIVQILDTGNLVVRN 139

Query:   166 AGSDE-ILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGF 224
             +G D+  +WQS DYP D  LP MK G +  TG   +LTSW++ DDPSTG+ + K+D +G 
Sbjct:   140 SGDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDPNGV 199

Query:   225 PEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFS 284
             P+ FL       +R+GPWNG+RF+G+P +KP     +E+   ++ +VYY++ +EN ++ +
Sbjct:   200 PQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEE-EVYYTYKLENPSVLT 258

Query:   285 RLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFE 344
             R+ ++P+G LQR+TW++  + WN +  A  D CD Y  CG +G C+ N SP C+C++GF 
Sbjct:   259 RMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINESPACRCLKGFV 318

Query:   345 PKDPQAWSLRDGSGGCVRKTELQCS--EDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFC 402
              K PQAW   D S GCVR+ +L C   ED FL++  +KLPDT TS+ D NM L EC+  C
Sbjct:   319 AKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLNECKKVC 378

Query:   403 SRNCSCTAYANTNIT-GGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDI 451
              RNC+C+AY+  +I  GG GC+ W G+L DIR+Y E GQDLYVRLA+S+I
Sbjct:   379 LRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNENGQDLYVRLASSEI 428

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)]

 Score = 828 (296.5 bits), Expect = 4.4e-154, Sum P(2) = 4.4e-154
 Identities = 183/488 (37%), Positives = 282/488 (57%)

Query:    52 TIAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGK---WYIGIWYKNIAQRTYVW 108
             ++A+  + +T  + L  G TL S D VF+LGFFS     +    ++G+WY  +     VW
Sbjct:    20 SVALDYNVITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWY--MEPFAVVW 77

Query:   109 VANRDDPLANSSGVLRIINQR-IGLFDGSQNLVWSSNQ--TKAT----NPVAQLQDSGNF 161
             VANR++PL  +SG L + +   + LFDG    +WSS+   TKA+    NP+ ++  SGN 
Sbjct:    78 VANRNNPLYGTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTANNPLLKISCSGNL 137

Query:   162 VLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDF 221
             +  + G + +LWQSFDYP +T+L  MK+G + KT  EW L+SWK+  DPS GD +  LD 
Sbjct:   138 ISSD-GEEAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSLDT 196

Query:   222 HGFPEGFLWNKQERKY--RSGPWNGVRFSGVPEMKPIEGINFEF-FIDQDHDVYYSFFIE 278
              G P+  L    +  Y  R G WNG+ F+G P M   E   F++ F     +V YS+   
Sbjct:   197 RGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGR-ENSLFDYKFTSSAQEVNYSWTPR 255

Query:   279 NKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNA--SPV 336
             ++ + SRL+++  G L RF   + N+ W     AP+D+CD Y  CG + +C  N+  +P 
Sbjct:   256 HR-IVSRLVLNNTGKLHRFIQSKQNQ-WILANTAPEDECDYYSICGAYAVCGINSKNTPS 313

Query:   337 CQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSE-DKFLQLKNMKLPDTTTSFVDYN--M 393
             C C++GF+PK  + W++  G+ GCV +    C + D F++   +KLPDT+ S+ D    M
Sbjct:   314 CSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSWSWYDAKNEM 373

Query:   394 TLKECEAFCSRNCSCTAYANTNIT-GGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIG 452
             TL++C+  CS NCSCTAYANT+I  GG GC+ W G+L D+R+Y+  GQD+Y+R+  + I 
Sbjct:   374 TLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQDVYIRMGFAKIE 433

Query:   453 -DGANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDL-LLNQ 510
               G     +++G  V  A++++ + ACF   RK ++ R   +   +G  E   DL + ++
Sbjct:   434 FKGREVVGMVVGSVVAIAVVLVVVFACF---RKKIMKRYRGENFRKGIEEEDLDLPIFDR 490

Query:   511 VVISSKRD 518
               IS   D
Sbjct:   491 KTISIATD 498

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 1437 (510.9 bits), Expect = 3.9e-147, P = 3.9e-147
 Identities = 309/686 (45%), Positives = 417/686 (60%)

Query:    54 AISVDTLTATQNLTYG---KTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVA 110
             +++ +T+   ++L  G   K LVS    FELGFFSPGSS   ++GIWY NI  +  VWVA
Sbjct:    23 SMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWYGNIEDKAVVWVA 82

Query:   111 NRDDPLANSSGVLRIINQ-RIGLFDGSQNLVWSSNQTKAT----NPVAQLQDSGNFVLKE 165
             NR  P+++ SGVL I N   + L DG    VWSSN   +T    N V  + D+GNFVL E
Sbjct:    83 NRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVVSIHDTGNFVLSE 142

Query:   166 AGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFP 225
               +D  +W+SF++PTDT LPQM++  + +TG      SW+S  DPS G+ S  +D  G P
Sbjct:   143 TDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGVDPSGAP 202

Query:   226 EGFLWN-KQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFI----DQDHDVYYSFFIENK 280
             E  LW   + RK+RSG WN   F+G+P M  +    + F +    D+   VY+++   + 
Sbjct:   203 EIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPPDETGSVYFTYVPSDP 262

Query:   281 NLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASP-VCQC 339
             ++  R  V  +G  +   W E  K W  F   P  +CD Y  CG FGICD   S  +C C
Sbjct:   263 SVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKFGICDMKGSNGICSC 322

Query:   340 MRGFEPKDPQAWSLRDGSGGCVRKTELQCS------EDKFLQLKNMKLPDTTTSFVDYNM 393
             + G+E      WS      GC R+T L+C       ED+FL LK++KLPD      ++N+
Sbjct:   323 IHGYEQVSVGNWSR-----GCRRRTPLKCERNISVGEDEFLTLKSVKLPDF--EIPEHNL 375

Query:   394 TLKE-CEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIG 452
                E C   C RNCSC AY+   + GG GC+ W  +L D++++  GG  L++RLA S++G
Sbjct:   376 VDPEDCRERCLRNCSCNAYS---LVGGIGCMIWNQDLVDLQQFEAGGSSLHIRLADSEVG 432

Query:   453 DGANAT-PIIIGVTVGSAILILGLVACFLWR---RKTLLGRQIRKTEPRGHPERSQDLLL 508
             +       +I+ V VG  ++++G+ A  LWR   +K + G    K           DL  
Sbjct:   433 ENRKTKIAVIVAVLVG--VILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVA--DLTK 488

Query:   509 NQVVISS---KRDYSAD--KTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRL 563
             ++   S+     D   +    +  ELP+F    I  AT++F   N+LG+GGFG VYKG L
Sbjct:   489 SKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVL 548

Query:   564 LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENR 623
              +G+EIAVKRLS  SGQG++EFKNE+ LIAKLQHRNLVRLLGCC E +EKMLVYEYM N+
Sbjct:   549 EDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNK 608

Query:   624 SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP 683
             SLD  +FD+ + ++++W+ RF+II GIARGLLYLH+DSR RIIHRDLK SN+LLD EM P
Sbjct:   609 SLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNP 668

Query:   684 KISDFGMARIFGGDQTEQNTKRVVGT 709
             KISDFGMARIFGG+Q E NT RVVGT
Sbjct:   669 KISDFGMARIFGGNQNEANTVRVVGT 694

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)]

 Score = 1405 (499.6 bits), Expect = 9.6e-144, P = 9.6e-144
 Identities = 297/671 (44%), Positives = 411/671 (61%)

Query:    58 DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLA 117
             ++ T    +  G +L+S D+ FELGFF+P +S   Y+GIWYKNI  +T VWVANR+ PL 
Sbjct:    30 NSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIWYKNIEPQTVVWVANREKPLL 89

Query:   118 NSSGVLRIINQ-RIGLFDGSQNLVWSSN-QTKATNPVAQLQDSGNFVL-KEAGSDEILWQ 174
             +  G L+I +   + + +G    +WS+N + ++ N VA L  +G+ VL  ++   +  W+
Sbjct:    90 DHKGALKIADDGNLVIVNGQNETIWSTNVEPESNNTVAVLFKTGDLVLCSDSDRRKWYWE 149

Query:   175 SFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQE 234
             SF+ PTDT LP M++  +   G       WKS  DPS G  S  +D  G  E  +W  ++
Sbjct:   150 SFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPSPGKYSMGIDPVGALEIVIWEGEK 209

Query:   235 RKYRSGPWNGVRFSGVPEMKPIEGINFEFFI----DQDHDVYYSFFIENKNLFSRLIVSP 290
             RK+RSGPWN   F+G+P+M       + F +    D+D  VY+++   + + F R  + P
Sbjct:   210 RKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVYFTYVASDSSDFLRFWIRP 269

Query:   291 DGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNA---SPVCQCMRGFEPKD 347
             DG  ++F W +  + WN   + P  +C+ Y  CG + +CD +    S  C C+ GFEP  
Sbjct:   270 DGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYSVCDDSKEFDSGKCSCIDGFEPVH 329

Query:   348 PQAWSLRDGSGGCVRKTELQCS-------EDKFLQLKNMKLPDTTTSFVDYNMTLKECEA 400
                W+ RD SGGC R+  L C+       ED F  LK +K+PD   S V +N + + C+ 
Sbjct:   330 QDQWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVLKGIKVPDFG-SVVLHNNS-ETCKD 387

Query:   401 FCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGA-NATP 459
              C+R+CSC AYA   +  G GC+ WT +L D+  +  GG  + +RLA S +G G  N+T 
Sbjct:   388 VCARDCSCKAYA---LVVGIGCMIWTRDLIDMEHFERGGNSINIRLAGSKLGGGKENSTL 444

Query:   460 IIIGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSK-RD 518
              II  +V  A L LGL    LW+ K  L   + K +         D++ N+   SS  + 
Sbjct:   445 WIIVFSVIGAFL-LGLCIWILWKFKKSLKAFLWKKKDI----TVSDIIENRDYSSSPIKV 499

Query:   519 YSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS 578
                D+ D  +LP+F F+++  AT +F + NKLGQGGFG VYKG   EG+EIAVKRLS  S
Sbjct:   500 LVGDQVDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKS 559

Query:   579 GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSIL 638
              QG+EEFKNE+ LIAKLQHRNLVRLLGCC+E +EKML+YEYM N+SLD  +FD+++   L
Sbjct:   560 KQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSL 619

Query:   639 NWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
             +W++R+ +I GIARGLLYLH+DSR +IIHRDLKASNILLD EM PKISDFGMARIF   Q
Sbjct:   620 DWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQ 679

Query:   699 TEQNTKRVVGT 709
                NT RVVGT
Sbjct:   680 DHANTIRVVGT 690

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)]

 Score = 714 (256.4 bits), Expect = 2.2e-135, Sum P(2) = 2.2e-135
 Identities = 159/434 (36%), Positives = 238/434 (54%)

Query:    60 LTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANS 119
             +T    L+ G+TL S+++V+ELGFFSP ++   Y+GIW+K+   R  VWVANR+ P+ +S
Sbjct:    27 ITTESPLSMGQTLSSANEVYELGFFSPNNTQDQYVGIWFKDTIPRVVVWVANREKPVTDS 86

Query:   120 SGVLRIINQ-RIGLFDGSQNLVWSSNQTKATNPV-AQLQDSGNFVLKEAGSDEILWQSFD 177
             +  L I +   + L +G    VWSS  T +++   A+L DSGN  + +  S+  LWQSFD
Sbjct:    87 TAYLAISSSGSLLLLNGKHGTVWSSGVTFSSSGCRAELSDSGNLKVIDNVSERALWQSFD 146

Query:   178 YPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKY 237
             +  DTLL    + ++L T  +  LTSWKS  DPS GD   ++      +GF+       +
Sbjct:   147 HLGDTLLHTSSLTYNLATAEKRVLTSWKSYTDPSPGDFLGQITPQVPSQGFVMRGSTPYW 206

Query:   238 RSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDV--YYSFFIENKNLFSRLIVSPDGFLQ 295
             RSGPW   RF+G+P M   E     F + QD +   Y ++F  +  L SR+ ++ +G ++
Sbjct:   207 RSGPWAKTRFTGIPFMD--ESYTGPFTLHQDVNGSGYLTYFQRDYKL-SRITLTSEGSIK 263

Query:   296 RFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDPQAWSLRD 355
              F   +    W  ++ APK  CD YG CGPFG+C  + SP+C+C RGF PK  + W   +
Sbjct:   264 MFR--DNGMGWELYYEAPKKLCDFYGACGPFGLCVMSPSPMCKCFRGFVPKSVEEWKRGN 321

Query:   356 GSGGCVRKTELQC-------SEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSC 408
              +GGCVR TEL C         D F Q+ N+K PD    F   ++  +EC   C  NCSC
Sbjct:   322 WTGGCVRHTELDCLGNSTGEDADDFHQIANIKPPDFY-EFAS-SVNAEECHQRCVHNCSC 379

Query:   409 TAYANTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIIIGVTVGS 468
              A+A      G GC+ W  +L D  +++  G+ L +RLA S++        I+  +   +
Sbjct:   380 LAFAYIK---GIGCLVWNQDLMDAVQFSATGELLSIRLARSELDGNKRKKTIVASIVSLT 436

Query:   469 AILILGLVACFLWR 482
               +ILG  A  +WR
Sbjct:   437 LFMILGFTAFGVWR 450

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2200923 AT1G61550 [Arabidopsis thaliana (taxid:3702)]

 Score = 704 (252.9 bits), Expect = 1.6e-132, Sum P(2) = 1.6e-132
 Identities = 165/457 (36%), Positives = 244/457 (53%)

Query:    53 IAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANR 112
             ++ S   +T T  L+ G+TL S + +FELGFFSP +S   Y+GIW+K I  RT VWVANR
Sbjct:    14 LSFSYAAITPTSPLSIGQTLSSPNGIFELGFFSPNNSRNLYVGIWFKGIIPRTVVWVANR 73

Query:   113 DDPLANSSGVLRII-NQRIGLFDGSQNLVWSSNQTKATN-PVAQLQDSGNFVLKEAGSDE 170
             ++ + +++  L I  N  + LFDG  + VWS+ +T A+N   A+L DSGN ++ +  S  
Sbjct:    74 ENSVTDATADLAISSNGSLLLFDGKHSTVWSTGETFASNGSSAELSDSGNLLVIDKVSGI 133

Query:   171 ILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLW 230
              LWQSF++  DT+LP   + ++  TG +  L+SWKS  DP  G+    +     P+GF+ 
Sbjct:   134 TLWQSFEHLGDTMLPYSSLMYNPGTGEKRVLSSWKSYTDPLPGEFVGYITTQVPPQGFIM 193

Query:   231 NKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHD--VYYSFFIENKNLFSRLIV 288
                +  +RSGPW   RF+GVP     E     F + QD +  VY+S    N    S L++
Sbjct:   194 RGSKPYWRSGPWAKTRFTGVPLTD--ESYTHPFSVQQDANGSVYFSHLQRNFKR-SLLVL 250

Query:   289 SPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDP 348
             + +G L + T       W      P + CD YG CGPFG+C  +  P C+C +GF P+  
Sbjct:   251 TSEGSL-KVTHHNGTD-WVLNIDVPANTCDFYGVCGPFGLCVMSIPPKCKCFKGFVPQFS 308

Query:   349 QAWSLRDGSGGCVRKTELQCSEDK-------FLQLKNMKLPDTTTSFVDYNMTLKECEAF 401
             + W   + +GGCVR+TEL C  +        F  + N+K PD    FV    + +EC   
Sbjct:   309 EEWKRGNWTGGCVRRTELLCQGNSTGRHVNVFHPVANIKPPDFY-EFVSSG-SAEECYQS 366

Query:   402 CSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPII 461
             C  NCSC A+A  N   G GC+ W  EL D+ +++ GG+ L +RLA+S++G       II
Sbjct:   367 CLHNCSCLAFAYIN---GIGCLIWNQELMDVMQFSVGGELLSIRLASSEMGGNQRKKTII 423

Query:   462 IGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPRG 498
               +   S  + L   A   WR +      + K   +G
Sbjct:   424 ASIVSISLFVTLASAAFGFWRYRLKHNAIVSKVSLQG 460

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2197664 AT1G61490 [Arabidopsis thaliana (taxid:3702)]

 Score = 703 (252.5 bits), Expect = 2.6e-132, Sum P(2) = 2.6e-132
 Identities = 158/435 (36%), Positives = 238/435 (54%)

Query:    60 LTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANS 119
             +T    L+  +TL SS+ ++ELGFFSP +S   Y+GIW+K I  R  VWVANR+ P  ++
Sbjct:    26 ITTESPLSVEQTLSSSNGIYELGFFSPNNSQNLYVGIWFKGIIPRVVVWVANRETPTTDT 85

Query:   120 SGVLRII-NQRIGLFDGSQNLVWSSNQTKATNPV-AQLQDSGNFVLKEAGSDEILWQSFD 177
             S  L I  N  + LF+G   +VWS  +  A+N   A+L D+GN V+ +  S   LW+SF+
Sbjct:    86 SANLAISSNGSLLLFNGKHGVVWSIGENFASNGSRAELTDNGNLVVIDNASGRTLWESFE 145

Query:   178 YPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKY 237
             +  DT+LP   + ++L TG +  LTSWK+  DPS G    ++      +  +     R Y
Sbjct:   146 HFGDTMLPFSSLMYNLATGEKRVLTSWKTDTDPSPGVFVGQITPQVPSQVLIMRGSTRYY 205

Query:   238 RSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVSPDGFLQRF 297
             R+GPW   RF+G+P M       F    D +   ++++F  +  L SR+I+S +G ++RF
Sbjct:   206 RTGPWAKTRFTGIPLMDDTYASPFSLQQDANGSGFFTYFDRSFKL-SRIIISSEGSMKRF 264

Query:   298 TWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDPQAWSLRDGS 357
                  +  W   + AP + CD YG CGPFG+C  +    C+C++GF P   + W   + +
Sbjct:   265 RHNGTD--WELSYMAPANSCDIYGVCGPFGLCIVSVPLKCKCLKGFVPHSTEEWKRGNWT 322

Query:   358 GGCVRKTELQC---SEDK----FLQLKNMKLPDTTTSFVDYNMTL--KECEAFCSRNCSC 408
             GGC R TEL C   S  K    F  + N+KLPD    F +Y  ++  +EC   C  NCSC
Sbjct:   323 GGCARLTELHCQGNSTGKDVNIFHPVTNVKLPD----FYEYESSVDAEECHQSCLHNCSC 378

Query:   409 TAYANTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIIIGVTVGS 468
              A+A  +   G GC+ W   L D  +++ GG+ L +RLA S++G G     II+  TV  
Sbjct:   379 LAFAYIH---GIGCLIWNQNLMDAVQFSAGGEILSIRLAHSELG-GNKRNKIIVASTVSL 434

Query:   469 AILILGLVACF-LWR 482
             ++ ++   A F  WR
Sbjct:   435 SLFVILTSAAFGFWR 449

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
O81905	SD18_ARATH	2, ., 7, ., 1, 1, ., 1	0.6264	0.9252	0.7717	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pg.C_LG_IV000163 hypothetical protein (834 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	709
pfam00954	110	pfam00954, S_locus_glycop, S-locus glycoprotein fa	2e-57
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-43
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-43
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-41
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-40
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-39
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-38
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-36
pfam01453	109	pfam01453, B_lectin, D-mannose binding lectin	3e-35
cd00028	116	cd00028, B_lectin, Bulb-type mannose-specific lect	1e-33
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-31
pfam08276	66	pfam08276, PAN_2, PAN-like domain	8e-31
smart00108	114	smart00108, B_lectin, Bulb-type mannose-specific l	2e-30
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-30
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-28
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-28
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-25
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-25
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-24
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-24
cd01098	84	cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain	7e-24
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-23
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-23
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-23
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-23
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-22
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-22
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-22
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-22
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-22
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-22
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-22
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-21
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-21
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-20
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-20
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-20
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-20
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-20
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-20
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	9e-20
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-20
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-19
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-19
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-19
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-18
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-18
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-18
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-18
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-17
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-17
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-17
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-17
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-17
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-17
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-17
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-17
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	9e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	9e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-16
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-16
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-16
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-16
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-16
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-16
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-16
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-16
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-16
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-16
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-16
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-16
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-16
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	8e-16
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-15
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-15
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-15
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-15
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-15
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	7e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	8e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-14
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-14
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-14
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-14
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-14
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-14
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-14
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-14
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-14
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-14
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-14
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	8e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	8e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	9e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-13
pfam12398	42	pfam12398, DUF3660, Receptor serine/threonine kina	2e-13
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	9e-13
smart00473	78	smart00473, PAN_AP, divergent subfamily of APPLE d	1e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-12
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-12
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-12
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-12
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-12
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	8e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-11
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-11
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-11
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-11
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-11
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-11
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	6e-11
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-11
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-11
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	9e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-10
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-10
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-10
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	9e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	9e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-09
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	7e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-08
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-08
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-08
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	7e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-08
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	9e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-07
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-07
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	9e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-06
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-06
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-06
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-06
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	9e-06
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-05
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-05
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-05
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-05
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-05
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	7e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	8e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	9e-05
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	9e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	9e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-04
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-04
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-04
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-04
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-04
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-04
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-04
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-04
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	5e-04
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-04
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	5e-04
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-04
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	0.002
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.002
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	0.002
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	0.002
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	0.002
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.003
cd00054	38	cd00054, EGF_CA, Calcium-binding EGF-like domain,	0.004
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	0.004

>gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family

 Score =  189 bits (483), Expect = 2e-57
 Identities = 58/110 (52%), Positives = 81/110 (73%), Gaps = 1/110 (0%)

Query: 237 YRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVSPDGFLQR 296
           +RSGPWNG+RFSG+PEM+ +    + F  + + +VYY++ + N +++SRL +S +G L+R
Sbjct: 1   WRSGPWNGIRFSGIPEMQKLSYYVYNF-TENNEEVYYTYRMTNNSIYSRLTLSSEGSLER 59

Query: 297 FTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPK 346
           FTWI  ++ WN FW APKDQCD YG CGP+G CD N SP C C++GF PK
Sbjct: 60  FTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPK 109

In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  157 bits (400), Expect = 1e-43
 Identities = 64/165 (38%), Positives = 90/165 (54%), Gaps = 12/165 (7%)

Query: 549 KLGQGGFGIVYKGRLL-----EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVR 602
           KLG+G FG VYKG+L      +  E+AVK L  + S Q IEEF  E R++ KL H N+V+
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           LLG C E +   +V EYME   L S +  +     L+     +    IARG+ YL     
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLESK-- 121

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTKRV 706
              IHRDL A N L+ + +  KISDFG++R ++  D   +   ++
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL 165

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  156 bits (397), Expect = 3e-43
 Identities = 65/150 (43%), Positives = 85/150 (56%), Gaps = 10/150 (6%)

Query: 549 KLGQGGFGIVYKGRLL-----EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVR 602
           KLG+G FG VYKG L      +  E+AVK L  + S Q IEEF  E R++ KL H N+V+
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           LLG C E +  M+V EYM    L   +  K R   L+     +    IARG+ YL   S+
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLE--SK 122

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              IHRDL A N L+ + +  KISDFG++R
Sbjct: 123 -NFIHRDLAARNCLVGENLVVKISDFGLSR 151

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  148 bits (377), Expect = 4e-41
 Identities = 60/163 (36%), Positives = 89/163 (54%), Gaps = 10/163 (6%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSR-NSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           LG+GGFG VY  R  + G+++A+K + + +S   +EE   E+ ++ KL H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
            + +   LV EY E  SL  ++  K     L+      I+  I  GL YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 668 RDLKASNILLDK-EMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           RDLK  NILLD      K++DFG++++   D  +   K +VGT
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSD--KSLLKTIVGT 156

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  148 bits (375), Expect = 4e-40
 Identities = 61/156 (39%), Positives = 87/156 (55%), Gaps = 14/156 (8%)

Query: 548 NKLGQGGFGIVYKGRLLEGQ----EIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVR 602
            KLG+G FG VYKG+L        E+AVK L  + S +  ++F  E R++ KL H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVI------FDKARSSILNWQRRFNIICGIARGLLY 656
           LLG C E +   LV EYME   L   +      F     S L+ +   +    IA+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           L   S+ + +HRDL A N L+ +++  KISDFG++R
Sbjct: 121 LA--SK-KFVHRDLAARNCLVGEDLVVKISDFGLSR 153

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  144 bits (367), Expect = 3e-39
 Identities = 56/150 (37%), Positives = 79/150 (52%), Gaps = 11/150 (7%)

Query: 549 KLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVR 602
           KLG+G FG VYKG L         ++AVK L   +  +  EEF  E  ++ KL H N+VR
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           LLG C + +   +V EYM    L    F +     L  +    +   IA+G+ YL   S+
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLD--FLRKHGEKLTLKDLLQMALQIAKGMEYLE--SK 121

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              +HRDL A N L+ + +  KISDFG++R
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSR 150

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  142 bits (360), Expect = 3e-38
 Identities = 57/168 (33%), Positives = 86/168 (51%), Gaps = 11/168 (6%)

Query: 544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEE-FKNEVRLIAKLQHRNLV 601
           +    KLG+G FG VY  R  + G+ +A+K + +   +   E    E++++ KL+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           RL     + D+  LV EY E   L  ++  K R  +   + RF  +  I   L YLH   
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARF-YLRQILSALEYLHS-- 115

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
              I+HRDLK  NILLD++   K++DFG+AR     +        VGT
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGT 159

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  136 bits (344), Expect = 6e-36
 Identities = 63/165 (38%), Positives = 82/165 (49%), Gaps = 13/165 (7%)

Query: 549 KLGQGGFGIVYKGRLL-EGQEIAVKRL---SRNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           KLG G FG VYK +    G+ +AVK L   S  S +       E+R++ +L H N+VRL+
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTAR-REIRILRRLSHPNIVRLI 64

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
               + D   LV EY E   L   +   +R   L+      I   I RGL YLH      
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNG 118

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IIHRDLK  NILLD+    KI+DFG+A+      +   T   VGT
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGT 161

Length = 260

>gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin

 Score =  128 bits (324), Expect = 3e-35
 Identities = 57/113 (50%), Positives = 72/113 (63%), Gaps = 8/113 (7%)

Query: 103 QRTYVWVANRDDPLANSSGVLRIINQRIG---LFDGSQNLVWSSN-QTKATNPVAQLQDS 158
            +T VWVANR +PL +SS  L + +   G   L+DG+  +VWSSN   K +  VA LQD 
Sbjct: 1   NQTVVWVANRLNPLTDSSYTLILQSD--GNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDD 58

Query: 159 GNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPS 211
           GN VL +  S ++LWQSFD+PTDTLLP  K G ++  G    LTSWKS  DPS
Sbjct: 59  GNLVLYDN-SGKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109

These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109

>gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin

 Score =  124 bits (314), Expect = 1e-33
 Identities = 54/116 (46%), Positives = 68/116 (58%), Gaps = 5/116 (4%)

Query: 66  LTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRI 125
           L+ G+TLVSS  +FELGFF      + Y  I YK    RT VWVANRD+P   SS  L +
Sbjct: 4   LSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGS-SRTVVWVANRDNPS-GSSCTLTL 61

Query: 126 INQ-RIGLFDGSQNLVWSSNQTKATNP-VAQLQDSGNFVLKEAGSDEILWQSFDYP 179
            +   + ++DGS  +VWSSN T+     V  L D GN VL ++     LWQSFDYP
Sbjct: 62  QSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSD-GNFLWQSFDYP 116

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  121 bits (306), Expect = 6e-31
 Identities = 58/176 (32%), Positives = 93/176 (52%), Gaps = 29/176 (16%)

Query: 548 NKLGQGGFGIVYKGRLLE-GQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
             LG+G FG VY     + G+ +AVK   LS +S + +E  + E+R+++ LQH N+VR  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 605 GCCVEMDEKML-VY-EYMENRSLDSVIFDKARSSILNWQRRF-----NIICG----IARG 653
           G   + ++  L ++ EY+   SL S++            ++F      +I      I  G
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLL------------KKFGKLPEPVIRKYTRQILEG 113

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           L YLH +    I+HRD+K +NIL+D +   K++DFG A+  G  +T + T  V GT
Sbjct: 114 LAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain

 Score =  114 bits (288), Expect = 8e-31
 Identities = 39/64 (60%), Positives = 47/64 (73%)

Query: 369 SEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGE 428
             D FL+L NMKLPDTT + VD ++ LKECE  C  NCSCTAYA  +I GG+GC+ WTGE
Sbjct: 3   GGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRGGSGCLIWTGE 62

Query: 429 LKDI 432
           L D+
Sbjct: 63  LVDM 66

Length = 66

>gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin

 Score =  115 bits (290), Expect = 2e-30
 Identities = 51/115 (44%), Positives = 68/115 (59%), Gaps = 6/115 (5%)

Query: 66  LTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRI 125
           L+ G+TLVS + +FELGFF+       Y  I YK+   RT VWVANRD+P+ + S  L +
Sbjct: 4   LSSGQTLVSGNSLFELGFFTLIMQN-DYNLILYKSS-SRTVVWVANRDNPV-SDSCTLTL 60

Query: 126 INQ-RIGLFDGSQNLVWSSNQTKATNP-VAQLQDSGNFVLKEAGSDEILWQSFDY 178
            +   + L+DG   +VWSSN T A    V  L D GN V+ ++     LWQSFDY
Sbjct: 61  QSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDS-DGNFLWQSFDY 114

Length = 114

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  119 bits (301), Expect = 3e-30
 Identities = 55/172 (31%), Positives = 91/172 (52%), Gaps = 15/172 (8%)

Query: 543 NFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRN 599
           N+   + +G+G FG+VYKG  L  G  +A+K++S      + ++    E+ L+  L+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVI--FDKARSSILNWQRRFNIICGIARGLLYL 657
           +V+ +G     D   ++ EY EN SL  +I  F     S++        +  + +GL YL
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVA-----VYVYQVLQGLAYL 115

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           H+     +IHRD+KA+NIL  K+   K++DFG+A         ++   VVGT
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV--SKDDASVVGT 162

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  114 bits (288), Expect = 2e-28
 Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 21/173 (12%)

Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           F    K+G+GGFG VYK R    G+E+A+K +   S +  E+  NE++++ K +H N+V+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN------IICGIARGLLY 656
             G  ++ DE  +V E+    SL  +        + +  +         +   + +GL Y
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDL--------LKSTNQTLTESQIAYVCKELLKGLEY 113

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           LH      IIHRD+KA+NILL  +   K+ DFG++         +    +VGT
Sbjct: 114 LHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGT 160

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  113 bits (286), Expect = 7e-28
 Identities = 57/173 (32%), Positives = 92/173 (53%), Gaps = 15/173 (8%)

Query: 541 TDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN 599
            + + +  K+G+G  G VYK      G+E+A+K++ R   Q  E   NE+ ++   +H N
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPN 76

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICG-IARGLLYLH 658
           +V      +  DE  +V EYM+  SL  +I        +N + +   +C  + +GL YLH
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN--FVRMN-EPQIAYVCREVLQGLEYLH 133

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGT 709
                 +IHRD+K+ NILL K+ + K++DFG    F    T++ +KR  VVGT
Sbjct: 134 S---QNVIHRDIKSDNILLSKDGSVKLADFG----FAAQLTKEKSKRNSVVGT 179

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 2e-25
 Identities = 52/155 (33%), Positives = 84/155 (54%), Gaps = 19/155 (12%)

Query: 549 KLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFK----NEVRLIAKLQHRNLVRL 603
           KLG+G +G+VYK R    G+ +A+K++ R      E        E+ L+ +L+H N+V+L
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKI-RLD-NEEEGIPSTALREISLLKELKHPNIVKL 63

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRR--FNIICGIARGLLYLHQD 660
           L       +  LV+EY +   L   + DK    +  N  +   + ++ G+A    Y H  
Sbjct: 64  LDVIHTERKLYLVFEYCD-MDLKKYL-DKRPGPLSPNLIKSIMYQLLRGLA----YCHSH 117

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
              RI+HRDLK  NIL++++   K++DFG+AR FG
Sbjct: 118 ---RILHRDLKPQNILINRDGVLKLADFGLARAFG 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  104 bits (262), Expect = 5e-25
 Identities = 53/179 (29%), Positives = 83/179 (46%), Gaps = 25/179 (13%)

Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKR--LSRNSGQGIEEFKNEVRLIAKLQHRN 599
            +    ++G+G FG VY  R     ++  +K   LS  S +  E+  NEV+++ KL H N
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSS-------ILNW--QRRFNIICGI 650
           +++      E  +  +V EY +   L   I  + +         IL+W  Q        +
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--------L 112

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
              L YLH  SR +I+HRD+K  NI L      K+ DFG++++     T    K VVGT
Sbjct: 113 CLALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVL--SSTVDLAKTVVGT 166

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  102 bits (256), Expect = 2e-24
 Identities = 49/162 (30%), Positives = 84/162 (51%), Gaps = 10/162 (6%)

Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           KLG+G +G VYK    E GQ +A+K +       ++E   E+ ++ +     +V+  G  
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSY 67

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
            +  +  +V EY    S+  ++  K  +  L  +    I+    +GL YLH +   + IH
Sbjct: 68  FKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIH 122

Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           RD+KA NILL++E   K++DFG++        ++NT  V+GT
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGT 162

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  102 bits (255), Expect = 3e-24
 Identities = 48/155 (30%), Positives = 83/155 (53%), Gaps = 4/155 (2%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR 598
           R  + FT   KLG G FG V++G       +A+K L  +     ++F+ EV+ + +L+H+
Sbjct: 3   RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHK 62

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
           +L+ L   C   +   ++ E ME  SL + +       +L      ++ C +A G+ YL 
Sbjct: 63  HLISLFAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLE 121

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI 693
           +      IHRDL A NIL+ +++  K++DFG+AR+
Sbjct: 122 EQ---NSIHRDLAARNILVGEDLVCKVADFGLARL 153

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

 Score = 95.6 bits (238), Expect = 7e-24
 Identities = 39/88 (44%), Positives = 52/88 (59%), Gaps = 8/88 (9%)

Query: 364 TELQC----SEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTAYANTNITGG 419
           T L C    S D FL+L ++KLPD  ++     ++L+EC   C  NCSCTAYA  N  G 
Sbjct: 1   TPLNCGGDGSTDGFLKLPDVKLPDNASAIT--AISLEECREACLSNCSCTAYAYNN--GS 56

Query: 420 TGCVTWTGELKDIRKYAEGGQDLYVRLA 447
            GC+ W G L ++R  + GG  LY+RLA
Sbjct: 57  GGCLLWNGLLNNLRSLSSGGGTLYLRLA 84

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  100 bits (250), Expect = 1e-23
 Identities = 52/162 (32%), Positives = 83/162 (51%), Gaps = 6/162 (3%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
              T   ++G G FG+V+ G  LE +++A+K + R      E+F  E +++ KL H  LV
Sbjct: 4   SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLV 62

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +L G C E     LV+E+ME+  L    + +A+    + +    +   +  G+ YL   +
Sbjct: 63  QLYGVCTERSPICLVFEFMEHGCLSD--YLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
              +IHRDL A N L+ +    K+SDFGM R    DQ   +T
Sbjct: 121 ---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 2e-23
 Identities = 53/162 (32%), Positives = 85/162 (52%), Gaps = 22/162 (13%)

Query: 550 LGQGGFGIVYKGRLL-EGQ----EIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRL 603
           LG G FG VYKG  + EG+     +A+K L   +  +  +E  +E  ++A + H ++VRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 604 LGCCVEMDEK-MLVYEYMENRSLDSVIF---DKARS-SILNWQRRFNIICGIARGLLYLH 658
           LG C  +  +  L+ + M    L   +    D   S  +LNW  +      IA+G+ YL 
Sbjct: 75  LGIC--LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE 700
           +    R++HRDL A N+L+      KI+DFG+A++   D+ E
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  100 bits (252), Expect = 2e-23
 Identities = 51/167 (30%), Positives = 88/167 (52%), Gaps = 15/167 (8%)

Query: 548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEF----KNEVRLIAKLQHRNLVR 602
            ++G+G +G VYK R  + G+ +A+K++        E F      E++L+ KL+H N+VR
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVR 62

Query: 603 LLGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           L        +    +V+EYM++  L  ++ D         Q +   +  +  GL YLH +
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDH-DLTGLL-DSPEVKFTESQIKC-YMKQLLEGLQYLHSN 119

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
               I+HRD+K SNIL++ +   K++DFG+AR +    +   T RV+
Sbjct: 120 ---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 99.7 bits (249), Expect = 3e-23
 Identities = 48/158 (30%), Positives = 82/158 (51%), Gaps = 9/158 (5%)

Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN--EVRLIAKLQHRNL 600
           +    K+G+G +G+VYK R  L G+ +A+K++               E++L+ +L H N+
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           ++LL       +  LV+E+M+   L  +I  K R   L      + +  + +GL + H  
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDT-DLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSH 117

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
               I+HRDLK  N+L++ E   K++DFG+AR FG   
Sbjct: 118 ---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 97.9 bits (244), Expect = 9e-23
 Identities = 48/146 (32%), Positives = 79/146 (54%), Gaps = 12/146 (8%)

Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE 609
           +G+G FG V  G    GQ++AVK L  +S    + F  E  ++  L+H NLV+LLG  ++
Sbjct: 14  IGKGEFGDVMLG-DYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 610 MDEKMLVYEYMENRSLDSVIFDKARS---SILNWQRRFNIICGIARGLLYLHQDSRFRII 666
            +   +V EYM   SL     D  RS   +++   ++      +  G+ YL +      +
Sbjct: 72  GNPLYIVTEYMAKGSL----VDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFV 124

Query: 667 HRDLKASNILLDKEMTPKISDFGMAR 692
           HRDL A N+L+ +++  K+SDFG+A+
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 55/161 (34%), Positives = 76/161 (47%), Gaps = 18/161 (11%)

Query: 548 NKLGQGGFGIVYKGRLLE--GQEI--AVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVR 602
            +LG G FG V KG  L   G+E+  AVK L +     G +EF  E  ++A+L H  +VR
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNIICGIARGLLYLHQ 659
           L+G C   +  MLV E      L   +  +     S +     +      +A G+ YL +
Sbjct: 61  LIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYL-E 112

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE 700
              F  +HRDL A N+LL      KISDFGM+R  G     
Sbjct: 113 SKHF--VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 97.5 bits (243), Expect = 2e-22
 Identities = 50/161 (31%), Positives = 82/161 (50%), Gaps = 15/161 (9%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLL-----EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKL 595
            +     +LG+G FG V   R        G+++AVK L+ +   Q   +F+ E+ ++  L
Sbjct: 4   RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63

Query: 596 QHRNLVRLLGCCVEMDEK--MLVYEYMENRSLDSVI-FDKARSSILNWQRRFNIICGIAR 652
            H N+V+  G C +   +   L+ EY+ + SL   +   + +   +N +R       I +
Sbjct: 64  DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKRLLLFSSQICK 120

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI 693
           G+ YL      R IHRDL A NIL++ E   KISDFG+A++
Sbjct: 121 GMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV 158

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 96.6 bits (241), Expect = 3e-22
 Identities = 54/160 (33%), Positives = 85/160 (53%), Gaps = 10/160 (6%)

Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRL-SRNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V +GRL L G++   +A+K L + +S +   +F  E  ++ +  H N++RL 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M++ EYMEN SLD   F +         +   ++ GIA G+ YL   S   
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDK--FLRENDGKFTVGQLVGMLRGIASGMKYL---SEMN 126

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
            +HRDL A NIL++  +  K+SDFG++R     +    TK
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 96.8 bits (241), Expect = 4e-22
 Identities = 59/179 (32%), Positives = 88/179 (49%), Gaps = 24/179 (13%)

Query: 550 LGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVR 602
           LG+G FG VYKG L           +A+K L  N   +  +EF+ E  L++ LQH N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 603 LLGCCVEMDEKMLVYEYMENRSL----------DSVIF---DKARSSILNWQRRFNIICG 649
           LLG C +     +++EY+ +  L            V     D+   S L+     +I   
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTKRVV 707
           IA G+ YL   S    +HRDL A N L+ + +T KISDFG++R I+  D     +K ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 96.1 bits (240), Expect = 5e-22
 Identities = 48/167 (28%), Positives = 83/167 (49%), Gaps = 17/167 (10%)

Query: 549 KLGQGGFGIVYKGRL-LEGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
            LGQG  G+VYK R    G+  A+K++  +   +  ++   E++ +   +   +V+  G 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIAR----GLLYLHQDSR 662
             +  E  +V EYM+  SL  ++    +   +       ++  IAR    GL YLH    
Sbjct: 68  FYKEGEISIVLEYMDGGSLADLL---KKVGKIPEP----VLAYIARQILKGLDYLHTKRH 120

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             IIHRD+K SN+L++ +   KI+DFG++++   + T       VGT
Sbjct: 121 --IIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGT 163

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 97.9 bits (242), Expect = 7e-22
 Identities = 52/172 (30%), Positives = 87/172 (50%), Gaps = 10/172 (5%)

Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH-R 598
           ++    KLG+G FG VY  R    + +A+K L++   +  + +E F  E++++A L H  
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
           N+V+L     +     LV EY++  SL+ ++    R   L+      I+  I   L YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 659 QDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFGGDQTEQNTKRVVGT 709
                 IIHRD+K  NILLD++    K+ DFG+A++     +  +   +  T
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST 167

Length = 384

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 95.8 bits (239), Expect = 8e-22
 Identities = 53/159 (33%), Positives = 90/159 (56%), Gaps = 16/159 (10%)

Query: 548 NKLGQGGFGIVYKGR-LLEGQEIAVKRLS-RNSGQGIEEFK-NEVRLIAKLQ---HRNLV 601
            ++G+G +G VYK R L  G+ +A+K++    S +GI      E+ L+ +L+   H N+V
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 602 RLLGCC--VEMDEKM---LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           RLL  C     D ++   LV+E+++ + L + +  K     L  +   +++  + RG+ +
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHVD-QDLATYL-SKCPKPGLPPETIKDLMRQLLRGVDF 122

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           LH     RI+HRDLK  NIL+  +   KI+DFG+ARI+ 
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 51/161 (31%), Positives = 76/161 (47%), Gaps = 21/161 (13%)

Query: 550 LGQGGFGIVYKGR---LLEGQE---IAVKRLSRNSGQGIEE-FKNEVRLIAKLQHRNLVR 602
           LG+G FG V+ G    L    +   +AVK L   +     + F+ E  L+   QH N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 603 LLGCCVEMDEKMLVYEYMENRSL---------DSVIFDKARSSI--LNWQRRFNIICGIA 651
             G C E D  ++V+EYME+  L         D+       S +  L   +   I   IA
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            G++YL   +    +HRDL   N L+  ++  KI DFGM+R
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 93.5 bits (233), Expect = 6e-21
 Identities = 49/169 (28%), Positives = 86/169 (50%), Gaps = 23/169 (13%)

Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRL-SRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL- 604
           ++G+G  GIV+K +  E G+ +A+K++  R    GI  +   E++ +   QH  +V+LL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 605 -----GCCVEMDEKMLVYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIARGLLYLH 658
                   V      LV EYM    L  V+ D+ R       +    ++    +G+ Y+H
Sbjct: 67  VFPHGSGFV------LVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLL---KGVAYMH 116

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
            +    I+HRDLK +N+L+  +   KI+DFG+AR+F  ++    + +V 
Sbjct: 117 AN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA 162

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 54/152 (35%), Positives = 76/152 (50%), Gaps = 11/152 (7%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLG G FG V+ G      ++AVK L +      E F  E +++ KL+H  LV+L   C 
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARS---SILNWQRRFNIICGIARGLLYLHQDSRFRI 665
           E +   +V EYM   SL     D  +S     L   +  ++   IA G+ YL        
Sbjct: 72  EEEPIYIVTEYMSKGSL----LDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNY 124

Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
           IHRDL A NIL+ + +  KI+DFG+AR+   D
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDD 156

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 53/173 (30%), Positives = 77/173 (44%), Gaps = 18/173 (10%)

Query: 540 ATDNFTDYNKLGQGGFGIVYKG----RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLI 592
             D+ T    LG G FG VY+G    R  +  E+ V   +     S Q   +F  E  ++
Sbjct: 4   PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63

Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIIC 648
           +K  H+N+VRL+G   E   + ++ E M    L S + +      R S L  +       
Sbjct: 64  SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMAR-IFGGD 697
            +A+G  YL +      IHRD+ A N LL         KI+DFGMAR I+   
Sbjct: 124 DVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRAS 173

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 90.3 bits (224), Expect = 5e-20
 Identities = 55/151 (36%), Positives = 83/151 (54%), Gaps = 8/151 (5%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLG G FG V+ G      ++A+K L + S    E F  E  L+ +LQH  LVRL    V
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAV-V 70

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
             +   ++ EYMEN SL  V F K    I L   +  ++   IA G+ ++ + +    IH
Sbjct: 71  TQEPIYIITEYMENGSL--VDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIH 125

Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           RDL+A+NIL+ + +  KI+DFG+AR+   ++
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNE 156

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 90.6 bits (225), Expect = 5e-20
 Identities = 51/159 (32%), Positives = 89/159 (55%), Gaps = 13/159 (8%)

Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLS-RNSGQGIEEFK-NEVRLIAKLQHRN 599
           ++T   K+G+G +G+VYKGR    GQ +A+K++   +  +G+      E+ L+ +LQH N
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 600 LVRLLGCCVEMDEKMLVYEYME---NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           +V L    ++     L++E++     + LDS+   +   + L     + I+ GI    L+
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI----LF 116

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
            H     R++HRDLK  N+L+D +   K++DFG+AR FG
Sbjct: 117 CH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 89.8 bits (223), Expect = 6e-20
 Identities = 48/149 (32%), Positives = 77/149 (51%), Gaps = 6/149 (4%)

Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE 609
           LG G FG+V+ G+     ++A+K + R      ++F  E +++ KL H NLV+L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 610 MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRD 669
                +V EYM N  L +  + + R   L  +   ++   +   + YL  +     IHRD
Sbjct: 71  QRPIFIVTEYMANGCLLN--YLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125

Query: 670 LKASNILLDKEMTPKISDFGMARIFGGDQ 698
           L A N L+ ++   K+SDFG+AR    DQ
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQ 154

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 90.7 bits (226), Expect = 6e-20
 Identities = 53/158 (33%), Positives = 86/158 (54%), Gaps = 20/158 (12%)

Query: 548 NKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN-----EVRLIAKLQHRNLV 601
            KLG+G + +VYK R    G+ +A+K++     +  ++  N     E++L+ +L+H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDK----ARSSILNWQRRFNIICGIARGLLYL 657
            LL          LV+E+ME   L+ VI DK      + I ++           RGL YL
Sbjct: 66  GLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLM------TLRGLEYL 118

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           H  S + I+HRDLK +N+L+  +   K++DFG+AR FG
Sbjct: 119 H--SNW-ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 91.1 bits (227), Expect = 6e-20
 Identities = 53/175 (30%), Positives = 86/175 (49%), Gaps = 31/175 (17%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---------EVRLIAKLQHRN 599
           +G G +G+V        G+++A+K++S         F +         E++L+  L+H N
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60

Query: 600 LVRLL-----GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           ++ LL         + ++  +V E ME   L  VI  K+   + +   ++  +  I RGL
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVI--KSPQPLTDDHIQY-FLYQILRGL 116

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN--TKRVV 707
            YLH      +IHRDLK SNIL++     KI DFG+AR    D+ E+   T+ VV
Sbjct: 117 KYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 90.5 bits (225), Expect = 9e-20
 Identities = 55/188 (29%), Positives = 87/188 (46%), Gaps = 34/188 (18%)

Query: 543 NFTDYN---KLGQGGFGIVYKGR-LLEGQEIAVKRL---SRNSGQGIEEFKNEVRLIAKL 595
              DY    KLG+G FG VYK R +  G+ +A+K++   +   G  I   + E++++ KL
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL 64

Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIF-------DKARSSILNWQR-RFN-- 645
           +H N+V L    ++M       E  +                D   S +L     +    
Sbjct: 65  KHPNVVPL----IDM-----AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES 115

Query: 646 -IIC---GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ 701
            I C    +  G+ YLH++    I+HRD+KA+NIL+D +   KI+DFG+AR + G     
Sbjct: 116 QIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172

Query: 702 NTKRVVGT 709
                 GT
Sbjct: 173 KGGGGGGT 180

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 89.9 bits (224), Expect = 9e-20
 Identities = 55/148 (37%), Positives = 79/148 (53%), Gaps = 10/148 (6%)

Query: 549 KLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKN--EVRLIAKLQ-HRNLVRLL 604
           +LG G FG VY  R  E  E+ A+K++ +      EE  N  EV+ + KL  H N+V+L 
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNEHPNIVKLK 64

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
               E DE   V+EYME  +L  ++ D+          R +II  I +GL ++H+   F 
Sbjct: 65  EVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIR-SIIYQILQGLAHIHKHGFF- 121

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMAR 692
             HRDLK  N+L+      KI+DFG+AR
Sbjct: 122 --HRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 90.1 bits (224), Expect = 1e-19
 Identities = 64/181 (35%), Positives = 94/181 (51%), Gaps = 24/181 (13%)

Query: 538 VRATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNS---GQGIEEFKNEVRLIA 593
            R+   F   N++G+G +GIVY+ R     EI A+K++  ++   G  I   + E+ L+ 
Sbjct: 3   CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLL 61

Query: 594 KLQHRNLVRLLGCCV--EMDEKMLVYEYMEN---RSLDSVI--FDKARSSILNWQRRFNI 646
            L+H N+V L    V   +D   LV EY E      LD++   F +++   L  Q     
Sbjct: 62  NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQ----- 116

Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              + RGL YLH    F IIHRDLK SN+LL  +   KI+DFG+AR + G   +  T +V
Sbjct: 117 ---LLRGLQYLH--ENF-IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKV 169

Query: 707 V 707
           V
Sbjct: 170 V 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 88.8 bits (221), Expect = 2e-19
 Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 11/168 (6%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSR---NSGQGIEEFKNEVRLIAKL-Q 596
           D+F     +G+G F  V   +  E  +E A+K L +      + ++  K E  ++ +L  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           H  +++L     + +    V EY  N  L   I    +   L+ +        I   L Y
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALEY 117

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
           LH      IIHRDLK  NILLDK+M  KI+DFG A++   + + ++ K
Sbjct: 118 LHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 53/153 (34%), Positives = 69/153 (45%), Gaps = 18/153 (11%)

Query: 549 KLGQGGFGIVYKGRLLEGQ----EIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRL 603
           KLG G FG+V +G           +AVK L  +    I ++F  E  ++  L H NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICG----IARGLLYLHQ 659
            G  V     M+V E     SL   +   A    L      + +C     IA G+ YL  
Sbjct: 62  YGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFL-----ISTLCDYAVQIANGMRYLES 115

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
               R IHRDL A NILL  +   KI DFG+ R
Sbjct: 116 K---RFIHRDLAARNILLASDDKVKIGDFGLMR 145

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 87.3 bits (217), Expect = 6e-19
 Identities = 50/171 (29%), Positives = 85/171 (49%), Gaps = 17/171 (9%)

Query: 544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLV 601
           FT    +G+G FG VYK       Q +A+K +     +  IE+ + E++ +++ +   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 602 RLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           +  G  ++   K+ ++ EY    S      D  +   L+      I+  +  GL YLH++
Sbjct: 63  KYYGSFLK-GSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE 117

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGT 709
                IHRD+KA+NILL +E   K++DFG++    G  T   +KR   VGT
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVS----GQLTSTMSKRNTFVGT 161

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 86.4 bits (214), Expect = 6e-19
 Identities = 48/145 (33%), Positives = 73/145 (50%), Gaps = 6/145 (4%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLLGCC 607
           K+G+G FG VYKG L    E+AVK         +  +F  E  ++ +  H N+V+L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
           V+     +V E +   SL + +  K     +    + ++    A G+ YL   +    IH
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSL--DAAAGMEYLESKN---CIH 116

Query: 668 RDLKASNILLDKEMTPKISDFGMAR 692
           RDL A N L+ +    KISDFGM+R
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 85.2 bits (211), Expect = 2e-18
 Identities = 47/152 (30%), Positives = 77/152 (50%), Gaps = 5/152 (3%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLG G FG V++G       +AVK L   +    ++F  E +++ KL+H  L++L   C 
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
             +   +V E M+  SL   +   A  + L   +  ++   +A G+ YL   +    IHR
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLEAQN---YIHR 127

Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQTE 700
           DL A N+L+ +    K++DFG+AR+   D  E
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYE 159

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 52/168 (30%), Positives = 84/168 (50%), Gaps = 19/168 (11%)

Query: 550 LGQGGFGIVYKGRLLEG----QEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LG+G FG V +G+L +      ++AVK  +L  ++   IEEF +E   +    H N+++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 604 LGCCVEMDEK------MLVYEYMENRSLDSVIFD---KARSSILNWQRRFNIICGIARGL 654
           +G C E          M++  +M++  L S +           L  Q     +  IA G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQ 701
            YL   S    IHRDL A N +L ++MT  ++DFG+++ I+ GD   Q
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQ 171

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 85.5 bits (211), Expect = 3e-18
 Identities = 57/159 (35%), Positives = 88/159 (55%), Gaps = 12/159 (7%)

Query: 550 LGQGGFGIVYKGRLL-EGQEI----AVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRL 603
           LG G FG VYKG  + EG+ +    A+K L+  +G +   EF +E  ++A + H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           LG C+      LV + M +  L   + +   +  +  Q   N    IA+G++YL +    
Sbjct: 75  LGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDN--IGSQLLLNWCVQIAKGMMYLEER--- 128

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN 702
           R++HRDL A N+L+      KI+DFG+AR+  GD+ E N
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 167

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 84.8 bits (210), Expect = 4e-18
 Identities = 52/162 (32%), Positives = 86/162 (53%), Gaps = 20/162 (12%)

Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFK-NEVRLIAKLQHRNL 600
           NF    KLG+G +  VYKGR     EI A+K +  ++ +G       E+ L+ +L+H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 601 VRLLGCCVEMDEKMLVYEYMEN---RSLDS----VIFDKARSSILNWQRRFNIICGIARG 653
           VRL       ++ MLV+EYM+    + +D+       D        +Q        + +G
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQ--------LLKG 112

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           + + H++   R++HRDLK  N+L++K    K++DFG+AR FG
Sbjct: 113 IAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG 151

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 84.3 bits (209), Expect = 5e-18
 Identities = 56/175 (32%), Positives = 86/175 (49%), Gaps = 18/175 (10%)

Query: 546 DYN---KLGQGGFGIVYKGRLLEGQE-IAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNL 600
           DY     +G G   +VY    L   E +A+KR+        ++E + EV+ +++  H N+
Sbjct: 2   DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNV 61

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL----Y 656
           V+     V  DE  LV  Y+   SL  ++        L+      II  + + +L    Y
Sbjct: 62  VKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDE----AIIATVLKEVLKGLEY 117

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM-ARIF-GGDQTEQNTKRVVGT 709
           LH       IHRD+KA NILL ++ + KI+DFG+ A +  GGD+T +  K  VGT
Sbjct: 118 LH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 83.9 bits (208), Expect = 6e-18
 Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 16/163 (9%)

Query: 530 PLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKNE 588
           P  D+E I           ++G G +G VYK R +   E+ A+K +    G   E  + E
Sbjct: 1   PQEDYELI----------QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQE 50

Query: 589 VRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC 648
           + ++ + +H N+V   G  +  D+  +V EY    SL   I+   R  +   Q  + +  
Sbjct: 51  ISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAY-VCR 108

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
              +GL YLH+      IHRD+K +NILL ++   K++DFG++
Sbjct: 109 ETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVS 148

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 83.7 bits (207), Expect = 7e-18
 Identities = 48/150 (32%), Positives = 77/150 (51%), Gaps = 6/150 (4%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           +LG G FG+V+ G+     ++A+K +        E+F  E +++ KL H  LV+L G C 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           +     +V E+MEN  L  + + + R   L+     ++   +  G+ YL ++S    IHR
Sbjct: 70  QQKPLYIVTEFMENGCL--LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           DL A N L+      K+SDFGM R    D+
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 51/158 (32%), Positives = 87/158 (55%), Gaps = 24/158 (15%)

Query: 549 KLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHRNLVRLLG 605
           K+G+G +G+VYK R  L G+ +A+K++   +  +G+      E+ L+ +L H N+VRLL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 606 CCVEMDEK--MLVYEYME---NRSLDSVIFDKARSSILN---WQRRFNIICGIARGLLYL 657
             V   E    LV+E+++    + +DS         ++    +Q        + +G+ Y 
Sbjct: 66  --VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQ--------LLQGIAYC 115

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           H     R++HRDLK  N+L+D+E   K++DFG+AR FG
Sbjct: 116 HSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFG 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 11/150 (7%)

Query: 548 NKLGQGGFGIVYKG-RLLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           NK+G G FG VY    L  G+ +AVK  R+  N  + I+E  +E++++  L+H NLV+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 605 GCCVEMDEKMLVY-EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G  V   EK+ ++ EY    +L+ ++ +  R    +  R + +   +  GL YLH     
Sbjct: 66  GVEVH-REKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTL--QLLEGLAYLHSH--- 118

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARI 693
            I+HRD+K +NI LD     K+ DFG A  
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVK 148

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 83.3 bits (206), Expect = 2e-17
 Identities = 55/177 (31%), Positives = 82/177 (46%), Gaps = 34/177 (19%)

Query: 550 LGQGGFGIVYKGR---LLEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVR 602
           +GQG FG V++ R   LL  +    +AVK L    S     +F+ E  L+A+  H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARS---------------------SILNWQ 641
           LLG C       L++EYM    L+   F + RS                       L+  
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNE--FLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGD 697
            +  I   +A G+ YL   S  + +HRDL   N L+ + M  KI+DFG++R I+  D
Sbjct: 131 EQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 51/152 (33%), Positives = 79/152 (51%), Gaps = 18/152 (11%)

Query: 550 LGQGGFGIVYKG-RLLEGQEIAVKRLS-----RNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LG G FG VY+G  L +G   AVK +S     +   + +++ + E+ L++KLQH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVI--FDKARSS-ILNWQRRFNIICGIARGLLYLHQD 660
           LG   E D   +  E +   SL  ++  +       I  + R+      I  GL YLH  
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ------ILLGLEYLHDR 121

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
                +HRD+K +NIL+D     K++DFGMA+
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAK 150

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 51/187 (27%), Positives = 88/187 (47%), Gaps = 29/187 (15%)

Query: 535 ETIVRATD---NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVR 590
           + +V   D      ++ K+G+G  GIV        G+++AVK++     Q  E   NEV 
Sbjct: 9   QLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVV 68

Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN----- 645
           ++   QH N+V +    +  DE  +V E++E  +L  ++             R N     
Sbjct: 69  IMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVT----------HTRMNEEQIA 118

Query: 646 IIC-GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
            +C  + + L +LH      +IHRD+K+ +ILL  +   K+SDFG    F    +++  +
Sbjct: 119 TVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPR 171

Query: 705 R--VVGT 709
           R  +VGT
Sbjct: 172 RKSLVGT 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 53/170 (31%), Positives = 89/170 (52%), Gaps = 9/170 (5%)

Query: 543 NFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKR--LSRNSGQGIEEFKNEVRLIAKLQHRN 599
           +F   NK+G+G FG+V+K  R  + +  A+K+  LS+ + +  EE  +E R++AKL    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           ++R     ++  +  +V EY EN  L  ++    R   L   + +     I  GL +LH 
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
               +I+HRD+K+ N+ LD     KI D G+A++   +    NT  +VGT
Sbjct: 120 K---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGT 164

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 82.6 bits (204), Expect = 2e-17
 Identities = 53/160 (33%), Positives = 79/160 (49%), Gaps = 20/160 (12%)

Query: 550 LGQGGFGIVYKGRLL-------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLV 601
           LG G FG VY+G              +AVK L + +  Q  +EF  E  L++   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIICGIARGLLYL 657
           +LLG C+  + + ++ E ME   L S + D    +    +L  +   +I   +A+G +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 658 HQDSRFRIIHRDLKASNILL-----DKEMTPKISDFGMAR 692
            +   F  IHRDL A N L+     D +   KI DFG+AR
Sbjct: 123 -EQMHF--IHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 81.9 bits (202), Expect = 4e-17
 Identities = 51/155 (32%), Positives = 86/155 (55%), Gaps = 14/155 (9%)

Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V++G L + G++   +A+K L    + +  ++F +E  ++ +  H N++RL 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDK--ARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           G   +    M++ EYMEN +LD  + D     SS     +   ++ GIA G+ YL   S 
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY----QLVGMLRGIAAGMKYL---SD 125

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
              +HRDL A NIL++  +  K+SDFG++R+   D
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 82.0 bits (202), Expect = 4e-17
 Identities = 56/168 (33%), Positives = 82/168 (48%), Gaps = 22/168 (13%)

Query: 549 KLGQGGFGIVYKGR---LLEGQE---IAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           +LG+G FG V+      LL  Q+   +AVK L   S    ++F+ E  L+  LQH+++VR
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 603 LLGCCVEMDEKMLVYEYME----NRSL-----DSVIFDKARSSI---LNWQRRFNIICGI 650
             G C E    ++V+EYM     NR L     D+ I           L   +   I   I
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGD 697
           A G++YL   +    +HRDL   N L+ + +  KI DFGM+R I+  D
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 81.1 bits (200), Expect = 6e-17
 Identities = 54/161 (33%), Positives = 83/161 (51%), Gaps = 10/161 (6%)

Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL L G+    +A+K L    + +   +F +E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V EYMEN SLD+  F +         +   ++ GIA G+ YL   S   
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDA--FLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMG 126

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
            +HRDL A NIL++  +  K+SDFG++R+   D     T R
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 81.8 bits (202), Expect = 7e-17
 Identities = 55/157 (35%), Positives = 84/157 (53%), Gaps = 16/157 (10%)

Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIAKLQHRN 599
           FTD  ++G G FG VY  R +   + +A+K++S +  Q  E++++   EVR + +L+H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI--IC-GIARGLLY 656
            +   GC +      LV EY    + D  I +  +  +    +   I  IC G  +GL Y
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPL----QEVEIAAICHGALQGLAY 130

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI 693
           LH   R   IHRD+KA NILL +  T K++DFG A +
Sbjct: 131 LHSHER---IHRDIKAGNILLTEPGTVKLADFGSASL 164

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 80.8 bits (200), Expect = 8e-17
 Identities = 53/183 (28%), Positives = 77/183 (42%), Gaps = 23/183 (12%)

Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QH 597
            T  F     +G+G +G VYK R  + GQ +A+K +        EE K E  ++ K   H
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD-IIEDEEEEIKEEYNILRKYSNH 62

Query: 598 RNLVRLLGC------CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN-----I 646
            N+    G           D+  LV E     S    + D  +      +R        I
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVKGLRKKGKRLKEEWIAYI 118

Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
           +    RGL YLH++   ++IHRD+K  NILL K    K+ DFG++     D T       
Sbjct: 119 LRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNTF 173

Query: 707 VGT 709
           +GT
Sbjct: 174 IGT 176

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 80.4 bits (199), Expect = 9e-17
 Identities = 54/177 (30%), Positives = 81/177 (45%), Gaps = 24/177 (13%)

Query: 548 NKLGQGGFGIVYK------GRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
             +G+G FG V K      G++L  +EI    ++    Q +    +EV ++ +L+H N+V
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQL---VSEVNILRELKHPNIV 62

Query: 602 RLLGCCVEMDEKML--VYEYMENRSLDSVI--FDKARSSILN---WQRRFNIICGIARGL 654
           R     ++   + L  V EY E   L  +I    K R  I     W+    I+  +   L
Sbjct: 63  RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWR----ILTQLLLAL 118

Query: 655 LYLH--QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
              H   D    ++HRDLK +NI LD     K+ DFG+A+I G D      K  VGT
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS--SFAKTYVGT 173

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 81.0 bits (200), Expect = 9e-17
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 14/157 (8%)

Query: 550 LGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 605 GCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           G C     +   LV EY+   SL D +   + R   L+ ++       I +G+ YL    
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYL---G 125

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
             R +HRDL   NIL++ E   KI DFG+ ++   D+
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 80.3 bits (198), Expect = 1e-16
 Identities = 50/156 (32%), Positives = 83/156 (53%), Gaps = 10/156 (6%)

Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V +GRL L G+    +A+K L    + +   +F +E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M++ E+MEN +LDS  F +         +   ++ GIA G+ YL   S   
Sbjct: 72  GVVTKSRPVMIITEFMENGALDS--FLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMN 126

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE 700
            +HRDL A NIL++  +  K+SDFG++R    D ++
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 52/170 (30%), Positives = 74/170 (43%), Gaps = 29/170 (17%)

Query: 549 KLGQGGFGIVY-----------------KGRLLEGQEIAVKRLSRN-SGQGIEEFKNEVR 590
           KLG+G FG V+                          +AVK L  + S    E+F  EV+
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLD-----SVIFDKAR---SSILNWQR 642
           ++++L   N+ RLLG C       ++ EYMEN  L+      V         S  L++  
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 643 RFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              +   IA G+ YL        +HRDL   N L+ K  T KI+DFGM+R
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 79.9 bits (198), Expect = 1e-16
 Identities = 50/165 (30%), Positives = 75/165 (45%), Gaps = 14/165 (8%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G FG V   R  + G+  A+K L +      + +E    E  +++++ H  +V+L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 606 CCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + +EK+ LV EY     L S +           + RF     I   L YLH      
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARF-YAAEIVLALEYLH---SLG 113

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           II+RDLK  NILLD +   K++DFG+A+          T    GT
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKEL--SSEGSRTNTFCGT 156

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 81.5 bits (202), Expect = 1e-16
 Identities = 61/170 (35%), Positives = 98/170 (57%), Gaps = 20/170 (11%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEI-AVKRLS---RNSGQGIEEFKNEVRLIAKL-QHRNLVR 602
            KLG+G +GIV+K      +E+ A+K++    RN+      F+ E+  + +L  H N+V+
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVK 71

Query: 603 LLGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSIL-NWQRRFNIICGIARGLLYLHQ 659
           LL      ++K   LV+EYME   L +VI    R++IL +  +R+ I+  + + L Y+H 
Sbjct: 72  LLNVIKAENDKDIYLVFEYMET-DLHAVI----RANILEDVHKRY-IMYQLLKALKYIH- 124

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
            S   +IHRDLK SNILL+ +   K++DFG+AR     + E+N +  V T
Sbjct: 125 -SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVLT 170

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 48/153 (31%), Positives = 82/153 (53%), Gaps = 15/153 (9%)

Query: 549 KLGQGGFGIVYKGRLLEGQEI-AVKRLS-RNSGQGIEEFK-NEVRLIAKLQHRNLVRLLG 605
           K+G+G +G V+K +  E  EI A+KR+   +  +G+      E+ L+ +L+H+N+VRL  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 606 CCVEMDEKMLVYEYMEN---RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
                 +  LV+EY +    +  DS   D     +    + F  +  + +GL + H    
Sbjct: 67  VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIV----KSF--MFQLLKGLAFCHSH-- 118

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
             ++HRDLK  N+L++K    K++DFG+AR FG
Sbjct: 119 -NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 47/151 (31%), Positives = 79/151 (52%), Gaps = 6/151 (3%)

Query: 548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           +KLG G +G VY+G   +    +AVK L +     +EEF  E  ++ +++H NLV+LLG 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
           C       ++ E+M   +L   + +  R   +N      +   I+  + YL + +    I
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 126

Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGD 697
           HRDL A N L+ +    K++DFG++R+  GD
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGD 157

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 80.3 bits (199), Expect = 2e-16
 Identities = 55/175 (31%), Positives = 96/175 (54%), Gaps = 14/175 (8%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL---SRNSGQGIEEFKNEVRLIAK 594
           R+ D +   N++ +G +G+VY+ R  +  EI A+K+L       G  I   + E+ ++ K
Sbjct: 2   RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLK 60

Query: 595 LQHRNLVRLLGCCV--EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIAR 652
           LQH N+V +    V   +D+  +V EY+E+  L S++ +  +   L  + +  ++  +  
Sbjct: 61  LQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLM-ETMKQPFLQSEVKC-LMLQLLS 117

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
           G+ +LH +    I+HRDLK SN+LL+     KI DFG+AR + G   +  T+ VV
Sbjct: 118 GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVV 168

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 80.8 bits (200), Expect = 2e-16
 Identities = 52/168 (30%), Positives = 83/168 (49%), Gaps = 34/168 (20%)

Query: 549 KLGQGGFGIVYKGRLLE---GQEIAVKRL--SRNSGQGIEEFK-NEVRLIAKLQHRNLVR 602
            +G+G +G VYK +      G+E A+K+    +    GI +    E+ L+ +L+H N+V 
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66

Query: 603 LLGCCVEMDEKM--LVYEYME---------NRSLDSV-IFDKARSSILNWQRRFNIICGI 650
           L+   +E  +K   L+++Y E         +R    V I      S+L WQ    I+ G+
Sbjct: 67  LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLL-WQ----ILNGV 121

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMARIF 694
                YLH +    ++HRDLK +NIL+  E       KI D G+AR+F
Sbjct: 122 H----YLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 48/161 (29%), Positives = 73/161 (45%), Gaps = 25/161 (15%)

Query: 550 LGQGGFGIVYKGRLL------EGQEIAVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVR 602
           LGQG FG+VY+G             +A+K ++ N+      EF NE  ++ +    ++VR
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARS-----------SILNWQRRFNIICGIA 651
           LLG        ++V E M    L S +    RS                Q+   +   IA
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYL----RSRRPEAENNPGLGPPTLQKFIQMAAEIA 129

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            G+ YL      + +HRDL A N ++ +++T KI DFGM R
Sbjct: 130 DGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 79.5 bits (196), Expect = 2e-16
 Identities = 51/167 (30%), Positives = 83/167 (49%), Gaps = 17/167 (10%)

Query: 550 LGQGGFGIVYKGRLLEGQ------EIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +G+G FGIV+  R    Q      +I V++++++     +   NE +++  L H N++  
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
               +E    M+V EY    +L   I  K  +S+L+     +    I   L ++H     
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYI-QKRCNSLLDEDTILHFFVQILLALHHVHTKL-- 121

Query: 664 RIIHRDLKASNILLDK-EMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
            I+HRDLK  NILLDK +M  KI DFG+++I     ++     VVGT
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGT 164

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 49/164 (29%), Positives = 81/164 (49%), Gaps = 17/164 (10%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLEGQ-EIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN 599
            D   +   LG+G +GIVY  R L  Q  IA+K +     + ++    E+ L + L+HRN
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK------ARSSILNWQRRFNIICGIARG 653
           +V+ LG   E     +  E +   SL +++  K         +I+ + ++      I  G
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ------ILEG 120

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDK-EMTPKISDFGMARIFGG 696
           L YLH +   +I+HRD+K  N+L++      KISDFG ++   G
Sbjct: 121 LKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 47/150 (31%), Positives = 77/150 (51%), Gaps = 5/150 (3%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLG G FG V+ G      ++AVK L   +   ++ F  E  L+  LQH  LVRL     
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           + +   ++ EYM   SL   +       +L   +  +    IA G+ Y+ + +    IHR
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKN---YIHR 127

Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           DL+A+N+L+ + +  KI+DFG+AR+   ++
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNE 157

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 79.1 bits (195), Expect = 4e-16
 Identities = 52/158 (32%), Positives = 91/158 (57%), Gaps = 12/158 (7%)

Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVK--RLSRNSGQGIEEFK-NEVRLIAKLQHR 598
           NF    K+G+G +G+VYK R  L G+ +A+K  RL   + +G+      E+ L+ +L H 
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHP 59

Query: 599 NLVRLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
           N+V+LL   +  + K+ LV+E++ ++ L   + D +  S +      + +  + +GL + 
Sbjct: 60  NIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFC 116

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 117 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 79.3 bits (196), Expect = 4e-16
 Identities = 57/187 (30%), Positives = 92/187 (49%), Gaps = 34/187 (18%)

Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKR-LSRNSGQG--IEEFKNEVRLIAKLQH 597
             +    K+GQG FG V+K R     Q +A+K+ L  N  +G  I   + E++++  L+H
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKH 70

Query: 598 RNLVRLLGCCVEMDEK--------MLVYEYMENRSLDSVIFDKARSSILNWQRRFN---- 645
            N+V L+  C               LV+E+ E+        D A   + N   +F     
Sbjct: 71  ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH--------DLAGL-LSNKNVKFTLSEI 121

Query: 646 --IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG---GDQTE 700
             ++  +  GL Y+H   R +I+HRD+KA+NIL+ K+   K++DFG+AR F      +  
Sbjct: 122 KKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN 178

Query: 701 QNTKRVV 707
           + T RVV
Sbjct: 179 RYTNRVV 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 78.7 bits (194), Expect = 4e-16
 Identities = 51/159 (32%), Positives = 80/159 (50%), Gaps = 28/159 (17%)

Query: 550 LGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQG---------IEEFKNEVRLIAKLQHRN 599
           +G G FG VY G     G+ +AVK++   S            ++    E+ L+ +LQH N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF------NIICGIARG 653
           +V+ LG  ++ D   +  EY+   S+         +++LN    F      N +  I +G
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSV---------AALLNNYGAFEETLVRNFVRQILKG 118

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           L YLH      IIHRD+K +NIL+D +   KISDFG+++
Sbjct: 119 LNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 78.7 bits (194), Expect = 4e-16
 Identities = 50/149 (33%), Positives = 84/149 (56%), Gaps = 11/149 (7%)

Query: 550 LGQGGFGIVYKGRLL--EGQEI--AVKRLSR-NSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G L+  +GQ+I  AVK L+R    + +E+F  E  ++    H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I  +  +  +     F +   +A+G+ YL      
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYLASK--- 117

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
           + +HRDL A N +LD+  T K++DFG+AR
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 78.8 bits (194), Expect = 5e-16
 Identities = 54/151 (35%), Positives = 71/151 (47%), Gaps = 15/151 (9%)

Query: 550 LGQGGFGIVYKGRLL-----EGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKLQHRNLVRL 603
           LG+G FG V            G+ +AVK L R  GQ     +K E+ ++  L H N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 604 LGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            GCC E   K   L+ EY+   SL     D      LN  +       I  G+ YLH   
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSL----RDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ- 126

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
               IHRDL A N+LLD +   KI DFG+A+
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 79.2 bits (195), Expect = 5e-16
 Identities = 54/184 (29%), Positives = 92/184 (50%), Gaps = 38/184 (20%)

Query: 549 KLGQGGFGIVYKGRLLEGQE-----------------IAVKRLSRNSGQGIE-EFKNEVR 590
           KLG+G FG V+   ++  Q+                 +AVK L  ++ +    +F  EV+
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDS-----VIFDKARSS--------- 636
           ++++L+  N++RLLG CV+ D   ++ EYMEN  L+       + DK  +          
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 637 --ILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-I 693
              +++    ++   IA G+ YL   S    +HRDL   N L+ + +T KI+DFGM+R +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188

Query: 694 FGGD 697
           + GD
Sbjct: 189 YAGD 192

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 77.9 bits (192), Expect = 7e-16
 Identities = 56/181 (30%), Positives = 85/181 (46%), Gaps = 19/181 (10%)

Query: 543 NFTDYNKLGQGGFGIVYK-------GRLLEGQEIAVKRLS-----RNSGQGIEEFKNEVR 590
            +     LG G FG VYK         LL  +EI V   +     R   + I +  +EV 
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 591 LIAK-LQHRNLVRLLGCCVEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIIC 648
           +I + L+H N+VR     +E D   +V + +E   L +     K +      +R +NI  
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            +   L YLH++ R  I+HRDL  +NI+L ++    I+DFG+A+     Q E     VVG
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVG 175

Query: 709 T 709
           T
Sbjct: 176 T 176

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 78.2 bits (192), Expect = 7e-16
 Identities = 52/160 (32%), Positives = 80/160 (50%), Gaps = 19/160 (11%)

Query: 549 KLGQGGFGIVYKGR---LLEGQE---IAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           +LG+G FG V+      L   Q+   +AVK L   S    ++F  E  L+  LQH ++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 603 LLGCCVEMDEKMLVYEYMENRSL---------DSVIFDKARSSI-LNWQRRFNIICGIAR 652
             G CVE D  ++V+EYM++  L         D+V+  +      L   +  +I   IA 
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           G++YL        +HRDL   N L+ + +  KI DFGM+R
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSR 168

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 78.4 bits (193), Expect = 8e-16
 Identities = 55/184 (29%), Positives = 88/184 (47%), Gaps = 32/184 (17%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQE------------------IAVKRLSRNSGQGIE 583
              T   KLG+G FG V+     EG E                  +AVK L  ++ +   
Sbjct: 5   KRLTFKEKLGEGQFGEVHLCEA-EGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNAR 63

Query: 584 -EFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI--------FDKAR 634
            +F  E++++++L+  N++RLL  C+  D   ++ EYMEN  L+  +         +KA 
Sbjct: 64  NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKAD 123

Query: 635 SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-I 693
              +++     +   IA G+ YL   S    +HRDL   N L+ K  T KI+DFGM+R +
Sbjct: 124 VVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180

Query: 694 FGGD 697
           + GD
Sbjct: 181 YSGD 184

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 77.7 bits (191), Expect = 8e-16
 Identities = 49/146 (33%), Positives = 83/146 (56%), Gaps = 10/146 (6%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
            +G+G FG V +G    GQ++AVK +  +     + F  E  ++ KL H+NLVRLLG  +
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR-RFNIICGIARGLLYLHQDSRFRIIH 667
             +   +V E M   +L + +  + R+ +   Q  +F++   +A G+ YL      +++H
Sbjct: 70  H-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL--DVAEGMEYLESK---KLVH 123

Query: 668 RDLKASNILLDKEMTPKISDFGMARI 693
           RDL A NIL+ ++   K+SDFG+AR+
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV 149

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 78.0 bits (192), Expect = 8e-16
 Identities = 48/152 (31%), Positives = 83/152 (54%), Gaps = 18/152 (11%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLS--RNSGQG----IEEFKNEVRLIAKLQHRNLVR 602
           LG G F   Y+ R +  G  +AVK+++  RN+       +E  + E+RL+A+L H +++R
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVI--FDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           +LG   E     L  E+M   S+  ++  +   + +++      N    + RGL YLH++
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII-----NYTEQLLRGLSYLHEN 122

Query: 661 SRFRIIHRDLKASNILLDKE-MTPKISDFGMA 691
              +IIHRD+K +N+L+D      +I+DFG A
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAA 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 78.1 bits (192), Expect = 1e-15
 Identities = 52/175 (29%), Positives = 83/175 (47%), Gaps = 29/175 (16%)

Query: 549 KLGQGGFGIVY---KGRLLEGQE------------IAVKRLSRNSGQGIE-EFKNEVRLI 592
           KLG+G FG V+      L E               +AVK L  +  +    +F  E++++
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSIL---------NWQRR 643
           ++L++ N++RLLG CV  D   ++ EYMEN  L+  +  +   S           +    
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131

Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGD 697
             +   IA G+ YL   +    +HRDL   N L+    T KI+DFGM+R ++ GD
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 76.8 bits (189), Expect = 2e-15
 Identities = 47/170 (27%), Positives = 82/170 (48%), Gaps = 31/170 (18%)

Query: 550 LGQGGFGIVYKG-RLLEGQEIAVKRL---SRNSGQG-------IEEFKNEVRLIAKLQHR 598
           +G+G +G VY    +  G+ +AVK++   +  +G+        ++  ++E+  +  L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVI-----FDKARSSILNWQRRFNIICGIARG 653
           N+V+ LG     +   +  EY+   S+ S +     F++        Q        +  G
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VLEG 120

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR----IFGGDQT 699
           L YLH      I+HRDLKA N+L+D +   KISDFG+++    I+  DQ 
Sbjct: 121 LAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN 167

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 8/153 (5%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIE-EFKNEVRLIAKLQHRN 599
           +   + ++LG+G  G V K RL     I A+K ++ +    ++ +   E+ +    +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 600 LVRLLGCCVEMDEKML--VYEYMENRSLDSVIFD-KARSSILNWQRRFNIICGIARGLLY 656
           +V+  G  ++     +    EY E  SLDS+    K R   +  +    I   + +GL Y
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           LH     +IIHRD+K SNILL ++   K+ DFG
Sbjct: 121 LHSR---KIIHRDIKPSNILLTRKGQVKLCDFG 150

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 47/156 (30%), Positives = 74/156 (47%), Gaps = 27/156 (17%)

Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN----EVRLIAKLQHRNLVRL 603
            +G+G +G+V K R    G+ +A+K+   +     E+ K     EV+++ +L+H N+V L
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRHENIVNL 65

Query: 604 LGCCVEMDEKMLVYEYMENRSLD-------SVIFDKARSSILNWQRRFNIICGIARGLLY 656
                      LV+EY+E   L+        +  D  RS I  WQ        + + + Y
Sbjct: 66  KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYI--WQ--------LLQAIAY 115

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            H      IIHRD+K  NIL+ +    K+ DFG AR
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 76.8 bits (189), Expect = 3e-15
 Identities = 54/163 (33%), Positives = 89/163 (54%), Gaps = 19/163 (11%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLS-RNSGQGIEEFK-NEVRLIAKLQHR 598
           D +    K+G+G +G+VYK R     E IA+K++      +G+      E+ L+ ++QH 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 599 NLVRLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNII----CGIARG 653
           N+VRL    V  ++++ LV+EY++   LD     K   S  ++ +   +I      I RG
Sbjct: 62  NIVRLQDV-VHSEKRLYLVFEYLD---LD---LKKHMDSSPDFAKNPRLIKTYLYQILRG 114

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIFG 695
           + Y H     R++HRDLK  N+L+D+     K++DFG+AR FG
Sbjct: 115 IAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154

Length = 294

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 76.6 bits (188), Expect = 3e-15
 Identities = 52/154 (33%), Positives = 80/154 (51%), Gaps = 10/154 (6%)

Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKN---EVRLIAKLQHRN 599
           F+D  ++G G FG VY  R +   E+ A+K++S +  Q  E++++   EVR + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
            ++  GC +      LV EY    + D +   +     L       +  G  +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARI 693
            +   +IHRD+KA NILL +    K+ DFG A I
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASI 164

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 76.7 bits (188), Expect = 3e-15
 Identities = 53/181 (29%), Positives = 95/181 (52%), Gaps = 15/181 (8%)

Query: 534 FETIVRATD---NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEV 589
             TIV   D    +T Y K+GQG  G V+    +  GQE+A+K+++       E   NE+
Sbjct: 8   LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67

Query: 590 RLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC- 648
            ++ +L++ N+V  L   +  DE  +V EY+   SL  V+ +         + +   +C 
Sbjct: 68  LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMD-----EAQIAAVCR 122

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
              + L +LH +   ++IHRD+K+ N+LL  + + K++DFG       +Q++++T  +VG
Sbjct: 123 ECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177

Query: 709 T 709
           T
Sbjct: 178 T 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 76.0 bits (187), Expect = 5e-15
 Identities = 54/186 (29%), Positives = 100/186 (53%), Gaps = 27/186 (14%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLS-RNSGQG--IEEFKNEVRLIAK 594
           R  D F    ++G+G +G VYK R    G+ +A+K++   N  +G  I   + E++++ +
Sbjct: 4   RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQ 62

Query: 595 LQHRNLVRLLGCCVE----MDEK------MLVYEYMENR---SLDSVIFDKARSSILNWQ 641
           L HRN+V L     +    +D K       LV+EYM++     L+S +   +   I ++ 
Sbjct: 63  LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122

Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ 701
           ++      +  GL Y H+ +    +HRD+K SNILL+ +   K++DFG+AR++  +++  
Sbjct: 123 KQ------LLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173

Query: 702 NTKRVV 707
            T +V+
Sbjct: 174 YTNKVI 179

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 76.3 bits (187), Expect = 6e-15
 Identities = 51/154 (33%), Positives = 80/154 (51%), Gaps = 10/154 (6%)

Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKN---EVRLIAKLQHRN 599
           FTD  ++G G FG VY  R +   E+ A+K++S +  Q  E++++   EV+ + +++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
            +   GC +      LV EY    + D +   +     L       I  G  +GL YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARI 693
            +   +IHRD+KA NILL +    K++DFG A I
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI 174

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 75.2 bits (185), Expect = 6e-15
 Identities = 49/160 (30%), Positives = 78/160 (48%), Gaps = 24/160 (15%)

Query: 550 LGQGGFGIVY----KGRLLEGQE--IAVKRL-SRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           LG+G FG V+    KG   EG E  + VK L          EF+ E+ +  KL H+N+VR
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 603 LLGCCVEMDEKMLVYEYME----------NRSLDSVIFDKARSSILNWQRRFNIICGIAR 652
           LLG C E +   ++ EY +           +S D    +K +   L+ +++  +   IA 
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKD----EKLKPPPLSTKQKVALCTQIAL 128

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           G+ +L   S  R +HRDL A N L+  +   K+S   +++
Sbjct: 129 GMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 75.1 bits (185), Expect = 7e-15
 Identities = 45/147 (30%), Positives = 80/147 (54%), Gaps = 9/147 (6%)

Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKR-LSRNSGQGIEEFK-NEVRLIAKLQHRNLVRLLG 605
            +G+G +G+V K +  E GQ +A+K+ L     + +++    E+R++ +L+H NLV L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
                    LV+E++++  LD +   +   + L+  R    +  I RG+ + H  +   I
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSHN---I 121

Query: 666 IHRDLKASNILLDKEMTPKISDFGMAR 692
           IHRD+K  NIL+ +    K+ DFG AR
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 74.7 bits (183), Expect = 8e-15
 Identities = 49/148 (33%), Positives = 76/148 (51%), Gaps = 12/148 (8%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLG G FG V+     +  ++AVK +   S   +E F  E  ++  LQH  LV+L    V
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAVV 70

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNII---CGIARGLLYLHQDSRFRI 665
             +   ++ E+M   SL     D  +S   + Q    +I     IA G+ ++ Q +    
Sbjct: 71  TKEPIYIITEFMAKGSL----LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---Y 123

Query: 666 IHRDLKASNILLDKEMTPKISDFGMARI 693
           IHRDL+A+NIL+   +  KI+DFG+AR+
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARV 151

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 48/178 (26%), Positives = 84/178 (47%), Gaps = 18/178 (10%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLS---RNSGQGIEEFKNEVRLIAKLQ 596
             NF    K+G+G F +VYK   LL+G+ +A+K++        +  ++   E+ L+ +L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI--FDKARSSILN---WQRRFNIICGIA 651
           H N+++ L   +E +E  +V E  +   L  +I  F K +  I     W         + 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW----KYFVQLC 116

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             L ++H     RI+HRD+K +N+ +      K+ D G+ R F    T  ++   VGT
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 75.2 bits (185), Expect = 1e-14
 Identities = 53/174 (30%), Positives = 83/174 (47%), Gaps = 32/174 (18%)

Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN----- 587
           F T+   T+ + D   +G G FG+V   R  L GQ +A+K++       ++ F       
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAK 54

Query: 588 ----EVRLIAKLQHRNLVRLLGCCVEMDEKM-LVYEYME---NRSLDSVIFDKARSSILN 639
               E++L+  L+H N++ L    +   E +  V E +    +R L S   +K       
Sbjct: 55  RTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFL 114

Query: 640 WQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI 693
           +Q        I RGL Y+H      ++HRDLK SNIL+++    KI DFG+ARI
Sbjct: 115 YQ--------ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 49/151 (32%), Positives = 81/151 (53%), Gaps = 16/151 (10%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKR-----LSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LGQG FG VY    ++ G+E+AVK+      S  + + +   + E++L+  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 604 LGCCVEMDEKMLVY-EYMENRSLDSVIFDKARSSIL-NWQRRFNIICGIARGLLYLHQDS 661
            GC +  DE + ++ EYM   S+   +  KA  ++     R++     I  G+ YLH + 
Sbjct: 70  YGC-LRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTR--QILEGVEYLHSN- 123

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              I+HRD+K +NIL D     K+ DFG ++
Sbjct: 124 --MIVHRDIKGANILRDSAGNVKLGDFGASK 152

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 75.0 bits (184), Expect = 1e-14
 Identities = 56/177 (31%), Positives = 93/177 (52%), Gaps = 27/177 (15%)

Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 3   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61

Query: 591 LIAKLQHRNLVRLLGCC----VEMDEKMLVYEYMENRSLDSVIFDKAR---SSILNWQRR 643
           ++A + + ++ RLLG C    V++  +++ +  +    LD V   K       +LNW   
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCL----LDYVREHKDNIGSQYLLNW--- 114

Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE 700
                 IA+G+ YL +    R++HRDL A N+L+      KI+DFG+A++ G D+ E
Sbjct: 115 ---CVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 46/150 (30%), Positives = 75/150 (50%), Gaps = 6/150 (4%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           +LG G FG+V  G+     ++A+K +   S    +EF  E +++ KL H  LV+L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           +     +V EYM N  L + + +  +       +   +   +  G+ YL      + IHR
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFIHR 124

Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           DL A N L+D +   K+SDFG++R    D+
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 56/178 (31%), Positives = 86/178 (48%), Gaps = 25/178 (14%)

Query: 543 NFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKR--LSRNSGQGIEEFKNEVRLIAKLQHRN 599
           +F    KLG+G +G VYK  RL + Q  A+K   L   S +  E+  NE+R++A + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 600 LVR-----LLGC--CVEMDEKMLVYEYMENRSLDSVIFD-KARSSILNWQRRFNIICGIA 651
           ++      L G   C+ M       EY     L   I   K +  ++  Q  + I   + 
Sbjct: 61  IISYKEAFLDGNKLCIVM-------EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           RGL  LH+    +I+HRDLK++NILL      KI D G++++      +   K  +GT
Sbjct: 114 RGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGT 164

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 50/146 (34%), Positives = 77/146 (52%), Gaps = 8/146 (5%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKAR-SSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
           E +   +V EYM   SL  + F K      L   +  ++   IA G+ Y+    R   +H
Sbjct: 72  E-EPIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 125

Query: 668 RDLKASNILLDKEMTPKISDFGMARI 693
           RDL+A+NIL+ + +  K++DFG+AR+
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARL 151

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 55/182 (30%), Positives = 92/182 (50%), Gaps = 21/182 (11%)

Query: 536 TIVRATD---NFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKNEVRL 591
           TIV   D    +T + K+GQG  G VY    +  GQE+A+K+++       E   NE+ +
Sbjct: 10  TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILV 69

Query: 592 IAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIA 651
           + + +H N+V  L   +  DE  +V EY+   SL  V+ +               I  + 
Sbjct: 70  MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE--------GQIAAVC 121

Query: 652 RGLL----YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
           R  L    +LH +   ++IHRD+K+ NILL  + + K++DFG       +Q++++T  +V
Sbjct: 122 RECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MV 176

Query: 708 GT 709
           GT
Sbjct: 177 GT 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 47/144 (32%), Positives = 75/144 (52%), Gaps = 6/144 (4%)

Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRNLVRLLGCCV 608
           LG+G FG V+KG L +   +AVK    +  Q ++ +F +E R++ +  H N+V+L+G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           +     +V E +     D + F + +   L  ++        A G+ YL   +    IHR
Sbjct: 63  QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 669 DLKASNILLDKEMTPKISDFGMAR 692
           DL A N L+ +    KISDFGM+R
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 45/144 (31%), Positives = 75/144 (52%), Gaps = 8/144 (5%)

Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE 609
           +G+G FG V  G    G ++AVK +  ++    + F  E  ++ +L+H NLV+LLG  VE
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 610 MDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
               + +V EYM   SL   +  + RS +L           +   + YL  ++    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126

Query: 669 DLKASNILLDKEMTPKISDFGMAR 692
           DL A N+L+ ++   K+SDFG+ +
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 74.0 bits (182), Expect = 3e-14
 Identities = 45/169 (26%), Positives = 82/169 (48%), Gaps = 30/169 (17%)

Query: 544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           + D   LG G  G+V+     +  + +AVK++     Q ++    E+++I +L H N+V+
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 603 L--------------LGCCVEMDEKMLVYEYMEN---RSLDSVIFDKARSSILNWQRRFN 645
           +              +G   E++   +V EYME      L+     +  + +  +Q    
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQ---- 122

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARI 693
               + RGL Y+H  +   ++HRDLK +N+ ++ E +  KI DFG+ARI
Sbjct: 123 ----LLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARI 164

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 72.6 bits (178), Expect = 5e-14
 Identities = 52/164 (31%), Positives = 84/164 (51%), Gaps = 30/164 (18%)

Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGI------EEFKNEVRLIAKLQH 597
           +T    LG+G +G VY G   +GQ IAVK++  ++   +      E+ + EV L+  L+H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN-----IIC---- 648
            N+V+ LG C++ +   +  E++   S+         SSILN   RF      + C    
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSI---------SSILN---RFGPLPEPVFCKYTK 109

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            I  G+ YLH +    ++HRD+K +N++L      K+ DFG AR
Sbjct: 110 QILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 72.8 bits (179), Expect = 6e-14
 Identities = 46/156 (29%), Positives = 79/156 (50%), Gaps = 19/156 (12%)

Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-------EVRLIAKLQHRNL 600
           K+G+G +G+V+K R  E GQ +A+K+   +     E+          E+R++ +L+H NL
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVES-----EDDPVIKKIALREIRMLKQLKHPNL 62

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V L+       +  LV+EY ++  L+ +   +     +       II    + + + H+ 
Sbjct: 63  VNLIEVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           +    IHRD+K  NIL+ K+   K+ DFG ARI  G
Sbjct: 120 N---CIHRDVKPENILITKQGQIKLCDFGFARILTG 152

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 73.6 bits (181), Expect = 6e-14
 Identities = 57/166 (34%), Positives = 81/166 (48%), Gaps = 36/166 (21%)

Query: 550 LGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN---------EVRLIAKLQHRN 599
           +G G  GIV      + GQ +A+K+LSR        F+N         E+ L+  + H+N
Sbjct: 24  IGSGAQGIVCAAYDTVTGQNVAIKKLSR-------PFQNVTHAKRAYRELVLMKLVNHKN 76

Query: 600 LVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGIA 651
           ++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI 
Sbjct: 77  IIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQ----MLCGIK 132

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               +LH      IIHRDLK SNI++  + T KI DFG+AR  G  
Sbjct: 133 ----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 72.3 bits (177), Expect = 7e-14
 Identities = 56/170 (32%), Positives = 85/170 (50%), Gaps = 24/170 (14%)

Query: 549 KLGQGGFGIVYKGRL-LEGQE----IAVKRLSR-NSGQGIEEFKNEVRLIAKLQHRNLVR 602
           +LG+  FG +YKG L L G +    +A+K L   N+ Q   EF+ E  L+A+L H N+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIF--------------DKARSSILNWQRRFNIIC 648
           LLG   +     +++EY+    L   +               D    S L+     +I  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGD 697
            IA G+ YL   S F  +H+DL A NIL+ +++  KISD G++R I+  D
Sbjct: 132 QIAAGMEYL--SSHF-FVHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 71.9 bits (176), Expect = 8e-14
 Identities = 52/158 (32%), Positives = 78/158 (49%), Gaps = 17/158 (10%)

Query: 549 KLGQGGFGIVY---------KGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN 599
           +LG+G FG VY         + RL   +EI V  L+ N      +   E +L++KL H  
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE---TVQANQEAQLLSKLDHPA 63

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD-KARSSILNWQRRFNIICGIARGLLYLH 658
           +V+     +E D   ++ EY E R LD  + + K     L+  +       +  G+ Y+H
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           Q    RI+HRDLKA NI L   +  KI DFG++R+  G
Sbjct: 124 QR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMG 157

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 72.0 bits (176), Expect = 8e-14
 Identities = 56/164 (34%), Positives = 85/164 (51%), Gaps = 26/164 (15%)

Query: 550 LGQGGFGIVYKGRLLEGQE-----IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LG G FG VYKG  +   E     +A+K L  N S +  +E  +E  ++A +    + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 604 LGCC----VEMDEKMLVYEYMENRSLDSVIFDKAR---SSILNWQRRFNIICGIARGLLY 656
           LG C    V++  +++ Y  +    LD V  +K R     +LNW         IA+G+ Y
Sbjct: 75  LGICLTSTVQLVTQLMPYGCL----LDYVRENKDRIGSQDLLNW------CVQIAKGMSY 124

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE 700
           L +    R++HRDL A N+L+      KI+DFG+AR+   D+TE
Sbjct: 125 LEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 72.1 bits (177), Expect = 9e-14
 Identities = 45/144 (31%), Positives = 79/144 (54%), Gaps = 8/144 (5%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           LG G FG VYK +  E G   A K +   S + +E+F  E+ ++++ +H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-GIARGLLYLHQDSRFRIIH 667
             ++  ++ E+ +  +LDS++  +    +   Q R+  +C  +   L +LH     ++IH
Sbjct: 73  YENKLWILIEFCDGGALDSIM-LELERGLTEPQIRY--VCRQMLEALNFLH---SHKVIH 126

Query: 668 RDLKASNILLDKEMTPKISDFGMA 691
           RDLKA NILL  +   K++DFG++
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 72.7 bits (179), Expect = 1e-13
 Identities = 50/170 (29%), Positives = 83/170 (48%), Gaps = 21/170 (12%)

Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN---EV 589
            +T+    D + + + +G G +G V      + G+++A+K+LSR   Q     K    E+
Sbjct: 7   NKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSR-PFQSAIHAKRTYREL 65

Query: 590 RLIAKLQHRNLVRLLGCCVEMDEKM------LVYEYMENRSLDSVIFDKARSSILNWQR- 642
           RL+  + H N++ LL                LV   M    L++++    +   L+    
Sbjct: 66  RLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIV----KCQKLSDDHI 120

Query: 643 RFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +F ++  I RGL Y+H      IIHRDLK SNI ++++   KI DFG+AR
Sbjct: 121 QF-LVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 51/170 (30%), Positives = 82/170 (48%), Gaps = 24/170 (14%)

Query: 549 KLGQGGFGIVYKGRLL------EGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLV 601
           +LG+  FG VYKG L       + Q +A+K L  +  G   EEFK+E  + ++LQH N+V
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIF-------------DKARSSILNWQRRFNIIC 648
            LLG   +     +++ Y  +  L   +              DK   S L      +I+ 
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGD 697
            IA G+ +L   S   ++H+DL   N+L+  ++  KISD G+ R ++  D
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAAD 178

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 72.5 bits (178), Expect = 1e-13
 Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 22/165 (13%)

Query: 548 NKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN--------------EVRLI 592
             LG+G +G V K    L G+ +A+K++                           E++++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIAR 652
            +++H N++ L+   VE D   LV + M +  L  V+  K R +     +   I+  I  
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTE---SQVKCILLQILN 130

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
           GL  LH+      +HRDL  +NI ++ +   KI+DFG+AR +G  
Sbjct: 131 GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYP 172

Length = 335

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 72.3 bits (178), Expect = 1e-13
 Identities = 45/177 (25%), Positives = 83/177 (46%), Gaps = 33/177 (18%)

Query: 542 DNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN---------EVRL 591
             + + + +G+G +G+V        G ++A+K+        I  F++         E+++
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKK--------ISPFEHQTFCQRTLREIKI 56

Query: 592 IAKLQHRNLVRLL-----GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI 646
           + + +H N++ +L           ++  +V E ME   L  +I    ++  L+       
Sbjct: 57  LRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLI----KTQHLSNDHIQYF 111

Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
           +  I RGL Y+H  +   ++HRDLK SN+LL+     KI DFG+ARI   D    +T
Sbjct: 112 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHT 163

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 30/167 (17%)

Query: 549 KLGQGGFGIVY----------KGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR 598
           +LG+G FG V+          K ++L    +AVK L   +    ++F+ E  L+  LQH 
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKML----VAVKALKDPTLAARKDFQREAELLTNLQHE 67

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-------------LNWQRRFN 645
           ++V+  G C + D  ++V+EYM++  L+  +      ++             L   +  +
Sbjct: 68  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           I   IA G++YL        +HRDL   N L+   +  KI DFGM+R
Sbjct: 128 IASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|204904 pfam12398, DUF3660, Receptor serine/threonine kinase

 Score = 64.6 bits (158), Expect = 2e-13
 Identities = 21/40 (52%), Positives = 31/40 (77%), Gaps = 1/40 (2%)

Query: 496 PRGHPERSQDLLLNQVVISSKRDYSAD-KTDDLELPLFDF 534
           P  + +R+QDLL+N +V+SSKR  S + KT++LELPL +F
Sbjct: 3   PIVNRQRNQDLLMNGMVLSSKRQLSGENKTEELELPLIEF 42

This domain family is found in eukaryotes, and is approximately 40 amino acids in length. The family is found in association with pfam00954, pfam01453, pfam00069, pfam08276. There is a conserved ELPL sequence motif. Length = 42

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 49/145 (33%), Positives = 74/145 (51%), Gaps = 6/145 (4%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLG G FG V+ G      ++AVK L   +    E F  E +++ KL+H  LV+L    V
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAV-V 70

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
             +   +V EYM   SL   + D      L      ++   +A G+ Y+    R   IHR
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126

Query: 669 DLKASNILLDKEMTPKISDFGMARI 693
           DL+++NIL+   +  KI+DFG+AR+
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARL 151

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 70.5 bits (172), Expect = 4e-13
 Identities = 49/168 (29%), Positives = 90/168 (53%), Gaps = 12/168 (7%)

Query: 544 FTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           +T + K+GQG  G VY    +  GQE+A+K+++       E   NE+ ++ + ++ N+V 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-GIARGLLYLHQDS 661
            L   +  DE  +V EY+   SL  V+ +         + +   +C    + L +LH + 
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALDFLHSN- 134

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             ++IHRD+K+ NILL  + + K++DFG       +Q++++T  +VGT
Sbjct: 135 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 70.1 bits (171), Expect = 6e-13
 Identities = 49/154 (31%), Positives = 77/154 (50%), Gaps = 10/154 (6%)

Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKN---EVRLIAKLQHRN 599
           F   +++G G FG VY        E+ AVK++S +  Q  E++++   EV+ + +L+H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
            +   GC ++     LV EY    + D +   +     L       I  G  +GL YLH 
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARI 693
            +   +IHRD+KA NILL +    K++DFG A  
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASK 170

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 69.3 bits (169), Expect = 8e-13
 Identities = 45/145 (31%), Positives = 78/145 (53%), Gaps = 8/145 (5%)

Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           +LG G FG VYK +  E G   A K +   S + +E++  E+ ++A   H  +V+LLG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-GIARGLLYLHQDSRFRII 666
               +  ++ E+    ++D+++ +  R      + +  +IC  +   L YLH     +II
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQYLHS---MKII 132

Query: 667 HRDLKASNILLDKEMTPKISDFGMA 691
           HRDLKA N+LL  +   K++DFG++
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVS 157

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 68.9 bits (168), Expect = 9e-13
 Identities = 49/167 (29%), Positives = 85/167 (50%), Gaps = 18/167 (10%)

Query: 550 LGQGGFGIVYKGRLLEGQEI---AVK--RLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           LG+G FG V +G+L +   I   AVK  +++  +   +E+F +E   + +  H N++RL+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 605 GCCVEMDEK------MLVYEYMENRSLDSVIFDKA---RSSILNWQRRFNIICGIARGLL 655
           G C++  E       +++  +M++  L S +           L  Q     +  IA G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA-RIFGGDQTEQ 701
           YL   S    IHRDL A N +L++ M   ++DFG++ +I+ GD   Q
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQ 170

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains

 Score = 63.8 bits (155), Expect = 1e-12
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 5/81 (6%)

Query: 368 CSEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSR-NCSCTAYANTNITGGTGCVTWT 426
            S+D F++L N KLP  +   +    +L+EC + C   NCSC ++   N  G  GC+ W+
Sbjct: 1   KSDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNN--GTKGCLLWS 57

Query: 427 -GELKDIRKYAEGGQDLYVRL 446
              L D R +  GG DLY ++
Sbjct: 58  ESSLGDARLFPSGGVDLYEKI 78

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 46/146 (31%), Positives = 74/146 (50%), Gaps = 7/146 (4%)

Query: 549 KLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRNLVRLLGC 606
           ++G+G FG V+ GRL  +   +AVK         ++ +F  E R++ +  H N+VRL+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
           C +     +V E ++    D + F +     L  +    ++   A G+ YL        I
Sbjct: 62  CTQKQPIYIVMELVQGG--DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 667 HRDLKASNILLDKEMTPKISDFGMAR 692
           HRDL A N L+ ++   KISDFGM+R
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 49/180 (27%), Positives = 78/180 (43%), Gaps = 18/180 (10%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKN---EVRLIAKLQH 597
           D+     +LG G  G+V K      G+ +AVK +     +     K    E+ ++ K   
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNS 58

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             +V   G      +  +  EYM+  SLD  I  + +  I        I   + +GL YL
Sbjct: 59  PYIVGFYGAFYNNGDISICMEYMDGGSLD-KILKEVQGRIPERILGK-IAVAVLKGLTYL 116

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFG--------MARIFGGDQTEQNTKRVVGT 709
           H   + +IIHRD+K SNIL++     K+ DFG        +A+ F G  +    +R+ G 
Sbjct: 117 H--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGN 174

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 51/168 (30%), Positives = 87/168 (51%), Gaps = 11/168 (6%)

Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLV 601
           FT   ++G+G FG VYKG     +E+ A+K +     +  IE+ + E+ ++++     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           R  G  ++  +  ++ EY+   S      D  +   L       I+  I +GL YLH + 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 120

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             R IHRD+KA+N+LL ++   K++DFG+A      Q ++NT   VGT
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 51/158 (32%), Positives = 82/158 (51%), Gaps = 18/158 (11%)

Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQG-----IEEFKNEVRLIAKL 595
           + +   +KLG+G +  VYKGR  L GQ +A+K +     +G     I E      L+  L
Sbjct: 5   ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIRE----ASLLKDL 60

Query: 596 QHRNLVRLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           +H N+V  L   +   + + LV+EY++   L   + D      ++  R F  +  + RGL
Sbjct: 61  KHANIV-TLHDIIHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLF--LFQLLRGL 116

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            Y HQ    R++HRDLK  N+L+ +    K++DFG+AR
Sbjct: 117 AYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 55/177 (31%), Positives = 85/177 (48%), Gaps = 25/177 (14%)

Query: 544 FTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSR--NSGQGIEEFKNEVRLIAKLQH 597
           FT    LG+G FG V + +L       Q++AVK L     S   IEEF  E   + +  H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 598 RNLVRLLGCCVEMDEK------MLVYEYMENRSLDSVIFDKARSSI------LNWQRRFN 645
            N+++L+G  +    K      M++  +M++  L + +     S I      L  Q    
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL---MSRIGEEPFTLPLQTLVR 117

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQ 701
            +  IA G+ YL   S    IHRDL A N +L++ MT  ++DFG+++ I+ GD   Q
Sbjct: 118 FMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQ 171

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 53/154 (34%), Positives = 77/154 (50%), Gaps = 12/154 (7%)

Query: 550 LGQGGFGIVYKGRLL-EGQEI----AVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRL 603
           LG G FG V+KG  + EG  I    A+K +   SG Q  +E  + +  +  L H  +VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           LG C       LV +     SL   +  +     L+ QR  N    IA+G+ YL +    
Sbjct: 75  LGIC-PGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
           R++HR+L A NILL  +   +I+DFG+A +   D
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 68.6 bits (167), Expect = 1e-12
 Identities = 51/167 (30%), Positives = 86/167 (51%), Gaps = 13/167 (7%)

Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCV 608
           +G G +G VYKGR ++  ++A  ++   +G   EE K E+ ++ K   HRN+    G  +
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 609 E-----MDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           +     MD+++ LV E+    S+  +I    + + L  +    I   I RGL +LHQ   
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
            ++IHRD+K  N+LL +    K+ DFG++     D+T       +GT
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGT 174

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 51/170 (30%), Positives = 80/170 (47%), Gaps = 25/170 (14%)

Query: 543 NFTDYNKLGQGGFGIVY--KGRLLEGQEIAVKR--LSRNSGQGIEEFKNEVRLIAKLQHR 598
            +    K+G+G FG +Y  K +  + +   +K   L++   +  E  K EV L+AK++H 
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSL-------DSVIFDKARSSILNWQRRFNIICGIA 651
           N+V       E     +V EY +   L         V+F +    IL+W         I+
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSE--DQILSW------FVQIS 111

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFGGDQTE 700
            GL ++H     +I+HRD+K+ NI L K  M  K+ DFG+AR    D  E
Sbjct: 112 LGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSME 157

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 49/161 (30%), Positives = 81/161 (50%), Gaps = 21/161 (13%)

Query: 550 LGQGGFGIVYKGRLLEG---QEIAVKRLSRNSGQGIE-EFKNEVRLIAKL-QHRNLVRLL 604
           +G+G FG V K R+ +     + A+KR+   + +    +F  E+ ++ KL  H N++ LL
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 605 GCCVEMDEKMLVYEYM----------ENRSLDS---VIFDKARSSILNWQRRFNIICGIA 651
           G C       L  EY           ++R L++        + +S L+ Q+  +    +A
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           RG+ YL Q    + IHRDL A NIL+ +    KI+DFG++R
Sbjct: 135 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 50/157 (31%), Positives = 84/157 (53%), Gaps = 16/157 (10%)

Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQ-GIE-EFKNEVRLIAKLQ---HRNLVR 602
           ++G G +G VYK R    G  +A+K +   + + G+      EV L+ +L+   H N+VR
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 603 LLGCCVEM--DEKM---LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
           L+  C     D +    LV+E+++ + L + + DK     L  +   +++    RGL +L
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVD-QDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
           H +    I+HRDLK  NIL+      K++DFG+ARI+
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 68.2 bits (166), Expect = 2e-12
 Identities = 50/170 (29%), Positives = 89/170 (52%), Gaps = 16/170 (9%)

Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           +T + K+GQG  G VY    +  GQE+A+++++       E   NE+ ++ + ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-GIARGLLYLHQDS 661
            L   +  DE  +V EY+   SL  V+ +         + +   +C    + L +LH + 
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLHSN- 135

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGT 709
             ++IHRD+K+ NILL  + + K++DFG    F    T + +KR  +VGT
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGT 179

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 67.8 bits (165), Expect = 2e-12
 Identities = 49/145 (33%), Positives = 75/145 (51%), Gaps = 6/145 (4%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G      ++A+K L   +    E F  E +++ KL+H  LV L     
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E +   +V E+M   SL   +  +     L   +  ++   IA G+ Y+    R   IHR
Sbjct: 72  E-EPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126

Query: 669 DLKASNILLDKEMTPKISDFGMARI 693
           DL+A+NIL+   +  KI+DFG+AR+
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARL 151

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 43/175 (24%), Positives = 94/175 (53%), Gaps = 22/175 (12%)

Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQG-IEEFKNEVRLIAKLQH---R 598
           +     +G+G +G VY+G+ +  G+ +A+K ++ ++    + + + EV L+++L+     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL--- 655
           N+ +  G  ++     ++ EY E  S+ +++    ++  +    ++  I  I R +L   
Sbjct: 63  NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPI--AEKY--ISVIIREVLVAL 114

Query: 656 -YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
            Y+H+     +IHRD+KA+NIL+      K+ DFG+A +   + ++++T   VGT
Sbjct: 115 KYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGT 164

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 44/145 (30%), Positives = 78/145 (53%), Gaps = 8/145 (5%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAV-KRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           +LG G FG VYK +  E   +A  K +   S + +E++  E+ ++A   H N+V+LL   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICG-IARGLLYLHQDSRFRII 666
              +   ++ E+    ++D+V+ +  R      + +  ++C      L YLH++   +II
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNYLHEN---KII 125

Query: 667 HRDLKASNILLDKEMTPKISDFGMA 691
           HRDLKA NIL   +   K++DFG++
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 51/155 (32%), Positives = 83/155 (53%), Gaps = 12/155 (7%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHR 598
           + +    KLG+G +  V+KGR  L    +A+K  RL    G      + EV L+  L+H 
Sbjct: 6   ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHA 64

Query: 599 NLVRLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
           N+V L    V  D+ + LV+EY++ + L   + D    +I++       +  I RGL Y 
Sbjct: 65  NIVTLHDI-VHTDKSLTLVFEYLD-KDLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYC 120

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           H   R +++HRDLK  N+L+++    K++DFG+AR
Sbjct: 121 H---RRKVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 10/154 (6%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHR 598
           + +   +KLG+G +  VYKGR  L    +A+K  RL    G      + EV L+  L+H 
Sbjct: 6   ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHA 64

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
           N+V L           LV+EY++ + L   + D   S  ++  + F  +  + RGL Y H
Sbjct: 65  NIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH 121

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              R +++HRDLK  N+L+++    K++DFG+AR
Sbjct: 122 ---RRKVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 68.3 bits (167), Expect = 3e-12
 Identities = 53/169 (31%), Positives = 84/169 (49%), Gaps = 24/169 (14%)

Query: 548 NKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRNLVRLLG 605
           N++G G  G VYK      G+  A+K +  N    +  +   E+ ++  + H N+V+   
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK--- 136

Query: 606 CCVEM----DEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            C +M     E  ++ E+M+  SL+   I D+   + +  Q    I+ GIA    YLH  
Sbjct: 137 -CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ----ILSGIA----YLH-- 185

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
            R  I+HRD+K SN+L++     KI+DFG++RI    QT       VGT
Sbjct: 186 -RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA--QTMDPCNSSVGT 231

Length = 353

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 66.6 bits (162), Expect = 7e-12
 Identities = 51/171 (29%), Positives = 86/171 (50%), Gaps = 17/171 (9%)

Query: 542 DNFTDYNKLGQGGFGIV-YKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           D+F    K+G+G  GIV        G+++AVK++     Q  E   NEV ++    H N+
Sbjct: 25  DSFI---KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENV 81

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V +    +  DE  +V E++E  +L  ++      + +N ++   +   + R L YLH  
Sbjct: 82  VDMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLSVLRALSYLHNQ 137

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGT 709
               +IHRD+K+ +ILL  +   K+SDFG    F    +++  KR  +VGT
Sbjct: 138 G---VIHRDIKSDSILLTSDGRIKLSDFG----FCAQVSKEVPKRKSLVGT 181

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 66.1 bits (161), Expect = 8e-12
 Identities = 49/157 (31%), Positives = 81/157 (51%), Gaps = 13/157 (8%)

Query: 550 LGQGGFGIVYKGRL-----LEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LG+G FG V   R        G+++AVK L   + G  I + K E+ ++  L H N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 604 LGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            G C E       L+ E++ + SL   +  + ++ I N +++      I +G+ YL   S
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKI-NLKQQLKYAVQICKGMDYL--GS 127

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           R + +HRDL A N+L++ E   KI DFG+ +    D+
Sbjct: 128 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 66.1 bits (161), Expect = 8e-12
 Identities = 47/171 (27%), Positives = 79/171 (46%), Gaps = 31/171 (18%)

Query: 550 LGQGGFGIVYKGRLLEGQ------EIAVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVR 602
           LG+G FG V K      +       +AVK L  N+    + +  +E  L+ ++ H ++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDS------------VIFDKARSSI---------LNWQ 641
           L G C +    +L+ EY +  SL S            +  D  R+S          L   
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              +    I+RG+ YL   +  +++HRDL A N+L+ +    KISDFG++R
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 28/166 (16%)

Query: 550 LGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLV 601
           LG+G FG V K   +      E   +AVK L  + + + + +  +E+ ++  + +H+N++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKAR-------SSILNWQRRFNIIC------ 648
            LLG C +     +V EY  + +L    F +AR       S          +        
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRD--FLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 649 --GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              +ARG+ +L      + IHRDL A N+L+ ++   KI+DFG+AR
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 65.5 bits (159), Expect = 1e-11
 Identities = 48/151 (31%), Positives = 73/151 (48%), Gaps = 14/151 (9%)

Query: 550 LGQGGFGIVY------KGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LGQG FG VY       GR L  +++     S  + + +   + E++L+  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 604 LGCCVEMDEKMLV--YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            GC  +  EK L    EYM   S+   +  KA  ++     R      I  G+ YLH + 
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTR-KYTRQILEGMSYLHSN- 125

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              I+HRD+K +NIL D     K+ DFG ++
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 49/159 (30%), Positives = 81/159 (50%), Gaps = 20/159 (12%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHR 598
           + +   +KLG+G +  V+KGR  L    +A+K  RL    G      + EV L+  L+H 
Sbjct: 5   ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHA 63

Query: 599 NLVRLLGCCVEMDEKMLVYEYMEN---RSLDSV--IFDKARSSILNWQRRFNIICGIARG 653
           N+V L           LV+EY+++   + LD+   +       I  +Q        + RG
Sbjct: 64  NIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQ--------LLRG 115

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           L Y H   + +I+HRDLK  N+L++++   K++DFG+AR
Sbjct: 116 LSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 12/157 (7%)

Query: 540 ATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFK--NEVRLIAKLQ 596
           A  ++ +  KLG+G +  VYKG   + GQ +A+K +S  + +G+  F    E  L+  L+
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLK 61

Query: 597 HRNLVRLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           H N+V LL   +   E +  V+EYM     D   +       L+       +  + RGL 
Sbjct: 62  HANIV-LLHDIIHTKETLTFVFEYMHT---DLAQYMIQHPGGLHPYNVRLFMFQLLRGLA 117

Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           Y+H      I+HRDLK  N+L+      K++DFG+AR
Sbjct: 118 YIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 57/162 (35%), Positives = 74/162 (45%), Gaps = 23/162 (14%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSR---NSGQGIEEFKNEVRLIAKL-QHRNLVRLL 604
           LG+G FG V    L    E+ AVK L +        +E    E R++A   +H  L +L 
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 605 GCCVEMDEKMLVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
            C    D    V EY+    L      S  FD+ R+       RF     I  GL +LH+
Sbjct: 63  SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRA-------RFYAAE-IVLGLQFLHE 114

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQT 699
                II+RDLK  N+LLD E   KI+DFGM +  I GG  T
Sbjct: 115 RG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT 153

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 46/158 (29%), Positives = 85/158 (53%), Gaps = 17/158 (10%)

Query: 549 KLGQGGFGIVYKGRLLE--GQEIAVKRL---SRNSGQGIEEFKNE--VRLIAKLQHRNLV 601
           ++G+G +G V+K R L+  G+ +A+KR+   +   G  +   +    +R +   +H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 602 RLLGCCV----EMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           RL   C     + + K+ LV+E+++     +   DK     +  +   +++  + RGL +
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQDL--TTYLDKVPEPGVPTETIKDMMFQLLRGLDF 125

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
           LH     R++HRDLK  NIL+      K++DFG+ARI+
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 160

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 47/152 (30%), Positives = 79/152 (51%), Gaps = 16/152 (10%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRL-----SRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LGQG FG VY     + G+E+AVK++     S  + + +   + E++L+  L H  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 604 LGCCVEMDEKML--VYEYMENRSLDSVIFDKARSSIL-NWQRRFNIICGIARGLLYLHQD 660
            GC  +  E+ L    E+M   S+   +  K+  ++  N  R++     I  G+ YLH +
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTR--QILEGVSYLHSN 125

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
               I+HRD+K +NIL D     K+ DFG ++
Sbjct: 126 ---MIVHRDIKGANILRDSVGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 50/152 (32%), Positives = 83/152 (54%), Gaps = 16/152 (10%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRL-----SRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LG+G FG VY     + G+E+AVK++     S+ + + +   + E++L+  L+H  +V+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 604 LGCCVEMDEKML--VYEYMENRSLDSVIFDKARSSIL-NWQRRFNIICGIARGLLYLHQD 660
            GC  + +EK L    EYM   S+   +  KA  ++  N  RR+     I +G+ YLH +
Sbjct: 70  YGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTR--QILQGVSYLHSN 125

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
               I+HRD+K +NIL D     K+ DFG ++
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 17/167 (10%)

Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63

Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  + ++   
Sbjct: 64  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +   IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 65.1 bits (158), Expect = 3e-11
 Identities = 48/166 (28%), Positives = 84/166 (50%), Gaps = 12/166 (7%)

Query: 546 DYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +Y K+G+G  GIV   R    G+++AVK +     Q  E   NEV ++   QH+N+V + 
Sbjct: 25  NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-GIARGLLYLHQDSRF 663
              +  +E  ++ E+++  +L  ++     S     + +   +C  + + L YLH     
Sbjct: 85  KSYLVGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVCESVLQALCYLHSQG-- 137

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
            +IHRD+K+ +ILL  +   K+SDFG       D  ++  K +VGT
Sbjct: 138 -VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSLVGT 180

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 45/155 (29%), Positives = 80/155 (51%), Gaps = 10/155 (6%)

Query: 549 KLGQGGFGIVYKG--RLLEGQ-EIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL 604
           +LG G FG V KG  ++ + Q ++A+K L   + + + +E   E  ++ +L +  +VR++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G C E +  MLV E      L+   F   +   +       ++  ++ G+ YL   +   
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNK--FLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
            +HRDL A N+LL  +   KISDFG+++  G D +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 46/172 (26%), Positives = 82/172 (47%), Gaps = 27/172 (15%)

Query: 550 LGQGGFG--IVYK----GRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LG+G FG   +Y+      L+  +E+ + RLS    +   +  NE+ +++ LQH N++  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE---KERRDALNEIVILSLLQHPNIIAY 64

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRR------FNIICGIARGLLYL 657
               ++ +  ++  EY    +L   I    R     ++        F I+  ++    Y+
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTLYDKI---VRQKGQLFEEEMVLWYLFQIVSAVS----YI 117

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           H+     I+HRD+K  NI L K    K+ DFG+++I G + +   T  VVGT
Sbjct: 118 HKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGT 164

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 15/152 (9%)

Query: 549 KLGQGGFGIVYKGRLLEG---QEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLL 604
           ++G G FG V  G +  G    ++ VK L  ++  Q   +F  E +    LQH NL++ L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 605 GCCVEMDEKMLVYEYME----NRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           G C E+   +LV E+         L S    +         QR   + C IA GLL+LH+
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR---MACEIALGLLHLHK 118

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
           ++    IH DL   N LL  ++T KI D+G++
Sbjct: 119 NN---FIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 50/170 (29%), Positives = 85/170 (50%), Gaps = 15/170 (8%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           DNF    K+G+G  GIV    +   G+ +AVK++     Q  E   NEV ++   QH N+
Sbjct: 23  DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V +    +  DE  +V E++E  +L  ++      + +N ++   +   + + L  LH  
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLKALSVLHAQ 135

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGM-ARIFGGDQTEQNTKRVVGT 709
               +IHRD+K+ +ILL  +   K+SDFG  A++    +     K +VGT
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKSLVGT 179

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 49/154 (31%), Positives = 78/154 (50%), Gaps = 10/154 (6%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHR 598
           D++    KLG+G +  VYKG+  + G+ +A+K  RL    G      + E  L+  L+H 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
           N+V L       +   LV+EY+     D   +       L+ +     +  + RGL Y+H
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYVHT---DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH 120

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           Q  R+ I+HRDLK  N+L+      K++DFG+AR
Sbjct: 121 Q--RY-ILHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 47/168 (27%), Positives = 89/168 (52%), Gaps = 11/168 (6%)

Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLV 601
           FT   ++G+G FG V+KG     Q++ A+K +     +  IE+ + E+ ++++     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +  G  ++  +  ++ EY+   S      D  R+   +  +   ++  I +GL YLH + 
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           +   IHRD+KA+N+LL ++   K++DFG+A      Q ++NT   VGT
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 66.0 bits (161), Expect = 4e-11
 Identities = 42/142 (29%), Positives = 73/142 (51%), Gaps = 11/142 (7%)

Query: 545 TDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
            + N + +G  G  YKG+ ++ G +  VK +  N    I    +E+  + KLQH N+V+L
Sbjct: 693 KEENVISRGKKGASYKGKSIKNGMQFVVKEI--NDVNSIPS--SEIADMGKLQHPNIVKL 748

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           +G C       L++EY+E ++L  V+        L+W+RR  I  GIA+ L +LH     
Sbjct: 749 IGLCRSEKGAYLIHEYIEGKNLSEVL------RNLSWERRRKIAIGIAKALRFLHCRCSP 802

Query: 664 RIIHRDLKASNILLDKEMTPKI 685
            ++  +L    I++D +  P +
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHL 824

Length = 968

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 64.1 bits (156), Expect = 5e-11
 Identities = 48/167 (28%), Positives = 82/167 (49%), Gaps = 20/167 (11%)

Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKR-LSRNSGQGIEEFK-NEVRLIAKLQHR 598
           D +    K+G+G +G VYK R    G+ +A+K+       +GI      E+ L+  L   
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 599 N-LVRLLGCCVEMDEKM------LVYEYMEN---RSLDSVIFDKARSSILNWQRRFNIIC 648
             +VRLL     ++EK       LV+EY+++   + +DS      R       + F  + 
Sbjct: 61  IYIVRLL-DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF--MY 117

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIF 694
            + +G+ + H+     ++HRDLK  N+L+DK+    KI+D G+ R F
Sbjct: 118 QLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 63.4 bits (155), Expect = 5e-11
 Identities = 49/167 (29%), Positives = 75/167 (44%), Gaps = 19/167 (11%)

Query: 550 LGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEE-FKNEVRLIAKLQHRNLVRLLG 605
           LG GGFG V   ++  + +  A+K + +      G +E   +E  ++ +  H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59

Query: 606 CCVEMDEK---MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
                D+K   ML+ EY     L +++ D+       +  RF I C +     YLH    
Sbjct: 60  -RTFKDKKYIYMLM-EYCLGGELWTILRDRGLFD--EYTARFYIAC-VVLAFEYLHNRG- 113

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             II+RDLK  N+LLD     K+ DFG A+        Q T    GT
Sbjct: 114 --IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS---GQKTWTFCGT 155

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 63.1 bits (154), Expect = 5e-11
 Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 27/170 (15%)

Query: 551 GQGGFGIVYKGRLLEGQEI-AVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           G+G FG V   +  + +++ A+K +++        +    NE R++ +L H  LV L   
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68

Query: 607 CVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFN------IICGIARGLLYLHQ 659
             + +E M LV + +    L        R  +   + +F+       IC I   L YLH 
Sbjct: 69  -FQDEENMYLVVDLLLGGDL--------RYHLSQ-KVKFSEEQVKFWICEIVLALEYLHS 118

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
                IIHRD+K  NILLD++    I+DF +A        +  T    GT
Sbjct: 119 K---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGT 162

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 63.4 bits (155), Expect = 6e-11
 Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 34/161 (21%)

Query: 548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN--EVRLIAKLQ-HRNLVRL 603
            K+G+G F  V K +  + G+  A+K + +   + +E+  N  E++ + +L  H N++RL
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63

Query: 604 L--------GC----CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIA 651
           +        G        MD  M +YE ++ R        + R     +Q        + 
Sbjct: 64  IEVLFDRKTGRLALVFELMD--MNLYELIKGRKR---PLPEKRVKSYMYQ--------LL 110

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           + L ++H++    I HRD+K  NIL+  +   K++DFG  R
Sbjct: 111 KSLDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCR 147

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 62.9 bits (153), Expect = 6e-11
 Identities = 51/170 (30%), Positives = 88/170 (51%), Gaps = 21/170 (12%)

Query: 549 KLGQGGFG--IVYKGRLLEGQEIAVKRL--SRNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           K+G+G FG  I+ K +  +G++  +K +  S+ S +  EE + EV +++ ++H N+V+  
Sbjct: 7   KIGEGSFGKAILVKSKE-DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDK-----ARSSILNWQRRFNIICGIARGLLYLHQ 659
               E     +V +Y E   L   I  +         IL+W   F  IC     L ++H 
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW---FVQIC---LALKHVHD 119

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
               +I+HRD+K+ NI L K+ T K+ DFG+AR+   + T +  +  +GT
Sbjct: 120 R---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVELARTCIGT 164

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 63.0 bits (153), Expect = 7e-11
 Identities = 44/150 (29%), Positives = 70/150 (46%), Gaps = 9/150 (6%)

Query: 548 NKLGQGGFGIVYKG---RLLEGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRL 603
           +++G G FG V  G   R +    + VK L  ++       F  EV+   +L H N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF--NIICGIARGLLYLHQDS 661
           LG C+E    +LV E+     L + +           Q+     + C +A GLL+LHQ  
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMA 691
               IH DL   N  L  +++ KI D+G+A
Sbjct: 121 ---FIHSDLALRNCQLTADLSVKIGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 63.2 bits (153), Expect = 7e-11
 Identities = 50/170 (29%), Positives = 87/170 (51%), Gaps = 15/170 (8%)

Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLV 601
           FT   K+G+G FG V+KG     Q++ A+K +     +  IE+ + E+ ++++     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +  G  ++  +  ++ EY+   S      D      L+  +   I+  I +GL YLH + 
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGT 709
           +   IHRD+KA+N+LL +    K++DFG+A    G  T+   KR   VGT
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNTFVGT 164

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 62.8 bits (153), Expect = 9e-11
 Identities = 47/175 (26%), Positives = 88/175 (50%), Gaps = 18/175 (10%)

Query: 536 TIVRATDNFTDYNKLGQGGFGIVYKGRLLEG-----QEIAVKRLSRNSGQ-GIEEFKNEV 589
            I R  D  T  + L +G FG ++ G L++      +E+ VK +  ++ +  +     E 
Sbjct: 2   AISR--DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQES 59

Query: 590 RLIAKLQHRNLVRLLGCCVEMDEK-MLVYEYMENRSL-----DSVIFDKARSSILNWQRR 643
            L+  L H+N++ +L  C+E  E   ++Y YM   +L        + +      L+ Q+ 
Sbjct: 60  CLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQL 119

Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGD 697
            ++   IA G+ YLH   +  +IH+D+ A N ++D+E+  KI+D  ++R +F  D
Sbjct: 120 VHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 45/155 (29%), Positives = 83/155 (53%), Gaps = 12/155 (7%)

Query: 549 KLGQGGFGIVYKG--RLLEGQE-IAVKRLSRNSGQGI--EEFKNEVRLIAKLQHRNLVRL 603
           +LG G FG V KG  ++ + ++ +AVK L  ++      +E   E  ++ +L +  +VR+
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           +G C E +  MLV E  E   L+  +    ++  +  +    ++  ++ G+ YL + +  
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
             +HRDL A N+LL  +   KISDFG+++  G D+
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 51/168 (30%), Positives = 82/168 (48%), Gaps = 19/168 (11%)

Query: 540 ATDNFTDYNKLGQGGFGIVYKG---RLLEGQ---EIAVKRLSRN-SGQGIEEFKNEVRLI 592
           + +  T   +LGQG FG+VY+G    +++G+    +AVK ++ + S +   EF NE  ++
Sbjct: 4   SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63

Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRR--------F 644
                 ++VRLLG   +    ++V E M +  L S +    R    N   R         
Sbjct: 64  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL-RSLRPEAENNPGRPPPTLQEMI 122

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            +   IA G+ YL+     + +HRDL A N ++  + T KI DFGM R
Sbjct: 123 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 46/160 (28%), Positives = 74/160 (46%), Gaps = 20/160 (12%)

Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQH 597
           D+      +G G FG V+  R  +     A+K ++       +  +   NE R++ ++ H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 598 RNLVRLLGCCVEMDEKML--VYEYMENRSLDSVIFDKARSSILNWQRRF---NIICGIAR 652
             ++RL     E D++ L  + EY+    L S +  +      N    F    I+C +  
Sbjct: 61  PFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALE- 115

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              YLH      I++RDLK  NILLDKE   K++DFG A+
Sbjct: 116 ---YLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK 149

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 43/177 (24%), Positives = 82/177 (46%), Gaps = 20/177 (11%)

Query: 532 FDFETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--E 588
           FD  +  +  +N      +G G +G+V        G+++A+K++           +   E
Sbjct: 1   FDVGSRYKPIEN------IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRE 54

Query: 589 VRLIAKLQHRNLVRLLGCCV----EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF 644
           ++++   +H N++ +         +  +  +V + ME+  L  +I      +     R F
Sbjct: 55  LKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLT-EEHIRYF 112

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ 701
             +  + RGL Y+H  +   +IHRDLK SN+L++++   +I DFGMAR      TE 
Sbjct: 113 --LYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEH 164

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 62.2 bits (152), Expect = 2e-10
 Identities = 59/183 (32%), Positives = 78/183 (42%), Gaps = 37/183 (20%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRN----SGQGIEEFKNEVRLIAKLQ 596
           D+F     LG G FG V   R     +  A+K LS+       Q +E   NE R++  ++
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59

Query: 597 HRNLVRLLGCCVEMDEKML--VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIAR-- 652
           H  LV L G     D+  L  V EY+    L    F   R S      RF     +AR  
Sbjct: 60  HPFLVNLYGS--FQDDSNLYLVMEYVPGGEL----FSHLRKS-----GRFPE--PVARFY 106

Query: 653 ------GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
                  L YLH      I++RDLK  N+LLD +   KI+DFG A+   G      T  +
Sbjct: 107 AAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTL 158

Query: 707 VGT 709
            GT
Sbjct: 159 CGT 161

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 55/156 (35%), Positives = 78/156 (50%), Gaps = 26/156 (16%)

Query: 550 LGQGGFGIVYKG-RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           +G G  GIV      + G  +AVK+LSR   N       ++ E+ L+  + H+N++ LL 
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 87

Query: 606 CCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIICGIARGLLY 656
                    E  +  LV E M+  +L  VI    D  R S L +Q    ++CGI     +
Sbjct: 88  VFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELDHERMSYLLYQ----MLCGIK----H 138

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           LH      IIHRDLK SNI++  + T KI DFG+AR
Sbjct: 139 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 48/176 (27%), Positives = 85/176 (48%), Gaps = 18/176 (10%)

Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLS---RNSGQGIEEFKNEVRLIAKLQHR 598
           NF    K+G+G F  VY+   LL+ + +A+K++        +  ++   E+ L+ +L H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVI--FDKARSSILN---WQRRFNIICGIARG 653
           N+++ L   +E +E  +V E  +   L  +I  F K +  I     W + F  +C     
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW-KYFVQLCSAVE- 120

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
               H  SR R++HRD+K +N+ +      K+ D G+ R F    T  ++  +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 47/161 (29%), Positives = 80/161 (49%), Gaps = 25/161 (15%)

Query: 550 LGQGGFGIVYKGRL---------LEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRN 599
           LGQG F  +YKG L           GQE++V      S       F     L+++L H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLH 658
           LV+L G CV  DE ++V EY++   LD V   + ++++ L+W  + ++   +A  L YL 
Sbjct: 63  LVKLYGVCVR-DENIMVEEYVKFGPLD-VFLHREKNNVSLHW--KLDVAKQLASALHYLE 118

Query: 659 QDSRFRIIHRDLKASNILL-----DKEMTP--KISDFGMAR 692
                +++H ++   NIL+     ++   P  K+SD G+  
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 47/151 (31%), Positives = 76/151 (50%), Gaps = 15/151 (9%)

Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCV 608
           +G G +G VYKGR ++  ++A  ++   +    EE K E+ ++ K   HRN+    G  +
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83

Query: 609 EM------DEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIIC-GIARGLLYLHQD 660
           +       D+  LV E+    S+ D V   K  +   +W      IC  I RGL +LH  
Sbjct: 84  KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW---IAYICREILRGLAHLHAH 140

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
              ++IHRD+K  N+LL +    K+ DFG++
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVS 168

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 60.7 bits (148), Expect = 4e-10
 Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 32/178 (17%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQG---IEEFKNEVRLIAKLQHRNLVRLLG 605
           + +G +G V+  +    G   A+K + +        +++   E  ++++ Q   +V+L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 606 CCVEMDEKM-LVYEYMENRSLDSVI-----FDK--ARSSILNWQRRFNIICGIARGLLYL 657
              +  + + LV EY+    L S++      D+  AR            I  I   L YL
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR----------IYIAEIVLALEYL 109

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFG------MARIFGGDQTEQNTKRVVGT 709
           H      IIHRDLK  NIL+D     K++DFG      + R    +  E+  KR+VGT
Sbjct: 110 HS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 61.1 bits (148), Expect = 5e-10
 Identities = 51/174 (29%), Positives = 85/174 (48%), Gaps = 26/174 (14%)

Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRN-SGQGIEEFKNEVRLI 592
           D       LG+G FG V         K R  +   +AVK L  N + + + +  +E+ L+
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71

Query: 593 AKL-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI-----------FDKARSS--IL 638
             + +H+N++ LLG C +     ++ EY    +L   +           FD  +     L
Sbjct: 72  KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131

Query: 639 NWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +++   +    +ARG+ YL  +SR R IHRDL A N+L+ ++   KI+DFG+AR
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 41/151 (27%), Positives = 70/151 (46%), Gaps = 15/151 (9%)

Query: 549 KLGQGGFGIVYKG--RLLEGQEI--AVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRL 603
            +G+G FG VY+G     E ++I  AVK     +   + E+F  E  ++ +  H ++V+L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 604 LGCCVEMDE--KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +G   E      M +    E RS     + +     L+          ++  L YL   S
Sbjct: 73  IGVITENPVWIVMELAPLGELRS-----YLQVNKYSLDLASLILYSYQLSTALAYLE--S 125

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           + R +HRD+ A N+L+      K+ DFG++R
Sbjct: 126 K-RFVHRDIAARNVLVSSPDCVKLGDFGLSR 155

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 59.7 bits (144), Expect = 9e-10
 Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 19/164 (11%)

Query: 530 PLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNE 588
           P  D+E I R          +G G +G VYK R L  G+  AVK +    G      + E
Sbjct: 7   PQHDYELIQR----------VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQE 56

Query: 589 VRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC 648
           + ++ + +H N+V   G  +  ++  +  EY    SL  +       S L    +   +C
Sbjct: 57  IFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL----QIAYVC 112

Query: 649 -GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
               +GL YLH   +   +HRD+K +NILL      K++DFG+A
Sbjct: 113 RETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 55/175 (31%), Positives = 78/175 (44%), Gaps = 21/175 (12%)

Query: 544 FTDYNKLGQGGFGIV------YKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH 597
           F  Y  LG+GGFG V        G++   +++  KR+ +  G+ +    NE +++ K+  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNS 59

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF---NIICGIARGL 654
           R +V L       D   LV   M    L   I+    +     +  F    I CG    L
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----L 115

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             LHQ+   RI++RDLK  NILLD     +ISD G+A      QT    K  VGT
Sbjct: 116 EDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGT 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 60.1 bits (146), Expect = 9e-10
 Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 34/168 (20%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRL-SRNSGQGIEEFKNEVRLIAKLQH-R 598
           ++  D  ++G+G FG V K      G  +AVKR+ S    +  +    ++ ++ +     
Sbjct: 4   EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63

Query: 599 NLVRLLG-------C--CVE-MD---EK--MLVYEYMENRSLDSVIFDKARSSILNWQRR 643
            +V+  G       C  C+E MD   +K    VYE +    +   I  K           
Sbjct: 64  YIVKFYGALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILGK----------- 111

Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
             I     + L YL ++   +IIHRD+K SNILLD+    K+ DFG++
Sbjct: 112 --IAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGIS 155

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 54/173 (31%), Positives = 78/173 (45%), Gaps = 29/173 (16%)

Query: 550 LGQGGFGIVY------KGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LG+GGFG V        G++   +++  KRL +  G+ +    NE +++ K+  R +V L
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA--LNEKKILEKVSSRFIVSL 58

Query: 604 LGCCVEMDEKMLVYEYMENRSL-------DSVIFDKARSSILNWQRRFNIICGIARGLLY 656
                  D+  LV   M    L           F +AR+     Q    IICG    L +
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ----IICG----LEH 110

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           LHQ    RI++RDLK  N+LLD     +ISD G+A    G +     K   GT
Sbjct: 111 LHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGT 157

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 19/164 (11%)

Query: 530 PLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNE 588
           P  DFE I R          +G G +G VYK R +  G+  A+K +    G+     + E
Sbjct: 7   PQEDFELIQR----------IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQE 56

Query: 589 VRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC 648
           + ++   +H N+V   G  +  D+  +  E+    SL  +       S    + +   + 
Sbjct: 57  IIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLS----ESQIAYVS 112

Query: 649 -GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
               +GL YLH   +   +HRD+K +NILL      K++DFG++
Sbjct: 113 RETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVS 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 48/176 (27%), Positives = 83/176 (47%), Gaps = 18/176 (10%)

Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLS---RNSGQGIEEFKNEVRLIAKLQHR 598
           NF    K+G+G F  VY+   LL+G  +A+K++        +   +   E+ L+ +L H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVI--FDKARSSILN---WQRRFNIICGIARG 653
           N+++     +E +E  +V E  +   L  +I  F K +  I     W + F  +C     
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW-KYFVQLCSALE- 120

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
               H  SR R++HRD+K +N+ +      K+ D G+ R F    T  ++  +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 46/150 (30%), Positives = 73/150 (48%), Gaps = 14/150 (9%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIA---VKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLL 604
           ++G G FG V    +     +A   VK L  N+  +   EF  +      LQH N+++ L
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVI----FDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           G CVE    +LV+EY E   L S +    + +  S +L  QR   + C IA G+ ++H  
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR---MACEIAAGVTHMH-- 116

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGM 690
            +   +H DL   N  L  ++T K+ D+G+
Sbjct: 117 -KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 57/175 (32%), Positives = 79/175 (45%), Gaps = 30/175 (17%)

Query: 550 LGQGGFGIVY------KGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LG+GGFG V        G+L   +++  KRL +   +G E    E R++AK+  R +V L
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVI---------FDKARSSILNWQRRFNIICGIARGL 654
                   +  LV   M    L   I         F + R+     Q    II G    L
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ----IISG----L 110

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
            +LHQ    RII+RDLK  N+LLD +   +ISD G+A      Q++  TK   GT
Sbjct: 111 EHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGT 160

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 50/188 (26%), Positives = 88/188 (46%), Gaps = 31/188 (16%)

Query: 528 ELPLFDFETIVRATDNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSG 579
           E P ++F     + D  T    LG+G FG V         K +  E   +AVK L  ++ 
Sbjct: 6   EDPRWEF-----SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT 60

Query: 580 Q-GIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI-------- 629
           +  + +  +E+ ++  + +H+N++ LLG C +     ++ EY    +L   +        
Sbjct: 61  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 120

Query: 630 ---FDKARSS--ILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK 684
              +D AR     + ++   +    +ARG+ YL      + IHRDL A N+L+ +    K
Sbjct: 121 EYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 177

Query: 685 ISDFGMAR 692
           I+DFG+AR
Sbjct: 178 IADFGLAR 185

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 56/167 (33%), Positives = 82/167 (49%), Gaps = 30/167 (17%)

Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75

Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M+  +L  VI    D  R S L +Q    ++C
Sbjct: 76  KNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSYLLYQ----MLC 130

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           GI     +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 131 GIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 56/165 (33%), Positives = 84/165 (50%), Gaps = 26/165 (15%)

Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83

Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCGI 139

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 45/168 (26%), Positives = 89/168 (52%), Gaps = 20/168 (11%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN---EVRLIAKLQHRNLVRLLG 605
           +G+G +GIV   +  E  +++A+K+++ N+     + K    E++L+  L H N++ +  
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIA-NAFDNRIDAKRTLREIKLLRHLDHENVIAIKD 71

Query: 606 CCVEMDEKM------LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
             +    +       +VYE M+   L  +I  ++  ++ +   ++  +  + RGL Y+H 
Sbjct: 72  I-MPPPHREAFNDVYIVYELMDT-DLHQII--RSSQTLSDDHCQY-FLYQLLRGLKYIHS 126

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
            +   ++HRDLK SN+LL+     KI DFG+AR    ++ +  T+ VV
Sbjct: 127 AN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVV 170

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 27/168 (16%)

Query: 549 KLGQGGFGIVYKGRLLEGQE---IAVKRLSRNSGQGIEEFKNEVRLIAKLQ----HRNLV 601
           +LGQG +GIV   R  E  E   +A+K+++    + I   K  +R +  L+    H+N+ 
Sbjct: 7   ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKIL-AKRALRELKLLRHFRGHKNIT 65

Query: 602 RLLGCCVEMD--------EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
               C  +MD        E  L  E ME   L  +I      +  ++Q   + I  I  G
Sbjct: 66  ----CLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQ---SFIYQILCG 117

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ 701
           L Y+H  +   ++HRDLK  N+L++ +   KI DFG+AR F  +  E 
Sbjct: 118 LKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGEN 162

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 35/168 (20%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRL--SRNSGQGIEEFKNEVRLIAKLQHR 598
           D+     +LG+G +G+V K R +  G  +AVKR+  + NS    +E K   RL+  L   
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS----QEQK---RLLMDL--- 50

Query: 599 NLVRLLGCCVEMDE---KML----VYEYME--NRSLDSV---IFDKARS---SILNWQRR 643
           ++      C         +     V+  ME  + SLD     ++DK  +    IL     
Sbjct: 51  DISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILG---- 106

Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
             I   I + L YLH  S+  +IHRD+K SN+L+++    K+ DFG++
Sbjct: 107 -KIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 47/154 (30%), Positives = 71/154 (46%), Gaps = 12/154 (7%)

Query: 544 FTDYNKLGQGGFGIV------YKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH 597
           F  Y  LG+GGFG V        G++   +++  KR+ +  G+ +    NE R++ K+  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNS 59

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
           R +V L       D   LV   M    L   I++       + QR       +  GL  L
Sbjct: 60  RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FDEQRAIFYAAELCCGLEDL 118

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
            ++   RI++RDLK  NILLD     +ISD G+A
Sbjct: 119 QRE---RIVYRDLKPENILLDDRGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 58.9 bits (142), Expect = 4e-09
 Identities = 50/169 (29%), Positives = 81/169 (47%), Gaps = 21/169 (12%)

Query: 535 ETIVRATDNFTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSRNSGQGIEEFKN--EV 589
           +T+    + + +   +G G +G V   Y  RL   Q++AVK+LSR     I   +   E+
Sbjct: 8   KTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYREL 65

Query: 590 RLIAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRR 643
           RL+  ++H N++ LL            +E  LV   M     + V   K     + +   
Sbjct: 66  RLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF--- 122

Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             +I  + RGL Y+H      IIHRDLK SN+ ++++   +I DFG+AR
Sbjct: 123 --LIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 166

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 57.5 bits (139), Expect = 4e-09
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 21/158 (13%)

Query: 550 LGQGGFGIVYKGRLLE----GQ----EIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           LGQG F  ++KG   E    G+    E+ +K L ++     E F     ++++L H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
              G CV  DE ++V EY++  SLD+ +  K   +++N   +  +   +A  L +L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120

Query: 662 RFRIIHRDLKASNILL-----DKEMTP---KISDFGMA 691
              + H ++ A N+LL      K   P   K+SD G++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 58.5 bits (141), Expect = 5e-09
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 19/168 (11%)

Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN---EVR 590
           +TI    + + + + +G G +G V        G  +AVK+LSR   Q I   K    E+R
Sbjct: 10  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 68

Query: 591 LIAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF 644
           L+  ++H N++ LL          E ++  LV   M    L++++    +   L      
Sbjct: 69  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQ 123

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 124 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 168

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 57.2 bits (138), Expect = 6e-09
 Identities = 44/145 (30%), Positives = 70/145 (48%), Gaps = 10/145 (6%)

Query: 550 LGQGGFGIVYKG--RLLEGQE--IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           LG G FG + +G  +L   +E  +A+  L    S +    F  E   + +  H N+VRL 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G     +  M+V EYM N +LDS  F +     L   +   ++ G+A G+ YL   S   
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDS--FLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMG 127

Query: 665 IIHRDLKASNILLDKEMTPKISDFG 689
            +H+ L A  +L++ ++  KIS F 
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 57.3 bits (138), Expect = 7e-09
 Identities = 45/155 (29%), Positives = 76/155 (49%), Gaps = 27/155 (17%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKN----EVRLIAKLQHRNLVRLL 604
           +G+G +G+V K R  E +EI A+K+   +     EE K     E++++  L+  N+V L 
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLKQENIVELK 66

Query: 605 GCCVEMDEKMLVYEYMENRSLD-------SVIFDKARSSILNWQRRFNIICGIARGLLYL 657
                  +  LV+EY+E   L+        V  +K RS I      + +I    + + + 
Sbjct: 67  EAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYI------YQLI----KAIHWC 116

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           H++    I+HRD+K  N+L+      K+ DFG AR
Sbjct: 117 HKND---IVHRDIKPENLLISHNDVLKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 57.6 bits (139), Expect = 7e-09
 Identities = 54/162 (33%), Positives = 75/162 (46%), Gaps = 23/162 (14%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIA-KLQHRNLVRLL 604
           LG+G FG V   RL E G+  AVK L ++       +E    E R+++    H  L +L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 605 GCCVEMDEKMLVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
            C    D    V E++    L      S  FD+AR+     +        I   L++LH 
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE--------ITSALMFLHD 114

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQT 699
                II+RDLK  N+LLD E   K++DFGM +  IF G  T
Sbjct: 115 KG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT 153

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 15/158 (9%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFK-NEVRLIAKLQHRNLVRLLGCC 607
           K+G+G +G VYK +  +G++     L +  G GI      E+ L+ +L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 608 VEMDEKM--LVYEYMENRSLDSVIF---DKARSSILNWQRRF--NIICGIARGLLYLHQD 660
           +   ++   L+++Y E+     + F    KA    +   R    +++  I  G+ YLH +
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127

Query: 661 SRFRIIHRDLKASNILLDKEMTP----KISDFGMARIF 694
               ++HRDLK +NIL+  E       KI+D G AR+F
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 18/166 (10%)

Query: 536 TIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGI--EEFKNEVRLI 592
           T+    + +T   ++G G +G V        G+++A+K+LSR     I  +    E+ L+
Sbjct: 9   TVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLL 68

Query: 593 AKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI 646
             +QH N++ LL          E  +  LV  YM+          K     L+  +   +
Sbjct: 69  KHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD------LQKIMGHPLSEDKVQYL 122

Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +  +  GL Y+H      IIHRDLK  N+ ++++   KI DFG+AR
Sbjct: 123 VYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 57/192 (29%), Positives = 89/192 (46%), Gaps = 24/192 (12%)

Query: 531 LFDFETIVRATDNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIEEFKNEV 589
           +   E++   TD +     +G+G +G VYK     +G   AVK L   S    EE + E 
Sbjct: 11  MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69

Query: 590 RLIAKL-QHRNLVRLLGCCVEMDEKM-----LVYEYMENRSLDSVIFDKARSSILNWQRR 643
            ++  L  H N+V+  G   + D+ +     LV E     S+  ++       +L   +R
Sbjct: 70  NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQR 124

Query: 644 FN------IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
            +      I+ G   GL +LH +   RIIHRD+K +NILL  E   K+ DFG++      
Sbjct: 125 LDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181

Query: 698 QTEQNTKRVVGT 709
           +  +NT   VGT
Sbjct: 182 RLRRNTS--VGT 191

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 51/161 (31%), Positives = 73/161 (45%), Gaps = 26/161 (16%)

Query: 544 FTDYNKLGQGGFGIV------YKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH 597
           F  Y  LG+GGFG V        G++   +++  KR+ +  G+ +    NE +++ K+  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNS 59

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI-------FDKARSSILNWQRRFNIICGI 650
           R +V L       D   LV   M    L   I       FD+ R+     +    I CG 
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE----ITCG- 114

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
              L  LH   R RI++RDLK  NILLD     +ISD G+A
Sbjct: 115 ---LEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 45/161 (27%), Positives = 80/161 (49%), Gaps = 21/161 (13%)

Query: 550 LGQGGFGIVYKGRLL-EGQEI--AVKRLSRNSGQGIE-EFKNEVRLIAKL-QHRNLVRLL 604
           +G+G FG V +  +  +G ++  A+K L   + +    +F  E+ ++ KL  H N++ LL
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 605 GCCVEMDEKMLVYEYM----------ENRSLDS---VIFDKARSSILNWQRRFNIICGIA 651
           G C       +  EY           ++R L++      +   +S L  Q+       +A
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            G+ YL  + +F  IHRDL A N+L+ + +  KI+DFG++R
Sbjct: 130 TGMQYL-SEKQF--IHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)

Query: 544 FTDYNKLGQGGFGIV------YKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH 597
           F  Y  LG+GGFG V        G++   + +  KR+ +  G+ +    NE +++ K+  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNS 59

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF---NIICGIARGL 654
           + +V L       D   LV   M    L   I++         +  F    I+CG    L
Sbjct: 60  QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG----L 115

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
             LH+++    ++RDLK  NILLD     +ISD G+A
Sbjct: 116 EDLHREN---TVYRDLKPENILLDDYGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 26/166 (15%)

Query: 550 LGQGGFGIVY--------KGRLLEGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRN 599
           LG+G FG V         K +  +   +AVK L  + + + + +  +E+ ++  + +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 600 LVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN--IIC 648
           ++ LLG C         VE   K  + EY+  R    + +      +   Q  F   + C
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 649 G--IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              +ARG+ YL      + IHRDL A N+L+ ++   KI+DFG+AR
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 55.5 bits (134), Expect = 4e-08
 Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 37/177 (20%)

Query: 550 LGQGGFGIVYK---GRLLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIAKLQHRNLVRL 603
           +G G FG+V+     R  +G+ +A+K++  N  Q +   K    E++++   +H N++  
Sbjct: 8   IGYGAFGVVWSVTDPR--DGKRVALKKMP-NVFQNLVSCKRVFRELKMLCFFKHDNVLSA 64

Query: 604 L--------GCCVEMDEKMLVYEYMENRSLDSVIFDKARSS-----ILNWQRRFNIICGI 650
           L            E+    +V E M++  L  +I      S     +  +Q        I
Sbjct: 65  LDILQPPHIDPFEEI---YVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQ--------I 112

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
            RGL YLH      I+HRD+K  N+L++     KI DFG+AR+   D+++  T+ VV
Sbjct: 113 LRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 16/153 (10%)

Query: 550 LGQGGFGIVYKGR---LLEGQ---EIAVKRL---SRNSGQGIEEFKNEVRLIAKL-QHRN 599
           LG G FG V +     L +     ++AVK L   + +S +  E   +E+++++ L  H N
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER--EALMSELKIMSHLGNHEN 100

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V LLG C      +++ EY     L + +  K R S L  +   +    +A+G+ +L  
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLAS 159

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            +    IHRDL A N+LL      KI DFG+AR
Sbjct: 160 KN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 19/168 (11%)

Query: 535 ETIVRATDNFTDYNKLGQGGFGIV-YKGRLLEGQEIAVKRLSR--NSGQGIEEFKNEVRL 591
           +TI    D + D  ++G G +G V        G ++A+K+L R   S    +    E+RL
Sbjct: 8   KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL 67

Query: 592 IAKLQHRNLVRLLGCCVEMDEKM-------LVYEYMENRSLDSVIFDKARSSILNWQRRF 644
           +  ++H N++ LL      D  +       LV  +M    L  ++    +   L+  R  
Sbjct: 68  LKHMKHENVIGLLDVFTP-DLSLDRFHDFYLVMPFM-GTDLGKLM----KHEKLSEDRIQ 121

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            ++  + +GL Y+H      IIHRDLK  N+ ++++   KI DFG+AR
Sbjct: 122 FLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 21/160 (13%)

Query: 546 DYNKL---GQGGFG-IVYKGRLLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRN 599
            YN L   G+G FG  +    +   Q+ A+K  RL ++S   +E+ + E  L+AK++H N
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPN 59

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK-----ARSSILNWQRRFNIICGIARGL 654
           +V             +V EY +   L   I  +        +IL W   F  +C    G+
Sbjct: 60  IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW---FVQMC---LGV 113

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
            ++H+    R++HRD+K+ NI L +    K+ DFG AR+ 
Sbjct: 114 QHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 54.8 bits (132), Expect = 5e-08
 Identities = 27/52 (51%), Positives = 33/52 (63%), Gaps = 5/52 (9%)

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQT 699
           IA GL +LH      II+RDLK  N++LD E   KI+DFGM +  IFGG  T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT 158

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 54.3 bits (131), Expect = 7e-08
 Identities = 44/151 (29%), Positives = 68/151 (45%), Gaps = 20/151 (13%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN---EVRLIAKLQHR--NLVRL 603
           +G G  G VYK R  + G  +AVK++ R   +  EE K    ++ ++ K  H    +V+ 
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLK-SHDCPYIVKC 79

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF---NIICGIARGLLYLHQD 660
            G  +   +  +  E M      S   DK    I           +   I + L YL + 
Sbjct: 80  YGYFITDSDVFICMELM------STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE- 132

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
            +  +IHRD+K SNILLD     K+ DFG++
Sbjct: 133 -KHGVIHRDVKPSNILLDASGNVKLCDFGIS 162

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 54.9 bits (132), Expect = 7e-08
 Identities = 31/105 (29%), Positives = 46/105 (43%), Gaps = 6/105 (5%)

Query: 588 EVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNII 647
           E  L+  + H +++R+    V      +V   + + S D   +   RS  L   +   I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             I  GL YLH     RIIHRD+K  NI ++      I D G A+
Sbjct: 164 KQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ 205

Length = 357

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 54.7 bits (132), Expect = 7e-08
 Identities = 50/155 (32%), Positives = 69/155 (44%), Gaps = 28/155 (18%)

Query: 550 LGQGGFGIV----YKGRLLEGQEIAVKRLSRN---SGQGIEEFKNEVRL---IAKLQHRN 599
           LG+G FG V    YK     G+  A+K L +    +   +E    E R+       +H  
Sbjct: 7   LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVI----FDKARSSILNWQRRFNIICGIARGLL 655
           LV L  C    D    V EY     L   I    F + R+        F   C +  GL 
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRA-------VFYAAC-VVLGLQ 115

Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM 690
           YLH++   +I++RDLK  N+LLD E   KI+DFG+
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL 147

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 54.2 bits (130), Expect = 8e-08
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 26/166 (15%)

Query: 550 LGQGGFGIVY--------KGRLLEGQEIAVKRL-SRNSGQGIEEFKNEVRLIAKL-QHRN 599
           LG+G FG V         K +     ++AVK L S  + + + +  +E+ ++  + +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 600 LVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN--IIC 648
           ++ LLG C         VE   K  + EY+  R    + +    + +   Q  F   + C
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 649 G--IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              +ARG+ YL      + IHRDL A N+L+ ++   KI+DFG+AR
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 188

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 54.3 bits (130), Expect = 8e-08
 Identities = 46/158 (29%), Positives = 81/158 (51%), Gaps = 15/158 (9%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFK-NEVRLIAKLQHRNLVRLLGCC 607
           K+G+G +G VYK +  +G++     L +  G GI      E+ L+ +L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 608 V-EMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY-----LHQD 660
           +   D K+ L+++Y E+     + F +A  +    ++   +  G+ + LLY     +H  
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 661 SRFRIIHRDLKASNILLDKEMTP----KISDFGMARIF 694
               ++HRDLK +NIL+  E       KI+D G AR+F
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 54.1 bits (130), Expect = 9e-08
 Identities = 47/153 (30%), Positives = 72/153 (47%), Gaps = 21/153 (13%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G FG V    L    E+ A+K L ++       ++    E R++A       +  L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 606 CCVEMDEKML-VYEYMENRSLDSVI-----FDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           CC +  +++  V EY+    L   I     FD+ RS       RF     +   L++LH+
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRS-------RF-YAAEVTLALMFLHR 114

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
                +I+RDLK  NILLD E   K++DFGM +
Sbjct: 115 HG---VIYRDLKLDNILLDAEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 49/161 (30%), Positives = 82/161 (50%), Gaps = 21/161 (13%)

Query: 550 LGQGGFGIVYKGRLLEG---QEIAVKRLSRNSGQGI-EEFKNEVRLIAKL-QHRNLVRLL 604
           +G+G FG V K R+ +     + A+KR+   + +    +F  E+ ++ KL  H N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 605 GCCVEMDEKMLVYEYM----------ENRSLDS---VIFDKARSSILNWQRRFNIICGIA 651
           G C       L  EY           ++R L++        + +S L+ Q+  +    +A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           RG+ YL   S+ + IHRDL A NIL+ +    KI+DFG++R
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 50/186 (26%), Positives = 86/186 (46%), Gaps = 31/186 (16%)

Query: 542 DNFTDYNKLGQGGFGIVYK-----GRLLEGQEI---AVKRLSRNSGQGIEEFKNEVRLIA 593
           D+F   ++LG G  G+V K       L+  +++    +K   RN      +   E++++ 
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRN------QIIRELQVLH 58

Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKAR--SSILNWQRRFNIICGIA 651
           +     +V   G      E  +  E+M+  SLD V+ +  R    IL       +   + 
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVL 113

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG--------MARIFGGDQTEQNT 703
           RGL YL +  + +I+HRD+K SNIL++     K+ DFG        MA  F G ++  + 
Sbjct: 114 RGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSP 171

Query: 704 KRVVGT 709
           +R+ GT
Sbjct: 172 ERLQGT 177

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 43/153 (28%), Positives = 79/153 (51%), Gaps = 17/153 (11%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEE---FKNEVRLIAKLQHRNLVRLLG 605
           +G+G +G+V        G+++A+K++  +  + + +      E++L+  L+H ++V +  
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 606 CCV-----EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
             +     E  +  +V+E ME+  L  VI  KA   +     +F  +  + R L Y+H  
Sbjct: 67  IMLPPSRREFKDIYVVFELMES-DLHQVI--KANDDLTPEHHQF-FLYQLLRALKYIHTA 122

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARI 693
           + F   HRDLK  NIL + +   KI DFG+AR+
Sbjct: 123 NVF---HRDLKPKNILANADCKLKICDFGLARV 152

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 40/158 (25%), Positives = 70/158 (44%), Gaps = 22/158 (13%)

Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFK---NEVRLIAKLQHRN 599
           F    ++GQGG+G V+  +  +  EI A+KR+ ++    + E +    E  ++   +   
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 600 LVRLLGCCVEMDEKMLVYEYM---ENRSLDSVIFDKARSSILNWQRRFNI---ICGIARG 653
           LV+LL    + +   L  EY+   + R+L +         +     RF +      +   
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN-----NLGVLSEDHARFYMAEMFEAVDA- 116

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
              LH       IHRDLK  N L+D     K++DFG++
Sbjct: 117 ---LH---ELGYIHRDLKPENFLIDASGHIKLTDFGLS 148

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 48/172 (27%), Positives = 86/172 (50%), Gaps = 36/172 (20%)

Query: 548 NKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQGIEEFKNEVRLIAK-LQHRNLVRLLG 605
           N +G G FG+VY+   ++  E +A+K++ ++      ++KN   LI K L H N++ L  
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKD 126

Query: 606 C----CVEMDEKML------------VYEYMENRSLDSVIFDKARSSILNWQRRFNIICG 649
                C + +EK +            V++YM++ + ++         + ++Q        
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQ-------- 178

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLD-KEMTPKISDFGMAR-IFGGDQT 699
           + R L Y+H  S+F I HRDLK  N+L+D    T K+ DFG A+ +  G ++
Sbjct: 179 LCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS 227

Length = 440

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 50/156 (32%), Positives = 76/156 (48%), Gaps = 19/156 (12%)

Query: 550 LGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G FG V    L  +G+  AVK L ++       +E    E R++A       +  L 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 606 CCVEMDEKML-VYEYMENRSLDSVIFDKARSSILNWQRRF---NIICGIARGLLYLHQDS 661
           C  +  E +  V E++    L   I DK R  +  ++  F    I+CG    L +LH   
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAAEIVCG----LQFLHSKG 116

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFG 695
              II+RDLK  N++LD++   KI+DFGM +  +FG
Sbjct: 117 ---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG 149

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 51.9 bits (124), Expect = 5e-07
 Identities = 48/153 (31%), Positives = 70/153 (45%), Gaps = 21/153 (13%)

Query: 550 LGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G FG V+   L    Q  A+K L ++       +E    E R+++       +  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 606 CCVEMDEKML-VYEYMENRSLDSVI-----FDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           C  +  E +  V EY+    L   I     FD  R++    +    IICG    L +LH 
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAE----IICG----LQFLHS 114

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
                I++RDLK  NILLD +   KI+DFGM +
Sbjct: 115 KG---IVYRDLKLDNILLDTDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 51.2 bits (122), Expect = 8e-07
 Identities = 50/186 (26%), Positives = 86/186 (46%), Gaps = 31/186 (16%)

Query: 542 DNFTDYNKLGQGGFGIVYK------GRLLEGQEI--AVKRLSRNSGQGIEEFKNEVRLIA 593
           D+F   ++LG G  G+V+K      G ++  + I   +K   RN      +   E++++ 
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRN------QIIRELQVLH 58

Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKAR--SSILNWQRRFNIICGIA 651
           +     +V   G      E  +  E+M+  SLD V+    R    IL       +   + 
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVI 113

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG--------MARIFGGDQTEQNT 703
           +GL YL +  + +I+HRD+K SNIL++     K+ DFG        MA  F G ++  + 
Sbjct: 114 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSP 171

Query: 704 KRVVGT 709
           +R+ GT
Sbjct: 172 ERLQGT 177

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 52.2 bits (125), Expect = 9e-07
 Identities = 43/156 (27%), Positives = 67/156 (42%), Gaps = 18/156 (11%)

Query: 566 GQEIAVKRLSRNSGQGIEE---FKNEVRLIAKLQHRNLVRLLGCCVEMDEKML-VYEYME 621
           G E+A+K L  ++ +   +   F+ E  L A+L H N+V LL         +  V+EY+ 
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL---D 678
            R+L  V+   A    L       ++  +   L   H      I+HRDLK  NI++    
Sbjct: 63  GRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116

Query: 679 KEMTPKISDFGMARIFGG-----DQTEQNTKRVVGT 709
                K+ DFG+  +  G       T   T  V+GT
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGT 152

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 55/157 (35%), Positives = 73/157 (46%), Gaps = 29/157 (18%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRN---SGQGIEEFKNEVR-LIAKLQHRNLVRLL 604
           LG+G FG V    L    E  A+K L ++       +E    E R L    +H  L  L 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 605 GCCVEMDEKML-VYEYMENRSL-----DSVIFDKARSSILNWQRRF---NIICGIARGLL 655
            C  +  E +  V EY+    L      S  FD+AR+       RF    IICG    L 
Sbjct: 63  -CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARA-------RFYAAEIICG----LQ 110

Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +LH+     II+RDLK  N+LLDK+   KI+DFGM +
Sbjct: 111 FLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 56/188 (29%), Positives = 85/188 (45%), Gaps = 35/188 (18%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIE-EFKNEVR--LIAKLQ-- 596
           D+F    +LG G  G+V K        I  ++L       I  E K  +R  +I +L+  
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKL-------IHLEIKPAIRNQIIRELKVL 53

Query: 597 HR----NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKAR---SSILNWQRRFNIICG 649
           H      +V   G      E  +  E+M+  SLD V+  KA     +IL       I   
Sbjct: 54  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPENILG-----KISIA 107

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG--------MARIFGGDQTEQ 701
           + RGL YL +  + +I+HRD+K SNIL++     K+ DFG        MA  F G ++  
Sbjct: 108 VLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 165

Query: 702 NTKRVVGT 709
           + +R+ GT
Sbjct: 166 SPERLQGT 173

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 46/163 (28%), Positives = 73/163 (44%), Gaps = 17/163 (10%)

Query: 552 QGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN--EVRLIAKLQHR--NLVRLLGC 606
           +G FG VY  +    G   A+K L ++      +  N    R I  +Q     + +L   
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65

Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
               D   LV EY+      S+I         +W +++  I  +  G+  LHQ     II
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG---II 119

Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           HRD+K  N+L+D+    K++DFG++R        +N K+ VGT
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRN-----GLEN-KKFVGT 156

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 19/162 (11%)

Query: 550 LGQGGFGIV------YKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LG+GGFG V        G++   +++  KRL + SG+ +   + E+     L+  N   +
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI-----LEKVNSPFI 55

Query: 604 LGCCVEMDEKM---LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           +      + K    LV   M    L   I++      L  +R  +    I  G+L+LH  
Sbjct: 56  VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-LEMERVIHYSAQITCGILHLHS- 113

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMA-RIFGGDQTEQ 701
               I++RD+K  N+LLD +   ++SD G+A  +  G    Q
Sbjct: 114 --MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQ 153

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 47.9 bits (114), Expect = 8e-06
 Identities = 32/101 (31%), Positives = 47/101 (46%), Gaps = 17/101 (16%)

Query: 618 EYMENRSLDSVI--FDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNI 675
           E+M+  SLD +          IL       I   +  GL YL+  +  RI+HRD+K SNI
Sbjct: 83  EFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLY--NVHRIMHRDIKPSNI 135

Query: 676 LLDKEMTPKISDFG--------MARIFGGDQTEQNTKRVVG 708
           L++     K+ DFG        +A  F G  T  + +R+ G
Sbjct: 136 LVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQG 176

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 47.7 bits (113), Expect = 9e-06
 Identities = 43/169 (25%), Positives = 79/169 (46%), Gaps = 17/169 (10%)

Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQE----IAVKRLSRNS----GQGIEEFKNEVRLIAK 594
           NF     LG G +G V+  R + G +     A+K L + +     +  E  + E +++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 595 LQHRNLVRLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICG-IAR 652
           ++    +  L    + D K+ L+ +Y+    L + +  + R      ++   I  G I  
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK----EQEVQIYSGEIVL 116

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ 701
            L +LH   +  II+RD+K  NILLD      ++DFG+++ F  D+ E+
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER 162

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 39/145 (26%), Positives = 70/145 (48%), Gaps = 12/145 (8%)

Query: 550 LGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRNLVRLLGCC 607
           LG G  G VYK   LL  + +AVK +  +    ++ +  +E+ ++ K     ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
              +   +  E+M+  SLD  ++ K    +L       I   + +GL YL      +I+H
Sbjct: 69  FVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWS---LKILH 118

Query: 668 RDLKASNILLDKEMTPKISDFGMAR 692
           RD+K SN+L++     K+ DFG++ 
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST 143

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 22/55 (40%), Positives = 33/55 (60%), Gaps = 3/55 (5%)

Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ 701
           I  I   L +LHQ     II+RD+K  NILLD E    ++DFG+++ F  ++ E+
Sbjct: 111 IAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER 162

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 55/190 (28%), Positives = 84/190 (44%), Gaps = 26/190 (13%)

Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGI-EEFKNEVRL 591
           F++    +D +     +G+G +G V+K      G + AVK L  +    I EE + E  +
Sbjct: 10  FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL--DPIHDIDEEIEAEYNI 67

Query: 592 IAKLQ-HRNLVRLLGCCVEMDEK-----MLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  L  H N+V+  G   + D K      LV E     S+  ++        L    R  
Sbjct: 68  LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV-----KGFLKRGERME 122

Query: 646 --IICGIAR----GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
             II  I      GL +LH +   + IHRD+K +NILL  E   K+ DFG++      + 
Sbjct: 123 EPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 179

Query: 700 EQNTKRVVGT 709
            +NT   VGT
Sbjct: 180 RRNTS--VGT 187

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 46.9 bits (112), Expect = 2e-05
 Identities = 46/172 (26%), Positives = 71/172 (41%), Gaps = 38/172 (22%)

Query: 533 DFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSR----NSGQGIEEFKN 587
           DFE I            +G+G FG V+  R  +  ++ A+K L +       Q I   + 
Sbjct: 2   DFEVIKV----------IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRA 50

Query: 588 EVRLIAKLQHRNLVRLLGCCVEMDEKML--VYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           E  ++A      +V+L       DE+ L  V EYM    L            +N   R +
Sbjct: 51  ERDILADADSPWIVKLY--YSFQDEEHLYLVMEYMPGGDL------------MNLLIRKD 96

Query: 646 IICG------IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
           +         IA  +L L    +   IHRD+K  NIL+D +   K++DFG+ 
Sbjct: 97  VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLC 148

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 32/150 (21%), Positives = 56/150 (37%), Gaps = 25/150 (16%)

Query: 550 LGQGGFGIVYK----GRLLEGQEIAVKRLSRNSGQGIEEFK---NEVRLIAKLQHRNLVR 602
                   + K      L+     AVK+++ +S    E+ K    E+    +LQH N++ 
Sbjct: 10  FEDLMIVHLAKHKPTNTLV-----AVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 603 LLGCCVEMDEKMLVYEYMENRS----LDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
            +   +   E  +V   M   S    L +   +      +       I+  +   L Y+H
Sbjct: 64  YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIA-----FILKDVLNALDYIH 118

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDF 688
                  IHR +KAS+ILL  +    +S  
Sbjct: 119 SKG---FIHRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 44/147 (29%), Positives = 66/147 (44%), Gaps = 10/147 (6%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIAKLQHRNLVRLLG 605
           LG+G FG V   R    G+  A+K L +      +E  +   E R++   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
                D    V EY+    L    F  +R  + +  R       I   L YLH     +I
Sbjct: 63  SFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KI 116

Query: 666 IHRDLKASNILLDKEMTPKISDFGMAR 692
           ++RDLK  N++LDK+   KI+DFG+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 6/147 (4%)

Query: 548 NKLGQGGFGIVYKGR-LLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           ++LG+G +G VYK      G  +A+K  RL  +  +   +   E+ ++ K     +V   
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFY 65

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G         +  EYM+  SLD +      +  +       I   + +GL +L ++    
Sbjct: 66  GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HN 123

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMA 691
           IIHRD+K +N+L++     K+ DFG++
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVS 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 46.0 bits (109), Expect = 4e-05
 Identities = 30/112 (26%), Positives = 47/112 (41%), Gaps = 23/112 (20%)

Query: 588 EVRLIAKLQHRNLVRLLG--------CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILN 639
           E+ ++  + HR ++ L+         C V    K  ++ Y++            RS  L 
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVD------------RSGPLP 183

Query: 640 WQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
            ++   I   +   L YLH      IIHRD+K  NI LD+     + DFG A
Sbjct: 184 LEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232

Length = 392

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 45.4 bits (107), Expect = 6e-05
 Identities = 43/148 (29%), Positives = 66/148 (44%), Gaps = 11/148 (7%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRN---SGQGIEEFKNEVRLIAKLQHRN-LVRLL 604
           LG+G FG V         E+ A+K L ++       +E    E R++A       L +L 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
            C   +D    V EY+    L   ++   +       +       I+ GL +LH+     
Sbjct: 68  SCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--- 121

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMAR 692
           II+RDLK  N++LD E   KI+DFGM +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 45.6 bits (108), Expect = 7e-05
 Identities = 27/84 (32%), Positives = 45/84 (53%), Gaps = 16/84 (19%)

Query: 615 LVYEYMENRSLDSVI-----FDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRD 669
           LV EY+    + S++     FD+  +       ++  I  +A  L YLH+     IIHRD
Sbjct: 81  LVMEYLIGGDVKSLLHIYGYFDEEMA------VKY--ISEVALALDYLHRHG---IIHRD 129

Query: 670 LKASNILLDKEMTPKISDFGMARI 693
           LK  N+L+  E   K++DFG++++
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.2 bits (102), Expect = 8e-05
 Identities = 33/147 (22%), Positives = 56/147 (38%), Gaps = 15/147 (10%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV--RLLGC 606
            L  G    VY     +  +  +K     S +   + + EV ++  L  + L   ++L  
Sbjct: 5   LLKGGLTNRVYLLGTKDE-DYVLKIN--PSREKGADREREVAILQLLARKGLPVPKVLAS 61

Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
                   L+ E++E  +LD V          + + + +I   +A  L  LHQ     + 
Sbjct: 62  GESDGWSYLLMEWIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLC 111

Query: 667 HRDLKASNILLDKEMTPKISDFGMARI 693
           H DL   NIL+D      I D+  A  
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 45.5 bits (108), Expect = 9e-05
 Identities = 42/169 (24%), Positives = 74/169 (43%), Gaps = 23/169 (13%)

Query: 549 KLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN----EVRLIAKLQHRNLVRL 603
            +G+GG G VY     +  + +A+K++ R         K     E ++ A L H  +V +
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 604 LGCCVEMDEKMLVYEYMENRSL----------DSVIFDKA-RSSILNWQRRFNIICGIAR 652
              C + D       Y+E  +L          +S+  + A ++S+  +   F+ IC    
Sbjct: 68  YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC---A 124

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ 701
            + Y+H  S+  ++HRDLK  NILL       I D+G A     ++ + 
Sbjct: 125 TIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDL 170

Length = 932

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 45.0 bits (106), Expect = 9e-05
 Identities = 48/149 (32%), Positives = 65/149 (43%), Gaps = 13/149 (8%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRN---SGQGIEEFKNEVRLIAKLQHRN--LVRL 603
           LG+G FG V         E+ A+K L ++       +E    E R++A L  +   L +L
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLA-LSGKPPFLTQL 66

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
             C   MD    V EY+    L   I    R               IA GL +LH     
Sbjct: 67  HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR---FKEPHAVFYAAEIAIGLFFLHSKG-- 121

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
            II+RDLK  N++LD E   KI+DFGM +
Sbjct: 122 -IIYRDLKLDNVMLDSEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 45.5 bits (107), Expect = 9e-05
 Identities = 33/134 (24%), Positives = 63/134 (47%), Gaps = 22/134 (16%)

Query: 571 VKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE---YMENRSLD- 626
           + +  +   +   + +NE+  + +L H N++++        E++L  E   YM  +  D 
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDF 247

Query: 627 ---SVIFDKA---RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE 680
              S ++D+A   +   L  Q R  I+  +   + Y+H     ++IHRD+K  NI L+ +
Sbjct: 248 DLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCD 303

Query: 681 MTPKISDFGMARIF 694
               + DFG A  F
Sbjct: 304 GKIVLGDFGTAMPF 317

Length = 501

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 23/43 (53%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +ARG+ +L   SR + IHRDL A NILL +    KI DFG+AR
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLAR 221

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 41/147 (27%), Positives = 65/147 (44%), Gaps = 9/147 (6%)

Query: 550 LGQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIAKLQHRNLVRLLG 605
           LG+G FG ++       G+  A+K L +      +E  +   E R++   +H  L  L  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
                D    V EY     L    F  +R  + +  R       I   L YLH +    +
Sbjct: 63  SFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--V 117

Query: 666 IHRDLKASNILLDKEMTPKISDFGMAR 692
           ++RDLK  N++LDK+   KI+DFG+ +
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK 144

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 14/152 (9%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRL-----SRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +G+G +G V   R   +G++  +K+L     SR   +  E+   E +L+++L+H N+V  
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ---EAQLLSQLKHPNIVAY 64

Query: 604 LGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
                  D  + +V  + E   L   +  + +  +L   +       IA  L YLH+   
Sbjct: 65  RESWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQIAMALQYLHEK-- 121

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
             I+HRDLK  N+ L +    K+ D G+AR+ 
Sbjct: 122 -HILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 40/148 (27%), Positives = 68/148 (45%), Gaps = 11/148 (7%)

Query: 550 LGQGGFGIVYKGRLLEGQEI----AVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           +G+G +  V   RL + + I     VK+   N  + I+  + E  +  +  +   +  L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 606 CCVEMDEKML-VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
            C + + ++  V EY+    L   +F   R   L  +        I+  L YLH+     
Sbjct: 63  SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG--- 116

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMAR 692
           II+RDLK  N+LLD E   K++D+GM +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 44.0 bits (104), Expect = 2e-04
 Identities = 51/170 (30%), Positives = 75/170 (44%), Gaps = 23/170 (13%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVR--------LIAKLQHRNL 600
           +G+G FG V   +   +G+  AVK L + +   I + K E +        L+  ++H  L
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKA---ILK-KKEQKHIMAERNVLLKNVKHPFL 58

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIARGLLYLHQ 659
           V L       D+   V +Y+    L    F   R  S    + RF     IA  L YLH 
Sbjct: 59  VGLHYSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARF-YAAEIASALGYLHS 114

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
                II+RDLK  NILLD +    ++DFG+ +   G +  + T    GT
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGT 159

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 44.0 bits (104), Expect = 2e-04
 Identities = 52/188 (27%), Positives = 79/188 (42%), Gaps = 34/188 (18%)

Query: 516 KRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIV----YKGRLLEGQEIAV 571
           K  Y   K D     L DFE  +  T        LG G FG V    +KG    G+  A+
Sbjct: 2   KAAYMFTKPDTSSWKLSDFE--MGET--------LGTGSFGRVRIAKHKGT---GEYYAI 48

Query: 572 KRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML--VYEYMENRSLD 626
           K L +      + ++    E  ++ +L H  +V ++  C   DE  +  + E++    L 
Sbjct: 49  KCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMM--CSFQDENRVYFLLEFVVGGEL- 105

Query: 627 SVIFDKARSS--ILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK 684
              F   R +    N   +F     +     YLH      II+RDLK  N+LLD +   K
Sbjct: 106 ---FTHLRKAGRFPNDVAKF-YHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVK 158

Query: 685 ISDFGMAR 692
           ++DFG A+
Sbjct: 159 VTDFGFAK 166

Length = 329

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.0 bits (104), Expect = 2e-04
 Identities = 47/180 (26%), Positives = 77/180 (42%), Gaps = 38/180 (21%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSGQGIEEFKNEVRL----- 591
           D+F    KLG+G FG+VYK  L+        +  +K+ +   G  +E + NE R+     
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK-ATEYGA-VEIWMNE-RVRRACP 188

Query: 592 --IAKLQHRNLVRLLGCCVEMDEKMLVYEY---------MENR----SLDSVIFDKARSS 636
              A   +  L  +     + DE  LV+ Y         M+++    +++  +  K +  
Sbjct: 189 NSCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDL 246

Query: 637 ILNWQRRFNIICGIARGLLY----LHQDSRFRIIHRDLKASNILLD-KEMTPKISDFGMA 691
               +R   II  I R +L+    LH      I+HRD+K  NI+      + KI D G A
Sbjct: 247 PKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 43.5 bits (102), Expect = 3e-04
 Identities = 25/51 (49%), Positives = 33/51 (64%), Gaps = 6/51 (11%)

Query: 645 NIIC---GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           ++IC    +ARG+ +L   SR + IHRDL A NILL +    KI DFG+AR
Sbjct: 175 DLICYSFQVARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 222

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 42/147 (28%), Positives = 63/147 (42%), Gaps = 10/147 (6%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKN---EVRLIAKLQHRNLVRLLG 605
           LG+G FG V   R     +  A+K L +      +E  +   E R++   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62

Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
                D    V EY     L    F  +R  + +  R       I   L YLH      +
Sbjct: 63  SFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALGYLH---SCDV 116

Query: 666 IHRDLKASNILLDKEMTPKISDFGMAR 692
           ++RDLK  N++LDK+   KI+DFG+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 43.2 bits (102), Expect = 3e-04
 Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 18/161 (11%)

Query: 550 LGQGGFGIVYKGRLLEGQE----IAVKRLSR----NSGQGIEEFKNEVRLIAKLQHRNLV 601
           LG+GG+G V++ R + G +     A+K L +     + +     K E  ++  ++H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 602 RLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            L+    +   K+ L+ EY+    L        R  I         +  I+  L +LHQ 
Sbjct: 64  DLI-YAFQTGGKLYLILEYLSGGEL---FMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQT 699
               II+RDLK  NILLD +   K++DFG+ +  I  G  T
Sbjct: 120 G---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT 157

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 46/165 (27%), Positives = 72/165 (43%), Gaps = 13/165 (7%)

Query: 550 LGQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVR----LIAKLQHRNLVRLL 604
           +G+G FG ++   R  +G   AVK L + +    +E  + +     L+  L+H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
                 ++   V +Y+    L    F   R       R       +A  + YLH      
Sbjct: 63  YSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARFYAAEVASAIGYLHS---LN 116

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           II+RDLK  NILLD +    ++DFG+ +   G + E+ T    GT
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGT 159

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 43.1 bits (101), Expect = 4e-04
 Identities = 30/79 (37%), Positives = 44/79 (55%), Gaps = 8/79 (10%)

Query: 619 YMENRSLDSVIFDKARSSIL--NWQRRFNIIC---GIARGLLYLHQDSRFRIIHRDLKAS 673
           ++E +SL  V  ++A    L        ++IC    +A+G+ +L   SR + IHRDL A 
Sbjct: 152 FVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA--SR-KCIHRDLAAR 208

Query: 674 NILLDKEMTPKISDFGMAR 692
           NILL +    KI DFG+AR
Sbjct: 209 NILLSENNVVKICDFGLAR 227

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 42.7 bits (100), Expect = 4e-04
 Identities = 42/147 (28%), Positives = 64/147 (43%), Gaps = 10/147 (6%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIAKLQHRNLVRLLG 605
           LG+G FG V   R    G+  A+K L +      +E  +   E R++   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
                D    V EY     L    F  +R  +   +R       I   L YLH      +
Sbjct: 63  AFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHSRD---V 116

Query: 666 IHRDLKASNILLDKEMTPKISDFGMAR 692
           ++RD+K  N++LDK+   KI+DFG+ +
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 41.5 bits (98), Expect = 5e-04
 Identities = 30/114 (26%), Positives = 48/114 (42%), Gaps = 26/114 (22%)

Query: 586 KNEVRLIAKLQHRNLVRLLGCC------VEMDEKMLVYEYMENRSLDSVIFDKARSSILN 639
           + E R++AK       R  G        V+ D  ++V EY+E   L   + ++AR  +L 
Sbjct: 47  RREARILAKA------REAGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL-EEARPDLL- 98

Query: 640 WQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI 693
             R    +  + +    LH   +  I+H DL  SNI+L         DFG+   
Sbjct: 99  --REVGRL--VGK----LH---KAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140

Length = 204

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 42.7 bits (100), Expect = 5e-04
 Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 20/161 (12%)

Query: 544 FTDYN---KLGQGGFGIVYKGRLLEGQ--EIAVKRLSRNS---GQGIEEFKNEVRLIAKL 595
           + D+N    LG G FG V            +A+KR  ++     + ++   +E +++  +
Sbjct: 29  YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI 88

Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI---AR 652
            H   V L G   +     LV E++    +    F     + L   +RF    G    A+
Sbjct: 89  NHPFCVNLYGSFKDESYLYLVLEFV----IGGEFF-----TFLRRNKRFPNDVGCFYAAQ 139

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI 693
            +L         I++RDLK  N+LLDK+   K++DFG A++
Sbjct: 140 IVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180

Length = 340

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 42.5 bits (100), Expect = 5e-04
 Identities = 42/150 (28%), Positives = 74/150 (49%), Gaps = 14/150 (9%)

Query: 550 LGQGGFGIVYKGRLL----EGQEIAVKRLSRNSGQGIEEF--KNEVRLIAKLQHRNLVRL 603
           LGQG FG V+  R +     GQ  A+K L + + +  +    K E  ++A++ H  +V+L
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI-ICGIARGLLYLHQDSR 662
                   +  L+ +++    L    F +    ++  +      +  +A  L +LH    
Sbjct: 64  HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH---S 116

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             II+RDLK  NILLD+E   K++DFG+++
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSK 146

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 42.2 bits (99), Expect = 5e-04
 Identities = 32/107 (29%), Positives = 55/107 (51%), Gaps = 12/107 (11%)

Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++ H+++V L G CV   E ++V E++E   LD  +F   +S +L    +F +   +
Sbjct: 57  MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQL 114

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILL-----DKEMTP--KISDFGM 690
           A  L YL       ++H ++   NILL     D E  P  K+SD G+
Sbjct: 115 ASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 42.3 bits (99), Expect = 6e-04
 Identities = 42/148 (28%), Positives = 67/148 (45%), Gaps = 11/148 (7%)

Query: 550 LGQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVR----LIAKLQHRNLVRLL 604
           +G+G FG ++   R L+G+  AVK L +      +E K+ +     L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
                 ++   V +++    L    F   R       R       IA  L YLH      
Sbjct: 63  YSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---IN 116

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMAR 692
           I++RDLK  NILLD +    ++DFG+ +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 41/157 (26%), Positives = 70/157 (44%), Gaps = 13/157 (8%)

Query: 550 LGQGGFGIVYKGRLLEGQEI----AVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           +G+G +  V   RL +  +I     VK+   +  + I+  + E  +  +      +  L 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 606 CCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
            C +   ++ LV EY+    L   +F   R   L  +        I   L +LH+     
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHERG--- 116

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQT 699
           II+RDLK  N+LLD +   K++D+GM +  +  GD T
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT 153

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 41.1 bits (96), Expect = 0.002
 Identities = 30/112 (26%), Positives = 51/112 (45%), Gaps = 23/112 (20%)

Query: 588 EVRLIAKLQHRNLVRLLG--------CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILN 639
           E  ++  + H ++++L G        C +    K  +Y Y+  +       + A   IL 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKR------NIAICDILA 186

Query: 640 WQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
            +R       + R + YLH++   RIIHRD+KA NI ++      + DFG A
Sbjct: 187 IER------SVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229

Length = 391

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 23/52 (44%), Positives = 32/52 (61%), Gaps = 5/52 (9%)

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQT 699
           I+  L +LH+     II+RDLK  N+LLD E   K++D+GM +  I  GD T
Sbjct: 105 ISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT 153

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 41.0 bits (97), Expect = 0.002
 Identities = 33/161 (20%), Positives = 61/161 (37%), Gaps = 38/161 (23%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEF---------KNEVRLIAKLQHR 598
           + +G+G    + KG  L    +  +R+ +  G    E          + E RL+      
Sbjct: 339 HLIGKGAEADIKKGEYLGRDAVIKERVPK--GYRHPELDERLRTERTRAEARLL------ 390

Query: 599 NLVRLLGCC------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIAR 652
           +  R  G        V+ +EK +V EY+  + L  V+                ++  +  
Sbjct: 391 SEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLEG-----------NPELVRKVGE 439

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI 693
            +  LH   +  I+H DL  SN ++  +    I DFG+ + 
Sbjct: 440 IVAKLH---KAGIVHGDLTTSNFIVRDDRLYLI-DFGLGKY 476

Length = 535

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 46/190 (24%), Positives = 79/190 (41%), Gaps = 41/190 (21%)

Query: 550 LGQGGFGIVYKGRLL--------EGQEIAVKRLSRNSGQGIE-----------------E 584
           LGQG    +Y GRL         E +      L   +  G E                  
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 585 FKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRR 643
           F     L++++ H +L  + G CV   E ++V E++E+  LD V   K +  + + W  +
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD-VCLRKEKGRVPVAW--K 119

Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-----MTP--KISDFGMARIFGG 696
             +   +A  L YL   +   ++H ++ A NILL +       +P  K+SD G++  F  
Sbjct: 120 ITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTA 174

Query: 697 DQTEQNTKRV 706
              E+  +R+
Sbjct: 175 LSREERVERI 184

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 40.3 bits (94), Expect = 0.003
 Identities = 20/43 (46%), Positives = 26/43 (60%), Gaps = 3/43 (6%)

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +A+G+ +L   +    IHRDL A NILL      KI DFG+AR
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR 262

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|238011 cd00054, EGF_CA, Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins

 Score = 35.3 bits (82), Expect = 0.004
 Identities = 10/33 (30%), Positives = 15/33 (45%), Gaps = 1/33 (3%)

Query: 315 DQCDNYGECGPFGIC-DTNASPVCQCMRGFEPK 346
           D+C +   C   G C +T  S  C C  G+  +
Sbjct: 3   DECASGNPCQNGGTCVNTVGSYRCSCPPGYTGR 35

Many of these proteins require calcium for their biological function and calcium-binding sites have been found to be located at the N-terminus of particular EGF-like domains; calcium-binding may be crucial for numerous protein-protein interactions. Six conserved core cysteines form three disulfide bridges as in non calcium-binding EGF domains, whose structures are very similar. EGF_CA can be found in tandem repeat arrangements. Length = 38

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 39.7 bits (93), Expect = 0.004
 Identities = 17/41 (41%), Positives = 25/41 (60%)

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM 690
           IA  +L +    +   IHRD+K  N+LLD +   K+SDFG+
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	709
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.97
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.96
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.96
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.96
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.96
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.96
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.96
PF00954	110	S_locus_glycop: S-locus glycoprotein family; Inter	99.95
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.95
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	99.95
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.95
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.95
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.95
KOG3653	534	consensus Transforming growth factor beta/activin	99.95
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.94
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.94
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.94
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.94
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.94
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.94
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	99.93
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.93
KOG0198	313	consensus MEKK and related serine/threonine protei	99.93
KOG0605	550	consensus NDR and related serine/threonine kinases	99.93
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.93
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.93
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.93
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.93
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.93
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.92
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.92
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.92
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.92
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.92
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.92
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.92
KOG0578	550	consensus p21-activated serine/threonine protein k	99.92
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.91
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	99.91
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.91
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.91
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.91
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.91
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.91
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.91
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.91
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.91
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.91
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.91
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.91
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.91
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.9
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.9
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.9
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.9
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.9
PTZ00267	478	NIMA-related protein kinase; Provisional	99.9
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.9
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.9
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.9
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.9
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.9
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.9
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.9
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.9
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.9
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.9
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.9
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.9
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.9
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.9
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.9
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.9
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.9
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.9
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.9
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.9
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.9
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.9
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.89
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.89
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.89
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.89
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.89
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.89
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.89
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.89
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.89
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.89
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.89
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.89
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.89
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.89
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.89
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.89
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.89
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.89
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.89
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.89
PTZ00283	496	serine/threonine protein kinase; Provisional	99.89
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.89
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.89
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.89
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.89
PHA03212	391	serine/threonine kinase US3; Provisional	99.89
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.89
PHA02988	283	hypothetical protein; Provisional	99.89
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.89
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.89
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.89
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.89
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.89
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.89
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.89
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.89
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.89
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.89
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.89
KOG0586	596	consensus Serine/threonine protein kinase [General	99.89
KOG0589	426	consensus Serine/threonine protein kinase [General	99.89
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.89
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.89
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.89
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.89
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.89
PHA03211	461	serine/threonine kinase US3; Provisional	99.89
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.89
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.88
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.88
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.88
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.88
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.88
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.88
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.88
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.88
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.88
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.88
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.88
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.88
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.88
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.88
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.88
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.88
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.88
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.88
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.88
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.88
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.88
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.88
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.88
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.88
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.88
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.88
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.88
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.88
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.88
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.88
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.88
KOG0610	459	consensus Putative serine/threonine protein kinase	99.88
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.88
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.88
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.88
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.88
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.88
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.87
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.87
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.87
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.87
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.87
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.87
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.87
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.87
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.87
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.87
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.87
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.87
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.87
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.87
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.87
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.87
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.87
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.87
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.87
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.87
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.87
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.87
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.87
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.87
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.87
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.87
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.87
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.87
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.87
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.87
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.87
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.87
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.87
PHA03207	392	serine/threonine kinase US3; Provisional	99.87
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.87
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.87
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.87
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.87
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.87
PHA03209	357	serine/threonine kinase US3; Provisional	99.87
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.87
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.87
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.87
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.87
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.87
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.87
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.87
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.87
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.87
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.87
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.87
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.87
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.87
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.86
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.86
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.86
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.86
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.86
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.86
PTZ00036	440	glycogen synthase kinase; Provisional	99.86
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.86
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.86
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.86
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.86
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.86
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.86
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.86
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.86
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.86
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.86
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.86
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.86
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.86
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.86
KOG0584	632	consensus Serine/threonine protein kinase [General	99.86
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.86
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.86
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.86
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.86
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.86
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.86
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.86
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.86
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.86
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.86
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.86
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.86
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.86
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.86
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.86
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.86
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.85
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.85
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.85
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.85
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.85
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.85
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.85
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.85
PRK09188	365	serine/threonine protein kinase; Provisional	99.85
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.85
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.85
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.85
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.85
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.85
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.85
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.85
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.85
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.85
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.85
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.85
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.85
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.85
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.85
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.85
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.85
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.85
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.85
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.85
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.85
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.85
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.85
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.85
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.85
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.85
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.85
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.85
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.85
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.85
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.85
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.85
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.85
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.85
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.85
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.84
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.84
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.84
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.84
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.84
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.84
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.84
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.84
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.84
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.84
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.84
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.84
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.84
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.84
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.84
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.84
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.84
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.84
KOG1152	772	consensus Signal transduction serine/threonine kin	99.84
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.84
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.84
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.84
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.84
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.83
PHA03210	501	serine/threonine kinase US3; Provisional	99.83
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.83
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.83
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.83
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.83
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.83
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.83
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.83
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.83
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.83
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.83
PTZ00284	467	protein kinase; Provisional	99.83
PLN00009	294	cyclin-dependent kinase A; Provisional	99.83
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.83
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.83
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.83
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.83
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.83
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.83
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.83
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.83
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.82
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.82
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.82
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.82
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.82
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.82
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.82
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.82
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.82
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.82
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.82
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.82
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.82
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.81
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.81
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.81
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.81
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.81
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.81
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.81
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.81
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.81
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.81
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.81
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.81
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.81
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.81
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.8
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.8
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.8
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.8
PHA02882	294	putative serine/threonine kinase; Provisional	99.8
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.8
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.8
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.8
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.79
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.79
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.79
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.79
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.79
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.79
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.78
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.78
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.77
PRK10345	210	hypothetical protein; Provisional	99.77
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.77
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.76
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.76
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.75
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.75
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.75
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.74
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.74
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.74
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.73
PRK14879	211	serine/threonine protein kinase; Provisional	99.73
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.73
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.73
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.72
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.71
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.71
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.71
smart00090	237	RIO RIO-like kinase.	99.71
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.71
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.71
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.69
PRK12274	218	serine/threonine protein kinase; Provisional	99.69
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.67
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.66
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.64
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.64
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.63
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.63
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.62
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.62
PF08276	66	PAN_2: PAN-like domain; InterPro: IPR013227 PAN do	99.6
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.59
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.58
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.56
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.54
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.48
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.45
cd00129	80	PAN_APPLE PAN/APPLE-like domain; present in N-term	99.37
cd01098	84	PAN_AP_plant Plant PAN/APPLE-like domain; present	99.34
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.29
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.29
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.2
PLN00181	793	protein SPA1-RELATED; Provisional	99.16
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.12
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.12
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.05
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.0
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	98.96
KOG3087	229	consensus Serine/threonine protein kinase [General	98.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	98.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	98.85
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.81
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	98.8
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.78
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	98.75
KOG0590	601	consensus Checkpoint kinase and related serine/thr	98.68
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.5
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.5
KOG1243	690	consensus Protein kinase [General function predict	98.46
PRK09902	216	hypothetical protein; Provisional	98.4
smart00473	78	PAN_AP divergent subfamily of APPLE domains. Apple	98.37
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.32
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	98.32
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.29
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.28
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.27
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	98.26
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	98.24
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.22
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.14
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.14
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.12
PF01636	239	APH: Phosphotransferase enzyme family This family	98.09
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.06
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	98.0
KOG1266	458	consensus Protein kinase [Signal transduction mech	97.98
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.98
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.84
PLN02876	822	acyl-CoA dehydrogenase	97.84
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.73
PRK10593	297	hypothetical protein; Provisional	97.6
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.59
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.56
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.54
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	97.46
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.44
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.33
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.28
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.17
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.11
cd01100	73	APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d	96.99
PLN02236	344	choline kinase	96.86
PRK05231	319	homoserine kinase; Provisional	96.72
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.67
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.46
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.44
KOG0606	1205	consensus Microtubule-associated serine/threonine	95.92
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.77
KOG2270	520	consensus Serine/threonine protein kinase involved	95.61
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.55
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	95.49
KOG0576	829	consensus Mitogen-activated protein kinase kinase	95.26
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.21
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.07
PLN02756	418	S-methyl-5-thioribose kinase	94.75
COG2334	331	Putative homoserine kinase type II (protein kinase	94.63
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	94.47
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	93.79
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	93.68

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=328.74  Aligned_cols=168  Identities=50%  Similarity=0.864  Sum_probs=154.4

Q ss_pred             CCCCCChHHHHHHhcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEE
Q 005206          528 ELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC  607 (709)
Q Consensus       528 ~~~~~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~  607 (709)
                      ....|+++++..||++|+..+.||+|+||.||+|.+.+++.||||++.....+..++|.+|+.++.+++|||||+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45679999999999999999999999999999999999999999988765433256799999999999999999999999


Q ss_pred             EeCC-eeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEE
Q 005206          608 VEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKIS  686 (709)
Q Consensus       608 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~  686 (709)
                      .+.+ +++||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9999 599999999999999999875544 78999999999999999999999998899999999999999999999999


Q ss_pred             ecCCceeeCC
Q 005206          687 DFGMARIFGG  696 (709)
Q Consensus       687 DFGla~~l~~  696 (709)
                      |||||+....
T Consensus       220 DFGLa~~~~~  229 (361)
T KOG1187|consen  220 DFGLAKLGPE  229 (361)
T ss_pred             CccCcccCCc
Confidence            9999976643

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-31  Score=274.65  Aligned_cols=159  Identities=33%  Similarity=0.573  Sum_probs=140.6

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      .+|...++||+|+|+.||+|++.. +.+||||.+.+.  .....+-+..|+.+|+.++|||||+|++++.+++..+||||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            567777889999999999999976 789999999765  45567778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC------CcEEEEecCCce
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE------MTPKISDFGMAR  692 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~------~~~KI~DFGla~  692 (709)
                      ||.+|+|.+||....   .+++.+...++.|+|.||++||+++   ||||||||+||||+..      -.+||+|||+||
T Consensus        90 yC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             eCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            999999999997654   4899999999999999999999998   9999999999999765      468999999999


Q ss_pred             eeCCCCccccccceecC
Q 005206          693 IFGGDQTEQNTKRVVGT  709 (709)
Q Consensus       693 ~l~~~~~~~~~~~~~GT  709 (709)
                      .+.+..   ...+++|+
T Consensus       164 ~L~~~~---~a~tlcGS  177 (429)
T KOG0595|consen  164 FLQPGS---MAETLCGS  177 (429)
T ss_pred             hCCchh---HHHHhhCC
Confidence            996443   34456775

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.8e-29  Score=259.36  Aligned_cols=159  Identities=30%  Similarity=0.490  Sum_probs=135.3

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCcc-------chHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQ-------GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~-------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  613 (709)
                      +.|...+.||+|+||.|-+|.... ++.||||++++....       ......+|+++|++|+|||||++++++...+..
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            456677899999999999997754 899999999764211       223457999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC---CcEEEEecCC
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE---MTPKISDFGM  690 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~KI~DFGl  690 (709)
                      |||||||++|+|.+++.....   +.+..-..+++|++.|+.|||+++   |+||||||+|||+..+   ..+||+||||
T Consensus       252 YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             EEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccch
Confidence            999999999999999865433   666666779999999999999998   9999999999999765   7899999999


Q ss_pred             ceeeCCCCccccccceecC
Q 005206          691 ARIFGGDQTEQNTKRVVGT  709 (709)
Q Consensus       691 a~~l~~~~~~~~~~~~~GT  709 (709)
                      |+..+..   ..+.++|||
T Consensus       326 AK~~g~~---sfm~TlCGT  341 (475)
T KOG0615|consen  326 AKVSGEG---SFMKTLCGT  341 (475)
T ss_pred             hhccccc---eehhhhcCC
Confidence            9998633   245668998

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=6.6e-29  Score=268.78  Aligned_cols=160  Identities=31%  Similarity=0.461  Sum_probs=144.9

Q ss_pred             cCcCcceeecccCceEEEEEEE-cCCcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ..|...+.||+|+|..||+++. ..|+.||+|++.+.   .....+...+||++.+.|+|||||+++++|.+.++.|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4688889999999999999998 66999999999764   3455678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      |+|++++|.+++.   +...+++.+...+..||+.||.|||+++   |||||||..|++|++++++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999985   3456999999999999999999999998   999999999999999999999999999999876


Q ss_pred             CccccccceecC
Q 005206          698 QTEQNTKRVVGT  709 (709)
Q Consensus       698 ~~~~~~~~~~GT  709 (709)
                      +.+..  ++|||
T Consensus       172 ~Erk~--TlCGT  181 (592)
T KOG0575|consen  172 GERKK--TLCGT  181 (592)
T ss_pred             ccccc--eecCC
Confidence            55443  48998

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.96  E-value=7.9e-29  Score=265.99  Aligned_cols=148  Identities=39%  Similarity=0.607  Sum_probs=131.5

Q ss_pred             cceeecccCceEEEEEEEcCCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC-eeEEEEEccCC
Q 005206          546 DYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD-EKMLVYEYMEN  622 (709)
Q Consensus       546 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~Ey~~~  622 (709)
                      ..+.||+|+||+||+|.+.....||||++....  ....++|.+|+.+|.+++|||||+++|+|.+.. ..+||||||++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            334699999999999999765559999997643  222679999999999999999999999999988 78999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-cEEEEecCCceeeCC
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIFGG  696 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~KI~DFGla~~l~~  696 (709)
                      |+|..+++.. ....+++..++.++.|||+||.|||++..  ||||||||+||||+.++ ++||+|||+++....
T Consensus       125 GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~  196 (362)
T KOG0192|consen  125 GSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVI  196 (362)
T ss_pred             CcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence            9999999774 34569999999999999999999999863  99999999999999998 999999999998754

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=5.5e-29  Score=266.91  Aligned_cols=150  Identities=36%  Similarity=0.636  Sum_probs=135.6

Q ss_pred             cCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENR  623 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  623 (709)
                      +...+.||+|-||.|+.|.+.....||+|.++.. ....++|.+|+.+|.+|+|+|||+++|+|..++..+||||||++|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            3456789999999999999988889999999754 445688999999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          624 SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       624 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      +|.+||... ....+...+.+.++.|||+||+||++++   +|||||.++||||+++..+||+||||||...+++
T Consensus       287 sLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  287 SLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             cHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence            999999763 3345888999999999999999999997   9999999999999999999999999999665554

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.1e-28  Score=260.74  Aligned_cols=161  Identities=31%  Similarity=0.525  Sum_probs=138.9

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeeEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKML  615 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l  615 (709)
                      .+.|..+++||+|.||.||+|+... |+.||+|++....  +....-..+||.+|++|+||||++|.+...+.  ...||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            3457777899999999999998754 8999999997553  23345567999999999999999999999887  67999


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      |+|||++ +|.-++..  ..-.++..++..++.|++.||+|||.++   |+|||||.+|||||.+|.+||+|||||+++.
T Consensus       196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999987 77777643  2234899999999999999999999998   9999999999999999999999999999998


Q ss_pred             CCCcccccccee
Q 005206          696 GDQTEQNTKRVV  707 (709)
Q Consensus       696 ~~~~~~~~~~~~  707 (709)
                      .......|.+++
T Consensus       270 ~~~~~~~T~rVv  281 (560)
T KOG0600|consen  270 PSGSAPYTSRVV  281 (560)
T ss_pred             CCCCcccccceE
Confidence            888777777765

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-28  Score=252.47  Aligned_cols=161  Identities=29%  Similarity=0.436  Sum_probs=142.8

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      .++|..+++||+|+||+||.++..+ ++.+|+|++++.   ...+.+..++|..+|.+++||.||+++-.|++.+..|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            3578999999999999999998876 788999999765   234577889999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      +||+.||.|..+|.++.   .+++....-++..|+.||.|||+++   ||||||||+|||||++|+++|+||||++.-..
T Consensus       104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999996543   4888888889999999999999998   99999999999999999999999999997655


Q ss_pred             CCccccccceecC
Q 005206          697 DQTEQNTKRVVGT  709 (709)
Q Consensus       697 ~~~~~~~~~~~GT  709 (709)
                      ++.  .+.++|||
T Consensus       178 ~~~--~t~tfcGT  188 (357)
T KOG0598|consen  178 DGD--ATRTFCGT  188 (357)
T ss_pred             CCC--ccccccCC
Confidence            443  34558998

>PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation

Probab=99.95  E-value=2.6e-28  Score=218.86  Aligned_cols=110  Identities=53%  Similarity=1.174  Sum_probs=105.1

Q ss_pred             cccCCCCCccccccccCccccceeEEEEEcCCceEEEEEEecCCCcEEEEEEccCCcEEEEEEeCCCCceEEEEcccCCc
Q 005206          237 YRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQ  316 (709)
Q Consensus       237 ~~sg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~Ld~dG~l~~y~w~~~~~~W~~~~~~p~~~  316 (709)
                      ||+|||||..|+|+|++.....+.+.|+.+++ |.+++|.+.+.+.++|++||.+|++|+|.|.+.+++|...|.+|.++
T Consensus         1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~-e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~   79 (110)
T PF00954_consen    1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNE-EVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQ   79 (110)
T ss_pred             CCccccCCeEECCcccccccceeEEEEEECCC-eEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccC
Confidence            89999999999999999987889999998888 99999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCCCccccCCCCCCCCCCCCCccCC
Q 005206          317 CDNYGECGPFGICDTNASPVCQCMRGFEPKD  347 (709)
Q Consensus       317 C~~~~~CG~~g~C~~~~~~~C~C~~gf~~~~  347 (709)
                      ||+|+.||+||+|+.+..+.|+||+||+|++
T Consensus        80 Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n  110 (110)
T PF00954_consen   80 CDVYGFCGPNGICNSNNSPKCSCLPGFEPKN  110 (110)
T ss_pred             CCCccccCCccEeCCCCCCceECCCCcCCCc
Confidence            9999999999999988889999999999975

This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.95  E-value=4.2e-28  Score=249.31  Aligned_cols=157  Identities=31%  Similarity=0.430  Sum_probs=136.3

Q ss_pred             cCcceeecccCceEEEEEEEcC-CcEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC-eeEEEEEcc
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD-EKMLVYEYM  620 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~Ey~  620 (709)
                      +..++.||+|..|+|||+.++. ++.+|+|++... .+...+++.+|++++++.+||+||+++|.|.... +..|+||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            3445789999999999999976 778999999544 3445678999999999999999999999999988 599999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCCcc
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~~~  700 (709)
                      .+|+|++++...   ..+++...-.|+.+|++||.|||+..  +||||||||+||||+..|++||+|||.++.+...   
T Consensus       161 DgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---  232 (364)
T KOG0581|consen  161 DGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---  232 (364)
T ss_pred             CCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence            999999999654   34899999999999999999999742  4999999999999999999999999999988543   


Q ss_pred             ccccceecC
Q 005206          701 QNTKRVVGT  709 (709)
Q Consensus       701 ~~~~~~~GT  709 (709)
                       ...+++||
T Consensus       233 -~a~tfvGT  240 (364)
T KOG0581|consen  233 -IANTFVGT  240 (364)
T ss_pred             -hccccccc
Confidence             33457776

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=99.95  E-value=1.9e-29  Score=226.79  Aligned_cols=108  Identities=48%  Similarity=0.767  Sum_probs=80.5

Q ss_pred             CceEEEEcCCCCCCCCC--cceEEEEcCc-eEEEcCCCceEEec-CCCCC--CCceeEEecCCCEEEEecCCCceeEeec
Q 005206          103 QRTYVWVANRDDPLANS--SGVLRIINQR-IGLFDGSQNLVWSS-NQTKA--TNPVAQLQDSGNFVLKEAGSDEILWQSF  176 (709)
Q Consensus       103 ~~tvVWvANr~~Pv~~~--~~~l~l~~~G-Lvl~d~~g~~vWst-~~~~~--~~~~a~LldsGNlVl~~~~~~~~lWQSF  176 (709)
                      ++||||+|||+.|+...  .++|.|+.|| |+|.|..++.+|++ ++.+.  .+..|+|+|+|||||+|. .+.+|||||
T Consensus         1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~-~~~~lW~Sf   79 (114)
T PF01453_consen    1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS-SGNVLWQSF   79 (114)
T ss_dssp             ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEET-TSEEEEEST
T ss_pred             CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEee-cceEEEeec
Confidence            47999999999999543  4899999999 99999999999999 55544  378999999999999995 788999999


Q ss_pred             cCCCCccCCCCcccceeccCCeeEEEEecCCCCCC
Q 005206          177 DYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPS  211 (709)
Q Consensus       177 d~PtDTlLpg~~l~~~~~tg~~~~L~S~~s~~dps  211 (709)
                      ||||||+||+|+|+.+..+|....++||++.+|||
T Consensus        80 ~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps  114 (114)
T PF01453_consen   80 DYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS  114 (114)
T ss_dssp             TSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred             CCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence            99999999999999888877667899999999996

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.95  E-value=2.9e-28  Score=273.21  Aligned_cols=151  Identities=34%  Similarity=0.583  Sum_probs=134.0

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC------CcEEEEEEeccCCcc-chHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  613 (709)
                      +.+....++||+|+||+||+|+...      .+.||||.+++.+.. ...+|++|++++..++|||||+|+|+|.+++..
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            3455666899999999999998643      457999999877655 788999999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc
Q 005206          614 MLVYEYMENRSLDSVIFDKAR-----------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT  682 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~  682 (709)
                      +||+|||..|+|.+||.....           ..+|+..+.+.||.|||.||+||-++.   +|||||+.||+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence            999999999999999974321           234889999999999999999999987   999999999999999999


Q ss_pred             EEEEecCCceee
Q 005206          683 PKISDFGMARIF  694 (709)
Q Consensus       683 ~KI~DFGla~~l  694 (709)
                      +||+||||+|..
T Consensus       642 VKIsDfGLsRdi  653 (774)
T KOG1026|consen  642 VKISDFGLSRDI  653 (774)
T ss_pred             EEecccccchhh
Confidence            999999999953

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.95  E-value=4.6e-28  Score=266.30  Aligned_cols=150  Identities=33%  Similarity=0.557  Sum_probs=135.8

Q ss_pred             cCcceeecccCceEEEEEEEcC----CcEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ..+.++||.|.||+|++|+++.    ...||||.|+.. .+....+|+.|+.||.+++||||++|.|+.......+||.|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            3456889999999999999864    346999999765 45567899999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      ||+||+|+.||++..  ..+.+.+..-++++||.||+||.+.+   +|||||.++||||+.+..+|++||||+|.+.++.
T Consensus       711 yMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  711 YMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             hhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence            999999999997654  34899999999999999999999987   9999999999999999999999999999987665

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.95  E-value=1e-27  Score=255.99  Aligned_cols=150  Identities=33%  Similarity=0.543  Sum_probs=134.2

Q ss_pred             hcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCcc-chHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      .......++||+|.||.|.++....+..||||+++..+.. ...+|..|+++|.+++|||||+|+|+|..++..++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            3445667899999999999999988899999999876544 458999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      |++|+|..||....... ++-....+|+.|||.||+||.+.+   +|||||.++|+|+|.++++||+|||++|-+
T Consensus       617 mEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~l  687 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNL  687 (807)
T ss_pred             HhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccc
Confidence            99999999997654332 455667789999999999999987   999999999999999999999999999955

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-27  Score=251.35  Aligned_cols=159  Identities=31%  Similarity=0.492  Sum_probs=138.1

Q ss_pred             CcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHh--cCCCceeeEEEEEEeCC----eeEEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAK--LQHRNLVRLLGCCVEMD----EKMLV  616 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~~~~~----~~~lV  616 (709)
                      .....++||+|+||.||||++. ++.||||++.   .+..+.|++|-+++..  |+|+||+++++.-..+.    +.+||
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            3455578999999999999995 4999999985   3456778888888765  68999999999987666    78999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCceEecCCCCCCEEEcCCCcEEEEecCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD------SRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~iiHrDlkp~NILl~~~~~~KI~DFGl  690 (709)
                      +||.++|+|.+||..    ..++|....+|+..+++||+|||+.      .+++|+|||||++||||.+|+++.|+||||
T Consensus       287 t~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             eeeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            999999999999954    4589999999999999999999976      356899999999999999999999999999


Q ss_pred             ceeeCCCCccccccceecC
Q 005206          691 ARIFGGDQTEQNTKRVVGT  709 (709)
Q Consensus       691 a~~l~~~~~~~~~~~~~GT  709 (709)
                      |.++........+..-+||
T Consensus       363 Al~~~p~~~~~d~~~qVGT  381 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGT  381 (534)
T ss_pred             eEEecCCCCCcchhhhhhh
Confidence            9999887766666667776

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.94  E-value=4.6e-27  Score=233.85  Aligned_cols=157  Identities=33%  Similarity=0.444  Sum_probs=140.7

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|..++.||.|+||+|.+++.+. |..+|+|++++..   -.+.+...+|..+|+.+.||.+++|++.+.+.+..+|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            467788899999999999999876 7789999997652   344567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+++|.|..+|++..+   +++.....+|.||+.||+|||+..   |++|||||+|||||.+|.+||.|||.|+.+.+ 
T Consensus       124 eyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-  196 (355)
T ss_pred             eccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence            99999999999976543   889999999999999999999998   99999999999999999999999999998853 


Q ss_pred             CccccccceecC
Q 005206          698 QTEQNTKRVVGT  709 (709)
Q Consensus       698 ~~~~~~~~~~GT  709 (709)
                          .|-++|||
T Consensus       197 ----rT~TlCGT  204 (355)
T KOG0616|consen  197 ----RTWTLCGT  204 (355)
T ss_pred             ----cEEEecCC
Confidence                25668887

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.94  E-value=2.8e-27  Score=252.16  Aligned_cols=154  Identities=31%  Similarity=0.429  Sum_probs=137.6

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeE
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKM  614 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~  614 (709)
                      ..++|...+.||+|+|.+|++|+... ++++|||++.+.   .+...+-...|-.+|.+| .||.|++|+..|.+....|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            34678888999999999999998766 889999999764   344456677899999999 8999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      +|+||++||+|.++|.+..   .+++.....++.+|+.||+|||..+   ||||||||+|||||+|+++||+|||-|+.+
T Consensus       151 FvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             EEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence            9999999999999996653   4888888899999999999999998   999999999999999999999999999999


Q ss_pred             CCCCc
Q 005206          695 GGDQT  699 (709)
Q Consensus       695 ~~~~~  699 (709)
                      .+.+.
T Consensus       225 ~~~~~  229 (604)
T KOG0592|consen  225 SPSQK  229 (604)
T ss_pred             Chhhc
Confidence            76543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.94  E-value=6.6e-28  Score=240.13  Aligned_cols=149  Identities=26%  Similarity=0.466  Sum_probs=130.2

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCc-cc-hHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG-QG-IEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~-~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      .|..+.++|+|+||.|||++.++ |+.||||++....+ .. .+-.++|+++|++++|+|+|.|+.+|......+||+||
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            46667799999999999999987 89999999976533 23 34568999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ++.--|+++-.   ...-++.....+|++|+++|+.|+|+++   ||||||||+||||+.++.+||+|||+||.+..+
T Consensus        83 ~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   83 CDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             cchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            99866655432   2234888899999999999999999998   999999999999999999999999999999753

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.94  E-value=6.3e-27  Score=229.75  Aligned_cols=151  Identities=34%  Similarity=0.608  Sum_probs=132.9

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccc-hHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQG-IEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +|...++||+|.||.||+|++.. |+.||||+++... .++ .....+||+.|+.++|+||+.|++++.+.+...||+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            56677899999999999998755 8999999997542 222 34578999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCCc
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~~  699 (709)
                      |+- +|...+.+.  ...+...+...++.++++||+|||++.   |+||||||.|+||++++.+||+||||||.++....
T Consensus        83 m~t-dLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   83 MPT-DLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             ccc-cHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            974 898888654  346888999999999999999999997   99999999999999999999999999999986643

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=7.5e-27  Score=254.24  Aligned_cols=147  Identities=37%  Similarity=0.533  Sum_probs=131.0

Q ss_pred             CcCcceeecccCceEEEEEEEcCC----cE-EEEEEecc---CCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLEG----QE-IAVKRLSR---NSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~g----~~-VAVK~l~~---~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  614 (709)
                      +....++||+|+||.||+|++...    .. ||||..+.   ......++|++|+++|.+++|||||+++|++....+.|
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            334447999999999999988652    23 89998874   24567889999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      ||||+|+||+|+++|.+...  .++..+++.++.+.|+||+|||+++   +|||||.+||+|++.++.+||+||||++.-
T Consensus       238 ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCC
Confidence            99999999999999976543  5899999999999999999999998   999999999999999999999999998854

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=6.6e-27  Score=240.05  Aligned_cols=159  Identities=25%  Similarity=0.484  Sum_probs=140.3

Q ss_pred             cCcCcceeecccCceEEEEEEE-cCCcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      .+|.+.+.||+|.||+|-++.. ..|++||||.+++.   +++..-.+++||++|+.|+||||+.++.+|...+.+.|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            3567778999999999999976 56999999999765   3455667899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||..+|.|.+|+.+..   .|++....+++.||..|+.|+|.++   ++|||||.+|||||.++++||+||||+.++..+
T Consensus       133 EYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  133 EYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            9999999999997654   3899999999999999999999997   999999999999999999999999999988654


Q ss_pred             CccccccceecC
Q 005206          698 QTEQNTKRVVGT  709 (709)
Q Consensus       698 ~~~~~~~~~~GT  709 (709)
                      .   -.+++||.
T Consensus       207 k---fLqTFCGS  215 (668)
T KOG0611|consen  207 K---FLQTFCGS  215 (668)
T ss_pred             c---HHHHhcCC
Confidence            3   23456663

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=99.93  E-value=1.1e-25  Score=204.04  Aligned_cols=113  Identities=49%  Similarity=0.772  Sum_probs=101.1

Q ss_pred             CCcCCCCEEEecCCeEEEEeeCCCCCCcEEEEEEEeccCCceEEEEcCCCCCCCCCcceEEEEcCc-eEEEcCCCceEEe
Q 005206           64 QNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQR-IGLFDGSQNLVWS  142 (709)
Q Consensus        64 ~~l~~~~~lvS~~g~F~lGFf~~~~~~~~~lgIw~~~~~~~tvVWvANr~~Pv~~~~~~l~l~~~G-Lvl~d~~g~~vWs  142 (709)
                      ++|++|++|+|+++.|++|||.+......+.+|||.+.+ +++||.|||+.|. ...+.|.|+.+| |+|.|.+|.++|+
T Consensus         2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~~-~~~~~l~l~~dGnLvl~~~~g~~vW~   79 (116)
T cd00028           2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPS-GSSCTLTLQSDGNLVIYDGSGTVVWS   79 (116)
T ss_pred             cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCCC-CCCEEEEEecCCCeEEEcCCCcEEEE
Confidence            578899999999999999999987653499999999877 8899999999994 455889999999 9999999999999


Q ss_pred             cCCCC-CCCceeEEecCCCEEEEecCCCceeEeeccCC
Q 005206          143 SNQTK-ATNPVAQLQDSGNFVLKEAGSDEILWQSFDYP  179 (709)
Q Consensus       143 t~~~~-~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~P  179 (709)
                      |++.+ ....+|+|+|+|||||++. .+.++|||||||
T Consensus        80 S~~~~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf~~P  116 (116)
T cd00028          80 SNTTRVNGNYVLVLLDDGNLVLYDS-DGNFLWQSFDYP  116 (116)
T ss_pred             ecccCCCCceEEEEeCCCCEEEECC-CCCEEEcCCCCC
Confidence            99876 4677899999999999997 578999999999

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-25  Score=236.03  Aligned_cols=165  Identities=32%  Similarity=0.470  Sum_probs=135.3

Q ss_pred             HHHhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--------------ccchHHHHHHHHHHHhcCCCceee
Q 005206          538 VRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--------------GQGIEEFKNEVRLIAKLQHRNLVR  602 (709)
Q Consensus       538 ~~~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--------------~~~~~~f~~Ei~~l~~l~H~nIv~  602 (709)
                      ....++|...+.||+|.||+|-+|.... ++.||||++.+..              ....+..++||.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            3445889999999999999999998754 8899999997641              112357899999999999999999


Q ss_pred             EEEEEEeC--CeeEEEEEccCCCCHHHHHhccCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC
Q 005206          603 LLGCCVEM--DEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK  679 (709)
Q Consensus       603 l~g~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~  679 (709)
                      |+.+..+.  +..|||+|||..|.+..    .....+ ++..+..+|+.+++.||+|||.++   ||||||||+|+||++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w----~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKW----CPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSS  245 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCcccc----CCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcC
Confidence            99998764  56899999999998743    222334 889999999999999999999998   999999999999999


Q ss_pred             CCcEEEEecCCceeeCCCC---ccccccceecC
Q 005206          680 EMTPKISDFGMARIFGGDQ---TEQNTKRVVGT  709 (709)
Q Consensus       680 ~~~~KI~DFGla~~l~~~~---~~~~~~~~~GT  709 (709)
                      ++++||+|||.+-.+....   ......+.+||
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGT  278 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGT  278 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCC
Confidence            9999999999998773321   12224446666

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=2.2e-25  Score=232.72  Aligned_cols=150  Identities=31%  Similarity=0.487  Sum_probs=133.2

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC--eeEEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD--EKMLVYE  618 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~E  618 (709)
                      .+|...+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+.+|.....+  ..++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            456777899999999999999876 8999999987654444778999999999999999999999865555  5889999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-CCcEEEEecCCceeeCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-EMTPKISDFGMARIFGG  696 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~KI~DFGla~~l~~  696 (709)
                      |+++|+|.+++.....  .+++.....+..||++||+|||+++   ||||||||+||||+. ++.+||+|||+|+....
T Consensus        97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            9999999999976543  5899999999999999999999998   999999999999999 79999999999998864

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.93  E-value=1.7e-25  Score=238.87  Aligned_cols=150  Identities=25%  Similarity=0.392  Sum_probs=135.9

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      ..++|..+++||+|+||.||+++-++ |..+|+|++++.   ...+.+..++|-.+|...++|.||+|+..|++.+..||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            45678899999999999999998876 899999999875   34567788999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ||||+|||++..+|...   ..|++.....++.+++.||.-||+.+   +|||||||+|+|||..|++||+||||+.-+.
T Consensus       219 iMEylPGGD~mTLL~~~---~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRK---DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHHhc---CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence            99999999999999653   45888888889999999999999998   9999999999999999999999999997553

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.8e-25  Score=239.53  Aligned_cols=162  Identities=29%  Similarity=0.431  Sum_probs=138.6

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC----Cc-cchHHHHHHHHHHHhcC-CCceeeEEEEEEeCCe
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN----SG-QGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDE  612 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~----~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~  612 (709)
                      ..++|...+.||+|+||+|+.|.... ++.||+|.+.+.    .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            34678888999999999999998764 799999977653    12 23456678999999998 9999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CcEEEEecCCc
Q 005206          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMA  691 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~KI~DFGla  691 (709)
                      .++||||+.+|+|.+++.+.   ..+.+.....++.|++.|++|||+++   |+||||||+|||++.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            99999999999999999763   34778899999999999999999998   9999999999999999 99999999999


Q ss_pred             eeeCCCCccccccceecC
Q 005206          692 RIFGGDQTEQNTKRVVGT  709 (709)
Q Consensus       692 ~~l~~~~~~~~~~~~~GT  709 (709)
                      ....  .........+||
T Consensus       169 ~~~~--~~~~~l~t~cGs  184 (370)
T KOG0583|consen  169 AISP--GEDGLLKTFCGS  184 (370)
T ss_pred             cccC--CCCCcccCCCCC
Confidence            9884  112234556775

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.5e-26  Score=243.00  Aligned_cols=149  Identities=33%  Similarity=0.508  Sum_probs=131.6

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchH-HHHHHHHHHHhcC-CCceeeEEEEEEeCC-eeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQ-HRNLVRLLGCCVEMD-EKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~-~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~-~~~lV~  617 (709)
                      ++|..+++||.|.||.||+|+-.. +..||||+++++.....+ -=++|+..|.+|. |||||+|..++.+.+ ..++||
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf   89 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF   89 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence            578888999999999999998765 889999999766433222 2368999999998 999999999999988 899999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+. +|.+++.++  ..++++..+..|+.||++||+|+|.+|   +.|||+||+|||+..+..+||+||||||-+..
T Consensus        90 E~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   90 EFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             Hhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence            99964 788888654  567999999999999999999999998   99999999999999999999999999997744

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.93  E-value=1.3e-25  Score=226.59  Aligned_cols=151  Identities=32%  Similarity=0.525  Sum_probs=128.9

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCcc-c-hHHHHHHHHHHHhcCCCceeeEEEEEEe--CCeeEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQ-G-IEEFKNEVRLIAKLQHRNLVRLLGCCVE--MDEKML  615 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~-~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~l  615 (709)
                      .+.|..++.|++|+||.||+|++.. ++.||+|+++...+. + --.-++||.+|.+++|||||.+..+..-  .+..||
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            3567888999999999999999875 788999999754321 1 1245789999999999999999887654  467999


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      |||||+. +|...+..-.  ..+...+...+..|+++|++|||.+-   |+|||||++|+|++..|.+||+||||||.++
T Consensus       155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence            9999986 8888885433  45788888899999999999999986   9999999999999999999999999999997


Q ss_pred             CC
Q 005206          696 GD  697 (709)
Q Consensus       696 ~~  697 (709)
                      .+
T Consensus       229 sp  230 (419)
T KOG0663|consen  229 SP  230 (419)
T ss_pred             CC
Confidence            66

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=5.5e-27  Score=231.42  Aligned_cols=166  Identities=27%  Similarity=0.481  Sum_probs=139.1

Q ss_pred             cCcCcceeecccCceEEEEEEE-cCCcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEE-EEEeCCe-eEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLG-CCVEMDE-KMLV  616 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g-~~~~~~~-~~lV  616 (709)
                      .+|.+.++||+|.||+|||+.. .+|..||.|.+.-.  ..+..+....|+.+|++|+|||||+.++ -+.+..+ .+||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            3577778999999999999975 56899999988633  3445667899999999999999999999 4555555 7899


Q ss_pred             EEccCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC-CCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          617 YEYMENRSLDSVIFDKAR-SSILNWQRRFNIICGIARGLLYLHQDS-RFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      |||+..|+|..++....+ ...+++++.++++.|+++||..+|.+- +..|+||||||.||+|+.+|.+||.||||+|.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999999865332 456899999999999999999999832 124999999999999999999999999999999


Q ss_pred             CCCCccccccceecC
Q 005206          695 GGDQTEQNTKRVVGT  709 (709)
Q Consensus       695 ~~~~~~~~~~~~~GT  709 (709)
                      ....+  ..+.++||
T Consensus       179 ~s~~t--fA~S~VGT  191 (375)
T KOG0591|consen  179 SSKTT--FAHSLVGT  191 (375)
T ss_pred             cchhH--HHHhhcCC
Confidence            76543  34568887

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.93  E-value=6.1e-26  Score=241.74  Aligned_cols=159  Identities=31%  Similarity=0.540  Sum_probs=141.2

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ++|...+.||+|.||.||||+-+. .+.||+|.+.+.  .+++.+.+++|++++++++|||||.++.+|....+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            467788899999999999998765 788999999765  34456789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      |+.+ +|..+|.+..+   +++.....|+.+++.||.|||+++   |+|||+||+||||+..+.+|++|||+||.++.+.
T Consensus        82 ~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             hhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            9987 99999976543   899999999999999999999997   9999999999999999999999999999886543


Q ss_pred             ccccccceecC
Q 005206          699 TEQNTKRVVGT  709 (709)
Q Consensus       699 ~~~~~~~~~GT  709 (709)
                        ...+++.||
T Consensus       155 --~vltsikGt  163 (808)
T KOG0597|consen  155 --SVLTSIKGT  163 (808)
T ss_pred             --eeeeeccCc
Confidence              345667776

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=3.3e-26  Score=221.69  Aligned_cols=160  Identities=31%  Similarity=0.445  Sum_probs=138.9

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...+.||+|-||.||.|+.+. +..||+|++.+.   ..+...++++|+++-+.|+||||+++++++.+....||++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            568888999999999999998865 678999999764   2344678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||.+.|+|...|.+. +...+++.....++.|+|.||.|+|..+   +|||||||+|+|++.++.+||+|||-+..-.  
T Consensus       102 Eya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            999999999999643 3345788888899999999999999987   9999999999999999999999999987553  


Q ss_pred             CccccccceecC
Q 005206          698 QTEQNTKRVVGT  709 (709)
Q Consensus       698 ~~~~~~~~~~GT  709 (709)
                      ..++  ..++||
T Consensus       176 ~~kR--~tlcgt  185 (281)
T KOG0580|consen  176 SNKR--KTLCGT  185 (281)
T ss_pred             CCCc--eeeecc
Confidence            3333  347887

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.2e-25  Score=260.73  Aligned_cols=149  Identities=38%  Similarity=0.630  Sum_probs=133.4

Q ss_pred             CcCcceeecccCceEEEEEEEcC--Cc----EEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE--GQ----EIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~--g~----~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      +.+..+.||+|+||.||+|...+  +.    .||||.+.+. +.+.+.+|.+|..+|++++|||||+++|+|.+....+|
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            44566789999999999998865  33    4999999876 45667899999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCc
Q 005206          616 VYEYMENRSLDSVIFDKAR----SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla  691 (709)
                      ++|||++|+|..||.+.+.    ...+.-.+.+.++.|||+|+.||+++.   +|||||.+||+||++...+||+|||||
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchh
Confidence            9999999999999986522    346889999999999999999999997   999999999999999999999999999


Q ss_pred             eee
Q 005206          692 RIF  694 (709)
Q Consensus       692 ~~l  694 (709)
                      |.+
T Consensus       850 rDi  852 (1025)
T KOG1095|consen  850 RDI  852 (1025)
T ss_pred             Hhh
Confidence            943

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.92  E-value=6.8e-25  Score=225.53  Aligned_cols=150  Identities=31%  Similarity=0.524  Sum_probs=128.9

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCcc--chHHHHHHHHHHHhcCCCc-eeeEEEEEEeCC------
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQ--GIEEFKNEVRLIAKLQHRN-LVRLLGCCVEMD------  611 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~------  611 (709)
                      ..|..+++||+|+||+||+|+... |+.||+|++.-..++  .-....+|+.++.+++|+| ||+|.+++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            346666789999999999998765 889999999755332  2344678999999999999 999999999877      


Q ss_pred             eeEEEEEccCCCCHHHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCC
Q 005206          612 EKMLVYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGl  690 (709)
                      ..+||+||+. -+|..++...... ..++......++.||++||+|||+++   |+||||||+||||++++.+||+|||+
T Consensus        91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            6789999996 4899998765432 34777888999999999999999998   99999999999999999999999999


Q ss_pred             ceeeC
Q 005206          691 ARIFG  695 (709)
Q Consensus       691 a~~l~  695 (709)
                      ||.+.
T Consensus       167 Ara~~  171 (323)
T KOG0594|consen  167 ARAFS  171 (323)
T ss_pred             HHHhc
Confidence            99775

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.92  E-value=1.2e-24  Score=234.72  Aligned_cols=153  Identities=30%  Similarity=0.470  Sum_probs=129.9

Q ss_pred             hcCcCcceeecccCceEEEEEEEc------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCC-
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMD-  611 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~-  611 (709)
                      .++|...++||+|+||.||+|.+.      .++.||||++.... ....+.+.+|+.++.++ +||||++++++|...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            467888899999999999999752      24679999986543 23456799999999999 8999999999987654 


Q ss_pred             eeEEEEEccCCCCHHHHHhccCC---------------------------------------------------------
Q 005206          612 EKMLVYEYMENRSLDSVIFDKAR---------------------------------------------------------  634 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------  634 (709)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            57899999999999999864321                                                         


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          635 --SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       635 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                        ...+++.+...++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~  226 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK  226 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeeccccccccc
Confidence              124788889999999999999999987   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=4.6e-25  Score=230.16  Aligned_cols=162  Identities=31%  Similarity=0.453  Sum_probs=136.5

Q ss_pred             CCCCCCCChHHHHHHhcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHh--cCCCceeeE
Q 005206          526 DLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAK--LQHRNLVRL  603 (709)
Q Consensus       526 ~~~~~~~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l  603 (709)
                      ..++|.+-...+.+   .....+.||+|.||+||+|.+ .|+.||||++...   +++.+.+|.+++..  |+|+||+.+
T Consensus       198 GSGlplLVQRTiar---qI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgF  270 (513)
T KOG2052|consen  198 GSGLPLLVQRTIAR---QIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGF  270 (513)
T ss_pred             CCCchhHhHHhhhh---eeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhh
Confidence            35677766666543   567778999999999999998 5789999999643   35667778887765  599999999


Q ss_pred             EEEEEeCC----eeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCceEecCCCCCC
Q 005206          604 LGCCVEMD----EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ-----DSRFRIIHRDLKASN  674 (709)
Q Consensus       604 ~g~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~iiHrDlkp~N  674 (709)
                      ++.-..++    +.+||.||.++|||.+||..    .+++-...++++..+|.||++||.     ++++.|.|||||+.|
T Consensus       271 IaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKN  346 (513)
T KOG2052|consen  271 IAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKN  346 (513)
T ss_pred             hhccccCCCceEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccccc
Confidence            98765443    57999999999999999944    458999999999999999999995     478899999999999


Q ss_pred             EEEcCCCcEEEEecCCceeeCCCC
Q 005206          675 ILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       675 ILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      |||.+++.+.|+|+|||-...++.
T Consensus       347 ILVKkn~~C~IADLGLAv~h~~~t  370 (513)
T KOG2052|consen  347 ILVKKNGTCCIADLGLAVRHDSDT  370 (513)
T ss_pred             EEEccCCcEEEeeceeeEEecccC
Confidence            999999999999999999886663

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.3e-24  Score=238.15  Aligned_cols=162  Identities=30%  Similarity=0.450  Sum_probs=141.2

Q ss_pred             HHhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCee
Q 005206          539 RATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEK  613 (709)
Q Consensus       539 ~~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~  613 (709)
                      ...++|..+++||+|.||+|+++.++. ++.+|||.+++.   .....+..+.|.+++... +||.|++|+++++..++.
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            345789999999999999999999976 778999999876   456778889999998887 599999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ++||||+.+|++..    ......+++.+...|+..|+.||+|||+++   ||+||||.+|||||.+|.+||+||||+|.
T Consensus       445 ~fvmey~~Ggdm~~----~~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMH----HIHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEEecCCCcEEE----EEecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence            99999999999432    233445899999999999999999999998   99999999999999999999999999996


Q ss_pred             eCCCCccccccceecC
Q 005206          694 FGGDQTEQNTKRVVGT  709 (709)
Q Consensus       694 l~~~~~~~~~~~~~GT  709 (709)
                      -.....  .|.++|||
T Consensus       518 ~m~~g~--~TsTfCGT  531 (694)
T KOG0694|consen  518 GMGQGD--RTSTFCGT  531 (694)
T ss_pred             cCCCCC--ccccccCC
Confidence            543333  46779998

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.92  E-value=2.6e-24  Score=228.56  Aligned_cols=152  Identities=32%  Similarity=0.540  Sum_probs=131.3

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-----------------CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-----------------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRL  603 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-----------------g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l  603 (709)
                      ++|...++||+|+||.||++.+.+                 +..||+|.+.... .....+|.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            467788899999999999997643                 2369999986543 3345689999999999999999999


Q ss_pred             EEEEEeCCeeEEEEEccCCCCHHHHHhccC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 005206          604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKA----------------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH  667 (709)
Q Consensus       604 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH  667 (709)
                      ++++.+.+..++||||+++|+|.+++....                ....+++.....++.||+.||.|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            999999999999999999999999985421                1134788899999999999999999997   999


Q ss_pred             cCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          668 RDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       668 rDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||||+|||++.++.+||+|||+++.+..
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~  190 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYA  190 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceeccc
Confidence            99999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=6.3e-25  Score=236.21  Aligned_cols=159  Identities=36%  Similarity=0.561  Sum_probs=142.4

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      ..|...++||+|+.|.||.+.-.. +++||||++........+-+.+|+.+|+..+|+|||+++..+...++.++|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            446666899999999999997654 8899999997665555667889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCCcc
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~~~  700 (709)
                      ++|+|.+.+...    .+++.++..|.+++++||+|||.++   |||||||.+|||++.++.+||+|||++..+...+.+
T Consensus       353 ~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K  425 (550)
T KOG0578|consen  353 EGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK  425 (550)
T ss_pred             CCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence            999999988443    3899999999999999999999998   999999999999999999999999999999888876


Q ss_pred             ccccceecC
Q 005206          701 QNTKRVVGT  709 (709)
Q Consensus       701 ~~~~~~~GT  709 (709)
                      +.  +++||
T Consensus       426 R~--TmVGT  432 (550)
T KOG0578|consen  426 RS--TMVGT  432 (550)
T ss_pred             cc--cccCC
Confidence            54  48887

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.91  E-value=3.8e-24  Score=233.42  Aligned_cols=148  Identities=22%  Similarity=0.367  Sum_probs=132.4

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|+..+.||+|+||+||++.... ++.||||++.+..   ......+.+|+.++.+++|+||+++++.+.+....+|||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            468888999999999999998765 7899999996532   233467889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ||+++|+|.+++.+.   ..+++.....++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+.
T Consensus        81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence            999999999998653   34889999999999999999999997   9999999999999999999999999998664

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=99.91  E-value=3.2e-24  Score=193.87  Aligned_cols=111  Identities=46%  Similarity=0.766  Sum_probs=99.7

Q ss_pred             CCcCCCCEEEecCCeEEEEeeCCCCCCcEEEEEEEeccCCceEEEEcCCCCCCCCCcceEEEEcCc-eEEEcCCCceEEe
Q 005206           64 QNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQR-IGLFDGSQNLVWS  142 (709)
Q Consensus        64 ~~l~~~~~lvS~~g~F~lGFf~~~~~~~~~lgIw~~~~~~~tvVWvANr~~Pv~~~~~~l~l~~~G-Lvl~d~~g~~vWs  142 (709)
                      +.|..|++|+|+++.|++|||.+... ..+.+|||.+.+ +++||+|||+.|+..+ +.|.++++| |+|.|.+|.++|+
T Consensus         2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~-~~~vW~snt~~~~~~~-~~l~l~~dGnLvl~~~~g~~vW~   78 (114)
T smart00108        2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSDS-CTLTLQSDGNLVLYDGDGRVVWS   78 (114)
T ss_pred             cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCC-CcEEEECCCCCCCCCC-EEEEEeCCCCEEEEeCCCCEEEE
Confidence            56888999999999999999998654 689999999887 8899999999998765 889999999 9999999999999


Q ss_pred             cCCC-CCCCceeEEecCCCEEEEecCCCceeEeeccC
Q 005206          143 SNQT-KATNPVAQLQDSGNFVLKEAGSDEILWQSFDY  178 (709)
Q Consensus       143 t~~~-~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~  178 (709)
                      |++. +....+|+|+|+|||||++. .+.++||||||
T Consensus        79 S~t~~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf~~  114 (114)
T smart00108       79 SNTTGANGNYVLVLLDDGNLVIYDS-DGNFLWQSFDY  114 (114)
T ss_pred             ecccCCCCceEEEEeCCCCEEEECC-CCCEEeCCCCC
Confidence            9987 34677899999999999986 57899999997

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.91  E-value=5.1e-24  Score=233.97  Aligned_cols=146  Identities=24%  Similarity=0.371  Sum_probs=130.7

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      .|..++.||+|+||+||+|+... ++.||||++.+.   .....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            57788999999999999998765 789999999653   23345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      |+++|+|.+++.+.   ..+++.....++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.+
T Consensus        82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            99999999998653   24788888889999999999999987   999999999999999999999999998754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.91  E-value=7.1e-25  Score=225.07  Aligned_cols=150  Identities=33%  Similarity=0.530  Sum_probs=121.8

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCe-----eEEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE-----KMLV  616 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-----~~lV  616 (709)
                      .|...+++|.|+||.||+|.+.+ +++||||++....+    .-..|+.+|++++|||||+|+-++....+     ..||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            46667899999999999999876 68999999865432    12368999999999999999998876433     2489


Q ss_pred             EEccCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CcEEEEecCCceee
Q 005206          617 YEYMENRSLDSVIFDKAR-SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIF  694 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~KI~DFGla~~l  694 (709)
                      |||||. +|..++.+..+ ...++.....-+..||.+||.|||+.+   |+||||||+|+|+|.+ +.+||+|||-|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999986 78877764211 233666666678999999999999987   9999999999999977 89999999999999


Q ss_pred             CCCCcc
Q 005206          695 GGDQTE  700 (709)
Q Consensus       695 ~~~~~~  700 (709)
                      ..++..
T Consensus       177 ~~~epn  182 (364)
T KOG0658|consen  177 VKGEPN  182 (364)
T ss_pred             ccCCCc
Confidence            766543

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.91  E-value=6.5e-24  Score=232.12  Aligned_cols=150  Identities=24%  Similarity=0.278  Sum_probs=133.2

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      ..++|...+.||+|+||.||+++... ++.+|+|.+.+.   .....+.+.+|+.++..++||||+++++++.+.+..++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            44678999999999999999999875 788999998642   22334568899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ||||+++|+|.+++...    .+++.....++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+.+.
T Consensus       121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            99999999999988532    3788888999999999999999987   9999999999999999999999999999875


Q ss_pred             C
Q 005206          696 G  696 (709)
Q Consensus       696 ~  696 (709)
                      .
T Consensus       194 ~  194 (370)
T cd05621         194 E  194 (370)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=7.1e-24  Score=232.44  Aligned_cols=147  Identities=23%  Similarity=0.349  Sum_probs=131.1

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...++||+|+||.||++.... ++.||||++.+.   .....+++.+|++++.+++||||+++++++.+.+..+|||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            368888999999999999998764 889999998643   2334567899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      ||+++|+|.+++...   ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+|+.+
T Consensus        81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~  151 (377)
T cd05629          81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF  151 (377)
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence            999999999998643   34788888899999999999999998   999999999999999999999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=9.4e-24  Score=227.44  Aligned_cols=149  Identities=23%  Similarity=0.390  Sum_probs=133.1

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...+.||+|+||.||+|+... ++.||||++.+..   ....+.+.+|+.++..++||||+++++++.+.+..+|||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            368888999999999999999875 7899999996542   234567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ||+++|+|.+++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            999999999998543   34788999999999999999999997   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.91  E-value=1.1e-23  Score=225.88  Aligned_cols=141  Identities=28%  Similarity=0.343  Sum_probs=126.2

Q ss_pred             eeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005206          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENR  623 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  623 (709)
                      +.||+|+||.||+++... ++.||+|++.+.   .......+.+|+.++.+++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            369999999999998764 889999999753   2334567889999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          624 SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       624 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      +|.+++...   ..+++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~  145 (323)
T cd05571          81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence            999888543   35889999999999999999999997   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=7.2e-24  Score=231.16  Aligned_cols=149  Identities=23%  Similarity=0.379  Sum_probs=133.4

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|+..+.||+|+||.||+++... ++.||||++...   .....+.+.+|+.++..++||||+++++++.+.+..+|||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            468888999999999999999864 889999999653   2334567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ||+++|+|.+++...   ..+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            999999999998653   24889999999999999999999997   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.91  E-value=1.2e-23  Score=227.52  Aligned_cols=149  Identities=24%  Similarity=0.352  Sum_probs=132.4

Q ss_pred             cCcCcceeecccCceEEEEEEEcC--CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE--GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~--g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      ++|...+.||+|+||.||+|.+..  +..||+|++...   .....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            468888999999999999998654  368999998643   233456788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+++|+|.+++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       110 ~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            9999999999998653   34889999999999999999999997   99999999999999999999999999997743

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.91  E-value=1.1e-23  Score=226.67  Aligned_cols=149  Identities=23%  Similarity=0.352  Sum_probs=133.2

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...+.||+|+||.||+|+... ++.||+|.+.+.   .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            468888999999999999999865 789999998653   2234567899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ||+++|+|.+++.+.   ..+++.....++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+..
T Consensus        98 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         98 EFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             cCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            999999999998653   24788888899999999999999997   99999999999999999999999999997743

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.91  E-value=2.1e-23  Score=219.56  Aligned_cols=149  Identities=32%  Similarity=0.429  Sum_probs=131.2

Q ss_pred             cCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          544 FTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      |...+.||+|+||.||++... +++.||+|++....   ......+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            667789999999999999875 58999999986432   23345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      +++|+|..++.... ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+..
T Consensus        82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05631          82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE  154 (285)
T ss_pred             cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence            99999998885432 235899999999999999999999987   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.91  E-value=1.6e-23  Score=225.34  Aligned_cols=141  Identities=29%  Similarity=0.360  Sum_probs=126.6

Q ss_pred             eeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005206          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENR  623 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  623 (709)
                      +.||+|+||.||++.... ++.||+|++.+.   ......++.+|+.++.+++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            369999999999998764 889999999754   2344567889999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          624 SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       624 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      +|..++...   ..+++.....++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus        81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~  145 (328)
T cd05593          81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (328)
T ss_pred             CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccC
Confidence            999888543   34889999999999999999999997   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.91  E-value=2.1e-24  Score=232.90  Aligned_cols=147  Identities=33%  Similarity=0.614  Sum_probs=130.7

Q ss_pred             HHhcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          539 RATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       539 ~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      ...+.+...+.||+|+||+||+|++.  -.||||++...  ..+..++|++|+.++++-+|.||+-+.|+|..... .||
T Consensus       389 Ip~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi  465 (678)
T KOG0193|consen  389 IPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII  465 (678)
T ss_pred             cCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence            33445566789999999999999984  47999999765  44578899999999999999999999999998777 999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ..++++-+|..+|+...  ..++..+...||.|||+||.|||.++   |||||||..||+|.+++.+||.|||||..
T Consensus       466 TqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  466 TQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             ehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence            99999999999997543  34888899999999999999999998   99999999999999999999999999964

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.90  E-value=1.3e-23  Score=230.72  Aligned_cols=146  Identities=26%  Similarity=0.408  Sum_probs=130.3

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      .|..+++||+|+||.||+|+... ++.+|+|++.+..   ....+.+.+|+.++.+++|+||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            57888999999999999998765 7889999986532   2345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      |+++|+|.+++.+.   ..+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+
T Consensus        82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625          82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence            99999999998653   34788888899999999999999997   999999999999999999999999998754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.90  E-value=9.9e-25  Score=233.74  Aligned_cols=152  Identities=32%  Similarity=0.517  Sum_probs=137.8

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      .++...++||-|.||.||.|.++. .-.||||.++.. ....++|+.|..+|+.++|||+|+|+|+|......|||.|||
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM  345 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM  345 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence            455667899999999999999976 668999999654 456899999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      .+|+|.+||.+..+. .++.-..+.+|.||+.||+||..++   +|||||.++|+|+.++..+||+||||+|++.++.
T Consensus       346 ~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT  419 (1157)
T KOG4278|consen  346 CYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT  419 (1157)
T ss_pred             cCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence            999999999876553 4677788899999999999999987   9999999999999999999999999999998774

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=1.8e-23  Score=223.16  Aligned_cols=140  Identities=24%  Similarity=0.304  Sum_probs=125.9

Q ss_pred             ecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCCH
Q 005206          550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL  625 (709)
Q Consensus       550 LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  625 (709)
                      ||+|+||.||+++..+ ++.||+|++.+.   .....+.+..|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            7999999999999865 789999998643   234566788999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       626 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      .+++...   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~  144 (312)
T cd05585          81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNM  144 (312)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCc
Confidence            9998653   34889999999999999999999987   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.90  E-value=1.7e-23  Score=229.27  Aligned_cols=146  Identities=25%  Similarity=0.385  Sum_probs=130.4

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      +|+..++||+|+||.||+++... ++.||||++.+.   .....+.+.+|++++.+++|+||+++++.+.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            58888999999999999998765 789999998643   22345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      |+++|+|.+++.+.   ..+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|..+
T Consensus        82 ~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~  151 (376)
T cd05598          82 YIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (376)
T ss_pred             CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence            99999999998653   34788888889999999999999997   999999999999999999999999998644

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=8.5e-24  Score=223.35  Aligned_cols=149  Identities=28%  Similarity=0.349  Sum_probs=132.4

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...++||+|+||.||++.... ++.||+|++....   ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            367888999999999999999864 8899999986432   234567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ||+++|+|.+++...   ..+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            999999999998653   24888999999999999999999997   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.90  E-value=3.2e-23  Score=234.28  Aligned_cols=164  Identities=18%  Similarity=0.225  Sum_probs=137.4

Q ss_pred             CcCcceeecccCceEEEEEEEcC--CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE--GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~--g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      .|...+.||+|+||.||++....  ++.||+|++..........+.+|+.++.+++|||||++++++...+..+|||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            37788999999999999997654  5678888775554455567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCCc
Q 005206          621 ENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (709)
Q Consensus       621 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~~  699 (709)
                      ++|+|.++|.+.. ....+++.....++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+|+.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            9999999886532 2345889999999999999999999987   99999999999999999999999999998754432


Q ss_pred             cccccceecC
Q 005206          700 EQNTKRVVGT  709 (709)
Q Consensus       700 ~~~~~~~~GT  709 (709)
                      ......++||
T Consensus       225 ~~~~~~~~gt  234 (478)
T PTZ00267        225 LDVASSFCGT  234 (478)
T ss_pred             cccccccCCC
Confidence            2223334454

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=3.1e-23  Score=223.33  Aligned_cols=151  Identities=24%  Similarity=0.313  Sum_probs=133.3

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...+.||+|+||.||+++... ++.||+|++.+.   .....+.|.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            468888999999999999999865 889999998642   2234567899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+++|+|.+++.+.  ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            999999999998542  234888999999999999999999997   999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.90  E-value=1.6e-23  Score=229.45  Aligned_cols=153  Identities=29%  Similarity=0.433  Sum_probs=131.8

Q ss_pred             hcCcCcceeecccCceEEEEEEE------cCCcEEEEEEeccCC-ccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCe
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDE  612 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~  612 (709)
                      .++|...+.||+|+||.||+|+.      ..+..||||+++... ....+.+.+|+.++..+ +||||++++++|.+.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            34678889999999999999974      235689999996443 33456789999999999 89999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHhccCC----------------------------------------------------------
Q 005206          613 KMLVYEYMENRSLDSVIFDKAR----------------------------------------------------------  634 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------------------  634 (709)
                      .++||||+++|+|.+++.+...                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999999864221                                                          


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          635 --------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       635 --------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                                    ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                          124789999999999999999999987   99999999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.90  E-value=3.3e-23  Score=223.11  Aligned_cols=151  Identities=22%  Similarity=0.275  Sum_probs=133.2

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...+.||+|+||.||+++... ++.||+|.+.+.   .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            468888999999999999999865 788999998642   2233456889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+++|+|.+++.+..  ..+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+..+
T Consensus        81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999999996532  34788899999999999999999987   999999999999999999999999999877544

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.90  E-value=1.8e-23  Score=224.32  Aligned_cols=141  Identities=28%  Similarity=0.353  Sum_probs=126.0

Q ss_pred             eeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005206          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENR  623 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  623 (709)
                      +.||+|+||.||+++... ++.||+|++...   .......+.+|+.++.+++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            369999999999998754 889999999653   2334567889999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          624 SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       624 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      +|..++...   ..+++.....++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  145 (323)
T cd05595          81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence            999888543   34889999999999999999999997   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=2.5e-23  Score=217.36  Aligned_cols=153  Identities=27%  Similarity=0.402  Sum_probs=136.6

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +.|...++||.|..+.||+|... .+..||||++.-. .....+++++|+..|+.++||||++.+..|..+.+.|+||.|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf  105 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF  105 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence            56888899999999999999875 4789999999643 334478999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      |.+|++.++++..-.. -+++..+..|.+++++||.|||.++   .||||||+.||||+++|.+||+|||.+..+-...
T Consensus       106 Ma~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            9999999999765433 4899999999999999999999998   9999999999999999999999999887765544

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.90  E-value=2.5e-23  Score=227.69  Aligned_cols=155  Identities=23%  Similarity=0.262  Sum_probs=135.1

Q ss_pred             HHHHHhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC
Q 005206          536 TIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD  611 (709)
Q Consensus       536 ~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~  611 (709)
                      ++....++|...+.||+|+||.||+++... ++.+|+|.+.+.   .....+.+.+|+.++..++||||+++++.+.+.+
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            334455789999999999999999999875 788999998642   2233456889999999999999999999999999


Q ss_pred             eeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCc
Q 005206          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla  691 (709)
                      ..++||||+++|+|.+++...    .++...+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            999999999999999988542    3788888889999999999999997   999999999999999999999999999


Q ss_pred             eeeCCC
Q 005206          692 RIFGGD  697 (709)
Q Consensus       692 ~~l~~~  697 (709)
                      +.+...
T Consensus       190 ~~~~~~  195 (371)
T cd05622         190 MKMNKE  195 (371)
T ss_pred             eEcCcC
Confidence            987543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.90  E-value=2.8e-23  Score=223.39  Aligned_cols=151  Identities=23%  Similarity=0.306  Sum_probs=134.2

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...+.||+|+||.||++.... ++.||+|++....   ....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            468888999999999999998764 8899999997532   234567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+++|+|.+++.+..  ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            9999999999986542  35889999999999999999999997   999999999999999999999999999987543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.90  E-value=1.7e-23  Score=228.82  Aligned_cols=150  Identities=25%  Similarity=0.292  Sum_probs=132.3

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      .++|...++||+|+||.||+++... ++.+|+|++.+.   .....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            4678889999999999999998865 789999998643   223345688999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+++|+|.+++...    .++......++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       122 ~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         122 MEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            9999999999988542    3778888889999999999999987   99999999999999999999999999987754


Q ss_pred             C
Q 005206          697 D  697 (709)
Q Consensus       697 ~  697 (709)
                      .
T Consensus       195 ~  195 (370)
T cd05596         195 N  195 (370)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.90  E-value=4.6e-23  Score=221.33  Aligned_cols=142  Identities=27%  Similarity=0.331  Sum_probs=125.5

Q ss_pred             eeecccCceEEEEEEEc-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005206          548 NKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENR  623 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  623 (709)
                      +.||+|+||.||++... .++.||+|.+.+.   ......++..|++++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999875 4889999999653   2334567889999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          624 SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ-DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       624 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      +|..++...   ..+++.....++.||+.||.|||+ .+   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~  147 (325)
T cd05594          81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  147 (325)
T ss_pred             cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence            999888543   348999999999999999999997 55   9999999999999999999999999998643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.90  E-value=3.8e-23  Score=225.22  Aligned_cols=148  Identities=23%  Similarity=0.377  Sum_probs=132.2

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...+.||+|+||.||++.... ++.||+|++...   .....+.+.+|+.++.+++||||+++++.+.+.+..+|||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            367888999999999999998865 789999999643   2334567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ||+++|+|.+++.+.   ..+++.....++.|++.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+.
T Consensus        81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~  152 (360)
T cd05627          81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK  152 (360)
T ss_pred             eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence            999999999998643   34889999999999999999999997   9999999999999999999999999998664

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.90  E-value=5.2e-23  Score=221.67  Aligned_cols=151  Identities=21%  Similarity=0.278  Sum_probs=132.4

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...++||+|+||.||+++... ++.+|+|++.+.   .....+.|.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            367888999999999999999876 678999998642   2233456889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+++|+|.+++.+..  ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            9999999999996532  34889999999999999999999987   999999999999999999999999999876433

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.90  E-value=5.8e-24  Score=233.54  Aligned_cols=160  Identities=32%  Similarity=0.496  Sum_probs=137.2

Q ss_pred             cCcceeecccCceEEEEEEEcC-CcEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeC------CeeEE
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM------DEKML  615 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~l  615 (709)
                      |...+.||+|+||.||+|+.+. |+.||||.+.+. .....+...+|++++++++|+|||++++.-.+.      ....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            3444689999999999999765 999999999764 344567889999999999999999999876543      35689


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc--CCC--cEEEEecCCc
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD--KEM--TPKISDFGMA  691 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~--~~~--~~KI~DFGla  691 (709)
                      ||||+++|+|...|.+.....-|++...+.+..+++.||.|||+++   |+||||||.||++-  +++  .-||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999988777777999999999999999999999998   99999999999983  333  5799999999


Q ss_pred             eeeCCCCccccccceecC
Q 005206          692 RIFGGDQTEQNTKRVVGT  709 (709)
Q Consensus       692 ~~l~~~~~~~~~~~~~GT  709 (709)
                      |-+.+++   ..+.++||
T Consensus       172 rel~d~s---~~~S~vGT  186 (732)
T KOG4250|consen  172 RELDDNS---LFTSLVGT  186 (732)
T ss_pred             ccCCCCC---eeeeecCc
Confidence            9996654   45678887

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=2.7e-23  Score=225.14  Aligned_cols=150  Identities=27%  Similarity=0.412  Sum_probs=134.8

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...+.||+|+||.||++... +++.||||++...   .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36888899999999999999986 4889999999653   2244667899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+++++|.+++.+.   ..+++.....++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.+...
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999998654   35889999999999999999999987   999999999999999999999999999977544

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.90  E-value=4.7e-23  Score=227.29  Aligned_cols=153  Identities=29%  Similarity=0.440  Sum_probs=131.6

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC------CcEEEEEEeccCC-ccchHHHHHHHHHHHhcC-CCceeeEEEEEEeCCe
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDE  612 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~  612 (709)
                      .+.|...++||+|+||.||+|+...      +..||||++.... ....+.|.+|+.++.++. ||||++++++|.+.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            4578888999999999999998632      3479999996543 334567999999999996 9999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHhccCC----------------------------------------------------------
Q 005206          613 KMLVYEYMENRSLDSVIFDKAR----------------------------------------------------------  634 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------------------  634 (709)
                      .+|||||+++|+|.++|.+...                                                          
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            9999999999999998864210                                                          


Q ss_pred             -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC
Q 005206          635 -----------------------------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK  679 (709)
Q Consensus       635 -----------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~  679 (709)
                                                         ...+++..+..++.||++||+|||+.+   |+||||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence                                               124788888999999999999999987   999999999999999


Q ss_pred             CCcEEEEecCCceeeCC
Q 005206          680 EMTPKISDFGMARIFGG  696 (709)
Q Consensus       680 ~~~~KI~DFGla~~l~~  696 (709)
                      ++.+||+|||+++.+..
T Consensus       273 ~~~~kL~DfGla~~~~~  289 (400)
T cd05105         273 GKIVKICDFGLARDIMH  289 (400)
T ss_pred             CCEEEEEeCCcceeccc
Confidence            99999999999987644

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.90  E-value=2.7e-24  Score=237.30  Aligned_cols=151  Identities=35%  Similarity=0.539  Sum_probs=132.7

Q ss_pred             CcceeecccCceEEEEEEEc-CCc----EEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          545 TDYNKLGQGGFGIVYKGRLL-EGQ----EIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       545 ~~~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ...++||+|+||+||+|.+. +|+    +||+|++... ..+..++|+.|+-+|.+++||||+||+|+|.... ..||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            34479999999999999763 343    6899988655 4456789999999999999999999999998766 889999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      |||.|.|.+|++.++  ..+-.+..+.+..|||+||.|||++.   ++||||.+|||||.+-..+||.|||+|+++..+.
T Consensus       778 ~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             hcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            999999999997643  34788899999999999999999987   9999999999999999999999999999998876


Q ss_pred             ccc
Q 005206          699 TEQ  701 (709)
Q Consensus       699 ~~~  701 (709)
                      .+-
T Consensus       853 ~ey  855 (1177)
T KOG1025|consen  853 KEY  855 (1177)
T ss_pred             ccc
Confidence            553

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.90  E-value=6.3e-23  Score=216.34  Aligned_cols=148  Identities=28%  Similarity=0.477  Sum_probs=129.8

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ++|...++||+|+||.||+|.... ++.||+|++.... ......+.+|+.++.+++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            468888999999999999998864 7899999986442 23345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      +++ +|.+++...  ...+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~  154 (288)
T cd07871          85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKS  154 (288)
T ss_pred             CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence            985 898888543  234788999999999999999999987   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.90  E-value=3.1e-23  Score=227.19  Aligned_cols=152  Identities=32%  Similarity=0.482  Sum_probs=131.0

Q ss_pred             cCcCcceeecccCceEEEEEEEc------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCee
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEK  613 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~  613 (709)
                      ++|...+.||+|+||.||++...      ++..||||++.... ....+.+.+|+.++.++ +|+|||+++++|...+..
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            46888899999999999998752      23579999997543 33456789999999999 899999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhccCC-----------------------------------------------------------
Q 005206          614 MLVYEYMENRSLDSVIFDKAR-----------------------------------------------------------  634 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~-----------------------------------------------------------  634 (709)
                      ++||||+++|+|.+++.....                                                           
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            999999999999999864211                                                           


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          635 --------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       635 --------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                              ...+++.+..+++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++.+..
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~  264 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMN  264 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence                    124788899999999999999999987   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.90  E-value=6.7e-23  Score=220.62  Aligned_cols=149  Identities=26%  Similarity=0.362  Sum_probs=130.0

Q ss_pred             CcCcceeecccCceEEEEEEEc----CCcEEEEEEeccC----CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCee
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSRN----SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEK  613 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~----~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~  613 (709)
                      +|...++||+|+||.||+++..    .++.||+|++.+.    .....+.+..|+.++.++ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4777899999999999999763    4789999998643    223356788999999999 599999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ++||||+++|+|.+++...   ..+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            9999999999999998653   34889999999999999999999987   99999999999999999999999999987


Q ss_pred             eCCC
Q 005206          694 FGGD  697 (709)
Q Consensus       694 l~~~  697 (709)
                      +...
T Consensus       155 ~~~~  158 (332)
T cd05614         155 FLSE  158 (332)
T ss_pred             cccc
Confidence            6433

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.90  E-value=2.8e-23  Score=219.32  Aligned_cols=154  Identities=31%  Similarity=0.496  Sum_probs=131.2

Q ss_pred             eeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCC
Q 005206          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRS  624 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  624 (709)
                      +.||.|.||.||-|+++. |+.||||++.+.  ...+...+++|+.+|.+++||.||.|-..|...+..++|||-+. |+
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GD  648 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-GD  648 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-ch
Confidence            689999999999999865 999999999765  34556889999999999999999999999999999999999995 55


Q ss_pred             HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC---CcEEEEecCCceeeCCCCccc
Q 005206          625 LDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE---MTPKISDFGMARIFGGDQTEQ  701 (709)
Q Consensus       625 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~KI~DFGla~~l~~~~~~~  701 (709)
                      ..++|....+ ..|++.....++.||+.||.|||.++   |+|+||||+||||.+.   -.+||+|||.||++++.+.++
T Consensus       649 MLEMILSsEk-gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr  724 (888)
T KOG4236|consen  649 MLEMILSSEK-GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR  724 (888)
T ss_pred             HHHHHHHhhc-ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhhh
Confidence            5555544333 34788777788999999999999998   9999999999999654   479999999999998766543


Q ss_pred             cccceecC
Q 005206          702 NTKRVVGT  709 (709)
Q Consensus       702 ~~~~~~GT  709 (709)
                         .++||
T Consensus       725 ---sVVGT  729 (888)
T KOG4236|consen  725 ---SVVGT  729 (888)
T ss_pred             ---hhcCC
Confidence               36776

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.90  E-value=6.6e-23  Score=220.00  Aligned_cols=142  Identities=29%  Similarity=0.404  Sum_probs=124.9

Q ss_pred             eeecccCceEEEEEEEc----CCcEEEEEEeccC----CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          548 NKLGQGGFGIVYKGRLL----EGQEIAVKRLSRN----SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ++||+|+||.||+++..    .++.||||.+.+.    .......+.+|+.++.+++||||+++++++...+..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            58999999999999863    4788999998653    223345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      +++++|.+++...   ..+.+.....++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  151 (323)
T cd05584          82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESI  151 (323)
T ss_pred             CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence            9999999988543   34778888889999999999999997   9999999999999999999999999998643

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.5e-23  Score=214.98  Aligned_cols=149  Identities=30%  Similarity=0.526  Sum_probs=129.1

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEe-----CCee
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE-----MDEK  613 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-----~~~~  613 (709)
                      ..|...+.||+|+||.|..+.... |+.||||++...  .....++-.+|+++++.++|+||+.+++.+..     -+..
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            445556889999999999998865 899999999743  44557788999999999999999999998865     3467


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      |+|+|+| .-+|...+...   ..++......+++||++||+|+|+.+   |+||||||.|+|++.+..+||+||||||.
T Consensus       102 YiV~elM-etDL~~iik~~---~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen  102 YLVFELM-ETDLHQIIKSQ---QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             EEehhHH-hhHHHHHHHcC---ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence            9999999 56888888543   23888888899999999999999998   99999999999999999999999999999


Q ss_pred             eCCC
Q 005206          694 FGGD  697 (709)
Q Consensus       694 l~~~  697 (709)
                      +...
T Consensus       175 ~~~~  178 (359)
T KOG0660|consen  175 LDKF  178 (359)
T ss_pred             cccc
Confidence            8654

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.90  E-value=5.6e-23  Score=219.69  Aligned_cols=150  Identities=31%  Similarity=0.563  Sum_probs=129.9

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-Cc----EEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQ----EIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~----~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      .+|+..+.||+|+||.||+|.+.. ++    .||+|++.... ....++|.+|+.++..++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            458888999999999999998643 33    48999986543 34467899999999999999999999999864 5789


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      |+||+++|+|.+++.+..  ..+++...+.++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            999999999999986533  34889999999999999999999987   9999999999999999999999999999875


Q ss_pred             CC
Q 005206          696 GD  697 (709)
Q Consensus       696 ~~  697 (709)
                      ..
T Consensus       161 ~~  162 (316)
T cd05108         161 AD  162 (316)
T ss_pred             CC
Confidence            43

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.89  E-value=8.5e-23  Score=219.76  Aligned_cols=141  Identities=28%  Similarity=0.371  Sum_probs=124.9

Q ss_pred             eeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      +.||+|+||.||++.... ++.+|+|++.+.   .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            479999999999999865 789999999754   233456688899988877 899999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      |+|..++...   ..+++.....++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            9999887543   34889999999999999999999997   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.89  E-value=5.5e-23  Score=214.00  Aligned_cols=148  Identities=27%  Similarity=0.416  Sum_probs=131.0

Q ss_pred             cCcCcceeecccCceEEEEEEEc----CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      ++|+..+.||+|+||.||+|.+.    .+..||+|+++... ....+.|.+|+.++.+++||||++++|++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46788899999999999999864    25689999987543 33456799999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      |||+++|+|.+++....  ..+++..++.++.||+.||+|||+++   ++||||||+|||++.++.+|++|||++...
T Consensus        85 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          85 TEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            99999999999986532  35889999999999999999999987   999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.89  E-value=7.5e-23  Score=218.98  Aligned_cols=144  Identities=28%  Similarity=0.359  Sum_probs=126.7

Q ss_pred             eeecccCceEEEEEEEc----CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          548 NKLGQGGFGIVYKGRLL----EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      +.||+|+||.||+++..    .++.+|+|++....  ......+..|++++.+++||||+++++++.+.+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            57999999999998752    47899999996532  2234567889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      +|+|.+++.+.   ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  151 (318)
T cd05582          82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  151 (318)
T ss_pred             CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence            99999988543   34899999999999999999999997   999999999999999999999999999876433

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.89  E-value=1e-22  Score=218.54  Aligned_cols=146  Identities=32%  Similarity=0.405  Sum_probs=127.9

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCC-CceeeEEEEEEeCCeeEEEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQH-RNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~  617 (709)
                      +|...+.||+|+||.||+|+... ++.||||++.+.   .....+.+..|++++..++| ++|+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            46778999999999999998865 678999998653   23446678899999999976 56888999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      ||+++|+|.+++...   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05587          81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN  151 (324)
T ss_pred             cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence            999999999988543   24789999999999999999999987   999999999999999999999999999854

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.89  E-value=1.2e-22  Score=218.69  Aligned_cols=150  Identities=26%  Similarity=0.358  Sum_probs=133.0

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ++|+..+.||+|+||.||+++... +..+|+|.+.... ....+++.+|++++.+++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            678888999999999999999875 7889999886542 23456799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      +++++|.+++....   .+++..+..++.|++.||.|||+.+  .|+||||||+|||++.++.+||+|||+++.+..
T Consensus        85 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          85 MDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            99999999986532   4889999999999999999999853  399999999999999999999999999987643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=2.1e-23  Score=226.89  Aligned_cols=150  Identities=29%  Similarity=0.389  Sum_probs=133.5

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      +-|+..+.||+|+.|.|-.|++.. |+.+|||++.+.   .......+.+|+.+|+.|.|||+++|++++.+..+.|||.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            346777899999999999999865 999999999765   2333556789999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+++|.|.+++....   .+++.+..+++.||+.|+.|+|..+   |+||||||+|+|||.++++||+|||||.+-.++
T Consensus        92 Eyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            9999999999996543   4888899999999999999999987   999999999999999999999999999875444

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.89  E-value=8.6e-23  Score=218.87  Aligned_cols=142  Identities=30%  Similarity=0.410  Sum_probs=125.3

Q ss_pred             eeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      ++||+|+||.||+|+... ++.||||++.+.   .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            369999999999998865 789999998653   234456788899998876 799999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      |+|..++...   ..+++.....++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~  147 (321)
T cd05591          81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGI  147 (321)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecc
Confidence            9999888543   34889999999999999999999997   9999999999999999999999999998643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.89  E-value=1.3e-22  Score=215.46  Aligned_cols=149  Identities=30%  Similarity=0.460  Sum_probs=129.8

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCc-cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      .++|...++||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            367888999999999999999986 478999999865432 234567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      |++ ++|.+++...  ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS  154 (303)
T ss_pred             CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence            996 6787777543  234788889999999999999999998   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.89  E-value=1.3e-22  Score=217.73  Aligned_cols=147  Identities=31%  Similarity=0.396  Sum_probs=128.1

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      +|...+.||+|+||.||+|.... ++.||||.+.+..   ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            46778899999999999998865 6799999987542   23345677888888877 5899999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus        81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~  152 (323)
T cd05616          81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM  152 (323)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence            999999999888543   24889999999999999999999987   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.89  E-value=9.6e-23  Score=219.34  Aligned_cols=141  Identities=26%  Similarity=0.344  Sum_probs=125.5

Q ss_pred             eeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      ++||+|+||.||+++... ++.||+|++++.   .....+.+..|..++.++ +||||+++++++.+.+..+|||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            479999999999998865 789999999753   233456788999999998 799999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      |+|..++...   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  146 (329)
T cd05588          81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  146 (329)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccc
Confidence            9999888543   34899999999999999999999997   999999999999999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.89  E-value=1.1e-22  Score=211.12  Aligned_cols=146  Identities=41%  Similarity=0.646  Sum_probs=127.0

Q ss_pred             cceeecccCceEEEEEEEc-----CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          546 DYNKLGQGGFGIVYKGRLL-----EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       546 ~~~~LG~G~fG~Vykg~~~-----~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ..+.||+|.||.||+|.+.     .+..|+||.++... ....++|.+|++.+.+++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3578999999999999987     25689999996543 33478999999999999999999999999988889999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      +++|+|.++|.... ...+++..+..|+.|||+||.|||+++   ++|+||+++||++++++.+||+|||+++...
T Consensus        83 ~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   83 CPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS  154 (259)
T ss_dssp             -TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred             cccccccccccccc-ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence            99999999997652 345899999999999999999999987   9999999999999999999999999999873

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.89  E-value=1.1e-22  Score=213.44  Aligned_cols=145  Identities=32%  Similarity=0.423  Sum_probs=127.1

Q ss_pred             ecccCceEEEEEEEc-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCCH
Q 005206          550 LGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL  625 (709)
Q Consensus       550 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  625 (709)
                      ||+|+||+||++... +++.+|+|++....   ....+.+..|++++.+++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999876 47899999986532   23346788999999999999999999999999999999999999999


Q ss_pred             HHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          626 DSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       626 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ..++.... ....+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  150 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDG  150 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence            98875432 2345899999999999999999999987   999999999999999999999999999877543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.89  E-value=8.9e-23  Score=214.56  Aligned_cols=149  Identities=25%  Similarity=0.435  Sum_probs=130.5

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ++|...+.||+|+||.||+++... ++.||||++....  ....+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            468888999999999999999875 7889999986542  3345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |++++.+..+...   ...+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  152 (287)
T cd07848          81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE  152 (287)
T ss_pred             cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence            9999877655422   235889999999999999999999987   99999999999999999999999999998743

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.89  E-value=4.9e-23  Score=223.75  Aligned_cols=144  Identities=29%  Similarity=0.457  Sum_probs=126.0

Q ss_pred             CcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      +|...++||+|+||.||+++.. +++.||||++.... ....+.+.+|++++.+++|+||+++++++.+.+..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            3556678999999999999876 48899999986543 234567999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ++|+|....       ..++.....++.||+.||.|||+++   |+||||||+||||++++.+||+|||+++.+..
T Consensus       155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~  220 (353)
T PLN00034        155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ  220 (353)
T ss_pred             CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence            999985422       3567778889999999999999997   99999999999999999999999999997753

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.89  E-value=1.3e-23  Score=194.99  Aligned_cols=149  Identities=29%  Similarity=0.489  Sum_probs=128.7

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +|...++||+|.||+||||+..+ ++.||+|++.-..  +-.-...++|+.+++.++|.|||+++++.......-||+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            45566899999999999999876 7889999986442  22345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      +. .+|..|.....  .-++......++.|+++||.|+|+++   +.||||||+|.||+.++++|++|||+||-++-+
T Consensus        83 cd-qdlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip  154 (292)
T KOG0662|consen   83 CD-QDLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP  154 (292)
T ss_pred             hh-HHHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence            95 47888875433  34888888999999999999999997   999999999999999999999999999987644

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.89  E-value=1.1e-22  Score=217.58  Aligned_cols=142  Identities=32%  Similarity=0.410  Sum_probs=123.0

Q ss_pred             eeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      +.||+|+||.||+|+... ++.||||.+...   .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            379999999999999865 788999998653   223445566777777654 899999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      |+|..++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~  147 (316)
T cd05592          81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM  147 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence            9999888543   24888899999999999999999987   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.89  E-value=3.1e-23  Score=234.02  Aligned_cols=150  Identities=28%  Similarity=0.460  Sum_probs=132.6

Q ss_pred             cCcCcceeecccCceEEEEEEEcCC-cEEEEEEeccCCccchHHHHHHHHHHHhcC-CCceeeEEEE-EEe------CCe
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEG-QEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGC-CVE------MDE  612 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g-~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~-~~~------~~~  612 (709)
                      .+.++.+.|.+|||+.||.+.+..+ .++|+|++....+...+..++||++|++|+ |+|||.+++. ...      .-+
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            4566778999999999999999876 999999998777888899999999999997 9999999993 221      135


Q ss_pred             eEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCce
Q 005206          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~  692 (709)
                      .+|.||||++|.|-+++..+.... |++.++++|+.|+++|+++||.. +++|||||||.|||||+.++..||||||-|.
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            789999999999999997554433 99999999999999999999998 4899999999999999999999999999986


Q ss_pred             e
Q 005206          693 I  693 (709)
Q Consensus       693 ~  693 (709)
                      -
T Consensus       195 t  195 (738)
T KOG1989|consen  195 T  195 (738)
T ss_pred             c
Confidence            3

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.89  E-value=1.4e-22  Score=212.70  Aligned_cols=152  Identities=32%  Similarity=0.531  Sum_probs=131.5

Q ss_pred             cCcCcceeecccCceEEEEEEEc-----CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-----EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-----~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      +.|+..++||+|+||.||+|...     .++.||+|.+.... .+...+|.+|+.++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            35677789999999999999852     35789999996433 3445789999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC
Q 005206          616 VYEYMENRSLDSVIFDKAR--------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM  681 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~  681 (709)
                      ||||+++++|.+++.....              ...+++.+.+.++.|++.||.|||+++   |+||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            9999999999999853221              234789999999999999999999987   99999999999999999


Q ss_pred             cEEEEecCCceeeCC
Q 005206          682 TPKISDFGMARIFGG  696 (709)
Q Consensus       682 ~~KI~DFGla~~l~~  696 (709)
                      .+||+|||+++.+..
T Consensus       162 ~~kl~dfg~~~~~~~  176 (283)
T cd05090         162 HVKISDLGLSREIYS  176 (283)
T ss_pred             cEEeccccccccccC
Confidence            999999999987643

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.89  E-value=1e-22  Score=218.56  Aligned_cols=144  Identities=32%  Similarity=0.470  Sum_probs=125.3

Q ss_pred             cCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHH---HhcCCCceeeEEEEEEeCCeeEEE
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLI---AKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l---~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      |...+.||+|+||.||++.... ++.||||++.+.   .....+.+..|++++   .+++||||+++++++.+.+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            4567899999999999998764 889999999653   233455677777665   466899999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      |||+++++|..++..    ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05589          81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG  151 (324)
T ss_pred             EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence            999999999888743    34899999999999999999999987   999999999999999999999999998854

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=1.6e-22  Score=212.95  Aligned_cols=149  Identities=32%  Similarity=0.427  Sum_probs=131.2

Q ss_pred             CcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      +|+..++||+|+||.||++... +++.||+|++....   ......+.+|+.++.+++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4677889999999999999875 48899999986532   2234567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      |+++|+|.+++.... ...+++.....++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.+.
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05605          81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIP  153 (285)
T ss_pred             ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            999999998886432 245899999999999999999999997   9999999999999999999999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=1e-22  Score=230.67  Aligned_cols=157  Identities=22%  Similarity=0.310  Sum_probs=134.0

Q ss_pred             HHHhcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC---
Q 005206          538 VRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD---  611 (709)
Q Consensus       538 ~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~---  611 (709)
                      ....++|...++||+|+||.||+++.. +++.||||++...  .......+.+|+.++..++|+||+++...+...+   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            334578999999999999999999875 4899999998654  3344567899999999999999999988775433   


Q ss_pred             -----eeEEEEEccCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEE
Q 005206          612 -----EKMLVYEYMENRSLDSVIFDKAR-SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKI  685 (709)
Q Consensus       612 -----~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI  685 (709)
                           ..++||||+++|+|.+++..... ...+++.....++.|++.||.|||+.+   |+||||||+||||+.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence                 25799999999999999865332 346889999999999999999999987   999999999999999999999


Q ss_pred             EecCCceeeCCC
Q 005206          686 SDFGMARIFGGD  697 (709)
Q Consensus       686 ~DFGla~~l~~~  697 (709)
                      +|||+++.+...
T Consensus       185 ~DFGls~~~~~~  196 (496)
T PTZ00283        185 GDFGFSKMYAAT  196 (496)
T ss_pred             EecccCeecccc
Confidence            999999987544

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.89  E-value=1.4e-22  Score=217.56  Aligned_cols=146  Identities=30%  Similarity=0.398  Sum_probs=127.5

Q ss_pred             cCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEEEE
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      |...+.||+|+||.||++.... ++.||+|++.+.   .....+.+..|..++..+. |++|+++.+++.+.+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            6677899999999999998764 789999998653   2334567888999998885 5778889999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      |+++|+|.+++...   ..+++.+...++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus        82 y~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~  152 (323)
T cd05615          82 YVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM  152 (323)
T ss_pred             CCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence            99999999988543   34889999999999999999999987   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.89  E-value=1.6e-22  Score=217.20  Aligned_cols=141  Identities=27%  Similarity=0.339  Sum_probs=122.1

Q ss_pred             eeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHH-HHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVR-LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      +.||+|+||+||+++... ++.+|+|++.+.   .....+++..|.. ++..++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            469999999999998754 889999998653   2233455666665 46778999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      |+|..++...   ..+++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            9998888543   34889999999999999999999997   999999999999999999999999999854

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.89  E-value=1.8e-22  Score=217.67  Aligned_cols=149  Identities=26%  Similarity=0.372  Sum_probs=131.9

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ++|+..++||+|+||.||++.+.. +..+|+|.+.... ....+++.+|++++.+++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            678888999999999999999874 7889999886542 33456799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      +++|+|.+++...   ..+++.....++.|++.||.|||+..  +|+||||||+|||++.++.+||+|||+++.+.
T Consensus        85 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          85 MDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             CCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            9999999998643   34788999999999999999999853  39999999999999999999999999998663

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.89  E-value=1.5e-22  Score=217.06  Aligned_cols=141  Identities=33%  Similarity=0.461  Sum_probs=125.1

Q ss_pred             eeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      +.||+|+||.||+++... ++.||||++.+.   .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            379999999999999865 789999998653   234456788899998877 699999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      |+|.+++...   ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            9999888543   34889999999999999999999987   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.89  E-value=1.6e-22  Score=222.60  Aligned_cols=142  Identities=20%  Similarity=0.287  Sum_probs=126.2

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      .++|...++||+|+||.||++.... ++.||+|+..      .+.+.+|+.++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            3579999999999999999998865 7899999653      24578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      +. ++|..++...   ..+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+...
T Consensus       165 ~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~  233 (391)
T PHA03212        165 YK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPV  233 (391)
T ss_pred             CC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence            95 6888887543   24789999999999999999999997   9999999999999999999999999998643

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.89  E-value=1.9e-22  Score=211.72  Aligned_cols=150  Identities=30%  Similarity=0.543  Sum_probs=132.0

Q ss_pred             cCcCcceeecccCceEEEEEEEc-----CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeeE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-----EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKM  614 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-----~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~  614 (709)
                      ++|+..+.||+|+||.||++...     .++.||+|++........+.|.+|++++.+++||||+++++++...  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46788899999999999999753     4779999999766666677899999999999999999999987643  4578


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      +|+||+++++|.+++.+.  ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.+
T Consensus        84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            999999999999998543  234899999999999999999999997   999999999999999999999999999976


Q ss_pred             CC
Q 005206          695 GG  696 (709)
Q Consensus       695 ~~  696 (709)
                      ..
T Consensus       159 ~~  160 (284)
T cd05081         159 PQ  160 (284)
T ss_pred             cC
Confidence            44

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>PHA02988 hypothetical protein; Provisional

Probab=99.89  E-value=2e-22  Score=212.11  Aligned_cols=143  Identities=17%  Similarity=0.359  Sum_probs=125.1

Q ss_pred             eeecccCceEEEEEEEcCCcEEEEEEeccCCccc---hHHHHHHHHHHHhcCCCceeeEEEEEEe----CCeeEEEEEcc
Q 005206          548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQG---IEEFKNEVRLIAKLQHRNLVRLLGCCVE----MDEKMLVYEYM  620 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~---~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~Ey~  620 (709)
                      ..||+|++|.||+|.+ +++.||||++.......   .+.|.+|+.++.+++||||++++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            5799999999999998 68899999997543322   5778899999999999999999999987    34678999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ++|+|.+++.+.   ..+++.....++.|++.||.|||+..  .++||||||+|||+++++.+||+|||+++.+..
T Consensus       105 ~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~  175 (283)
T PHA02988        105 TRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSS  175 (283)
T ss_pred             CCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence            999999999653   34889999999999999999999852  278999999999999999999999999997644

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.89  E-value=1.6e-22  Score=210.62  Aligned_cols=143  Identities=29%  Similarity=0.454  Sum_probs=123.5

Q ss_pred             eecccCceEEEEEEEcC---CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCC
Q 005206          549 KLGQGGFGIVYKGRLLE---GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRS  624 (709)
Q Consensus       549 ~LG~G~fG~Vykg~~~~---g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  624 (709)
                      +||+|+||.||+|....   ...+|+|.+.... .....+|.+|+.+++.++|+||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            69999999999997654   3468888775432 3345678999999999999999999999999999999999999999


Q ss_pred             HHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          625 LDSVIFDKAR--SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       625 L~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      |.+++.....  ....++.....++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  150 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ  150 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccccc
Confidence            9999965432  233567888899999999999999987   999999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.89  E-value=1e-23  Score=224.55  Aligned_cols=148  Identities=31%  Similarity=0.519  Sum_probs=128.7

Q ss_pred             CcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCC
Q 005206          545 TDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRS  624 (709)
Q Consensus       545 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  624 (709)
                      +.++-||.|+-|.||+|++ .++.||||+++...       ..+|+.|++|+||||+.+.|+|.+..-.+|||||++.|.
T Consensus       127 sELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            3446799999999999999 46899999986432       358889999999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCCcccccc
Q 005206          625 LDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK  704 (709)
Q Consensus       625 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~~~~~~~  704 (709)
                      |.+.|...+   ++.......+..+||.||.|||.+.   |||||||.-||||..+..+||+|||-++.+.+..++   .
T Consensus       199 L~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk---M  269 (904)
T KOG4721|consen  199 LYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK---M  269 (904)
T ss_pred             HHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhhh---h
Confidence            999996543   4777888899999999999999997   999999999999999999999999999988655333   2


Q ss_pred             ceecC
Q 005206          705 RVVGT  709 (709)
Q Consensus       705 ~~~GT  709 (709)
                      .|+||
T Consensus       270 SFaGT  274 (904)
T KOG4721|consen  270 SFAGT  274 (904)
T ss_pred             hhhhh
Confidence            46776

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.89  E-value=2e-22  Score=216.66  Aligned_cols=141  Identities=27%  Similarity=0.362  Sum_probs=125.5

Q ss_pred             eeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      ++||+|+||+||+++... ++.+|+|++.+.   .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            479999999999998865 789999999754   233456788999999888 699999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      |+|..++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~  146 (327)
T cd05617          81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG  146 (327)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceec
Confidence            9999888543   34899999999999999999999997   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.89  E-value=1.6e-22  Score=216.81  Aligned_cols=141  Identities=28%  Similarity=0.346  Sum_probs=121.1

Q ss_pred             eeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHH-HHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVR-LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      ++||+|+||.||+++... ++.||+|++.+..   .....++..|.. ++..++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            379999999999999865 7899999986432   223445556655 57889999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      |+|..++...   ..+++.....++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  146 (321)
T cd05603          81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (321)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence            9998888543   34778888889999999999999987   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.89  E-value=1.9e-22  Score=208.42  Aligned_cols=148  Identities=32%  Similarity=0.526  Sum_probs=132.4

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      +.|...+.||+|+||.||++...++..+|+|.+... ....++|.+|+.++.+++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            347777899999999999999988889999988533 3345789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      +|+|.+++....  ..+++..+..++.|++.||.|||+++   |+||||||+||++++++.+||+|||+++.+.
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~  151 (256)
T cd05114          83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL  151 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence            999999986432  24889999999999999999999987   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.89  E-value=1.8e-22  Score=216.48  Aligned_cols=141  Identities=29%  Similarity=0.357  Sum_probs=121.9

Q ss_pred             eeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHH-HHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVR-LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      +.||+|+||+||++.... ++.||+|++.+..   ....+++..|.. ++..++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            379999999999999864 8899999996432   223345555655 56789999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      |+|..++...   ..+++.....++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            9999988543   34888999999999999999999997   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.89  E-value=1.9e-22  Score=217.21  Aligned_cols=146  Identities=27%  Similarity=0.462  Sum_probs=125.8

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----eeE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD-----EKM  614 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~  614 (709)
                      +|...++||+|+||.||+|.... ++.||||++...  ......++.+|+.++.+++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            46778899999999999998764 889999998643  2234567899999999999999999999886533     479


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      +||||++ ++|.+++...   ..+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999996 6888888543   24889999999999999999999997   999999999999999999999999999865


Q ss_pred             C
Q 005206          695 G  695 (709)
Q Consensus       695 ~  695 (709)
                      .
T Consensus       154 ~  154 (338)
T cd07859         154 F  154 (338)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.89  E-value=1.8e-22  Score=218.72  Aligned_cols=159  Identities=31%  Similarity=0.485  Sum_probs=139.8

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCc---cchHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~l  615 (709)
                      ...|...++||+|.||.||+++.+. |+.+|+|.+.+...   ...+.+.+|+.+|.++. |||||.+.+.+.+....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            3567777899999999999999887 89999999976533   24568999999999998 9999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC----CcEEEEecCCc
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE----MTPKISDFGMA  691 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~----~~~KI~DFGla  691 (709)
                      |||++.+|.|.+.|...   . +++.....++.||+.++.|||+.+   |+||||||+|+|+...    +.+|++|||+|
T Consensus       114 vmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             EEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            99999999999998765   2 899999999999999999999987   9999999999999643    47999999999


Q ss_pred             eeeCCCCccccccceecC
Q 005206          692 RIFGGDQTEQNTKRVVGT  709 (709)
Q Consensus       692 ~~l~~~~~~~~~~~~~GT  709 (709)
                      +.+..   ......++||
T Consensus       187 ~~~~~---~~~~~~~~Gt  201 (382)
T KOG0032|consen  187 KFIKP---GERLHTIVGT  201 (382)
T ss_pred             eEccC---CceEeeecCC
Confidence            99876   2345567876

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.89  E-value=2.6e-22  Score=208.01  Aligned_cols=151  Identities=30%  Similarity=0.487  Sum_probs=135.6

Q ss_pred             hcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      .++|+..+.||+|+||.||+|...+++.||+|.+... ....++|.+|+.++.+++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            3568888999999999999999877889999998643 334678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ++++|.+++.+.. ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.+..
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            9999999986543 345899999999999999999999987   99999999999999999999999999997753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.89  E-value=2.1e-22  Score=222.12  Aligned_cols=152  Identities=28%  Similarity=0.449  Sum_probs=130.5

Q ss_pred             cCcCcceeecccCceEEEEEEEcC------CcEEEEEEeccCC-ccchHHHHHHHHHHHhcC-CCceeeEEEEEEeCCee
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEK  613 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~  613 (709)
                      ++|...++||+|+||.||+|++..      ++.||||++.... ....+.+.+|++++.++. |||||+++++|...+..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            456777899999999999998642      4689999997543 233457899999999997 99999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhccCC-----------------------------------------------------------
Q 005206          614 MLVYEYMENRSLDSVIFDKAR-----------------------------------------------------------  634 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~-----------------------------------------------------------  634 (709)
                      ++||||+++|+|.+++.....                                                           
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            999999999999999864311                                                           


Q ss_pred             ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc
Q 005206          635 ------------------------------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD  678 (709)
Q Consensus       635 ------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~  678 (709)
                                                          ...+++.....++.||+.||+|||+.+   |+||||||+|||++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~  273 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLIC  273 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEe
Confidence                                                124678888999999999999999987   99999999999999


Q ss_pred             CCCcEEEEecCCceeeCC
Q 005206          679 KEMTPKISDFGMARIFGG  696 (709)
Q Consensus       679 ~~~~~KI~DFGla~~l~~  696 (709)
                      +++.+||+|||+++.+..
T Consensus       274 ~~~~~kL~DfGla~~~~~  291 (401)
T cd05107         274 EGKLVKICDFGLARDIMR  291 (401)
T ss_pred             CCCEEEEEecCcceeccc
Confidence            999999999999987643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.89  E-value=2.2e-22  Score=208.43  Aligned_cols=150  Identities=31%  Similarity=0.529  Sum_probs=134.7

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      ++|+..++||+|+||.||+|...+++.||+|.+... ....+.+.+|+.++.+++|+||+++++.+.+.+..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            568888999999999999999888889999988643 3346789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      +++|.+++.... ...+++.+++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.+..
T Consensus        85 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          85 KGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             CCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence            999999986542 335788999999999999999999987   99999999999999999999999999997754

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.89  E-value=1.2e-22  Score=220.51  Aligned_cols=153  Identities=29%  Similarity=0.449  Sum_probs=135.8

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCc--cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG--QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      ....|...+.||+|.|++|.++++.. +.+||||.+.+...  .....+.+|+++|..|+|||||+++.+.......|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            35678888999999999999998865 89999999977632  2334588999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+.+|.+.+||.+..+   +.......++.|+.++++|||+++   |+|||||++||||+.++++||+|||++..+..
T Consensus       134 ~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence            999999999999976654   445777789999999999999998   99999999999999999999999999998864


Q ss_pred             CC
Q 005206          697 DQ  698 (709)
Q Consensus       697 ~~  698 (709)
                      ..
T Consensus       208 ~~  209 (596)
T KOG0586|consen  208 GL  209 (596)
T ss_pred             cc
Confidence            43

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.89  E-value=2.9e-23  Score=222.23  Aligned_cols=162  Identities=28%  Similarity=0.466  Sum_probs=141.2

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCe-eEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE-KMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-~~lV~  617 (709)
                      ++|..++++|+|+||.++..+++. +..+++|++.-.  .....+....|+.++++++|||||...+.+.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            567788999999999999998764 678999988543  34445578899999999999999999999999988 89999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||++||+|.+.|.+.+ ...+++++.+.++.|++.|+.|||++.   |+|||||+.||+++.+..+||.|||+||.+..+
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999986644 456899999999999999999999876   999999999999999999999999999999876


Q ss_pred             CccccccceecC
Q 005206          698 QTEQNTKRVVGT  709 (709)
Q Consensus       698 ~~~~~~~~~~GT  709 (709)
                      ..  ...+++||
T Consensus       160 ~~--~a~tvvGT  169 (426)
T KOG0589|consen  160 DS--LASTVVGT  169 (426)
T ss_pred             hh--hhheecCC
Confidence            53  33457777

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.89  E-value=2.2e-22  Score=210.64  Aligned_cols=153  Identities=29%  Similarity=0.485  Sum_probs=131.9

Q ss_pred             HhcCcCcceeecccCceEEEEEEEc------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCe
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE  612 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~  612 (709)
                      .+++|+..++||+|+||.||+|.+.      .+..||||++.... .....+|.+|+.++.+++||||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3567888999999999999999764      24679999986432 2345679999999999999999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEE
Q 005206          613 KMLVYEYMENRSLDSVIFDKAR-------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKI  685 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI  685 (709)
                      .++||||+++++|.+++.+...       ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999999865321       234678899999999999999999987   999999999999999999999


Q ss_pred             EecCCceeeC
Q 005206          686 SDFGMARIFG  695 (709)
Q Consensus       686 ~DFGla~~l~  695 (709)
                      +|||+++.+.
T Consensus       161 ~dfg~~~~~~  170 (277)
T cd05062         161 GDFGMTRDIY  170 (277)
T ss_pred             CCCCCccccC
Confidence            9999998653

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.89  E-value=3.9e-22  Score=207.28  Aligned_cols=149  Identities=28%  Similarity=0.458  Sum_probs=133.7

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      ++|...++||+|+||.||+|+.. +++.||+|++........+.+.+|+.++.+++||||+++++.+...+..++|+||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            46888899999999999999975 47899999987555555677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ++++|.+++.+.   ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        89 ~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          89 GGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            999999988543   34789999999999999999999987   99999999999999999999999999987643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.89  E-value=2.7e-22  Score=207.61  Aligned_cols=150  Identities=31%  Similarity=0.534  Sum_probs=133.3

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      ++|...+.||+|+||.||+++..++..+|+|.+... ....++|.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            356777899999999999998877778999988643 3345789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      +|+|.+++.....  .+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+..+
T Consensus        83 ~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05113          83 NGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD  153 (256)
T ss_pred             CCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence            9999999865332  5899999999999999999999987   999999999999999999999999999876443

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.89  E-value=2.7e-22  Score=214.56  Aligned_cols=141  Identities=31%  Similarity=0.420  Sum_probs=123.8

Q ss_pred             eeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      +.||+|+||.||+|.... ++.||||++...   .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            479999999999999865 789999999754   123455677788888764 899999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      |+|.+++.+.   ..+++.+...++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            9999998543   34789999999999999999999987   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.89  E-value=2.8e-22  Score=208.82  Aligned_cols=145  Identities=31%  Similarity=0.447  Sum_probs=125.2

Q ss_pred             eeecccCceEEEEEEEcC---CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005206          548 NKLGQGGFGIVYKGRLLE---GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENR  623 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~---g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  623 (709)
                      +.||+|+||.||+|...+   +..+|+|++.... ......|.+|+.++.+++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            369999999999998754   3579999886543 234467999999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          624 SLDSVIFDKAR--SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       624 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      +|.+++.....  ....++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~  151 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKY  151 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccccccc
Confidence            99999965332  234677888899999999999999987   9999999999999999999999999997643

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.89  E-value=2.6e-22  Score=224.34  Aligned_cols=145  Identities=24%  Similarity=0.299  Sum_probs=128.1

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ...|...+.||+|+||.||++.+.. ++.||||...      ...+.+|++++++++|+|||++++++...+..+||||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4578888999999999999999876 7889999642      23467899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      +. ++|.+++....  ..+++.+++.|+.||++||.|||+++   ||||||||+||||+.++.+||+|||+++.+...
T Consensus       242 ~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        242 YR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             cC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence            95 78888875432  35899999999999999999999997   999999999999999999999999999987544

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.89  E-value=3e-22  Score=208.13  Aligned_cols=149  Identities=33%  Similarity=0.549  Sum_probs=132.7

Q ss_pred             cCcCcceeecccCceEEEEEEEcC----CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      ++|+..+.||+|+||.||+|.+..    ...||||.+.... .....+|.+|+.++.+++||||+++++.+.+.+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568888999999999999998753    3579999886543 33456899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      |||+++++|.+++....  ..+++..++.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.+.
T Consensus        84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            99999999999986533  25899999999999999999999987   9999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.88  E-value=3.1e-22  Score=234.20  Aligned_cols=150  Identities=25%  Similarity=0.354  Sum_probs=132.1

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...++||+|+||.||+|.... ++.||+|++....   ....++|.+|++++.+++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            578888999999999999998865 8899999996542   223567999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecC
Q 005206          618 EYMENRSLDSVIFDKA--------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG  689 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFG  689 (709)
                      ||+++|+|.+++....        ....+++...+.++.||++||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999986421        1123567888999999999999999987   9999999999999999999999999


Q ss_pred             Cceee
Q 005206          690 MARIF  694 (709)
Q Consensus       690 la~~l  694 (709)
                      +|+..
T Consensus       159 LAk~i  163 (932)
T PRK13184        159 AAIFK  163 (932)
T ss_pred             cceec
Confidence            99977

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.88  E-value=2.8e-22  Score=211.23  Aligned_cols=153  Identities=31%  Similarity=0.488  Sum_probs=131.3

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcC------CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCe
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE  612 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~  612 (709)
                      ..++|+..++||+|+||.||+|...+      +..||+|.+.... .....++.+|+.++.+++||||+++++++.+.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            34678889999999999999997642      4579999886443 2334578899999999999999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEE
Q 005206          613 KMLVYEYMENRSLDSVIFDKAR-------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKI  685 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI  685 (709)
                      .++||||+++|+|.+++.+...       ...+++.....++.|++.||.|||+++   |+||||||+|||+++++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999964321       234677888999999999999999987   999999999999999999999


Q ss_pred             EecCCceeeC
Q 005206          686 SDFGMARIFG  695 (709)
Q Consensus       686 ~DFGla~~l~  695 (709)
                      +|||+++.+.
T Consensus       161 ~Dfg~~~~~~  170 (288)
T cd05061         161 GDFGMTRDIY  170 (288)
T ss_pred             CcCCcccccc
Confidence            9999998653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.88  E-value=1.2e-22  Score=210.27  Aligned_cols=153  Identities=31%  Similarity=0.554  Sum_probs=138.2

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +..+|+..++||+|+||.||+|...+++.+|+|.+.........++.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34568888999999999999999988999999999766555677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      +++++|.+++.+.. ...+++.++..++.||+.||.|||+.+   |+||||||+||++++++.+||+|||+++.+..
T Consensus        84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            99999999996543 345899999999999999999999987   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.88  E-value=2.7e-22  Score=214.56  Aligned_cols=141  Identities=32%  Similarity=0.435  Sum_probs=123.6

Q ss_pred             eeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      ++||+|+||.||+++... ++.||+|.+++..   ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            479999999999999875 7899999996532   23455677788888765 899999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      |+|..++...   ..+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05620          81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKEN  146 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence            9999988543   34788999999999999999999997   999999999999999999999999999854

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.88  E-value=3.4e-22  Score=214.63  Aligned_cols=142  Identities=28%  Similarity=0.332  Sum_probs=120.5

Q ss_pred             eeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHH-HHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVR-LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      +.||+|+||.||+++... ++.+|+|++.+..   .....++..|.. ++..++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            369999999999999865 6789999986432   223344555544 56778999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      |+|.+++...   ..+.+.....++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~  147 (325)
T cd05602          81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  147 (325)
T ss_pred             CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence            9999988653   23677788889999999999999998   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.88  E-value=4.2e-22  Score=209.87  Aligned_cols=152  Identities=33%  Similarity=0.574  Sum_probs=133.7

Q ss_pred             cCcCcceeecccCceEEEEEEEc------CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      ++|...+.||+|+||+||++...      ++..+|+|.+........+.+.+|+.++.+++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            56788889999999999999752      245689999876655567789999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEE
Q 005206          616 VYEYMENRSLDSVIFDKA----------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKI  685 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI  685 (709)
                      ||||+++++|.+++....          ....+++..++.++.|++.||+|||+++   ++||||||+|||+++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence            999999999999986432          2234899999999999999999999987   999999999999999999999


Q ss_pred             EecCCceeeCC
Q 005206          686 SDFGMARIFGG  696 (709)
Q Consensus       686 ~DFGla~~l~~  696 (709)
                      +|||+++.+..
T Consensus       162 ~dfg~~~~~~~  172 (288)
T cd05093         162 GDFGMSRDVYS  172 (288)
T ss_pred             ccCCccccccC
Confidence            99999986643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.88  E-value=6.5e-22  Score=208.35  Aligned_cols=149  Identities=30%  Similarity=0.498  Sum_probs=124.1

Q ss_pred             CcCcceeecccCceEEEEEEEc--CCcEEEEEEeccCC--ccchHHHHHHHHHHHhc---CCCceeeEEEEEEe-----C
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLL--EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKL---QHRNLVRLLGCCVE-----M  610 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~--~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~-----~  610 (709)
                      +|...++||+|+||.||+|+..  +++.||+|++....  ......+.+|+.++..+   +||||++++++|..     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            6788899999999999999874  36789999886442  22344667788777766   69999999999863     3


Q ss_pred             CeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCC
Q 005206          611 DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (709)
Q Consensus       611 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGl  690 (709)
                      ...++||||++ ++|.+++.... ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence            45799999997 68988885432 234889999999999999999999997   99999999999999999999999999


Q ss_pred             ceeeCC
Q 005206          691 ARIFGG  696 (709)
Q Consensus       691 a~~l~~  696 (709)
                      ++.+..
T Consensus       157 ~~~~~~  162 (290)
T cd07862         157 ARIYSF  162 (290)
T ss_pred             eEeccC
Confidence            987653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.88  E-value=3.1e-22  Score=211.62  Aligned_cols=151  Identities=31%  Similarity=0.497  Sum_probs=130.3

Q ss_pred             cCcCcceeecccCceEEEEEEEcC---------------CcEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE---------------GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLG  605 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~---------------g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g  605 (709)
                      ++|...++||+|+||.||++....               ...||+|++... .....+.|.+|++++.+++|+||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            568888999999999999987643               125899998654 2334567999999999999999999999


Q ss_pred             EEEeCCeeEEEEEccCCCCHHHHHhccCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEE
Q 005206          606 CCVEMDEKMLVYEYMENRSLDSVIFDKAR---------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNIL  676 (709)
Q Consensus       606 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NIL  676 (709)
                      ++...+..++||||+++++|.+++.+...         ...+++..++.++.|++.||+|||+.+   ++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            99999999999999999999999854321         124688999999999999999999987   999999999999


Q ss_pred             EcCCCcEEEEecCCceeeC
Q 005206          677 LDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       677 l~~~~~~KI~DFGla~~l~  695 (709)
                      +++++.+||+|||+++.+.
T Consensus       162 l~~~~~~kl~dfg~~~~~~  180 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLY  180 (295)
T ss_pred             EcCCCcEEecccccccccc
Confidence            9999999999999998653

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.88  E-value=6.3e-22  Score=205.96  Aligned_cols=154  Identities=31%  Similarity=0.435  Sum_probs=134.0

Q ss_pred             HHhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          539 RATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       539 ~~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      .+++++.....||+|+||.||+|.+.+ +..||+|.+........+.+.+|+.++.+++|+||+++++++..++..++|+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            455667667799999999999998764 6789999987666666778999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-CCcEEEEecCCceeeC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-EMTPKISDFGMARIFG  695 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~KI~DFGla~~l~  695 (709)
                      ||+++++|.+++.........++..+..++.||+.||+|||+.+   |+||||||+||+++. ++.+||+|||++..+.
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            99999999999965432212378888899999999999999987   999999999999986 6799999999998764

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.88  E-value=3.2e-22  Score=209.47  Aligned_cols=141  Identities=26%  Similarity=0.385  Sum_probs=121.3

Q ss_pred             eecccCceEEEEEEEcC-------------------------CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeE
Q 005206          549 KLGQGGFGIVYKGRLLE-------------------------GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL  603 (709)
Q Consensus       549 ~LG~G~fG~Vykg~~~~-------------------------g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l  603 (709)
                      +||+|+||.||+|.+..                         ...||+|++.........+|.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997521                         13588998865544456689999999999999999999


Q ss_pred             EEEEEeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC--
Q 005206          604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM--  681 (709)
Q Consensus       604 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~--  681 (709)
                      +++|.+....++||||+++|+|+.++....  ..+++..++.++.||++||+|||+++   |+||||||+|||++.++  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            999999999999999999999999985432  35789999999999999999999987   99999999999997643  


Q ss_pred             -----cEEEEecCCceee
Q 005206          682 -----TPKISDFGMARIF  694 (709)
Q Consensus       682 -----~~KI~DFGla~~l  694 (709)
                           .+||+|||+++..
T Consensus       157 ~~~~~~~kl~d~g~~~~~  174 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTA  174 (274)
T ss_pred             cCccceeeecCCcccccc
Confidence                 4899999998754

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.88  E-value=6e-22  Score=210.93  Aligned_cols=148  Identities=30%  Similarity=0.491  Sum_probs=129.4

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ++|...++||+|+||.||+|+... ++.||+|++.... ......+.+|+.++.+++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            468888999999999999998864 7889999986443 23345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      +++ +|.+++...  ...+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  155 (309)
T cd07872          86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS  155 (309)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecC
Confidence            985 788877543  234788899999999999999999987   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.88  E-value=4.3e-22  Score=208.34  Aligned_cols=151  Identities=32%  Similarity=0.593  Sum_probs=133.0

Q ss_pred             cCcCcceeecccCceEEEEEEEcC------CcEEEEEEeccCCcc-chHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  614 (709)
                      ++|...+.||+|+||.||+|...+      ++.||||.+...... ..+.|.+|++++.+++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            457777899999999999998743      478999998765443 4678999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcE
Q 005206          615 LVYEYMENRSLDSVIFDKA-----------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  683 (709)
                      +||||+++++|.+++....           ....+++.+...++.||+.||.|||+++   ++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            9999999999999996532           1234789999999999999999999997   9999999999999999999


Q ss_pred             EEEecCCceeeC
Q 005206          684 KISDFGMARIFG  695 (709)
Q Consensus       684 KI~DFGla~~l~  695 (709)
                      ||+|||+++.+.
T Consensus       162 kl~d~g~~~~~~  173 (280)
T cd05049         162 KIGDFGMSRDVY  173 (280)
T ss_pred             EECCcccceecc
Confidence            999999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.88  E-value=4.6e-22  Score=205.65  Aligned_cols=148  Identities=30%  Similarity=0.529  Sum_probs=132.0

Q ss_pred             CcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      +|+..+.||+|+||.||++....+..+|+|.+.+. ....++|.+|+.++.+++||||+++++++...+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            46777899999999999999877778999988543 23456789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ++|.+++....  ..+++...+.++.||+.||+|||+.+   ++||||||+||++++++.+||+|||+++....
T Consensus        84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccc
Confidence            99999986533  25899999999999999999999997   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.88  E-value=5.3e-22  Score=208.21  Aligned_cols=150  Identities=33%  Similarity=0.502  Sum_probs=126.9

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-Cc----EEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQ----EIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~----~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      +.|...+.||+|+||.||+|.... ++    .+++|++.... .....++..|+.++.+++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            356777899999999999998753 44    47888875433 234567888999999999999999999875 456789


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ++||+++|+|.+++....  ..+++.....++.||+.||.|||+.+   ++||||||+|||+++++.+||+|||+++.+.
T Consensus        86 i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            999999999999996532  35899999999999999999999987   9999999999999999999999999999775


Q ss_pred             CC
Q 005206          696 GD  697 (709)
Q Consensus       696 ~~  697 (709)
                      ..
T Consensus       161 ~~  162 (279)
T cd05111         161 PD  162 (279)
T ss_pred             CC
Confidence            43

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.88  E-value=5.4e-22  Score=208.07  Aligned_cols=151  Identities=35%  Similarity=0.596  Sum_probs=131.3

Q ss_pred             cCcCcceeecccCceEEEEEEEcCC------cEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEG------QEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g------~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  614 (709)
                      ++|+..+.||+|+||.||+|.....      ..||+|.+.... .....+|.+|+.++.+++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            3577788999999999999987542      579999986543 334567999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC
Q 005206          615 LVYEYMENRSLDSVIFDKAR-------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM  681 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~  681 (709)
                      ++|||+++++|.+++.....             ...+++...+.++.|++.||.|||+.+   ++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999999865321             135788999999999999999999997   99999999999999999


Q ss_pred             cEEEEecCCceeeC
Q 005206          682 TPKISDFGMARIFG  695 (709)
Q Consensus       682 ~~KI~DFGla~~l~  695 (709)
                      .+||+|||+++...
T Consensus       162 ~~~L~dfg~~~~~~  175 (283)
T cd05048         162 TVKISDFGLSRDIY  175 (283)
T ss_pred             cEEECCCcceeecc
Confidence            99999999998753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.88  E-value=5e-22  Score=212.68  Aligned_cols=141  Identities=34%  Similarity=0.441  Sum_probs=125.3

Q ss_pred             eeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      +.||+|+||.||++.... ++.||||++.+.   .....+.+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999998865 789999999753   234456778899999888 799999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      |+|..++.+.   ..+++.....++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  146 (318)
T cd05570          81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG  146 (318)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeec
Confidence            9999888543   24899999999999999999999987   999999999999999999999999999753

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.88  E-value=3.1e-22  Score=216.61  Aligned_cols=151  Identities=29%  Similarity=0.465  Sum_probs=128.4

Q ss_pred             cCcCcceeecccCceEEEEEEE------cCCcEEEEEEeccCC-ccchHHHHHHHHHHHhc-CCCceeeEEEEEEeC-Ce
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEM-DE  612 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~-~~  612 (709)
                      ++|...+.||+|+||.||+|..      ..++.||||++.... ......+.+|+.++.++ +||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            5788889999999999999974      246789999996543 33456788999999999 789999999988754 45


Q ss_pred             eEEEEEccCCCCHHHHHhccCC----------------------------------------------------------
Q 005206          613 KMLVYEYMENRSLDSVIFDKAR----------------------------------------------------------  634 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------------------  634 (709)
                      .++||||+++|+|.+++.....                                                          
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            7899999999999999864210                                                          


Q ss_pred             ------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          635 ------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       635 ------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                            ...+++.++..++.||++||+|||+++   |+||||||+|||+++++.+||+|||+++.+.
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~  230 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY  230 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccc
Confidence                  123688889999999999999999987   9999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.88  E-value=5.9e-22  Score=206.37  Aligned_cols=149  Identities=29%  Similarity=0.526  Sum_probs=125.7

Q ss_pred             CcceeecccCceEEEEEEEcCCc---EEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeC------Cee
Q 005206          545 TDYNKLGQGGFGIVYKGRLLEGQ---EIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM------DEK  613 (709)
Q Consensus       545 ~~~~~LG~G~fG~Vykg~~~~g~---~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~  613 (709)
                      ...++||+|+||.||+|......   .+|+|.++..  .....+.|..|+.++.+++|+||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            34578999999999999986532   5899988653  234467899999999999999999999988543      246


Q ss_pred             EEEEEccCCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCC
Q 005206          614 MLVYEYMENRSLDSVIFDKA---RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGl  690 (709)
                      +++|||+++|+|.+++....   ....+++.....++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence            89999999999999874322   2345899999999999999999999987   99999999999999999999999999


Q ss_pred             ceeeCC
Q 005206          691 ARIFGG  696 (709)
Q Consensus       691 a~~l~~  696 (709)
                      ++.+..
T Consensus       159 ~~~~~~  164 (272)
T cd05075         159 SKKIYN  164 (272)
T ss_pred             ccccCc
Confidence            997643

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.88  E-value=4.4e-22  Score=208.49  Aligned_cols=154  Identities=27%  Similarity=0.446  Sum_probs=134.2

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-----CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEe-CCee
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE-MDEK  613 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~  613 (709)
                      .++|...+.||+|+||.||+|...+     +..|++|++.... ....+.+.+|+.++.+++|+||+++++++.. +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678888999999999999999876     6789999886543 3446778999999999999999999999876 4678


Q ss_pred             EEEEEccCCCCHHHHHhccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEec
Q 005206          614 MLVYEYMENRSLDSVIFDKARS-----SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDF  688 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DF  688 (709)
                      ++++||+++++|.+++......     ..+++.+++.++.||+.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999998654322     45899999999999999999999987   999999999999999999999999


Q ss_pred             CCceeeCCC
Q 005206          689 GMARIFGGD  697 (709)
Q Consensus       689 Gla~~l~~~  697 (709)
                      |+++.+.+.
T Consensus       162 g~~~~~~~~  170 (280)
T cd05043         162 ALSRDLFPM  170 (280)
T ss_pred             CCcccccCC
Confidence            999976433

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.88  E-value=5e-22  Score=206.71  Aligned_cols=151  Identities=32%  Similarity=0.532  Sum_probs=132.3

Q ss_pred             cCcCcceeecccCceEEEEEEEcC----CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      .+|...+.||+|+||.||+|....    ...+|+|.+.... ....+.|.+|+.++.+++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            467788999999999999998742    3379999886542 33456899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+++++|.+++....  ..+++.+.+.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            99999999999986532  35799999999999999999999987   99999999999999999999999999997754


Q ss_pred             C
Q 005206          697 D  697 (709)
Q Consensus       697 ~  697 (709)
                      .
T Consensus       159 ~  159 (267)
T cd05066         159 D  159 (267)
T ss_pred             c
Confidence            3

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.88  E-value=6.5e-22  Score=208.86  Aligned_cols=152  Identities=33%  Similarity=0.501  Sum_probs=132.8

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-----------------CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-----------------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRL  603 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-----------------g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l  603 (709)
                      ++|...++||+|+||.||++...+                 +..||+|++.... ....++|.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            567888999999999999997653                 2458999987543 3456789999999999999999999


Q ss_pred             EEEEEeCCeeEEEEEccCCCCHHHHHhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCE
Q 005206          604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKAR--------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNI  675 (709)
Q Consensus       604 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NI  675 (709)
                      ++++...+..++++||+++++|.+++.+...        ...+++..++.++.|++.||+|||+.+   |+||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhce
Confidence            9999999999999999999999999965431        225899999999999999999999987   99999999999


Q ss_pred             EEcCCCcEEEEecCCceeeCC
Q 005206          676 LLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       676 Ll~~~~~~KI~DFGla~~l~~  696 (709)
                      +++.++.+||+|||+++.+..
T Consensus       162 li~~~~~~~l~dfg~~~~~~~  182 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYS  182 (296)
T ss_pred             eecCCCceEEccccceeeccc
Confidence            999999999999999987643

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.88  E-value=8.8e-22  Score=204.90  Aligned_cols=150  Identities=31%  Similarity=0.533  Sum_probs=128.6

Q ss_pred             cCcceeecccCceEEEEEEEcC----CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCe-----
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE-----  612 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-----  612 (709)
                      |...+.||+|+||.||+|.+..    +..||+|+++..  .....+++.+|+..+..++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4556789999999999998753    367999998643  23345789999999999999999999999876654     


Q ss_pred             -eEEEEEccCCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEec
Q 005206          613 -KMLVYEYMENRSLDSVIFDKA---RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDF  688 (709)
Q Consensus       613 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DF  688 (709)
                       .++++||+++|+|..++....   ....+++.....++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             699999999999999986532   2235899999999999999999999987   999999999999999999999999


Q ss_pred             CCceeeCC
Q 005206          689 GMARIFGG  696 (709)
Q Consensus       689 Gla~~l~~  696 (709)
                      |+++.+..
T Consensus       158 g~~~~~~~  165 (273)
T cd05035         158 GLSKKIYS  165 (273)
T ss_pred             cceeeccc
Confidence            99997643

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.88  E-value=1e-21  Score=206.75  Aligned_cols=148  Identities=31%  Similarity=0.419  Sum_probs=130.2

Q ss_pred             cCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      |+..+.||+|+||+||++.... ++.+|+|.+....   ....+.+.+|++++.+++|+||+++.+.+..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            5667899999999999998864 8899999986532   22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      +++++|.+++.... ...+++.....++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.+.
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05632          82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIP  153 (285)
T ss_pred             ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence            99999998886532 235899999999999999999999987   9999999999999999999999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=5.8e-22  Score=213.24  Aligned_cols=139  Identities=27%  Similarity=0.335  Sum_probs=120.4

Q ss_pred             ecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhc---CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKL---QHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       550 LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      ||+|+||.||+|+... ++.||||++.+..   ......+..|..++.+.   +||||+++++.+.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            7999999999998865 8899999986432   22334556677777665   699999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      |+|..++.+.   ..+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~  146 (330)
T cd05586          81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKAN  146 (330)
T ss_pred             ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence            9999888543   34889999999999999999999997   999999999999999999999999999864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.88  E-value=5.9e-22  Score=204.08  Aligned_cols=143  Identities=31%  Similarity=0.521  Sum_probs=127.3

Q ss_pred             eeecccCceEEEEEEEc-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCCH
Q 005206          548 NKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL  625 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  625 (709)
                      ++||+|+||.||+|.+. +++.+|+|.+.... ......|.+|++++.+++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36999999999999886 58899999886443 33456799999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       626 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      .+++...  ...+++.....++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+.
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  145 (252)
T cd05084          81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE  145 (252)
T ss_pred             HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence            9998543  235889999999999999999999987   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.88  E-value=7.3e-22  Score=208.89  Aligned_cols=152  Identities=31%  Similarity=0.501  Sum_probs=131.3

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-----------------CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-----------------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRL  603 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-----------------g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l  603 (709)
                      ++|+..++||+|+||.||++...+                 ...+|+|++.... ....++|.+|+.++.+++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            568888999999999999985431                 3468999986543 3345789999999999999999999


Q ss_pred             EEEEEeCCeeEEEEEccCCCCHHHHHhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCE
Q 005206          604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKAR--------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNI  675 (709)
Q Consensus       604 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NI  675 (709)
                      ++++...+..++||||+++++|.+++.+...        ...+++.+...++.||+.||+|||+.+   ++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            9999999999999999999999999865321        124778899999999999999999997   99999999999


Q ss_pred             EEcCCCcEEEEecCCceeeCC
Q 005206          676 LLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       676 Ll~~~~~~KI~DFGla~~l~~  696 (709)
                      |++.++.+||+|||+++.+..
T Consensus       162 li~~~~~~~l~dfg~~~~~~~  182 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYS  182 (296)
T ss_pred             EEcCCCCEEeccCcccccccC
Confidence            999999999999999987643

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.88  E-value=7.9e-22  Score=207.90  Aligned_cols=151  Identities=30%  Similarity=0.491  Sum_probs=129.5

Q ss_pred             CcCcceeecccCceEEEEEEEcC------CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      +|...+.||+|+||.||+|....      ...+|+|.+.... ....+++.+|+.++.+++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            35667899999999999998642      2578888886543 2345679999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCC
Q 005206          616 VYEYMENRSLDSVIFDKA---------------------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASN  674 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~N  674 (709)
                      ++||+++++|.+++....                     ....+++...+.++.|++.||+|||+.+   |+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999986421                     1134789999999999999999999987   9999999999


Q ss_pred             EEEcCCCcEEEEecCCceeeCC
Q 005206          675 ILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       675 ILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ||+++++.+||+|||+++.+..
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~  179 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYE  179 (290)
T ss_pred             EEEcCCCcEEeccccccccccC
Confidence            9999999999999999987643

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.88  E-value=6.9e-22  Score=209.91  Aligned_cols=152  Identities=29%  Similarity=0.519  Sum_probs=131.7

Q ss_pred             cCcCcceeecccCceEEEEEEEc--------CCcEEEEEEeccC-CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCC
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL--------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMD  611 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~  611 (709)
                      ++|...+.||+|+||.||+++..        ++..||+|.+... .....+++.+|+.++..+ +||||+++++++....
T Consensus        15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   94 (304)
T cd05101          15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   94 (304)
T ss_pred             HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence            56777889999999999999742        2357999988643 234567899999999999 8999999999999999


Q ss_pred             eeEEEEEccCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc
Q 005206          612 EKMLVYEYMENRSLDSVIFDKAR-------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD  678 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~  678 (709)
                      ..++||||+++|+|.+++.+...             ...+++.+++.++.||+.||.|||+++   |+||||||+|||++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~  171 (304)
T cd05101          95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVT  171 (304)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEc
Confidence            99999999999999999975321             234788999999999999999999997   99999999999999


Q ss_pred             CCCcEEEEecCCceeeCC
Q 005206          679 KEMTPKISDFGMARIFGG  696 (709)
Q Consensus       679 ~~~~~KI~DFGla~~l~~  696 (709)
                      +++.+||+|||+++.+..
T Consensus       172 ~~~~~kl~D~g~~~~~~~  189 (304)
T cd05101         172 ENNVMKIADFGLARDVNN  189 (304)
T ss_pred             CCCcEEECCCccceeccc
Confidence            999999999999997743

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.88  E-value=6.8e-23  Score=201.48  Aligned_cols=162  Identities=29%  Similarity=0.415  Sum_probs=137.6

Q ss_pred             HHhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC----cc----chHHHHHHHHHHHhc-CCCceeeEEEEEE
Q 005206          539 RATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS----GQ----GIEEFKNEVRLIAKL-QHRNLVRLLGCCV  608 (709)
Q Consensus       539 ~~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~----~~----~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~  608 (709)
                      ..-++|...+.||.|..+.|-++.++. +++.|+|++....    ..    ..++-+.|+.+|+++ -||+|+++.+++.
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            334567777899999999999887765 7899999885431    11    234567899999998 6999999999999


Q ss_pred             eCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEec
Q 005206          609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDF  688 (709)
Q Consensus       609 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DF  688 (709)
                      .....++|+|.|+.|.|.++|.+.   -.++++...+|+.|+..|+.|||..+   ||||||||+|||+|++.++||+||
T Consensus        94 s~sF~FlVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence            999999999999999999999543   35899999999999999999999998   999999999999999999999999


Q ss_pred             CCceeeCCCCccccccceecC
Q 005206          689 GMARIFGGDQTEQNTKRVVGT  709 (709)
Q Consensus       689 Gla~~l~~~~~~~~~~~~~GT  709 (709)
                      |+|..+.+...   ...+|||
T Consensus       168 GFa~~l~~Gek---LrelCGT  185 (411)
T KOG0599|consen  168 GFACQLEPGEK---LRELCGT  185 (411)
T ss_pred             ceeeccCCchh---HHHhcCC
Confidence            99999976643   3446776

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.88  E-value=8e-22  Score=230.96  Aligned_cols=149  Identities=27%  Similarity=0.409  Sum_probs=133.1

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...++||+|+||.||+|.+. .++.||||++....   ......+..|+.++..++||||+++++++...+..+|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999987 48899999996532   233467899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ||+++++|.+++...   ..+++...+.|+.||+.||.|||.++   ||||||||+||||+.++.+||+|||+++....
T Consensus        84 Ey~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~  156 (669)
T cd05610          84 EYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN  156 (669)
T ss_pred             eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence            999999999998543   24788889999999999999999987   99999999999999999999999999997643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.88  E-value=8.2e-22  Score=207.97  Aligned_cols=152  Identities=30%  Similarity=0.534  Sum_probs=132.7

Q ss_pred             cCcCcceeecccCceEEEEEEEc------CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      .+|...+.||+|+||.||+++..      ++..+++|.+........+.+.+|+.++.+++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            35677789999999999999753      245689999876555556789999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc
Q 005206          616 VYEYMENRSLDSVIFDKA-------------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT  682 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~  682 (709)
                      ||||+++++|.+++....             ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999996532             1234899999999999999999999997   999999999999999999


Q ss_pred             EEEEecCCceeeCC
Q 005206          683 PKISDFGMARIFGG  696 (709)
Q Consensus       683 ~KI~DFGla~~l~~  696 (709)
                      +||+|||+++....
T Consensus       162 ~~l~dfg~a~~~~~  175 (291)
T cd05094         162 VKIGDFGMSRDVYS  175 (291)
T ss_pred             EEECCCCcccccCC
Confidence            99999999986644

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.88  E-value=2.8e-22  Score=208.08  Aligned_cols=149  Identities=25%  Similarity=0.293  Sum_probs=133.3

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      +.|..++.||.|.-|+||++++.+ +..+|+|++.+.   ..+...+...|-+||+.++||.++.|++.+...+..+|||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            346677899999999999999987 588999999765   3455667889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      |||+||+|...+++ +....+++.....++..|+.||+|||-.|   ||.|||||+||||-++|++-|+||.|+...
T Consensus       157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence            99999999987754 44566888888889999999999999998   999999999999999999999999999865

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.88  E-value=8.7e-24  Score=209.94  Aligned_cols=158  Identities=30%  Similarity=0.502  Sum_probs=140.7

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      -|.++.+||+|+||.|||+.++. |+.||||++..  +....++..|+.+|.+.+.|++|+.+|.+......++|||||.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            36677899999999999998876 89999999854  4457899999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCCccc
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~~~~  701 (709)
                      .|++.++++.  +.++|.+.++..++...++||+|||...   -||||||+.||||+.++.+||+|||.|-.+.+.-.++
T Consensus       112 AGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR  186 (502)
T KOG0574|consen  112 AGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR  186 (502)
T ss_pred             CCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence            9999999854  4457999999999999999999999976   8999999999999999999999999999987655554


Q ss_pred             cccceecC
Q 005206          702 NTKRVVGT  709 (709)
Q Consensus       702 ~~~~~~GT  709 (709)
                      ++  ++||
T Consensus       187 NT--VIGT  192 (502)
T KOG0574|consen  187 NT--VIGT  192 (502)
T ss_pred             Cc--cccC
Confidence            44  7776

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.88  E-value=5.6e-22  Score=217.05  Aligned_cols=148  Identities=28%  Similarity=0.452  Sum_probs=128.1

Q ss_pred             CcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----eeE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD-----EKM  614 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~  614 (709)
                      +|+..++||+|+||.||++... +++.||||++....  ....+++.+|++++..++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            3677789999999999999875 58999999986532  234567899999999999999999999998776     789


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      +|+||+. ++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+..
T Consensus        81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999997 5787777432   35899999999999999999999997   999999999999999999999999999876


Q ss_pred             CCC
Q 005206          695 GGD  697 (709)
Q Consensus       695 ~~~  697 (709)
                      ...
T Consensus       154 ~~~  156 (372)
T cd07853         154 EPD  156 (372)
T ss_pred             ccC
Confidence            443

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.88  E-value=6.6e-22  Score=208.62  Aligned_cols=153  Identities=29%  Similarity=0.511  Sum_probs=133.1

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC------CcEEEEEEeccC-CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCe
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDE  612 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~  612 (709)
                      .++|+..+.||+|+||.||++....      ...+|+|.+... ......++.+|+.++.++ +|+||+++++++...+.
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            4568888999999999999998743      357999988654 234456789999999999 89999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC
Q 005206          613 KMLVYEYMENRSLDSVIFDK-------------ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK  679 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~  679 (709)
                      .+++|||+++|+|.+++...             .....+++..++.++.|++.||.|||+.+   |+||||||+||+++.
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~  167 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTE  167 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcC
Confidence            99999999999999998642             12345899999999999999999999987   999999999999999


Q ss_pred             CCcEEEEecCCceeeCC
Q 005206          680 EMTPKISDFGMARIFGG  696 (709)
Q Consensus       680 ~~~~KI~DFGla~~l~~  696 (709)
                      ++.+||+|||+++.+..
T Consensus       168 ~~~~kL~Dfg~~~~~~~  184 (293)
T cd05053         168 DHVMKIADFGLARDIHH  184 (293)
T ss_pred             CCeEEeCcccccccccc
Confidence            99999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.88  E-value=1.3e-21  Score=205.06  Aligned_cols=143  Identities=28%  Similarity=0.395  Sum_probs=125.0

Q ss_pred             ecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCCH
Q 005206          550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL  625 (709)
Q Consensus       550 LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  625 (709)
                      ||+|+||.||++.... ++.+|+|++....   ....+.+..|++++.+++||||+++++.+.+....++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            7999999999998765 8999999986431   22344566799999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       626 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      .+++.... ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++..+..
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~  147 (277)
T cd05607          81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD  147 (277)
T ss_pred             HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence            98885433 234889999999999999999999987   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.88  E-value=1.1e-21  Score=209.00  Aligned_cols=149  Identities=27%  Similarity=0.356  Sum_probs=130.9

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ++|...+.||+|+||.||++.... +..+|+|.+.... ....+++.+|++++.+++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            368888999999999999998764 7788998886442 33356789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      +++++|.+++...   ..+++.....++.||++||.|||+..  +++||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (308)
T cd06615          81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  151 (308)
T ss_pred             cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence            9999999998653   34889999999999999999999842  39999999999999999999999999998663

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.87  E-value=8.4e-22  Score=204.56  Aligned_cols=151  Identities=31%  Similarity=0.520  Sum_probs=133.7

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      ..|...++||+|+||.||+|...+ ++.||+|++... ....+++.+|++++.+++|+||+++++++...+..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            346777899999999999998765 788999988643 345678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ++++|.+++.... ...+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++.+...
T Consensus        85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            9999999986533 345899999999999999999999987   999999999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.87  E-value=4.6e-22  Score=214.79  Aligned_cols=153  Identities=31%  Similarity=0.488  Sum_probs=129.2

Q ss_pred             cCcCcceeecccCceEEEEEEEcC------CcEEEEEEeccCC-ccchHHHHHHHHHHHhc-CCCceeeEEEEEEeC-Ce
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEM-DE  612 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~-~~  612 (709)
                      ++|...+.||+|+||.||+|...+      ++.||+|++.... ....+.+..|+.++.++ +|+||++++++|... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            468888999999999999996432      4689999986443 23356788999999999 899999999988754 56


Q ss_pred             eEEEEEccCCCCHHHHHhccCC----------------------------------------------------------
Q 005206          613 KMLVYEYMENRSLDSVIFDKAR----------------------------------------------------------  634 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------------------  634 (709)
                      .+++|||+++++|.+++.....                                                          
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            7899999999999999854221                                                          


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          635 SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       635 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ...++|..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+...
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~  226 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKD  226 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccC
Confidence            125899999999999999999999987   999999999999999999999999999976443

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.87  E-value=1.4e-22  Score=217.89  Aligned_cols=151  Identities=28%  Similarity=0.489  Sum_probs=131.7

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC---C--cEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE---G--QEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~---g--~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  614 (709)
                      .+.....++||+|-||.||+|...+   |  -.||||..+.+ .....+.|+.|..+|++++|||||+|+|+|.+ ...+
T Consensus       388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W  466 (974)
T KOG4257|consen  388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW  466 (974)
T ss_pred             hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence            3445566789999999999998643   3  25899988764 44557889999999999999999999999986 5689


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      ||||.++.|.|.+||..+.  ..++..+...++.||..+|.|||+..   +|||||.++|||+.+...+||+||||+|.+
T Consensus       467 ivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~  541 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYL  541 (974)
T ss_pred             EEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhc
Confidence            9999999999999996543  34888899999999999999999987   999999999999999999999999999988


Q ss_pred             CCC
Q 005206          695 GGD  697 (709)
Q Consensus       695 ~~~  697 (709)
                      .++
T Consensus       542 ed~  544 (974)
T KOG4257|consen  542 EDD  544 (974)
T ss_pred             ccc
Confidence            655

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.87  E-value=7.7e-22  Score=206.07  Aligned_cols=152  Identities=31%  Similarity=0.491  Sum_probs=132.5

Q ss_pred             cCcCcceeecccCceEEEEEEEcC------CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  614 (709)
                      ++|...+.||+|+||.||+|....      +..||+|.+.... .....++.+|+.++..++||||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            578888999999999999998753      3689999986543 234567899999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEe
Q 005206          615 LVYEYMENRSLDSVIFDKAR-------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISD  687 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~D  687 (709)
                      +||||+++|+|.+++.....       ...+++..++.++.||+.||.|||+.+   |+||||||+||++++++.+||+|
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECC
Confidence            99999999999999865321       234789999999999999999999987   99999999999999999999999


Q ss_pred             cCCceeeCC
Q 005206          688 FGMARIFGG  696 (709)
Q Consensus       688 FGla~~l~~  696 (709)
                      ||+++.+..
T Consensus       163 fg~~~~~~~  171 (277)
T cd05032         163 FGMTRDIYE  171 (277)
T ss_pred             cccchhhcc
Confidence            999986643

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.87  E-value=1.3e-21  Score=205.31  Aligned_cols=147  Identities=30%  Similarity=0.463  Sum_probs=131.8

Q ss_pred             cCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      |+..+.||+|+||.||+|.... +..+++|.+........+.+.+|+.++..++||||+++++.+...+..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            5566789999999999999875 678899988766556677899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ++|..++.+.  ...+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+++...
T Consensus        87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  154 (282)
T cd06643          87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT  154 (282)
T ss_pred             CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence            9999887542  235899999999999999999999987   9999999999999999999999999997653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.87  E-value=8.7e-22  Score=205.11  Aligned_cols=153  Identities=33%  Similarity=0.527  Sum_probs=132.5

Q ss_pred             HHhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhc-CCCceeeEEEEEEeC------
Q 005206          539 RATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEM------  610 (709)
Q Consensus       539 ~~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~------  610 (709)
                      .+++.|...+.||+|+||.||+|.... ++.||+|++... .....++..|+.++.++ +|+||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            356778888999999999999998865 788999998643 34456889999999998 799999999998763      


Q ss_pred             CeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCC
Q 005206          611 DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (709)
Q Consensus       611 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGl  690 (709)
                      ...++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            4578999999999999998653 2345889999999999999999999987   99999999999999999999999999


Q ss_pred             ceeeCC
Q 005206          691 ARIFGG  696 (709)
Q Consensus       691 a~~l~~  696 (709)
                      ++.+..
T Consensus       158 ~~~~~~  163 (272)
T cd06637         158 SAQLDR  163 (272)
T ss_pred             ceeccc
Confidence            987643

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.87  E-value=1.5e-21  Score=204.76  Aligned_cols=149  Identities=31%  Similarity=0.566  Sum_probs=131.2

Q ss_pred             CcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +|+..+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|+.++.+++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            3677789999999999999986 48899999986432  22356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ++ ++|.+++........+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++.+.
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  152 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG  152 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence            97 689888865444456899999999999999999999987   9999999999999999999999999998664

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.87  E-value=9.7e-22  Score=204.29  Aligned_cols=148  Identities=26%  Similarity=0.475  Sum_probs=133.0

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      ++|...++||+|+||.||+|.... ++.||+|.++.........+.+|+.++..++||||+++++.+...+..++|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            467777899999999999998764 7899999987655555667889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ++++|.+++...   ..+++.+...++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+.
T Consensus        89 ~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd06645          89 GGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQIT  157 (267)
T ss_pred             CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence            999999988543   24889999999999999999999997   9999999999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.87  E-value=1.6e-21  Score=205.29  Aligned_cols=149  Identities=32%  Similarity=0.422  Sum_probs=130.3

Q ss_pred             cCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      |+..+.||+|+||.||++.... ++.+|||++....   ....+.+.+|+.++.+++|+|++.+++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            5667899999999999998864 7899999986542   22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++.....
T Consensus        82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05630          82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE  154 (285)
T ss_pred             cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence            99999999885432 234889999999999999999999987   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.87  E-value=7.6e-22  Score=205.69  Aligned_cols=142  Identities=29%  Similarity=0.467  Sum_probs=121.7

Q ss_pred             eecccCceEEEEEEEcCC---cEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCC
Q 005206          549 KLGQGGFGIVYKGRLLEG---QEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRS  624 (709)
Q Consensus       549 ~LG~G~fG~Vykg~~~~g---~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  624 (709)
                      +||+|+||.||+++..++   ..+++|.+.... ....+.|.+|+.++..++||||+++++.|.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            699999999999976543   345677665433 3446789999999999999999999999999999999999999999


Q ss_pred             HHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          625 LDSVIFDKAR-SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       625 L~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      |.+++.+... ...+++.....++.||+.||+|||+.+   ++||||||+|||++.++.+||+|||+++.
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~  148 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS  148 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence            9999965422 234677778899999999999999987   99999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.87  E-value=8.6e-22  Score=203.30  Aligned_cols=142  Identities=28%  Similarity=0.481  Sum_probs=123.8

Q ss_pred             eeecccCceEEEEEEEcCCc-----------EEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          548 NKLGQGGFGIVYKGRLLEGQ-----------EIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~g~-----------~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      +.||+|+||.||+|.+.+..           .+++|.+...... ..+|.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            36999999999999987533           5778877544333 6889999999999999999999999988 788999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-------cEEEEecC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-------TPKISDFG  689 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-------~~KI~DFG  689 (709)
                      |||+++|+|.+++.....  .+++..++.++.||+.||+|||+++   |+||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            999999999999865432  5889999999999999999999987   99999999999999888       79999999


Q ss_pred             CceeeCC
Q 005206          690 MARIFGG  696 (709)
Q Consensus       690 la~~l~~  696 (709)
                      +++.+..
T Consensus       154 ~a~~~~~  160 (259)
T cd05037         154 IPITVLS  160 (259)
T ss_pred             ccccccc
Confidence            9987543

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.87  E-value=9.8e-22  Score=204.63  Aligned_cols=149  Identities=31%  Similarity=0.541  Sum_probs=131.4

Q ss_pred             CcCcceeecccCceEEEEEEEcC-C---cEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-G---QEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g---~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      .|...+.||+|+||.||+|.+.. +   ..||||.+... .....++|..|+.++.+++||||+++++++.++...++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            46777899999999999998764 2   36999998654 3345678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ||+++++|.+++...  ...+++.+++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++.+..
T Consensus        85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            999999999998653  235889999999999999999999987   99999999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=8.5e-22  Score=206.35  Aligned_cols=150  Identities=29%  Similarity=0.443  Sum_probs=135.3

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      .++|...+.||+|+||.||++... +++.+|+|.+........+.|..|+.++.+++||||+++++.+......++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            456888899999999999999886 4789999998766556677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      +++++|.+++.+..  ..+++.....++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++....
T Consensus        84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~  154 (280)
T cd06611          84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNK  154 (280)
T ss_pred             cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence            99999999986532  35899999999999999999999997   9999999999999999999999999987654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.87  E-value=9e-22  Score=203.13  Aligned_cols=145  Identities=34%  Similarity=0.543  Sum_probs=128.5

Q ss_pred             cCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccch--HHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGI--EEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~--~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      |+..+.||+|+||.||+++... ++.+|+|.+........  .....|+.++.+++||||+++++++.+.+..++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            4567899999999999999877 56899999976543322  23456999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      ++++|.+++...   ..+++..+..++.||++||.|||+.+   |+|+||||+||++++++.+||+|||++..+
T Consensus        81 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~  148 (260)
T PF00069_consen   81 PGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL  148 (260)
T ss_dssp             TTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred             cccccccccccc---cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence            999999999722   34899999999999999999999997   999999999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.87  E-value=1.2e-21  Score=203.34  Aligned_cols=149  Identities=31%  Similarity=0.507  Sum_probs=130.7

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      ++|...++||+|+||.||+|++.+...||+|++... ....++|.+|+.++.+++||||+++++.+. .+..++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            568888999999999999999877778999998643 234568999999999999999999999874 456899999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      +|+|.+++.+.. ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++.+..
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~  154 (262)
T cd05071          84 KGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED  154 (262)
T ss_pred             CCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence            999999996532 235789999999999999999999987   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.87  E-value=7.5e-22  Score=207.11  Aligned_cols=151  Identities=30%  Similarity=0.492  Sum_probs=129.8

Q ss_pred             CcCcceeecccCceEEEEEEEcC------CcEEEEEEeccCCcc-chHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      .|...++||+|+||.||+|...+      ++.||+|++...... ..++|.+|+.++.+++||||+++++++.+.+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            35666799999999999998643      468999999754332 34678999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc
Q 005206          616 VYEYMENRSLDSVIFDKA-------------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT  682 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~  682 (709)
                      ++||+++++|.+++....             ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence            999999999999985321             1234788899999999999999999987   999999999999999999


Q ss_pred             EEEEecCCceeeCC
Q 005206          683 PKISDFGMARIFGG  696 (709)
Q Consensus       683 ~KI~DFGla~~l~~  696 (709)
                      +||+|||+++.+..
T Consensus       163 ~kl~Dfg~~~~~~~  176 (283)
T cd05091         163 VKISDLGLFREVYA  176 (283)
T ss_pred             eEeccccccccccc
Confidence            99999999987643

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.87  E-value=1.4e-21  Score=201.88  Aligned_cols=148  Identities=31%  Similarity=0.562  Sum_probs=133.3

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      ++|...+.||+|+||.||++... ++.||+|.+..... ..+++.+|+.++.+++|+||+++++++.+.+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            46777889999999999999874 78999999965533 57789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      +++|.+++..... ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~  153 (256)
T cd05039          84 KGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS  153 (256)
T ss_pred             CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence            9999999865432 35899999999999999999999997   9999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.87  E-value=1.2e-21  Score=203.64  Aligned_cols=144  Identities=27%  Similarity=0.415  Sum_probs=123.8

Q ss_pred             eeecccCceEEEEEEEcC-------------CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 005206          548 NKLGQGGFGIVYKGRLLE-------------GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-------------g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  614 (709)
                      +.||+|+||.||+|+...             ...|++|.+..........|.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998532             2258899886655555668999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc-------EEEEe
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT-------PKISD  687 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~-------~KI~D  687 (709)
                      +||||+++|+|+.++...  ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.       +|++|
T Consensus        81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            999999999999888543  235899999999999999999999987   999999999999987664       89999


Q ss_pred             cCCceeeCC
Q 005206          688 FGMARIFGG  696 (709)
Q Consensus       688 FGla~~l~~  696 (709)
                      ||++..+..
T Consensus       156 ~g~~~~~~~  164 (262)
T cd05077         156 PGIPITVLS  164 (262)
T ss_pred             CCCCccccC
Confidence            999986643

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.87  E-value=1.8e-21  Score=206.16  Aligned_cols=149  Identities=29%  Similarity=0.482  Sum_probs=134.7

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      .+|...+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            57888899999999999999875 58999999997655555678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ++++|.+++.+    ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.....
T Consensus        99 ~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            99999998843    24788999999999999999999987   999999999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.87  E-value=1.1e-21  Score=205.75  Aligned_cols=151  Identities=31%  Similarity=0.529  Sum_probs=132.7

Q ss_pred             cCcCcceeecccCceEEEEEEEc------CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      .++...++||+|+||.||++...      ++..+|+|.+........+.|.+|++++.+++|+||+++++++.+.+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            35667789999999999999743      255789999876666667789999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcE
Q 005206          616 VYEYMENRSLDSVIFDKAR------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  683 (709)
                      +|||+++++|.+++.....            ...+++..++.++.||+.||+|||+.+   ++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999999865321            134889999999999999999999987   9999999999999999999


Q ss_pred             EEEecCCceeeC
Q 005206          684 KISDFGMARIFG  695 (709)
Q Consensus       684 KI~DFGla~~l~  695 (709)
                      ||+|||+++.+.
T Consensus       162 kL~dfg~~~~~~  173 (280)
T cd05092         162 KIGDFGMSRDIY  173 (280)
T ss_pred             EECCCCceeEcC
Confidence            999999998654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.87  E-value=1.7e-21  Score=205.36  Aligned_cols=150  Identities=33%  Similarity=0.413  Sum_probs=133.7

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|+..+.||+|+||.||++.... ++.+|+|.+....   ....+.+.+|++++.+++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            367888999999999999998864 7899999986432   234567899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   |+|+||+|+||+++.++.+||+|||+++.+...
T Consensus        81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            999999999998654   35889999999999999999999987   999999999999999999999999999877543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.87  E-value=1.3e-21  Score=205.51  Aligned_cols=150  Identities=31%  Similarity=0.544  Sum_probs=130.7

Q ss_pred             cCcCcceeecccCceEEEEEEEc-----CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeC--Cee
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-----EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEK  613 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-----~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~  613 (709)
                      ..|+..++||+|+||.||+++..     .+..||+|.+.... ....+++.+|+.++++++||||+++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            35678889999999999999752     36789999986543 34457899999999999999999999999875  567


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ++||||+++++|.+++.+..  ..+++..++.++.||+.||+|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            89999999999999985432  35899999999999999999999997   99999999999999999999999999987


Q ss_pred             eCC
Q 005206          694 FGG  696 (709)
Q Consensus       694 l~~  696 (709)
                      +..
T Consensus       159 ~~~  161 (284)
T cd05079         159 IET  161 (284)
T ss_pred             ccc
Confidence            644

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.87  E-value=1.5e-21  Score=204.42  Aligned_cols=149  Identities=32%  Similarity=0.527  Sum_probs=128.6

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCc----EEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQ----EIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      +.|...++||+|+||.||+|+.. +++    .||+|++... .....+++.+|+.++.+++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            46778899999999999999864 344    4899998654 33346689999999999999999999999975 45789


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ++||+++|+|.+++.+..  ..+++...+.++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+.
T Consensus        86 ~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          86 VTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence            999999999999986532  35899999999999999999999987   9999999999999999999999999999875


Q ss_pred             C
Q 005206          696 G  696 (709)
Q Consensus       696 ~  696 (709)
                      .
T Consensus       161 ~  161 (279)
T cd05109         161 I  161 (279)
T ss_pred             c
Confidence            3

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.87  E-value=2.3e-21  Score=204.53  Aligned_cols=149  Identities=30%  Similarity=0.447  Sum_probs=134.4

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      +.|...++||+|+||.||+|+... ++.+++|.+........+++.+|+.++.+++|+||+++++.+......++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            567788899999999999999865 7899999997666666788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ++++|..++.+..  ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        92 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  161 (292)
T cd06644          92 PGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNV  161 (292)
T ss_pred             CCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecc
Confidence            9999988875432  34899999999999999999999987   9999999999999999999999999987643

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.87  E-value=2.2e-21  Score=199.91  Aligned_cols=151  Identities=29%  Similarity=0.465  Sum_probs=134.1

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +|+..+.||+|+||.||++.... ++.|++|.+...  .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            36677899999999999998864 789999988643  334567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      +++++|.+++.... ...+++.....++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.+...
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            99999999987542 345899999999999999999999987   999999999999999999999999999977543

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.87  E-value=1.8e-21  Score=201.68  Aligned_cols=143  Identities=30%  Similarity=0.546  Sum_probs=123.8

Q ss_pred             eecccCceEEEEEEEc---CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCC
Q 005206          549 KLGQGGFGIVYKGRLL---EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRS  624 (709)
Q Consensus       549 ~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  624 (709)
                      .||+|+||.||+|.+.   .+..||+|++.... ....++|.+|+.++.+++||||+++++++. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999764   24579999986543 233567999999999999999999999885 457899999999999


Q ss_pred             HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          625 LDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       625 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      |.+++...  ...+++..++.++.||+.||.|||+++   ++||||||+|||++.++.+||+|||+++.+..+
T Consensus        81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  148 (257)
T cd05115          81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCC
Confidence            99998543  235899999999999999999999987   999999999999999999999999999876443

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.87  E-value=1.7e-21  Score=202.29  Aligned_cols=152  Identities=22%  Similarity=0.446  Sum_probs=133.1

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...++||+|+||.||+|+.. +++.||||++...   .......|.+|+.++++++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            46888899999999999999876 4889999987542   2333567899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          618 EYMENRSLDSVIFDKAR-SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ||+++++|.+++..... ...+++.....++.||++||.|||+++   ++|+||||+||+++.++.++|+|||+++.+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988854322 345788999999999999999999987   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.87  E-value=2.1e-21  Score=205.64  Aligned_cols=148  Identities=28%  Similarity=0.480  Sum_probs=133.6

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      .+|...+.||+|+||.||+|... +++.||+|.+........+.+.+|+.++..++|+||+++++.+..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            57888899999999999999865 47899999997665555678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ++++|.+++.+    ..+++.+...++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus       100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            99999998843    24789999999999999999999997   99999999999999999999999999986643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.87  E-value=1.8e-21  Score=202.39  Aligned_cols=150  Identities=32%  Similarity=0.600  Sum_probs=132.4

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-C---cEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-G---QEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g---~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      ++|+..+.||+|+||.||+|.+.. +   ..+|+|++... .....+++..|++++.+++|+||+++.+++.+.+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            467788999999999999998863 3   37999988654 234467899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+++++|.+++.+..  ..+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.+..
T Consensus        85 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          85 TEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            99999999999986432  35899999999999999999999987   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.87  E-value=1.1e-21  Score=208.58  Aligned_cols=149  Identities=34%  Similarity=0.571  Sum_probs=129.3

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-Cc--EEEEEEeccC-CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQ--EIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~--~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      ++|+..+.||+|+||.||+|.+.+ +.  .+|+|++... .....++|.+|+.++.++ +|+||+++++++.+.+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            567788899999999999998754 43  4688877643 234556899999999999 899999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcE
Q 005206          617 YEYMENRSLDSVIFDKAR-------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  683 (709)
                      |||+++++|.+++.....             ...+++.+++.++.||+.||+|||+.+   |+||||||+|||+++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            999999999999965321             235789999999999999999999987   9999999999999999999


Q ss_pred             EEEecCCcee
Q 005206          684 KISDFGMARI  693 (709)
Q Consensus       684 KI~DFGla~~  693 (709)
                      ||+|||+++.
T Consensus       164 kl~dfg~~~~  173 (303)
T cd05088         164 KIADFGLSRG  173 (303)
T ss_pred             EeCccccCcc
Confidence            9999999974

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.87  E-value=2.3e-21  Score=200.70  Aligned_cols=151  Identities=34%  Similarity=0.536  Sum_probs=135.6

Q ss_pred             hcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      .++|...++||+|+||.||++...+++.||||.+... ....+++.+|+.++.+++|+||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            3678888999999999999999888889999998643 344678999999999999999999999999989999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ++++|.+++.+.. ...+++.++..++.|++.||.|||+++   ++|+||||+||++++++.+||+|||+++.+..
T Consensus        84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccc
Confidence            9999999996532 235899999999999999999999997   99999999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.87  E-value=2.9e-21  Score=199.28  Aligned_cols=151  Identities=25%  Similarity=0.419  Sum_probs=134.0

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +|+..+.||+|+||.||.++... ++.+++|++...  .....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            47788999999999999998755 788999988643  344567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      +++++|.+++.+.. ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.+...
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~  154 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE  154 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence            99999999986542 345899999999999999999999987   999999999999999999999999999877544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.87  E-value=1.8e-21  Score=200.12  Aligned_cols=143  Identities=32%  Similarity=0.501  Sum_probs=127.8

Q ss_pred             eeecccCceEEEEEEEcCCcEEEEEEeccCCc-cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCCHH
Q 005206          548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLD  626 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~  626 (709)
                      ++||+|+||.||+|...+++.+|+|++..... .....|.+|+.++.+++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36999999999999988889999999865533 33457899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          627 SVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       627 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      +++....  ..+++..+..++.|++.+|.|||+++   ++||||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  144 (250)
T cd05085          81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQED  144 (250)
T ss_pred             HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecc
Confidence            9885432  34789999999999999999999987   9999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.87  E-value=1e-21  Score=216.48  Aligned_cols=146  Identities=23%  Similarity=0.324  Sum_probs=127.1

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC---CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~---g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ..+|...+.||+|+||.||++...+   ++.||+|.+...     +.+.+|++++.+++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            3578999999999999999997643   568999988542     34568999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+. ++|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       166 e~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9996 688888732   245899999999999999999999997   999999999999999999999999999877544


Q ss_pred             C
Q 005206          698 Q  698 (709)
Q Consensus       698 ~  698 (709)
                      .
T Consensus       239 ~  239 (392)
T PHA03207        239 P  239 (392)
T ss_pred             c
Confidence            3

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.87  E-value=1.4e-21  Score=207.67  Aligned_cols=152  Identities=31%  Similarity=0.482  Sum_probs=132.3

Q ss_pred             cCcCcceeecccCceEEEEEEEc------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCee
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEK  613 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~  613 (709)
                      ++|...+.||+|+||.||++...      .+..||||+++... ....+.+.+|+.++.++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            56888899999999999999752      24579999986543 33456799999999999 799999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ++||||+++|+|.+++.... ...+++.++..++.||+.||+|||+++   |+|+||||+|||++.++.+||+|||+++.
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence            99999999999999986432 234899999999999999999999987   99999999999999999999999999987


Q ss_pred             eCCC
Q 005206          694 FGGD  697 (709)
Q Consensus       694 l~~~  697 (709)
                      +...
T Consensus       191 ~~~~  194 (302)
T cd05055         191 IMND  194 (302)
T ss_pred             ccCC
Confidence            6443

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.87  E-value=3.5e-21  Score=199.73  Aligned_cols=152  Identities=25%  Similarity=0.483  Sum_probs=134.8

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|+..+.||+|+||.||+|... +++.||+|.++..   .....+++.+|++++.+++|+||+++++.+.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888899999999999999987 5899999988632   2334678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          618 EYMENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ||+++++|.+++.+.. ....+++.++..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999986532 2345899999999999999999999987   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.87  E-value=1.6e-21  Score=208.32  Aligned_cols=151  Identities=29%  Similarity=0.516  Sum_probs=131.1

Q ss_pred             cCcCcceeecccCceEEEEEEEc--------CCcEEEEEEeccC-CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCC
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL--------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMD  611 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~  611 (709)
                      ++|...++||+|+||.||+++..        ....+|+|.+... .....+++..|+.++.++ +||||+++++++.+.+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            56778899999999999999752        2457899988654 234467799999999999 6999999999999999


Q ss_pred             eeEEEEEccCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc
Q 005206          612 EKMLVYEYMENRSLDSVIFDKAR-------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD  678 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~  678 (709)
                      ..++||||+++|+|.+++.+...             ...+++.+...++.||+.||.|||+++   |+||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence            99999999999999999965321             235889999999999999999999987   99999999999999


Q ss_pred             CCCcEEEEecCCceeeC
Q 005206          679 KEMTPKISDFGMARIFG  695 (709)
Q Consensus       679 ~~~~~KI~DFGla~~l~  695 (709)
                      .++.+||+|||+++.+.
T Consensus       169 ~~~~~kL~Dfg~~~~~~  185 (314)
T cd05099         169 EDNVMKIADFGLARGVH  185 (314)
T ss_pred             CCCcEEEcccccccccc
Confidence            99999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.87  E-value=1.6e-21  Score=207.58  Aligned_cols=151  Identities=28%  Similarity=0.503  Sum_probs=131.6

Q ss_pred             cCcCcceeecccCceEEEEEEEcC--------CcEEEEEEeccC-CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCC
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE--------GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMD  611 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~  611 (709)
                      ++|...+.||+|+||.||++....        ...+|+|.+... ......++..|+.++.++ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            568888999999999999997532        346999998754 234456788999999999 7999999999999999


Q ss_pred             eeEEEEEccCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc
Q 005206          612 EKMLVYEYMENRSLDSVIFDKAR-------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD  678 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~  678 (709)
                      ..++||||+++|+|.+++.....             ...+++.+++.++.||+.||+|||+.+   ++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence            99999999999999999965321             134889999999999999999999987   99999999999999


Q ss_pred             CCCcEEEEecCCceeeC
Q 005206          679 KEMTPKISDFGMARIFG  695 (709)
Q Consensus       679 ~~~~~KI~DFGla~~l~  695 (709)
                      .++.+||+|||+++.+.
T Consensus       175 ~~~~~kL~dfg~a~~~~  191 (307)
T cd05098         175 EDNVMKIADFGLARDIH  191 (307)
T ss_pred             CCCcEEECCCccccccc
Confidence            99999999999998664

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.87  E-value=1.5e-21  Score=203.78  Aligned_cols=150  Identities=27%  Similarity=0.465  Sum_probs=131.9

Q ss_pred             cCcCcceeecccCceEEEEEEEcC------CcEEEEEEeccCCcc-chHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  614 (709)
                      ++|+..+.||+|+||.||+|+...      .+.|++|.+...... ..++|.+|++++.+++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            567888999999999999998642      457999988654433 4678999999999999999999999999989999


Q ss_pred             EEEEccCCCCHHHHHhccCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEec
Q 005206          615 LVYEYMENRSLDSVIFDKARS------SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDF  688 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DF  688 (709)
                      +||||+++|+|.+++......      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999654321      25899999999999999999999987   999999999999999999999999


Q ss_pred             CCceee
Q 005206          689 GMARIF  694 (709)
Q Consensus       689 Gla~~l  694 (709)
                      |+++..
T Consensus       162 ~~~~~~  167 (275)
T cd05046         162 SLSKDV  167 (275)
T ss_pred             cccccc
Confidence            998754

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.87  E-value=2.5e-21  Score=210.77  Aligned_cols=144  Identities=24%  Similarity=0.292  Sum_probs=126.0

Q ss_pred             HHhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          539 RATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       539 ~~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ....+|...+.||+|+||.||+|+... ++.||+|.....      ....|+.++.+++|+||+++++++.+....++|+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            345679999999999999999999865 678999875322      2356999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      ||+. ++|.+++...  ...+++..+..|+.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       137 e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  207 (357)
T PHA03209        137 PHYS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP  207 (357)
T ss_pred             EccC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence            9995 6888887543  345899999999999999999999997   999999999999999999999999999854

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.87  E-value=2.3e-21  Score=200.85  Aligned_cols=148  Identities=34%  Similarity=0.552  Sum_probs=131.8

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      +.|...++||+|+||.||+|...+++.||+|.+.... ...++|.+|+.++.+++|+||+++++++ ..+..+++|||++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~   83 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYME   83 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCC
Confidence            5678889999999999999998889999999986433 3457899999999999999999999986 4567899999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      +++|.+++.... ...+++.+++.++.|++.||+|||+.+   ++||||||+||++++++.++|+|||+++.+.
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          84 NGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE  153 (260)
T ss_pred             CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence            999999986543 345899999999999999999999987   9999999999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.87  E-value=1.4e-21  Score=205.58  Aligned_cols=152  Identities=31%  Similarity=0.535  Sum_probs=132.7

Q ss_pred             hcCcCcceeecccCceEEEEEEEc------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  613 (709)
                      .++|+..+.||+|+||.||++...      .+..||+|++.... ....++|.+|+.++.+++||||+++++++.+.+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            457888899999999999999864      35789999986543 33457799999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCC
Q 005206          614 MLVYEYMENRSLDSVIFDKA-------------------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASN  674 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~N  674 (709)
                      ++||||+++|+|.+++....                   ....+++..++.++.|++.||+|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999996421                   1124788999999999999999999987   9999999999


Q ss_pred             EEEcCCCcEEEEecCCceeeC
Q 005206          675 ILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       675 ILl~~~~~~KI~DFGla~~l~  695 (709)
                      |++++++.+||+|||+++.+.
T Consensus       161 il~~~~~~~~l~dfg~~~~~~  181 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIY  181 (288)
T ss_pred             eEecCCCceEECccccceecc
Confidence            999999999999999998654

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.87  E-value=2.8e-21  Score=202.65  Aligned_cols=150  Identities=30%  Similarity=0.492  Sum_probs=132.0

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ++|+..+.||+|+||.||+|.... ++.||+|++....  ....+.+.+|+.++.+++|+||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            367788899999999999999874 8899999886442  2234678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      |++++.|..++...   ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.+...
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            99999888776432   24899999999999999999999987   999999999999999999999999999987543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.87  E-value=2.3e-21  Score=200.82  Aligned_cols=149  Identities=32%  Similarity=0.528  Sum_probs=131.2

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      ++|...++||+|+||.||++...++..+|+|.+.... ...+.|.+|+.++.+++|+|++++++++. .+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            4577788999999999999998888899999986533 24567999999999999999999999874 456899999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      +++|.+++.+.. ...+++.++..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.+..
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          84 KGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIED  154 (260)
T ss_pred             CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence            999999986532 334799999999999999999999987   99999999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.87  E-value=3.3e-21  Score=202.05  Aligned_cols=144  Identities=25%  Similarity=0.365  Sum_probs=127.7

Q ss_pred             CcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      +|...++||+|+||.||+|... .++.||+|++... .....++|.+|+.++.+++||||+++++.+...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            5677789999999999999875 4789999998654 2344567999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ++++|..+.       .+++.....++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence            999997543       3678888899999999999999997   99999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.87  E-value=1.2e-21  Score=205.82  Aligned_cols=151  Identities=24%  Similarity=0.393  Sum_probs=132.4

Q ss_pred             CcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      +|+..+.||+|+||.||++... .++.+|+|.+... .....+++.+|+.++.+++|+||+++++.+...+..++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            5677789999999999999986 5889999988643 2334568999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ++++|..++........+++..+..++.|++.||.|||+..  +|+||||||+||+++.++.+||+|||+++.+.
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99999998865433346899999999999999999999742  39999999999999999999999999998663

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.87  E-value=2.2e-21  Score=203.04  Aligned_cols=152  Identities=34%  Similarity=0.505  Sum_probs=131.7

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC------CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  613 (709)
                      +++|...+.||+|+||.||+|.+.+      +..||+|.+.... ......|..|+.++.+++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678888999999999999998864      4678999886443 33456799999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC---cEEEE
Q 005206          614 MLVYEYMENRSLDSVIFDKAR----SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM---TPKIS  686 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~KI~  686 (709)
                      ++||||+++++|.+++.....    ...+++..++.++.||+.||+|||+.+   ++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            999999999999999865431    235899999999999999999999997   99999999999998754   69999


Q ss_pred             ecCCceeeC
Q 005206          687 DFGMARIFG  695 (709)
Q Consensus       687 DFGla~~l~  695 (709)
                      |||+++.+.
T Consensus       162 dfg~~~~~~  170 (277)
T cd05036         162 DFGMARDIY  170 (277)
T ss_pred             cCccccccC
Confidence            999998763

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=3e-21  Score=199.87  Aligned_cols=149  Identities=30%  Similarity=0.497  Sum_probs=131.7

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-----ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-----GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      ++|...+.||+|++|.||++...+ ++.+|+|.+....     ....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            568888999999999999998754 8899999886432     1234578999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      |+||+++++|.+++...   ..+++.....++.|++.||.|||+.+   |+||||+|+||++++++.+||+|||+++.+.
T Consensus        82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            99999999999988543   34788889999999999999999987   9999999999999999999999999998764


Q ss_pred             C
Q 005206          696 G  696 (709)
Q Consensus       696 ~  696 (709)
                      .
T Consensus       156 ~  156 (263)
T cd06625         156 T  156 (263)
T ss_pred             c
Confidence            3

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.87  E-value=1.6e-21  Score=206.49  Aligned_cols=150  Identities=29%  Similarity=0.515  Sum_probs=129.5

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-C--cEEEEEEeccC-CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-G--QEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g--~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      ++|+..+.||+|+||.||+|...+ +  ..+++|.++.. .....+.|.+|+.++.++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            467888899999999999998865 3  34788888643 334456899999999999 799999999999999999999


Q ss_pred             EEccCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcE
Q 005206          617 YEYMENRSLDSVIFDKA-------------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  683 (709)
                      +||+++++|.+++....             ....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999996532             1134889999999999999999999987   9999999999999999999


Q ss_pred             EEEecCCceee
Q 005206          684 KISDFGMARIF  694 (709)
Q Consensus       684 KI~DFGla~~l  694 (709)
                      ||+|||+++..
T Consensus       159 kl~dfg~~~~~  169 (297)
T cd05089         159 KIADFGLSRGE  169 (297)
T ss_pred             EECCcCCCccc
Confidence            99999998743

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.87  E-value=1.8e-21  Score=204.32  Aligned_cols=159  Identities=28%  Similarity=0.387  Sum_probs=134.6

Q ss_pred             hHHHHHHhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhc-CCCceeeEEEEEE---
Q 005206          534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCV---  608 (709)
Q Consensus       534 ~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~---  608 (709)
                      ++.+..+.++|+..+.||+|+||.||++.... ++.+|+|.+... .....++.+|+.++.++ +||||+++++++.   
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            34455677899999999999999999998865 789999987543 23346788999999999 6999999999885   


Q ss_pred             --eCCeeEEEEEccCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEE
Q 005206          609 --EMDEKMLVYEYMENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKI  685 (709)
Q Consensus       609 --~~~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI  685 (709)
                        .++..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence              3456899999999999999876422 2345889999999999999999999987   999999999999999999999


Q ss_pred             EecCCceeeCC
Q 005206          686 SDFGMARIFGG  696 (709)
Q Consensus       686 ~DFGla~~l~~  696 (709)
                      +|||+++.+..
T Consensus       166 ~dfg~~~~~~~  176 (286)
T cd06638         166 VDFGVSAQLTS  176 (286)
T ss_pred             ccCCceeeccc
Confidence            99999987643

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.87  E-value=3e-21  Score=198.90  Aligned_cols=147  Identities=40%  Similarity=0.647  Sum_probs=131.3

Q ss_pred             eeecccCceEEEEEEEcC----CcEEEEEEeccCCcc-chHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          548 NKLGQGGFGIVYKGRLLE----GQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      +.||+|+||.||++....    +..+++|.+...... ..+++.+|++++.+++|+||+++++++.+....++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999998865    778999999765333 368899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          623 RSLDSVIFDKAR------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       623 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ++|.+++.....      ...+++..+..++.|++.||+|||+++   ++||||||+||++++++.+||+|||+++.+..
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999976421      256899999999999999999999987   99999999999999999999999999998765


Q ss_pred             C
Q 005206          697 D  697 (709)
Q Consensus       697 ~  697 (709)
                      .
T Consensus       158 ~  158 (262)
T cd00192         158 D  158 (262)
T ss_pred             c
Confidence            3

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.87  E-value=3.2e-21  Score=202.46  Aligned_cols=145  Identities=35%  Similarity=0.548  Sum_probs=126.5

Q ss_pred             CcceeecccCceEEEEEEE-----cCCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeeEEE
Q 005206          545 TDYNKLGQGGFGIVYKGRL-----LEGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKMLV  616 (709)
Q Consensus       545 ~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV  616 (709)
                      ...+.||+|+||+||++..     .+++.||+|.+.... ....+.|.+|++++.+++||||+++++++...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            7778999999999988653     246789999986543 23467889999999999999999999998764  357899


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+++++|.+++...    .+++.++..++.|++.||.|||+++   |+||||||+|||+++++.+||+|||+++.+..
T Consensus        87 ~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          87 MEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             ecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence            9999999999998542    3899999999999999999999997   99999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.87  E-value=2.4e-21  Score=208.80  Aligned_cols=152  Identities=28%  Similarity=0.491  Sum_probs=131.1

Q ss_pred             cCcCcceeecccCceEEEEEEEcC--------CcEEEEEEeccCC-ccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCC
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE--------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMD  611 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~  611 (709)
                      .+|...+.||+|+||.||++....        ...||+|.+.... ....+++.+|+.++.++ +||||++++++|.+.+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            357788999999999999997532        2368999886442 34467899999999999 8999999999999999


Q ss_pred             eeEEEEEccCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc
Q 005206          612 EKMLVYEYMENRSLDSVIFDKA-------------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD  678 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~  678 (709)
                      ..++++||+++|+|.+++.+..             ....+++.+++.++.||+.||+|||+++   |+||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence            9999999999999999986532             1235889999999999999999999987   99999999999999


Q ss_pred             CCCcEEEEecCCceeeCC
Q 005206          679 KEMTPKISDFGMARIFGG  696 (709)
Q Consensus       679 ~~~~~KI~DFGla~~l~~  696 (709)
                      .++.+||+|||+++.+..
T Consensus       169 ~~~~~kL~Dfg~~~~~~~  186 (334)
T cd05100         169 EDNVMKIADFGLARDVHN  186 (334)
T ss_pred             CCCcEEECCcccceeccc
Confidence            999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.86  E-value=4e-21  Score=199.58  Aligned_cols=148  Identities=29%  Similarity=0.456  Sum_probs=128.3

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-----ccchHHHHHHHHHHHhcCCCceeeEEEEEEeC--Cee
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-----GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEK  613 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~  613 (709)
                      ++|...+.||+|+||.||++...+ ++.||||.+....     ....+.+.+|+.++.+++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            468888999999999999998865 8899999885321     22356788999999999999999999998764  457


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      +++|||+++++|.+++.+.   ..+++...+.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            8999999999999998643   23788888999999999999999987   99999999999999999999999999986


Q ss_pred             eC
Q 005206          694 FG  695 (709)
Q Consensus       694 l~  695 (709)
                      +.
T Consensus       156 ~~  157 (265)
T cd06652         156 LQ  157 (265)
T ss_pred             cc
Confidence            54

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.86  E-value=4.3e-21  Score=198.85  Aligned_cols=149  Identities=32%  Similarity=0.494  Sum_probs=130.1

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      ++|...++||+|+||.||++....+..+|+|++... ....+.|.+|+.++.+++|+|++++++++. .+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            457777899999999999999887778999988543 234567899999999999999999999875 466899999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      +++|.+++.+.. ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.+..
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          84 KGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED  154 (260)
T ss_pred             CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence            999999996532 334789999999999999999999987   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.86  E-value=2.8e-21  Score=202.39  Aligned_cols=150  Identities=31%  Similarity=0.557  Sum_probs=130.4

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-Cc----EEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQ----EIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~----~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      .+|...+.||+|+||.||+|.... ++    .+|+|.+.... .....++.+|+.++.+++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            456777899999999999998754 32    58999886553 3345789999999999999999999999987 78899


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      |+||+++|+|.+++.+..  ..+++...+.++.||+.||+|||+.+   ++||||||+|||+++++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            999999999999986532  24899999999999999999999987   9999999999999999999999999998775


Q ss_pred             CC
Q 005206          696 GD  697 (709)
Q Consensus       696 ~~  697 (709)
                      ..
T Consensus       161 ~~  162 (279)
T cd05057         161 VD  162 (279)
T ss_pred             Cc
Confidence            43

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.86  E-value=3.9e-21  Score=198.16  Aligned_cols=148  Identities=33%  Similarity=0.476  Sum_probs=131.5

Q ss_pred             cCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC-----ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          544 FTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-----GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      |+..+.||+|+||+||+|... +++.|++|.+....     .+..+++.+|+.++++++|+||+++++++.+....++++
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            566689999999999999987 68899999886532     234578999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+++++|.+++.+.   ..+++.....++.||+.||+|||+.+   ++|+||+|+||+++.++.+||+|||+++.+...
T Consensus        82 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          82 ELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            999999999998543   24789999999999999999999987   999999999999999999999999999876443

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.86  E-value=3.6e-21  Score=199.77  Aligned_cols=145  Identities=32%  Similarity=0.525  Sum_probs=129.5

Q ss_pred             cCcceeecccCceEEEEEEEcCCcEEEEEEeccCC------ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS------GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      |...+.||+|+||.||+|...+++.+|+|.+....      ....+.+.+|+.++++++|+||+++++++.+.+..++|+
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM   81 (265)
T ss_pred             ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence            66778999999999999998889999999886432      122456889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      ||+++++|.+++.+.   ..+++.....++.|++.||+|||+.+   |+|+||+|+||++++++.+||+|||+++.+
T Consensus        82 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  152 (265)
T cd06631          82 EFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL  152 (265)
T ss_pred             ecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence            999999999998543   24788999999999999999999987   999999999999999999999999999865

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.86  E-value=7.1e-21  Score=196.43  Aligned_cols=150  Identities=25%  Similarity=0.416  Sum_probs=132.4

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      +|...++||+|+||.||++.... ++.+|+|.+... .....+.+.+|+.++.+++|+||+++++.+.+.+..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            36677899999999999998764 789999988543 3345678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ++++|.+++... ....+++.....++.||+.||.|||+++   |+|+||||+||++++++.++|+|||+++.+..
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  152 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS  152 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence            999999988543 2345788999999999999999999987   99999999999999999999999999987754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.86  E-value=2.4e-21  Score=216.62  Aligned_cols=149  Identities=24%  Similarity=0.386  Sum_probs=122.4

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeC--------
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--------  610 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--------  610 (709)
                      ..++|...++||+|+||.||+|...+ ++.||||++....    ....+|+.++.+++|||||++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            34679999999999999999998864 7899999885432    2345799999999999999999886532        


Q ss_pred             CeeEEEEEccCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-cEEEEec
Q 005206          611 DEKMLVYEYMENRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDF  688 (709)
Q Consensus       611 ~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~KI~DF  688 (709)
                      ...++||||+++ +|.+++... .....+++.....++.||+.||+|||+.+   |+||||||+||||+.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            135689999985 676666432 22345889999999999999999999998   99999999999999665 7999999


Q ss_pred             CCceeeCC
Q 005206          689 GMARIFGG  696 (709)
Q Consensus       689 Gla~~l~~  696 (709)
                      |+|+.+..
T Consensus       216 Gla~~~~~  223 (440)
T PTZ00036        216 GSAKNLLA  223 (440)
T ss_pred             ccchhccC
Confidence            99997754

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.86  E-value=4.8e-21  Score=198.98  Aligned_cols=147  Identities=33%  Similarity=0.535  Sum_probs=129.6

Q ss_pred             cCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCcc---------chHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQ---------GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~---------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  613 (709)
                      |...+.||+|+||.||+|.... ++.+|+|.+......         ..+.+.+|+.++.+++||||+++++++.+.+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            5666899999999999998754 789999988654221         235688999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ++|+||+++++|.+++...   ..+++.....++.|++.||+|||+.+   ++||||+|+||++++++.+||+|||+++.
T Consensus        82 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             EEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            9999999999999999543   34788899999999999999999987   99999999999999999999999999987


Q ss_pred             eCC
Q 005206          694 FGG  696 (709)
Q Consensus       694 l~~  696 (709)
                      +..
T Consensus       156 ~~~  158 (267)
T cd06628         156 LEA  158 (267)
T ss_pred             ccc
Confidence            753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=4.6e-21  Score=198.24  Aligned_cols=151  Identities=28%  Similarity=0.499  Sum_probs=135.6

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      .++|...+.||+|+||.||++.... ++.+++|.+........+.+.+|+.++.+++||||+++++++.+.+..+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            3578888999999999999998864 678999999766555678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      +++++|.+++....  ..+++.....++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||++..+..
T Consensus        82 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          82 CGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            99999999885532  34889999999999999999999987   99999999999999999999999999987643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.86  E-value=3.2e-21  Score=199.43  Aligned_cols=142  Identities=31%  Similarity=0.534  Sum_probs=123.8

Q ss_pred             eecccCceEEEEEEEc---CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005206          549 KLGQGGFGIVYKGRLL---EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENR  623 (709)
Q Consensus       549 ~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  623 (709)
                      +||+|+||.||+|.+.   +++.+|+|++....  ....+++.+|+.++.+++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            6999999999999753   46789999886443  234578999999999999999999999885 45679999999999


Q ss_pred             CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          624 SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       624 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      +|.+++...   ..+++.....++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++.+...
T Consensus        81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~  148 (257)
T cd05116          81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence            999998543   24889999999999999999999987   999999999999999999999999999877544

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.86  E-value=3.4e-21  Score=203.68  Aligned_cols=149  Identities=34%  Similarity=0.543  Sum_probs=131.1

Q ss_pred             CcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCcc-----chHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQ-----GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~-----~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      +|...+.||+|+||.||+|... +++.||||++......     ....+..|+.++.+++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            3667789999999999999876 4889999999754322     345678899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+ +++|.+++....  ..+++..+..++.||++||.|||+++   |+|+||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899999986533  35899999999999999999999997   99999999999999999999999999997754


Q ss_pred             C
Q 005206          697 D  697 (709)
Q Consensus       697 ~  697 (709)
                      .
T Consensus       155 ~  155 (298)
T cd07841         155 P  155 (298)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.86  E-value=2.9e-21  Score=199.42  Aligned_cols=144  Identities=34%  Similarity=0.502  Sum_probs=128.4

Q ss_pred             eeecccCceEEEEEEEcC--C--cEEEEEEeccCCc-cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          548 NKLGQGGFGIVYKGRLLE--G--QEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~--g--~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      ++||+|++|.||+|.+..  +  ..||||.+..... ...++|.+|+.++.+++||||+++++.+.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998754  2  3689999976654 567789999999999999999999999988 889999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ++|.+++.+... ..+++.....++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.+..
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~  149 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ  149 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence            999999876432 45899999999999999999999987   99999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.86  E-value=6.9e-21  Score=233.61  Aligned_cols=142  Identities=28%  Similarity=0.560  Sum_probs=122.6

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      ..+...+.||+|+||.||+|+.. ++..||||++......    ...|++++++++|||||+++|+|.+.+..++||||+
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~  765 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI  765 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence            45677789999999999999984 5889999998643321    234688999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      ++|+|.+++..      ++|.++.+|+.|||+||+|||+.+..+|+||||||+||+++.++.+++. ||++...
T Consensus       766 ~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~  832 (968)
T PLN00113        766 EGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL  832 (968)
T ss_pred             CCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence            99999999842      8999999999999999999997755679999999999999999998886 7766544

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.86  E-value=2.9e-22  Score=218.10  Aligned_cols=151  Identities=35%  Similarity=0.571  Sum_probs=133.1

Q ss_pred             cCcceeecccCceEEEEEEEcC--Cc--EEEEEEeccCCcc-chHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLE--GQ--EIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~--g~--~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ....++||+|.||.|++|.+..  |+  .||||.+...... ....|++|+.+|.+|+|+|++||+|+..+ ...+||+|
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            3455789999999999998864  43  6899999766433 67899999999999999999999999987 67899999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      .++.|+|.+.|++ .....+--.....++.|||.||.||..+.   +|||||.++|+||...-.+||+||||.|-++.++
T Consensus       191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            9999999999987 34445777888899999999999999987   9999999999999999999999999999997765


Q ss_pred             c
Q 005206          699 T  699 (709)
Q Consensus       699 ~  699 (709)
                      .
T Consensus       267 d  267 (1039)
T KOG0199|consen  267 D  267 (1039)
T ss_pred             c
Confidence            3

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.86  E-value=2.1e-21  Score=201.58  Aligned_cols=152  Identities=23%  Similarity=0.451  Sum_probs=133.2

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|+..+.||+|+||.||++... +++.+|||.+...   .....++|.+|+.++..++|+||+++++++.+.+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46777789999999999999864 5889999988643   2234568999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          618 EYMENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ||+++++|.+++.... ....+++.....++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999999886422 2345899999999999999999999987   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.86  E-value=4.4e-21  Score=199.91  Aligned_cols=147  Identities=29%  Similarity=0.446  Sum_probs=128.5

Q ss_pred             CcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCc----------cchHHHHHHHHHHHhcCCCceeeEEEEEEeCC
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG----------QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD  611 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~----------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~  611 (709)
                      +|...+.||+|+||.||+|... +++.+|+|.+.....          ...+.+..|+.++.+++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            3566689999999999999875 488999998853210          12346889999999999999999999999999


Q ss_pred             eeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCc
Q 005206          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla  691 (709)
                      ..++||||+++++|.+++.+.   ..+++..+..++.||+.||.|||+++   ++||||+|+||+++.++.+||+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999998654   35889999999999999999999987   999999999999999999999999999


Q ss_pred             eeeC
Q 005206          692 RIFG  695 (709)
Q Consensus       692 ~~l~  695 (709)
                      +...
T Consensus       156 ~~~~  159 (272)
T cd06629         156 KKSD  159 (272)
T ss_pred             cccc
Confidence            8664

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.86  E-value=4.8e-21  Score=202.92  Aligned_cols=149  Identities=29%  Similarity=0.507  Sum_probs=134.5

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      .+|+..+.||.|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            46888899999999999999864 58899999997655555678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ++++|.+++.+    ..+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.+...
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            99999998853    24899999999999999999999997   999999999999999999999999999876544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.86  E-value=4.2e-21  Score=203.62  Aligned_cols=148  Identities=30%  Similarity=0.493  Sum_probs=129.7

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +.|...++||+|+||.||+|.... ++.||+|.+.... ......+.+|+.++.+++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            468888999999999999998864 7899999986442 33345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ++ ++|..++....  ..+++.....++.||+.||.|||+.+   |+||||||+||++++++.+||+|||+++...
T Consensus        86 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  155 (301)
T cd07873          86 LD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS  155 (301)
T ss_pred             cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence            97 58988885432  34788999999999999999999987   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.86  E-value=3.2e-21  Score=210.02  Aligned_cols=146  Identities=33%  Similarity=0.468  Sum_probs=125.1

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC------
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD------  611 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------  611 (709)
                      .++|...+.||+|+||.||++.... ++.||||++...  .....+++.+|+.++..++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            4789999999999999999998754 889999999643  2334567889999999999999999999986543      


Q ss_pred             eeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCc
Q 005206          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla  691 (709)
                      ..++||||+++ +|...+..     .+++.....++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence            46999999976 45555522     3788888899999999999999997   999999999999999999999999999


Q ss_pred             eeeC
Q 005206          692 RIFG  695 (709)
Q Consensus       692 ~~l~  695 (709)
                      +...
T Consensus       171 ~~~~  174 (359)
T cd07876         171 RTAC  174 (359)
T ss_pred             cccc
Confidence            8654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.86  E-value=4.5e-21  Score=200.91  Aligned_cols=152  Identities=26%  Similarity=0.414  Sum_probs=127.7

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHH-HHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRL-IAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ++|+..+.||+|+||.||++.... ++.||+|++.... .....++..|+.+ ++.++||||+++++++...+..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            367888999999999999998864 8999999986542 2334566667765 556689999999999999999999999


Q ss_pred             ccCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          619 YMENRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       619 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |++ |+|.+++... .....+++.....++.||+.||+|||++.  +++||||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            997 6888887543 22346899999999999999999999872  399999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.86  E-value=5.8e-21  Score=201.29  Aligned_cols=150  Identities=31%  Similarity=0.450  Sum_probs=129.5

Q ss_pred             HhcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCc-cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++++|...+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++.+++|+||+++.+++...+..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999875 488999999865432 33456789999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ||++ ++|.+++....  ..+.+.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  154 (291)
T cd07870          83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKS  154 (291)
T ss_pred             eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccC
Confidence            9996 67777664432  34778888899999999999999987   9999999999999999999999999998653

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.86  E-value=3.6e-22  Score=217.06  Aligned_cols=154  Identities=32%  Similarity=0.502  Sum_probs=130.4

Q ss_pred             eeecccCceEEEEEEEcC-CcEEEEEEe--cc--CCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCe--eEEEEEcc
Q 005206          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRL--SR--NSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE--KMLVYEYM  620 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l--~~--~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~~lV~Ey~  620 (709)
                      .+||+|+|-+||||.+.. |.+||--.+  .+  .++...++|..|+.+|+.|+|||||+++..+.+...  .-+|.|.|
T Consensus        46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~  125 (632)
T KOG0584|consen   46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF  125 (632)
T ss_pred             hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence            589999999999998854 777764322  11  244556899999999999999999999999998776  67899999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CcEEEEecCCceeeCCCCc
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFGGDQT  699 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~KI~DFGla~~l~~~~~  699 (709)
                      ..|+|..|+.+..+   ++.+....++.||++||.|||++. +||||||||.+||+|+.+ |.+||.|.|||.++.... 
T Consensus       126 TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-  200 (632)
T KOG0584|consen  126 TSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-  200 (632)
T ss_pred             cCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence            99999999976654   778889999999999999999986 799999999999999866 899999999999985443 


Q ss_pred             cccccceecC
Q 005206          700 EQNTKRVVGT  709 (709)
Q Consensus       700 ~~~~~~~~GT  709 (709)
                         ...++||
T Consensus       201 ---aksvIGT  207 (632)
T KOG0584|consen  201 ---AKSVIGT  207 (632)
T ss_pred             ---cceeccC
Confidence               3347887

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.86  E-value=5.2e-21  Score=203.34  Aligned_cols=146  Identities=24%  Similarity=0.390  Sum_probs=130.5

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...+.||+|+||.||++.... ++.||+|.+....   ....+.+.+|+.++..++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            367888999999999999998865 7899999986542   234567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ||+++++|.+++...   ..+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus        81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            999999999998543   34889999999999999999999987   99999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.86  E-value=5.4e-21  Score=200.14  Aligned_cols=148  Identities=32%  Similarity=0.543  Sum_probs=130.8

Q ss_pred             CcCcceeecccCceEEEEEEEc-----CCcEEEEEEeccCCcc-chHHHHHHHHHHHhcCCCceeeEEEEEEe--CCeeE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLL-----EGQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRNLVRLLGCCVE--MDEKM  614 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~-----~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~  614 (709)
                      .|+..+.||+|+||.||++.+.     .+..+|||.+...... ..++|.+|+.++.+++|+||+++++++..  ....+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            4666789999999999999864     2678999999755432 56789999999999999999999999887  55789


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      +||||+++++|.+++....  ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++.+
T Consensus        85 lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             EEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            9999999999999996533  24899999999999999999999987   999999999999999999999999999987


Q ss_pred             C
Q 005206          695 G  695 (709)
Q Consensus       695 ~  695 (709)
                      .
T Consensus       160 ~  160 (284)
T cd05038         160 P  160 (284)
T ss_pred             c
Confidence            5

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.86  E-value=5.4e-21  Score=199.38  Aligned_cols=143  Identities=35%  Similarity=0.601  Sum_probs=124.1

Q ss_pred             eeecccCceEEEEEEEcC-Cc--EEEEEEeccC-CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          548 NKLGQGGFGIVYKGRLLE-GQ--EIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-g~--~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      +.||+|+||.||+|.+.+ +.  .+|+|.+... .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999865 33  5788888643 234556899999999999 899999999999999999999999999


Q ss_pred             CCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecC
Q 005206          623 RSLDSVIFDKA-------------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG  689 (709)
Q Consensus       623 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFG  689 (709)
                      |+|.+++.+..             ....+++.++..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999986532             1234789999999999999999999987   9999999999999999999999999


Q ss_pred             Ccee
Q 005206          690 MARI  693 (709)
Q Consensus       690 la~~  693 (709)
                      +++.
T Consensus       158 l~~~  161 (270)
T cd05047         158 LSRG  161 (270)
T ss_pred             Cccc
Confidence            9863

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.86  E-value=7.4e-21  Score=195.67  Aligned_cols=143  Identities=34%  Similarity=0.520  Sum_probs=128.7

Q ss_pred             eeecccCceEEEEEEEcCCcEEEEEEeccCCcc-chHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCCHH
Q 005206          548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLD  626 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~  626 (709)
                      ++||+|+||.||++.+.+++.||+|++...... ..++|.+|+.++.+++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            479999999999999877999999988754333 5678999999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          627 SVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       627 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      +++.+..  ..+++...+.++.+++.||.|||+++   ++||||||+||+++.++.+||+|||+++...
T Consensus        81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~  144 (251)
T cd05041          81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE  144 (251)
T ss_pred             HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence            9986532  24789999999999999999999997   9999999999999999999999999998664

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.86  E-value=7.1e-21  Score=199.53  Aligned_cols=149  Identities=32%  Similarity=0.576  Sum_probs=131.8

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCc-cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      +|+..++||+|++|.||+|+... ++.||||++..... ...+.+.+|+.++.+++|+||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            47788999999999999999864 88999999875432 33567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ++ +|.+++........+++..+..++.||+.||.|||+.+   ++||||||+||++++++.+||+|||+++.+.
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~  151 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFG  151 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence            85 88888865544456899999999999999999999987   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.86  E-value=6.2e-21  Score=201.08  Aligned_cols=161  Identities=30%  Similarity=0.417  Sum_probs=136.9

Q ss_pred             CChHHHHHHhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhc-CCCceeeEEEEEEe
Q 005206          532 FDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVE  609 (709)
Q Consensus       532 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~  609 (709)
                      +..+++..++++|...+.||+|+||.||++...+ ++.+|+|.+... ....+++.+|+.++.++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            3445566678899999999999999999998854 789999988643 23356788899999999 89999999999876


Q ss_pred             CC-----eeEEEEEccCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcE
Q 005206          610 MD-----EKMLVYEYMENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (709)
Q Consensus       610 ~~-----~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  683 (709)
                      .+     ..++|+||+++++|.+++.... ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence            43     5799999999999999885422 2345899999999999999999999987   9999999999999999999


Q ss_pred             EEEecCCceeeCC
Q 005206          684 KISDFGMARIFGG  696 (709)
Q Consensus       684 KI~DFGla~~l~~  696 (709)
                      ||+|||+++.+..
T Consensus       168 kl~dfg~~~~~~~  180 (291)
T cd06639         168 KLVDFGVSAQLTS  180 (291)
T ss_pred             EEeecccchhccc
Confidence            9999999987643

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.86  E-value=1.1e-20  Score=195.90  Aligned_cols=153  Identities=29%  Similarity=0.474  Sum_probs=135.6

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ++|+..+.||+|+||.||+|...+ +..+|+|++.... ....+.+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            468888999999999999998754 7889999986442 33567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      +++++|.+++........+++.....++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++..+...
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            999999999965433345899999999999999999999987   999999999999999999999999999877544

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.86  E-value=6.2e-21  Score=197.66  Aligned_cols=149  Identities=30%  Similarity=0.500  Sum_probs=132.2

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      +.|...++||+|+||.||++...++..+|+|.+... ....+.|.+|+.++.+++|+||+++.+.+.+ ...+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA   83 (260)
T ss_pred             cceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence            568888999999999999999877888999988643 3345789999999999999999999999887 77899999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      +++|.+++.... ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.+..
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          84 KGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             CCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            999999986532 345789999999999999999999987   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=2.3e-22  Score=215.16  Aligned_cols=156  Identities=34%  Similarity=0.529  Sum_probs=132.7

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCcc---chHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQ---GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~---~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ..|+.++.||.|+||.||-+++.. .+.||||++.-...+   ...+++.|++.|.+++|||+|...|||....-.+|||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            357788899999999999998765 678999999754333   3457899999999999999999999999988899999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      |||- |+-.++|.-.  .+++.+..+..|..+.+.||+|||+++   .||||||+.||||++.+.+||+|||.|.+..+.
T Consensus       106 EYCl-GSAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA  179 (948)
T KOG0577|consen  106 EYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA  179 (948)
T ss_pred             HHHh-ccHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch
Confidence            9995 5666666432  245888888899999999999999998   999999999999999999999999999988654


Q ss_pred             CccccccceecC
Q 005206          698 QTEQNTKRVVGT  709 (709)
Q Consensus       698 ~~~~~~~~~~GT  709 (709)
                            +.|+||
T Consensus       180 ------nsFvGT  185 (948)
T KOG0577|consen  180 ------NSFVGT  185 (948)
T ss_pred             ------hcccCC
Confidence                  236666

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=2e-22  Score=210.61  Aligned_cols=159  Identities=28%  Similarity=0.462  Sum_probs=140.3

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      .|+..+.||+|.||.||||.+.. ++.||+|++.-. .+...++...|+.++..++|+||.+.+|.+..+...+++|||+
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            46666899999999999998865 788999999644 4566788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCCcc
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~~~  700 (709)
                      .+|++.+.|..   ..++++....-|+.+++.||.|||.++   .+|||||+.|||+..++.+|++|||.|-.+.....+
T Consensus        94 ~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   94 GGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             cCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            99999998843   234577777788999999999999998   999999999999999999999999999999777665


Q ss_pred             ccccceecC
Q 005206          701 QNTKRVVGT  709 (709)
Q Consensus       701 ~~~~~~~GT  709 (709)
                      +  .+++||
T Consensus       168 r--~tfvGT  174 (467)
T KOG0201|consen  168 R--KTFVGT  174 (467)
T ss_pred             c--cccccc
Confidence            5  458887

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.86  E-value=8.6e-21  Score=196.01  Aligned_cols=148  Identities=30%  Similarity=0.512  Sum_probs=128.8

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEe-CCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE-MDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~Ey~  620 (709)
                      ++|...+.||+|+||.||++... +..+|+|.+...  ...+.|.+|+.++.+++|+|++++++++.. .+..++++||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46777889999999999999774 778999988543  335689999999999999999999998654 45689999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ++++|.+++.+.. ...+++..++.++.||+.||+|||+++   ++||||||+||++++++.+||+|||+++....
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccc
Confidence            9999999986533 335889999999999999999999987   99999999999999999999999999986543

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.86  E-value=3.8e-21  Score=204.31  Aligned_cols=150  Identities=35%  Similarity=0.626  Sum_probs=127.3

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-Cc----EEEEEEeccCCc-cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQ----EIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~----~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      +.|...+.||+|+||.||+|.... ++    .||+|.+..... ....++.+|+.++.+++||||++++|+|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            456777899999999999998753 43    578888865432 3345789999999999999999999998754 5779


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ++||+++|+|.+++....  ..+++..++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence            999999999999986432  34789999999999999999999987   9999999999999999999999999999775


Q ss_pred             CC
Q 005206          696 GD  697 (709)
Q Consensus       696 ~~  697 (709)
                      ..
T Consensus       161 ~~  162 (303)
T cd05110         161 GD  162 (303)
T ss_pred             Cc
Confidence            43

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.86  E-value=6.3e-21  Score=203.67  Aligned_cols=144  Identities=28%  Similarity=0.467  Sum_probs=119.0

Q ss_pred             eeecccCceEEEEEEEc---CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEe--CCeeEEEEEccCC
Q 005206          548 NKLGQGGFGIVYKGRLL---EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE--MDEKMLVYEYMEN  622 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~~  622 (709)
                      ++||+|+||.||+|+..   .++.+|+|.+...  .....+.+|+.++.+++||||+++++++..  ....+++|||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07868           7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH   84 (317)
T ss_pred             cccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence            58999999999999875   3578999998643  223567889999999999999999999865  3467899999864


Q ss_pred             CCHHHHHhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE----cCCCcEEEEecCCce
Q 005206          623 RSLDSVIFDKA------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL----DKEMTPKISDFGMAR  692 (709)
Q Consensus       623 gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~KI~DFGla~  692 (709)
                       +|.+++....      ....+++.....++.||+.||.|||+++   |+||||||+|||+    +.++.+||+|||+|+
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence             7877764321      1234888999999999999999999998   9999999999999    456789999999999


Q ss_pred             eeCCC
Q 005206          693 IFGGD  697 (709)
Q Consensus       693 ~l~~~  697 (709)
                      .+...
T Consensus       161 ~~~~~  165 (317)
T cd07868         161 LFNSP  165 (317)
T ss_pred             ccCCC
Confidence            87543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.86  E-value=3.2e-21  Score=208.50  Aligned_cols=149  Identities=30%  Similarity=0.473  Sum_probs=127.3

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeC------
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM------  610 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------  610 (709)
                      ..++|...+.||+|+||.||++.... ++.||||++....  ....+++.+|+.++.+++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            34678899999999999999998754 7899999986532  23356788999999999999999999987643      


Q ss_pred             CeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCC
Q 005206          611 DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (709)
Q Consensus       611 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGl  690 (709)
                      ...++++|++ +++|.+++..    ..+++..+..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence            3468999988 7788887732    34889999999999999999999997   99999999999999999999999999


Q ss_pred             ceeeCC
Q 005206          691 ARIFGG  696 (709)
Q Consensus       691 a~~l~~  696 (709)
                      ++.+..
T Consensus       165 ~~~~~~  170 (343)
T cd07878         165 ARQADD  170 (343)
T ss_pred             ceecCC
Confidence            997644

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.86  E-value=6.4e-21  Score=200.85  Aligned_cols=147  Identities=31%  Similarity=0.503  Sum_probs=129.3

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCc-cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ++|...+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888899999999999999886 478999999865432 2335678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      +++ +|.+++.+..  ..+++.....++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus        85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  153 (291)
T cd07844          85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK  153 (291)
T ss_pred             CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence            985 8998886433  25789999999999999999999987   999999999999999999999999998754

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.86  E-value=1.2e-20  Score=196.16  Aligned_cols=148  Identities=30%  Similarity=0.492  Sum_probs=128.6

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-----ccchHHHHHHHHHHHhcCCCceeeEEEEEEeC--Cee
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-----GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEK  613 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~  613 (709)
                      .+|...+.||+|+||.||++.... +..||+|++....     ....+.+.+|+.++.+++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            468888999999999999998764 8899999886432     12345788999999999999999999998763  567


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ++++||+++++|.+++...   ..+++.....++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            8999999999999998543   24788999999999999999999987   99999999999999999999999999986


Q ss_pred             eC
Q 005206          694 FG  695 (709)
Q Consensus       694 l~  695 (709)
                      +.
T Consensus       156 ~~  157 (266)
T cd06651         156 LQ  157 (266)
T ss_pred             cc
Confidence            64

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.85  E-value=6.2e-21  Score=198.71  Aligned_cols=150  Identities=25%  Similarity=0.411  Sum_probs=129.6

Q ss_pred             cCcCcceeecccCceEEEEEEEcCC----cEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEG----QEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g----~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      ++|...++||+|+||.||+|...+.    ..||||...... ....+.|.+|+.++.+++||||+++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            4577778999999999999987542    468999886554 3456789999999999999999999998875 567899


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+++|+|.+++....  ..+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.+..
T Consensus        85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence            99999999999996532  34899999999999999999999987   99999999999999999999999999987644


Q ss_pred             C
Q 005206          697 D  697 (709)
Q Consensus       697 ~  697 (709)
                      .
T Consensus       160 ~  160 (270)
T cd05056         160 E  160 (270)
T ss_pred             c
Confidence            3

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.85  E-value=3.3e-21  Score=202.32  Aligned_cols=149  Identities=30%  Similarity=0.511  Sum_probs=131.5

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCc--cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG--QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ++|+..++||+|+||.||+|...+ ++.+|+|++.....  ...+.+.+|++++.+++||||+++++++...+..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            367888999999999999999865 78999998865422  235678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |+++++|..+....   ..+++..+..++.||+.||+|||+.+   ++|+||+|+||++++++.+||+|||+++.+..
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence            99999998876432   23899999999999999999999987   99999999999999999999999999987644

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.85  E-value=3e-21  Score=204.12  Aligned_cols=145  Identities=30%  Similarity=0.489  Sum_probs=129.1

Q ss_pred             CcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCC
Q 005206          545 TDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENR  623 (709)
Q Consensus       545 ~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g  623 (709)
                      .....||+|+||.||++.... +..||||++........+.+.+|+.++.+++|+||+++++.+..++..++||||++++
T Consensus        25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~  104 (292)
T cd06658          25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG  104 (292)
T ss_pred             hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence            334579999999999998754 7899999987655556678999999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          624 SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       624 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      +|.+++..    ..+++.....++.||+.||.|||+++   |+||||||+||++++++.+||+|||+++.+..
T Consensus       105 ~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (292)
T cd06658         105 ALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK  170 (292)
T ss_pred             cHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence            99998743    23789999999999999999999997   99999999999999999999999999986643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.85  E-value=1e-20  Score=198.37  Aligned_cols=149  Identities=30%  Similarity=0.515  Sum_probs=133.0

Q ss_pred             CcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +|+..+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            3677789999999999999975 48899999987543  33457899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      + +++|.+++....  ..+++.++..++.||++||+|||+.+   ++|+||||+||+++.++.+||+|||+++.+...
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~  152 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE  152 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence            9 999999986543  45899999999999999999999987   999999999999999999999999999987544

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.85  E-value=1.1e-20  Score=194.98  Aligned_cols=149  Identities=32%  Similarity=0.579  Sum_probs=132.2

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      ..|+..+.||+|+||.||++...++..+|+|.+... ....++|.+|++++.+++|||++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            356777899999999999998877889999988643 3345689999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      +++|.+++....  ..+++.....++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++....
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  152 (256)
T cd05112          83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD  152 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence            999999985432  34789999999999999999999987   99999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.8e-21  Score=211.36  Aligned_cols=156  Identities=31%  Similarity=0.468  Sum_probs=134.4

Q ss_pred             eecccCceEEEEEEEcCC-cEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCCHHH
Q 005206          549 KLGQGGFGIVYKGRLLEG-QEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDS  627 (709)
Q Consensus       549 ~LG~G~fG~Vykg~~~~g-~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~  627 (709)
                      +||+|.||+||-|++.+. ..+|||-+.....+...-+.+||.+.++|+|.|||+.+|.+.+++...|.||-+|+|+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            799999999999998774 4799999987777777889999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-CCCcEEEEecCCceeeCCCCccccccce
Q 005206          628 VIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD-KEMTPKISDFGMARIFGGDQTEQNTKRV  706 (709)
Q Consensus       628 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~KI~DFGla~~l~~~~~~~~~~~~  706 (709)
                      +|...=..-.-.+.+.-.+-.||++||.|||++.   |||||||-+||||+ -.|.+||+|||-++.+.+-  ...|.++
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETF  736 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETF  736 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Ccccccc
Confidence            9965322211267777788999999999999997   99999999999996 4689999999999988543  3456667


Q ss_pred             ecC
Q 005206          707 VGT  709 (709)
Q Consensus       707 ~GT  709 (709)
                      -||
T Consensus       737 TGT  739 (1226)
T KOG4279|consen  737 TGT  739 (1226)
T ss_pred             ccc
Confidence            776

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.85  E-value=1.1e-20  Score=199.19  Aligned_cols=148  Identities=27%  Similarity=0.354  Sum_probs=129.6

Q ss_pred             CcCcceeecccCceEEEEEEEc----CCcEEEEEEeccCC----ccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCee
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEK  613 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~  613 (709)
                      +|+..+.||+|+||.||+++..    +++.||+|++....    ....+++.+|+.++.++ +|+||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4677789999999999999863    57899999986532    22346788999999999 599999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ++|+||+++++|.+++...   ..+++.....++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            9999999999999998653   34788888899999999999999987   99999999999999999999999999987


Q ss_pred             eCC
Q 005206          694 FGG  696 (709)
Q Consensus       694 l~~  696 (709)
                      +..
T Consensus       155 ~~~  157 (290)
T cd05613         155 FHE  157 (290)
T ss_pred             ccc
Confidence            654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.4e-22  Score=217.68  Aligned_cols=161  Identities=27%  Similarity=0.458  Sum_probs=140.1

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCc-EEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQ-EIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~-~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      +.|.++..||.|+||+||++..++.. ..|.|.+...+....+.|+-||++|...+||+||+|++.|...+..+|++|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            45666778999999999999887644 45678887778888999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCCcc
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~~~  700 (709)
                      .||-.+.++....  ..|.+.++..+++|++.||.|||++.   |||||||+.|||++-+|.++|+|||.+........+
T Consensus       112 ~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk  186 (1187)
T KOG0579|consen  112 GGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK  186 (1187)
T ss_pred             CCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence            9999999886543  45899999999999999999999997   999999999999999999999999998876544333


Q ss_pred             ccccceecC
Q 005206          701 QNTKRVVGT  709 (709)
Q Consensus       701 ~~~~~~~GT  709 (709)
                      +  ..++||
T Consensus       187 R--DsFIGT  193 (1187)
T KOG0579|consen  187 R--DSFIGT  193 (1187)
T ss_pred             h--ccccCC
Confidence            3  347776

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=6.5e-21  Score=204.92  Aligned_cols=141  Identities=23%  Similarity=0.289  Sum_probs=114.4

Q ss_pred             HhcCcCcceeecccCceEEEEEEEc--CCcEEEEEEeccC-----CccchHHHHHHHHHHHhcCCCceee-EEEEEEeCC
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLL--EGQEIAVKRLSRN-----SGQGIEEFKNEVRLIAKLQHRNLVR-LLGCCVEMD  611 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~--~g~~VAVK~l~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~-l~g~~~~~~  611 (709)
                      ..++|...+.||+|+||+||+|.+.  +++.||||++...     .....+.|.+|++++.+++|+|++. ++.    .+
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~   91 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TG   91 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cC
Confidence            3467888999999999999999875  4677899987533     1223567999999999999999985 443    24


Q ss_pred             eeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC-CCCCEEEcCCCcEEEEecCC
Q 005206          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDL-KASNILLDKEMTPKISDFGM  690 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDl-kp~NILl~~~~~~KI~DFGl  690 (709)
                      ..+|||||+++++|.. + .  .   ..   ...++.|++++|.|||+++   |+|||| ||+|||++.++.+||+|||+
T Consensus        92 ~~~LVmE~~~G~~L~~-~-~--~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         92 KDGLVRGWTEGVPLHL-A-R--P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             CcEEEEEccCCCCHHH-h-C--c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            6899999999999962 2 1  1   11   1357889999999999997   999999 99999999999999999999


Q ss_pred             ceeeCCC
Q 005206          691 ARIFGGD  697 (709)
Q Consensus       691 a~~l~~~  697 (709)
                      |+.+...
T Consensus       159 A~~~~~~  165 (365)
T PRK09188        159 ASVFRRR  165 (365)
T ss_pred             ceecccC
Confidence            9987554

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.85  E-value=1.1e-20  Score=196.95  Aligned_cols=150  Identities=31%  Similarity=0.510  Sum_probs=126.2

Q ss_pred             cCcceeecccCceEEEEEEEc----CCcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC------
Q 005206          544 FTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD------  611 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------  611 (709)
                      |...+.||+|+||.||+|.+.    .++.||||++...  .....+++.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            455678999999999999864    2678999998654  2345678999999999999999999999887543      


Q ss_pred             eeEEEEEccCCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEec
Q 005206          612 EKMLVYEYMENRSLDSVIFDKA---RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDF  688 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DF  688 (709)
                      ..++++||+++|+|..++....   ....+++.....++.||+.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2378999999999998875322   1234788999999999999999999987   999999999999999999999999


Q ss_pred             CCceeeCC
Q 005206          689 GMARIFGG  696 (709)
Q Consensus       689 Gla~~l~~  696 (709)
                      |+++.+..
T Consensus       158 g~~~~~~~  165 (273)
T cd05074         158 GLSKKIYS  165 (273)
T ss_pred             cccccccC
Confidence            99997643

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.85  E-value=5.5e-21  Score=207.80  Aligned_cols=148  Identities=32%  Similarity=0.463  Sum_probs=125.9

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD-----  611 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----  611 (709)
                      ..++|...+.||+|+||.||++.... ++.||||++....  ....+++.+|+.++..++||||+++++++....     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            44689999999999999999998754 7899999996542  234567889999999999999999999886543     


Q ss_pred             -eeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCC
Q 005206          612 -EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (709)
Q Consensus       612 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGl  690 (709)
                       ..++||||+++ +|...+..     .+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence             46999999975 56665532     3788889999999999999999997   99999999999999999999999999


Q ss_pred             ceeeCC
Q 005206          691 ARIFGG  696 (709)
Q Consensus       691 a~~l~~  696 (709)
                      ++....
T Consensus       166 ~~~~~~  171 (355)
T cd07874         166 ARTAGT  171 (355)
T ss_pred             cccCCC
Confidence            987643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.85  E-value=6.9e-21  Score=197.74  Aligned_cols=149  Identities=31%  Similarity=0.529  Sum_probs=130.2

Q ss_pred             CcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC------ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS------GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      +|+..+.||+|+||.||++... +++.+|+|.+....      ....+.+..|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4677789999999999999874 47899999986432      1235689999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-cEEEEecCCceee
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIF  694 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~KI~DFGla~~l  694 (709)
                      |+||+++++|.+++.+.   ..+++.....++.||+.||.|||+.+   ++|+||||+||+++.++ .+||+|||+++.+
T Consensus        81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            99999999999998643   24789999999999999999999997   99999999999998776 6999999999877


Q ss_pred             CCC
Q 005206          695 GGD  697 (709)
Q Consensus       695 ~~~  697 (709)
                      ...
T Consensus       155 ~~~  157 (268)
T cd06630         155 AAK  157 (268)
T ss_pred             ccc
Confidence            543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.85  E-value=9.3e-21  Score=195.24  Aligned_cols=149  Identities=30%  Similarity=0.496  Sum_probs=134.5

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      ++|+..++||+|+||.||+|...+ ++.+++|.+.....  .+++.+|++++++++|+||+++++.+.+....++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578888999999999999999876 78999999864422  778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ++++|.+++...  ...+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++..+...
T Consensus        81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            999999998543  245899999999999999999999987   999999999999999999999999999977543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.85  E-value=1.4e-20  Score=194.65  Aligned_cols=143  Identities=36%  Similarity=0.554  Sum_probs=125.1

Q ss_pred             eeecccCceEEEEEEEcC-C---cEEEEEEeccCCc-cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          548 NKLGQGGFGIVYKGRLLE-G---QEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-g---~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      ++||+|+||.||+|.... +   ..+|+|.+..... ...+++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            479999999999997643 2   6899999875543 34678999999999999999999999875 5678999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ++|.+++.+..   .+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+++.+...
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~  148 (257)
T cd05060          80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG  148 (257)
T ss_pred             CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence            99999996543   5899999999999999999999987   999999999999999999999999999977443

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.85  E-value=1.2e-20  Score=195.43  Aligned_cols=149  Identities=32%  Similarity=0.517  Sum_probs=133.1

Q ss_pred             CcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCc--cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG--QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +|...+.||+|+||.||+|... +++.|++|.+.....  ...+++.+|+.++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4677789999999999999875 578999999875543  3677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      +++++|.+++.+.   ..+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.+||+|||++..+...
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~  152 (264)
T cd06626          81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN  152 (264)
T ss_pred             CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence            9999999998643   34788899999999999999999987   999999999999999999999999999877543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.85  E-value=1e-20  Score=203.26  Aligned_cols=144  Identities=20%  Similarity=0.293  Sum_probs=125.2

Q ss_pred             ceeeccc--CceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          547 YNKLGQG--GFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       547 ~~~LG~G--~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      .++||+|  +|++||++.... ++.||+|++....  ....+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            4689999  789999998854 8899999996542  2334567889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      +|+|.+++..... ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+|++||+.+..+
T Consensus        83 ~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~  151 (327)
T cd08227          83 YGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM  151 (327)
T ss_pred             CCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence            9999999865322 34889999999999999999999987   999999999999999999999999876543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.85  E-value=8.7e-21  Score=196.42  Aligned_cols=143  Identities=32%  Similarity=0.548  Sum_probs=122.3

Q ss_pred             eeecccCceEEEEEEEcC----CcEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEe-CCeeEEEEEccC
Q 005206          548 NKLGQGGFGIVYKGRLLE----GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE-MDEKMLVYEYME  621 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~Ey~~  621 (709)
                      +.||+|+||.||+|.+.+    ...+|+|++... .....+.+.+|+.+++.++||||+++++++.. ....++|+||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            368999999999998643    357999988543 23446789999999999999999999998764 455789999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      +|+|.+++.+..  ..+++...+.++.||+.||.|||+.+   ++||||||+|||+++++.+||+|||+++.+.
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~  149 (262)
T cd05058          81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY  149 (262)
T ss_pred             CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence            999999986432  23678888899999999999999987   9999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.85  E-value=8.1e-21  Score=207.21  Aligned_cols=147  Identities=31%  Similarity=0.467  Sum_probs=125.8

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeC------C
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM------D  611 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~  611 (709)
                      .++|...+.||+|+||.||++.... ++.||||++...  .....+++.+|+.++..++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            4689999999999999999998754 789999999653  233456788999999999999999999987643      3


Q ss_pred             eeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCc
Q 005206          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla  691 (709)
                      ..++||||+++ +|..++..     .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            46999999975 66666632     3788899999999999999999987   999999999999999999999999999


Q ss_pred             eeeCC
Q 005206          692 RIFGG  696 (709)
Q Consensus       692 ~~l~~  696 (709)
                      +....
T Consensus       174 ~~~~~  178 (364)
T cd07875         174 RTAGT  178 (364)
T ss_pred             cccCC
Confidence            87643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.85  E-value=1.3e-20  Score=198.09  Aligned_cols=149  Identities=31%  Similarity=0.512  Sum_probs=123.8

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhc---CCCceeeEEEEEEeC-----C
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKL---QHRNLVRLLGCCVEM-----D  611 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~-----~  611 (709)
                      +|...+.||+|+||.||+|.... ++.||+|.+....  ......+.+|+.++.++   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            46778899999999999998875 7899999986532  22234566788777765   699999999988653     3


Q ss_pred             eeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCc
Q 005206          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla  691 (709)
                      ..++||||+++ +|.+++.... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57899999984 8888875432 234899999999999999999999998   999999999999999999999999999


Q ss_pred             eeeCC
Q 005206          692 RIFGG  696 (709)
Q Consensus       692 ~~l~~  696 (709)
                      +.+..
T Consensus       156 ~~~~~  160 (288)
T cd07863         156 RIYSC  160 (288)
T ss_pred             ccccC
Confidence            87753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.85  E-value=1.2e-20  Score=199.50  Aligned_cols=149  Identities=30%  Similarity=0.490  Sum_probs=133.4

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      ++|...+.||+|+||.||++... +++.||+|.+........+.+.+|+.++.+++||||+++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            57888899999999999999865 47889999986554555678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ++++|.+++.+.    .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..+...
T Consensus        99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~  168 (293)
T cd06647          99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (293)
T ss_pred             CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence            999999998542    3788999999999999999999997   999999999999999999999999998866543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=1.4e-20  Score=196.45  Aligned_cols=148  Identities=28%  Similarity=0.428  Sum_probs=133.2

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      +|+..+.||.|+||.||+|.... ++.||+|.+.... .....++.+|+.++++++|+||+++++++.+....++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            57777899999999999998864 7899999986543 445678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ++++|.+++...    .+++.....++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||+++.+...
T Consensus        82 ~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          82 GGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            999999998543    5899999999999999999999987   999999999999999999999999999987644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.85  E-value=1.9e-20  Score=196.03  Aligned_cols=147  Identities=28%  Similarity=0.470  Sum_probs=130.4

Q ss_pred             CcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      -|+..++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++..++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3667789999999999999875 47899999886432 334567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ++++|.+++..    ..+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.+..
T Consensus        85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            99999998843    24889999999999999999999987   99999999999999999999999999987644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.85  E-value=5.8e-21  Score=202.37  Aligned_cols=143  Identities=30%  Similarity=0.484  Sum_probs=128.3

Q ss_pred             ceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCCH
Q 005206          547 YNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL  625 (709)
Q Consensus       547 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  625 (709)
                      ...||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++|+||+++++|
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            357999999999999875 4889999998765555567789999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       626 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ..++..    ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.+..
T Consensus       106 ~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~  169 (297)
T cd06659         106 TDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK  169 (297)
T ss_pred             HHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence            987743    34789999999999999999999987   99999999999999999999999999986643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.85  E-value=1.4e-20  Score=193.76  Aligned_cols=149  Identities=42%  Similarity=0.646  Sum_probs=131.5

Q ss_pred             CcceeecccCceEEEEEEEcC-----CcEEEEEEeccCCcc-chHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          545 TDYNKLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       545 ~~~~~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ...+.||+|+||.||++...+     +..||+|++...... ..+.+..|+.++.+++|+||+++++++.+.+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            455789999999999998865     378999999655433 57789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      |+++++|.+++..... ..+++.++..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.....
T Consensus        82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            9999999999865332 12899999999999999999999997   999999999999999999999999999877543

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=1.7e-20  Score=196.08  Aligned_cols=148  Identities=26%  Similarity=0.502  Sum_probs=131.6

Q ss_pred             CcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC-CccchHHHHHHHHHHHhcC---CCceeeEEEEEEeCCeeEEEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQ---HRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      .|+..+.||+|+||.||+|... +++.+|+|.+... .....+++.+|+.++++++   |||++++++++.+....++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4667789999999999999975 4889999998654 3345678899999999996   999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+++++|.+++...    .+++.....++.|++.||.|||+.+   |+|+||+|+||++++++.+||+|||++..+...
T Consensus        82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            999999999988432    5889999999999999999999987   999999999999999999999999999877544

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.85  E-value=1.6e-20  Score=198.10  Aligned_cols=150  Identities=29%  Similarity=0.467  Sum_probs=128.4

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcC-CCceeeEEEEEEeCCe-----
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDE-----  612 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~-----  612 (709)
                      ++|+..+.||+|+||.||+|.... ++.||+|++....  ......+.+|+.++.+++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            468888999999999999999864 8899999886542  223467889999999995 6999999999987666     


Q ss_pred             eEEEEEccCCCCHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-CCcEEEEecC
Q 005206          613 KMLVYEYMENRSLDSVIFDKAR--SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-EMTPKISDFG  689 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~KI~DFG  689 (709)
                      .++||||+++ +|.+++.....  ...+++.....++.||+.||.|||+++   |+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999985 78888765332  245899999999999999999999987   999999999999998 8999999999


Q ss_pred             CceeeC
Q 005206          690 MARIFG  695 (709)
Q Consensus       690 la~~l~  695 (709)
                      +++.+.
T Consensus       157 ~~~~~~  162 (295)
T cd07837         157 LGRAFS  162 (295)
T ss_pred             cceecC
Confidence            998664

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=1.8e-20  Score=200.05  Aligned_cols=150  Identities=26%  Similarity=0.325  Sum_probs=133.4

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCc---cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...+.||+|+||.||++...+ ++.+|+|.+.....   ...+.+..|+.++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            367888999999999999999875 88999999975432   24567899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ||+++++|.+++... ....+++.....++.||+.||+|||+.+   ++|+||||+||+++.++.+||+|||++....
T Consensus        81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  154 (316)
T cd05574          81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD  154 (316)
T ss_pred             EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence            999999999988643 2345899999999999999999999987   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.85  E-value=5.9e-21  Score=209.45  Aligned_cols=148  Identities=28%  Similarity=0.396  Sum_probs=128.3

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcC-C-----CceeeEEEEEEeCCeeEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-H-----RNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H-----~nIv~l~g~~~~~~~~~l  615 (709)
                      +|.+.+.||+|+||+|-+|.+.. ++.||||+++.. ..-..+-..|+.+|..|+ |     -|+|++++++...++.+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            67888999999999999998765 899999999654 344566678999999996 4     489999999999999999


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC--CcEEEEecCCcee
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE--MTPKISDFGMARI  693 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~KI~DFGla~~  693 (709)
                      |+|.+. -+|.++|... +...++......|+.||+.||.+||+.+   |||+|||||||||.+.  ..+||+|||.|..
T Consensus       266 VfELL~-~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELLS-TNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhhh-hhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence            999985 5899999664 4456899999999999999999999987   9999999999999654  4799999999986


Q ss_pred             eCC
Q 005206          694 FGG  696 (709)
Q Consensus       694 l~~  696 (709)
                      ...
T Consensus       341 ~~q  343 (586)
T KOG0667|consen  341 ESQ  343 (586)
T ss_pred             cCC
Confidence            643

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.85  E-value=8.3e-21  Score=223.09  Aligned_cols=157  Identities=24%  Similarity=0.365  Sum_probs=130.8

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeeE
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKM  614 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~  614 (709)
                      ..++|.++++||+|+||.||++.... ++.+|+|.+...  .......|..|+.++.+|+|||||++++++.+.  ...+
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            34689999999999999999999866 678899988643  233467899999999999999999999988654  4689


Q ss_pred             EEEEccCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CceEecCCCCCCEEEcCC---------
Q 005206          615 LVYEYMENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSR----FRIIHRDLKASNILLDKE---------  680 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~iiHrDlkp~NILl~~~---------  680 (709)
                      |||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.+.    .+||||||||+||||+.+         
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            9999999999999986532 23458999999999999999999998531    249999999999999642         


Q ss_pred             --------CcEEEEecCCceeeCC
Q 005206          681 --------MTPKISDFGMARIFGG  696 (709)
Q Consensus       681 --------~~~KI~DFGla~~l~~  696 (709)
                              ..+||+|||+++.+..
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~  194 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGI  194 (1021)
T ss_pred             cccccCCCCceEEccCCccccccc
Confidence                    3589999999987743

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.85  E-value=5.4e-21  Score=200.02  Aligned_cols=147  Identities=29%  Similarity=0.475  Sum_probs=130.3

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      .|+..+.||+|+||.||+|.+.. ++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            35666789999999999998754 7789999886443 344568999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ++++|.+++..    ..+++..+..++.|+++||.|||+++   ++|+||+|+||++++++.+||+|||+++.+..
T Consensus        85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06642          85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccC
Confidence            99999998843    34889999999999999999999987   99999999999999999999999999987654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.85  E-value=1.8e-20  Score=196.24  Aligned_cols=148  Identities=26%  Similarity=0.459  Sum_probs=131.8

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      .|+..++||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++.+++|+||+++++++.+....++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            46677899999999999998764 7899999886442 345678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ++++|.+++..    ..+++.....++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||+++.+...
T Consensus        85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence            99999998843    24788899999999999999999987   999999999999999999999999999877543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.85  E-value=1.9e-20  Score=193.63  Aligned_cols=150  Identities=29%  Similarity=0.451  Sum_probs=135.6

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCc-cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ++|...+.||+|++|.||++.... ++.|+||++..... ...+++.+|+.++.+++|+||+++++++...+..++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            367788999999999999999876 89999999876543 4567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ-DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      +++++|.+++...   ..+++..+..++.|+++||.|||+ .+   ++||||+|+||+++.++.+||+|||+++.+...
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            9999999999654   458999999999999999999999 87   999999999999999999999999999977544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.85  E-value=2.2e-20  Score=192.77  Aligned_cols=150  Identities=27%  Similarity=0.461  Sum_probs=132.4

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +|+..++||+|+||.||++.... ++.+|+|++...  .....+++.+|+.++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            47778999999999999998764 789999998643  234456899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      +++++|.+++.... ...+++.+.+.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++..+..
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~  153 (256)
T cd08218          81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS  153 (256)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence            99999999885432 234789999999999999999999987   99999999999999999999999999987644

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=6e-22  Score=198.90  Aligned_cols=160  Identities=29%  Similarity=0.350  Sum_probs=137.4

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|..+++||+|.||+|.+++-+. ++.+|+|++++.   ...+...-+.|-++|...+||.+..|.-.++..+..++||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            567888999999999999998764 889999999765   3445566788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||..+|.|.-+|..   ...+++.+...+...|+.||.|||+++   ||.||||.+|+|||.+|++||+||||++--...
T Consensus       248 eyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  248 EYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             EEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccc
Confidence            99999999877744   345777777788999999999999987   999999999999999999999999999854333


Q ss_pred             CccccccceecC
Q 005206          698 QTEQNTKRVVGT  709 (709)
Q Consensus       698 ~~~~~~~~~~GT  709 (709)
                      .  ..+.++|||
T Consensus       322 g--~t~kTFCGT  331 (516)
T KOG0690|consen  322 G--DTTKTFCGT  331 (516)
T ss_pred             c--ceeccccCC
Confidence            2  346678987

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.85  E-value=3.5e-21  Score=199.43  Aligned_cols=144  Identities=29%  Similarity=0.453  Sum_probs=124.3

Q ss_pred             eeecccCceEEEEEEEcC--------CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          548 NKLGQGGFGIVYKGRLLE--------GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +.||+|+||.||+|....        ..++|+|.+........+++.+|+.++..++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            369999999999997643        234888887655455567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc--------EEEEecCCc
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT--------PKISDFGMA  691 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~--------~KI~DFGla  691 (709)
                      +++|+|..++....  ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.        +|++|||++
T Consensus        81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            99999999986543  25889999999999999999999987   999999999999987765        699999998


Q ss_pred             eeeCC
Q 005206          692 RIFGG  696 (709)
Q Consensus       692 ~~l~~  696 (709)
                      .....
T Consensus       156 ~~~~~  160 (258)
T cd05078         156 ITVLP  160 (258)
T ss_pred             cccCC
Confidence            76543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.85  E-value=2.1e-20  Score=199.51  Aligned_cols=144  Identities=29%  Similarity=0.472  Sum_probs=119.0

Q ss_pred             eeecccCceEEEEEEEcC---CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEe--CCeeEEEEEccCC
Q 005206          548 NKLGQGGFGIVYKGRLLE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE--MDEKMLVYEYMEN  622 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~---g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~~  622 (709)
                      .+||+|+||.||+|+..+   +..||+|.+....  ....+.+|+.++.+++||||+++++++..  ....++|+||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            589999999999998754   4689999886432  23567899999999999999999999864  4567899999875


Q ss_pred             CCHHHHHhcc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE----cCCCcEEEEecCCce
Q 005206          623 RSLDSVIFDK------ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL----DKEMTPKISDFGMAR  692 (709)
Q Consensus       623 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~KI~DFGla~  692 (709)
                       +|.+++...      .....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             676666421      12235789999999999999999999987   9999999999999    566799999999999


Q ss_pred             eeCCC
Q 005206          693 IFGGD  697 (709)
Q Consensus       693 ~l~~~  697 (709)
                      .+...
T Consensus       161 ~~~~~  165 (317)
T cd07867         161 LFNSP  165 (317)
T ss_pred             ccCCC
Confidence            77543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.85  E-value=1.1e-20  Score=198.69  Aligned_cols=148  Identities=24%  Similarity=0.384  Sum_probs=130.6

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ++|+..++||+|+||.||++.... ++.+|+|++.... ....+++.+|++++..++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            457777899999999999998764 7889999886543 34467899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      +++++|.+++...   ..+++.....++.+++.||.|||+..  .++||||||+||++++++.++|+|||+++.+
T Consensus        85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~  154 (284)
T cd06620          85 MDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGEL  154 (284)
T ss_pred             CCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence            9999999988543   34899999999999999999999742  3999999999999999999999999998765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.85  E-value=1.6e-20  Score=200.07  Aligned_cols=150  Identities=29%  Similarity=0.473  Sum_probs=127.9

Q ss_pred             CcCcceeecccCceEEEEEEEcC---CcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeeE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE---GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKM  614 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~---g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~  614 (709)
                      .|...++||+|+||.||+|....   ++.||+|.+....   ....+.+.+|+.++.+++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            36777899999999999999865   6899999997632   33456788999999999999999999999988  7899


Q ss_pred             EEEEccCCCCHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC----CCcEEEEec
Q 005206          615 LVYEYMENRSLDSVIFDKAR--SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK----EMTPKISDF  688 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~----~~~~KI~DF  688 (709)
                      +||||+++ +|.+++.....  ...+++.....++.||+.||.|||+.+   |+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999985 66666543222  235888999999999999999999987   999999999999999    999999999


Q ss_pred             CCceeeCC
Q 005206          689 GMARIFGG  696 (709)
Q Consensus       689 Gla~~l~~  696 (709)
                      |+++.+..
T Consensus       157 g~~~~~~~  164 (316)
T cd07842         157 GLARLFNA  164 (316)
T ss_pred             ccccccCC
Confidence            99997643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.85  E-value=2.9e-20  Score=191.78  Aligned_cols=150  Identities=25%  Similarity=0.411  Sum_probs=130.2

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeC-CeeEEEEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-DEKMLVYE  618 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~lV~E  618 (709)
                      +|...+.||+|++|.||++.... ++.+|+|++...  .....+.+.+|+.++++++|+|++++++.+... ...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            36778999999999999998765 688999998643  234456789999999999999999999987644 45789999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |+++++|.+++... ....+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            99999999998653 2345899999999999999999999997   99999999999999999999999999987743

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.85  E-value=1.3e-20  Score=194.57  Aligned_cols=146  Identities=32%  Similarity=0.567  Sum_probs=127.6

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      ++|...+.||+|+||.||++.. .++.+|+|++...  ...+.+.+|+.++.+++|||++++++++.. +..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence            3577888999999999999975 6788999988543  234689999999999999999999999865 45799999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      +++|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~  151 (254)
T cd05083          82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS  151 (254)
T ss_pred             CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence            999999986543 235789999999999999999999987   9999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.85  E-value=6.5e-21  Score=197.06  Aligned_cols=149  Identities=29%  Similarity=0.410  Sum_probs=133.6

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      +|...+.||.|+||.||++.... ++.+|+|.+.+..   ....+.+.+|+.++++++||||+++++++.+.+..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            47778999999999999999864 8899999996542   2456789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      |+++++|.+++...   ..+++.....++.||++||.|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            99999999998553   35889999999999999999999987   999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.85  E-value=7.8e-21  Score=199.35  Aligned_cols=148  Identities=28%  Similarity=0.501  Sum_probs=128.7

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +|...+.||+|+||.||+|.... |+.+|+|++....  ....+.+.+|+.++.+++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            46777899999999999999864 8899999986432  22345788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ++ ++|.+++....  ..+++.....++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  151 (284)
T cd07839          81 CD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI  151 (284)
T ss_pred             CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence            97 57877775432  34899999999999999999999987   99999999999999999999999999987643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.85  E-value=1.2e-20  Score=198.04  Aligned_cols=149  Identities=30%  Similarity=0.542  Sum_probs=130.3

Q ss_pred             CcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +|+..+.||+|+||.||+|+.. +++.||||++....  ....+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4777889999999999999886 48899999886432  22346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ++ ++|.+++.... ...+++.....++.||+.||+|||+.+   ++||||+|+||+++.++.+||+|||+++.+..
T Consensus        81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~  152 (284)
T cd07860          81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV  152 (284)
T ss_pred             cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence            96 68988885533 345899999999999999999999987   99999999999999999999999999986643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.84  E-value=2e-22  Score=195.51  Aligned_cols=149  Identities=31%  Similarity=0.471  Sum_probs=128.1

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      +++|+..++||+|.|+.||++... .|+.+|+|.+...  +....+++.+|+++-..|+|||||+|.....+....|||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            356777789999999999998765 4888888877533  3457788999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC---CcEEEEecCCceee
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE---MTPKISDFGMARIF  694 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~KI~DFGla~~l  694 (709)
                      |+|.+++|..-|.+.   -..++...-+++.||+.+|.|+|.++   |||||+||+|+||.+.   --+||+|||+|..+
T Consensus        90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            999999997666443   23677788889999999999999998   9999999999999543   46899999999999


Q ss_pred             C
Q 005206          695 G  695 (709)
Q Consensus       695 ~  695 (709)
                      +
T Consensus       164 ~  164 (355)
T KOG0033|consen  164 N  164 (355)
T ss_pred             C
Confidence            7

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=7.6e-22  Score=225.40  Aligned_cols=168  Identities=25%  Similarity=0.277  Sum_probs=145.6

Q ss_pred             HHHHHHhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeC
Q 005206          535 ETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM  610 (709)
Q Consensus       535 ~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~  610 (709)
                      .++.-..++|.++++||+|+||.|..++++. ++.+|+|++.+.   ......-|..|-++|..-+.+-||.|.-.|.+.
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            3444456789999999999999999999976 778899999762   344567899999999999999999999999999


Q ss_pred             CeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCC
Q 005206          611 DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (709)
Q Consensus       611 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGl  690 (709)
                      .+.|||||||+||+|-.++.+..   .+++.....++..|+.||.-||+.|   +|||||||+|||||..|++||+|||-
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence            99999999999999999996544   4788887788999999999999988   99999999999999999999999999


Q ss_pred             ceeeCCCCccccccceecC
Q 005206          691 ARIFGGDQTEQNTKRVVGT  709 (709)
Q Consensus       691 a~~l~~~~~~~~~~~~~GT  709 (709)
                      +-.+..+.+-+ ....+||
T Consensus       222 Clkm~~dG~V~-s~~aVGT  239 (1317)
T KOG0612|consen  222 CLKMDADGTVR-SSVAVGT  239 (1317)
T ss_pred             HHhcCCCCcEE-eccccCC
Confidence            99998776554 3446776

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.84  E-value=3e-20  Score=197.73  Aligned_cols=149  Identities=34%  Similarity=0.529  Sum_probs=129.2

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      +.|...++||+|+||.||+|... +++.||+|++....   ....+++.+|+.++.+++||||+++.+++.+.+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45788889999999999999886 48899999886432   233467899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ||++ |++.+++....  ..+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.+||+|||+++....
T Consensus        95 e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          95 EYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            9997 57777664322  35899999999999999999999987   99999999999999999999999999987643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.84  E-value=2e-20  Score=196.09  Aligned_cols=158  Identities=30%  Similarity=0.489  Sum_probs=133.8

Q ss_pred             ChHHHHHHhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhc-CCCceeeEEEEEEe-
Q 005206          533 DFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVE-  609 (709)
Q Consensus       533 ~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~-  609 (709)
                      ++.++..+.+.|+..+.||+|+||.||+|.... ++.+|+|.+... .....++..|+.++.++ +|+||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            334444566788888999999999999999854 788999988543 33456788999999998 69999999999863 


Q ss_pred             -----CCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEE
Q 005206          610 -----MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK  684 (709)
Q Consensus       610 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~K  684 (709)
                           .+..+++|||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+   |+|+||||+||++++++.+|
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence                 456799999999999999886532 345788888999999999999999987   99999999999999999999


Q ss_pred             EEecCCceeeC
Q 005206          685 ISDFGMARIFG  695 (709)
Q Consensus       685 I~DFGla~~l~  695 (709)
                      |+|||+++.+.
T Consensus       162 l~dfg~~~~~~  172 (282)
T cd06636         162 LVDFGVSAQLD  172 (282)
T ss_pred             EeeCcchhhhh
Confidence            99999988653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.84  E-value=2e-21  Score=189.39  Aligned_cols=153  Identities=29%  Similarity=0.359  Sum_probs=135.3

Q ss_pred             hcCcCcceeecccCceEEEEEEE-cCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----eeE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD-----EKM  614 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~  614 (709)
                      .++|.+.++||+|+|.-||.++. .+++.+|+|++.-.+.++.+..++|++..++++||||++++++...+.     ..|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            46799999999999999999984 457889999997777778889999999999999999999998876443     489


Q ss_pred             EEEEccCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          615 LVYEYMENRSLDSVIFDKAR-SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      |++.|...|+|.+.+..... ...+++.+.+.|+.+|++||++||+.. ++++||||||.|||+.+.+.++|.|||-+..
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence            99999999999999865443 346899999999999999999999985 5899999999999999999999999999875


Q ss_pred             e
Q 005206          694 F  694 (709)
Q Consensus       694 l  694 (709)
                      .
T Consensus       179 a  179 (302)
T KOG2345|consen  179 A  179 (302)
T ss_pred             c
Confidence            3

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.84  E-value=2.1e-20  Score=197.31  Aligned_cols=150  Identities=31%  Similarity=0.499  Sum_probs=130.1

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeeEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKMLV  616 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV  616 (709)
                      ++|...+.||+|+||.||+|.... ++.+|+|.++...  ......+.+|+.++.+++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            467888899999999999999874 7899999986442  22234678899999999999999999999887  889999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||++ ++|.+++....  ..+++.....++.||+.||+|||+.+   ++|+||||+||+++.++.+||+|||+++.+..
T Consensus        85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            99998 48988875432  35899999999999999999999997   99999999999999999999999999997755


Q ss_pred             C
Q 005206          697 D  697 (709)
Q Consensus       697 ~  697 (709)
                      .
T Consensus       159 ~  159 (293)
T cd07843         159 P  159 (293)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.84  E-value=1.7e-20  Score=196.97  Aligned_cols=150  Identities=27%  Similarity=0.447  Sum_probs=131.5

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ++|+..++||+|+||.||+|...+ ++.||+|++...  .....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            367888999999999999999875 789999988643  23345789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      |++++.+..++.+.   ..+++.....++.||+.||.|||+++   ++||||+|+||++++++.+||+|||+++.+...
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          81 YVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            99987777655332   34889999999999999999999997   999999999999999999999999999877544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.84  E-value=1.2e-20  Score=196.23  Aligned_cols=145  Identities=37%  Similarity=0.590  Sum_probs=125.8

Q ss_pred             eeecccCceEEEEEEEcC-------CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          548 NKLGQGGFGIVYKGRLLE-------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-------g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +.||+|+||.||+|+..+       ++.+|+|.+.... .....+|.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            369999999999998753       2578999886543 34567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-----cEEEEecCC
Q 005206          620 MENRSLDSVIFDKA----RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-----TPKISDFGM  690 (709)
Q Consensus       620 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-----~~KI~DFGl  690 (709)
                      +++++|.+++.+..    ....+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.+.     .+||+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999996532    2234789999999999999999999987   99999999999999887     899999999


Q ss_pred             ceeeC
Q 005206          691 ARIFG  695 (709)
Q Consensus       691 a~~l~  695 (709)
                      ++.+.
T Consensus       158 ~~~~~  162 (269)
T cd05044         158 ARDIY  162 (269)
T ss_pred             ccccc
Confidence            98654

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.84  E-value=1.5e-21  Score=195.38  Aligned_cols=152  Identities=29%  Similarity=0.484  Sum_probs=125.0

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-----CcEEEEEEeccCCcc-c-hHHHHHHHHHHHhcCCCceeeEEEEEEe-CCee
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSGQ-G-IEEFKNEVRLIAKLQHRNLVRLLGCCVE-MDEK  613 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~~~~-~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~  613 (709)
                      ..|.....||+|.||.||++.-.+     ..++|+|+++..... + .....+|+.+++.|+||||+.|..++.. ....
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            457777899999999999995433     237899999654221 2 2345789999999999999999999887 6678


Q ss_pred             EEEEEccCCCCHHHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC----CcEEEEe
Q 005206          614 MLVYEYMENRSLDSVIFDK--ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE----MTPKISD  687 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~----~~~KI~D  687 (709)
                      +|++||.+. +|..+|+-.  .+...++......|+.||+.|+.|||++=   |+||||||.||||..+    |.+||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence            999999987 677776532  23356888999999999999999999984   9999999999999877    9999999


Q ss_pred             cCCceeeCCC
Q 005206          688 FGMARIFGGD  697 (709)
Q Consensus       688 FGla~~l~~~  697 (709)
                      ||+||++..+
T Consensus       180 lGlaR~~~~p  189 (438)
T KOG0666|consen  180 LGLARLFNNP  189 (438)
T ss_pred             ccHHHHhhcc
Confidence            9999998654

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=2.9e-20  Score=193.05  Aligned_cols=148  Identities=29%  Similarity=0.481  Sum_probs=128.8

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC-----CccchHHHHHHHHHHHhcCCCceeeEEEEEEeC--Cee
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN-----SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEK  613 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~  613 (709)
                      .+|...+.||+|+||.||++.... ++.+|+|.+...     ..+..+.+.+|+.++.+++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            468888999999999999998754 889999987432     223456889999999999999999999998764  457


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ++++||+++++|.+++...   ..+++.....++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            8999999999999998543   23788899999999999999999987   99999999999999999999999999987


Q ss_pred             eC
Q 005206          694 FG  695 (709)
Q Consensus       694 l~  695 (709)
                      +.
T Consensus       156 ~~  157 (264)
T cd06653         156 IQ  157 (264)
T ss_pred             cc
Confidence            63

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=2.3e-20  Score=194.11  Aligned_cols=153  Identities=31%  Similarity=0.481  Sum_probs=133.2

Q ss_pred             HHhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCC-----
Q 005206          539 RATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMD-----  611 (709)
Q Consensus       539 ~~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~-----  611 (709)
                      .++++|...+.||+|+||.||+|.... ++.+++|++.... ...++|.+|+.++.++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            356889999999999999999999864 7889999886443 3457899999999999 6999999999997654     


Q ss_pred             -eeEEEEEccCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecC
Q 005206          612 -EKMLVYEYMENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG  689 (709)
Q Consensus       612 -~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFG  689 (709)
                       ..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence             4899999999999999886432 2346899999999999999999999987   9999999999999999999999999


Q ss_pred             CceeeC
Q 005206          690 MARIFG  695 (709)
Q Consensus       690 la~~l~  695 (709)
                      ++....
T Consensus       159 ~~~~~~  164 (275)
T cd06608         159 VSAQLD  164 (275)
T ss_pred             cceecc
Confidence            998654

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.84  E-value=3.4e-20  Score=192.92  Aligned_cols=153  Identities=30%  Similarity=0.514  Sum_probs=129.2

Q ss_pred             CcCcceeecccCceEEEEEEEcC--CcEEEEEEeccC----------CccchHHHHHHHHHHHh-cCCCceeeEEEEEEe
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE--GQEIAVKRLSRN----------SGQGIEEFKNEVRLIAK-LQHRNLVRLLGCCVE  609 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~--g~~VAVK~l~~~----------~~~~~~~f~~Ei~~l~~-l~H~nIv~l~g~~~~  609 (709)
                      +|+..+.||+|+||.||+|.+..  ++.+|+|.+...          ......++..|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            36677899999999999999876  678999987532          12234567889998875 799999999999999


Q ss_pred             CCeeEEEEEccCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEec
Q 005206          610 MDEKMLVYEYMENRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDF  688 (709)
Q Consensus       610 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DF  688 (709)
                      .+..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+..  +++|+||+|+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999987542 22345899999999999999999999632  3999999999999999999999999


Q ss_pred             CCceeeCCC
Q 005206          689 GMARIFGGD  697 (709)
Q Consensus       689 Gla~~l~~~  697 (709)
                      |++......
T Consensus       159 g~~~~~~~~  167 (269)
T cd08528         159 GLAKQKQPE  167 (269)
T ss_pred             cceeecccc
Confidence            999876544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.84  E-value=3.5e-20  Score=195.09  Aligned_cols=151  Identities=28%  Similarity=0.421  Sum_probs=130.4

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~  617 (709)
                      ++|...+.||.|++|.||++.+.. ++.+|+|.+.... ....+++.+|++++++++||||+++++++.+.  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            357788999999999999999865 7889999987543 24567899999999999999999999998754  3679999


Q ss_pred             EccCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          618 EYMENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ||+++++|.+++.... ....+++.....++.||+.||.|||+.+   ++|+||+|+||++++++.+||+|||++..+.
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            9999999998875422 2345788999999999999999999987   9999999999999999999999999987653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.84  E-value=4.1e-20  Score=190.43  Aligned_cols=151  Identities=29%  Similarity=0.468  Sum_probs=131.8

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +|...+.||+|+||.||++.... ++.+|+|++...  .....+++.+|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            47778899999999999998754 789999998654  234567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CcEEEEecCCceeeCCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFGGD  697 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~KI~DFGla~~l~~~  697 (709)
                      +++++|.+++.+.. ...+++..+..++.|++.||.|||+++   ++|+||||+||+++++ ..+||+|||+++.+...
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            99999999996533 345899999999999999999999987   9999999999999865 56899999999977543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.84  E-value=3.3e-21  Score=201.43  Aligned_cols=155  Identities=30%  Similarity=0.393  Sum_probs=138.5

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      +.|+..++||+|+||.||-++... |+.+|.|++.++   ..++..--++|-.+|.+++.+.||.|--.+...+..+||+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            457888999999999999998765 889999998654   3455667789999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ..|.+|+|.-+|.+... +.+++.+...++.+|+.||++||...   ||.|||||+|||||+.|+++|+|.|||..+.+.
T Consensus       265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999998876554 56899999999999999999999987   999999999999999999999999999998766


Q ss_pred             Ccc
Q 005206          698 QTE  700 (709)
Q Consensus       698 ~~~  700 (709)
                      +..
T Consensus       341 ~~~  343 (591)
T KOG0986|consen  341 KPI  343 (591)
T ss_pred             Ccc
Confidence            544

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=6.2e-20  Score=188.54  Aligned_cols=149  Identities=34%  Similarity=0.553  Sum_probs=133.5

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCc--cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG--QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +|+..+.||+|++|.||++.... ++.+++|.+.....  ...+.+.+|++++.+++|+|++++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            36677899999999999998764 78999999976543  4567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      +++++|.+++...   ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  152 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV  152 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence            9999999998543   35899999999999999999999987   999999999999999999999999999987543

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.84  E-value=3e-20  Score=194.53  Aligned_cols=142  Identities=32%  Similarity=0.426  Sum_probs=125.4

Q ss_pred             ecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCCH
Q 005206          550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL  625 (709)
Q Consensus       550 LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  625 (709)
                      ||+|+||+||++.... ++.+|+|.+....   ....+.+.+|+.++.+++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            6899999999998754 8899999986432   23345678899999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       626 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      .+++.+... ..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||+++.+.
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~  146 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELK  146 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence            999865432 35899999999999999999999987   9999999999999999999999999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.84  E-value=3.1e-20  Score=196.61  Aligned_cols=151  Identities=29%  Similarity=0.514  Sum_probs=129.8

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD-----  611 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----  611 (709)
                      ..++|+..+.||+|+||.||+|.... ++.||+|++....  ......+.+|+.++.+++||||+++++++.+..     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            45788889999999999999999865 7899999986542  233457788999999999999999999987655     


Q ss_pred             -----eeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEE
Q 005206          612 -----EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKIS  686 (709)
Q Consensus       612 -----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~  686 (709)
                           ..++|+||+++ ++..++...  ...+++..+..++.||+.||+|||+.+   |+||||||+||++++++.+||+
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence                 78999999986 676666432  335899999999999999999999997   9999999999999999999999


Q ss_pred             ecCCceeeCC
Q 005206          687 DFGMARIFGG  696 (709)
Q Consensus       687 DFGla~~l~~  696 (709)
                      |||+++.+..
T Consensus       159 dfg~~~~~~~  168 (302)
T cd07864         159 DFGLARLYNS  168 (302)
T ss_pred             cccccccccC
Confidence            9999987644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.84  E-value=8.6e-21  Score=203.23  Aligned_cols=158  Identities=26%  Similarity=0.366  Sum_probs=132.6

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--------ccchHHHHHHHHHHHhcC---CCceeeEEEEEEe
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--------GQGIEEFKNEVRLIAKLQ---HRNLVRLLGCCVE  609 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--------~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~  609 (709)
                      ..|+.++.+|+|+||+|..+.++. ..+|+||.+.+..        ....-..-.||.+|..++   |+||++++.+|.+
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            458888999999999999999876 5689999886531        112234567999999997   9999999999999


Q ss_pred             CCeeEEEEEccC-CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEec
Q 005206          610 MDEKMLVYEYME-NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDF  688 (709)
Q Consensus       610 ~~~~~lV~Ey~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DF  688 (709)
                      ++..||++|-.. +.+|.++|.-.   +.+++.....|+.||+.|+++||+++   |||||||-+||.++.+|.+||+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~k---p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFK---PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhcc---CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence            999999999874 55788888432   34899999999999999999999998   999999999999999999999999


Q ss_pred             CCceeeCCCCccccccceecC
Q 005206          689 GMARIFGGDQTEQNTKRVVGT  709 (709)
Q Consensus       689 Gla~~l~~~~~~~~~~~~~GT  709 (709)
                      |-|........    ..++||
T Consensus       715 gsaa~~ksgpf----d~f~gt  731 (772)
T KOG1152|consen  715 GSAAYTKSGPF----DVFVGT  731 (772)
T ss_pred             cchhhhcCCCc----ceeeee
Confidence            99987765543    336665

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.84  E-value=5.4e-20  Score=193.63  Aligned_cols=146  Identities=29%  Similarity=0.485  Sum_probs=130.2

Q ss_pred             cCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          544 FTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      |...+.||+|++|.||++... +++.+++|++........+.+.+|+.++.+++||||+++++++...+..++++||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            444579999999999999875 4789999998655555567789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ++|.+++..    ..+++..+..++.|++.||+|||+++   |+||||+|+||+++.++.+||+|||+++....
T Consensus       101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~  167 (285)
T cd06648         101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK  167 (285)
T ss_pred             CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence            999999855    24789999999999999999999997   99999999999999999999999999886543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.84  E-value=5.3e-20  Score=193.16  Aligned_cols=141  Identities=28%  Similarity=0.357  Sum_probs=118.9

Q ss_pred             eecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHH---hcCCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIA---KLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       549 ~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~---~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      .||+|+||.||++...+ ++.+|+|.+.+..   ......+.+|..++.   ..+||||+.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            48999999999998864 7899999886542   122233455554443   3479999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      +++|.+++...   ..+++.....++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+.
T Consensus        81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~  148 (279)
T cd05633          81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (279)
T ss_pred             CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence            99999988643   34899999999999999999999997   9999999999999999999999999998664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.84  E-value=1e-19  Score=186.05  Aligned_cols=149  Identities=34%  Similarity=0.574  Sum_probs=134.5

Q ss_pred             cCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          544 FTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      |...+.||+|++|.||++... +++.+++|++........+++.+|+.++.+++|+|++++++++......++++||+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   81 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG   81 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence            566789999999999999986 5889999999765555678899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ++|.+++....  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        82 ~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          82 GSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             CcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            99999985532  45899999999999999999999987   999999999999999999999999999887654

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.84  E-value=2.3e-20  Score=208.92  Aligned_cols=153  Identities=25%  Similarity=0.387  Sum_probs=121.6

Q ss_pred             HhcCcCcceeecccCceEEEEEEE-----------------cCCcEEEEEEeccCCccchHH--------------HHHH
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRL-----------------LEGQEIAVKRLSRNSGQGIEE--------------FKNE  588 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~-----------------~~g~~VAVK~l~~~~~~~~~~--------------f~~E  588 (709)
                      ..++|...++||+|+||.||+|.+                 ..++.||||++........++              +..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            357899999999999999999964                 235679999986543222233              3457


Q ss_pred             HHHHHhcCCCce-----eeEEEEEEe--------CCeeEEEEEccCCCCHHHHHhccCC---------------------
Q 005206          589 VRLIAKLQHRNL-----VRLLGCCVE--------MDEKMLVYEYMENRSLDSVIFDKAR---------------------  634 (709)
Q Consensus       589 i~~l~~l~H~nI-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~~---------------------  634 (709)
                      +.++.+++|.++     ++++++|..        .+..+|||||+++++|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777888877655     678888754        3568999999999999998864211                     


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          635 SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       635 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ...++|..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  360 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMC  360 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccc
Confidence            123567888899999999999999987   9999999999999999999999999998654

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.83  E-value=8.1e-20  Score=187.61  Aligned_cols=150  Identities=33%  Similarity=0.507  Sum_probs=134.5

Q ss_pred             CcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeeEEEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKMLVY  617 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~  617 (709)
                      +|+..+.||+|++|.||+|... +++.|++|++....  ....+.+.+|+.++++++|+||+++++.+.+.  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3667789999999999999987 58899999986543  24578899999999999999999999999988  8899999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+++++|.+++.+..   .+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            9999999999986543   5899999999999999999999987   999999999999999999999999999987654


Q ss_pred             C
Q 005206          698 Q  698 (709)
Q Consensus       698 ~  698 (709)
                      .
T Consensus       155 ~  155 (260)
T cd06606         155 E  155 (260)
T ss_pred             c
Confidence            3

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.83  E-value=2.3e-20  Score=211.92  Aligned_cols=154  Identities=21%  Similarity=0.351  Sum_probs=120.2

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcC--CcEEEEEE--------------ec---cCCccchHHHHHHHHHHHhcCCCce
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLE--GQEIAVKR--------------LS---RNSGQGIEEFKNEVRLIAKLQHRNL  600 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~--g~~VAVK~--------------l~---~~~~~~~~~f~~Ei~~l~~l~H~nI  600 (709)
                      ..++|...++||+|+||+||++.+..  +...++|.              +.   .........+.+|+.++.+++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            34689999999999999999987643  11222221              10   1112234578899999999999999


Q ss_pred             eeEEEEEEeCCeeEEEEEccCCCCHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc
Q 005206          601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKAR--SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD  678 (709)
Q Consensus       601 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~  678 (709)
                      |++++++.+.+..++|+|++. ++|.+++.....  ...........|+.||+.||.|||+++   ||||||||+||||+
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence            999999999999999999985 567676643221  112335566789999999999999987   99999999999999


Q ss_pred             CCCcEEEEecCCceeeCCC
Q 005206          679 KEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       679 ~~~~~KI~DFGla~~l~~~  697 (709)
                      .++.+||+|||+++.+...
T Consensus       302 ~~~~vkL~DFGla~~~~~~  320 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKE  320 (501)
T ss_pred             CCCCEEEEeCCCceecCcc
Confidence            9999999999999987544

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.83  E-value=3e-20  Score=200.49  Aligned_cols=149  Identities=33%  Similarity=0.544  Sum_probs=128.1

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeC--CeeE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEM--DEKM  614 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~--~~~~  614 (709)
                      .++|...+.||+|+||.||+|.... ++.+|+|++...  .......+..|+.++.++ +||||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            4678888999999999999998864 789999988543  233456678899999999 999999999998754  3579


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      +||||++ ++|..++...    .+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++.+
T Consensus        86 lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            9999997 5898887442    5789999999999999999999987   999999999999999999999999999876


Q ss_pred             CCC
Q 005206          695 GGD  697 (709)
Q Consensus       695 ~~~  697 (709)
                      ...
T Consensus       158 ~~~  160 (337)
T cd07852         158 SEL  160 (337)
T ss_pred             ccc
Confidence            543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.83  E-value=6.1e-20  Score=193.00  Aligned_cols=151  Identities=31%  Similarity=0.500  Sum_probs=135.4

Q ss_pred             HhcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      .+++|...+.||+|+||.||++.+. +++.+++|++..... ..+.+.+|++++.+++|+|++++++.+...+..++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4567888889999999999999987 488999999965433 56789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |+++++|.+++....  ..+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.+||+|||++..+..
T Consensus        96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            999999999996643  35899999999999999999999987   99999999999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.83  E-value=5.8e-20  Score=192.51  Aligned_cols=148  Identities=30%  Similarity=0.518  Sum_probs=130.1

Q ss_pred             cCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeeEEEEE
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKMLVYE  618 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E  618 (709)
                      |+..++||+|+||.||+|...+ ++.+|+|++....  ....+.+.+|+.++.+++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            4567899999999999998875 7899999997653  33456788999999999999999999999988  78999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      |+++ +|.+++....  ..+++..+..++.||++||+|||+.+   ++|+||||+||++++++.+||+|||+++.+...
T Consensus        81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9985 8888875432  35899999999999999999999987   999999999999999999999999999977554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.83  E-value=2.3e-20  Score=192.79  Aligned_cols=141  Identities=27%  Similarity=0.410  Sum_probs=126.7

Q ss_pred             ecccCceEEEEEEEcC-CcEEEEEEeccCCc---cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCCH
Q 005206          550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL  625 (709)
Q Consensus       550 LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  625 (709)
                      ||+|+||.||+++... ++.+++|.+.....   ...+.+.+|++++.+++||||+++++.+......++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999875 89999999865432   4567899999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       626 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      .+++.+..   .+++..+..++.||+.||+|||+.+   ++|+||+|+||++++++.+||+|||++.....
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~  145 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV  145 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence            99986533   5899999999999999999999987   99999999999999999999999999886543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.83  E-value=5.3e-21  Score=191.99  Aligned_cols=151  Identities=30%  Similarity=0.421  Sum_probs=131.7

Q ss_pred             ChHHHHHHhcCcCcceeecccCceEEEEEEE-cCCcEEEEEEeccCCccchHHHHHHHHHHHhcC-CCceeeEEEEEEeC
Q 005206          533 DFETIVRATDNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEM  610 (709)
Q Consensus       533 ~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~  610 (709)
                      .++++.+.|+     +.||+|+|+.|-.+.. ..+.++|||++.+.......+..+|++++...+ |+||++|+.+|.+.
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            3555555444     5799999999998864 569999999998877777888999999999985 99999999999999


Q ss_pred             CeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC---cEEEEe
Q 005206          611 DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM---TPKISD  687 (709)
Q Consensus       611 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~KI~D  687 (709)
                      ...|||||-|.+|+|..+|.+...   +++.+.-++..+||.||.|||.++   |.||||||+|||-.+..   -+||+|
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~~---F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCD  222 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRKH---FNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICD  222 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhhh---ccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeec
Confidence            999999999999999999876543   788899999999999999999998   99999999999996654   489999


Q ss_pred             cCCceee
Q 005206          688 FGMARIF  694 (709)
Q Consensus       688 FGla~~l  694 (709)
                      |.|+.-+
T Consensus       223 fDLgSg~  229 (463)
T KOG0607|consen  223 FDLGSGI  229 (463)
T ss_pred             ccccccc
Confidence            9998654

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.83  E-value=5.8e-20  Score=190.37  Aligned_cols=142  Identities=26%  Similarity=0.378  Sum_probs=127.0

Q ss_pred             ecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCCH
Q 005206          550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL  625 (709)
Q Consensus       550 LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  625 (709)
                      ||+|+||.||+++... ++.+|+|++.+..   ....+.+.+|+.++.+++||||+++++.+.+++..++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6899999999999865 7899999986542   23456899999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       626 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      .+++.+.   ..+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.+||+|||+++.+...
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~  146 (262)
T cd05572          81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG  146 (262)
T ss_pred             HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence            9998553   24888999999999999999999987   999999999999999999999999999977543

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.83  E-value=2.6e-20  Score=193.03  Aligned_cols=148  Identities=27%  Similarity=0.401  Sum_probs=131.9

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      +|...+.||+|+||.||++.+.. ++.+|+|++.... ....+++.+|+.++++++||||+++++.+...+..++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            56677899999999999999874 7899999987653 345678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ-DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ++++|.+++....  ..+++.....++.|++.||+|||+ .+   ++|+||||+||++++++.+||+|||++..+.
T Consensus        82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            9999999986542  458889999999999999999999 76   9999999999999999999999999987653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.83  E-value=5.2e-20  Score=190.15  Aligned_cols=156  Identities=28%  Similarity=0.467  Sum_probs=130.3

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEe--CCeeEEEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE--MDEKMLVY  617 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~  617 (709)
                      +|...+.||.|+||.||++.... ++.+|+|.+...  .....+++.+|+.++++++|+||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            36677899999999999998754 788999988643  23445678999999999999999999998764  34578999


Q ss_pred             EccCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          618 EYMENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDS--RFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      ||+++++|.+++.... ....+++...+.++.||+.||.|||..+  ...++|+||||+||+++.++.+||+|||+++.+
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            9999999999986532 2346899999999999999999999332  224999999999999999999999999999987


Q ss_pred             CCCC
Q 005206          695 GGDQ  698 (709)
Q Consensus       695 ~~~~  698 (709)
                      ....
T Consensus       161 ~~~~  164 (265)
T cd08217         161 GHDS  164 (265)
T ss_pred             cCCc
Confidence            5443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=1.2e-20  Score=199.24  Aligned_cols=157  Identities=26%  Similarity=0.384  Sum_probs=134.3

Q ss_pred             cCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          544 FTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      |...+.||+|-|..|-++++- .|..||||++.+..  .-....+..|++.|+.++|||||+|+.+...+...|||+|.-
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG   99 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG   99 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence            444468999999999999874 58999999997653  233457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CcEEEEecCCceeeCCCCc
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFGGDQT  699 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~KI~DFGla~~l~~~~~  699 (709)
                      .+|+|.+||.+...  -+.+....+++.||+.|+.|+|+..   +|||||||+||.+.+. |.+||.|||++-.+.+.+.
T Consensus       100 D~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k  174 (864)
T KOG4717|consen  100 DGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK  174 (864)
T ss_pred             CCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence            99999999987654  3888889999999999999999986   9999999999988654 7899999999998876542


Q ss_pred             cccccceec
Q 005206          700 EQNTKRVVG  708 (709)
Q Consensus       700 ~~~~~~~~G  708 (709)
                         .++.||
T Consensus       175 ---L~TsCG  180 (864)
T KOG4717|consen  175 ---LTTSCG  180 (864)
T ss_pred             ---hhcccc
Confidence               344565

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.83  E-value=4.6e-20  Score=195.06  Aligned_cols=142  Identities=30%  Similarity=0.465  Sum_probs=127.9

Q ss_pred             eeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCCHH
Q 005206          548 NKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLD  626 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~  626 (709)
                      .+||+|+||.||++... +++.||||++........+.+.+|+.++.+++|+||+++++.+...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            57999999999999885 48899999986555555677999999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          627 SVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       627 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      +++..    ..+++.....++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++..+..
T Consensus       106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~  168 (292)
T cd06657         106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  168 (292)
T ss_pred             HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence            88743    23789999999999999999999987   99999999999999999999999999887644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PTZ00284 protein kinase; Provisional

Probab=99.83  E-value=4.1e-20  Score=208.50  Aligned_cols=152  Identities=23%  Similarity=0.280  Sum_probs=122.5

Q ss_pred             HHHHHHhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCC------CceeeEEEEE
Q 005206          535 ETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH------RNLVRLLGCC  607 (709)
Q Consensus       535 ~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H------~nIv~l~g~~  607 (709)
                      +++...+++|...++||+|+||+||+|.+.. ++.||||+++.. ....+++..|+.++.+++|      .+++++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            3444556889999999999999999998865 788999998643 2234456677777777654      4588999988


Q ss_pred             EeC-CeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCCEEEcCCC----
Q 005206          608 VEM-DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD-SRFRIIHRDLKASNILLDKEM----  681 (709)
Q Consensus       608 ~~~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~~~~----  681 (709)
                      ... .+.++|||++ +++|.+++.+.   ..+++..+..|+.||+.||.|||++ +   ||||||||+|||++.++    
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence            764 4678999988 67888887543   3489999999999999999999974 5   99999999999998765    


Q ss_pred             ------------cEEEEecCCceee
Q 005206          682 ------------TPKISDFGMARIF  694 (709)
Q Consensus       682 ------------~~KI~DFGla~~l  694 (709)
                                  .+||+|||++...
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~  298 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDE  298 (467)
T ss_pred             cccccccCCCCceEEECCCCccccC
Confidence                        4999999988643

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.83  E-value=1e-19  Score=192.10  Aligned_cols=149  Identities=32%  Similarity=0.540  Sum_probs=127.0

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ++|+..+.||+|++|.||+|... +++.||+|++....  ....+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999986 48899999886432  2334678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-CCcEEEEecCCceeeC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-EMTPKISDFGMARIFG  695 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~KI~DFGla~~l~  695 (709)
                      |++ ++|.+++.... ...+++.....++.||+.||+|||+++   ++||||+|+||+++. ++.+||+|||+++.+.
T Consensus        82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            996 57877774432 233678888899999999999999987   999999999999985 5679999999998664

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.83  E-value=1.2e-19  Score=194.21  Aligned_cols=148  Identities=32%  Similarity=0.530  Sum_probs=128.0

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      .|...+.||+|+||.||+++... +..+|+|++....   ....+++.+|++++++++|||++++++++.+.+..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            36667899999999999998754 7899999986432   2334578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |++ |+|.+++...  ...+++.++..++.||+.||.|||+.+   |+||||+|+||+++.++.+||+|||++.....
T Consensus       106 ~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (317)
T cd06635         106 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP  177 (317)
T ss_pred             CCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence            997 5777776433  234899999999999999999999987   99999999999999999999999999886643

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=2.2e-20  Score=184.48  Aligned_cols=141  Identities=16%  Similarity=0.188  Sum_probs=108.9

Q ss_pred             eeecccCceEEEEEEEcCCcEEEEEEeccCCc--cc-------hHHH-----------------HHHHHHHHhcCCCcee
Q 005206          548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG--QG-------IEEF-----------------KNEVRLIAKLQHRNLV  601 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~--~~-------~~~f-----------------~~Ei~~l~~l~H~nIv  601 (709)
                      ..||+|+||.||+|...+|+.||||+++....  ..       ...|                 ..|+..+.++.|+++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            57999999999999988899999999965421  11       1223                 3499999999877764


Q ss_pred             eEEEEEEeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecCCCCCCEEEcCC
Q 005206          602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL-HQDSRFRIIHRDLKASNILLDKE  680 (709)
Q Consensus       602 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiHrDlkp~NILl~~~  680 (709)
                      ....+.  ....+|||||++++++......   ...++..+...++.|++.+|.|| |+.+   |+||||||+|||++ +
T Consensus        83 ~p~~~~--~~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~  153 (190)
T cd05147          83 CPEPIL--LKSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCcEEE--ecCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-C
Confidence            333222  2234899999999877654322   23578899999999999999999 6776   99999999999998 4


Q ss_pred             CcEEEEecCCceeeCCC
Q 005206          681 MTPKISDFGMARIFGGD  697 (709)
Q Consensus       681 ~~~KI~DFGla~~l~~~  697 (709)
                      +.++|+|||+|.....+
T Consensus       154 ~~v~LiDFG~a~~~~~~  170 (190)
T cd05147         154 GKLYIIDVSQSVEHDHP  170 (190)
T ss_pred             CcEEEEEccccccCCCc
Confidence            78999999999876443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.83  E-value=7.3e-20  Score=194.27  Aligned_cols=150  Identities=31%  Similarity=0.530  Sum_probs=127.1

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCe-----
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE-----  612 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-----  612 (709)
                      .++|+..++||+|+||.||++.... ++.||||++....  ......+.+|+.++++++||||+++++++...+.     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            3578889999999999999998864 8899999886432  2223456789999999999999999999876543     


Q ss_pred             ---eEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecC
Q 005206          613 ---KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG  689 (709)
Q Consensus       613 ---~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFG  689 (709)
                         .++||||+++ +|.+++...  ...+++.+...++.||+.||.|||+++   ++|+||||+||+++.++.+||+|||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence               4999999975 787777432  235899999999999999999999997   9999999999999999999999999


Q ss_pred             CceeeCC
Q 005206          690 MARIFGG  696 (709)
Q Consensus       690 la~~l~~  696 (709)
                      +++.+..
T Consensus       165 ~~~~~~~  171 (310)
T cd07865         165 LARAFSL  171 (310)
T ss_pred             CcccccC
Confidence            9987643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.83  E-value=5.4e-20  Score=189.64  Aligned_cols=151  Identities=28%  Similarity=0.473  Sum_probs=131.8

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +|+..+.||+|+||.||++.... +..+|+|.+...  .....+.+.+|+.++++++|+||+++++.+.+.+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            46778899999999999999865 788999998643  223456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-cEEEEecCCceeeCCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIFGGD  697 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~KI~DFGla~~l~~~  697 (709)
                      +++++|.+++.+.. ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++ .+||+|||++..+...
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            99999999986532 235799999999999999999999987   99999999999999885 5799999999877543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.83  E-value=7.7e-20  Score=194.64  Aligned_cols=151  Identities=35%  Similarity=0.557  Sum_probs=129.3

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeeEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKML  615 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l  615 (709)
                      .++|...+.||+|+||.||+|.... ++.||+|++....  ......+.+|+.++.+++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            4678888999999999999999865 8899999986432  22234567899999999999999999998765  46899


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ||||+++ +|.+++....  ..+++..+..++.||+.||+|||+.+   ++||||||+||++++++.+||+|||+++.+.
T Consensus        86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999974 7888875432  45899999999999999999999998   9999999999999999999999999999875


Q ss_pred             CC
Q 005206          696 GD  697 (709)
Q Consensus       696 ~~  697 (709)
                      ..
T Consensus       160 ~~  161 (309)
T cd07845         160 LP  161 (309)
T ss_pred             Cc
Confidence            43

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.83  E-value=7.4e-20  Score=191.83  Aligned_cols=147  Identities=31%  Similarity=0.555  Sum_probs=128.8

Q ss_pred             cCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          544 FTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      |+..++||+|++|.||+|... ++..||+|++....  ....+.+.+|+.++.+++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            456689999999999999875 58999999986543  223467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      + ++|.+++..... ..+++..+..++.|+++||+|||+++   ++||||+|+||+++.++.+||+|||+++.+.
T Consensus        81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~  150 (283)
T cd07835          81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG  150 (283)
T ss_pred             C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence            5 689988854332 35899999999999999999999987   9999999999999999999999999998664

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.83  E-value=9.5e-21  Score=218.13  Aligned_cols=150  Identities=37%  Similarity=0.557  Sum_probs=122.4

Q ss_pred             HHhcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEe-------
Q 005206          539 RATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE-------  609 (709)
Q Consensus       539 ~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-------  609 (709)
                      +..++|..++.||+||||.|||++.+ ||+.+|||++... +......+.+|+.++++|+|||||+.+..+.+       
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            45567888899999999999999876 6999999999755 34445678899999999999999988752100       


Q ss_pred             -----------------------------------------------------------------------C--------
Q 005206          610 -----------------------------------------------------------------------M--------  610 (709)
Q Consensus       610 -----------------------------------------------------------------------~--------  610 (709)
                                                                                             +        
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                   0        


Q ss_pred             ---------------------------------CeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 005206          611 ---------------------------------DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL  657 (709)
Q Consensus       611 ---------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL  657 (709)
                                                       --.||=||||+.-.+.+++.+.....  .-...++++.+|+.||+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence                                             01367888998888887775543221  3456678999999999999


Q ss_pred             HhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       658 H~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      |+++   ||||||||.||+||++..+||.|||+|..
T Consensus       714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~  746 (1351)
T KOG1035|consen  714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD  746 (1351)
T ss_pred             HhCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence            9998   99999999999999999999999999987

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.83  E-value=6.4e-20  Score=197.87  Aligned_cols=148  Identities=28%  Similarity=0.491  Sum_probs=127.3

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----ee
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD-----EK  613 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~  613 (709)
                      .++|...++||+|+||.||+|... +++.||+|++... ......++.+|+.++.+++|+||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            467999999999999999999875 4889999998643 2334567889999999999999999999876543     57


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ++|+||+++ +|..++..    ..+++.....++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            999999975 77776632    34899999999999999999999997   99999999999999999999999999987


Q ss_pred             eCC
Q 005206          694 FGG  696 (709)
Q Consensus       694 l~~  696 (709)
                      ...
T Consensus       156 ~~~  158 (336)
T cd07849         156 ADP  158 (336)
T ss_pred             ccc
Confidence            643

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.83  E-value=1.3e-19  Score=190.15  Aligned_cols=141  Identities=28%  Similarity=0.353  Sum_probs=118.9

Q ss_pred             eecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHH---HHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRL---IAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       549 ~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~---l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      .||+|+||.||++.... ++.||+|.+.+..   ......+..|..+   +....||||+++++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999998754 7899999986542   1222334455443   444579999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      +++|..++...   ..+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++.+.
T Consensus        81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~  148 (278)
T cd05606          81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (278)
T ss_pred             CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence            99999888543   35899999999999999999999987   9999999999999999999999999998664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=1.2e-19  Score=179.58  Aligned_cols=142  Identities=20%  Similarity=0.206  Sum_probs=112.2

Q ss_pred             ceeecccCceEEEEEEEcCCcEEEEEEeccCCccc--------------------------hHHHHHHHHHHHhcCCCce
Q 005206          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQG--------------------------IEEFKNEVRLIAKLQHRNL  600 (709)
Q Consensus       547 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~--------------------------~~~f~~Ei~~l~~l~H~nI  600 (709)
                      ...||+|+||+||+|.+.+|+.||||++.......                          ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            35899999999999998889999999987542110                          1124578999999999987


Q ss_pred             eeEEEEEEeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCCEEEcC
Q 005206          601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ-DSRFRIIHRDLKASNILLDK  679 (709)
Q Consensus       601 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILl~~  679 (709)
                      .....+...  ..+|||||++++++.......   ..++......++.|++.+|.+||+ .+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            544443332  358999999988654332221   236778888999999999999999 77   99999999999999 


Q ss_pred             CCcEEEEecCCceeeCCC
Q 005206          680 EMTPKISDFGMARIFGGD  697 (709)
Q Consensus       680 ~~~~KI~DFGla~~l~~~  697 (709)
                      ++.++|+|||+|+.+..+
T Consensus       153 ~~~~~liDFG~a~~~~~~  170 (190)
T cd05145         153 DGKPYIIDVSQAVELDHP  170 (190)
T ss_pred             CCCEEEEEcccceecCCC
Confidence            899999999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.82  E-value=8.5e-20  Score=197.59  Aligned_cols=149  Identities=30%  Similarity=0.483  Sum_probs=128.1

Q ss_pred             HhcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD-----  611 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----  611 (709)
                      ..++|+..+.||+|+||.||++... +++.||||++...  .....+.+.+|+.++.+++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            4567999999999999999999865 4889999998543  2233457889999999999999999999987654     


Q ss_pred             -eeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCC
Q 005206          612 -EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (709)
Q Consensus       612 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGl  690 (709)
                       ..++||||+ +++|.+++..    ..+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence             358999999 6789887743    34889999999999999999999987   99999999999999999999999999


Q ss_pred             ceeeCC
Q 005206          691 ARIFGG  696 (709)
Q Consensus       691 a~~l~~  696 (709)
                      ++....
T Consensus       165 ~~~~~~  170 (343)
T cd07880         165 ARQTDS  170 (343)
T ss_pred             cccccc
Confidence            987643

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.82  E-value=1.1e-19  Score=197.40  Aligned_cols=148  Identities=33%  Similarity=0.495  Sum_probs=126.8

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeC------C
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM------D  611 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~  611 (709)
                      .++|+..+.||+|+||.||++... .++.||+|++.+.  .....+++.+|+.++.+++|+||+++++++...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            467999999999999999999876 4889999998643  233456788899999999999999999988644      3


Q ss_pred             eeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCc
Q 005206          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla  691 (709)
                      ..++||||++ ++|.+.+...     +++.....++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             cEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence            4699999996 4787776321     788889999999999999999987   999999999999999999999999999


Q ss_pred             eeeCCC
Q 005206          692 RIFGGD  697 (709)
Q Consensus       692 ~~l~~~  697 (709)
                      +.....
T Consensus       166 ~~~~~~  171 (353)
T cd07850         166 RTAGTS  171 (353)
T ss_pred             eeCCCC
Confidence            977543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.82  E-value=4e-20  Score=192.99  Aligned_cols=150  Identities=31%  Similarity=0.450  Sum_probs=133.7

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV  616 (709)
                      ++|...+.||+|+||.||++... +++.||+|++...   .....+.+.+|+.++.+++ |+||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36788899999999999999886 4889999998653   2334567899999999998 99999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+++++|.+++.+.   ..+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..+..
T Consensus        81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            9999999999998653   25899999999999999999999987   99999999999999999999999999997754


Q ss_pred             C
Q 005206          697 D  697 (709)
Q Consensus       697 ~  697 (709)
                      .
T Consensus       155 ~  155 (280)
T cd05581         155 N  155 (280)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.82  E-value=1.1e-19  Score=203.44  Aligned_cols=170  Identities=29%  Similarity=0.485  Sum_probs=143.7

Q ss_pred             ChHHHHHHhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhc-CCCceeeEEEEEEe-
Q 005206          533 DFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVE-  609 (709)
Q Consensus       533 ~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~-  609 (709)
                      .++.+...++-|.+.+.||.|.+|+||+++... ++.+|+|++... ....++...|..++... +|||+++++|++.. 
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            344445566778888999999999999998765 788899988644 44556778888888887 69999999999874 


Q ss_pred             ----CCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEE
Q 005206          610 ----MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKI  685 (709)
Q Consensus       610 ----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI  685 (709)
                          +++++||||||.+|+.-+++.... ...+.|..+..|+..+++||.+||.+.   +||||||-.|||++.++.+|+
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence                467899999999999999987655 566999999999999999999999986   999999999999999999999


Q ss_pred             EecCCceeeCCCCccccccceecC
Q 005206          686 SDFGMARIFGGDQTEQNTKRVVGT  709 (709)
Q Consensus       686 ~DFGla~~l~~~~~~~~~~~~~GT  709 (709)
                      .|||.+..+.....++  .+.+||
T Consensus       165 vDFGvSaQldsT~grR--nT~iGt  186 (953)
T KOG0587|consen  165 VDFGVSAQLDSTVGRR--NTFIGT  186 (953)
T ss_pred             eeeeeeeeeecccccc--cCcCCC
Confidence            9999999996554443  446776

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.82  E-value=1.4e-19  Score=189.30  Aligned_cols=146  Identities=26%  Similarity=0.402  Sum_probs=124.0

Q ss_pred             cCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcC-CCceeeEEEEEEeC--CeeEEEEE
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEM--DEKMLVYE  618 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~E  618 (709)
                      |+..++||+|+||.||+|.... ++.+|+|++.... .........|+.++.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            4567899999999999998764 7899999986542 222334567899999985 99999999999987  88999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |++ ++|.+++....  ..+++..+..++.||+.||+|||+.+   ++||||||+||+++. +.+||+|||+++.+..
T Consensus        81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            997 57877775432  35899999999999999999999997   999999999999999 9999999999987643

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.82  E-value=2.1e-19  Score=184.67  Aligned_cols=152  Identities=26%  Similarity=0.458  Sum_probs=134.8

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCc--cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG--QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +|...+.||+|+||.||++.... ++.+++|++.....  ...+++.+|++++.+++|+|++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            46777899999999999999864 78999999875432  4567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          620 MENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       620 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      +++++|.+++.+.. ....+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++..+...
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            99999999986532 1356899999999999999999999997   999999999999999999999999999877544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.82  E-value=6e-20  Score=197.90  Aligned_cols=148  Identities=25%  Similarity=0.492  Sum_probs=128.1

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEe----CCeeE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE----MDEKM  614 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~  614 (709)
                      ++|+..+.||+|+||.||+|.... ++.||+|++....  ....+.+.+|+.++.+++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            678888999999999999998764 8899999987542  2345678899999999999999999988763    34679


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      +||||+. ++|.+++...   ..+++.....++.||+.||.|||+.+   |+||||||+||++++++.+||+|||+++.+
T Consensus        85 lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          85 VVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence            9999996 6888887432   34899999999999999999999987   999999999999999999999999999876


Q ss_pred             CC
Q 005206          695 GG  696 (709)
Q Consensus       695 ~~  696 (709)
                      ..
T Consensus       158 ~~  159 (334)
T cd07855         158 SS  159 (334)
T ss_pred             cc
Confidence            44

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.82  E-value=3.3e-19  Score=185.90  Aligned_cols=150  Identities=23%  Similarity=0.332  Sum_probs=122.4

Q ss_pred             HHHHhcCcCcceee--cccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCe
Q 005206          537 IVRATDNFTDYNKL--GQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDE  612 (709)
Q Consensus       537 l~~~t~~f~~~~~L--G~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~  612 (709)
                      +....++|...+.+  |+|+||.||++.... ++.+|+|.+........     |+.....+ +||||+++++.+...+.
T Consensus         9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390          9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence            34445566666665  999999999998764 77889998864321111     22222222 79999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-cEEEEecCCc
Q 005206          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMA  691 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~KI~DFGla  691 (709)
                      .++||||+++++|.+++....   .+++.....++.||++||.|||+.+   ++||||||+||+++.++ .+||+|||++
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~  157 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC  157 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence            999999999999999986532   5899999999999999999999997   99999999999999998 9999999999


Q ss_pred             eeeCCC
Q 005206          692 RIFGGD  697 (709)
Q Consensus       692 ~~l~~~  697 (709)
                      +.+...
T Consensus       158 ~~~~~~  163 (267)
T PHA03390        158 KIIGTP  163 (267)
T ss_pred             eecCCC
Confidence            877543

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.82  E-value=1.6e-19  Score=195.55  Aligned_cols=154  Identities=31%  Similarity=0.462  Sum_probs=130.6

Q ss_pred             hHHHHHHhcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeC
Q 005206          534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM  610 (709)
Q Consensus       534 ~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~  610 (709)
                      .+++...+++|...+.||+|+||.||++... +++.||+|++....  ....+.+.+|+.++.+++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            3456667899999999999999999999864 58899999986532  23356788999999999999999999988643


Q ss_pred             ------CeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEE
Q 005206          611 ------DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK  684 (709)
Q Consensus       611 ------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~K  684 (709)
                            ...++++|++ +++|.+++..    ..+++..+..++.||++||+|||+.+   |+||||||+||++++++.+|
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence                  2367888876 7889887743    24889999999999999999999987   99999999999999999999


Q ss_pred             EEecCCceeeC
Q 005206          685 ISDFGMARIFG  695 (709)
Q Consensus       685 I~DFGla~~l~  695 (709)
                      |+|||+++...
T Consensus       161 l~dfg~~~~~~  171 (345)
T cd07877         161 ILDFGLARHTD  171 (345)
T ss_pred             Eeccccccccc
Confidence            99999998754

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.82  E-value=1.1e-19  Score=191.28  Aligned_cols=149  Identities=28%  Similarity=0.377  Sum_probs=128.9

Q ss_pred             CcCcceeecccCceEEEEEEEc----CCcEEEEEEeccCC----ccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCee
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEK  613 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~  613 (709)
                      +|+..+.||+|+||.||+++..    +++.+|||.+.+..    ....+.+.+|+.++.++ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3667789999999999999753    46789999986431    23346788999999999 599999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ++||||+++|+|.+++...   ..+++.....++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            9999999999999988543   34788999999999999999999987   99999999999999999999999999987


Q ss_pred             eCCC
Q 005206          694 FGGD  697 (709)
Q Consensus       694 l~~~  697 (709)
                      +...
T Consensus       155 ~~~~  158 (288)
T cd05583         155 FLAE  158 (288)
T ss_pred             cccc
Confidence            6443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=3e-20  Score=200.30  Aligned_cols=145  Identities=25%  Similarity=0.384  Sum_probs=128.5

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      .|..++.||-|+||+|.++.-.+ ...+|+|.|.+.   ........++|-+||..-+.+-||+|+-.|.+.+.+|+|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            47778899999999999997666 557899999765   34556778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      |+++|++..+|.+.   ..+++.....++..+..|+++.|..+   +|||||||+|||||.+|++||.||||+.-
T Consensus       710 YIPGGDmMSLLIrm---gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTG  778 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRM---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG  778 (1034)
T ss_pred             ccCCccHHHHHHHh---ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccc
Confidence            99999999998653   34777777778889999999999988   99999999999999999999999999863

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.82  E-value=1.9e-19  Score=186.31  Aligned_cols=142  Identities=27%  Similarity=0.376  Sum_probs=120.7

Q ss_pred             eeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHH-HhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLI-AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l-~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      +.||+|+||.||+|.... ++.||+|.+.+..   ......+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            579999999999998854 7899999986532   22233455565544 445899999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ++|.+++...   ..+++..+..++.||+.||.|||+.+   ++||||+|+||++++++.+||+|||+++...
T Consensus        82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  148 (260)
T cd05611          82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL  148 (260)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence            9999998543   24788999999999999999999987   9999999999999999999999999998654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=1.6e-20  Score=195.10  Aligned_cols=154  Identities=32%  Similarity=0.409  Sum_probs=128.4

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-------ccchHHHHHHHHHHHhcCCCceeeEEEEEEe-CCe
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-------GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE-MDE  612 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~  612 (709)
                      ++|-.+++||+|+|..|||+.+.. .+.||||+-.-+.       ....+...+|-++.+.|+||.||++++++.- .+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            346667889999999999997654 6789998764321       1223456789999999999999999999864 566


Q ss_pred             eEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCcEEEEecC
Q 005206          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK---EMTPKISDFG  689 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~KI~DFG  689 (709)
                      .+-|+||+++.+|+-||.+.   ..++++....|+.||+.||.||.+. ++||||-||||.||||-.   -|.+||.|||
T Consensus       543 FCTVLEYceGNDLDFYLKQh---klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQH---KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ceeeeeecCCCchhHHHHhh---hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            78999999999999999654   3589999999999999999999998 479999999999999954   4789999999


Q ss_pred             CceeeCCCCc
Q 005206          690 MARIFGGDQT  699 (709)
Q Consensus       690 la~~l~~~~~  699 (709)
                      |++++.++..
T Consensus       619 LSKIMdddSy  628 (775)
T KOG1151|consen  619 LSKIMDDDSY  628 (775)
T ss_pred             hhhhccCCcc
Confidence            9999977643

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.81  E-value=8.7e-20  Score=210.94  Aligned_cols=153  Identities=32%  Similarity=0.483  Sum_probs=132.3

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC--------CcEEEEEEeccCC-ccchHHHHHHHHHHHhc-CCCceeeEEEEEEeC
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE--------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEM  610 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~  610 (709)
                      .++....+.||+|.||+|++|....        ...||||.++... ..+.+.+..|+.+|..+ +|+||+.++|+|.+.
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~  374 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD  374 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence            3444555699999999999997542        3579999997653 35677899999999998 699999999999999


Q ss_pred             CeeEEEEEccCCCCHHHHHhccC---------C--C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE
Q 005206          611 DEKMLVYEYMENRSLDSVIFDKA---------R--S--SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL  677 (709)
Q Consensus       611 ~~~~lV~Ey~~~gsL~~~l~~~~---------~--~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl  677 (709)
                      ...++|.||++.|+|.+||+..+         .  .  ..+...+.+.++.|||.||+||++..   +|||||.+|||||
T Consensus       375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi  451 (609)
T KOG0200|consen  375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI  451 (609)
T ss_pred             CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence            99999999999999999998655         0  0  23888999999999999999999986   9999999999999


Q ss_pred             cCCCcEEEEecCCceeeCC
Q 005206          678 DKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       678 ~~~~~~KI~DFGla~~l~~  696 (709)
                      .++..+||+||||||....
T Consensus       452 ~~~~~~kIaDFGlar~~~~  470 (609)
T KOG0200|consen  452 TKNKVIKIADFGLARDHYN  470 (609)
T ss_pred             cCCCEEEEccccceeccCC
Confidence            9999999999999996543

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.81  E-value=1.7e-19  Score=194.36  Aligned_cols=147  Identities=29%  Similarity=0.411  Sum_probs=126.1

Q ss_pred             cCcCc-ceeecccCceEEEEEEEc-CCcEEEEEEeccCCccc--------------hHHHHHHHHHHHhcCCCceeeEEE
Q 005206          542 DNFTD-YNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQG--------------IEEFKNEVRLIAKLQHRNLVRLLG  605 (709)
Q Consensus       542 ~~f~~-~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~--------------~~~f~~Ei~~l~~l~H~nIv~l~g  605 (709)
                      ++|.. .+.||+|+||.||+|... .++.||||++.......              ...+.+|++++.+++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            34543 367999999999999876 48899999986432211              125789999999999999999999


Q ss_pred             EEEeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEE
Q 005206          606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKI  685 (709)
Q Consensus       606 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI  685 (709)
                      ++...+..++||||++ |+|.+++...   ..+++.....++.|++.||.|||+.+   |+|+||||+||+++.++.+||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence            9999999999999997 6898888542   34888999999999999999999987   999999999999999999999


Q ss_pred             EecCCceeeC
Q 005206          686 SDFGMARIFG  695 (709)
Q Consensus       686 ~DFGla~~l~  695 (709)
                      +|||+++.+.
T Consensus       161 ~dfg~~~~~~  170 (335)
T PTZ00024        161 ADFGLARRYG  170 (335)
T ss_pred             CCccceeecc
Confidence            9999998775

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.81  E-value=1.3e-19  Score=195.49  Aligned_cols=149  Identities=28%  Similarity=0.518  Sum_probs=128.2

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----e
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD-----E  612 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~  612 (709)
                      .++|...+.||+|+||.||++.... ++.||||++...  ......++.+|+.++.+++|+||+++++++....     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            3578889999999999999998754 789999998653  2334567889999999999999999999886543     4


Q ss_pred             eEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCce
Q 005206          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~  692 (709)
                      .++||||+. ++|.+++...   ..+++.....++.||+.||.|||+++   ++||||||+||+++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 6888887543   34899999999999999999999987   9999999999999999999999999998


Q ss_pred             eeCC
Q 005206          693 IFGG  696 (709)
Q Consensus       693 ~l~~  696 (709)
                      ....
T Consensus       157 ~~~~  160 (337)
T cd07858         157 TTSE  160 (337)
T ss_pred             ccCC
Confidence            7644

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.81  E-value=1.4e-19  Score=186.40  Aligned_cols=152  Identities=31%  Similarity=0.513  Sum_probs=132.9

Q ss_pred             CcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +|+..++||+|+||.||+++.. +++.+|+|++...  ......++.+|++++++++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4677789999999999999875 4789999998653  233456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          620 MENRSLDSVIFDKAR-SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      +++++|.+++.+... ...+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++.+...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            999999999865322 345899999999999999999999987   999999999999999999999999999877544

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.81  E-value=2e-19  Score=190.20  Aligned_cols=150  Identities=25%  Similarity=0.424  Sum_probs=126.9

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ++|...+.||+|+||.||+|.... ++.||||.+.... .....++..|+.++.+.+ ||||+++++++.+....+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            567778899999999999999876 8899999996543 234556777888777775 9999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |++ ++|.+++....  ..+++..+..++.||+.||+|||+..  +|+||||+|+||++++++.+||+|||+++.+..
T Consensus        95 ~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          95 LMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             ccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            985 47777664422  36899999999999999999999742  399999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.81  E-value=2.3e-19  Score=192.94  Aligned_cols=150  Identities=31%  Similarity=0.534  Sum_probs=128.8

Q ss_pred             HHHhcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEe-CCee
Q 005206          538 VRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE-MDEK  613 (709)
Q Consensus       538 ~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~  613 (709)
                      ...+++|+..+.||+|+||.||++... +++.||||++.+.  .....+.+..|+.++.+++||||+++.+++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            346788999999999999999999876 5889999988643  22345678899999999999999999999876 5578


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ++++||+ +++|.+++..    ..+++.....++.|++.||.|||+.+   |+||||+|+||++++++.+||+|||+++.
T Consensus        86 ~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          86 YFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence            9999998 4688887743    24778888889999999999999997   99999999999999999999999999986


Q ss_pred             eC
Q 005206          694 FG  695 (709)
Q Consensus       694 l~  695 (709)
                      ..
T Consensus       158 ~~  159 (328)
T cd07856         158 QD  159 (328)
T ss_pred             cC
Confidence            53

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.81  E-value=1.7e-19  Score=189.03  Aligned_cols=148  Identities=33%  Similarity=0.480  Sum_probs=128.2

Q ss_pred             cCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCc-cchHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEEEEcc
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      |+..+.||+|+||.||+|...+ ++.|+||++..... .......+|+..+.+++ |+||+++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            4566899999999999999865 78899999865422 22334567999999999 999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                       +|+|.+++.... ...+++..+..++.|++.+|.|||+++   ++|+||+|+||++++++.+||+|||+++.+..
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence             889988886543 245899999999999999999999987   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.81  E-value=6e-19  Score=188.39  Aligned_cols=145  Identities=32%  Similarity=0.507  Sum_probs=125.6

Q ss_pred             cCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      |...++||+|+||.||+|+... ++.|++|++....   ....+.+.+|+.++.+++|||++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            5556789999999999998754 7899999986432   23345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      ++ |+|.+++...  ...+++.++..++.||+.||.|||+.+   ++|+||+|+||+++.++.+||+|||++...
T Consensus       103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~  171 (313)
T cd06633         103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS  171 (313)
T ss_pred             CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence            96 5777776432  235899999999999999999999987   999999999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.81  E-value=3.3e-19  Score=191.97  Aligned_cols=147  Identities=31%  Similarity=0.473  Sum_probs=123.6

Q ss_pred             CcCcceeecccCceEEEEEEEcC---CcEEEEEEeccCC--ccchHHHHHHHHHHHhc-CCCceeeEEEEEEeC----Ce
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE---GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEM----DE  612 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~---g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~----~~  612 (709)
                      +|...+.||+|+||.||++....   +..||+|++....  ....+.+.+|+.++.++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            46777899999999999998753   6789999986432  22356788999999999 599999999976543    34


Q ss_pred             eEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCce
Q 005206          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~  692 (709)
                      .++++||+. ++|.+++...   ..+++.....++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            688889886 6898888543   34889999999999999999999997   9999999999999999999999999998


Q ss_pred             eeCC
Q 005206          693 IFGG  696 (709)
Q Consensus       693 ~l~~  696 (709)
                      .+..
T Consensus       154 ~~~~  157 (332)
T cd07857         154 GFSE  157 (332)
T ss_pred             eccc
Confidence            7653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.81  E-value=3.5e-19  Score=189.72  Aligned_cols=148  Identities=34%  Similarity=0.544  Sum_probs=127.7

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      .|+..+.||+|+||.||+|.... ++.+|+|.+...   .....+++.+|+.++.+++|+|++++++++......++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            46667889999999999999864 788999988642   22345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |+. |+|.+++....  ..+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..+..
T Consensus        96 ~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          96 YCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             ccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            997 67877764332  34789999999999999999999987   99999999999999999999999999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.81  E-value=6.2e-19  Score=184.81  Aligned_cols=149  Identities=32%  Similarity=0.534  Sum_probs=126.1

Q ss_pred             cCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCc--cchHHHHHHHHHHHhc---CCCceeeEEEEEEeCCe-----
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG--QGIEEFKNEVRLIAKL---QHRNLVRLLGCCVEMDE-----  612 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~~-----  612 (709)
                      |+..+.||+|+||.||+|+... ++.+|+|++.....  .....+.+|+.++.++   +|+||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            4567899999999999999875 88999999964322  2234677788877666   59999999999998877     


Q ss_pred             eEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCce
Q 005206          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~  692 (709)
                      .+++|||+++ +|.+++..... ..+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.+||+|||+++
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999974 78888854322 35899999999999999999999987   9999999999999999999999999998


Q ss_pred             eeCCC
Q 005206          693 IFGGD  697 (709)
Q Consensus       693 ~l~~~  697 (709)
                      .+...
T Consensus       156 ~~~~~  160 (287)
T cd07838         156 IYSFE  160 (287)
T ss_pred             eccCC
Confidence            87543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.81  E-value=2.6e-19  Score=190.80  Aligned_cols=142  Identities=20%  Similarity=0.202  Sum_probs=121.7

Q ss_pred             eecccCceEEEEEEEcCCcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCCHH
Q 005206          549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLD  626 (709)
Q Consensus       549 ~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~  626 (709)
                      .+|.|+++.||+++. +++.||||++...  .....+.+..|+.++++++|+||+++++++.+.+..+++|||+++|+|.
T Consensus         9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   87 (314)
T cd08216           9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE   87 (314)
T ss_pred             hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence            445555655565554 5889999998654  3445678999999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          627 SVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       627 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      +++.+... ..+++.....++.|++.||+|||+++   |+||||||+||+++.++.+||+|||.+..+.
T Consensus        88 ~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~  152 (314)
T cd08216          88 DLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMI  152 (314)
T ss_pred             HHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeec
Confidence            99865432 34788889999999999999999997   9999999999999999999999999997653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.81  E-value=2.6e-19  Score=188.35  Aligned_cols=151  Identities=26%  Similarity=0.405  Sum_probs=124.5

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEEEEc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +|...++||+|+||.||++.... ++.+|+|++.... ......+.+|+.++.++. |+||+++++++......+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            44556789999999999998865 7899999986543 344567899999999996 99999999999999999999999


Q ss_pred             cCCCCHHHHHhc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          620 MENRSLDSVIFD--KARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       620 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      +.. ++.++...  ......+++.....++.|++.||+|||+..  .++||||||+||+++.++.+||+|||+++.+..
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            864 55443321  112245899999999999999999999752  399999999999999999999999999986543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.81  E-value=2.9e-19  Score=192.13  Aligned_cols=142  Identities=25%  Similarity=0.319  Sum_probs=123.4

Q ss_pred             eeeccc--CceEEEEEEEc-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          548 NKLGQG--GFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       548 ~~LG~G--~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      .+||+|  +||+||++++. .++.||+|.+....  ....+.+.+|+.++..++||||+++++++..++..++|+||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            357776  99999999985 58999999986432  23457889999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ++|.+++.+.. ...+++.....++.||+.||+|||+.+   |+||||||+|||++.++.+|++||+.+..
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~  150 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYS  150 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence            99999886542 234889999999999999999999987   99999999999999999999999986543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.80  E-value=3.8e-19  Score=192.40  Aligned_cols=145  Identities=30%  Similarity=0.496  Sum_probs=124.2

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC------e
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD------E  612 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------~  612 (709)
                      ++|...+.||+|+||.||+|... .++.||||++.+.  .......+.+|+.++.+++||||+++++++....      +
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            67888899999999999999875 4889999998653  2233456889999999999999999999987543      4


Q ss_pred             eEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCce
Q 005206          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~  692 (709)
                      .++|+||+.. +|..++.     ..+++.....++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++
T Consensus        95 ~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          95 FYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             EEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            6899999974 6766541     24789999999999999999999997   9999999999999999999999999998


Q ss_pred             eeC
Q 005206          693 IFG  695 (709)
Q Consensus       693 ~l~  695 (709)
                      ...
T Consensus       166 ~~~  168 (342)
T cd07879         166 HAD  168 (342)
T ss_pred             CCC
Confidence            653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.80  E-value=3.1e-19  Score=186.75  Aligned_cols=148  Identities=31%  Similarity=0.554  Sum_probs=129.7

Q ss_pred             cCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCc--cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          544 FTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG--QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      |...+.||+|++|.||++... +++.+++|++.....  .....+..|+.++++++|+||+++++++..++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            455678999999999999886 488899999865432  24567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ++ +|.+++....  ..+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||.+..+...
T Consensus        81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~  151 (283)
T cd05118          81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP  151 (283)
T ss_pred             CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence            75 8888775532  35899999999999999999999997   999999999999999999999999999887654

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.80  E-value=3.2e-19  Score=189.42  Aligned_cols=150  Identities=33%  Similarity=0.556  Sum_probs=126.8

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC------
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD------  611 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------  611 (709)
                      .++|+..++||+|+||.||+|.... ++.+|||++....  ......+.+|++++.+++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            4689999999999999999999764 7899999886442  222356789999999999999999999876543      


Q ss_pred             --eeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecC
Q 005206          612 --EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG  689 (709)
Q Consensus       612 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFG  689 (709)
                        ..++|+||+.. +|...+...  ...+++..+..++.||++||.|||+.+   |+||||||+||++++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              35999999975 676666432  235899999999999999999999997   9999999999999999999999999


Q ss_pred             CceeeCC
Q 005206          690 MARIFGG  696 (709)
Q Consensus       690 la~~l~~  696 (709)
                      +++.+..
T Consensus       161 ~~~~~~~  167 (311)
T cd07866         161 LARPYDG  167 (311)
T ss_pred             cchhccC
Confidence            9987644

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.80  E-value=2.2e-19  Score=192.83  Aligned_cols=148  Identities=32%  Similarity=0.494  Sum_probs=130.3

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----eeE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD-----EKM  614 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~  614 (709)
                      +|...+.||+|+||.||+|.... ++.+|+|++....  ....+.+.+|+.++..++|+||+++++++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            46777899999999999999865 8899999997643  345678999999999999999999999998875     789


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      +||||++ ++|.+++.+.   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999998 4788887543   25899999999999999999999997   999999999999999999999999999987


Q ss_pred             CCC
Q 005206          695 GGD  697 (709)
Q Consensus       695 ~~~  697 (709)
                      ...
T Consensus       154 ~~~  156 (330)
T cd07834         154 DPD  156 (330)
T ss_pred             ccc
Confidence            554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.80  E-value=8e-19  Score=185.74  Aligned_cols=148  Identities=21%  Similarity=0.288  Sum_probs=110.3

Q ss_pred             cCcCcceeecccCceEEEEEEEcCC----cEEEEEEeccCCccch-----------HHHHHHHHHHHhcCCCceeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEG----QEIAVKRLSRNSGQGI-----------EEFKNEVRLIAKLQHRNLVRLLGC  606 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g----~~VAVK~l~~~~~~~~-----------~~f~~Ei~~l~~l~H~nIv~l~g~  606 (709)
                      +.|...++||+|+||.||+|...++    ..+|+|+.........           .....+...+..++|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            5788889999999999999987654    3455554322221111           112233345566789999999998


Q ss_pred             EEeCC----eeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc
Q 005206          607 CVEMD----EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT  682 (709)
Q Consensus       607 ~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~  682 (709)
                      +....    ..++++|++.. ++.+.+...   ...++.....|+.|++.||+|||+.+   |+||||||+|||++.++.
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence            76554    34778887743 555555332   22567888899999999999999987   999999999999999999


Q ss_pred             EEEEecCCceeeCC
Q 005206          683 PKISDFGMARIFGG  696 (709)
Q Consensus       683 ~KI~DFGla~~l~~  696 (709)
                      +||+|||+|+.+..
T Consensus       165 ~~l~DFGla~~~~~  178 (294)
T PHA02882        165 GYIIDYGIASHFII  178 (294)
T ss_pred             EEEEEcCCceeecc
Confidence            99999999998753

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.80  E-value=3.4e-19  Score=186.32  Aligned_cols=147  Identities=33%  Similarity=0.567  Sum_probs=129.9

Q ss_pred             cCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      |+..+.||+|.||.||+|+... ++.+|+|++....  ....+.+..|+.++++++|+||+++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            4456789999999999999875 8899999997653  334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      + ++|.+++.+..  ..+++..+..++.|++.||.|||+++   |+||||+|+||++++++.+||+|||+++.+..
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~  150 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI  150 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence            8 58999986542  35899999999999999999999997   99999999999999999999999999987644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=2.7e-21  Score=188.44  Aligned_cols=151  Identities=30%  Similarity=0.607  Sum_probs=122.5

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC-Cccc-hHHHHHHHHHHHhcCCCceeeEEEEEEeC--------
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN-SGQG-IEEFKNEVRLIAKLQHRNLVRLLGCCVEM--------  610 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~-~~~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--------  610 (709)
                      ..|....+||+|.||.||+++..+ ++.||+|++... ...+ -..-++|+++|..++|+|++.++..|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            345556789999999999998876 778899876432 2222 23457899999999999999999888643        


Q ss_pred             CeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCC
Q 005206          611 DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (709)
Q Consensus       611 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGl  690 (709)
                      ...+||+++++. +|..+|.+.  ...++..++.+++.++..||.|+|...   |+|||+||.|+||+.++.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence            236999999976 777777443  234788889999999999999999986   99999999999999999999999999


Q ss_pred             ceeeCCCC
Q 005206          691 ARIFGGDQ  698 (709)
Q Consensus       691 a~~l~~~~  698 (709)
                      ||.+....
T Consensus       171 ar~fs~~~  178 (376)
T KOG0669|consen  171 ARAFSTSK  178 (376)
T ss_pred             ccceeccc
Confidence            99875443

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.80  E-value=7.5e-19  Score=180.33  Aligned_cols=141  Identities=31%  Similarity=0.422  Sum_probs=126.6

Q ss_pred             ecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCCH
Q 005206          550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL  625 (709)
Q Consensus       550 LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  625 (709)
                      ||+|+||.||++.... ++.+|+|.+....   ....+.+..|+.++.+++|+||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6899999999999864 8899999986542   23466899999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       626 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      .+++....   .+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~  145 (250)
T cd05123          81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSS  145 (250)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence            99985432   4899999999999999999999987   99999999999999999999999999987654

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.79  E-value=3.4e-20  Score=214.51  Aligned_cols=153  Identities=32%  Similarity=0.445  Sum_probs=132.1

Q ss_pred             HHhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          539 RATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       539 ~~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      ..+-+|.....||.|.||+||.+...+ |...|||-+...  .....+...+|+.++..|+|||+|+.+|+-.+.+..+|
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            344557777899999999999997765 788899977533  34456778899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      .||||++|+|.+.+...   ...++.....+-.|++.|+.|||+++   ||||||||.||+|+.++.+|+.|||.|+.+.
T Consensus      1312 FMEyC~~GsLa~ll~~g---ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHG---RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHHhccCcHHHHHHhc---chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence            99999999999998543   23566666678899999999999998   9999999999999999999999999999986


Q ss_pred             CC
Q 005206          696 GD  697 (709)
Q Consensus       696 ~~  697 (709)
                      .+
T Consensus      1386 ~~ 1387 (1509)
T KOG4645|consen 1386 NN 1387 (1509)
T ss_pred             Cc
Confidence            65

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.79  E-value=4e-19  Score=183.86  Aligned_cols=150  Identities=31%  Similarity=0.470  Sum_probs=124.9

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC-----CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN-----SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      +|...++||+|+||.||++.... +..+++|.++..     ......++..|+.++.+++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            36677899999999999998765 344555555432     223345677899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          617 YEYMENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      |||+++++|.+++.+.. ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++. +.+||+|||+++.+.
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            99999999999886432 2346899999999999999999999987   999999999999975 569999999998764


Q ss_pred             C
Q 005206          696 G  696 (709)
Q Consensus       696 ~  696 (709)
                      .
T Consensus       157 ~  157 (260)
T cd08222         157 G  157 (260)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.79  E-value=4.4e-20  Score=190.53  Aligned_cols=160  Identities=33%  Similarity=0.399  Sum_probs=134.3

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      .+|..+.+||+|+||+|.++.-+. .+.+|||++++..   ....+--+.|-++|+.. +-|.+++|..+++..+..|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            468888999999999999998765 4678999998762   33455567788888776 578999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+.+|+|..++.+-.+   +.+.....+|..||-||-|||+++   ||.||||.+|||||.++++||+|||+++.-.-
T Consensus       429 MEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             EEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence            999999999988866544   666778889999999999999998   99999999999999999999999999984322


Q ss_pred             CCccccccceecC
Q 005206          697 DQTEQNTKRVVGT  709 (709)
Q Consensus       697 ~~~~~~~~~~~GT  709 (709)
                      +  ...|.+++||
T Consensus       503 ~--~~TTkTFCGT  513 (683)
T KOG0696|consen  503 D--GVTTKTFCGT  513 (683)
T ss_pred             C--CcceeeecCC
Confidence            2  2345668887

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.79  E-value=5.1e-19  Score=191.41  Aligned_cols=146  Identities=29%  Similarity=0.544  Sum_probs=126.1

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeC----------
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM----------  610 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~----------  610 (709)
                      .+|...+.||+|+||.||+|.... ++.||+|++........+.+.+|+.++.+++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            578889999999999999998865 789999998766556677899999999999999999999776543          


Q ss_pred             ----CeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-CCcEEE
Q 005206          611 ----DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-EMTPKI  685 (709)
Q Consensus       611 ----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~KI  685 (709)
                          ...++||||++ ++|.+++.+    ..+++.....++.||+.||.|||+.+   |+||||||+||+++. +..+||
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence                35789999997 588887743    24789999999999999999999987   999999999999974 567899


Q ss_pred             EecCCceeeC
Q 005206          686 SDFGMARIFG  695 (709)
Q Consensus       686 ~DFGla~~l~  695 (709)
                      +|||+++.+.
T Consensus       157 ~dfg~~~~~~  166 (342)
T cd07854         157 GDFGLARIVD  166 (342)
T ss_pred             CCcccceecC
Confidence            9999998764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.79  E-value=3.3e-19  Score=190.72  Aligned_cols=161  Identities=26%  Similarity=0.355  Sum_probs=138.0

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccC--CccchHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ..|+++++||.||..+||++...+.+.+|+|++...  ..+...-|.+|+.+|.+|+ |.+||+|++|-...+..|||||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            457888999999999999999988889999887543  4566789999999999995 9999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      |= ..+|..+|.+... ...+| .+..+..||+.++.++|+++   |||.||||.|+|+ -.|.+||+|||+|..+..+.
T Consensus       441 ~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  441 CG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             cc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeeechhcccCccc
Confidence            86 4589999966443 33446 55678999999999999998   9999999999999 45799999999999998888


Q ss_pred             ccccccceecC
Q 005206          699 TEQNTKRVVGT  709 (709)
Q Consensus       699 ~~~~~~~~~GT  709 (709)
                      +.......+||
T Consensus       514 TsI~kdsQvGT  524 (677)
T KOG0596|consen  514 TSIVKDSQVGT  524 (677)
T ss_pred             cceeeccccCc
Confidence            77666667776

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.79  E-value=3.2e-19  Score=169.57  Aligned_cols=152  Identities=26%  Similarity=0.426  Sum_probs=128.0

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC-CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      +.......||+|++|.|-+-++.. |+..|+|++... ..+..++.+.|+.+..+. ..|.+|+++|........++.||
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            334445689999999999888764 899999999754 456678889999987665 79999999999988899999999


Q ss_pred             ccCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          619 YMENRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       619 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      .|. -+|+.+-.+- .+...+++...-+|+..|..||.|||++-  .+||||+||+||||+.+|++||+|||++-.+.+
T Consensus       126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            995 4787775432 23456889999999999999999999974  699999999999999999999999999987743

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.78  E-value=6.1e-19  Score=190.89  Aligned_cols=149  Identities=32%  Similarity=0.501  Sum_probs=128.7

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCe----
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE----  612 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----  612 (709)
                      ..++|...+.||+|+||.||+|.... ++.||||++...  .....+.+.+|+.++++++|+||+++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            35678899999999999999999865 789999988643  22344667889999999999999999988776654    


Q ss_pred             --eEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCC
Q 005206          613 --KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (709)
Q Consensus       613 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGl  690 (709)
                        .++|+||+ +++|.+++..    ..+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence              89999998 5689888853    34899999999999999999999987   99999999999999999999999999


Q ss_pred             ceeeCC
Q 005206          691 ARIFGG  696 (709)
Q Consensus       691 a~~l~~  696 (709)
                      ++.+..
T Consensus       165 ~~~~~~  170 (343)
T cd07851         165 ARHTDD  170 (343)
T ss_pred             cccccc
Confidence            987643

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.78  E-value=1.9e-18  Score=176.82  Aligned_cols=133  Identities=25%  Similarity=0.174  Sum_probs=115.8

Q ss_pred             cCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCCHHHHHhc
Q 005206          553 GGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD  631 (709)
Q Consensus       553 G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~  631 (709)
                      |.||.||++.... ++.+|+|++....     .+..|...+....||||+++++++.+.+..++||||+++|+|.+++.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            8899999998865 7899999986542     334555666667899999999999999999999999999999999865


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          632 KARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       632 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ..   .+++.....++.|++.||.|||+.+   |+||||||+||+++.++.+|++|||+++.+..
T Consensus        79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~  137 (237)
T cd05576          79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED  137 (237)
T ss_pred             hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccc
Confidence            32   3899999999999999999999987   99999999999999999999999998876643

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.77  E-value=1.8e-20  Score=184.26  Aligned_cols=151  Identities=27%  Similarity=0.463  Sum_probs=123.8

Q ss_pred             ceeecccCceEEEEEEEc-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC-----eeEEEEE
Q 005206          547 YNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD-----EKMLVYE  618 (709)
Q Consensus       547 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~lV~E  618 (709)
                      .+.||-|+||.||.++++ +|+.||.|++..-.  --..+++.+|++++.-++|.|++..++...-..     +.|++.|
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            367999999999999886 48999999985432  223578889999999999999999988765432     4678888


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      .|. .+|.++|...   ..++.....-+.+||++||+|||+.+   |.||||||.|.|++++..+||+||||||.-..++
T Consensus       138 LmQ-SDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  138 LMQ-SDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             HHH-hhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhh
Confidence            885 4777776443   34777777778999999999999998   9999999999999999999999999999887776


Q ss_pred             cccccc
Q 005206          699 TEQNTK  704 (709)
Q Consensus       699 ~~~~~~  704 (709)
                      ...+|.
T Consensus       211 ~~hMTq  216 (449)
T KOG0664|consen  211 RLNMTH  216 (449)
T ss_pred             hhhhHH
Confidence            655544

>PRK10345 hypothetical protein; Provisional

Probab=99.77  E-value=5e-18  Score=169.61  Aligned_cols=139  Identities=19%  Similarity=0.269  Sum_probs=108.0

Q ss_pred             CcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhc-----CCCceeeEEEEEEeCC---eeE-E
Q 005206          545 TDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-----QHRNLVRLLGCCVEMD---EKM-L  615 (709)
Q Consensus       545 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-----~H~nIv~l~g~~~~~~---~~~-l  615 (709)
                      ...+.||+|+||.||.  +++....+||++........+++.+|+.++..+     .||||++++|++.+..   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3446899999999996  544333479988665445567899999999999     5799999999998864   333 7


Q ss_pred             EEEc--cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCceEecCCCCCCEEEcC----CCcEEEEec
Q 005206          616 VYEY--MENRSLDSVIFDKARSSILNWQRRFNIICGIARGL-LYLHQDSRFRIIHRDLKASNILLDK----EMTPKISDF  688 (709)
Q Consensus       616 V~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~iiHrDlkp~NILl~~----~~~~KI~DF  688 (709)
                      |+||  +++|+|.+++.+.    .+++.  ..++.+++.++ +|||+++   |+||||||+|||++.    +..++|+||
T Consensus        83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            8999  6689999999542    24544  35677888887 8999998   999999999999974    348999995


Q ss_pred             CCceee
Q 005206          689 GMARIF  694 (709)
Q Consensus       689 Gla~~l  694 (709)
                      +-++.+
T Consensus       154 ~G~~~~  159 (210)
T PRK10345        154 IGESTF  159 (210)
T ss_pred             CCCcce
Confidence            444444

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.77  E-value=6.8e-18  Score=169.69  Aligned_cols=149  Identities=38%  Similarity=0.535  Sum_probs=133.2

Q ss_pred             cCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCcc-chHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      |...+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4556789999999999999976 889999999765444 67889999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      +++|.+++.....  .+++.....++.+++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++..+...
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221       81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence            9999999865322  1789999999999999999999987   999999999999999999999999999988654

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.76  E-value=2.4e-18  Score=197.21  Aligned_cols=150  Identities=27%  Similarity=0.350  Sum_probs=106.4

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcC-----CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEE------EE
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC------CV  608 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~------~~  608 (709)
                      ..++|...++||+|+||.||+|++.+     +..||||++.....  .+.+..|  .+.+..+.+++.++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            35688999999999999999999865     57899998864321  1112222  1112222222222111      24


Q ss_pred             eCCeeEEEEEccCCCCHHHHHhccCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 005206          609 EMDEKMLVYEYMENRSLDSVIFDKARS-----------------SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLK  671 (709)
Q Consensus       609 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk  671 (709)
                      ...+.+|||||+++++|.+++......                 ..........++.||+.||.|||+++   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            566789999999999999988643210                 01123345578999999999999987   9999999


Q ss_pred             CCCEEEcC-CCcEEEEecCCceeeCC
Q 005206          672 ASNILLDK-EMTPKISDFGMARIFGG  696 (709)
Q Consensus       672 p~NILl~~-~~~~KI~DFGla~~l~~  696 (709)
                      |+|||++. ++.+||+|||+|+.+..
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~  308 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRV  308 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccc
Confidence            99999986 57999999999987643

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.76  E-value=1.2e-19  Score=178.35  Aligned_cols=148  Identities=30%  Similarity=0.407  Sum_probs=123.2

Q ss_pred             cCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      .+.+..||.|+||.|+|-.++. |+.+|||+++... +.+.++++.|.++..+- +.||||+++|.+.....-++.||.|
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            3445689999999999988765 8999999997653 46678899999976665 7899999999999999999999999


Q ss_pred             CCCCHHHHHh---ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          621 ENRSLDSVIF---DKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       621 ~~gsL~~~l~---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      . .+|+.+-.   ..+ ...+++...-.|....+.||.||-++-  .|||||+||+||||+..|.+||+|||++-.+.
T Consensus       146 d-~SlDklYk~vy~vq-~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  146 D-ISLDKLYKRVYSVQ-KSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             h-hhHHHHHHHHHHHH-hccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            5 46665532   222 234788888888889999999998764  69999999999999999999999999987663

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.75  E-value=7.7e-19  Score=169.22  Aligned_cols=146  Identities=23%  Similarity=0.471  Sum_probs=123.8

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcC-CCceeeEEEEEEeCCe--eEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDE--KMLV  616 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~--~~lV  616 (709)
                      .++|+..+++|+|.+++||.|... +++.++||.++..   ..+.+.+|+.+|..|. ||||++|++...+...  ..||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            356888899999999999999754 4778999998643   3567899999999997 9999999999987654  4799


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CcEEEEecCCceeeC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFG  695 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~KI~DFGla~~l~  695 (709)
                      +||+.+.+...+-      +.++-..+..++.++++||.|+|+.|   |+|||+||.|++||.. -.++|+|+|||..+.
T Consensus       114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence            9999998876554      23666677789999999999999998   9999999999999965 579999999999886


Q ss_pred             CCC
Q 005206          696 GDQ  698 (709)
Q Consensus       696 ~~~  698 (709)
                      +..
T Consensus       185 p~~  187 (338)
T KOG0668|consen  185 PGK  187 (338)
T ss_pred             CCc
Confidence            553

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.75  E-value=4.4e-17  Score=160.77  Aligned_cols=143  Identities=38%  Similarity=0.662  Sum_probs=127.7

Q ss_pred             ecccCceEEEEEEEcC-CcEEEEEEeccCCcc-chHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCCHHH
Q 005206          550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDS  627 (709)
Q Consensus       550 LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~  627 (709)
                      ||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..+.+++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999876 889999998754332 35789999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-CCcEEEEecCCceeeCCC
Q 005206          628 VIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-EMTPKISDFGMARIFGGD  697 (709)
Q Consensus       628 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~KI~DFGla~~l~~~  697 (709)
                      ++....  ..+++..+..++.+++++|.|||+.+   ++|+||+|.||+++. ++.++|+|||.+......
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~  146 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD  146 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence            986532  34889999999999999999999997   999999999999999 899999999999977543

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.75  E-value=1.3e-18  Score=173.76  Aligned_cols=147  Identities=27%  Similarity=0.338  Sum_probs=121.0

Q ss_pred             hcCcCcc-eeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhc-CCCceeeEEEEEEeC----Cee
Q 005206          541 TDNFTDY-NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEM----DEK  613 (709)
Q Consensus       541 t~~f~~~-~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~----~~~  613 (709)
                      +++|++. ++||-|-.|+|-.+..+. ++.+|+|++...     ...++|+++.-+. .|||||++++++...    .-.
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            4555543 579999999999998865 788999988532     3456788876555 699999999998643    346


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCcEEEEecCC
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK---EMTPKISDFGM  690 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~KI~DFGl  690 (709)
                      ++|||.|++|.|...+.+. ....+++++.-.|+.||+.|+.|||+.+   |.||||||+|+|...   |-.+||+|||+
T Consensus       135 LiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             EeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence            7999999999999988654 3456899999999999999999999997   999999999999964   45799999999


Q ss_pred             ceeeCC
Q 005206          691 ARIFGG  696 (709)
Q Consensus       691 a~~l~~  696 (709)
                      |+.-..
T Consensus       211 AK~t~~  216 (400)
T KOG0604|consen  211 AKETQE  216 (400)
T ss_pred             ccccCC
Confidence            997653

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.74  E-value=2.9e-18  Score=172.95  Aligned_cols=160  Identities=27%  Similarity=0.354  Sum_probs=135.1

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      ++|..+++||+|+|.+|..+++.. .+.+|+|++++.   ..+.++-.+.|-.+.... +||.+|.|..++......++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            568888999999999999999876 678899998764   344566678888888776 799999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      .||+++|+|.-++.+.   ..+++.....+...|..||.|||+.+   ||.||||.+|||||.++++||.|+|+.+.--.
T Consensus       330 ieyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~  403 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG  403 (593)
T ss_pred             EEEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence            9999999997655333   34888888888999999999999998   99999999999999999999999999985433


Q ss_pred             CCccccccceecC
Q 005206          697 DQTEQNTKRVVGT  709 (709)
Q Consensus       697 ~~~~~~~~~~~GT  709 (709)
                      +.  ..|.+++||
T Consensus       404 ~g--d~tstfcgt  414 (593)
T KOG0695|consen  404 PG--DTTSTFCGT  414 (593)
T ss_pred             CC--cccccccCC
Confidence            32  235668887

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.74  E-value=2e-19  Score=190.19  Aligned_cols=158  Identities=25%  Similarity=0.353  Sum_probs=136.0

Q ss_pred             CcCcceeecccCceEEEEEEEcCCc-EEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLEGQ-EIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~g~-~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ++..+..||-|+||.|-+++..... .+|+|.+++.   ...+.+....|-.+|...+.|.||+|+-.+.+....|++||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            3445567999999999999886543 3788888654   33456678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      -|-+|.|...|.+...   ++..+...++..+++|++|||.++   ||.|||||+|++||.+|.+||.|||+|+.++...
T Consensus       501 aClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  501 ACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             hhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence            9999999999976543   777777778889999999999998   9999999999999999999999999999997543


Q ss_pred             ccccccceecC
Q 005206          699 TEQNTKRVVGT  709 (709)
Q Consensus       699 ~~~~~~~~~GT  709 (709)
                         .|-+++||
T Consensus       575 ---KTwTFcGT  582 (732)
T KOG0614|consen  575 ---KTWTFCGT  582 (732)
T ss_pred             ---ceeeecCC
Confidence               46679998

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.74  E-value=9.1e-18  Score=172.87  Aligned_cols=159  Identities=23%  Similarity=0.326  Sum_probs=135.4

Q ss_pred             HHHHHHhcCcCcceeecccCceEEEEEEEcC------CcEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEE
Q 005206          535 ETIVRATDNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCC  607 (709)
Q Consensus       535 ~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~  607 (709)
                      .++.....+++...++-+|.||.||.|.+.+      .++|-||.++.. +..+...|+.|..++..+.|||+..+.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            4455556667777789999999999996543      456888888765 445678899999999999999999999999


Q ss_pred             EeC-CeeEEEEEccCCCCHHHHHh-----ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC
Q 005206          608 VEM-DEKMLVYEYMENRSLDSVIF-----DKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM  681 (709)
Q Consensus       608 ~~~-~~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~  681 (709)
                      .+. +..+.+|.++.-|+|+.||.     +......+.-.+...++.|++.||+|||.++   +||.||.++|++||+..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence            864 56789999999999999998     4444556788888999999999999999998   99999999999999999


Q ss_pred             cEEEEecCCceeeCC
Q 005206          682 TPKISDFGMARIFGG  696 (709)
Q Consensus       682 ~~KI~DFGla~~l~~  696 (709)
                      ++||+|=.|+|.+-+
T Consensus       434 qVkltDsaLSRDLFP  448 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFP  448 (563)
T ss_pred             eEEeccchhccccCc
Confidence            999999999996643

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.73  E-value=4.9e-18  Score=167.65  Aligned_cols=149  Identities=25%  Similarity=0.406  Sum_probs=125.0

Q ss_pred             cCcceeecccCceEEEEEEEcC-CcEEEEEEeccC-CccchHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEEEEcc
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      .+.+..||.|.-|.|++.+... |..+|||.+.+. ..++.++++..++++.+-+ .|.||+.+|+|......++.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            3445679999999999999876 789999999766 3456678888999888775 899999999999999999999998


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      .- -++.+|....  .++++...-++...+++||.||-++.  .|||||+||+|||+|+.|++|++|||++-.+.+.
T Consensus       174 s~-C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  174 ST-CAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             HH-HHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence            43 3455554332  34888888889999999999998875  6999999999999999999999999999877543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.73  E-value=3.9e-17  Score=164.00  Aligned_cols=135  Identities=23%  Similarity=0.327  Sum_probs=114.5

Q ss_pred             eeecccCceEEEEEEEcCCcEEEEEEeccCCc--c------chHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG--Q------GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~--~------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +.||+|++|.||+|.. .+..+++|+......  .      ...++.+|+.++..++|+++.....++...+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 677899997653321  1      124688999999999999998888787788889999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      +++++|.+++...      .+ .+..++.+++.+|.+||+.+   ++|+|++|.|||++ ++.++|+|||+++..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            9999999988432      12 77889999999999999997   99999999999999 789999999999864

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.73  E-value=3.7e-17  Score=165.75  Aligned_cols=138  Identities=35%  Similarity=0.519  Sum_probs=124.8

Q ss_pred             CceEEEEEEEcC-CcEEEEEEeccCCccc-hHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCCHHHHHhc
Q 005206          554 GFGIVYKGRLLE-GQEIAVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD  631 (709)
Q Consensus       554 ~fG~Vykg~~~~-g~~VAVK~l~~~~~~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~  631 (709)
                      +||.||+|.... ++.+|+|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999875 8899999997655444 78999999999999999999999999999999999999999999999865


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          632 KARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       632 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ...   +++..+..++.+++++|.|||+.+   ++|+||+|+||+++.++.++|+|||++..+...
T Consensus        81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~  140 (244)
T smart00220       81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPG  140 (244)
T ss_pred             ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence            332   789999999999999999999987   999999999999999999999999999987653

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.73  E-value=8.8e-18  Score=187.66  Aligned_cols=149  Identities=31%  Similarity=0.497  Sum_probs=119.5

Q ss_pred             cCcceeecccCce-EEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          544 FTDYNKLGQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       544 f~~~~~LG~G~fG-~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      |...+.+|.|+-| .||+|.. ++++||||++-.   ...+-..+|+..|..- +||||||.++.-.+....||..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            4555679999988 5799998 678999998853   2334567899999887 69999999999999999999999995


Q ss_pred             CCCHHHHHhccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---C--CcEEEEecCCceeeC
Q 005206          622 NRSLDSVIFDKARSS-ILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK---E--MTPKISDFGMARIFG  695 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~--~~~KI~DFGla~~l~  695 (709)
                       .+|.+++....... ...-.....+..|++.||++||+.+   ||||||||+||||+.   +  ..++|+|||+++.+.
T Consensus       587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence             59999997631111 1111334568899999999999976   999999999999976   2  579999999999998


Q ss_pred             CCCcc
Q 005206          696 GDQTE  700 (709)
Q Consensus       696 ~~~~~  700 (709)
                      .+.+.
T Consensus       663 ~~~sS  667 (903)
T KOG1027|consen  663 GGKSS  667 (903)
T ss_pred             CCcch
Confidence            77654

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.72  E-value=5.1e-17  Score=161.81  Aligned_cols=147  Identities=20%  Similarity=0.186  Sum_probs=114.1

Q ss_pred             HHHHHhcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCc--c--------------------chHHHHHHHHHHH
Q 005206          536 TIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG--Q--------------------GIEEFKNEVRLIA  593 (709)
Q Consensus       536 ~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~--~--------------------~~~~f~~Ei~~l~  593 (709)
                      ++......|...+.||+|+||.||++...+++.||||++.....  .                    ....+..|..++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            34444444777789999999999999988899999998754220  0                    1123677899999


Q ss_pred             hcCCC--ceeeEEEEEEeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 005206          594 KLQHR--NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLK  671 (709)
Q Consensus       594 ~l~H~--nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk  671 (709)
                      ++.|+  .+++.++.    ...++||||+++++|......         .....++.+++.++.++|+.+   |+|||||
T Consensus        89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~  152 (198)
T cd05144          89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLS  152 (198)
T ss_pred             HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence            99887  45555542    456899999999998765420         234568899999999999987   9999999


Q ss_pred             CCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          672 ASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       672 p~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      |+||++++++.+||+|||++..+..+.
T Consensus       153 p~Nill~~~~~~~liDfg~~~~~~~~~  179 (198)
T cd05144         153 EFNILVDDDEKIYIIDWPQMVSTDHPN  179 (198)
T ss_pred             cccEEEcCCCcEEEEECCccccCCCcc
Confidence            999999999999999999998776543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.71  E-value=5e-17  Score=158.01  Aligned_cols=152  Identities=24%  Similarity=0.363  Sum_probs=126.6

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCC-CceeeEEEEEEeCCeeEEEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH-RNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      .++|..+++||.|+||.+|.|... +|.+||||.-+....  .-++..|.++...|+| ..|.++.-+..+.+...||||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            467999999999999999999865 599999998754432  3457789999999975 688888889999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC---CcEEEEecCCceeeC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE---MTPKISDFGMARIFG  695 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~KI~DFGla~~l~  695 (709)
                      .+ +-+|.+++.-..+  .++-++.+-++-|++.-++|+|.++   +|||||||+|+|+.-+   ..+.++|||||+.+-
T Consensus        92 LL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence            88 5688877643332  3788899999999999999999998   9999999999999644   578999999999886


Q ss_pred             CCCcc
Q 005206          696 GDQTE  700 (709)
Q Consensus       696 ~~~~~  700 (709)
                      +..++
T Consensus       166 d~~t~  170 (341)
T KOG1163|consen  166 DIRTR  170 (341)
T ss_pred             ccccc
Confidence            65544

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.71  E-value=4.6e-17  Score=186.43  Aligned_cols=140  Identities=21%  Similarity=0.327  Sum_probs=113.5

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccC-Cc------cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN-SG------QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-~~------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  614 (709)
                      ..|...++||+|+||.||+|.+.....++.+++.+. ..      ...+++.+|++++.+++|++++....++.+.+..+
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            344556899999999999998865443332223221 11      12356889999999999999999888888888889


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      +||||+++++|.+++.           ....++.+++++|.|||+.+   ++||||||+|||+ +++.++|+|||+++..
T Consensus       413 lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        413 IVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            9999999999998873           34678999999999999997   9999999999999 6789999999999875


Q ss_pred             CC
Q 005206          695 GG  696 (709)
Q Consensus       695 ~~  696 (709)
                      ..
T Consensus       478 ~~  479 (535)
T PRK09605        478 DL  479 (535)
T ss_pred             Cc
Confidence            43

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.71  E-value=6.5e-17  Score=162.36  Aligned_cols=142  Identities=14%  Similarity=0.147  Sum_probs=116.0

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchH---H------HHHHHHHHHhcCCCceeeEEEEEEeC
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIE---E------FKNEVRLIAKLQHRNLVRLLGCCVEM  610 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~---~------f~~Ei~~l~~l~H~nIv~l~g~~~~~  610 (709)
                      ..++|...++||.|+||.||+... ++..+|||.+........+   .      |.+|+..+.+++|++|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            357899999999999999999765 5778999999754322222   2      68999999999999999999886643


Q ss_pred             --------CeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc
Q 005206          611 --------DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT  682 (709)
Q Consensus       611 --------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~  682 (709)
                              ...+|||||+++.+|.++..       ++.    ....+|+.+|..||+.+   ++|||+||.||+++.++ 
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence                    35789999999999987631       222    24568999999999998   99999999999999988 


Q ss_pred             EEEEecCCceeeCCC
Q 005206          683 PKISDFGMARIFGGD  697 (709)
Q Consensus       683 ~KI~DFGla~~l~~~  697 (709)
                      ++|+|||..+....+
T Consensus       173 i~liDfg~~~~~~e~  187 (232)
T PRK10359        173 LRIIDLSGKRCTAQR  187 (232)
T ss_pred             EEEEECCCcccccch
Confidence            999999999877433

>smart00090 RIO RIO-like kinase

Probab=99.71  E-value=5.9e-17  Score=165.58  Aligned_cols=146  Identities=18%  Similarity=0.153  Sum_probs=112.9

Q ss_pred             CcCcceeecccCceEEEEEE--EcCCcEEEEEEeccCCcc------------------------chHHHHHHHHHHHhcC
Q 005206          543 NFTDYNKLGQGGFGIVYKGR--LLEGQEIAVKRLSRNSGQ------------------------GIEEFKNEVRLIAKLQ  596 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~--~~~g~~VAVK~l~~~~~~------------------------~~~~f~~Ei~~l~~l~  596 (709)
                      .|...+.||+|+||.||+|.  ..+|+.||||++......                        ....+..|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            46777899999999999998  467999999998643210                        0123568999999997


Q ss_pred             CC--ceeeEEEEEEeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCC
Q 005206          597 HR--NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASN  674 (709)
Q Consensus       597 H~--nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~N  674 (709)
                      |.  .+.++++.    ...+|||||+++.+|.......   ..++..+...++.||+.+|.+||+++  .|+||||||+|
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N  179 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN  179 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence            53  34455543    2358999999998886654221   23555566789999999999999986  49999999999


Q ss_pred             EEEcCCCcEEEEecCCceeeCCCC
Q 005206          675 ILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       675 ILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      |+++ ++.++|+|||+|+....+.
T Consensus       180 Ili~-~~~i~LiDFg~a~~~~~~~  202 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVELDHPM  202 (237)
T ss_pred             EEEE-CCCEEEEEChhhhccCCcc
Confidence            9999 8899999999999776543

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.71  E-value=1.5e-17  Score=164.19  Aligned_cols=154  Identities=25%  Similarity=0.397  Sum_probs=122.7

Q ss_pred             CCCCCChHHHHHHhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhc-CCCceeeEEE
Q 005206          528 ELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLG  605 (709)
Q Consensus       528 ~~~~~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g  605 (709)
                      +++..+++      +.|.+.+.||+|.||.+-+++++. .+.+++|-+.+. ....++|.+|..---.| .|.||+.-++
T Consensus        16 el~kv~l~------d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~   88 (378)
T KOG1345|consen   16 ELKKVDLE------DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYE   88 (378)
T ss_pred             cccccchh------hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHH
Confidence            44555555      357788899999999999999976 678899887542 33467899998754445 6899998775


Q ss_pred             E-EEeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc--CCCc
Q 005206          606 C-CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD--KEMT  682 (709)
Q Consensus       606 ~-~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~--~~~~  682 (709)
                      . +...+...+++||+|.|+|.+-+..    .-+-+.....++.|++.||.|||+++   +||||||.+||||-  +..+
T Consensus        89 vaFqt~d~YvF~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~r  161 (378)
T KOG1345|consen   89 VAFQTSDAYVFVQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYR  161 (378)
T ss_pred             HHhhcCceEEEeeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccE
Confidence            4 5566777899999999999876633    33667777789999999999999998   99999999999993  3458


Q ss_pred             EEEEecCCceeeC
Q 005206          683 PKISDFGMARIFG  695 (709)
Q Consensus       683 ~KI~DFGla~~l~  695 (709)
                      +||+|||+.+..+
T Consensus       162 vKlcDFG~t~k~g  174 (378)
T KOG1345|consen  162 VKLCDFGLTRKVG  174 (378)
T ss_pred             EEeeecccccccC
Confidence            9999999998664

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.71  E-value=9.4e-17  Score=159.76  Aligned_cols=132  Identities=27%  Similarity=0.413  Sum_probs=108.5

Q ss_pred             eecccCceEEEEEEEcCCcEEEEEEeccCCc--------cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG--------QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       549 ~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~--------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      .||+|+||.||+|.. ++..+++|+......        ...+++.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 568899998654321        11356789999999999887666555666777789999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ++++|.+++....         . .++.+++.+|.+||+.+   ++|+|++|+||+++ ++.+++.|||+++...
T Consensus        80 ~g~~l~~~~~~~~---------~-~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~  140 (199)
T TIGR03724        80 EGKPLKDVIEEGN---------D-ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD  140 (199)
T ss_pred             CCccHHHHHhhcH---------H-HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence            9999998874321         0 78999999999999997   99999999999999 8999999999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.69  E-value=3.4e-18  Score=186.29  Aligned_cols=161  Identities=29%  Similarity=0.472  Sum_probs=138.8

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      .++|..+..+|.|.+|.|||+++.. ++..|||.++-.......-...|+-+++..+|||||-++|-+...+..++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            3567777899999999999999865 788999999876667778888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCCc
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~~  699 (709)
                      +.+|+|.+.-+-   ..++++.++-.+.+..++||+|||..+   -+|||||-.|||+++.+.+|++|||.+..++..-.
T Consensus        94 cgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~  167 (829)
T KOG0576|consen   94 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIA  167 (829)
T ss_pred             cCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhh
Confidence            999999886533   235888888889999999999999998   89999999999999999999999999988754432


Q ss_pred             cccccceecC
Q 005206          700 EQNTKRVVGT  709 (709)
Q Consensus       700 ~~~~~~~~GT  709 (709)
                      +  ...+.||
T Consensus       168 K--rksfiGt  175 (829)
T KOG0576|consen  168 K--RKSFIGT  175 (829)
T ss_pred             h--hhcccCC
Confidence            2  3346665

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=2.9e-16  Score=154.56  Aligned_cols=133  Identities=21%  Similarity=0.192  Sum_probs=105.7

Q ss_pred             cceeecccCceEEEEEEEcCCcEEEEEEeccCCcc----chHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEEEEcc
Q 005206          546 DYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQ----GIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       546 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~----~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      ....|++|+||+||.+.- .+..++.+.+.....-    ....|.+|+++|.+|+ |+++++++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            346899999999997765 5778887777543221    1125889999999995 5889999886    4579999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC-CCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDL-KASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDl-kp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ++.+|...+..          ....++.|++++|.++|+++   |+|||| ||+|||++.++.++|+|||+|....+
T Consensus        81 ~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~  144 (218)
T PRK12274         81 AGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP  144 (218)
T ss_pred             cCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence            99888643310          11357789999999999998   999999 79999999999999999999996543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.67  E-value=5.3e-16  Score=166.43  Aligned_cols=145  Identities=26%  Similarity=0.376  Sum_probs=121.3

Q ss_pred             CcCcceeecccCceEEEEEEEcCC--cEEEEEEeccCCccchHHHHHHHHHHHhcCC----CceeeEEEEE-EeCCeeEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLEG--QEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH----RNLVRLLGCC-VEMDEKML  615 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~g--~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H----~nIv~l~g~~-~~~~~~~l  615 (709)
                      +|...++||+|+||.||++.....  ..+|+|............+..|+.++..+.+    +++.++++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            788999999999999999998664  4788887765433333378889999999873    5888999888 47778899


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-----CcEEEEecCC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-----MTPKISDFGM  690 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-----~~~KI~DFGl  690 (709)
                      ||+.+ +.+|.++..... ...++..+.++|+.|++.+|++||+.+   ++||||||.|+++...     ..++|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99977 678988764433 456899999999999999999999998   9999999999999765     4699999999


Q ss_pred             ce
Q 005206          691 AR  692 (709)
Q Consensus       691 a~  692 (709)
                      |+
T Consensus       174 ar  175 (322)
T KOG1164|consen  174 AR  175 (322)
T ss_pred             Cc
Confidence            99

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.66  E-value=5.9e-16  Score=156.95  Aligned_cols=153  Identities=23%  Similarity=0.370  Sum_probs=127.9

Q ss_pred             cCcCcceeecccCceEEEEEEE-cCCcEEEEEEeccCCccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      -+|.+.++||+|.||.++.|+. -+++.||||.-...+  ..-++..|-+..+.| ..++|...+-+..++-+..||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            3688899999999999999974 568999999764433  345677788888887 468999999999999999999998


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-----CCcEEEEecCCceee
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-----EMTPKISDFGMARIF  694 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-----~~~~KI~DFGla~~l  694 (709)
                      + +-+|.++..-..  ..++.++...||.|++.-|+|+|++.   +|.|||||+|+||..     ...+.|+|||||+.+
T Consensus       106 L-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             h-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            8 668888764333  34889999999999999999999998   999999999999964     356899999999999


Q ss_pred             CCCCcccc
Q 005206          695 GGDQTEQN  702 (709)
Q Consensus       695 ~~~~~~~~  702 (709)
                      .++.+++.
T Consensus       180 rDp~TkqH  187 (449)
T KOG1165|consen  180 RDPKTKQH  187 (449)
T ss_pred             cCcccccc
Confidence            88876643

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.64  E-value=6.5e-16  Score=159.62  Aligned_cols=152  Identities=20%  Similarity=0.245  Sum_probs=126.4

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcC-C-C----ceeeEEEEEEeCCee
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-H-R----NLVRLLGCCVEMDEK  613 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H-~----nIv~l~g~~~~~~~~  613 (709)
                      +++|.++.++|+|.||+|-++.+.. +..||||+++. .....++-+-|++++.+|. + |    -+|.+.+++.-.++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            6789999999999999999998765 68899999853 3444566788999999993 2 2    377888899999999


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC--------------
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK--------------  679 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~--------------  679 (709)
                      +||+|.+ +-++.++|... ...+++..+...|+.|++++++|||+..   ++|-||||+|||+.+              
T Consensus       167 Civfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             EEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence            9999988 45899999653 3456888999999999999999999997   999999999999822              


Q ss_pred             ------CCcEEEEecCCceeeCCCC
Q 005206          680 ------EMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       680 ------~~~~KI~DFGla~~l~~~~  698 (709)
                            +..+||+|||-|..-.+.+
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~h  266 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEHH  266 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccCc
Confidence                  3468999999999775554

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.64  E-value=4e-16  Score=170.93  Aligned_cols=146  Identities=25%  Similarity=0.347  Sum_probs=121.3

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ++.|.....+|.|+|+.|-.+.+.. ++..+||++.+..    .+-.+|+.++.+. +||||+++.+.+.++.+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            4566667789999999999887754 7889999997552    2334567666555 79999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE-cCCCcEEEEecCCceeeCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL-DKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl-~~~~~~KI~DFGla~~l~~~  697 (709)
                      ++.++-+.+-+....    .....+..|+.+|+.++.|||+++   +|||||||+|||+ ++.++++|+|||.++.+.+.
T Consensus       397 ~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            999998877664432    223667789999999999999998   9999999999999 58999999999999988655

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.63  E-value=4.2e-16  Score=163.05  Aligned_cols=147  Identities=28%  Similarity=0.497  Sum_probs=127.7

Q ss_pred             HHHHhcCcCcceeecccCceEEEEEEEcC----CcEEEEEEeccCCccchHHHHHHHHHHHhcC-CCceeeEEEEEEeCC
Q 005206          537 IVRATDNFTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMD  611 (709)
Q Consensus       537 l~~~t~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~  611 (709)
                      +....+.|..+++||+|.|+.||++.+..    .+.||+|.+...+  ...+..+|+++|..+. |.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            34455678888999999999999998754    5689999986543  3456899999999995 999999999999999


Q ss_pred             eeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CcEEEEecCC
Q 005206          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGM  690 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~KI~DFGl  690 (709)
                      ...+|+||+++-...+++..      ++......++..+.+||.++|.++   ||||||||.|+|.+.. +.-.|.||||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence            99999999999999988854      567788889999999999999998   9999999999999865 6778999999


Q ss_pred             ceee
Q 005206          691 ARIF  694 (709)
Q Consensus       691 a~~l  694 (709)
                      |...
T Consensus       180 A~~~  183 (418)
T KOG1167|consen  180 AQRY  183 (418)
T ss_pred             HHHH
Confidence            9854

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.63  E-value=2.6e-15  Score=140.88  Aligned_cols=136  Identities=23%  Similarity=0.213  Sum_probs=115.8

Q ss_pred             cceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCC--CceeeEEEEEEeCCeeEEEEEccCCC
Q 005206          546 DYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH--RNLVRLLGCCVEMDEKMLVYEYMENR  623 (709)
Q Consensus       546 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~lV~Ey~~~g  623 (709)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+.+|+.++..++|  .++++++++....+..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            34689999999999999855 7899998865433  5679999999999976  58999999988888899999999988


Q ss_pred             CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          624 SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       624 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      .+..+          +......++.+++++|++||......++|+|++|+||++++.+.+++.|||+++..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            77533          45666778999999999999875456999999999999999999999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.62  E-value=2.8e-15  Score=147.55  Aligned_cols=139  Identities=20%  Similarity=0.241  Sum_probs=100.5

Q ss_pred             ceeecccCceEEEEEEEcCCcEEEEEEeccCCcc--chHHH----------------------HHHHHHHHhcCCC--ce
Q 005206          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQ--GIEEF----------------------KNEVRLIAKLQHR--NL  600 (709)
Q Consensus       547 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~--~~~~f----------------------~~Ei~~l~~l~H~--nI  600 (709)
                      .+.||+|+||.||+|...+++.||||++......  ...++                      ..|...+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            3579999999999999888999999988653211  11111                      3566666666443  34


Q ss_pred             eeEEEEEEeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCCEEEcC
Q 005206          601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ-DSRFRIIHRDLKASNILLDK  679 (709)
Q Consensus       601 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILl~~  679 (709)
                      .+.+++    ...++||||++++.+.........   .. .....++.+++.++.++|. .+   |+||||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence            455543    346899999999544221111100   11 4567789999999999999 76   99999999999999 


Q ss_pred             CCcEEEEecCCceeeCCC
Q 005206          680 EMTPKISDFGMARIFGGD  697 (709)
Q Consensus       680 ~~~~KI~DFGla~~l~~~  697 (709)
                      ++.++|+|||+|+....+
T Consensus       150 ~~~~~liDfg~a~~~~~~  167 (187)
T cd05119         150 DGKVYIIDVPQAVEIDHP  167 (187)
T ss_pred             CCcEEEEECcccccccCc
Confidence            999999999999877554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.62  E-value=5.2e-16  Score=156.91  Aligned_cols=146  Identities=33%  Similarity=0.486  Sum_probs=118.4

Q ss_pred             cCcCcceeecccCceEEEEEEE-cCCcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC------e
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD------E  612 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------~  612 (709)
                      .+|..++.+|.|+- .|-.+-+ ..++.||+|++...  .....++-.+|..++..++|+||++++.++.-..      +
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45666677888877 4444433 24889999988654  2344667789999999999999999999987543      4


Q ss_pred             eEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCce
Q 005206          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~  692 (709)
                      .|+|||||. .+|...+..     .++-.+...|.+|++.|++|||+.+   |+||||||+||++..+..+||.|||+|+
T Consensus        96 ~y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence            699999995 578777752     2677888899999999999999998   9999999999999999999999999999


Q ss_pred             eeCCC
Q 005206          693 IFGGD  697 (709)
Q Consensus       693 ~l~~~  697 (709)
                      .-+.+
T Consensus       167 ~e~~~  171 (369)
T KOG0665|consen  167 TEDTD  171 (369)
T ss_pred             ccCcc
Confidence            65443

>PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions []

Probab=99.60  E-value=7.9e-16  Score=124.18  Aligned_cols=64  Identities=55%  Similarity=1.061  Sum_probs=56.8

Q ss_pred             CccceeEeecccCCCCccccccccCCHHHHHHHHhcCCcccceeccccCCCceeEEecccccch
Q 005206          369 SEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDI  432 (709)
Q Consensus       369 ~~~~f~~~~~~~~p~~~~~~~~~~~~~~~C~~~Cl~nCsC~aya~~~~~~g~~C~~w~~~l~~~  432 (709)
                      .+|+|+++++|++|+++...++.+.++++|++.||+||||+||+|.+..++++|++|.++|+|+
T Consensus         3 ~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d~   66 (66)
T PF08276_consen    3 SGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVDL   66 (66)
T ss_pred             CCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeecC
Confidence            3689999999999999887766679999999999999999999998654567999999999874

These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.59  E-value=3.7e-14  Score=148.79  Aligned_cols=150  Identities=34%  Similarity=0.561  Sum_probs=128.2

Q ss_pred             cCcceeecccCceEEEEEEEcCCcEEEEEEeccCCcc---chHHHHHHHHHHHhcCCC-ceeeEEEEEEeCCeeEEEEEc
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQ---GIEEFKNEVRLIAKLQHR-NLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~---~~~~f~~Ei~~l~~l~H~-nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      |...+.||.|+||.||++...  ..+++|.+......   ....|.+|+.++..+.|+ +++++...+......++++||
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            556678999999999999887  78899998765332   377899999999999988 799999999777778999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-cEEEEecCCceeeCCCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIFGGDQ  698 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~KI~DFGla~~l~~~~  698 (709)
                      +.++++.+++........+.......++.|++.++.|+|+.+   ++|||+||+||+++... .+|+.|||+++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999976643321125788889999999999999999998   99999999999999998 79999999999775544

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.58  E-value=8e-15  Score=155.39  Aligned_cols=134  Identities=25%  Similarity=0.335  Sum_probs=111.3

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcC-----C---CceeeEEEEEEe---
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-----H---RNLVRLLGCCVE---  609 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-----H---~nIv~l~g~~~~---  609 (709)
                      ++|...++||=|-|.+||++.+.. .+.||+|+++ ......+.-+.||++|++++     |   ..||+|++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK-SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK-SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEe-hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            678899999999999999998865 6789999985 34455667789999999983     3   369999999975   


Q ss_pred             -CCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC
Q 005206          610 -MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE  680 (709)
Q Consensus       610 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~  680 (709)
                       +.+.+||+|++ +-+|..+|..... +-++.....+|++||+.||.|||.++  +|||-||||+||||...
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST  224 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence             45789999999 4567777755433 34888899999999999999999998  69999999999999654

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.56  E-value=4.3e-14  Score=144.74  Aligned_cols=136  Identities=24%  Similarity=0.285  Sum_probs=106.6

Q ss_pred             eeec-ccCceEEEEEEEcCCcEEEEEEeccCC-------------ccchHHHHHHHHHHHhcCCCce--eeEEEEEEeCC
Q 005206          548 NKLG-QGGFGIVYKGRLLEGQEIAVKRLSRNS-------------GQGIEEFKNEVRLIAKLQHRNL--VRLLGCCVEMD  611 (709)
Q Consensus       548 ~~LG-~G~fG~Vykg~~~~g~~VAVK~l~~~~-------------~~~~~~f~~Ei~~l~~l~H~nI--v~l~g~~~~~~  611 (709)
                      ..|| .|+.|+||++... +..++||++....             ......+.+|+.++.+|+|++|  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4787 8999999999874 6788998875321             1223568889999999998775  77787754432


Q ss_pred             e----eEEEEEccCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEE
Q 005206          612 E----KMLVYEYMEN-RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKIS  686 (709)
Q Consensus       612 ~----~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~  686 (709)
                      .    .++|+||+++ .+|.+++.+.    .++..    .+.+|+.+|.+||+.+   |+||||||+|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence            2    3599999997 6898887432    24433    3578999999999998   9999999999999999999999


Q ss_pred             ecCCceeeC
Q 005206          687 DFGMARIFG  695 (709)
Q Consensus       687 DFGla~~l~  695 (709)
                      |||.++...
T Consensus       185 Dfg~~~~~~  193 (239)
T PRK01723        185 DFDRGELRT  193 (239)
T ss_pred             ECCCcccCC
Confidence            999998764

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.54  E-value=1.1e-14  Score=155.05  Aligned_cols=153  Identities=24%  Similarity=0.308  Sum_probs=129.7

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcC------CCceeeEEEEEEeCCee
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ------HRNLVRLLGCCVEMDEK  613 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~------H~nIv~l~g~~~~~~~~  613 (709)
                      -.+|.+....|+|-|+.|.+|.+.. |+.||||++..+ +...+.=+.|+++|.+|+      .-|.++|+-.|...++.
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL  509 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL  509 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence            3567777788999999999998865 889999999644 344556678999999995      35889999999999999


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CcEEEEecCCce
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMAR  692 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~KI~DFGla~  692 (709)
                      +||+|-+. -+|.+.|.+..+.--|..+....++.|+.-||..|-.-+   |+|.||||.||||++. ..+||+|||-|.
T Consensus       510 ClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~  585 (752)
T KOG0670|consen  510 CLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSAS  585 (752)
T ss_pred             EEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcccc
Confidence            99999874 589999987777666888888899999999999998876   9999999999999876 568999999998


Q ss_pred             eeCCCC
Q 005206          693 IFGGDQ  698 (709)
Q Consensus       693 ~l~~~~  698 (709)
                      ..++++
T Consensus       586 ~~~ene  591 (752)
T KOG0670|consen  586 FASENE  591 (752)
T ss_pred             cccccc
Confidence            776554

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.48  E-value=2.1e-13  Score=151.63  Aligned_cols=142  Identities=23%  Similarity=0.302  Sum_probs=102.3

Q ss_pred             eeecccCceEEEEEEEcCCcEEEEEEeccCCccch----------------------------------------HHHHH
Q 005206          548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGI----------------------------------------EEFKN  587 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~----------------------------------------~~f~~  587 (709)
                      +.||.|++|+||+|++.+|+.||||+.........                                        -.|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            57999999999999999999999999865421110                                        12555


Q ss_pred             HHHHHHhcC----CCceeeEEEEEE-eCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 005206          588 EVRLIAKLQ----HRNLVRLLGCCV-EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIAR-GLLYLHQDS  661 (709)
Q Consensus       588 Ei~~l~~l~----H~nIv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~~  661 (709)
                      |.+.+.+++    |.+-+.+-..+. .....+|||||+++++|.++......  ..   .+..++..++. .+..+|..+
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence            666666552    333333333332 23467999999999999887643211  12   23456666666 467889887


Q ss_pred             CCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       662 ~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                         ++|+|+||.||+++.++.+++.|||++..+.+.
T Consensus       278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~  310 (437)
T TIGR01982       278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSEE  310 (437)
T ss_pred             ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence               999999999999999999999999999988643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.45  E-value=1.7e-13  Score=160.33  Aligned_cols=145  Identities=23%  Similarity=0.335  Sum_probs=113.1

Q ss_pred             hcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcC---CCceeeEEEEEEeCCeeEEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ---HRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      .+.|.+.++||+|+||+||+|...+++.||+|.-+....   -+|--=.+++.||+   -+-|..+.....-.+.-+||+
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~  773 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS  773 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence            456788899999999999999998999999998765432   12222223334444   233444445555667789999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-------CCcEEEEecCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-------EMTPKISDFGM  690 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-------~~~~KI~DFGl  690 (709)
                      ||.+.|+|.+++.   ..+.++|...+.++.|+++-++.||..+   |||+||||+|+||..       ...++|+|||-
T Consensus       774 ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~  847 (974)
T KOG1166|consen  774 EYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGR  847 (974)
T ss_pred             eccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEeccc
Confidence            9999999999985   4456999999999999999999999998   999999999999932       35699999999


Q ss_pred             ceee
Q 005206          691 ARIF  694 (709)
Q Consensus       691 a~~l  694 (709)
                      +-.+
T Consensus       848 siDm  851 (974)
T KOG1166|consen  848 SIDM  851 (974)
T ss_pred             ceee
Confidence            8643

>cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins

Probab=99.37  E-value=8.5e-13  Score=110.01  Aligned_cols=69  Identities=25%  Similarity=0.372  Sum_probs=60.6

Q ss_pred             ccceeEeecccCCCCccccccccCCHHHHHHHHhc---CCcccceeccccCCCceeEEecccc-cchhcccCCCceeEEe
Q 005206          370 EDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSR---NCSCTAYANTNITGGTGCVTWTGEL-KDIRKYAEGGQDLYVR  445 (709)
Q Consensus       370 ~~~f~~~~~~~~p~~~~~~~~~~~~~~~C~~~Cl~---nCsC~aya~~~~~~g~~C~~w~~~l-~~~~~~~~~~~~lyvr  445 (709)
                      .+.|+.+.++++|++..      .+++||++.|++   ||||+||+|.+.  +.+|++|.+++ .+++.....+.++|+|
T Consensus         8 ~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~--~~gC~~W~~~l~~d~~~~~~~g~~Ly~r   79 (80)
T cd00129           8 AGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA--RKQCLWFPFNSMSGVRKEFSHGFDLYEN   79 (80)
T ss_pred             CCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC--CCCeEEecCcchhhHHhccCCCceeEeE
Confidence            46799999999998755      589999999999   999999999764  35899999999 9999887778999998


Q ss_pred             e
Q 005206          446 L  446 (709)
Q Consensus       446 v  446 (709)
                      .
T Consensus        80 ~   80 (80)
T cd00129          80 K   80 (80)
T ss_pred             C
Confidence            3

Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

Probab=99.34  E-value=1.7e-12  Score=110.34  Aligned_cols=79  Identities=46%  Similarity=0.944  Sum_probs=64.2

Q ss_pred             ccccCc----cceeEeecccCCCCccccccccCCHHHHHHHHhcCCcccceeccccCCCceeEEecccccchhcccCCCc
Q 005206          365 ELQCSE----DKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEGGQ  440 (709)
Q Consensus       365 ~l~C~~----~~f~~~~~~~~p~~~~~~~~~~~~~~~C~~~Cl~nCsC~aya~~~~~~g~~C~~w~~~l~~~~~~~~~~~  440 (709)
                      +++|.+    ++|+.++++++|+.....  ...++++|++.||+||+|+||+|.+.  +++|++|.+++.+.+.....+.
T Consensus         2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~~--~~~C~~~~~~~~~~~~~~~~~~   77 (84)
T cd01098           2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNNG--SGGCLLWNGLLNNLRSLSSGGG   77 (84)
T ss_pred             CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecCC--CCeEEEEeceecceEeecCCCc
Confidence            345642    589999999999876543  56899999999999999999999863  4589999999988776544568


Q ss_pred             eeEEeec
Q 005206          441 DLYVRLA  447 (709)
Q Consensus       441 ~lyvrv~  447 (709)
                      ++||||+
T Consensus        78 ~~yiKv~   84 (84)
T cd01098          78 TLYLRLA   84 (84)
T ss_pred             EEEEEeC
Confidence            9999985

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.29  E-value=1.4e-11  Score=138.65  Aligned_cols=144  Identities=19%  Similarity=0.253  Sum_probs=95.4

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccc------------------------------h---------
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQG------------------------------I---------  582 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~------------------------------~---------  582 (709)
                      .|.. +.||.|++|+||+|++.+ |++||||++.+...+.                              .         
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            3555 689999999999999988 9999999997542110                              0         


Q ss_pred             -HHHHHHHHHHHhcC----CCceeeEEEEEEe-CCeeEEEEEccCCCCHHHHHhccCCC---CCCCHHHHHHHHHHHHHH
Q 005206          583 -EEFKNEVRLIAKLQ----HRNLVRLLGCCVE-MDEKMLVYEYMENRSLDSVIFDKARS---SILNWQRRFNIICGIARG  653 (709)
Q Consensus       583 -~~f~~Ei~~l~~l~----H~nIv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~ia~g  653 (709)
                       -+|.+|+..+.+++    +.+.+.+-.++.+ ....+|||||++++.+.++-.-....   ..+.......++.|    
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q----  275 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ----  275 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH----
Confidence             12455555555552    4444443333333 45688999999999998753111111   01222222222333    


Q ss_pred             HHHHHhCCCCceEecCCCCCCEEEcCCC----cEEEEecCCceeeCCC
Q 005206          654 LLYLHQDSRFRIIHRDLKASNILLDKEM----TPKISDFGMARIFGGD  697 (709)
Q Consensus       654 L~yLH~~~~~~iiHrDlkp~NILl~~~~----~~KI~DFGla~~l~~~  697 (709)
                         ++..+   ++|+|+||.||+++.++    .+++.|||++..+.+.
T Consensus       276 ---if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        276 ---VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             ---HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence               33455   99999999999999988    9999999999988544

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.29  E-value=1.5e-11  Score=118.66  Aligned_cols=131  Identities=19%  Similarity=0.169  Sum_probs=98.3

Q ss_pred             ceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCce-eeEEEEEEeCCeeEEEEEccCCCCH
Q 005206          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL-VRLLGCCVEMDEKMLVYEYMENRSL  625 (709)
Q Consensus       547 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~gsL  625 (709)
                      ++.|+.|.++.||+++.. ++.+++|....... ....+..|+.++..+.+.++ .+++++.  ....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            357899999999999875 77899998754322 23456889999999865554 4555543  3346899999999887


Q ss_pred             HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS--RFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       626 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ...-        .   ....++.+++++|+.||...  ...++|+|++|.||+++ ++.+++.|||.|..
T Consensus        79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            5320        1   11235678999999999876  23469999999999999 67899999999885

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.20  E-value=8.9e-12  Score=143.02  Aligned_cols=147  Identities=26%  Similarity=0.318  Sum_probs=112.7

Q ss_pred             cceeecccCceEEEEEEEcC-CcEEEEEEec----cC-Cc-cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          546 DYNKLGQGGFGIVYKGRLLE-GQEIAVKRLS----RN-SG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       546 ~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~----~~-~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ..+.+|.|++|.|+...... ....+.|...    .. .. +....+..|+.+-..++|+|++..+....+....+-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            34689999999777765433 3333333221    11 11 112226677778888999999888888777777777799


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      |+++ +|..++...   ..+.-.++..++.|++.|++|||+.+   |.|||||++|++++.++.+||+|||.+..+.-+.
T Consensus       402 ~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             cccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            9999 999888654   23677788889999999999999998   9999999999999999999999999999875554


Q ss_pred             c
Q 005206          699 T  699 (709)
Q Consensus       699 ~  699 (709)
                      .
T Consensus       475 e  475 (601)
T KOG0590|consen  475 E  475 (601)
T ss_pred             c
Confidence            3

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.16  E-value=2.2e-11  Score=146.40  Aligned_cols=94  Identities=19%  Similarity=0.264  Sum_probs=73.5

Q ss_pred             hcCC-CceeeEEEEE-------EeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 005206          594 KLQH-RNLVRLLGCC-------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI  665 (709)
Q Consensus       594 ~l~H-~nIv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  665 (709)
                      .++| +||.++++.+       .+.+..++++||+ .++|.++|.+.  ...+++.+++.|+.||++||.|||+++   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            4456 5788888877       2334567888988 55999999643  345899999999999999999999987   9


Q ss_pred             EecCCCCCCEEEcC-------------------CCcEEEEecCCcee
Q 005206          666 IHRDLKASNILLDK-------------------EMTPKISDFGMARI  693 (709)
Q Consensus       666 iHrDlkp~NILl~~-------------------~~~~KI~DFGla~~  693 (709)
                      |||||||+||||+.                   ++.+||+|||+++.
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~  148 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRR  148 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccc
Confidence            99999999999954                   44566666666664

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.12  E-value=4.9e-10  Score=112.88  Aligned_cols=143  Identities=19%  Similarity=0.288  Sum_probs=111.1

Q ss_pred             eeecccCceEEEEEEEcCCcEEEEEEeccCCc-cchHHHHHHHHHHHhcCC--CceeeEEEEEEeCC---eeEEEEEccC
Q 005206          548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQH--RNLVRLLGCCVEMD---EKMLVYEYME  621 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~---~~~lV~Ey~~  621 (709)
                      +.|+.|.++.||+++..+|+.+++|....... ....++..|+.++..+++  .++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            57899999999999987778899998754322 245678999999999975  45677888776543   5689999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS----------------------------------------  661 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------  661 (709)
                      +.++.+.+..    ..++..++..++.++++.|.+||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9888654421    23667777788888888888888531                                        


Q ss_pred             -------------CCceEecCCCCCCEEEcC--CCcEEEEecCCceee
Q 005206          662 -------------RFRIIHRDLKASNILLDK--EMTPKISDFGMARIF  694 (709)
Q Consensus       662 -------------~~~iiHrDlkp~NILl~~--~~~~KI~DFGla~~l  694 (709)
                                   ...++|+|++|.||+++.  +..+.|+||+.+..-
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                         245899999999999998  667899999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.12  E-value=9.6e-10  Score=108.28  Aligned_cols=138  Identities=14%  Similarity=0.135  Sum_probs=101.3

Q ss_pred             eeecccCceEEEEEEEcC-------CcEEEEEEeccCC------------c----------cchHHHH----HHHHHHHh
Q 005206          548 NKLGQGGFGIVYKGRLLE-------GQEIAVKRLSRNS------------G----------QGIEEFK----NEVRLIAK  594 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-------g~~VAVK~l~~~~------------~----------~~~~~f~----~Ei~~l~~  594 (709)
                      ..||.|--+.||.|...+       +..+|||..+...            +          ...+.+.    +|++.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997653       4789999875421            0          0012233    79999999


Q ss_pred             cC--CCceeeEEEEEEeCCeeEEEEEccCCCCHHH-HHhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecCC
Q 005206          595 LQ--HRNLVRLLGCCVEMDEKMLVYEYMENRSLDS-VIFDKARSSILNWQRRFNIICGIARGLLYL-HQDSRFRIIHRDL  670 (709)
Q Consensus       595 l~--H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiHrDl  670 (709)
                      +.  ..++.+++++    ...+|||||+.+..+.. .+.+    ..++..+...+..+++.+|.+| |+.+   |||+||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            85  3567777765    56789999998754422 2211    1244556667889999999999 7776   999999


Q ss_pred             CCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          671 KASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       671 kp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ++.|||++ ++.++|+|||-|-....+
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~hp  177 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPTHP  177 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCCCC
Confidence            99999997 468999999999877544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.05  E-value=1.6e-09  Score=103.44  Aligned_cols=132  Identities=27%  Similarity=0.393  Sum_probs=100.9

Q ss_pred             eeecccCceEEEEEEEcCCcEEEEE-EeccC-Cc------cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          548 NKLGQGGFGIVYKGRLLEGQEIAVK-RLSRN-SG------QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~g~~VAVK-~l~~~-~~------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ..+++|+-..||.+.+.+ ..+.+| ++.+. ..      ...++-++|++++.+++-..|..-+=+..+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            357899999999997643 334444 33222 11      1134678899999999766665555567788889999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      +++-.|.+++...          +..++..|-.-+.-||..+   |||+||.++||++..+. +.++||||++.-
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence            9999999888543          2456777888888999998   99999999999998765 999999999854

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.00  E-value=5.5e-11  Score=131.02  Aligned_cols=143  Identities=24%  Similarity=0.270  Sum_probs=116.0

Q ss_pred             eecccCceEEEEEEE----cCCcEEEEEEeccCCcc--chHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEEEEccC
Q 005206          549 KLGQGGFGIVYKGRL----LEGQEIAVKRLSRNSGQ--GIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       549 ~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~~~--~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      .+|+|.||.|++++-    +.+..+|+|.+++....  .......|..++..++ ||.+|++.-.+......+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999997642    33667888888654211  1225667888889997 9999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      +|.|...+.+.   ...+......+...+|-+++++|+.+   |+|||+|++||+++.+|++|+.|||+++.+-..
T Consensus        81 gg~lft~l~~~---~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~  150 (612)
T KOG0603|consen   81 GGDLFTRLSKE---VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE  150 (612)
T ss_pred             cchhhhccccC---CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhh
Confidence            99998776443   23555566667778999999999998   999999999999999999999999999977544

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=98.96  E-value=1.4e-10  Score=115.11  Aligned_cols=136  Identities=24%  Similarity=0.460  Sum_probs=112.3

Q ss_pred             ceeecccCceEEEEEEEcCCcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCC
Q 005206          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRS  624 (709)
Q Consensus       547 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  624 (709)
                      +.+|.+.-.|+.|+|+++. ..+++|++...  .....++|.+|.-.++-+.||||..++|.|....+..++..||+.|+
T Consensus       195 ~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            3578899999999999954 55556666432  33345679999998888999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe-cCCCCCCEEEcCCCcEEEE
Q 005206          625 LDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH-RDLKASNILLDKEMTPKIS  686 (709)
Q Consensus       625 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH-rDlkp~NILl~~~~~~KI~  686 (709)
                      |...|++.. .-..+..+..+++.+||+||+|||+..  ++|- --|.++.++||++.+++|+
T Consensus       274 lynvlhe~t-~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltaris  333 (448)
T KOG0195|consen  274 LYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARIS  333 (448)
T ss_pred             HHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhhee
Confidence            999997643 335788899999999999999999986  3444 3688999999999988875

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.93  E-value=1.3e-08  Score=96.79  Aligned_cols=145  Identities=23%  Similarity=0.333  Sum_probs=106.0

Q ss_pred             cceeecccCceEEEEEEEcCCcEEEEE-EeccC-------CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          546 DYNKLGQGGFGIVYKGRLLEGQEIAVK-RLSRN-------SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       546 ~~~~LG~G~fG~Vykg~~~~g~~VAVK-~l~~~-------~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      .+..|-+|+-+.|+++.+. |+...|| +..+.       ..-..++.++|++++.+++--.|.--.-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4468999999999999884 5555555 33322       1122457889999999987555544444667777889999


Q ss_pred             EccCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC---cEEEEecCCcee
Q 005206          618 EYMEN-RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM---TPKISDFGMARI  693 (709)
Q Consensus       618 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~KI~DFGla~~  693 (709)
                      ||+++ .++.+++.........+ .....++..|-+-+.-||.+.   |||+||..+||+|..++   .+.++||||+..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 47888886543332222 233678889999999999998   99999999999997654   468999999875


Q ss_pred             eC
Q 005206          694 FG  695 (709)
Q Consensus       694 l~  695 (709)
                      -.
T Consensus       166 s~  167 (229)
T KOG3087|consen  166 SR  167 (229)
T ss_pred             cc
Confidence            43

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=98.90  E-value=7.7e-09  Score=107.36  Aligned_cols=149  Identities=25%  Similarity=0.351  Sum_probs=98.2

Q ss_pred             cCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCC----------CceeeEEEEE--
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQH----------RNLVRLLGCC--  607 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H----------~nIv~l~g~~--  607 (709)
                      +...+.||.|+|+.||.+++.+ ++++|||.....   .....+++++|.-.+..+.+          -.++--++..  
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            4556789999999999999987 899999988543   23456778888766655433          1122111211  


Q ss_pred             -------EeCC--------eeEEEEEccCCCCHHHHHh---ccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEec
Q 005206          608 -------VEMD--------EKMLVYEYMENRSLDSVIF---DKARS-SILNWQRRFNIICGIARGLLYLHQDSRFRIIHR  668 (709)
Q Consensus       608 -------~~~~--------~~~lV~Ey~~~gsL~~~l~---~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHr  668 (709)
                             ....        +.+++|+-+ .++|.+++.   ..... ..+....++.+-.|+++.+++||.++   ++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence                   1111        235677766 568877753   22221 22445556777899999999999998   9999


Q ss_pred             CCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          669 DLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       669 Dlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ||||+|++++.+|.++|+||+-....+.
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~  197 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGT  197 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTE
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCc
Confidence            9999999999999999999998876543

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=98.85  E-value=4.2e-10  Score=130.03  Aligned_cols=142  Identities=20%  Similarity=0.247  Sum_probs=111.0

Q ss_pred             CcCcceeecccCceEEEEEEEcCCcEEEEEEeccCC-ccchHHHHHHHHH--HHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS-GQGIEEFKNEVRL--IAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~--l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ++...+.||.+.|=+|.++++++|. |+||++.+.. ....+.|.++++-  ...++|||.+.+.-+-....-.|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            4556678999999999999998887 8899886654 3445666555544  4455899998877665555566888888


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCce
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~  692 (709)
                      +.+ +|.+.|.   .++.+...+..-|+.|++.||.-+|..+   |.|+|||.+||||+.-+-+.|+||.--|
T Consensus       103 vkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK  168 (1431)
T KOG1240|consen  103 VKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK  168 (1431)
T ss_pred             Hhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence            865 5665552   2334566667779999999999999998   9999999999999999999999998665

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.81  E-value=1.2e-07  Score=98.64  Aligned_cols=140  Identities=17%  Similarity=0.113  Sum_probs=102.0

Q ss_pred             eecccCceEEEEEEEcCCcEEEEEEeccCCc-----------cchHHHHHHHHHHHhcC--CCceeeEEEEEEeC-----
Q 005206          549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG-----------QGIEEFKNEVRLIAKLQ--HRNLVRLLGCCVEM-----  610 (709)
Q Consensus       549 ~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~-----------~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~-----  610 (709)
                      .+-+-....|++..+ +|+.+.||+......           .....+.+|...+.++.  .-..++++++....     
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            444444445777765 577899997743321           11124789999999884  34445666666542     


Q ss_pred             CeeEEEEEccCCC-CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-------CCc
Q 005206          611 DEKMLVYEYMENR-SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-------EMT  682 (709)
Q Consensus       611 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-------~~~  682 (709)
                      ...+||+|++++- +|.+++.+.. ....+...+..++.+++..+.-||..+   |+|+|+++.|||++.       +..
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence            3468999999986 8998875322 123456677789999999999999998   999999999999975       478


Q ss_pred             EEEEecCCcee
Q 005206          683 PKISDFGMARI  693 (709)
Q Consensus       683 ~KI~DFGla~~  693 (709)
                      +.++||+.++.
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999999964

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=98.80  E-value=6.9e-09  Score=114.45  Aligned_cols=99  Identities=30%  Similarity=0.532  Sum_probs=89.9

Q ss_pred             HhcCCCceeeEEEEEEeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCC
Q 005206          593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKA  672 (709)
Q Consensus       593 ~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp  672 (709)
                      +.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+...  ...++|.-...+..+|+.||+|||.-.  -..|+.+++
T Consensus         2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s   77 (484)
T KOG1023|consen    2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKS   77 (484)
T ss_pred             cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeecc
Confidence            5688999999999999999999999999999999999763  345899999999999999999999864  239999999


Q ss_pred             CCEEEcCCCcEEEEecCCceeeC
Q 005206          673 SNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       673 ~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      +|+++|..+.+||+|||+..+..
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~  100 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLE  100 (484)
T ss_pred             ccceeeeeEEEEechhhhccccc
Confidence            99999999999999999998874

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.78  E-value=3.1e-08  Score=97.24  Aligned_cols=128  Identities=25%  Similarity=0.282  Sum_probs=85.0

Q ss_pred             EEEEEEEcCCcEEEEEEeccCC-------------cc-------------chHHHHHHHHHHHhcCCC--ceeeEEEEEE
Q 005206          557 IVYKGRLLEGQEIAVKRLSRNS-------------GQ-------------GIEEFKNEVRLIAKLQHR--NLVRLLGCCV  608 (709)
Q Consensus       557 ~Vykg~~~~g~~VAVK~l~~~~-------------~~-------------~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~  608 (709)
                      .||.|...++..+|||......             ..             ......+|.+.|.++...  ++.+++.+  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            4899999999999999875421             00             012457899999999765  56777755  


Q ss_pred             eCCeeEEEEEccC--CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecCCCCCCEEEcCCCcEEE
Q 005206          609 EMDEKMLVYEYME--NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL-HQDSRFRIIHRDLKASNILLDKEMTPKI  685 (709)
Q Consensus       609 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiHrDlkp~NILl~~~~~~KI  685 (709)
                        ....|||||++  +..+..+....     ++......++.+++..+..+ |..+   |||+||.+.|||++++ .+.|
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence              25689999999  65554433211     11233455777888866665 5666   9999999999999988 9999


Q ss_pred             EecCCceeeCCC
Q 005206          686 SDFGMARIFGGD  697 (709)
Q Consensus       686 ~DFGla~~l~~~  697 (709)
                      +|||.|.....+
T Consensus       148 IDf~qav~~~~p  159 (188)
T PF01163_consen  148 IDFGQAVDSSHP  159 (188)
T ss_dssp             --GTTEEETTST
T ss_pred             EecCcceecCCc
Confidence            999999876543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=98.75  E-value=1.2e-08  Score=106.55  Aligned_cols=89  Identities=26%  Similarity=0.469  Sum_probs=68.2

Q ss_pred             CCCceeeEEEEEEeC---------------------------CeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHH
Q 005206          596 QHRNLVRLLGCCVEM---------------------------DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC  648 (709)
Q Consensus       596 ~H~nIv~l~g~~~~~---------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  648 (709)
                      +|||||++.++|.+.                           ...|+||.-.+. +|.+|+-...    .+.....-|+.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence            699999998876542                           124788876653 7888884432    34455556889


Q ss_pred             HHHHHHHHHHhCCCCceEecCCCCCCEEE--cCCC--cEEEEecCCce
Q 005206          649 GIARGLLYLHQDSRFRIIHRDLKASNILL--DKEM--TPKISDFGMAR  692 (709)
Q Consensus       649 ~ia~gL~yLH~~~~~~iiHrDlkp~NILl--~~~~--~~KI~DFGla~  692 (709)
                      |+++|+.|||.++   |.|||+|++||||  |+|.  .+.|+|||.+-
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL  393 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCL  393 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceee
Confidence            9999999999998   9999999999999  3443  57899999874

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.68  E-value=2.1e-09  Score=123.54  Aligned_cols=162  Identities=27%  Similarity=0.353  Sum_probs=123.2

Q ss_pred             CcCcceeecccCceEEEEEEEcC--CcEEEEEEeccCC--ccchHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE--GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~--g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      .|...+.||+|+|+.|-......  ...+|+|.+....  ....+....|..+-..+. |+|++++++...+.+..+++.
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            45556679999999998876644  3456777665432  333445556777777776 999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEecCCCCCCEEEcCCC-cEEEEecCCceeeC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH-QDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIFG  695 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iiHrDlkp~NILl~~~~-~~KI~DFGla~~l~  695 (709)
                      ||..++++.+.+.... ....+....-.++.|+..++.|+| +.+   +.||||||+|.+++..+ ..|++|||+|..+.
T Consensus       101 ~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             CcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999987763211 112444555678999999999999 776   99999999999999999 99999999999887


Q ss_pred             C-CCccccccceec
Q 005206          696 G-DQTEQNTKRVVG  708 (709)
Q Consensus       696 ~-~~~~~~~~~~~G  708 (709)
                      . +.........+|
T Consensus       177 ~~~g~~~~~~~~~g  190 (601)
T KOG0590|consen  177 NKNGAERSLKDRCG  190 (601)
T ss_pred             ccCCcceeeecccC
Confidence            6 444444443444

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.50  E-value=9.8e-07  Score=95.79  Aligned_cols=140  Identities=21%  Similarity=0.309  Sum_probs=111.5

Q ss_pred             eEEEEEEE-cCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEe----CCeeEEEEEccCC-CCHHHHH
Q 005206          556 GIVYKGRL-LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE----MDEKMLVYEYMEN-RSLDSVI  629 (709)
Q Consensus       556 G~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~Ey~~~-gsL~~~l  629 (709)
                      .+-||+.. .+|..+++|++.....+....-..-++..+++.|+|+|.+..++..    ....+|||+|.|+ ++|.++-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            46788865 4699999999954443434344556788899999999999988873    3457899999987 4676665


Q ss_pred             hccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          630 FDKAR------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       630 ~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      +....            ...+++...+.++.|++.||.++|+.|   +.-+-|.+++||++.+.+++|+..|+..++..+
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            53221            224678899999999999999999998   888999999999999999999999999988766


Q ss_pred             C
Q 005206          698 Q  698 (709)
Q Consensus       698 ~  698 (709)
                      .
T Consensus       447 ~  447 (655)
T KOG3741|consen  447 P  447 (655)
T ss_pred             C
Confidence            5

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.50  E-value=1.2e-06  Score=87.70  Aligned_cols=108  Identities=22%  Similarity=0.242  Sum_probs=87.2

Q ss_pred             hHHHHHHHHHHHhcC--CCceeeEEEEEEeCC----eeEEEEEccCCC-CHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 005206          582 IEEFKNEVRLIAKLQ--HRNLVRLLGCCVEMD----EKMLVYEYMENR-SLDSVIFDKARSSILNWQRRFNIICGIARGL  654 (709)
Q Consensus       582 ~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL  654 (709)
                      .....+|...+.+++  .-.+.+.+++.....    ..+||+|++++- +|.+++.+...   ++......++.+++..+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence            446788999888885  445667778776633    348999999984 79998865322   45566778999999999


Q ss_pred             HHHHhCCCCceEecCCCCCCEEEcCCC---cEEEEecCCceeeC
Q 005206          655 LYLHQDSRFRIIHRDLKASNILLDKEM---TPKISDFGMARIFG  695 (709)
Q Consensus       655 ~yLH~~~~~~iiHrDlkp~NILl~~~~---~~KI~DFGla~~l~  695 (709)
                      .-||+.+   |+|+|+++.|||++.+.   .+.++||+.++...
T Consensus       132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            9999998   99999999999999887   89999999988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.46  E-value=7.3e-07  Score=99.73  Aligned_cols=122  Identities=19%  Similarity=0.278  Sum_probs=100.3

Q ss_pred             cCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHH
Q 005206          564 LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRR  643 (709)
Q Consensus       564 ~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~  643 (709)
                      .++.+|.|...+.......+...+-++.|+.++||||++++.........|||.|-+.  .|..++.+..      ....
T Consensus        35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~------~~~v  106 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG------KEEV  106 (690)
T ss_pred             ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH------HHHH
Confidence            3578888888876655445567788889999999999999999999999999999884  5776764422      3344


Q ss_pred             HHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       644 ~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      .-.+.||+.||.|||+.+  .++|++|.-..|+|++.|.-||.+|-++....
T Consensus       107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~  156 (690)
T KOG1243|consen  107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKAS  156 (690)
T ss_pred             HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence            456889999999999877  59999999999999999999999999886543

>PRK09902 hypothetical protein; Provisional

Probab=98.40  E-value=7.9e-06  Score=80.97  Aligned_cols=139  Identities=19%  Similarity=0.136  Sum_probs=104.3

Q ss_pred             ecccCceEEEEEEEcCCcEEEEEEeccC---C---ccchHHHHHHHHHHHhcC--CCceeeEEEEEEeCC----eeEEEE
Q 005206          550 LGQGGFGIVYKGRLLEGQEIAVKRLSRN---S---GQGIEEFKNEVRLIAKLQ--HRNLVRLLGCCVEMD----EKMLVY  617 (709)
Q Consensus       550 LG~G~fG~Vykg~~~~g~~VAVK~l~~~---~---~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~----~~~lV~  617 (709)
                      -|+||-+.|++-.+. |+.+-+|+-...   +   +.+...|.+|+..|.+|.  ...+.+.+.......    ..+||+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            466888889988774 446888877522   1   446778999999999985  334556553322222    358999


Q ss_pred             EccCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc--EEEEecCCcee
Q 005206          618 EYMEN-RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT--PKISDFGMARI  693 (709)
Q Consensus       618 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~--~KI~DFGla~~  693 (709)
                      |-+++ -+|.+++.+... ...+...+..++.+|++.+.-||+.+   +.|+|+-+.||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97764 588888854322 24677778899999999999999998   999999999999986666  99999987764

>smart00473 PAN_AP divergent subfamily of APPLE domains

Probab=98.37  E-value=8e-07  Score=73.84  Aligned_cols=72  Identities=39%  Similarity=0.809  Sum_probs=54.9

Q ss_pred             cceeEeecccCCCCccccccccCCHHHHHHHHhc-CCcccceeccccCCCceeEEec-ccccchhcccCCCceeEEe
Q 005206          371 DKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSR-NCSCTAYANTNITGGTGCVTWT-GELKDIRKYAEGGQDLYVR  445 (709)
Q Consensus       371 ~~f~~~~~~~~p~~~~~~~~~~~~~~~C~~~Cl~-nCsC~aya~~~~~~g~~C~~w~-~~l~~~~~~~~~~~~lyvr  445 (709)
                      ..|..++++.+++..... ....++++|++.|++ +|+|.||.|..  ++.+|.+|. +.+.+.......+.++|.|
T Consensus         4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~--~~~~C~l~~~~~~~~~~~~~~~~~~~y~~   77 (78)
T smart00473        4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN--GTKGCLLWSESSLGDARLFPSGGVDLYEK   77 (78)
T ss_pred             ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC--CCCEEEEeeCCccccceecccCCceeEEe
Confidence            468999999998654432 346799999999999 99999999975  345899999 7777766444445566654

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.32  E-value=4e-06  Score=85.01  Aligned_cols=137  Identities=20%  Similarity=0.205  Sum_probs=95.1

Q ss_pred             CcceeecccCceEEEEEEEcCCcEEEEEEeccCC----------cc------------chHHHHHHHHHHHhcCCC--ce
Q 005206          545 TDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS----------GQ------------GIEEFKNEVRLIAKLQHR--NL  600 (709)
Q Consensus       545 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~----------~~------------~~~~f~~Ei~~l~~l~H~--nI  600 (709)
                      ....+||.|--+.||.|..+.|.++|||.=....          ..            ......+|.+.|.+|.-.  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            3446899999999999999999999998542210          00            112346789999998644  67


Q ss_pred             eeEEEEEEeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC
Q 005206          601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE  680 (709)
Q Consensus       601 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~  680 (709)
                      .+.+++    +...+||||+++-.|...-        ++-...-.|+..|+.-+.-+-..+   |||+|+.+-||+++++
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~d  238 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTED  238 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence            766654    5668999999986664221        112222234444555444444555   9999999999999999


Q ss_pred             CcEEEEecCCceeeCC
Q 005206          681 MTPKISDFGMARIFGG  696 (709)
Q Consensus       681 ~~~KI~DFGla~~l~~  696 (709)
                      +.+.++||-=+-....
T Consensus       239 g~~~vIDwPQ~v~~~h  254 (304)
T COG0478         239 GDIVVIDWPQAVPISH  254 (304)
T ss_pred             CCEEEEeCcccccCCC
Confidence            9999999976655433

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=98.32  E-value=2.7e-06  Score=76.76  Aligned_cols=85  Identities=24%  Similarity=0.352  Sum_probs=60.2

Q ss_pred             EEEEcCc-eEEEcCC-CceEEecCCCCC--CCceeEEecCCCEEEEecCCCceeEeeccCCCCccCCCCcccceeccCCe
Q 005206          123 LRIINQR-IGLFDGS-QNLVWSSNQTKA--TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFE  198 (709)
Q Consensus       123 l~l~~~G-Lvl~d~~-g~~vWst~~~~~--~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PtDTlLpg~~l~~~~~tg~~  198 (709)
                      +....+| ||+.+.. +.+||++|+...  ....+.|.++|||||++. .+.++|+|  +   |                
T Consensus        24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~-~g~~vW~S--~---t----------------   81 (114)
T smart00108       24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDG-DGRVVWSS--N---T----------------   81 (114)
T ss_pred             cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeC-CCCEEEEe--c---c----------------
Confidence            4455788 8888765 579999997644  236789999999999986 56789997  1   1                


Q ss_pred             eEEEEecCCCCCCCCcceEeecCCCCcEEEEecCCccccccC
Q 005206          199 WYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSG  240 (709)
Q Consensus       199 ~~L~S~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~sg  240 (709)
                                ....|.+.+.|+++|+..++- ....+.|.|.
T Consensus        82 ----------~~~~~~~~~~L~ddGnlvl~~-~~~~~~W~Sf  112 (114)
T smart00108       82 ----------TGANGNYVLVLLDDGNLVIYD-SDGNFLWQSF  112 (114)
T ss_pred             ----------cCCCCceEEEEeCCCCEEEEC-CCCCEEeCCC
Confidence                      012456788999999865542 2345677764

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.29  E-value=5.1e-07  Score=105.05  Aligned_cols=110  Identities=25%  Similarity=0.420  Sum_probs=75.9

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      .+|..++.|-.|++|.||..+++. .+.+|+| +.+..-    -.++   ++.....|.+|                   
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l----ilRn---ilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL----ILRN---ILTFAGNPFVV-------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccch----hhhc---cccccCCccee-------------------
Confidence            568888999999999999999876 5678884 332210    0011   22222344433                   


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                        |+-...+...   ..++-        +++.+++|||+.+   |+|||+||+|.||+.-+++|+.||||.++.
T Consensus       136 --gDc~tllk~~---g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G  193 (1205)
T KOG0606|consen  136 --GDCATLLKNI---GPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG  193 (1205)
T ss_pred             --chhhhhcccC---CCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence              4444444221   11221        2388999999998   999999999999999999999999999853

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.28  E-value=3.8e-06  Score=94.53  Aligned_cols=141  Identities=16%  Similarity=0.281  Sum_probs=94.1

Q ss_pred             eeecccCceEEEEEEEcCCcEEEEEEeccCCccc------------------------------hH----------HHHH
Q 005206          548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQG------------------------------IE----------EFKN  587 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~------------------------------~~----------~f~~  587 (709)
                      +-|+.++-|+||+|++++|++||||+....-.+.                              .+          .|..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            5789999999999999999999999987642111                              01          1234


Q ss_pred             HHHHHHhcC-----CCceeeEEEEE-EeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHH-HHHHHhC
Q 005206          588 EVRLIAKLQ-----HRNLVRLLGCC-VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG-LLYLHQD  660 (709)
Q Consensus       588 Ei~~l~~l~-----H~nIv~l~g~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g-L~yLH~~  660 (709)
                      |..-+.+++     .+++ ++=.++ .-.....|+|||++|-.+.+......  ..++.+.   ++..++++ +.-+-..
T Consensus       211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~q~~~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHHHHHhc
Confidence            444444442     2333 222233 23567899999999999988753222  2244333   33333332 2222234


Q ss_pred             CCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       661 ~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      +   ++|.|..|.||+++.++.+-+.|||+...+.+.
T Consensus       285 g---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         285 G---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             C---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            4   999999999999999999999999999888544

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.27  E-value=4.8e-07  Score=100.17  Aligned_cols=149  Identities=24%  Similarity=0.263  Sum_probs=117.5

Q ss_pred             HHhcCcCcceeecccCceEEEEEEEc--CCcEEEEEEeccCCccchHH--HHHHHHHHHhc-CCCceeeEEEEEEeCCee
Q 005206          539 RATDNFTDYNKLGQGGFGIVYKGRLL--EGQEIAVKRLSRNSGQGIEE--FKNEVRLIAKL-QHRNLVRLLGCCVEMDEK  613 (709)
Q Consensus       539 ~~t~~f~~~~~LG~G~fG~Vykg~~~--~g~~VAVK~l~~~~~~~~~~--f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~  613 (709)
                      ..+..|..+..||.|.|+.|++...+  ++..+++|.+.+.......+  -..|+.+...+ .|.++++....+.+.++.
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            34567888899999999999998654  36788998886553222222  23455555555 588888888888888888


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CcEEEEecCCce
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMAR  692 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~KI~DFGla~  692 (709)
                      ++=.||++++++...+.   -...++...++++..|++.++.++|+..   ++|+|+||+||++..+ +..++.|||++.
T Consensus       342 ~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             cCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence            99999999999876652   2234788888999999999999999887   9999999999999886 889999999986


Q ss_pred             e
Q 005206          693 I  693 (709)
Q Consensus       693 ~  693 (709)
                      .
T Consensus       416 ~  416 (524)
T KOG0601|consen  416 R  416 (524)
T ss_pred             c
Confidence            3

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=98.26  E-value=3.5e-06  Score=76.22  Aligned_cols=85  Identities=21%  Similarity=0.307  Sum_probs=60.4

Q ss_pred             EEEc-Cc-eEEEcCC-CceEEecCCCCC--CCceeEEecCCCEEEEecCCCceeEeeccCCCCccCCCCcccceeccCCe
Q 005206          124 RIIN-QR-IGLFDGS-QNLVWSSNQTKA--TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFE  198 (709)
Q Consensus       124 ~l~~-~G-Lvl~d~~-g~~vWst~~~~~--~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PtDTlLpg~~l~~~~~tg~~  198 (709)
                      .... +| |++.+.. +.++|++|+...  ....+.|.++|||||++. .+.++|+|=..                    
T Consensus        25 ~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~-~g~~vW~S~~~--------------------   83 (116)
T cd00028          25 IMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDG-SGTVVWSSNTT--------------------   83 (116)
T ss_pred             CCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcC-CCcEEEEeccc--------------------
Confidence            3444 78 8888765 589999997653  456789999999999986 56789997210                    


Q ss_pred             eEEEEecCCCCCCCCcceEeecCCCCcEEEEecCCccccccCC
Q 005206          199 WYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGP  241 (709)
Q Consensus       199 ~~L~S~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~sg~  241 (709)
                                 ...+.+.+.|+.+|+..++-. ...+.|.|..
T Consensus        84 -----------~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf~  114 (116)
T cd00028          84 -----------RVNGNYVLVLLDDGNLVLYDS-DGNFLWQSFD  114 (116)
T ss_pred             -----------CCCCceEEEEeCCCCEEEECC-CCCEEEcCCC
Confidence                       024668889999998655422 3456787653

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=98.24  E-value=2.7e-06  Score=82.35  Aligned_cols=62  Identities=24%  Similarity=0.227  Sum_probs=54.1

Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      |+|.+++.+.  ...+++.++..|+.||++||.|||+++         ||+|||++.++.+|+  ||+++.....
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~   62 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE   62 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc
Confidence            6899998643  235899999999999999999999875         999999999999999  9999987543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.22  E-value=2.2e-05  Score=79.83  Aligned_cols=138  Identities=15%  Similarity=0.187  Sum_probs=85.4

Q ss_pred             eeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCc--eeeEEEEEEeCCeeEEEEEccCCCC-
Q 005206          548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN--LVRLLGCCVEMDEKMLVYEYMENRS-  624 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~~~~~~~~~lV~Ey~~~gs-  624 (709)
                      ..||+|..+.||+.   .+..+++|......  ......+|.+++..+..-.  +.+.+++....+...+|||+++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57999999999984   24566777765322  3456788999999886443  4677888877777889999999863 


Q ss_pred             HHHHH---------------------hccCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHhC-CCCceEecCC
Q 005206          625 LDSVI---------------------FDKARSSILNWQRRF-NIIC----------GIAR-GLLYLHQD-SRFRIIHRDL  670 (709)
Q Consensus       625 L~~~l---------------------~~~~~~~~l~~~~~~-~i~~----------~ia~-gL~yLH~~-~~~~iiHrDl  670 (709)
                      +...+                     +.. .........+. .+..          .+.. ...+|... ....++|+|+
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~-~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHST-KCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCC-CCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence            21111                     110 00001111100 0000          0111 12222211 2345789999


Q ss_pred             CCCCEEEcCCCcEEEEecCCce
Q 005206          671 KASNILLDKEMTPKISDFGMAR  692 (709)
Q Consensus       671 kp~NILl~~~~~~KI~DFGla~  692 (709)
                      .|.||++++++ +.|.||+.+.
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcC
Confidence            99999999888 9999999886

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.14  E-value=1.6e-06  Score=96.04  Aligned_cols=150  Identities=24%  Similarity=0.271  Sum_probs=118.5

Q ss_pred             CcCcceeecc--cCceEEEEEEE--c-CCcEEEEEEeccC--CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeE
Q 005206          543 NFTDYNKLGQ--GGFGIVYKGRL--L-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKM  614 (709)
Q Consensus       543 ~f~~~~~LG~--G~fG~Vykg~~--~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~  614 (709)
                      .|...+.+|.  |.+|.||.+..  . ++..+|+|+-+..  .......=.+|+....++ .|+|.++....+..++..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            3555678999  99999999987  3 4778999874332  223333445677777777 4999999888999999999


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCceEecCCCCCCEEEcCC-CcEEEEecC
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIAR----GLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFG  689 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~KI~DFG  689 (709)
                      +-.|++. .+|..+.....  ..++......+..+..+    ||..+|...   ++|-|+||.||.+..+ ...|+.|||
T Consensus       195 iqtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             eeecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence            9999886 67777764432  23566677777777878    999999987   9999999999999999 899999999


Q ss_pred             CceeeCCCC
Q 005206          690 MARIFGGDQ  698 (709)
Q Consensus       690 la~~l~~~~  698 (709)
                      +...+++..
T Consensus       269 ~v~~i~~~~  277 (524)
T KOG0601|consen  269 LVSKISDGN  277 (524)
T ss_pred             eeEEccCCc
Confidence            999987664

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.14  E-value=1.7e-05  Score=89.10  Aligned_cols=140  Identities=14%  Similarity=0.218  Sum_probs=90.7

Q ss_pred             eeecccCceEEEEEEEcCCcEEEEEEeccCCccc-------------------------------------hHHHHHHHH
Q 005206          548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQG-------------------------------------IEEFKNEVR  590 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~-------------------------------------~~~f~~Ei~  590 (709)
                      +.||..+.|+||+|++++|+.||||+-+..-+..                                     +-.|.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            5799999999999999999999999886542111                                     002344554


Q ss_pred             HHHh----cCCCc------eeeEEEEEEeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 005206          591 LIAK----LQHRN------LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD  660 (709)
Q Consensus       591 ~l~~----l~H~n------Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~  660 (709)
                      -..+    +.|-+      |.+++--  -...+.|+||||+|..+.+.-.-..  ..++......-+.+...-+-+  ..
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~~~l~~~~~~qIf--~~  320 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDK--RGISPHDILNKLVEAYLEQIF--KT  320 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHH--cCCCHHHHHHHHHHHHHHHHH--hc
Confidence            3333    34555      3333222  2357899999999998766532111  124444443333333222222  22


Q ss_pred             CCCceEecCCCCCCEEEcC----CCcEEEEecCCceeeCC
Q 005206          661 SRFRIIHRDLKASNILLDK----EMTPKISDFGMARIFGG  696 (709)
Q Consensus       661 ~~~~iiHrDlkp~NILl~~----~~~~KI~DFGla~~l~~  696 (709)
                      |   ++|+|-.|-||++..    +..+.+-|||+.+.+..
T Consensus       321 G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  321 G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             C---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            3   999999999999984    67899999999987743

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.12  E-value=1e-05  Score=79.68  Aligned_cols=105  Identities=22%  Similarity=0.238  Sum_probs=83.2

Q ss_pred             HHHHHHHHhcCC-CceeeEEEEEEeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 005206          586 KNEVRLIAKLQH-RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR  664 (709)
Q Consensus       586 ~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  664 (709)
                      .+|.-++..+++ +++++++|.|    ..++|.||.+.+++...-..-..-...+|..|.+||.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            458888999976 6999999999    45789999998766421000001113689999999999999999999865445


Q ss_pred             eEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          665 IIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       665 iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      +.-+|++++|+.+++++.+|+.|...+-..
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999987644

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.09  E-value=5.9e-05  Score=76.13  Aligned_cols=145  Identities=21%  Similarity=0.180  Sum_probs=87.9

Q ss_pred             ceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCC--ceeeEEEEEEeC---CeeEEEEEccC
Q 005206          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR--NLVRLLGCCVEM---DEKMLVYEYME  621 (709)
Q Consensus       547 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~~~---~~~~lV~Ey~~  621 (709)
                      ++.|+.|..+.||+....+ ..+++|.....  .....+..|..++..+...  .+.+++......   ...+++||+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            3679999999999999877 68899987433  4567788899998888533  356777755433   34689999999


Q ss_pred             CCCHHH----------------HHh---cc-CCCCCCCHHHH---------HHH------------HHHHHH-HHHHHHh
Q 005206          622 NRSLDS----------------VIF---DK-ARSSILNWQRR---------FNI------------ICGIAR-GLLYLHQ  659 (709)
Q Consensus       622 ~gsL~~----------------~l~---~~-~~~~~l~~~~~---------~~i------------~~~ia~-gL~yLH~  659 (709)
                      +..+..                .+.   +. .......+...         ...            ...+.+ .+..+++
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988777                111   11 01111111110         000            111222 3333332


Q ss_pred             ----CCCCceEecCCCCCCEEEc-CCCcEEEEecCCceee
Q 005206          660 ----DSRFRIIHRDLKASNILLD-KEMTPKISDFGMARIF  694 (709)
Q Consensus       660 ----~~~~~iiHrDlkp~NILl~-~~~~~KI~DFGla~~l  694 (709)
                          .....++|+|+.|.|||++ +++.+.|.||+.+..-
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~  198 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG  198 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence                2345699999999999999 6677789999998754

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.06  E-value=5.5e-05  Score=77.69  Aligned_cols=141  Identities=13%  Similarity=0.130  Sum_probs=87.3

Q ss_pred             eecccCc-eEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEEEEccCCCCHH
Q 005206          549 KLGQGGF-GIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYEYMENRSLD  626 (709)
Q Consensus       549 ~LG~G~f-G~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~  626 (709)
                      .|..|.+ ..||+.... +..+.||+.....   ..++.+|++++..+. +.-+.+++++....+..++|||++++.++.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            4556666 689999764 4677778764332   445778999888883 455668888887766789999999998776


Q ss_pred             HHH-------------------hccCC-CCCCC--HHHHHHH-HH-------------------HHHHHHHHHHh----C
Q 005206          627 SVI-------------------FDKAR-SSILN--WQRRFNI-IC-------------------GIARGLLYLHQ----D  660 (709)
Q Consensus       627 ~~l-------------------~~~~~-~~~l~--~~~~~~i-~~-------------------~ia~gL~yLH~----~  660 (709)
                      ...                   +.... .....  ...++.- ..                   .+...+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            431                   01000 00111  0011100 00                   01111222211    1


Q ss_pred             CCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       661 ~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ..+.++|+|+.|.|||++++..+.|+||+.|..
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            234599999999999999988889999998863

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=98.00  E-value=1.5e-06  Score=94.76  Aligned_cols=81  Identities=26%  Similarity=0.377  Sum_probs=71.8

Q ss_pred             eeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCc
Q 005206          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla  691 (709)
                      ..++.|+++...+|.++|.........++...+.++.|++.|++|   ++   .+|||+||.||....+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            468999999999999999766555667888999999999999999   54   999999999999999999999999999


Q ss_pred             eeeCCCC
Q 005206          692 RIFGGDQ  698 (709)
Q Consensus       692 ~~l~~~~  698 (709)
                      .......
T Consensus       404 ts~~~~~  410 (516)
T KOG1033|consen  404 TSQDKDE  410 (516)
T ss_pred             eecccCC
Confidence            8776554

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=97.98  E-value=5e-06  Score=85.53  Aligned_cols=99  Identities=23%  Similarity=0.288  Sum_probs=80.8

Q ss_pred             HHHHHHHhcCCCceeeEEEEEEeCC-----eeEEEEEccCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 005206          587 NEVRLIAKLQHRNLVRLLGCCVEMD-----EKMLVYEYMENRSLDSVIFDKAR-SSILNWQRRFNIICGIARGLLYLHQD  660 (709)
Q Consensus       587 ~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~  660 (709)
                      .-..-|-.+.|.|||++..++.+..     +..++.|||.-|+|..+|.+..+ ...+......++..||..||.|||+-
T Consensus       116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~  195 (458)
T KOG1266|consen  116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence            3344556678999999999886543     46889999999999999976544 23456666667999999999999996


Q ss_pred             CCCceEecCCCCCCEEEcCCCcEEEE
Q 005206          661 SRFRIIHRDLKASNILLDKEMTPKIS  686 (709)
Q Consensus       661 ~~~~iiHrDlkp~NILl~~~~~~KI~  686 (709)
                       .++|+|+++..+-|.+..++.+||.
T Consensus       196 -~PpiihgnlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  196 -DPPIIHGNLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             -CCccccCCcchhheeecCCceEEec
Confidence             4789999999999999999999885

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.98  E-value=5.4e-05  Score=75.38  Aligned_cols=139  Identities=15%  Similarity=0.184  Sum_probs=89.8

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHH---------HHHHHHHHhcCCC---ceeeEEEEE
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEF---------KNEVRLIAKLQHR---NLVRLLGCC  607 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f---------~~Ei~~l~~l~H~---nIv~l~g~~  607 (709)
                      ..++|...+++-....-.|.+-.. +++...+|..........+.|         .+++..+.+++..   ..+.++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            346677777777766666666655 467788887754432222222         2344444444322   222222222


Q ss_pred             E-----eCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc
Q 005206          608 V-----EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT  682 (709)
Q Consensus       608 ~-----~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~  682 (709)
                      .     -....+|+|||++|..|.++..       ++.    .++..++.+|.-||+.|   +.|+|..|.|++++.++ 
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence            2     1234568999999988865431       222    25567888899999998   99999999999998554 


Q ss_pred             EEEEecCCceee
Q 005206          683 PKISDFGMARIF  694 (709)
Q Consensus       683 ~KI~DFGla~~l  694 (709)
                      +++.||+..+..
T Consensus       173 i~iID~~~k~~~  184 (229)
T PF06176_consen  173 IRIIDTQGKRMS  184 (229)
T ss_pred             EEEEECcccccc
Confidence            999999988754

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.84  E-value=0.00015  Score=73.00  Aligned_cols=154  Identities=19%  Similarity=0.239  Sum_probs=101.2

Q ss_pred             ChHHHHHHhcCcCcce---eecccCceEEEEEEEcCCcEEEEEEeccCCcc---------chHH---------------H
Q 005206          533 DFETIVRATDNFTDYN---KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQ---------GIEE---------------F  585 (709)
Q Consensus       533 ~~~~l~~~t~~f~~~~---~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~---------~~~~---------------f  585 (709)
                      +.+.+....+......   .|.+|.-..||+|.-.++..+|||+.......         +..+               .
T Consensus        36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~  115 (268)
T COG1718          36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA  115 (268)
T ss_pred             HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence            3444444444444433   45567777999998888999999998643110         0011               2


Q ss_pred             HHHHHHHHhcC--CCceeeEEEEEEeCCeeEEEEEccCCCCHH-HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 005206          586 KNEVRLIAKLQ--HRNLVRLLGCCVEMDEKMLVYEYMENRSLD-SVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR  662 (709)
Q Consensus       586 ~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~-~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~  662 (709)
                      ..|..-|.++.  +-.+.+-+++.    +..|||||+...... -.|    +...+.......+..++++.|.-|-... 
T Consensus       116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a-  186 (268)
T COG1718         116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA-  186 (268)
T ss_pred             HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc-
Confidence            35777777763  45555555553    458999999654211 001    1111233356677888899998887743 


Q ss_pred             CceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       663 ~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                       .+||+||..-|||+. ++.+.|+|||=|.....+
T Consensus       187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp  219 (268)
T COG1718         187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP  219 (268)
T ss_pred             -CcccccchhhheEEE-CCeEEEEECccccccCCC
Confidence             399999999999999 899999999998877543

>PLN02876 acyl-CoA dehydrogenase

Probab=97.84  E-value=0.00025  Score=85.71  Aligned_cols=78  Identities=15%  Similarity=0.344  Sum_probs=58.0

Q ss_pred             ceeecccCceEEEEEEEcCC---cEEEEEEeccCC-ccchHHHHHHHHHHHhcC-CCce--eeEEEEEEeC---CeeEEE
Q 005206          547 YNKLGQGGFGIVYKGRLLEG---QEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQ-HRNL--VRLLGCCVEM---DEKMLV  616 (709)
Q Consensus       547 ~~~LG~G~fG~Vykg~~~~g---~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~-H~nI--v~l~g~~~~~---~~~~lV  616 (709)
                      ++.++.|.+..+|+....++   ..+++|+..... ......+.+|++++..+. |+++  .+++++|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            56799999999999877654   356777654322 223457889999999995 6665  7888888764   357899


Q ss_pred             EEccCCCC
Q 005206          617 YEYMENRS  624 (709)
Q Consensus       617 ~Ey~~~gs  624 (709)
                      |||+++..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998764

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.73  E-value=0.00043  Score=68.26  Aligned_cols=134  Identities=25%  Similarity=0.394  Sum_probs=95.5

Q ss_pred             CCCCCChHHHHHHhcCcCcceeecccCc-eEEEEEEEcCCcEEEEEEecc---CC--------c----------cchHHH
Q 005206          528 ELPLFDFETIVRATDNFTDYNKLGQGGF-GIVYKGRLLEGQEIAVKRLSR---NS--------G----------QGIEEF  585 (709)
Q Consensus       528 ~~~~~~~~~l~~~t~~f~~~~~LG~G~f-G~Vykg~~~~g~~VAVK~l~~---~~--------~----------~~~~~f  585 (709)
                      .+..|+..     +.+++.++.||.|.- |.||++++ +|+.+|+|....   ..        .          ...+-|
T Consensus        28 KL~~F~~h-----~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF  101 (207)
T PF13095_consen   28 KLEPFTHH-----GDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPF  101 (207)
T ss_pred             CcCCcCCC-----CCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChH
Confidence            44456552     267888899999999 99999998 577999999321   00        0          123458


Q ss_pred             HHHHHHHHhcC---CCce--eeEEEEEEeCC------------------eeEEEEEccCCCCHHHHHhccCCCCCCCHHH
Q 005206          586 KNEVRLIAKLQ---HRNL--VRLLGCCVEMD------------------EKMLVYEYMENRSLDSVIFDKARSSILNWQR  642 (709)
Q Consensus       586 ~~Ei~~l~~l~---H~nI--v~l~g~~~~~~------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~  642 (709)
                      ..|.+...+|+   +.++  |+.+||..-..                  ..-||.||++...            .+.   
T Consensus       102 ~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~---  166 (207)
T PF13095_consen  102 NCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ---  166 (207)
T ss_pred             HHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc---
Confidence            89999999885   4456  89999874321                  1357888776543            011   


Q ss_pred             HHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCc
Q 005206          643 RFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (709)
Q Consensus       643 ~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla  691 (709)
                       ..=+.+|.+-|..+|..+   |+-+|+|++|..     .-||.|||.+
T Consensus       167 -~~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  167 -IRDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             -hhHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence             223567888899999988   999999999975     4589999864

>PRK10593 hypothetical protein; Provisional

Probab=97.60  E-value=0.00095  Score=70.82  Aligned_cols=78  Identities=9%  Similarity=0.060  Sum_probs=57.4

Q ss_pred             CcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCC---CceeeEEEEEEeC---CeeEEEEE
Q 005206          545 TDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH---RNLVRLLGCCVEM---DEKMLVYE  618 (709)
Q Consensus       545 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H---~nIv~l~g~~~~~---~~~~lV~E  618 (709)
                      ...+.||.|..+.||+....+++ +.+|..+ . ......|.+|.+.+..|.-   ..+.+++++|...   +..+||||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~-~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQGN-PMPLMAR-S-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcCCCC-EEEEEec-c-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            34467999999999998776664 5555532 2 1134688999999998853   4688899888653   56899999


Q ss_pred             ccCCCCH
Q 005206          619 YMENRSL  625 (709)
Q Consensus       619 y~~~gsL  625 (709)
                      +++++++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998754

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.59  E-value=0.0011  Score=65.80  Aligned_cols=128  Identities=19%  Similarity=0.254  Sum_probs=90.5

Q ss_pred             ceeecccCceEEEEEEEcCCcEEEEEEeccCC----------------ccchHHHHHHHHHHHhcC------CCceeeEE
Q 005206          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS----------------GQGIEEFKNEVRLIAKLQ------HRNLVRLL  604 (709)
Q Consensus       547 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~----------------~~~~~~f~~Ei~~l~~l~------H~nIv~l~  604 (709)
                      ...||+|+.=.||.  +++.....||++....                ....+++.+|+.-...+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            35799999999985  4556667888876544                223567778888766665      88999999


Q ss_pred             EEEEeCCeeEEEEEccCC------CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc
Q 005206          605 GCCVEMDEKMLVYEYMEN------RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD  678 (709)
Q Consensus       605 g~~~~~~~~~lV~Ey~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~  678 (709)
                      |+..+.-..-+|+|.+.+      -+|.+++.+.    .++. .   +...+-+-..||-++.   |+.+|++|.||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence            999999889999998743      3577777432    2444 2   2333344455676665   99999999999995


Q ss_pred             CCC----cEEEEe
Q 005206          679 KEM----TPKISD  687 (709)
Q Consensus       679 ~~~----~~KI~D  687 (709)
                      ...    .+.|.|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            432    566776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.56  E-value=0.00053  Score=70.04  Aligned_cols=140  Identities=20%  Similarity=0.245  Sum_probs=77.2

Q ss_pred             eeecccCce-EEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCC---ceeeEEEEEEeCC---eeEEEEEcc
Q 005206          548 NKLGQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR---NLVRLLGCCVEMD---EKMLVYEYM  620 (709)
Q Consensus       548 ~~LG~G~fG-~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~---nIv~l~g~~~~~~---~~~lV~Ey~  620 (709)
                      +.|+.|+.. .||+.    +..+.+|....  ......+.+|.+++..+...   -+.++++.....+   ..+++||++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            467777766 58875    23456665432  22355788999999887532   3445555443322   348899999


Q ss_pred             CCCCHHHH------------------HhccCCCC-C------------C-CHHHHH--HHH-------HHHHHHH-H-HH
Q 005206          621 ENRSLDSV------------------IFDKARSS-I------------L-NWQRRF--NII-------CGIARGL-L-YL  657 (709)
Q Consensus       621 ~~gsL~~~------------------l~~~~~~~-~------------l-~~~~~~--~i~-------~~ia~gL-~-yL  657 (709)
                      ++.++.+.                  |+...... .            + .|....  .+.       .+.+..+ + ++
T Consensus        77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  156 (235)
T cd05155          77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL  156 (235)
T ss_pred             cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence            98766321                  11100000 0            0 121110  000       0111111 1 11


Q ss_pred             Hh--CCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          658 HQ--DSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       658 H~--~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      +.  .....++|+|+.+.|||++.+...-|.||+.|..
T Consensus       157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            11  1233489999999999999876678999998763

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.54  E-value=0.0011  Score=67.64  Aligned_cols=141  Identities=18%  Similarity=0.232  Sum_probs=82.1

Q ss_pred             eeecccCceEEEEEEEcC--CcEEEEEEeccCCccchHHHHHHHHHHHhcCC-CceeeEEEEEEeCCeeEEEEEccCCCC
Q 005206          548 NKLGQGGFGIVYKGRLLE--GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH-RNLVRLLGCCVEMDEKMLVYEYMENRS  624 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~--g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~Ey~~~gs  624 (709)
                      +.|..|-...+|+....+  ++.+.+|........ ...-.+|+.++..+.. .-.+++++...    ..++|||+++.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            568888889999998764  577888876533221 1233478888888843 33445554432    248999999876


Q ss_pred             HHHH-------H----------hccCCC--------CCC-CHHHHHHHHH----------------------HHHHHHHH
Q 005206          625 LDSV-------I----------FDKARS--------SIL-NWQRRFNIIC----------------------GIARGLLY  656 (709)
Q Consensus       625 L~~~-------l----------~~~~~~--------~~l-~~~~~~~i~~----------------------~ia~gL~y  656 (709)
                      +...       +          ++....        ... -|.....+..                      .+..-+..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            5321       1          111110        011 1222111111                      11111112


Q ss_pred             H----HhC-CCCceEecCCCCCCEEEcC-CCcEEEEecCCcee
Q 005206          657 L----HQD-SRFRIIHRDLKASNILLDK-EMTPKISDFGMARI  693 (709)
Q Consensus       657 L----H~~-~~~~iiHrDlkp~NILl~~-~~~~KI~DFGla~~  693 (709)
                      |    ... ....++|+|+.+.|||+++ +..+.|+||..|..
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            2    111 2346999999999999998 57899999998864

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=97.46  E-value=0.0016  Score=58.70  Aligned_cols=99  Identities=24%  Similarity=0.395  Sum_probs=62.7

Q ss_pred             CEEEecCCeEEEEeeCCCCCCcEEEEEEEeccCCceEEEEc-CCCCCCCCCcceEEEEcCc-eEEEcCCCceEEecCCCC
Q 005206           70 KTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVA-NRDDPLANSSGVLRIINQR-IGLFDGSQNLVWSSNQTK  147 (709)
Q Consensus        70 ~~lvS~~g~F~lGFf~~~~~~~~~lgIw~~~~~~~tvVWvA-Nr~~Pv~~~~~~l~l~~~G-Lvl~d~~g~~vWst~~~~  147 (709)
                      +.+.+.+|.+.|-|-..|+     |-| |..  ..++||.. +...+.. ..+.+.|.++| |||+|..+.++|+|.. .
T Consensus        12 ~p~~~~s~~~~L~l~~dGn-----Lvl-~~~--~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~-~   81 (114)
T PF01453_consen   12 SPLTSSSGNYTLILQSDGN-----LVL-YDS--NGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFD-Y   81 (114)
T ss_dssp             EEEEECETTEEEEEETTSE-----EEE-EET--TTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTT-S
T ss_pred             cccccccccccceECCCCe-----EEE-EcC--CCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecC-C
Confidence            4455545777777755442     323 332  35679999 4333332 45789999999 9999999999999943 2


Q ss_pred             CCCceeEEec--CCCEEEEecCCCceeEeeccCCC
Q 005206          148 ATNPVAQLQD--SGNFVLKEAGSDEILWQSFDYPT  180 (709)
Q Consensus       148 ~~~~~a~Lld--sGNlVl~~~~~~~~lWQSFd~Pt  180 (709)
                      ...+.+.+.+  .||++ +.. ...+.|.|=+.|+
T Consensus        82 ptdt~L~~q~l~~~~~~-~~~-~~~~sw~s~~dps  114 (114)
T PF01453_consen   82 PTDTLLPGQKLGDGNVT-GKN-DSLTSWSSNTDPS  114 (114)
T ss_dssp             SS-EEEEEET--TSEEE-EES-TSSEEEESS----
T ss_pred             CccEEEeccCcccCCCc-ccc-ceEEeECCCCCCC
Confidence            3456677777  89998 653 4568899876663

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.44  E-value=0.0022  Score=70.37  Aligned_cols=75  Identities=13%  Similarity=0.235  Sum_probs=55.6

Q ss_pred             eeecccCceEEEEEEEcCC-cEEEEEEeccC-----C--ccchHHHHHHHHHHHhcC---CCceeeEEEEEEeCCeeEEE
Q 005206          548 NKLGQGGFGIVYKGRLLEG-QEIAVKRLSRN-----S--GQGIEEFKNEVRLIAKLQ---HRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~g-~~VAVK~l~~~-----~--~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV  616 (709)
                      +.||.|.+..||++...+| +.|.||.-...     .  ....+++..|.+.|..+.   -..+.+++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5799999999999999877 58999974321     1  234567888888888762   3467778777  44667999


Q ss_pred             EEccCCCC
Q 005206          617 YEYMENRS  624 (709)
Q Consensus       617 ~Ey~~~gs  624 (709)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998743

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.33  E-value=0.0019  Score=61.81  Aligned_cols=129  Identities=20%  Similarity=0.288  Sum_probs=87.2

Q ss_pred             ceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCcee-eEEEEEEeCCeeEEEEEccCCCCH
Q 005206          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV-RLLGCCVEMDEKMLVYEYMENRSL  625 (709)
Q Consensus       547 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~~gsL  625 (709)
                      .+.|++|.+|.||+|.+. +.++|+|+-...  .....+..|++++..++-.++. +++.+    ++..+.|||+.+..|
T Consensus        27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G~~L   99 (201)
T COG2112          27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDGRPL   99 (201)
T ss_pred             hhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcCcch
Confidence            467999999999999885 458888876443  3456788999999998866654 34444    234566999999888


Q ss_pred             HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC-CCCEEEcCCCcEEEEecCCceeeC
Q 005206          626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLK-ASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       626 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk-p~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      .+.-..      .+.++..    .+++.---|-..+   |-|..|. |...+|..+..+.|+||.-|+...
T Consensus       100 ~~~~~~------~~rk~l~----~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k~  157 (201)
T COG2112         100 GKLEIG------GDRKHLL----RVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFKK  157 (201)
T ss_pred             hhhhhc------ccHHHHH----HHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence            765421      1223333    3444423333334   7787775 555666666699999999998543

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.28  E-value=0.0016  Score=67.42  Aligned_cols=139  Identities=17%  Similarity=0.144  Sum_probs=79.4

Q ss_pred             eecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCce-eeEEEEEEeCCeeEEEEEccCCCCHHH
Q 005206          549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL-VRLLGCCVEMDEKMLVYEYMENRSLDS  627 (709)
Q Consensus       549 ~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~gsL~~  627 (709)
                      .+..|-...+|+... +++.+++|........-.....+|..++..+....+ .++++..    ...+||||+++..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence            355677889998873 566788886543322211245788888888854333 3455443    2478999999866532


Q ss_pred             H-----------------HhccCC-CCCCCHHHH-HHHHHHH---------HHHHHHHHhC-----CCCceEecCCCCCC
Q 005206          628 V-----------------IFDKAR-SSILNWQRR-FNIICGI---------ARGLLYLHQD-----SRFRIIHRDLKASN  674 (709)
Q Consensus       628 ~-----------------l~~~~~-~~~l~~~~~-~~i~~~i---------a~gL~yLH~~-----~~~~iiHrDlkp~N  674 (709)
                      .                 |++... ...++...+ ..+..++         ..-+..+...     .+..++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 111111 111222211 1111111         1112222211     12358999999999


Q ss_pred             EEEcCCCcEEEEecCCcee
Q 005206          675 ILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       675 ILl~~~~~~KI~DFGla~~  693 (709)
                      |++++++ ++|+||..|..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 78999998863

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.17  E-value=0.0025  Score=67.36  Aligned_cols=142  Identities=18%  Similarity=0.170  Sum_probs=86.8

Q ss_pred             ceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCC--ceeeEEEE------EEeCCeeEEEEE
Q 005206          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR--NLVRLLGC------CVEMDEKMLVYE  618 (709)
Q Consensus       547 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~------~~~~~~~~lV~E  618 (709)
                      .+.|..|....+|+....+ ..+++|+...   ...++...|++++..+++.  .+.+++..      ....+..++|+|
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            4578888888999987644 4677887753   2345667788888887433  34555442      123345689999


Q ss_pred             ccCCCCHHH----H----------HhccC----C----CCCCCHHHHHH----------HHHHHHHHHHHHHhC----CC
Q 005206          619 YMENRSLDS----V----------IFDKA----R----SSILNWQRRFN----------IICGIARGLLYLHQD----SR  662 (709)
Q Consensus       619 y~~~gsL~~----~----------l~~~~----~----~~~l~~~~~~~----------i~~~ia~gL~yLH~~----~~  662 (709)
                      |+++..+..    .          ++...    .    .....|.....          ....+...+.++.+.    -.
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999876521    1          11100    0    01123322210          112234455555531    12


Q ss_pred             CceEecCCCCCCEEEcCCCcEEEEecCCce
Q 005206          663 FRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (709)
Q Consensus       663 ~~iiHrDlkp~NILl~~~~~~KI~DFGla~  692 (709)
                      ..++|+|+.|.|||++++..+.|.||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            359999999999999998888999999875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.11  E-value=0.0038  Score=66.29  Aligned_cols=141  Identities=22%  Similarity=0.292  Sum_probs=84.3

Q ss_pred             eeecccCceEEEEEEEcC-------CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCc-eeeEEEEEEeCCeeEEEEEc
Q 005206          548 NKLGQGGFGIVYKGRLLE-------GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN-LVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-------g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +.|..|-...+|+....+       ++.+++|+..... .......+|.+++..+.... ..++++++..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            456677778999988765       4778888865432 23345677888888874322 3455665532    358999


Q ss_pred             cCCCCHHHH-----------------HhccCCCC------CC--CHHHHHH--------------------------HHH
Q 005206          620 MENRSLDSV-----------------IFDKARSS------IL--NWQRRFN--------------------------IIC  648 (709)
Q Consensus       620 ~~~gsL~~~-----------------l~~~~~~~------~l--~~~~~~~--------------------------i~~  648 (709)
                      +++..+...                 +++.....      ..  -|.....                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            988766431                 11111100      01  1111110                          111


Q ss_pred             HHHHHHHHHHh------CCCCceEecCCCCCCEEEcCC----CcEEEEecCCcee
Q 005206          649 GIARGLLYLHQ------DSRFRIIHRDLKASNILLDKE----MTPKISDFGMARI  693 (709)
Q Consensus       649 ~ia~gL~yLH~------~~~~~iiHrDlkp~NILl~~~----~~~KI~DFGla~~  693 (709)
                      .+..-+.+|..      .....++|+|+.+.|||++++    +.++++||..|..
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            22233344432      234579999999999999985    8899999998874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins

Probab=96.99  E-value=0.00071  Score=55.68  Aligned_cols=50  Identities=20%  Similarity=0.422  Sum_probs=36.9

Q ss_pred             eecccCCCCccccccccCCHHHHHHHHhcCCcccceeccccCCCceeEEeccc
Q 005206          376 LKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGE  428 (709)
Q Consensus       376 ~~~~~~p~~~~~~~~~~~~~~~C~~~Cl~nCsC~aya~~~~~~g~~C~~w~~~  428 (709)
                      ++++.++..+.... ...+.++|++.|+.||+|.||.|...  ...|+++...
T Consensus         9 ~~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~~--~~~C~lk~~~   58 (73)
T cd01100           9 GSNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNTK--SKKCFLKSSE   58 (73)
T ss_pred             cCCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEECC--CCeEEcccCC
Confidence            45666666555433 25689999999999999999999753  3479987653

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>PLN02236 choline kinase

Probab=96.86  E-value=0.0096  Score=64.55  Aligned_cols=141  Identities=21%  Similarity=0.291  Sum_probs=83.0

Q ss_pred             eeecccCceEEEEEEEcC-----CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCcee-eEEEEEEeCCeeEEEEEccC
Q 005206          548 NKLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV-RLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      +.|-.|-.-.+|+....+     ++.+.+|..........++ .+|..++..+...++. ++++.+..+    .|+||++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            456567788999987543     3578888776544333333 6788888888544443 556665332    5899998


Q ss_pred             CCCHHHH-----------------HhccC-C-CC-CCCHHHHHHHHHH-----------------HHHHHHHH----Hh-
Q 005206          622 NRSLDSV-----------------IFDKA-R-SS-ILNWQRRFNIICG-----------------IARGLLYL----HQ-  659 (709)
Q Consensus       622 ~gsL~~~-----------------l~~~~-~-~~-~l~~~~~~~i~~~-----------------ia~gL~yL----H~-  659 (709)
                      +.+|...                 +++.. . .. ...|.+...+..+                 +...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7666421                 11111 0 00 1123333222211                 11122222    21 


Q ss_pred             CCCCceEecCCCCCCEEEcC-CCcEEEEecCCcee
Q 005206          660 DSRFRIIHRDLKASNILLDK-EMTPKISDFGMARI  693 (709)
Q Consensus       660 ~~~~~iiHrDlkp~NILl~~-~~~~KI~DFGla~~  693 (709)
                      .....++|+|+++.|||+++ +..++|+||..|..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            22346899999999999986 46899999998874

>PRK05231 homoserine kinase; Provisional

Probab=96.72  E-value=0.036  Score=59.31  Aligned_cols=141  Identities=16%  Similarity=0.179  Sum_probs=77.0

Q ss_pred             eeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCC--CceeeEEE------EEEeCCeeEEEEEc
Q 005206          548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH--RNLVRLLG------CCVEMDEKMLVYEY  619 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g------~~~~~~~~~lV~Ey  619 (709)
                      +.|+.|....+|+.+..++ .+++|+...   ...+....|+.++..|..  -.+.+.+.      +....+..++++||
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            4567777789999887655 577887752   123344445555555532  22334442      12234567899999


Q ss_pred             cCCCCHH-----------HHH---hccCC--------CCCCCH-HHHHHH------------HHH-HHHHHHHHHhC---
Q 005206          620 MENRSLD-----------SVI---FDKAR--------SSILNW-QRRFNI------------ICG-IARGLLYLHQD---  660 (709)
Q Consensus       620 ~~~gsL~-----------~~l---~~~~~--------~~~l~~-~~~~~i------------~~~-ia~gL~yLH~~---  660 (709)
                      +++..+.           ..|   +....        ...+.| .....-            ..+ +...+..+.+.   
T Consensus       104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  183 (319)
T PRK05231        104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP  183 (319)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence            9987531           111   11100        001212 221111            111 11122333211   


Q ss_pred             -CCCceEecCCCCCCEEEcCCCcEEEEecCCce
Q 005206          661 -SRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (709)
Q Consensus       661 -~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~  692 (709)
                       -+..+||+|+.|.|||++.+...-|+||+.+.
T Consensus       184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence             13359999999999999977667899999875

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.67  E-value=0.027  Score=59.97  Aligned_cols=143  Identities=18%  Similarity=0.215  Sum_probs=83.1

Q ss_pred             ceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCC--ceeeEEEEE------EeCCeeEEEEE
Q 005206          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR--NLVRLLGCC------VEMDEKMLVYE  618 (709)
Q Consensus       547 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~------~~~~~~~lV~E  618 (709)
                      .+.++.|.-..+|+.+..++ .+.+|+....  ...++...|+.++..|...  .+.+++...      ...+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            35677777789999876555 5667876432  1234556677777777422  244544421      12355789999


Q ss_pred             ccCCCCHH----H-------H---HhccCCC---------CCCCHHHHHH------------HHHHHHHHHHHHHh----
Q 005206          619 YMENRSLD----S-------V---IFDKARS---------SILNWQRRFN------------IICGIARGLLYLHQ----  659 (709)
Q Consensus       619 y~~~gsL~----~-------~---l~~~~~~---------~~l~~~~~~~------------i~~~ia~gL~yLH~----  659 (709)
                      |+++..+.    .       .   ++.....         ..-.|.....            ....+.+.++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            99885532    1       1   1110000         0112221110            11223445655643    


Q ss_pred             CCCCceEecCCCCCCEEEcCCCcEEEEecCCce
Q 005206          660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (709)
Q Consensus       660 ~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~  692 (709)
                      .....++|+|+.+.||+++.+..+.|.||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            123469999999999999998877999999884

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.46  E-value=0.021  Score=60.17  Aligned_cols=75  Identities=20%  Similarity=0.276  Sum_probs=49.9

Q ss_pred             CcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcC---CCceeeEEEEEEeCCeeEEEEEccC
Q 005206          545 TDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ---HRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       545 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      +..+.|+-|....+|+.. .+++.+-||.-.   ......|..|.+-|+.|.   -..+.+++++....+..+||+||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            445678989999999987 567788888765   334567889999888883   4567799999888888899999998


Q ss_pred             CC
Q 005206          622 NR  623 (709)
Q Consensus       622 ~g  623 (709)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            77

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.44  E-value=0.019  Score=60.20  Aligned_cols=31  Identities=26%  Similarity=0.536  Sum_probs=26.3

Q ss_pred             CceEecCCCCCCEEEcCCCc-EEEEecCCcee
Q 005206          663 FRIIHRDLKASNILLDKEMT-PKISDFGMARI  693 (709)
Q Consensus       663 ~~iiHrDlkp~NILl~~~~~-~KI~DFGla~~  693 (709)
                      ..++|+|+.|.|||+++++. .-|.||+.+.+
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997554 57999999874

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=95.92  E-value=0.00096  Score=78.60  Aligned_cols=146  Identities=18%  Similarity=0.192  Sum_probs=99.5

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEecc---CCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~---~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      +.+...+-+-+|.++.++.++-.. +...++|....   ......+..+.+-.++..-+||-+++...-+......+|++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~  883 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG  883 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence            455666677889999988765432 22222222211   11222333334444444456787777666666778899999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      +|..+++|...|+...   ..+..-....+..+..+++|||...   ++|||++|.|+|+..++..+++|||+.+.
T Consensus       884 ~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~  953 (1205)
T KOG0606|consen  884 HYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSK  953 (1205)
T ss_pred             HHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccc
Confidence            9999999988886543   2333333445666889999999875   89999999999999999999999996554

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.77  E-value=0.074  Score=57.31  Aligned_cols=141  Identities=18%  Similarity=0.293  Sum_probs=80.7

Q ss_pred             eeecccCceEEEEEEEcC----CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCce-eeEEEEEEeCCeeEEEEEccCC
Q 005206          548 NKLGQGGFGIVYKGRLLE----GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL-VRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      +.|..|=.-.+|+....+    +..+.+|........ .-.-.+|..++..+...++ .++++++..+    +|.||+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence            456557777899887643    237888877554332 2233678888888865444 3566665322    58999977


Q ss_pred             CCHHH-------HH----------hccC-C--CCCCCHHHHHHHHHHH----------------------HHHHHHHHh-
Q 005206          623 RSLDS-------VI----------FDKA-R--SSILNWQRRFNIICGI----------------------ARGLLYLHQ-  659 (709)
Q Consensus       623 gsL~~-------~l----------~~~~-~--~~~l~~~~~~~i~~~i----------------------a~gL~yLH~-  659 (709)
                      ..|..       .+          ++.. .  ..+.-|....++..++                      ..-+..+.+ 
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            65522       11          1111 0  0011233332222221                      111222211 


Q ss_pred             ----CCCCceEecCCCCCCEEEcC-CCcEEEEecCCcee
Q 005206          660 ----DSRFRIIHRDLKASNILLDK-EMTPKISDFGMARI  693 (709)
Q Consensus       660 ----~~~~~iiHrDlkp~NILl~~-~~~~KI~DFGla~~  693 (709)
                          .......|.|+-+.|||+++ ++.++++||..|..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence                12235799999999999975 57899999998763

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=95.61  E-value=0.055  Score=57.74  Aligned_cols=139  Identities=19%  Similarity=0.218  Sum_probs=93.8

Q ss_pred             eeecccCceEEEEEEEcCCcEEEEEEeccCC-------c--cchHH-----------------HHHHHHHHHhcCCCcee
Q 005206          548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS-------G--QGIEE-----------------FKNEVRLIAKLQHRNLV  601 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~-------~--~~~~~-----------------f~~Ei~~l~~l~H~nIv  601 (709)
                      ..|..|--..||.+.-.+|..+|||+++..-       .  .+.-+                 ...|++-|.+|+...|.
T Consensus       150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP  229 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP  229 (520)
T ss_pred             cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            4688899999999999999999999885420       0  00011                 23577788887655443


Q ss_pred             eEEEEEEeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC
Q 005206          602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM  681 (709)
Q Consensus       602 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~  681 (709)
                      ----...  ....|||+|+..-.-   -.-..+.-.++......+..|++.-|.-|.+.|  ++||.||.--|+|+ .+|
T Consensus       230 ~PePIlL--k~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-hdG  301 (520)
T KOG2270|consen  230 CPEPILL--KNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-HDG  301 (520)
T ss_pred             CCCceee--ecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-ECC
Confidence            1111100  234699999953221   111112223666677788889999999999888  59999999999998 457


Q ss_pred             cEEEEecCCceee
Q 005206          682 TPKISDFGMARIF  694 (709)
Q Consensus       682 ~~KI~DFGla~~l  694 (709)
                      .+.|+|.+-+.-.
T Consensus       302 ~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  302 KLYIIDVSQSVEH  314 (520)
T ss_pred             EEEEEEccccccC
Confidence            8999999876644

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.55  E-value=0.016  Score=60.70  Aligned_cols=132  Identities=17%  Similarity=0.163  Sum_probs=88.5

Q ss_pred             cCcceeecccCceEEEEEEEcCCcEEEEEEecc--CC-------c-----------cc--hHHHHHHHHHHHhcC-C-Cc
Q 005206          544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSR--NS-------G-----------QG--IEEFKNEVRLIAKLQ-H-RN  599 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~--~~-------~-----------~~--~~~f~~Ei~~l~~l~-H-~n  599 (709)
                      ++..++||-|.-+.||.+-..+|++.++|.-.-  .+       .           ..  .-...+|..-|+.|. | --
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            566789999999999999999899888773211  00       0           00  112356788888874 2 23


Q ss_pred             eeeEEEEEEeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC
Q 005206          600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK  679 (709)
Q Consensus       600 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~  679 (709)
                      +.+.+++    +..++|||++.+-.|...-      ...+..+.+   ..+..-+.-|..++   +||+|..-=||+|++
T Consensus       174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly---~~lm~~Iv~la~~G---lIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  174 VPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPTLY---DDLMGLIVRLANHG---LIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCCcccc----cceeeHHHhhcccceeeee------ecCChHHHH---HHHHHHHHHHHHcC---ceecccchheeEEec
Confidence            4444443    4568999999887774321      112333333   33334445566777   999999999999999


Q ss_pred             CCcEEEEecCCc
Q 005206          680 EMTPKISDFGMA  691 (709)
Q Consensus       680 ~~~~KI~DFGla  691 (709)
                      +..++++||--.
T Consensus       238 d~~i~vIDFPQm  249 (465)
T KOG2268|consen  238 DDKIVVIDFPQM  249 (465)
T ss_pred             CCCEEEeechHh
Confidence            999999999543

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=95.49  E-value=0.13  Score=54.83  Aligned_cols=143  Identities=17%  Similarity=0.295  Sum_probs=82.7

Q ss_pred             eecccCceEEEEEEEcCCcEEEEEEecc--CCccchHHHHHHHHHHHhcCC--CceeeEEEEEEeCC--eeEEEEEccCC
Q 005206          549 KLGQGGFGIVYKGRLLEGQEIAVKRLSR--NSGQGIEEFKNEVRLIAKLQH--RNLVRLLGCCVEMD--EKMLVYEYMEN  622 (709)
Q Consensus       549 ~LG~G~fG~Vykg~~~~g~~VAVK~l~~--~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~--~~~lV~Ey~~~  622 (709)
                      .+-.|..-.+|..... ++..++. ...  ..........+|..+|+.+.-  .-+.+.++.|.++.  ..+.||||+++
T Consensus        32 ~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG  109 (321)
T COG3173          32 EISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG  109 (321)
T ss_pred             eccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence            3433433344444333 5666666 221  122344556778888887743  33456677777766  56999999987


Q ss_pred             CCH---------H---------HHHhc---c--------------CCCCCCCHHHHHHHH--------HHHHHHHHHHHh
Q 005206          623 RSL---------D---------SVIFD---K--------------ARSSILNWQRRFNII--------CGIARGLLYLHQ  659 (709)
Q Consensus       623 gsL---------~---------~~l~~---~--------------~~~~~l~~~~~~~i~--------~~ia~gL~yLH~  659 (709)
                      ..+         .         ++|..   -              ...+...|...+..+        -...+-..+|++
T Consensus       110 e~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~  189 (321)
T COG3173         110 EVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEA  189 (321)
T ss_pred             eeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHh
Confidence            322         1         11110   0              001112233332111        123334566665


Q ss_pred             C-----CCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          660 D-----SRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       660 ~-----~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      +     ++..++|+|+.+.|++++.+.-+-|.||+++.+
T Consensus       190 ~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         190 NRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             cCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            4     235799999999999999998899999999874

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=95.26  E-value=0.0028  Score=71.24  Aligned_cols=140  Identities=19%  Similarity=0.124  Sum_probs=93.5

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCc-eeeEEEEEEeCCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN-LVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      .-+...+.+++++.++++|.+....+....+.+...     ....-++++|.+++||| .++-++-+...+..+++++++
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            334444678999999999987644444445544322     44566889999999999 666666666667788999999


Q ss_pred             CCC-C-HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          621 ENR-S-LDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       621 ~~g-s-L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ..+ + .....   .....+..-+...+...-+++++|||+..   -+|||    ||+..+ ...|..||+.+..+.+.
T Consensus       317 s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  317 STGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             cCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence            877 2 11100   00001222233344555677899999864   58998    777655 78899999999887654

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.21  E-value=0.48  Score=50.26  Aligned_cols=29  Identities=28%  Similarity=0.334  Sum_probs=25.4

Q ss_pred             CceEecCCCCCCEEEcCCCcEEEEecCCce
Q 005206          663 FRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (709)
Q Consensus       663 ~~iiHrDlkp~NILl~~~~~~KI~DFGla~  692 (709)
                      ..++|+|+.+.||+++. +.+.|.||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            46899999999999988 678999999664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.07  E-value=0.21  Score=53.97  Aligned_cols=79  Identities=14%  Similarity=0.188  Sum_probs=50.9

Q ss_pred             eecccCceEEEEEEEcCC-cEEEEEEeccC-------CccchHHHHHHHHHHHhcC--CC-ceeeEEEEEEeCCeeEEEE
Q 005206          549 KLGQGGFGIVYKGRLLEG-QEIAVKRLSRN-------SGQGIEEFKNEVRLIAKLQ--HR-NLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       549 ~LG~G~fG~Vykg~~~~g-~~VAVK~l~~~-------~~~~~~~f~~Ei~~l~~l~--H~-nIv~l~g~~~~~~~~~lV~  617 (709)
                      +||-|...-||++..+++ +.|+||.-..-       -+...++-..|...|....  -| .+.+++.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            589999999999998764 57888854321       1333456667777776652  23 45555543  556677999


Q ss_pred             EccCCCC-HHHHH
Q 005206          618 EYMENRS-LDSVI  629 (709)
Q Consensus       618 Ey~~~gs-L~~~l  629 (709)
                      |+++... |.+.|
T Consensus        80 EdL~~~~ilR~~L   92 (370)
T TIGR01767        80 EDLSHHKIARKGL   92 (370)
T ss_pred             hhCccchHHHHHH
Confidence            9996533 43433

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02756 S-methyl-5-thioribose kinase

Probab=94.75  E-value=0.4  Score=52.77  Aligned_cols=73  Identities=12%  Similarity=0.112  Sum_probs=50.1

Q ss_pred             ceeecccCceEEEEEEEcCCcEEEEEEeccCC----c---cchHHHHHHHHHHHhcC---CCceeeEEEEEEeCCeeEEE
Q 005206          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS----G---QGIEEFKNEVRLIAKLQ---HRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       547 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~----~---~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV  616 (709)
                      .+.||-|..-.||+.... ++.+.||.-....    .   ....+-..|...|..+.   ...+.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            468999999999998874 4568888664211    1   13344445566666553   357888888877  457889


Q ss_pred             EEccCC
Q 005206          617 YEYMEN  622 (709)
Q Consensus       617 ~Ey~~~  622 (709)
                      |||+++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.63  E-value=0.25  Score=53.01  Aligned_cols=139  Identities=23%  Similarity=0.278  Sum_probs=81.2

Q ss_pred             ecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCc------eeeEEEE----EEeCCeeEEEEEc
Q 005206          550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN------LVRLLGC----CVEMDEKMLVYEY  619 (709)
Q Consensus       550 LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n------Iv~l~g~----~~~~~~~~lV~Ey  619 (709)
                      |.+ .-..||+....+++. ++|.....  ....+...|+..+..|.-..      |..+=|-    ...+...+-+++|
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~  109 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY  109 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence            444 445788888877776 77776543  44556666777777663211      2222221    1112367789999


Q ss_pred             cCCCCHHH-----H----------Hhc----cC--C---CCCCCHHH---H----------HHHHHHHHHHHHHHHhC--
Q 005206          620 MENRSLDS-----V----------IFD----KA--R---SSILNWQR---R----------FNIICGIARGLLYLHQD--  660 (709)
Q Consensus       620 ~~~gsL~~-----~----------l~~----~~--~---~~~l~~~~---~----------~~i~~~ia~gL~yLH~~--  660 (709)
                      ++|..+..     .          |+.    ..  +   .....|..   .          .....++...+..+++.  
T Consensus       110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~  189 (331)
T COG2334         110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP  189 (331)
T ss_pred             cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence            99987762     1          111    00  1   11244541   0          11233445555555543  


Q ss_pred             -----CCCceEecCCCCCCEEEcCCCc-EEEEecCCce
Q 005206          661 -----SRFRIIHRDLKASNILLDKEMT-PKISDFGMAR  692 (709)
Q Consensus       661 -----~~~~iiHrDlkp~NILl~~~~~-~KI~DFGla~  692 (709)
                           ....+||+|+.|.||+++.+.. +.+.||+-+.
T Consensus       190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                 1122999999999999999885 8999999775

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=94.47  E-value=0.058  Score=54.01  Aligned_cols=31  Identities=35%  Similarity=0.531  Sum_probs=22.1

Q ss_pred             CceEecCCCCCCEEE-cCCCcEEEEecCCcee
Q 005206          663 FRIIHRDLKASNILL-DKEMTPKISDFGMARI  693 (709)
Q Consensus       663 ~~iiHrDlkp~NILl-~~~~~~KI~DFGla~~  693 (709)
                      ..+.|.|+.|.|||+ +.++.++++||..|..
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            358999999999999 8899999999998874

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=93.79  E-value=0.38  Score=48.36  Aligned_cols=74  Identities=19%  Similarity=0.266  Sum_probs=50.6

Q ss_pred             eecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhc---CCCceeeEEEEEEeCCeeEEEEEccCCCCH
Q 005206          549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL---QHRNLVRLLGCCVEMDEKMLVYEYMENRSL  625 (709)
Q Consensus       549 ~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  625 (709)
                      .+.-|.--.-|.... ...++-||+-   .......|.+|+.-|..|   +-.++.+++.+-.+..+.|||+||++-|.+
T Consensus        23 ~v~gG~inea~~v~d-g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~   98 (286)
T COG3001          23 EVSGGDINEAWRLRD-GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL   98 (286)
T ss_pred             ccCCccccceeEeec-CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence            343333333343332 3456777753   334457788898877666   446688899999999999999999998777


Q ss_pred             H
Q 005206          626 D  626 (709)
Q Consensus       626 ~  626 (709)
                      +
T Consensus        99 d   99 (286)
T COG3001          99 D   99 (286)
T ss_pred             C
Confidence            6

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=93.68  E-value=0.87  Score=48.47  Aligned_cols=32  Identities=25%  Similarity=0.334  Sum_probs=28.5

Q ss_pred             CCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          662 RFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       662 ~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      +..++|+|+.+.|||++.++.+.|+||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            34699999999999999999999999998764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	709
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-35
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-35
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		8e-28
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		9e-28
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-26
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-26
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-26
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-25
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-18
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-18
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-17
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-17
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		8e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		8e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		8e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-15
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-15
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-15
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-15
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-15
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-15
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-15
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-15
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-15
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-15
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-15
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-15
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-15
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-15
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-15
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-15
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-15
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		7e-15
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-15
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-15
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-15
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-15
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-15
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		7e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-15
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-15
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-15
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		7e-15
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		7e-15
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		7e-15
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-15
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-15
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-15
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		9e-15
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-14
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-14
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-14
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-14
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-14
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-14
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		8e-14
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		8e-14
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		8e-14
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-14
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-14
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		9e-14
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-14
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-14
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		9e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-13
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-13
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-13
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-13
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-13
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-13
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-13
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-13
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-13
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		7e-13
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		7e-13
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		8e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		8e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		8e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		9e-13
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-13
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		9e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-12
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-12
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-12
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-12
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-12
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-12
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-12
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-12
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-12
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-12
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-12
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-12
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-12
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-12
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-12
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-12
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-12
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-12
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-12
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-12
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-12
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-12
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-12
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-12
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-12
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-12
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		6e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-12
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		9e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-12
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-11
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-11
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-11
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-11
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		6e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		7e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		7e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-11
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		8e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-11
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		8e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		9e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		9e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		9e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-10
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-10
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-10
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-10
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-10
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-10
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-10
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-10
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-10
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-10
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-10
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-10
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-10
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-10
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-10
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-10
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-10
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-10
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-10
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-10
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-10
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-10
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-10
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-10
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-10
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-10
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		7e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		7e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		7e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-10
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		8e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		8e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		8e-10
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		9e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		9e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		9e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		9e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-09
3soa_A	444	Full-Length Human Camkii Length = 444		1e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-09
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-09
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-09
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-09
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-09
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-09
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-09
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-09
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-09
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-09
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		6e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		6e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-09
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-09
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-09
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		7e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		8e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		9e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		9e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-08
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		5e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-08
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		5e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-08
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		6e-08
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		6e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-08
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		8e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		8e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		9e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		9e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		9e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		9e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-07
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-07
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-07
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-07
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-07
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-07
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-07
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-07
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-07
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-07
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-07
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-07
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-07
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-07
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-07
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-07
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-07
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-07
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-07
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-07
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-07
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-07
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-07
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-07
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-07
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		8e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-06
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-06
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		1e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-06
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-06
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-06
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-06
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-06
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-06
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-06
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-06
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-06
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-06
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-06
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-06
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-06
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		7e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-06
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		7e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		7e-06
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		8e-06
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		9e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		9e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-05
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-05
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-05
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-05
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-05
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-05
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-05
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-05
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-05
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-05
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-05
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-05
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-05
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-05
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-05
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-05
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-05
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		6e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		7e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-05
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-04
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-04
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-04
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-04
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-04
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-04
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-04
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-04
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-04
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-04
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-04
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-04
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-04
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-04
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-04
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-04
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-04
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-04
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-04
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-04
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-04
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-04
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-04
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-04
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-04
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-04
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-04
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-04
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-04
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-04
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-04
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-04
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-04
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-04
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-04
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-04
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-04
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-04
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-04
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-04
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-04
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-04
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-04
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-04
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-04
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-04
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-04
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-04
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-04
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-04
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-04
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-04
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-04
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-04
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-04
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-04
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-04
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-04
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-04
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		6e-04
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-04
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-04
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  148 bits (373), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 79/169 (46%), Positives = 109/169 (64%), Gaps = 2/169 (1%)
Query: 528 ELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIE-EFK 586
           +L  F    +  A+DNF++ N LG+GGFG VYKGRL +G  +AVKRL     QG E +F+
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQ 83
Query: 587 NEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFN 645
            EV +I+   HRNL+RL G C+   E++LVY YM N S+ S + ++  S   L+W +R  
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 143
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
           I  G ARGL YLH     +IIHRD+KA+NILLD+E    + DFG+A++ 
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 192

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 79/169 (46%), Positives = 108/169 (63%), Gaps = 2/169 (1%)
Query: 528 ELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIE-EFK 586
           +L  F    +  A+DNF + N LG+GGFG VYKGRL +G  +AVKRL     QG E +F+
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQ 75
Query: 587 NEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFN 645
            EV +I+   HRNL+RL G C+   E++LVY YM N S+ S + ++  S   L+W +R  
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
           I  G ARGL YLH     +IIHRD+KA+NILLD+E    + DFG+A++ 
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  122 bits (305), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 72/165 (43%), Positives = 108/165 (65%), Gaps = 7/165 (4%)
Query: 529 LPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNE 588
           +PL D E    AT+NF     +G G FG VYKG L +G ++A+KR +  S QGIEEF+ E
Sbjct: 29  VPLVDLE---EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETE 85
Query: 589 VRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNII 647
           +  ++  +H +LV L+G C E +E +L+Y+YMEN +L   ++     ++ ++W++R  I 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            G ARGL YLH  +   IIHRD+K+ NILLD+   PKI+DFG+++
Sbjct: 146 IGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  122 bits (305), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 72/165 (43%), Positives = 108/165 (65%), Gaps = 7/165 (4%)
Query: 529 LPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNE 588
           +PL D E    AT+NF     +G G FG VYKG L +G ++A+KR +  S QGIEEF+ E
Sbjct: 29  VPLVDLE---EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETE 85
Query: 589 VRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNII 647
           +  ++  +H +LV L+G C E +E +L+Y+YMEN +L   ++     ++ ++W++R  I 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            G ARGL YLH  +   IIHRD+K+ NILLD+   PKI+DFG+++
Sbjct: 146 IGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 75/188 (39%), Positives = 104/188 (55%), Gaps = 14/188 (7%)
Query: 532 FDFETIVRATDNFTDY------NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEF 585
           F F  +   T+NF +       NK+G+GGFG+VYKG  +    +AVK+L+       EE 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 73
Query: 586 KN----EVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ 641
           K     E++++AK QH NLV LLG   + D+  LVY YM N SL   +     +  L+W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ 701
            R  I  G A G+ +LH++     IHRD+K++NILLD+  T KISDFG+AR         
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 702 NTKRVVGT 709
              R+VGT
Sbjct: 191 MXSRIVGT 198

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 75/188 (39%), Positives = 104/188 (55%), Gaps = 14/188 (7%)
Query: 532 FDFETIVRATDNFTDY------NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEF 585
           F F  +   T+NF +       NK+G+GGFG+VYKG  +    +AVK+L+       EE 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 67
Query: 586 KN----EVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ 641
           K     E++++AK QH NLV LLG   + D+  LVY YM N SL   +     +  L+W 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ 701
            R  I  G A G+ +LH++     IHRD+K++NILLD+  T KISDFG+AR         
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 702 NTKRVVGT 709
              R+VGT
Sbjct: 185 MXXRIVGT 192

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 75/188 (39%), Positives = 104/188 (55%), Gaps = 14/188 (7%)
Query: 532 FDFETIVRATDNFTDY------NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEF 585
           F F  +   T+NF +       NK+G+GGFG+VYKG  +    +AVK+L+       EE 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 73
Query: 586 KN----EVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ 641
           K     E++++AK QH NLV LLG   + D+  LVY YM N SL   +     +  L+W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ 701
            R  I  G A G+ +LH++     IHRD+K++NILLD+  T KISDFG+AR         
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 702 NTKRVVGT 709
              R+VGT
Sbjct: 191 MXXRIVGT 198

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 74/188 (39%), Positives = 101/188 (53%), Gaps = 14/188 (7%)
Query: 532 FDFETIVRATDNFTDY------NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEF 585
           F F  +   T+NF +       NK G+GGFG+VYKG  +    +AVK+L+       EE 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 64
Query: 586 KN----EVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ 641
           K     E+++ AK QH NLV LLG   + D+  LVY Y  N SL   +     +  L+W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ 701
            R  I  G A G+ +LH++     IHRD+K++NILLD+  T KISDFG+AR         
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 702 NTKRVVGT 709
              R+VGT
Sbjct: 182 XXSRIVGT 189

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 91/171 (53%), Gaps = 14/171 (8%)
Query: 525 DDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGI 582
           DD+++P  D               K+G G FG V++     G ++AVK L       + +
Sbjct: 30  DDMDIPWCDLNI----------KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERV 78
Query: 583 EEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
            EF  EV ++ +L+H N+V  +G   +     +V EY+   SL  ++        L+ +R
Sbjct: 79  NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 643 RFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI 693
           R ++   +A+G+ YLH  +   I+HRDLK+ N+L+DK+ T K+ DFG++R+
Sbjct: 139 RLSMAYDVAKGMNYLHNRNP-PIVHRDLKSPNLLVDKKYTVKVCDFGLSRL 188

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 97/187 (51%), Gaps = 16/187 (8%)
Query: 525 DDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGI 582
           DD+++P  D               K+G G FG V++     G ++AVK L       + +
Sbjct: 30  DDMDIPWCDLNI----------KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERV 78
Query: 583 EEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
            EF  EV ++ +L+H N+V  +G   +     +V EY+   SL  ++        L+ +R
Sbjct: 79  NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 643 RFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN 702
           R ++   +A+G+ YLH +    I+HR+LK+ N+L+DK+ T K+ DFG++R+     T  +
Sbjct: 139 RLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLS 195
Query: 703 TKRVVGT 709
           +K   GT
Sbjct: 196 SKSAAGT 202

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 81/161 (50%), Gaps = 6/161 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
             T   ++G G FG+V+ G  L   ++A+K + R      E+F  E  ++ KL H  LV+
Sbjct: 8   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 66
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C+E     LV+E+ME+  L   +  + +  +   +    +   +  G+ YL + S 
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS- 123
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
             +IHRDL A N L+ +    K+SDFGM R    DQ   +T
Sbjct: 124 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 162

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/160 (35%), Positives = 88/160 (55%), Gaps = 12/160 (7%)
Query: 550 LGQGGFGIVYKGR-LLEGQ----EIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRNLVRL 603
           LG G FG VYKG  + EG+     +A+K L+  +G     EF +E  ++A + H +LVRL
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           LG C+    + LV + M +  L   + +   +  +  Q   N    IA+G++YL +    
Sbjct: 106 LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDN--IGSQLLLNWCVQIAKGMMYLEER--- 159
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
           R++HRDL A N+L+      KI+DFG+AR+  GD+ E N 
Sbjct: 160 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 199

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/160 (35%), Positives = 87/160 (54%), Gaps = 12/160 (7%)
Query: 550 LGQGGFGIVYKGR-LLEGQ----EIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRNLVRL 603
           LG G FG VYKG  + EG+     +A+K L+  +G     EF +E  ++A + H +LVRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           LG C+      LV + M +  L   + +   +  +  Q   N    IA+G++YL +    
Sbjct: 83  LGVCLS-PTIQLVTQLMPHGCLLEYVHEHKDN--IGSQLLLNWCVQIAKGMMYLEER--- 136
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
           R++HRDL A N+L+      KI+DFG+AR+  GD+ E N 
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 176

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/157 (36%), Positives = 85/157 (54%), Gaps = 21/157 (13%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           +G GGFG VY+   + G E+AVK    +      Q IE  + E +L A L+H N++ L G
Sbjct: 15  IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDK--ARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
            C++     LV E+     L+ V+  K      ++NW  +      IARG+ YLH ++  
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ------IARGMNYLHDEAIV 127
Query: 664 RIIHRDLKASNILLDKEM--------TPKISDFGMAR 692
            IIHRDLK+SNIL+ +++          KI+DFG+AR
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 80/161 (49%), Gaps = 6/161 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
             T   ++G G FG+V+ G  L   ++A+K + R      E+F  E  ++ KL H  LV+
Sbjct: 8   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 66
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C+E     LV+E+ME+  L   +  + +  +   +    +   +  G+ YL +   
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 123
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
             +IHRDL A N L+ +    K+SDFGM R    DQ   +T
Sbjct: 124 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 162

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 80/161 (49%), Gaps = 6/161 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
             T   ++G G FG+V+ G  L   ++A+K + R      E+F  E  ++ KL H  LV+
Sbjct: 11  ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 69
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C+E     LV+E+ME+  L   +  + +  +   +    +   +  G+ YL +   
Sbjct: 70  LYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 126
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
             +IHRDL A N L+ +    K+SDFGM R    DQ   +T
Sbjct: 127 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 80/161 (49%), Gaps = 6/161 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
             T   ++G G FG+V+ G  L   ++A+K + R      E+F  E  ++ KL H  LV+
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C+E     LV+E+ME+  L   +  + +  +   +    +   +  G+ YL +   
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 121
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
             +IHRDL A N L+ +    K+SDFGM R    DQ   +T
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 79/161 (49%), Gaps = 6/161 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
             T   ++G G FG+V+ G  L   ++A+K + R      E+F  E  ++ KL H  LV+
Sbjct: 9   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 67
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C+E     LV E+ME+  L   +  + +  +   +    +   +  G+ YL +   
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 124
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
             +IHRDL A N L+ +    K+SDFGM R    DQ   +T
Sbjct: 125 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/161 (34%), Positives = 82/161 (50%), Gaps = 10/161 (6%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V EYMEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
            +HRDL A NIL++  +  K+SDFG+AR+   D     T R
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTR 208

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 80/161 (49%), Gaps = 6/161 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
             T   ++G G FG+V+ G  L   ++A+K +   S    ++F  E  ++ KL H  LV+
Sbjct: 28  ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQ 86
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C+E     LV+E+ME+  L   +  + +  +   +    +   +  G+ YL +   
Sbjct: 87  LYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 143
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
             +IHRDL A N L+ +    K+SDFGM R    DQ   +T
Sbjct: 144 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 182

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 82/161 (50%), Gaps = 10/161 (6%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V EYMEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
            +HRDL A NIL++  +  K+SDFG++R+   D     T R
Sbjct: 168 FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 82/161 (50%), Gaps = 10/161 (6%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V EYMEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
            +HRDL A NIL++  +  K+SDFG++R+   D     T R
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 82/161 (50%), Gaps = 10/161 (6%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V EYMEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
            +HRDL A NIL++  +  K+SDFG++R+   D     T R
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 82/161 (50%), Gaps = 10/161 (6%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V EYMEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 84  GVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 138
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
            +HRDL A NIL++  +  K+SDFG++R+   D     T R
Sbjct: 139 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 179

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 82/161 (50%), Gaps = 10/161 (6%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V EYMEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
            +HRDL A NIL++  +  K+SDFG++R+   D     T R
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 82/161 (50%), Gaps = 10/161 (6%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V EYMEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
            +HRDL A NIL++  +  K+SDFG++R+   D     T R
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 82/161 (50%), Gaps = 10/161 (6%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 110
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V EYMEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 111 GVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 165
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
            +HRDL A NIL++  +  K+SDFG++R+   D     T R
Sbjct: 166 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 206

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 82/161 (50%), Gaps = 10/161 (6%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 100
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V EYMEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 101 GVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 155
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
            +HRDL A NIL++  +  K+SDFG++R+   D     T R
Sbjct: 156 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 196

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 92/166 (55%), Gaps = 19/166 (11%)
Query: 541 TDNFTDYNK-LGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQG-------IEEFKNEVRL 591
            DN  +Y K +G+GGFG+V+KGRL++ +  +A+K L     +G        +EF+ EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 592 IAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIA 651
           ++ L H N+V+L G     +   +V E++    L   + DKA    + W  +  ++  IA
Sbjct: 77  MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIA 132
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDK--EMTP---KISDFGMAR 692
            G+ Y+ Q+    I+HRDL++ NI L    E  P   K++DFG+++
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 81/161 (50%), Gaps = 10/161 (6%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V EYMEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
            +HRDL A NIL++  +  K+SDFG+ R+   D     T R
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR 208

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 92/156 (58%), Gaps = 8/156 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHRN 599
           + +    K+G+G +G+VYK +  +G+ +A+KR+  ++  +GI      E+ L+ +L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V L+          LV+E+ME + L  V+ D+ ++ + + Q +  +   + RG+ + HQ
Sbjct: 81  IVSLIDVIHSERCLTLVFEFME-KDLKKVL-DENKTGLQDSQIKIYLY-QLLRGVAHCHQ 137
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
               RI+HRDLK  N+L++ +   K++DFG+AR FG
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 92/156 (58%), Gaps = 8/156 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHRN 599
           + +    K+G+G +G+VYK +  +G+ +A+KR+  ++  +GI      E+ L+ +L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V L+          LV+E+ME + L  V+ D+ ++ + + Q +  +   + RG+ + HQ
Sbjct: 81  IVSLIDVIHSERCLTLVFEFME-KDLKKVL-DENKTGLQDSQIKIYLY-QLLRGVAHCHQ 137
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
               RI+HRDLK  N+L++ +   K++DFG+AR FG
Sbjct: 138 H---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/186 (32%), Positives = 94/186 (50%), Gaps = 20/186 (10%)
Query: 520 SADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG 579
           S D +DD E+P              T   ++G G FG VYKG+      + +  ++  + 
Sbjct: 12  SRDSSDDWEIP----------DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTP 61
Query: 580 QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILN 639
           Q ++ FKNEV ++ K +H N++  +G   +  +  +V ++ E  SL   +   A  +   
Sbjct: 62  QQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLH--ASETKFE 118
Query: 640 WQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA----RIFG 695
            ++  +I    ARG+ YLH  S   IIHRDLK++NI L ++ T KI DFG+A    R  G
Sbjct: 119 MKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175
Query: 696 GDQTEQ 701
             Q EQ
Sbjct: 176 SHQFEQ 181

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/148 (37%), Positives = 83/148 (56%), Gaps = 8/148 (5%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLY-AV 82
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    I
Sbjct: 83  VTQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 137
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIF 694
           HRDL+A+NIL+   ++ KI+DFG+AR+ 
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLI 165

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/148 (37%), Positives = 83/148 (56%), Gaps = 8/148 (5%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    
Sbjct: 27  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLY-AV 84
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    I
Sbjct: 85  VTQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 139
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIF 694
           HRDL+A+NIL+   ++ KI+DFG+AR+ 
Sbjct: 140 HRDLRAANILVSDTLSCKIADFGLARLI 167

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/148 (37%), Positives = 83/148 (56%), Gaps = 8/148 (5%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    
Sbjct: 29  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLY-AV 86
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    I
Sbjct: 87  VTQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 141
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIF 694
           HRDL+A+NIL+   ++ KI+DFG+AR+ 
Sbjct: 142 HRDLRAANILVSDTLSCKIADFGLARLI 169

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/152 (36%), Positives = 85/152 (55%), Gaps = 8/152 (5%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV- 82
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    I
Sbjct: 83  VTQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 137
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           HRDL+A+NIL+   ++ KI+DFG+AR+   ++
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNE 169

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/152 (36%), Positives = 85/152 (55%), Gaps = 8/152 (5%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLY-AV 76
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    I
Sbjct: 77  VTQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 131
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           HRDL+A+NIL+   ++ KI+DFG+AR+   ++
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNE 163

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/152 (36%), Positives = 85/152 (55%), Gaps = 8/152 (5%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    
Sbjct: 28  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV- 85
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    I
Sbjct: 86  VTQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 140
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           HRDL+A+NIL+   ++ KI+DFG+AR+   ++
Sbjct: 141 HRDLRAANILVSDTLSCKIADFGLARLIEDNE 172

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/152 (36%), Positives = 85/152 (55%), Gaps = 8/152 (5%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    
Sbjct: 24  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV- 81
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    I
Sbjct: 82  VTQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 136
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           HRDL+A+NIL+   ++ KI+DFG+AR+   ++
Sbjct: 137 HRDLRAANILVSDTLSCKIADFGLARLIEDNE 168

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/152 (36%), Positives = 85/152 (55%), Gaps = 8/152 (5%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    
Sbjct: 21  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV- 78
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    I
Sbjct: 79  VTQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 133
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           HRDL+A+NIL+   ++ KI+DFG+AR+   ++
Sbjct: 134 HRDLRAANILVSDTLSCKIADFGLARLIEDNE 165

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/152 (36%), Positives = 85/152 (55%), Gaps = 8/152 (5%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV- 76
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    I
Sbjct: 77  VTQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 131
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           HRDL+A+NIL+   ++ KI+DFG+AR+   ++
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNE 163

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 89/164 (54%), Gaps = 11/164 (6%)
Query: 538 VRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFK-NEVRLIAKL 595
           + ++  F    KLG G +  VYKG     G  +A+K +  +S +G       E+ L+ +L
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMEN---RSLDS-VIFDKARSSILNWQRRFNIICGIA 651
           +H N+VRL       ++  LV+E+M+N   + +DS  + +  R   LN  + F     + 
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ--WQLL 118
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           +GL + H++   +I+HRDLK  N+L++K    K+ DFG+AR FG
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/152 (36%), Positives = 85/152 (55%), Gaps = 8/152 (5%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV- 76
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    I
Sbjct: 77  VTQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 131
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           HRDL+A+NIL+   ++ KI+DFG+AR+   ++
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNE 163

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/152 (36%), Positives = 85/152 (55%), Gaps = 8/152 (5%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    
Sbjct: 20  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV- 77
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    I
Sbjct: 78  VTQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 132
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           HRDL+A+NIL+   ++ KI+DFG+AR+   ++
Sbjct: 133 HRDLRAANILVSDTLSCKIADFGLARLIEDNE 164

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 89/159 (55%), Gaps = 8/159 (5%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           H N+V+LL      ++  LV+E++     D    D +  + +      + +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKD--FMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
            H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG 154

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 91/166 (54%), Gaps = 19/166 (11%)
Query: 541 TDNFTDYNK-LGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQG-------IEEFKNEVRL 591
            DN  +Y K +G+GGFG+V+KGRL++ +  +A+K L     +G        +EF+ EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 592 IAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIA 651
           ++ L H N+V+L G     +   +V E++    L   + DKA    + W  +  ++  IA
Sbjct: 77  MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIA 132
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDK--EMTP---KISDFGMAR 692
            G+ Y+ Q+    I+HRDL++ NI L    E  P   K++DFG ++
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ 177

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 93/184 (50%), Gaps = 20/184 (10%)
Query: 522 DKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQG 581
           D +DD E+P              T   ++G G FG VYKG+      + +  ++  + Q 
Sbjct: 2   DSSDDWEIP----------DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ 51
Query: 582 IEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ 641
           ++ FKNEV ++ K +H N++  +G   +  +  +V ++ E  SL   +   A  +    +
Sbjct: 52  LQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLH--ASETKFEMK 108
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA----RIFGGD 697
           +  +I    ARG+ YLH  S   IIHRDLK++NI L ++ T KI DFG+A    R  G  
Sbjct: 109 KLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSH 165
Query: 698 QTEQ 701
           Q EQ
Sbjct: 166 QFEQ 169

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 94/160 (58%), Gaps = 10/160 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L + +   A + I L   + +  +  + +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSY--LFQLLQGLA 120
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 157

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/151 (36%), Positives = 85/151 (56%), Gaps = 8/151 (5%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    V
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 72
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
             +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    IH
Sbjct: 73  TQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 127
Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           RDL+A+NIL+   ++ KI+DFG+AR+   ++
Sbjct: 128 RDLRAANILVSDTLSCKIADFGLARLIEDNE 158

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/186 (32%), Positives = 92/186 (49%), Gaps = 20/186 (10%)
Query: 520 SADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG 579
           S D  DD E+P              T   ++G G FG VYKG+      + +  ++  + 
Sbjct: 12  SRDAADDWEIP----------DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTP 61
Query: 580 QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILN 639
           Q ++ FKNEV ++ K +H N++  +G      +  +V ++ E  SL   +   A  +   
Sbjct: 62  QQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLH--ASETKFE 118
Query: 640 WQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA----RIFG 695
            ++  +I    ARG+ YLH  S   IIHRDLK++NI L ++ T KI DFG+A    R  G
Sbjct: 119 MKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175
Query: 696 GDQTEQ 701
             Q EQ
Sbjct: 176 SHQFEQ 181

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 80/155 (51%), Gaps = 13/155 (8%)
Query: 550 LGQGGFGIVYKGRLLEGQ-----EIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRNLVRL 603
           +G G FG VYKG L          +A+K L     +    +F  E  ++ +  H N++RL
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLHQDSR 662
            G   +    M++ EYMEN +LD  + +K    S+L       ++ GIA G+ YL   + 
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL---VGMLRGIAAGMKYL---AN 165
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
              +HRDL A NIL++  +  K+SDFG++R+   D
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 95/170 (55%), Gaps = 17/170 (10%)
Query: 530 PLFDFETIVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK- 586
           PL D E       NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+     
Sbjct: 2   PLVDME-------NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI 54
Query: 587 NEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFN 645
            E+ L+ +L H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + + 
Sbjct: 55  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY- 112
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
            +  + +GL + H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 113 -LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 158

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 92/160 (57%), Gaps = 10/160 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIF-DKARSSILNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++   S+D   F D +  + +      + +  + +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 121 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG 157

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 93/160 (58%), Gaps = 10/160 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 117
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 93/160 (58%), Gaps = 10/160 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 119
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 120 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG 156

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 93/160 (58%), Gaps = 10/160 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 119
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 156

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 92/160 (57%), Gaps = 10/160 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIF-DKARSSILNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++   S+D   F D +  + +      + +  + +GL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG 155

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 93/160 (58%), Gaps = 10/160 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 117
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 93/160 (58%), Gaps = 10/160 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 118
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG 155

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 93/160 (58%), Gaps = 10/160 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 120
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 157

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 93/160 (58%), Gaps = 10/160 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 117
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 93/160 (58%), Gaps = 10/160 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 118
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 155

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 93/160 (58%), Gaps = 10/160 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 121
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 122 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 158

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 93/160 (58%), Gaps = 10/160 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 120
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 157

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 89/159 (55%), Gaps = 8/159 (5%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           H N+V+LL      ++  LV+E++     D    D +  + +      + +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKD--FMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
            H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 157

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 93/160 (58%), Gaps = 10/160 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 119
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 156

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 93/160 (58%), Gaps = 10/160 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 118
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 155

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 92/158 (58%), Gaps = 10/158 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFC 118
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 92/158 (58%), Gaps = 10/158 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFC 126
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 161

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 93/160 (58%), Gaps = 10/160 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 117
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 89/159 (55%), Gaps = 8/159 (5%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           H N+V+LL      ++  LV+E++     D    D +  + +      + +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKD--FMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
            H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 156

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 93/158 (58%), Gaps = 10/158 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L + +   A + I L   + +  +  + +GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSY--LFQLLQGLAFC 118
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 92/158 (58%), Gaps = 10/158 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFC 119
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 92/158 (58%), Gaps = 10/158 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFC 120
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 121 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 155

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 92/158 (58%), Gaps = 10/158 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFC 118
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 92/158 (58%), Gaps = 10/158 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFC 126
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 161

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 92/158 (58%), Gaps = 10/158 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFC 119
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 92/158 (58%), Gaps = 10/158 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFC 118
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 92/158 (58%), Gaps = 10/158 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFC 119
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 91/166 (54%), Gaps = 19/166 (11%)
Query: 541 TDNFTDYNK-LGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQG-------IEEFKNEVRL 591
            DN  +Y K +G+GGFG+V+KGRL++ +  +A+K L     +G        +EF+ EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 592 IAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIA 651
           ++ L H N+V+L G     +   +V E++    L   + DKA    + W  +  ++  IA
Sbjct: 77  MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIA 132
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDK--EMTP---KISDFGMAR 692
            G+ Y+ Q+    I+HRDL++ NI L    E  P   K++DF +++
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ 177

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 92/158 (58%), Gaps = 10/158 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFC 118
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 81/161 (50%), Gaps = 10/161 (6%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V E MEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
            +HRDL A NIL++  +  K+SDFG++R+   D     T R
Sbjct: 168 AVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 92/158 (58%), Gaps = 10/158 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLSFC 119
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 81/161 (50%), Gaps = 10/161 (6%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V E MEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
            +HRDL A NIL++  +  K+SDFG++R+   D     T R
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 208

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 81/161 (50%), Gaps = 10/161 (6%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V E MEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 84  GVVTKSKPVMIVTEXMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 138
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
            +HRDL A NIL++  +  K+SDFG++R+   D     T R
Sbjct: 139 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 179

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 85/151 (56%), Gaps = 8/151 (5%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    V
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 73
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
             +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    IH
Sbjct: 74  TQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 128
Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           R+L+A+NIL+   ++ KI+DFG+AR+   ++
Sbjct: 129 RNLRAANILVSDTLSCKIADFGLARLIEDNE 159

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 93/160 (58%), Gaps = 10/160 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 120
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 157

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKN---EVRLIAKLQHRN 599
           F+D  ++G G FG VY  R +   E+ A+K++S +  Q  E++++   EVR + KL+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
            ++  GC +      LV EY    + D +   +     L       +  G  +GL YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
            +   +IHRD+KA NILL +    K+ DFG A I  
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKN---EVRLIAKLQHRN 599
           F+D  ++G G FG VY  R +   E+ A+K++S +  Q  E++++   EVR + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
            ++  GC +      LV EY    + D +   +     L       +  G  +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
            +   +IHRD+KA NILL +    K+ DFG A I  
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 82/161 (50%), Gaps = 10/161 (6%)
Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL L G+    +A+K L    + +   +F  E  ++ +  H N++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V EYMEN SLD+  F K         +   ++ GI+ G+ YL   S   
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDT--FLKKNDGQFTVIQLVGMLRGISAGMKYL---SDMG 144
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
            +HRDL A NIL++  +  K+SDFG++R+   D     T R
Sbjct: 145 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 185

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 82/166 (49%), Gaps = 19/166 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGR---LLEGQE---IAVKRLSRNSGQGIEEFKNEVRLIAKLQ 596
           N     +LG+G FG V+      L   Q+   +AVK L   S    ++F  E  L+  LQ
Sbjct: 14  NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 73
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ----------RRFNI 646
           H ++V+  G CVE D  ++V+EYM++  L+  +      ++L  +          +  +I
Sbjct: 74  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              IA G++YL   +    +HRDL   N L+ + +  KI DFGM+R
Sbjct: 134 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 176

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/148 (36%), Positives = 82/148 (55%), Gaps = 8/148 (5%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G  G V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    
Sbjct: 19  ERLGAGQAGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLY-AV 76
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    I
Sbjct: 77  VTQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 131
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIF 694
           HRDL+A+NIL+   ++ KI+DFG+AR+ 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLI 159

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 82/161 (50%), Gaps = 10/161 (6%)
Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL + G+    +A+K L    + +   +F +E  ++ +  H N++ L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M++ EYMEN SLD+  F +         +   ++ GI  G+ YL   S   
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDA--FLRKNDGRFTVIQLVGMLRGIGSGMKYL---SDMS 151
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
            +HRDL A NIL++  +  K+SDFGM+R+   D     T R
Sbjct: 152 AVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 192

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 91/158 (57%), Gaps = 10/158 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+ ++  ++  +G+      E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFC 119
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 91/158 (57%), Gaps = 10/158 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+ ++  ++  +G+      E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFC 118
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           H     R++HRDLK  N+L++ E   K++DFG+AR FG
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 82/161 (50%), Gaps = 10/161 (6%)
Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL + G+    +A+K L    + +   +F +E  ++ +  H N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M++ EYMEN SLD+  F +         +   ++ GI  G+ YL   S   
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDA--FLRKNDGRFTVIQLVGMLRGIGSGMKYL---SDMS 130
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
            +HRDL A NIL++  +  K+SDFGM+R+   D     T R
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 171

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 93/185 (50%), Gaps = 20/185 (10%)
Query: 521 ADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQ 580
           +D +DD E+P              T   ++G G FG VYKG+      + +  ++  + Q
Sbjct: 2   SDSSDDWEIP----------DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQ 51
Query: 581 GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNW 640
            ++ FKNEV ++ K +H N++  +G   +  +  +V ++ E  SL   +      +    
Sbjct: 52  QLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL--HIIETKFEM 108
Query: 641 QRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA----RIFGG 696
            +  +I    A+G+ YLH  S   IIHRDLK++NI L +++T KI DFG+A    R  G 
Sbjct: 109 IKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 165
Query: 697 DQTEQ 701
            Q EQ
Sbjct: 166 HQFEQ 170

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 76/148 (51%), Gaps = 7/148 (4%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG V+ G      ++AVK L   +   ++ F  E  L+  LQH  LVRL    
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 608 VEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
              +   ++ EYM   SL D +  D+    +L   +  +    IA G+ Y+    R   I
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYI 132
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIF 694
           HRDL+A+N+L+ + +  KI+DFG+AR+ 
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVI 160

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 82/161 (50%), Gaps = 10/161 (6%)
Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL + G+    +A+K L    + +   +F +E  ++ +  H N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M++ EYMEN SLD+  F +         +   ++ GI  G+ YL   S   
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDA--FLRKNDGRFTVIQLVGMLRGIGSGMKYL---SDMS 136
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
            +HRDL A NIL++  +  K+SDFGM+R+   D     T R
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 177

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 93/185 (50%), Gaps = 20/185 (10%)
Query: 521 ADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQ 580
           +D +DD E+P              T   ++G G FG VYKG+      + +  ++  + Q
Sbjct: 2   SDSSDDWEIP----------DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQ 51
Query: 581 GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNW 640
            ++ FKNEV ++ K +H N++  +G   +  +  +V ++ E  SL   +      +    
Sbjct: 52  QLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL--HIIETKFEM 108
Query: 641 QRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA----RIFGG 696
            +  +I    A+G+ YLH  S   IIHRDLK++NI L +++T KI DFG+A    R  G 
Sbjct: 109 IKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 165
Query: 697 DQTEQ 701
            Q EQ
Sbjct: 166 HQFEQ 170

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 77/148 (52%), Gaps = 7/148 (4%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            KLG G FG V+ G      ++AVK L   +   ++ F  E  L+  LQH  LVRL    
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 608 VEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
            + +   ++ E+M   SL D +  D+    +L   +  +    IA G+ Y+    R   I
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYI 131
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIF 694
           HRDL+A+N+L+ + +  KI+DFG+AR+ 
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVI 159

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 93/165 (56%), Gaps = 12/165 (7%)
Query: 535 ETIVRATDNFTDYNK-LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNE 588
             ++  +     +N+ +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E
Sbjct: 40  HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 99
Query: 589 VRLIAKLQHRNLVRLLGCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNII 647
             ++    H N++ LLG C+  +   ++V  YM++  L + I ++  +  +     F + 
Sbjct: 100 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL- 158
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             +A+G+ YL   +  + +HRDL A N +LD++ T K++DFG+AR
Sbjct: 159 -QVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 199

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 92/165 (55%), Gaps = 12/165 (7%)
Query: 535 ETIVRATDNFTDYNK-LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNE 588
             ++  +     +N+ +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E
Sbjct: 41  HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 100
Query: 589 VRLIAKLQHRNLVRLLGCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNII 647
             ++    H N++ LLG C+  +   ++V  YM++  L + I ++  +  +     F + 
Sbjct: 101 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL- 159
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             +A+G+ YL      + +HRDL A N +LD++ T K++DFG+AR
Sbjct: 160 -QVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR 200

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 92/165 (55%), Gaps = 12/165 (7%)
Query: 535 ETIVRATDNFTDYNK-LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNE 588
             ++  +     +N+ +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E
Sbjct: 14  HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 73
Query: 589 VRLIAKLQHRNLVRLLGCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNII 647
             ++    H N++ LLG C+  +   ++V  YM++  L + I ++  +  +     F + 
Sbjct: 74  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL- 132
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             +A+G+ YL      + +HRDL A N +LD++ T K++DFG+AR
Sbjct: 133 -QVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR 173

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 87/149 (58%), Gaps = 11/149 (7%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ YL   +  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 151
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
           + +HRDL A N +LD++ T K++DFG+AR
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 87/149 (58%), Gaps = 11/149 (7%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ YL   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 152
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
           + +HRDL A N +LD++ T K++DFG+AR
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 93/165 (56%), Gaps = 12/165 (7%)
Query: 535 ETIVRATDNFTDYNK-LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNE 588
             ++  +     +N+ +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E
Sbjct: 20  HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 79
Query: 589 VRLIAKLQHRNLVRLLGCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNII 647
             ++    H N++ LLG C+  +   ++V  YM++  L + I ++  +  +     F + 
Sbjct: 80  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL- 138
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             +A+G+ YL   +  + +HRDL A N +LD++ T K++DFG+AR
Sbjct: 139 -QVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 93/165 (56%), Gaps = 12/165 (7%)
Query: 535 ETIVRATDNFTDYNK-LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNE 588
             ++  +     +N+ +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E
Sbjct: 19  HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 78
Query: 589 VRLIAKLQHRNLVRLLGCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNII 647
             ++    H N++ LLG C+  +   ++V  YM++  L + I ++  +  +     F + 
Sbjct: 79  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL- 137
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             +A+G+ YL   +  + +HRDL A N +LD++ T K++DFG+AR
Sbjct: 138 -QVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 87/149 (58%), Gaps = 11/149 (7%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ YL   +  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 151
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
           + +HRDL A N +LD++ T K++DFG+AR
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 87/149 (58%), Gaps = 11/149 (7%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ YL   +  
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 147
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
           + +HRDL A N +LD++ T K++DFG+AR
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 87/149 (58%), Gaps = 11/149 (7%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ YL   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 152
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
           + +HRDL A N +LD++ T K++DFG+AR
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 92/184 (50%), Gaps = 20/184 (10%)
Query: 522 DKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQG 581
           D +DD E+P              T   ++G G FG VYKG+      + +  ++  + Q 
Sbjct: 18  DSSDDWEIP----------DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ 67
Query: 582 IEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ 641
           ++ FKNEV ++ K +H N++  +G   +  +  +V ++ E  SL   +      +     
Sbjct: 68  LQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL--HIIETKFEMI 124
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA----RIFGGD 697
           +  +I    A+G+ YLH  S   IIHRDLK++NI L +++T KI DFG+A    R  G  
Sbjct: 125 KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSH 181
Query: 698 QTEQ 701
           Q EQ
Sbjct: 182 QFEQ 185

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 87/162 (53%), Gaps = 13/162 (8%)
Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V +GRL   G++   +A+K L    + +   EF +E  ++ + +H N++RL 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G        M++ E+MEN +LDS  F +         +   ++ GIA G+ YL + S   
Sbjct: 84  GVVTNSMPVMILTEFMENGALDS--FLRLNDGQFTVIQLVGMLRGIASGMRYLAEMS--- 138
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIF---GGDQTEQNT 703
            +HRDL A NIL++  +  K+SDFG++R       D TE ++
Sbjct: 139 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSS 180

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 549 KLGQGGFGIVYKGR---LLEGQE---IAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           +LG+G FG V+      LL  Q+   +AVK L   S    ++F+ E  L+  LQH+++VR
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSS------------ILNWQRRFNIICGI 650
             G C E    ++V+EYM +  L+  +      +             L   +   +   +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           A G++YL   +    +HRDL   N L+ + +  KI DFGM+R
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 80/159 (50%), Gaps = 10/159 (6%)
Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G  G V  GRL + GQ    +A+K L    + +   +F +E  ++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G        M+V EYMEN SLD+  F +         +   ++ G+  G+ YL   S   
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
            +HRDL A N+L+D  +  K+SDFG++R+   D     T
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXT 210

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 79/153 (51%), Gaps = 10/153 (6%)
Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G  G V  GRL + GQ    +A+K L    + +   +F +E  ++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G        M+V EYMEN SLD+  F +         +   ++ G+  G+ YL   S   
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
            +HRDL A N+L+D  +  K+SDFG++R+   D
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 92/184 (50%), Gaps = 20/184 (10%)
Query: 522 DKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQG 581
           D +DD E+P              T   ++G G FG VYKG+      + +  ++  + Q 
Sbjct: 26  DSSDDWEIP----------DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ 75
Query: 582 IEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ 641
           ++ FKNEV ++ K +H N++  +G   +  +  +V ++ E  SL   +      +     
Sbjct: 76  LQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL--HIIETKFEMI 132
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA----RIFGGD 697
           +  +I    A+G+ YLH  S   IIHRDLK++NI L +++T KI DFG+A    R  G  
Sbjct: 133 KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 189
Query: 698 QTEQ 701
           Q EQ
Sbjct: 190 QFEQ 193

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 84/164 (51%), Gaps = 10/164 (6%)
Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRL-SRNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  G L L G+    +A+K L S  + +   +F +E  ++ +  H N++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M++ E+MEN SLDS  F +         +   ++ GIA G+ YL   +   
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDS--FLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMN 155
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            +HRDL A NIL++  +  K+SDFG++R    D ++      +G
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 199

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 92/184 (50%), Gaps = 20/184 (10%)
Query: 522 DKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQG 581
           D +DD E+P              T   ++G G FG VYKG+      + +  ++  + Q 
Sbjct: 25  DSSDDWEIP----------DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ 74
Query: 582 IEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ 641
           ++ FKNEV ++ K +H N++  +G   +  +  +V ++ E  SL   +      +     
Sbjct: 75  LQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL--HIIETKFEMI 131
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA----RIFGGD 697
           +  +I    A+G+ YLH  S   IIHRDLK++NI L +++T KI DFG+A    R  G  
Sbjct: 132 KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 188
Query: 698 QTEQ 701
           Q EQ
Sbjct: 189 QFEQ 192

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 87/164 (53%), Gaps = 10/164 (6%)
Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V +GRL   G++   +A+K L    + +   EF +E  ++ + +H N++RL 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G        M++ E+MEN +LDS  F +         +   ++ GIA G+ YL + S   
Sbjct: 82  GVVTNSMPVMILTEFMENGALDS--FLRLNDGQFTVIQLVGMLRGIASGMRYLAEMS--- 136
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            +HRDL A NIL++  +  K+SDFG++R    + ++      +G
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLG 180

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 92/184 (50%), Gaps = 20/184 (10%)
Query: 522 DKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQG 581
           D +DD E+P              T   ++G G FG VYKG+      + +  ++  + Q 
Sbjct: 26  DSSDDWEIP----------DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ 75
Query: 582 IEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ 641
           ++ FKNEV ++ K +H N++  +G   +  +  +V ++ E  SL   +      +     
Sbjct: 76  LQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL--HIIETKFEMI 132
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA----RIFGGD 697
           +  +I    A+G+ YLH  S   IIHRDLK++NI L +++T KI DFG+A    R  G  
Sbjct: 133 KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSH 189
Query: 698 QTEQ 701
           Q EQ
Sbjct: 190 QFEQ 193

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 93/165 (56%), Gaps = 12/165 (7%)
Query: 535 ETIVRATDNFTDYNK-LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNE 588
             ++  +     +N+ +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E
Sbjct: 81  HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 140
Query: 589 VRLIAKLQHRNLVRLLGCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNII 647
             ++    H N++ LLG C+  +   ++V  YM++  L + I ++  +  +     F + 
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL- 199
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             +A+G+ +L   +  + +HRDL A N +LD++ T K++DFG+AR
Sbjct: 200 -QVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 549 KLGQGGFGIVYKGR---LLEGQE---IAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           +LG+G FG V+      LL  Q+   +AVK L   S    ++F+ E  L+  LQH+++VR
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSS------------ILNWQRRFNIICGI 650
             G C E    ++V+EYM +  L+  +      +             L   +   +   +
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           A G++YL   +    +HRDL   N L+ + +  KI DFGM+R
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 177

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 87/149 (58%), Gaps = 11/149 (7%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ +L   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 152
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
           + +HRDL A N +LD++ T K++DFG+AR
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 87/149 (58%), Gaps = 11/149 (7%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ +L   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 152
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
           + +HRDL A N +LD++ T K++DFG+AR
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 549 KLGQGGFGIVYKGR---LLEGQE---IAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           +LG+G FG V+      LL  Q+   +AVK L   S    ++F+ E  L+  LQH+++VR
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIF------------DKARSSILNWQRRFNIICGI 650
             G C E    ++V+EYM +  L+  +             +      L   +   +   +
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           A G++YL   +    +HRDL   N L+ + +  KI DFGM+R
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 183

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 87/149 (58%), Gaps = 11/149 (7%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ +L   +  
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 157
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
           + +HRDL A N +LD++ T K++DFG+AR
Sbjct: 158 KFVHRDLAARNCMLDEKFTVKVADFGLAR 186

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 87/149 (58%), Gaps = 11/149 (7%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ +L   +  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 153
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
           + +HRDL A N +LD++ T K++DFG+AR
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 87/149 (58%), Gaps = 11/149 (7%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ +L   +  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 150
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
           + +HRDL A N +LD++ T K++DFG+AR
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 87/149 (58%), Gaps = 11/149 (7%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ +L   +  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 153
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
           + +HRDL A N +LD++ T K++DFG+AR
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
           E +   +V EYM   SL  + F K  +   L   +  ++   IA G+ Y+    R   +H
Sbjct: 333 E-EPIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 386
Query: 668 RDLKASNILLDKEMTPKISDFGMARIF 694
           RDL+A+NIL+ + +  K++DFG+AR+ 
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLI 413

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 89/167 (53%), Gaps = 18/167 (10%)
Query: 550 LGQGGFGIVYKGRLLE----GQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LG+G FG V +G L +      ++AVK  +L  +S + IEEF +E   +    H N++RL
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 604 LGCCVEMDEK-----MLVYEYMENRSLDS-VIFDKARS--SILNWQRRFNIICGIARGLL 655
           LG C+EM  +     M++  +M+   L + +++ +  +    +  Q     +  IA G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA-RIFGGDQTEQ 701
           YL   S    +HRDL A N +L  +MT  ++DFG++ +I+ GD   Q
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ 205

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/171 (32%), Positives = 83/171 (48%), Gaps = 24/171 (14%)
Query: 538 VRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ 596
           +R   +F +   LGQG FG V K R  L+ +  A+K++ R++ + +    +EV L+A L 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLN 60
Query: 597 H-------------RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR- 642
           H             RN V+ +    +     +  EY ENR+L    +D   S  LN QR 
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTL----YDLIHSENLNQQRD 116
Query: 643 -RFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             + +   I   L Y+H      IIHRDLK  NI +D+    KI DFG+A+
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 91/182 (50%), Gaps = 20/182 (10%)
Query: 524 TDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIE 583
           +DD E+P              T   ++G G FG VYKG+      + +  ++  + Q ++
Sbjct: 2   SDDWEIP----------DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQ 51
Query: 584 EFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRR 643
            FKNEV ++ K +H N++  +G   +  +  +V ++ E  SL   +      +     + 
Sbjct: 52  AFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL--HIIETKFEMIKL 108
Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA----RIFGGDQT 699
            +I    A+G+ YLH  S   IIHRDLK++NI L +++T KI DFG+A    R  G  Q 
Sbjct: 109 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 165
Query: 700 EQ 701
           EQ
Sbjct: 166 EQ 167

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 84/158 (53%), Gaps = 10/158 (6%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            ++G G FG VYKG+      + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
            +  +  +V ++ E  SL   +      +     +  +I    A+G+ YLH  S   IIH
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 668 RDLKASNILLDKEMTPKISDFGMA----RIFGGDQTEQ 701
           RDLK++NI L +++T KI DFG+A    R  G  Q EQ
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 165

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 86/163 (52%), Gaps = 10/163 (6%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           ++G G FG VYKG+      + + ++   + +  + F+NEV ++ K +H N++  +G   
Sbjct: 43  RIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           + D   +V ++ E  SL   +    + +     +  +I    A+G+ YLH  +   IIHR
Sbjct: 103 K-DNLAIVTQWCEGSSLYKHL--HVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHR 156
Query: 669 DLKASNILLDKEMTPKISDFGMA----RIFGGDQTEQNTKRVV 707
           D+K++NI L + +T KI DFG+A    R  G  Q EQ T  V+
Sbjct: 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL 199

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 84/158 (53%), Gaps = 10/158 (6%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            ++G G FG VYKG+      + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
            +  +  +V ++ E  SL   +      +     +  +I    A+G+ YLH  S   IIH
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 668 RDLKASNILLDKEMTPKISDFGMA----RIFGGDQTEQ 701
           RDLK++NI L +++T KI DFG+A    R  G  Q EQ
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ 165

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 83/163 (50%), Gaps = 12/163 (7%)
Query: 549 KLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 604 LGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            G C     +   L+ EY+   SL   +  +A +  ++  +       I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QAHAERIDHIKLLQYTSQICKGMEYLGTK- 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
             R IHRDL   NIL++ E   KI DFG+ ++   D+     K
Sbjct: 137 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 177

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
           E +   +V EYM   SL  + F K  +   L   +  ++   IA G+ Y+    R   +H
Sbjct: 250 E-EPIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 668 RDLKASNILLDKEMTPKISDFGMARIF 694
           RDL+A+NIL+ + +  K++DFG+AR+ 
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLI 330

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
           E +   +V EYM   SL  + F K  +   L   +  ++   IA G+ Y+    R   +H
Sbjct: 250 E-EPIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 668 RDLKASNILLDKEMTPKISDFGMARIF 694
           RDL+A+NIL+ + +  K++DFG+AR+ 
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLI 330

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 83/158 (52%), Gaps = 10/158 (6%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            ++G G FG VYKG+      + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
               +  +V ++ E  SL   +      +     +  +I    A+G+ YLH  S   IIH
Sbjct: 74  TA-PQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 668 RDLKASNILLDKEMTPKISDFGMA----RIFGGDQTEQ 701
           RDLK++NI L +++T KI DFG+A    R  G  Q EQ
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 165

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 6/157 (3%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           +  T   +LG G FG+V  G+     ++AVK +   S    +EF  E + + KL H  LV
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLV 66
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +  G C +     +V EY+ N  L + +  ++    L   +   +   +  G+ +L    
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLESH- 123
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
             + IHRDL A N L+D+++  K+SDFGM R    DQ
Sbjct: 124 --QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/171 (32%), Positives = 87/171 (50%), Gaps = 24/171 (14%)
Query: 538 VRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ 596
           +R   +F +   LGQG FG V K R  L+ +  A+K++ R++ + +    +EV L+A L 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLN 60
Query: 597 HRNLVRLLGCCVE----------MDEKMLVY---EYMENRSLDSVIFDKARSSILNWQR- 642
           H+ +VR     +E          + +K  ++   EY ENR+L    +D   S  LN QR 
Sbjct: 61  HQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTL----YDLIHSENLNQQRD 116
Query: 643 -RFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             + +   I   L Y+H      IIHR+LK  NI +D+    KI DFG+A+
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAK 164

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 83/156 (53%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               IHRDL A N L+ +    K++DFG++R+  GD
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
           E +   +V EYM   SL  + F K  +   L   +  ++   IA G+ Y+    R   +H
Sbjct: 250 E-EPIYIVGEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 668 RDLKASNILLDKEMTPKISDFGMARIF 694
           RDL+A+NIL+ + +  K++DFG+AR+ 
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLI 330

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 83/156 (53%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               IHRDL A N L+ +    K++DFG++R+  GD
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
           E +   +V EYM   SL  + F K  +   L   +  ++   IA G+ Y+    R   +H
Sbjct: 74  E-EPIXIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 127
Query: 668 RDLKASNILLDKEMTPKISDFGMARIF 694
           RDL+A+NIL+ + +  K++DFG+AR+ 
Sbjct: 128 RDLRAANILVGENLVCKVADFGLARLI 154

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 19/199 (9%)
Query: 518 DYSADKTDDL------ELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI- 569
           DY    T++L      E P      I++ T+ F     LG G FG VYKG  + EG+++ 
Sbjct: 11  DYDIPTTENLYFQGSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVK 69
Query: 570 ---AVKRLSR-NSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL 625
              A+K L    S +  +E  +E  ++A + + ++ RLLG C+    +++         L
Sbjct: 70  IPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLL 129
Query: 626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKI 685
           D V   +     +  Q   N    IA+G+ YL      R++HRDL A N+L+      KI
Sbjct: 130 DYV---REHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKI 183
Query: 686 SDFGMARIFGGDQTEQNTK 704
           +DFG+A++ G ++ E + +
Sbjct: 184 TDFGLAKLLGAEEKEYHAE 202

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 83/156 (53%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               IHRDL A N L+ +    K++DFG++R+  GD
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 82/171 (47%), Gaps = 24/171 (14%)
Query: 548 NKLGQGGFGIVYKGRLL------EGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNL 600
            +LG+  FG VYKG L       + Q +A+K L  +  G   EEF++E  L A+LQH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIF-------------DKARSSILNWQRRFNII 647
           V LLG   +     +++ Y  +  L   +              D+   S L      +++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGD 697
             IA G+ YL   S   ++H+DL   N+L+  ++  KISD G+ R ++  D
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
           E +   +V EYM   SL  + F K  +   L   +  ++   IA G+ Y+    R   +H
Sbjct: 77  E-EPIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 130
Query: 668 RDLKASNILLDKEMTPKISDFGMARIF 694
           RDL+A+NIL+ + +  K++DFG+AR+ 
Sbjct: 131 RDLRAANILVGENLVCKVADFGLARLI 157

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 83/156 (53%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 76
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 135
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               IHRDL A N L+ +    K++DFG++R+  GD
Sbjct: 136 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 82/154 (53%), Gaps = 9/154 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQH 597
           ++F   N LG+G F  VY+   +  G E+A+K + + +      ++  +NEV++  +L+H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            +++ L     + +   LV E   N  ++  + ++ +    N  R F  +  I  G+LYL
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF--MHQIITGMLYL 128
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
           H      I+HRDL  SN+LL + M  KI+DFG+A
Sbjct: 129 HSHG---ILHRDLTLSNLLLTRNMNIKIADFGLA 159

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 91/177 (51%), Gaps = 19/177 (10%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 12  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNII 647
           ++A + + ++ RLLG C+    ++++        LD V   K       +LNW       
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNW------C 124
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
             IA+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +
Sbjct: 125 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 178

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 83/156 (53%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 73
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 74  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 132
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               IHRDL A N L+ +    K++DFG++R+  GD
Sbjct: 133 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 165

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 83/156 (53%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 73
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 74  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 132
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               IHRDL A N L+ +    K++DFG++R+  GD
Sbjct: 133 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 165

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 83/156 (53%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 131
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               IHRDL A N L+ +    K++DFG++R+  GD
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 83/156 (53%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               IHRDL A N L+ +    K++DFG++R+  GD
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 82/171 (47%), Gaps = 24/171 (14%)
Query: 548 NKLGQGGFGIVYKGRLL------EGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNL 600
            +LG+  FG VYKG L       + Q +A+K L  +  G   EEF++E  L A+LQH N+
Sbjct: 32  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIF-------------DKARSSILNWQRRFNII 647
           V LLG   +     +++ Y  +  L   +              D+   S L      +++
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGD 697
             IA G+ YL   S   ++H+DL   N+L+  ++  KISD G+ R ++  D
Sbjct: 152 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 199

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 83/156 (53%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 131
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               IHRDL A N L+ +    K++DFG++R+  GD
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 83/156 (53%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 133
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               IHRDL A N L+ +    K++DFG++R+  GD
Sbjct: 134 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 166

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 76/146 (52%), Gaps = 6/146 (4%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E +   +V EYM   SL   +  +     L   +  ++   IA G+ Y+    R   +HR
Sbjct: 84  E-EPIYIVIEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 669 DLKASNILLDKEMTPKISDFGMARIF 694
           DL+A+NIL+ + +  K++DFG+AR+ 
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI 164

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 76/146 (52%), Gaps = 6/146 (4%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E +   +V EYM   SL   +  +     L   +  ++   IA G+ Y+    R   +HR
Sbjct: 84  E-EPIYIVIEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 669 DLKASNILLDKEMTPKISDFGMARIF 694
           DL+A+NIL+ + +  K++DFG+AR+ 
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI 164

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 76/146 (52%), Gaps = 6/146 (4%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E +   +V EYM   SL   +  +     L   +  ++   IA G+ Y+    R   +HR
Sbjct: 84  E-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 669 DLKASNILLDKEMTPKISDFGMARIF 694
           DL+A+NIL+ + +  K++DFG+AR+ 
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI 164

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 83/156 (53%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 133
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               IHRDL A N L+ +    K++DFG++R+  GD
Sbjct: 134 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 166

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 102/201 (50%), Gaps = 26/201 (12%)
Query: 521 ADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKR-LSRNS 578
           A + D +E P  D          +    K+GQG FG V+K R  + GQ++A+K+ L  N 
Sbjct: 3   AKQYDSVECPFCD------EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE 56
Query: 579 GQGIE-EFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM--------LVYEYMENRSLDSVI 629
            +G       E++++  L+H N+V L+  C               LV+++ E+  L  ++
Sbjct: 57  KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL 115
Query: 630 FDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
            +      L+  +R  ++  +  GL Y+H   R +I+HRD+KA+N+L+ ++   K++DFG
Sbjct: 116 SNVLVKFTLSEIKR--VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG 170
Query: 690 MARIFGGDQTEQNTK---RVV 707
           +AR F   +  Q  +   RVV
Sbjct: 171 LARAFSLAKNSQPNRYXNRVV 191

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
           E +   +V EYM   SL  + F K  +   L   +  ++   IA G+ Y+    R   +H
Sbjct: 81  E-EPIYIVTEYMNKGSL--LDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 668 RDLKASNILLDKEMTPKISDFGMARIF 694
           RDL+A+NIL+ + +  K++DFG+AR+ 
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLI 161

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 76/146 (52%), Gaps = 6/146 (4%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E +   +V EYM   SL   +  +     L   +  ++   IA G+ Y+    R   +HR
Sbjct: 73  E-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 127
Query: 669 DLKASNILLDKEMTPKISDFGMARIF 694
           DL+A+NIL+ + +  K++DFG+AR+ 
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLI 153

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 83/156 (53%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 27  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 85
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 86  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 144
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               IHRDL A N L+ +    K++DFG++R+  GD
Sbjct: 145 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 177

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 82/156 (52%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 91
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       +V EYM   +L   + +  R  +      + +   I+  + YL + +
Sbjct: 92  QLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLY-MATQISSAMEYLEKKN 150
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               IHRDL A N L+ +    K++DFG++R+  GD
Sbjct: 151 ---FIHRDLAARNCLVGENHVVKVADFGLSRLMTGD 183

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 89/174 (51%), Gaps = 13/174 (7%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    +++         LD V   +     +  Q   N    I
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGXLLDYV---REHKDNIGSQYLLNWCVQI 126
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 76/146 (52%), Gaps = 6/146 (4%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E +   +V EYM   SL   +  +     L   +  ++   IA G+ Y+    R   +HR
Sbjct: 75  E-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 129
Query: 669 DLKASNILLDKEMTPKISDFGMARIF 694
           DL+A+NIL+ + +  K++DFG+AR+ 
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLI 155

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 83/164 (50%), Gaps = 10/164 (6%)
Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRL-SRNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  G L L G+    +A+K L S  + +   +F +E  ++ +  H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M++ E+MEN SLDS  F +         +   ++ GIA G+ YL   +   
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDS--FLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMN 129
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            +HR L A NIL++  +  K+SDFG++R    D ++      +G
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 173

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 83/156 (53%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 133
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               IHRDL A N L+ +    K++DFG++R+  GD
Sbjct: 134 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 166

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 76/146 (52%), Gaps = 6/146 (4%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E +   +V EYM   SL   +  +     L   +  ++   IA G+ Y+    R   +HR
Sbjct: 84  E-EPIYIVCEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 669 DLKASNILLDKEMTPKISDFGMARIF 694
           DL+A+NIL+ + +  K++DFG+AR+ 
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI 164

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 90/174 (51%), Gaps = 13/174 (7%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 15  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    ++++        LD V   +     +  Q   N    I
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 130
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +
Sbjct: 131 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 181

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
           E +   +V EYM   SL  + F K  +   L   +  ++   IA G+ Y+    R   +H
Sbjct: 81  E-EPIYIVTEYMNKGSL--LDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 668 RDLKASNILLDKEMTPKISDFGMARIF 694
           RDL+A+NIL+ + +  K++DFG+AR+ 
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLI 161

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 79/153 (51%), Gaps = 10/153 (6%)
Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL L G+    +A+K L    + +   +F  E  ++ +  H N+V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G        M+V E+MEN +LD+  F +         +   ++ GIA G+ YL   +   
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDA--FLRKHDGQFTVIQLVGMLRGIAAGMRYL---ADMG 165
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
            +HRDL A NIL++  +  K+SDFG++R+   D
Sbjct: 166 YVHRDLAARNILVNSNLVCKVSDFGLSRVIEDD 198

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 95/186 (51%), Gaps = 15/186 (8%)
Query: 528 ELPLFDFETIVRATDNFTD-YNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEF 585
           +L   D +++ +  +   D   KLG+G +G VYK    E GQ +A+K++   S   ++E 
Sbjct: 14  QLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEI 71
Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
             E+ ++ +    ++V+  G   +  +  +V EY    S+  +I  + R+  L       
Sbjct: 72  IKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIAT 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           I+    +GL YLH     R IHRD+KA NILL+ E   K++DFG+A    G  T+   KR
Sbjct: 130 ILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVA----GQLTDXMAKR 182
Query: 706 --VVGT 709
             V+GT
Sbjct: 183 NXVIGT 188

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 90/184 (48%), Gaps = 22/184 (11%)
Query: 537 IVRATDNFTDY--------NKLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIE 583
           + R + N T +         +LG+G FG V   R   L+   G+ +AVK+L  ++ + + 
Sbjct: 15  VPRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR 74
Query: 584 EFKNEVRLIAKLQHRNLVRLLGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNW 640
           +F+ E+ ++  LQH N+V+  G C     +   L+ EY+   SL D +   K R   +  
Sbjct: 75  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 134
Query: 641 QRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE 700
            +  + IC   +G+ YL      R IHRDL   NIL++ E   KI DFG+ ++   D+  
Sbjct: 135 LQYTSQIC---KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 188
Query: 701 QNTK 704
              K
Sbjct: 189 XKVK 192

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 75/146 (51%), Gaps = 6/146 (4%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L +      E F  E +++ KL+H  LV+L     
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E +   +V EYM   SL   +  +     L   +  ++   IA G+ Y+    R   +HR
Sbjct: 251 E-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 305
Query: 669 DLKASNILLDKEMTPKISDFGMARIF 694
           DL+A+NIL+ + +  K++DFG+ R+ 
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLI 331

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 91/177 (51%), Gaps = 19/177 (10%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 12  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNII 647
           ++A + + ++ RLLG C+    ++++        LD V   K       +LNW       
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------C 124
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
             IA+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +
Sbjct: 125 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 178

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 90/174 (51%), Gaps = 13/174 (7%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    ++++        LD V   +     +  Q   N    I
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 129
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +
Sbjct: 130 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 90/174 (51%), Gaps = 13/174 (7%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    ++++        LD V   +     +  Q   N    I
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 128
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +
Sbjct: 129 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 179

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 90/184 (48%), Gaps = 22/184 (11%)
Query: 537 IVRATDNFTDY--------NKLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIE 583
           + R + N T +         +LG+G FG V   R   L+   G+ +AVK+L  ++ + + 
Sbjct: 15  VPRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR 74
Query: 584 EFKNEVRLIAKLQHRNLVRLLGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNW 640
           +F+ E+ ++  LQH N+V+  G C     +   L+ EY+   SL D +   K R   +  
Sbjct: 75  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 134
Query: 641 QRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE 700
            +  + IC   +G+ YL      R IHRDL   NIL++ E   KI DFG+ ++   D+  
Sbjct: 135 LQYTSQIC---KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 188
Query: 701 QNTK 704
              K
Sbjct: 189 XKVK 192

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 90/174 (51%), Gaps = 13/174 (7%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    ++++        LD V   +     +  Q   N    I
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 126
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 102/201 (50%), Gaps = 26/201 (12%)
Query: 521 ADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKR-LSRNS 578
           A + D +E P  D          +    K+GQG FG V+K R  + GQ++A+K+ L  N 
Sbjct: 3   AKQYDSVECPFCD------EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE 56
Query: 579 GQGIE-EFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM--------LVYEYMENRSLDSVI 629
            +G       E++++  L+H N+V L+  C               LV+++ E+  L  ++
Sbjct: 57  KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLL 115
Query: 630 FDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
            +      L+  +R  ++  +  GL Y+H   R +I+HRD+KA+N+L+ ++   K++DFG
Sbjct: 116 SNVLVKFTLSEIKR--VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG 170
Query: 690 MARIFGGDQTEQNTK---RVV 707
           +AR F   +  Q  +   RVV
Sbjct: 171 LARAFSLAKNSQPNRYXNRVV 191

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 102/201 (50%), Gaps = 26/201 (12%)
Query: 521 ADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKR-LSRNS 578
           A + D +E P  D          +    K+GQG FG V+K R  + GQ++A+K+ L  N 
Sbjct: 2   AKQYDSVECPFCD------EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE 55
Query: 579 GQGIE-EFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM--------LVYEYMENRSLDSVI 629
            +G       E++++  L+H N+V L+  C               LV+++ E+  L  ++
Sbjct: 56  KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL 114
Query: 630 FDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
            +      L+  +R  ++  +  GL Y+H   R +I+HRD+KA+N+L+ ++   K++DFG
Sbjct: 115 SNVLVKFTLSEIKR--VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG 169
Query: 690 MARIFGGDQTEQNTK---RVV 707
           +AR F   +  Q  +   RVV
Sbjct: 170 LARAFSLAKNSQPNRYXNRVV 190

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 75/146 (51%), Gaps = 6/146 (4%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E +   +V EYM   SL   +  +     L   +  ++   IA G+ Y+    R   +HR
Sbjct: 84  E-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 669 DLKASNILLDKEMTPKISDFGMARIF 694
           DL A+NIL+ + +  K++DFG+AR+ 
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLI 164

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 102/201 (50%), Gaps = 26/201 (12%)
Query: 521 ADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKR-LSRNS 578
           A + D +E P  D          +    K+GQG FG V+K R  + GQ++A+K+ L  N 
Sbjct: 3   AKQYDSVECPFCD------EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE 56
Query: 579 GQGIE-EFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM--------LVYEYMENRSLDSVI 629
            +G       E++++  L+H N+V L+  C               LV+++ E+  L  ++
Sbjct: 57  KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL 115
Query: 630 FDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
            +      L+  +R  ++  +  GL Y+H   R +I+HRD+KA+N+L+ ++   K++DFG
Sbjct: 116 SNVLVKFTLSEIKR--VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG 170
Query: 690 MARIFGGDQTEQNTK---RVV 707
           +AR F   +  Q  +   RVV
Sbjct: 171 LARAFSLAKNSQPNRYXNRVV 191

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 83/156 (53%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G FG VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + +      +   I+  + YL + +
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN 129
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               IHRDL A N L+ +    K++DFG++R+  GD
Sbjct: 130 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 162

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 80/160 (50%), Gaps = 12/160 (7%)
Query: 550 LGQGGFGIVYKGRLLEGQE-----IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LG G FG VYKG  +   E     +A+K L  N S +  +E  +E  ++A +    + RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           LG C+    +++         LD V  ++ R   L  Q   N    IA+G+ YL      
Sbjct: 85  LGICLTSTVQLVTQLMPYGCLLDHVRENRGR---LGSQDLLNWCMQIAKGMSYLED---V 138
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
           R++HRDL A N+L+      KI+DFG+AR+   D+TE + 
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA 178

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 549 KLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 604 LGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            G C     +   L+ EY+   SL D +   K R   +   +  + IC   +G+ YL   
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC---KGMEYLGTK 164
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
              R IHRDL   NIL++ E   KI DFG+ ++   D+     K
Sbjct: 165 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 205

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 549 KLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 604 LGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            G C     +   L+ EY+   SL D +   K R   +   +  + IC   +G+ YL   
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC---KGMEYLGTK 133
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
              R IHRDL   NIL++ E   KI DFG+ ++   D+     K
Sbjct: 134 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 174

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 85/159 (53%), Gaps = 14/159 (8%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLS-RNSGQGIEEFK-NEVRLIAKLQHRN 599
           + +    K+G+G +G+VYK +   G+  A+K++      +GI      E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 600 LVRLLGCCVEMDEKMLVYEYMEN---RSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           +V+L          +LV+E+++    + LD  + +    S+        ++ GIA    Y
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIA----Y 115
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
            H     R++HRDLK  N+L+++E   KI+DFG+AR FG
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG 151

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 89/174 (51%), Gaps = 13/174 (7%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    +++         LD V   +     +  Q   N    I
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 126
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 89/174 (51%), Gaps = 13/174 (7%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    +++         LD V   +     +  Q   N    I
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 128
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +
Sbjct: 129 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 179

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 89/174 (51%), Gaps = 13/174 (7%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 5   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    +++         LD V   +     +  Q   N    I
Sbjct: 64  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 120
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +
Sbjct: 121 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 85/159 (53%), Gaps = 14/159 (8%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLS-RNSGQGIEEFK-NEVRLIAKLQHRN 599
           + +    K+G+G +G+VYK +   G+  A+K++      +GI      E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 600 LVRLLGCCVEMDEKMLVYEYMEN---RSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           +V+L          +LV+E+++    + LD  + +    S+        ++ GIA    Y
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIA----Y 115
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
            H     R++HRDLK  N+L+++E   KI+DFG+AR FG
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG 151

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 76/146 (52%), Gaps = 6/146 (4%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ K++H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E +   +V EYM   SL   +  +     L   +  ++   IA G+ Y+    R   +HR
Sbjct: 84  E-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 669 DLKASNILLDKEMTPKISDFGMARIF 694
           DL+A+NIL+ + +  K++DFG+AR+ 
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI 164

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 85/159 (53%), Gaps = 14/159 (8%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLS-RNSGQGIEEFK-NEVRLIAKLQHRN 599
           + +    K+G+G +G+VYK +   G+  A+K++      +GI      E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 600 LVRLLGCCVEMDEKMLVYEYMEN---RSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           +V+L          +LV+E+++    + LD  + +    S+        ++ GIA    Y
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIA----Y 115
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
            H     R++HRDLK  N+L+++E   KI+DFG+AR FG
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG 151

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 89/174 (51%), Gaps = 13/174 (7%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    +++         LD V   +     +  Q   N    I
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 129
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +
Sbjct: 130 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 549 KLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 604 LGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            G C     +   L+ EY+   SL D +   K R   +   +  + IC   +G+ YL   
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC---KGMEYLGTK 140
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
              R IHRDL   NIL++ E   KI DFG+ ++   D+     K
Sbjct: 141 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 181

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 89/174 (51%), Gaps = 13/174 (7%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 17  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 75
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    +++         LD V   +     +  Q   N    I
Sbjct: 76  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 132
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +
Sbjct: 133 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 183

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 89/174 (51%), Gaps = 13/174 (7%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    +++         LD V   +     +  Q   N    I
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 129
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +
Sbjct: 130 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 89/174 (51%), Gaps = 13/174 (7%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    +++         LD V   +     +  Q   N    I
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 129
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +
Sbjct: 130 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 549 KLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 21  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 604 LGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            G C     +   L+ EY+   SL D +   K R   +   +  + IC   +G+ YL   
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC---KGMEYLGTK 137
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
              R IHRDL   NIL++ E   KI DFG+ ++   D+     K
Sbjct: 138 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 178

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 549 KLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 604 LGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            G C     +   L+ EY+   SL D +   K R   +   +  + IC   +G+ YL   
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC---KGMEYLGTK 132
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
              R IHRDL   NIL++ E   KI DFG+ ++   D+     K
Sbjct: 133 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 173

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 90/177 (50%), Gaps = 19/177 (10%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 21  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 79
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNII 647
           ++A + + ++ RLLG C+    +++         LD V   K       +LNW       
Sbjct: 80  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 133
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
             IA+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +
Sbjct: 134 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 187

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 82/164 (50%), Gaps = 14/164 (8%)
Query: 549 KLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R        G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 604 LGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            G C     +   L+ EY+   SL D +   K R   +   +  + IC   +G+ YL   
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC---KGMEYLGTK 138
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
              R IHRDL   NIL++ E   KI DFG+ ++   D+     K
Sbjct: 139 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 179

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 549 KLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 604 LGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            G C     +   L+ EY+   SL D +   K R   +   +  + IC   +G+ YL   
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC---KGMEYLGTK 139
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
              R IHRDL   NIL++ E   KI DFG+ ++   D+     K
Sbjct: 140 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 180

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 82/164 (50%), Gaps = 14/164 (8%)
Query: 549 KLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R        G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 604 LGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            G C     +   L+ EY+   SL D +   K R   +   +  + IC   +G+ YL   
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC---KGMEYLGTK 136
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
              R IHRDL   NIL++ E   KI DFG+ ++   D+     K
Sbjct: 137 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 177

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 549 KLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 15  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 604 LGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            G C     +   L+ EY+   SL D +   K R   +   +  + IC   +G+ YL   
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC---KGMEYLGTK 131
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
              R IHRDL   NIL++ E   KI DFG+ ++   D+     K
Sbjct: 132 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 172

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 90/177 (50%), Gaps = 19/177 (10%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 18  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNII 647
           ++A + + ++ RLLG C+    +++         LD V   K       +LNW       
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 130
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
             IA+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +
Sbjct: 131 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 184

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 80/166 (48%), Gaps = 11/166 (6%)
Query: 548 NKLGQGGFGIVYKGR-LLEGQEIAVKRL---SRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +KLG GG   VY     +   ++A+K +    R   + ++ F+ EV   ++L H+N+V +
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           +    E D   LV EY+E  +L   I        L+     N    I  G+ + H     
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHD---M 130
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           RI+HRD+K  NIL+D   T KI DFG+A+        Q T  V+GT
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGT 175

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 549 KLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 604 LGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            G C     +   L+ EY+   SL D +   K R   +   +  + IC   +G+ YL   
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC---KGMEYLGTK 133
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
              R IHRDL   NIL++ E   KI DFG+ ++   D+     K
Sbjct: 134 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 174

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 6/157 (3%)
Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           LG+G FG   K    E G+ + +K L R   +    F  EV+++  L+H N+++ +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           +      + EY++  +L  +I  K+  S   W +R +    IA G+ YLH      IIHR
Sbjct: 78  KDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           DL + N L+ +     ++DFG+AR+   ++T+    R
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 90/177 (50%), Gaps = 19/177 (10%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNII 647
           ++A + + ++ RLLG C+    +++         LD V   K       +LNW       
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 123
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
             IA+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 83/156 (53%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + +      +   I+  + YL + +
Sbjct: 71  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN 129
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               IHRDL A N L+ +    K++DFG++R+  GD
Sbjct: 130 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 162

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 82/171 (47%), Gaps = 24/171 (14%)
Query: 538 VRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ 596
           +R   +F +   LGQG FG V K R  L+ +  A+K++ R++ + +    +EV L+A L 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLN 60
Query: 597 H-------------RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR- 642
           H             RN V+ +    +     +  EY EN +L    +D   S  LN QR 
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRD 116
Query: 643 -RFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             + +   I   L Y+H      IIHRDLK  NI +D+    KI DFG+A+
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 75/146 (51%), Gaps = 6/146 (4%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E +   +V EYM    L   +  +     L   +  ++   IA G+ Y+    R   +HR
Sbjct: 84  E-EPIYIVMEYMSKGCLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 669 DLKASNILLDKEMTPKISDFGMARIF 694
           DL+A+NIL+ + +  K++DFG+AR+ 
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI 164

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 75/146 (51%), Gaps = 6/146 (4%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E +   +V EYM    L   +  +     L   +  ++   IA G+ Y+    R   +HR
Sbjct: 84  E-EPIYIVTEYMSKGCLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 669 DLKASNILLDKEMTPKISDFGMARIF 694
           DL+A+NIL+ + +  K++DFG+AR+ 
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI 164

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 83/156 (53%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + +      +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               IHRDL A N L+ +    K++DFG++R+  GD
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 83/156 (53%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + +      +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN 131
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               IHRDL A N L+ +    K++DFG++R+  GD
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 83/158 (52%), Gaps = 14/158 (8%)
Query: 549 KLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 604 LGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            G C     +   L+ EY+   SL D +   K R   +   +  + IC   +G+ YL   
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC---KGMEYLGTK 133
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              R IHRDL   NIL++ E   KI DFG+ ++   D+
Sbjct: 134 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 83/156 (53%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + +      +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN 131
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               IHRDL A N L+ +    K++DFG++R+  GD
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 78/152 (51%), Gaps = 12/152 (7%)
Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLS----RNSGQGIEEFK-NEVRLIAKLQHRNLVRL 603
           LG+G F  VYK R     Q +A+K++       +  GI      E++L+ +L H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           L          LV+++ME    D  +  K  S +L        +    +GL YLHQ    
Sbjct: 78  LDAFGHKSNISLVFDFMET---DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 132
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
            I+HRDLK +N+LLD+    K++DFG+A+ FG
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 83/156 (53%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 318
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 319 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 377
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               IHR+L A N L+ +    K++DFG++R+  GD
Sbjct: 378 ---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 410

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 83/156 (53%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + +      +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN 131
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               IHRDL A N L+ +    K++DFG++R+  GD
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 83/156 (53%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + +      +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN 131
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               IHRDL A N L+ +    K++DFG++R+  GD
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 88/174 (50%), Gaps = 13/174 (7%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 8   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    +++         LD V   +     +  Q   N    I
Sbjct: 67  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
           A G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +
Sbjct: 124 AEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 174

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 83/156 (53%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + +      +   I+  + YL + +
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN 129
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               IHRDL A N L+ +    K++DFG++R+  GD
Sbjct: 130 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 162

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 90/177 (50%), Gaps = 19/177 (10%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNII 647
           ++A + + ++ RLLG C+    ++++        LD V   K       +LNW       
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------C 125
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
             IA+G+ YL      R++HRDL A N+L+      KI+DFG A++ G ++ E + +
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 179

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 90/177 (50%), Gaps = 19/177 (10%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNII 647
           ++A + + ++ RLLG C+    ++++        LD V   K       +LNW       
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------C 125
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
             IA+G+ YL      R++HRDL A N+L+      KI+DFG A++ G ++ E + +
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 179

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 90/177 (50%), Gaps = 19/177 (10%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 15  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNII 647
           ++A + + ++ RLLG C+    ++++        LD V   K       +LNW       
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------C 127
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
             IA+G+ YL      R++HRDL A N+L+      KI+DFG A++ G ++ E + +
Sbjct: 128 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 181

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 88/153 (57%), Gaps = 16/153 (10%)
Query: 549 KLGQGGFGIVYKG-RLLEGQEIAVKRLS---RNSGQGIEEFKNEVRLIAKLQ-HRNLVRL 603
           KLG+G +GIV+K      G+ +AVK++    +NS      F+ E+ ++ +L  H N+V L
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNL 74
Query: 604 LGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           L      +++   LV++YME   L +VI    R++IL    +  ++  + + + YLH   
Sbjct: 75  LNVLRADNDRDVYLVFDYMET-DLHAVI----RANILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
              ++HRD+K SNILL+ E   K++DFG++R F
Sbjct: 130 ---LLHRDMKPSNILLNAECHVKVADFGLSRSF 159

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 84/164 (51%), Gaps = 12/164 (7%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQ-GIE-EFKNEVRLIAKLQ 596
           AT  +    ++G G +G VYK R    G  +A+K +   +G+ G+      EV L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 597 ---HRNLVRLLGCCV--EMDEKMLVYEYMENRSLD-SVIFDKARSSILNWQRRFNIICGI 650
              H N+VRL+  C     D ++ V    E+   D     DKA    L  +   +++   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
            RGL +LH +    I+HRDLK  NIL+    T K++DFG+ARI+
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 162

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 75/143 (52%), Gaps = 6/143 (4%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE 609
           +G+G FG+V K +    +++A+K++   S +  + F  E+R ++++ H N+V+L G C  
Sbjct: 17  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC-- 71
Query: 610 MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRD 669
           ++   LV EY E  SL +V+               +     ++G+ YLH      +IHRD
Sbjct: 72  LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 131
Query: 670 LKASNILLDKEMTP-KISDFGMA 691
           LK  N+LL    T  KI DFG A
Sbjct: 132 LKPPNLLLVAGGTVLKICDFGTA 154

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 89/177 (50%), Gaps = 19/177 (10%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNII 647
           ++A + + ++ RLLG C+    +++         LD V   K       +LNW       
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 125
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
             IA+G+ YL      R++HRDL A N+L+      KI+DFG A++ G ++ E + +
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 179

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 84/164 (51%), Gaps = 12/164 (7%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQ-GIE-EFKNEVRLIAKLQ 596
           AT  +    ++G G +G VYK R    G  +A+K +   +G+ G+      EV L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 597 ---HRNLVRLLGCCV--EMDEKMLVYEYMENRSLD-SVIFDKARSSILNWQRRFNIICGI 650
              H N+VRL+  C     D ++ V    E+   D     DKA    L  +   +++   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
            RGL +LH +    I+HRDLK  NIL+    T K++DFG+ARI+
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 162

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 90/172 (52%), Gaps = 19/172 (11%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLLE--GQEIAVKRLSRNSGQ------GIEEFKNE 588
           + RA   +    ++G+G +G V+K R L+  G+ +A+KR+   +G+       I E    
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV- 64
Query: 589 VRLIAKLQHRNLVRLLGCCV----EMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRR 643
           +R +   +H N+VRL   C     + + K+ LV+E+++     +   DK     +  +  
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL--TTYLDKVPEPGVPTETI 122
Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
            +++  + RGL +LH     R++HRDLK  NIL+      K++DFG+ARI+ 
Sbjct: 123 KDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 30/167 (17%)
Query: 549 KLGQGGFGIVY----------KGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR 598
           +LG+G FG V+          K ++L    +AVK L   +    ++F+ E  L+  LQH 
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKML----VAVKALKDPTLAARKDFQREAELLTNLQHE 77
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-------------LNWQRRFN 645
           ++V+  G C + D  ++V+EYM++  L+  +      ++             L   +  +
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           I   IA G++YL        +HRDL   N L+   +  KI DFGM+R
Sbjct: 138 IASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR 181

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 84/164 (51%), Gaps = 12/164 (7%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQ-GIE-EFKNEVRLIAKLQ 596
           AT  +    ++G G +G VYK R    G  +A+K +   +G+ G+      EV L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 597 ---HRNLVRLLGCCV--EMDEKMLVYEYMENRSLD-SVIFDKARSSILNWQRRFNIICGI 650
              H N+VRL+  C     D ++ V    E+   D     DKA    L  +   +++   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
            RGL +LH +    I+HRDLK  NIL+    T K++DFG+ARI+
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 162

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 89/177 (50%), Gaps = 19/177 (10%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNII 647
           ++A + + ++ RLLG C+    +++         LD V   K       +LNW       
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 123
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
             IA+G+ YL      R++HRDL A N+L+      KI+DFG A++ G ++ E + +
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 177

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 75/143 (52%), Gaps = 6/143 (4%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE 609
           +G+G FG+V K +    +++A+K++   S +  + F  E+R ++++ H N+V+L G C  
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC-- 70
Query: 610 MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRD 669
           ++   LV EY E  SL +V+               +     ++G+ YLH      +IHRD
Sbjct: 71  LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 670 LKASNILLDKEMTP-KISDFGMA 691
           LK  N+LL    T  KI DFG A
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTA 153

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 89/177 (50%), Gaps = 19/177 (10%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 18  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNII 647
           ++A + + ++ RLLG C+    +++         LD V   K       +LNW       
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 130
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
             IA+G+ YL      R++HRDL A N+L+      KI+DFG A++ G ++ E + +
Sbjct: 131 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 184

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 81/163 (49%), Gaps = 12/163 (7%)
Query: 549 KLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 604 LGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            G C     +   L+ E++   SL   +  +     ++  +       I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKLLQYTSQICKGMEYLGTK- 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
             R IHRDL   NIL++ E   KI DFG+ ++   D+     K
Sbjct: 137 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 177

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 74/147 (50%), Gaps = 6/147 (4%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG V+ G      ++A+K L   +    E F  E +++ KL+H  LV+L    
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
            E +   +V EYM   SL   + D      L      ++   +A G+ Y+    R   IH
Sbjct: 74  SE-EPIYIVTEYMNKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 128
Query: 668 RDLKASNILLDKEMTPKISDFGMARIF 694
           RDL+++NIL+   +  KI+DFG+AR+ 
Sbjct: 129 RDLRSANILVGNGLICKIADFGLARLI 155

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 90/182 (49%), Gaps = 16/182 (8%)
Query: 517 RDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQE----IAVK 572
           RD  +    +++  L   E +V  +D       +G+G FG+VY G  ++  +     A+K
Sbjct: 1   RDLDSALLAEVKDVLIPHERVVTHSDRV-----IGKGHFGVVYHGEYIDQAQNRIQCAIK 55
Query: 573 RLSR-NSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE-KMLVYEYMENRSLDSVIF 630
            LSR    Q +E F  E  L+  L H N++ L+G  +  +    ++  YM +  L   I 
Sbjct: 56  SLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR 115
Query: 631 DKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM 690
              R+  +     F +   +ARG+ YL +    + +HRDL A N +LD+  T K++DFG+
Sbjct: 116 SPQRNPTVKDLISFGL--QVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGL 170
Query: 691 AR 692
           AR
Sbjct: 171 AR 172

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 90/172 (52%), Gaps = 19/172 (11%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLLE--GQEIAVKRLSRNSGQ------GIEEFKNE 588
           + RA   +    ++G+G +G V+K R L+  G+ +A+KR+   +G+       I E    
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV- 64
Query: 589 VRLIAKLQHRNLVRLLGCCV----EMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRR 643
           +R +   +H N+VRL   C     + + K+ LV+E+++     +   DK     +  +  
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL--TTYLDKVPEPGVPTETI 122
Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
            +++  + RGL +LH     R++HRDLK  NIL+      K++DFG+ARI+ 
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 90/177 (50%), Gaps = 19/177 (10%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     L  G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 18  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNII 647
           ++A + + ++ RLLG C+    ++++        LD V   K       +LNW       
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------C 130
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
             IA+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +
Sbjct: 131 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 184

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 90/172 (52%), Gaps = 19/172 (11%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLLE--GQEIAVKRLSRNSGQ------GIEEFKNE 588
           + RA   +    ++G+G +G V+K R L+  G+ +A+KR+   +G+       I E    
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV- 64
Query: 589 VRLIAKLQHRNLVRLLGCCV----EMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRR 643
           +R +   +H N+VRL   C     + + K+ LV+E+++     +   DK     +  +  
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL--TTYLDKVPEPGVPTETI 122
Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
            +++  + RGL +LH     R++HRDLK  NIL+      K++DFG+ARI+ 
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 89/177 (50%), Gaps = 19/177 (10%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     L  G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 11  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNII 647
           ++A + + ++ RLLG C+    +++         LD V   K       +LNW       
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 123
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
             IA+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 83/156 (53%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 279
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  +      + +   I+  + YL + +
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-MATQISSAMEYLEKKN 338
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               IHR+L A N L+ +    K++DFG++R+  GD
Sbjct: 339 ---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 95/184 (51%), Gaps = 15/184 (8%)
Query: 531 LFDFETIVRATD---NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFK 586
           L    +IV   D    +T + K+GQG  G VY    +  GQE+A+++++       E   
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 587 NEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI 646
           NE+ ++ + ++ N+V  L   +  DE  +V EY+   SL  V+ +         + +   
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAA 120
Query: 647 IC-GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +C    + L +LH +   ++IHRD+K+ NILL  + + K++DFG       +Q++++T  
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-- 175
Query: 706 VVGT 709
           +VGT
Sbjct: 176 MVGT 179

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 21/161 (13%)
Query: 550 LGQGGFGIVYKGRLLEG---QEIAVKRLSR-NSGQGIEEFKNEVRLIAKL-QHRNLVRLL 604
           +G+G FG V K R+ +     + A+KR+    S     +F  E+ ++ KL  H N++ LL
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 605 GCCVEMDEKMLVYEYMENRSL-------------DSVIFDKARSSILNWQRRFNIICGIA 651
           G C       L  EY  + +L              +     + +S L+ Q+  +    +A
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           RG+ YL Q    + IHRDL A NIL+ +    KI+DFG++R
Sbjct: 153 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 190

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 19/198 (9%)
Query: 516 KRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI----A 570
           +R+     T   E P      I++ T+ F     LG G FG VYKG  + EG+++    A
Sbjct: 24  ERELVEPLTPSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVA 82
Query: 571 VKRLSR-NSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI 629
           +  L    S +  +E  +E  ++A + + ++ RLLG C+    +++         LD V 
Sbjct: 83  IMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR 142
Query: 630 FDK---ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKIS 686
             K       +LNW         IA+G+ YL      R++HRDL A N+L+      KI+
Sbjct: 143 EHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT 193
Query: 687 DFGMARIFGGDQTEQNTK 704
           DFG+A++ G ++ E + +
Sbjct: 194 DFGLAKLLGAEEKEYHAE 211

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 89/177 (50%), Gaps = 19/177 (10%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     L  G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 18  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNII 647
           ++A + + ++ RLLG C+    +++         LD V   K       +LNW       
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 130
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
             IA+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +
Sbjct: 131 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 184

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 21/161 (13%)
Query: 550 LGQGGFGIVYKGRLLEG---QEIAVKRLSR-NSGQGIEEFKNEVRLIAKL-QHRNLVRLL 604
           +G+G FG V K R+ +     + A+KR+    S     +F  E+ ++ KL  H N++ LL
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 605 GCCVEMDEKMLVYEYMENRSL-------------DSVIFDKARSSILNWQRRFNIICGIA 651
           G C       L  EY  + +L              +     + +S L+ Q+  +    +A
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           RG+ YL Q    + IHRDL A NIL+ +    KI+DFG++R
Sbjct: 143 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 180

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            KLG G FG V+     +  ++AVK +   S   +E F  E  ++  LQH  LV+L    
Sbjct: 188 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAV 245
Query: 608 VEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ E+M   SL D +  D+     L   +  +    IA G+ ++ Q +    I
Sbjct: 246 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YI 300
Query: 667 HRDLKASNILLDKEMTPKISDFGMARI 693
           HRDL+A+NIL+   +  KI+DFG+AR+
Sbjct: 301 HRDLRAANILVSASLVCKIADFGLARV 327

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 75/147 (51%), Gaps = 7/147 (4%)
Query: 548 NKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRNLVRLLG 605
            ++G+G FG V+ GRL  +   +AVK         ++ +F  E R++ +  H N+VRL+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
            C +     +V E ++    D + F +   + L  +    ++   A G+ YL        
Sbjct: 180 VCTQKQPIYIVMELVQGG--DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 666 IHRDLKASNILLDKEMTPKISDFGMAR 692
           IHRDL A N L+ ++   KISDFGM+R
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 89/171 (52%), Gaps = 19/171 (11%)
Query: 551 GQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC---- 606
            +G FG V+K +LL  + +AVK       Q  +  + EV  +  ++H N+++ +G     
Sbjct: 33  ARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRG 90
Query: 607 -CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD----- 660
             V++D   L+  + E  SL     D  ++++++W    +I   +ARGL YLH+D     
Sbjct: 91  TSVDVD-LWLITAFHEKGSLS----DFLKANVVSWNELCHIAETMARGLAYLHEDIPGLK 145
Query: 661 --SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
              +  I HRD+K+ N+LL   +T  I+DFG+A  F   ++  +T   VGT
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGT 196

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 75/147 (51%), Gaps = 7/147 (4%)
Query: 548 NKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRNLVRLLG 605
            ++G+G FG V+ GRL  +   +AVK         ++ +F  E R++ +  H N+VRL+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
            C +     +V E ++    D + F +   + L  +    ++   A G+ YL        
Sbjct: 180 VCTQKQPIYIVMELVQGG--DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 666 IHRDLKASNILLDKEMTPKISDFGMAR 692
           IHRDL A N L+ ++   KISDFGM+R
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 81/149 (54%), Gaps = 11/149 (7%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCV 608
           +G G +G VYKGR ++  ++A  ++   +G   EE K E+ ++ K   HRN+    G  +
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 609 E-----MDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           +     MD+++ LV E+    S+  +I +  + + L  +    I   I RGL +LHQ   
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLHQ--- 147
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMA 691
            ++IHRD+K  N+LL +    K+ DFG++
Sbjct: 148 HKVIHRDIKGQNVLLTENAEVKLVDFGVS 176

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 8/152 (5%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            KLG G FG V+     +  ++AVK +   S   +E F  E  ++  LQH  LV+L    
Sbjct: 21  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAV 78
Query: 608 VEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ E+M   SL D +  D+     L   +  +    IA G+ ++ Q +    I
Sbjct: 79  VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YI 133
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           HRDL+A+NIL+   +  KI+DFG+AR+   ++
Sbjct: 134 HRDLRAANILVSASLVCKIADFGLARVIEDNE 165

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 76/148 (51%), Gaps = 8/148 (5%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            KLG G FG V+     +  ++AVK +   S   +E F  E  ++  LQH  LV+L    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAV 251
Query: 608 VEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ E+M   SL D +  D+     L   +  +    IA G+ ++ Q +    I
Sbjct: 252 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YI 306
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIF 694
           HRDL+A+NIL+   +  KI+DFG+AR+ 
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVI 334

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 83/158 (52%), Gaps = 14/158 (8%)
Query: 549 KLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 604 LGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            G C     +   L+ EY+   SL D +   K R   +   +  + IC   +G+ YL   
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC---KGMEYLGTK 134
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              R IHR+L   NIL++ E   KI DFG+ ++   D+
Sbjct: 135 ---RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDK 169

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 9/155 (5%)
Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRN 599
           N+     +G+G F  V   R +L G+E+A+K + +   +   +++   EVR++  L H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V+L           L+ EY     +   +    R      + +F  I    +   Y HQ
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCHQ 129
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
               RI+HRDLKA N+LLD +M  KI+DFG +  F
Sbjct: 130 K---RIVHRDLKAENLLLDADMNIKIADFGFSNEF 161

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 74/149 (49%), Gaps = 5/149 (3%)
Query: 550 LGQGGFGIVYKGRLLEGQ-EIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           LG+G +GIVY GR L  Q  IA+K +     +  +    E+ L   L+H+N+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E     +  E +   SL +++  K      N Q        I  GL YLH +   +I+HR
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146
Query: 669 DLKASNILLDK-EMTPKISDFGMARIFGG 696
           D+K  N+L++      KISDFG ++   G
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAG 175

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 83/163 (50%), Gaps = 13/163 (7%)
Query: 550 LGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRL 603
           LG+G FG V   R        G+++AVK L   SG   I + K E+ ++  L H N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 604 LGCCVE--MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            G C E   +   L+ E++ + SL   +  K ++ I N +++      I +G+ YL   S
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKI-NLKQQLKYAVQICKGMDYL--GS 144
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
           R + +HRDL A N+L++ E   KI DFG+ +    D+     K
Sbjct: 145 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVK 186

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 87/162 (53%), Gaps = 11/162 (6%)
Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKR-LSRNSGQGIEEFK-NEVRLIAKL 595
           ++ + + +   +G+G +G+V K R  + G+ +A+K+ L  +  + +++    E++L+ +L
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGL 654
           +H NLV LL  C +     LV+E++++  LD + +F       +  +  F II GI  G 
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI--GF 139
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
            + H      IIHRD+K  NIL+ +    K+ DFG AR    
Sbjct: 140 CHSHN-----IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRN 599
           N+     +G+G F  V   R +L G+E+AVK + +   +   +++   EVR++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V+L           LV EY     +   +    R      + +F  I    +   Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQ 131
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
             +F I+HRDLKA N+LLD +M  KI+DFG +  F
Sbjct: 132 --KF-IVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRN 599
           N+     +G+G F  V   R +L G+E+AVK + +   +   +++   EVR++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V+L           LV EY     +   +    R      + +F  I    +   Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQ 131
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
             +F I+HRDLKA N+LLD +M  KI+DFG +  F
Sbjct: 132 --KF-IVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHR 598
           + +   +KLG+G +  VYKG+  L    +A+K  RL    G      + EV L+  L+H 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHA 60
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
           N+V L           LV+EY+ ++ L   + D    +I+N       +  + RGL Y H
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCH 117
Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              R +++HRDLK  N+L+++    K++DFG+AR
Sbjct: 118 ---RQKVLHRDLKPQNLLINERGELKLADFGLAR 148

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           + T   +LG G FG+V  G+     ++A+K +   S    +EF  E +++  L H  LV+
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C +     ++ EYM N  L + +  +        Q+   +   +   + YL     
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK-- 139
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
            + +HRDL A N L++ +   K+SDFG++R    D+
Sbjct: 140 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           + T   +LG G FG+V  G+     ++A+K +   S    +EF  E +++  L H  LV+
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C +     ++ EYM N  L + +  +        Q+   +   +   + YL     
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK-- 139
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
            + +HRDL A N L++ +   K+SDFG++R    D+
Sbjct: 140 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 9/155 (5%)
Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRN 599
           N+     +G+G F  V   R +L G+E+A+K + +   +   +++   EVR++  L H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V+L           L+ EY     +   +    R      + +F  I    +   Y HQ
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCHQ 132
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
               RI+HRDLKA N+LLD +M  KI+DFG +  F
Sbjct: 133 K---RIVHRDLKAENLLLDADMNIKIADFGFSNEF 164

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 74/149 (49%), Gaps = 5/149 (3%)
Query: 550 LGQGGFGIVYKGRLLEGQ-EIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           LG+G +GIVY GR L  Q  IA+K +     +  +    E+ L   L+H+N+V+ LG   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E     +  E +   SL +++  K      N Q        I  GL YLH +   +I+HR
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 132
Query: 669 DLKASNILLDK-EMTPKISDFGMARIFGG 696
           D+K  N+L++      KISDFG ++   G
Sbjct: 133 DIKGDNVLINTYSGVLKISDFGTSKRLAG 161

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRN 599
           N+     +G+G F  V   R +L G+E+AVK + +   +   +++   EVR++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V+L           LV EY     +   +    R      + +F  I    +   Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQ 131
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
             +F I+HRDLKA N+LLD +M  KI+DFG +  F
Sbjct: 132 --KF-IVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 77/145 (53%), Gaps = 8/145 (5%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAV-KRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           +LG G FG VYK +  E   +A  K +   S + +E++  E+ ++A   H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICG-IARGLLYLHQDSRFRII 666
              +   ++ E+    ++D+V+ +  R      + +  ++C      L YLH +   +II
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLHDN---KII 157
Query: 667 HRDLKASNILLDKEMTPKISDFGMA 691
           HRDLKA NIL   +   K++DFG++
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 77/145 (53%), Gaps = 8/145 (5%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAV-KRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           +LG G FG VYK +  E   +A  K +   S + +E++  E+ ++A   H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICG-IARGLLYLHQDSRFRII 666
              +   ++ E+    ++D+V+ +  R      + +  ++C      L YLH +   +II
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLHDN---KII 157
Query: 667 HRDLKASNILLDKEMTPKISDFGMA 691
           HRDLKA NIL   +   K++DFG++
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 77/145 (53%), Gaps = 8/145 (5%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAV-KRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           +LG G FG VYK +  E   +A  K +   S + +E++  E+ ++A   H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICG-IARGLLYLHQDSRFRII 666
              +   ++ E+    ++D+V+ +  R      + +  ++C      L YLH +   +II
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLHDN---KII 157
Query: 667 HRDLKASNILLDKEMTPKISDFGMA 691
           HRDLKA NIL   +   K++DFG++
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 83/163 (50%), Gaps = 13/163 (7%)
Query: 550 LGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRL 603
           LG+G FG V   R        G+++AVK L   SG   I + K E+ ++  L H N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 604 LGCCVE--MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            G C E   +   L+ E++ + SL   +  K ++ I N +++      I +G+ YL   S
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKI-NLKQQLKYAVQICKGMDYL--GS 132
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
           R + +HRDL A N+L++ E   KI DFG+ +    D+     K
Sbjct: 133 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVK 174

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 78/145 (53%), Gaps = 8/145 (5%)
Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           +LG G FG VYK +  E G   A K +   S + +E++  E+ ++A   H  +V+LLG  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-GIARGLLYLHQDSRFRII 666
               +  ++ E+    ++D+++ +  R      + +  ++C  +   L +LH     RII
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEALNFLHSK---RII 131
Query: 667 HRDLKASNILLDKEMTPKISDFGMA 691
           HRDLKA N+L+  E   +++DFG++
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVS 156

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           + T   +LG G FG+V  G+     ++A+K +   S    +EF  E +++  L H  LV+
Sbjct: 9   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 67
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C +     ++ EYM N  L + +  +        Q+   +   +   + YL     
Sbjct: 68  LYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK-- 123
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
            + +HRDL A N L++ +   K+SDFG++R    D+
Sbjct: 124 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 158

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           + T   +LG G FG+V  G+     ++A+K +   S    +EF  E +++  L H  LV+
Sbjct: 16  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 74
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C +     ++ EYM N  L + +  +        Q+   +   +   + YL     
Sbjct: 75  LYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK-- 130
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
            + +HRDL A N L++ +   K+SDFG++R    D+
Sbjct: 131 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 165

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/164 (33%), Positives = 82/164 (50%), Gaps = 15/164 (9%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLS-RNSGQGIEEFK-NEVRLIAKLQ 596
           + D +    KLG+G +G VYK    +  + +A+KR+   +  +G+      EV L+ +LQ
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ 91
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           HRN++ L           L++EY EN        DK     +   + F  +  +  G+ +
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYAENDL--KKYMDKNPDVSMRVIKSF--LYQLINGVNF 147
Query: 657 LHQDSRFRIIHRDLKASNILL---DKEMTP--KISDFGMARIFG 695
            H  SR R +HRDLK  N+LL   D   TP  KI DFG+AR FG
Sbjct: 148 CH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 94/186 (50%), Gaps = 19/186 (10%)
Query: 531 LFDFETIVRATD---NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFK 586
           L    +IV   D    +T + K+GQG  G VY    +  GQE+A+++++       E   
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 587 NEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI 646
           NE+ ++ + ++ N+V  L   +  DE  +V EY+   SL  V+ +         + +   
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAA 120
Query: 647 IC-GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +C    + L +LH +   ++IHRD+K+ NILL  + + K++DFG    F    T + +KR
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKR 173
Query: 706 --VVGT 709
             +VGT
Sbjct: 174 SXMVGT 179

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 94/186 (50%), Gaps = 19/186 (10%)
Query: 531 LFDFETIVRATD---NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFK 586
           L    +IV   D    +T + K+GQG  G VY    +  GQE+A+++++       E   
Sbjct: 7   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 66
Query: 587 NEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI 646
           NE+ ++ + ++ N+V  L   +  DE  +V EY+   SL  V+ +         + +   
Sbjct: 67  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAA 121
Query: 647 IC-GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +C    + L +LH +   ++IHRD+K+ NILL  + + K++DFG    F    T + +KR
Sbjct: 122 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKR 174
Query: 706 --VVGT 709
             +VGT
Sbjct: 175 SXMVGT 180

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 94/186 (50%), Gaps = 19/186 (10%)
Query: 531 LFDFETIVRATD---NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFK 586
           L    +IV   D    +T + K+GQG  G VY    +  GQE+A+++++       E   
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 587 NEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI 646
           NE+ ++ + ++ N+V  L   +  DE  +V EY+   SL  V+ +         + +   
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAA 120
Query: 647 IC-GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +C    + L +LH +   ++IHRD+K+ NILL  + + K++DFG    F    T + +KR
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKR 173
Query: 706 --VVGT 709
             +VGT
Sbjct: 174 SEMVGT 179

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           + T   +LG G FG+V  G+     ++A+K +   S    +EF  E +++  L H  LV+
Sbjct: 10  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 68
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C +     ++ EYM N  L + +  +        Q+   +   +   + YL     
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK-- 124
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
            + +HRDL A N L++ +   K+SDFG++R    D+
Sbjct: 125 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 159

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           + T   +LG G FG+V  G+     ++A+K +   S    +EF  E +++  L H  LV+
Sbjct: 10  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 68
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C +     ++ EYM N  L + +  +        Q+   +   +   + YL     
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK-- 124
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
            + +HRDL A N L++ +   K+SDFG++R    D+
Sbjct: 125 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 159

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 78/145 (53%), Gaps = 8/145 (5%)
Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           +LG G FG VYK +  E G   A K +   S + +E++  E+ ++A   H  +V+LLG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-GIARGLLYLHQDSRFRII 666
               +  ++ E+    ++D+++ +  R      + +  ++C  +   L +LH     RII
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEALNFLHSK---RII 139
Query: 667 HRDLKASNILLDKEMTPKISDFGMA 691
           HRDLKA N+L+  E   +++DFG++
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVS 164

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 6/156 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           + T   +LG G FG+V  G+     ++A+K +   S    +EF  E +++  L H  LV+
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C +     ++ EYM N  L + +  +        Q+   +   +   + YL     
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK-- 119
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
            + +HRDL A N L++ +   K+SDFG++R    D+
Sbjct: 120 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 79/168 (47%), Gaps = 15/168 (8%)
Query: 536 TIVRATD------NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRN--SGQGIEEFK 586
           +I  ATD      N+     +G+G F  V   R +L G+E+AVK + +   +   +++  
Sbjct: 3   SITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLF 62
Query: 587 NEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI 646
            EVR++  L H N+V+L           LV EY     +   +    R      + +F  
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 122
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
           I    +   Y HQ     I+HRDLKA N+LLD +M  KI+DFG +  F
Sbjct: 123 IVSAVQ---YCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEF 164

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 15/158 (9%)
Query: 543 NFTDYNKLGQGGFGIVYKG-RLLEGQEIAVK-----RLSRNSGQGIEEFKNEVRLIAKLQ 596
           N+     LG+G FG V        GQ++A+K      L+++  QG    + E+  +  L+
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 71
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           H ++++L       DE ++V EY  N   D ++     S      RRF     I   + Y
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE--QEARRF--FQQIISAVEY 127
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
            H   R +I+HRDLK  N+LLD+ +  KI+DFG++ I 
Sbjct: 128 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 162

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 15/158 (9%)
Query: 543 NFTDYNKLGQGGFGIVYKG-RLLEGQEIAVK-----RLSRNSGQGIEEFKNEVRLIAKLQ 596
           N+     LG+G FG V        GQ++A+K      L+++  QG    + E+  +  L+
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 62
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           H ++++L       DE ++V EY  N   D ++     S      RRF     I   + Y
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE--QEARRF--FQQIISAVEY 118
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
            H   R +I+HRDLK  N+LLD+ +  KI+DFG++ I 
Sbjct: 119 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 153

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 15/158 (9%)
Query: 543 NFTDYNKLGQGGFGIVYKG-RLLEGQEIAVK-----RLSRNSGQGIEEFKNEVRLIAKLQ 596
           N+     LG+G FG V        GQ++A+K      L+++  QG    + E+  +  L+
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 66
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           H ++++L       DE ++V EY  N   D ++     S      RRF     I   + Y
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE--QEARRF--FQQIISAVEY 122
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
            H   R +I+HRDLK  N+LLD+ +  KI+DFG++ I 
Sbjct: 123 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 157

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 15/158 (9%)
Query: 543 NFTDYNKLGQGGFGIVYKG-RLLEGQEIAVK-----RLSRNSGQGIEEFKNEVRLIAKLQ 596
           N+     LG+G FG V        GQ++A+K      L+++  QG    + E+  +  L+
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 72
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           H ++++L       DE ++V EY  N   D ++     S      RRF     I   + Y
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE--QEARRF--FQQIISAVEY 128
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
            H   R +I+HRDLK  N+LLD+ +  KI+DFG++ I 
Sbjct: 129 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 163

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRN 599
           N+     +G+G F  V   R +L G+E+AV+ + +   +   +++   EVR++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V+L           LV EY     +   +    R      + +F  I    +   Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQ 131
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
             +F I+HRDLKA N+LLD +M  KI+DFG +  F
Sbjct: 132 --KF-IVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 21/161 (13%)
Query: 550 LGQGGFGIVYKGRLLEG---QEIAVKRLSR-NSGQGIEEFKNEVRLIAKL-QHRNLVRLL 604
           +G+G FG V K R+ +     + A+KR+    S     +F  E+ ++ KL  H N++ LL
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 605 GCCVEMDEKMLVYEYMENRSL-------------DSVIFDKARSSILNWQRRFNIICGIA 651
           G C       L  EY  + +L              +     + +S L+ Q+  +    +A
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           RG+ YL Q    + IHR+L A NIL+ +    KI+DFG++R
Sbjct: 150 RGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSR 187

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRN 599
           N+     +G+G F  V   R +L G+E+AV+ + +   +   +++   EVR++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V+L           LV EY     +   +    R      + +F  I    +   Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQ 131
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
             +F I+HRDLKA N+LLD +M  KI+DFG +  F
Sbjct: 132 --KF-IVHRDLKAENLLLDADMNIKIADFGFSNEF 163

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 88/185 (47%), Gaps = 32/185 (17%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR---LLEGQE---IAVKRLSRNSGQGIE-EFKNEVRLIAK 594
           +N      +G+G FG V++ R   LL  +    +AVK L   +   ++ +F+ E  L+A+
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLD----------------SVIFDKARSS-- 636
             + N+V+LLG C       L++EYM    L+                S +  +AR S  
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 637 ---ILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR- 692
               L+   +  I   +A G+ YL   S  + +HRDL   N L+ + M  KI+DFG++R 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 693 IFGGD 697
           I+  D
Sbjct: 224 IYSAD 228

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  +  +   
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +   IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R
Sbjct: 143 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 90/168 (53%), Gaps = 12/168 (7%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           +T + K+GQG  G VY    +  GQE+A+++++       E   NE+ ++ + ++ N+V 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-GIARGLLYLHQDS 661
            L   +  DE  +V EY+   SL  V+ +         + +   +C    + L +LH + 
Sbjct: 83  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLHSN- 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             ++IHR++K+ NILL  + + K++DFG       +Q++++T  +VGT
Sbjct: 137 --QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 180

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 73/146 (50%), Gaps = 6/146 (4%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE 609
           +G+G FG VY GR      I +  + R++   ++ FK EV    + +H N+V  +G C+ 
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 610 MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRD 669
                ++    + R+L SV+ D     +L+  +   I   I +G+ YLH      I+H+D
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 670 LKASNILLDKEMTPKISDFGMARIFG 695
           LK+ N+  D      I+DFG+  I G
Sbjct: 156 LKSKNVFYDNGKV-VITDFGLFSISG 180

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 17/164 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           N T    LG G FG VY+G++          ++AVK L     +  E +F  E  +I+KL
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 105
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIICGIA 651
            H+N+VR +G  ++   + ++ E M    L S + +     ++ S L      ++   IA
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMAR 692
            G  YL ++     IHRD+ A N LL         KI DFGMAR
Sbjct: 166 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 17/164 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           N T    LG G FG VY+G++          ++AVK L     +  E +F  E  +I+KL
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 91
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIICGIA 651
            H+N+VR +G  ++   + ++ E M    L S + +     ++ S L      ++   IA
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMAR 692
            G  YL ++     IHRD+ A N LL         KI DFGMAR
Sbjct: 152 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  +  +   
Sbjct: 73  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 132
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +   IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R
Sbjct: 133 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 176

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR---LLEGQ---EIAVKRLSRNSG-QGIEEFKNEVRLIAK 594
           +  T   +LGQG FG+VY+G    +++G+    +AVK ++ ++  +   EF NE  ++  
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 76
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFNII 647
               ++VRLLG   +    ++V E M +       RSL     +         Q    + 
Sbjct: 77  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             IA G+ YL+     + +HRDL A N ++  + T KI DFGM R
Sbjct: 137 AEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR---LLEGQ---EIAVKRLSRNSG-QGIEEFKNEVRLIAK 594
           +  T   +LGQG FG+VY+G    +++G+    +AVK ++ ++  +   EF NE  ++  
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 76
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFNII 647
               ++VRLLG   +    ++V E M +       RSL     +         Q    + 
Sbjct: 77  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             IA G+ YL+     + +HRDL A N ++  + T KI DFGM R
Sbjct: 137 AEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 179

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR---LLEGQ---EIAVKRLSRNSG-QGIEEFKNEVRLIAK 594
           +  T   +LGQG FG+VY+G    +++G+    +AVK ++ ++  +   EF NE  ++  
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 76
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFNII 647
               ++VRLLG   +    ++V E M +       RSL     +         Q    + 
Sbjct: 77  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             IA G+ YL+     + +HRDL A N ++  + T KI DFGM R
Sbjct: 137 AEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 179

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR---LLEGQ---EIAVKRLSRNSG-QGIEEFKNEVRLIAK 594
           +  T   +LGQG FG+VY+G    +++G+    +AVK ++ ++  +   EF NE  ++  
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 76
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFNII 647
               ++VRLLG   +    ++V E M +       RSL     +         Q    + 
Sbjct: 77  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             IA G+ YL+     + +HRDL A N ++  + T KI DFGM R
Sbjct: 137 AEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 82/167 (49%), Gaps = 15/167 (8%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKL- 595
           AT  +    ++G G +G VYK R    G  +A+K  R+    G G     + VR +A L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 596 -----QHRNLVRLLGCCV--EMDEKMLVYEYMENRSLD-SVIFDKARSSILNWQRRFNII 647
                +H N+VRL+  C     D ++ V    E+   D     DKA    L  +   +++
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
               RGL +LH +    I+HRDLK  NIL+    T K++DFG+ARI+
Sbjct: 127 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 170

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 85/167 (50%), Gaps = 24/167 (14%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           + D   LG GG G+V+     +  + +A+K++     Q ++    E+++I +L H N+V+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 603 L--------------LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC 648
           +              +G   E++   +V EYME   L +V+    +  +L    R   + 
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL---EQGPLLEEHARL-FMY 127
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIF 694
            + RGL Y+H  +   ++HRDLK +N+ ++ E +  KI DFG+ARI 
Sbjct: 128 QLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIM 171

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR---LLEGQ---EIAVKRLSRNSG-QGIEEFKNEVRLIAK 594
           +  T   +LGQG FG+VY+G    +++G+    +AVK ++ ++  +   EF NE  ++  
Sbjct: 14  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 73
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFNII 647
               ++VRLLG   +    ++V E M +       RSL     +         Q    + 
Sbjct: 74  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 133
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             IA G+ YL+     + +HRDL A N ++  + T KI DFGM R
Sbjct: 134 AEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 175

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 90/178 (50%), Gaps = 13/178 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRN 599
           D++     +G G   +V        +E +A+KR++    Q  ++E   E++ +++  H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD-----KARSSILNWQRRFNIICGIARGL 654
           +V      V  DE  LV + +   S+  +I       + +S +L+      I+  +  GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF--GGDQTEQNTKRV-VGT 709
            YLH++ +   IHRD+KA NILL ++ + +I+DFG++     GGD T    ++  VGT
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 154

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 140 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 170

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR---LLEGQ---EIAVKRLSRNSG-QGIEEFKNEVRLIAK 594
           +  T   +LGQG FG+VY+G    +++G+    +AVK ++ ++  +   EF NE  ++  
Sbjct: 16  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 75
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFNII 647
               ++VRLLG   +    ++V E M +       RSL     +         Q    + 
Sbjct: 76  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 135
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             IA G+ YL+     + +HRDL A N ++  + T KI DFGM R
Sbjct: 136 AEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 177

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 90/178 (50%), Gaps = 13/178 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRN 599
           D++     +G G   +V        +E +A+KR++    Q  ++E   E++ +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD-----KARSSILNWQRRFNIICGIARGL 654
           +V      V  DE  LV + +   S+  +I       + +S +L+      I+  +  GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF--GGDQTEQNTKRV-VGT 709
            YLH++ +   IHRD+KA NILL ++ + +I+DFG++     GGD T    ++  VGT
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 157

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 154

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 154

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 155

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 152

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRN 599
           N+     +G+G F  V   R +L G+E+AVK + +   +   +++   EVR+   L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V+L           LV EY     +   +    R      + +F  I    +   Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ---YCHQ 131
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
             +F I+HRDLKA N+LLD +   KI+DFG +  F
Sbjct: 132 --KF-IVHRDLKAENLLLDADXNIKIADFGFSNEF 163

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 10/152 (6%)
Query: 548 NKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIE---EFKNEVRLIAKLQHRNLVRL 603
           + LG G FG V  G+  L G ++AVK L+R   + ++   + + E++ +   +H ++++L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
                   +  +V EY+    L   I    R      +R F  I     G+ Y H   R 
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS---GVDYCH---RH 135
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
            ++HRDLK  N+LLD  M  KI+DFG++ +  
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 17/164 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           N T    LG G FG VY+G++          ++AVK L     +  E +F  E  +I+K 
Sbjct: 23  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 82
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIICGIA 651
            H+N+VR +G  ++   + ++ E M    L S + +     ++ S L      ++   IA
Sbjct: 83  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 142
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMAR 692
            G  YL ++     IHRD+ A N LL         KI DFGMAR
Sbjct: 143 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 183

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 17/164 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           N T    LG G FG VY+G++          ++AVK L     +  E +F  E  +I+K 
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIICGIA 651
            H+N+VR +G  ++   + ++ E M    L S + +     ++ S L      ++   IA
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMAR 692
            G  YL ++     IHRD+ A N LL         KI DFGMAR
Sbjct: 152 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 86/171 (50%), Gaps = 14/171 (8%)
Query: 542 DNFTDYNKLGQGGFGIV-YKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           +   ++ K+G+G  GIV        G+++AVK++     Q  E   NEV ++    H N+
Sbjct: 45  EYLANFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNV 104
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V +    +  DE  +V E++E  +L  ++      + +N ++   +   + R L YLH  
Sbjct: 105 VDMYSSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLSVLRALSYLHNQ 160
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGT 709
               +IHRD+K+ +ILL  +   K+SDFG    F    +++  KR  +VGT
Sbjct: 161 G---VIHRDIKSDSILLTSDGRIKLSDFG----FCAQVSKEVPKRKXLVGT 204

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 533 DFETIVRATDNFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EF 585
           D + + R   N T    LG G FG VY+G++          ++AVK L     +  E +F
Sbjct: 64  DLKEVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF 121
Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQ 641
             E  +I+K  H+N+VR +G  ++   + ++ E M    L S + +     ++ S L   
Sbjct: 122 LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 181
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMAR 692
              ++   IA G  YL ++     IHRD+ A N LL         KI DFGMAR
Sbjct: 182 DLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  +  +   
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 142
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +   IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R
Sbjct: 143 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 17/164 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           N T    LG G FG VY+G++          ++AVK L     +  E +F  E  +I+K 
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 105
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIICGIA 651
            H+N+VR +G  ++   + ++ E M    L S + +     ++ S L      ++   IA
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMAR 692
            G  YL ++     IHRD+ A N LL         KI DFGMAR
Sbjct: 166 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  +  +   
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +   IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R
Sbjct: 137 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  +  +   
Sbjct: 74  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 133
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +   IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R
Sbjct: 134 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 177

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 533 DFETIVRATDNFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EF 585
           D + + R   N T    LG G FG VY+G++          ++AVK L     +  E +F
Sbjct: 41  DLKEVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF 98
Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQ 641
             E  +I+K  H+N+VR +G  ++   + ++ E M    L S + +     ++ S L   
Sbjct: 99  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 158
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMAR 692
              ++   IA G  YL ++     IHRD+ A N LL         KI DFGMAR
Sbjct: 159 DLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 209

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  +  +   
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +   IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R
Sbjct: 137 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 17/164 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           N T    LG G FG VY+G++          ++AVK L     +  E +F  E  +I+K 
Sbjct: 38  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 97
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIICGIA 651
            H+N+VR +G  ++   + ++ E M    L S + +     ++ S L      ++   IA
Sbjct: 98  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 157
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMAR 692
            G  YL ++     IHRD+ A N LL         KI DFGMAR
Sbjct: 158 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 198

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  +  +   
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +   IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R
Sbjct: 130 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 173

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  +  +   
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +   IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R
Sbjct: 136 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 77/164 (46%), Gaps = 17/164 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSR-NSGQGIEEFKNEVRLIAKL 595
           N T    LG G FG VY+G++          ++AVK L    S Q   +F  E  +I+K 
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKF 105
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIICGIA 651
            H+N+VR +G  ++   + ++ E M    L S + +     ++ S L      ++   IA
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMAR 692
            G  YL ++     IHRD+ A N LL         KI DFGMAR
Sbjct: 166 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 17/164 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           N T    LG G FG VY+G++          ++AVK L     +  E +F  E  +I+K 
Sbjct: 48  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 107
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIICGIA 651
            H+N+VR +G  ++   + ++ E M    L S + +     ++ S L      ++   IA
Sbjct: 108 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 167
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMAR 692
            G  YL ++     IHRD+ A N LL         KI DFGMAR
Sbjct: 168 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 208

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 17/164 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           N T    LG G FG VY+G++          ++AVK L     +  E +F  E  +I+K 
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIICGIA 651
            H+N+VR +G  ++   + ++ E M    L S + +     ++ S L      ++   IA
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMAR 692
            G  YL ++     IHRD+ A N LL         KI DFGMAR
Sbjct: 151 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 17/164 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           N T    LG G FG VY+G++          ++AVK L     +  E +F  E  +I+K 
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIICGIA 651
            H+N+VR +G  ++   + ++ E M    L S + +     ++ S L      ++   IA
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMAR 692
            G  YL ++     IHRD+ A N LL         KI DFGMAR
Sbjct: 151 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  +  +   
Sbjct: 68  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 127
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +   IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R
Sbjct: 128 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 171

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  +  +   
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +   IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R
Sbjct: 136 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQE---IAVKRL--SRNSGQGIE-EFKNEVRLIA 593
           A ++F     LG+G FG VY  R  E Q    +A+K L  ++    G+E + + EV + +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAR--EKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
            L+H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANA 117
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           L Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 118 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 150

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 75/144 (52%), Gaps = 8/144 (5%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE 609
           +G+G FG V  G    G ++AVK +  ++    + F  E  ++ +L+H NLV+LLG  VE
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 610 MDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
               + +V EYM   SL   +  + RS +L           +   + YL  ++    +HR
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 313
Query: 669 DLKASNILLDKEMTPKISDFGMAR 692
           DL A N+L+ ++   K+SDFG+ +
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK 337

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR---LLEGQ---EIAVKRLSRNSG-QGIEEFKNEVRLIAK 594
           +  T   +LGQG FG+VY+G    +++G+    +AVK ++ ++  +   EF NE  ++  
Sbjct: 18  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 77
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFNII 647
               ++VRLLG   +    ++V E M +       RSL     +         Q    + 
Sbjct: 78  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 137
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             IA G+ YL+     + +HR+L A N ++  + T KI DFGM R
Sbjct: 138 AEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR 179

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR---LLEGQ---EIAVKRLSRNSG-QGIEEFKNEVRLIAK 594
           +  T   +LGQG FG+VY+G    +++G+    +AVK ++ ++  +   EF NE  ++  
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 76
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFNII 647
               ++VRLLG   +    ++V E M +       RSL     +         Q    + 
Sbjct: 77  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             IA G+ YL+     + +HR+L A N ++  + T KI DFGM R
Sbjct: 137 AEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 75/155 (48%), Gaps = 9/155 (5%)
Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRN 599
           N+     +G+G F  V   R +L G+E+AVK + +   +   +++   EVR++  L H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V+L           LV EY     +   +           + +F  I    +   Y HQ
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ---YCHQ 124
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
             +F I+HRDLKA N+LLD +M  KI+DFG +  F
Sbjct: 125 --KF-IVHRDLKAENLLLDADMNIKIADFGFSNEF 156

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  +  +   
Sbjct: 105 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 164
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +   IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R
Sbjct: 165 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 208

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 89/159 (55%), Gaps = 17/159 (10%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLS-RNSGQGIEEFK-NEVRLIAKLQHRNL 600
           +    K+G+G +G V+K +  E  EI A+KR+   +  +G+      E+ L+ +L+H+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 601 VRLLGCCVEMDEKM-LVYEYMEN---RSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           VRL    +  D+K+ LV+E+ +    +  DS   D      L+ +   + +  + +GL +
Sbjct: 64  VRLHDV-LHSDKKLTLVFEFCDQDLKKYFDSCNGD------LDPEIVKSFLFQLLKGLGF 116
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
            H  +   ++HRDLK  N+L+++    K++DFG+AR FG
Sbjct: 117 CHSRN---VLHRDLKPQNLLINRNGELKLADFGLARAFG 152

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 548 NKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIE---EFKNEVRLIAKLQHRNLVRL 603
           + LG G FG V  G   L G ++AVK L+R   + ++   + K E++ +   +H ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
                   +  +V EY+    L   I    R   +  +R F     I   + Y H   R 
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ---QILSAVDYCH---RH 130
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIF 694
            ++HRDLK  N+LLD  M  KI+DFG++ + 
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 548 NKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIE---EFKNEVRLIAKLQHRNLVRL 603
           + LG G FG V  G   L G ++AVK L+R   + ++   + K E++ +   +H ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
                   +  +V EY+    L   I    R   +  +R F     I   + Y H   R 
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ---QILSAVDYCH---RH 130
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIF 694
            ++HRDLK  N+LLD  M  KI+DFG++ + 
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQ--GIE-EFKNEVRLIAKLQH 597
           ++F     LG+G FG VY  R  + + I A+K L +   +  G+E + + EV + + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG 157

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQ--GIE-EFKNEVRLIAKLQH 597
           ++F     LG+G FG VY  R  + + I A+K L +   +  G+E + + EV + + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG 157

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI++FG
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG 155

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 75/144 (52%), Gaps = 8/144 (5%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE 609
           +G+G FG V  G    G ++AVK +  ++    + F  E  ++ +L+H NLV+LLG  VE
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 610 MDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
               + +V EYM   SL   +  + RS +L           +   + YL  ++    +HR
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 132
Query: 669 DLKASNILLDKEMTPKISDFGMAR 692
           DL A N+L+ ++   K+SDFG+ +
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTK 156

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 533 DFETIVRATDNFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EF 585
           D + + R   N T    LG G FG VY+G++          ++AVK L     +  E +F
Sbjct: 50  DLKEVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF 107
Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQ 641
             E  +I+K  H+N+VR +G  ++   + ++ E M    L S + +     ++ S L   
Sbjct: 108 LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 167
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMAR 692
              ++   IA G  YL ++     IHRD+ A N LL         KI DFGMAR
Sbjct: 168 DLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 218

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKR-LSRNSGQGIEEFK-NEVRLIAKLQHR 598
           + +    K+G+G +G+V+K R  + GQ +A+K+ L       I++    E+R++ +L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
           NLV LL          LV+EY ++  L  +  D+ +  +     + +I     + + + H
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHEL--DRYQRGVPEHLVK-SITWQTLQAVNFCH 119
Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           + +    IHRD+K  NIL+ K    K+ DFG AR+  G
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI++FG
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFG 156

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 90/181 (49%), Gaps = 23/181 (12%)
Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRL--SRNSGQGIEEFKNEVRLIAKL 595
           ++ + +    K+G+G FG     +  E G++  +K +  SR S +  EE + EV ++A +
Sbjct: 21  QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM 80
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSL-------DSVIFDKARSSILNWQRRFNIIC 648
           +H N+V+      E     +V +Y E   L         V+F +    IL+W   F  IC
Sbjct: 81  KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE--DQILDW---FVQIC 135
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
                L   H   R +I+HRD+K+ NI L K+ T ++ DFG+AR+   + T +  +  +G
Sbjct: 136 -----LALKHVHDR-KILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIG 187
Query: 709 T 709
           T
Sbjct: 188 T 188

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 75/144 (52%), Gaps = 8/144 (5%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE 609
           +G+G FG V  G    G ++AVK +  ++    + F  E  ++ +L+H NLV+LLG  VE
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 610 MDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
               + +V EYM   SL   +  + RS +L           +   + YL  ++    +HR
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 141
Query: 669 DLKASNILLDKEMTPKISDFGMAR 692
           DL A N+L+ ++   K+SDFG+ +
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK 165

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 75/144 (52%), Gaps = 8/144 (5%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE 609
           +G+G FG V  G    G ++AVK +  ++    + F  E  ++ +L+H NLV+LLG  VE
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 610 MDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
               + +V EYM   SL   +  + RS +L           +   + YL  ++    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 126
Query: 669 DLKASNILLDKEMTPKISDFGMAR 692
           DL A N+L+ ++   K+SDFG+ +
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK 150

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 84/164 (51%), Gaps = 10/164 (6%)
Query: 547 YNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           Y K+G+G  GIV   R    G+++AVK +     Q  E   NEV ++   QH N+V +  
Sbjct: 50  YVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
             +  +E  ++ E+++  +L  ++  + R   LN ++   +   + + L YLH      +
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIV-SQVR---LNEEQIATVCEAVLQALAYLHAQG---V 162
Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IHRD+K+ +ILL  +   K+SDFG       D  ++  K +VGT
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KXLVGT 204

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 77/164 (46%), Gaps = 17/164 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           N T    LG G FG VY+G++          ++AVK L     +  E +F  E  +I+K 
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIICGIA 651
            H+N+VR +G  ++   + ++ E M    L S + +     ++ S L      ++   IA
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMAR 692
            G  YL ++     IHRD+ A N LL         KI DFGMA+
Sbjct: 152 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ 192

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/130 (34%), Positives = 66/130 (50%), Gaps = 10/130 (7%)
Query: 566 GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK--MLVYEYMEN 622
           G+ +AVK L  + G Q    +K E+ ++  L H ++++  GCC +  EK   LV EY+  
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPL 102
Query: 623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT 682
            SL   +    R SI    +       I  G+ YLH       IHR+L A N+LLD +  
Sbjct: 103 GSLRDYL---PRHSI-GLAQLLLFAQQICEGMAYLHSQ---HYIHRNLAARNVLLDNDRL 155
Query: 683 PKISDFGMAR 692
            KI DFG+A+
Sbjct: 156 VKIGDFGLAK 165

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  +  +   
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +   IA G+ YL+ +   + +HRDL A N  + ++ T KI DFGM R
Sbjct: 130 MAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR 173

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 24/219 (10%)
Query: 499 HPERSQDLL-LNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYN--------- 548
           HP+R  D L  +       R  S DK   + +    FE+     +   D           
Sbjct: 279 HPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLL 338
Query: 549 ----KLGQGGFGIVYKG--RLLEGQ-EIAVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNL 600
               +LG G FG V +G  R+ + Q ++A+K L + + +   EE   E +++ +L +  +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           VRL+G C + +  MLV E      L   +  K     +       ++  ++ G+ YL + 
Sbjct: 399 VRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEEK 455
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
           +    +HR+L A N+LL      KISDFG+++  G D +
Sbjct: 456 N---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 82/167 (49%), Gaps = 14/167 (8%)
Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIEEFKN---EV 589
           F+      D +     +G G +G+V   R  L GQ++A+K++  N+   +   K    E+
Sbjct: 47  FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIP-NAFDVVTNAKRTLREL 105
Query: 590 RLIAKLQHRNLVRL---LGCCVEMDEKMLVYEYMENRSLD-SVIFDKARSSILNWQRRFN 645
           +++   +H N++ +   L   V   E   VY  ++    D   I   ++   L   R F 
Sbjct: 106 KILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYF- 164
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            +  + RGL Y+H     ++IHRDLK SN+L+++    KI DFGMAR
Sbjct: 165 -LYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMAR 207

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 76/154 (49%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY        V  +  + S  + QR    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPR---GEVYKELQKLSKFDEQRTATYITELANALS 127
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/130 (34%), Positives = 66/130 (50%), Gaps = 10/130 (7%)
Query: 566 GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK--MLVYEYMEN 622
           G+ +AVK L  + G Q    +K E+ ++  L H ++++  GCC +  EK   LV EY+  
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPL 102
Query: 623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT 682
            SL   +    R SI    +       I  G+ YLH       IHR+L A N+LLD +  
Sbjct: 103 GSLRDYL---PRHSI-GLAQLLLFAQQICEGMAYLHAQ---HYIHRNLAARNVLLDNDRL 155
Query: 683 PKISDFGMAR 692
            KI DFG+A+
Sbjct: 156 VKIGDFGLAK 165

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 82/167 (49%), Gaps = 30/167 (17%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNH 82
Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M+  +L  VI    D  R S L +Q    ++C
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLXQVIQMELDHERMSYLLYQ----MLC 137
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           GI     +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 138 GIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG 177

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/140 (34%), Positives = 70/140 (50%), Gaps = 13/140 (9%)
Query: 559 YKGRLLEGQEIAVKRLSRNSGQGI----EEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM 614
           Y+  LLE +    K  S N    I    ++FKNE+++I  +++   +   G     DE  
Sbjct: 62  YEKSLLEKKRDFTK--SNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVY 119
Query: 615 LVYEYMENRSL---DSVIF--DKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRD 669
           ++YEYMEN S+   D   F  DK  +  +  Q    II  +     Y+H +    I HRD
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--NICHRD 177
Query: 670 LKASNILLDKEMTPKISDFG 689
           +K SNIL+DK    K+SDFG
Sbjct: 178 VKPSNILMDKNGRVKLSDFG 197

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 76/159 (47%), Gaps = 16/159 (10%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAV----KRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRL 603
           LG G FG V+KG  + EG+ I +    K +   SG Q  +   + +  I  L H ++VRL
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSS--ILNWQRRFNIICGIARGLLYLHQDS 661
           LG C       LV +Y+   SL     D  R     L  Q   N    IA+G+ YL +  
Sbjct: 99  LGLC-PGSSLQLVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 153
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE 700
              ++HR+L A N+LL      +++DFG+A +   D  +
Sbjct: 154 ---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 189

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 76/159 (47%), Gaps = 16/159 (10%)
Query: 550 LGQGGFGIVYKGR-LLEGQEI----AVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRL 603
           LG G FG V+KG  + EG+ I     +K +   SG Q  +   + +  I  L H ++VRL
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSS--ILNWQRRFNIICGIARGLLYLHQDS 661
           LG C       LV +Y+   SL     D  R     L  Q   N    IA+G+ YL +  
Sbjct: 81  LGLC-PGSSLQLVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE 700
              ++HR+L A N+LL      +++DFG+A +   D  +
Sbjct: 136 ---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 86/160 (53%), Gaps = 19/160 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 103
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 162
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMAR 692
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 163 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 199

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 80/161 (49%), Gaps = 17/161 (10%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQG--IEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G FG V K +  +  QE AVK +++ S +         EV L+ KL H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
             +     +V E      L   I  + R S  +  R   II  +  G+ Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN---IV 143
Query: 667 HRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTK 704
           HRDLK  NILL   +K+   KI DFG++  F     +QNTK
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCF-----QQNTK 179

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 80/161 (49%), Gaps = 17/161 (10%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQG--IEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G FG V K +  +  QE AVK +++ S +         EV L+ KL H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
             +     +V E      L   I  + R S  +  R   II  +  G+ Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN---IV 143
Query: 667 HRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTK 704
           HRDLK  NILL   +K+   KI DFG++  F     +QNTK
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCF-----QQNTK 179

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 77/154 (50%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R    + I A+K L  ++    G+E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     ++IHRD+K  N+LL      KI+DFG
Sbjct: 123 YCHSK---KVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 86/160 (53%), Gaps = 19/160 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 113
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 172
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMAR 692
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 173 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 209

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 86/160 (53%), Gaps = 19/160 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 109
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 168
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMAR 692
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 169 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 76/154 (49%), Gaps = 10/154 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY        V  +  + S  + QR    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPR---GEVYKELQKLSKFDEQRTATYITELANALS 127
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           Y H     R+IHRD+K  N+LL      KI+DFG
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 86/160 (53%), Gaps = 19/160 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 111
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 170
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMAR 692
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 171 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 207

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 86/160 (53%), Gaps = 19/160 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 154
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 213
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMAR 692
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 214 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 250

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 86/160 (53%), Gaps = 19/160 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 109
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 168
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMAR 692
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 169 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 11/149 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           DNF    K+G+G  GIV    +   G+ +AVK++     Q  E   NEV ++   QH N+
Sbjct: 154 DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 210
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V +    +  DE  +V E++E  +L  ++      + +N ++   +   + + L  LH  
Sbjct: 211 VEMYNSYLVGDELWVVMEFLEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQ 266
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFG 689
               +IHRD+K+ +ILL  +   K+SDFG
Sbjct: 267 G---VIHRDIKSDSILLTHDGRVKLSDFG 292

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ + A L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGH 73
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 123
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 82/167 (49%), Gaps = 14/167 (8%)
Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIEEFKN---EV 589
           F+      D +     +G G +G+V   R  L GQ++A+K++  N+   +   K    E+
Sbjct: 46  FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIP-NAFDVVTNAKRTLREL 104
Query: 590 RLIAKLQHRNLVRL---LGCCVEMDEKMLVYEYMENRSLD-SVIFDKARSSILNWQRRFN 645
           +++   +H N++ +   L   V   E   VY  ++    D   I   ++   L   R F 
Sbjct: 105 KILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYF- 163
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            +  + RGL Y+H     ++IHRDLK SN+L+++    KI DFGMAR
Sbjct: 164 -LYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMAR 206

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 81/155 (52%), Gaps = 10/155 (6%)
Query: 549 KLGQGGFGIVYKG--RLLEGQ-EIAVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +LG G FG V +G  R+ + Q ++A+K L + + +   EE   E +++ +L +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G C + +  MLV E      L   +  K     ++      ++  ++ G+ YL + +   
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYLEEKN--- 130
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
            +HRDL A N+LL      KISDFG+++  G D +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 11/149 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           DNF    K+G+G  GIV    +   G+ +AVK++     Q  E   NEV ++   QH N+
Sbjct: 23  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V +    +  DE  +V E++E  +L  ++      + +N ++   +   + + L  LH  
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQ 135
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFG 689
               +IHRD+K+ +ILL  +   K+SDFG
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFG 161

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 11/149 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           DNF    K+G+G  GIV    +   G+ +AVK++     Q  E   NEV ++   QH N+
Sbjct: 27  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 83
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V +    +  DE  +V E++E  +L  ++      + +N ++   +   + + L  LH  
Sbjct: 84  VEMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQ 139
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFG 689
               +IHRD+K+ +ILL  +   K+SDFG
Sbjct: 140 G---VIHRDIKSDSILLTHDGRVKLSDFG 165

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 83/172 (48%), Gaps = 17/172 (9%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQ 596
           D F    KLG G FG V+   L+E    G E  +K ++++  Q  +E+ + E+ ++  L 
Sbjct: 22  DLFIFKRKLGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD 78
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYME-NRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           H N++++     +     +V E  E    L+ ++  +AR   L+      ++  +   L 
Sbjct: 79  HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMARIFGGDQTEQNT 703
           Y H      ++H+DLK  NIL  ++ +P    KI DFG+A +F  D+   N 
Sbjct: 139 YFHSQ---HVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHSTNA 186

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 86/160 (53%), Gaps = 19/160 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 80
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 139
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMAR 692
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 140 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 176

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 11/149 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           DNF    K+G+G  GIV    +   G+ +AVK++     Q  E   NEV ++   QH N+
Sbjct: 34  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 90
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V +    +  DE  +V E++E  +L  ++      + +N ++   +   + + L  LH  
Sbjct: 91  VEMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQ 146
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFG 689
               +IHRD+K+ +ILL  +   K+SDFG
Sbjct: 147 G---VIHRDIKSDSILLTHDGRVKLSDFG 172

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 79/161 (49%), Gaps = 17/161 (10%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQG--IEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G FG V K +  +  QE AVK +++ S +         EV L+ KL H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
             +     +V E      L   I  + R S  +  R   II  +  G+ Y+H   +  I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMH---KHNIV 143
Query: 667 HRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTK 704
           HRDLK  NILL   +K+   KI DFG++  F     +QNTK
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCF-----QQNTK 179

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 11/149 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           DNF    K+G+G  GIV    +   G+ +AVK++     Q  E   NEV ++   QH N+
Sbjct: 32  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 88
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V +    +  DE  +V E++E  +L  ++      + +N ++   +   + + L  LH  
Sbjct: 89  VEMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQ 144
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFG 689
               +IHRD+K+ +ILL  +   K+SDFG
Sbjct: 145 G---VIHRDIKSDSILLTHDGRVKLSDFG 170

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 84/165 (50%), Gaps = 26/165 (15%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHK 83
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ----MLCGI 139
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG 177

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 82/159 (51%), Gaps = 17/159 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 601 VRLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIA-----RGL 654
           VRL        EK  +VY  +    +   ++  AR      Q    I   +      R L
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMAR 692
            Y+H    F I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 89/159 (55%), Gaps = 17/159 (10%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLS-RNSGQGIEEFK-NEVRLIAKLQHRNL 600
           +    K+G+G +G V+K +  E  EI A+KR+   +  +G+      E+ L+ +L+H+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 601 VRLLGCCVEMDEKM-LVYEYMEN---RSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           VRL    +  D+K+ LV+E+ +    +  DS   D      L+ +   + +  + +GL +
Sbjct: 64  VRLHDV-LHSDKKLTLVFEFCDQDLKKYFDSCNGD------LDPEIVKSFLFQLLKGLGF 116
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
            H  +   ++HRDLK  N+L+++    K+++FG+AR FG
Sbjct: 117 CHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG 152

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 79/178 (44%), Gaps = 23/178 (12%)
Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           +F +   +G GGFG V+K +  ++G+   +KR+  N+    E+ + EV+ +AKL H N+V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIV 67
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIF---------------DKARSSILNWQRRFNI 646
              GC    D          +RS    +F               +K R   L+      +
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
              I +G+ Y+H     ++I+RDLK SNI L      KI DFG+      D     +K
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSK 182

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 72/154 (46%), Gaps = 13/154 (8%)
Query: 548 NKLGQGGFGIVYKGR--LLEGQ--EIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNL 600
            KLG G FG+V +G      G+   +AVK L  +     + +++F  EV  +  L HRNL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           +RL G  +    KM V E     SL   +       +L    R+ +   +A G+ YL   
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 134
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
              R IHRDL A N+LL      KI DFG+ R  
Sbjct: 135 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 165

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 86/160 (53%), Gaps = 19/160 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 88
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 147
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMAR 692
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 148 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 184

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 86/184 (46%), Gaps = 19/184 (10%)
Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQ----EIAVKRLSRN--SGQGIEEFKN 587
            E ++     FT    LG+G FG V + +L +      ++AVK L  +  +   IEEF  
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 588 EVRLIAKLQHRNLVRLLGCCVEMDEK------MLVYEYMENRSLDSVIFDK---ARSSIL 638
           E   + +  H ++ +L+G  +    K      M++  +M++  L + +           L
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 639 NWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGD 697
             Q     +  IA G+ YL   S    IHRDL A N +L ++MT  ++DFG++R I+ GD
Sbjct: 135 PLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 698 QTEQ 701
              Q
Sbjct: 192 YYRQ 195

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/130 (33%), Positives = 65/130 (50%), Gaps = 10/130 (7%)
Query: 566 GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK--MLVYEYMEN 622
           G+ +AVK L  ++G Q    +K E+ ++  L H ++++  GCC +       LV EY+  
Sbjct: 60  GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPL 119
Query: 623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT 682
            SL   +    R SI    +       I  G+ YLH       IHRDL A N+LLD +  
Sbjct: 120 GSLRDYL---PRHSI-GLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRL 172
Query: 683 PKISDFGMAR 692
            KI DFG+A+
Sbjct: 173 VKIGDFGLAK 182

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 72/154 (46%), Gaps = 13/154 (8%)
Query: 548 NKLGQGGFGIVYKGR--LLEGQ--EIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNL 600
            KLG G FG+V +G      G+   +AVK L  +     + +++F  EV  +  L HRNL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           +RL G  +    KM V E     SL   +       +L    R+ +   +A G+ YL   
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
              R IHRDL A N+LL      KI DFG+ R  
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 83/172 (48%), Gaps = 18/172 (10%)
Query: 536 TIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAV-----KRLSRNSGQGIEEFKNEV 589
           T  R T+ +  + +LG+G F +V +  ++L GQE A      K+LS    Q +E    E 
Sbjct: 5   TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REA 61
Query: 590 RLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICG 649
           R+   L+H N+VRL     E     L+++ +    L   I  +   S  +     + I  
Sbjct: 62  RICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---HCIQQ 118
Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEM---TPKISDFGMARIFGGDQ 698
           I   +L+ HQ     ++HR+LK  N+LL  ++     K++DFG+A    G+Q
Sbjct: 119 ILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 86/160 (53%), Gaps = 19/160 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 83
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 142
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMAR 692
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 143 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 179

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 11/149 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           DNF    K+G+G  GIV    +   G+ +AVK++     Q  E   NEV ++   QH N+
Sbjct: 77  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 133
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V +    +  DE  +V E++E  +L  ++      + +N ++   +   + + L  LH  
Sbjct: 134 VEMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQ 189
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFG 689
               +IHRD+K+ +ILL  +   K+SDFG
Sbjct: 190 G---VIHRDIKSDSILLTHDGRVKLSDFG 215

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 72/154 (46%), Gaps = 13/154 (8%)
Query: 548 NKLGQGGFGIVYKGR--LLEGQ--EIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNL 600
            KLG G FG+V +G      G+   +AVK L  +     + +++F  EV  +  L HRNL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           +RL G  +    KM V E     SL   +       +L    R+ +   +A G+ YL   
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
              R IHRDL A N+LL      KI DFG+ R  
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 86/160 (53%), Gaps = 19/160 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 94
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 153
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMAR 692
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 154 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 190

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 86/160 (53%), Gaps = 19/160 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 87
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 146
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMAR 692
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 147 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 183

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 78/155 (50%), Gaps = 23/155 (14%)
Query: 550 LGQGGFGIV-----YKGRLLEGQEIAVKRLSRNSGQGIE---EFKNEVRLIAKLQHRNLV 601
           LG+G FG V     YK +    Q++A+K +SR   +  +     + E+  +  L+H +++
Sbjct: 17  LGEGSFGKVKLATHYKTQ----QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF--NIICGIARGLLYLHQ 659
           +L        + ++V EY      D ++  K  +   +  RRF   IIC I     Y H 
Sbjct: 73  KLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTE--DEGRRFFQQIICAIE----YCH- 125
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
             R +I+HRDLK  N+LLD  +  KI+DFG++ I 
Sbjct: 126 --RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 86/160 (53%), Gaps = 19/160 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 87
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 146
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMAR 692
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 147 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 183

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/152 (34%), Positives = 72/152 (47%), Gaps = 13/152 (8%)
Query: 548 NKLGQGGFGIVYKGR--LLEGQ--EIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNL 600
            KLG G FG+V +G      G+   +AVK L  +     + +++F  EV  +  L HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           +RL G  +    KM V E     SL   +       +L    R+ +   +A G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              R IHRDL A N+LL      KI DFG+ R
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMR 159

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 86/160 (53%), Gaps = 19/160 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 134
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMAR 692
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/152 (34%), Positives = 72/152 (47%), Gaps = 13/152 (8%)
Query: 548 NKLGQGGFGIVYKGR--LLEGQ--EIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNL 600
            KLG G FG+V +G      G+   +AVK L  +     + +++F  EV  +  L HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           +RL G  +    KM V E     SL   +       +L    R+ +   +A G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              R IHRDL A N+LL      KI DFG+ R
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMR 159

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 122
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 122
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 85/179 (47%), Gaps = 17/179 (9%)
Query: 539 RATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQ 596
           R   +F     LG+GGFG+V++ +  ++    A+KR+   N     E+   EV+ +AKL+
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 597 HRNLVRLLGCCVEMD--EKML-----VYEYMEN---RSLDSVIFDKARSSILNWQRR--F 644
           H  +VR     +E +  EK+      VY Y++    R  +   +   R +I   +R    
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
           +I   IA  + +LH      ++HRDLK SNI    +   K+ DFG+      D+ EQ  
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 86/160 (53%), Gaps = 19/160 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 134
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMAR 692
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/152 (34%), Positives = 72/152 (47%), Gaps = 13/152 (8%)
Query: 548 NKLGQGGFGIVYKGR--LLEGQ--EIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNL 600
            KLG G FG+V +G      G+   +AVK L  +     + +++F  EV  +  L HRNL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           +RL G  +    KM V E     SL   +       +L    R+ +   +A G+ YL   
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 134
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              R IHRDL A N+LL      KI DFG+ R
Sbjct: 135 ---RFIHRDLAARNLLLATRDLVKIGDFGLMR 163

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 86/160 (53%), Gaps = 19/160 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 79
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 138
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMAR 692
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 139 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 175

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 82/167 (49%), Gaps = 30/167 (17%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNH 82
Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M+  +L  VI    D  R S L +Q    ++C
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQ----MLC 137
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           GI     +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 138 GIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG 177

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 86/160 (53%), Gaps = 19/160 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 76
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 135
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMAR 692
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 136 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 172

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 86/160 (53%), Gaps = 19/160 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 134
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMAR 692
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 81/153 (52%), Gaps = 19/153 (12%)
Query: 550 LGQGGFGIV---YKGRLLEGQEIAVKRLSRNSGQGIEEFKN--EVRLIAKLQHRNLVRLL 604
           +G G +G V   Y  RL   Q++AVK+LSR     I   +   E+RL+  L+H N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 605 -----GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
                   +E   ++ +   +    L++++    +S  L+ +    ++  + RGL Y+H 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIV----KSQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
                IIHRDLK SN+ ++++   +I DFG+AR
Sbjct: 150 AG---IIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 84/165 (50%), Gaps = 26/165 (15%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ----MLCGI 139
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG 177

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 12/164 (7%)
Query: 541 TDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLS--RNSGQGIEEFKNEVRLIAKLQH 597
           TD +  Y  +G+G F +V +  +L  G E A K ++  + S +  ++ + E R+   L+H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            N+VRL     E     LV++ +    L   I  +   S  +     + I  I   +L+ 
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIQQILEAVLHC 119
Query: 658 HQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQ 698
           HQ     ++HRDLK  N+LL    K    K++DFG+A    GDQ
Sbjct: 120 HQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQ 160

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 123
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 170

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/152 (34%), Positives = 72/152 (47%), Gaps = 13/152 (8%)
Query: 548 NKLGQGGFGIVYKGR--LLEGQ--EIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNL 600
            KLG G FG+V +G      G+   +AVK L  +     + +++F  EV  +  L HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           +RL G  +    KM V E     SL   +       +L    R+ +   +A G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              R IHRDL A N+LL      KI DFG+ R
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMR 159

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 123
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 84/160 (52%), Gaps = 19/160 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ +        FKN E++++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNI 75
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 134
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMAR 692
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 122
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 82/166 (49%), Gaps = 31/166 (18%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ +        FKN E++++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNI 75
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN-------------II 647
           VRL        EK       ++    +++ D   +++    R ++              +
Sbjct: 76  VRLRYFFYSSGEK-------KDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMAR 692
             + R L Y+H    F I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 129 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 84/160 (52%), Gaps = 19/160 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ +        FKN E++++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNI 75
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 134
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMAR 692
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 84/165 (50%), Gaps = 26/165 (15%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ----MLCGI 139
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/166 (33%), Positives = 83/166 (50%), Gaps = 28/166 (16%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 120
Query: 598 RNLVRLLGCCVE---MDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICG 649
           +N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CG
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ----MLCG 176
Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           I     +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 177 IK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQH 597
           DNF     LG+G FG V   R+ E G   AVK L ++       +E    E R+++  ++
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
              +  L CC +  +++     ME  +   ++F   +S   +  R       I   L++L
Sbjct: 83  HPFLTQLFCCFQTPDRLFFV--MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFL 140
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           H      II+RDLK  N+LLD E   K++DFGM +
Sbjct: 141 HDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK 172

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 122
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 87/176 (49%), Gaps = 16/176 (9%)
Query: 541 TDNFTDYNKLGQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQ---GIEEFKNEVRLIAKLQ 596
           +D +     LG+G FG ++     + GQE AVK +S+   +     E    EV+L+ +L 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           H N+++L     +     LV E      L   I  + R S ++  R   II  +  G+ Y
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITY 147
Query: 657 LHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           +H++   +I+HRDLK  N+LL+   K+   +I DFG++  F   +  +  K  +GT
Sbjct: 148 MHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGT 197

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 123
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 123
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 123
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 89/177 (50%), Gaps = 18/177 (10%)
Query: 541 TDNFTDYNKLGQGGFG--IVYKGRLLEGQEIAVKRLSRNSGQ---GIEEFKNEVRLIAKL 595
           +D +     LG+G FG  I+ K ++  GQE AVK +S+   +     E    EV+L+ +L
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
            H N+++L     +     LV E      L   I  + R S ++  R   II  +  G+ 
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 163
Query: 656 YLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           Y+H++   +I+HRDLK  N+LL+   K+   +I DFG++  F   +  +  K  +GT
Sbjct: 164 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGT 214

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 62/130 (47%), Gaps = 10/130 (7%)
Query: 566 GQEIAVKRLSRNSGQGIEE-FKNEVRLIAKLQHRNLVRLLGCCVEMDEK--MLVYEYMEN 622
           G+ +AVK L    G  +   ++ E+ ++  L H ++V+  GCC +  EK   LV EY+  
Sbjct: 37  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 96
Query: 623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT 682
            SL     D      +   +       I  G+ YLH       IHR L A N+LLD +  
Sbjct: 97  GSLR----DYLPRHCVGLAQLLLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRL 149
Query: 683 PKISDFGMAR 692
            KI DFG+A+
Sbjct: 150 VKIGDFGLAK 159

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 123
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 122
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 122
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/166 (33%), Positives = 83/166 (50%), Gaps = 28/166 (16%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 120
Query: 598 RNLVRLLGCCVE---MDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICG 649
           +N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CG
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ----MLCG 176
Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           I     +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 177 IK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 62/130 (47%), Gaps = 10/130 (7%)
Query: 566 GQEIAVKRLSRNSGQGIEE-FKNEVRLIAKLQHRNLVRLLGCCVEMDEK--MLVYEYMEN 622
           G+ +AVK L    G  +   ++ E+ ++  L H ++V+  GCC +  EK   LV EY+  
Sbjct: 38  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 97
Query: 623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT 682
            SL     D      +   +       I  G+ YLH       IHR L A N+LLD +  
Sbjct: 98  GSLR----DYLPRHCVGLAQLLLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRL 150
Query: 683 PKISDFGMAR 692
            KI DFG+A+
Sbjct: 151 VKIGDFGLAK 160

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 122
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 13  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 72  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 121
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 89/177 (50%), Gaps = 18/177 (10%)
Query: 541 TDNFTDYNKLGQGGFG--IVYKGRLLEGQEIAVKRLSRNSGQ---GIEEFKNEVRLIAKL 595
           +D +     LG+G FG  I+ K ++  GQE AVK +S+   +     E    EV+L+ +L
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
            H N+++L     +     LV E      L   I  + R S ++  R   II  +  G+ 
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 164
Query: 656 YLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           Y+H++   +I+HRDLK  N+LL+   K+   +I DFG++  F   +  +  K  +GT
Sbjct: 165 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGT 215

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 82/167 (49%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    + + L       
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCAKLTDDHVQF 125
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 122
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 122
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 122
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 122
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + +   + +G G +G V     +  G +IAVK+LSR     I   +   E+RL
Sbjct: 44  KTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRL 103
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 104 LKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 158
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 159 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 202

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 123
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 82/167 (49%), Gaps = 30/167 (17%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M+  +L  VI    D  R S L +Q    ++C
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQ----MLC 137
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           GI     +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 138 GIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 82/167 (49%), Gaps = 30/167 (17%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 83
Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M+  +L  VI    D  R S L +Q    ++C
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQ----MLC 138
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           GI     +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 139 GIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 89/177 (50%), Gaps = 18/177 (10%)
Query: 541 TDNFTDYNKLGQGGFG--IVYKGRLLEGQEIAVKRLSRNSGQ---GIEEFKNEVRLIAKL 595
           +D +     LG+G FG  I+ K ++  GQE AVK +S+   +     E    EV+L+ +L
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
            H N+++L     +     LV E      L   I  + R S ++  R   II  +  G+ 
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 140
Query: 656 YLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           Y+H++   +I+HRDLK  N+LL+   K+   +I DFG++  F   +  +  K  +GT
Sbjct: 141 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGT 191

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/166 (33%), Positives = 83/166 (50%), Gaps = 28/166 (16%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75
Query: 598 RNLVRLLGCCVE---MDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICG 649
           +N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CG
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ----MLCG 131
Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           I     +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 132 IK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/166 (33%), Positives = 83/166 (50%), Gaps = 28/166 (16%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 76
Query: 598 RNLVRLLGCCVE---MDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICG 649
           +N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CG
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ----MLCG 132
Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           I     +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 133 IK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 171

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 82/167 (49%), Gaps = 30/167 (17%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 81
Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M + +L  VI    D  R S L +Q    ++C
Sbjct: 82  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQ----MLC 136
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           GI     +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 137 GIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 176

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 80/167 (47%), Gaps = 30/167 (17%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNH 82
Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M + +L  VI    D  R S L +Q       
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYLLYQ------- 134
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
            +  G+ +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 135 -MLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG 177

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 79/168 (47%), Gaps = 17/168 (10%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           DN      +G+G +G VYKG L E + +AVK  S  + Q     KN  R +  ++H N+ 
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSLDE-RPVAVKVFSFANRQNFINEKNIYR-VPLMEHDNIA 70
Query: 602 RLL--GCCVEMDEKM---LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           R +     V  D +M   LV EY  N SL   +         +W     +   + RGL Y
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRLAHSVTRGLAY 126
Query: 657 LHQD------SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           LH +       +  I HRDL + N+L+  + T  ISDFG++    G++
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 82/167 (49%), Gaps = 30/167 (17%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 83
Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M + +L  VI    D  R S L +Q    ++C
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQ----MLC 138
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           GI     +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 139 GIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 82/167 (49%), Gaps = 30/167 (17%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M + +L  VI    D  R S L +Q    ++C
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQ----MLC 137
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           GI     +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 138 GIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/167 (33%), Positives = 82/167 (49%), Gaps = 30/167 (17%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 76
Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M + +L  VI    D  R S L +Q    ++C
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQ----MLC 131
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           GI     +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 132 GIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 171

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 88/170 (51%), Gaps = 15/170 (8%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLV 601
           FT  +++G+G FG VYKG     +E+ A+K +    +   IE+ + E+ ++++     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           R  G  ++  +  ++ EY+   S      D  +   L       I+  I +GL YLH + 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 135
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGT 709
             R IHRD+KA+N+LL ++   K++DFG+A    G  T+   KR   VGT
Sbjct: 136 --RKIHRDIKAANVLLSEQGDVKLADFGVA----GQLTDTQIKRNXFVGT 179

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 79/162 (48%), Gaps = 26/162 (16%)
Query: 544 FTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHRN 599
           +     +G G  GIV      + G  +AVK+LSR   N       ++ E+ L+  + H+N
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKN 84
Query: 600 LVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           ++ LL          E  +  LV E M + +L  VI    D  R S L +Q    ++CGI
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQ----MLCGI 139
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
                +LH      IIHRDLK SNI++  + T KI DFG+AR
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 77/148 (52%), Gaps = 8/148 (5%)
Query: 550 LGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           LG G FG V+K      G ++A K +     +  EE KNE+ ++ +L H NL++L     
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
             ++ +LV EY++   L   I D++ +  L        +  I  G+ ++HQ     I+H 
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYN--LTELDTILFMKQICEGIRHMHQ---MYILHL 211
Query: 669 DLKASNIL-LDKEMTP-KISDFGMARIF 694
           DLK  NIL ++++    KI DFG+AR +
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRY 239

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 81/174 (46%), Gaps = 26/174 (14%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 593 AKL-QHRNLVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
             + +H+N++ LLG C         VE   K  + EY+  R    + +    + +   Q 
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 643 RFNIICG----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            F  +      +ARG+ YL      + IHRDL A N+L+ +    KI+DFG+AR
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 79/162 (48%), Gaps = 26/162 (16%)
Query: 544 FTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHRN 599
           +     +G G  GIV      + G  +AVK+LSR   N       ++ E+ L+  + H+N
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKN 82
Query: 600 LVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           ++ LL          E  +  LV E M + +L  VI    D  R S L +Q    ++CGI
Sbjct: 83  IISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQ----MLCGI 137
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
                +LH      IIHRDLK SNI++  + T KI DFG+AR
Sbjct: 138 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 172

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 84/165 (50%), Gaps = 26/165 (15%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCGI 139
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 125
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 82/174 (47%), Gaps = 26/174 (14%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 593 AKL-QHRNLVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
             + +H+N++ LLG C         VE   K  + EY+  R    + +    + +   Q 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 643 RFNIICG----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            F  +      +ARG+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 125
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 26/185 (14%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 593 AKL-QHRNLVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
             + +H+N++ LLG C         VE   K  + EY+  R    + +    + +   Q 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 643 RFNIICG----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
            F  +      +ARG+ YL      + IHRDL A N+L+ +    KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 699 TEQNT 703
             +NT
Sbjct: 212 YYKNT 216

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 84/165 (50%), Gaps = 26/165 (15%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 88
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 89  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCGI 144
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 145 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 182

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/165 (33%), Positives = 83/165 (50%), Gaps = 26/165 (15%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVVAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHK 83
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++ GI
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ----MLVGI 139
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG 177

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 84/165 (50%), Gaps = 26/165 (15%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 84
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCGI 140
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 141 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 84/165 (50%), Gaps = 26/165 (15%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCGI 139
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 84/165 (50%), Gaps = 26/165 (15%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 85
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 86  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCGI 141
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 142 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 179

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 84/165 (50%), Gaps = 26/165 (15%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCGI 139
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 81/174 (46%), Gaps = 26/174 (14%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 593 AKL-QHRNLVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
             + +H+N++ LLG C         VE   K  + EY+  R    + +    + +   Q 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 643 RFNIICG----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            F  +      +ARG+ YL      + IHRDL A N+L+ +    KI+DFG+AR
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 84/165 (50%), Gaps = 26/165 (15%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 77
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 78  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCGI 133
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 134 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 171

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 82/153 (53%), Gaps = 19/153 (12%)
Query: 550 LGQGGFGIV---YKGRLLEGQEIAVKRLSRNSGQGIEEFKN--EVRLIAKLQHRNLVRLL 604
           +G G +G V   Y  RL   Q++AVK+LSR     I   +   E+RL+  L+H N++ LL
Sbjct: 28  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 605 -----GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
                   +E   ++ +   +    L++++  +A S   +   +F ++  + RGL Y+H 
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALS---DEHVQF-LVYQLLRGLKYIHS 141
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
                IIHRDLK SN+ ++++   +I DFG+AR
Sbjct: 142 AG---IIHRDLKPSNVAVNEDCELRILDFGLAR 171

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 84/165 (50%), Gaps = 26/165 (15%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCGI 139
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 148
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 149 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 192

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 81/174 (46%), Gaps = 26/174 (14%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 593 AKL-QHRNLVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
             + +H+N++ LLG C         VE   K  + EY+  R    + +    + +   Q 
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 643 RFNIICG----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            F  +      +ARG+ YL      + IHRDL A N+L+ +    KI+DFG+AR
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 82/153 (53%), Gaps = 19/153 (12%)
Query: 550 LGQGGFGIV---YKGRLLEGQEIAVKRLSRNSGQGIEEFKN--EVRLIAKLQHRNLVRLL 604
           +G G +G V   Y  RL   Q++AVK+LSR     I   +   E+RL+  L+H N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 605 -----GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
                   +E   ++ +   +    L++++  +A S   +   +F ++  + RGL Y+H 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALS---DEHVQF-LVYQLLRGLKYIHS 149
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
                IIHRDLK SN+ ++++   +I DFG+AR
Sbjct: 150 AG---IIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 83/167 (49%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++       + +   +F 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV---KXQKLTDDHVQF- 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 173

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 149
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 150 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 80/158 (50%), Gaps = 12/158 (7%)
Query: 547 YNKLGQGGFGIVYKG-RLLEGQEIAVKRLS--RNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           + +LG+G F +V +  ++L GQE A K ++  + S +  ++ + E R+   L+H N+VRL
Sbjct: 27  FEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL 86
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
                E     L+++ +    L   I  +   S  +     + I  I   +L+ HQ    
Sbjct: 87  HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---HCIQQILEAVLHCHQ---M 140
Query: 664 RIIHRDLKASNILLDKEM---TPKISDFGMARIFGGDQ 698
            ++HRDLK  N+LL  ++     K++DFG+A    G+Q
Sbjct: 141 GVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 178

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 84/165 (50%), Gaps = 26/165 (15%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCGI 139
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 149
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 150 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 84/172 (48%), Gaps = 10/172 (5%)
Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLS---RNSGQGIEEFKNEVRLIAKLQHR 598
           NF    K+G+G F  VY+   LL+G  +A+K++        +   +   E+ L+ +L H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD-KARSSILNWQRRFNIICGIARGLLYL 657
           N+++     +E +E  +V E  +   L  +I   K +  ++  +  +     +   L ++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           H  SR R++HRD+K +N+ +      K+ D G+ R F    T  ++  +VGT
Sbjct: 153 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 135
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 20  KTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 134
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 20/172 (11%)
Query: 551 GQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLL-----G 605
            +G FG V+K +L+    +AVK       Q  +  + E+     ++H NL++ +     G
Sbjct: 24  ARGRFGCVWKAQLM-NDFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRG 81
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD----- 660
             +E+ E  L+  + +  SL     D  + +I+ W    ++   ++RGL YLH+D     
Sbjct: 82  SNLEV-ELWLITAFHDKGSLT----DYLKGNIITWNELCHVAETMSRGLSYLHEDVPWCR 136
Query: 661 ---SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
               +  I HRD K+ N+LL  ++T  ++DFG+A  F   +   +T   VGT
Sbjct: 137 GEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGT 188

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 18/158 (11%)
Query: 550 LGQGGFGIVYKGRLLE-GQE-----IAVKRL-SRNSGQGIEEFKNEVRLIAKL-QHRNLV 601
           LG G FG V +      G+E     +AVK L S       E   +E+++++ L QH N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-------LNWQRRFNIICGIARGL 654
            LLG C      +++ EY     L + +  KA + +       L  +   +    +A+G+
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 165
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            +L   +    IHRD+ A N+LL      KI DFG+AR
Sbjct: 166 AFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLAR 200

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 79/166 (47%), Gaps = 23/166 (13%)
Query: 549 KLGQGGFGIVYKGRLLEGQ-EIAVKRLSR---------NSGQGIEEFK----NEVRLIAK 594
           KLG G +G V   +   G  E A+K + +         +  + IE+F     NE+ L+  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           L H N+++L     +     LV E+ E   L   I ++ +    +     NI+  I  G+
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA---NIMKQILSGI 159
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKE---MTPKISDFGMARIFGGD 697
            YLH+ +   I+HRD+K  NILL+ +   +  KI DFG++  F  D
Sbjct: 160 CYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 22/162 (13%)
Query: 550 LGQGGFGIVYKGRLLE-GQE-----IAVKRL-SRNSGQGIEEFKNEVRLIAKL-QHRNLV 601
           LG G FG V +      G+E     +AVK L S       E   +E+++++ L QH N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKAR-----------SSILNWQRRFNIICGI 650
            LLG C      +++ EY     L + +  K+R           +S L+ +   +    +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQV 173
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           A+G+ +L   +    IHRD+ A N+LL      KI DFG+AR
Sbjct: 174 AQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLAR 212

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 18/177 (10%)
Query: 541 TDNFTDYNKLGQGGFG--IVYKGRLLEGQEIAVKRLSRNSGQ---GIEEFKNEVRLIAKL 595
           +D +     LG+G FG  I+ K ++  GQE AVK +S+   +     E    EV+L+ +L
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
            H N+ +L     +     LV E      L   I  + R S ++  R   II  +  G+ 
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 140
Query: 656 YLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           Y H++   +I+HRDLK  N+LL+   K+   +I DFG++  F   +  +  K  +GT
Sbjct: 141 YXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKXKDKIGT 191

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 83/167 (49%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++       + +   +F 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV---KXQKLTDDHVQF- 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 80/167 (47%), Gaps = 30/167 (17%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M + +L  VI    D  R S L +Q       
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYLLYQ------- 134
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
            +  G+ +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 135 -MLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG 177

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 17/174 (9%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 136
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR    + T
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT 187

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 18/158 (11%)
Query: 550 LGQGGFGIVYKGRLLE-GQE-----IAVKRL-SRNSGQGIEEFKNEVRLIAKL-QHRNLV 601
           LG G FG V +      G+E     +AVK L S       E   +E+++++ L QH N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-------LNWQRRFNIICGIARGL 654
            LLG C      +++ EY     L + +  KA + +       L  +   +    +A+G+
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 173
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            +L   +    IHRD+ A N+LL      KI DFG+AR
Sbjct: 174 AFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLAR 208

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 17/174 (9%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 136
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR    + T
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT 187

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 134
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 140
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 141 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 184

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 81/174 (46%), Gaps = 26/174 (14%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQG-IEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 593 AKL-QHRNLVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
             + +H+N++ LLG C         VE   K  + EY+  R    + +    + +   Q 
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 643 RFNIICG----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            F  +      +ARG+ YL      + IHRDL A N+L+ +    KI+DFG+AR
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 251

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/165 (33%), Positives = 83/165 (50%), Gaps = 26/165 (15%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHK 83
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++ GI
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ----MLVGI 139
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG 177

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 80/167 (47%), Gaps = 30/167 (17%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75
Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M+  +L  VI    D  R S L +Q       
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLXQVIQMELDHERMSYLLYQ------- 127
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
            +  G+ +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 128 -MLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG 170

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 17/174 (9%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 136
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR    + T
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT 187

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 75/165 (45%), Gaps = 12/165 (7%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 103
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
            C + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 104 FCFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 157
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT
Sbjct: 158 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 80/167 (47%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + +   +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 25  KTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 84
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 85  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 139
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 140 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 183

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 548 NKLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           ++LG+G FG V   R        G  +AVK+L  +      +F+ E++++  L    +V+
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 603 LLGCCVE--MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
             G        E  LV EY+ +  L    F +   + L+  R       I +G+ YL   
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQICKGMEYL--G 128
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           SR R +HRDL A NIL++ E   KI+DFG+A++   D+
Sbjct: 129 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 165

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 81/167 (48%), Gaps = 18/167 (10%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G  G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAAGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 122
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 13  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 72
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 73  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 127
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 128 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 171

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 26/174 (14%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 593 AKL-QHRNLVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
             + +H+N++ LLG C         VE   K  + EY+  R    + +    + +   Q 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 643 RFNIICG----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            F  +      +ARG+ YL      + IHRDL A N+L+ +    +I+DFG+AR
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLAR 205

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 82/165 (49%), Gaps = 26/165 (15%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHK 83
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q        +
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ--------M 135
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
             G+ +LH      IIHRDLK SNI++  + T KI DFG+AR  G
Sbjct: 136 LVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG 177

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 81/174 (46%), Gaps = 26/174 (14%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 593 AKL-QHRNLVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
             + +H+N++ LLG C         VE   K  + EY+  R    + +    + +   Q 
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 643 RFNIICG----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            F  +      +ARG+ YL      + IHRDL A N+L+ +    KI+DFG+AR
Sbjct: 147 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 197

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 125
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 126
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 127 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 83/191 (43%), Gaps = 36/191 (18%)
Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           +F +   +G GGFG V+K +  ++G+   ++R+  N+    E+ + EV+ +AKL H N+V
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN----EKAEREVKALAKLDHVNIV 68
Query: 602 RLLGC-------CVEMDEKMLVYEY------MENRSLDSVIF---------------DKA 633
              GC           D+ +   +Y        +RS    +F               +K 
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 634 RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI 693
           R   L+      +   I +G+ Y+H     ++IHRDLK SNI L      KI DFG+   
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 694 FGGDQTEQNTK 704
              D     +K
Sbjct: 186 LKNDGKRTRSK 196

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 131
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +S  L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KSQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+ R
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR 173

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 131
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 89/168 (52%), Gaps = 11/168 (6%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLV 601
           FT   ++G+G FG V+KG     Q++ A+K +    +   IE+ + E+ ++++     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +  G  ++  +  ++ EY+   S      D  R+   +  +   ++  I +GL YLH + 
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 140
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           +   IHRD+KA+N+LL ++   K++DFG+A      Q ++NT   VGT
Sbjct: 141 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 183

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 97
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 98  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 152
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 153 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 196

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 81/174 (46%), Gaps = 26/174 (14%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 593 AKL-QHRNLVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
             + +H+N++ LLG C         VE   K  + EY+  R    + +    + +   Q 
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 643 RFNIICG----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            F  +      +ARG+ YL      + IHRDL A N+L+ +    KI+DFG+AR
Sbjct: 144 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 194

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 548 NKLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           ++LG+G FG V   R        G  +AVK+L  +      +F+ E++++  L    +V+
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 603 LLGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
             G       +   LV EY+ +  L    F +   + L+  R       I +G+ YL   
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQICKGMEYL--G 131
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           SR R +HRDL A NIL++ E   KI+DFG+A++   D+
Sbjct: 132 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 168

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 126
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 127 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 131
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR 175

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 134
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 178

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 131
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 81/174 (46%), Gaps = 26/174 (14%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQG-IEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 593 AKL-QHRNLVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
             + +H+N++ LLG C         VE   K  + EY+  R    + +    + +   Q 
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 643 RFNIICG----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            F  +      +ARG+ YL      + IHRDL A N+L+ +    KI+DFG+AR
Sbjct: 142 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLAR 192

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 134
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 178

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 14  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 73
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 74  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 128
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 129 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 172

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 140
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 141 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 184

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 136
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 141
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 141
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 548 NKLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           ++LG+G FG V   R        G  +AVK+L  +      +F+ E++++  L    +V+
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 603 LLGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
             G       +   LV EY+ +  L    F +   + L+  R       I +G+ YL   
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQICKGMEYL--G 132
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           SR R +HRDL A NIL++ E   KI+DFG+A++   D+
Sbjct: 133 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 169

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 149
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 150 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 135
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR 179

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 148
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 149 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 192

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 135
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 82/179 (45%), Gaps = 11/179 (6%)
Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAV-KRLSRNSGQGIEE--FKNEVRLIAKL 595
           RA D    Y  +G G +G   K R     +I V K L   S    E+    +EV L+ +L
Sbjct: 4   RAEDYEVLYT-IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 596 QHRNLVRLLGCCVEMDEKML--VYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIAR 652
           +H N+VR     ++     L  V EY E   L SVI    +    L+ +    ++  +  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 653 GLLYLHQ--DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
            L   H+  D    ++HRDLK +N+ LD +   K+ DFG+ARI   D  E   K  VGT
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--EDFAKEFVGT 179

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 548 NKLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           ++LG+G FG V   R        G  +AVK+L  +      +F+ E++++  L    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 603 LLGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
             G       +   LV EY+ +  L    F +   + L+  R       I +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQICKGMEYL--G 144
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           SR R +HRDL A NIL++ E   KI+DFG+A++   D+
Sbjct: 145 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 12/169 (7%)
Query: 536 TIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLS--RNSGQGIEEFKNEVRLI 592
           T  R TD++  + +LG+G F +V +  +    QE A K ++  + S +  ++ + E R+ 
Sbjct: 25  TCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARIC 84
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIAR 652
             L+H N+VRL     E     LV++ +    L   I  +   S  +     + I  I  
Sbjct: 85  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIHQILE 141
Query: 653 GLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQ 698
            + ++HQ     I+HRDLK  N+LL    K    K++DFG+A    G+Q
Sbjct: 142 SVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQ 187

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 81/174 (46%), Gaps = 26/174 (14%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 593 AKL-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI-------------FDKARSSIL 638
             + +H+N++ LLG C +     ++ EY    +L   +              ++     +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 639 NWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            ++   +    +ARG+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 135
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 87/168 (51%), Gaps = 11/168 (6%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLV 601
           FT   K+G+G FG V+KG     Q++ A+K +    +   IE+ + E+ ++++     + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +  G  ++  +  ++ EY+   S      D      L+  +   I+  I +GL YLH + 
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 144
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           +   IHRD+KA+N+LL +    K++DFG+A      Q ++NT   VGT
Sbjct: 145 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGT 187

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 97
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 98  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 152
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 153 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 196

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 87/168 (51%), Gaps = 11/168 (6%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLV 601
           FT   K+G+G FG V+KG     Q++ A+K +    +   IE+ + E+ ++++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +  G  ++  +  ++ EY+   S      D      L+  +   I+  I +GL YLH + 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 124
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           +   IHRD+KA+N+LL +    K++DFG+A      Q ++NT   VGT
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGT 167

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 72/161 (44%), Gaps = 20/161 (12%)
Query: 550 LGQGGFGIVYKGRLLE-GQE-----IAVKRL-SRNSGQGIEEFKNEVRLIAKL-QHRNLV 601
           LG G FG V +      G+E     +AVK L S       E   +E+++++ L QH N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            LLG C      +++ EY     L  + F + +S +L     F I    A     LH  S
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDL--LNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 662 RF----------RIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +             IHRD+ A N+LL      KI DFG+AR
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 36/201 (17%)
Query: 520 SADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRL--LEGQE----IAVKR 573
           S D    LE P ++F        N      LG+G FG V K     L+G+     +AVK 
Sbjct: 6   SVDAFKILEDPKWEF-----PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM 60
Query: 574 LSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI--- 629
           L  N S   + +  +E  ++ ++ H ++++L G C +    +L+ EY +  SL   +   
Sbjct: 61  LKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRES 120
Query: 630 ------------------FDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLK 671
                              D      L      +    I++G+ YL   +  +++HRDL 
Sbjct: 121 RKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLA 177
Query: 672 ASNILLDKEMTPKISDFGMAR 692
           A NIL+ +    KISDFG++R
Sbjct: 178 ARNILVAEGRKMKISDFGLSR 198

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 80/174 (45%), Gaps = 26/174 (14%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 593 AKL-QHRNLVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
             + +H+N++ LLG C         V    K  + EY+  R    + +    + +   Q 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 643 RFNIICG----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            F  +      +ARG+ YL      + IHRDL A N+L+ +    KI+DFG+AR
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 80/164 (48%), Gaps = 12/164 (7%)
Query: 541 TDNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLS--RNSGQGIEEFKNEVRLIAKLQH 597
           TD +  + +LG+G F +V +  ++  GQE A K ++  + S +  ++ + E R+   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            N+VRL     E     LV++ +    L   I  +   S  +     + I  I   + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIQQILESVNHC 119
Query: 658 HQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQ 698
           H +    I+HRDLK  N+LL    K    K++DFG+A    GDQ
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ 160

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 36/201 (17%)
Query: 520 SADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRL--LEGQE----IAVKR 573
           S D    LE P ++F        N      LG+G FG V K     L+G+     +AVK 
Sbjct: 6   SVDAFKILEDPKWEF-----PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM 60
Query: 574 LSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI--- 629
           L  N S   + +  +E  ++ ++ H ++++L G C +    +L+ EY +  SL   +   
Sbjct: 61  LKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRES 120
Query: 630 ------------------FDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLK 671
                              D      L      +    I++G+ YL   +  +++HRDL 
Sbjct: 121 RKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLA 177
Query: 672 ASNILLDKEMTPKISDFGMAR 692
           A NIL+ +    KISDFG++R
Sbjct: 178 ARNILVAEGRKMKISDFGLSR 198

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 80/164 (48%), Gaps = 12/164 (7%)
Query: 541 TDNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLS--RNSGQGIEEFKNEVRLIAKLQH 597
           TD +  + +LG+G F +V +  ++  GQE A K ++  + S +  ++ + E R+   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            N+VRL     E     LV++ +    L   I  +   S  +     + I  I   + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIQQILESVNHC 119
Query: 658 HQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQ 698
           H +    I+HRDLK  N+LL    K    K++DFG+A    GDQ
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ 160

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 88/187 (47%), Gaps = 20/187 (10%)
Query: 524 TDDLELPLFDFETIVRATDNFTDYN-------KLGQGGFGIVYKG--RLLEGQEIAVKRL 574
           T+  E P  D E I R  + + D         +LG G FG V KG  ++ +  +    ++
Sbjct: 345 TEVFESPFADPEEI-RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKI 403
Query: 575 SRNSGQGI---EEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD 631
            +N        +E   E  ++ +L +  +VR++G C E +  MLV E  E   L+  +  
Sbjct: 404 LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 462
Query: 632 KARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
                  N      ++  ++ G+ YL ++S F  +HRDL A N+LL  +   KISDFG++
Sbjct: 463 NRHVKDKNI---IELVHQVSMGMKYL-EESNF--VHRDLAARNVLLVTQHYAKISDFGLS 516
Query: 692 RIFGGDQ 698
           +    D+
Sbjct: 517 KALRADE 523

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 73/139 (52%), Gaps = 13/139 (9%)
Query: 550 LGQGGFGIVYKGRLLE----GQ----EIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           LGQG F  ++KG   E    GQ    E+ +K L +      E F     +++KL H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
              G CV  DE +LV E+++  SLD+ +  K   + +N   +  +   +A  + +L +++
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFLEENT 133
Query: 662 RFRIIHRDLKASNILLDKE 680
              +IH ++ A NILL +E
Sbjct: 134 ---LIHGNVCAKNILLIRE 149

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LS+     I   +   E+RL
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRL 86
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 141
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI D+G+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR 173

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 28/175 (16%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 593 AKL-QHRNLVRLLGCCVEMDEKMLVY----------EYMENRSLDSVIFDKARSSILNWQ 641
             + +H+N++ LLG C + D  + V           EY+  R    + +    + +   Q
Sbjct: 95  KMIGKHKNIINLLGACTQ-DGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 642 RRFNIICG----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             F  +      +ARG+ YL      + IHRDL A N+L+ +    KI+DFG+AR
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 36/201 (17%)
Query: 520 SADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRL--LEGQE----IAVKR 573
           S D    LE P ++F        N      LG+G FG V K     L+G+     +AVK 
Sbjct: 6   SVDAFKILEDPKWEF-----PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM 60
Query: 574 LSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI--- 629
           L  N S   + +  +E  ++ ++ H ++++L G C +    +L+ EY +  SL   +   
Sbjct: 61  LKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRES 120
Query: 630 ------------------FDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLK 671
                              D      L      +    I++G+ YL + S   ++HRDL 
Sbjct: 121 RKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLA 177
Query: 672 ASNILLDKEMTPKISDFGMAR 692
           A NIL+ +    KISDFG++R
Sbjct: 178 ARNILVAEGRKMKISDFGLSR 198

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 79/157 (50%), Gaps = 5/157 (3%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFK-NEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      L    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              ++HRDLK SN+LL+     KI DFG+AR+   D 
Sbjct: 149 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH 182

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 79/157 (50%), Gaps = 5/157 (3%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      L    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              ++HRDLK SN+LL+     KI DFG+AR+   D 
Sbjct: 149 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH 182

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 82/179 (45%), Gaps = 11/179 (6%)
Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAV-KRLSRNSGQGIEE--FKNEVRLIAKL 595
           RA D    Y  +G G +G   K R     +I V K L   S    E+    +EV L+ +L
Sbjct: 4   RAEDYEVLYT-IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 596 QHRNLVRLLGCCVEMDEKML--VYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIAR 652
           +H N+VR     ++     L  V EY E   L SVI    +    L+ +    ++  +  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 653 GLLYLHQ--DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
            L   H+  D    ++HRDLK +N+ LD +   K+ DFG+ARI   D +   T   VGT
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGT 179

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 76/152 (50%), Gaps = 10/152 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKLQH 597
           D+F     LG+G FG VY  R  +   I A+K L  S+   +G+E + + E+ + A L H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            N++RL     +     L+ EY     L   +    +S   + QR   I+  +A  L+Y 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKEL---QKSCTFDEQRTATIMEELADALMYC 139
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           H     ++IHRD+K  N+LL  +   KI+DFG
Sbjct: 140 HGK---KVIHRDIKPENLLLGLKGELKIADFG 168

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 82/195 (42%), Gaps = 29/195 (14%)
Query: 539 RATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKNEVRLI---AK 594
           R T  F +  K+G G FG V+K  + L+G   A+KR  +     ++E +N +R +   A 
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDE-QNALREVYAHAV 64
Query: 595 L-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKAR-SSILNWQRRFNIICGIAR 652
           L QH ++VR      E D  ++  EY    SL   I +  R  S        +++  + R
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTP-------------------KISDFGMARI 693
           GL Y+H  S   ++H D+K SNI + +   P                   KI D G    
Sbjct: 125 GLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 181
Query: 694 FGGDQTEQNTKRVVG 708
               Q E+   R + 
Sbjct: 182 ISSPQVEEGDSRFLA 196

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 77/165 (46%), Gaps = 11/165 (6%)
Query: 532 FDFETIVRATDNFTDYNKLGQGGFGIV--YKGRLLEGQEIAVKRLSRNSGQGIEEFKNEV 589
           F    ++    ++    KLG+GGF  V   +G L +G   A+KR+  +  Q  EE + E 
Sbjct: 19  FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREA 77
Query: 590 RLIAKLQHRNLVRLLGCCVE----MDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRF 644
            +     H N++RL+  C+       E  L+  + +  +L + +   K + + L   +  
Sbjct: 78  DMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137
Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
            ++ GI RGL  +H        HRDLK +NILL  E  P + D G
Sbjct: 138 WLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLG 179

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 83/199 (41%), Gaps = 29/199 (14%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKNEVRLI- 592
           E   R T  F +  K+G G FG V+K  + L+G   A+KR  +     ++E +N +R + 
Sbjct: 2   EMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDE-QNALREVY 60
Query: 593 --AKL-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKAR-SSILNWQRRFNIIC 648
             A L QH ++VR      E D  ++  EY    SL   I +  R  S        +++ 
Sbjct: 61  AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 120
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP-------------------KISDFG 689
            + RGL Y+H  S   ++H D+K SNI + +   P                   KI D G
Sbjct: 121 QVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 177
Query: 690 MARIFGGDQTEQNTKRVVG 708
                   Q E+   R + 
Sbjct: 178 HVTRISSPQVEEGDSRFLA 196

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 82/179 (45%), Gaps = 11/179 (6%)
Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAV-KRLSRNSGQGIEE--FKNEVRLIAKL 595
           RA D    Y  +G G +G   K R     +I V K L   S    E+    +EV L+ +L
Sbjct: 4   RAEDYEVLYT-IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 596 QHRNLVRLLGCCVEMDEKML--VYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIAR 652
           +H N+VR     ++     L  V EY E   L SVI    +    L+ +    ++  +  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 653 GLLYLHQ--DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
            L   H+  D    ++HRDLK +N+ LD +   K+ DFG+ARI   D +    K  VGT
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGT 179

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 79/157 (50%), Gaps = 5/157 (3%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      L    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 149
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              ++HRDLK SN+LL+     KI DFG+AR+   D 
Sbjct: 150 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 183

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 79/157 (50%), Gaps = 5/157 (3%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      L    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 91  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 150
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              ++HRDLK SN+LL+     KI DFG+AR+   D 
Sbjct: 151 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 184

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 79/157 (50%), Gaps = 5/157 (3%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      L    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 82  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 141
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              ++HRDLK SN+LL+     KI DFG+AR+   D 
Sbjct: 142 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 175

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 79/157 (50%), Gaps = 5/157 (3%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      L    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              ++HRDLK SN+LL+     KI DFG+AR+   D 
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 79/157 (50%), Gaps = 5/157 (3%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      L    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 142
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              ++HRDLK SN+LL+     KI DFG+AR+   D 
Sbjct: 143 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 176

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 79/157 (50%), Gaps = 5/157 (3%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      L    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 142
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              ++HRDLK SN+LL+     KI DFG+AR+   D 
Sbjct: 143 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 176

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 79/157 (50%), Gaps = 5/157 (3%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      L    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              ++HRDLK SN+LL+     KI DFG+AR+   D 
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 79/157 (50%), Gaps = 5/157 (3%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      L    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 149
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              ++HRDLK SN+LL+     KI DFG+AR+   D 
Sbjct: 150 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 183

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 82/195 (42%), Gaps = 29/195 (14%)
Query: 539 RATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKNEVRLI---AK 594
           R T  F +  K+G G FG V+K  + L+G   A+KR  +     ++E +N +R +   A 
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDE-QNALREVYAHAV 66
Query: 595 L-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKAR-SSILNWQRRFNIICGIAR 652
           L QH ++VR      E D  ++  EY    SL   I +  R  S        +++  + R
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTP-------------------KISDFGMARI 693
           GL Y+H  S   ++H D+K SNI + +   P                   KI D G    
Sbjct: 127 GLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 694 FGGDQTEQNTKRVVG 708
               Q E+   R + 
Sbjct: 184 ISSPQVEEGDSRFLA 198

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 82/195 (42%), Gaps = 29/195 (14%)
Query: 539 RATDNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLI---AK 594
           R T  F +  K+G G FG V+K  + L+G   A+KR  +     ++E +N +R +   A 
Sbjct: 4   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDE-QNALREVYAHAV 62
Query: 595 L-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKAR-SSILNWQRRFNIICGIAR 652
           L QH ++VR      E D  ++  EY    SL   I +  R  S        +++  + R
Sbjct: 63  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 122
Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTP-------------------KISDFGMARI 693
           GL Y+H  S   ++H D+K SNI + +   P                   KI D G    
Sbjct: 123 GLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 179
Query: 694 FGGDQTEQNTKRVVG 708
               Q E+   R + 
Sbjct: 180 ISSPQVEEGDSRFLA 194

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 15/178 (8%)
Query: 542 DNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRN 599
           D+F   ++LG G  G+V+K      G  +A K +       I  +   E++++ +     
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V   G      E  +  E+M+  SLD V+    R   +  Q    +   + +GL YL +
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 184
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFG--------MARIFGGDQTEQNTKRVVGT 709
             + +I+HRD+K SNIL++     K+ DFG        MA  F G ++  + +R+ GT
Sbjct: 185 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 240

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 82/160 (51%), Gaps = 18/160 (11%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNLVR 602
           +T+   +G G FG+V++ +L+E  E+A+K++ ++     + FKN E++++  ++H N+V 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVD 96
Query: 603 LLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           L        +K       LV EY+ E     S  + K + ++     +   +  + R L 
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL-YMYQLLRSLA 155
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIF 694
           Y+H      I HRD+K  N+LLD      K+ DFG A+I 
Sbjct: 156 YIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 80/167 (47%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DF +AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR 173

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 15/178 (8%)
Query: 542 DNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRN 599
           D+F   ++LG G  G+V+K      G  +A K +       I  +   E++++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V   G      E  +  E+M+  SLD V+    R   +  Q    +   + +GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFG--------MARIFGGDQTEQNTKRVVGT 709
             + +I+HRD+K SNIL++     K+ DFG        MA  F G ++  + +R+ GT
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 178

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 88/187 (47%), Gaps = 20/187 (10%)
Query: 524 TDDLELPLFDFETIVRATDNFTDYN-------KLGQGGFGIVYKG--RLLEGQEIAVKRL 574
           T+  E P  D E I R  + + D         +LG G FG V KG  ++ +  +    ++
Sbjct: 346 TEVYESPYADPEEI-RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKI 404
Query: 575 SRNSGQGI---EEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD 631
            +N        +E   E  ++ +L +  +VR++G C E +  MLV E  E   L+  +  
Sbjct: 405 LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 463
Query: 632 KARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
                  N      ++  ++ G+ YL ++S F  +HRDL A N+LL  +   KISDFG++
Sbjct: 464 NRHVKDKNI---IELVHQVSMGMKYL-EESNF--VHRDLAARNVLLVTQHYAKISDFGLS 517
Query: 692 RIFGGDQ 698
           +    D+
Sbjct: 518 KALRADE 524

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 86/168 (51%), Gaps = 11/168 (6%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLV 601
           FT   K+G+G FG V+KG     Q++ A+K +    +   IE+ + E+ ++++     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +  G  ++  +  ++ EY+   S      D      L+  +   I+  I +GL YLH + 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 139
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           +   IHRD+KA+N+LL +    K++DFG+A      Q ++N    VGT
Sbjct: 140 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGT 182

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 15/178 (8%)
Query: 542 DNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRN 599
           D+F   ++LG G  G+V+K      G  +A K +       I  +   E++++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V   G      E  +  E+M+  SLD V+    R   +  Q    +   + +GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFG--------MARIFGGDQTEQNTKRVVGT 709
             + +I+HRD+K SNIL++     K+ DFG        MA  F G ++  + +R+ GT
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 178

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 73/146 (50%), Gaps = 10/146 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+GGF   ++    + +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
              + D   +V E    RSL  +   K R ++   + R+  +  I  G  YLH++   R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RV 162
Query: 666 IHRDLKASNILLDKEMTPKISDFGMA 691
           IHRDLK  N+ L++++  KI DFG+A
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLA 188

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 81/165 (49%), Gaps = 7/165 (4%)
Query: 538 VRATDNFTDYNKLGQGGFGIVYKGRLLEG-QEIAVKRLSRNSGQGIE--EFKNEVRLIAK 594
           V+  DN+   + +G+G +G VY        + +A+K+++R     I+      E+ ++ +
Sbjct: 24  VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNR 83
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARG 653
           L+   ++RL    +  D       Y+     DS +    ++ I L  Q    I+  +  G
Sbjct: 84  LKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLG 143
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
             ++H+     IIHRDLK +N LL+++ + KI DFG+AR    D+
Sbjct: 144 EKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDK 185

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 87/170 (51%), Gaps = 15/170 (8%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLV 601
           FT   K+G+G FG V+KG     Q++ A+K +    +   IE+ + E+ ++++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +  G  ++  +  ++ EY+   S      D      L+  +   I+  I +GL YLH + 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 124
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGT 709
           +   IHRD+KA+N+LL +    K++DFG+A    G  T+   KR   VGT
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNXFVGT 167

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 73/146 (50%), Gaps = 10/146 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+GGF   ++    + +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
              + D   +V E    RSL  +   K R ++   + R+  +  I  G  YLH++   R+
Sbjct: 89  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RV 142
Query: 666 IHRDLKASNILLDKEMTPKISDFGMA 691
           IHRDLK  N+ L++++  KI DFG+A
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLA 168

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 15/178 (8%)
Query: 542 DNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRN 599
           D+F   ++LG G  G+V+K      G  +A K +       I  +   E++++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V   G      E  +  E+M+  SLD V+    R   +  Q    +   + +GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFG--------MARIFGGDQTEQNTKRVVGT 709
             + +I+HRD+K SNIL++     K+ DFG        MA  F G ++  + +R+ GT
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 178

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 73/146 (50%), Gaps = 10/146 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+GGF   ++    + +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
              + D   +V E    RSL  +   K R ++   + R+  +  I  G  YLH++   R+
Sbjct: 107 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RV 160
Query: 666 IHRDLKASNILLDKEMTPKISDFGMA 691
           IHRDLK  N+ L++++  KI DFG+A
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLA 186

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 12/157 (7%)
Query: 541 TDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLS--RNSGQGIEEFKNEVRLIAKLQH 597
           +DN+    +LG+G F +V +      G E A K ++  + S +  ++ + E R+  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            N+VRL     E     LV++ +    L   I  +   S  +     + I  I   + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAYC 121
Query: 658 HQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMA 691
           H +    I+HR+LK  N+LL    K    K++DFG+A
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 155

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 79/157 (50%), Gaps = 5/157 (3%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      +    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              ++HRDLK SN+LL+     KI DFG+AR+   D 
Sbjct: 145 ---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDH 178

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 73/146 (50%), Gaps = 10/146 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+GGF   ++    + +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
              + D   +V E    RSL  +   K R ++   + R+  +  I  G  YLH++   R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RV 138
Query: 666 IHRDLKASNILLDKEMTPKISDFGMA 691
           IHRDLK  N+ L++++  KI DFG+A
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLA 164

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 78/157 (49%), Gaps = 5/157 (3%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      L    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   +   L+       +  I RGL Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              ++HRDLK SN+LL+     KI DFG+AR+   D 
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/171 (23%), Positives = 80/171 (46%), Gaps = 11/171 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           D++  + +LG G FG+V++      G   A K +        E  + E++ ++ L+H  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V L     + +E +++YE+M    L   + D+     ++       +  + +GL ++H++
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHEN 274
Query: 661 SRFRIIHRDLKASNILLDKEMTP--KISDFGMARIFGGDQTEQNTKRVVGT 709
           +    +H DLK  NI+   + +   K+ DFG+         +Q+ K   GT
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGT 319

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 12/157 (7%)
Query: 541 TDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLS--RNSGQGIEEFKNEVRLIAKLQH 597
           +DN+    +LG+G F +V +      G E A K ++  + S +  ++ + E R+  KLQH
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            N+VRL     E     LV++ +    L   I  +   S  +     + I  I   + Y 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAYC 120
Query: 658 HQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMA 691
           H +    I+HR+LK  N+LL    K    K++DFG+A
Sbjct: 121 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 154

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 12/157 (7%)
Query: 541 TDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLS--RNSGQGIEEFKNEVRLIAKLQH 597
           +DN+    +LG+G F +V +      G E A K ++  + S +  ++ + E R+  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            N+VRL     E     LV++ +    L   I  +   S  +     + I  I   + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAYC 121
Query: 658 HQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMA 691
           H +    I+HR+LK  N+LL    K    K++DFG+A
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 155

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 79/157 (50%), Gaps = 5/157 (3%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      +    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              ++HRDLK SN+LL+     KI DFG+AR+   D 
Sbjct: 145 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH 178

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 73/146 (50%), Gaps = 10/146 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+GGF   Y+   ++ +E+   ++   S        E+   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
              + D   +V E    RSL  +   K R ++   + R+ +   I +G+ YLH +   R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 666 IHRDLKASNILLDKEMTPKISDFGMA 691
           IHRDLK  N+ L+ +M  KI DFG+A
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 73/146 (50%), Gaps = 10/146 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+GGF   ++    + +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
              + D   +V E    RSL  +   K R ++   + R+  +  I  G  YLH++   R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RV 138
Query: 666 IHRDLKASNILLDKEMTPKISDFGMA 691
           IHRDLK  N+ L++++  KI DFG+A
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLA 164

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 73/146 (50%), Gaps = 10/146 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+GGF   Y+   ++ +E+   ++   S        E+   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
              + D   +V E    RSL  +   K R ++   + R+ +   I +G+ YLH +   R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 666 IHRDLKASNILLDKEMTPKISDFGMA 691
           IHRDLK  N+ L+ +M  KI DFG+A
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 79/157 (50%), Gaps = 5/157 (3%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      L    +A++++S    Q   +    E++++ + +H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              ++HRDLK SN+LL+     KI DFG+AR+   D 
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 78/157 (49%), Gaps = 5/157 (3%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      +    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    + + ++   ++  L+       +  I RGL Y+H  +
Sbjct: 105 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 164
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              ++HRDLK SN+LL+     KI DFG+AR+   D 
Sbjct: 165 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH 198

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 12/166 (7%)
Query: 532 FDFETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLS--RNSGQGIEEFKNE 588
           F      + +DN+    +LG+G F +V +      G E A K ++  + S +  ++ + E
Sbjct: 19  FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE 78
Query: 589 VRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC 648
            R+  KLQH N+VRL     E     LV++ +    L   I  +   S  +     + I 
Sbjct: 79  ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQ 135
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMA 691
            I   + Y H +    I+HR+LK  N+LL    K    K++DFG+A
Sbjct: 136 QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 178

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 79/157 (50%), Gaps = 5/157 (3%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      +    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              ++HRDLK SN+LL+     KI DFG+AR+   D 
Sbjct: 145 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH 178

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 74/171 (43%), Gaps = 31/171 (18%)
Query: 550 LGQGGFGIVYKGRLLE-GQE-----IAVKRL-SRNSGQGIEEFKNEVRLIAKL-QHRNLV 601
           LG G FG V +      G+E     +AVK L S       E   +E+++++ L QH N+V
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 602 RLLGCCVEMDEKMLVYEY----------------MENRSL----DSVIFDKARSSILNWQ 641
            LLG C      +++ EY                M   SL    D    DK     L  +
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              +    +A+G+ +L   +    IHRD+ A N+LL      KI DFG+AR
Sbjct: 159 DLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLAR 206

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 79/157 (50%), Gaps = 5/157 (3%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      +    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              ++HRDLK SN+LL+     KI DFG+AR+   D 
Sbjct: 147 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 180

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 84/182 (46%), Gaps = 20/182 (10%)
Query: 529 LPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRL-SRNSGQGIEEFKN 587
           LPL    TI +         ++G+G +G V+ G+   G+++AVK   +        E   
Sbjct: 27  LPLLVQRTIAKQIQMV---KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRE--T 80
Query: 588 EVRLIAKLQHRNLVRLLGCCVE----MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRR 643
           E+     ++H N++  +   ++      +  L+ +Y EN SL    +D  +S+ L+ +  
Sbjct: 81  EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSM 136
Query: 644 FNIICGIARGLLYLHQD-----SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
             +      GL +LH +      +  I HRDLK+ NIL+ K  T  I+D G+A  F  D 
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT 196
Query: 699 TE 700
            E
Sbjct: 197 NE 198

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 74/154 (48%), Gaps = 10/154 (6%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHR 598
           +F     LG G FG V+  R    G+  A+K L +      + +E   +E  +++ + H 
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
            ++R+ G   +  +  ++ +Y+E   L S++    R    N   +F     +   L YLH
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP--NPVAKF-YAAEVCLALEYLH 123
Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
                 II+RDLK  NILLDK    KI+DFG A+
Sbjct: 124 SKD---IIYRDLKPENILLDKNGHIKITDFGFAK 154

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 15/178 (8%)
Query: 542 DNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRN 599
           D+F   ++LG G  G+V+K      G  +A K +       I  +   E++++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V   G      E  +  E+M+  SLD V+    R   +  Q    +   + +GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFG--------MARIFGGDQTEQNTKRVVGT 709
             + +I+HRD+K SNIL++     K+ DFG        MA  F G ++  + +R+ GT
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 178

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 15/178 (8%)
Query: 542 DNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRN 599
           D+F   ++LG G  G+V+K      G  +A K +       I  +   E++++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V   G      E  +  E+M+  SLD V+    R   +  Q    +   + +GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFG--------MARIFGGDQTEQNTKRVVGT 709
             + +I+HRD+K SNIL++     K+ DFG        MA  F G ++  + +R+ GT
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 178

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 79/157 (50%), Gaps = 5/157 (3%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      +    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              ++HRDLK SN+LL+     KI DFG+AR+   D 
Sbjct: 145 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 178

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 80/167 (47%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI  FG+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR 173

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 91/188 (48%), Gaps = 20/188 (10%)
Query: 524 TDDLELPLFDFETIVRATDNFTDYN-------KLGQGGFGIVYKG--RLLEGQEIAVKRL 574
           T+  E P  D E I R  + + D         +LG G FG V KG  ++ +  +    ++
Sbjct: 3   TEVYESPYADPEEI-RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKI 61
Query: 575 SRNSGQGI---EEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD 631
            +N        +E   E  ++ +L +  +VR++G C E +  MLV E  E   L+  +  
Sbjct: 62  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-- 118
Query: 632 KARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
             ++  +  +    ++  ++ G+ YL ++S F  +HRDL A N+LL  +   KISDFG++
Sbjct: 119 -QQNRHVKDKNIIELVHQVSMGMKYL-EESNF--VHRDLAARNVLLVTQHYAKISDFGLS 174
Query: 692 RIFGGDQT 699
           +    D+ 
Sbjct: 175 KALRADEN 182

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 91/188 (48%), Gaps = 20/188 (10%)
Query: 524 TDDLELPLFDFETIVRATDNFTDYN-------KLGQGGFGIVYKG--RLLEGQEIAVKRL 574
           T+  E P  D E I R  + + D         +LG G FG V KG  ++ +  +    ++
Sbjct: 3   TEVYESPYADPEEI-RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKI 61
Query: 575 SRNSGQGI---EEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD 631
            +N        +E   E  ++ +L +  +VR++G C E +  MLV E  E   L+  +  
Sbjct: 62  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-- 118
Query: 632 KARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
             ++  +  +    ++  ++ G+ YL ++S F  +HRDL A N+LL  +   KISDFG++
Sbjct: 119 -QQNRHVKDKNIIELVHQVSMGMKYL-EESNF--VHRDLAARNVLLVTQHYAKISDFGLS 174
Query: 692 RIFGGDQT 699
           +    D+ 
Sbjct: 175 KALRADEN 182

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 76/152 (50%), Gaps = 5/152 (3%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T    +G+G +G+V      +    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   +S  L+       +  I RGL Y+H  +
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN 164
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARI 693
              ++HRDLK SN+L++     KI DFG+ARI
Sbjct: 165 ---VLHRDLKPSNLLINTTCDLKICDFGLARI 193

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 79/157 (50%), Gaps = 5/157 (3%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      +    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 93  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 152
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              ++HRDLK SN+LL+     KI DFG+AR+   D 
Sbjct: 153 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 186

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 79/157 (50%), Gaps = 5/157 (3%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      +    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              ++HRDLK SN+LL+     KI DFG+AR+   D 
Sbjct: 145 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 178

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 76/152 (50%), Gaps = 10/152 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKLQH 597
           D+F     LG+G FG VY  R  + + I A+K L  S+   +G+E + + E+ + + L+H
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            N++R+     +     L+ E+     L   +    R    + QR    +  +A  L Y 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYC 130
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           H+    ++IHRD+K  N+L+  +   KI+DFG
Sbjct: 131 HER---KVIHRDIKPENLLMGYKGELKIADFG 159

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 73/146 (50%), Gaps = 10/146 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+GGF   Y+   ++ +E+   ++   S        E+   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
              + D   +V E    RSL  +   K R ++   + R+ +   I +G+ YLH +   R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 666 IHRDLKASNILLDKEMTPKISDFGMA 691
           IHRDLK  N+ L+ +M  KI DFG+A
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 73/146 (50%), Gaps = 10/146 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+GGF   Y+   ++ +E+   ++   S        E+   E+ +   L + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
              + D   +V E    RSL  +   K R ++   + R+ +   I +G+ YLH +   R+
Sbjct: 94  FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 147
Query: 666 IHRDLKASNILLDKEMTPKISDFGMA 691
           IHRDLK  N+ L+ +M  KI DFG+A
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLA 173

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/171 (23%), Positives = 80/171 (46%), Gaps = 11/171 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           D++  + +LG G FG+V++      G   A K +        E  + E++ ++ L+H  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V L     + +E +++YE+M    L   + D+     ++       +  + +GL ++H++
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHEN 168
Query: 661 SRFRIIHRDLKASNILLDKEMTP--KISDFGMARIFGGDQTEQNTKRVVGT 709
           +    +H DLK  NI+   + +   K+ DFG+         +Q+ K   GT
Sbjct: 169 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGT 213

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 73/146 (50%), Gaps = 10/146 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+GGF   ++    + +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
              + D   +V E    RSL  +   K R ++   + R+  +  I  G  YLH++   R+
Sbjct: 83  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RV 136
Query: 666 IHRDLKASNILLDKEMTPKISDFGMA 691
           IHRDLK  N+ L++++  KI DFG+A
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLA 162

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 81/166 (48%), Gaps = 26/166 (15%)
Query: 550 LGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKL-QHRN 599
           LG+G FG V         K +     ++AVK L  ++ +  + +  +E+ ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVI-----------FDKARSSILNWQRRFNIIC 648
           ++ LLG C +     ++ EY    +L   +           F+ + +       +  + C
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 649 G--IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              +ARG+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 12/165 (7%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 18  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 76
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 77  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 130
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT
Sbjct: 131 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 12/165 (7%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 101
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 102 FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 155
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT
Sbjct: 156 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 12/165 (7%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 99
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 100 FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 153
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 15/178 (8%)
Query: 542 DNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRN 599
           D+F   ++LG G  G+V+K      G  +A K +       I  +   E++++ +     
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V   G      E  +  E+M+  SLD V+    R   +  Q    +   + +GL YL +
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 125
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFG--------MARIFGGDQTEQNTKRVVGT 709
             + +I+HRD+K SNIL++     K+ DFG        MA  F G ++  + +R+ GT
Sbjct: 126 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPERLQGT 181

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 12/165 (7%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 152
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 80/167 (47%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI D G+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR 173

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 12/165 (7%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 99
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 100 FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 153
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 79/157 (50%), Gaps = 5/157 (3%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      +    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 105 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 164
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              ++HRDLK SN+LL+     KI DFG+AR+   D 
Sbjct: 165 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 198

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 12/165 (7%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 17  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 75
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 76  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 129
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT
Sbjct: 130 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 12/165 (7%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 150
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 12/165 (7%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 15  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 73
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 74  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 127
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT
Sbjct: 128 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 12/165 (7%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 150
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 80/156 (51%), Gaps = 12/156 (7%)
Query: 549 KLGQGGFGIVYKG--RLLEGQEIAVKRLSRNSGQGI---EEFKNEVRLIAKLQHRNLVRL 603
           +LG G FG V KG  ++ +  +    ++ +N        +E   E  ++ +L +  +VR+
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           +G C E +  MLV E  E   L+  +    ++  +  +    ++  ++ G+ YL ++S F
Sbjct: 92  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL-EESNF 146
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
             +HRDL A N+LL  +   KISDFG+++    D+ 
Sbjct: 147 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 180

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 15/178 (8%)
Query: 542 DNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRN 599
           D+F   ++LG G  G+V+K      G  +A K +       I  +   E++++ +     
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V   G      E  +  E+M+  SLD V+    R   +  Q    +   + +GL YL +
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 149
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFG--------MARIFGGDQTEQNTKRVVGT 709
             + +I+HRD+K SNIL++     K+ DFG        MA  F G ++  + +R+ GT
Sbjct: 150 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 205

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 12/165 (7%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 150
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 12/165 (7%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 152
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 12/165 (7%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 74
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 75  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 128
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 12/165 (7%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 152
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 12/165 (7%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 152
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 12/165 (7%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 152
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 12/165 (7%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 80
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 81  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 134
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT
Sbjct: 135 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 83/166 (50%), Gaps = 26/166 (15%)
Query: 550 LGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQG-IEEFKNEVRLIAKL-QHRN 599
           LG+G FG V         K +     ++AVK L  ++ +  + +  +E+ ++  + +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 600 LVRLLGCC---------VEMDEKMLVYEYMENRSLDSV--IFDKARSSILNWQRRFNIIC 648
           ++ LLG C         VE   K  + EY++ R    +   ++ + +       +  + C
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 649 G--IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              +ARG+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 183

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 78/157 (49%), Gaps = 5/157 (3%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      +    +A+K++S    Q   +    E++++   +H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              ++HRDLK SN+LL+     KI DFG+AR+   D 
Sbjct: 147 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 180

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 81/166 (48%), Gaps = 26/166 (15%)
Query: 550 LGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQG-IEEFKNEVRLIAKL-QHRN 599
           LG+G FG V         K +     ++AVK L  ++ +  + +  +E+ ++  + +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVI-----------FDKARSSILNWQRRFNIIC 648
           ++ LLG C +     ++ EY    +L   +           ++ + +       +  + C
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 649 G--IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              +ARG+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 12/165 (7%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 95
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 96  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 149
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 80/156 (51%), Gaps = 12/156 (7%)
Query: 549 KLGQGGFGIVYKG--RLLEGQEIAVKRLSRNSGQGI---EEFKNEVRLIAKLQHRNLVRL 603
           +LG G FG V KG  ++ +  +    ++ +N        +E   E  ++ +L +  +VR+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           +G C E +  MLV E  E   L+  +    ++  +  +    ++  ++ G+ YL ++S F
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL-EESNF 132
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
             +HRDL A N+LL  +   KISDFG+++    D+ 
Sbjct: 133 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 12/165 (7%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 99  FTFQDDEKLYFGLSYAKNGCLLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 152
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 12/165 (7%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 95
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 96  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 149
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 80/156 (51%), Gaps = 12/156 (7%)
Query: 549 KLGQGGFGIVYKG--RLLEGQEIAVKRLSRNSGQGI---EEFKNEVRLIAKLQHRNLVRL 603
           +LG G FG V KG  ++ +  +    ++ +N        +E   E  ++ +L +  +VR+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           +G C E +  MLV E  E   L+  +    ++  +  +    ++  ++ G+ YL ++S F
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL-EESNF 132
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
             +HRDL A N+LL  +   KISDFG+++    D+ 
Sbjct: 133 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 84/168 (50%), Gaps = 30/168 (17%)
Query: 550 LGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQG-IEEFKNEVRLIAKL-QHRN 599
           LG+G FG V         K +     ++AVK L  ++ +  + +  +E+ ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 600 LVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN----I 646
           ++ LLG C         VE   K  + EY++ R    + +    S   N + + +    +
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSH--NPEEQLSSKDLV 153
Query: 647 ICG--IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            C   +ARG+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 17/170 (10%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIE---EFKNEVRLIAKLQHRNLVRLLG 605
           LG GG   V+  R L + +++AVK L  +  +       F+ E +  A L H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 606 CC-VEMDEKMLVY---EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
               E     L Y   EY++  +L  ++  +     +  +R   +I    + L + HQ+ 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFG--GDQTEQNTKRVVGT 709
              IIHRD+K +NIL+      K+ DFG+AR     G+   Q T  V+GT
Sbjct: 137 ---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQ-TAAVIGT 182

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 80/167 (47%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI D G+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR 173

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 84/176 (47%), Gaps = 30/176 (17%)
Query: 542 DNFTDYNKLGQGGFGIVYK------GRLLEGQEIAVKRLSRNSGQGIEEF--KNEVRLIA 593
           D +    +LG G FG+V++      GR+   + I       N+   ++++  KNE+ ++ 
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI-------NTPYPLDKYTVKNEISIMN 103
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI----FDKARSSILNWQRRFNIICG 649
           +L H  L+ L     +  E +L+ E++    L   I    +  + + ++N+ R+      
Sbjct: 104 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ------ 157
Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLD--KEMTPKISDFGMARIFGGDQTEQNT 703
              GL ++H+ S   I+H D+K  NI+ +  K  + KI DFG+A     D+  + T
Sbjct: 158 ACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT 210

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 80/167 (47%), Gaps = 17/167 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI D G+AR
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR 173

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 21/166 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 7   ENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMAR 692
             G+ YLH     +I H DLK  NI+L     P    KI DFG+A 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 76/152 (50%), Gaps = 10/152 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKLQH 597
           D+F     LG+G FG VY  R  + + I A+K L  S+   +G+E + + E+ + + L+H
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            N++R+     +     L+ E+     L   +    R    + QR    +  +A  L Y 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYC 131
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           H+    ++IHRD+K  N+L+  +   KI+DFG
Sbjct: 132 HER---KVIHRDIKPENLLMGYKGELKIADFG 160

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 83/166 (50%), Gaps = 26/166 (15%)
Query: 550 LGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKL-QHRN 599
           LG+G FG V         K +     ++AVK L  ++ +  + +  +E+ ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 600 LVRLLGCC---------VEMDEKMLVYEYMENRSLDSV--IFDKARSSILNWQRRFNIIC 648
           ++ LLG C         VE   K  + EY++ R    +   ++ + +       +  + C
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 649 G--IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              +ARG+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 78/157 (49%), Gaps = 5/157 (3%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      +    +A+K++S    Q   +    E++++   +H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              ++HRDLK SN+LL+     KI DFG+AR+   D 
Sbjct: 147 ---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDH 180

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 21/166 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 122
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMAR 692
             G+ YLH     +I H DLK  NI+L     P    KI DFG+A 
Sbjct: 123 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 72/139 (51%), Gaps = 13/139 (9%)
Query: 550 LGQGGFGIVYKGRLLE----GQ----EIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           LGQG F  ++KG   E    GQ    E+ +K L +      E F     +++KL H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
              G C   DE +LV E+++  SLD+ +  K   + +N   +  +   +A  + +L +++
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAWAMHFLEENT 133
Query: 662 RFRIIHRDLKASNILLDKE 680
              +IH ++ A NILL +E
Sbjct: 134 ---LIHGNVCAKNILLIRE 149

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 80/156 (51%), Gaps = 12/156 (7%)
Query: 549 KLGQGGFGIVYKG--RLLEGQEIAVKRLSRNSGQGI---EEFKNEVRLIAKLQHRNLVRL 603
           +LG G FG V KG  ++ +  +    ++ +N        +E   E  ++ +L +  +VR+
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           +G C E +  MLV E  E   L+  +    ++  +  +    ++  ++ G+ YL ++S F
Sbjct: 72  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL-EESNF 126
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
             +HRDL A N+LL  +   KISDFG+++    D+ 
Sbjct: 127 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 160

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 21/166 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMAR 692
             G+ YLH     +I H DLK  NI+L     P    KI DFG+A 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 21/166 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 122
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMAR 692
             G+ YLH     +I H DLK  NI+L     P    KI DFG+A 
Sbjct: 123 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 80/156 (51%), Gaps = 12/156 (7%)
Query: 549 KLGQGGFGIVYKG--RLLEGQEIAVKRLSRNSGQGI---EEFKNEVRLIAKLQHRNLVRL 603
           +LG G FG V KG  ++ +  +    ++ +N        +E   E  ++ +L +  +VR+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           +G C E +  MLV E  E   L+  +    ++  +  +    ++  ++ G+ YL ++S F
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL-EESNF 128
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
             +HRDL A N+LL  +   KISDFG+++    D+ 
Sbjct: 129 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 84/168 (50%), Gaps = 30/168 (17%)
Query: 550 LGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQG-IEEFKNEVRLIAKL-QHRN 599
           LG+G FG V         K +     ++AVK L  ++ +  + +  +E+ ++  + +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 600 LVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN----I 646
           ++ LLG C         VE   K  + EY++ R    + +    S   N + + +    +
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH--NPEEQLSSKDLV 145
Query: 647 ICG--IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            C   +ARG+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR
Sbjct: 146 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 190

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 80/156 (51%), Gaps = 12/156 (7%)
Query: 549 KLGQGGFGIVYKG--RLLEGQEIAVKRLSRNSGQGI---EEFKNEVRLIAKLQHRNLVRL 603
           +LG G FG V KG  ++ +  +    ++ +N        +E   E  ++ +L +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           +G C E +  MLV E  E   L+  +    ++  +  +    ++  ++ G+ YL ++S F
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL-EESNF 138
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
             +HRDL A N+LL  +   KISDFG+++    D+ 
Sbjct: 139 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 84/168 (50%), Gaps = 30/168 (17%)
Query: 550 LGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQG-IEEFKNEVRLIAKL-QHRN 599
           LG+G FG V         K +     ++AVK L  ++ +  + +  +E+ ++  + +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 600 LVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN----I 646
           ++ LLG C         VE   K  + EY++ R    + +    S   N + + +    +
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH--NPEEQLSSKDLV 142
Query: 647 ICG--IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            C   +ARG+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR
Sbjct: 143 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 187

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 84/168 (50%), Gaps = 30/168 (17%)
Query: 550 LGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQG-IEEFKNEVRLIAKL-QHRN 599
           LG+G FG V         K +     ++AVK L  ++ +  + +  +E+ ++  + +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 600 LVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN----I 646
           ++ LLG C         VE   K  + EY++ R    + +    S   N + + +    +
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH--NPEEQLSSKDLV 146
Query: 647 ICG--IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            C   +ARG+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR
Sbjct: 147 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 191

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 84/168 (50%), Gaps = 30/168 (17%)
Query: 550 LGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQG-IEEFKNEVRLIAKL-QHRN 599
           LG+G FG V         K +     ++AVK L  ++ +  + +  +E+ ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 600 LVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN----I 646
           ++ LLG C         VE   K  + EY++ R    + +    S   N + + +    +
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH--NPEEQLSSKDLV 153
Query: 647 ICG--IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            C   +ARG+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 72/151 (47%), Gaps = 11/151 (7%)
Query: 550 LGQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKLQHRNLVRLLGCC 607
           LG G F  +V       G+  AVK + + + +G E   +NE+ ++ K++H N+V L    
Sbjct: 30  LGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIY 89
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
              +   LV + +    L   I +K        +    +I  +   + YLH   R  I+H
Sbjct: 90  ESPNHLYLVMQLVSGGELFDRIVEKG---FYTEKDASTLIRQVLDAVYYLH---RMGIVH 143
Query: 668 RDLKASNILL---DKEMTPKISDFGMARIFG 695
           RDLK  N+L    D+E    ISDFG++++ G
Sbjct: 144 RDLKPENLLYYSQDEESKIMISDFGLSKMEG 174

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 71/137 (51%), Gaps = 25/137 (18%)
Query: 582 IEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML--VYEY------MENRSLDSVIFDKA 633
           IE+   E+ ++ KL H N+V+L+    + +E  L  V+E       ME  +L  +  D+A
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 634 RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI 693
           R    +          + +G+ YLH     +IIHRD+K SN+L+ ++   KI+DFG++  
Sbjct: 140 RFYFQD----------LIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 694 F-GGDQTEQNTKRVVGT 709
           F G D    NT   VGT
Sbjct: 187 FKGSDALLSNT---VGT 200

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 21/166 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 7   ENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMAR 692
             G+ YLH     +I H DLK  NI+L     P    KI DFG+A 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 15/178 (8%)
Query: 542 DNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRN 599
           D+F   ++LG G  G+V+K      G  +A K +       I  +   E++++ +     
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V   G      E  +  E+M+  SLD V+    R   +  Q    +   + +GL YL +
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 141
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFG--------MARIFGGDQTEQNTKRVVGT 709
             + +I+HRD+K SNIL++     K+ DFG        MA  F G ++  + +R+ GT
Sbjct: 142 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 197

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 21/166 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMAR 692
             G+ YLH     +I H DLK  NI+L     P    KI DFG+A 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 21/166 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMAR 692
             G+ YLH     +I H DLK  NI+L     P    KI DFG+A 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 72/171 (42%), Gaps = 26/171 (15%)
Query: 550 LGQGGFGIVYKGRLL------EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKL-QHRNLV 601
           LG G FG V +              +AVK L  ++     E   +E+++++ L  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 602 RLLGCCVEMDEKMLVYEY--------MENRSLDSVIFDKARSSILNWQRRF-------NI 646
            LLG C      +++ EY           R  DS I  K   +I+             + 
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
              +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D
Sbjct: 174 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARHIKND 221

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 21/166 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMAR 692
             G+ YLH     +I H DLK  NI+L     P    KI DFG+A 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 21/166 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMAR 692
             G+ YLH     +I H DLK  NI+L     P    KI DFG+A 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 79/170 (46%), Gaps = 17/170 (10%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIE---EFKNEVRLIAKLQHRNLVRLLG 605
           LG GG   V+  R L + +++AVK L  +  +       F+ E +  A L H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 606 CC-VEMDEKMLVY---EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
               E     L Y   EY++  +L  ++  +     +  +R   +I    + L + HQ+ 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFG--GDQTEQNTKRVVGT 709
              IIHRD+K +NI++      K+ DFG+AR     G+   Q T  V+GT
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGT 182

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 21/166 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMAR 692
             G+ YLH     +I H DLK  NI+L     P    KI DFG+A 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 80/177 (45%), Gaps = 28/177 (15%)
Query: 529 LPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN- 587
           LPL    TI R          +G+G FG V++G+   G+E+AVK  S  S +    F+  
Sbjct: 19  LPLLVQRTIAR---TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREA 72
Query: 588 EVRLIAKLQHRNLVRLLGCCVEMDEK--------MLVYEYMENRSLDSVIFDKARSSILN 639
           E+     L+H N++  +      D K         LV +Y E+ SL    FD      + 
Sbjct: 73  EIYQTVMLRHENILGFIAA----DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVT 124
Query: 640 WQRRFNIICGIARGLLYLHQD-----SRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
            +    +    A GL +LH +      +  I HRDLK+ NIL+ K  T  I+D G+A
Sbjct: 125 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 181

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 80/177 (45%), Gaps = 28/177 (15%)
Query: 529 LPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN- 587
           LPL    TI R          +G+G FG V++G+   G+E+AVK  S  S +    F+  
Sbjct: 32  LPLLVQRTIAR---TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREA 85
Query: 588 EVRLIAKLQHRNLVRLLGCCVEMDEK--------MLVYEYMENRSLDSVIFDKARSSILN 639
           E+     L+H N++  +      D K         LV +Y E+ SL    FD      + 
Sbjct: 86  EIYQTVMLRHENILGFIAA----DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVT 137
Query: 640 WQRRFNIICGIARGLLYLHQD-----SRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
            +    +    A GL +LH +      +  I HRDLK+ NIL+ K  T  I+D G+A
Sbjct: 138 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 79/170 (46%), Gaps = 17/170 (10%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIE---EFKNEVRLIAKLQHRNLVRLLG 605
           LG GG   V+  R L + +++AVK L  +  +       F+ E +  A L H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 606 CC-VEMDEKMLVY---EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
               E     L Y   EY++  +L  ++  +     +  +R   +I    + L + HQ+ 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFG--GDQTEQNTKRVVGT 709
              IIHRD+K +NI++      K+ DFG+AR     G+   Q T  V+GT
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGT 182

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 21/166 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMAR 692
             G+ YLH     +I H DLK  NI+L     P    KI DFG+A 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 72/171 (42%), Gaps = 26/171 (15%)
Query: 550 LGQGGFGIVYKGRLL------EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKL-QHRNLV 601
           LG G FG V +              +AVK L  ++     E   +E+++++ L  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 602 RLLGCCVEMDEKMLVYEY--------MENRSLDSVIFDKARSSILNWQRRF-------NI 646
            LLG C      +++ EY           R  DS I  K   +I+             + 
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
              +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D
Sbjct: 174 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKND 221

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 21/166 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMAR 692
             G+ YLH     +I H DLK  NI+L     P    KI DFG+A 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 72/172 (41%), Gaps = 26/172 (15%)
Query: 550 LGQGGFGIVYKGRLL------EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKL-QHRNLV 601
           LG G FG V +              +AVK L  ++     E   +E+++++ L  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 602 RLLGCCVEMDEKMLVYEY--------MENRSLDSVIFDKARSSILNWQRRF-------NI 646
            LLG C      +++ EY           R  DS I  K   +I+             + 
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D 
Sbjct: 151 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 21/166 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMAR 692
             G+ YLH     +I H DLK  NI+L     P    KI DFG+A 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 77/177 (43%), Gaps = 15/177 (8%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQGIEE-FKNEVRLIAK 594
           I+  +D +     +G G FG+    R  +  E +AVK + R  G+ I+E  K E+     
Sbjct: 14  IMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIER--GEKIDENVKREIINHRS 71
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           L+H N+VR     +      +V EY     L   I +  R S    + RF     +  G+
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS--EDEARF-FFQQLISGV 128
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTP--KISDFGMARIFGGDQTEQNTKRVVGT 709
            Y H     ++ HRDLK  N LLD    P  KI+DFG ++           K  VGT
Sbjct: 129 SYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQPKSAVGT 179

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 21/166 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMAR 692
             G+ YLH     +I H DLK  NI+L     P    KI DFG+A 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 73/161 (45%), Gaps = 21/161 (13%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 602 RLLGCCVEMDEKMLVY----------EYMENRSLDSVIFDKARSSILNWQRRFNIICGIA 651
            LLG C +    ++V            Y+ ++  + V +       L  +        +A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +G+ +L   +  + IHRDL A NILL ++   KI DFG+AR
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLAR 192

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 73/165 (44%), Gaps = 12/165 (7%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F      R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 150
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 72/171 (42%), Gaps = 26/171 (15%)
Query: 550 LGQGGFGIVYKGRLL------EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKL-QHRNLV 601
           LG G FG V +              +AVK L  ++     E   +E+++++ L  H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 602 RLLGCCVEMDEKMLVYEY--------MENRSLDSVIFDKARSSILNWQRRF-------NI 646
            LLG C      +++ EY           R  DS I  K   +I+             + 
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
              +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D
Sbjct: 169 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKND 216

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 72/171 (42%), Gaps = 26/171 (15%)
Query: 550 LGQGGFGIVYKGRLL------EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKL-QHRNLV 601
           LG G FG V +              +AVK L  ++     E   +E+++++ L  H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 602 RLLGCCVEMDEKMLVYEY--------MENRSLDSVIFDKARSSILNWQRRF-------NI 646
            LLG C      +++ EY           R  DS I  K   +I+             + 
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
              +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D
Sbjct: 167 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKND 214

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 78/170 (45%), Gaps = 17/170 (10%)
Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIE---EFKNEVRLIAKLQHRNLVRLLG 605
           LG GG   V+  R L   +++AVK L  +  +       F+ E +  A L H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYA 79
Query: 606 CC-VEMDEKMLVY---EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
               E     L Y   EY++  +L  ++  +     +  +R   +I    + L + HQ+ 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFG--GDQTEQNTKRVVGT 709
              IIHRD+K +NI++      K+ DFG+AR     G+   Q T  V+GT
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGT 182

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 24/164 (14%)
Query: 550 LGQGGFGIVYKGRLLE-GQE-----IAVKRL-SRNSGQGIEEFKNEVRLIAKL-QHRNLV 601
           LG G FG V +      G+E     +AVK L S       E   +E+++++ L QH N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-------------LNWQRRFNIIC 648
            LLG C      +++ EY     L + +  K    +             L+ +   +   
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSS 173
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            +A+G+ +L   +    IHRD+ A N+LL      KI DFG+AR
Sbjct: 174 QVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLAR 214

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 82/162 (50%), Gaps = 23/162 (14%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 602 RLLGCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRF-------NIIC---GI 650
            LLG C +     M++ E+ +  +L + +  K R+  + ++  +       ++IC    +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVPYKDLYKDFLTLEHLICYSFQV 153
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR
Sbjct: 154 AKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLAR 192

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/172 (31%), Positives = 82/172 (47%), Gaps = 17/172 (9%)
Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRL--- 603
           +LG GGFG V +    + G+++A+K+  +  S +  E +  E++++ KL H N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 604 ---LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
              L      D  +L  EY E   L   +        L       ++  I+  L YLH++
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 661 SRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
              RIIHRDLK  NI+L    + +  KI D G A+    DQ E  T+  VGT
Sbjct: 141 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTE-FVGT 186

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/172 (31%), Positives = 82/172 (47%), Gaps = 17/172 (9%)
Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRL--- 603
           +LG GGFG V +    + G+++A+K+  +  S +  E +  E++++ KL H N+V     
Sbjct: 22  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 81
Query: 604 ---LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
              L      D  +L  EY E   L   +        L       ++  I+  L YLH++
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 141
Query: 661 SRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
              RIIHRDLK  NI+L    + +  KI D G A+    DQ E  T+  VGT
Sbjct: 142 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTE-FVGT 187

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 15/162 (9%)
Query: 538 VRATDNFTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR--NSGQGIEEFKNEVRLI 592
           VRA   + D   +G G +G V     GR   G ++A+K+L R   S    +    E+RL+
Sbjct: 23  VRAV--YRDLQPVGSGAYGAVCSAVDGR--TGAKVAIKKLYRPFQSELFAKRAYRELRLL 78
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYE--YMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
             ++H N++ LL      DE +  +   Y+    + + +    +   L   R   ++  +
Sbjct: 79  KHMRHENVIGLLDVFTP-DETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 137
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            +GL Y+H      IIHRDLK  N+ ++++   KI DFG+AR
Sbjct: 138 LKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 10/173 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI----AVKRLSRNSGQGIEEFKNEVRLIAKLQH 597
           D F D+  LG+GGFG V+  ++    ++     + +      +G +    E +++AK+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLY 656
           R +V L        +  LV   M    +   I++    +      R       I  GL +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           LHQ +   II+RDLK  N+LLD +   +ISD G+A      QT+  TK   GT
Sbjct: 305 LHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGT 352

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 10/173 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI----AVKRLSRNSGQGIEEFKNEVRLIAKLQH 597
           D F D+  LG+GGFG V+  ++    ++     + +      +G +    E +++AK+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLY 656
           R +V L        +  LV   M    +   I++    +      R       I  GL +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           LHQ +   II+RDLK  N+LLD +   +ISD G+A      QT+  TK   GT
Sbjct: 305 LHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGT 352

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 10/173 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI----AVKRLSRNSGQGIEEFKNEVRLIAKLQH 597
           D F D+  LG+GGFG V+  ++    ++     + +      +G +    E +++AK+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLY 656
           R +V L        +  LV   M    +   I++    +      R       I  GL +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           LHQ +   II+RDLK  N+LLD +   +ISD G+A      QT+  TK   GT
Sbjct: 305 LHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGT 352

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 78/170 (45%), Gaps = 17/170 (10%)
Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIE---EFKNEVRLIAKLQHRNLVRLLG 605
           LG GG   V+  R L   +++AVK L  +  +       F+ E +  A L H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 606 CC-VEMDEKMLVY---EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
               E     L Y   EY++  +L  ++  +     +  +R   +I    + L + HQ+ 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFG--GDQTEQNTKRVVGT 709
              IIHRD+K +NI++      K+ DFG+AR     G+   Q T  V+GT
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGT 182

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 78/169 (46%), Gaps = 24/169 (14%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 602 RLLGCCVEMDEKMLVY----------EYMENRSLDSVIFDKARSSILNWQRRFNIIC--- 648
            LLG C +    ++V            Y+ ++  + V +        ++    ++IC   
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
            +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR    D
Sbjct: 156 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 201

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 10/173 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI----AVKRLSRNSGQGIEEFKNEVRLIAKLQH 597
           D F D+  LG+GGFG V+  ++    ++     + +      +G +    E +++AK+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLY 656
           R +V L        +  LV   M    +   I++    +      R       I  GL +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           LHQ +   II+RDLK  N+LLD +   +ISD G+A      QT+  TK   GT
Sbjct: 305 LHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGT 352

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 85/175 (48%), Gaps = 37/175 (21%)
Query: 534 FETIVRATDNFTDYNKLGQGGFGIVY--KGRLLEGQE--IAVKRLSRNSGQGIEEFKNEV 589
           +E + + ++ F   +K+G+G F  VY    +L  G E  IA+K L   S        + +
Sbjct: 13  YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--------HPI 64
Query: 590 RLIAKLQ-------HRNLVRLLGCCVEMDEKMLVYEYMENRS----LDSVIFDKARSSIL 638
           R+ A+LQ         N++ +  C  + D  ++   Y+E+ S    L+S+ F + R  +L
Sbjct: 65  RIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYML 124
Query: 639 NWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMAR 692
           N          + + L  +HQ   F I+HRD+K SN L ++ +    + DFG+A+
Sbjct: 125 N----------LFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 71/160 (44%), Gaps = 6/160 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGI--EEFKNEVRLIAKLQHRN 599
            +     +G G +G V        G+++A+K+LSR     I  +    E+ L+  +QH N
Sbjct: 43  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           ++ LL            Y++            K      + ++   ++  + +GL Y+H 
Sbjct: 103 VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHS 162
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
                ++HRDLK  N+ ++++   KI DFG+AR    + T
Sbjct: 163 AG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT 199

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 31/171 (18%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG G FG V         +     ++AVK L   +     E   +E++++ +L  H N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 602 RLLGCCVEMDEKMLVYEYM-------------ENRSLDSVIFDKARS-------SILNWQ 641
            LLG C       L++EY              E  S D + ++  +        ++L ++
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
                   +A+G+ +L   S    +HRDL A N+L+      KI DFG+AR
Sbjct: 173 DLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLAR 220

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 70/153 (45%), Gaps = 6/153 (3%)
Query: 550 LGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGI--EEFKNEVRLIAKLQHRNLVRLLGC 606
           +G G +G V        G+++A+K+LSR     I  +    E+ L+  +QH N++ LL  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
                     Y++            K      + ++   ++  + +GL Y+H      ++
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG---VV 148
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
           HRDLK  N+ ++++   KI DFG+AR    + T
Sbjct: 149 HRDLKPGNLAVNEDCELKILDFGLARHADAEMT 181

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 76/177 (42%), Gaps = 15/177 (8%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQGIEE-FKNEVRLIAK 594
           I+  +D +     +G G FG+    R  +  E +AVK + R  G+ I+E  K E+     
Sbjct: 13  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIER--GEKIDENVKREIINHRS 70
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           L+H N+VR     +      +V EY     L   I +  R S    + RF     +  G+
Sbjct: 71  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS--EDEARF-FFQQLISGV 127
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTP--KISDFGMARIFGGDQTEQNTKRVVGT 709
            Y H     ++ HRDLK  N LLD    P  KI DFG ++           K  VGT
Sbjct: 128 SYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGT 178

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 25/165 (15%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 602 RLLGCCVEMDEKMLVY----------EYMENRSLDSVIFDKARSSIL-NWQRRFNIIC-- 648
            LLG C +    ++V            Y+ ++  + V + +A   +  ++    ++IC  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 649 -GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR
Sbjct: 157 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 198

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 82/180 (45%), Gaps = 19/180 (10%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGI--EEFKNEVRLIAKLQHRN 599
           D+F   ++LG G  G+V K +      I  ++L     +     +   E++++ +     
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKAR--SSILNWQRRFNIICGIARGLLYL 657
           +V   G      E  +  E+M+  SLD V+ +  R    IL       +   + RGL YL
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYL 130
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFG--------MARIFGGDQTEQNTKRVVGT 709
            +  + +I+HRD+K SNIL++     K+ DFG        MA  F G ++    +R+ GT
Sbjct: 131 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPERLQGT 188

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 81/165 (49%), Gaps = 7/165 (4%)
Query: 538 VRATDNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQGIE--EFKNEVRLIAK 594
           V   DN+   + +G+G +G VY       ++ +A+K+++R     I+      E+ ++ +
Sbjct: 22  VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNR 81
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARG 653
           L+   ++RL    +  D       Y+     DS +    ++ I L  +    I+  +  G
Sbjct: 82  LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLG 141
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
             ++H+     IIHRDLK +N LL+++ + K+ DFG+AR    ++
Sbjct: 142 ENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 13/156 (8%)
Query: 550 LGQGGFGIVYKGRLLE-GQEIAVK-----RLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +G+G F +V +    E GQ+ AVK     + + + G   E+ K E  +   L+H ++V L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSS-ILNWQRRFNIICGIARGLLYLHQDSR 662
           L          +V+E+M+   L   I  +A +  + +     + +  I   L Y H ++ 
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN- 150
Query: 663 FRIIHRDLKASNILL---DKEMTPKISDFGMARIFG 695
             IIHRD+K  N+LL   +     K+ DFG+A   G
Sbjct: 151 --IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG 184

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/128 (32%), Positives = 61/128 (47%), Gaps = 18/128 (14%)
Query: 581 GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME------NRSLDSVIFDKAR 634
           G    K E++L+ +L+H+N+++L+      +EK  +Y  ME         LDSV   + R
Sbjct: 49  GEANVKKEIQLLRRLRHKNVIQLVDVLYN-EEKQKMYMVMEYCVCGMQEMLDSV--PEKR 105
Query: 635 SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI- 693
             +      F   C +  GL YLH      I+H+D+K  N+LL    T KIS  G+A   
Sbjct: 106 FPVCQAHGYF---CQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159
Query: 694 --FGGDQT 699
             F  D T
Sbjct: 160 HPFAADDT 167

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 18/160 (11%)
Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN 599
           +D F   ++LG+G   IVY+ +    Q+  A+K L +   + I   + E+ ++ +L H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSHPN 109
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +++L        E  LV E +    L   I +K   S    +   + +  I   + YLH+
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYS---ERDAADAVKQILEAVAYLHE 166
Query: 660 DSRFRIIHRDLKASNILLDKEMTP------KISDFGMARI 693
           +    I+HRDLK  N+L     TP      KI+DFG+++I
Sbjct: 167 NG---IVHRDLKPENLLY---ATPAPDAPLKIADFGLSKI 200

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 82/175 (46%), Gaps = 25/175 (14%)
Query: 541 TDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSR-------NSGQGIEEFKNEVRLI 592
           +D +    KLG G +G V   +  L G E A+K + +       NSG  +    +EV ++
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALL----DEVAVL 75
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYE-YMENRSLDSVIFDKARSSILNWQRRFNIICGIA 651
            +L H N+++L     +     LV E Y      D +I  +  S +        I+  + 
Sbjct: 76  KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV----DAAVIMKQVL 131
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIF--GGDQTEQ 701
            G  YLH+ +   I+HRDLK  N+LL+   ++   KI DFG++  F  GG   E+
Sbjct: 132 SGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER 183

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 74/152 (48%), Gaps = 12/152 (7%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCC 607
           L +GGF  VY+ + +  G+E A+KRL  N  +       EV  + KL  H N+V+     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 608 V----EMD----EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
                E D    E +L+ E  + + ++ +   ++R   L+      I     R + ++H+
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP-LSCDTVLKIFYQTCRAVQHMHR 154
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
             +  IIHRDLK  N+LL  + T K+ DFG A
Sbjct: 155 Q-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 78/170 (45%), Gaps = 17/170 (10%)
Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIE---EFKNEVRLIAKLQHRNLVRLLG 605
           LG GG   V+  R L   +++AVK L  +  +       F+ E +  A L H  +V +  
Sbjct: 37  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 96
Query: 606 CC-VEMDEKMLVY---EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
               E     L Y   EY++  +L  ++  +     +  +R   +I    + L + HQ+ 
Sbjct: 97  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 153
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFG--GDQTEQNTKRVVGT 709
              IIHRD+K +NI++      K+ DFG+AR     G+   Q T  V+GT
Sbjct: 154 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGT 199

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 88/181 (48%), Gaps = 11/181 (6%)
Query: 516 KRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRL 574
           K+ +S+  T  +  P  D++      D +   + +G G +G V +    LE + +A+K++
Sbjct: 31  KQHHSSKPTASMPRPHSDWQI----PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI 86
Query: 575 SRNSGQGIE--EFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK 632
            R     I+      E+ ++ +L H ++V++L   +  D +     Y+     DS     
Sbjct: 87  LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKL 146
Query: 633 ARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
            R+ + L       ++  +  G+ Y+H      I+HRDLK +N L++++ + K+ DFG+A
Sbjct: 147 FRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203
Query: 692 R 692
           R
Sbjct: 204 R 204

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 79/165 (47%), Gaps = 25/165 (15%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 602 RLLGCCVEMDEKMLVY----------EYMENRSLDSVIFDKARSSIL-NWQRRFNIIC-- 648
            LLG C +    ++V            Y+ ++  + V +  A   +  ++    ++IC  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 649 -GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 83/186 (44%), Gaps = 24/186 (12%)
Query: 518 DYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLS-R 576
           D+S        LP     T+ R     T    +G+G +G V++G   +G+ +AVK  S R
Sbjct: 16  DHSCTSGSGSGLPFLVQRTVAR---QITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR 71
Query: 577 NSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM------LVYEYMENRSLDSVIF 630
           +      E   E+     L+H N++  +    +M  +       L+  Y E  SL    +
Sbjct: 72  DEKSWFRE--TELYNTVMLRHENILGFIAS--DMTSRHSSTQLWLITHYHEMGSL----Y 123
Query: 631 DKARSSILNWQRRFNIICGIARGLLYLHQD-----SRFRIIHRDLKASNILLDKEMTPKI 685
           D  + + L+      I+  IA GL +LH +      +  I HRDLK+ NIL+ K     I
Sbjct: 124 DYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 183
Query: 686 SDFGMA 691
           +D G+A
Sbjct: 184 ADLGLA 189

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 80/170 (47%), Gaps = 25/170 (14%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 602 RLLGCCVEMDEKMLVY----------EYMENRSLDSVIFDKARSSIL-NWQRRFNIIC-- 648
            LLG C +    ++V            Y+ ++  + V +  A   +  ++    ++IC  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 649 -GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
             +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR    D
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 201

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 79/165 (47%), Gaps = 25/165 (15%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 602 RLLGCCVEMDEKMLVY----------EYMENRSLDSVIFDKARSSIL-NWQRRFNIIC-- 648
            LLG C +    ++V            Y+ ++  + V +  A   +  ++    ++IC  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 649 -GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 79/165 (47%), Gaps = 25/165 (15%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 602 RLLGCCVEMDEKMLVYE----------YMENRSLDSVIFDKARSSIL-NWQRRFNIIC-- 648
            LLG C +    ++V            Y+ ++  + V +  A   +  ++    ++IC  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 649 -GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 82/196 (41%), Gaps = 21/196 (10%)
Query: 518 DYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSR 576
           D +   T  L++P      I+  +D +     +G G FG+    R  L  + +AVK + R
Sbjct: 2   DRAPVTTGPLDMP------IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIER 55
Query: 577 NSGQGIEE-FKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARS 635
             G  I+E  + E+     L+H N+VR     +      ++ EY     L   I +  R 
Sbjct: 56  --GAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRF 113
Query: 636 SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP--KISDFGMARI 693
           S    + RF     +  G+ Y H     +I HRDLK  N LLD    P  KI DFG ++ 
Sbjct: 114 S--EDEARF-FFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSK- 166
Query: 694 FGGDQTEQNTKRVVGT 709
                     K  VGT
Sbjct: 167 --SSVLHSQPKSTVGT 180

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 81/170 (47%), Gaps = 17/170 (10%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI----AVKRLSRNS----GQGIEEFKNEVRLIA 593
           +NF     LG G +G V+  R + G +     A+K L + +     +  E  + E +++ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 594 KLQHRNLVRLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICG-IA 651
            ++    +  L    + + K+ L+ +Y+    L + +  + R +    +    I  G I 
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFT----EHEVQIYVGEIV 169
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ 701
             L +LH   +  II+RD+K  NILLD      ++DFG+++ F  D+TE+
Sbjct: 170 LALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 216

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 79/165 (47%), Gaps = 25/165 (15%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 602 RLLGCCVEMDEKMLVYE----------YMENRSLDSVIFDKARSSIL-NWQRRFNIIC-- 648
            LLG C +    ++V            Y+ ++  + V +  A   +  ++    ++IC  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 649 -GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 25/175 (14%)
Query: 541 TDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSR-------NSGQGIEEFKNEVRLI 592
           +D +    KLG G +G V   +  L G E A+K + +       NSG  +    +EV ++
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALL----DEVAVL 58
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYE-YMENRSLDSVIFDKARSSILNWQRRFNIICGIA 651
            +L H N+++L     +     LV E Y      D +I  +  S +        I+  + 
Sbjct: 59  KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV----DAAVIMKQVL 114
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIF--GGDQTEQ 701
            G  YLH   +  I+HRDLK  N+LL+   ++   KI DFG++  F  GG   E+
Sbjct: 115 SGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER 166

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 79/165 (47%), Gaps = 25/165 (15%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 602 RLLGCCVEMDEKMLVYE----------YMENRSLDSVIFDKARSSIL-NWQRRFNIIC-- 648
            LLG C +    ++V            Y+ ++  + V +  A   +  ++    ++IC  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 649 -GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 74/156 (47%), Gaps = 25/156 (16%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNLVRLLGCCV 608
           +G+G FG V++G+   G+E+AVK  S  S +    F+  E+     L+H N++  +    
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIAA-- 66
Query: 609 EMDEK--------MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
             D K         LV +Y E+ SL    FD      +  +    +    A GL +LH +
Sbjct: 67  --DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 120
Query: 661 -----SRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
                 +  I HRDLK+ NIL+ K  T  I+D G+A
Sbjct: 121 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 156

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 79/165 (47%), Gaps = 25/165 (15%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 602 RLLGCCVEMDEKMLVY----------EYMENRSLDSVIFDKARSSIL-NWQRRFNIIC-- 648
            LLG C +    ++V            Y+ ++  + V +  A   +  ++    ++IC  
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 649 -GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 79/165 (47%), Gaps = 25/165 (15%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 602 RLLGCCVEMDEKMLVY----------EYMENRSLDSVIFDKARSSIL-NWQRRFNIIC-- 648
            LLG C +    ++V            Y+ ++  + V +  A   +  ++    ++IC  
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 649 -GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR
Sbjct: 192 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 233

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 74/156 (47%), Gaps = 25/156 (16%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNLVRLLGCCV 608
           +G+G FG V++G+   G+E+AVK  S  S +    F+  E+     L+H N++  +    
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIAA-- 71
Query: 609 EMDEK--------MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
             D K         LV +Y E+ SL    FD      +  +    +    A GL +LH +
Sbjct: 72  --DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 125
Query: 661 -----SRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
                 +  I HRDLK+ NIL+ K  T  I+D G+A
Sbjct: 126 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 161

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 81/158 (51%), Gaps = 15/158 (9%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFK-NEVRLIAKLQHRNLVRLLGCC 607
           K+G+G +G VYK +  +G++     L +  G GI      E+ L+ +L+H N++ L    
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 608 V-EMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY-----LHQD 660
           +   D K+ L+++Y E+     + F +A  +    ++   +  G+ + LLY     +H  
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 661 SRFRIIHRDLKASNILLDKEMTP----KISDFGMARIF 694
               ++HRDLK +NIL+  E       KI+D G AR+F
Sbjct: 145 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 74/156 (47%), Gaps = 25/156 (16%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNLVRLLGCCV 608
           +G+G FG V++G+   G+E+AVK  S  S +    F+  E+     L+H N++  +    
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIAA-- 68
Query: 609 EMDEK--------MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
             D K         LV +Y E+ SL    FD      +  +    +    A GL +LH +
Sbjct: 69  --DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 122
Query: 661 -----SRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
                 +  I HRDLK+ NIL+ K  T  I+D G+A
Sbjct: 123 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 158

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 74/156 (47%), Gaps = 25/156 (16%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNLVRLLGCCV 608
           +G+G FG V++G+   G+E+AVK  S  S +    F+  E+     L+H N++  +    
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIAA-- 65
Query: 609 EMDEK--------MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
             D K         LV +Y E+ SL    FD      +  +    +    A GL +LH +
Sbjct: 66  --DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 119
Query: 661 -----SRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
                 +  I HRDLK+ NIL+ K  T  I+D G+A
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 82/174 (47%), Gaps = 24/174 (13%)
Query: 536 TIVRATDNFTDYNKLGQGGFGIVY--KGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIA 593
           T +R T  F +   LG G F  V+  K RL  G+  A+K + ++        +NE+ ++ 
Sbjct: 5   TNIRKTFIFMEV--LGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLK 61
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYME-----NRSLDSVIFDKARSSILNWQRRFNIIC 648
           K++H N+V L           LV + +      +R L+  ++ +  +S+        +I 
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL--------VIQ 113
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN 702
            +   + YLH++    I+HRDLK  N+L    +TP+ +   M   FG  + EQN
Sbjct: 114 QVLSAVKYLHENG---IVHRDLKPENLLY---LTPEENSKIMITDFGLSKMEQN 161

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 75/166 (45%), Gaps = 21/166 (12%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLI 592
           I    ++F  +  LG+G FG V+     +  Q  A+K L ++       +E    E R++
Sbjct: 12  IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 71
Query: 593 AKLQHRNLVRLLGCCVEMDEKML-VYEYMENRSLDSVI-----FDKARSSILNWQRRFNI 646
           +       +  + C  +  E +  V EY+    L   I     FD +R++    +     
Sbjct: 72  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE----- 126
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              I  GL +LH      I++RDLK  NILLDK+   KI+DFGM +
Sbjct: 127 ---IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 71/153 (46%), Gaps = 23/153 (15%)
Query: 550 LGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCC 607
           LG+G    V     L+  QE AVK + +  G        EV ++ + Q HRN++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN------IICGIARGLLYLHQDS 661
            E D   LV+E M   S+ S I  +         R FN      ++  +A  L +LH   
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKR---------RHFNELEASVVVQDVASALDFLHNKG 131
Query: 662 RFRIIHRDLKASNILLDK--EMTP-KISDFGMA 691
              I HRDLK  NIL +   +++P KI DFG+ 
Sbjct: 132 ---IAHRDLKPENILCEHPNQVSPVKICDFGLG 161

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 23/163 (14%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 602 RLLGCCVEMDEK-MLVYEYMENRSLDSVIFDKARSSI-----------LNWQRRFNIICG 649
            LLG C +     M++ E+ +  +L + +  K    +           L  +        
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLAR 196

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 82/170 (48%), Gaps = 20/170 (11%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVK-----RLSRNSGQGI--EEFKNEVRLIA 593
           D++    +LG G F IV K R    G+E A K     RLS +S +G+  EE + EV ++ 
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLS-SSRRGVSREEIEREVNILR 70
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           +++H N++ L        + +L+ E +    L   + +K     L        +  I  G
Sbjct: 71  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDG 127
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMA-RIFGGDQ 698
           + YLH     RI H DLK  NI+L  +  P    K+ DFG+A +I  G++
Sbjct: 128 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 174

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 536 TIVRATDNFTDYNKL-GQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN---EVR 590
            + R T N  +Y KL G+G FG ++       G+  A+K L +      +E  +   E R
Sbjct: 2   AMARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 61
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++   +H  L  L       D    V EY     L    F  +R  + +  R       I
Sbjct: 62  VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEI 118
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              L YLH +    +++RDLK  N++LDK+   KI+DFG+ +
Sbjct: 119 VSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK 158

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 75/166 (45%), Gaps = 21/166 (12%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLI 592
           I    ++F  +  LG+G FG V+     +  Q  A+K L ++       +E    E R++
Sbjct: 13  IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 72
Query: 593 AKLQHRNLVRLLGCCVEMDEKML-VYEYMENRSLDSVI-----FDKARSSILNWQRRFNI 646
           +       +  + C  +  E +  V EY+    L   I     FD +R++    +     
Sbjct: 73  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE----- 127
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              I  GL +LH      I++RDLK  NILLDK+   KI+DFGM +
Sbjct: 128 ---IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 167

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 79/176 (44%), Gaps = 18/176 (10%)
Query: 542 DNFTDYNKLGQGGFGIV------YKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL 595
           + F  Y  LG+GGFG V        G++   +++  KR+ +  G+ +    NE +++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKV 241
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF---NIICGIAR 652
             R +V L       D   LV   M    L   I+   ++     +  F    I CG+  
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301
Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
               LH++   RI++RDLK  NILLD     +ISD G+A      QT +     VG
Sbjct: 302 ----LHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVG 350

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 74/147 (50%), Gaps = 11/147 (7%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE 609
           LG+G FGIV++      ++  + +  +  G      K E+ ++   +HRN++ L      
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 610 MDEKMLVYEYMENRSLDSVIFDKARSSI--LNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
           M+E ++++E++    LD  IF++  +S   LN +   + +  +   L +LH  +   I H
Sbjct: 73  MEELVMIFEFISG--LD--IFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGH 125
Query: 668 RDLKASNILLD--KEMTPKISDFGMAR 692
            D++  NI+    +  T KI +FG AR
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQAR 152

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 82/170 (48%), Gaps = 20/170 (11%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVK-----RLSRNSGQGI--EEFKNEVRLIA 593
           D++    +LG G F IV K R    G+E A K     RLS +S +G+  EE + EV ++ 
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLS-SSRRGVSREEIEREVNILR 63
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           +++H N++ L        + +L+ E +    L   + +K     L        +  I  G
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDG 120
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMA-RIFGGDQ 698
           + YLH     RI H DLK  NI+L  +  P    K+ DFG+A +I  G++
Sbjct: 121 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 167

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 79/176 (44%), Gaps = 18/176 (10%)
Query: 542 DNFTDYNKLGQGGFGIV------YKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL 595
           + F  Y  LG+GGFG V        G++   +++  KR+ +  G+ +    NE +++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKV 241
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF---NIICGIAR 652
             R +V L       D   LV   M    L   I+   ++     +  F    I CG+  
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301
Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
               LH++   RI++RDLK  NILLD     +ISD G+A      QT +     VG
Sbjct: 302 ----LHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVG 350

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 86/177 (48%), Gaps = 20/177 (11%)
Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSR----NSGQGI--EEFK 586
           F+++V   D++    +LG G F IV K R    G+E A K + +    +S +G+  EE +
Sbjct: 20  FQSMVE--DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIE 77
Query: 587 NEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI 646
            EV ++ +++H N++ L        + +L+ E +    L   + +K     L        
Sbjct: 78  REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQF 134
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMA-RIFGGDQ 698
           +  I  G+ YLH     RI H DLK  NI+L  +  P    K+ DFG+A +I  G++
Sbjct: 135 LKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 188

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 84/180 (46%), Gaps = 25/180 (13%)
Query: 541 TDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFK--NEVRLIAKLQH 597
           ++ +    KLG G +G V   R  +   E A+K + + S       K   EV ++  L H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 598 RNLVRLLGCCVEMDEKMLVYE-YMENRSLDSVI----FDKARSSILNWQRRFNIICGIAR 652
            N+++L     +     LV E Y      D +I    F++  +++        II  +  
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV--------IIKQVLS 147
Query: 653 GLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           G+ YLH   +  I+HRDLK  N+LL   +K+   KI DFG++ +F   + ++  K  +GT
Sbjct: 148 GVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGT 201

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 75/177 (42%), Gaps = 15/177 (8%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQGIEE-FKNEVRLIAK 594
           I+  +D +     +G G FG+    R  +  E +AVK + R  G+ I+E  K E+     
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIER--GEKIDENVKREIINHRS 71
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           L+H N+VR     +      +V EY     L   I +  R S    + RF     +  G+
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS--EDEARF-FFQQLISGV 128
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTP--KISDFGMARIFGGDQTEQNTKRVVGT 709
            Y H     ++ HRDLK  N LLD    P  KI  FG ++           K  VGT
Sbjct: 129 SYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKSTVGT 179

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 74/177 (41%), Gaps = 15/177 (8%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQGI-EEFKNEVRLIAK 594
           I+  +D +     +G G FG+    R  +  E +AVK + R  G+ I    K E+     
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIER--GEKIAANVKREIINHRS 71
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           L+H N+VR     +      +V EY     L   I +  R S    + RF     +  G+
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS--EDEARF-FFQQLISGV 128
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTP--KISDFGMARIFGGDQTEQNTKRVVGT 709
            Y H     ++ HRDLK  N LLD    P  KI DFG ++           K  VGT
Sbjct: 129 SYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGT 179

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 78/157 (49%), Gaps = 11/157 (7%)
Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           LGQG    V++GR  + G   A+K  +  S  + ++    E  ++ KL H+N+V+L    
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 608 VEMD--EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
            E     K+L+ E+    SL +V+ + + +  L       ++  +  G+ +L ++    I
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133
Query: 666 IHRDLKASNILL----DKEMTPKISDFGMARIFGGDQ 698
           +HR++K  NI+     D +   K++DFG AR    D+
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 71/160 (44%), Gaps = 12/160 (7%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQGIEE-FKNEVRLIAK 594
           I+  +D +     +G G FG+    R  +  E +AVK + R  G+ I+E  K E+     
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIER--GEKIDENVKREIINHRS 71
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           L+H N+VR     +      +V EY     L   I +  R S    + RF     +  G+
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS--EDEARF-FFQQLISGV 128
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTP--KISDFGMAR 692
            Y H     ++ HRDLK  N LLD    P  KI  FG ++
Sbjct: 129 SYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSK 165

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 70/159 (44%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     +G G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EYM    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   K++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG 193

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 78/161 (48%), Gaps = 13/161 (8%)
Query: 538 VRATDNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           +R   +F D   LG G F  V        Q+ +A+K +++ + +G E   +NE+ ++ K+
Sbjct: 16  IRDIYDFRDV--LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI 73
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N+V L           L+ + +    L   I +K   +  +  R   +I  +   + 
Sbjct: 74  KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVK 130
Query: 656 YLHQDSRFRIIHRDLKASNIL---LDKEMTPKISDFGMARI 693
           YLH      I+HRDLK  N+L   LD++    ISDFG++++
Sbjct: 131 YLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 78/161 (48%), Gaps = 13/161 (8%)
Query: 538 VRATDNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           +R   +F D   LG G F  V        Q+ +A+K +++ + +G E   +NE+ ++ K+
Sbjct: 16  IRDIYDFRDV--LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKI 73
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N+V L           L+ + +    L   I +K   +  +  R   +I  +   + 
Sbjct: 74  KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVK 130
Query: 656 YLHQDSRFRIIHRDLKASNIL---LDKEMTPKISDFGMARI 693
           YLH      I+HRDLK  N+L   LD++    ISDFG++++
Sbjct: 131 YLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 70/159 (44%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     +G G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EYM    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   K++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG 193

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 71/159 (44%), Gaps = 10/159 (6%)
Query: 539 RATDNFTDYNKL-GQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIA 593
           R T N  +Y KL G+G FG ++       G+  A+K L +      +E  +   E R++ 
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 65
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
             +H  L  L       D    V EY     L    F  +R  + +  R       I   
Sbjct: 66  NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSA 122
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           L YLH +    +++RDLK  N++LDK+   KI+DFG+ +
Sbjct: 123 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK 159

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 72/158 (45%), Gaps = 14/158 (8%)
Query: 543 NFTDYN---KLGQGGFGIVYKGRLLEGQEI-AVKRLSRN---SGQGIEEFKNEVRLIAKL 595
             TD+N    LG+G FG V        +E+ A+K L ++       +E    E R++A L
Sbjct: 17  KLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALL 76
Query: 596 QHRNLVRLLGCCVE-MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
                +  L  C + +D    V EY+    L   ++   +       +       I+ GL
Sbjct: 77  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISIGL 133
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            +LH+     II+RDLK  N++LD E   KI+DFGM +
Sbjct: 134 FFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 168

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 78/161 (48%), Gaps = 13/161 (8%)
Query: 538 VRATDNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           +R   +F D   LG G F  V        Q+ +A+K +++ + +G E   +NE+ ++ K+
Sbjct: 16  IRDIYDFRDV--LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKI 73
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N+V L           L+ + +    L   I +K   +  +  R   +I  +   + 
Sbjct: 74  KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVK 130
Query: 656 YLHQDSRFRIIHRDLKASNIL---LDKEMTPKISDFGMARI 693
           YLH      I+HRDLK  N+L   LD++    ISDFG++++
Sbjct: 131 YLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 71/159 (44%), Gaps = 10/159 (6%)
Query: 539 RATDNFTDYNKL-GQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIA 593
           R T N  +Y KL G+G FG ++       G+  A+K L +      +E  +   E R++ 
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 63
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
             +H  L  L       D    V EY     L    F  +R  + +  R       I   
Sbjct: 64  NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSA 120
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           L YLH +    +++RDLK  N++LDK+   KI+DFG+ +
Sbjct: 121 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK 157

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 71/159 (44%), Gaps = 10/159 (6%)
Query: 539 RATDNFTDYNKL-GQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIA 593
           R T N  +Y KL G+G FG ++       G+  A+K L +      +E  +   E R++ 
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 203
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
             +H  L  L       D    V EY     L    F  +R  + +  R       I   
Sbjct: 204 NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSA 260
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           L YLH +    +++RDLK  N++LDK+   KI+DFG+ +
Sbjct: 261 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK 297

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 71/159 (44%), Gaps = 10/159 (6%)
Query: 539 RATDNFTDYNKL-GQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIA 593
           R T N  +Y KL G+G FG ++       G+  A+K L +      +E  +   E R++ 
Sbjct: 147 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 206
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
             +H  L  L       D    V EY     L    F  +R  + +  R       I   
Sbjct: 207 NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSA 263
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           L YLH +    +++RDLK  N++LDK+   KI+DFG+ +
Sbjct: 264 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK 300

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 78/161 (48%), Gaps = 13/161 (8%)
Query: 538 VRATDNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           +R   +F D   LG G F  V        Q+ +A+K +++ + +G E   +NE+ ++ K+
Sbjct: 16  IRDIYDFRDV--LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKI 73
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N+V L           L+ + +    L   I +K   +  +  R   +I  +   + 
Sbjct: 74  KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVK 130
Query: 656 YLHQDSRFRIIHRDLKASNIL---LDKEMTPKISDFGMARI 693
           YLH      I+HRDLK  N+L   LD++    ISDFG++++
Sbjct: 131 YLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 78/157 (49%), Gaps = 11/157 (7%)
Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           LGQG    V++GR  + G   A+K  +  S  + ++    E  ++ KL H+N+V+L    
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 608 VEMD--EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
            E     K+L+ E+    SL +V+ + + +  L       ++  +  G+ +L ++    I
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133
Query: 666 IHRDLKASNILL----DKEMTPKISDFGMARIFGGDQ 698
           +HR++K  NI+     D +   K++DFG AR    D+
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 21/154 (13%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           +G+G +G V++G   +G+ +AVK  S R+      E   E+     L+H N++  +    
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIAS-- 70
Query: 609 EMDEKM------LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD-- 660
           +M  +       L+  Y E  SL    +D  + + L+      I+  IA GL +LH +  
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 661 ---SRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
               +  I HRDLK+ NIL+ K     I+D G+A
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 21/154 (13%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           +G+G +G V++G   +G+ +AVK  S R+      E   E+     L+H N++  +    
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIAS-- 70
Query: 609 EMDEKM------LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD-- 660
           +M  +       L+  Y E  SL    +D  + + L+      I+  IA GL +LH +  
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 661 ---SRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
               +  I HRDLK+ NIL+ K     I+D G+A
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 70/159 (44%), Gaps = 11/159 (6%)
Query: 539 RATDNFTDYNKL-GQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIA 593
           + T N  DY KL G+G FG V   R    G+  A+K L +      +E  +   E R++ 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
             +H  L  L       D    V EY     L    F  +R  +   +R       I   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 117
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           L YLH      +++RD+K  N++LDK+   KI+DFG+ +
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 70/159 (44%), Gaps = 11/159 (6%)
Query: 539 RATDNFTDYNKL-GQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIA 593
           + T N  DY KL G+G FG V   R    G+  A+K L +      +E  +   E R++ 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
             +H  L  L       D    V EY     L    F  +R  +   +R       I   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 117
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           L YLH      +++RD+K  N++LDK+   KI+DFG+ +
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 11/160 (6%)
Query: 538 VRATDNFTDYNKL-GQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---EVRLI 592
            + T N  DY KL G+G FG V   R    G+  A+K L +      +E  +   E R++
Sbjct: 3   AKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 62
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIAR 652
              +H  L  L       D    V EY     L    F  +R  +   +R       I  
Sbjct: 63  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVS 119
Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            L YLH      +++RD+K  N++LDK+   KI+DFG+ +
Sbjct: 120 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 156

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 12/156 (7%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI--AVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           +T  N +G+G +G V K  + +G  I  A K++ +   + ++ FK E+ ++  L H N++
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           RL     +  +  LV E      L   +  K    +        I+  +   + Y H   
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCH--- 123
Query: 662 RFRIIHRDLKASNILL--DKEMTP-KISDFGMARIF 694
           +  + HRDLK  N L   D   +P K+ DFG+A  F
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 14/162 (8%)
Query: 550 LGQGGFGIVYKGRLLEGQE----IAVKRLSR----NSGQGIEEFKNEVRLIAKLQHRNLV 601
           LG+GG+G V++ R + G       A+K L +     + +     K E  ++ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            L+       +  L+ EY+    L        R  I         +  I+  L +LHQ  
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
              II+RDLK  NI+L+ +   K++DFG+ +    D T  +T
Sbjct: 142 ---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT 180

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 70/159 (44%), Gaps = 11/159 (6%)
Query: 539 RATDNFTDYNKL-GQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIA 593
           + T N  DY KL G+G FG V   R    G+  A+K L +      +E  +   E R++ 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
             +H  L  L       D    V EY     L    F  +R  +   +R       I   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 117
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           L YLH      +++RD+K  N++LDK+   KI+DFG+ +
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 12/156 (7%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI--AVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           +T  N +G+G +G V K  + +G  I  A K++ +   + ++ FK E+ ++  L H N++
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           RL     +  +  LV E      L   +  K    +        I+  +   + Y H   
Sbjct: 87  RLYETFEDNTDIYLVMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCH--- 140
Query: 662 RFRIIHRDLKASNILL--DKEMTP-KISDFGMARIF 694
           +  + HRDLK  N L   D   +P K+ DFG+A  F
Sbjct: 141 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 176

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 70/159 (44%), Gaps = 11/159 (6%)
Query: 539 RATDNFTDYNKL-GQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIA 593
           + T N  DY KL G+G FG V   R    G+  A+K L +      +E  +   E R++ 
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 65
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
             +H  L  L       D    V EY     L    F  +R  +   +R       I   
Sbjct: 66  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 122
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           L YLH      +++RD+K  N++LDK+   KI+DFG+ +
Sbjct: 123 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 158

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 70/159 (44%), Gaps = 11/159 (6%)
Query: 539 RATDNFTDYNKL-GQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIA 593
           + T N  DY KL G+G FG V   R    G+  A+K L +      +E  +   E R++ 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
             +H  L  L       D    V EY     L    F  +R  +   +R       I   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 117
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           L YLH      +++RD+K  N++LDK+   KI+DFG+ +
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 70/159 (44%), Gaps = 11/159 (6%)
Query: 539 RATDNFTDYNKL-GQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIA 593
           + T N  DY KL G+G FG V   R    G+  A+K L +      +E  +   E R++ 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
             +H  L  L       D    V EY     L    F  +R  +   +R       I   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 117
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           L YLH      +++RD+K  N++LDK+   KI+DFG+ +
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 70/151 (46%), Gaps = 14/151 (9%)
Query: 550 LGQGGFGIVYKGRLLEGQE----IAVKRLSR----NSGQGIEEFKNEVRLIAKLQHRNLV 601
           LG+GG+G V++ R + G       A+K L +     + +     K E  ++ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            L+       +  L+ EY+    L        R  I         +  I+  L +LHQ  
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              II+RDLK  NI+L+ +   K++DFG+ +
Sbjct: 142 ---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 71/159 (44%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFK---NEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +     ++E +   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY     + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+++D++   K++DFG+A+   G
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKG 193

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 82/180 (45%), Gaps = 38/180 (21%)
Query: 549 KLGQGGFGIVYKGRLLEGQ------EIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           ++G+G F  VYKG   E        E+  ++L+++  Q    FK E   +  LQH N+VR
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIVR 89
Query: 603 LLGC---------CVEMDEKMLVYEYMENRSLDSVI--FDKARSSIL-NWQRRFNIICGI 650
                        C+     +LV E   + +L + +  F   +  +L +W R+      I
Sbjct: 90  FYDSWESTVKGKKCI-----VLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------I 138
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIFGGDQTEQNTKRVVGT 709
            +GL +LH  +   IIHRDLK  NI +     + KI D G+A +    +     K V+GT
Sbjct: 139 LKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGT 193

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 83/171 (48%), Gaps = 20/171 (11%)
Query: 539 RATDNFTDY-----NKLGQGGFGIVYKG-RLLEGQEIAVKRLS-RNSGQGIE-EFKNEVR 590
           ++ +NF ++      +LG+G F +V +      GQE A K L  R  GQ    E  +E+ 
Sbjct: 21  QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIA 80
Query: 591 LI--AKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC 648
           ++  AK   R ++ L        E +L+ EY     + S+   +  + +++      +I 
Sbjct: 81  VLELAKSCPR-VINLHEVYENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIK 138
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMARIFG 695
            I  G+ YLHQ++   I+H DLK  NILL   + P    KI DFGM+R  G
Sbjct: 139 QILEGVYYLHQNN---IVHLDLKPQNILLSS-IYPLGDIKIVDFGMSRKIG 185

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 65/159 (40%), Gaps = 22/159 (13%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQG-----------IEEFKNEVRLIAKLQHR 598
           +  G +G V  G   EG  +A+KR+      G            +    E+RL+    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 599 NLVRLLGCCVEMDEKM-----LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           N++ L    V  +E       LV E M    L  VI D+    +++ Q     +  I  G
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQ--RIVISPQHIQYFMYHILLG 146
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           L  LH+     ++HRDL   NILL       I DF +AR
Sbjct: 147 LHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR 182

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 65/159 (40%), Gaps = 22/159 (13%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQG-----------IEEFKNEVRLIAKLQHR 598
           +  G +G V  G   EG  +A+KR+      G            +    E+RL+    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 599 NLVRLLGCCVEMDEKM-----LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           N++ L    V  +E       LV E M    L  VI D+    +++ Q     +  I  G
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQ--RIVISPQHIQYFMYHILLG 146
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           L  LH+     ++HRDL   NILL       I DF +AR
Sbjct: 147 LHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR 182

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 27/165 (16%)
Query: 541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL--QH 597
            D+     +LG+G +G+V K R +  GQ +AVKR+           + + RL+  L    
Sbjct: 50  ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-----QEQKRLLMDLDISM 104
Query: 598 RNL-----VRLLGCCVEMDEKMLVYEYMENRSLDSV---IFDKARS---SILNWQRRFNI 646
           R +     V   G      +  +  E M+  SLD     + DK ++    IL       I
Sbjct: 105 RTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILG-----KI 158
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
              I + L +LH  S+  +IHRD+K SN+L++     K+ DFG++
Sbjct: 159 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS 201

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 70/159 (44%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     +G G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   K++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG 193

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 70/159 (44%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 143
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 144 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 179

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 70/152 (46%), Gaps = 23/152 (15%)
Query: 550 LGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCC 607
           LG+G    V     L+  QE AVK + +  G        EV ++ + Q HRN++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN------IICGIARGLLYLHQDS 661
            E D   LV+E M   S+ S I  +         R FN      ++  +A  L +LH   
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKR---------RHFNELEASVVVQDVASALDFLHNKG 131
Query: 662 RFRIIHRDLKASNILLDK--EMTP-KISDFGM 690
              I HRDLK  NIL +   +++P KI DF +
Sbjct: 132 ---IAHRDLKPENILCEHPNQVSPVKICDFDL 160

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 79/170 (46%), Gaps = 12/170 (7%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRN-- 599
           ++   ++G GG   V++    + Q  A+K   L     Q ++ ++NE+  + KLQ  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           ++RL    +       +Y  ME  ++D   + K + SI  W+R+ +    +   +  +HQ
Sbjct: 118 IIRLYDYEIT---DQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQ 173
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
                I+H DLK +N L+   M  K+ DFG+A     D T       VGT
Sbjct: 174 HG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 219

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 27/165 (16%)
Query: 541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL--QH 597
            D+     +LG+G +G+V K R +  GQ +AVKR+           + + RL+  L    
Sbjct: 6   ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-----QEQKRLLMDLDISM 60
Query: 598 RNL-----VRLLGCCVEMDEKMLVYEYMENRSLDSV---IFDKARS---SILNWQRRFNI 646
           R +     V   G      +  +  E M+  SLD     + DK ++    IL       I
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILG-----KI 114
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
              I + L +LH  S+  +IHRD+K SN+L++     K+ DFG++
Sbjct: 115 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS 157

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 79/170 (46%), Gaps = 12/170 (7%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRN-- 599
           ++   ++G GG   V++    + Q  A+K   L     Q ++ ++NE+  + KLQ  +  
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           ++RL    +       +Y  ME  ++D   + K + SI  W+R+ +    +   +  +HQ
Sbjct: 90  IIRLYDYEIT---DQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQ 145
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
                I+H DLK +N L+   M  K+ DFG+A     D T       VGT
Sbjct: 146 HG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 191

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 69/149 (46%), Gaps = 13/149 (8%)
Query: 550 LGQGGFGIVYKGRLLEGQE----IAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG V++G  +  +     +A+K     +   + E+F  E   + +  H ++V+L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 605 GCCVEMDEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G   E      V+  ME  +L  +  F + R   L+          ++  L YL      
Sbjct: 106 GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--- 158
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
           R +HRD+ A N+L+      K+ DFG++R
Sbjct: 159 RFVHRDIAARNVLVSSNDCVKLGDFGLSR 187

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 70/159 (44%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 158
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 194

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 70/159 (44%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 70/159 (44%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 70/159 (44%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 550 LGQGGFGIVYKGRLLEGQEI----AVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           +G+G +  V   RL +   I     VK+   N  + I+  + E  +  +  +   +  L 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 606 CCVEMDEKML-VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
            C + + ++  V EY+    L   +F   R   L  +        I+  L YLH+     
Sbjct: 77  SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG--- 130
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMAR 692
           II+RDLK  N+LLD E   K++D+GM +
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCK 158

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSR----NSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           +G+G +  V   RL +   I   R+ +    N  + I+  + E  +  +  +   +  L 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 606 CCVEMDEKML-VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
            C + + ++  V EY+    L   +F   R   L  +        I+  L YLH+     
Sbjct: 120 SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG--- 173
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMAR 692
           II+RDLK  N+LLD E   K++D+GM +
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCK 201

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 70/159 (44%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 70/159 (44%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 158
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 194

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 80/170 (47%), Gaps = 12/170 (7%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRN-- 599
           ++   ++G GG   V++    + Q  A+K   L     Q ++ ++NE+  + KLQ  +  
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 73
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           ++RL     E+ ++  +Y  ME  ++D   + K + SI  W+R+          L  +H 
Sbjct: 74  IIRLYD--YEITDQ-YIYMVMECGNIDLNSWLKKKKSIDPWERK----SYWKNMLEAVHT 126
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             +  I+H DLK +N L+   M  K+ DFG+A     D T       VGT
Sbjct: 127 IHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 175

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY     + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+++D++   K++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG 193

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 14/157 (8%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSRNSGQGIEEFKNEVR--LIAKLQ 596
           +F     LGQG FG V+  R +     G   A+K L + + +  +  + ++   ++A + 
Sbjct: 29  HFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVN 88
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI-ICGIARGLL 655
           H  +V+L        +  L+ +++    L    F +    ++  +      +  +A GL 
Sbjct: 89  HPFVVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALGLD 144
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +LH      II+RDLK  NILLD+E   K++DFG+++
Sbjct: 145 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK 178

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 550 LGQGGFGIVYKGRLLEGQEI----AVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           +G+G +  V   RL +   I     VK+   N  + I+  + E  +  +  +   +  L 
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 606 CCVEMDEKML-VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
            C + + ++  V EY+    L   +F   R   L  +        I+  L YLH+     
Sbjct: 73  SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG--- 126
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMAR 692
           II+RDLK  N+LLD E   K++D+GM +
Sbjct: 127 IIYRDLKLDNVLLDSEGHIKLTDYGMCK 154

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 69/149 (46%), Gaps = 13/149 (8%)
Query: 550 LGQGGFGIVYKGRLLEGQE----IAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG V++G  +  +     +A+K     +   + E+F  E   + +  H ++V+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 605 GCCVEMDEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G   E      V+  ME  +L  +  F + R   L+          ++  L YL      
Sbjct: 83  GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--- 135
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
           R +HRD+ A N+L+      K+ DFG++R
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSR 164

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 68/149 (45%), Gaps = 13/149 (8%)
Query: 550 LGQGGFGIVYKGRLLE----GQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG V++G  +        +A+K     +   + E+F  E   + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 605 GCCVEMDEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G   E      V+  ME  +L  +  F + R   L+          ++  L YL      
Sbjct: 78  GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--- 130
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
           R +HRD+ A N+L+      K+ DFG++R
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSR 159

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 79/170 (46%), Gaps = 12/170 (7%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRN-- 599
           ++   ++G GG   V++    + Q  A+K   L     Q ++ ++NE+  + KLQ  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           ++RL    +       +Y  ME  ++D   + K + SI  W+R+ +    +   +  +HQ
Sbjct: 118 IIRLYDYEIT---DQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQ 173
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
                I+H DLK +N L+   M  K+ DFG+A     D T       VGT
Sbjct: 174 HG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 219

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 550 LGQGGFGIVYKGRLLEGQEI----AVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           +G+G +  V   RL +   I     VK+   N  + I+  + E  +  +  +   +  L 
Sbjct: 28  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 87
Query: 606 CCVEMDEKML-VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
            C + + ++  V EY+    L   +F   R   L  +        I+  L YLH+     
Sbjct: 88  SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG--- 141
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMAR 692
           II+RDLK  N+LLD E   K++D+GM +
Sbjct: 142 IIYRDLKLDNVLLDSEGHIKLTDYGMCK 169

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 69/149 (46%), Gaps = 13/149 (8%)
Query: 550 LGQGGFGIVYKGRLLEGQE----IAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG V++G  +  +     +A+K     +   + E+F  E   + +  H ++V+L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 605 GCCVEMDEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G   E      V+  ME  +L  +  F + R   L+          ++  L YL      
Sbjct: 81  GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--- 133
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
           R +HRD+ A N+L+      K+ DFG++R
Sbjct: 134 RFVHRDIAARNVLVSSNDCVKLGDFGLSR 162

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 69/149 (46%), Gaps = 13/149 (8%)
Query: 550 LGQGGFGIVYKGRLLEGQE----IAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG V++G  +  +     +A+K     +   + E+F  E   + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 605 GCCVEMDEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G   E      V+  ME  +L  +  F + R   L+          ++  L YL      
Sbjct: 78  GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--- 130
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
           R +HRD+ A N+L+      K+ DFG++R
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSR 159

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 69/149 (46%), Gaps = 13/149 (8%)
Query: 550 LGQGGFGIVYKGRLLEGQE----IAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG V++G  +  +     +A+K     +   + E+F  E   + +  H ++V+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 605 GCCVEMDEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G   E      V+  ME  +L  +  F + R   L+          ++  L YL      
Sbjct: 75  GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--- 127
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
           R +HRD+ A N+L+      K+ DFG++R
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSR 156

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 70/151 (46%), Gaps = 4/151 (2%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           ++  +  ++G G  G V+K R  + G  IAVK++ R SG   E  +  + L   L+  + 
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDVVLKSHDC 83
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
             ++ C         V+  ME     +    K     +  +    +   I + L YL + 
Sbjct: 84  PYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE- 142
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
            +  +IHRD+K SNILLD+    K+ DFG++
Sbjct: 143 -KHGVIHRDVKPSNILLDERGQIKLCDFGIS 172

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 82/170 (48%), Gaps = 12/170 (7%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRN-- 599
           ++   ++G GG   V++    + Q  A+K   L     Q ++ ++NE+  + KLQ  +  
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 69
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           ++RL     E+ ++  +Y  ME  ++D   + K + SI  W+R+ +    +   +  +HQ
Sbjct: 70  IIRLYD--YEITDQ-YIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQ 125
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
                I+H DLK +N L+   M  K+ DFG+A     D T       VGT
Sbjct: 126 HG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 171

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 69/149 (46%), Gaps = 13/149 (8%)
Query: 550 LGQGGFGIVYKGRLLEGQE----IAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG V++G  +  +     +A+K     +   + E+F  E   + +  H ++V+L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 605 GCCVEMDEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G   E      V+  ME  +L  +  F + R   L+          ++  L YL      
Sbjct: 80  GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--- 132
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
           R +HRD+ A N+L+      K+ DFG++R
Sbjct: 133 RFVHRDIAARNVLVSSNDCVKLGDFGLSR 161

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 67/158 (42%), Gaps = 14/158 (8%)
Query: 543 NFTDYN---KLGQGGFGIVYKGRLLEGQEI-AVKRLSRN---SGQGIEEFKNEVRLIA-K 594
             TD+N    LG+G FG V         E+ AVK L ++       +E    E R++A  
Sbjct: 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 398
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
            +   L +L  C   MD    V EY+    L   I    R               IA GL
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGL 455
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            +L       II+RDLK  N++LD E   KI+DFGM +
Sbjct: 456 FFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 490

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 79/170 (46%), Gaps = 12/170 (7%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRN-- 599
           ++   ++G GG   V++    + Q  A+K   L     Q ++ ++NE+  + KLQ  +  
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           ++RL    +       +Y  ME  ++D   + K + SI  W+R+ +    +   +  +HQ
Sbjct: 71  IIRLYDYEIT---DQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQ 126
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
                I+H DLK +N L+   M  K+ DFG+A     D T       VGT
Sbjct: 127 HG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 172

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFK---NEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +     ++E +   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY     + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+++D++   +++DFG+A+   G
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKG 193

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 68/149 (45%), Gaps = 13/149 (8%)
Query: 550 LGQGGFGIVYKGRLLE----GQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG V++G  +        +A+K     +   + E+F  E   + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 605 GCCVEMDEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G   E      V+  ME  +L  +  F + R   L+          ++  L YL      
Sbjct: 78  GVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK--- 130
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
           R +HRD+ A N+L+      K+ DFG++R
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSR 159

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 68/149 (45%), Gaps = 13/149 (8%)
Query: 550 LGQGGFGIVYKGRLLE----GQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG V++G  +        +A+K     +   + E+F  E   + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 605 GCCVEMDEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G   E      V+  ME  +L  +  F + R   L+          ++  L YL      
Sbjct: 78  GVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK--- 130
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
           R +HRD+ A N+L+      K+ DFG++R
Sbjct: 131 RFVHRDIAARNVLVSATDCVKLGDFGLSR 159

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 15/135 (11%)
Query: 566 GQEIAVKRLS----RNSGQGIEEFKNEVR-----LIAKLQHRNLVRLLGCCVEMDEKMLV 616
           G E AVK +     R S + +EE +   R     L     H +++ L+          LV
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNIL 676
           ++ M    L   + +K     L+ +   +I+  +   + +LH ++   I+HRDLK  NIL
Sbjct: 179 FDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENIL 232
Query: 677 LDKEMTPKISDFGMA 691
           LD  M  ++SDFG +
Sbjct: 233 LDDNMQIRLSDFGFS 247

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 69/149 (46%), Gaps = 13/149 (8%)
Query: 550 LGQGGFGIVYKGRLLEGQE----IAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG V++G  +  +     +A+K     +   + E+F  E   + +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 605 GCCVEMDEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G   E      V+  ME  +L  +  F + R   L+          ++  L YL      
Sbjct: 458 GVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK--- 510
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
           R +HRD+ A N+L+      K+ DFG++R
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSR 539

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R        RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R        RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R        RF     I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 158
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 194

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 67/158 (42%), Gaps = 14/158 (8%)
Query: 543 NFTDYN---KLGQGGFGIVYKGRLLEGQEI-AVKRLSRN---SGQGIEEFKNEVRLIA-K 594
             TD+N    LG+G FG V         E+ AVK L ++       +E    E R++A  
Sbjct: 18  KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 77
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
            +   L +L  C   MD    V EY+    L   I    R               IA GL
Sbjct: 78  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGL 134
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            +L       II+RDLK  N++LD E   KI+DFGM +
Sbjct: 135 FFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 169

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 68/159 (42%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY     + S +    R        RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+++D++   K++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG 193

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 68/149 (45%), Gaps = 13/149 (8%)
Query: 550 LGQGGFGIVYKGRLLE----GQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG V++G  +        +A+K     +   + E+F  E   + +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 605 GCCVEMDEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G   E      V+  ME  +L  +  F + R   L+          ++  L YL      
Sbjct: 458 GVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK--- 510
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
           R +HRD+ A N+L+      K+ DFG++R
Sbjct: 511 RFVHRDIAARNVLVSATDCVKLGDFGLSR 539

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY     + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+++D++   +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKG 193

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 80/174 (45%), Gaps = 21/174 (12%)
Query: 530 PLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKN- 587
           P+FD    V   D+F     +G+G FG V   +  + +++ A+K +++       E +N 
Sbjct: 4   PVFDENEDVNF-DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNV 62
Query: 588 --EVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL-----DSVIFDKARSSILNW 640
             E++++  L+H  LV L     + ++  +V + +    L      +V F +    +   
Sbjct: 63  FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF-- 120
Query: 641 QRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
                 IC +   L YL      RIIHRD+K  NILLD+     I+DF +A + 
Sbjct: 121 ------ICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML 165

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 150
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 151 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 186

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLI 592
           FE + + T        LG+G +  V     L+ G+E AVK + + +G        EV  +
Sbjct: 10  FEDMYKLTSEL-----LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETL 64
Query: 593 AKLQ-HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIA 651
            + Q ++N++ L+    +     LV+E ++  S+ + I    +    N +    ++  +A
Sbjct: 65  YQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHI---QKQKHFNEREASRVVRDVA 121
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD--KEMTP-KISDFGMA 691
             L +LH      I HRDLK  NIL +  ++++P KI DF + 
Sbjct: 122 AALDFLHTKG---IAHRDLKPENILCESPEKVSPVKICDFDLG 161

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 78/178 (43%), Gaps = 34/178 (19%)
Query: 541 TDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN---------EVR 590
           + +F   + LG+G +G+V        G+ +A+K+        IE F           E++
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIK 61
Query: 591 LIAKLQHRNLVRLLGC-----CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           ++   +H N++ +            +E  ++ E M+   L  VI     + +L+      
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI----STQMLSDDHIQY 116
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF---GGDQTE 700
            I    R +  LH  +   +IHRDLK SN+L++     K+ DFG+ARI      D +E
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 158
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 194

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 68/159 (42%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             L +L     +     +V EY     + S +    R S      RF     I     YL
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 158
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+++D++   K++DFG A+   G
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG 194

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 78/178 (43%), Gaps = 34/178 (19%)
Query: 541 TDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN---------EVR 590
           + +F   + LG+G +G+V        G+ +A+K+        IE F           E++
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIK 61
Query: 591 LIAKLQHRNLVRLLGC-----CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           ++   +H N++ +            +E  ++ E M+   L  VI     + +L+      
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI----STQMLSDDHIQY 116
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF---GGDQTE 700
            I    R +  LH  +   +IHRDLK SN+L++     K+ DFG+ARI      D +E
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 178
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 179 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 214

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 68/159 (42%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             L +L     +     +V EY     + S +    R S      RF     I     YL
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 158
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+++D++   K++DFG A+   G
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG 194

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 78/178 (43%), Gaps = 34/178 (19%)
Query: 541 TDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN---------EVR 590
           + +F   + LG+G +G+V        G+ +A+K+        IE F           E++
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIK 61
Query: 591 LIAKLQHRNLVRLLGC-----CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           ++   +H N++ +            +E  ++ E M+   L  VI     + +L+      
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI----STQMLSDDHIQY 116
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF---GGDQTE 700
            I    R +  LH  +   +IHRDLK SN+L++     K+ DFG+ARI      D +E
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 178
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 179 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 214

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 158
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 194

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 158
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 194

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 17/171 (9%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV- 608
           +G+G +G V++G L  G+ +AVK  S    Q     + E+     L+H N++  +   + 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFR-ETEIYNTVLLRHDNILGFIASDMT 73
Query: 609 ---EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD----- 660
                 +  L+  Y E+ SL    +D  +   L       +    A GL +LH +     
Sbjct: 74  SRNSSTQLWLITHYHEHGSL----YDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIF--GGDQTEQNTKRVVGT 709
            +  I HRD K+ N+L+   +   I+D G+A +   G D  +      VGT
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGT 180

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 144
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 145 HS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKG 180

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 158
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 194

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 68/159 (42%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY     + S +    R S      RF     I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 158
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+++D++   K++DFG A+   G
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG 194

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 12/160 (7%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRN-- 599
           ++   ++G GG   V++    + Q  A+K   L     Q ++ ++NE+  + KLQ  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           ++RL    +       +Y  ME  ++D   + K + SI  W+R+ +    +   +  +HQ
Sbjct: 118 IIRLYDYEIT---DQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQ 173
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
                I+H DLK +N L+   M  K+ DFG+A     D T
Sbjct: 174 HG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTT 209

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 69/148 (46%), Gaps = 11/148 (7%)
Query: 550 LGQGGFGIVYKGRLL----EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           LG+G FG VY+G       E   +AVK   ++ +    E+F +E  ++  L H ++V+L+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G  +E +   ++ E      L   +     S  +     +++   I + + YL       
Sbjct: 92  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 145
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMAR 692
            +HRD+   NIL+      K+ DFG++R
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSR 173

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 69/148 (46%), Gaps = 11/148 (7%)
Query: 550 LGQGGFGIVYKGRLL----EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           LG+G FG VY+G       E   +AVK   ++ +    E+F +E  ++  L H ++V+L+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G  +E +   ++ E      L   +     S  +     +++   I + + YL       
Sbjct: 76  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 129
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMAR 692
            +HRD+   NIL+      K+ DFG++R
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSR 157

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 69/148 (46%), Gaps = 11/148 (7%)
Query: 550 LGQGGFGIVYKGRLL----EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           LG+G FG VY+G       E   +AVK   ++ +    E+F +E  ++  L H ++V+L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G  +E +   ++ E      L   +     S  +     +++   I + + YL       
Sbjct: 80  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 133
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMAR 692
            +HRD+   NIL+      K+ DFG++R
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSR 161

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 74/165 (44%), Gaps = 27/165 (16%)
Query: 541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL--QH 597
            D+     +LG+G +G+V K R +  GQ  AVKR+           + + RL+  L    
Sbjct: 33  ADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNS-----QEQKRLLXDLDISX 87
Query: 598 RNL-----VRLLGCCVEMDEKMLVYEYMENRSLDSV---IFDKARS---SILNWQRRFNI 646
           R +     V   G      +  +  E + + SLD     + DK ++    IL       I
Sbjct: 88  RTVDCPFTVTFYGALFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDILG-----KI 141
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
              I + L +LH  S+  +IHRD+K SN+L++     K  DFG++
Sbjct: 142 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGIS 184

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 78/170 (45%), Gaps = 12/170 (7%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRN-- 599
           ++   ++G GG   V++    + Q  A+K   L     Q ++ ++NE+  + KLQ  +  
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           ++RL    +       +Y  ME  ++D   + K + SI  W+R+ +    +   +  +HQ
Sbjct: 90  IIRLYDYEIT---DQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQ 145
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
                I+H DLK +N L+   M  K+ DFG+A     D         VGT
Sbjct: 146 HG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDXXXVVKDSQVGT 191

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 78/190 (41%), Gaps = 48/190 (25%)
Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRN-----SGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +GQG +G+V      + + I A+K +++N     + + +E  K EVRL+ KL H N+ RL
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 604 LGCCVEMDEKMLVYEYMENRSL---------DSV---IFDKARSSI-------------- 637
                +     LV E      L         DS      D  ++ I              
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 638 -------LNWQRRFNIICGIAR----GLLYLHQDSRFRIIHRDLKASNILL--DKEMTPK 684
                  L++ +R  +I  I R     L YLH      I HRD+K  N L   +K    K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIK 210
Query: 685 ISDFGMARIF 694
           + DFG+++ F
Sbjct: 211 LVDFGLSKEF 220

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 74/150 (49%), Gaps = 14/150 (9%)
Query: 550 LGQGGFGIVYKGRLLEG----QEIAVKRLSRNSGQGIEEFKNEVR--LIAKLQHRNLVRL 603
           LGQG FG V+  + + G    Q  A+K L + + +  +  + ++   ++ ++ H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI-ICGIARGLLYLHQDSR 662
                   +  L+ +++    L    F +    ++  +      +  +A  L +LH    
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS--- 144
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             II+RDLK  NILLD+E   K++DFG+++
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSK 174

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+++D++   +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKG 193

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 68/159 (42%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R        RF     I     YL
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 150
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 151 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 186

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 59/114 (51%), Gaps = 12/114 (10%)
Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRF 644
           + E+ ++ KL H  ++++     + ++  +V E ME   L D V+ +K           +
Sbjct: 188 ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 246
Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFG 695
            ++  +     YLH++    IIHRDLK  N+LL   +++   KI+DFG ++I G
Sbjct: 247 QMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 67/149 (44%), Gaps = 13/149 (8%)
Query: 550 LGQGGFGIVYKGRLLEGQEI--AVKRLSRNSGQGIEEFKNEVR----LIAKLQHRNLVRL 603
           +G+G FG V   R  + +E+  AVK L + +    +E K+ +     L+  ++H  LV L
Sbjct: 46  IGKGSFGKVLLARH-KAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
                  D+   V +Y+    L    +   R       R       IA  L YLH     
Sbjct: 105 HFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARFYAAEIASALGYLHS---L 158
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
            I++RDLK  NILLD +    ++DFG+ +
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCK 187

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 68/159 (42%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R        RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 59/114 (51%), Gaps = 12/114 (10%)
Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRF 644
           + E+ ++ KL H  ++++     + ++  +V E ME   L D V+ +K           +
Sbjct: 202 ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 260
Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFG 695
            ++  +     YLH++    IIHRDLK  N+LL   +++   KI+DFG ++I G
Sbjct: 261 QMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 307

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R +      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFA--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 67/159 (42%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             L +L     +     +V EY     + S +    R        RF     I     YL
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 158
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+++D++   K++DFG A+   G
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG 194

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 68/159 (42%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R        RF     I     YL
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 178
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 179 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 214

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 68/159 (42%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R        RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 18/161 (11%)
Query: 541 TDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN 599
            ++  D  ++G+G +G V K      GQ +AVKR+ R++    E+ +  + L   ++  +
Sbjct: 21  AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSD 79
Query: 600 ---LVRLLGCCVEMDEKMLVYEYMEN------RSLDSVIFDKARSSILNWQRRFNIICGI 650
              +V+  G      +  +  E M        + + SV+ D     IL       I    
Sbjct: 80  CPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG-----KITLAT 134
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
            + L +L ++   +IIHRD+K SNILLD+    K+ DFG++
Sbjct: 135 VKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGIS 173

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 59/114 (51%), Gaps = 12/114 (10%)
Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRF 644
           + E+ ++ KL H  ++++     + ++  +V E ME   L D V+ +K           +
Sbjct: 69  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 127
Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFG 695
            ++  +     YLH++    IIHRDLK  N+LL   +++   KI+DFG ++I G
Sbjct: 128 QMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 174

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 68/159 (42%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R        RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 68/159 (42%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R        RF     I     YL
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 152
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 153 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 188

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 59/114 (51%), Gaps = 12/114 (10%)
Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRF 644
           + E+ ++ KL H  ++++     + ++  +V E ME   L D V+ +K           +
Sbjct: 62  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 120
Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFG 695
            ++  +     YLH++    IIHRDLK  N+LL   +++   KI+DFG ++I G
Sbjct: 121 QMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 167

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 59/114 (51%), Gaps = 12/114 (10%)
Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRF 644
           + E+ ++ KL H  ++++     + ++  +V E ME   L D V+ +K           +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFG 695
            ++  +     YLH++    IIHRDLK  N+LL   +++   KI+DFG ++I G
Sbjct: 122 QMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 59/114 (51%), Gaps = 12/114 (10%)
Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRF 644
           + E+ ++ KL H  ++++     + ++  +V E ME   L D V+ +K           +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFG 695
            ++  +     YLH++    IIHRDLK  N+LL   +++   KI+DFG ++I G
Sbjct: 122 QMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 67/159 (42%), Gaps = 10/159 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R+   +  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY     + S +    R S      RF     I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 158
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           H      +I+RDLK  N+L+D++   K++DFG A+   G
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG 194

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 59/114 (51%), Gaps = 12/114 (10%)
Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRF 644
           + E+ ++ KL H  ++++     + ++  +V E ME   L D V+ +K           +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFG 695
            ++  +     YLH++    IIHRDLK  N+LL   +++   KI+DFG ++I G
Sbjct: 122 QMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 33/211 (15%)
Query: 484 KTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDN 543
           KT   R  R  EP    E ++ +LL + +     +Y               E +  AT  
Sbjct: 53  KTWAARGSRSREPSPKTEDNEGVLLTEKLKPVDYEYR--------------EEVHWATHQ 98
Query: 544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFK-NEVRLIAKLQHRNLV 601
                +LG+G FG V++    + G + AVK++       +E F+  E+   A L    +V
Sbjct: 99  L----RLGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIV 148
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            L G   E     +  E +E  SL  ++ ++     L   R    +     GL YLH  S
Sbjct: 149 PLYGAVREGPWVNIFMELLEGGSLGQLVKEQG---CLPEDRALYYLGQALEGLEYLH--S 203
Query: 662 RFRIIHRDLKASNILLDKEMT-PKISDFGMA 691
           R RI+H D+KA N+LL  + +   + DFG A
Sbjct: 204 R-RILHGDVKADNVLLSSDGSHAALCDFGHA 233

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 33/211 (15%)
Query: 484 KTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDN 543
           KT   R  R  EP    E ++ +LL + +     +Y               E +  AT  
Sbjct: 34  KTWAARGSRSREPSPKTEDNEGVLLTEKLKPVDYEYR--------------EEVHWATHQ 79
Query: 544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFK-NEVRLIAKLQHRNLV 601
                +LG+G FG V++    + G + AVK++       +E F+  E+   A L    +V
Sbjct: 80  L----RLGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIV 129
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            L G   E     +  E +E  SL  ++ ++     L   R    +     GL YLH  S
Sbjct: 130 PLYGAVREGPWVNIFMELLEGGSLGQLVKEQG---CLPEDRALYYLGQALEGLEYLH--S 184
Query: 662 RFRIIHRDLKASNILLDKEMT-PKISDFGMA 691
           R RI+H D+KA N+LL  + +   + DFG A
Sbjct: 185 R-RILHGDVKADNVLLSSDGSHAALCDFGHA 214

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 74/150 (49%), Gaps = 14/150 (9%)
Query: 550 LGQGGFGIVYKGRLLEG----QEIAVKRLSRNSGQGIEEFKNEVR--LIAKLQHRNLVRL 603
           LGQG FG V+  + + G    Q  A+K L + + +  +  + ++   ++ ++ H  +V+L
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI-ICGIARGLLYLHQDSR 662
                   +  L+ +++    L    F +    ++  +      +  +A  L +LH    
Sbjct: 93  HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS--- 145
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             II+RDLK  NILLD+E   K++DFG+++
Sbjct: 146 LGIIYRDLKPENILLDEEGHIKLTDFGLSK 175

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 74/150 (49%), Gaps = 14/150 (9%)
Query: 550 LGQGGFGIVYKGRLLEG----QEIAVKRLSRNSGQGIEEFKNEVR--LIAKLQHRNLVRL 603
           LGQG FG V+  + + G    Q  A+K L + + +  +  + ++   ++ ++ H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI-ICGIARGLLYLHQDSR 662
                   +  L+ +++    L    F +    ++  +      +  +A  L +LH    
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS--- 144
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             II+RDLK  NILLD+E   K++DFG+++
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSK 174

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 72/158 (45%), Gaps = 19/158 (12%)
Query: 550 LGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN------EVRLIAKL----QHR 598
           LG+GGFG V+ G RL +  ++A+K + RN   G     +      EV L+ K+     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 599 NLVRLLGCCVEMDEKMLVYEY-MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            ++RLL      +  MLV E  +  + L   I +K        +  F  +    +     
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQ----- 153
Query: 658 HQDSRFRIIHRDLKASNILLD-KEMTPKISDFGMARIF 694
           H  SR  ++HRD+K  NIL+D +    K+ DFG   + 
Sbjct: 154 HCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALL 190

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 59/119 (49%), Gaps = 11/119 (9%)
Query: 578 SGQGIEEFKN----EVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK 632
           S + ++E +     EV ++ K+  H N+++L           LV++ M+   L   + +K
Sbjct: 59  SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK 118
Query: 633 ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
                L+ +    I+  +   +  LH   +  I+HRDLK  NILLD +M  K++DFG +
Sbjct: 119 V---TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 171

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 59/119 (49%), Gaps = 11/119 (9%)
Query: 578 SGQGIEEFKN----EVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK 632
           S + ++E +     EV ++ K+  H N+++L           LV++ M+   L   + +K
Sbjct: 46  SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK 105
Query: 633 ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
                L+ +    I+  +   +  LH   +  I+HRDLK  NILLD +M  K++DFG +
Sbjct: 106 V---TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 158

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 59/119 (49%), Gaps = 11/119 (9%)
Query: 578 SGQGIEEFKN----EVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK 632
           S + ++E +     EV ++ K+  H N+++L           LV++ M+   L   + +K
Sbjct: 59  SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK 118
Query: 633 ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
                L+ +    I+  +   +  LH   +  I+HRDLK  NILLD +M  K++DFG +
Sbjct: 119 V---TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 171

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 69/151 (45%), Gaps = 15/151 (9%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFK-NEVRLIAKLQHRNLV 601
            T   +LG+G FG V++ +  + G + AVK++       +E F+  E+   A L    +V
Sbjct: 74  MTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIV 127
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            L G   E     +  E +E  SL  +I    +   L   R    +     GL YLH   
Sbjct: 128 PLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR- 183
Query: 662 RFRIIHRDLKASNILLDKEMT-PKISDFGMA 691
             RI+H D+KA N+LL  + +   + DFG A
Sbjct: 184 --RILHGDVKADNVLLSSDGSRAALCDFGHA 212

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	709
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	8e-95
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	9e-92
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-83
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-64
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-53
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-49
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	8e-46
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-45
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-45
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-44
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-43
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-43
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-42
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-41
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-40
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-39
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-39
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-38
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-35
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-35
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-35
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-35
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	8e-35
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-34
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-34
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-34
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-34
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-34
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-33
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-33
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-33
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-33
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-33
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-33
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-33
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-33
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-33
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-32
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-32
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-32
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-32
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-32
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-32
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-32
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-32
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-32
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-32
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-32
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-32
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	7e-32
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-32
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-32
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-31
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-31
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-31
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-31
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-31
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-31
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-31
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-31
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-31
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-31
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-31
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	9e-31
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-30
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-30
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-30
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-30
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-30
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-30
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-30
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-30
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-30
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-30
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-30
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-30
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-30
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-30
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-29
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-29
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-28
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-28
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-28
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-28
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-28
3o0g_A	292	Cell division protein kinase 5; kinase activator c	8e-28
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	8e-28
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-27
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-27
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-27
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-27
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-27
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-27
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-27
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-27
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-27
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-27
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-26
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-26
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-26
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-26
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-26
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-26
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-26
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-25
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-25
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-25
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-25
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-25
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-25
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-25
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-25
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	9e-25
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-24
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-24
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-24
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-24
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-23
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-23
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-23
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-23
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-23
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-23
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-23
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-22
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-22
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-22
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-22
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-22
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-22
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-22
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-22
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-22
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-22
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-22
3fme_A	290	Dual specificity mitogen-activated protein kinase;	8e-22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	9e-22
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-22
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-21
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-21
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-21
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-21
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-21
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-21
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-21
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-21
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-21
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-21
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-20
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-20
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-20
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-20
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-20
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-20
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-20
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-20
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-20
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-20
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-20
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-19
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-19
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-19
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-19
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-19
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-19
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-19
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-19
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-18
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-18
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-18
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-18
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-18
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-18
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-18
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-17
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-17
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-16
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-16
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-16
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-15
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-15
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-14
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-12
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-12
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-12
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	8e-12
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-11
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-11
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-11
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-11
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	7e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-10
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-10
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-10
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-10
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-10
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-10
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-09
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-09
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-09
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-08
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	2e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-09
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	3e-08
1kj1_A	109	Lectin I, lecgna 1; BULB lectin, mannose, plant pr	6e-08
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-08
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-07
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	1e-06
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-06
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	1e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-05
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	3e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-04
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	1e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	7e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  295 bits (757), Expect = 8e-95
 Identities = 75/194 (38%), Positives = 107/194 (55%), Gaps = 14/194 (7%)

Query: 526 DLELPLFDFETIVRATDNF------TDYNKLGQGGFGIVYKGRLLEGQEIAVKRLS---- 575
           D     F F  +   T+NF         NK+G+GGFG+VYKG +     +AVK+L+    
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVD 67

Query: 576 RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARS 635
             + +  ++F  E++++AK QH NLV LLG   + D+  LVY YM N SL   +     +
Sbjct: 68  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 127

Query: 636 SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
             L+W  R  I  G A G+ +LH++     IHRD+K++NILLD+  T KISDFG+AR   
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASE 184

Query: 696 GDQTEQNTKRVVGT 709
                  T R+VGT
Sbjct: 185 KFAQTVMTSRIVGT 198

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  287 bits (738), Expect = 9e-92
 Identities = 83/180 (46%), Positives = 112/180 (62%), Gaps = 3/180 (1%)

Query: 532 FDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIE-EFKNEVR 590
           F    +  A+DNF++ N LG+GGFG VYKGRL +G  +AVKRL     QG E +F+ EV 
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICG 649
           +I+   HRNL+RL G C+   E++LVY YM N S+ S + ++  S   L+W +R  I  G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
            ARGL YLH     +IIHRD+KA+NILLD+E    + DFG+A++     T   T  V GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  264 bits (678), Expect = 5e-83
 Identities = 75/180 (41%), Positives = 112/180 (62%), Gaps = 6/180 (3%)

Query: 532 FDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRL 591
                +  AT+NF     +G G FG VYKG L +G ++A+KR +  S QGIEEF+ E+  
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 592 IAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGI 650
           ++  +H +LV L+G C E +E +L+Y+YMEN +L   ++     ++ ++W++R  I  G 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF-GGDQTEQNTKRVVGT 709
           ARGL YLH  +   IIHRD+K+ NILLD+   PKI+DFG+++     DQT  +T  V GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVKGT 204

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  215 bits (549), Expect = 3e-64
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 17/189 (8%)

Query: 532 FDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRL 591
              E +   +          +G FG V+K +L   + +AVK       Q   + + EV  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71

Query: 592 IAKLQHRNLVRLLGCCVE----MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNII 647
           +  ++H N+++ +G          +  L+  + E  SL   +    ++++++W    +I 
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127

Query: 648 CGIARGLLYLHQD-------SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE 700
             +ARGL YLH+D        +  I HRD+K+ N+LL   +T  I+DFG+A  F   ++ 
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 701 QNTKRVVGT 709
            +T   VGT
Sbjct: 188 GDTHGQVGT 196

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  187 bits (476), Expect = 1e-53
 Identities = 53/197 (26%), Positives = 82/197 (41%), Gaps = 27/197 (13%)

Query: 532 FDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNE--V 589
                     DN      +G+G +G VYKG L + + +AVK  S  + Q    F NE  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58

Query: 590 RLIAKLQHRNLVRLLGCCVEMD-----EKMLVYEYMENRSLDSVIFDKARSSILNWQRRF 644
             +  ++H N+ R +     +      E +LV EY  N SL   +         +W    
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSC 114

Query: 645 NIICGIARGLLYLHQD------SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG-- 696
            +   + RGL YLH +       +  I HRDL + N+L+  + T  ISDFG++    G  
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 697 ----DQTEQNTKRVVGT 709
                + +      VGT
Sbjct: 175 LVRPGEEDNAAISEVGT 191

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  173 bits (441), Expect = 5e-49
 Identities = 52/164 (31%), Positives = 89/164 (54%), Gaps = 6/164 (3%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRL--SRNSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
            K+G G FG V++     G ++AVK L       + + EF  EV ++ +L+H N+V  +G
Sbjct: 43  EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
              +     +V EY+   SL  ++        L+ +RR ++   +A+G+ YLH      I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160

Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           +HR+LK+ N+L+DK+ T K+ DFG++R+     T  ++K   GT
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLK--ASTFLSSKSAAGT 202

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  164 bits (418), Expect = 8e-46
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 6/159 (3%)

Query: 548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
             LG+G FG   K    E G+ + +K L R   +    F  EV+++  L+H N+++ +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
             +      + EY++  +L  +I          W +R +    IA G+ YLH      II
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHS---MNII 130

Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           HRDL + N L+ +     ++DFG+AR+   ++T+    R
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  163 bits (414), Expect = 3e-45
 Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 11/169 (6%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
                   +G+G FG+V K +    +++A+K++   S    + F  E+R ++++ H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIV 64

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +L G C  ++   LV EY E  SL +V+               +     ++G+ YLH   
Sbjct: 65  KLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 662 RFRIIHRDLKASNILLDKEMT-PKISDFGMARIFGGDQTEQNTKRVVGT 709
              +IHRDLK  N+LL    T  KI DFG A        + +     G+
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGS 166

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  161 bits (409), Expect = 6e-45
 Identities = 48/175 (27%), Positives = 89/175 (50%), Gaps = 23/175 (13%)

Query: 548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQG-------IEEFKNEVRLIAKLQHRN 599
            ++G+GGFG+V+KGRL++    +A+K L     +G        +EF+ EV +++ L H N
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V+L G     +   +V E++    L   + DKA    + W  +  ++  IA G+ Y+  
Sbjct: 85  IVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALGIEYMQN 140

Query: 660 DSRFRIIHRDLKASNILLDK-----EMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
                I+HRDL++ NI L        +  K++DFG+++      +  +   ++G 
Sbjct: 141 -QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGN 189

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  158 bits (402), Expect = 5e-44
 Identities = 56/174 (32%), Positives = 82/174 (47%), Gaps = 21/174 (12%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRL----SRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
             +G GGFG VY+   + G E+AVK        +  Q IE  + E +L A L+H N++ L
Sbjct: 13  EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
            G C++     LV E+     L+ V+        +      N    IARG+ YLH ++  
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 664 RIIHRDLKASNILLDKEMTP--------KISDFGMARIFGGDQTEQNTKRVVGT 709
            IIHRDLK+SNIL+ +++          KI+DFG+AR               G 
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAGA 177

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  157 bits (398), Expect = 2e-43
 Identities = 37/151 (24%), Positives = 70/151 (46%), Gaps = 7/151 (4%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRL--SRNSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
            KL +   G ++KGR  +G +I VK L     S +   +F  E   +    H N++ +LG
Sbjct: 16  TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 606 CCVE--MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
            C         L+  +M   SL +V+ +   + +++  +       +ARG+ +LH     
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHT-LEP 132

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIF 694
            I    L + ++++D++MT +IS   +   F
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSF 163

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  154 bits (392), Expect = 2e-42
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 22/199 (11%)

Query: 514 SSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKR 573
                 S D  DD E+P                  ++G G FG VYKG+     ++AVK 
Sbjct: 6   HHHHHGSRDAADDWEIPDGQITVG----------QRIGSGSFGTVYKGKWH--GDVAVKM 53

Query: 574 L--SRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM-LVYEYMENRSLDSVIF 630
           L  +  + Q ++ FKNEV ++ K +H N++  +G       ++ +V ++ E  SL   + 
Sbjct: 54  LNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS--TAPQLAIVTQWCEGSSLYHHL- 110

Query: 631 DKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM 690
             A  +    ++  +I    ARG+ YLH  S   IIHRDLK++NI L ++ T KI DFG+
Sbjct: 111 -HASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGL 166

Query: 691 ARIFGGDQTEQNTKRVVGT 709
           A            +++ G+
Sbjct: 167 ATEKSRWSGSHQFEQLSGS 185

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  150 bits (382), Expect = 8e-41
 Identities = 46/167 (27%), Positives = 80/167 (47%), Gaps = 13/167 (7%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRL--SRNSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
             +G+G FG VY GR     E+A++ +   R++   ++ FK EV    + +H N+V  +G
Sbjct: 39  ELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
            C+      ++    + R+L SV+  +    +L+  +   I   I +G+ YLH      I
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---I 151

Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR---VVGT 709
           +H+DLK+ N+  D      I+DFG+  I G  Q  +   +     G 
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGW 197

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  148 bits (376), Expect = 7e-40
 Identities = 48/194 (24%), Positives = 84/194 (43%), Gaps = 24/194 (12%)

Query: 529 LPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNE 588
           LPL    TI +         ++G+G +G V+ G+   G+++AVK            +  E
Sbjct: 27  LPLLVQRTIAK---QIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRE 79

Query: 589 --VRLIAKLQHRNLVRLLGCCVEMDEK----MLVYEYMENRSLDSVIFDKARSSILNWQR 642
             +     ++H N++  +   ++         L+ +Y EN SL   +    +S+ L+ + 
Sbjct: 80  TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKS 135

Query: 643 RFNIICGIARGLLYLHQDSRFR-----IIHRDLKASNILLDKEMTPKISDFGMARIF--G 695
              +      GL +LH +         I HRDLK+ NIL+ K  T  I+D G+A  F   
Sbjct: 136 MLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISD 195

Query: 696 GDQTEQNTKRVVGT 709
            ++ +      VGT
Sbjct: 196 TNEVDIPPNTRVGT 209

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  145 bits (368), Expect = 4e-39
 Identities = 46/175 (26%), Positives = 78/175 (44%), Gaps = 21/175 (12%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNE--VRLIAKLQHRNLVRLLG 605
             +G+G +G V++G   +G+ +AVK  S    +  + +  E  +     L+H N++  + 
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 606 CCVEMDEK----MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
             +          L+  Y E  SL    +D  + + L+      I+  IA GL +LH + 
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 662 RFR-----IIHRDLKASNILLDKEMTPKISDFGMARIF--GGDQTEQNTKRVVGT 709
                   I HRDLK+ NIL+ K     I+D G+A +     +Q +      VGT
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  144 bits (365), Expect = 2e-38
 Identities = 54/194 (27%), Positives = 82/194 (42%), Gaps = 24/194 (12%)

Query: 529 LPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNE 588
           LPL    TI R          +G+G FG V++G+   G+E+AVK  S    +    +  E
Sbjct: 32  LPLLVQRTIAR---TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFRE 84

Query: 589 --VRLIAKLQHRNLVRLLGCCVEMDEK----MLVYEYMENRSLDSVIFDKARSSILNWQR 642
             +     L+H N++  +    + +       LV +Y E+ SL    FD      +  + 
Sbjct: 85  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEG 140

Query: 643 RFNIICGIARGLLYLHQDSRFR-----IIHRDLKASNILLDKEMTPKISDFGMARIF--G 695
              +    A GL +LH +         I HRDLK+ NIL+ K  T  I+D G+A      
Sbjct: 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 200

Query: 696 GDQTEQNTKRVVGT 709
            D  +      VGT
Sbjct: 201 TDTIDIAPNHRVGT 214

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  136 bits (344), Expect = 1e-35
 Identities = 48/209 (22%), Positives = 87/209 (41%), Gaps = 22/209 (10%)

Query: 497 RGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFG 556
             H           +        + +  D  +              +     +LG+G FG
Sbjct: 6   HHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFE----------ERHLKFLQQLGKGNFG 55

Query: 557 IVYKGRLL-----EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD 611
            V   R        G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+  G C    
Sbjct: 56  SVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115

Query: 612 EK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRD 669
            +   L+ EY+   SL    + +     ++  +       I +G+ YL   ++ R IHRD
Sbjct: 116 RRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYLG--TK-RYIHRD 170

Query: 670 LKASNILLDKEMTPKISDFGMARIFGGDQ 698
           L   NIL++ E   KI DFG+ ++   D+
Sbjct: 171 LATRNILVENENRVKIGDFGLTKVLPQDK 199

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  137 bits (348), Expect = 1e-35
 Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 7/162 (4%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRL-SRNSGQGIEEFKNEVRLIAKLQHRN 599
           ++     ++G+G FG V+ GRL  +   +AVK            +F  E R++ +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +VRL+G C +     +V E ++     +  F +   + L  +    ++   A G+ YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLT--FLRTEGARLRVKTLLQMVGDAAAGMEYLES 231

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ 701
                 IHRDL A N L+ ++   KISDFGM+R         
Sbjct: 232 K---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  135 bits (341), Expect = 2e-35
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 12/158 (7%)

Query: 548 NKLGQGGFGIVYKGRLL-----EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
            +LG+G FG V   R        G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 603 LLGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
             G C     +   L+ EY+   SL    + +     ++  +       I +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYLG-- 131

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           ++ R IHRDL   NIL++ E   KI DFG+ ++   D+
Sbjct: 132 TK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  135 bits (342), Expect = 2e-35
 Identities = 47/159 (29%), Positives = 72/159 (45%), Gaps = 15/159 (9%)

Query: 548 NKLGQGGFGIVYKGRLL-----EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLV 601
             LG+G FG V            G+ +AVK L  ++G Q    +K E+ ++  L H +++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 602 RLLGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +  GCC +       LV EY+   SL   +        +   +       I  G+ YLH 
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH- 151

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
            ++   IHRDL A N+LLD +   KI DFG+A+      
Sbjct: 152 -AQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  134 bits (338), Expect = 8e-35
 Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 12/160 (7%)

Query: 548 NKLGQGGFGIVYKGRLL-----EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           ++LG+G FG V   R        G  +AVK+L  +      +F+ E++++  L    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 603 LLGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
             G       +   LV EY+ +  L    F +   + L+  R       I +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQICKGMEYLG-- 144

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE 700
           SR R +HRDL A NIL++ E   KI+DFG+A++   D+  
Sbjct: 145 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 183

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  132 bits (333), Expect = 2e-34
 Identities = 53/188 (28%), Positives = 84/188 (44%), Gaps = 28/188 (14%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH 597
           R   +F +   +G GGFG V+K +  ++G+   +KR+  N+    E+ + EV+ +AKL H
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDH 63

Query: 598 RNLVRLLGCCVEMDEKM----------------LVYEYMENRSLDSVIFDKARSSILNWQ 641
            N+V   GC    D                   +  E+ +  +L+  I +K R   L+  
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKV 122

Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ 701
               +   I +G+ Y+H     ++I+RDLK SNI L      KI DFG+      D    
Sbjct: 123 LALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---G 176

Query: 702 NTKRVVGT 709
              R  GT
Sbjct: 177 KRTRSKGT 184

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  132 bits (333), Expect = 3e-34
 Identities = 47/159 (29%), Positives = 77/159 (48%), Gaps = 13/159 (8%)

Query: 548 NKLGQGGFGIVYKGRLL-----EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLV 601
             LG+G FG V   R        G+++AVK L   SG   I + K E+ ++  L H N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 602 RLLGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +  G C E       L+ E++ + SL    +     + +N +++      I +G+ YL  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKE--YLPKNKNKINLKQQLKYAVQICKGMDYLGS 144

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
               + +HRDL A N+L++ E   KI DFG+ +    D+
Sbjct: 145 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  132 bits (335), Expect = 3e-34
 Identities = 47/159 (29%), Positives = 77/159 (48%), Gaps = 12/159 (7%)

Query: 548 NKLGQGGFGIVYKGRLLEGQE-----IAVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLV 601
             LG G FG VYKG  +   E     +A+K L   +     +E  +E  ++A + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           RLLG C+      L+ + M    L    + +     +  Q   N    IA+G+ YL    
Sbjct: 81  RLLGICLT-STVQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL---E 134

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE 700
             R++HRDL A N+L+      KI+DFG+A++ G ++ E
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  137 bits (346), Expect = 5e-34
 Identities = 58/273 (21%), Positives = 101/273 (36%), Gaps = 26/273 (9%)

Query: 451 IGDGANATPIIIGV-----TVGSAILILGLVAC------FLWRRKTLLGRQIRKTEPRGH 499
           +       P+ +           A LI G              R    G +   + P+  
Sbjct: 288 LKIAGAPEPLTVTAPSLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLA 347

Query: 500 PERSQDLLLNQVVISSKRDYS--ADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGI 557
               Q +  + V +S   DY+   D+ D   +P      I R  +       +G+G FG 
Sbjct: 348 NNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQR--ERIELGRCIGEGQFGD 405

Query: 558 VYKGRLL--EGQEI--AVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE 612
           V++G  +  E   +  A+K      S    E+F  E   + +  H ++V+L+G   E + 
Sbjct: 406 VHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NP 464

Query: 613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKA 672
             ++ E      L S  F + R   L+          ++  L YL      R +HRD+ A
Sbjct: 465 VWIIMELCTLGELRS--FLQVRKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAA 519

Query: 673 SNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
            N+L+      K+ DFG++R        + +K 
Sbjct: 520 RNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 552

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  129 bits (327), Expect = 7e-34
 Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 6/151 (3%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            ++G G FG+V+ G  L   ++A+K + R      E+F  E  ++ KL H  LV+L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
           +E     LV E+ME+  L    + + +  +   +    +   +  G+ YL       +IH
Sbjct: 73  LEQAPICLVTEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIH 127

Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           RDL A N L+ +    K+SDFGM R    DQ
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  128 bits (325), Expect = 1e-33
 Identities = 46/150 (30%), Positives = 75/150 (50%), Gaps = 6/150 (4%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           +LG G FG+V  G+     ++AVK + +      +EF  E + + KL H  LV+  G C 
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           +     +V EY+ N  L +  + ++    L   +   +   +  G+ +L      + IHR
Sbjct: 74  KEYPIYIVTEYISNGCLLN--YLRSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHR 128

Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           DL A N L+D+++  K+SDFGM R    DQ
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  129 bits (326), Expect = 2e-33
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 6/151 (3%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG+V  G+     ++A+K + +      +EF  E +++  L H  LV+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
            +     ++ EYM N  L +  + +        Q+   +   +   + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLH 143

Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           RDL A N L++ +   K+SDFG++R    D+
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  130 bits (328), Expect = 2e-33
 Identities = 41/179 (22%), Positives = 80/179 (44%), Gaps = 22/179 (12%)

Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRL---SRNSGQGIEEFKNEVRLIAKLQH 597
            NF    K+G+G F  VY+   LL+G  +A+K++        +   +   E+ L+ +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKAR-------SSILNWQRRFNIICGI 650
            N+++     +E +E  +V E  +   L  +I    +        ++  +         +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY------FVQL 145

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
              L ++H     R++HRD+K +N+ +      K+ D G+ R F    T  ++  +VGT
Sbjct: 146 CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  130 bits (328), Expect = 2e-33
 Identities = 48/156 (30%), Positives = 75/156 (48%), Gaps = 10/156 (6%)

Query: 548 NKLGQGGFGIVYKGRLL----EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVR 602
             +G G  G V  GRL         +A+K L      +   +F +E  ++ +  H N++R
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G        M+V EYMEN SLD+  F +         +   ++ G+  G+ YL   S 
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTIMQLVGMLRGVGAGMRYL---SD 169

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              +HRDL A N+L+D  +  K+SDFG++R+   D 
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  130 bits (328), Expect = 4e-33
 Identities = 44/171 (25%), Positives = 81/171 (47%), Gaps = 9/171 (5%)

Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHR 598
           + +    K+G+G FG     +   +G++  +K   +SR S +  EE + EV ++A ++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
           N+V+      E     +V +Y E   L   I +  +  +    +  +    I   L ++H
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
                +I+HRD+K+ NI L K+ T ++ DFG+AR+             +GT
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  128 bits (325), Expect = 5e-33
 Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 12/162 (7%)

Query: 548 NKLGQGGFGIVYKGRLL---EGQEI--AVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLV 601
             LG G FG V+KG  +   E  +I   +K +   SG Q  +   + +  I  L H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           RLLG C       LV +Y+   SL      +     L  Q   N    IA+G+ YL    
Sbjct: 79  RLLGLCPG-SSLQLVTQYLPLGSLLD--HVRQHRGALGPQLLLNWGVQIAKGMYYL---E 132

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
              ++HR+L A N+LL      +++DFG+A +   D  +   
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 174

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  127 bits (322), Expect = 5e-33
 Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 21/166 (12%)

Query: 549 KLGQGGFGIVYKGRL--------LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
            LGQG F  ++KG          L   E+ +K L +      E F     +++KL H++L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V   G CV  DE +LV E+++  SLD+  + K   + +N   +  +   +A  + +L   
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDT--YLKKNKNCINILWKLEVAKQLAAAMHFL--- 129

Query: 661 SRFRIIHRDLKASNILLDKEMTP--------KISDFGMARIFGGDQ 698
               +IH ++ A NILL +E           K+SD G++       
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  127 bits (322), Expect = 6e-33
 Identities = 44/179 (24%), Positives = 75/179 (41%), Gaps = 17/179 (9%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQ 596
           R   +F     LG+GGFG+V++ +  ++    A+KR+   N     E+   EV+ +AKL+
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61

Query: 597 HRNLVRLLGCCVEMDEKM------------LVYEYMENRSLDSVIFDKARSSILNWQRRF 644
           H  +VR     +E +               +  +     +L   +  +            
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
           +I   IA  + +LH      ++HRDLK SNI    +   K+ DFG+      D+ EQ  
Sbjct: 122 HIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  128 bits (324), Expect = 8e-33
 Identities = 50/176 (28%), Positives = 81/176 (46%), Gaps = 22/176 (12%)

Query: 548 NKLGQGGFGIVYKGR---LLEGQE---IAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
            +LG+G FG V+      LL  Q+   +AVK L   S    ++F+ E  L+  LQH+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDS------------VIFDKARSSILNWQRRFNIICG 649
           R  G C E    ++V+EYM +  L+                +      L   +   +   
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTK 704
           +A G++YL   +    +HRDL   N L+ + +  KI DFGM+R I+  D      +
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 219

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  126 bits (320), Expect = 1e-32
 Identities = 48/159 (30%), Positives = 67/159 (42%), Gaps = 13/159 (8%)

Query: 549 KLGQGGFGIVYKGRLL--EGQEI--AVKRL---SRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           KLG G FG+V +G      G+ +  AVK L     +  + +++F  EV  +  L HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           RL G  +      +V E     SL      +                 +A G+ YL    
Sbjct: 85  RLYGVVLT-PPMKMVTELAPLGSLLD--RLRKHQGHFLLGTLSRYAVQVAEGMGYL---E 138

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE 700
             R IHRDL A N+LL      KI DFG+ R    +   
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  126 bits (320), Expect = 1e-32
 Identities = 48/173 (27%), Positives = 84/173 (48%), Gaps = 12/173 (6%)

Query: 526 DLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEG----QEIAVKRLSRN-SGQ 580
           +L   +     I  ++        +G+G FG VY G LL+        AVK L+R     
Sbjct: 10  ELVQAVQHVV-IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 68

Query: 581 GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK-MLVYEYMENRSLDSVIFDKARSSILN 639
            + +F  E  ++    H N++ LLG C+  +   ++V  YM++  L +  F +  +    
Sbjct: 69  EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPT 126

Query: 640 WQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            +        +A+G+ YL   +  + +HRDL A N +LD++ T K++DFG+AR
Sbjct: 127 VKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  127 bits (321), Expect = 2e-32
 Identities = 50/163 (30%), Positives = 81/163 (49%), Gaps = 11/163 (6%)

Query: 549 KLGQGGFGIVYKGRLLEGQE-----IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVR 602
            +G G FG VYKG L          +A+K L    + +   +F  E  ++ +  H N++R
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G   +    M++ EYMEN +LD   F + +    +  +   ++ GIA G+ YL   + 
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAGMKYL---AN 165

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
              +HRDL A NIL++  +  K+SDFG++R+   D     T  
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 208

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  126 bits (318), Expect = 2e-32
 Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 10/156 (6%)

Query: 549 KLGQGGFGIVYKGRLLEGQE---IAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +LG G FG V +G     ++   +A+K L + +     EE   E +++ +L +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G C   +  MLV E      L    F   +   +       ++  ++ G+ YL       
Sbjct: 77  GVCQA-EALMLVMEMAGGGPLHK--FLVGKREEIPVSNVAELLHQVSMGMKYL---EEKN 130

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE 700
            +HRDL A N+LL      KISDFG+++  G D + 
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  127 bits (321), Expect = 2e-32
 Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 12/162 (7%)

Query: 548 NKLGQGGFGIVYKGRLLEGQE-----IAVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLV 601
             LG G FG VYKG  +   E     +A+K L   +     +E  +E  ++A + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           RLLG C+      L+ + M    L    + +     +  Q   N    IA+G+ YL    
Sbjct: 81  RLLGICLT-STVQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL---E 134

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
             R++HRDL A N+L+      KI+DFG+A++ G ++ E + 
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  126 bits (318), Expect = 2e-32
 Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 22/164 (13%)

Query: 548 NKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
            +LG+G FG V+           +   +AVK L   +    ++F+ E  L+  LQH ++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDS-------------VIFDKARSSILNWQRRFNIIC 648
           +  G C + D  ++V+EYM++  L+                  +     L   +  +I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            IA G++YL   +    +HRDL   N L+   +  KI DFGM+R
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  126 bits (318), Expect = 3e-32
 Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 12/177 (6%)

Query: 522 DKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQE----IAVKRLSRN 577
           D    L   + D   I            +G+G FG+VY G  ++  +     A+K LSR 
Sbjct: 2   DLDSALLAEVKDVL-IPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI 60

Query: 578 SGQG-IEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE-KMLVYEYMENRSLDSVIFDKARS 635
           +    +E F  E  L+  L H N++ L+G  +  +    ++  YM +  L    F ++  
Sbjct: 61  TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQ--FIRSPQ 118

Query: 636 SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
                +   +    +ARG+ YL   +  + +HRDL A N +LD+  T K++DFG+AR
Sbjct: 119 RNPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  127 bits (321), Expect = 4e-32
 Identities = 52/156 (33%), Positives = 78/156 (50%), Gaps = 10/156 (6%)

Query: 548 NKLGQGGFGIVYKGRLLEGQE----IAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVR 602
             +G G FG V  GRL    +    +A+K L      +   +F  E  ++ +  H N++R
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G   +    M+V EYMEN SLDS  F +   +     +   ++ GIA G+ YL   S 
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SD 165

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              +HRDL A NIL++  +  K+SDFG+ R+   D 
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  125 bits (317), Expect = 4e-32
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 28/208 (13%)

Query: 512 VISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLL----EGQ 567
           ++    +   +K +D+ +         R  +       LG+G FG V +G L        
Sbjct: 14  LVPRGSEELQNKLEDVVID--------R--NLLILGKILGEGEFGSVMEGNLKQEDGTSL 63

Query: 568 EIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD-----EKMLVYEYM 620
           ++AVK +  +  S + IEEF +E   +    H N++RLLG C+EM      + M++  +M
Sbjct: 64  KVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFM 123

Query: 621 ENRSLDSVI---FDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL 677
           +   L + +     +     +  Q     +  IA G+ YL   S    +HRDL A N +L
Sbjct: 124 KYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCML 180

Query: 678 DKEMTPKISDFGMAR-IFGGDQTEQNTK 704
             +MT  ++DFG+++ I+ GD   Q   
Sbjct: 181 RDDMTVCVADFGLSKKIYSGDYYRQGRI 208

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  129 bits (325), Expect = 4e-32
 Identities = 45/146 (30%), Positives = 71/146 (48%), Gaps = 8/146 (5%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
             +G+G FG V  G    G ++AVK +  ++    + F  E  ++ +L+H NLV+LLG  
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 608 VEMDEK-MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
           VE      +V EYM   SL   +  + RS  L           +   + YL        +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL---EGNNFV 311

Query: 667 HRDLKASNILLDKEMTPKISDFGMAR 692
           HRDL A N+L+ ++   K+SDFG+ +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK 337

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  125 bits (315), Expect = 5e-32
 Identities = 46/152 (30%), Positives = 77/152 (50%), Gaps = 6/152 (3%)

Query: 548 NKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           +KLG G +G VY+G        +AVK L +     +EEF  E  ++ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
           C       ++ E+M   +L   + +  R   ++      +   I+  + YL    +   I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL---EKKNFI 133

Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           HRDL A N L+ +    K++DFG++R+  GD 
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  124 bits (314), Expect = 5e-32
 Identities = 45/146 (30%), Positives = 70/146 (47%), Gaps = 8/146 (5%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
             +G+G FG V  G    G ++AVK +   +    + F  E  ++ +L+H NLV+LLG  
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 608 VEMDEK-MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
           VE      +V EYM   SL   +  + RS  L           +   + YL        +
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL---EGNNFV 139

Query: 667 HRDLKASNILLDKEMTPKISDFGMAR 692
           HRDL A N+L+ ++   K+SDFG+ +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK 165

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  124 bits (314), Expect = 7e-32
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 23/165 (13%)

Query: 548 NKLGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNL 600
            +LG+  FG VYKG L       + Q +A+K L     G   EEF++E  L A+LQH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDS-------------VIFDKARSSILNWQRRFNII 647
           V LLG   +     +++ Y  +  L                  D+   S L      +++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             IA G+ YL   S   ++H+DL   N+L+  ++  KISD G+ R
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  126 bits (318), Expect = 8e-32
 Identities = 46/151 (30%), Positives = 80/151 (52%), Gaps = 11/151 (7%)

Query: 548 NKLGQGGFGIVYKGRLLEG----QEIAVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVR 602
             +G+G FG VY G LL+        AVK L+R +  G + +F  E  ++    H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 603 LLGCCVEMDEK-MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           LLG C+  +   ++V  YM++  L +  F +  +     +        +A+G+ +L   +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL---A 209

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
             + +HRDL A N +LD++ T K++DFG+AR
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  126 bits (318), Expect = 9e-32
 Identities = 60/240 (25%), Positives = 97/240 (40%), Gaps = 32/240 (13%)

Query: 482 RRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRAT 541
             +  +G +++  E +    R+  ++ +          ++  +D  E+P           
Sbjct: 21  YFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPR---------- 70

Query: 542 DNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAK 594
            N T    LG G FG VY+G++          ++AVK L    S Q   +F  E  +I+K
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130

Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIF------DKARSSILNWQRRFNIIC 648
             H+N+VR +G  ++   + ++ E M    L S  F        ++ S L      ++  
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS--FLRETRPRPSQPSSLAMLDLLHVAR 188

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKE---MTPKISDFGMAR-IFGGDQTEQNTK 704
            IA G  YL        IHRD+ A N LL         KI DFGMAR I+      +   
Sbjct: 189 DIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC 245

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  125 bits (315), Expect = 1e-31
 Identities = 51/196 (26%), Positives = 87/196 (44%), Gaps = 28/196 (14%)

Query: 525 DDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRN- 577
           D+ E+            +  T   +LGQG FG+VY+G             +A+K ++   
Sbjct: 18  DEWEVAR----------EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 67

Query: 578 SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIF 630
           S +   EF NE  ++ +    ++VRLLG   +    +++ E M         RSL   + 
Sbjct: 68  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 127

Query: 631 DKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM 690
           +    +  +  +   +   IA G+ YL   +  + +HRDL A N ++ ++ T KI DFGM
Sbjct: 128 NNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGM 184

Query: 691 AR-IFGGDQTEQNTKR 705
            R I+  D   +  K 
Sbjct: 185 TRDIYETDYYRKGGKG 200

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  129 bits (326), Expect = 1e-31
 Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 12/206 (5%)

Query: 499 HPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIV 558
            P R       + +      + +  +D  EL       + R      D  +LG G FG V
Sbjct: 295 EPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLF-LKRDNLLIAD-IELGCGNFGSV 352

Query: 559 YKGRL-LEGQEI--AVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM 614
            +G   +  ++I  A+K L + +     EE   E +++ +L +  +VRL+G C   +  M
Sbjct: 353 RQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411

Query: 615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASN 674
           LV E      L    F   +   +       ++  ++ G+ YL        +HR+L A N
Sbjct: 412 LVMEMAGGGPLHK--FLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARN 466

Query: 675 ILLDKEMTPKISDFGMARIFGGDQTE 700
           +LL      KISDFG+++  G D + 
Sbjct: 467 VLLVNRHYAKISDFGLSKALGADDSY 492

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  128 bits (323), Expect = 1e-31
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 6/152 (3%)

Query: 548 NKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           +KLG G +G VY+G        +AVK L +     +EEF  E  ++ +++H NLV+LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
           C       ++ E+M   +L   + +  R   ++      +   I+  + YL    +   I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL---EKKNFI 340

Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           HR+L A N L+ +    K++DFG++R+  GD 
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  123 bits (311), Expect = 2e-31
 Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 12/157 (7%)

Query: 549 KLGQGGFGIVYKGRL-LEGQEI--AVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG G FG V KG   ++      AVK L          +E   E  ++ +L +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           +G C   +  MLV E  E   L+   + +     +  +    ++  ++ G+ YL      
Sbjct: 84  IGICEA-ESWMLVMEMAELGPLNK--YLQQNRH-VKDKNIIELVHQVSMGMKYL---EES 136

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE 700
             +HRDL A N+LL  +   KISDFG+++    D+  
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  124 bits (313), Expect = 2e-31
 Identities = 51/172 (29%), Positives = 75/172 (43%), Gaps = 18/172 (10%)

Query: 548 NKLGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNL 600
             LG G FG VY+G++          ++AVK L    S Q   +F  E  +I+K  H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVI----FDKARSSILNWQRRFNIICGIARGLLY 656
           VR +G  ++   + ++ E M    L S +       ++ S L      ++   IA G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 657 LHQDSRFRIIHRDLKASNILLDKE---MTPKISDFGMAR-IFGGDQTEQNTK 704
           L        IHRD+ A N LL         KI DFGMAR I+      +   
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 204

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  122 bits (309), Expect = 3e-31
 Identities = 48/151 (31%), Positives = 79/151 (52%), Gaps = 6/151 (3%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG V+ G      ++AVK L +      + F  E  L+ +LQH+ LVRL    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
            + +   ++ EYMEN SL   +   +    L   +  ++   IA G+ ++        IH
Sbjct: 78  TQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFI---EERNYIH 132

Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           RDL+A+NIL+   ++ KI+DFG+AR+   ++
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNE 163

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  122 bits (309), Expect = 3e-31
 Identities = 51/162 (31%), Positives = 76/162 (46%), Gaps = 7/162 (4%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           LG+G +GIVY GR L     IA+K +     +  +    E+ L   L+H+N+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E     +  E +   SL +++  K      N Q        I  GL YLH +   +I+HR
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146

Query: 669 DLKASNILLD-KEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           D+K  N+L++      KISDFG ++   G      T    GT
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGT 186

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  123 bits (310), Expect = 4e-31
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 32/214 (14%)

Query: 507 LLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLL-- 564
           +L+ + IS +     +K +D+ +P             FT    LG+G FG V + +L   
Sbjct: 1   MLDSLGISDE---LKEKLEDVLIP--------E--QQFTLGRMLGKGEFGSVREAQLKQE 47

Query: 565 --EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK------M 614
                ++AVK L  +  +   IEEF  E   + +  H ++ +L+G  +    K      M
Sbjct: 48  DGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPM 107

Query: 615 LVYEYMENRSLDSVIFD---KARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLK 671
           ++  +M++  L + +           L  Q     +  IA G+ YL   S    IHRDL 
Sbjct: 108 VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLA 164

Query: 672 ASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTK 704
           A N +L ++MT  ++DFG++R I+ GD   Q   
Sbjct: 165 ARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA 198

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  121 bits (306), Expect = 6e-31
 Identities = 39/155 (25%), Positives = 70/155 (45%), Gaps = 11/155 (7%)

Query: 549 KLGQGGFGIVYKGRLL--EGQEI--AVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRL 603
            LG+G FG VY+G     +G++I  AVK   ++ +    E+F +E  ++  L H ++V+L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           +G   E +   ++ E      L    + +   + L           I + + YL      
Sbjct: 79  IGIIEE-EPTWIIMELYPYGELGH--YLERNKNSLKVLTLVLYSLQICKAMAYL---ESI 132

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
             +HRD+   NIL+      K+ DFG++R    + 
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  122 bits (308), Expect = 6e-31
 Identities = 50/183 (27%), Positives = 89/183 (48%), Gaps = 17/183 (9%)

Query: 534 FETIVRATD---NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEV 589
           +E + R  D    +    +LG G FG VYK +  E G   A K +   S + +E++  E+
Sbjct: 8   YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEI 67

Query: 590 RLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC- 648
            ++A   H  +V+LLG      +  ++ E+    ++D+++        L  + +  ++C 
Sbjct: 68  EILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLT-EPQIQVVCR 124

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--V 706
            +   L +LH     RIIHRDLKA N+L+  E   +++DFG++        +   KR   
Sbjct: 125 QMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSF 177

Query: 707 VGT 709
           +GT
Sbjct: 178 IGT 180

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  125 bits (316), Expect = 7e-31
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 6/151 (3%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            KLG G FG V+     +  ++AVK + +     +E F  E  ++  LQH  LV+L    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
            + +   ++ E+M   SL   +     S      +  +    IA G+ ++    +   IH
Sbjct: 253 TK-EPIYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFI---EQRNYIH 307

Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           RDL+A+NIL+   +  KI+DFG+AR+   ++
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNE 338

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  122 bits (307), Expect = 9e-31
 Identities = 43/180 (23%), Positives = 79/180 (43%), Gaps = 12/180 (6%)

Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGIEEFKNEVRL 591
           F+++      ++   ++G GG   V++    + Q  A+K ++      Q ++ ++NE+  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79

Query: 592 IAKLQHRNL--VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICG 649
           + KLQ  +   +RL    +      +V E   N  L+S +  K     ++   R +    
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKN 135

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           +   +  +HQ     I+H DLK +N L+   M  K+ DFG+A     D T       VGT
Sbjct: 136 MLEAVHTIHQ---HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 191

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  121 bits (306), Expect = 1e-30
 Identities = 49/170 (28%), Positives = 76/170 (44%), Gaps = 20/170 (11%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH 597
           R   +F +   LGQG FG V K R  L+ +  A+K++     + +    +EV L+A L H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNH 61

Query: 598 RNLVRLLGCCVEMDEKM-------------LVYEYMENRSLDSVIFDKARSSILNWQRRF 644
           + +VR     +E    +             +  EY EN +L  +I   + +        +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYW 119

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
            +   I   L Y+H      IIHRDLK  NI +D+    KI DFG+A+  
Sbjct: 120 RLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  121 bits (305), Expect = 1e-30
 Identities = 39/155 (25%), Positives = 67/155 (43%), Gaps = 11/155 (7%)

Query: 549 KLGQGGFGIVYKGRLL--EGQEI--AVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRL 603
            +G+G FG V++G  +  E   +  A+K      S    E+F  E   + +  H ++V+L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           +G   E +   ++ E      L S  F + R   L+          ++  L YL      
Sbjct: 82  IGVITE-NPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYL---ESK 135

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           R +HRD+ A N+L+      K+ DFG++R      
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  121 bits (306), Expect = 1e-30
 Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 19/182 (10%)

Query: 535 ETIVRATD---NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVR 590
             +V   D       Y K+G+G  GIV   R    G+++AVK +     Q  E   NEV 
Sbjct: 35  RMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVV 94

Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-G 649
           ++   QH N+V +    +  +E  ++ E+++  +L  ++        LN + +   +C  
Sbjct: 95  IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV----SQVRLN-EEQIATVCEA 149

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VV 707
           + + L YLH      +IHRD+K+ +ILL  +   K+SDFG    F    ++   KR  +V
Sbjct: 150 VLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLV 202

Query: 708 GT 709
           GT
Sbjct: 203 GT 204

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  123 bits (310), Expect = 1e-30
 Identities = 48/228 (21%), Positives = 84/228 (36%), Gaps = 20/228 (8%)

Query: 489 RQIRKTEPRGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDY- 547
                  PRG   +       +       D   D  D       +  ++         Y 
Sbjct: 5   HHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISV-----KGRIYS 59

Query: 548 --NKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNL--V 601
              ++G GG   V++    + Q  A+K ++      Q ++ ++NE+  + KLQ  +   +
Sbjct: 60  ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           RL    +      +V E   N  L+S +  K     ++   R +    +   +  +HQ  
Sbjct: 120 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ-- 173

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
              I+H DLK +N L+   M  K+ DFG+A     D T       VG 
Sbjct: 174 -HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGA 219

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  120 bits (304), Expect = 2e-30
 Identities = 50/173 (28%), Positives = 91/173 (52%), Gaps = 16/173 (9%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN 599
              +T + K+GQG  G VY    +  GQE+A+++++       E   NE+ ++ + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-GIARGLLYLH 658
           +V  L   +  DE  +V EY+   SL  V+      + ++ + +   +C    + L +LH
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMD-EGQIAAVCRECLQALEFLH 133

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGT 709
            +   ++IHRD+K+ NILL  + + K++DFG    F    T + +KR  +VGT
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGT 179

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  122 bits (307), Expect = 2e-30
 Identities = 45/166 (27%), Positives = 76/166 (45%), Gaps = 12/166 (7%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNL--VRL 603
            ++G GG   V++    + Q  A+K ++      Q ++ ++NE+  + KLQ  +   +RL
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
               +      +V E   N  L+S +  K + SI  W+R+      +   +  +HQ    
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKS-YWKNMLEAVHTIHQ---H 127

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
            I+H DLK +N L+   M  K+ DFG+A     D T       VGT
Sbjct: 128 GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 172

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  120 bits (303), Expect = 2e-30
 Identities = 47/182 (25%), Positives = 77/182 (42%), Gaps = 22/182 (12%)

Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHR 598
           +++     +G G +G   K R   +G+ +  K       +    +   +EV L+ +L+H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 599 NLVRLLGCCVEMDEKML--VYEYMENRSLDSVIFDKARSS-------ILNWQRRFNIICG 649
           N+VR     ++     L  V EY E   L SVI    +         +L        +  
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV------MTQ 119

Query: 650 IARGLLYLHQ--DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
           +   L   H+  D    ++HRDLK +N+ LD +   K+ DFG+ARI   +      K  V
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFV 177

Query: 708 GT 709
           GT
Sbjct: 178 GT 179

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  121 bits (305), Expect = 2e-30
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 9/157 (5%)

Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           ++    KLG+GGF  V     L +G   A+KR+  +  Q  EE + E  +     H N++
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 602 RLLGCCVEMDEKM----LVYEYMENRSLDSVIFD-KARSSILNWQRRFNIICGIARGLLY 656
           RL+  C+          L+  + +  +L + I   K + + L   +   ++ GI RGL  
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI 693
           +H        HRDLK +NILL  E  P + D G    
Sbjct: 150 IHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  120 bits (303), Expect = 2e-30
 Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 24/205 (11%)

Query: 517 RDYSADKTDDLELPLFDFETIVRATDNFTDYNK----LGQGGFGIVYKGR-LLEGQEIAV 571
           ++    + DD+E    + ET      N   + K    +G+G F  VYKG       E+A 
Sbjct: 1   QEERNQQQDDIE----ELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAW 56

Query: 572 K--RLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM----LVYEYMENRSL 625
              +  + +    + FK E  ++  LQH N+VR         +      LV E M + +L
Sbjct: 57  CELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL 116

Query: 626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD-KEMTPK 684
            + +    R  ++  +   +    I +GL +LH  +   IIHRDLK  NI +     + K
Sbjct: 117 KTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVK 172

Query: 685 ISDFGMARIFGGDQTEQNTKRVVGT 709
           I D G+A +    +     K V+GT
Sbjct: 173 IGDLGLATL----KRASFAKAVIGT 193

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  120 bits (304), Expect = 3e-30
 Identities = 49/163 (30%), Positives = 78/163 (47%), Gaps = 21/163 (12%)

Query: 548 NKLGQGGFGIVYKGRLLEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVR 602
           + +G+G FG V K R+ +       A+KR+    S     +F  E+ ++ KL  H N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDS-------------VIFDKARSSILNWQRRFNIICG 649
           LLG C       L  EY  + +L                    + +S L+ Q+  +    
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +ARG+ YL   S+ + IHRDL A NIL+ +    KI+DFG++R
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  121 bits (306), Expect = 4e-30
 Identities = 58/248 (23%), Positives = 103/248 (41%), Gaps = 37/248 (14%)

Query: 479 FLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDYSADK-----TDDLELPLFD 533
               ++  L RQ+           S +     V I+++   +AD        + ELP   
Sbjct: 18  HKLTKRIPLRRQV---TVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDP 74

Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLL--------EGQEIAVKRLSRN-SGQGIEE 584
                R  D  T    LG+G FG V     +        E   +AVK L  + + + + +
Sbjct: 75  KWEFPR--DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD 132

Query: 585 FKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMENRSL-------------DSVIF 630
             +E+ ++  + +H+N++ LLG C +     ++ EY    +L              S   
Sbjct: 133 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192

Query: 631 DKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM 690
           ++     + ++   +    +ARG+ YL   +  + IHRDL A N+L+ +    KI+DFG+
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGL 249

Query: 691 AR-IFGGD 697
           AR I   D
Sbjct: 250 ARDINNID 257

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  120 bits (303), Expect = 5e-30
 Identities = 50/240 (20%), Positives = 85/240 (35%), Gaps = 48/240 (20%)

Query: 482 RRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRAT 541
             KT      +        E ++ +LL + +     +Y  +                   
Sbjct: 16  LAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREE------------------V 57

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFK-NEVRLIAKLQHRN 599
              T   ++G+G FG V++ +  + G + AVK++       +E F+  E+   A L    
Sbjct: 58  HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPR 111

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF--NIICGIAR----G 653
           +V L G   E     +  E +E  SL           ++        +           G
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSL---------GQLIKQMGCLPEDRALYYLGQALEG 162

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQ---TEQNTKRVVGT 709
           L YLH     RI+H D+KA N+LL  + +   + DFG A     D    +      + GT
Sbjct: 163 LEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  122 bits (309), Expect = 5e-30
 Identities = 48/151 (31%), Positives = 76/151 (50%), Gaps = 6/151 (3%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            KLGQG FG V+ G       +A+K L +      E F  E +++ KL+H  LV+L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
            E +   +V EYM   SL            L   +  ++   IA G+ Y+    R   +H
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 303

Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           RDL+A+NIL+ + +  K++DFG+AR+   ++
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNE 334

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  120 bits (303), Expect = 6e-30
 Identities = 48/179 (26%), Positives = 75/179 (41%), Gaps = 32/179 (17%)

Query: 548 NKLGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNL 600
             +G+G FG V++ R            +AVK L    S     +F+ E  L+A+  + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDS---------------------VIFDKARSSILN 639
           V+LLG C       L++EYM    L+                                L+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 640 WQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGD 697
              +  I   +A G+ YL   S  + +HRDL   N L+ + M  KI+DFG++R I+  D
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  123 bits (310), Expect = 8e-30
 Identities = 48/151 (31%), Positives = 76/151 (50%), Gaps = 6/151 (3%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
            E +   +V EYM   SL            L   +  ++   IA G+ Y+    R   +H
Sbjct: 332 SE-EPIYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 386

Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           RDL+A+NIL+ + +  K++DFG+AR+   ++
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNE 417

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  118 bits (298), Expect = 2e-29
 Identities = 55/226 (24%), Positives = 94/226 (41%), Gaps = 42/226 (18%)

Query: 496 PRGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGF 555
              H   SQD +L  V      +Y   +    E P           D  T    LG+G F
Sbjct: 4   SHHHHHHSQDPMLAGVS-----EYELPEDPKWEFPR----------DKLTLGKPLGEGAF 48

Query: 556 GIVYKGRLL--------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLG 605
           G V     +        E   +AVK L  + + + + +  +E+ ++  + +H+N++ LLG
Sbjct: 49  GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 108

Query: 606 CCVEMDEKMLVYEYMENRSL-------------DSVIFDKARSSILNWQRRFNIICGIAR 652
            C +     ++ EY    +L              S   ++     + ++   +    +AR
Sbjct: 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLAR 168

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGD 697
           G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR I   D
Sbjct: 169 GMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  116 bits (294), Expect = 6e-29
 Identities = 46/187 (24%), Positives = 81/187 (43%), Gaps = 32/187 (17%)

Query: 548 NKLGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNL 600
             LG+G FG V K              +AVK L  N S   + +  +E  ++ ++ H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSL---------------------DSVIFDKARSSILN 639
           ++L G C +    +L+ EY +  SL                     +S   D      L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 640 WQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQ 698
                +    I++G+ YL   +  +++HRDL A NIL+ +    KISDFG++R ++  D 
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205

Query: 699 TEQNTKR 705
             + ++ 
Sbjct: 206 YVKRSQG 212

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  115 bits (291), Expect = 1e-28
 Identities = 51/182 (28%), Positives = 87/182 (47%), Gaps = 31/182 (17%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN--------EVR 590
              + +    K+G+G +G+VYK +  +G+ +A+KR+       ++            E+ 
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREIS 71

Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN---RSLDS--VIFDKARSSILNWQRRFN 645
           L+ +L H N+V L+          LV+E+ME    + LD        ++  I  +Q    
Sbjct: 72  LLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ---- 127

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
               + RG+ + HQ    RI+HRDLK  N+L++ +   K++DFG+AR F G      T  
Sbjct: 128 ----LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHE 179

Query: 706 VV 707
           VV
Sbjct: 180 VV 181

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  115 bits (291), Expect = 1e-28
 Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 25/167 (14%)

Query: 548 NKLGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRN 599
             LG+G FG V +            + +AVK L    +        +E++++  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 600 LVRLLGCCVEMDE-KMLVYEYMENRSL-------------DSVIFDKARSSILNWQRRFN 645
           +V LLG C +     M++ E+ +  +L               V  +      L  +    
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
               +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  114 bits (288), Expect = 3e-28
 Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 33/181 (18%)

Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN--------EVRLI 592
           +NF    K+G+G +G+VYK R  L G+ +A+K++       ++            E+ L+
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56

Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN------RSLDSVIFDKARSSILNWQRRFNI 646
            +L H N+V+LL      ++  LV+E++         +               +Q     
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----- 111

Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              + +GL + H     R++HRDLK  N+L++ E   K++DFG+AR F G      T  V
Sbjct: 112 ---LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEV 164

Query: 707 V 707
           V
Sbjct: 165 V 165

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  114 bits (288), Expect = 3e-28
 Identities = 54/173 (31%), Positives = 85/173 (49%), Gaps = 16/173 (9%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN 599
            + F    KLG+G +G VYK    E GQ +A+K++       ++E   E+ ++ +    +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-GIARGLLYLH 658
           +V+  G   +  +  +V EY    S+  +I  + R+  L  +     I     +GL YLH
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLT-EDEIATILQSTLKGLEYLH 142

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGT 709
                R IHRD+KA NILL+ E   K++DFG      G  T+   KR  V+GT
Sbjct: 143 FM---RKIHRDIKAGNILLNTEGHAKLADFG----VAGQLTDTMAKRNTVIGT 188

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  114 bits (289), Expect = 4e-28
 Identities = 50/183 (27%), Positives = 81/183 (44%), Gaps = 29/183 (15%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN--------EV 589
                +   + LG+G F  VYK R     Q +A+K++         E K+        E+
Sbjct: 7   SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALREI 63

Query: 590 RLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN---RSLDS--VIFDKARSSILNWQRRF 644
           +L+ +L H N++ LL          LV+++ME      +    ++   +           
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM--- 120

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
                  +GL YLHQ     I+HRDLK +N+LLD+    K++DFG+A+ F G      T 
Sbjct: 121 -----TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTH 171

Query: 705 RVV 707
           +VV
Sbjct: 172 QVV 174

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  113 bits (285), Expect = 6e-28
 Identities = 47/179 (26%), Positives = 84/179 (46%), Gaps = 15/179 (8%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRN 599
           D++     +G G   +V         +++A+KR++    Q  ++E   E++ +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN-----IIC-GIARG 653
           +V      V  DE  LV + +   S+  +I     +   +     +      I   +  G
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDII-KHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM-ARIFGGDQTEQNTKR--VVGT 709
           L YLH++     IHRD+KA NILL ++ + +I+DFG+ A +  G    +N  R   VGT
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  112 bits (284), Expect = 8e-28
 Identities = 43/180 (23%), Positives = 82/180 (45%), Gaps = 32/180 (17%)

Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN--------EVRLI 592
             +    K+G+G +G V+K +     + +A+KR+       +++           E+ L+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55

Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN---RSLDS--VIFDKARSSILNWQRRFNII 647
            +L+H+N+VRL        +  LV+E+ +    +  DS     D        +Q      
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ------ 109

Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             + +GL + H      ++HRDLK  N+L+++    K+++FG+AR F G      +  VV
Sbjct: 110 --LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV 163

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  114 bits (287), Expect = 8e-28
 Identities = 52/176 (29%), Positives = 80/176 (45%), Gaps = 22/176 (12%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLS---RNSGQGIEEFKNEVRLIAKLQ 596
              F+D  ++G G FG VY  R +   + +A+K++S   + S +  ++   EVR + KL+
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-GIARGLL 655
           H N ++  GC +      LV EY    + D +   +     L  +     +  G  +GL 
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQ-EVEIAAVTHGALQGLA 168

Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGT 709
           YLH      +IHRD+KA NILL +    K+ DFG A                 VGT
Sbjct: 169 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGT 213

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  112 bits (283), Expect = 1e-27
 Identities = 46/179 (25%), Positives = 86/179 (48%), Gaps = 31/179 (17%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN--------EVRLIA 593
           + +    K+G+G +G+VYK +   G+  A+K++       +E+           E+ ++ 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55

Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMEN---RSLDS--VIFDKARSSILNWQRRFNIIC 648
           +L+H N+V+L          +LV+E+++    + LD      +   +     Q       
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ------- 108

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
            +  G+ Y H     R++HRDLK  N+L+++E   KI+DFG+AR F G    + T  +V
Sbjct: 109 -LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV 162

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  113 bits (285), Expect = 1e-27
 Identities = 47/181 (25%), Positives = 81/181 (44%), Gaps = 28/181 (15%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVK--RLSRNSGQGIEEFKN----EVRL 591
           ++ + + +   +G+G +G+V K R  + G+ +A+K    S +     +  K     E++L
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD----KMVKKIAMREIKL 77

Query: 592 IAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN---RSLDS--VIFDKARSSILNWQRRFNI 646
           + +L+H NLV LL  C +     LV+E++++     L+      D        +Q     
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ----- 132

Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              I  G+ + H      IIHRD+K  NIL+ +    K+ DFG AR       E     V
Sbjct: 133 ---IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEV 185

Query: 707 V 707
            
Sbjct: 186 A 186

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  113 bits (284), Expect = 1e-27
 Identities = 51/179 (28%), Positives = 87/179 (48%), Gaps = 18/179 (10%)

Query: 538 VRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN-----EVRL 591
           + ++  F    KLG G +  VYKG     G  +A+K +  +S +G           E+ L
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAIREISL 56

Query: 592 IAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN---RSLDSVIFDKARSSILNWQRRFNIIC 648
           + +L+H N+VRL       ++  LV+E+M+N   + +DS         +     +     
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK-YFQW 115

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
            + +GL + H++   +I+HRDLK  N+L++K    K+ DFG+AR F G      +  VV
Sbjct: 116 QLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV 170

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  113 bits (284), Expect = 1e-27
 Identities = 52/200 (26%), Positives = 83/200 (41%), Gaps = 24/200 (12%)

Query: 512 VISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLL------E 565
           +I S    S    D  +LP  +     R  +N      LG G FG V +           
Sbjct: 18  IIESYEGNSYTFIDPTQLPYNEKWEFPR--NNLQFGKTLGAGAFGKVVEATAFGLGKEDA 75

Query: 566 GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMEN- 622
             ++AVK L         E   +E+++++ L QH N+V LLG C      +++ EY    
Sbjct: 76  VLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 135

Query: 623 ----------RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKA 672
                     R L++       +S  + +   +    +A+G+ +L   +    IHRD+ A
Sbjct: 136 DLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAA 192

Query: 673 SNILLDKEMTPKISDFGMAR 692
            N+LL      KI DFG+AR
Sbjct: 193 RNVLLTNGHVAKIGDFGLAR 212

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  112 bits (282), Expect = 2e-27
 Identities = 48/174 (27%), Positives = 88/174 (50%), Gaps = 17/174 (9%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQG-IEEFKNEVRLIAKLQHR 598
            + FT   K+G+G FG V+KG      + +A+K +     +  IE+ + E+ ++++    
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-GIARGLLYL 657
            + +  G  ++  +  ++ EY+   S   ++        L+ + +   I   I +GL YL
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLD-ETQIATILREILKGLDYL 135

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGT 709
           H +   + IHRD+KA+N+LL +    K++DFG+A    G  T+   KR   VGT
Sbjct: 136 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNTFVGT 182

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  112 bits (282), Expect = 2e-27
 Identities = 46/168 (27%), Positives = 69/168 (41%), Gaps = 26/168 (15%)

Query: 548 NKLGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRN 599
             LG G FG V +              +AVK L  +      E   +E+++++ L  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICG---------- 649
           +V LLG C      +++ EY     L + +  K  S I +      +             
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 650 -----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
                +A+G+ +L   +    IHRDL A NILL      KI DFG+AR
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  111 bits (281), Expect = 4e-27
 Identities = 48/177 (27%), Positives = 81/177 (45%), Gaps = 27/177 (15%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-----EVRLIAKL 595
           + +   +KLG+G +  VYKG+       +A+K +     +G           EV L+  L
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA----PCTAIREVSLLKDL 57

Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMEN---RSLDS--VIFDKARSSILNWQRRFNIICGI 650
           +H N+V L           LV+EY++    + LD    I +     +  +Q        +
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ--------L 109

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
            RGL Y H+    +++HRDLK  N+L+++    K++DFG+AR      T+     VV
Sbjct: 110 LRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV 162

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  111 bits (280), Expect = 4e-27
 Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 28/178 (15%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVK--RLSRNSGQGIEEFKN----EVRLIAK 594
           + +    K+G+G +G+V+K R  + GQ +A+K    S +        K     E+R++ +
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD----PVIKKIALREIRMLKQ 58

Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMEN---RSLDS--VIFDKARSSILNWQRRFNIICG 649
           L+H NLV LL          LV+EY ++     LD       +     + WQ        
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ-------- 110

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             + + + H+      IHRD+K  NIL+ K    K+ DFG AR+     ++     V 
Sbjct: 111 TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA 164

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  111 bits (279), Expect = 5e-27
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 11/165 (6%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRN 599
             +   + LGQG    V++GR  + G   A+K  +  S  + ++    E  ++ KL H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 600 LVRLLGCCVEMDEKM--LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
           +V+L     E   +   L+ E+    SL +V+ + + +  L       ++  +  G+ +L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 658 HQDSRFRIIHRDLKASNILL----DKEMTPKISDFGMARIFGGDQ 698
            ++    I+HR++K  NI+     D +   K++DFG AR    D+
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  112 bits (282), Expect = 6e-27
 Identities = 45/181 (24%), Positives = 82/181 (45%), Gaps = 27/181 (14%)

Query: 548 NKLGQGGFGIVYKGRLL--------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QH 597
             LG+G FG V     +           ++AVK L  + + + + +  +E+ ++  + +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSL-------------DSVIFDKARSSILNWQRRF 644
           +N++ LLG C +     ++ EY    +L              S          L+ +   
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNT 703
           +    +ARG+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR I   D  ++ T
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251

Query: 704 K 704
            
Sbjct: 252 N 252

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  110 bits (278), Expect = 7e-27
 Identities = 50/221 (22%), Positives = 81/221 (36%), Gaps = 16/221 (7%)

Query: 496 PRGHPERSQDLLLNQVVISSKRDYS--ADKTDDLELPLFD-FETIVRATDNFTDYNKLGQ 552
             G    +++L    +     R  S   + ++ L+ P +D          +F   ++LG 
Sbjct: 8   SSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGH 67

Query: 553 GGFGIVYKGR-LLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCV 608
           G +G V+K R   +G+  AVK         +       EV    K+ QH   VRL     
Sbjct: 68  GSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE 127

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E     L  E     SL      +A  + L   + +  +      L +LH      ++H 
Sbjct: 128 EGGILYLQTELCG-PSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHL 181

Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           D+K +NI L      K+ DFG+    G   T    +   G 
Sbjct: 182 DVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGD 219

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  110 bits (278), Expect = 1e-26
 Identities = 51/187 (27%), Positives = 79/187 (42%), Gaps = 36/187 (19%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN--------EV 589
            + D +    KLG+G +G VYK    +  + +A+KR+       +E  +         EV
Sbjct: 31  TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREV 84

Query: 590 RLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN---RSLDS-VIFDKARSSILNWQRRFN 645
            L+ +LQHRN++ L           L++EY EN   + +D              +Q    
Sbjct: 85  SLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQ---- 140

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP-----KISDFGMARIFGGDQTE 700
               +  G+ + H     R +HRDLK  N+LL           KI DFG+AR F G    
Sbjct: 141 ----LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIR 192

Query: 701 QNTKRVV 707
           Q T  ++
Sbjct: 193 QFTHEII 199

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  111 bits (279), Expect = 1e-26
 Identities = 59/233 (25%), Positives = 94/233 (40%), Gaps = 21/233 (9%)

Query: 488 GRQIRKTEPRGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDY 547
            +  R          S   L  ++ + SKR  +           FD   +         +
Sbjct: 29  DQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSF 88

Query: 548 ------NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
                   LG G FG V+K      G ++A K +     +  EE KNE+ ++ +L H NL
Sbjct: 89  YTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANL 148

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK--ARSSILNWQRRFNIICGIARGLLYLH 658
           ++L       ++ +LV EY++   L    FD+    S  L        +  I  G+ ++H
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICEGIRHMH 204

Query: 659 QDSRFRIIHRDLKASNILL-DKEMTP-KISDFGMARIFGGDQTEQNTKRVVGT 709
           Q     I+H DLK  NIL  +++    KI DFG+AR +      +  K   GT
Sbjct: 205 QM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR---EKLKVNFGT 251

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  111 bits (280), Expect = 1e-26
 Identities = 51/191 (26%), Positives = 87/191 (45%), Gaps = 34/191 (17%)

Query: 533 DFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN-EVRL 591
           D +T  +    +T+   +G G FG+V++ +L+E  E+A+K++ ++     + FKN E+++
Sbjct: 31  DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQI 85

Query: 592 IAKLQHRNLVRLLGCCVEMDEKM------LVYEYME---NRSLDSVIFDKARSSILN--- 639
           +  ++H N+V L        +K       LV EY+     R+       K    +L    
Sbjct: 86  MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL 145

Query: 640 --WQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGG 696
             +Q        + R L Y+H      I HRD+K  N+LLD      K+ DFG A+I   
Sbjct: 146 YMYQ--------LLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-- 192

Query: 697 DQTEQNTKRVV 707
              E N   + 
Sbjct: 193 IAGEPNVSYIC 203

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  110 bits (277), Expect = 1e-26
 Identities = 53/224 (23%), Positives = 80/224 (35%), Gaps = 35/224 (15%)

Query: 497 RGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFG 556
           +        L + QV  SS  +Y     D  E          R  +N      LG G FG
Sbjct: 4   KKQFRYESQLQMVQVTGSSDNEYFY--VDFREYEYDLKWEFPR--ENLEFGKVLGSGAFG 59

Query: 557 IVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCV 608
            V               ++AVK L         E   +E++++ +L  H N+V LLG C 
Sbjct: 60  KVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119

Query: 609 EMDEKMLVYEYMENRSL-----------DSVIFDKARSSILNWQRRFNIICG-------- 649
                 L++EY     L                +      L  +   N++          
Sbjct: 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 179

Query: 650 -IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            +A+G+ +L        +HRDL A N+L+      KI DFG+AR
Sbjct: 180 QVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  111 bits (278), Expect = 2e-26
 Identities = 40/166 (24%), Positives = 76/166 (45%), Gaps = 13/166 (7%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRN 599
             +   + LGQG    V++GR  + G   A+K  +  S  + ++    E  ++ KL H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 600 LVRLLGCCVEMDEKMLVY---EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           +V+L     E           E+    SL +V+ + + +  L       ++  +  G+ +
Sbjct: 69  IVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 657 LHQDSRFRIIHRDLKASNILL----DKEMTPKISDFGMARIFGGDQ 698
           L ++    I+HR++K  NI+     D +   K++DFG AR    D+
Sbjct: 128 LREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  110 bits (276), Expect = 2e-26
 Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 42/194 (21%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKN--------EV 589
                +    K+GQG FG V+K R  +  +  A+K++       +E  K         E+
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREI 67

Query: 590 RLIAKLQHRNLVRLLGCCVEMDEKM--------LVYEYMEN---RSLDS--VIFDKARSS 636
           +++  L+H N+V L+  C               LV+++ E+     L +  V F  +   
Sbjct: 68  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 127

Query: 637 ILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
            +           +  GL Y+H++   +I+HRD+KA+N+L+ ++   K++DFG+AR F  
Sbjct: 128 RVMQM--------LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSL 176

Query: 697 DQTEQN---TKRVV 707
            +  Q    T RVV
Sbjct: 177 AKNSQPNRYTNRVV 190

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  108 bits (272), Expect = 3e-26
 Identities = 50/196 (25%), Positives = 73/196 (37%), Gaps = 37/196 (18%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKR--LSRNSGQGIEEFKNEVRLIAKL 595
           R T  F +  K+G G FG V+K    L+G   A+KR           +    EV   A L
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 596 -QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF------NIIC 648
            QH ++VR      E D  ++  EY    SL   I +  R         F      +++ 
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRI-----MSYFKEAELKDLLL 122

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKE-------------------MTPKISDFG 689
            + RGL Y+H      ++H D+K SNI + +                    +  KI D G
Sbjct: 123 QVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179

Query: 690 MARIFGGDQTEQNTKR 705
                   Q E+   R
Sbjct: 180 HVTRISSPQVEEGDSR 195

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  109 bits (274), Expect = 3e-26
 Identities = 54/188 (28%), Positives = 88/188 (46%), Gaps = 19/188 (10%)

Query: 532 FDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVR 590
            D   +      F     +G G +G VYKGR ++ GQ  A+K +   +G   EE K E+ 
Sbjct: 14  IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEIN 72

Query: 591 LIAKL-QHRNLVRLLGC-----CVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRR 643
           ++ K   HRN+    G         MD+++ LV E+    S+  +I +   +++      
Sbjct: 73  MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 132

Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
           + I   I RGL +LHQ    ++IHRD+K  N+LL +    K+ DFG++            
Sbjct: 133 Y-ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS----AQLDRTVG 184

Query: 704 KR--VVGT 709
           +R   +GT
Sbjct: 185 RRNTFIGT 192

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  107 bits (269), Expect = 9e-26
 Identities = 55/189 (29%), Positives = 79/189 (41%), Gaps = 33/189 (17%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLS-RNSGQGIEEFKN----EVRLI 592
            AT  +    ++G G +G VYK R    G  +A+K +   N G G          EV L+
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 593 AKLQ---HRNLVRLLGCCVEMDEK-----MLVYEYMEN------RSLDSVIFDKARSSIL 638
            +L+   H N+VRL+  C            LV+E+++                      L
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125

Query: 639 NWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
             Q          RGL +LH +    I+HRDLK  NIL+    T K++DFG+ARI+    
Sbjct: 126 MRQ--------FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 174

Query: 699 TEQNTKRVV 707
               T  VV
Sbjct: 175 A--LTPVVV 181

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  109 bits (274), Expect = 1e-25
 Identities = 51/178 (28%), Positives = 91/178 (51%), Gaps = 23/178 (12%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHR 598
             ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107

Query: 599 NLVRLLGCCVEMDEKM------LVYEYMENRSLDSVI--FDKARSSILNWQRRFNIICGI 650
           N+VRL        EK       LV +Y+   ++  V   + +A+ ++     +   +  +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKL-YMYQL 165

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVV 707
            R L Y+H    F I HRD+K  N+LLD +    K+ DFG A+     + E N   + 
Sbjct: 166 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYIC 218

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  107 bits (269), Expect = 2e-25
 Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 16/149 (10%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQG---IEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+GGF   ++    +  +  A K + ++        E+   E+ +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 606 CCVEMDEKMLVY---EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
                ++   V+   E    RSL  +   K R ++   + R+  +  I  G  YLH++  
Sbjct: 109 F---FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARY-YLRQIVLGCQYLHRN-- 160

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMA 691
            R+IHRDLK  N+ L++++  KI DFG+A
Sbjct: 161 -RVIHRDLKLGNLFLNEDLEVKIGDFGLA 188

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  106 bits (266), Expect = 2e-25
 Identities = 42/165 (25%), Positives = 78/165 (47%), Gaps = 19/165 (11%)

Query: 537 IVRATDNFTDYNK---LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQG---IEEFKNEV 589
           ++    +   Y +   LG+GGF   ++    +  +  A K + ++        E+   E+
Sbjct: 7   VLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEI 66

Query: 590 RLIAKLQHRNLVRLLGCCVEMDEKMLVY---EYMENRSLDSVIFDKARSSILNWQRRFNI 646
            +   L H+++V   G     ++   V+   E    RSL  +   K R ++   + R+  
Sbjct: 67  SIHRSLAHQHVVGFHGF---FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARY-Y 120

Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
           +  I  G  YLH++   R+IHRDLK  N+ L++++  KI DFG+A
Sbjct: 121 LRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA 162

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  104 bits (262), Expect = 4e-25
 Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 27/155 (17%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEE-FKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  VY+   +  G E+A+K + + +    G+ +  +NEV++  +L+H +++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 606 CCVEMDEKMLVY---EYMENRSLDSVIFDKARSSILNWQRRFN------IICGIARGLLY 656
                ++   VY   E   N  +        ++      + F+       +  I  G+LY
Sbjct: 79  Y---FEDSNYVYLVLEMCHNGEM----NRYLKNR----VKPFSENEARHFMHQIITGMLY 127

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
           LH      I+HRDL  SN+LL + M  KI+DFG+A
Sbjct: 128 LH---SHGILHRDLTLSNLLLTRNMNIKIADFGLA 159

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  105 bits (265), Expect = 5e-25
 Identities = 50/193 (25%), Positives = 84/193 (43%), Gaps = 43/193 (22%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLE--GQEIAVKRLSRNSGQGIEEFKN--------E 588
           RA   +    ++G+G +G V+K R L+  G+ +A+KR+       ++  +         E
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIRE 61

Query: 589 VRLIAKLQ---HRNLVRLLGCCVEMDEK-----MLVYEYMEN------RSLDSVIFDKAR 634
           V ++  L+   H N+VRL   C            LV+E+++         +         
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 121

Query: 635 SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
              + +Q        + RGL +LH     R++HRDLK  NIL+      K++DFG+ARI+
Sbjct: 122 IKDMMFQ--------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170

Query: 695 GGDQTEQNTKRVV 707
                   T  VV
Sbjct: 171 SFQMAL--TSVVV 181

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  106 bits (266), Expect = 7e-25
 Identities = 35/185 (18%), Positives = 63/185 (34%), Gaps = 26/185 (14%)

Query: 541 TDNFTDYNKLGQG--GFGIVYKGRLLE-GQEIAVKR--LSRNSGQGIEEFKNEVRLIAKL 595
              +     +G+G      V   R    G+ + V+R  L   S + +   + E+ +    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN-----IIC-G 649
            H N+V      +  +E  +V  +M   S   +I         ++    N      I  G
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI-------CTHFMDGMNELAIAYILQG 136

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT-----K 704
           + + L Y+H       +HR +KAS+IL+  +    +S              Q       K
Sbjct: 137 VLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193

Query: 705 RVVGT 709
             V  
Sbjct: 194 YSVKV 198

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  106 bits (266), Expect = 8e-25
 Identities = 46/197 (23%), Positives = 82/197 (41%), Gaps = 19/197 (9%)

Query: 522 DKTDDLELPLFDFETIVRATDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSR 576
           DK  +     +  + +     +  DY     +LG G FG+V++      G+    K ++ 
Sbjct: 27  DKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT 86

Query: 577 NSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK--AR 634
                    KNE+ ++ +L H  L+ L     +  E +L+ E++    L    FD+  A 
Sbjct: 87  PYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL----FDRIAAE 142

Query: 635 SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL-DKEMTP-KISDFGMAR 692
              ++     N +     GL ++H+     I+H D+K  NI+   K+ +  KI DFG+A 
Sbjct: 143 DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLAT 199

Query: 693 IFGGDQTEQNTKRVVGT 709
               D   +  K    T
Sbjct: 200 KLNPD---EIVKVTTAT 213

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  106 bits (267), Expect = 8e-25
 Identities = 41/176 (23%), Positives = 73/176 (41%), Gaps = 20/176 (11%)

Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLV 601
           +F   + LG G  G +    + + +++AVKR+     +       EV+L+ +  +H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81

Query: 602 RLLGCCVEMDEKM--LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           R    C E D +   +  E     +L   +  + +           ++     GL +LH 
Sbjct: 82  RYF--CTEKDRQFQYIAIELCAA-TLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHS 136

Query: 660 DSRFRIIHRDLKASNILL-----DKEMTPKISDFGMARIFGGDQTE-QNTKRVVGT 709
                I+HRDLK  NIL+       ++   ISDFG+ +     +        V GT
Sbjct: 137 ---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  105 bits (263), Expect = 8e-25
 Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 24/162 (14%)

Query: 549 KLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGC 606
            L +GGF  VY+ + +  G+E A+KRL  N  +       EV  + KL  H N+V+    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 607 CVEMDEK--------MLVYEYMENRSLDSVIFDKARSSILNWQRRF------NIICGIAR 652
                E+        +L+ E  + + ++     K  S     +          I     R
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVE--FLKKMES-----RGPLSCDTVLKIFYQTCR 147

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
            + ++H+  +  IIHRDLK  N+LL  + T K+ DFG A   
Sbjct: 148 AVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  109 bits (272), Expect = 9e-25
 Identities = 45/171 (26%), Positives = 73/171 (42%), Gaps = 14/171 (8%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKLQ 596
           +    +    +LG GGFG V +      G+++A+K+  +       E +  E++++ KL 
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70

Query: 597 HRNLVRLLGCCVEM------DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           H N+V        +      D  +L  EY E   L   +        L       ++  I
Sbjct: 71  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQ 698
           +  L YLH+    RIIHRDLK  NI+L    + +  KI D G A+     +
Sbjct: 131 SSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  103 bits (260), Expect = 1e-24
 Identities = 52/165 (31%), Positives = 80/165 (48%), Gaps = 11/165 (6%)

Query: 549 KLGQGGFGIVYKGR-LLEGQEIAVKRLS---RNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           KLG GG   VY     +   ++A+K +    R   + ++ F+ EV   ++L H+N+V ++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
               E D   LV EY+E  +L   I        L+     N    I  G+ + H     R
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DMR 131

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           I+HRD+K  NIL+D   T KI DFG+A+    + +   T  V+GT
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGT 175

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  105 bits (263), Expect = 1e-24
 Identities = 46/192 (23%), Positives = 80/192 (41%), Gaps = 31/192 (16%)

Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN----E 588
            E   +  D F      GQG FG V  G+    G  +A+K++ ++       F+N     
Sbjct: 15  DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQI 69

Query: 589 VRLIAKLQHRNLVRLLGCCVEMDEK-------MLVYEYMENRSLDSVIFDKARSSILNWQ 641
           ++ +A L H N+V+L      + E+        +V EY+ + +L        R+      
Sbjct: 70  MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC----RNYYRRQV 124

Query: 642 RRFNIICG-----IARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIFG 695
               I+       + R +  LH  S   + HRD+K  N+L+++   T K+ DFG A+   
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL- 182

Query: 696 GDQTEQNTKRVV 707
              +E N   + 
Sbjct: 183 -SPSEPNVAYIC 193

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  105 bits (264), Expect = 2e-24
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 21/162 (12%)

Query: 549 KLGQGGFGIVYKGRLLE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           K+G+G +G VYK +  +    ++ A+K++   +G  +   + E+ L+ +L+H N++ L  
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 85

Query: 606 CCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFN------IICGIARGLLYL 657
             +   ++   L+++Y E+  L  +I     S       +        ++  I  G+ YL
Sbjct: 86  VFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMARIFG 695
           H +    ++HRDLK +NIL+  E       KI+D G AR+F 
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  106 bits (266), Expect = 3e-24
 Identities = 46/230 (20%), Positives = 94/230 (40%), Gaps = 21/230 (9%)

Query: 491 IRKTEPRGHPERSQDLLLNQVVISSKRDYSADKTDDLE--LPLFDFETIVRATDNFTDY- 547
           +          R  D+     ++  K   S++  + +      +  + +    D+  D+ 
Sbjct: 100 VLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHY 159

Query: 548 ---NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
               +LG G FG+V++      G   A K +        E  + E++ ++ L+H  LV L
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDK--ARSSILNWQRRFNIICGIARGLLYLHQDS 661
                + +E +++YE+M    L    F+K     + ++       +  + +GL ++H+++
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275

Query: 662 RFRIIHRDLKASNILL--DKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
               +H DLK  NI+    +    K+ DFG+          Q+ K   GT
Sbjct: 276 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---QSVKVTTGT 319

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  101 bits (253), Expect = 2e-23
 Identities = 51/217 (23%), Positives = 89/217 (41%), Gaps = 33/217 (15%)

Query: 501 ERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYK 560
           ++ ++L L++        +   K    EL   DFE I          ++LG G  G+V+K
Sbjct: 2   KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKI----------SELGAGNGGVVFK 51

Query: 561 GRLLE-GQEIAVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE 618
                 G  +A K +          +   E++++ +     +V   G      E  +  E
Sbjct: 52  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111

Query: 619 YMENRSLDSVIFDKARSSILNWQRRFN--IICGIAR----GLLYLHQDSRFRIIHRDLKA 672
           +M+  SLD          +L    R    I+  ++     GL YL    + +I+HRD+K 
Sbjct: 112 HMDGGSLDQ---------VLKKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKP 160

Query: 673 SNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           SNIL++     K+ DFG++       +  N+   VGT
Sbjct: 161 SNILVNSRGEIKLCDFGVSGQL--IDSMANS--FVGT 193

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 98.4 bits (246), Expect = 5e-23
 Identities = 42/185 (22%), Positives = 75/185 (40%), Gaps = 29/185 (15%)

Query: 539 RATDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIA 593
               +   Y    N +G+G +G V            A K++ +   + ++ FK E+ ++ 
Sbjct: 2   STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 61

Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN------II 647
            L H N++RL     +  +  LV E      L    F++    +++ +R F       I+
Sbjct: 62  SLDHPNIIRLYETFEDNTDIYLVMELCTGGEL----FER----VVH-KRVFRESDAARIM 112

Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTK 704
             +   + Y H+     + HRDLK  N L      +   K+ DFG+A  F   +     +
Sbjct: 113 KDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MR 166

Query: 705 RVVGT 709
             VGT
Sbjct: 167 TKVGT 171

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  100 bits (250), Expect = 5e-23
 Identities = 21/180 (11%), Positives = 44/180 (24%), Gaps = 38/180 (21%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRL---SRNSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           L  G   +V+  R +E  ++ A+K     + NS   +E         A+L   +      
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 606 CCVEM--------------------------DEKMLVYEYMENRSLDSVI----FDKARS 635
               +                             +L+        L+ +     F     
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188

Query: 636 SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
                     +   + R    L       ++H      N+ +  +    + D       G
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 99.2 bits (248), Expect = 6e-23
 Identities = 35/176 (19%), Positives = 72/176 (40%), Gaps = 20/176 (11%)

Query: 543 NFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH 597
              +       LG+G FGIV++       +    K +    G      K E+ ++   +H
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARH 60

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK--ARSSILNWQRRFNIICGIARGLL 655
           RN++ L      M+E ++++E++    +    F++    +  LN +   + +  +   L 
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQ 116

Query: 656 YLHQDSRFRIIHRDLKASNILL-DKEMTP-KISDFGMARIFGGDQTEQNTKRVVGT 709
           +LH  +   I H D++  NI+   +  +  KI +FG AR           + +   
Sbjct: 117 FLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTA 166

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  102 bits (255), Expect = 6e-23
 Identities = 52/189 (27%), Positives = 84/189 (44%), Gaps = 31/189 (16%)

Query: 537 IVRATDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEV 589
           I     + ++      KLG G +G V   R      E A+K + +   S     +   EV
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87

Query: 590 RLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN---- 645
            ++  L H N+++L     +     LV E  +   L    FD+    I++ + +FN    
Sbjct: 88  AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL----FDE----IIH-RMKFNEVDA 138

Query: 646 --IICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTE 700
             II  +  G+ YLH+     I+HRDLK  N+LL   +K+   KI DFG++ +F   +  
Sbjct: 139 AVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK- 194

Query: 701 QNTKRVVGT 709
              K  +GT
Sbjct: 195 --MKERLGT 201

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 98.9 bits (247), Expect = 7e-23
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 17/171 (9%)

Query: 549 KLGQGGFGIVYKGR-LLEGQEIAVK----RLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
            LG GG   V+  R L + +++AVK     L+R+       F+ E +  A L H  +V +
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDP-SFYLRFRREAQNAAALNHPAIVAV 77

Query: 604 L--GCCVEMDEKM--LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
              G        +  +V EY++  +L  ++  +     +  +R   +I    + L + H 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH- 133

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTKRVVGT 709
             +  IIHRD+K +NI++      K+ DFG+AR I     +   T  V+GT
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 98.5 bits (246), Expect = 7e-23
 Identities = 54/185 (29%), Positives = 84/185 (45%), Gaps = 31/185 (16%)

Query: 541 TDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIA 593
              F +       LG+G FG V K +     QE AVK +++     +       EV L+ 
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN------II 647
           KL H N+++L     +     +V E      L    FD+    I+  ++RF+      II
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDE----IIK-RKRFSEHDAARII 127

Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTK 704
             +  G+ Y+H+ +   I+HRDLK  NILL   +K+   KI DFG++  F  +      K
Sbjct: 128 KQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MK 181

Query: 705 RVVGT 709
             +GT
Sbjct: 182 DRIGT 186

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 99.7 bits (249), Expect = 8e-23
 Identities = 45/186 (24%), Positives = 74/186 (39%), Gaps = 29/186 (15%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVK-----RLSRNSGQGIEEFKNEVRLIAK 594
            D +     +G+G F +V +    E GQ+ AVK     + + + G   E+ K E  +   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK--ARSSILNWQRRF------NI 646
           L+H ++V LL          +V+E+M+   L      +   R+        +      + 
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADL----CFEIVKRADAGF---VYSEAVASHY 135

Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNT 703
           +  I   L Y H +    IIHRD+K   +LL   +     K+  FG+A   G        
Sbjct: 136 MRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 192

Query: 704 KRVVGT 709
              VGT
Sbjct: 193 --RVGT 196

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  100 bits (251), Expect = 1e-22
 Identities = 45/184 (24%), Positives = 74/184 (40%), Gaps = 31/184 (16%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGC 606
             LG G  G V      +G+ +AVKR+  +     +    E++L+ +   H N++R    
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYY-- 75

Query: 607 CVEMDEKM--LVYEYMENRSLDSVIFDKARSS----ILNWQRRFNIICGIARGLLYLHQD 660
           C E  ++   +  E     +L  ++  K  S     +       +++  IA G+ +LH  
Sbjct: 76  CSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 134

Query: 661 SRFRIIHRDLKASNILLDKEMTP-------------KISDFGMARIFGGDQT--EQNTKR 705
              +IIHRDLK  NIL+                    ISDFG+ +     Q+    N   
Sbjct: 135 ---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191

Query: 706 VVGT 709
             GT
Sbjct: 192 PSGT 195

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 40/179 (22%), Positives = 72/179 (40%), Gaps = 18/179 (10%)

Query: 520 SADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS 578
           S + +  L++            ++  D  ++G+G +G V K      GQ +AVKR+    
Sbjct: 2   SIESSGKLKISPEQHWDF--TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV 59

Query: 579 G-QGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSS 636
             +  ++   ++ ++ +      +V+  G      +  +  E M + S D       +  
Sbjct: 60  DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY----KYV 114

Query: 637 ILNWQRRF--NIICGIAR----GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
                      I+  I       L +L      +IIHRD+K SNILLD+    K+ DFG
Sbjct: 115 YSVLDDVIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFG 171

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 97.3 bits (243), Expect = 1e-22
 Identities = 44/179 (24%), Positives = 75/179 (41%), Gaps = 16/179 (8%)

Query: 541 TDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLS-RNSGQGIEEFKNEVRLIAK 594
                D      KLG G FG V+       G E  +K ++   S   +E+ + E+ ++  
Sbjct: 17  QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKS 76

Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARG 653
           L H N++++     +     +V E  E   L + ++  +AR   L+      ++  +   
Sbjct: 77  LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136

Query: 654 LLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           L Y H      ++H+DLK  NIL          KI DFG+A +F  D+    +    GT
Sbjct: 137 LAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGT 189

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 98.4 bits (245), Expect = 2e-22
 Identities = 46/240 (19%), Positives = 77/240 (32%), Gaps = 72/240 (30%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQ 596
           R   +F     +G+GGFG+V++ +  ++    A+KR+   N     E+   EV+ +AKL+
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62

Query: 597 HRNLVRLLGC------------------------CVEMDEKMLVYEYMENRSLDSVIFDK 632
           H  +VR                                    +    ++ R +D      
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122

Query: 633 ARSSILNWQRRF---------------------------------NIICGIARGLLYLHQ 659
               +     +                                  +I   IA  + +LH 
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK----------RVVGT 709
                ++HRDLK SNI    +   K+ DFG+      D+ EQ               VGT
Sbjct: 183 K---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  101 bits (253), Expect = 2e-22
 Identities = 38/170 (22%), Positives = 65/170 (38%), Gaps = 25/170 (14%)

Query: 549 KLGQGGFGIVYKGR--LLEGQEIAVKRLSRNSG--QGIEEFKNEVRLIAKLQHRNLVRLL 604
            +  GG G +Y      + G+ + +K L  +SG  +       E + +A++ H ++V++ 
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 605 GCCVEMDEKM-----LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
                 D        +V EY+  +SL      K     L        +  I   L YLH 
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH- 199

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
                +++ DLK  NI+L +E   K+ D G                + GT
Sbjct: 200 --SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGT 240

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  100 bits (250), Expect = 2e-22
 Identities = 56/190 (29%), Positives = 89/190 (46%), Gaps = 32/190 (16%)

Query: 537 IVRATDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNE 588
           +  +T  F+D       LG+G FG V   +    GQE AVK +S+         E    E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 589 VRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN--- 645
           V+L+ +L H N+++L     +     LV E      L    FD+    I++ ++RF+   
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDE----IIS-RKRFSEVD 127

Query: 646 ---IICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQT 699
              II  +  G+ Y+H+    +I+HRDLK  N+LL    K+   +I DFG++  F   + 
Sbjct: 128 AARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184

Query: 700 EQNTKRVVGT 709
               K  +GT
Sbjct: 185 ---MKDKIGT 191

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 99.8 bits (249), Expect = 3e-22
 Identities = 54/185 (29%), Positives = 83/185 (44%), Gaps = 31/185 (16%)

Query: 541 TDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIA 593
              F +       LG+G FG V K +     QE AVK +++     +       EV L+ 
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN------II 647
           KL H N+++L     +     +V E      L    FD+    I+  ++RF+      II
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDE----IIK-RKRFSEHDAARII 127

Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTK 704
             +  G+ Y+H+     I+HRDLK  NILL   +K+   KI DFG++  F  +      K
Sbjct: 128 KQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MK 181

Query: 705 RVVGT 709
             +GT
Sbjct: 182 DRIGT 186

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 96.6 bits (241), Expect = 4e-22
 Identities = 39/168 (23%), Positives = 68/168 (40%), Gaps = 17/168 (10%)

Query: 549 KLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQG---IEEFKNEVRLIAKLQHRNLVRL- 603
            +G+GG G VY+    +  + +A+K +S             + E R   +LQ  ++V + 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 604 -LGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
             G   E+D ++ +    +    L +++  +     L   R   I+  I   L   H   
Sbjct: 101 DFG---EIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA- 153

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
                HRD+K  NIL+  +    + DFG+A     D+        VGT
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASA-TTDEKLTQLGNTVGT 198

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 96.1 bits (240), Expect = 4e-22
 Identities = 50/186 (26%), Positives = 79/186 (42%), Gaps = 33/186 (17%)

Query: 541 TDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIA 593
           +  F+D      +LG+G F +V +      G E A K ++    S +  ++ + E R+  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF-------NI 646
           KLQH N+VRL     E     LV++ +    L    F+     I+   R F       + 
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FED----IV--AREFYSEADASHC 110

Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNT 703
           I  I   + Y H +    I+HR+LK  N+LL    K    K++DFG+A      +     
Sbjct: 111 IQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---W 164

Query: 704 KRVVGT 709
               GT
Sbjct: 165 HGFAGT 170

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 98.2 bits (244), Expect = 5e-22
 Identities = 30/194 (15%), Positives = 57/194 (29%), Gaps = 38/194 (19%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLS---RNSGQGIEEFKNEVRLIAKLQH-------- 597
           LGQ       +      G+   V       R     I++ K EV  +  L+         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 598 --------RNLVRLLGCCVEMDEK-----------MLVYEYMENRSLD--SVIFDKARSS 636
                    +LV+       +  +             +Y  M++       V+   + + 
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 637 -ILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
             L    R  +   + R L  LH    + ++H  L+  +I+LD+     ++ F      G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 696 GDQTEQNTKRVVGT 709
                    R    
Sbjct: 263 ASAVSPIG-RGFAP 275

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 97.5 bits (243), Expect = 5e-22
 Identities = 48/241 (19%), Positives = 90/241 (37%), Gaps = 35/241 (14%)

Query: 489 RQIRKTEPRGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDY- 547
           R+      R  P +S +LL     ++  +    +      +   D      A   F    
Sbjct: 37  RRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKY 96

Query: 548 ---NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQG--------IEEFKNEVRLIAKL 595
              + +G+G   +V +      G E AVK +   + +          E  + E  ++ ++
Sbjct: 97  DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156

Query: 596 -QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF------NIIC 648
             H +++ L+          LV++ M    L    FD     +   +         +I+ 
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDY----LTE-KVALSEKETRSIMR 207

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            +   + +LH +    I+HRDLK  NILLD  M  ++SDFG +      +     + + G
Sbjct: 208 SLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCG 261

Query: 709 T 709
           T
Sbjct: 262 T 262

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 97.1 bits (242), Expect = 5e-22
 Identities = 42/176 (23%), Positives = 74/176 (42%), Gaps = 29/176 (16%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRN-----------------SGQGIEEFKNEVRL 591
            L QG F  +      + +  A+K+  ++                      ++FKNE+++
Sbjct: 38  TLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 592 IAKLQHRNLVRLLGCCVEMDEKM--LVYEYMENRSLDSVI-----FDKARSSILNWQRRF 644
           I  +++   +   G  +  +     ++YEYMEN S+          DK  +  +  Q   
Sbjct: 97  ITDIKNEYCLTCEG--IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE 700
            II  +     Y+H  +   I HRD+K SNIL+DK    K+SDFG +      + +
Sbjct: 155 CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 97.4 bits (243), Expect = 5e-22
 Identities = 51/193 (26%), Positives = 82/193 (42%), Gaps = 35/193 (18%)

Query: 535 ETIVRATDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKN 587
           E ++ A+  F+D      +LG+G F +V +      G E A K ++    S +  ++ + 
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77

Query: 588 EVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK--ARSSILNWQRRF- 644
           E R+  KLQH N+VRL     E     LV++ +    L    F+   AR         + 
Sbjct: 78  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREF-------YS 126

Query: 645 -----NIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGG 696
                + I  I   + Y H +    I+HR+LK  N+LL    K    K++DFG+A     
Sbjct: 127 EADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183

Query: 697 DQTEQNTKRVVGT 709
            +         GT
Sbjct: 184 SEA---WHGFAGT 193

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 95.4 bits (238), Expect = 8e-22
 Identities = 41/157 (26%), Positives = 71/157 (45%), Gaps = 17/157 (10%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG-QGIEEFKNEVR-LIAKLQHR 598
           D+     +LG+G +G+V K R +  GQ +AVKR+      Q  +    ++   +  +   
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF--NIICGIAR---- 652
             V   G      +  +  E M + SLD          +++  +    +I+  IA     
Sbjct: 67  FTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVK 120

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
            L +LH  S+  +IHRD+K SN+L++     K+ DFG
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFG 155

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 95.8 bits (239), Expect = 9e-22
 Identities = 52/190 (27%), Positives = 76/190 (40%), Gaps = 33/190 (17%)

Query: 541 TDNFTDY-----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAK 594
           +  F D      + LG+G    V     L   QE AVK + +  G        EV ++ +
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66

Query: 595 LQ-HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN------II 647
            Q HRN++ L+    E D   LV+E M   S+           I   +R FN      ++
Sbjct: 67  CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----LSH----IHK-RRHFNELEASVVV 117

Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIF--GGDQTEQN 702
             +A  L +LH      I HRDLK  NIL    ++    KI DF +       GD +  +
Sbjct: 118 QDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174

Query: 703 TKR---VVGT 709
           T       G+
Sbjct: 175 TPELLTPCGS 184

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 95.0 bits (237), Expect = 9e-22
 Identities = 44/162 (27%), Positives = 72/162 (44%), Gaps = 26/162 (16%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQH 597
           ++F     LG+G FG VY  R  +    +A+K L +          + + EV + + L+H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 598 RNLVRLLGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFN------IICG 649
            N++RL G     D     L+ EY    ++    + + +        +F+       I  
Sbjct: 69  PNILRLYG--YFHDATRVYLILEYAPLGTV----YRELQK-----LSKFDEQRTATYITE 117

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
           +A  L Y H     R+IHRD+K  N+LL      KI+DFG +
Sbjct: 118 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS 156

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 95.7 bits (238), Expect = 1e-21
 Identities = 46/222 (20%), Positives = 70/222 (31%), Gaps = 54/222 (24%)

Query: 539 RATDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVK-----RLSRNSGQGIEEFKNE 588
            +             +GQG +G+V      +     A+K     ++ + + + +E  K E
Sbjct: 19  GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTE 78

Query: 589 VRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF---- 644
           VRL+ KL H N+ RL     +     LV E      L   +      S            
Sbjct: 79  VRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQ 138

Query: 645 ---------------------------------NIICGIARGLLYLHQDSRFRIIHRDLK 671
                                            NI+  I   L YLH      I HRD+K
Sbjct: 139 ICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIK 195

Query: 672 ASNILL--DKEMTPKISDFGMARIFGGDQTEQNT--KRVVGT 709
             N L   +K    K+ DFG+++ F      +        GT
Sbjct: 196 PENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 94.2 bits (235), Expect = 2e-21
 Identities = 46/192 (23%), Positives = 75/192 (39%), Gaps = 36/192 (18%)

Query: 539 RATDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGI---------EE 584
            +T  F +       LG+G   +V +       +E AVK +    G            E 
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 585 FKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRR 643
              EV ++ K+  H N+++L           LV++ M+   L    FD     +   +  
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDY----LTE-KVT 120

Query: 644 F------NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
                   I+  +   +  LH+     I+HRDLK  NILLD +M  K++DFG +      
Sbjct: 121 LSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177

Query: 698 QTEQNTKRVVGT 709
           +     + V GT
Sbjct: 178 EK---LREVCGT 186

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 54/190 (28%), Positives = 78/190 (41%), Gaps = 27/190 (14%)

Query: 536 TIVRATDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRL------SRNSGQGIEE 584
           T+ R  +N  DY     +LG G F +V K R    G + A K +      S   G   E+
Sbjct: 2   TVFR-QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 60

Query: 585 FKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK-ARSSILNWQRR 643
            + EV ++ ++QH N++ L        + +L+ E +    L    FD  A    L  +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEA 116

Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMARIFGGDQT 699
              +  I  G+ YLH      I H DLK  NI+L     P    KI DFG+A        
Sbjct: 117 TEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173

Query: 700 EQNTKRVVGT 709
               K + GT
Sbjct: 174 ---FKNIFGT 180

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 94.6 bits (236), Expect = 3e-21
 Identities = 51/185 (27%), Positives = 75/185 (40%), Gaps = 26/185 (14%)

Query: 541 TDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVK------RLSRNSGQGIEEFKNEV 589
                D+     +LG G F IV K R    G E A K        +   G   EE + EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 590 RLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK-ARSSILNWQRRFNIIC 648
            ++ ++ H N++ L        + +L+ E +    L    FD  A+   L+ +   + I 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIK 122

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMARIFGGDQTEQNTK 704
            I  G+ YLH      I H DLK  NI+L  +  P    K+ DFG+A            K
Sbjct: 123 QILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FK 176

Query: 705 RVVGT 709
            + GT
Sbjct: 177 NIFGT 181

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 95.1 bits (237), Expect = 3e-21
 Identities = 46/181 (25%), Positives = 68/181 (37%), Gaps = 22/181 (12%)

Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEE--FKN---- 587
              +      +T    +  G +G V  G   EG  +A+KR+      G       +    
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73

Query: 588 -----EVRLIAKLQHRNLVRLLGCCV-----EMDEKMLVYEYMENRSLDSVIFDKARSSI 637
                E+RL+    H N++ L    V      M +  LV E M    L  VI    +  +
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIV 130

Query: 638 LNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
           ++ Q     +  I  GL  LH+     ++HRDL   NILL       I DF +AR    D
Sbjct: 131 ISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTAD 187

Query: 698 Q 698
            
Sbjct: 188 A 188

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 93.9 bits (234), Expect = 3e-21
 Identities = 43/156 (27%), Positives = 69/156 (44%), Gaps = 20/156 (12%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSR----NSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           LG+G +G V +          AVK L +        G    K E++L+ +L+H+N+++L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 605 G-CCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILN-WQ-RRF--NIICGIARGLLYLH 658
                E  +KM +V EY      +  + D          Q   +   +I G+     YLH
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
                 I+H+D+K  N+LL    T KIS  G+A   
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 95.1 bits (237), Expect = 3e-21
 Identities = 51/186 (27%), Positives = 75/186 (40%), Gaps = 28/186 (15%)

Query: 541 TDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVK------RLSRNSGQGIEEFKNEV 589
                D+     +LG G F IV K R    G E A K        +   G   EE + EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66

Query: 590 RLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK--ARSSILNWQRRFNII 647
            ++ ++ H N++ L        + +L+ E +    L    FD    + S L+ +   + I
Sbjct: 67  SILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKES-LSEEEATSFI 121

Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMARIFGGDQTEQNT 703
             I  G+ YLH      I H DLK  NI+L  +  P    K+ DFG+A            
Sbjct: 122 KQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---F 175

Query: 704 KRVVGT 709
           K + GT
Sbjct: 176 KNIFGT 181

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 95.5 bits (237), Expect = 3e-21
 Identities = 29/188 (15%), Positives = 58/188 (30%), Gaps = 37/188 (19%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLS---RNSGQGIEEFKNEVRLIAKLQ--------- 596
           LGQ       +    E G+   V       R     I++ K EV  +  L+         
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 597 ----------------HRNLVRLLGCCVEMDEKMLVYEYM----ENRSLDSVIFDKARSS 636
                            + ++R+     +M      + Y       ++   V+   + + 
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 637 -ILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
             L    R  +   + R L  LH    + ++H  L+  +I+LD+     ++ F      G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257

Query: 696 GDQTEQNT 703
                  +
Sbjct: 258 ARVVSSVS 265

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 95.9 bits (239), Expect = 5e-21
 Identities = 51/200 (25%), Positives = 85/200 (42%), Gaps = 42/200 (21%)

Query: 537 IVRATDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN-------------S 578
           + +      +      KLG G +G V   +      E A+K + ++              
Sbjct: 27  VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86

Query: 579 GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSIL 638
            +  EE  NE+ L+  L H N+++L     +     LV E+ E   L    F++    I+
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQ----II 138

Query: 639 NWQRRFN------IICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFG 689
           N + +F+      I+  I  G+ YLH+     I+HRD+K  NILL   +  +  KI DFG
Sbjct: 139 N-RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFG 194

Query: 690 MARIFGGDQTEQNTKRVVGT 709
           ++  F  D      +  +GT
Sbjct: 195 LSSFFSKDYK---LRDRLGT 211

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 93.0 bits (232), Expect = 6e-21
 Identities = 43/186 (23%), Positives = 75/186 (40%), Gaps = 32/186 (17%)

Query: 539 RATDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIA 593
             T N          LG G F  V+  +    G+  A+K + ++        +NE+ ++ 
Sbjct: 2   MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLK 61

Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF-------NI 646
           K++H N+V L           LV + +    L    FD+    IL  +R          +
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGEL----FDR----IL--ERGVYTEKDASLV 111

Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNT 703
           I  +   + YLH++    I+HRDLK  N+L    ++     I+DFG++++          
Sbjct: 112 IQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIM 164

Query: 704 KRVVGT 709
               GT
Sbjct: 165 STACGT 170

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 93.2 bits (232), Expect = 6e-21
 Identities = 42/185 (22%), Positives = 76/185 (41%), Gaps = 27/185 (14%)

Query: 518 DYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSR 576
             S  +T  L +    ++      ++  +  ++G G  G V+K R  + G  IAVK++ R
Sbjct: 4   GSSGKQTGYLTIGGQRYQA---EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60

Query: 577 NSGQGIEEFKNEVR----LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK 632
           +  +  EE K  +     ++       +V+  G  +   +  +  E M     + +    
Sbjct: 61  SGNK--EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLK--- 114

Query: 633 ARSSILNWQRRF--NIICGIAR----GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKIS 686
                   Q      I+  +       L YL    +  +IHRD+K SNILLD+    K+ 
Sbjct: 115 -----KRMQGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLC 167

Query: 687 DFGMA 691
           DFG++
Sbjct: 168 DFGIS 172

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 91.9 bits (229), Expect = 9e-21
 Identities = 50/189 (26%), Positives = 75/189 (39%), Gaps = 38/189 (20%)

Query: 543 NFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVK------RLSRNSGQGIEEFKNEVRL 591
              D+     +LG G F IV K R    G+E A K        S   G   EE + EV +
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 592 IAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF------- 644
           + +++H N++ L        + +L+ E +    L    FD     +   ++         
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDF----LA--EKESLTEDEAT 111

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMARIFGGDQTE 700
             +  I  G+ YLH     RI H DLK  NI+L  +  P    K+ DFG+A         
Sbjct: 112 QFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE- 167

Query: 701 QNTKRVVGT 709
              K + GT
Sbjct: 168 --FKNIFGT 174

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 94.5 bits (235), Expect = 1e-20
 Identities = 38/179 (21%), Positives = 81/179 (45%), Gaps = 29/179 (16%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---------EVR 590
            D +   + +G G +G V +    LE + +A+K++ R        F++         E+ 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104

Query: 591 LIAKLQHRNLVRLL-----GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           ++ +L H ++V++L         + DE  +V E  +      +   +    +     +  
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLF--RTPVYLTELHIKT- 160

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
           ++  +  G+ Y+H  S   I+HRDLK +N L++++ + K+ DFG+AR     +   +  
Sbjct: 161 LLYNLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 93.1 bits (231), Expect = 1e-20
 Identities = 24/188 (12%), Positives = 52/188 (27%), Gaps = 22/188 (11%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGR------LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAK 594
           +     ++ LG+G F  VY+            Q+  +K     +          +  +  
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI--FDKARSSILNWQRRFNIICGIAR 652
                 ++     +  +  +LV E     +L + I  +      ++      +    +  
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTP-----------KISDFGMARIFGGDQTEQ 701
            +  +H      IIH D+K  N +L                  + D G +          
Sbjct: 184 MIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 702 NTKRVVGT 709
                  T
Sbjct: 241 IFTAKCET 248

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 91.1 bits (227), Expect = 2e-20
 Identities = 49/163 (30%), Positives = 75/163 (46%), Gaps = 10/163 (6%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKLQHRNLVRLLGCC 607
           LG+G +G V      +  + +AVK +         E  K E+ +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN-IICGIARGLLYLHQDSRFRII 666
            E + + L  EY     L   I         + QR F+ ++ G+     YLH      I 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---GIGIT 127

Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 93.9 bits (234), Expect = 2e-20
 Identities = 49/186 (26%), Positives = 82/186 (44%), Gaps = 32/186 (17%)

Query: 541 TDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIA 593
              FT+      +LG+G F +V +   +  GQE A   ++    S +  ++ + E R+  
Sbjct: 6   CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65

Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF-------NI 646
            L+H N+VRL     E     L+++ +    L    F+     I+   R +       + 
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FED----IV--AREYYSEADASHC 115

Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNT 703
           I  I   +L+ HQ     ++HR+LK  N+LL    K    K++DFG+A    G+Q  Q  
Sbjct: 116 IQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAW 170

Query: 704 KRVVGT 709
               GT
Sbjct: 171 FGFAGT 176

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 92.7 bits (231), Expect = 2e-20
 Identities = 40/176 (22%), Positives = 77/176 (43%), Gaps = 32/176 (18%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN---------EVR 590
              +     +G G +G V        G+++A+K+LSR        F++         E+ 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-------PFQSEIFAKRAYRELL 75

Query: 591 LIAKLQHRNLVRLL------GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF 644
           L+  +QH N++ LL             +  LV  +M+   L  ++           + ++
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM----GLKFSEEKIQY 130

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE 700
            ++  + +GL Y+H      ++HRDLK  N+ ++++   KI DFG+AR    + T 
Sbjct: 131 -LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 182

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 92.9 bits (231), Expect = 2e-20
 Identities = 43/217 (19%), Positives = 86/217 (39%), Gaps = 58/217 (26%)

Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRL 591
            ET    +  ++    LG G FGIV +   +E G+  A+K++ ++       +KN E+ +
Sbjct: 2   LETS---SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDI 53

Query: 592 IAKLQHRNLVRLLGCCVEMDEKM------------------------------------- 614
           +  L H N+++L+       ++                                      
Sbjct: 54  MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113

Query: 615 -LVYEYMENRSLDSVI--FDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLK 671
            ++ EY+ + +L  V+  F ++  SI         I  + R + ++H      I HRD+K
Sbjct: 114 NVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISI-YIYQLFRAVGFIHS---LGICHRDIK 168

Query: 672 ASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVV 707
             N+L++ +    K+ DFG A+      +E +   + 
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYIC 203

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 92.0 bits (229), Expect = 3e-20
 Identities = 47/192 (24%), Positives = 79/192 (41%), Gaps = 34/192 (17%)

Query: 534 FETIVRATDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNE 588
            + + R +  FTD       +G G + +  +        E AVK + ++      +   E
Sbjct: 10  VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEE 65

Query: 589 VRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN-- 645
           + ++ +  QH N++ L     +     +V E M+   L     DK    IL  Q+ F+  
Sbjct: 66  IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL----LDK----ILR-QKFFSER 116

Query: 646 ----IICGIARGLLYLHQDSRFRIIHRDLKASNILL-DKEMTP---KISDFGMARIFGGD 697
               ++  I + + YLH      ++HRDLK SNIL  D+   P   +I DFG A+    +
Sbjct: 117 EASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173

Query: 698 QTEQNTKRVVGT 709
                T     T
Sbjct: 174 NGLLMT--PCYT 183

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 90.7 bits (226), Expect = 3e-20
 Identities = 39/152 (25%), Positives = 69/152 (45%), Gaps = 26/152 (17%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G FG VY  R  +    +A+K L ++         + + E+ + + L+H N++R+  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 606 CCVEMDEKM--LVYEYMENRSLDSVIFDKARSSILNWQRRFN------IICGIARGLLYL 657
                D K   L+ E+     L    + + +        RF+       +  +A  L Y 
Sbjct: 82  --YFHDRKRIYLMLEFAPRGEL----YKELQK-----HGRFDEQRSATFMEELADALHYC 130

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
           H     ++IHRD+K  N+L+  +   KI+DFG
Sbjct: 131 H---ERKVIHRDIKPENLLMGYKGELKIADFG 159

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 50/171 (29%), Positives = 76/171 (44%), Gaps = 26/171 (15%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKLQHRNLVRLLGCC 607
           LG+G +G V      +  + +AVK +         E  K E+ +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ-------RRF--NIICGIARGLLYLH 658
            E + + L  EY     L    FD+    I           +RF   ++ G+     YLH
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDR----IEPDIGMPEPDAQRFFHQLMAGVV----YLH 122

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
                 I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 91.2 bits (227), Expect = 6e-20
 Identities = 45/183 (24%), Positives = 79/183 (43%), Gaps = 31/183 (16%)

Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN----- 587
            +T       + D   +G G +G V        G ++A+K+L R        F++     
Sbjct: 17  TKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-------PFQSELFAK 69

Query: 588 ----EVRLIAKLQHRNLVRLL------GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI 637
               E+RL+  ++H N++ LL          +  +  LV  +M    L  ++    +   
Sbjct: 70  RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM----KHEK 124

Query: 638 LNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
           L   R   ++  + +GL Y+H      IIHRDLK  N+ ++++   KI DFG+AR    +
Sbjct: 125 LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181

Query: 698 QTE 700
            T 
Sbjct: 182 MTG 184

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 90.4 bits (225), Expect = 6e-20
 Identities = 48/194 (24%), Positives = 76/194 (39%), Gaps = 37/194 (19%)

Query: 537 IVRATDNFTDY-----NKLGQGGFGIVYKGRLLE-GQEIAVK--RLSRNSGQGIEEFKNE 588
             ++ +NF ++      +LG+G F +V +      GQE A K  +  R       E  +E
Sbjct: 19  YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHE 78

Query: 589 VRLIAKLQHR-NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF--- 644
           + ++   +    ++ L        E +L+ EY     +    F       L         
Sbjct: 79  IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FSL----CL--PELAEMV 128

Query: 645 ------NIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFG 695
                  +I  I  G+ YLHQ+    I+H DLK  NILL         KI DFGM+R  G
Sbjct: 129 SENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185

Query: 696 GDQTEQNTKRVVGT 709
                   + ++GT
Sbjct: 186 HACE---LREIMGT 196

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 90.4 bits (225), Expect = 7e-20
 Identities = 46/154 (29%), Positives = 79/154 (51%), Gaps = 13/154 (8%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           +G+G F  V   R +L G+E+A+K + +   +   +++   EVR++  L H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 607 CVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFN-IICGIARGLLYLHQDSRFR 664
            +E ++ + L+ EY     +   +    R      + +F  I+  +     Y H   + R
Sbjct: 83  -IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YCH---QKR 134

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           I+HRDLKA N+LLD +M  KI+DFG +  F    
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 89.6 bits (223), Expect = 2e-19
 Identities = 43/177 (24%), Positives = 82/177 (46%), Gaps = 31/177 (17%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---------EVR 590
              +T+ + +G+G +G+V      L    +A+K++S         F++         E++
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77

Query: 591 LIAKLQHRNLVRLL-----GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           ++ + +H N++ +          +M +  +V + ME   L  ++    ++  L+      
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICY 132

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN 702
            +  I RGL Y+H  S   ++HRDLK SN+LL+     KI DFG+AR+   D     
Sbjct: 133 FLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 89.7 bits (223), Expect = 2e-19
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 31/176 (17%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN---------EVR 590
            + + + + +G G +G V      + G  +AVK+LSR        F++         E+R
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80

Query: 591 LIAKLQHRNLVRLL------GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF 644
           L+  ++H N++ LL          E ++  LV   M    L++++    +   L      
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIV----KCQKLTDDHVQ 135

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE 700
            +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR    + T 
Sbjct: 136 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG 188

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 87.6 bits (218), Expect = 3e-19
 Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 14/155 (9%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG G FG V  G   L G ++AVK L+R    S   + + K E++ +   +H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 606 CCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFN-IICGIARGLLYLHQDSRF 663
             +       +V EY+    L   I    R   +  +R F  I+  +     Y H   R 
Sbjct: 79  V-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD----YCH---RH 130

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
            ++HRDLK  N+LLD  M  KI+DFG++ +    +
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 44/187 (23%), Positives = 80/187 (42%), Gaps = 34/187 (18%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEE--------FKNEVRL 591
            D +     LG G  G V      +  +++A+K +S+                 + E+ +
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 592 IAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF------N 645
           + KL H  ++++     + ++  +V E ME   L    FDK    ++   +R        
Sbjct: 69  LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDK----VVG-NKRLKEATCKL 118

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQN 702
               +   + YLH++    IIHRDLK  N+LL   +++   KI+DFG ++I G       
Sbjct: 119 YFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--- 172

Query: 703 TKRVVGT 709
            + + GT
Sbjct: 173 MRTLCGT 179

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 88.5 bits (220), Expect = 4e-19
 Identities = 52/226 (23%), Positives = 92/226 (40%), Gaps = 31/226 (13%)

Query: 498 GHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDY----NKLGQG 553
            H     DL    +   S    +A         + D+       D  +D+    ++LG+G
Sbjct: 5   HHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRG 64

Query: 554 GFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE 612
              IVY+ +     +  A+K L +      +  + E+ ++ +L H N+++L        E
Sbjct: 65  ATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE 122

Query: 613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRF------NIICGIARGLLYLHQDSRFRII 666
             LV E +    L    FD+    I+  +  +      + +  I   + YLH++    I+
Sbjct: 123 ISLVLELVTGGEL----FDR----IVE-KGYYSERDAADAVKQILEAVAYLHEN---GIV 170

Query: 667 HRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           HRDLK  N+L      +   KI+DFG+++I          K V GT
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGT 213

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 89.4 bits (222), Expect = 4e-19
 Identities = 40/192 (20%), Positives = 80/192 (41%), Gaps = 36/192 (18%)

Query: 539 RATDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--------SGQGIEEF 585
                  D       LG G  G V      +  +++A++ +S+                 
Sbjct: 128 VYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNV 187

Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME-----NRSLDSVIFDKARSSILNW 640
           + E+ ++ KL H  ++++     + ++  +V E ME     ++ + +    +A   +  +
Sbjct: 188 ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 246

Query: 641 QRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGD 697
           Q        +   + YLH++    IIHRDLK  N+LL   +++   KI+DFG ++I G  
Sbjct: 247 Q--------MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-- 293

Query: 698 QTEQNTKRVVGT 709
                 + + GT
Sbjct: 294 -ETSLMRTLCGT 304

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 87.7 bits (218), Expect = 5e-19
 Identities = 45/187 (24%), Positives = 81/187 (43%), Gaps = 42/187 (22%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---------EVR 590
              + D   LG GG G+V+        + +A+K++            +         E++
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60

Query: 591 LIAKLQHRNLVRLL--------------GCCVEMDEKMLVYEYMENRSLDSVIFDKARSS 636
           +I +L H N+V++               G   E++   +V EYME   L +V+       
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL----EQG 115

Query: 637 ILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFG 695
            L  +     +  + RGL Y+H  +   ++HRDLK +N+ ++ E +  KI DFG+ARI  
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

Query: 696 GDQTEQN 702
              + + 
Sbjct: 173 PHYSHKG 179

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 87.3 bits (217), Expect = 5e-19
 Identities = 46/185 (24%), Positives = 78/185 (42%), Gaps = 52/185 (28%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSR--------------------------NSGQGI 582
           +G+G +G+V       +    A+K LS+                               I
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 583 EEFKNEVRLIAKLQHRNLVRLLGCCVEM------DEKMLVYEYMENRSLDSVIFDKARSS 636
           E+   E+ ++ KL H N+V+L    VE+      D   +V+E +    +     +     
Sbjct: 81  EQVYQEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPV----MEVPTLK 132

Query: 637 ILNWQ--RRF--NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            L+    R +  ++I GI     YLH     +IIHRD+K SN+L+ ++   KI+DFG++ 
Sbjct: 133 PLSEDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185

Query: 693 IFGGD 697
            F G 
Sbjct: 186 EFKGS 190

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 87.7 bits (218), Expect = 6e-19
 Identities = 43/187 (22%), Positives = 72/187 (38%), Gaps = 35/187 (18%)

Query: 541 TDNFTDY-------NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLI 592
              F  +         LG+G F I  K    +  Q  AVK +S+         + E+  +
Sbjct: 3   DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITAL 59

Query: 593 AKLQ-HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN------ 645
              + H N+V+L     +     LV E +    L    F++    I   ++ F+      
Sbjct: 60  KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL----FER----IKK-KKHFSETEASY 110

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQN 702
           I+  +   + ++H      ++HRDLK  N+L    +  +  KI DFG AR+   D     
Sbjct: 111 IMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167

Query: 703 TKRVVGT 709
           T     T
Sbjct: 168 T--PCFT 172

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 88.7 bits (220), Expect = 8e-19
 Identities = 40/180 (22%), Positives = 80/180 (44%), Gaps = 29/180 (16%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---------EVR 590
            DN+   + +G+G +G VY        + +A+K+++R        F++         E+ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILREIT 77

Query: 591 LIAKLQHRNLVRLLGCCV-----EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           ++ +L+   ++RL    +     + DE  +V E  +   L  +   K    +     +  
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLF--KTPIFLTEEHIKT- 133

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           I+  +  G  ++H      IIHRDLK +N LL+++ + K+ DFG+AR    ++       
Sbjct: 134 ILYNLLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 86.9 bits (216), Expect = 1e-18
 Identities = 42/178 (23%), Positives = 77/178 (43%), Gaps = 31/178 (17%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN---------EVR 590
           + +F   + LG+G +G+V        G+ +A+K+        IE F           E++
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIK 61

Query: 591 LIAKLQHRNLVRLL-----GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           ++   +H N++ +            +E  ++ E M+   L  VI     + +L+      
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI----STQMLSDDHIQY 116

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
            I    R +  LH  +   +IHRDLK SN+L++     K+ DFG+ARI      + + 
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 87.9 bits (218), Expect = 2e-18
 Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 14/155 (9%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG G FG V  G+  L G ++AVK L+R    S   + + + E++ +   +H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 606 CCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFN-IICGIARGLLYLHQDSRF 663
             +     + +V EY+    L   I    R      +R F  I+ G+     Y H   R 
Sbjct: 84  V-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD----YCH---RH 135

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
            ++HRDLK  N+LLD  M  KI+DFG++ +    +
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 87.6 bits (217), Expect = 2e-18
 Identities = 49/174 (28%), Positives = 81/174 (46%), Gaps = 32/174 (18%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---------EVR 590
              + +   +G G  GIV      +  + +A+K+LSR        F+N         E+ 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-------PFQNQTHAKRAYRELV 113

Query: 591 LIAKLQHRNLVRLL------GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF 644
           L+  + H+N++ LL          E  +  LV E M+  +L  VI    +  + + +  +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVI----QMELDHERMSY 168

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
            ++  +  G+ +LH  S   IIHRDLK SNI++  + T KI DFG+AR  G   
Sbjct: 169 -LLYQMLCGIKHLH--SA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 85.8 bits (213), Expect = 3e-18
 Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 37/166 (22%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G FG V         Q++A+K +SR            + E+  +  L+H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74

Query: 606 CCVEMDEKMLVYEYMENRS-----LDSV---IFDK-ARSSILNWQ--RRF--NIICGIAR 652
                      Y+ +   +     ++     +FD       +     RRF   IIC I  
Sbjct: 75  -----------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE- 122

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
              Y H   R +I+HRDLK  N+LLD  +  KI+DFG++ I     
Sbjct: 123 ---YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 86.3 bits (214), Expect = 3e-18
 Identities = 53/178 (29%), Positives = 88/178 (49%), Gaps = 28/178 (15%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---------EVR 590
              +    KLG+G +GIV+K      G+ +AVK++          F+N         E+ 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-------AFQNSTDAQRTFREIM 60

Query: 591 LIAKLQ-HRNLVRLLGCCV--EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNII 647
           ++ +L  H N+V LL         +  LV++YME   L +VI    R++IL    +  ++
Sbjct: 61  ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVI----RANILEPVHKQYVV 115

Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
             + + + YLH  S   ++HRD+K SNILL+ E   K++DFG++R F   +   N   
Sbjct: 116 YQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 85.5 bits (212), Expect = 4e-18
 Identities = 34/163 (20%), Positives = 67/163 (41%), Gaps = 24/163 (14%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN--------SGQGIEEFKNEVRLIAKLQHRNL 600
           LG G FG V+      + +E+ VK + +             + +   E+ ++++++H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK-ARSSILNWQ--RRF--NIICGIARGLL 655
           +++L      + +      ME       +F    R   L+          ++  +     
Sbjct: 92  IKVLDI---FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG---- 144

Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           YL       IIHRD+K  NI++ ++ T K+ DFG A      +
Sbjct: 145 YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK 184

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 85.5 bits (212), Expect = 5e-18
 Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 32/174 (18%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---------EVR 590
              + +   +G G  GIV      +  + +A+K+LSR        F+N         E+ 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-------PFQNQTHAKRAYRELV 76

Query: 591 LIAKLQHRNLVRLL------GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF 644
           L+  + H+N++ LL          E  +  +V E M+  +L  VI    +  + + +  +
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI----QMELDHERMSY 131

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
            ++  +  G+ +LH      IIHRDLK SNI++  + T KI DFG+AR  G   
Sbjct: 132 -LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 47/172 (27%), Positives = 70/172 (40%), Gaps = 26/172 (15%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L      A+K L +        +     E  ++++L H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97

Query: 606 CCVEMDEKML--VYEYMENRSLDSVIFDKARSSILNWQRRFNIICG------IARGLLYL 657
                D++ L     Y +N  L            +     F+  C       I   L YL
Sbjct: 98  TF--QDDEKLYFGLSYAKNGEL----L-----KYIRKIGSFDETCTRFYTAEIVSALEYL 146

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           H      IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT
Sbjct: 147 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 84.1 bits (208), Expect = 4e-17
 Identities = 56/182 (30%), Positives = 84/182 (46%), Gaps = 28/182 (15%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRN---SGQGIEEFKNEVRLIAKLQH 597
           D F D+  LG+GGFG V+  ++    ++ A K+L++      +G +    E +++AK+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 598 RNLVRLLGCCVEMDEKM-LVYEYM---------ENRSLDSVIFDKARSSILNWQRRFNII 647
           R +V L     E    + LV   M          N   D+  F + R+        F   
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA-------IFYTA 296

Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             I  GL +LHQ     II+RDLK  N+LLD +   +ISD G+A      QT+  TK   
Sbjct: 297 Q-IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYA 350

Query: 708 GT 709
           GT
Sbjct: 351 GT 352

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 82.9 bits (205), Expect = 5e-17
 Identities = 39/192 (20%), Positives = 68/192 (35%), Gaps = 39/192 (20%)

Query: 538 VRATDNFTDYN----KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLI 592
           ++      DY      LG G  G V +       ++ A+K L         + + EV L 
Sbjct: 54  IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELH 108

Query: 593 AKLQ-HRNLVRLLGCCVEMDEKM----LVYEYMENRSLDSVIFDKARSSILN-WQRRF-- 644
            +     ++VR++     +        +V E ++   L    F +    I +   + F  
Sbjct: 109 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSR----IQDRGDQAFTE 160

Query: 645 ----NIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGD 697
                I+  I   + YLH  +   I HRD+K  N+L          K++DFG A+     
Sbjct: 161 REASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217

Query: 698 QTEQNTKRVVGT 709
            +         T
Sbjct: 218 NS---LTTPCYT 226

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 15/149 (10%), Positives = 45/149 (30%), Gaps = 14/149 (9%)

Query: 549 KLGQGGFGIVYKGR--LLEGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRL 603
             G       ++     L  +++A+  +          ++E  +    ++++    + R+
Sbjct: 38  FHGGVPPLQFWQALDTAL-DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           L         ++V E++   SL  V       +  +       +  +A      H   R 
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---RA 148

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR 692
            +       S + +  +    ++      
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPATMP 177

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 81.6 bits (202), Expect = 6e-17
 Identities = 45/166 (27%), Positives = 69/166 (41%), Gaps = 37/166 (22%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN------EVRLIAKLQHR--NL 600
           LG GGFG VY G  + +   +A+K + ++      E  N      EV L+ K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK-----------ARSSILNWQRRFNIICG 649
           +RLL      D  +L+ E  E    D  +FD            ARS    WQ    ++  
Sbjct: 111 IRLLDWFERPDSFVLILERPEP-VQD--LFDFITERGALQEELARS--FFWQ----VLEA 161

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIF 694
           +     + H      ++HRD+K  NIL+D      K+ DFG   + 
Sbjct: 162 VR----HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 81.6 bits (202), Expect = 7e-17
 Identities = 45/162 (27%), Positives = 68/162 (41%), Gaps = 30/162 (18%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKLQHRNLVRLLGCC 607
           +G G FG+    R  L  + +AVK + R  G  I+E  + E+     L+H N+VR     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ-------RRF--NIICGIARGLLYLH 658
           +      ++ EY     L    +++    I N         R F   ++ G++    Y H
Sbjct: 86  LTPTHLAIIMEYASGGEL----YER----ICNAGRFSEDEARFFFQQLLSGVS----YCH 133

Query: 659 QDSRFRIIHRDLKASNILLDKEMTP--KISDFGMARIFGGDQ 698
                +I HRDLK  N LLD    P  KI DFG ++      
Sbjct: 134 ---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 82.5 bits (204), Expect = 1e-16
 Identities = 56/179 (31%), Positives = 76/179 (42%), Gaps = 25/179 (13%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRN---SGQGIEEFKNEVRLIAKLQH 597
           + F  Y  LG+GGFG V   ++    ++ A K+L +      +G     NE +++ K+  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSL-------DSVIFDKARSSILNWQRRFNIICGI 650
           R +V L       D   LV   M    L           F +AR+        F     I
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA-------VFYAAE-I 295

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             GL  LH   R RI++RDLK  NILLD     +ISD G+A      QT    K  VGT
Sbjct: 296 CCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGT 348

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 43/190 (22%), Positives = 70/190 (36%), Gaps = 41/190 (21%)

Query: 541 TDNFTD-YN----KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAK 594
               TD Y      LG G  G V +      GQ+ A+K L  +      + + EV    +
Sbjct: 23  KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQ 77

Query: 595 LQ-HRNLVRLLGCCVEMDEKM----LVYEYMENRSLDSVIFDKARSSILNWQRRF----- 644
                ++V +L     M        ++ E ME   L    F +    I     +      
Sbjct: 78  ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL----FSR----IQERGDQAFTERE 129

Query: 645 --NIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQT 699
              I+  I   + +LH  +   I HRD+K  N+L    +K+   K++DFG A+      T
Sbjct: 130 AAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----T 182

Query: 700 EQNTKRVVGT 709
           +   +    T
Sbjct: 183 QNALQTPCYT 192

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 39/174 (22%), Positives = 80/174 (45%), Gaps = 23/174 (13%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HR 598
            D++    KLG+G +  V++   +   +++ VK L     +   + K E++++  L+   
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGP 91

Query: 599 NLVRLLGCCVEMDEKM----LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           N++ L    +  D       LV+E++ N     +       ++ ++  RF  +  I + L
Sbjct: 92  NIITLA--DIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRF-YMYEILKAL 143

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFGGDQTEQNTKRVV 707
            Y H  S   I+HRD+K  N+++D E    ++ D+G+A        ++   RV 
Sbjct: 144 DYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVA 192

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 45/168 (26%), Positives = 70/168 (41%), Gaps = 39/168 (23%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN------EVRLIAKL----QHR 598
           LG+GGFG V+ G  L +  ++A+K + RN   G     +      EV L+ K+     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK-----------ARSSILNWQRRFNII 647
            ++RLL      +  MLV E     + D  +FD            +R      Q    ++
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLP-AQD--LFDYITEKGPLGEGPSRC--FFGQ----VV 149

Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIF 694
             I     + H      ++HRD+K  NIL+D      K+ DFG   + 
Sbjct: 150 AAIQ----HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL 190

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 38/174 (21%), Positives = 65/174 (37%), Gaps = 36/174 (20%)

Query: 538 VRATDNFTDYN----KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLI 592
           ++      DY      LG G  G V +       ++ A+K L         + + EV L 
Sbjct: 10  IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELH 64

Query: 593 AKL-QHRNLVRLLGCCVEMDEKM----LVYEYMENRSLDSVIFDKARSSILNWQRRF--- 644
            +  Q  ++VR++     +        +V E ++   L    F +    I +   +    
Sbjct: 65  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSR----IQDRGDQAFTE 116

Query: 645 ----NIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMA 691
                I+  I   + YLH  +   I HRD+K  N+L          K++DFG A
Sbjct: 117 REASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 77.6 bits (191), Expect = 5e-15
 Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 25/171 (14%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRN---SGQGIEEFKNEVRLIAKL-- 595
           ++F+ +  +G+GGFG VY  R  +  ++ A+K L +      QG     NE  +++ +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 596 -QHRNLVRLLGCCVEMDEKM-LVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIIC 648
                +V +        +K+  + + M    L        +F +A         RF    
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-------RFYAAE 300

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
            I  GL ++H      +++RDLK +NILLD+    +ISD G+A  F   + 
Sbjct: 301 -IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 347

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 74.9 bits (183), Expect = 1e-14
 Identities = 29/203 (14%), Positives = 58/203 (28%), Gaps = 54/203 (26%)

Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS--------GQGIEEFKNEVRL 591
            T+      K+G+G FG V++    +   +A+K ++            +  EE   E+ +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 592 IAKLQ---------HRNLVRLLGCCV--------------EMDEKM-------------- 614
             +L              + L                     +                 
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 615 --LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKA 672
             +V E+           ++ R+ + +     +I+  +   L         R  HRDL  
Sbjct: 137 LFIVLEFEFGGID----LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190

Query: 673 SNILLDKEMTPKISDFGMARIFG 695
            N+LL K    K+      +   
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSST 213

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 69.3 bits (170), Expect = 1e-12
 Identities = 49/195 (25%), Positives = 85/195 (43%), Gaps = 41/195 (21%)

Query: 528 ELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLS------RNSGQ 580
           ++    FE I+RA         +G+G FG V   +  + +++ A+K ++      RN   
Sbjct: 11  DVNFDHFE-ILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE-- 58

Query: 581 GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM-LVYEYM---ENRSL--DSVIFDKAR 634
            +     E++++  L+H  LV L     + +E M +V + +   + R     +V F +  
Sbjct: 59  -VRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET 116

Query: 635 SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
                   +   IC +   L YL      RIIHRD+K  NILLD+     I+DF +A + 
Sbjct: 117 V-------KL-FICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165

Query: 695 GGDQTEQNTKRVVGT 709
             +        + GT
Sbjct: 166 PRETQ---ITTMAGT 177

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 48/209 (22%), Positives = 78/209 (37%), Gaps = 38/209 (18%)

Query: 513 ISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AV 571
             S+   + +K  DL +   D+E +            +G+G FG V   R    +++ A+
Sbjct: 50  FLSRYKDTINKIRDLRMKAEDYEVV----------KVIGRGAFGEVQLVRHKSTRKVYAM 99

Query: 572 KRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSV 628
           K LS+           F  E  ++A      +V+L     +     +V EYM    L   
Sbjct: 100 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL--- 156

Query: 629 IFDKARSSILNWQRRFNIICGIAR--------GLLYLHQDSRFRIIHRDLKASNILLDKE 680
                    +N    +++    AR         L  +H       IHRD+K  N+LLDK 
Sbjct: 157 ---------VNLMSNYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKS 204

Query: 681 MTPKISDFGMARIFGGDQTEQNTKRVVGT 709
              K++DFG       +   +     VGT
Sbjct: 205 GHLKLADFGTCMKMNKEGMVR-CDTAVGT 232

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 67.4 bits (165), Expect = 6e-12
 Identities = 40/198 (20%), Positives = 77/198 (38%), Gaps = 34/198 (17%)

Query: 523 KTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRN---S 578
           +  ++ L   DFE +            +G+G F  V   ++ +  ++ A+K +++     
Sbjct: 52  RLKEVRLQRDDFEIL----------KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLK 101

Query: 579 GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM-LVYEYMENRSL------DSVIFD 631
              +  F+ E  ++     R + +L     + +  + LV EY     L            
Sbjct: 102 RGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIP 160

Query: 632 KARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
              +       RF  +  I   +  +H+      +HRD+K  NILLD+    +++DFG  
Sbjct: 161 AEMA-------RF-YLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSC 209

Query: 692 RIFGGDQTEQNTKRVVGT 709
                D T + +   VGT
Sbjct: 210 LKLRADGTVR-SLVAVGT 226

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 66.2 bits (162), Expect = 8e-12
 Identities = 46/166 (27%), Positives = 68/166 (40%), Gaps = 24/166 (14%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSR----NSGQGIEEFKNEVRLIAKLQ 596
           D F     LG G FG V   +  E     A+K L +       Q IE   NE R++  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99

Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN------IICGI 650
              LV+L     +     +V EY+    +    F     S L    RF+          I
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM----F-----SHLRRIGRFSEPHARFYAAQI 150

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
                YLH      +I+RDLK  N+L+D++   +++DFG A+   G
Sbjct: 151 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 66.7 bits (163), Expect = 1e-11
 Identities = 39/179 (21%), Positives = 70/179 (39%), Gaps = 24/179 (13%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRN---SGQGIEEFKNEVRLIAKLQH 597
           ++F     +G+G FG V   +L    ++ A+K L++           F+ E  ++     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 598 RNLVRLLGCCVEMDEKM-LVYEYMENRSL------DSVIFDKARSSILNWQRRFNIICGI 650
           + +  L     + D  + LV +Y     L            +  +       RF  +  +
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA-------RF-YLAEM 184

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
              +  +HQ      +HRD+K  NIL+D     +++DFG       D T Q +   VGT
Sbjct: 185 VIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-SSVAVGT 239

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 64.8 bits (158), Expect = 4e-11
 Identities = 44/173 (25%), Positives = 71/173 (41%), Gaps = 29/173 (16%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL------SRNSGQGIEEFKNEVRLIAK 594
           + F     LG+G FG V   +        A+K L      +++    +     E R++  
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE---VAHTLTENRVLQN 204

Query: 595 LQHRNLVRLLGCCVEMDEKM-LVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIIC 648
            +H  L  L     +  +++  V EY     L        +F + R+       RF    
Sbjct: 205 SRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-------RFYGAE 256

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQT 699
            I   L YLH  S   +++RDLK  N++LDK+   KI+DFG+ +  I  G   
Sbjct: 257 -IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 306

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 63.7 bits (156), Expect = 5e-11
 Identities = 47/161 (29%), Positives = 71/161 (44%), Gaps = 24/161 (14%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNS----GQGIEEFKNEVRLIAKLQ 596
            +F     LG G FG V+  R        A+K L +       Q +E   +E  +++ + 
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVT 64

Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI------ICGI 650
           H  ++R+ G   +  +  ++ +Y+E   L    F     S+L   +RF           +
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGEL----F-----SLLRKSQRFPNPVAKFYAAEV 115

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
              L YLH      II+RDLK  NILLDK    KI+DFG A
Sbjct: 116 CLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFA 153

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 63.4 bits (155), Expect = 7e-11
 Identities = 43/173 (24%), Positives = 71/173 (41%), Gaps = 30/173 (17%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL------SRNSGQGIEEFKNEVRLIAK 594
           ++F     LG+G FG V   R        A+K L      +++    +     E R++  
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE---VAHTVTESRVLQN 61

Query: 595 LQHRNLVRLLGCCVEMDEKM-LVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIIC 648
            +H  L  L     +  +++  V EY     L        +F + R+       RF    
Sbjct: 62  TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-------RFYGAE 113

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQT 699
            I   L YLH      +++RD+K  N++LDK+   KI+DFG+ +  I  G   
Sbjct: 114 -IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 64.3 bits (156), Expect = 7e-11
 Identities = 51/170 (30%), Positives = 69/170 (40%), Gaps = 23/170 (13%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRN---SGQGIEEFKNEVR-LIAKLQ 596
            +F     LG+G FG V         E+ AVK L ++       +E    E R L    +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIICGIA 651
              L +L  C   MD    V EY+    L         F +  +        F     IA
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAE-IA 452

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQT 699
            GL +L       II+RDLK  N++LD E   KI+DFGM +  I+ G  T
Sbjct: 453 IGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 499

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 63.9 bits (155), Expect = 7e-11
 Identities = 41/177 (23%), Positives = 76/177 (42%), Gaps = 30/177 (16%)

Query: 549 KLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV-RLLGC 606
           K+G G FG +Y G  +   +E+A+K  +  +     +   E ++   LQ    +  +   
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWF 71

Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI--ICGIARGLL----YLHQD 660
            VE D  +LV + +   SL+  +F+          R+ ++  +  +A  ++    ++H  
Sbjct: 72  GVEGDYNVLVMDLL-GPSLED-LFNFCS-------RKLSLKTVLMLADQMINRVEFVHSK 122

Query: 661 SRFRIIHRDLKASNILLDKEMTPK---ISDFGMARIFGGDQTEQ-----NTKRVVGT 709
           S    +HRD+K  N L+          I DFG+A+ +    T Q       K + GT
Sbjct: 123 S---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 40/164 (24%), Positives = 73/164 (44%), Gaps = 25/164 (15%)

Query: 549 KLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH-RNLVRLLGC 606
           K+G G FG +Y G  +  G+E+A+K     +         E ++   +Q    +  +  C
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWC 73

Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI--ICGIARGLL----YLHQD 660
             E D  ++V E +   SL+  +F+          R+F++  +  +A  ++    Y+H  
Sbjct: 74  GAEGDYNVMVMELL-GPSLED-LFNFCS-------RKFSLKTVLLLADQMISRIEYIHSK 124

Query: 661 SRFRIIHRDLKASNILLDKEMTPK---ISDFGMARIFGGDQTEQ 701
           +    IHRD+K  N L+          I DFG+A+ +   +T Q
Sbjct: 125 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 60.8 bits (148), Expect = 4e-10
 Identities = 41/179 (22%), Positives = 80/179 (44%), Gaps = 32/179 (17%)

Query: 549 KLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH-RNLVRLLGC 606
           ++G+G FG++++G  LL  Q++A+K   R S       ++E R    L     +  +   
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTGIPNVYYF 74

Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI--ICGIARGLL----YLHQD 660
             E    +LV + +   SL+  + D          R+F++  +   A+ +L     +H+ 
Sbjct: 75  GQEGLHNVLVIDLL-GPSLED-LLDLCG-------RKFSVKTVAMAAKQMLARVQSIHEK 125

Query: 661 SRFRIIHRDLKASNILLDKEMTPK-----ISDFGMARIFGGDQTEQ-----NTKRVVGT 709
           S   +++RD+K  N L+ +  +       + DFGM + +    T+Q       K + GT
Sbjct: 126 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 61.1 bits (149), Expect = 4e-10
 Identities = 46/167 (27%), Positives = 70/167 (41%), Gaps = 33/167 (19%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKNEVR--------LIAKLQHRNL 600
           LG+G FG V         E+ AVK L ++    + +  ++V         L    +   L
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDV---VIQ-DDDVECTMVEKRVLALPGKPPFL 83

Query: 601 VRLLGCCVEMDEKM-LVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIICGIARGL 654
            +L   C +  +++  V EY+    L         F +  +        F     IA GL
Sbjct: 84  TQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAE-IAIGL 134

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQT 699
            +L       II+RDLK  N++LD E   KI+DFGM +  I+ G  T
Sbjct: 135 FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 178

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 35/182 (19%), Positives = 70/182 (38%), Gaps = 41/182 (22%)

Query: 549 KLGQGGFGIVYKGRLLEGQEI------AVKRLSRNSGQGIEEFKNEVRL-----IAKLQH 597
            +GQGGFG +Y   +   + +       VK    ++G    E K   R      I K   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 598 RNLVRLLG----------CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI- 646
              ++ LG                 + ++ +      L   I++          +RF+  
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQK-IYEANA-------KRFSRK 152

Query: 647 -ICGIARGLL----YLHQDSRFRIIHRDLKASNILLDKEMTPKI--SDFGMARIFGGDQT 699
            +  ++  +L    Y+H+      +H D+KASN+LL+ +   ++   D+G+A  +  +  
Sbjct: 153 TVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209

Query: 700 EQ 701
            +
Sbjct: 210 HK 211

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 36/180 (20%), Positives = 69/180 (38%), Gaps = 40/180 (22%)

Query: 549 KLGQGGFGIVYKG-RLLEGQEIA---VKRLSRNSGQGIEEFKNEVRL-----IAKLQHRN 599
           K+G GGFG++Y      + ++ A   VK   + +G    E K   R+     I K   R 
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 600 LVRLLG----------CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI--I 647
            +  LG                 + +V E +    L           I      F    +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK---------ISGQNGTFKKSTV 153

Query: 648 CGIARGLL----YLHQDSRFRIIHRDLKASNILLDKEMTPKI--SDFGMARIFGGDQTEQ 701
             +   +L    Y+H++     +H D+KA+N+LL  +   ++  +D+G++  +  +   +
Sbjct: 154 LQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 60.7 bits (148), Expect = 5e-10
 Identities = 53/166 (31%), Positives = 73/166 (43%), Gaps = 31/166 (18%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKNEVR--------LIAKLQHRNL 600
           LG+G FG V   R+ E  ++ AVK L ++    I +  ++V         L     H  L
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDV---ILQ-DDDVECTMTEKRILSLARNHPFL 86

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIICGIARGLL 655
            +L  C    D    V E++    L      S  FD+AR+       RF     I   L+
Sbjct: 87  TQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA-------RFYAAE-IISALM 138

Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA--RIFGGDQT 699
           +LH      II+RDLK  N+LLD E   K++DFGM    I  G  T
Sbjct: 139 FLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT 181

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 60.7 bits (148), Expect = 5e-10
 Identities = 45/166 (27%), Positives = 69/166 (41%), Gaps = 31/166 (18%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKNEVR--------LIAKLQHRNL 600
           LG+G FG V+     +  +  A+K L ++    +    ++V         L    +H  L
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDV---VLM-DDDVECTMVEKRVLSLAWEHPFL 80

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIICGIARGLL 655
             +       +    V EY+    L         FD +R+        F     I  GL 
Sbjct: 81  THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA-------TFYAAE-IILGLQ 132

Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQT 699
           +LH      I++RDLK  NILLDK+   KI+DFGM +  + G  +T
Sbjct: 133 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 175

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 60.5 bits (147), Expect = 6e-10
 Identities = 40/179 (22%), Positives = 73/179 (40%), Gaps = 32/179 (17%)

Query: 549 KLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH-RNLVRLLGC 606
           K+G G FG +  G+ L   + +A+K     S     +   E R   +L     + ++   
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYF 73

Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI--ICGIARGLL----YLHQD 660
                   +V E +   SL+  +FD          R F++  +  IA  L+    Y+H  
Sbjct: 74  GPCGKYNAMVLELL-GPSLED-LFDLCD-------RTFSLKTVLMIAIQLISRMEYVHSK 124

Query: 661 SRFRIIHRDLKASNILLDKEMTPK-----ISDFGMARIFGGDQTEQ-----NTKRVVGT 709
           +   +I+RD+K  N L+ +          I DF +A+ +   +T++       K + GT
Sbjct: 125 N---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT 180

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 60.7 bits (148), Expect = 6e-10
 Identities = 47/167 (28%), Positives = 71/167 (42%), Gaps = 33/167 (19%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKNEVR--------LIAKLQHRNL 600
           +G+G FG V   R    +   AVK L + +   I + K E +        L+  ++H  L
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKA---ILK-KKEEKHIMSERNVLLKNVKHPFL 101

Query: 601 VRLLGCCVEMDEKM-LVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIICGIARGL 654
           V L     +  +K+  V +Y+    L         F + R+       RF     IA  L
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-------RFYAAE-IASAL 152

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQT 699
            YLH      I++RDLK  NILLD +    ++DFG+ +  I     T
Sbjct: 153 GYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT 196

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 59.9 bits (146), Expect = 8e-10
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 28/166 (16%)

Query: 550 LGQGGFGIVYKGRLLEG---QEI-AVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLV 601
           LG+GG+G V++ R + G    +I A+K L +       +     K E  ++ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84

Query: 602 RLLGCCVEMDEKM-LVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIICGIARGLL 655
            L+    +   K+ L+ EY+    L        IF +  +        F +   I+  L 
Sbjct: 85  DLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-------CFYLAE-ISMALG 135

Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQT 699
           +LHQ     II+RDLK  NI+L+ +   K++DFG+ +  I  G  T
Sbjct: 136 HLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT 178

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 39/195 (20%), Positives = 76/195 (38%), Gaps = 58/195 (29%)

Query: 537 IVRATDNFTDY-----NKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVR 590
                + + D       KLG G F  V+  + ++    +A+K + R      E  ++E++
Sbjct: 9   PAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIK 67

Query: 591 LIAKLQ-----------HRNLVRLLGC-----------CVEMDEKMLVYEYMENRSLDSV 628
           L+ ++              ++++LL                     +V+E +   +L ++
Sbjct: 68  LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVV-------MVFEVL-GENLLAL 119

Query: 629 IFDKARSSILNWQRRFNI--ICGIAR----GLLYLHQDSRFRIIHRDLKASNILLDKEMT 682
           I            R   +  +  I++    GL Y+H   R  IIH D+K  N+L++   +
Sbjct: 120 IKK-------YEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDS 170

Query: 683 P------KISDFGMA 691
           P      KI+D G A
Sbjct: 171 PENLIQIKIADLGNA 185

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 44/163 (26%), Positives = 71/163 (43%), Gaps = 25/163 (15%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSR---NSGQGIEEFKNEVR-LIAKLQHRNLVRLL 604
           +G+G +  V   RL +   I A++ + +   N  + I+  + E         H  LV L 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119

Query: 605 GCCVEMDEKM-LVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
             C + + ++  V EY+    L           +  +       RF     I+  L YLH
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYSAE-ISLALNYLH 170

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQT 699
           +     II+RDLK  N+LLD E   K++D+GM +  +  GD T
Sbjct: 171 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 210

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 59.1 bits (144), Expect = 1e-09
 Identities = 43/164 (26%), Positives = 80/164 (48%), Gaps = 26/164 (15%)

Query: 550 LGQGGFGIVYKGRLLEG---QEI-AVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRL 603
           LGQG FG V+  + + G   +++ A+K L + +   +     K E  ++ ++ H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 604 LGCCVEMDEKM-LVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
                + + K+ L+ +++    L       V+F +          +F +   +A  L +L
Sbjct: 92  H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-------KFYLAE-LALALDHL 142

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQT 699
           H      II+RDLK  NILLD+E   K++DFG+++  I    + 
Sbjct: 143 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 183

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 45/163 (27%), Positives = 71/163 (43%), Gaps = 25/163 (15%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSR---NSGQGIEEFKNEVR-LIAKLQHRNLVRLL 604
           +G+G +  V   RL +   I A+K + +   N  + I+  + E         H  LV L 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76

Query: 605 GCCVEMDEKM-LVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
             C + + ++  V EY+    L           +  +       RF     I+  L YLH
Sbjct: 77  -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYSAE-ISLALNYLH 127

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQT 699
           +     II+RDLK  N+LLD E   K++D+GM +  +  GD T
Sbjct: 128 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 167

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 29/154 (18%), Positives = 56/154 (36%), Gaps = 19/154 (12%)

Query: 548 NKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNSGQG-IEEFKNEVRLIAKL-QHRN 599
             LG+G FG V +            + +AVK L   +         +E++++  +  H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 600 LVRLLGCCVEMDEK-MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
           +V LLG C +     M++ E+ +  +L + +            +R   +    +G  +  
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFRQ 137

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
                  I  DLK     +    +   S F   +
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 20/43 (46%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
           +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 58.5 bits (140), Expect = 2e-09
 Identities = 40/282 (14%), Positives = 71/282 (25%), Gaps = 29/282 (10%)

Query: 49  LFPTIAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIG--IWYKNIAQRTY 106
             P   +    L A Q L+ G+ L+S +  F+L     G+      G  +W  N  Q   
Sbjct: 6   RIPFNGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQQPFS 65

Query: 107 VWVANRDDP---LANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVL 163
             +  R+              + +        + N  ++SN          LQD GN V 
Sbjct: 66  STIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQ-WNRTHLVLQDDGNIV- 123

Query: 164 KEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHG 223
                        D                           +       G  + KL F G
Sbjct: 124 -----------LVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQG 172

Query: 224 FPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLF 283
                 +        +    G    G          N   +    + V +          
Sbjct: 173 DGNLVAYGPNGAATWNAGTQG---KGAVRAVFQGDGNLVVY-GAGNAVLWHSHTGGHASA 228

Query: 284 SRLIVSPDGFL----QRFTWIEANKIWNPFWYAPKDQCDNYG 321
             L +  +G +    ++  W  A   + P +   +    +  
Sbjct: 229 -VLRLQANGSIAILDEKPVW--ARFGFQPTYRHIRKINPDQK 267

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 30/176 (17%), Positives = 63/176 (35%), Gaps = 41/176 (23%)

Query: 548 NKLGQGGFGIVYKGR---------LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR 598
           +   +   GI+Y+             + Q+ ++K  +++ G+   E     R    LQ  
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVN 106

Query: 599 NLVRLLGC------------CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI 646
              +L                 +   + LV   +  RSL S +    +          + 
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK-------HVLSE 158

Query: 647 --ICGIARGLL----YLHQDSRFRIIHRDLKASNILLDKEMTPKI--SDFGMARIF 694
             +  +A  LL    +LH++     +H ++ A NI +D E   ++  + +G A  +
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110

 Score = 51.3 bits (123), Expect = 3e-08
 Identities = 21/120 (17%), Positives = 44/120 (36%), Gaps = 16/120 (13%)

Query: 57  VDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPL 116
           V++L++  +L  G +L      + L      +       + Y +      VW +N     
Sbjct: 1   VNSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNF------VLYDS---GKPVWASNTGGLG 50

Query: 117 ANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNP-VAQLQDSGNFVLKEAGSDEILWQS 175
           +     L   N  + ++D S  ++W +      +  V  LQ   N V+       ++W +
Sbjct: 51  SGCRLTLHN-NGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVI----YGPVVWAT 105

>1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109

 Score = 50.6 bits (121), Expect = 6e-08
 Identities = 20/125 (16%), Positives = 44/125 (35%), Gaps = 22/125 (17%)

Query: 58  DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLA 117
           + LT  + L  G++L      +        +     + ++  + +     W +N      
Sbjct: 2   NLLTNGEGLYAGQSLDVEP--YHFIMQEDCN-----LVLYDHSTSV----WASNTGIL-- 48

Query: 118 NSSGVLRIINQRIG---LFDGSQNLVWSSNQTKATNP-VAQLQDSGNFVLKEAGSDEILW 173
                 + + Q  G   ++D     +W+S+  +     V  LQ+ GN V+        +W
Sbjct: 49  -GKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVI----YGSDIW 103

Query: 174 QSFDY 178
            +  Y
Sbjct: 104 STGTY 108

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 53.8 bits (130), Expect = 7e-08
 Identities = 37/157 (23%), Positives = 69/157 (43%), Gaps = 27/157 (17%)

Query: 550 LGQGGFGIVYKGRLLEG---QEI-AVKRLSRNS----GQGIEEFKNEVRLIAKLQHRN-L 600
           LG G +G V+  R + G    ++ A+K L + +     +  E  + E +++  ++    L
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121

Query: 601 VRLLGCCVEMDEKM-LVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIICGIARGL 654
           V L     + + K+ L+ +Y+    L         F +          +   +  I   L
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV-------QI-YVGEIVLAL 172

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
            +LH+     II+RD+K  NILLD      ++DFG++
Sbjct: 173 EHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 206

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 51.6 bits (124), Expect = 4e-07
 Identities = 43/163 (26%), Positives = 65/163 (39%), Gaps = 31/163 (19%)

Query: 547 YNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR------N 599
            + +G+G FG V K    +E + +A+K + +N    + + + EVRL+  +          
Sbjct: 59  DSLIGKGSFGQVVKAYDRVEQEWVAIK-IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYY 117

Query: 600 LVRLLG--------CCV-EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           +V L          C V EM    L Y+ + N +   V  +  R               +
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSYNL-YDLLRNTNFRGVSLNLTRK----------FAQQM 166

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP--KISDFGMA 691
              LL+L       IIH DLK  NILL        KI DFG +
Sbjct: 167 CTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 51.4 bits (123), Expect = 5e-07
 Identities = 43/206 (20%), Positives = 73/206 (35%), Gaps = 58/206 (28%)

Query: 537 IVRATDNFTD----YNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRL 591
           +V+  D F        KLG G F  V+    +   + +A+K + +++    E   +E+RL
Sbjct: 28  LVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRL 86

Query: 592 IAKLQ--------HRNLVRLLGC-----------CVEMDEKMLVYEYMENRSLDSVIFDK 632
           +  ++           +V+LL             C       +V+E +            
Sbjct: 87  LKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC-------MVFEVL------------ 127

Query: 633 ARSSILNWQRRFN-----------IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM 681
               +L W  + N           II  + +GL YLH  ++ RIIH D+K  NILL    
Sbjct: 128 -GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNE 184

Query: 682 TPKISDFGMARIFGGDQTEQNTKRVV 707
                    A  +        +   V
Sbjct: 185 QYIRRLAAEATEWQRSGAPPPSGSAV 210

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115

 Score = 46.8 bits (111), Expect = 1e-06
 Identities = 23/119 (19%), Positives = 42/119 (35%), Gaps = 17/119 (14%)

Query: 58  DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLA 117
           + L + Q L    +L +    + L   +  +       + Y+N      +W +N D   +
Sbjct: 3   NVLLSGQTLHADHSLQAGA--YTLTIQNKCNL------VKYQN---GRQIWASNTDRRGS 51

Query: 118 NSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNP-VAQLQDSGNFVLKEAGSDEILWQS 175
                L   +  + ++D + N VW S            LQ  G FV+       +LW  
Sbjct: 52  GCRLTLLS-DGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVI----YGPVLWSL 105

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 40/167 (23%), Positives = 70/167 (41%), Gaps = 47/167 (28%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR------NLVR 602
           +G+G FG V K       Q +A+K + RN  +   +   E+R++  L+ +      N++ 
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163

Query: 603 LLGC-------CVEMDEKML---VYEYMENRSLDSVIFDKARSSILNWQRRFNI--ICGI 650
           +L         C+  +  +L   +YE ++                    + F++  +   
Sbjct: 164 MLENFTFRNHICMTFE--LLSMNLYELIKKNKF----------------QGFSLPLVRKF 205

Query: 651 AR----GLLYLHQDSRFRIIHRDLKASNILLDKEMTP--KISDFGMA 691
           A      L  LH   + RIIH DLK  NILL ++     K+ DFG +
Sbjct: 206 AHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112

 Score = 44.1 bits (104), Expect = 1e-05
 Identities = 18/118 (15%), Positives = 44/118 (37%), Gaps = 13/118 (11%)

Query: 58  DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLA 117
           D L +   L  G +L      +     +  +     + ++  N A     W +  +   +
Sbjct: 2   DRLNSGHQLDTGGSLAEGG--YLFIIQNDCN-----LVLYDNNRAV----WASGTNGKAS 50

Query: 118 NSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKEAGSDEILWQS 175
                ++  +  + ++ GS+ +  S+   +  N    LQ   N V+ +  S+  +W +
Sbjct: 51  GCVLKMQN-DGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDN-SNNAIWAT 106

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 48/222 (21%), Positives = 74/222 (33%), Gaps = 61/222 (27%)

Query: 514 SSKRDYSADKTDDLELPLFDFETIVRATDNFTD----YNKLGQGGFGIVYKGR-LLEGQE 568
           SS R+    + DD       F    +      +      K+G G FG V   + +   + 
Sbjct: 8   SSGRENLYFQGDDEI---VHF--SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKY 62

Query: 569 IAVKRLSRNSGQGIEEFKN----EVRLIAKLQHR-----NLVRLLGC-------CVEMDE 612
            AVK + RN    I+++      E  ++ K+Q+      N+V+  G        C+  + 
Sbjct: 63  YAVKVV-RN----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE- 116

Query: 613 KML---VYEYMENRSLDSVIFDKARSSILNWQRRFNI--ICGIARGLL----YLHQDSRF 663
             L   +YE +                  N    F+I  I      +L    YL    + 
Sbjct: 117 -PLGPSLYEIITR----------------NNYNGFHIEDIKLYCIEILKALNYLR---KM 156

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
            + H DLK  NILLD     K          G       TK 
Sbjct: 157 SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109

 Score = 42.9 bits (101), Expect = 3e-05
 Identities = 18/119 (15%), Positives = 39/119 (32%), Gaps = 17/119 (14%)

Query: 58  DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLA 117
           + L + + L+ G+ L +    +        +       + Y        +W  N      
Sbjct: 2   NILYSGETLSPGEFLNNGR--YVFIMQEDCNL------VLYDV---DKPIWATNTGGLDR 50

Query: 118 NSSGVLRIINQRIGLFDGSQNLVWSSN-QTKATNPVAQLQDSGNFVLKEAGSDEILWQS 175
                ++  +  + ++    N +W+SN   +  N V  LQ   N V+         W +
Sbjct: 51  RCHLSMQS-DGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIY----GTARWAT 104

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.4 bits (109), Expect = 3e-05
 Identities = 79/582 (13%), Positives = 158/582 (27%), Gaps = 177/582 (30%)

Query: 152 VAQLQDSGNFVLKEAGSDEIL-------------WQSFDYPTDTLLPQMKIGWDLKTGFE 198
              +QD    +L +   D I+             W       + +  Q  +   L+  ++
Sbjct: 35  CKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMV--QKFVEEVLRINYK 92

Query: 199 WYLTSWKSTD-DPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVR-FS--GVPEMK 254
           + ++  K+    PS     +                  + R   +N  + F+   V  ++
Sbjct: 93  FLMSPIKTEQRQPSMMTRMYI-----------------EQRDRLYNDNQVFAKYNVSRLQ 135

Query: 255 PIEGINFEFFIDQDHDVYYSFFIENKNLF---------SRL---IVSPDGFLQRFTWIEA 302
           P   +       +            KN+          + +   +        +      
Sbjct: 136 PYLKLRQALLELRPA----------KNVLIDGVLGSGKTWVALDVCLSYKVQCKM----D 181

Query: 303 NKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDPQAWSLRDGSGGC-V 361
            KI   FW                  C++  + +    +     DP   S  D S    +
Sbjct: 182 FKI---FWLN-------------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKL 225

Query: 362 RKTELQCSEDKFLQLKNMKLPDTTTSFVDYNMTL---------KECEAFCSRNCSCTAYA 412
           R   +Q    + L+ K             Y   L         K   AF   N SC    
Sbjct: 226 RIHSIQAELRRLLKSK------------PYENCLLVLLNVQNAKAWNAF---NLSCK--- 267

Query: 413 NTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIII-----GVTVG 467
              +T     VT                         D    A  T I +      +T  
Sbjct: 268 -ILLTTRFKQVT-------------------------DFLSAATTTHISLDHHSMTLTPD 301

Query: 468 SAILILGLVACFLWRRKTLLGRQIRKTEP----------RGHPERSQDLL-LNQVVISSK 516
                  L+  +L  R   L R++  T P          R       +   +N   +++ 
Sbjct: 302 EV---KSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTI 358

Query: 517 RDYSADKTDDLEL-PLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLS 575
            + S +  +  E   +FD  ++      F     +      +++   +     + V +L 
Sbjct: 359 IESSLNVLEPAEYRKMFDRLSV------FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLH 412

Query: 576 RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARS 635
           + S            L+ K    + + +    +E+  K+     +    +D     K   
Sbjct: 413 KYS------------LVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFD 460

Query: 636 S---ILNWQRRFNIICGIARGLLYLHQDSR---FRIIHRDLK 671
           S   I  +  ++     I   L  +    R   FR++  D +
Sbjct: 461 SDDLIPPYLDQY-FYSHIGHHLKNIEHPERMTLFRMVFLDFR 501

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.9 bits (100), Expect = 4e-04
 Identities = 49/328 (14%), Positives = 84/328 (25%), Gaps = 102/328 (31%)

Query: 19  ERRETSAK--NMIMNDITSHPCYTNLFLIIFI---------------------LFPTIAI 55
           E +    K  +    D+      TN   +  I                     L   I  
Sbjct: 302 EVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIES 361

Query: 56  SVDTLTATQNLTYGKTLVSSDDVFE-LGFFSPGSSGKWYIGIWYKNIAQRTY--VWVA-N 111
           S++ L   +              F+ L  F P +           +I       +W    
Sbjct: 362 SLNVLEPAEYRKM----------FDRLSVFPPSA-----------HIPTILLSLIWFDVI 400

Query: 112 RDDP------LANSSGVLRIINQ-RIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLK 164
           + D       L   S V +   +  I +      L        A +    + D  N    
Sbjct: 401 KSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH--RSIVDHYNIPKT 458

Query: 165 EAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFK---LDF 221
                        + +D L+P     +     F  ++       +       F+   LDF
Sbjct: 459 -------------FDSDDLIPPYLDQY-----FYSHIGHHLKNIEHPERMTLFRMVFLDF 500

Query: 222 HGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKN 281
                 FL  K            +R            +N      Q    Y  +  +N  
Sbjct: 501 R-----FLEQK------------IRHDSTAWNASGSILN----TLQQLKFYKPYICDNDP 539

Query: 282 LFSRLIVSPDGFLQRFTWIEANKIWNPF 309
            + RL+ +   FL +   IE N I + +
Sbjct: 540 KYERLVNAILDFLPK---IEENLICSKY 564

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 29/158 (18%), Positives = 55/158 (34%), Gaps = 28/158 (17%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVK--RLSRNSGQGIEE--------FKNEVRLIAKLQH 597
             +G+G    V+     +  E  VK  ++   S + ++E        F       A+ + 
Sbjct: 96  KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 155

Query: 598 RNLVRLLGCCV----EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           R L +L G  V      +   ++ E ++ + L  V  +             ++I      
Sbjct: 156 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEV-------LDMILEEVAK 208

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
                      I+H DL   N+L+ +E    I DF  +
Sbjct: 209 F------YHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS 239

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 43.0 bits (102), Expect = 2e-04
 Identities = 33/173 (19%), Positives = 66/173 (38%), Gaps = 58/173 (33%)

Query: 537 IVRATDNFTD----YNKLGQGGFGIVYKGRLLE--GQEIAVKRLSRNSGQGIEEFKN--- 587
           I ++ D  +      + LG+G FG V +    +  G+ +AVK + +N    ++ +     
Sbjct: 5   ICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-KN----VDRYCEAAR 59

Query: 588 -EVRLIAKLQHR------NLVRLLGC-------CVEMDEKML---VYEYMENRSLDSVIF 630
            E++++  L           V++L         C+  +  +L    Y++++         
Sbjct: 60  SEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKE-------- 109

Query: 631 DKARSSILNWQRRFNI--ICGIARGLL----YLHQDSRFRIIHRDLKASNILL 677
                   N    F +  I  +A  +     +LH     ++ H DLK  NIL 
Sbjct: 110 --------NGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILF 151

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 41.5 bits (98), Expect = 7e-04
 Identities = 31/182 (17%), Positives = 66/182 (36%), Gaps = 46/182 (25%)

Query: 537 IVRATDNFTD----YNKLGQGGFGIVYKGR-LLEGQEI-AVKRLSRNSGQGIEEFKN--- 587
           + R  D   +       LG+G FG V +      G+   A+K + RN    + +++    
Sbjct: 10  VCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII-RN----VGKYREAAR 64

Query: 588 -EVRLIAKLQHR------NLVRLLGC-------CVEMDEKML---VYEYMENRSLDSVIF 630
            E+ ++ K++ +        V +          C+  +  +L    +E+++  +      
Sbjct: 65  LEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKENNFQPYPL 122

Query: 631 DKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM 690
              R   + +Q        +   L +LH     ++ H DLK  NIL        + +   
Sbjct: 123 PHVRH--MAYQ--------LCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHK 169

Query: 691 AR 692
           + 
Sbjct: 170 SC 171

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	709
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	100.0
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.97
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.97
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.97
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.97
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.97
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.97
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.96
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.96
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.96
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.95
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.94
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.94
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.94
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.94
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.94
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.94
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.94
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.94
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.94
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.93
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.93
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.93
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.93
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.93
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.93
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.93
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.93
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.93
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.93
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.93
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.93
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.93
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.93
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.93
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.93
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.93
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.93
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.93
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.93
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.93
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.93
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.92
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.92
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.92
3niz_A	311	Rhodanese family protein; structural genomics, str	99.92
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.92
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.92
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.92
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.92
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.92
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.92
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.92
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.92
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.92
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.92
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.92
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.92
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.92
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.92
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.92
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.92
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.92
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.92
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.92
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.92
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.92
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.92
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.92
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.92
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.92
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.92
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.92
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.92
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.92
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.92
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.92
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.92
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.92
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.92
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.92
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.92
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.92
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.92
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.91
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.91
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.91
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.91
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.91
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.91
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.91
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.91
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.91
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.91
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.91
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.91
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.91
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.91
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.91
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.91
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.91
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.91
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.91
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.91
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.91
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.91
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.91
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.91
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.91
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.91
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.91
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.91
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.91
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.91
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.91
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.91
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.91
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.91
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.91
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.91
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.91
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.91
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.91
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.91
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.91
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.91
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.91
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.91
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.91
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.91
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.91
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.91
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.91
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.9
3bhy_A	283	Death-associated protein kinase 3; death associate	99.9
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.9
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.9
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.9
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.9
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.9
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.9
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.9
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.9
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.9
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.9
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.9
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.9
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.9
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.9
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.9
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.9
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.9
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.9
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.9
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.9
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.9
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.9
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.9
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.9
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.9
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.9
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.9
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.9
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.9
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.9
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.9
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.9
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.9
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.9
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.9
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.9
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.9
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.9
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.9
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.9
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.9
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.9
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.9
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.9
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.9
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.9
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.9
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.9
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.9
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.9
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.9
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.9
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.9
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.9
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.9
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.9
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.9
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.9
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.89
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.89
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.89
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.89
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.89
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.89
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.89
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.89
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.89
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.89
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.89
3uqc_A	286	Probable conserved transmembrane protein; structur	99.89
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.89
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.89
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.89
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.89
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.89
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.89
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.89
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.89
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.89
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.89
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.89
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.89
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.88
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.88
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.88
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.88
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.88
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.88
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.88
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.88
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.88
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.88
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.88
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.88
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.87
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.87
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.87
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.87
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.87
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.87
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.86
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.86
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.86
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.86
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.86
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.86
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.85
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.85
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	99.82
4h3o_A	105	Lectin; cadmium, plant protein; 2.17A {Allium sati	99.8
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.8
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	99.8
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.78
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	99.78
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	99.76
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	99.7
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	99.62
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	99.61
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.61
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	99.58
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	99.58
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	99.54
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	99.52
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	99.52
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	99.34
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	99.22
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	99.21
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	99.13
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.12
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	98.98
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.98
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	98.95
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	98.9
4h3o_A	105	Lectin; cadmium, plant protein; 2.17A {Allium sati	98.69
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	98.68
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.59
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.5
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.47
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.38
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.28
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.2
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.19
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.92
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.9
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.67
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.62
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.49
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.13
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.05
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.01
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.97
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.93
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.84
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.8
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.4
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.88
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.74
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.86
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	89.85
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	86.42
2ll3_A	82	Micronemal protein 4; cell adhesion; NMR {Toxoplas	86.1
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	85.45
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	80.26

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A*

Probab=100.00  E-value=2.1e-45  Score=380.86  Aligned_cols=232  Identities=21%  Similarity=0.271  Sum_probs=180.9

Q ss_pred             ccccccccCCCCCcCCCCEEEecCCeEEEEeeCCCCCCcEEEEEEEeccCCceEEEEcCCCCCCCCC----cceEEEEcC
Q 005206           53 IAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANS----SGVLRIINQ  128 (709)
Q Consensus        53 ~~~~~~~l~~g~~l~~~~~lvS~~g~F~lGFf~~~~~~~~~lgIw~~~~~~~tvVWvANr~~Pv~~~----~~~l~l~~~  128 (709)
                      ++++.|+|++|++|++|++|||++|.|+||||+++   ++||   |+  +.+ |||+||||+|+.++    +++|+|+.+
T Consensus        10 ~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~   80 (276)
T 3m7h_A           10 NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAFY   80 (276)
T ss_dssp             CCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEEE
T ss_pred             ccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeCC
Confidence            35667999999999999999999999999999442   5777   76  777 99999999999875    789999999


Q ss_pred             c-eEE--EcCCCceEEecCCCC------CCCceeEEecCCCEEEEecCCCceeEeeccCCCCccCCCCcccceeccCCee
Q 005206          129 R-IGL--FDGSQNLVWSSNQTK------ATNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEW  199 (709)
Q Consensus       129 G-Lvl--~d~~g~~vWst~~~~------~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PtDTlLpg~~l~~~~~tg~~~  199 (709)
                      | |+|  .|++|++||+|+++.      ..+++|+|+|+|||||+|   +.+||||  ||||||||||+|++++++|.. 
T Consensus        81 G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~---~~~lWqS--~ptdtlLpg~~~~~~l~~g~~-  154 (276)
T 3m7h_A           81 VQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD---SLALWNG--TPAIPLVPGAIDSLLLAPGSE-  154 (276)
T ss_dssp             ESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE---EEEEEES--CTTSCCCCSCTTCEEECSSEE-
T ss_pred             CcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC---CceeeCc--ccccccccccccccccccCcc-
Confidence            9 999  788899999999765      235789999999999997   5799999  999999999999999998755 


Q ss_pred             EEEEecCCCCCCCCcceEeecCCCCcEEEEec-CCccccccCCCCCccccccccCccccceeEEEEEcCCceEEEEEEec
Q 005206          200 YLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWN-KQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIE  278 (709)
Q Consensus       200 ~L~S~~s~~dps~G~~~l~~~~~g~~~~~~~~-~~~~~~~sg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (709)
                       |   ++.+||++|.|++.|+++|.  +++++ +...||++|+|++..    ..+.......+.+..+++....+++  .
T Consensus       155 -L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~----~~l~l~~dGnLvl~d~~~~~vWsS~--t  222 (276)
T 3m7h_A          155 -L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGA----VRAVFQGDGNLVVYGAGNAVLWHSH--T  222 (276)
T ss_dssp             -E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTC----CEEEECTTSCEEEECTTSCEEEECS--C
T ss_pred             -c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCcc----EEEEEcCCCeEEEEeCCCcEEEEec--C
Confidence             6   67899999999999999995  44454 468999999997632    1111112223333333321222222  2


Q ss_pred             CCCcEEEEEEccCCcEEEEEEeCCCCceEEEEcccC
Q 005206          279 NKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPK  314 (709)
Q Consensus       279 ~~~~~~r~~Ld~dG~l~~y~w~~~~~~W~~~~~~p~  314 (709)
                      .....+|++|+.||+|++|.|   ...|..++..|.
T Consensus       223 ~~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~  255 (276)
T 3m7h_A          223 GGHASAVLRLQANGSIAILDE---KPVWARFGFQPT  255 (276)
T ss_dssp             TTCTTCEEEECTTSCEEEEEE---EEEEESSSCCTT
T ss_pred             CCCCCEEEEEcCCccEEEEcC---CCeEEccCccCC
Confidence            222348999999999999998   345666666654

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1

Probab=100.00  E-value=9.8e-37  Score=310.46  Aligned_cols=215  Identities=14%  Similarity=0.172  Sum_probs=165.9

Q ss_pred             ccccccCCCCCcCCCCEEEecCCeEEEEeeCCCCCCcEEEEEEEeccCCceEEEEcCCCCCCCCCcceEEEEcCc-eEEE
Q 005206           55 ISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQR-IGLF  133 (709)
Q Consensus        55 ~~~~~l~~g~~l~~~~~lvS~~g~F~lGFf~~~~~~~~~lgIw~~~~~~~tvVWvANr~~Pv~~~~~~l~l~~~G-Lvl~  133 (709)
                      ++.|+|++|++|++|++|  ++|.|+|||+.+++     +. +|..   +|+||+|||+.|   ..++|+|++|| |||.
T Consensus         6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~-ly~~---~~~vW~an~~~~---~~~~l~l~~dGnLvl~   71 (236)
T 1dlp_A            6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LV-LFDS---DVRVWASNTAGA---TGCRAVLQSDGLLVIL   71 (236)
T ss_dssp             CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EE-EEES---SSEEECCCCCSC---SCCBCCBCSSSCBCCB
T ss_pred             eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EE-EEEC---CEEEEECCCCCC---CCeEEEEcCCCcEEEE
Confidence            356999999999999999  59999999987653     22 3443   799999999998   45899999999 9999


Q ss_pred             cCCCceEEecCCCCC-CCceeEEecCCCEEEEecCCCceeEeeccCCCCcc-CCCCccccee-ccCC-----eeEEEEec
Q 005206          134 DGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTL-LPQMKIGWDL-KTGF-----EWYLTSWK  205 (709)
Q Consensus       134 d~~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PtDTl-Lpg~~l~~~~-~tg~-----~~~L~S~~  205 (709)
                      |.+|.+||+|++... ....|+|+|+|||||++.    ++|||||||+||+ ||+|  +.|. .+|.     ++.|+   
T Consensus        72 d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~----~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~---  142 (236)
T 1dlp_A           72 TAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP----GLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLH---  142 (236)
T ss_dssp             CTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS----EEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEEC---
T ss_pred             cCCCcEEEeCCccccCCcEEEEEeCCCCEEEecC----CEEECCCCCCcccccCCc--cceEEecCCcCCCccceEE---
Confidence            999999999997643 346899999999999952    8999999999887 6665  5555 5554     56787   


Q ss_pred             CCCCCCCCcceEeecCCCCcEEEEecCCccccccCCCCCccccccccCccccceeEEEEEcCCceEEEEEEecCCCcEEE
Q 005206          206 STDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSR  285 (709)
Q Consensus       206 s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~sg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r  285 (709)
                      +..||++|.|+|.|+++|  +++++++...||++++|++. +...+.+....  .+.....++.+.+.++..... ..+|
T Consensus       143 s~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~G--nl~ly~~~~~~vw~s~~~~~~-~~~r  216 (236)
T 1dlp_A          143 ATQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNG--RMDVLTNQNIAVWTSGNSRSA-GRYV  216 (236)
T ss_dssp             SSCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTT--EEEEEETTTEEEEECCCCCSS-SCCE
T ss_pred             cCcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCC--cEEEEeCCCcEEEEeCCCCCC-CCEE
Confidence            578999999999999999  57778888899999999764 55666664322  222223333244444433333 4589


Q ss_pred             EEEccCCcEEEEE
Q 005206          286 LIVSPDGFLQRFT  298 (709)
Q Consensus       286 ~~Ld~dG~l~~y~  298 (709)
                      ++||+||++++|.
T Consensus       217 l~Ld~dG~l~ly~  229 (236)
T 1dlp_A          217 FVLQPDRNLAIYG  229 (236)
T ss_dssp             EEECSSSCEEEEC
T ss_pred             EEEcCCCcEEEeC
Confidence            9999999999994

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=9e-35  Score=306.23  Aligned_cols=165  Identities=30%  Similarity=0.501  Sum_probs=141.6

Q ss_pred             cCcCcceeecccCceEEEEEEEc------CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      ++|...++||+|+||+||+|++.      +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            46778899999999999999874      367899999987666677899999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEE
Q 005206          616 VYEYMENRSLDSVIFDKA----------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKI  685 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI  685 (709)
                      |||||++|+|.++|....          ....++|.+++.|+.|||+||+|||+++   ||||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            999999999999997532          2346999999999999999999999987   999999999999999999999


Q ss_pred             EecCCceeeCCCCccccccceecC
Q 005206          686 SDFGMARIFGGDQTEQNTKRVVGT  709 (709)
Q Consensus       686 ~DFGla~~l~~~~~~~~~~~~~GT  709 (709)
                      +|||+|+.+.............||
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt  193 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLP  193 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEEC
T ss_pred             CCcccceecCCCCceeecCceecC
Confidence            999999987554433333344554

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.3e-34  Score=307.14  Aligned_cols=165  Identities=28%  Similarity=0.471  Sum_probs=134.2

Q ss_pred             cCcCcceeecccCceEEEEEEEc------CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      ++|...++||+|+||+||+|++.      +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45677789999999999999874      367899999987766677899999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcE
Q 005206          616 VYEYMENRSLDSVIFDKAR------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  683 (709)
                      |||||++|+|.++|.+...            ...++|.+++.|+.|||+||+|||+++   ||||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            9999999999999975432            245999999999999999999999987   9999999999999999999


Q ss_pred             EEEecCCceeeCCCCccccccceecC
Q 005206          684 KISDFGMARIFGGDQTEQNTKRVVGT  709 (709)
Q Consensus       684 KI~DFGla~~l~~~~~~~~~~~~~GT  709 (709)
                      ||+|||+|+.+............+||
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt  223 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLP  223 (329)
T ss_dssp             EECCCC----------------CCCC
T ss_pred             EEcccccceeccCCCcceecCccccc
Confidence            99999999987655443334445565

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.3e-34  Score=302.31  Aligned_cols=164  Identities=29%  Similarity=0.459  Sum_probs=139.2

Q ss_pred             CcCcceeecccCceEEEEEEEc------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      .++..++||+|+||+||+|++.      +++.||||+++... ....++|++|+.++++++|||||+++|+|.+.+..+|
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            4566789999999999999873      36789999997543 3456789999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc
Q 005206          616 VYEYMENRSLDSVIFDKAR-------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT  682 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~  682 (709)
                      |||||++|+|.++|.....             ...++|.++++|+.|||+||+|||+++   ||||||||+||||++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence            9999999999999965321             235899999999999999999999997   999999999999999999


Q ss_pred             EEEEecCCceeeCCCCccccccceecC
Q 005206          683 PKISDFGMARIFGGDQTEQNTKRVVGT  709 (709)
Q Consensus       683 ~KI~DFGla~~l~~~~~~~~~~~~~GT  709 (709)
                      +||+|||+|+.+........+...+||
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt  210 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLP  210 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBC
T ss_pred             EEECCcccceeccCCCceeEecccccC
Confidence            999999999987554433334445565

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.8e-33  Score=296.28  Aligned_cols=162  Identities=28%  Similarity=0.415  Sum_probs=146.1

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...++||+|+||+||+|+... ++.||||++.+.   .....+.+.+|++++++++|||||++++++.+.+..||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            469999999999999999999865 899999999653   2345678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+++|+|.++|.+..   .+++.....|+.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+..+
T Consensus       112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            9999999999996543   4899999999999999999999998   999999999999999999999999999999766


Q ss_pred             CccccccceecC
Q 005206          698 QTEQNTKRVVGT  709 (709)
Q Consensus       698 ~~~~~~~~~~GT  709 (709)
                      .....+..++||
T Consensus       186 ~~~~~~~~~~GT  197 (311)
T 4aw0_A          186 SKQARANSFVGT  197 (311)
T ss_dssp             TTCCCBCCCCSC
T ss_pred             CCcccccCcccC
Confidence            555556678898

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-33  Score=295.95  Aligned_cols=160  Identities=31%  Similarity=0.513  Sum_probs=131.6

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +++...++||+|+||+||+|++.+  .||||+++..  ..+..++|.+|+.++++++|||||+++|+|.+ ++.+|||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            567778899999999999998753  6999998643  34456789999999999999999999998864 568999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCCc
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~~  699 (709)
                      |++|+|.++|....  ..++|.+++.|+.|||+||+|||+++   ||||||||+||||++++.+||+|||+|+.+.....
T Consensus       113 ~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          113 CEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             CSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             CCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            99999999996532  35999999999999999999999987   99999999999999999999999999998865544


Q ss_pred             cccccceecC
Q 005206          700 EQNTKRVVGT  709 (709)
Q Consensus       700 ~~~~~~~~GT  709 (709)
                      ...+...+||
T Consensus       188 ~~~~~~~~GT  197 (307)
T 3omv_A          188 SQQVEQPTGS  197 (307)
T ss_dssp             ------CCCC
T ss_pred             ceeecccccC
Confidence            4445566776

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.7e-33  Score=297.43  Aligned_cols=159  Identities=29%  Similarity=0.467  Sum_probs=143.3

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      +.|...++||+|+||+||+|+... |+.||||++........+.+.+|+.+|++++|||||++++++.+.+..||||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            568889999999999999999865 8999999997665566778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCCcc
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~~~  700 (709)
                      ++|+|.+++.+.    .+++.+...|+.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+..+...
T Consensus       154 ~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  226 (346)
T 4fih_A          154 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  226 (346)
T ss_dssp             TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence            999999998542    3899999999999999999999998   999999999999999999999999999988654432


Q ss_pred             ccccceecC
Q 005206          701 QNTKRVVGT  709 (709)
Q Consensus       701 ~~~~~~~GT  709 (709)
                        .+.++||
T Consensus       227 --~~~~~GT  233 (346)
T 4fih_A          227 --RKSLVGT  233 (346)
T ss_dssp             --BCCCCSC
T ss_pred             --ccccccC
Confidence              4457887

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.5e-33  Score=298.07  Aligned_cols=162  Identities=27%  Similarity=0.467  Sum_probs=136.1

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ++|..+++||+|+||+||+|+... ++.||||++.+.  .....++|.+|++++++|+|||||++++++.+.+..|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            589999999999999999999864 899999999754  33446789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      |+++|+|.++|... +...+++.+...|+.||+.||+|||+++   ||||||||+||||++++.+||+|||+|+.+....
T Consensus       104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            99999999999653 3345789999999999999999999998   9999999999999999999999999999875332


Q ss_pred             ccccccceecC
Q 005206          699 TEQNTKRVVGT  709 (709)
Q Consensus       699 ~~~~~~~~~GT  709 (709)
                        ..++.++||
T Consensus       180 --~~~~~~~GT  188 (350)
T 4b9d_A          180 --ELARACIGT  188 (350)
T ss_dssp             --HHHHHHHSC
T ss_pred             --ccccccCCC
Confidence              223446676

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.3e-32  Score=299.18  Aligned_cols=160  Identities=29%  Similarity=0.463  Sum_probs=144.1

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      .+.|...++||+|+||.||+|+... |+.||||++........+.+.+|+.+|++++|||||++++++.+.+..||||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            3568899999999999999999865 899999999776666677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCCc
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~~  699 (709)
                      |++|+|.+++...    .+++.+...|+.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+.....
T Consensus       230 ~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~  302 (423)
T 4fie_A          230 LEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  302 (423)
T ss_dssp             CTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred             CCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence            9999999998542    3899999999999999999999998   99999999999999999999999999998865443


Q ss_pred             cccccceecC
Q 005206          700 EQNTKRVVGT  709 (709)
Q Consensus       700 ~~~~~~~~GT  709 (709)
                      .  ...++||
T Consensus       303 ~--~~~~~GT  310 (423)
T 4fie_A          303 R--RKSLVGT  310 (423)
T ss_dssp             C--BCCCEEC
T ss_pred             c--ccccccC
Confidence            3  4457887

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.97  E-value=5.3e-32  Score=285.31  Aligned_cols=154  Identities=26%  Similarity=0.446  Sum_probs=128.2

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCc-cchHHHHHHHHHHHhcCCCceeeEEEEEEeCC--------
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD--------  611 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--------  611 (709)
                      ++|+.++.||+|+||+||+|+... ++.||||++..... ...+++.+|+.+|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            468889999999999999999864 89999999975433 34568999999999999999999999987654        


Q ss_pred             ----eeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEe
Q 005206          612 ----EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISD  687 (709)
Q Consensus       612 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~D  687 (709)
                          ..||||||+++|+|.+++.........++.....|+.||+.||+|||+++   ||||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999976544445677888899999999999999998   99999999999999999999999


Q ss_pred             cCCceeeCCCC
Q 005206          688 FGMARIFGGDQ  698 (709)
Q Consensus       688 FGla~~l~~~~  698 (709)
                      ||+|+.+..+.
T Consensus       162 FGla~~~~~~~  172 (299)
T 4g31_A          162 FGLVTAMDQDE  172 (299)
T ss_dssp             CCCC-------
T ss_pred             CccceecCCCc
Confidence            99999886553

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.97  E-value=3.9e-32  Score=292.44  Aligned_cols=175  Identities=26%  Similarity=0.392  Sum_probs=146.4

Q ss_pred             CChHHHHHHhcCcCcceeecccCceEEEEEEEcC------CcEEEEEEeccCCc-cchHHHHHHHHHHHhcCC-CceeeE
Q 005206          532 FDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQH-RNLVRL  603 (709)
Q Consensus       532 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H-~nIv~l  603 (709)
                      ++..+.+...++|...++||+|+||+||+|++..      ++.||||++..... ...++|.+|+.+|.+++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            4445555566889999999999999999998753      35799999976543 346789999999999965 899999


Q ss_pred             EEEEEeC-CeeEEEEEccCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecC
Q 005206          604 LGCCVEM-DEKMLVYEYMENRSLDSVIFDKAR-------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRD  669 (709)
Q Consensus       604 ~g~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrD  669 (709)
                      +|+|.+. +..+||||||++|+|.++|.+...             ...++|.+++.|+.|||+||+|||+++   |||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence            9999765 568999999999999999975321             245899999999999999999999997   99999


Q ss_pred             CCCCCEEEcCCCcEEEEecCCceeeCCCCccccccceecC
Q 005206          670 LKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT  709 (709)
Q Consensus       670 lkp~NILl~~~~~~KI~DFGla~~l~~~~~~~~~~~~~GT  709 (709)
                      |||+||||++++.+||+|||+|+.+..+.....+...+||
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt  250 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP  250 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEEC
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeecccccc
Confidence            9999999999999999999999988666544444556665

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.97  E-value=8.6e-32  Score=281.76  Aligned_cols=157  Identities=31%  Similarity=0.411  Sum_probs=133.0

Q ss_pred             CcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEe----CCeeEEEE
Q 005206          545 TDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE----MDEKMLVY  617 (709)
Q Consensus       545 ~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~  617 (709)
                      ...++||+|+||.||+|.+.. ++.||||++...  .....++|.+|+.++++++|||||++++++.+    .+..+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            445689999999999999865 889999999654  33446789999999999999999999999875    24579999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-CCcEEEEecCCceeeCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-EMTPKISDFGMARIFGG  696 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~KI~DFGla~~l~~  696 (709)
                      |||++|+|.++|.+..   .+++..+..|+.||+.||+|||+++ .+||||||||+||||+. ++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999996543   4899999999999999999999975 46999999999999985 78999999999986533


Q ss_pred             CCccccccceecC
Q 005206          697 DQTEQNTKRVVGT  709 (709)
Q Consensus       697 ~~~~~~~~~~~GT  709 (709)
                      .    .+..++||
T Consensus       185 ~----~~~~~~GT  193 (290)
T 3fpq_A          185 S----FAKAVIGT  193 (290)
T ss_dssp             T----SBEESCSS
T ss_pred             C----ccCCcccC
Confidence            2    23456787

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.97  E-value=1.3e-31  Score=283.16  Aligned_cols=161  Identities=28%  Similarity=0.374  Sum_probs=129.0

Q ss_pred             CcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC----eeEEEEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD----EKMLVYE  618 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV~E  618 (709)
                      +|...++||+|+||+||+|++ .|+.||||++.... .....+..|+..+.+++|||||+++|+|.+.+    ..+||||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            466778999999999999998 58999999996432 22223345666667899999999999998754    5799999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS-----RFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ||++|+|.++|...    .++|..+++++.|+|+||+|||+++     .++||||||||+||||+.++.+||+|||+|+.
T Consensus        82 y~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           82 YHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             CCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            99999999999643    4899999999999999999999872     33599999999999999999999999999998


Q ss_pred             eCCCCccc--cccceecC
Q 005206          694 FGGDQTEQ--NTKRVVGT  709 (709)
Q Consensus       694 l~~~~~~~--~~~~~~GT  709 (709)
                      ........  .+...+||
T Consensus       158 ~~~~~~~~~~~~~~~~GT  175 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGT  175 (303)
T ss_dssp             EETTTTEESCC-----CC
T ss_pred             ccCCCCceeeeccccccc
Confidence            86554322  23345676

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.97  E-value=1.2e-31  Score=285.68  Aligned_cols=157  Identities=28%  Similarity=0.347  Sum_probs=132.9

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      +.|...++||+|+||.||+|++.. |+.||||+++...     .+.+|+.++.+++|||||++++++.+.+..||||||+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            467788899999999999999865 8999999996532     2247999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-cEEEEecCCceeeCCCCc
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIFGGDQT  699 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~KI~DFGla~~l~~~~~  699 (709)
                      ++|+|.++|.+..   .+++.+...|+.||+.||+|||+++   ||||||||+||||+.++ .+||+|||+|+.+..+..
T Consensus       133 ~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          133 EGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             TTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            9999999996543   4899999999999999999999998   99999999999999987 699999999998865532


Q ss_pred             cc---cccceecC
Q 005206          700 EQ---NTKRVVGT  709 (709)
Q Consensus       700 ~~---~~~~~~GT  709 (709)
                      ..   ....++||
T Consensus       207 ~~~~~~~~~~~GT  219 (336)
T 4g3f_A          207 GKSLLTGDYIPGT  219 (336)
T ss_dssp             -------CCCCCC
T ss_pred             ccceecCCccccC
Confidence            21   22346787

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.97  E-value=2.1e-31  Score=276.50  Aligned_cols=158  Identities=28%  Similarity=0.465  Sum_probs=126.1

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|+..+.||+|+||+||+|+... ++.||||++.+..   ....+.+.+|+.++++++|||||++++++.+.+..+|||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            689999999999999999999864 8999999997542   334568999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+ +|+|.+++.+.   ..+++.+...++.||+.||+|||+++   |+||||||+||||++++.+||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 68999998654   34899999999999999999999998   999999999999999999999999999987543


Q ss_pred             CccccccceecC
Q 005206          698 QTEQNTKRVVGT  709 (709)
Q Consensus       698 ~~~~~~~~~~GT  709 (709)
                      .   .....+||
T Consensus       166 ~---~~~~~~GT  174 (275)
T 3hyh_A          166 N---FLKTSCGS  174 (275)
T ss_dssp             ------------
T ss_pred             C---ccCCeeEC
Confidence            2   22346676

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.97  E-value=4.5e-32  Score=285.44  Aligned_cols=160  Identities=26%  Similarity=0.331  Sum_probs=131.9

Q ss_pred             cCcCcceeecccCceEEEEEEEc----CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      ++|+..++||+|+||+||+|+..    .++.||||++.+..  .....++.+|++++.+++|||||++++++.+.+..||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            46899999999999999999863    36789999996542  2344578999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ||||+++|+|.++|.+..   .+++.+...++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+|+.+.
T Consensus       104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            999999999999996543   4899999999999999999999998   9999999999999999999999999999775


Q ss_pred             CCCccccccceecC
Q 005206          696 GDQTEQNTKRVVGT  709 (709)
Q Consensus       696 ~~~~~~~~~~~~GT  709 (709)
                      .....  ...++||
T Consensus       178 ~~~~~--~~~~~GT  189 (304)
T 3ubd_A          178 DHEKK--AYSFCGT  189 (304)
T ss_dssp             ---CC--CCSCCCC
T ss_pred             CCCcc--ccccccC
Confidence            44332  3457787

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.96  E-value=2.6e-29  Score=274.90  Aligned_cols=161  Identities=27%  Similarity=0.463  Sum_probs=135.4

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeC------Ce
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM------DE  612 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~  612 (709)
                      ++|..+++||+|+||+||+|.+.. |+.||||++.+..  ....+.+.+|+.+|++++|||||++++++...      +.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            579999999999999999999864 8999999996542  23456789999999999999999999997643      56


Q ss_pred             eEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCce
Q 005206          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~  692 (709)
                      .|||||||+ |+|.+++.+.   ..+++.....|+.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence            899999996 6899988543   35999999999999999999999998   9999999999999999999999999999


Q ss_pred             eeCCCC--ccccccceecC
Q 005206          693 IFGGDQ--TEQNTKRVVGT  709 (709)
Q Consensus       693 ~l~~~~--~~~~~~~~~GT  709 (709)
                      .+....  .......++||
T Consensus       207 ~~~~~~~~~~~~~~~~~GT  225 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVAT  225 (398)
T ss_dssp             CC-------CCCCCSSCCC
T ss_pred             ecccCccccccccccceeC
Confidence            875432  22234457776

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.96  E-value=2e-28  Score=264.86  Aligned_cols=148  Identities=24%  Similarity=0.370  Sum_probs=131.8

Q ss_pred             HHhcCcCcceeecccCceEEEEEEEc----CCcEEEEEEeccCCccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCee
Q 005206          539 RATDNFTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEK  613 (709)
Q Consensus       539 ~~t~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~  613 (709)
                      ...+.|...++||+|+||+||+|+.+    .++.||||++.+.  ....++.+|++++..+ +|||||++++++.+.++.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            34578999999999999999999864    3678999998654  2356788999999998 699999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CcEEEEecCCce
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMAR  692 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~KI~DFGla~  692 (709)
                      +|||||+++|+|.+++.      .+++.+...++.||+.||+|||+++   ||||||||+||||+.+ +.+||+|||+|+
T Consensus        96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            99999999999999882      3889999999999999999999998   9999999999999987 799999999999


Q ss_pred             eeCCC
Q 005206          693 IFGGD  697 (709)
Q Consensus       693 ~l~~~  697 (709)
                      .+.+.
T Consensus       167 ~~~~~  171 (361)
T 4f9c_A          167 GTHDT  171 (361)
T ss_dssp             ECTTC
T ss_pred             ccCCc
Confidence            77543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.96  E-value=1.3e-28  Score=281.63  Aligned_cols=158  Identities=27%  Similarity=0.358  Sum_probs=135.7

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHH---HHHHHHhcCCCceeeEEEEEEeCCeeE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKN---EVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~---Ei~~l~~l~H~nIv~l~g~~~~~~~~~  614 (709)
                      ++|...++||+|+||+||+|+... |+.||||++.+.   .......+.+   ++.++..++|||||++++++.+.+..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            568999999999999999999875 899999999653   1222333444   456677789999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      |||||+++|+|.++|.+..   .+++.....|+.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+
T Consensus       269 lVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence            9999999999999996543   4899999999999999999999998   999999999999999999999999999988


Q ss_pred             CCCCccccccceecC
Q 005206          695 GGDQTEQNTKRVVGT  709 (709)
Q Consensus       695 ~~~~~~~~~~~~~GT  709 (709)
                      ....    +..++||
T Consensus       343 ~~~~----~~t~~GT  353 (689)
T 3v5w_A          343 SKKK----PHASVGT  353 (689)
T ss_dssp             SSCC----CCSCCSC
T ss_pred             CCCC----CCCccCC
Confidence            5442    3457887

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.95  E-value=5.6e-28  Score=276.79  Aligned_cols=160  Identities=25%  Similarity=0.434  Sum_probs=141.5

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      ++|...++||+|+||.||+|.... |+.||||++........+.+.+|+.+|..++|||||++++++.+.+..+||||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            679999999999999999999865 8999999997665556778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC--CcEEEEecCCceeeCCCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE--MTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~KI~DFGla~~l~~~~  698 (709)
                      ++|+|.++|.+.  ...+++.+...|+.||+.||+|||+++   |+||||||+|||++.+  +.+||+|||+|+.+....
T Consensus       237 ~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          237 SGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             CCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             CCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            999999998543  235899999999999999999999998   9999999999999854  899999999999986543


Q ss_pred             ccccccceecC
Q 005206          699 TEQNTKRVVGT  709 (709)
Q Consensus       699 ~~~~~~~~~GT  709 (709)
                         .....+||
T Consensus       312 ---~~~~~~GT  319 (573)
T 3uto_A          312 ---SVKVTTGT  319 (573)
T ss_dssp             ---EEEEECSS
T ss_pred             ---ceeeeEEC
Confidence               23345676

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.94  E-value=2e-26  Score=243.01  Aligned_cols=167  Identities=41%  Similarity=0.667  Sum_probs=149.9

Q ss_pred             CCCCCChHHHHHHhcCcCcc------eeecccCceEEEEEEEcCCcEEEEEEeccCC----ccchHHHHHHHHHHHhcCC
Q 005206          528 ELPLFDFETIVRATDNFTDY------NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQH  597 (709)
Q Consensus       528 ~~~~~~~~~l~~~t~~f~~~------~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l~H  597 (709)
                      ..+.|++.++..++++|...      +.||+|+||.||+|.. +++.||||++....    ....+.|.+|+.++.+++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            45678999999999999877      8899999999999987 67899999986532    3346789999999999999


Q ss_pred             CceeeEEEEEEeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE
Q 005206          598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL  677 (709)
Q Consensus       598 ~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl  677 (709)
                      |||+++++++.+.+..++||||+++++|.+++........+++..+..++.||+.||.|||+++   |+||||||+||++
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence            9999999999999999999999999999999976555567999999999999999999999997   9999999999999


Q ss_pred             cCCCcEEEEecCCceeeCCCC
Q 005206          678 DKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       678 ~~~~~~KI~DFGla~~l~~~~  698 (709)
                      +.++.+||+|||+++......
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~  187 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFA  187 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCS
T ss_pred             cCCCcEEEeeccccccccccc
Confidence            999999999999999876543

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.94  E-value=2.7e-27  Score=251.67  Aligned_cols=162  Identities=42%  Similarity=0.733  Sum_probs=145.2

Q ss_pred             ChHHHHHHhcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCe
Q 005206          533 DFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE  612 (709)
Q Consensus       533 ~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~  612 (709)
                      .+.++...+++|...+.||+|+||.||+|++.+++.||||++........+++.+|+.++.+++||||+++++++.+.+.
T Consensus        30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  109 (321)
T 2qkw_B           30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE  109 (321)
T ss_dssp             CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred             cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence            33445567889999999999999999999988899999999977666677899999999999999999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCc
Q 005206          613 KMLVYEYMENRSLDSVIFDKAR-SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla  691 (709)
                      .++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS  186 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence            9999999999999998865432 235899999999999999999999997   999999999999999999999999999


Q ss_pred             eeeCCC
Q 005206          692 RIFGGD  697 (709)
Q Consensus       692 ~~l~~~  697 (709)
                      +.....
T Consensus       187 ~~~~~~  192 (321)
T 2qkw_B          187 KKGTEL  192 (321)
T ss_dssp             EECSSS
T ss_pred             cccccc
Confidence            976543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.94  E-value=3.1e-26  Score=243.90  Aligned_cols=163  Identities=28%  Similarity=0.421  Sum_probs=145.6

Q ss_pred             CCCCChHHHHHHhcC----------cCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCC
Q 005206          529 LPLFDFETIVRATDN----------FTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH  597 (709)
Q Consensus       529 ~~~~~~~~l~~~t~~----------f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H  597 (709)
                      .+.++++++..+++.          |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++.+++|
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred             CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence            356888888888765          666789999999999999987 589999999977666677889999999999999


Q ss_pred             CceeeEEEEEEeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE
Q 005206          598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL  677 (709)
Q Consensus       598 ~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl  677 (709)
                      |||+++++++...+..++||||+++++|.+++.+    ..+++..+..++.||+.||.|||+++   |+||||||+|||+
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll  174 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILL  174 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence            9999999999999999999999999999998843    24899999999999999999999997   9999999999999


Q ss_pred             cCCCcEEEEecCCceeeCCCC
Q 005206          678 DKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       678 ~~~~~~KI~DFGla~~l~~~~  698 (709)
                      +.++.+||+|||+++.+..+.
T Consensus       175 ~~~~~~kl~Dfg~~~~~~~~~  195 (321)
T 2c30_A          175 TLDGRVKLSDFGFCAQISKDV  195 (321)
T ss_dssp             CTTCCEEECCCTTCEECCSSS
T ss_pred             CCCCcEEEeeeeeeeecccCc
Confidence            999999999999999876543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.94  E-value=9.1e-27  Score=258.33  Aligned_cols=170  Identities=22%  Similarity=0.272  Sum_probs=145.3

Q ss_pred             hHHHHHHhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEe
Q 005206          534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE  609 (709)
Q Consensus       534 ~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~  609 (709)
                      +.++....++|...++||+|+||+||+|++.. ++.||||++.+.   .....+.+.+|+.++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            44555567889999999999999999999876 788999999653   22334558999999999999999999999999


Q ss_pred             CCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecC
Q 005206          610 MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG  689 (709)
Q Consensus       610 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFG  689 (709)
                      .+..+|||||+++|+|.+++.+.  ...+++..+..++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG  220 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG  220 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence            99999999999999999999653  235899999999999999999999998   9999999999999999999999999


Q ss_pred             CceeeCCCCccccccceecC
Q 005206          690 MARIFGGDQTEQNTKRVVGT  709 (709)
Q Consensus       690 la~~l~~~~~~~~~~~~~GT  709 (709)
                      +|+.+..+.... ....+||
T Consensus       221 la~~~~~~~~~~-~~~~~GT  239 (437)
T 4aw2_A          221 SCLKLMEDGTVQ-SSVAVGT  239 (437)
T ss_dssp             TCEECCTTSCEE-CCSCCSC
T ss_pred             hhhhcccCCCcc-cccccCC
Confidence            999876554332 2335565

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.94  E-value=1e-26  Score=247.40  Aligned_cols=171  Identities=44%  Similarity=0.772  Sum_probs=149.8

Q ss_pred             CCCCCChHHHHHHhcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEE
Q 005206          528 ELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGC  606 (709)
Q Consensus       528 ~~~~~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~  606 (709)
                      ....+++.++....++|...+.||+|+||.||+|+..+++.||||++.... ......|.+|+.++.+++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            355688999999999999999999999999999998889999999997543 2334479999999999999999999999


Q ss_pred             EEeCCeeEEEEEccCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEE
Q 005206          607 CVEMDEKMLVYEYMENRSLDSVIFDKAR-SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKI  685 (709)
Q Consensus       607 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI  685 (709)
                      +.+.+..++||||+++|+|.+++..... ...+++..+..++.||+.||.|||++...+|+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            9999999999999999999999976543 345899999999999999999999993223999999999999999999999


Q ss_pred             EecCCceeeCCCC
Q 005206          686 SDFGMARIFGGDQ  698 (709)
Q Consensus       686 ~DFGla~~l~~~~  698 (709)
                      +|||+++.+....
T Consensus       176 ~Dfg~~~~~~~~~  188 (326)
T 3uim_A          176 GDFGLAKLMDYKD  188 (326)
T ss_dssp             CCCSSCEECCSSS
T ss_pred             ccCccccccCccc
Confidence            9999999875443

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.94  E-value=3.7e-26  Score=241.52  Aligned_cols=151  Identities=29%  Similarity=0.511  Sum_probs=137.6

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      ++|...++||+|+||.||++.+.. ++.||+|++........+.|.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            568888999999999999999865 8899999997666667789999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ++|+|.+++...  ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        90 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           90 KGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             TTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred             CCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence            999999999653  235899999999999999999999998   999999999999999999999999999987544

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.94  E-value=5.7e-26  Score=239.06  Aligned_cols=152  Identities=28%  Similarity=0.480  Sum_probs=138.3

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      .++|...+.||+|+||.||+|... +++.||||++........+.+.+|+.++.+++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            367999999999999999999874 4889999999766556677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCCc
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~~  699 (709)
                      +++|+|.+++.+.    .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus        99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            9999999998653    4899999999999999999999997   99999999999999999999999999998865543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.94  E-value=3.8e-26  Score=242.88  Aligned_cols=154  Identities=25%  Similarity=0.444  Sum_probs=135.7

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCe------
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE------  612 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~------  612 (709)
                      .++|...+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+...      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            357888999999999999999987 58999999997543 3456789999999999999999999999876543      


Q ss_pred             ---------------------------------------------------eEEEEEccCCCCHHHHHhccCCCCCCCHH
Q 005206          613 ---------------------------------------------------KMLVYEYMENRSLDSVIFDKARSSILNWQ  641 (709)
Q Consensus       613 ---------------------------------------------------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~  641 (709)
                                                                         .++||||+++++|.+++.........++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                               79999999999999999776555557788


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       642 ~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      .+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+...
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  217 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD  217 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence            89999999999999999998   999999999999999999999999999988655

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.94  E-value=1.9e-26  Score=253.75  Aligned_cols=167  Identities=23%  Similarity=0.263  Sum_probs=142.8

Q ss_pred             HHHHHHhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeC
Q 005206          535 ETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM  610 (709)
Q Consensus       535 ~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~  610 (709)
                      +++....++|...++||+|+||+||+++... ++.||+|++.+.   .....+.+.+|+.++..++|||||++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            3444556789999999999999999999875 789999999653   223455689999999999999999999999999


Q ss_pred             CeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCC
Q 005206          611 DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (709)
Q Consensus       611 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGl  690 (709)
                      +..+|||||+++|+|.+++.+.    .+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence            9999999999999999998542    3889999999999999999999998   99999999999999999999999999


Q ss_pred             ceeeCCCCccccccceecC
Q 005206          691 ARIFGGDQTEQNTKRVVGT  709 (709)
Q Consensus       691 a~~l~~~~~~~~~~~~~GT  709 (709)
                      |+.+...... .....+||
T Consensus       215 a~~~~~~~~~-~~~~~~gt  232 (410)
T 3v8s_A          215 CMKMNKEGMV-RCDTAVGT  232 (410)
T ss_dssp             CEECCTTSEE-ECCSCCSC
T ss_pred             eEeeccCCcc-cccCCcCC
Confidence            9987654322 22345555

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.93  E-value=2.7e-26  Score=252.76  Aligned_cols=170  Identities=22%  Similarity=0.287  Sum_probs=144.9

Q ss_pred             hHHHHHHhcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEe
Q 005206          534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE  609 (709)
Q Consensus       534 ~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~  609 (709)
                      ++++....++|...++||+|+||+||+++.. +++.||||++.+.   .....+.+.+|..++.+++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3444455688999999999999999999986 4899999999653   22345568999999999999999999999999


Q ss_pred             CCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecC
Q 005206          610 MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG  689 (709)
Q Consensus       610 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFG  689 (709)
                      .+..+|||||+++|+|.+++.+..  ..+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence            999999999999999999996542  25899999999999999999999998   9999999999999999999999999


Q ss_pred             CceeeCCCCccccccceecC
Q 005206          690 MARIFGGDQTEQNTKRVVGT  709 (709)
Q Consensus       690 la~~l~~~~~~~~~~~~~GT  709 (709)
                      +|+.+..+... .....+||
T Consensus       208 la~~~~~~~~~-~~~~~~Gt  226 (412)
T 2vd5_A          208 SCLKLRADGTV-RSLVAVGT  226 (412)
T ss_dssp             TCEECCTTSCE-ECSSCCSC
T ss_pred             hheeccCCCcc-ccceeccc
Confidence            99988654332 22334565

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.93  E-value=5.3e-26  Score=247.14  Aligned_cols=154  Identities=28%  Similarity=0.499  Sum_probs=135.8

Q ss_pred             hcCcCcceeecccCceEEEEEEEc--------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhc-CCCceeeEEEEEEeC
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL--------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEM  610 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~  610 (709)
                      .++|...+.||+|+||.||+|++.        .+..||||++.... ....+++.+|+.++.++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            367888899999999999999863        24579999997553 33467899999999999 899999999999999


Q ss_pred             CeeEEEEEccCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE
Q 005206          611 DEKMLVYEYMENRSLDSVIFDKAR-------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL  677 (709)
Q Consensus       611 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl  677 (709)
                      +..++||||+++|+|.+++.....             ...+++..++.++.||+.||+|||+++   |+||||||+||||
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            999999999999999999975432             235899999999999999999999998   9999999999999


Q ss_pred             cCCCcEEEEecCCceeeCCC
Q 005206          678 DKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       678 ~~~~~~KI~DFGla~~l~~~  697 (709)
                      +.++.+||+|||+|+.+...
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~  256 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNI  256 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCC
T ss_pred             CCCCCEEEccccCCcccCcc
Confidence            99999999999999977544

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.93  E-value=5.1e-26  Score=243.18  Aligned_cols=151  Identities=28%  Similarity=0.477  Sum_probs=136.5

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      .++|...+.||+|+||.||+|.+. +++.||||++...  .....+++.+|++++.+++||||+++++++.+.+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            467999999999999999999984 5899999999654  3344677899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+++|+|.+++....   .+++.....++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus        94 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            9999999999996543   3899999999999999999999998   999999999999999999999999999877543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.93  E-value=5.2e-26  Score=243.98  Aligned_cols=149  Identities=27%  Similarity=0.344  Sum_probs=134.9

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...+.||+|+||+||+++... ++.||||++.+.   .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            578889999999999999999864 899999999653   2345678899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ||+++|+|..++....   .+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+....
T Consensus        85 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            9999999999986543   4889999999999999999999998   99999999999999999999999999987543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.93  E-value=6.2e-26  Score=245.00  Aligned_cols=161  Identities=32%  Similarity=0.432  Sum_probs=135.5

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l  615 (709)
                      .++|...++||+|+||.||+++... ++.||||++.+.   .....+.+.+|..++..+ +||||+++++++.+.+..+|
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            4689999999999999999999865 889999999753   234456788999999998 79999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ||||+++|+|..++....   .+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+...
T Consensus       102 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            999999999999996543   4899999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCccccccceecC
Q 005206          696 GDQTEQNTKRVVGT  709 (709)
Q Consensus       696 ~~~~~~~~~~~~GT  709 (709)
                      ....  .+..++||
T Consensus       176 ~~~~--~~~~~~gt  187 (353)
T 3txo_A          176 CNGV--TTATFCGT  187 (353)
T ss_dssp             C-----------CC
T ss_pred             cCCc--cccccCCC
Confidence            3322  23345555

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.93  E-value=5.7e-26  Score=242.17  Aligned_cols=162  Identities=28%  Similarity=0.394  Sum_probs=137.0

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            67999999999999999999987 58899999986543 23356789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCCc
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~~  699 (709)
                      +++|+|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus        87 ~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           87 CSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             CTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             CCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            9999999888432   34899999999999999999999998   99999999999999999999999999998754433


Q ss_pred             cccccceecC
Q 005206          700 EQNTKRVVGT  709 (709)
Q Consensus       700 ~~~~~~~~GT  709 (709)
                      .......+||
T Consensus       161 ~~~~~~~~gt  170 (323)
T 3tki_A          161 ERLLNKMCGT  170 (323)
T ss_dssp             ECCBCSCCSC
T ss_pred             ccccCCCccC
Confidence            3333334444

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.93  E-value=9.3e-26  Score=247.06  Aligned_cols=161  Identities=26%  Similarity=0.346  Sum_probs=137.0

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l  615 (709)
                      .++|...++||+|+||+||+++... ++.||||++.+.   .....+.+.+|..++.++ +||||+++++++.+.+..+|
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            3578899999999999999999875 788999999754   233456788999999887 89999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ||||+++|+|..++....   .+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+...
T Consensus       131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            999999999999986543   4899999999999999999999998   9999999999999999999999999999643


Q ss_pred             CCCccccccceecC
Q 005206          696 GDQTEQNTKRVVGT  709 (709)
Q Consensus       696 ~~~~~~~~~~~~GT  709 (709)
                      ....  .+..++||
T Consensus       205 ~~~~--~~~~~~gt  216 (396)
T 4dc2_A          205 RPGD--TTSTFCGT  216 (396)
T ss_dssp             CTTC--CBCCCCBC
T ss_pred             cCCC--ccccccCC
Confidence            3322  23345665

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.93  E-value=1.4e-25  Score=241.37  Aligned_cols=162  Identities=29%  Similarity=0.398  Sum_probs=139.1

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeE
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKM  614 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~  614 (709)
                      ..++|...+.||+|+||.||+|+... ++.||||++.+..   ....+.+..|..++.++ +||||+++++++.+.+..+
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            45789999999999999999999865 8899999997532   34566788999999887 9999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      +||||+++|+|.+++....   .+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+..
T Consensus        95 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            9999999999999996543   4899999999999999999999998   999999999999999999999999999875


Q ss_pred             CCCCccccccceecC
Q 005206          695 GGDQTEQNTKRVVGT  709 (709)
Q Consensus       695 ~~~~~~~~~~~~~GT  709 (709)
                      .....  .+..++||
T Consensus       169 ~~~~~--~~~~~~gt  181 (345)
T 1xjd_A          169 MLGDA--KTNTFCGT  181 (345)
T ss_dssp             CCTTC--CBCCCCSC
T ss_pred             ccCCC--cccCCCCC
Confidence            43322  23345554

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.93  E-value=8.8e-26  Score=240.39  Aligned_cols=160  Identities=30%  Similarity=0.503  Sum_probs=136.0

Q ss_pred             hcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC----eeEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD----EKMLV  616 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV  616 (709)
                      .++|...++||+|+||.||+|+.. ++.||||++... ......+..|+.++.+++||||+++++++.+..    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            367899999999999999999875 789999999643 333456677999999999999999999998854    36999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCceEecCCCCCCEEEcCCCcEEEE
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD----------SRFRIIHRDLKASNILLDKEMTPKIS  686 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------~~~~iiHrDlkp~NILl~~~~~~KI~  686 (709)
                      |||+++|+|.+++...    .+++..+..++.||+.||+|||+.          +   |+||||||+|||++.++.+||+
T Consensus       101 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          101 TAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence            9999999999999552    389999999999999999999998          6   9999999999999999999999


Q ss_pred             ecCCceeeCCCCccccccceecC
Q 005206          687 DFGMARIFGGDQTEQNTKRVVGT  709 (709)
Q Consensus       687 DFGla~~l~~~~~~~~~~~~~GT  709 (709)
                      |||+|+.+............+||
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt  196 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGT  196 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCC
T ss_pred             cCCcccccccccCccccccCccC
Confidence            99999988665443333334444

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.93  E-value=1.9e-25  Score=240.37  Aligned_cols=148  Identities=27%  Similarity=0.353  Sum_probs=133.3

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      ++|...+.||+|+||.||+++... ++.||||++.+..   ....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            568889999999999999999875 7899999997542   23456788999999988 899999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      |||+++|+|.+++....   .+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+...
T Consensus        89 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            99999999999986543   4899999999999999999999998   9999999999999999999999999998653

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.93  E-value=2.1e-25  Score=237.31  Aligned_cols=149  Identities=29%  Similarity=0.415  Sum_probs=134.7

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...+.||+|+||.||+++... ++.||+|++.+.   .....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            578889999999999999999864 899999999653   2244677889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ||+++|+|.+++....   .+++.....++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        86 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            9999999999996533   4889999999999999999999997   99999999999999999999999999998743

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.93  E-value=5.1e-26  Score=245.28  Aligned_cols=164  Identities=28%  Similarity=0.446  Sum_probs=140.2

Q ss_pred             CChHHHHHHhcCcCcceeecccCceEEEEEEEc------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhc-CCCceeeE
Q 005206          532 FDFETIVRATDNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRL  603 (709)
Q Consensus       532 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l  603 (709)
                      ++..+.....++|...+.||+|+||.||+|++.      +++.||||++.... ....+.+.+|++++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            455566667789999999999999999999843      35789999997643 33456899999999999 79999999


Q ss_pred             EEEEEeCCe-eEEEEEccCCCCHHHHHhccCC------------------------------------------------
Q 005206          604 LGCCVEMDE-KMLVYEYMENRSLDSVIFDKAR------------------------------------------------  634 (709)
Q Consensus       604 ~g~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------  634 (709)
                      ++++.+.+. .++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            999988654 8999999999999999975432                                                


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          635 ---------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       635 ---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                                     ...+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+....
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                           122889999999999999999999997   9999999999999999999999999999775443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.93  E-value=1.8e-25  Score=243.88  Aligned_cols=150  Identities=25%  Similarity=0.400  Sum_probs=135.8

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...+.||+|+||.||++.... ++.||+|++.+.   .....+.+.+|+.++.+++|||||++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            578889999999999999999865 789999998653   2345678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+++|+|..++...   ..+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.+...
T Consensus        95 e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             CCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            999999999999653   34899999999999999999999998   999999999999999999999999999987543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.93  E-value=1.8e-25  Score=234.75  Aligned_cols=150  Identities=31%  Similarity=0.458  Sum_probs=133.9

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...+.||+|+||.||+++... ++.||+|++....   ....++|.+|+.++.+++||||+++++++.+.+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            578999999999999999999764 8899999985432   234568999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+++++|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        91 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            9999999999996543   4899999999999999999999998   999999999999999999999999999877543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.93  E-value=9.2e-26  Score=245.80  Aligned_cols=151  Identities=29%  Similarity=0.489  Sum_probs=135.3

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      .++|...+.||+|+||.||+|++. +++.||||++.... ....++|.+|++++.+++||||+++++++.+.+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            357888899999999999999987 58899999987543 2345679999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |+++|+|.+++....  ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+....
T Consensus       193 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             CCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            999999999996532  24889999999999999999999998   99999999999999999999999999997644

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.93  E-value=9.4e-26  Score=238.94  Aligned_cols=156  Identities=31%  Similarity=0.562  Sum_probs=131.7

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ..++|...+.||+|+||.||+|+. .++.||||++....  ....++|.+|+.++.+++||||+++++++.+.+..++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            356788899999999999999987 68899999996543  334568999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+++|+|.+++........+++..++.++.||+.||+|||+++ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  192 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST  192 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence            99999999999965433334899999999999999999999985 35999999999999999999999999999866443

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.93  E-value=2.2e-25  Score=237.73  Aligned_cols=151  Identities=30%  Similarity=0.525  Sum_probs=134.2

Q ss_pred             cCcCcceeecccCceEEEEEEEc----CCcEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      ++|...+.||+|+||.||+|.+.    .+..||||++... .....++|.+|+.++.+++||||+++++++.+.+..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            56888899999999999999985    3456999999754 334567899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+++|+|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+..
T Consensus       129 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          129 TEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             EECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             eeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            9999999999999543  235899999999999999999999998   99999999999999999999999999998755


Q ss_pred             C
Q 005206          697 D  697 (709)
Q Consensus       697 ~  697 (709)
                      .
T Consensus       204 ~  204 (325)
T 3kul_A          204 D  204 (325)
T ss_dssp             -
T ss_pred             C
Confidence            4

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.93  E-value=4.9e-25  Score=234.02  Aligned_cols=154  Identities=27%  Similarity=0.414  Sum_probs=137.2

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC--eeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD--EKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~  617 (709)
                      ++|...++||+|+||.||+|.... ++.||||++.... ....+.+.+|+.++.+++||||+++++++....  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            568889999999999999999876 8899999997543 344678899999999999999999999998765  679999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE----cCCCcEEEEecCCcee
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL----DKEMTPKISDFGMARI  693 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~KI~DFGla~~  693 (709)
                      ||+++++|.+++........+++..+..++.||+.||.|||+++   |+||||||+||||    +.++.+||+|||+|+.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999977655555999999999999999999999998   9999999999999    7888999999999998


Q ss_pred             eCCCC
Q 005206          694 FGGDQ  698 (709)
Q Consensus       694 l~~~~  698 (709)
                      +....
T Consensus       166 ~~~~~  170 (319)
T 4euu_A          166 LEDDE  170 (319)
T ss_dssp             CCTTC
T ss_pred             cCCCC
Confidence            76543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.93  E-value=1.1e-25  Score=243.93  Aligned_cols=164  Identities=17%  Similarity=0.160  Sum_probs=137.4

Q ss_pred             HhcCcCcceeecccCceEEEEEE------EcCCcEEEEEEeccCCccchHHHHHHHHHHHhcC---CCceeeEEEEEEeC
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGR------LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ---HRNLVRLLGCCVEM  610 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~------~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~  610 (709)
                      ..++|...++||+|+||.||+|.      ...++.||||++...   ...++..|+.++.+++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            45678999999999999999994      345789999999643   3567888999888887   99999999999999


Q ss_pred             CeeEEEEEccCCCCHHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---------
Q 005206          611 DEKMLVYEYMENRSLDSVIFDKA--RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK---------  679 (709)
Q Consensus       611 ~~~~lV~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---------  679 (709)
                      +..+|||||+++|+|.+++....  ....+++..+..|+.||+.||+|||+++   ||||||||+||||+.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence            99999999999999999996532  2346999999999999999999999987   999999999999998         


Q ss_pred             --CCcEEEEecCCceeeCCCCccccccceecC
Q 005206          680 --EMTPKISDFGMARIFGGDQTEQNTKRVVGT  709 (709)
Q Consensus       680 --~~~~KI~DFGla~~l~~~~~~~~~~~~~GT  709 (709)
                        ++.+||+|||+|+.+............+||
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt  248 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCET  248 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCT
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCC
Confidence              899999999999876533322233344554

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.93  E-value=5.8e-25  Score=238.10  Aligned_cols=151  Identities=29%  Similarity=0.392  Sum_probs=135.3

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCc------cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG------QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  613 (709)
                      .+.|...+.||+|+||.||++.... ++.||+|.+.+...      ...+++.+|+.++.+++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            3678999999999999999999865 88999999975432      1357899999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC----cEEEEecC
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM----TPKISDFG  689 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~----~~KI~DFG  689 (709)
                      ++||||+++|+|.+++.+.   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            9999999999999999543   35899999999999999999999998   99999999999998877    79999999


Q ss_pred             CceeeCCC
Q 005206          690 MARIFGGD  697 (709)
Q Consensus       690 la~~l~~~  697 (709)
                      +++.+...
T Consensus       165 ~a~~~~~~  172 (361)
T 2yab_A          165 LAHEIEDG  172 (361)
T ss_dssp             SCEECCTT
T ss_pred             CceEcCCC
Confidence            99987654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.93  E-value=3.1e-25  Score=239.27  Aligned_cols=149  Identities=28%  Similarity=0.369  Sum_probs=135.3

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...+.||+|+||.||+++... ++.||||++.+.   .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            578889999999999999999864 899999999653   2345678899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ||+++|+|.+++.+..   .+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.+..
T Consensus       121 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence            9999999999996543   4899999999999999999999998   99999999999999999999999999998754

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.92  E-value=1.2e-25  Score=244.64  Aligned_cols=151  Identities=34%  Similarity=0.573  Sum_probs=128.0

Q ss_pred             cCcCcceeecccCceEEEEEEEc----CCcEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      ++|...+.||+|+||.||+|++.    .+..||||++... .....++|.+|+.++.+++||||+++++++.+.+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57888899999999999999875    4678999999754 334567899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+++|+|.+++.+.  ...+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       125 ~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          125 TEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             EECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            9999999999999653  335899999999999999999999997   99999999999999999999999999998755


Q ss_pred             C
Q 005206          697 D  697 (709)
Q Consensus       697 ~  697 (709)
                      .
T Consensus       200 ~  200 (373)
T 2qol_A          200 D  200 (373)
T ss_dssp             -
T ss_pred             C
Confidence            4

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.92  E-value=2.7e-25  Score=239.96  Aligned_cols=161  Identities=32%  Similarity=0.380  Sum_probs=139.0

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l  615 (709)
                      .++|...+.||+|+||+||+++... ++.||||++.+.   .....+.+..|..++..+ +||||+++++++.+.+..+|
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            4679999999999999999999876 789999999754   234567789999999988 89999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ||||+++|+|.+++.+..   .+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+...
T Consensus        99 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            999999999999996543   3899999999999999999999998   9999999999999999999999999999754


Q ss_pred             CCCccccccceecC
Q 005206          696 GDQTEQNTKRVVGT  709 (709)
Q Consensus       696 ~~~~~~~~~~~~GT  709 (709)
                      ....  .+..++||
T Consensus       173 ~~~~--~~~~~~gt  184 (353)
T 2i0e_A          173 WDGV--TTKTFCGT  184 (353)
T ss_dssp             CTTC--CBCCCCSC
T ss_pred             cCCc--ccccccCC
Confidence            3322  23335554

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.92  E-value=2.6e-25  Score=237.36  Aligned_cols=149  Identities=27%  Similarity=0.373  Sum_probs=124.9

Q ss_pred             cCcCcceeecccCceEEEEEEE----cCCcEEEEEEeccCC----ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRL----LEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  613 (709)
                      ++|...+.||+|+||.||+++.    ..++.||+|++.+..    ......+.+|+.++.+++||||+++++++.+.+..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            5788999999999999999987    368899999997542    23456788999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ++||||+++++|.+++....   .+++.....++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           97 YLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            99999999999999996543   4889999999999999999999998   99999999999999999999999999986


Q ss_pred             eCC
Q 005206          694 FGG  696 (709)
Q Consensus       694 l~~  696 (709)
                      ...
T Consensus       171 ~~~  173 (327)
T 3a62_A          171 SIH  173 (327)
T ss_dssp             ---
T ss_pred             ccc
Confidence            543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.92  E-value=4.7e-25  Score=233.62  Aligned_cols=151  Identities=30%  Similarity=0.515  Sum_probs=132.7

Q ss_pred             hcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      .++|...++||+|+||.||+|+..+++.||+|++....  ....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            36789999999999999999999889999999996542  2235678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      |+++ +|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus       100 ~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A          100 FMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             CCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             CCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            9985 788877543  235899999999999999999999997   999999999999999999999999999987533

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=1.1e-24  Score=232.14  Aligned_cols=151  Identities=24%  Similarity=0.368  Sum_probs=135.3

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      .++|...+.||+|+||.||++.... ++.+|+|.+... ....+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            3678899999999999999999865 788999998643 34456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC--CCcEEEEecCCceeeCCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK--EMTPKISDFGMARIFGGD  697 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~--~~~~KI~DFGla~~l~~~  697 (709)
                      +++|+|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.  ++.+||+|||+++.+...
T Consensus        83 ~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            9999999998543  235899999999999999999999998   999999999999987  789999999999988544

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.92  E-value=3.8e-25  Score=232.39  Aligned_cols=150  Identities=29%  Similarity=0.451  Sum_probs=128.2

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCc--------------------------cchHHHHHHHHHHH
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG--------------------------QGIEEFKNEVRLIA  593 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~--------------------------~~~~~f~~Ei~~l~  593 (709)
                      .++|...+.||+|+||.||+|.... ++.||||++.....                          ...+++.+|+.++.
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            3678899999999999999998864 78999999965421                          12457899999999


Q ss_pred             hcCCCceeeEEEEEEe--CCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 005206          594 KLQHRNLVRLLGCCVE--MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLK  671 (709)
Q Consensus       594 ~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk  671 (709)
                      +++||||+++++++.+  .+..++||||+++++|.+++    ....+++..+..++.||+.||.|||+++   |+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999987  56789999999999997654    2345899999999999999999999998   9999999


Q ss_pred             CCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          672 ASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       672 p~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      |+|||++.++.+||+|||+++.+...
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~  190 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGS  190 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             HHHEEECCCCCEEEecCCCccccccc
Confidence            99999999999999999999987544

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.92  E-value=3.8e-25  Score=228.75  Aligned_cols=150  Identities=31%  Similarity=0.570  Sum_probs=136.1

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      ++|...+.||+|+||.||+|...+++.||+|++... ....+++.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            568888999999999999999988999999999654 3345789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      +++|.+++...  ...+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.+...
T Consensus        89 ~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           89 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             CCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccc
Confidence            99999999543  345899999999999999999999998   999999999999999999999999999876443

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.92  E-value=1.9e-25  Score=239.05  Aligned_cols=155  Identities=29%  Similarity=0.504  Sum_probs=137.2

Q ss_pred             HHhcCcCcceeecccCceEEEEEEEcC------CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC
Q 005206          539 RATDNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD  611 (709)
Q Consensus       539 ~~t~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~  611 (709)
                      ...++|...+.||+|+||.||+|+...      ++.||||++.... ....++|.+|+.++.+++||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            345789999999999999999999853      4789999997553 334678999999999999999999999999999


Q ss_pred             eeEEEEEccCCCCHHHHHhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC
Q 005206          612 EKMLVYEYMENRSLDSVIFDKAR---------------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDL  670 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDl  670 (709)
                      ..++||||+++|+|.+++.....                     ...+++.+++.++.||+.||.|||+++   |+||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            99999999999999999975321                     146899999999999999999999998   999999


Q ss_pred             CCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          671 KASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       671 kp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ||+|||++.++.+||+|||+++.+..
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~  226 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYS  226 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTG
T ss_pred             CcceEEECCCCeEEEeecCCCccccc
Confidence            99999999999999999999987643

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.92  E-value=6.7e-25  Score=226.56  Aligned_cols=151  Identities=30%  Similarity=0.512  Sum_probs=137.0

Q ss_pred             hcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      .++|...+.||+|+||.||+++..++..||||++... ....+++.+|+.++.+++||||+++++++.+....++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            3678889999999999999999988889999999654 334578999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ++++|.+++....  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        86 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           86 SNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             TTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             CCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            9999999996543  24899999999999999999999997   999999999999999999999999999977554

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.92  E-value=3.9e-25  Score=233.53  Aligned_cols=155  Identities=28%  Similarity=0.473  Sum_probs=136.5

Q ss_pred             hcCcCcceeecccCceEEEEEEEc------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  613 (709)
                      .++|...+.||+|+||.||++...      +++.||||++.... ....+++.+|+.++.+++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            467888999999999999999873      34789999997543 34567899999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCC
Q 005206          614 MLVYEYMENRSLDSVIFDKAR---------------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKA  672 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp  672 (709)
                      ++||||+++++|.+++.....                     ...+++..+..++.||+.||.|||+++   |+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence            999999999999999976432                     124889999999999999999999998   99999999


Q ss_pred             CCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          673 SNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       673 ~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      +|||++.++.+||+|||+++.+....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~  204 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEED  204 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTS
T ss_pred             heEEEcCCCCEEEccccccccccccc
Confidence            99999999999999999999875543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.92  E-value=8.5e-25  Score=229.03  Aligned_cols=150  Identities=27%  Similarity=0.474  Sum_probs=131.5

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ++|...++||+|+||.||+|.... ++.||||++....  ....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            578889999999999999999865 8899999997543  3335788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      |+++ +|.+++...  ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus        82 ~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             cCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            9986 555555432  235899999999999999999999998   999999999999999999999999999987543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.92  E-value=4.2e-25  Score=240.93  Aligned_cols=154  Identities=27%  Similarity=0.471  Sum_probs=136.1

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC--------CcEEEEEEeccCC-ccchHHHHHHHHHHHhc-CCCceeeEEEEEEeC
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE--------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEM  610 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~  610 (709)
                      .++|...++||+|+||.||+|+...        +..||||++.... ....+++.+|++++.++ +||||+++++++.+.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            4678889999999999999998632        3579999997553 34457899999999999 999999999999999


Q ss_pred             CeeEEEEEccCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE
Q 005206          611 DEKMLVYEYMENRSLDSVIFDKAR-------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL  677 (709)
Q Consensus       611 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl  677 (709)
                      +..++||||+++|+|.+++.....             ...+++..+..++.||+.||.|||+++   |+||||||+||||
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence            999999999999999999976432             235899999999999999999999997   9999999999999


Q ss_pred             cCCCcEEEEecCCceeeCCC
Q 005206          678 DKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       678 ~~~~~~KI~DFGla~~l~~~  697 (709)
                      +.++.+||+|||+|+.+...
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~  244 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHI  244 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCC
T ss_pred             cCCCcEEEcccCcccccccc
Confidence            99999999999999977544

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.92  E-value=2e-25  Score=234.11  Aligned_cols=151  Identities=30%  Similarity=0.551  Sum_probs=131.8

Q ss_pred             cCcCcceeecccCceEEEEEEEc-----CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeeE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-----EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKM  614 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-----~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~  614 (709)
                      ++|+..++||+|+||.||++++.     .++.||||++........++|.+|+.++.+++||||+++++++...  ...+
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            57888999999999999999852     4789999999876666678899999999999999999999998654  4589


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      +||||+++|+|.+++....  ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus        90 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             EEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             EEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            9999999999999996543  24899999999999999999999997   999999999999999999999999999987


Q ss_pred             CCC
Q 005206          695 GGD  697 (709)
Q Consensus       695 ~~~  697 (709)
                      ..+
T Consensus       165 ~~~  167 (295)
T 3ugc_A          165 PQD  167 (295)
T ss_dssp             ---
T ss_pred             cCC
Confidence            544

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.92  E-value=9e-25  Score=235.60  Aligned_cols=153  Identities=28%  Similarity=0.418  Sum_probs=134.4

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC-----CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN-----SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      +.|...+.||+|+||.||++.... ++.||||++...     .....+++.+|+.++.+++||||+++++++.+.+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            568889999999999999998864 899999998532     12346789999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc---EEEEecCCc
Q 005206          616 VYEYMENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT---PKISDFGMA  691 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~KI~DFGla  691 (709)
                      ||||+++++|.+++.+.. ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            999999999988876533 2345899999999999999999999997   999999999999987654   999999999


Q ss_pred             eeeCCC
Q 005206          692 RIFGGD  697 (709)
Q Consensus       692 ~~l~~~  697 (709)
                      +.+...
T Consensus       181 ~~~~~~  186 (351)
T 3c0i_A          181 IQLGES  186 (351)
T ss_dssp             EECCTT
T ss_pred             eEecCC
Confidence            988654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.92  E-value=1.3e-24  Score=231.98  Aligned_cols=150  Identities=28%  Similarity=0.401  Sum_probs=134.6

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCc------cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG------QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  614 (709)
                      +.|...+.||+|+||.||++.... ++.||+|++.....      ...+++.+|+.++.+++||||+++++++.+....+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            568889999999999999999865 88999999965422      23678999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC----cEEEEecCC
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM----TPKISDFGM  690 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~----~~KI~DFGl  690 (709)
                      +||||+++++|.+++...   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++    .+||+|||+
T Consensus        91 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            999999999999999543   35899999999999999999999998   99999999999999887    899999999


Q ss_pred             ceeeCCC
Q 005206          691 ARIFGGD  697 (709)
Q Consensus       691 a~~l~~~  697 (709)
                      ++.+...
T Consensus       165 a~~~~~~  171 (326)
T 2y0a_A          165 AHKIDFG  171 (326)
T ss_dssp             CEECCTT
T ss_pred             CeECCCC
Confidence            9987543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=5.4e-25  Score=235.97  Aligned_cols=156  Identities=29%  Similarity=0.486  Sum_probs=134.1

Q ss_pred             HhcCcCcceeecccCceEEEEEEEc------CCcEEEEEEeccC-CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCC
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMD  611 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~  611 (709)
                      ..++|...+.||+|+||.||+|.+.      .++.||||++... .....+.+.+|+.++.++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            3468899999999999999999872      3568999999754 334567899999999999 8999999999999999


Q ss_pred             eeEEEEEccCCCCHHHHHhccCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 005206          612 EKMLVYEYMENRSLDSVIFDKARS--------------------SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLK  671 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk  671 (709)
                      ..++||||+++|+|.+++......                    ..+++..++.++.||+.||.|||+++   |+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence            999999999999999999754321                    34799999999999999999999997   9999999


Q ss_pred             CCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          672 ASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       672 p~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      |+||||+.++.+||+|||+++.+....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~  226 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDS  226 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCT
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCc
Confidence            999999999999999999999775443

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.92  E-value=4.4e-25  Score=249.16  Aligned_cols=152  Identities=30%  Similarity=0.505  Sum_probs=137.4

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      .++|...++||+|+||.||+|.+.. +..||||++... ....++|.+|+.++.+++||||++++++|.+.+..+|||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            4568888999999999999999876 789999999654 34578899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      +++|+|.+++.... ...+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+..+
T Consensus       298 ~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          298 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             cCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            99999999997543 345899999999999999999999998   999999999999999999999999999987544

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.92  E-value=1.6e-24  Score=224.88  Aligned_cols=151  Identities=25%  Similarity=0.387  Sum_probs=137.5

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      .++|...+.||+|+||.||+|.... +..||+|++........+++.+|+.++.+++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            3578899999999999999999876 678999999776566678999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE---cCCCcEEEEecCCceeeCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~KI~DFGla~~l~~  696 (709)
                      +++++|.+++....   .+++..+..++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||+++.+..
T Consensus        88 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           88 CTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            99999999886543   4899999999999999999999998   9999999999999   7889999999999998764


Q ss_pred             C
Q 005206          697 D  697 (709)
Q Consensus       697 ~  697 (709)
                      .
T Consensus       162 ~  162 (277)
T 3f3z_A          162 G  162 (277)
T ss_dssp             T
T ss_pred             c
Confidence            4

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.92  E-value=1e-24  Score=248.40  Aligned_cols=153  Identities=31%  Similarity=0.412  Sum_probs=137.0

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      .++|...+.||+|+||.||+++.. +++.||||++.+.   .....+.+.+|+.++.+++|||||++++++.+.+..+||
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            456888999999999999999986 4899999999653   234466789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+++|+|.+++.... ...+++..+..++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+.+..
T Consensus       263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            99999999999986543 234899999999999999999999998   99999999999999999999999999998854


Q ss_pred             C
Q 005206          697 D  697 (709)
Q Consensus       697 ~  697 (709)
                      .
T Consensus       339 ~  339 (576)
T 2acx_A          339 G  339 (576)
T ss_dssp             T
T ss_pred             C
Confidence            4

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.92  E-value=2.1e-25  Score=248.45  Aligned_cols=151  Identities=27%  Similarity=0.334  Sum_probs=125.1

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      .++|...++||+|+||.||++.... ++.||||++...   .......+.+|+.++.+++||||+++++++.+.+..+||
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            3578899999999999999999864 889999999653   334556788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ-DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      |||+++|+|.+++....   .+++..+..++.||+.||+|||+ .+   |+||||||+||||+.++.+||+|||+|+...
T Consensus       227 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            99999999999986543   48999999999999999999998 76   9999999999999999999999999998654


Q ss_pred             CC
Q 005206          696 GD  697 (709)
Q Consensus       696 ~~  697 (709)
                      ..
T Consensus       301 ~~  302 (446)
T 4ejn_A          301 KD  302 (446)
T ss_dssp             C-
T ss_pred             CC
Confidence            33

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.92  E-value=1.1e-24  Score=247.17  Aligned_cols=163  Identities=33%  Similarity=0.462  Sum_probs=141.4

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...+.||+|+||+||+++... ++.||||++.+.   .....+.+.+|+.++.+++||||+++++++.+.+..+|||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            568888999999999999999864 899999999653   2344678899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          618 EYMENRSLDSVIFDKAR-SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ||+++|+|.+++..... ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+..
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            99999999999875432 345899999999999999999999998   99999999999999999999999999998865


Q ss_pred             CCccccccceecC
Q 005206          697 DQTEQNTKRVVGT  709 (709)
Q Consensus       697 ~~~~~~~~~~~GT  709 (709)
                      ....  +..++||
T Consensus       342 ~~~~--~~~~~GT  352 (543)
T 3c4z_A          342 GQTK--TKGYAGT  352 (543)
T ss_dssp             TCCC--BCCCCSC
T ss_pred             CCcc--cccccCC
Confidence            4332  2334565

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.92  E-value=2.4e-25  Score=236.56  Aligned_cols=155  Identities=30%  Similarity=0.497  Sum_probs=123.0

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcCCc----EEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQ----EIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~g~----~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  613 (709)
                      ..++|...+.||+|+||.||+|.+....    .||||++...  .....+++.+|+.++.+++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            3467999999999999999999876532    7999999654  345578899999999999999999999999887665


Q ss_pred             ------EEEEEccCCCCHHHHHhccCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEE
Q 005206          614 ------MLVYEYMENRSLDSVIFDKAR---SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK  684 (709)
Q Consensus       614 ------~lV~Ey~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~K  684 (709)
                            ++||||+++|+|.+++.....   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence                  999999999999999865332   225899999999999999999999998   99999999999999999999


Q ss_pred             EEecCCceeeCCC
Q 005206          685 ISDFGMARIFGGD  697 (709)
Q Consensus       685 I~DFGla~~l~~~  697 (709)
                      |+|||+|+.+...
T Consensus       178 l~Dfg~a~~~~~~  190 (323)
T 3qup_A          178 VADFGLSRKIYSG  190 (323)
T ss_dssp             ECCCCC-------
T ss_pred             Eeecccccccccc
Confidence            9999999877544

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.92  E-value=2e-25  Score=242.28  Aligned_cols=151  Identities=34%  Similarity=0.494  Sum_probs=132.4

Q ss_pred             cCcCcceeecccCceEEEEEEEc------CCcEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  614 (709)
                      ++|...++||+|+||.||+|++.      .++.||||++... ......++.+|+.++.+++||||+++++++.+....+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            57888899999999999999853      3568999999654 3445668999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC---cEEEEe
Q 005206          615 LVYEYMENRSLDSVIFDKAR----SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM---TPKISD  687 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~KI~D  687 (709)
                      +||||+++|+|.+++.....    ...+++..++.++.||+.||+|||+++   |+||||||+||||+.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECC
Confidence            99999999999999976432    245899999999999999999999998   99999999999999554   599999


Q ss_pred             cCCceeeC
Q 005206          688 FGMARIFG  695 (709)
Q Consensus       688 FGla~~l~  695 (709)
                      ||+|+.+.
T Consensus       228 FG~a~~~~  235 (367)
T 3l9p_A          228 FGMARDIY  235 (367)
T ss_dssp             CHHHHHHH
T ss_pred             Cccccccc
Confidence            99998653

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.92  E-value=4.7e-25  Score=235.28  Aligned_cols=152  Identities=31%  Similarity=0.556  Sum_probs=129.0

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-Cc----EEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQ----EIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~----~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      ++|+..++||+|+||.||+|++.. ++    .||+|.+... .....++|.+|+.++.+++||||++++++|.+.. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            568888999999999999998754 43    4688888543 3455678999999999999999999999998754 789


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      |+||+++|+|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+.+.
T Consensus        94 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            999999999999996543  35899999999999999999999997   9999999999999999999999999999876


Q ss_pred             CCCc
Q 005206          696 GDQT  699 (709)
Q Consensus       696 ~~~~  699 (709)
                      ....
T Consensus       169 ~~~~  172 (327)
T 3poz_A          169 AEEK  172 (327)
T ss_dssp             TTCC
T ss_pred             CCcc
Confidence            5543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.92  E-value=4e-25  Score=246.78  Aligned_cols=151  Identities=29%  Similarity=0.485  Sum_probs=135.2

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ..++|...++||+|+||.||+|.+.++..||||++... ....++|.+|+.++.+++||||+++++++. .+..++||||
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            34678888999999999999999988899999999754 345789999999999999999999999986 6678999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      +++|+|.+++..... ..+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.+..
T Consensus       264 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          264 MAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             CTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             cCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            999999999965321 24788999999999999999999997   99999999999999999999999999998754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.92  E-value=1.6e-24  Score=236.84  Aligned_cols=152  Identities=26%  Similarity=0.387  Sum_probs=136.1

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      .+.|...+.||+|+||.||+|.... ++.||+|++..........+.+|+.++.+++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            3679999999999999999999864 889999999766555567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC--CCcEEEEecCCceeeCCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK--EMTPKISDFGMARIFGGD  697 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~--~~~~KI~DFGla~~l~~~  697 (709)
                      +++|+|.+++...  ...+++..+..++.||+.||+|||+++   |+||||||+|||++.  ++.+||+|||+|+.+..+
T Consensus       130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            9999999988543  235899999999999999999999998   999999999999974  478999999999988654

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.92  E-value=8.8e-25  Score=227.56  Aligned_cols=150  Identities=27%  Similarity=0.492  Sum_probs=133.3

Q ss_pred             hcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      .++|...+.||+|+||.||++...+++.||||++... ....+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            4678889999999999999999988889999999654 334578999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ++++|.+++....  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       102 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A          102 ANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             TTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             CCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            9999999996532  34899999999999999999999997   99999999999999999999999999987644

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.92  E-value=1.3e-24  Score=242.36  Aligned_cols=149  Identities=30%  Similarity=0.508  Sum_probs=132.9

Q ss_pred             hcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC-eeEEEEEc
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD-EKMLVYEY  619 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~Ey  619 (709)
                      .++|...++||+|+||.||+|.+. ++.||||+++...  ..++|.+|+.++.+++||||+++++++.+.+ ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            356888899999999999999885 7899999996543  5678999999999999999999999998766 78999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      +++|+|.+++.... ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       269 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          269 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             CTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             cCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            99999999997643 334789999999999999999999997   99999999999999999999999999996643

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.92  E-value=1.3e-24  Score=232.36  Aligned_cols=154  Identities=28%  Similarity=0.504  Sum_probs=135.0

Q ss_pred             hcCcCcceeecccCceEEEEEEEc--------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhc-CCCceeeEEEEEEeC
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL--------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEM  610 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~  610 (709)
                      .++|...+.||+|+||.||+|+..        +++.||||++.... ....+++.+|+.++.++ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            467889999999999999999874        36789999997543 34467899999999999 899999999999999


Q ss_pred             CeeEEEEEccCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE
Q 005206          611 DEKMLVYEYMENRSLDSVIFDKAR-------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL  677 (709)
Q Consensus       611 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl  677 (709)
                      +..++||||+++|+|.+++.....             ...+++..++.++.||+.||.|||+++   |+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence            999999999999999999975432             124899999999999999999999997   9999999999999


Q ss_pred             cCCCcEEEEecCCceeeCCC
Q 005206          678 DKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       678 ~~~~~~KI~DFGla~~l~~~  697 (709)
                      +.++.+||+|||+++.+...
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~  210 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNI  210 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTT
T ss_pred             cCCCCEEEcccccccccccc
Confidence            99999999999999987654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.92  E-value=4.4e-25  Score=240.05  Aligned_cols=160  Identities=27%  Similarity=0.322  Sum_probs=128.2

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHH-HHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRL-IAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      ++|...+.||+|+||+||+++... ++.||||++.+..   ....+.+..|..+ +..++||||+++++++.+.+..++|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            578999999999999999999875 7889999997542   2334567777776 4678999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+++|+|.+++....   .+++.....++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus       118 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          118 LDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            99999999999986543   4788999999999999999999998   99999999999999999999999999987543


Q ss_pred             CCccccccceecC
Q 005206          697 DQTEQNTKRVVGT  709 (709)
Q Consensus       697 ~~~~~~~~~~~GT  709 (709)
                      ...  .+..++||
T Consensus       192 ~~~--~~~~~~gt  202 (373)
T 2r5t_A          192 HNS--TTSTFCGT  202 (373)
T ss_dssp             CCC--CCCSBSCC
T ss_pred             CCC--ccccccCC
Confidence            322  23345555

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.92  E-value=1.1e-24  Score=236.96  Aligned_cols=147  Identities=32%  Similarity=0.436  Sum_probs=126.9

Q ss_pred             cceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCCCC
Q 005206          546 DYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRS  624 (709)
Q Consensus       546 ~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  624 (709)
                      ..+.||+|+||.||+|.... ++.||+|++........++|.+|+.++.+++||||+++++++.+.+..+|||||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            35689999999999998854 88999999976655667889999999999999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE--cCCCcEEEEecCCceeeCCC
Q 005206          625 LDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL--DKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       625 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl--~~~~~~KI~DFGla~~l~~~  697 (709)
                      |.+++.+..  ..+++..+..++.||+.||.|||+++   |+||||||+|||+  +.++.+||+|||+++.+...
T Consensus       173 L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~  242 (373)
T 2x4f_A          173 LFDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR  242 (373)
T ss_dssp             EHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred             HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence            999886532  34899999999999999999999998   9999999999999  56789999999999988654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.92  E-value=6.1e-25  Score=229.78  Aligned_cols=149  Identities=28%  Similarity=0.499  Sum_probs=133.1

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ++|...+.||+|+||.||+|+...++.||||++....  ....+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            4688899999999999999999779999999996543  23357889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      +++ +|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (288)
T ss_dssp             CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence            985 898888543  235899999999999999999999997   99999999999999999999999999987653

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.92  E-value=1.1e-24  Score=235.87  Aligned_cols=151  Identities=28%  Similarity=0.453  Sum_probs=134.2

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      .++|...+.||+|+||.||++.... ++.||+|++....  ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4679999999999999999999864 8899999996542  334567999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC---CcEEEEecCCceee
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE---MTPKISDFGMARIF  694 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~KI~DFGla~~l  694 (709)
                      ||+++|+|.+++...   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.+   +.+||+|||+++.+
T Consensus       108 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          108 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             CCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            999999999988543   35899999999999999999999998   9999999999999865   45999999999987


Q ss_pred             CCC
Q 005206          695 GGD  697 (709)
Q Consensus       695 ~~~  697 (709)
                      ...
T Consensus       182 ~~~  184 (362)
T 2bdw_A          182 NDS  184 (362)
T ss_dssp             TTC
T ss_pred             cCC
Confidence            543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.92  E-value=1.3e-24  Score=230.10  Aligned_cols=150  Identities=27%  Similarity=0.298  Sum_probs=129.5

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...++||+|+||+||+|.+. +++.||||++....  .....++..|+..+.++ +||||+++++++.+.+..+|||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57999999999999999999987 58999999986542  23344566677666665 8999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+ +++|.+++....  ..+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+...
T Consensus       137 e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             ECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             ecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            999 679988886543  35899999999999999999999997   999999999999999999999999999987544

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.92  E-value=3.3e-25  Score=234.60  Aligned_cols=151  Identities=27%  Similarity=0.430  Sum_probs=129.1

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCe----
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE----  612 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----  612 (709)
                      .++|...+.||+|+||.||++++. +++.||||++....   ....+.|.+|+.++.+++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            367899999999999999999974 58899999997542   2334678999999999999999999999876543    


Q ss_pred             eEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCce
Q 005206          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~  692 (709)
                      .++||||+++++|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            399999999999999996543   4899999999999999999999997   9999999999999999999999999999


Q ss_pred             eeCCC
Q 005206          693 IFGGD  697 (709)
Q Consensus       693 ~l~~~  697 (709)
                      .+...
T Consensus       165 ~~~~~  169 (311)
T 3ork_A          165 AIADS  169 (311)
T ss_dssp             -----
T ss_pred             ccccc
Confidence            77544

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.92  E-value=1.6e-24  Score=230.02  Aligned_cols=152  Identities=31%  Similarity=0.512  Sum_probs=121.2

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      .++|...++||+|+||.||+|.... ++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            3578888999999999999998864 8899999996543 3345788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          619 YMENRSLDSVIFDKA---RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       619 y~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      |++ |+|.+++....   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 69999886532   1235899999999999999999999997   9999999999999999999999999999875


Q ss_pred             C
Q 005206          696 G  696 (709)
Q Consensus       696 ~  696 (709)
                      .
T Consensus       160 ~  160 (317)
T 2pmi_A          160 I  160 (317)
T ss_dssp             S
T ss_pred             C
Confidence            4

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.92  E-value=1.9e-24  Score=230.73  Aligned_cols=149  Identities=21%  Similarity=0.291  Sum_probs=132.7

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ++|...+.||+|+||.||+|+.. +++.||||++....  ..+++.+|+.++.++ +||||+++++++...+..++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            57889999999999999999974 58899999986542  245789999999999 999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc-----EEEEecCCceee
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT-----PKISDFGMARIF  694 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~KI~DFGla~~l  694 (709)
                      + +++|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+||||+.++.     +||+|||+|+.+
T Consensus        87 ~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           87 L-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             C-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            9 99999998654  235899999999999999999999997   999999999999998887     999999999987


Q ss_pred             CCCC
Q 005206          695 GGDQ  698 (709)
Q Consensus       695 ~~~~  698 (709)
                      ....
T Consensus       161 ~~~~  164 (330)
T 2izr_A          161 IDPE  164 (330)
T ss_dssp             BCTT
T ss_pred             ecCC
Confidence            6544

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.92  E-value=8.3e-25  Score=230.86  Aligned_cols=155  Identities=30%  Similarity=0.452  Sum_probs=136.6

Q ss_pred             hcCcCcceeecccCceEEEEEEE------cCCcEEEEEEeccCCc-cchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCe
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDE  612 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~  612 (709)
                      .++|...+.||+|+||.||+|+.      ..++.||||++..... ...+.+.+|+.++.++ +||||+++++++.+.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            46788899999999999999985      2367899999975533 3457899999999999 99999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHhccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE
Q 005206          613 KMLVYEYMENRSLDSVIFDKAR---------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL  677 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl  677 (709)
                      .++||||+++|+|.+++.....               ...+++..+..++.||+.||.|||+++   |+||||||+|||+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence            9999999999999999975432               124899999999999999999999997   9999999999999


Q ss_pred             cCCCcEEEEecCCceeeCCCC
Q 005206          678 DKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       678 ~~~~~~KI~DFGla~~l~~~~  698 (709)
                      +.++.+||+|||+++.+....
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~  199 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDS  199 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCT
T ss_pred             cCCCCEEEccccccccccccc
Confidence            999999999999999876553

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.92  E-value=8.4e-25  Score=234.48  Aligned_cols=150  Identities=27%  Similarity=0.431  Sum_probs=133.6

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      .++|...+.||+|+||.||+|.+. .++.||||++.+.   .....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            367899999999999999999985 4889999998643   223356789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+ +|+|.+++.+..   .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        88 ~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 789988886543   4899999999999999999999998   99999999999999999999999999997754


Q ss_pred             C
Q 005206          697 D  697 (709)
Q Consensus       697 ~  697 (709)
                      .
T Consensus       161 ~  161 (336)
T 3h4j_B          161 G  161 (336)
T ss_dssp             S
T ss_pred             C
Confidence            4

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.92  E-value=2.9e-25  Score=235.65  Aligned_cols=157  Identities=29%  Similarity=0.453  Sum_probs=136.9

Q ss_pred             HHHhcCcCcceeecccCceEEEEEEEc------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeC
Q 005206          538 VRATDNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM  610 (709)
Q Consensus       538 ~~~t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~  610 (709)
                      ....++|...+.||+|+||.||+|...      .++.||||++.... .....+|.+|+.++.+++||||+++++++.+.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  100 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG  100 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence            345578999999999999999999875      26789999997543 23456799999999999999999999999999


Q ss_pred             CeeEEEEEccCCCCHHHHHhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcE
Q 005206          611 DEKMLVYEYMENRSLDSVIFDKA-------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (709)
Q Consensus       611 ~~~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  683 (709)
                      +..++||||+++|+|.+++....       ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+
T Consensus       101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~  177 (322)
T 1p4o_A          101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV  177 (322)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred             CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeE
Confidence            99999999999999999986532       1245789999999999999999999998   9999999999999999999


Q ss_pred             EEEecCCceeeCCC
Q 005206          684 KISDFGMARIFGGD  697 (709)
Q Consensus       684 KI~DFGla~~l~~~  697 (709)
                      ||+|||+++.+...
T Consensus       178 kl~Dfg~~~~~~~~  191 (322)
T 1p4o_A          178 KIGDFGMTRDIYET  191 (322)
T ss_dssp             EECCTTCCCGGGGG
T ss_pred             EECcCccccccccc
Confidence            99999999876443

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.92  E-value=1.4e-24  Score=241.50  Aligned_cols=153  Identities=27%  Similarity=0.439  Sum_probs=133.6

Q ss_pred             HhcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      ..++|...++||+|+||.||++... .++.+|+|++....  ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            3467999999999999999999875 48899999997543  23456799999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc---CCCcEEEEecCCcee
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARI  693 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~KI~DFGla~~  693 (709)
                      |||+++|+|.+++....   .+++.....++.||+.||.|||+++   |+||||||+|||++   .++.+||+|||+|+.
T Consensus        89 ~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            99999999999986543   4899999999999999999999998   99999999999998   457899999999988


Q ss_pred             eCCCC
Q 005206          694 FGGDQ  698 (709)
Q Consensus       694 l~~~~  698 (709)
                      +....
T Consensus       163 ~~~~~  167 (444)
T 3soa_A          163 VEGEQ  167 (444)
T ss_dssp             CCTTC
T ss_pred             ecCCC
Confidence            76543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.92  E-value=6.6e-25  Score=234.17  Aligned_cols=155  Identities=30%  Similarity=0.483  Sum_probs=135.8

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcC------CcEEEEEEeccCC-ccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCC
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMD  611 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~  611 (709)
                      ..++|...+.||+|+||.||+|....      ...||+|++.... ....+.+.+|+.++.++ +||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            45788999999999999999998754      2479999997553 33467899999999999 8999999999999999


Q ss_pred             eeEEEEEccCCCCHHHHHhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC
Q 005206          612 EKMLVYEYMENRSLDSVIFDKAR-----------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE  680 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~  680 (709)
                      ..++||||+++|+|.+++.....           ...+++..++.++.||+.||.|||+++   |+||||||+|||++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence            99999999999999999865321           235799999999999999999999997   9999999999999999


Q ss_pred             CcEEEEecCCceeeCCC
Q 005206          681 MTPKISDFGMARIFGGD  697 (709)
Q Consensus       681 ~~~KI~DFGla~~l~~~  697 (709)
                      +.+||+|||+++.+...
T Consensus       201 ~~~kl~Dfg~~~~~~~~  217 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMND  217 (333)
T ss_dssp             GEEEBCCCGGGCCGGGC
T ss_pred             CeEEECccccccccccc
Confidence            99999999999977544

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.91  E-value=4.5e-24  Score=223.28  Aligned_cols=151  Identities=32%  Similarity=0.457  Sum_probs=133.4

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      .|.....||+|+||.||+|.... ++.||||++........+.+.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            34555689999999999999754 78999999977666667889999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-CCcEEEEecCCceeeCC
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-EMTPKISDFGMARIFGG  696 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~KI~DFGla~~l~~  696 (709)
                      +++|.+++........+++..+..++.||+.||.|||+++   |+||||||+||+++. ++.+||+|||+++.+..
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            9999999976544445789999999999999999999997   999999999999987 89999999999998754

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.91  E-value=2.7e-24  Score=223.46  Aligned_cols=155  Identities=30%  Similarity=0.450  Sum_probs=135.9

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC--CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      .++|...+.||+|+||.||+|... +++.||||++...  ......++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            467899999999999999999987 5899999999754  334567889999999999 999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC----------------
Q 005206          617 YEYMENRSLDSVIFDKAR-SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK----------------  679 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~----------------  679 (709)
                      |||+++++|.+++..... ...+++..+..++.||+.||.|||+++   |+||||||+|||++.                
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999999999975422 245899999999999999999999998   999999999999984                


Q ss_pred             ---CCcEEEEecCCceeeCCCC
Q 005206          680 ---EMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       680 ---~~~~KI~DFGla~~l~~~~  698 (709)
                         ...+||+|||+++.+....
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~  188 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ  188 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC
T ss_pred             cCCceEEEEcccccccccCCcc
Confidence               4489999999999876543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.91  E-value=2.8e-24  Score=225.77  Aligned_cols=152  Identities=30%  Similarity=0.550  Sum_probs=132.0

Q ss_pred             cCcCcceeecccCceEEEEEEE-----cCCcEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeC--Cee
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRL-----LEGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEK  613 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~  613 (709)
                      +.|+..++||+|+||.||++++     ..++.||||++... .....+.+.+|+.++.+++||||+++++++.+.  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4588889999999999999984     34789999999754 334567899999999999999999999999876  568


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ++||||+++++|.+++....  ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence            99999999999999996543  34899999999999999999999998   99999999999999999999999999998


Q ss_pred             eCCCC
Q 005206          694 FGGDQ  698 (709)
Q Consensus       694 l~~~~  698 (709)
                      +....
T Consensus       176 ~~~~~  180 (302)
T 4e5w_A          176 IETDK  180 (302)
T ss_dssp             CCTTC
T ss_pred             ccCCC
Confidence            76543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.91  E-value=6.5e-25  Score=233.86  Aligned_cols=152  Identities=30%  Similarity=0.496  Sum_probs=131.1

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-Cc----EEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQ----EIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~----~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      ++|...++||+|+||.||+|.+.. ++    .||+|.+.... ....+++.+|+.++.+++||||+++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            468888999999999999998754 43    38888875442 344567889999999999999999999886 567899


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ||||+++|+|.+++....  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+.+.
T Consensus        92 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence            999999999999996532  34888999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCc
Q 005206          696 GDQT  699 (709)
Q Consensus       696 ~~~~  699 (709)
                      ....
T Consensus       167 ~~~~  170 (325)
T 3kex_A          167 PDDK  170 (325)
T ss_dssp             CCTT
T ss_pred             cccc
Confidence            5543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.91  E-value=1.2e-24  Score=233.74  Aligned_cols=161  Identities=25%  Similarity=0.350  Sum_probs=132.3

Q ss_pred             hcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccC--CccchHHHHHHHHHHHhcCC--CceeeEEEEEEeCCeeEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQH--RNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~lV  616 (709)
                      .+.|...+.||+|+||.||++...+++.||||++...  .....+++.+|+.++.+++|  |||+++++++.+....+||
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            3568899999999999999999988999999998654  33445789999999999976  9999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      || +.+++|.+++...   ..+++..+..++.||+.||.|||+++   |+||||||+||||+ ++.+||+|||+|+.+..
T Consensus        88 ~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             Ee-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99 5688999999653   34899999999999999999999997   99999999999997 67899999999998865


Q ss_pred             CCccccccceecC
Q 005206          697 DQTEQNTKRVVGT  709 (709)
Q Consensus       697 ~~~~~~~~~~~GT  709 (709)
                      +.........+||
T Consensus       160 ~~~~~~~~~~~gt  172 (343)
T 3dbq_A          160 DTTSVVKDSQVGT  172 (343)
T ss_dssp             ----------CCC
T ss_pred             ccccccCCCCcCC
Confidence            5433223334444

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.91  E-value=3e-24  Score=225.24  Aligned_cols=147  Identities=29%  Similarity=0.447  Sum_probs=127.4

Q ss_pred             hcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHh--cCCCceeeEEEEEEeC----CeeE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAK--LQHRNLVRLLGCCVEM----DEKM  614 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~~~~----~~~~  614 (709)
                      .++|...+.||+|+||.||+|+. +++.||||++...   ..+.+..|.+++..  ++||||+++++++...    ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            36789999999999999999988 6899999998542   34566777777776  7999999999997653    3578


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEecCCCCCCEEEcCCCcEEEE
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH--------QDSRFRIIHRDLKASNILLDKEMTPKIS  686 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~iiHrDlkp~NILl~~~~~~KI~  686 (709)
                      +||||+++|+|.+++..    ..+++..++.++.||+.||+|||        +.+   |+||||||+|||++.++.+||+
T Consensus        83 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred             EehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence            99999999999999943    35899999999999999999999        665   9999999999999999999999


Q ss_pred             ecCCceeeCCCC
Q 005206          687 DFGMARIFGGDQ  698 (709)
Q Consensus       687 DFGla~~l~~~~  698 (709)
                      |||+|+.+....
T Consensus       156 Dfg~a~~~~~~~  167 (301)
T 3q4u_A          156 DLGLAVMHSQST  167 (301)
T ss_dssp             CCTTCEEEETTT
T ss_pred             eCCCeeeccccc
Confidence            999999876543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=7.6e-25  Score=236.57  Aligned_cols=150  Identities=27%  Similarity=0.375  Sum_probs=134.3

Q ss_pred             cCcCcceeecccCceEEEEEEEc----CCcEEEEEEeccCC----ccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCe
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDE  612 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~  612 (709)
                      ++|...+.||+|+||.||+++..    .++.||||++....    ....+.+.+|+.++.++ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            57899999999999999999883    58899999986532    23456788999999999 69999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCce
Q 005206          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~  692 (709)
                      .+|||||+++|+|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            999999999999999996543   4889999999999999999999997   9999999999999999999999999999


Q ss_pred             eeCCC
Q 005206          693 IFGGD  697 (709)
Q Consensus       693 ~l~~~  697 (709)
                      .+...
T Consensus       208 ~~~~~  212 (355)
T 1vzo_A          208 EFVAD  212 (355)
T ss_dssp             ECCGG
T ss_pred             ecccC
Confidence            87544

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.91  E-value=2.8e-24  Score=226.88  Aligned_cols=150  Identities=29%  Similarity=0.467  Sum_probs=133.9

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCc--cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG--QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ++|...++||+|+||.||+|.... ++.||||++.....  ...+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            578899999999999999999865 89999999865432  235678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      |+++++|.+++...   ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        83 ~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           83 YCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             CCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             eCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            99999999887543   34899999999999999999999998   999999999999999999999999999987543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.91  E-value=1.8e-24  Score=237.13  Aligned_cols=153  Identities=27%  Similarity=0.413  Sum_probs=136.2

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC--eeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD--EKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~  617 (709)
                      ++|...++||+|+||.||+|.+.. ++.||||++.... ....+.+.+|++++.+++||||+++++++.+.+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            568889999999999999999876 8999999997543 344678899999999999999999999998765  679999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE----cCCCcEEEEecCCcee
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL----DKEMTPKISDFGMARI  693 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~KI~DFGla~~  693 (709)
                      ||+++|+|.+++........+++..+..++.||+.||.|||+++   |+||||||+|||+    +.++.+||+|||+|+.
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            99999999999976555455899999999999999999999998   9999999999999    7888899999999998


Q ss_pred             eCCC
Q 005206          694 FGGD  697 (709)
Q Consensus       694 l~~~  697 (709)
                      +...
T Consensus       166 ~~~~  169 (396)
T 4eut_A          166 LEDD  169 (396)
T ss_dssp             CCCG
T ss_pred             ccCC
Confidence            7554

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.91  E-value=1.8e-24  Score=242.32  Aligned_cols=150  Identities=27%  Similarity=0.480  Sum_probs=135.5

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...+.||+|+||.||+|++. +++.||||++....   ....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57888899999999999999986 58999999996532   234568999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+++|+|.+++.+.   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        96 E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            999999999998543   34899999999999999999999997   999999999999999999999999999987544

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.91  E-value=1.3e-24  Score=226.80  Aligned_cols=149  Identities=30%  Similarity=0.466  Sum_probs=134.2

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-C-------cEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-G-------QEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g-------~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  613 (709)
                      ++|...+.||+|+||.||+|.... +       ..||+|++........++|.+|+.++.+++||||+++++++.+.+..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            578888999999999999998764 3       47999999766666778899999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc--------EEE
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT--------PKI  685 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~--------~KI  685 (709)
                      ++||||+++|+|.+++....  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.        +||
T Consensus        88 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             EEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence            99999999999999996543  23889999999999999999999998   999999999999998887        999


Q ss_pred             EecCCceeeC
Q 005206          686 SDFGMARIFG  695 (709)
Q Consensus       686 ~DFGla~~l~  695 (709)
                      +|||+++...
T Consensus       163 ~Dfg~~~~~~  172 (289)
T 4fvq_A          163 SDPGISITVL  172 (289)
T ss_dssp             CCCCSCTTTS
T ss_pred             ccCccccccc
Confidence            9999997653

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.91  E-value=8.3e-25  Score=244.41  Aligned_cols=149  Identities=24%  Similarity=0.429  Sum_probs=122.6

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeC-----Cee
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-----DEK  613 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~  613 (709)
                      ++|...++||+|+||.||+|.+. +++.||||++...  .....+++.+|+.++.+++|||||++++++...     ...
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            67999999999999999999876 4889999999654  233457899999999999999999999999543     468


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ++||||+. ++|.+++...   ..+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.
T Consensus       133 ~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          133 YVVLEIAD-SDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEEECCCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEeccc-cchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence            99999985 7898888543   35899999999999999999999998   99999999999999999999999999998


Q ss_pred             eCCC
Q 005206          694 FGGD  697 (709)
Q Consensus       694 l~~~  697 (709)
                      +...
T Consensus       206 ~~~~  209 (458)
T 3rp9_A          206 VDYP  209 (458)
T ss_dssp             TTSC
T ss_pred             ccCc
Confidence            7543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.91  E-value=2.1e-24  Score=233.73  Aligned_cols=147  Identities=27%  Similarity=0.349  Sum_probs=130.6

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      .++|...+.||+|+||.||+++.. .++.||||++.... ...+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            367999999999999999999987 48899999996543 3346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc--EEEEecCCceee
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT--PKISDFGMARIF  694 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~--~KI~DFGla~~l  694 (709)
                      +++|+|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+||||+.++.  +||+|||+|+..
T Consensus        98 ~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           98 ASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            99999999986543   3899999999999999999999998   999999999999987765  999999999854

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.91  E-value=1.9e-24  Score=239.84  Aligned_cols=149  Identities=26%  Similarity=0.471  Sum_probs=131.1

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeC-----Cee
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-----DEK  613 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~  613 (709)
                      ++|...+.||+|+||.||+|.... ++.||||++...  .....+++.+|+.++.+++||||+++++++...     ...
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            689999999999999999999865 788999999754  233457899999999999999999999999876     568


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ++||||++ ++|.+++...   ..+++..+..++.||++||+|||+++   |+||||||+||||+.++.+||+|||+|+.
T Consensus       106 ~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          106 YIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            99999987 5999998543   34899999999999999999999998   99999999999999999999999999998


Q ss_pred             eCCC
Q 005206          694 FGGD  697 (709)
Q Consensus       694 l~~~  697 (709)
                      +...
T Consensus       179 ~~~~  182 (432)
T 3n9x_A          179 INSE  182 (432)
T ss_dssp             C---
T ss_pred             cccc
Confidence            7544

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.91  E-value=3.3e-24  Score=234.26  Aligned_cols=151  Identities=20%  Similarity=0.274  Sum_probs=135.7

Q ss_pred             hcCcCcceeeccc--CceEEEEEEEc-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          541 TDNFTDYNKLGQG--GFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       541 t~~f~~~~~LG~G--~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      .++|...++||+|  +||.||+++.. +++.||||++....  ....+.+.+|+.++++++|||||++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4679999999999  99999999987 48999999997542  3445678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ||||+++|+|.+++.... ...+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||++..+.
T Consensus       104 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            999999999999996542 234899999999999999999999998   9999999999999999999999999987653

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.91  E-value=2e-24  Score=223.76  Aligned_cols=151  Identities=28%  Similarity=0.392  Sum_probs=135.1

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      .++|...+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            357889999999999999999986 4889999998644 23446789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      |+++++|.+++...   ..+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++.+...
T Consensus        86 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           86 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             ecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            99999999888432   34899999999999999999999997   999999999999999999999999999876443

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.91  E-value=1e-24  Score=233.70  Aligned_cols=157  Identities=27%  Similarity=0.377  Sum_probs=133.6

Q ss_pred             HHHHhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC-----CccchHHHHHHHHHHHhcCCCceeeEEEEEEeC
Q 005206          537 IVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN-----SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM  610 (709)
Q Consensus       537 l~~~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~  610 (709)
                      +....++|...+.||+|+||.||+|.... ++.||+|++...     .....+++.+|+.++.+++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            44556789999999999999999998854 789999998643     244567899999999999999999999999999


Q ss_pred             CeeEEEEEccCCCCHHHHHhccCC-------------------------------------CCCCCHHHHHHHHHHHHHH
Q 005206          611 DEKMLVYEYMENRSLDSVIFDKAR-------------------------------------SSILNWQRRFNIICGIARG  653 (709)
Q Consensus       611 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~ia~g  653 (709)
                      +..++||||+++|+|.+++.....                                     ...+++..+..++.||+.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            999999999999999999842110                                     1123567788899999999


Q ss_pred             HHHHHhCCCCceEecCCCCCCEEEcCCC--cEEEEecCCceeeCC
Q 005206          654 LLYLHQDSRFRIIHRDLKASNILLDKEM--TPKISDFGMARIFGG  696 (709)
Q Consensus       654 L~yLH~~~~~~iiHrDlkp~NILl~~~~--~~KI~DFGla~~l~~  696 (709)
                      |+|||+++   |+||||||+||||+.++  .+||+|||+|+.+..
T Consensus       181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~  222 (345)
T 3hko_A          181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK  222 (345)
T ss_dssp             HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred             HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccc
Confidence            99999997   99999999999998776  899999999997643

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.91  E-value=8.7e-25  Score=243.95  Aligned_cols=151  Identities=31%  Similarity=0.525  Sum_probs=131.8

Q ss_pred             hcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      .++|...++||+|+||.||+|.+.++..||||++.... ...++|.+|+.++.+++||||+++++++.+ +..++||||+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            46788889999999999999999888899999997543 346789999999999999999999999876 6789999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ++|+|.+++.... ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       261 ~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          261 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             cCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            9999999996432 234899999999999999999999997   999999999999999999999999999987543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.91  E-value=5.3e-24  Score=223.08  Aligned_cols=150  Identities=27%  Similarity=0.380  Sum_probs=134.9

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...+.||+|+||.||++.... ++.+|+|++....   ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            578888999999999999999875 7889999986542   334577899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+++++|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        95 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           95 ELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             ECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            9999999999886542   4899999999999999999999997   999999999999999999999999999987533

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.91  E-value=3.2e-24  Score=222.67  Aligned_cols=152  Identities=29%  Similarity=0.508  Sum_probs=135.0

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      .++|...+.||+|+||.||+|+.. +++.||||++....   ....+++.+|+.++.+++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            357888999999999999999985 58999999996432   23357899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+++++|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            9999999999999653  245899999999999999999999997   99999999999999999999999999998753


Q ss_pred             C
Q 005206          697 D  697 (709)
Q Consensus       697 ~  697 (709)
                      .
T Consensus       165 ~  165 (278)
T 3cok_A          165 P  165 (278)
T ss_dssp             -
T ss_pred             C
Confidence            3

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.91  E-value=9.5e-25  Score=233.60  Aligned_cols=148  Identities=20%  Similarity=0.286  Sum_probs=126.5

Q ss_pred             hcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCC--------ccchHHHHHHHHHHHhcC---------CCceeeE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS--------GQGIEEFKNEVRLIAKLQ---------HRNLVRL  603 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--------~~~~~~f~~Ei~~l~~l~---------H~nIv~l  603 (709)
                      .++|...++||+|+||.||+|+. +++.||||++....        ....+.+.+|+.++++++         |||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35688889999999999999998 68999999997542        223478999999999885         8999988


Q ss_pred             EEEEE------------------------------eCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 005206          604 LGCCV------------------------------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG  653 (709)
Q Consensus       604 ~g~~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g  653 (709)
                      .+.+.                              +.+..+|||||+++|++.+.+.+    ..+++..+..|+.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            88754                              26789999999999976655532    358999999999999999


Q ss_pred             HHHHH-hCCCCceEecCCCCCCEEEcCCC--------------------cEEEEecCCceeeCC
Q 005206          654 LLYLH-QDSRFRIIHRDLKASNILLDKEM--------------------TPKISDFGMARIFGG  696 (709)
Q Consensus       654 L~yLH-~~~~~~iiHrDlkp~NILl~~~~--------------------~~KI~DFGla~~l~~  696 (709)
                      |.||| +++   |+||||||+||||+.++                    .+||+|||+|+.+..
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~  234 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD  234 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence            99999 887   99999999999999887                    999999999998754

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.91  E-value=4.6e-24  Score=225.78  Aligned_cols=148  Identities=30%  Similarity=0.379  Sum_probs=130.4

Q ss_pred             cCcCcc-eeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEE
Q 005206          542 DNFTDY-NKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       542 ~~f~~~-~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      +.|... +.||+|+||.||++... +++.||||++........+++.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            456664 67999999999999875 4889999999776666678899999999985 79999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc---EEEEecCCceeeC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT---PKISDFGMARIFG  695 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~KI~DFGla~~l~  695 (709)
                      |+++|+|.+++....   .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.   +||+|||+++.+.
T Consensus        92 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           92 KMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             cCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            999999999996643   4889999999999999999999997   999999999999998776   9999999998764

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.91  E-value=5e-24  Score=228.10  Aligned_cols=151  Identities=26%  Similarity=0.382  Sum_probs=135.6

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      .++|...+.||+|+||.||++...+ ++.+|+|++...   .....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            3678889999999999999999876 788999998654   223467799999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+++++|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       120 ~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            99999999999886542   4899999999999999999999997   99999999999999999999999999998753


Q ss_pred             C
Q 005206          697 D  697 (709)
Q Consensus       697 ~  697 (709)
                      .
T Consensus       194 ~  194 (335)
T 2owb_A          194 D  194 (335)
T ss_dssp             T
T ss_pred             C
Confidence            3

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.91  E-value=2.6e-24  Score=224.68  Aligned_cols=153  Identities=27%  Similarity=0.443  Sum_probs=133.3

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ++|...++||+|+||.||++.... ++.||+|++.... ....+++.+|++++.+++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            568889999999999999999864 8899999987543 34568899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE---cCCCcEEEEecCCceeeC
Q 005206          620 MENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFG  695 (709)
Q Consensus       620 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~KI~DFGla~~l~  695 (709)
                      +++|+|.+++.... ....+++..+..++.||+.||+|||+++   |+||||||+|||+   +.++.+||+|||+++.+.
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            99999999886532 2346899999999999999999999998   9999999999999   456889999999998775


Q ss_pred             CC
Q 005206          696 GD  697 (709)
Q Consensus       696 ~~  697 (709)
                      ..
T Consensus       179 ~~  180 (285)
T 3is5_A          179 SD  180 (285)
T ss_dssp             --
T ss_pred             Cc
Confidence            44

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.91  E-value=2.7e-24  Score=251.19  Aligned_cols=162  Identities=31%  Similarity=0.376  Sum_probs=139.9

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeE
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKM  614 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~  614 (709)
                      ..++|...++||+|+||.||+|+... ++.||||++.+.   .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            35679999999999999999999875 788999999753   234567788999999988 7999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      |||||+++|+|.+++....   .+++..+..|+.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+..
T Consensus       419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            9999999999999997643   4899999999999999999999997   999999999999999999999999999975


Q ss_pred             CCCCccccccceecC
Q 005206          695 GGDQTEQNTKRVVGT  709 (709)
Q Consensus       695 ~~~~~~~~~~~~~GT  709 (709)
                      ..+..  .+..++||
T Consensus       493 ~~~~~--~~~~~~GT  505 (674)
T 3pfq_A          493 IWDGV--TTKTFCGT  505 (674)
T ss_dssp             CCTTC--CBCCCCSC
T ss_pred             ccCCc--ccccccCC
Confidence            44332  23445665

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.91  E-value=3.4e-24  Score=231.35  Aligned_cols=163  Identities=27%  Similarity=0.343  Sum_probs=140.5

Q ss_pred             CCCCCChHHHHHHhcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcC-----CCcee
Q 005206          528 ELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-----HRNLV  601 (709)
Q Consensus       528 ~~~~~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-----H~nIv  601 (709)
                      +...+.+++.....++|...++||+|+||.||+|+.. +++.||||++.. .....+.+..|+.++.+++     ||||+
T Consensus        21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence            3444555555566789999999999999999999985 488999999963 3344567888999999996     99999


Q ss_pred             eEEEEEEeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC--
Q 005206          602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK--  679 (709)
Q Consensus       602 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~--  679 (709)
                      ++++++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+++   |+||||||+||||+.  
T Consensus       100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~  174 (360)
T 3llt_A          100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPY  174 (360)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTT
T ss_pred             cccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccc
Confidence            9999999999999999999 999999996543 234899999999999999999999998   999999999999975  


Q ss_pred             -----------------------CCcEEEEecCCceeeCC
Q 005206          680 -----------------------EMTPKISDFGMARIFGG  696 (709)
Q Consensus       680 -----------------------~~~~KI~DFGla~~l~~  696 (709)
                                             ++.+||+|||+|+....
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~  214 (360)
T 3llt_A          175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD  214 (360)
T ss_dssp             CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS
T ss_pred             ccccccchhcccccccccccccCCCCEEEEeccCceecCC
Confidence                                   78999999999997644

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.91  E-value=2.1e-24  Score=231.22  Aligned_cols=152  Identities=24%  Similarity=0.380  Sum_probs=134.7

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCc--------cchHHHHHHHHHHHhcCCCceeeEEEEEEeC
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG--------QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM  610 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~--------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~  610 (709)
                      ..++|...+.||+|+||.||+|.... ++.||||++.....        ...+.+.+|+.++.+++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            34679999999999999999998754 88999999975421        1345788999999999999999999999999


Q ss_pred             CeeEEEEEccCCC-CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecC
Q 005206          611 DEKMLVYEYMENR-SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG  689 (709)
Q Consensus       611 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFG  689 (709)
                      +..++||||+..| +|.+++...   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999877 999988543   34899999999999999999999998   9999999999999999999999999


Q ss_pred             CceeeCCC
Q 005206          690 MARIFGGD  697 (709)
Q Consensus       690 la~~l~~~  697 (709)
                      +++.+...
T Consensus       176 ~a~~~~~~  183 (335)
T 3dls_A          176 SAAYLERG  183 (335)
T ss_dssp             TCEECCTT
T ss_pred             cceECCCC
Confidence            99987654

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.91  E-value=3.5e-24  Score=234.04  Aligned_cols=149  Identities=32%  Similarity=0.560  Sum_probs=123.9

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcC-CCceeeEEEEEEeCC--ee
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMD--EK  613 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~--~~  613 (709)
                      ..++|...+.||+|+||.||+|.+.. ++.||||++...  .....+++.+|+.++.++. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            45789999999999999999998864 889999999653  2344667889999999997 999999999998654  68


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ++||||++ ++|..++..    ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+|+.
T Consensus        87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            99999998 689888854    24889999999999999999999998   99999999999999999999999999998


Q ss_pred             eCC
Q 005206          694 FGG  696 (709)
Q Consensus       694 l~~  696 (709)
                      +..
T Consensus       159 ~~~  161 (388)
T 3oz6_A          159 FVN  161 (388)
T ss_dssp             SSS
T ss_pred             ccc
Confidence            743

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.91  E-value=2.6e-24  Score=231.92  Aligned_cols=149  Identities=28%  Similarity=0.434  Sum_probs=122.1

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ..+.|...+.||+|+||.||+|+... ++.||||++....  ..+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            35679999999999999999999875 7899999997542  34678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCcEEEEecCCceeeC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK---EMTPKISDFGMARIFG  695 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~KI~DFGla~~l~  695 (709)
                      |+++|+|.+++...   ..+++.++..++.||+.||.|||+++   |+||||||+|||++.   ++.+||+|||+++...
T Consensus       129 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          129 LVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             eCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            99999999998543   34899999999999999999999997   999999999999975   8899999999999775


Q ss_pred             C
Q 005206          696 G  696 (709)
Q Consensus       696 ~  696 (709)
                      .
T Consensus       203 ~  203 (349)
T 2w4o_A          203 H  203 (349)
T ss_dssp             -
T ss_pred             c
Confidence            4

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.91  E-value=3.1e-24  Score=231.23  Aligned_cols=149  Identities=33%  Similarity=0.535  Sum_probs=131.9

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCc---cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      +.|...+.||+|+||.||+|+.. +++.||||++.....   ...+++.+|+.++.+++||||+++++++.+.+..+|||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45888899999999999999974 588999999965432   23467899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ||++ |+|.+++....  ..+++..+..++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++.+..
T Consensus       134 e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             ECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            9997 68888775432  35899999999999999999999997   99999999999999999999999999987754

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.91  E-value=4e-24  Score=227.76  Aligned_cols=151  Identities=29%  Similarity=0.464  Sum_probs=135.0

Q ss_pred             cCcCcceeecccCceEEEEEEE-----cCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEe--CCeeE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRL-----LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE--MDEKM  614 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~  614 (709)
                      ++|+..+.||+|+||.||++++     ..++.||||++........+.+.+|+.++.+++||||+++++++..  ....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5788899999999999999984     3478999999987666667789999999999999999999999874  45689


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      +||||+++++|.+++.....  .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus       103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence            99999999999999965332  4899999999999999999999997   999999999999999999999999999987


Q ss_pred             CCC
Q 005206          695 GGD  697 (709)
Q Consensus       695 ~~~  697 (709)
                      ...
T Consensus       178 ~~~  180 (327)
T 3lxl_A          178 PLD  180 (327)
T ss_dssp             CTT
T ss_pred             ccC
Confidence            544

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.91  E-value=2.8e-24  Score=235.25  Aligned_cols=160  Identities=25%  Similarity=0.347  Sum_probs=132.6

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccC--CccchHHHHHHHHHHHhcC--CCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQ--HRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      +.|...+.||+|+||.||++....++.||||++...  .....+++.+|+.++.+++  ||||+++++++...+..+|||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            458899999999999999999888999999998654  2345678999999999996  599999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      | +.+++|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+||||+ ++.+||+|||+|+.+...
T Consensus       136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            9 57889999996543   4888899999999999999999997   99999999999995 589999999999988655


Q ss_pred             CccccccceecC
Q 005206          698 QTEQNTKRVVGT  709 (709)
Q Consensus       698 ~~~~~~~~~~GT  709 (709)
                      .........+||
T Consensus       208 ~~~~~~~~~~gt  219 (390)
T 2zmd_A          208 TTSVVKDSQVGA  219 (390)
T ss_dssp             ------CCSCCC
T ss_pred             CccccCCCCCcC
Confidence            433223334454

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.91  E-value=1.6e-24  Score=229.05  Aligned_cols=164  Identities=28%  Similarity=0.447  Sum_probs=138.8

Q ss_pred             CChHHHHHHhcCcCcceeecccCceEEEEEEEc------CCcEEEEEEeccCCc-cchHHHHHHHHHHHhc-CCCceeeE
Q 005206          532 FDFETIVRATDNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKL-QHRNLVRL  603 (709)
Q Consensus       532 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l  603 (709)
                      ++........++|...+.||+|+||.||+|...      .++.||||++..... ...+++.+|+.++.++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            344455555678999999999999999999852      357899999976533 3456899999999999 79999999


Q ss_pred             EEEEEeCC-eeEEEEEccCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecC
Q 005206          604 LGCCVEMD-EKMLVYEYMENRSLDSVIFDKAR-------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRD  669 (709)
Q Consensus       604 ~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrD  669 (709)
                      ++++...+ ..++||||+++|+|.+++.....             ...+++..+..++.||+.||.|||+++   |+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence            99998765 48999999999999999975432             123789999999999999999999997   99999


Q ss_pred             CCCCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          670 LKASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       670 lkp~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      |||+||+++.++.+||+|||+++.+....
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  202 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDP  202 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCT
T ss_pred             CccceEEECCCCCEEECCCccccccccCc
Confidence            99999999999999999999999775543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.91  E-value=7e-24  Score=225.38  Aligned_cols=150  Identities=29%  Similarity=0.401  Sum_probs=134.9

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCc------cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG------QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  614 (709)
                      ++|...+.||+|+||.||++.... ++.||||++.....      ...+++.+|+.++.+++||||+++++++.+.+..+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            568889999999999999999864 88999999975422      13678999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC----cEEEEecCC
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM----TPKISDFGM  690 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~----~~KI~DFGl  690 (709)
                      +||||+++++|.+++...   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++    .+||+|||+
T Consensus        92 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            999999999999999643   34899999999999999999999997   99999999999999888    799999999


Q ss_pred             ceeeCCC
Q 005206          691 ARIFGGD  697 (709)
Q Consensus       691 a~~l~~~  697 (709)
                      ++.+...
T Consensus       166 ~~~~~~~  172 (321)
T 2a2a_A          166 AHEIEDG  172 (321)
T ss_dssp             CEECCTT
T ss_pred             ceecCcc
Confidence            9987654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.91  E-value=3.5e-24  Score=220.75  Aligned_cols=149  Identities=31%  Similarity=0.549  Sum_probs=135.5

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      ++|...+.||+|+||.||++...+++.||+|++.... ...+++.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            5688889999999999999999888999999997543 345789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      +++|.+++...  ...+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++....
T Consensus        87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccc
Confidence            99999999653  235899999999999999999999998   99999999999999999999999999987643

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.91  E-value=1.1e-23  Score=219.28  Aligned_cols=151  Identities=29%  Similarity=0.456  Sum_probs=134.4

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      .++|...+.||+|+||.||+|.... ++.||+|++...  .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4689999999999999999999865 889999998654  2344577899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc---EEEEecCCceee
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT---PKISDFGMARIF  694 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~KI~DFGla~~l  694 (709)
                      ||+++++|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+||+++.++.   +||+|||+++..
T Consensus        85 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            9999999998886543   4899999999999999999999998   999999999999987655   999999999877


Q ss_pred             CCC
Q 005206          695 GGD  697 (709)
Q Consensus       695 ~~~  697 (709)
                      ...
T Consensus       159 ~~~  161 (284)
T 3kk8_A          159 NDS  161 (284)
T ss_dssp             CSS
T ss_pred             ccC
Confidence            544

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.91  E-value=1.4e-24  Score=247.35  Aligned_cols=150  Identities=31%  Similarity=0.524  Sum_probs=134.1

Q ss_pred             hcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      .++|...++||+|+||.||+|.+.++..||||++.... ...++|.+|+.+|.+++||||+++++++.+ +..+|||||+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~  343 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  343 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence            45788889999999999999999888899999997543 346789999999999999999999999876 6789999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ++|+|.++|.... ...+++.+++.|+.||+.||+|||+++   ||||||||+||||+.++.+||+|||+++.+..
T Consensus       344 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          344 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED  415 (535)
T ss_dssp             TTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred             cCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence            9999999996432 234899999999999999999999997   99999999999999999999999999997753

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.91  E-value=1.8e-24  Score=228.73  Aligned_cols=156  Identities=30%  Similarity=0.528  Sum_probs=126.5

Q ss_pred             HHhcCcCcceeecccCceEEEEEEEcC----CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCe
Q 005206          539 RATDNFTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE  612 (709)
Q Consensus       539 ~~t~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~  612 (709)
                      ...++|...+.||+|+||.||+|....    ++.||||++...  .....+++.+|+.++.+++||||+++++++.+.+.
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            345678899999999999999998753    458999998654  23445789999999999999999999999987654


Q ss_pred             -----eEEEEEccCCCCHHHHHhcc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEE
Q 005206          613 -----KMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK  684 (709)
Q Consensus       613 -----~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~K  684 (709)
                           .++||||+++++|.+++...   .....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence                 49999999999999998543   22346899999999999999999999997   99999999999999999999


Q ss_pred             EEecCCceeeCCC
Q 005206          685 ISDFGMARIFGGD  697 (709)
Q Consensus       685 I~DFGla~~l~~~  697 (709)
                      |+|||+++.+...
T Consensus       188 l~Dfg~~~~~~~~  200 (313)
T 3brb_A          188 VADFGLSKKIYSG  200 (313)
T ss_dssp             ECSCSCC------
T ss_pred             EeecCcceecccc
Confidence            9999999877543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.91  E-value=1.5e-23  Score=220.56  Aligned_cols=150  Identities=28%  Similarity=0.472  Sum_probs=135.8

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +.|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            56888999999999999999875 48899999996543 44568899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      +++++|.+++..    ..+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++.+....
T Consensus       102 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          102 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            999999999843    35899999999999999999999998   9999999999999999999999999999876543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.91  E-value=5.1e-24  Score=221.32  Aligned_cols=151  Identities=32%  Similarity=0.551  Sum_probs=133.9

Q ss_pred             hcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      .++|...+.||+|+||.||+|...+++.||||++... ....+.+.+|+.++.+++||||+++++++. .+..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence            3578889999999999999999988889999999654 345678999999999999999999999986 45689999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ++++|.+++.... ...+++..+..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++.+...
T Consensus        90 ~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             CCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            9999999985432 124899999999999999999999998   999999999999999999999999999987544

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.91  E-value=8.9e-24  Score=225.35  Aligned_cols=141  Identities=28%  Similarity=0.367  Sum_probs=125.5

Q ss_pred             eeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEEEEccCCCCH
Q 005206          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYEYMENRSL  625 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  625 (709)
                      ++||+|+||.||++.... ++.||||++.+.   ....+.+|+.++.+++ ||||+++++++.+....++||||+++|+|
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L   93 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL   93 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence            689999999999999865 889999999642   4567889999999997 99999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC---cEEEEecCCceeeCCC
Q 005206          626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM---TPKISDFGMARIFGGD  697 (709)
Q Consensus       626 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~KI~DFGla~~l~~~  697 (709)
                      .+++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++   .+||+|||+++.....
T Consensus        94 ~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           94 FERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             HHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            9999654   34899999999999999999999998   99999999999998765   8999999999977544

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.91  E-value=1.5e-24  Score=226.19  Aligned_cols=154  Identities=30%  Similarity=0.504  Sum_probs=138.1

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ..++|...+.||+|+||.||+|.+.. ++.||+|++... ....+++.+|+.++.+++||||+++++++.+.+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            34678889999999999999999876 788999999643 4456789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      |+++++|.+++.... ...+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++.+....
T Consensus        90 ~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           90 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             CCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             cCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            999999999996533 345899999999999999999999998   9999999999999999999999999999775443

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.91  E-value=3.1e-24  Score=224.52  Aligned_cols=148  Identities=35%  Similarity=0.559  Sum_probs=123.4

Q ss_pred             hcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      .++|...++||+|+||.||+|+..  ..||||++....  ....+.|.+|+.++.+++||||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            367899999999999999999864  369999986543  34467899999999999999999999965 5567899999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |+++++|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A          100 WCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             ecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence            99999999998543  345899999999999999999999998   99999999999999999999999999987654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.91  E-value=3.6e-24  Score=222.97  Aligned_cols=151  Identities=22%  Similarity=0.368  Sum_probs=124.3

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC----CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      .++|...+.||+|+||.||+|.+..    +..||+|++.... ....+.|.+|+.++.+++||||+++++++ ..+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence            3578888999999999999998754    4579999986543 34467899999999999999999999997 4567899


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ||||+++++|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence            99999999999999653  235899999999999999999999997   9999999999999999999999999999875


Q ss_pred             CC
Q 005206          696 GD  697 (709)
Q Consensus       696 ~~  697 (709)
                      ..
T Consensus       168 ~~  169 (281)
T 1mp8_A          168 DS  169 (281)
T ss_dssp             --
T ss_pred             cc
Confidence            43

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.91  E-value=8.1e-24  Score=225.39  Aligned_cols=151  Identities=30%  Similarity=0.554  Sum_probs=134.3

Q ss_pred             cCcCcceeecccCceEEEEEEE-----cCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC--eeE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRL-----LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD--EKM  614 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~  614 (709)
                      ++|...+.||+|+||.||+++.     .+++.||||++........++|.+|+.++.+++||||+++++++...+  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            5688889999999999999984     348899999998766666788999999999999999999999987654  679


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      +||||+++++|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus       121 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             EEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            9999999999999996542  34899999999999999999999997   999999999999999999999999999987


Q ss_pred             CCC
Q 005206          695 GGD  697 (709)
Q Consensus       695 ~~~  697 (709)
                      ...
T Consensus       196 ~~~  198 (326)
T 2w1i_A          196 PQD  198 (326)
T ss_dssp             CSS
T ss_pred             ccc
Confidence            654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.91  E-value=6e-24  Score=219.61  Aligned_cols=151  Identities=37%  Similarity=0.579  Sum_probs=124.8

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCC----ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...+.||+|+||.||+|.+. ++.||||++....    ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            57888899999999999999974 8899999986542    234578999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC--------CCcEEEEecC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK--------EMTPKISDFG  689 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~--------~~~~KI~DFG  689 (709)
                      ||+++++|.+++..    ..+++..+..++.|++.||.|||+++..+|+||||||+|||++.        ++.+||+|||
T Consensus        86 e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           86 EFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             ECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            99999999999842    35899999999999999999999987556999999999999986        7789999999


Q ss_pred             CceeeCCC
Q 005206          690 MARIFGGD  697 (709)
Q Consensus       690 la~~l~~~  697 (709)
                      +++.+...
T Consensus       162 ~~~~~~~~  169 (271)
T 3dtc_A          162 LAREWHRT  169 (271)
T ss_dssp             C-------
T ss_pred             cccccccc
Confidence            99876543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.91  E-value=3.3e-24  Score=236.85  Aligned_cols=151  Identities=25%  Similarity=0.400  Sum_probs=128.0

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--------ccchHHHHHHHHHHHhcCCCceeeEEEEEEeC
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--------GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM  610 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~  610 (709)
                      ..++|...++||+|+||.||+|.... ++.||||++....        ......+.+|+.++.+++||||+++++++. .
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            45789999999999999999998865 7899999986531        122346899999999999999999999975 5


Q ss_pred             CeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC---CcEEEEe
Q 005206          611 DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE---MTPKISD  687 (709)
Q Consensus       611 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~KI~D  687 (709)
                      +..++||||+++|+|.+++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.+   ..+||+|
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             CceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence            6689999999999998887543   35899999999999999999999997   9999999999999754   4599999


Q ss_pred             cCCceeeCCC
Q 005206          688 FGMARIFGGD  697 (709)
Q Consensus       688 FGla~~l~~~  697 (709)
                      ||+|+.+...
T Consensus       286 FG~a~~~~~~  295 (419)
T 3i6u_A          286 FGHSKILGET  295 (419)
T ss_dssp             SSTTTSCC--
T ss_pred             cccceecCCC
Confidence            9999987543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.90  E-value=4.4e-24  Score=221.93  Aligned_cols=150  Identities=29%  Similarity=0.410  Sum_probs=132.9

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      .++|...+.||+|+||.||+|.... ++.||||++....   ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            4678899999999999999998865 6789999986432   23356789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+++++|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            99999999999986543   3899999999999999999999987   99999999999999999999999999876543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.90  E-value=1.6e-23  Score=217.87  Aligned_cols=150  Identities=29%  Similarity=0.442  Sum_probs=133.5

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC------ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS------GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  614 (709)
                      ++|...+.||+|+||.||++... +++.||+|.+....      ....+++.+|+.++.+++||||+++++++.+.+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46888999999999999999987 48999999986542      123678999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC----cEEEEecCC
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM----TPKISDFGM  690 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~----~~KI~DFGl  690 (709)
                      +||||+++++|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+||+++.++    .+||+|||+
T Consensus        85 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            9999999999999996532   4899999999999999999999997   99999999999998877    899999999


Q ss_pred             ceeeCCC
Q 005206          691 ARIFGGD  697 (709)
Q Consensus       691 a~~l~~~  697 (709)
                      ++.+...
T Consensus       159 ~~~~~~~  165 (283)
T 3bhy_A          159 AHKIEAG  165 (283)
T ss_dssp             CEECC--
T ss_pred             ceeccCC
Confidence            9987543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.90  E-value=2.2e-23  Score=218.50  Aligned_cols=151  Identities=27%  Similarity=0.362  Sum_probs=134.7

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC---------ccchHHHHHHHHHHHhcC-CCceeeEEEEEEe
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---------GQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVE  609 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---------~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~  609 (709)
                      .++|...+.||+|+||.||+|.... ++.||||++....         ....+.+.+|+.++.+++ ||||+++++++.+
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            4688999999999999999999864 7899999996542         122457889999999996 9999999999999


Q ss_pred             CCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecC
Q 005206          610 MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG  689 (709)
Q Consensus       610 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFG  689 (709)
                      ....++||||+++++|.+++.+.   ..+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence            99999999999999999999654   24899999999999999999999998   9999999999999999999999999


Q ss_pred             CceeeCCC
Q 005206          690 MARIFGGD  697 (709)
Q Consensus       690 la~~l~~~  697 (709)
                      +++.+...
T Consensus       170 ~~~~~~~~  177 (298)
T 1phk_A          170 FSCQLDPG  177 (298)
T ss_dssp             TCEECCTT
T ss_pred             chhhcCCC
Confidence            99987544

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.90  E-value=1.2e-23  Score=218.72  Aligned_cols=149  Identities=31%  Similarity=0.540  Sum_probs=131.9

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEe----------
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE----------  609 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----------  609 (709)
                      .++|...+.||+|+||.||+|... +++.||+|++....    +.+.+|+.++.+++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            457899999999999999999986 58999999996542    467889999999999999999999865          


Q ss_pred             ------CCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcE
Q 005206          610 ------MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (709)
Q Consensus       610 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  683 (709)
                            ....++||||+++++|.+++.... ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence                  344799999999999999996542 245899999999999999999999997   9999999999999999999


Q ss_pred             EEEecCCceeeCCC
Q 005206          684 KISDFGMARIFGGD  697 (709)
Q Consensus       684 KI~DFGla~~l~~~  697 (709)
                      ||+|||+++.+...
T Consensus       162 kl~Dfg~~~~~~~~  175 (284)
T 2a19_B          162 KIGDFGLVTSLKND  175 (284)
T ss_dssp             EECCCTTCEESSCC
T ss_pred             EECcchhheecccc
Confidence            99999999987654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.90  E-value=1.9e-23  Score=226.50  Aligned_cols=157  Identities=24%  Similarity=0.388  Sum_probs=138.1

Q ss_pred             HHHHHHhcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCc--------cchHHHHHHHHHHHhc-CCCceeeEE
Q 005206          535 ETIVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG--------QGIEEFKNEVRLIAKL-QHRNLVRLL  604 (709)
Q Consensus       535 ~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--------~~~~~f~~Ei~~l~~l-~H~nIv~l~  604 (709)
                      .......++|...+.||+|+||.||+|.+. +|+.||||++.....        ...+.+.+|+.++.++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            334445677999999999999999999986 589999999865431        1145688999999999 799999999


Q ss_pred             EEEEeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEE
Q 005206          605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK  684 (709)
Q Consensus       605 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~K  684 (709)
                      +++......++||||+++++|.+++.+..   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+|
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik  240 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR  240 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence            99999999999999999999999996542   4899999999999999999999997   99999999999999999999


Q ss_pred             EEecCCceeeCCC
Q 005206          685 ISDFGMARIFGGD  697 (709)
Q Consensus       685 I~DFGla~~l~~~  697 (709)
                      |+|||+++.+...
T Consensus       241 l~DfG~~~~~~~~  253 (365)
T 2y7j_A          241 LSDFGFSCHLEPG  253 (365)
T ss_dssp             ECCCTTCEECCTT
T ss_pred             EEecCcccccCCC
Confidence            9999999987654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.90  E-value=1.9e-23  Score=236.26  Aligned_cols=151  Identities=31%  Similarity=0.486  Sum_probs=132.4

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCc-------------cchHHHHHHHHHHHhcCCCceeeEEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG-------------QGIEEFKNEVRLIAKLQHRNLVRLLGC  606 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~-------------~~~~~f~~Ei~~l~~l~H~nIv~l~g~  606 (709)
                      .++|...++||+|+||.||+|.... ++.||||++.....             ...+++.+|+.++.+++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            4689999999999999999999865 78999999965321             335689999999999999999999999


Q ss_pred             EEeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC---cE
Q 005206          607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM---TP  683 (709)
Q Consensus       607 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~  683 (709)
                      +.+....++||||+++|+|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+|||++.++   .+
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence            999999999999999999999886543   4899999999999999999999998   99999999999998775   69


Q ss_pred             EEEecCCceeeCCC
Q 005206          684 KISDFGMARIFGGD  697 (709)
Q Consensus       684 KI~DFGla~~l~~~  697 (709)
                      ||+|||+|+.+...
T Consensus       189 kl~Dfg~a~~~~~~  202 (504)
T 3q5i_A          189 KIVDFGLSSFFSKD  202 (504)
T ss_dssp             EECCCTTCEECCTT
T ss_pred             EEEECCCCEEcCCC
Confidence            99999999988654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.90  E-value=7.2e-24  Score=224.37  Aligned_cols=152  Identities=30%  Similarity=0.437  Sum_probs=133.1

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEe----CCeeEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE----MDEKML  615 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~l  615 (709)
                      .++|...+.||+|+||.||+++.. +++.||||++........+.+.+|+.++.+++||||+++++++..    ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            467999999999999999999984 589999999976666667889999999999999999999999873    346789


Q ss_pred             EEEccCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          616 VYEYMENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      ||||+++|+|.+++.... ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            999999999999986532 2346899999999999999999999997   999999999999999999999999998865


Q ss_pred             C
Q 005206          695 G  695 (709)
Q Consensus       695 ~  695 (709)
                      .
T Consensus       185 ~  185 (317)
T 2buj_A          185 C  185 (317)
T ss_dssp             C
T ss_pred             c
Confidence            3

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.90  E-value=2e-23  Score=221.70  Aligned_cols=147  Identities=31%  Similarity=0.511  Sum_probs=130.9

Q ss_pred             cCcceeecccCceEEEEEEEc-----CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeeEE
Q 005206          544 FTDYNKLGQGGFGIVYKGRLL-----EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKML  615 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~~-----~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l  615 (709)
                      |...++||+|+||.||++.+.     +++.||||++.... ....+.+.+|++++.+++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488899999999999988653     47889999997653 34467899999999999999999999999984  57899


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ||||+++|+|.+++...    .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            99999999999998543    3899999999999999999999998   9999999999999999999999999999876


Q ss_pred             CC
Q 005206          696 GD  697 (709)
Q Consensus       696 ~~  697 (709)
                      ..
T Consensus       186 ~~  187 (318)
T 3lxp_A          186 EG  187 (318)
T ss_dssp             TT
T ss_pred             cc
Confidence            54

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=1.6e-23  Score=218.74  Aligned_cols=150  Identities=31%  Similarity=0.544  Sum_probs=131.7

Q ss_pred             cCcCcce-eecccCceEEEEEEEc---CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          542 DNFTDYN-KLGQGGFGIVYKGRLL---EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       542 ~~f~~~~-~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      ++|...+ .||+|+||.||+|.+.   .++.||||++.... ....+++.+|+.++.+++||||+++++++ +.+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4566665 8999999999999864   47789999997643 34567899999999999999999999999 56678999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+++++|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        88 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            9999999999998543  345899999999999999999999998   99999999999999999999999999998854


Q ss_pred             C
Q 005206          697 D  697 (709)
Q Consensus       697 ~  697 (709)
                      .
T Consensus       163 ~  163 (287)
T 1u59_A          163 D  163 (287)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.90  E-value=1.1e-23  Score=226.32  Aligned_cols=147  Identities=25%  Similarity=0.422  Sum_probs=128.6

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      .++|...+.||+|+||.||++.... ++.||||++.+...    .+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            4578999999999999999999865 88999999965432    345788888888 79999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC----CcEEEEecCCceee
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE----MTPKISDFGMARIF  694 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~----~~~KI~DFGla~~l  694 (709)
                      |+++|+|.+++...   ..+++..+..++.||+.||.|||+++   |+||||||+|||+.++    +.+||+|||+++.+
T Consensus        97 ~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           97 LMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             CCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            99999999998653   34899999999999999999999998   9999999999999543    35999999999987


Q ss_pred             CCC
Q 005206          695 GGD  697 (709)
Q Consensus       695 ~~~  697 (709)
                      ...
T Consensus       171 ~~~  173 (342)
T 2qr7_A          171 RAE  173 (342)
T ss_dssp             BCT
T ss_pred             cCC
Confidence            554

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.90  E-value=6.9e-24  Score=222.79  Aligned_cols=148  Identities=28%  Similarity=0.469  Sum_probs=132.1

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      .++|...+.||+|+||.||+|.... ++.||+|++........+++.+|+.++.+++||||+++++++.+.+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            4679999999999999999999875 889999999776666788999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      +++++|.+++....  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        98 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  166 (302)
T 2j7t_A           98 CPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAK  166 (302)
T ss_dssp             CTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred             CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence            99999999986532  34899999999999999999999997   99999999999999999999999999864

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.90  E-value=6.5e-24  Score=245.57  Aligned_cols=149  Identities=30%  Similarity=0.526  Sum_probs=129.4

Q ss_pred             CcCcce-eecccCceEEEEEEEc---CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          543 NFTDYN-KLGQGGFGIVYKGRLL---EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       543 ~f~~~~-~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++...+ +||+|+||.||+|.+.   ++..||||+++... ....++|.+|+.++.+++|||||++++++.. +..+|||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            344444 7999999999999875   35679999997653 3457889999999999999999999999976 6689999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+++|+|.+++...  ...+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+..+
T Consensus       415 E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             ECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             EeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            999999999999543  345899999999999999999999997   999999999999999999999999999987544

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.90  E-value=5.8e-24  Score=226.91  Aligned_cols=151  Identities=31%  Similarity=0.559  Sum_probs=126.5

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-Cc----EEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQ----EIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~----~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      ++|...++||+|+||.||+|.+.. ++    .||+|.+... .....+++.+|+.++.+++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            578899999999999999998754 43    4688877543 3456788999999999999999999999998754 789


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      |+||+++|+|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        94 v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            999999999999996543  35899999999999999999999998   9999999999999999999999999999875


Q ss_pred             CCC
Q 005206          696 GDQ  698 (709)
Q Consensus       696 ~~~  698 (709)
                      ...
T Consensus       169 ~~~  171 (327)
T 3lzb_A          169 AEE  171 (327)
T ss_dssp             ---
T ss_pred             Ccc
Confidence            543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=1.4e-23  Score=223.86  Aligned_cols=151  Identities=26%  Similarity=0.421  Sum_probs=127.1

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhc--CCCceeeEEEEEEeC----Cee
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL--QHRNLVRLLGCCVEM----DEK  613 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l--~H~nIv~l~g~~~~~----~~~  613 (709)
                      ..++|...++||+|+||.||+|+.. ++.||||++...   ....+..|.+++..+  +||||+++++++...    ...
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            3468999999999999999999885 899999998532   234555666666554  899999999999987    678


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEecCCCCCCEEEcCCCcEEEEec
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS-----RFRIIHRDLKASNILLDKEMTPKISDF  688 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiHrDlkp~NILl~~~~~~KI~DF  688 (709)
                      ++||||+++|+|.+++...    .+++..+..++.|++.||.|||++.     +.+|+||||||+|||++.++.+||+||
T Consensus       111 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  186 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL  186 (337)
T ss_dssp             EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence            9999999999999999543    4899999999999999999999881     113999999999999999999999999


Q ss_pred             CCceeeCCCC
Q 005206          689 GMARIFGGDQ  698 (709)
Q Consensus       689 Gla~~l~~~~  698 (709)
                      |+|+.+....
T Consensus       187 g~a~~~~~~~  196 (337)
T 3mdy_A          187 GLAVKFISDT  196 (337)
T ss_dssp             TTCEECC---
T ss_pred             CCceeecccc
Confidence            9998875543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.90  E-value=8.3e-24  Score=225.80  Aligned_cols=150  Identities=29%  Similarity=0.536  Sum_probs=130.3

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCc--cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG--QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ++|...+.||+|+||.||+++... ++.||||++.....  ...+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            578899999999999999999875 88999999865432  235668899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      |+++++|.+++...   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       105 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          105 FVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             CCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             cCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            99999998876433   34899999999999999999999998   999999999999999999999999999876543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.90  E-value=2.6e-23  Score=217.74  Aligned_cols=149  Identities=19%  Similarity=0.329  Sum_probs=132.5

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ++|...+.||+|+||.||+|... +++.||||++...  ...+++.+|+.++.++ +|+|++++++++.+....++||||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~   87 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   87 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence            57899999999999999999974 5889999998643  2345788999999999 799999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc-----EEEEecCCceee
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT-----PKISDFGMARIF  694 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~KI~DFGla~~l  694 (709)
                      + +++|.+++....  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.     +||+|||+|+.+
T Consensus        88 ~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           88 L-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             C-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             c-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            9 999999996532  35899999999999999999999987   999999999999987776     999999999988


Q ss_pred             CCCC
Q 005206          695 GGDQ  698 (709)
Q Consensus       695 ~~~~  698 (709)
                      ....
T Consensus       162 ~~~~  165 (298)
T 1csn_A          162 RDPV  165 (298)
T ss_dssp             BCTT
T ss_pred             cccc
Confidence            6553

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.90  E-value=5.7e-24  Score=226.10  Aligned_cols=160  Identities=32%  Similarity=0.511  Sum_probs=135.8

Q ss_pred             CChHHHHHHhcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhc-CCCceeeEEEEEEe
Q 005206          532 FDFETIVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVE  609 (709)
Q Consensus       532 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~  609 (709)
                      +++.++....++|...+.||+|+||.||+|+.. +++.||||++... ....+++.+|+.++.++ +||||+++++++..
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            344444456788999999999999999999985 5889999998643 34467899999999999 89999999999987


Q ss_pred             ------CCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcE
Q 005206          610 ------MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (709)
Q Consensus       610 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  683 (709)
                            .+..++||||+++++|.+++.... ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence                  467899999999999999996542 235889999999999999999999997   9999999999999999999


Q ss_pred             EEEecCCceeeCC
Q 005206          684 KISDFGMARIFGG  696 (709)
Q Consensus       684 KI~DFGla~~l~~  696 (709)
                      ||+|||+++.+..
T Consensus       169 kl~Dfg~~~~~~~  181 (326)
T 2x7f_A          169 KLVDFGVSAQLDR  181 (326)
T ss_dssp             EECCCTTTC----
T ss_pred             EEeeCcCceecCc
Confidence            9999999987754

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.90  E-value=1.4e-23  Score=220.65  Aligned_cols=152  Identities=26%  Similarity=0.400  Sum_probs=130.4

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC----ccchHHHHHHHHHHHhcCCCceeeEEEEEEe--CCee
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE--MDEK  613 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~  613 (709)
                      .++|...+.||+|+||.||++.... ++.||+|++....    ....+.+.+|+.++.+++||||+++++++..  ....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            4689999999999999999999864 7899999996532    3456789999999999999999999999853  4578


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ++||||++++ |.+++.... ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999987 777765432 345899999999999999999999998   99999999999999999999999999998


Q ss_pred             eCCC
Q 005206          694 FGGD  697 (709)
Q Consensus       694 l~~~  697 (709)
                      +...
T Consensus       159 ~~~~  162 (305)
T 2wtk_C          159 LHPF  162 (305)
T ss_dssp             CCTT
T ss_pred             cCcc
Confidence            7543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.90  E-value=1.4e-23  Score=236.78  Aligned_cols=150  Identities=29%  Similarity=0.439  Sum_probs=129.7

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      +.|...++||+|+||.||+|+... ++.||||++.+..  ....+.+.+|+.++.+++||||+++++++.+....++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            568899999999999999999864 7899999997542  3446789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC---CcEEEEecCCceeeC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE---MTPKISDFGMARIFG  695 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~KI~DFGla~~l~  695 (709)
                      |+++|+|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+|||++.+   +.+||+|||+|+.+.
T Consensus       117 ~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          117 CYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            999999999886543   3889999999999999999999998   9999999999999764   559999999999876


Q ss_pred             CC
Q 005206          696 GD  697 (709)
Q Consensus       696 ~~  697 (709)
                      ..
T Consensus       191 ~~  192 (494)
T 3lij_A          191 NQ  192 (494)
T ss_dssp             TT
T ss_pred             CC
Confidence            44

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=8.4e-24  Score=226.22  Aligned_cols=151  Identities=33%  Similarity=0.569  Sum_probs=128.6

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-----CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      ++|...+.||+|+||.||+|....     +..||||++.... .....+|.+|+.++.+++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            467778999999999999998754     2369999997543 3345679999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ||||+++|+|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       124 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          124 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            99999999999999653  235899999999999999999999998   9999999999999999999999999999875


Q ss_pred             CC
Q 005206          696 GD  697 (709)
Q Consensus       696 ~~  697 (709)
                      ..
T Consensus       199 ~~  200 (333)
T 1mqb_A          199 DD  200 (333)
T ss_dssp             --
T ss_pred             cc
Confidence            44

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.90  E-value=5.3e-24  Score=238.30  Aligned_cols=148  Identities=32%  Similarity=0.472  Sum_probs=125.1

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeC------C
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM------D  611 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~  611 (709)
                      .++|...++||+|+||.||+|.... ++.||||++.+.  .....+++.+|+.++.+++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            4679999999999999999998765 889999999754  334467889999999999999999999999755      3


Q ss_pred             eeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCc
Q 005206          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla  691 (709)
                      ..+|||||++++ |.+.+..     .+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|
T Consensus       141 ~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            569999999865 5555522     3889999999999999999999998   999999999999999999999999999


Q ss_pred             eeeCCC
Q 005206          692 RIFGGD  697 (709)
Q Consensus       692 ~~l~~~  697 (709)
                      +.....
T Consensus       212 ~~~~~~  217 (464)
T 3ttj_A          212 RTAGTS  217 (464)
T ss_dssp             -----C
T ss_pred             eecCCC
Confidence            987543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.90  E-value=1.3e-23  Score=222.05  Aligned_cols=151  Identities=21%  Similarity=0.260  Sum_probs=130.7

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      .++|...+.||+|+||.||++... +++.||||++....   ....+++.+|+.++.+++||||+++++++.+.+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            468999999999999999999986 48899999996542   22347899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+++++|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       113 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            99999999999996543   4899999999999999999999997   99999999999999999999999999987754


Q ss_pred             C
Q 005206          697 D  697 (709)
Q Consensus       697 ~  697 (709)
                      .
T Consensus       187 ~  187 (309)
T 2h34_A          187 E  187 (309)
T ss_dssp             -
T ss_pred             c
Confidence            3

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=6.2e-24  Score=228.37  Aligned_cols=152  Identities=33%  Similarity=0.523  Sum_probs=127.3

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCc-----cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG-----QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~-----~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  613 (709)
                      ..++|...+.||+|+||.||+|.... ++.||||++.....     ...+.+.+|+.++.+++||||+++++++.+.+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            35689999999999999999999865 88999999964321     1235788999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ++||||+++ +|..++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+.
T Consensus        88 ~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             EEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            999999986 888888543  235788899999999999999999998   99999999999999999999999999998


Q ss_pred             eCCC
Q 005206          694 FGGD  697 (709)
Q Consensus       694 l~~~  697 (709)
                      +...
T Consensus       162 ~~~~  165 (346)
T 1ua2_A          162 FGSP  165 (346)
T ss_dssp             TTSC
T ss_pred             ccCC
Confidence            7543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.90  E-value=8.5e-24  Score=228.39  Aligned_cols=158  Identities=28%  Similarity=0.411  Sum_probs=132.6

Q ss_pred             hHHHHHHhcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCcc-----------chHHHHHHHHHHHhcCCCceee
Q 005206          534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQ-----------GIEEFKNEVRLIAKLQHRNLVR  602 (709)
Q Consensus       534 ~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~-----------~~~~f~~Ei~~l~~l~H~nIv~  602 (709)
                      ..++....++|...+.||+|+||.||+|...+++.||||++......           ..+.+.+|+.++.+++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            45677788999999999999999999999988999999999643211           1378999999999999999999


Q ss_pred             EEEEEEeCC-----eeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE
Q 005206          603 LLGCCVEMD-----EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL  677 (709)
Q Consensus       603 l~g~~~~~~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl  677 (709)
                      +++++...+     ..++||||++ |+|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||+
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL  167 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence            999996533     5799999998 6888887543  335899999999999999999999998   9999999999999


Q ss_pred             cCCCcEEEEecCCceeeCCC
Q 005206          678 DKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       678 ~~~~~~KI~DFGla~~l~~~  697 (709)
                      +.++.+||+|||+++.....
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~  187 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTAD  187 (362)
T ss_dssp             CTTCCEEECCTTC-------
T ss_pred             cCCCCEEEEecCcccccccc
Confidence            99999999999999865443

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.90  E-value=2.3e-23  Score=219.86  Aligned_cols=152  Identities=32%  Similarity=0.522  Sum_probs=128.1

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC-----ccchHHHHHHHHHHHhcC---CCceeeEEEEEEeCC
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-----GQGIEEFKNEVRLIAKLQ---HRNLVRLLGCCVEMD  611 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-----~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~  611 (709)
                      .++|...++||+|+||.||+|+.. +++.||||++....     ......+.+|+.++.+++   ||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            578999999999999999999975 48899999986432     122356778888777764   999999999998865


Q ss_pred             -----eeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEE
Q 005206          612 -----EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKIS  686 (709)
Q Consensus       612 -----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~  686 (709)
                           ..++||||++ ++|.+++.... ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           88 TDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             SSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEe
Confidence                 4799999997 59999986543 234899999999999999999999998   9999999999999999999999


Q ss_pred             ecCCceeeCCC
Q 005206          687 DFGMARIFGGD  697 (709)
Q Consensus       687 DFGla~~l~~~  697 (709)
                      |||+|+.+...
T Consensus       163 Dfg~a~~~~~~  173 (308)
T 3g33_A          163 DFGLARIYSYQ  173 (308)
T ss_dssp             SCSCTTTSTTC
T ss_pred             eCccccccCCC
Confidence            99999877543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.90  E-value=7.8e-24  Score=229.23  Aligned_cols=151  Identities=20%  Similarity=0.302  Sum_probs=126.2

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC------CcEEEEEEeccCCccc-----------hHHHHHHHHHHHhcCCCceeeE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNSGQG-----------IEEFKNEVRLIAKLQHRNLVRL  603 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~~~~-----------~~~f~~Ei~~l~~l~H~nIv~l  603 (709)
                      .++|...++||+|+||.||+|.+..      ++.||||++.......           ...+..|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4679999999999999999998865      3689999986543211           1234456667778889999999


Q ss_pred             EEEEEeC----CeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-
Q 005206          604 LGCCVEM----DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD-  678 (709)
Q Consensus       604 ~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-  678 (709)
                      ++++...    ...+|||||+ +++|.+++...  ...+++..++.|+.||+.||.|||+++   |+||||||+||||+ 
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~  187 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence            9999875    4479999999 99999999653  245999999999999999999999997   99999999999999 


Q ss_pred             -CCCcEEEEecCCceeeCCC
Q 005206          679 -KEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       679 -~~~~~KI~DFGla~~l~~~  697 (709)
                       .++.+||+|||+|+.+...
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~  207 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPE  207 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGG
T ss_pred             CCCCeEEEEECCcceecccC
Confidence             8899999999999987544

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.90  E-value=3.1e-23  Score=219.23  Aligned_cols=151  Identities=30%  Similarity=0.490  Sum_probs=130.8

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ..++|...+.||+|+||.||+|.... ++.||||++...  ...+++.+|+.++.+++||||+++++++.+.+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            34679999999999999999999865 899999999653  345789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      |+++++|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+...
T Consensus       105 ~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          105 YCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             CCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            99999999998632  235899999999999999999999998   999999999999999999999999999887554

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.90  E-value=2.6e-23  Score=223.68  Aligned_cols=149  Identities=29%  Similarity=0.541  Sum_probs=130.0

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeC--------
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--------  610 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--------  610 (709)
                      ++|...++||+|+||.||+|+.. +++.||||++....  ......+.+|+.++.+++||||+++++++...        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            67999999999999999999985 58999999986543  23356788999999999999999999999874        


Q ss_pred             CeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCC
Q 005206          611 DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (709)
Q Consensus       611 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGl  690 (709)
                      +..++||||+++ +|.+.+....  ..+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence            468999999985 7777775432  34899999999999999999999998   99999999999999999999999999


Q ss_pred             ceeeCC
Q 005206          691 ARIFGG  696 (709)
Q Consensus       691 a~~l~~  696 (709)
                      |+.+..
T Consensus       171 a~~~~~  176 (351)
T 3mi9_A          171 ARAFSL  176 (351)
T ss_dssp             CEECCC
T ss_pred             cccccc
Confidence            998753

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.90  E-value=6.2e-24  Score=229.40  Aligned_cols=147  Identities=27%  Similarity=0.385  Sum_probs=133.2

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ++|...++||+|+||.||++... +++.||+|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            56888999999999999999987 48899999997553 33457899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD-SRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      +++++|.+++....   .+++..+..++.||+.||.|||+. +   |+||||||+|||++.++.+||+|||+++.+
T Consensus       113 ~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  182 (360)
T 3eqc_A          113 MDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL  182 (360)
T ss_dssp             CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence            99999999996543   388999999999999999999985 6   999999999999999999999999999765

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.90  E-value=5.4e-24  Score=226.76  Aligned_cols=149  Identities=30%  Similarity=0.501  Sum_probs=128.6

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCc-cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ++|...++||+|+||.||+|+.. +++.||||++..... .....+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57888999999999999999986 488999999965432 2233566899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ++ |+|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  152 (324)
T 3mtl_A           82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI  152 (324)
T ss_dssp             CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence            98 5898888654  335899999999999999999999998   99999999999999999999999999987653

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.90  E-value=6e-24  Score=226.89  Aligned_cols=150  Identities=30%  Similarity=0.475  Sum_probs=127.3

Q ss_pred             HhcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      ..++|...++||+|+||.||+|... +++.||||++....  ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            4468999999999999999999876 48899999996543  22356788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE-----cCCCcEEEEecCCc
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL-----DKEMTPKISDFGMA  691 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl-----~~~~~~KI~DFGla  691 (709)
                      |||++ |+|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+||||     +.++.+||+|||+|
T Consensus       112 ~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            99998 59999986543   4899999999999999999999998   9999999999999     45566999999999


Q ss_pred             eeeCC
Q 005206          692 RIFGG  696 (709)
Q Consensus       692 ~~l~~  696 (709)
                      +.+..
T Consensus       185 ~~~~~  189 (329)
T 3gbz_A          185 RAFGI  189 (329)
T ss_dssp             HHHC-
T ss_pred             cccCC
Confidence            87753

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=9.2e-24  Score=229.17  Aligned_cols=148  Identities=29%  Similarity=0.473  Sum_probs=124.8

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC------
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD------  611 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------  611 (709)
                      .++|...+.||+|+||.||+|... +++.||||++...  .....+++.+|+.++.+++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            367999999999999999999985 4899999999653  2334567899999999999999999999998753      


Q ss_pred             eeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCc
Q 005206          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla  691 (709)
                      ..++||||+ +++|.+++..    ..+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            459999999 7899999864    24889999999999999999999998   999999999999999999999999999


Q ss_pred             eeeCC
Q 005206          692 RIFGG  696 (709)
Q Consensus       692 ~~l~~  696 (709)
                      +....
T Consensus       176 ~~~~~  180 (367)
T 1cm8_A          176 RQADS  180 (367)
T ss_dssp             EECCS
T ss_pred             ccccc
Confidence            98754

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.90  E-value=1.9e-23  Score=217.76  Aligned_cols=149  Identities=26%  Similarity=0.396  Sum_probs=133.9

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...+.||+|+||.||+|+... ++.||||++...   .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            578889999999999999999865 778999998643   1234568999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ||+++++|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++.....
T Consensus        94 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            9999999999986543   4899999999999999999999997   99999999999999999999999999987654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.90  E-value=1.4e-23  Score=217.56  Aligned_cols=150  Identities=27%  Similarity=0.452  Sum_probs=135.0

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...+.||+|+||.||+|+.. +++.||||++...   .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            57888999999999999999986 5899999998643   2334568999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+++++|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++.+...
T Consensus        91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           91 EYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             eccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            9999999999996543   3889999999999999999999998   999999999999999999999999999877543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.90  E-value=1.6e-23  Score=221.10  Aligned_cols=153  Identities=23%  Similarity=0.449  Sum_probs=127.5

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...+.||+|+||.||+|... +++.||||++...   .....+++.+|+.++.+++||||+++++++.+.+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            57899999999999999999975 5899999999753   2334567999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          618 EYMENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ||+++++|.+++.... ....+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++.+..
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            9999999999986432 2345899999999999999999999998   99999999999999999999999999987754


Q ss_pred             C
Q 005206          697 D  697 (709)
Q Consensus       697 ~  697 (709)
                      .
T Consensus       189 ~  189 (310)
T 2wqm_A          189 K  189 (310)
T ss_dssp             -
T ss_pred             C
Confidence            3

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=8.1e-24  Score=221.62  Aligned_cols=149  Identities=31%  Similarity=0.467  Sum_probs=129.7

Q ss_pred             CcCcceeecccCceEEEEEEEcC-C---cEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCee-EEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-G---QEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK-MLV  616 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g---~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~-~lV  616 (709)
                      .|...++||+|+||.||+|.+.+ +   ..+|+|++.... ....+.|.+|+.++.+++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            35556899999999999998654 2   379999997543 34567899999999999999999999999877665 999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+.+|+|.+++...  ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       102 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            9999999999999653  345899999999999999999999998   99999999999999999999999999986644

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.90  E-value=1.1e-23  Score=220.98  Aligned_cols=151  Identities=30%  Similarity=0.500  Sum_probs=130.2

Q ss_pred             cCcCcceeecccCceEEEEEEEcCC----cEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEe-CCeeEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEG----QEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE-MDEKML  615 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g----~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~l  615 (709)
                      .+|...++||+|+||.||+|.+.+.    ..+|+|++.... ....+++.+|+.++.+++||||+++++++.+ .+..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            4577889999999999999987542    368999987543 3446789999999999999999999999755 457799


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ||||+++|+|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+.+.
T Consensus       105 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence            99999999999999653  345799999999999999999999998   9999999999999999999999999999775


Q ss_pred             CC
Q 005206          696 GD  697 (709)
Q Consensus       696 ~~  697 (709)
                      ..
T Consensus       180 ~~  181 (298)
T 3f66_A          180 DK  181 (298)
T ss_dssp             CG
T ss_pred             cc
Confidence            43

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.90  E-value=1.2e-23  Score=220.05  Aligned_cols=150  Identities=30%  Similarity=0.490  Sum_probs=130.2

Q ss_pred             cCcCcce-eecccCceEEEEEEEc---CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          542 DNFTDYN-KLGQGGFGIVYKGRLL---EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       542 ~~f~~~~-~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      ++|...+ .||+|+||.||+|.+.   .++.||||++....  ....+++.+|+.++.+++||||+++++++ +.+..++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            5677777 9999999999999653   26789999997543  23367899999999999999999999999 6677899


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ||||+++++|.+++...   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        95 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            99999999999999653   34899999999999999999999997   9999999999999999999999999999875


Q ss_pred             CCC
Q 005206          696 GDQ  698 (709)
Q Consensus       696 ~~~  698 (709)
                      ...
T Consensus       169 ~~~  171 (291)
T 1xbb_A          169 ADE  171 (291)
T ss_dssp             TTC
T ss_pred             cCC
Confidence            543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=5.5e-24  Score=231.46  Aligned_cols=150  Identities=31%  Similarity=0.519  Sum_probs=123.0

Q ss_pred             CcCcceeecccCceEEEEEEEcC--C--cEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeC-CeeEEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE--G--QEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-DEKMLV  616 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~--g--~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~lV  616 (709)
                      .|...++||+|+||.||+|++.+  +  ..||||.+... .....++|.+|+.++.+++||||+++++++.+. +..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            46667899999999999998753  2  36899998654 334567899999999999999999999998654 577999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+++|+|.+++...  ...+++..+..++.||++||.|||+++   |+||||||+||||+.++.+||+|||+|+.+..
T Consensus       170 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence            9999999999999643  335789999999999999999999998   99999999999999999999999999997644


Q ss_pred             C
Q 005206          697 D  697 (709)
Q Consensus       697 ~  697 (709)
                      .
T Consensus       245 ~  245 (373)
T 3c1x_A          245 K  245 (373)
T ss_dssp             -
T ss_pred             c
Confidence            3

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.90  E-value=1e-23  Score=220.88  Aligned_cols=149  Identities=32%  Similarity=0.518  Sum_probs=131.7

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEe----------
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE----------  609 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----------  609 (709)
                      .++|...+.||+|+||.||+|+.. +++.||||++.. .....+.+.+|+.++.+++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            457889999999999999999985 588999999954 33456789999999999999999999999876          


Q ss_pred             ---CCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEE
Q 005206          610 ---MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKIS  686 (709)
Q Consensus       610 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~  686 (709)
                         ....++||||+++|+|.+++....  ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence               345799999999999999996532  34788899999999999999999997   9999999999999999999999


Q ss_pred             ecCCceeeC
Q 005206          687 DFGMARIFG  695 (709)
Q Consensus       687 DFGla~~l~  695 (709)
                      |||+++.+.
T Consensus       159 dfg~~~~~~  167 (303)
T 1zy4_A          159 DFGLAKNVH  167 (303)
T ss_dssp             CCCCCSCTT
T ss_pred             eCcchhhcc
Confidence            999998764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.90  E-value=2.1e-23  Score=217.63  Aligned_cols=150  Identities=30%  Similarity=0.573  Sum_probs=128.9

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCcc-------chHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQ-------GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~-------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  613 (709)
                      ++|...+.||+|+||.||+|++. +++.||||++......       ..+++.+|+.++.+++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            57888899999999999999985 5889999998654321       1268999999999999999999999986544  


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc-----EEEEec
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT-----PKISDF  688 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~KI~DF  688 (709)
                      ++||||+++|+|.+++.+.  ...+++..+..++.|++.||+|||+++ .+|+||||||+|||++.++.     +||+||
T Consensus        97 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            7999999999999988653  345899999999999999999999985 34999999999999988776     999999


Q ss_pred             CCceeeCC
Q 005206          689 GMARIFGG  696 (709)
Q Consensus       689 Gla~~l~~  696 (709)
                      |+++....
T Consensus       174 g~~~~~~~  181 (287)
T 4f0f_A          174 GLSQQSVH  181 (287)
T ss_dssp             TTCBCCSS
T ss_pred             Cccccccc
Confidence            99986543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.90  E-value=4.5e-23  Score=219.50  Aligned_cols=144  Identities=24%  Similarity=0.424  Sum_probs=129.2

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcC-CCceeeEEEEEEe--CCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVE--MDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~--~~~~~lV~  617 (709)
                      ++|...++||+|+||.||+|... +++.||||++..   ...+.+.+|+.++.+++ ||||+++++++.+  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            67889999999999999999875 488999999863   33578999999999997 9999999999998  56789999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-cEEEEecCCceeeCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIFGG  696 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~KI~DFGla~~l~~  696 (709)
                      ||+++++|.+++..      +++..+..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+|+.+..
T Consensus       113 e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          113 EHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             ECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            99999999998732      788999999999999999999998   99999999999999776 899999999998754


Q ss_pred             C
Q 005206          697 D  697 (709)
Q Consensus       697 ~  697 (709)
                      .
T Consensus       184 ~  184 (330)
T 3nsz_A          184 G  184 (330)
T ss_dssp             T
T ss_pred             C
Confidence            4

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.90  E-value=1.8e-23  Score=222.67  Aligned_cols=150  Identities=33%  Similarity=0.560  Sum_probs=130.2

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcE--EEEEEeccC-CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQE--IAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~--VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      ++|...+.||+|+||.||+|+... +..  ||+|++... .....+++.+|+.++.++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            468888999999999999998765 554  599988653 334567899999999999 899999999999999999999


Q ss_pred             EEccCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcE
Q 005206          617 YEYMENRSLDSVIFDKA-------------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  683 (709)
                      |||+++++|.+++....             ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999996542             2346899999999999999999999997   9999999999999999999


Q ss_pred             EEEecCCceee
Q 005206          684 KISDFGMARIF  694 (709)
Q Consensus       684 KI~DFGla~~l  694 (709)
                      ||+|||+++..
T Consensus       182 kL~Dfg~~~~~  192 (327)
T 1fvr_A          182 KIADFGLSRGQ  192 (327)
T ss_dssp             EECCTTCEESS
T ss_pred             EEcccCcCccc
Confidence            99999999843

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.90  E-value=8.2e-24  Score=223.59  Aligned_cols=150  Identities=30%  Similarity=0.476  Sum_probs=125.7

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      ++|...+.||+|+||.||+++.. ++.||||++..  ....+.|.+|+.++.+++||||+++++++.  +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            46788899999999999999874 78899999853  345678999999999999999999999876  45899999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc-EEEEecCCceeeCC
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT-PKISDFGMARIFGG  696 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~-~KI~DFGla~~l~~  696 (709)
                      +|+|.+++........+++..++.++.||++||+|||+.+..+|+||||||+|||++.++. +||+|||+++.+..
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            9999999976554445789999999999999999999943224999999999999998886 79999999987643

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.90  E-value=7.5e-24  Score=225.66  Aligned_cols=153  Identities=34%  Similarity=0.487  Sum_probs=130.5

Q ss_pred             hcCcCcceeecccCceEEEEEEEc------CCcEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  613 (709)
                      .++|...+.||+|+||.||+|++.      .++.||||++... ......++.+|+.++.+++||||+++++++.+.+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            357889999999999999999842      3678999999654 344567899999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCcEEEE
Q 005206          614 MLVYEYMENRSLDSVIFDKAR----SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK---EMTPKIS  686 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~KI~  686 (709)
                      ++||||+++++|.+++.....    ...+++..++.++.||+.||.|||+++   |+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999976432    135899999999999999999999997   999999999999984   4569999


Q ss_pred             ecCCceeeCC
Q 005206          687 DFGMARIFGG  696 (709)
Q Consensus       687 DFGla~~l~~  696 (709)
                      |||+++.+..
T Consensus       186 Dfg~~~~~~~  195 (327)
T 2yfx_A          186 DFGMARDIYR  195 (327)
T ss_dssp             CCHHHHHHHC
T ss_pred             cccccccccc
Confidence            9999986543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.90  E-value=1.7e-23  Score=220.43  Aligned_cols=150  Identities=24%  Similarity=0.413  Sum_probs=131.7

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      .++|...+.||+|+||.||+++.. +++.||+|++........+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            357888999999999999999986 4889999999765544567799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE---cCCCcEEEEecCCceeeCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~KI~DFGla~~l~~  696 (709)
                      +++++|.+++.+..   .+++.....++.||+.||.|||+++   |+||||||+||++   +.++.+||+|||+++....
T Consensus        88 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           88 VSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             CCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            99999999986543   4889999999999999999999997   9999999999999   7889999999999986643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.90  E-value=2.5e-23  Score=228.49  Aligned_cols=146  Identities=26%  Similarity=0.340  Sum_probs=124.4

Q ss_pred             cCcCcc-eeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHh-cCCCceeeEEEEEEe----CCeeE
Q 005206          542 DNFTDY-NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAK-LQHRNLVRLLGCCVE----MDEKM  614 (709)
Q Consensus       542 ~~f~~~-~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~-l~H~nIv~l~g~~~~----~~~~~  614 (709)
                      ++|... +.||+|+||+||++.+.. ++.||||++..     ...+.+|+.++.+ .+||||+++++++..    ....+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456665 689999999999999865 88999999853     2467788888754 589999999999876    55689


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCcEEEEecCCc
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK---EMTPKISDFGMA  691 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~KI~DFGla  691 (709)
                      |||||+++|+|.+++.+.. ...+++..+..|+.||+.||.|||+++   |+||||||+||||+.   ++.+||+|||+|
T Consensus       136 lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence            9999999999999996532 245899999999999999999999997   999999999999998   789999999999


Q ss_pred             eeeCC
Q 005206          692 RIFGG  696 (709)
Q Consensus       692 ~~l~~  696 (709)
                      +....
T Consensus       212 ~~~~~  216 (400)
T 1nxk_A          212 KETTS  216 (400)
T ss_dssp             EECC-
T ss_pred             cccCC
Confidence            97754

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.90  E-value=2.3e-24  Score=234.63  Aligned_cols=151  Identities=18%  Similarity=0.219  Sum_probs=125.0

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC---CccchHHHHHHH---HHHHhcCCCceeeEE-------EE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEV---RLIAKLQHRNLVRLL-------GC  606 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei---~~l~~l~H~nIv~l~-------g~  606 (709)
                      .++|...+.||+|+||.||+|++. +++.||||++...   .....+.|.+|+   .++.+++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            467888899999999999999975 4899999999743   334567899999   555666899999998       66


Q ss_pred             EEeCC-----------------eeEEEEEccCCCCHHHHHhccCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 005206          607 CVEMD-----------------EKMLVYEYMENRSLDSVIFDKARS----SILNWQRRFNIICGIARGLLYLHQDSRFRI  665 (709)
Q Consensus       607 ~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  665 (709)
                      +.+.+                 ..+|||||+ +|+|.+++......    ..+++..++.|+.||+.||+|||+++   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            66553                 278999999 68999999754221    12446888899999999999999998   9


Q ss_pred             EecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          666 IHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       666 iHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      +||||||+||||+.++.+||+|||+|+...
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~  257 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG  257 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecC
Confidence            999999999999999999999999999653

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.90  E-value=3.8e-23  Score=221.09  Aligned_cols=149  Identities=28%  Similarity=0.422  Sum_probs=132.0

Q ss_pred             HHhcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHh--cCCCceeeEEEEEEeCC----e
Q 005206          539 RATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAK--LQHRNLVRLLGCCVEMD----E  612 (709)
Q Consensus       539 ~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~~~~~----~  612 (709)
                      ...++|...+.||+|+||.||+|+. .++.||||++..   ...+.+.+|++++..  ++||||+++++++....    .
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~  114 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ  114 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred             cccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence            3456899999999999999999998 589999999853   345678889999887  78999999999999876    7


Q ss_pred             eEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEecCCCCCCEEEcCCCcEE
Q 005206          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH--------QDSRFRIIHRDLKASNILLDKEMTPK  684 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~iiHrDlkp~NILl~~~~~~K  684 (709)
                      .++||||+++|+|.+++.+.    .+++..+..++.||+.||.|||        +.+   |+||||||+||||+.++.+|
T Consensus       115 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          115 LWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEE
T ss_pred             eEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEE
Confidence            89999999999999999542    4899999999999999999999        665   99999999999999999999


Q ss_pred             EEecCCceeeCCCC
Q 005206          685 ISDFGMARIFGGDQ  698 (709)
Q Consensus       685 I~DFGla~~l~~~~  698 (709)
                      |+|||+++.+....
T Consensus       188 L~Dfg~~~~~~~~~  201 (342)
T 1b6c_B          188 IADLGLAVRHDSAT  201 (342)
T ss_dssp             ECCCTTCEEEETTT
T ss_pred             EEECCCceeccccc
Confidence            99999999876543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.90  E-value=1.1e-23  Score=244.33  Aligned_cols=143  Identities=30%  Similarity=0.505  Sum_probs=126.1

Q ss_pred             eeecccCceEEEEEEEc---CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          548 NKLGQGGFGIVYKGRLL---EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      ++||+|+||.||+|.+.   .++.||||+++...  ....++|.+|+.++.+++|||||++++++. .+..+|||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            47999999999999764   35789999997542  334678999999999999999999999996 4568999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      |+|.+++...   ..+++..+..|+.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+..+
T Consensus       454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~  522 (635)
T 4fl3_A          454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  522 (635)
T ss_dssp             EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred             CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence            9999999643   34899999999999999999999998   999999999999999999999999999987544

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.90  E-value=1.7e-23  Score=235.63  Aligned_cols=151  Identities=30%  Similarity=0.465  Sum_probs=134.3

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      .++|...++||+|+||.||++... +++.||||++.+.  .....+.+.+|+.++.+++||||+++++++.+....++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            357999999999999999999986 4889999998643  2345678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc---CCCcEEEEecCCceee
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIF  694 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~KI~DFGla~~l  694 (709)
                      ||+++|+|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+|||++   .++.+||+|||+|+.+
T Consensus       101 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            9999999999886543   4899999999999999999999998   99999999999995   4568999999999877


Q ss_pred             CCC
Q 005206          695 GGD  697 (709)
Q Consensus       695 ~~~  697 (709)
                      ...
T Consensus       175 ~~~  177 (486)
T 3mwu_A          175 QQN  177 (486)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.90  E-value=3.2e-23  Score=226.08  Aligned_cols=152  Identities=24%  Similarity=0.381  Sum_probs=126.0

Q ss_pred             HHhcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeC-------
Q 005206          539 RATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-------  610 (709)
Q Consensus       539 ~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-------  610 (709)
                      ...++|...+.||+|+||.||+|.+. +++.||||++.....    ...+|+.+++.++||||+++++++...       
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            45678999999999999999999875 489999999864422    234799999999999999999998543       


Q ss_pred             -------------------------------CeeEEEEEccCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHH
Q 005206          611 -------------------------------DEKMLVYEYMENRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLH  658 (709)
Q Consensus       611 -------------------------------~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH  658 (709)
                                                     ...++||||++ |+|.+.+... .....+++..+..++.||++||.|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                           33789999998 5887777542 22346899999999999999999999


Q ss_pred             hCCCCceEecCCCCCCEEEc-CCCcEEEEecCCceeeCCCC
Q 005206          659 QDSRFRIIHRDLKASNILLD-KEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       659 ~~~~~~iiHrDlkp~NILl~-~~~~~KI~DFGla~~l~~~~  698 (709)
                      +++   |+||||||+|||++ .++.+||+|||+|+.+....
T Consensus       159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  196 (383)
T 3eb0_A          159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE  196 (383)
T ss_dssp             TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS
T ss_pred             HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC
Confidence            987   99999999999998 68899999999999875543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.90  E-value=1.1e-23  Score=224.31  Aligned_cols=155  Identities=28%  Similarity=0.390  Sum_probs=134.8

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcC-CCceeeEEEEEEe--------C
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVE--------M  610 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~--------~  610 (709)
                      ..+|...++||+|+||.||+++.. +++.||||++........+.+.+|+.++.++. ||||+++++++..        .
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            357889999999999999999986 48899999997666666778999999999996 9999999999953        2


Q ss_pred             CeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCC
Q 005206          611 DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (709)
Q Consensus       611 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGl  690 (709)
                      ...++||||++ |+|.+++........+++..+..++.||+.||.|||+++ .+|+||||||+||||+.++.+||+|||+
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  184 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS  184 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence            34789999996 799998876444556999999999999999999999874 3599999999999999999999999999


Q ss_pred             ceeeCCC
Q 005206          691 ARIFGGD  697 (709)
Q Consensus       691 a~~l~~~  697 (709)
                      ++.+...
T Consensus       185 ~~~~~~~  191 (337)
T 3ll6_A          185 ATTISHY  191 (337)
T ss_dssp             CBCCSSC
T ss_pred             ceecccc
Confidence            9987543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.90  E-value=2.4e-23  Score=220.01  Aligned_cols=147  Identities=30%  Similarity=0.566  Sum_probs=125.0

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEE------------
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV------------  608 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~------------  608 (709)
                      ++|...+.||+|+||.||+|.... ++.||||++........+++.+|+.++.+++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            678899999999999999999876 8899999997666666788999999999999999999999873            


Q ss_pred             --eCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-CCCcEEE
Q 005206          609 --EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD-KEMTPKI  685 (709)
Q Consensus       609 --~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~KI  685 (709)
                        +....++||||++ |+|.+++.+    ..+++..+..++.||+.||+|||+++   |+||||||+|||++ +++.+||
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred             ccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence              3467899999998 699998843    34889999999999999999999998   99999999999997 5679999


Q ss_pred             EecCCceeeCC
Q 005206          686 SDFGMARIFGG  696 (709)
Q Consensus       686 ~DFGla~~l~~  696 (709)
                      +|||+++.+..
T Consensus       163 ~Dfg~~~~~~~  173 (320)
T 2i6l_A          163 GDFGLARIMDP  173 (320)
T ss_dssp             CCCTTCBCC--
T ss_pred             ccCccccccCC
Confidence            99999997753

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.90  E-value=3e-23  Score=220.47  Aligned_cols=150  Identities=27%  Similarity=0.402  Sum_probs=127.8

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--------ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--------GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD  611 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~  611 (709)
                      .++|...+.||+|+||.||+|.... ++.||||++....        ......+.+|+.++.+++||||+++++++...+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            3578999999999999999999865 7899999986432        123456899999999999999999999987654


Q ss_pred             eeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc---EEEEec
Q 005206          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT---PKISDF  688 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~KI~DF  688 (709)
                       .++||||+++++|.+++...   ..+++.....++.||+.||.|||+++   |+||||||+|||++.++.   +||+||
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             -eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence             89999999999999988543   35899999999999999999999997   999999999999987654   999999


Q ss_pred             CCceeeCCC
Q 005206          689 GMARIFGGD  697 (709)
Q Consensus       689 Gla~~l~~~  697 (709)
                      |+++.+...
T Consensus       162 g~~~~~~~~  170 (322)
T 2ycf_A          162 GHSKILGET  170 (322)
T ss_dssp             TTCEECCCC
T ss_pred             ccceecccc
Confidence            999987543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.90  E-value=5.5e-24  Score=223.28  Aligned_cols=153  Identities=27%  Similarity=0.452  Sum_probs=120.1

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      .++|...+.||+|+||.||+|... +++.||||++.... ....+++.+|+.++.+++||||+++++++...+..++|||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            468999999999999999999875 48899999886442 3446788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          619 YMENRSLDSVIFDK-----ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       619 y~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      |+++++|.+++...     .....+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++.
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  170 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAF  170 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence            99999999998642     12345899999999999999999999997   99999999999999999999999999987


Q ss_pred             eCC
Q 005206          694 FGG  696 (709)
Q Consensus       694 l~~  696 (709)
                      +..
T Consensus       171 ~~~  173 (303)
T 2vwi_A          171 LAT  173 (303)
T ss_dssp             CC-
T ss_pred             ecc
Confidence            643

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.90  E-value=9.9e-24  Score=226.35  Aligned_cols=152  Identities=28%  Similarity=0.436  Sum_probs=134.4

Q ss_pred             hcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCc---cc--------------hHHHHHHHHHHHhcCCCceeeE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG---QG--------------IEEFKNEVRLIAKLQHRNLVRL  603 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~---~~--------------~~~f~~Ei~~l~~l~H~nIv~l  603 (709)
                      .++|...+.||+|+||.||+|.. +++.||||++.....   ..              .+.|.+|+.++.+++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            36799999999999999999999 899999999964321   11              1889999999999999999999


Q ss_pred             EEEEEeCCeeEEEEEccCCCCHHHH------HhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCCEE
Q 005206          604 LGCCVEMDEKMLVYEYMENRSLDSV------IFDKARSSILNWQRRFNIICGIARGLLYLHQ-DSRFRIIHRDLKASNIL  676 (709)
Q Consensus       604 ~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NIL  676 (709)
                      ++++.+.+..++||||+++++|.++      +.. .....+++..+..++.||+.||.|||+ .+   |+||||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999988      432 124568999999999999999999999 76   999999999999


Q ss_pred             EcCCCcEEEEecCCceeeCCC
Q 005206          677 LDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       677 l~~~~~~KI~DFGla~~l~~~  697 (709)
                      ++.++.+||+|||+++.+...
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~  205 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK  205 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT
T ss_pred             EcCCCcEEEeccccccccccc
Confidence            999999999999999987543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.90  E-value=2.5e-23  Score=221.90  Aligned_cols=161  Identities=27%  Similarity=0.401  Sum_probs=136.2

Q ss_pred             ChHHHHHHhcCcCcc-eeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhc-CCCceeeEEEEE
Q 005206          533 DFETIVRATDNFTDY-NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCC  607 (709)
Q Consensus       533 ~~~~l~~~t~~f~~~-~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~  607 (709)
                      .+.......+.|... ++||+|+||.||+|.... ++.||||++...  ......++.+|+.++.++ +||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            333444455677776 889999999999999875 899999999754  234467899999999999 469999999999


Q ss_pred             EeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCcEE
Q 005206          608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK---EMTPK  684 (709)
Q Consensus       608 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~K  684 (709)
                      .+.+..++||||+++|+|.+++... ....+++..+..++.||+.||+|||+++   |+||||||+|||++.   ++.+|
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k  174 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK  174 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence            9999999999999999999988543 2345899999999999999999999998   999999999999998   78999


Q ss_pred             EEecCCceeeCCC
Q 005206          685 ISDFGMARIFGGD  697 (709)
Q Consensus       685 I~DFGla~~l~~~  697 (709)
                      |+|||+++.+...
T Consensus       175 L~Dfg~a~~~~~~  187 (327)
T 3lm5_A          175 IVDFGMSRKIGHA  187 (327)
T ss_dssp             ECCGGGCEEC---
T ss_pred             EeeCccccccCCc
Confidence            9999999987544

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.90  E-value=2.8e-23  Score=217.77  Aligned_cols=150  Identities=30%  Similarity=0.547  Sum_probs=131.1

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ++|...+.||+|+||.||+|+.. +++.||||++....  ....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (299)
T 2r3i_A            3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence            57888999999999999999986 48999999986542  2345788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |++ ++|.+++.... ...+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++.+..
T Consensus        83 ~~~-~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  155 (299)
T 2r3i_A           83 FLH-QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV  155 (299)
T ss_dssp             CCS-EEHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred             ccc-CCHHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccC
Confidence            998 69999986543 234889999999999999999999997   99999999999999999999999999987654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.89  E-value=2.6e-23  Score=227.77  Aligned_cols=150  Identities=26%  Similarity=0.422  Sum_probs=125.7

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCe------eEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE------KML  615 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~------~~l  615 (709)
                      .+|...++||+|+||.||+|++..+..||+|++.....    ...+|+.++..++||||+++++++.....      .++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            46888999999999999999998888899999864422    22369999999999999999999976443      789


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-CCCcEEEEecCCceee
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD-KEMTPKISDFGMARIF  694 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~KI~DFGla~~l  694 (709)
                      ||||++++.+............+++..+..++.||++||+|||+++   |+||||||+||||+ .++.+||+|||+|+.+
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            9999987655444332233456899999999999999999999998   99999999999999 7999999999999987


Q ss_pred             CCCC
Q 005206          695 GGDQ  698 (709)
Q Consensus       695 ~~~~  698 (709)
                      ....
T Consensus       193 ~~~~  196 (394)
T 4e7w_A          193 IAGE  196 (394)
T ss_dssp             CTTC
T ss_pred             cCCC
Confidence            5443

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.89  E-value=4e-23  Score=223.69  Aligned_cols=149  Identities=26%  Similarity=0.453  Sum_probs=131.1

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeC-----Cee
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-----DEK  613 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~  613 (709)
                      .++|...+.||+|+||.||++.... ++.||||++.... ....+.+.+|+.++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            3579999999999999999998764 7889999997543 33457899999999999999999999999765     367


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ++||||++ |+|.+++...    .+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.
T Consensus       106 ~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999998 5899888542    4899999999999999999999998   99999999999999999999999999998


Q ss_pred             eCCC
Q 005206          694 FGGD  697 (709)
Q Consensus       694 l~~~  697 (709)
                      ....
T Consensus       178 ~~~~  181 (364)
T 3qyz_A          178 ADPD  181 (364)
T ss_dssp             CCGG
T ss_pred             cCCC
Confidence            7544

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.89  E-value=3.2e-23  Score=221.21  Aligned_cols=145  Identities=34%  Similarity=0.566  Sum_probs=122.1

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHH--HHhcCCCceeeEEEEEEe-----CCeeE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRL--IAKLQHRNLVRLLGCCVE-----MDEKM  614 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~--l~~l~H~nIv~l~g~~~~-----~~~~~  614 (709)
                      ++|...++||+|+||.||+|+. +++.||||++...   ....+..|.++  +..++||||+++++.+..     ....+
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~   88 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL   88 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence            5788899999999999999977 6899999998643   23445555554  445899999999987653     22468


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCceEecCCCCCCEEEcCCCcEEE
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD---------SRFRIIHRDLKASNILLDKEMTPKI  685 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------~~~~iiHrDlkp~NILl~~~~~~KI  685 (709)
                      +||||+++|+|.+++...    ..++..+..++.||+.||.|||+.         +   |+||||||+||||+.++.+||
T Consensus        89 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           89 LVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEE
T ss_pred             EEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEE
Confidence            999999999999999543    258899999999999999999998         6   999999999999999999999


Q ss_pred             EecCCceeeCCC
Q 005206          686 SDFGMARIFGGD  697 (709)
Q Consensus       686 ~DFGla~~l~~~  697 (709)
                      +|||+|+.+...
T Consensus       162 ~DFG~a~~~~~~  173 (336)
T 3g2f_A          162 SDFGLSMRLTGN  173 (336)
T ss_dssp             CCCTTCEECSSS
T ss_pred             eeccceeecccc
Confidence            999999987543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.89  E-value=1.9e-23  Score=215.34  Aligned_cols=151  Identities=24%  Similarity=0.401  Sum_probs=132.6

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~  617 (709)
                      ++|...+.||+|+||.||+|++. ++.||||++....  ....++|.+|+.++.+++||||+++++++.+.  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            56888899999999999999985 8899999997542  34456899999999999999999999999887  6789999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ||+++|+|.+++.... ...+++..+..++.||+.||.|||+++ .+|+||||||+|||++.++.+||.|||++....
T Consensus        89 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             ECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             cccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            9999999999996533 235899999999999999999999874 359999999999999999999999999886543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.89  E-value=1.9e-23  Score=224.47  Aligned_cols=149  Identities=18%  Similarity=0.303  Sum_probs=123.9

Q ss_pred             cCcCcceeecccCceEEEEEEEc----CCcEEEEEEeccCCcc-----------chHHHHHHHHHHHhcCCCceeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSRNSGQ-----------GIEEFKNEVRLIAKLQHRNLVRLLGC  606 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~~~-----------~~~~f~~Ei~~l~~l~H~nIv~l~g~  606 (709)
                      ++|...+.||+|+||.||+|...    .+..+|||++......           ..+.+.+|+..+..++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            57889999999999999999986    4678999998754321           12346788899999999999999999


Q ss_pred             EEe----CCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-
Q 005206          607 CVE----MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-  681 (709)
Q Consensus       607 ~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-  681 (709)
                      +..    ....++||||+ +++|.+++....   .+++..+..++.||+.||+|||+++   |+||||||+||||+.++ 
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSST
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCC
Confidence            988    67889999999 999999986543   5899999999999999999999997   99999999999999887 


Q ss_pred             -cEEEEecCCceeeCCC
Q 005206          682 -TPKISDFGMARIFGGD  697 (709)
Q Consensus       682 -~~KI~DFGla~~l~~~  697 (709)
                       .+||+|||+|+.+...
T Consensus       190 ~~~kL~Dfg~a~~~~~~  206 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPN  206 (345)
T ss_dssp             TSEEECCCTTCEESSGG
T ss_pred             CcEEEEeCCCceecccc
Confidence             9999999999987543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.89  E-value=2.4e-23  Score=234.15  Aligned_cols=151  Identities=31%  Similarity=0.470  Sum_probs=135.2

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      .++|...++||+|+||.||++... .++.||||++....   ....+.+.+|+.++.+++||||+++++++.+....++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            357888999999999999999987 58999999996542   34567899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE---cCCCcEEEEecCCcee
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARI  693 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~KI~DFGla~~  693 (709)
                      |||+++|+|.+++...   ..+++..+..++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+|+.
T Consensus       105 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          105 GEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             ECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            9999999999988653   34899999999999999999999998   9999999999999   5678999999999998


Q ss_pred             eCCC
Q 005206          694 FGGD  697 (709)
Q Consensus       694 l~~~  697 (709)
                      +...
T Consensus       179 ~~~~  182 (484)
T 3nyv_A          179 FEAS  182 (484)
T ss_dssp             BCCC
T ss_pred             cccc
Confidence            7544

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.89  E-value=4.7e-23  Score=215.35  Aligned_cols=151  Identities=29%  Similarity=0.392  Sum_probs=130.2

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEe----CCeeEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE----MDEKML  615 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~l  615 (709)
                      .|...+.||+|+||.||+|.... +..||+|++...  .....+.+.+|+.++.+++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            46777899999999999998865 788999998654  33456789999999999999999999999876    345799


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-CCCcEEEEecCCceee
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD-KEMTPKISDFGMARIF  694 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~KI~DFGla~~l  694 (709)
                      ||||+++++|.+++...   ..+++..+..++.||+.||.|||+++ .+|+||||||+|||++ .++.+||+|||+++..
T Consensus       107 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            99999999999999654   34889999999999999999999874 3599999999999998 7899999999999865


Q ss_pred             CCC
Q 005206          695 GGD  697 (709)
Q Consensus       695 ~~~  697 (709)
                      ...
T Consensus       183 ~~~  185 (290)
T 1t4h_A          183 RAS  185 (290)
T ss_dssp             CTT
T ss_pred             ccc
Confidence            443

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.89  E-value=1.7e-23  Score=218.24  Aligned_cols=153  Identities=27%  Similarity=0.370  Sum_probs=121.2

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCc-cc-hHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG-QG-IEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      .++|...+.||+|+||.||++... +++.||||++..... .. .+.+.++...+..++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            467889999999999999999985 588999999965422 22 334455555678889999999999999999999999


Q ss_pred             EccCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          618 EYMENRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLHQD-SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ||++ |+|.+++... .....+++..+..++.||+.||.|||++ +   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9998 5888877542 2334689999999999999999999997 7   9999999999999999999999999998775


Q ss_pred             CC
Q 005206          696 GD  697 (709)
Q Consensus       696 ~~  697 (709)
                      ..
T Consensus       162 ~~  163 (290)
T 3fme_A          162 DD  163 (290)
T ss_dssp             --
T ss_pred             cc
Confidence            44

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.89  E-value=2.9e-23  Score=215.94  Aligned_cols=151  Identities=25%  Similarity=0.399  Sum_probs=130.3

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC----CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      .++|...+.||+|+||.||+|....    +..||||++.... ....++|.+|+.++.+++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            4678888999999999999998754    2369999997653 3456789999999999999999999999764 56799


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ||||+++++|.+++....  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        90 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            999999999999996532  34899999999999999999999998   9999999999999999999999999998775


Q ss_pred             CC
Q 005206          696 GD  697 (709)
Q Consensus       696 ~~  697 (709)
                      ..
T Consensus       165 ~~  166 (281)
T 3cc6_A          165 DE  166 (281)
T ss_dssp             --
T ss_pred             cc
Confidence            43

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.89  E-value=2.1e-23  Score=216.48  Aligned_cols=157  Identities=29%  Similarity=0.456  Sum_probs=132.4

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEe--CCeeEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE--MDEKML  615 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~l  615 (709)
                      .++|...+.||+|+||.||++... +++.||+|++....  ....+.+.+|+.++.+++||||+++++++.+  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            367889999999999999999986 48899999997542  3445679999999999999999999998865  567899


Q ss_pred             EEEccCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCCEEEcCCCcEEEEecCCce
Q 005206          616 VYEYMENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDS--RFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlkp~NILl~~~~~~KI~DFGla~  692 (709)
                      ||||+++++|.+++.... ....+++..+..++.||+.||+|||+.+  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999997543 2345899999999999999999999975  1249999999999999999999999999998


Q ss_pred             eeCCC
Q 005206          693 IFGGD  697 (709)
Q Consensus       693 ~l~~~  697 (709)
                      .+...
T Consensus       165 ~~~~~  169 (279)
T 2w5a_A          165 ILNHD  169 (279)
T ss_dssp             HC---
T ss_pred             eeccc
Confidence            77543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.89  E-value=5.3e-23  Score=221.07  Aligned_cols=149  Identities=26%  Similarity=0.442  Sum_probs=130.5

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeC-----Cee
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-----DEK  613 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~  613 (709)
                      .++|...+.||+|+||.||+|.... ++.||||++.... .....++.+|+.++.+++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            3678999999999999999999864 8899999996543 33456788999999999999999999998764     678


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ++||||++ ++|.+++..    ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 689988854    24899999999999999999999997   99999999999999999999999999998


Q ss_pred             eCCC
Q 005206          694 FGGD  697 (709)
Q Consensus       694 l~~~  697 (709)
                      +...
T Consensus       162 ~~~~  165 (353)
T 2b9h_A          162 IDES  165 (353)
T ss_dssp             CC--
T ss_pred             cccc
Confidence            7543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.89  E-value=7e-23  Score=214.44  Aligned_cols=142  Identities=9%  Similarity=0.027  Sum_probs=126.5

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCc---cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...+.||+|+||.||+|.... ++.||||++.....   ...++|.+|+.++.+++||||+++++++.+.+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            579999999999999999999865 89999999975432   33478999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCc
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla  691 (709)
                      ||+++++|.+++.+.     ....+...|+.||+.||+|||+++   |+||||||+||||+.++.+||+++|..
T Consensus       111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~  176 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATM  176 (286)
T ss_dssp             ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred             EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecccc
Confidence            999999999998431     345567889999999999999998   999999999999999999999988754

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.89  E-value=5.1e-23  Score=227.42  Aligned_cols=148  Identities=30%  Similarity=0.459  Sum_probs=122.5

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeC----C--eeE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM----D--EKM  614 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~----~--~~~  614 (709)
                      .+|...+.||+|+||.||+|++.. ++.||||++....    +.+.+|++++.+++|||||++++++...    +  ..+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            468888999999999999999865 8999999986432    2234799999999999999999998642    2  257


Q ss_pred             EEEEccCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CcEEEEecCCce
Q 005206          615 LVYEYMENRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMAR  692 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~KI~DFGla~  692 (709)
                      +||||+++ +|.+++... .....+++..+..++.||++||+|||+++   |+||||||+||||+.+ +.+||+|||+|+
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            89999986 565555431 22346899999999999999999999987   9999999999999965 678999999999


Q ss_pred             eeCCC
Q 005206          693 IFGGD  697 (709)
Q Consensus       693 ~l~~~  697 (709)
                      .+...
T Consensus       206 ~~~~~  210 (420)
T 1j1b_A          206 QLVRG  210 (420)
T ss_dssp             ECCTT
T ss_pred             hcccC
Confidence            87544

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.89  E-value=4.6e-23  Score=215.15  Aligned_cols=150  Identities=31%  Similarity=0.475  Sum_probs=124.3

Q ss_pred             cCcCcceeecccCceEEEEEEEcC--Cc--EEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE--GQ--EIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~--g~--~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  614 (709)
                      ++|...+.||+|+||.||+|++..  ++  .||||++...   .....+++.+|+.++.+++||||+++++++.+.. .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            578889999999999999998643  33  6899988654   2345678999999999999999999999998754 89


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      +|+||+++++|.+++....  ..+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++.+
T Consensus        97 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence            9999999999999996543  34889999999999999999999997   999999999999999999999999999987


Q ss_pred             CCC
Q 005206          695 GGD  697 (709)
Q Consensus       695 ~~~  697 (709)
                      ...
T Consensus       172 ~~~  174 (291)
T 1u46_A          172 PQN  174 (291)
T ss_dssp             CC-
T ss_pred             ccc
Confidence            554

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.89  E-value=6.1e-23  Score=222.93  Aligned_cols=147  Identities=31%  Similarity=0.466  Sum_probs=124.9

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC------
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD------  611 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------  611 (709)
                      .++|...+.||+|+||.||+|.... ++.||||++...  .....+++.+|+.++.+++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            3679999999999999999998764 889999999754  2334567899999999999999999999998765      


Q ss_pred             eeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCc
Q 005206          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla  691 (709)
                      ..++||||+++ +|.+++..     .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            67999999985 78777742     3889999999999999999999998   999999999999999999999999999


Q ss_pred             eeeCC
Q 005206          692 RIFGG  696 (709)
Q Consensus       692 ~~l~~  696 (709)
                      +....
T Consensus       175 ~~~~~  179 (371)
T 2xrw_A          175 RTAGT  179 (371)
T ss_dssp             -----
T ss_pred             ccccc
Confidence            97754

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.89  E-value=6.7e-23  Score=220.94  Aligned_cols=159  Identities=25%  Similarity=0.335  Sum_probs=121.8

Q ss_pred             HHHHHHhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCe-
Q 005206          535 ETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE-  612 (709)
Q Consensus       535 ~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-  612 (709)
                      +......++|...+.||+|+||.||+|+... ++.||||++... .....++.+|+..+..++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            4456677899999999999999999999864 889999998643 3334567788999999999999999999976443 


Q ss_pred             ------eEEEEEccCCCCHHHHHhc-cCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCceEecCCCCCCEEEcC-CCc
Q 005206          613 ------KMLVYEYMENRSLDSVIFD-KARSSILNWQRRFNIICGIARGLLYLH--QDSRFRIIHRDLKASNILLDK-EMT  682 (709)
Q Consensus       613 ------~~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~iiHrDlkp~NILl~~-~~~  682 (709)
                            .++||||++++ |...+.. ......+++..+..++.||+.||.|||  +.+   |+||||||+||||+. ++.
T Consensus        95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred             cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence                  78999999874 4444332 233456889999999999999999999  776   999999999999997 899


Q ss_pred             EEEEecCCceeeCCCC
Q 005206          683 PKISDFGMARIFGGDQ  698 (709)
Q Consensus       683 ~KI~DFGla~~l~~~~  698 (709)
                      +||+|||+|+.+....
T Consensus       171 ~kl~Dfg~a~~~~~~~  186 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSE  186 (360)
T ss_dssp             EEECCCTTCBCCCTTS
T ss_pred             EEEeeCCCceecCCCC
Confidence            9999999999876543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.89  E-value=1.3e-22  Score=213.28  Aligned_cols=147  Identities=27%  Similarity=0.356  Sum_probs=127.9

Q ss_pred             cCcCcc-eeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHH-HhcCCCceeeEEEEEEe----CCeeE
Q 005206          542 DNFTDY-NKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLI-AKLQHRNLVRLLGCCVE----MDEKM  614 (709)
Q Consensus       542 ~~f~~~-~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l-~~l~H~nIv~l~g~~~~----~~~~~  614 (709)
                      ++|... +.||+|+||.||++... +++.||||++..     ...+.+|+.++ ..++||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            567766 67999999999999985 488999999853     35677899888 55699999999999987    66789


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCcEEEEecCCc
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK---EMTPKISDFGMA  691 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~KI~DFGla  691 (709)
                      +||||+++|+|.+++.... ...+++..+..++.||+.||.|||+++   |+||||||+|||++.   ++.+||+|||+|
T Consensus        92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            9999999999999997643 345899999999999999999999998   999999999999998   789999999999


Q ss_pred             eeeCCC
Q 005206          692 RIFGGD  697 (709)
Q Consensus       692 ~~l~~~  697 (709)
                      +.+.+.
T Consensus       168 ~~~~~~  173 (299)
T 3m2w_A          168 KETTGE  173 (299)
T ss_dssp             EECTTC
T ss_pred             cccccc
Confidence            987543

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.89  E-value=2.1e-23  Score=216.61  Aligned_cols=148  Identities=30%  Similarity=0.515  Sum_probs=125.2

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeC-CeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-DEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~lV~Ey~  620 (709)
                      ++|...+.||+|+||.||+++. .++.||||++...  ...++|.+|+.++.+++||||+++++++.+. +..++||||+
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   97 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   97 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             hhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence            5788899999999999999987 4889999998643  3567899999999999999999999997655 4689999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++....
T Consensus        98 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           98 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             CCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            9999999996532 123788999999999999999999997   99999999999999999999999999987644

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.89  E-value=2.3e-23  Score=220.38  Aligned_cols=157  Identities=24%  Similarity=0.348  Sum_probs=133.5

Q ss_pred             hHHHHHHhcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccC--CccchHHHHHHHHHHHhcC--CCceeeEEEEEEe
Q 005206          534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQ--HRNLVRLLGCCVE  609 (709)
Q Consensus       534 ~~~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~  609 (709)
                      ++.+....++|...+.||+|+||.||++...+++.||||++...  .....+++.+|+.++.+++  ||||+++++++.+
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   99 (313)
T 3cek_A           20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   99 (313)
T ss_dssp             CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred             eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence            33344455779999999999999999999988999999999654  2345678999999999997  5999999999999


Q ss_pred             CCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecC
Q 005206          610 MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG  689 (709)
Q Consensus       610 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFG  689 (709)
                      .+..++||| +.+++|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+|||+++ +.+||+|||
T Consensus       100 ~~~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg  171 (313)
T 3cek_A          100 DQYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFG  171 (313)
T ss_dssp             SSEEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCS
T ss_pred             CCEEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecc
Confidence            999999999 66889999996543   4889999999999999999999997   999999999999964 899999999


Q ss_pred             CceeeCCCC
Q 005206          690 MARIFGGDQ  698 (709)
Q Consensus       690 la~~l~~~~  698 (709)
                      +++.+....
T Consensus       172 ~~~~~~~~~  180 (313)
T 3cek_A          172 IANQMQPDT  180 (313)
T ss_dssp             SSCC-----
T ss_pred             ccccccCcc
Confidence            999875543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.89  E-value=4e-23  Score=242.17  Aligned_cols=147  Identities=22%  Similarity=0.347  Sum_probs=128.2

Q ss_pred             cCcCcceeecccCceEEEEEEEc--CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCe-----e
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL--EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE-----K  613 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~--~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-----~  613 (709)
                      ++|...+.||+|+||.||++.+.  +++.||||++.... ....+.|.+|+.++.+++||||+++++++.+.+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            68999999999999999999986  48899999986543 3445678999999999999999999999988665     6


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      +|||||+++++|.+++..     .+++.+++.|+.||+.||.|||+++   ||||||||+||||+.+ .+||+|||+++.
T Consensus       160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence            999999999999887633     4899999999999999999999998   9999999999999986 899999999998


Q ss_pred             eCCC
Q 005206          694 FGGD  697 (709)
Q Consensus       694 l~~~  697 (709)
                      +...
T Consensus       231 ~~~~  234 (681)
T 2pzi_A          231 INSF  234 (681)
T ss_dssp             TTCC
T ss_pred             cccC
Confidence            7543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.89  E-value=2.5e-23  Score=225.74  Aligned_cols=148  Identities=32%  Similarity=0.490  Sum_probs=115.7

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeC------C
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM------D  611 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~  611 (709)
                      .++|...+.||+|+||.||+|.... ++.||||++...  .....+++.+|+.++.+++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            3689999999999999999998754 889999999654  233457889999999999999999999998764      5


Q ss_pred             eeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCc
Q 005206          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla  691 (709)
                      ..++|+||+ +++|.+++..    ..+++..+..++.||++||.|||+.+   |+||||||+||||+.++.+||+|||+|
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            579999999 6899888743    34899999999999999999999998   999999999999999999999999999


Q ss_pred             eeeCC
Q 005206          692 RIFGG  696 (709)
Q Consensus       692 ~~l~~  696 (709)
                      +....
T Consensus       180 ~~~~~  184 (367)
T 2fst_X          180 RHTAD  184 (367)
T ss_dssp             -----
T ss_pred             ccccc
Confidence            87643

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.89  E-value=4.9e-23  Score=239.85  Aligned_cols=153  Identities=22%  Similarity=0.357  Sum_probs=132.8

Q ss_pred             HHhcCcCcceeecccCceEEEEEEEcC----CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCee
Q 005206          539 RATDNFTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (709)
Q Consensus       539 ~~t~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  613 (709)
                      ...++|...+.||+|+||.||+|.+..    +..||||++.... ....++|.+|+.++.+++||||+++++++. .+..
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~  465 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV  465 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence            345678889999999999999998753    4579999986543 334578999999999999999999999984 4678


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ++||||+++|+|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+.
T Consensus       466 ~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             EEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence            9999999999999999643  235899999999999999999999997   99999999999999999999999999998


Q ss_pred             eCCC
Q 005206          694 FGGD  697 (709)
Q Consensus       694 l~~~  697 (709)
                      +...
T Consensus       541 ~~~~  544 (656)
T 2j0j_A          541 MEDS  544 (656)
T ss_dssp             CCC-
T ss_pred             cCCC
Confidence            7543

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.89  E-value=2e-23  Score=238.95  Aligned_cols=150  Identities=17%  Similarity=0.224  Sum_probs=114.7

Q ss_pred             eecccCceEEEEEEEc-CCcEEEEEEeccCC----------ccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEE
Q 005206          549 KLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS----------GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       549 ~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~----------~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      ..+.|++|.+..++.. -|+.+|||.+.+..          +...++|.+|+++|.++ .|+||+++++++.+....|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            4667777766665432 37889999996541          22346799999999999 799999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||++|++|.++|.+.   ..++..   +|+.||+.||+|||+++   ||||||||+||||++++.+||+|||+|+.+..
T Consensus       321 MEyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            9999999999999653   346654   48899999999999998   99999999999999999999999999998865


Q ss_pred             CCccccccceecC
Q 005206          697 DQTEQNTKRVVGT  709 (709)
Q Consensus       697 ~~~~~~~~~~~GT  709 (709)
                      +.+.  +..++||
T Consensus       392 ~~~~--~~t~vGT  402 (569)
T 4azs_A          392 DCSW--PTNLVQS  402 (569)
T ss_dssp             --CC--SHHHHHH
T ss_pred             CCcc--ccCceec
Confidence            5432  2334554

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.88  E-value=1.4e-22  Score=211.49  Aligned_cols=151  Identities=30%  Similarity=0.455  Sum_probs=134.5

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      .++|...+.||+|+||.||+|+.. +++.||||++...  .....+.+.+|+.++.+++||||+++++++.+.+..++|+
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            467999999999999999999986 4889999998654  2345678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC---CcEEEEecCCceee
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE---MTPKISDFGMARIF  694 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~KI~DFGla~~l  694 (709)
                      ||+++++|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+||+++.+   ..+||+|||+++.+
T Consensus       101 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A          101 ELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             EccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            9999999999886543   4899999999999999999999997   9999999999999764   47999999999877


Q ss_pred             CCC
Q 005206          695 GGD  697 (709)
Q Consensus       695 ~~~  697 (709)
                      ...
T Consensus       175 ~~~  177 (287)
T 2wei_A          175 QQN  177 (287)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            544

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.88  E-value=9.4e-23  Score=216.52  Aligned_cols=152  Identities=30%  Similarity=0.501  Sum_probs=129.6

Q ss_pred             HhcCcCcceeecccCceEEEEEEEc--CCcEEEEEEeccCC--ccchHHHHHHHHHHHhc---CCCceeeEEEEEE----
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLL--EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKL---QHRNLVRLLGCCV----  608 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~--~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~----  608 (709)
                      +.++|...+.||+|+||.||+|...  +++.||||++....  ......+.+|+.++.++   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999984  57899999986432  22344677888877766   8999999999987    


Q ss_pred             -eCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEe
Q 005206          609 -EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISD  687 (709)
Q Consensus       609 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~D  687 (709)
                       .....++||||++ |+|.+++.... ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence             4566899999998 69999986543 234899999999999999999999998   99999999999999999999999


Q ss_pred             cCCceeeCC
Q 005206          688 FGMARIFGG  696 (709)
Q Consensus       688 FGla~~l~~  696 (709)
                      ||+++.+..
T Consensus       164 fg~~~~~~~  172 (326)
T 1blx_A          164 FGLARIYSF  172 (326)
T ss_dssp             CCSCCCCCG
T ss_pred             CcccccccC
Confidence            999987753

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.88  E-value=2.3e-23  Score=224.36  Aligned_cols=146  Identities=20%  Similarity=0.318  Sum_probs=128.1

Q ss_pred             cCcCcceeecccCceEEEEEEEcC---------CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceee----------
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE---------GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR----------  602 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~---------g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~----------  602 (709)
                      ++|...+.||+|+||.||+|+...         ++.||||++...     +.+.+|+.++.+++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            678999999999999999999864         789999998643     47889999999999999987          


Q ss_pred             -----EEEEEEe-CCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEE
Q 005206          603 -----LLGCCVE-MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNIL  676 (709)
Q Consensus       603 -----l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NIL  676 (709)
                           +++++.. ....++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+++   |+||||||+|||
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl  191 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF  191 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence                 6788877 67889999999 999999997542 245899999999999999999999997   999999999999


Q ss_pred             EcCCC--cEEEEecCCceeeCCC
Q 005206          677 LDKEM--TPKISDFGMARIFGGD  697 (709)
Q Consensus       677 l~~~~--~~KI~DFGla~~l~~~  697 (709)
                      ++.++  .+||+|||+++.+...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~  214 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPS  214 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGG
T ss_pred             EcCCCCceEEEecCcceeeccCC
Confidence            99998  9999999999887543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.88  E-value=2.3e-22  Score=210.16  Aligned_cols=151  Identities=23%  Similarity=0.384  Sum_probs=125.9

Q ss_pred             HhcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEE-EeCCeeEEEE
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC-VEMDEKMLVY  617 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~-~~~~~~~lV~  617 (709)
                      ..++|...+.||+|+||.||+|+.. .++.||||++....  ..+++.+|+.++.+++|++++..++.+ .+.+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            3578999999999999999999974 58899999875432  234688999999999988776666555 6677889999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE---cCCCcEEEEecCCceee
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIF  694 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~KI~DFGla~~l  694 (709)
                      ||+ +++|.+++....  ..+++..+..++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+|+.+
T Consensus        85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 999999986432  34899999999999999999999998   9999999999999   78999999999999988


Q ss_pred             CCCC
Q 005206          695 GGDQ  698 (709)
Q Consensus       695 ~~~~  698 (709)
                      ....
T Consensus       159 ~~~~  162 (296)
T 4hgt_A          159 RDAR  162 (296)
T ss_dssp             BCTT
T ss_pred             cCcc
Confidence            6553

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.88  E-value=2.4e-22  Score=222.70  Aligned_cols=150  Identities=23%  Similarity=0.296  Sum_probs=130.3

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhc------CCCceeeEEEEEEeCCee
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKL------QHRNLVRLLGCCVEMDEK  613 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l------~H~nIv~l~g~~~~~~~~  613 (709)
                      ..+|...++||+|+||.||+|.... ++.||||++... ....+++.+|+.++..+      .|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            3578999999999999999998865 789999999643 33456788899988887      577999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc--EEEEecCCc
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT--PKISDFGMA  691 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~--~KI~DFGla  691 (709)
                      ++||||+. ++|.+++.... ...+++..+..++.||+.||+|||+++   |+||||||+||||+.++.  +||+|||+|
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999996 68998886543 234899999999999999999999997   999999999999999987  999999999


Q ss_pred             eeeCC
Q 005206          692 RIFGG  696 (709)
Q Consensus       692 ~~l~~  696 (709)
                      +....
T Consensus       250 ~~~~~  254 (429)
T 3kvw_A          250 CYEHQ  254 (429)
T ss_dssp             EETTC
T ss_pred             eecCC
Confidence            87643

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.88  E-value=5.4e-23  Score=223.20  Aligned_cols=149  Identities=12%  Similarity=0.148  Sum_probs=113.7

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCc---cchHHHHHHHHHHHhc--CCCceeeEE-------EEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKL--QHRNLVRLL-------GCCV  608 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l--~H~nIv~l~-------g~~~  608 (709)
                      .+|...+.||+|+||.||+|++. +++.||||++.....   ...+.+.+|+.++..+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45888899999999999999986 588999999976532   3456788886555555  699988755       4544


Q ss_pred             eC-----------------CeeEEEEEccCCCCHHHHHhccCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCce
Q 005206          609 EM-----------------DEKMLVYEYMENRSLDSVIFDKARSSILNWQRR------FNIICGIARGLLYLHQDSRFRI  665 (709)
Q Consensus       609 ~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~i  665 (709)
                      ..                 ...+|||||++ |+|.+++.....  .+++..+      +.++.||+.||+|||+++   |
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i  215 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG---L  215 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence            33                 23799999999 899999976432  2455555      778899999999999998   9


Q ss_pred             EecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          666 IHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       666 iHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      +||||||+||||+.++.+||+|||+|+....
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~  246 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT  246 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTC
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCC
Confidence            9999999999999999999999999997754

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.88  E-value=5.1e-22  Score=207.72  Aligned_cols=150  Identities=23%  Similarity=0.378  Sum_probs=128.6

Q ss_pred             hcCcCcceeecccCceEEEEEEE-cCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEE-EeCCeeEEEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC-VEMDEKMLVYE  618 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~-~~~~~~~lV~E  618 (709)
                      .++|...+.||+|+||.||+|+. .+++.||||++....  ..+++.+|+.++.+++|++++..+..+ .+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46899999999999999999997 458999999986543  235789999999999988766555554 66778899999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE---cCCCcEEEEecCCceeeC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFG  695 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~KI~DFGla~~l~  695 (709)
                      |+ +++|.+++....  ..+++..+..++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+++.+.
T Consensus        86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 999999996432  35899999999999999999999998   9999999999999   588999999999999886


Q ss_pred             CCC
Q 005206          696 GDQ  698 (709)
Q Consensus       696 ~~~  698 (709)
                      ...
T Consensus       160 ~~~  162 (296)
T 3uzp_A          160 DAR  162 (296)
T ss_dssp             CTT
T ss_pred             ccc
Confidence            554

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.88  E-value=7.5e-23  Score=216.17  Aligned_cols=153  Identities=27%  Similarity=0.401  Sum_probs=125.8

Q ss_pred             HHhcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCc------cchHHHHHHHHHHHhc----CCCceeeEEEEE
Q 005206          539 RATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG------QGIEEFKNEVRLIAKL----QHRNLVRLLGCC  607 (709)
Q Consensus       539 ~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~------~~~~~f~~Ei~~l~~l----~H~nIv~l~g~~  607 (709)
                      ...++|...+.||+|+||.||+|... +++.||||++.....      .....+.+|+.++.++    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            34578999999999999999999875 488999999965432      2234567899999998    899999999999


Q ss_pred             EeCCeeEEEEEc-cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-CCCcEEE
Q 005206          608 VEMDEKMLVYEY-MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD-KEMTPKI  685 (709)
Q Consensus       608 ~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~KI  685 (709)
                      ...+..++|+|| +++++|.+++.+..   .+++..+..++.||+.||.|||+++   |+||||||+||+++ .++.+||
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence            999999999999 78999999996643   4899999999999999999999997   99999999999999 8899999


Q ss_pred             EecCCceeeCCC
Q 005206          686 SDFGMARIFGGD  697 (709)
Q Consensus       686 ~DFGla~~l~~~  697 (709)
                      +|||+++.+...
T Consensus       182 ~dfg~~~~~~~~  193 (312)
T 2iwi_A          182 IDFGSGALLHDE  193 (312)
T ss_dssp             CCCSSCEECCSS
T ss_pred             EEcchhhhcccC
Confidence            999999987544

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.88  E-value=4.6e-22  Score=223.24  Aligned_cols=150  Identities=23%  Similarity=0.364  Sum_probs=130.2

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCC-CceeeEEEEEEeCCeeEEEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH-RNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      .++|...++||+|+||.||+|++. +++.||||++....  ..+++..|++++..++| +++..+..++.+.+..+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            367899999999999999999975 48999999886443  23468899999999976 667777778888899999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE---cCCCcEEEEecCCceeeC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFG  695 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~KI~DFGla~~l~  695 (709)
                      |+ +++|.+++....  ..+++..++.|+.||+.||+|||+++   ||||||||+||||   +.++.+||+|||+|+.+.
T Consensus        84 ~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 999999996432  35899999999999999999999998   9999999999999   688999999999999886


Q ss_pred             CCC
Q 005206          696 GDQ  698 (709)
Q Consensus       696 ~~~  698 (709)
                      ...
T Consensus       158 ~~~  160 (483)
T 3sv0_A          158 DTS  160 (483)
T ss_dssp             CTT
T ss_pred             CCc
Confidence            654

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.88  E-value=1.1e-22  Score=223.36  Aligned_cols=148  Identities=28%  Similarity=0.455  Sum_probs=115.2

Q ss_pred             cCc-ceeecccCceEEEEEEEc---CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEe--CCeeEEEE
Q 005206          544 FTD-YNKLGQGGFGIVYKGRLL---EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE--MDEKMLVY  617 (709)
Q Consensus       544 f~~-~~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~  617 (709)
                      |.. .++||+|+||.||+|+..   .++.||||++...  ...+.+.+|+.++.+++||||+++++++..  ....+|||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            443 357999999999999976   3788999999643  234578899999999999999999999965  56789999


Q ss_pred             EccCCCCHHHHHhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE----cCCCcEEEEe
Q 005206          618 EYMENRSLDSVIFDKA------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL----DKEMTPKISD  687 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~KI~D  687 (709)
                      ||+++ +|.+++....      ....+++..+..|+.||+.||.|||+++   |+||||||+||||    +.++.+||+|
T Consensus       100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A          100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            99974 7777765321      1224899999999999999999999998   9999999999999    7789999999


Q ss_pred             cCCceeeCCC
Q 005206          688 FGMARIFGGD  697 (709)
Q Consensus       688 FGla~~l~~~  697 (709)
                      ||+|+.+...
T Consensus       176 fg~a~~~~~~  185 (405)
T 3rgf_A          176 MGFARLFNSP  185 (405)
T ss_dssp             TTCCC-----
T ss_pred             CCCceecCCC
Confidence            9999987543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.88  E-value=1.4e-22  Score=220.20  Aligned_cols=148  Identities=26%  Similarity=0.455  Sum_probs=126.4

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCee----
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK----  613 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~----  613 (709)
                      .++|...+.||+|+||.||+|.... ++.||||++....  ....+++.+|+.++.+++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            3678889999999999999998864 8899999997542  33357889999999999999999999999887655    


Q ss_pred             --EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCc
Q 005206          614 --MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (709)
Q Consensus       614 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla  691 (709)
                        ++||||++ ++|.+++.     ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999998 68877762     23899999999999999999999997   999999999999999999999999999


Q ss_pred             eeeCCC
Q 005206          692 RIFGGD  697 (709)
Q Consensus       692 ~~l~~~  697 (709)
                      +.....
T Consensus       192 ~~~~~~  197 (371)
T 4exu_A          192 RHADAE  197 (371)
T ss_dssp             ------
T ss_pred             cccccC
Confidence            876543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.88  E-value=2e-22  Score=219.81  Aligned_cols=135  Identities=27%  Similarity=0.342  Sum_probs=114.2

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcC--------CCceeeEEEEEE---
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ--------HRNLVRLLGCCV---  608 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~--------H~nIv~l~g~~~---  608 (709)
                      .++|...++||+|+||.||+|+... ++.||||++... ....+.+.+|+.++.+++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            3679999999999999999998765 789999999643 345678899999999985        788999999988   


Q ss_pred             -eCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCCEEEcCCC
Q 005206          609 -EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD-SRFRIIHRDLKASNILLDKEM  681 (709)
Q Consensus       609 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~~~~  681 (709)
                       .....+|||||+ +++|.+++.... ...+++..+..|+.||+.||.|||++ +   |+||||||+||||+.++
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~  184 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE  184 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence             456789999999 556666664432 24589999999999999999999998 6   99999999999999775

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.87  E-value=2.6e-22  Score=213.26  Aligned_cols=152  Identities=25%  Similarity=0.377  Sum_probs=132.9

Q ss_pred             HhcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCc------cchHHHHHHHHHHHhcC--CCceeeEEEEEEeC
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG------QGIEEFKNEVRLIAKLQ--HRNLVRLLGCCVEM  610 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~------~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~  610 (709)
                      ..++|...+.||+|+||.||+|... +++.||||++.....      ...+++.+|+.++.+++  |+||+++++++.+.
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            3467999999999999999999875 488999999965422      12356788999999996  59999999999999


Q ss_pred             CeeEEEEEccCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-CCCcEEEEec
Q 005206          611 DEKMLVYEYMEN-RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD-KEMTPKISDF  688 (709)
Q Consensus       611 ~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~KI~DF  688 (709)
                      +..++|+||+.+ ++|.+++.+..   .+++..+..++.||+.||+|||+.+   |+||||||+|||++ +++.+||+||
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred             CcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            999999999986 89999986543   4899999999999999999999997   99999999999999 7899999999


Q ss_pred             CCceeeCCC
Q 005206          689 GMARIFGGD  697 (709)
Q Consensus       689 Gla~~l~~~  697 (709)
                      |+++.+...
T Consensus       195 g~~~~~~~~  203 (320)
T 3a99_A          195 GSGALLKDT  203 (320)
T ss_dssp             TTCEECCSS
T ss_pred             ccccccccc
Confidence            999987543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.87  E-value=5.2e-22  Score=211.33  Aligned_cols=149  Identities=23%  Similarity=0.330  Sum_probs=130.1

Q ss_pred             cCcCcceeecccCceEEEEEEE-c-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCC------ceeeEEEEEEeCCee
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRL-L-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR------NLVRLLGCCVEMDEK  613 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~-~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~------nIv~l~g~~~~~~~~  613 (709)
                      ++|...+.||+|+||.||++.. . +++.||||++... ....+.+.+|+.++..++|+      +++++++++.+.+..
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            5789999999999999999987 3 4789999999643 34467889999999998765      499999999999999


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC--------------
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK--------------  679 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~--------------  679 (709)
                      ++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+++   |+||||||+|||++.              
T Consensus        93 ~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccc
Confidence            9999999 889999986543 235889999999999999999999997   999999999999987              


Q ss_pred             -----CCcEEEEecCCceeeCC
Q 005206          680 -----EMTPKISDFGMARIFGG  696 (709)
Q Consensus       680 -----~~~~KI~DFGla~~l~~  696 (709)
                           ++.+||+|||+++....
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~  189 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDE  189 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTS
T ss_pred             cccccCCCceEeeCcccccCcc
Confidence                 66899999999997644

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.87  E-value=3.7e-22  Score=212.43  Aligned_cols=152  Identities=24%  Similarity=0.368  Sum_probs=126.4

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC-ccchHHHHHHHH-HHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVR-LIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ++|...+.||+|+||.||+|... +++.||||++.... .....++..|+. ++..++||||+++++++.+.+..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            57888899999999999999986 48899999997543 234456666666 6677899999999999999999999999


Q ss_pred             ccCCCCHHHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          619 YMENRSLDSVIFDK--ARSSILNWQRRFNIICGIARGLLYLHQD-SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       619 y~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      |+++ +|.+++...  .....+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            9985 787776531  1234689999999999999999999998 7   9999999999999999999999999998775


Q ss_pred             CC
Q 005206          696 GD  697 (709)
Q Consensus       696 ~~  697 (709)
                      ..
T Consensus       178 ~~  179 (327)
T 3aln_A          178 DS  179 (327)
T ss_dssp             --
T ss_pred             cc
Confidence            43

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.87  E-value=1.8e-22  Score=217.35  Aligned_cols=146  Identities=26%  Similarity=0.451  Sum_probs=126.3

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCe------
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE------  612 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~------  612 (709)
                      ++|...+.||+|+||.||+|.... ++.||||++....  ....+++.+|+.++.+++||||+++++++...+.      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            578888999999999999999864 8899999996542  2335688999999999999999999999987654      


Q ss_pred             eEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCce
Q 005206          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~  692 (709)
                      .++||||++ ++|.+++.     ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             EEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence            499999998 58876652     23899999999999999999999998   9999999999999999999999999998


Q ss_pred             eeCC
Q 005206          693 IFGG  696 (709)
Q Consensus       693 ~l~~  696 (709)
                      ....
T Consensus       175 ~~~~  178 (353)
T 3coi_A          175 HADA  178 (353)
T ss_dssp             C---
T ss_pred             CCCC
Confidence            7643

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.87  E-value=5.2e-23  Score=217.79  Aligned_cols=148  Identities=30%  Similarity=0.530  Sum_probs=127.3

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ..++|...+.||+|+||.||+|....  .+|+|++...  .....+.|.+|+.++.+++||||+++++++.+.+..++||
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            35678889999999999999998754  5999998654  2334567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ||+++++|.+++.+.  ...+++..+..++.||+.||+|||+++   |+||||||+|||++ ++.+||+|||+++...
T Consensus       109 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          109 SLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISG  180 (319)
T ss_dssp             BCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred             ecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence            999999999998543  335889999999999999999999997   99999999999998 6799999999988653

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.87  E-value=3.7e-22  Score=221.49  Aligned_cols=149  Identities=27%  Similarity=0.346  Sum_probs=120.6

Q ss_pred             CcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      .|...+.||+|+||+||.+...+|+.||||++...   ..+.+.+|+.++.++ +|||||++++++.+.+..+|||||++
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            34556789999999998776677999999998642   345688999999886 89999999999999999999999996


Q ss_pred             CCCHHHHHhccCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-------------CcEE
Q 005206          622 NRSLDSVIFDKARSS----ILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-------------MTPK  684 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-------------~~~K  684 (709)
                       |+|.+++.......    ...+..+..++.||+.||+|||+++   |+||||||+||||+.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             69999996543211    1133345789999999999999997   9999999999999754             4899


Q ss_pred             EEecCCceeeCCCC
Q 005206          685 ISDFGMARIFGGDQ  698 (709)
Q Consensus       685 I~DFGla~~l~~~~  698 (709)
                      |+|||+|+.+....
T Consensus       169 L~DFG~a~~~~~~~  182 (434)
T 2rio_A          169 ISDFGLCKKLDSGQ  182 (434)
T ss_dssp             ECCCTTCEECCC--
T ss_pred             EcccccceecCCCC
Confidence            99999999886543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.86  E-value=4e-22  Score=221.01  Aligned_cols=147  Identities=24%  Similarity=0.372  Sum_probs=121.2

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      .+|...+.||+|+||+|+.....+++.||||++....   .+.+.+|+.++.++ +|||||++++++.+....+|||||+
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            4688889999999999766556678999999996432   23467899999999 7999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-----CCcEEEEecCCceeeC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-----EMTPKISDFGMARIFG  695 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-----~~~~KI~DFGla~~l~  695 (709)
                      + |+|.+++.....  .+.+.....++.||+.||.|||+++   |+||||||+||||+.     ...+||+|||+|+.+.
T Consensus       101 ~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A          101 A-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             S-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             C-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            7 699999865432  2444456789999999999999998   999999999999943     3468899999999875


Q ss_pred             CC
Q 005206          696 GD  697 (709)
Q Consensus       696 ~~  697 (709)
                      ..
T Consensus       175 ~~  176 (432)
T 3p23_A          175 VG  176 (432)
T ss_dssp             --
T ss_pred             CC
Confidence            44

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.86  E-value=2.2e-21  Score=207.72  Aligned_cols=149  Identities=24%  Similarity=0.304  Sum_probs=120.6

Q ss_pred             hcCcCcce-eecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEe----CCeeE
Q 005206          541 TDNFTDYN-KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE----MDEKM  614 (709)
Q Consensus       541 t~~f~~~~-~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~  614 (709)
                      .++|...+ .||+|+||.||+|.... ++.||||++...    .....+....+..++||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            36788854 69999999999999874 899999998642    1222223334566799999999999876    34579


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCcEEEEecCCc
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK---EMTPKISDFGMA  691 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~KI~DFGla  691 (709)
                      +||||+++|+|.+++.... ...+++..+..++.||+.||.|||+++   |+||||||+|||++.   ++.+||+|||++
T Consensus       103 lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            9999999999999996543 346899999999999999999999998   999999999999976   456999999999


Q ss_pred             eeeCCC
Q 005206          692 RIFGGD  697 (709)
Q Consensus       692 ~~l~~~  697 (709)
                      +.....
T Consensus       179 ~~~~~~  184 (336)
T 3fhr_A          179 KETTQN  184 (336)
T ss_dssp             EEC---
T ss_pred             eecccc
Confidence            977543

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.86  E-value=8.7e-22  Score=208.12  Aligned_cols=151  Identities=24%  Similarity=0.389  Sum_probs=115.8

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCc-cc-hHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG-QG-IEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      .++|...+.||+|+||.||+|... +++.||||++..... .. .+.+.++..++..++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            357888899999999999999986 489999999975432 22 234455556788889999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD-SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ||+ ++.+..+....  ...+++..+..++.||+.||.|||++ +   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       104 e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 44555544322  23589999999999999999999985 6   99999999999999999999999999987654


Q ss_pred             C
Q 005206          697 D  697 (709)
Q Consensus       697 ~  697 (709)
                      .
T Consensus       178 ~  178 (318)
T 2dyl_A          178 D  178 (318)
T ss_dssp             -
T ss_pred             C
Confidence            3

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.86  E-value=2.5e-21  Score=207.52  Aligned_cols=149  Identities=20%  Similarity=0.326  Sum_probs=128.2

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-C-cEEEEEEeccCCccchHHHHHHHHHHHhcCCCc------eeeEEEEEEeCCee
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-G-QEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN------LVRLLGCCVEMDEK  613 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g-~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n------Iv~l~g~~~~~~~~  613 (709)
                      ++|...+.||+|+||.||+|.... + +.||||++... ....+.+.+|+.++.+++|++      ++.+++++...+..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~   97 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM   97 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence            689999999999999999998854 4 68999999643 345677889999999997766      99999999999999


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE----------------
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL----------------  677 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl----------------  677 (709)
                      ++||||+ +++|.+++.... ...+++..+..++.||+.||.|||+++   |+||||||+||||                
T Consensus        98 ~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           98 CIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccccc
Confidence            9999999 667777765432 245899999999999999999999997   9999999999999                


Q ss_pred             ---cCCCcEEEEecCCceeeCC
Q 005206          678 ---DKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       678 ---~~~~~~KI~DFGla~~l~~  696 (709)
                         +.++.+||+|||+++....
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~  194 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHE  194 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTS
T ss_pred             ccccCCCcEEEeecCccccccc
Confidence               6788999999999997643

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.86  E-value=3.6e-21  Score=209.77  Aligned_cols=154  Identities=26%  Similarity=0.326  Sum_probs=129.5

Q ss_pred             HhcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcC-CC-----ceeeEEEEEEeCCe
Q 005206          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HR-----NLVRLLGCCVEMDE  612 (709)
Q Consensus       540 ~t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~-----nIv~l~g~~~~~~~  612 (709)
                      ..++|...++||+|+||.||+|.... ++.||||++... ....+++..|+.++..++ |+     +|+++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            35789999999999999999998864 789999999643 344567888999998885 55     49999999999999


Q ss_pred             eEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc--CCCcEEEEecCC
Q 005206          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD--KEMTPKISDFGM  690 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~--~~~~~KI~DFGl  690 (709)
                      .+|||||++ ++|.+++.... ...+++..+..++.||+.||.|||.+. .+|+||||||+||||+  .++.+||+|||+
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             eEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            999999996 59999986543 234899999999999999999999531 2499999999999995  478899999999


Q ss_pred             ceeeCCC
Q 005206          691 ARIFGGD  697 (709)
Q Consensus       691 a~~l~~~  697 (709)
                      |+.+...
T Consensus       208 a~~~~~~  214 (382)
T 2vx3_A          208 SCQLGQR  214 (382)
T ss_dssp             CEETTCC
T ss_pred             ceecccc
Confidence            9987543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.86  E-value=2.5e-22  Score=231.30  Aligned_cols=153  Identities=29%  Similarity=0.422  Sum_probs=132.1

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEe------CCee
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE------MDEK  613 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~------~~~~  613 (709)
                      ++|...++||+|+||.||+|.+.. ++.||||++... .....+++.+|+.++.+++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            679999999999999999998854 889999998654 33446789999999999999999999998765      6677


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCc---EEEEecCC
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT---PKISDFGM  690 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~KI~DFGl  690 (709)
                      ++||||+++|+|.+++........+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence            999999999999999976555456889999999999999999999997   999999999999997664   99999999


Q ss_pred             ceeeCCC
Q 005206          691 ARIFGGD  697 (709)
Q Consensus       691 a~~l~~~  697 (709)
                      ++.+...
T Consensus       171 a~~~~~~  177 (676)
T 3qa8_A          171 AKELDQG  177 (676)
T ss_dssp             CCBTTSC
T ss_pred             ccccccc
Confidence            9987544

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.85  E-value=1.4e-21  Score=211.45  Aligned_cols=149  Identities=23%  Similarity=0.366  Sum_probs=128.1

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcC-----------CCceeeEEEEEEe
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-----------HRNLVRLLGCCVE  609 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-----------H~nIv~l~g~~~~  609 (709)
                      ++|...+.||+|+||.||+|+.. +++.||||++.. .....+.+.+|+.++.+++           ||||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            57999999999999999999975 488999999964 2334567889999999886           8999999999986


Q ss_pred             CC----eeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCCEEEc------
Q 005206          610 MD----EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD-SRFRIIHRDLKASNILLD------  678 (709)
Q Consensus       610 ~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~------  678 (709)
                      .+    ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ +   |+||||||+||||+      
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence            54    689999999 899999986543 23489999999999999999999998 7   99999999999994      


Q ss_pred             CCCcEEEEecCCceeeCC
Q 005206          679 KEMTPKISDFGMARIFGG  696 (709)
Q Consensus       679 ~~~~~KI~DFGla~~l~~  696 (709)
                      ..+.+||+|||+|+.+..
T Consensus       173 ~~~~~kl~Dfg~a~~~~~  190 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDE  190 (373)
T ss_dssp             TEEEEEECCCTTCEETTB
T ss_pred             CcceEEEcccccccccCC
Confidence            345899999999998754

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.85  E-value=7.5e-22  Score=224.65  Aligned_cols=136  Identities=23%  Similarity=0.331  Sum_probs=109.3

Q ss_pred             CcceeecccCceEEEEEEEcCCcEEEEEEeccCCc--c------chHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          545 TDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG--Q------GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       545 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~--~------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      ...++||+|+||.||+++. .++.+++|+......  .      ..++|.+|++++.+++||||+++..++...++.+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3356899999999999944 578889998654321  1      134589999999999999999777777788888999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+++++|.+++.+           +..++.||++||.|||+++   |+||||||+|||++.  .+||+|||+|+.+..
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999854           4579999999999999998   999999999999999  999999999999865


Q ss_pred             C
Q 005206          697 D  697 (709)
Q Consensus       697 ~  697 (709)
                      .
T Consensus       482 ~  482 (540)
T 3en9_A          482 D  482 (540)
T ss_dssp             H
T ss_pred             c
Confidence            4

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=1.8e-21  Score=203.26  Aligned_cols=144  Identities=20%  Similarity=0.203  Sum_probs=115.1

Q ss_pred             HHHHHhcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCc------------------cchHHHHHHHHHHHhcCC
Q 005206          536 TIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG------------------QGIEEFKNEVRLIAKLQH  597 (709)
Q Consensus       536 ~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~------------------~~~~~f~~Ei~~l~~l~H  597 (709)
                      .+......|...+.||+|+||.||+|...+++.||||.+.....                  .....+.+|+.++.+++|
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~  163 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG  163 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence            44444555667799999999999999997799999999964321                  134578999999999994


Q ss_pred             CceeeEEEEEEeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE
Q 005206          598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL  677 (709)
Q Consensus       598 ~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl  677 (709)
                         +++.+++.. +..++||||+++++|.+ +.       .  .....++.||+.||.|||+.+   |+||||||+||||
T Consensus       164 ---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~-------~--~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl  226 (282)
T 1zar_A          164 ---LAVPKVYAW-EGNAVLMELIDAKELYR-VR-------V--ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV  226 (282)
T ss_dssp             ---SSSCCEEEE-ETTEEEEECCCCEEGGG-CC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred             ---CCcCeEEec-cceEEEEEecCCCcHHH-cc-------h--hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence               555554433 55699999999999987 41       1  123469999999999999998   9999999999999


Q ss_pred             cCCCcEEEEecCCceeeCCC
Q 005206          678 DKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       678 ~~~~~~KI~DFGla~~l~~~  697 (709)
                      + ++.+||+|||+|+.....
T Consensus       227 ~-~~~vkl~DFG~a~~~~~~  245 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVEVGEE  245 (282)
T ss_dssp             E-TTEEEECCCTTCEETTST
T ss_pred             E-CCcEEEEECCCCeECCCC
Confidence            9 999999999999977544

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1

Probab=99.82  E-value=1e-19  Score=163.98  Aligned_cols=105  Identities=17%  Similarity=0.233  Sum_probs=91.2

Q ss_pred             cccccCCCCCcCCCCEEE--ecCCeEEEEeeCCCCCCcEEEEEEEeccCCceEEEEcCCCCCCCCCcceEEEEcCc-eEE
Q 005206           56 SVDTLTATQNLTYGKTLV--SSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQR-IGL  132 (709)
Q Consensus        56 ~~~~l~~g~~l~~~~~lv--S~~g~F~lGFf~~~~~~~~~lgIw~~~~~~~tvVWvANr~~Pv~~~~~~l~l~~~G-Lvl  132 (709)
                      +.++|.+|++|.+|++|+  |++|.|+|+|+.+++   .   +||++   +++||+|||+.|  ..++.+.|.++| |||
T Consensus         7 ~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn---l---vly~~---~~~vW~sn~~~~--~~~~~l~l~~dGNLVl   75 (119)
T 1b2p_A            7 KQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN---L---VLYDN---NNPIWATNTGGL--GNGCRAVLQPDGVLVV   75 (119)
T ss_dssp             SCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC---E---EEEET---TEEEEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred             cCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC---E---EEEEC---CEEEEeCCCccC--CCceEEEEccCCEEEE
Confidence            568999999999999999  999999999998764   2   58875   799999999977  235789999999 999


Q ss_pred             EcCCCceEEecCCCCC-CCceeEEecCCCEEEEecCCCceeEee
Q 005206          133 FDGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQS  175 (709)
Q Consensus       133 ~d~~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQS  175 (709)
                      +|.++.++|+|++... +...++|+|+|||||++.    ++|||
T Consensus        76 ~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~~----~~W~S  115 (119)
T 1b2p_A           76 ITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGD----ALWAT  115 (119)
T ss_dssp             ECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEES----EEEEC
T ss_pred             EeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEECc----cEeCC
Confidence            9999999999986543 356899999999999972    89998

>4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D*

Probab=99.80  E-value=3.1e-19  Score=157.16  Aligned_cols=102  Identities=19%  Similarity=0.358  Sum_probs=87.2

Q ss_pred             cccCCCCCcCCCCEEEecCCeEEEEeeCCCCCCcEEEEEEEeccCCceEEEEcCCCCCCCCCcceEEEEcCc-eEEEcCC
Q 005206           58 DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQR-IGLFDGS  136 (709)
Q Consensus        58 ~~l~~g~~l~~~~~lvS~~g~F~lGFf~~~~~~~~~lgIw~~~~~~~tvVWvANr~~Pv~~~~~~l~l~~~G-Lvl~d~~  136 (709)
                      |+|.+||.|.+|++|+|  |.|.|.|...++     |.++.    ..++||+|||+.|.... +.|+|+.|| |||+|++
T Consensus         2 n~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~----~~~~vW~ant~~~~~~~-~~L~l~~dGnLvL~d~~   69 (105)
T 4h3o_A            2 NILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD----HSTSTWASNTEIGGKSG-CSAVLQSDGNFVVYDSS   69 (105)
T ss_dssp             CEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCCS-CEEEECTTSCEEEECTT
T ss_pred             CCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE----CCEEEEEecCCCCCCcc-EEEEEeCCccEEEECCC
Confidence            67999999999999998  789999876653     44543    46899999999998654 789999999 9999999


Q ss_pred             CceEEecCCCCC-CCceeEEecCCCEEEEecCCCceeEee
Q 005206          137 QNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQS  175 (709)
Q Consensus       137 g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQS  175 (709)
                      +.+||+|++... ...+|+|+|+|||||++.    .||||
T Consensus        70 ~~~vWss~t~~~~~~~~l~L~ddGNlVly~~----~~W~S  105 (105)
T 4h3o_A           70 GRSLWASHSTRGSGNYILILQDDGNVIIYGS----DIWST  105 (105)
T ss_dssp             CCEEEECCCCCCSSCEEEEECTTSCEEEEES----EEEEC
T ss_pred             cEEEEEecCCCCCCCEEEEEeCCCeEEEECC----cEecC
Confidence            999999998655 456899999999999974    69998

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.80  E-value=6.3e-20  Score=202.15  Aligned_cols=152  Identities=18%  Similarity=0.225  Sum_probs=114.4

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcCC-Cce---------------
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQH-RNL---------------  600 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H-~nI---------------  600 (709)
                      +.+|...+.||+|+||.||+|.+. +++.||||++....   ....+.|.+|+.++..++| +|.               
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            345777789999999999999975 48999999987432   2346789999999999987 221               


Q ss_pred             ee------EEEEEEe-----CCeeEEEEEccCCCCHHHHHhc----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 005206          601 VR------LLGCCVE-----MDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIICGIARGLLYLHQDSRFRI  665 (709)
Q Consensus       601 v~------l~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  665 (709)
                      +.      +..+...     ....+++|+++ .++|.+++..    ......+++..++.++.||++||+|||+++   |
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence            11      1111111     12346666654 6899988842    112334788899999999999999999998   9


Q ss_pred             EecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          666 IHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       666 iHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||||||+||||+.++.+||+|||+|+....
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~  263 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA  263 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTE
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCC
Confidence            9999999999999999999999999987643

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A*

Probab=99.80  E-value=2.8e-19  Score=158.98  Aligned_cols=108  Identities=21%  Similarity=0.386  Sum_probs=92.2

Q ss_pred             ccccCCCCCcCCCCEEEecCCeEEEEeeCCCCCCcEEEEEEEeccCCceEEEEcCCCCCCCCCcceEEEEcCc-eEEEcC
Q 005206           57 VDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQR-IGLFDG  135 (709)
Q Consensus        57 ~~~l~~g~~l~~~~~lvS~~g~F~lGFf~~~~~~~~~lgIw~~~~~~~tvVWvANr~~Pv~~~~~~l~l~~~G-Lvl~d~  135 (709)
                      +|+|.+||.|.+|++|+ ++|.|+|+|+..++     | |+|+   ..++||.||++.|.  ..+.+.|.++| |||.|.
T Consensus         1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~---~~~~vW~sn~~~~~--~~~~l~l~~dGNLVl~~~   68 (110)
T 3a0c_A            1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD---SGKPVWASNTGGLG--SGCRLTLHNNGNLVIYDQ   68 (110)
T ss_dssp             CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE---TTEEEEECCCTTSC--SSCEEEECTTSCEEEECT
T ss_pred             CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE---CCEEEEECCCCCCC--CcEEEEEeCCCCEEEECC
Confidence            37899999999999999 99999999987764     2 6776   37999999998773  34789999999 999999


Q ss_pred             CCceEEecCCCCC-CCceeEEecCCCEEEEecCCCceeEeeccCCC
Q 005206          136 SQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPT  180 (709)
Q Consensus       136 ~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQSFd~Pt  180 (709)
                      +|.++|+|++... ....++|+|+|||||++.    .+||||+||.
T Consensus        69 ~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~----~~W~S~~~~~  110 (110)
T 3a0c_A           69 SNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP----VVWATGSGPA  110 (110)
T ss_dssp             TCCEEEECCCCCSSSCCEEEECTTSCEEEECS----EEEECSCCC-
T ss_pred             CCcEEEecCCCCCCCCEEEEEeCCccEEEECC----CEecCCCcCC
Confidence            9999999987644 355899999999999862    7999999984

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.78  E-value=3.8e-19  Score=183.17  Aligned_cols=139  Identities=16%  Similarity=0.166  Sum_probs=108.1

Q ss_pred             cCcceeecccCceEEEEEEE-cCCcE--EEEEEeccCCcc------------------------chHHHHHHHHHHHhcC
Q 005206          544 FTDYNKLGQGGFGIVYKGRL-LEGQE--IAVKRLSRNSGQ------------------------GIEEFKNEVRLIAKLQ  596 (709)
Q Consensus       544 f~~~~~LG~G~fG~Vykg~~-~~g~~--VAVK~l~~~~~~------------------------~~~~f~~Ei~~l~~l~  596 (709)
                      |...+.||+|+||.||+|.. .+|+.  ||||++......                        ....+.+|+.++.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            55678999999999999998 67888  999987543111                        1136889999999998


Q ss_pred             CCce--eeEEEEEEeCCeeEEEEEccCC-C----CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEec
Q 005206          597 HRNL--VRLLGCCVEMDEKMLVYEYMEN-R----SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH-QDSRFRIIHR  668 (709)
Q Consensus       597 H~nI--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iiHr  668 (709)
                      |+++  ..+++.    +..+|||||+.+ |    +|.++...      .++.....++.||+.||.||| +.+   |+||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr  195 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA  195 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence            8754  444443    357899999942 4    67666432      123456789999999999999 877   9999


Q ss_pred             CCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          669 DLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       669 Dlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||||+|||++.  .+||+|||+|.....+
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~~~~  222 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTLRHP  222 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred             CCCHHHEEEcC--cEEEEECcccccCCCc
Confidence            99999999998  9999999999987544

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A*

Probab=99.78  E-value=7.2e-19  Score=157.80  Aligned_cols=108  Identities=21%  Similarity=0.317  Sum_probs=91.1

Q ss_pred             ccccCCCCCcCCCCEEEecCCeEEEEeeCCCCCCcEEEEEEEeccCCceEEEEcCCCCCCCCCcceEEEEcCc-eEEEcC
Q 005206           57 VDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQR-IGLFDG  135 (709)
Q Consensus        57 ~~~l~~g~~l~~~~~lvS~~g~F~lGFf~~~~~~~~~lgIw~~~~~~~tvVWvANr~~Pv~~~~~~l~l~~~G-Lvl~d~  135 (709)
                      .|+|.+||+|.+|++|+  +|.|+|+|+..++   ..   +|.   ..++||+|||+.|.  .++.|.|.++| |||.|.
T Consensus         2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn---lv---ly~---~~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d~   68 (115)
T 2dpf_A            2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN---LV---KYQ---NGRQIWASNTDRRG--SGCRLTLLSDGNLVIYDH   68 (115)
T ss_dssp             CCEEETTCEEETTEEEE--ETTEEEEECTTSC---EE---EEE---TTEEEEECSCTTSC--SSCEEEECTTSCEEEECT
T ss_pred             CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc---EE---EEe---CCEEEEeCCCCCCC--CceEEEECCCCcEEEECC
Confidence            47899999999999998  8999999987653   32   365   47899999999884  35789999999 999999


Q ss_pred             CCceEEecCCCCC-CCceeEEecCCCEEEEecCCCceeEeeccCCCC
Q 005206          136 SQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTD  181 (709)
Q Consensus       136 ~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PtD  181 (709)
                      ++.++|+|++... ...+|+|+|+|||||++.    ++||||.++..
T Consensus        69 ~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~----~~W~S~~~~~~  111 (115)
T 2dpf_A           69 NNNDVWGSACWGDNGKYALVLQKDGRFVIYGP----VLWSLGPNGCR  111 (115)
T ss_dssp             TCCEEEECCCCCSSSCCEEEECTTSCEEEECS----EEECSSTTCBC
T ss_pred             CceEEEEcCCCCCCCCEEEEEeCCCeEEEECC----CEEECCCCCCc
Confidence            8999999987643 456899999999999962    89999998764

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A

Probab=99.76  E-value=2.1e-18  Score=154.05  Aligned_cols=108  Identities=21%  Similarity=0.415  Sum_probs=90.7

Q ss_pred             ccccCCCCCcCCCCEEEecCCeEEEEeeCCCCCCcEEEEEEEeccCCceEEEEcCCCCCCCCCcceEEEEcCc-eEEEcC
Q 005206           57 VDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQR-IGLFDG  135 (709)
Q Consensus        57 ~~~l~~g~~l~~~~~lvS~~g~F~lGFf~~~~~~~~~lgIw~~~~~~~tvVWvANr~~Pv~~~~~~l~l~~~G-Lvl~d~  135 (709)
                      +|+|.+||+|.+|++|  ++|.|+|+|+.+++   .   ++|.+   .++||+||++.+  ..++.+.|.++| |||+| 
T Consensus         1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn---l---vl~~~---~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d-   66 (112)
T 1xd5_A            1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN---L---VLYDN---NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS-   66 (112)
T ss_dssp             CCEEETTEEECTTCEE--EETTEEEEECTTSC---E---EEEET---TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-
T ss_pred             CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc---E---EEEEC---CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-
Confidence            4899999999999999  58999999998874   2   46765   689999999864  345789999999 99999 


Q ss_pred             CCceEEecCCCCC-CCceeEEecCCCEEEEecCCCceeEeeccCC
Q 005206          136 SQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYP  179 (709)
Q Consensus       136 ~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQSFd~P  179 (709)
                      ++.++|+|++... ....++|+++|||||++. .+.++||||+|.
T Consensus        67 ~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~-~~~~~W~S~~~~  110 (112)
T 1xd5_A           67 GSRAIWASNTNRQNGNYYLILQRDRNVVIYDN-SNNAIWATHTNV  110 (112)
T ss_dssp             TTEEEEECCCCCSCCCCEEEECTTSCEEEECT-TSCEEEECCCCC
T ss_pred             CCEEEEECCccCCCCCEEEEEeCCCcEEEECC-CCceEEECCCcc
Confidence            7889999986543 456899999999999984 567999999985

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A*

Probab=99.70  E-value=5.2e-17  Score=144.13  Aligned_cols=101  Identities=19%  Similarity=0.333  Sum_probs=85.1

Q ss_pred             cccCCCCCcCCCCEEEecCCeEEEEeeCCCCCCcEEEEEEEeccCCceEEEEcCCCCCCCCCcceEEEEcCc-eEEEcCC
Q 005206           58 DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQR-IGLFDGS  136 (709)
Q Consensus        58 ~~l~~g~~l~~~~~lvS~~g~F~lGFf~~~~~~~~~lgIw~~~~~~~tvVWvANr~~Pv~~~~~~l~l~~~G-Lvl~d~~  136 (709)
                      ++|.+||.|.+|++|+  +|.|+|+|...++   .+|   |..   .++||++|++.|  ...+.|.|.++| |||.|.+
T Consensus         2 ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn---Lvl---y~~---~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~   68 (109)
T 3dzw_A            2 NILYSGETLSPGEFLN--NGRYVFIMQEDCN---LVL---YDV---DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPR   68 (109)
T ss_dssp             CEEETTEEECTTCEEE--ETTEEEEECTTSC---EEE---EET---TEEEEECCCTTS--SSSCEEEECTTSCEEEECTT
T ss_pred             CCcCCCCEeCCCCEEE--CCCEEEEEcCCCc---EEE---EeC---CEEEEECCcccC--CCCEEEEEeCCCCEEEECCC
Confidence            5799999999999997  7999999987763   333   654   589999999876  345789999999 9999999


Q ss_pred             CceEEecCCCCCC-CceeEEecCCCEEEEecCCCceeEee
Q 005206          137 QNLVWSSNQTKAT-NPVAQLQDSGNFVLKEAGSDEILWQS  175 (709)
Q Consensus       137 g~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~~lWQS  175 (709)
                      +.++|+|++.+.. ..+|+|+|+|||||++.    ++|||
T Consensus        69 ~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~----~~W~s  104 (109)
T 3dzw_A           69 NNPIWASNTGGENGNYVCVLQKDRNVVIYGT----ARWAT  104 (109)
T ss_dssp             SCEEEECCCCCSSSCEEEEECTTSCEEEEES----CCCCC
T ss_pred             CCEEEECCCCCCCCCEEEEEeCCCEEEEECC----CEEeC
Confidence            9999999976543 46899999999999973    79998

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A

Probab=99.62  E-value=1.4e-15  Score=135.68  Aligned_cols=95  Identities=20%  Similarity=0.363  Sum_probs=77.8

Q ss_pred             CCCCCCcceEEEEcCc-eEEEcCCCceEEecCCCCC-CCceeEEecCCCEEEEecCCCceeEeeccCCCCccCCCCcccc
Q 005206          114 DPLANSSGVLRIINQR-IGLFDGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGW  191 (709)
Q Consensus       114 ~Pv~~~~~~l~l~~~G-Lvl~d~~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PtDTlLpg~~l~~  191 (709)
                      .|+.+...+|.+..+| |+|++. +++||++|+... ...+|+|+|+|||||++  .+.++||||+              
T Consensus        14 ~~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d--~~~~~W~S~~--------------   76 (112)
T 1xd5_A           14 GSLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS--GSRAIWASNT--------------   76 (112)
T ss_dssp             CEEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE--TTEEEEECCC--------------
T ss_pred             CEEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc--CCEEEEECCc--------------
Confidence            3444556789999999 999988 789999997643 35789999999999998  4679999993              


Q ss_pred             eeccCCeeEEEEecCCCCCCCCcceEeecCCCCcEEEEec-CCccccccCCCCC
Q 005206          192 DLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWN-KQERKYRSGPWNG  244 (709)
Q Consensus       192 ~~~tg~~~~L~S~~s~~dps~G~~~l~~~~~g~~~~~~~~-~~~~~~~sg~~~~  244 (709)
                                       +|++|.|++.|+++|+  +++++ ....||+|++|+|
T Consensus        77 -----------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g  111 (112)
T 1xd5_A           77 -----------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG  111 (112)
T ss_dssp             -----------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred             -----------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence                             4567889999999998  45555 5678999999986

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.61  E-value=1.6e-15  Score=134.51  Aligned_cols=102  Identities=21%  Similarity=0.277  Sum_probs=81.5

Q ss_pred             cccccCCCCCcCCCCEEEecCCeEEEEeeCCCCCCcEEEEEEEeccCCceEEEEcCCCCCCCCCcceEEEEcCc-eEEEc
Q 005206           56 SVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQR-IGLFD  134 (709)
Q Consensus        56 ~~~~l~~g~~l~~~~~lvS~~g~F~lGFf~~~~~~~~~lgIw~~~~~~~tvVWvANr~~Pv~~~~~~l~l~~~G-Lvl~d  134 (709)
                      +.|+|.+||.|..|+.|+|.  .|.|-|-..+   +  |.+ |..    ++||.+|++..  ...+.|.|.++| |||.|
T Consensus         5 ~~dtL~~gq~L~~g~~L~sg--~~~L~~q~dG---n--Lvl-~~~----~~vW~snt~~~--~~~~~l~l~~dGNLvl~d   70 (110)
T 3r0e_B            5 TNNLLFSGQVLYGDGRLTAK--NHQLVMQGDC---N--LVL-YGG----KYGWQSNTHGN--GEHCFLRLNHKGELIIKD   70 (110)
T ss_dssp             BTTEEETTCEEETTEEEECS--SCEEEECTTS---C--EEE-ECS----SSCEECCCTTS--SSSCEEEECTTSCEEEEC
T ss_pred             ccCEECCCCEecCCCEEEeC--CEEEEEcCCC---e--EEE-ECC----eEEEECCCcCC--CcCEEEEEeCCCcEEEEe
Confidence            56999999999999999984  5888654333   2  333 544    47999999863  234789999999 99999


Q ss_pred             CCCceEEecCCCCC-CCceeEEecCCCEEEEecCCCceeEee
Q 005206          135 GSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQS  175 (709)
Q Consensus       135 ~~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQS  175 (709)
                      .++.++|++++... ...+|+|+|+|||||++    ..+|+|
T Consensus        71 ~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~----~~~W~t  108 (110)
T 3r0e_B           71 DDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG----PAIFET  108 (110)
T ss_dssp             TTCCEEEECCCCCSSSCCEEEECTTSCEEEEC----SEEEES
T ss_pred             CCCCEEEEcCCcCCCCCEEEEEcCCccEEEec----CCEecC
Confidence            99999999997543 34789999999999997    379997

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.61  E-value=2.3e-16  Score=169.94  Aligned_cols=143  Identities=15%  Similarity=0.176  Sum_probs=102.5

Q ss_pred             HHHHhcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCc--------------cchHH--------HHHHHHHHHh
Q 005206          537 IVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG--------------QGIEE--------FKNEVRLIAK  594 (709)
Q Consensus       537 l~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~--------------~~~~~--------f~~Ei~~l~~  594 (709)
                      +.....-|...+.||+|+||.||+|...+|+.||||+++....              .....        ...|...|.+
T Consensus        90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r  169 (397)
T 4gyi_A           90 HAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA  169 (397)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence            3333334888899999999999999999999999998753210              00111        1346666777


Q ss_pred             cCCCcee--eEEEEEEeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCC
Q 005206          595 LQHRNLV--RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKA  672 (709)
Q Consensus       595 l~H~nIv--~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp  672 (709)
                      +.+.++.  +.+++    ...+|||||+++++|..+..       .  .....++.||+.+|.|||+.+   ||||||||
T Consensus       170 L~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp  233 (397)
T 4gyi_A          170 LYEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG---LIHGDFNE  233 (397)
T ss_dssp             HHHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCST
T ss_pred             HHhcCCCCCeeeec----cCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCH
Confidence            7554432  23322    23479999999988854321       1  123467899999999999998   99999999


Q ss_pred             CCEEEcCCC----------cEEEEecCCceeeC
Q 005206          673 SNILLDKEM----------TPKISDFGMARIFG  695 (709)
Q Consensus       673 ~NILl~~~~----------~~KI~DFGla~~l~  695 (709)
                      .||||++++          .+.|+||+-+....
T Consensus       234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          234 FNILIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             TSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             HHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence            999998876          48999999877543

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.58  E-value=1.1e-14  Score=129.76  Aligned_cols=105  Identities=17%  Similarity=0.221  Sum_probs=85.0

Q ss_pred             cccccCCCCCcCCCCEEEecCCeEEEEeeCCCCCCcEEEEEEEeccCCceEEEEcCCCCCCCCCcceEEEEcCc-eEEEc
Q 005206           56 SVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQR-IGLFD  134 (709)
Q Consensus        56 ~~~~l~~g~~l~~~~~lvS~~g~F~lGFf~~~~~~~~~lgIw~~~~~~~tvVWvANr~~Pv~~~~~~l~l~~~G-Lvl~d  134 (709)
                      +.|+|.+||.|..|+.|.+  |.|.|-|...++     |.++. . ...++||.+|++.+-  ..+.|.|.++| |||.|
T Consensus         5 ~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~~-~-~~~~~vWssnt~~~~--~~~~l~l~~dGNLVl~d   73 (113)
T 3mez_B            5 VRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLTK-G-SKTNIVWESGTSGRG--QHCFMRLGHSGELDITD   73 (113)
T ss_dssp             CSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEE-T-TTTEEEEECCCTTSC--SSCEEEECTTSCEEEEC
T ss_pred             cCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEEE-C-CCCEEEEECCcccCC--cCEEEEEeCCCcEEEEC
Confidence            4689999999999999975  788888865542     44433 2 136899999998763  34789999999 99999


Q ss_pred             CCCceEEecCCCCC-CCceeEEecCCCEEEEecCCCceeEee
Q 005206          135 GSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQS  175 (709)
Q Consensus       135 ~~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQS  175 (709)
                      .++.++|+|++... ...+|+|+|+|||||++    ..+|+|
T Consensus        74 ~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~----~~~W~s  111 (113)
T 3mez_B           74 DRLNTVFVSNTVGQEGDYVLILQINGQAVVYG----PAVWST  111 (113)
T ss_dssp             TTSCEEEECSCCCSSSCCEEEECTTSCEEEEC----SEEEES
T ss_pred             CCCCEEEECCCcCCCCCEEEEEcCCceEEEec----CCEecC
Confidence            99999999998654 34689999999999996    489997

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A*

Probab=99.58  E-value=3.8e-15  Score=132.22  Aligned_cols=87  Identities=21%  Similarity=0.325  Sum_probs=72.6

Q ss_pred             CcceEEEEcCc-eEEEcCCCceEEecCCCCC-CCceeEEecCCCEEEEecCCCceeEeeccCCCCccCCCCcccceeccC
Q 005206          119 SSGVLRIINQR-IGLFDGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTG  196 (709)
Q Consensus       119 ~~~~l~l~~~G-Lvl~d~~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PtDTlLpg~~l~~~~~tg  196 (709)
                      ...+|.+..|| |+|+| .+++||++|+... ....|+|+|+|||||++. .+.++||||                    
T Consensus        20 ~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~-~~~~~W~S~--------------------   77 (110)
T 3a0c_A           20 PSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQ-SNRVIWQTK--------------------   77 (110)
T ss_dssp             TTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECT-TCCEEEECC--------------------
T ss_pred             CCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECC-CCcEEEecC--------------------
Confidence            45789999999 99999 4889999998654 356899999999999986 578999999                    


Q ss_pred             CeeEEEEecCCCCCCCCcceEeecCCCCcEEEEecCCccccccCCC
Q 005206          197 FEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPW  242 (709)
Q Consensus       197 ~~~~L~S~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~sg~~  242 (709)
                                 .++++|.|++.|+++|+  ++++++  .||+|+++
T Consensus        78 -----------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~  108 (110)
T 3a0c_A           78 -----------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG  108 (110)
T ss_dssp             -----------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred             -----------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence                       34567899999999998  455665  79999875

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.54  E-value=2.4e-14  Score=126.76  Aligned_cols=106  Identities=18%  Similarity=0.300  Sum_probs=85.1

Q ss_pred             cccccCCCCCcCCCCEEEecCCeEEEEeeCCCCCCcEEEEEEEeccCCceEEEEcCCCCCCCCCcceEEEEcCc-eEEEc
Q 005206           56 SVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQR-IGLFD  134 (709)
Q Consensus        56 ~~~~l~~g~~l~~~~~lvS~~g~F~lGFf~~~~~~~~~lgIw~~~~~~~tvVWvANr~~Pv~~~~~~l~l~~~G-Lvl~d  134 (709)
                      +.|+|.+||.|..|+.|  .+|.|.|.|...++   .   +.|..      +|.+|+..+  ...+.|.|.++| |||.|
T Consensus         2 ~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN---L---vl~~~------~Wssnt~~~--~~~~~l~l~~dGnLvl~d   65 (109)
T 3r0e_A            2 GTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN---L---VLYNG------NWQSNTANN--GRDCKLTLTDYGELVIKN   65 (109)
T ss_dssp             CCSEEETTCEECTTCEE--EETTEEEEECTTSC---E---EEETT------TEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred             ccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe---E---EEEeC------eEEcCCCCC--CCcEEEEEcCCCeEEEEe
Confidence            56899999999999999  57999999866553   2   22432      699998865  235789999999 99999


Q ss_pred             CCCceEEecCCCCC-CCceeEEecCCCEEEEecCCCceeEeeccCCCCccCCC
Q 005206          135 GSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQ  186 (709)
Q Consensus       135 ~~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PtDTlLpg  186 (709)
                      .++.++|++++.+. ...+|+|+|+|||||++    ..+|+|     .|.+||
T Consensus        66 ~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~----~~~W~s-----~t~~~~  109 (109)
T 3r0e_A           66 GDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG----PSVFKI-----DPWVRG  109 (109)
T ss_dssp             TTSCEEEECCCCCSSSCCEEEEETTTEEEEEC----SEEEEE-----CTTSCC
T ss_pred             CCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe----cCEECC-----CCccCC
Confidence            99999999997644 35689999999999996    479997     565554

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1

Probab=99.52  E-value=3.5e-14  Score=127.69  Aligned_cols=84  Identities=18%  Similarity=0.261  Sum_probs=70.5

Q ss_pred             ceEEEEcCc-eEEEcCCCceEEecCCCCC-CCceeEEecCCCEEEEecCCCceeEeeccCCCCccCCCCcccceeccCCe
Q 005206          121 GVLRIINQR-IGLFDGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFE  198 (709)
Q Consensus       121 ~~l~l~~~G-Lvl~d~~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PtDTlLpg~~l~~~~~tg~~  198 (709)
                      .+|.+..|| |+|++. +++||++|+... ....|+|+|+|||||+|. .+.++||||                      
T Consensus        32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~-~~~~lW~S~----------------------   87 (119)
T 1b2p_A           32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITN-ENVTVWQSP----------------------   87 (119)
T ss_dssp             EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT-TCCEEEECS----------------------
T ss_pred             EEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeC-CCcEEEcCC----------------------
Confidence            578889999 999987 889999997654 357899999999999985 678999999                      


Q ss_pred             eEEEEecCCCCCCCCcceEeecCCCCcEEEEecCCccccccCC
Q 005206          199 WYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGP  241 (709)
Q Consensus       199 ~~L~S~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~sg~  241 (709)
                               .+|++|.|++.|+++|+  +++++  ..||++|+
T Consensus        88 ---------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~  117 (119)
T 1b2p_A           88 ---------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT  117 (119)
T ss_dssp             ---------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred             ---------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence                     45678999999999998  44555  38999986

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A*

Probab=99.52  E-value=4.8e-14  Score=126.23  Aligned_cols=89  Identities=19%  Similarity=0.324  Sum_probs=73.9

Q ss_pred             cceEEEEcCc-eEEEcCCCceEEecCCCCC-CCceeEEecCCCEEEEecCCCceeEeeccCCCCccCCCCcccceeccCC
Q 005206          120 SGVLRIINQR-IGLFDGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGF  197 (709)
Q Consensus       120 ~~~l~l~~~G-Lvl~d~~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PtDTlLpg~~l~~~~~tg~  197 (709)
                      ...|.+..+| |+|++ .+++||++|+... ....++|+|+|||||+|. .+.++||||++                   
T Consensus        21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~-~~~~vW~S~~~-------------------   79 (115)
T 2dpf_A           21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDH-NNNDVWGSACW-------------------   79 (115)
T ss_dssp             TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECT-TCCEEEECCCC-------------------
T ss_pred             CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECC-CceEEEEcCCC-------------------
Confidence            4678898999 99998 4789999997654 356899999999999986 57799999997                   


Q ss_pred             eeEEEEecCCCCCCCCcceEeecCCCCcEEEEecCCccccccCCCCCc
Q 005206          198 EWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGV  245 (709)
Q Consensus       198 ~~~L~S~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~sg~~~~~  245 (709)
                                  +++|.|++.|+++|+  +++++.  .||+|++|...
T Consensus        80 ------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~  111 (115)
T 2dpf_A           80 ------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR  111 (115)
T ss_dssp             ------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred             ------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence                        356789999999998  555654  89999999753

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.34  E-value=2.7e-12  Score=113.94  Aligned_cols=101  Identities=15%  Similarity=0.217  Sum_probs=79.4

Q ss_pred             ccccCCCCCcCCCCEEEecCCeEEEEeeCCCCCCcEEEEEEEeccCCceEEEEcCCCCCCCCCcceEEEEcCc-eEEEcC
Q 005206           57 VDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQR-IGLFDG  135 (709)
Q Consensus        57 ~~~l~~g~~l~~~~~lvS~~g~F~lGFf~~~~~~~~~lgIw~~~~~~~tvVWvANr~~Pv~~~~~~l~l~~~G-Lvl~d~  135 (709)
                      .|+|.+||.|.+|+.|  .+|.|.|-|...++   ..  + |..   .. ||.+|+..|.  ..+.|.|.++| |||.|.
T Consensus         2 ~~~l~~gq~L~~g~~L--~~g~~~L~~q~dGn---Lv--l-~~~---~~-vW~snt~~~~--~~~~l~l~~dGNLVl~~~   67 (111)
T 3mez_A            2 NNVLLTGDVIHTDNQL--SYESAAFVMQGDCN---LV--L-YNE---AG-GFQSNTHGRG--VDCTLRLNNRGQLEIHSA   67 (111)
T ss_dssp             TTEEETTCEECTTCEE--EETTEEEEECTTSC---EE--E-ECS---SC-CEECCCTTSC--SSCEEEECTTSCEEEECS
T ss_pred             cCEeCCCCEeCCCCEE--ecCCEEEEEccCCe---EE--E-ECC---CC-EEECCcccCC--cCEEEEEcCCCcEEEEeC
Confidence            4789999999999999  47899999865542   32  2 543   23 9999998762  34789999999 999999


Q ss_pred             CCc-eEEecCCCCC---CCceeEEecCCCEEEEecCCCceeEee
Q 005206          136 SQN-LVWSSNQTKA---TNPVAQLQDSGNFVLKEAGSDEILWQS  175 (709)
Q Consensus       136 ~g~-~vWst~~~~~---~~~~a~LldsGNlVl~~~~~~~~lWQS  175 (709)
                      ++. ++|+|++...   ...+|.|+|+|||||++    ..+|+|
T Consensus        68 ~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~----~~~W~s  107 (111)
T 3mez_A           68 NSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG----PAIWST  107 (111)
T ss_dssp             SCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC----SEEEEC
T ss_pred             CCCEEEEEeccccCCCCcCEEEEECCCCeEEEec----cCEEcc
Confidence            876 5999996422   35689999999999996    479997

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.31  E-value=1e-11  Score=127.31  Aligned_cols=148  Identities=14%  Similarity=0.059  Sum_probs=116.4

Q ss_pred             HHHHhcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEE
Q 005206          537 IVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       537 l~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~l  615 (709)
                      +......|.....++.|+.+.||+.... ++.+++|+...........+.+|+.++..+. |..+.++++++.+.+..++
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            3444567877778888889999999754 6889999986432233457899999999984 7788899999999899999


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD-----------------------------------  660 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----------------------------------  660 (709)
                      ||||+++.+|.+.+.        +......++.+++++|..||+.                                   
T Consensus        88 v~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           88 LMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             EEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            999999999976531        1122346888999999999981                                   


Q ss_pred             ---------------------CCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          661 ---------------------SRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       661 ---------------------~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                                           ....++|+|++|.|||++++..+.|+||+.+..
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                 113499999999999998766678999998864

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.22  E-value=3.4e-11  Score=107.15  Aligned_cols=94  Identities=18%  Similarity=0.281  Sum_probs=72.4

Q ss_pred             CCCCCCCCcceEEEEcCc-eEEEcC-CCceEEecCCCCC-CCceeEEecCCCEEEEecCCCceeEeeccCCCCccCCCCc
Q 005206          112 RDDPLANSSGVLRIINQR-IGLFDG-SQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMK  188 (709)
Q Consensus       112 r~~Pv~~~~~~l~l~~~G-Lvl~d~-~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PtDTlLpg~~  188 (709)
                      .+.|+.+...+|.+..|| |||.+. .+.++|++++... ....|+|+|+|||||++. .+.++|||=.+          
T Consensus        17 ~g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~-~~~~iW~S~t~----------   85 (113)
T 3mez_B           17 DNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDD-RLNTVFVSNTV----------   85 (113)
T ss_dssp             TTCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECT-TSCEEEECSCC----------
T ss_pred             CCCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECC-CCCEEEECCCc----------
Confidence            355666666899999999 999998 4889999998654 356899999999999986 56789998221          


Q ss_pred             ccceeccCCeeEEEEecCCCCCCCCcceEeecCCCCcEEEEecCCccccccCC
Q 005206          189 IGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGP  241 (709)
Q Consensus       189 l~~~~~tg~~~~L~S~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~sg~  241 (709)
                                           -..|.|.+.++.+|+..++  +  ...|.+|+
T Consensus        86 ---------------------~~~~~~~~~L~~dGnlvly--~--~~~W~s~~  113 (113)
T 3mez_B           86 ---------------------GQEGDYVLILQINGQAVVY--G--PAVWSTAA  113 (113)
T ss_dssp             ---------------------CSSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred             ---------------------CCCCCEEEEEcCCceEEEe--c--CCEecCCC
Confidence                                 0135588999999986554  4  57888875

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A*

Probab=99.21  E-value=2.7e-11  Score=125.05  Aligned_cols=112  Identities=17%  Similarity=0.302  Sum_probs=88.5

Q ss_pred             ccccccCCCCC----cCCCCEEEecCCeEEEEeeCCC--CCCcEEEEEEEeccCCceEEEEcCCCCCCCCCcceEEEEcC
Q 005206           55 ISVDTLTATQN----LTYGKTLVSSDDVFELGFFSPG--SSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ  128 (709)
Q Consensus        55 ~~~~~l~~g~~----l~~~~~lvS~~g~F~lGFf~~~--~~~~~~lgIw~~~~~~~tvVWvANr~~Pv~~~~~~l~l~~~  128 (709)
                      ..+|++.||+.    |..|+.|+| +..++.|+|+..  ...+.+|   |.+  ..+++|.+++..+-  . ..|.+..+
T Consensus       134 ~ptdtlLpg~~~~~~l~~g~~L~S-~~dps~G~fsl~l~~dGnlvL---y~~--~~~~yW~Sgt~~~~--~-~~l~l~~d  204 (276)
T 3m7h_A          134 TPAIPLVPGAIDSLLLAPGSELVQ-GVVYGAGASKLVFQGDGNLVA---YGP--NGAATWNAGTQGKG--A-VRAVFQGD  204 (276)
T ss_dssp             CTTSCCCCSCTTCEEECSSEEECT-TCEEEETTEEEEECTTSCEEE---ECT--TSSEEEECCCTTTT--C-CEEEECTT
T ss_pred             ccccccccccccccccccCccccc-CCCCCCceEEEeecCCceEEE---EeC--CCeEEEECCCCCCc--c-EEEEEcCC
Confidence            45799999999    888999865 467777777532  2224443   332  25789999998763  2 68999999


Q ss_pred             c-eEEEcCCCceEEecCCCCCCCceeEEecCCCEEEEecCCCceeEeeccC
Q 005206          129 R-IGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKEAGSDEILWQSFDY  178 (709)
Q Consensus       129 G-Lvl~d~~g~~vWst~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~  178 (709)
                      | |++.|.++.++|++++......+|+|+++|||||++.   .++||||||
T Consensus       205 GnLvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~  252 (276)
T 3m7h_A          205 GNLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE---KPVWARFGF  252 (276)
T ss_dssp             SCEEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE---EEEEESSSC
T ss_pred             CeEEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC---CCeEEccCc
Confidence            9 9999998899999997655567899999999999974   589999998

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.13  E-value=1.3e-10  Score=102.91  Aligned_cols=94  Identities=14%  Similarity=0.215  Sum_probs=70.1

Q ss_pred             CCCCCCCcceEEEEcCc-eEEEcCCCceEEecCCCCC-CCceeEEecCCCEEEEecCCCceeEeeccCCCCccCCCCccc
Q 005206          113 DDPLANSSGVLRIINQR-IGLFDGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIG  190 (709)
Q Consensus       113 ~~Pv~~~~~~l~l~~~G-Lvl~d~~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PtDTlLpg~~l~  190 (709)
                      +.|+.+....|.+..|| |||.+.++  +|++++... ....|+|+|+|||||++.+.+.++|||..+            
T Consensus        14 g~~L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~------------   79 (111)
T 3mez_A           14 DNQLSYESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS------------   79 (111)
T ss_dssp             TCEEEETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSS------------
T ss_pred             CCEEecCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccc------------
Confidence            33444456789999999 99999876  999998654 347899999999999986323359999621            


Q ss_pred             ceeccCCeeEEEEecCCCCCCCCcceEeecCCCCcEEEEecCCccccccCC
Q 005206          191 WDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGP  241 (709)
Q Consensus       191 ~~~~tg~~~~L~S~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~sg~  241 (709)
                                       .....|.|.+.++.+|+..+|  .  ..+|.+++
T Consensus        80 -----------------~~~~~~~~~l~Lq~dGNlvly--~--~~~W~s~t  109 (111)
T 3mez_A           80 -----------------VNTVRGNYAATLGPDQHVTIY--G--PAIWSTPA  109 (111)
T ss_dssp             -----------------CCCCSSCCEEEECTTSCEEEE--C--SEEEECCC
T ss_pred             -----------------cCCCCcCEEEEECCCCeEEEe--c--cCEEccCC
Confidence                             111347899999999986554  3  67898774

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.12  E-value=8.8e-11  Score=119.52  Aligned_cols=137  Identities=15%  Similarity=0.128  Sum_probs=103.0

Q ss_pred             CcCcceeec-ccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCc--eeeEEEEEEeCCeeEEEEEc
Q 005206          543 NFTDYNKLG-QGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN--LVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       543 ~f~~~~~LG-~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~~~~~~~~~lV~Ey  619 (709)
                      .+.. +.++ .|..+.||+....+|+.+++|.....   ....+..|+.++..+.+.+  +.+++++....+..++||||
T Consensus        21 ~~~~-~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           21 GYDW-AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TCEE-EECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCce-EecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            3443 3454 55669999998777888999987543   3356889999999986444  56799988888889999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS--------------------------------------  661 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------  661 (709)
                      +++.+|.  ...      .+   ...++.++++.|..||+..                                      
T Consensus        97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            9998884  211      12   1256778888888888643                                      


Q ss_pred             -----------------CCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          662 -----------------RFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       662 -----------------~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                                       ...++|+|++|.|||++++..++|+|||.|..-
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                             123999999999999988777789999998754

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A*

Probab=98.98  E-value=2.5e-09  Score=94.47  Aligned_cols=85  Identities=16%  Similarity=0.274  Sum_probs=65.6

Q ss_pred             cceEEEEcCc-eEEEcCCCceEEecCCCCC-CCceeEEecCCCEEEEecCCCceeEeeccCCCCccCCCCcccceeccCC
Q 005206          120 SGVLRIINQR-IGLFDGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGF  197 (709)
Q Consensus       120 ~~~l~l~~~G-Lvl~d~~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PtDTlLpg~~l~~~~~tg~  197 (709)
                      ...|.+..|| |+|++. +.++|++++... ....++|+|+|||||+|. .+.++|||....                  
T Consensus        20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~-~~~~~W~S~t~~------------------   79 (109)
T 3dzw_A           20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSP-RNNPIWASNTGG------------------   79 (109)
T ss_dssp             TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECT-TSCEEEECCCCC------------------
T ss_pred             CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECC-CCCEEEECCCCC------------------
Confidence            4689999999 999988 789999998654 356899999999999986 567999984320                  


Q ss_pred             eeEEEEecCCCCCCCCcceEeecCCCCcEEEEecCCccccccCC
Q 005206          198 EWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGP  241 (709)
Q Consensus       198 ~~~L~S~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~sg~  241 (709)
                                   ..+.|.+.++.+|+..++  +.  ..|.|+.
T Consensus        80 -------------~~~~~~~~L~ddGNlvly--~~--~~W~s~t  106 (109)
T 3dzw_A           80 -------------ENGNYVCVLQKDRNVVIY--GT--ARWATGT  106 (109)
T ss_dssp             -------------SSSCEEEEECTTSCEEEE--ES--CCCCCCC
T ss_pred             -------------CCCCEEEEEeCCCEEEEE--CC--CEEeCCC
Confidence                         124678999999986554  32  6787764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.98  E-value=1.6e-09  Score=116.28  Aligned_cols=142  Identities=13%  Similarity=0.214  Sum_probs=107.2

Q ss_pred             cceeecccCceEEEEEEEcCCcEEEEEEec--cCC-ccchHHHHHHHHHHHhcC--CCceeeEEEEEEeC---CeeEEEE
Q 005206          546 DYNKLGQGGFGIVYKGRLLEGQEIAVKRLS--RNS-GQGIEEFKNEVRLIAKLQ--HRNLVRLLGCCVEM---DEKMLVY  617 (709)
Q Consensus       546 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~--~~~-~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~---~~~~lV~  617 (709)
                      ..+.|+.|.++.||+....+ ..+++|+..  ... ......+.+|+.++..+.  +..+.++++++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            45789999999999998754 577788765  221 123457889999999997  56688999998776   3479999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS------------------------------------  661 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------  661 (709)
                      ||+++..+.+.     ....++..++..++.++++.|..||...                                    
T Consensus       121 e~v~G~~l~~~-----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQ-----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCT-----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCC-----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            99999877431     1123678888899999999999999731                                    


Q ss_pred             -------------------CCceEecCCCCCCEEEcCCCc--EEEEecCCcee
Q 005206          662 -------------------RFRIIHRDLKASNILLDKEMT--PKISDFGMARI  693 (709)
Q Consensus       662 -------------------~~~iiHrDlkp~NILl~~~~~--~KI~DFGla~~  693 (709)
                                         ...++|+|+++.|||++.++.  +.|.||+++..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               246999999999999997753  69999999874

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=98.95  E-value=1.8e-09  Score=95.49  Aligned_cols=83  Identities=18%  Similarity=0.365  Sum_probs=63.8

Q ss_pred             cceEEEEcCc-eEEEcCCCceEEecCCCCC-CCceeEEecCCCEEEEecCCCceeEeeccCCCCccCCCCcccceeccCC
Q 005206          120 SGVLRIINQR-IGLFDGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGF  197 (709)
Q Consensus       120 ~~~l~l~~~G-Lvl~d~~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PtDTlLpg~~l~~~~~tg~  197 (709)
                      ...|.+..|| |+|++.  .++|++++... ....++|+|+|||||+|. .+.++|||-.+                   
T Consensus        25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~-~~~~iW~S~t~-------------------   82 (110)
T 3r0e_B           25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDD-DFKTIWSSRSS-------------------   82 (110)
T ss_dssp             SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECT-TCCEEEECCCC-------------------
T ss_pred             CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeC-CCCEEEEcCCc-------------------
Confidence            4689999999 999877  58999998654 346899999999999986 56799998321                   


Q ss_pred             eeEEEEecCCCCCCCCcceEeecCCCCcEEEEecCCccccccC
Q 005206          198 EWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSG  240 (709)
Q Consensus       198 ~~~L~S~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~sg  240 (709)
                                  -..|.|.+.++.+|+..++  +  ...|.+|
T Consensus        83 ------------~~~~~~~~~L~~dGNlvly--~--~~~W~t~  109 (110)
T 3r0e_B           83 ------------SKQGEYVLILQDDGFGVIY--G--PAIFETS  109 (110)
T ss_dssp             ------------CSSSCCEEEECTTSCEEEE--C--SEEEESC
T ss_pred             ------------CCCCCEEEEEcCCccEEEe--c--CCEecCC
Confidence                        0134588999999986554  4  3678776

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=98.90  E-value=2.8e-09  Score=94.06  Aligned_cols=91  Identities=22%  Similarity=0.404  Sum_probs=68.8

Q ss_pred             CCCCCCCcceEEEEcCc-eEEEcCCCceEEecCCCCC-CCceeEEecCCCEEEEecCCCceeEeeccCCCCccCCCCccc
Q 005206          113 DDPLANSSGVLRIINQR-IGLFDGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIG  190 (709)
Q Consensus       113 ~~Pv~~~~~~l~l~~~G-Lvl~d~~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PtDTlLpg~~l~  190 (709)
                      +.|+.+....|.+..|| |||+++    +|+|++... ....++|+++|||||+|. .+.++|+|-.             
T Consensus        15 g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~-~~~~vWss~t-------------   76 (109)
T 3r0e_A           15 EGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNG-DGSTVWKSGA-------------   76 (109)
T ss_dssp             TCEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECT-TSCEEEECCC-------------
T ss_pred             CCEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeC-CCCEEEcCCC-------------
Confidence            44555566789999999 999985    799998754 357899999999999986 5678997611             


Q ss_pred             ceeccCCeeEEEEecCCCCCCCCcceEeecCCCCcEEEEecCCccccccCCCC
Q 005206          191 WDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWN  243 (709)
Q Consensus       191 ~~~~tg~~~~L~S~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~sg~~~  243 (709)
                                        ....+.|.+.++++|+..++  .  ...|.+++|-
T Consensus        77 ------------------~~~~~~~~~~L~~dGNlvly--~--~~~W~s~t~~  107 (109)
T 3r0e_A           77 ------------------QSVKGNYAAVVHPDGRLVVF--G--PSVFKIDPWV  107 (109)
T ss_dssp             ------------------CCSSSCCEEEEETTTEEEEE--C--SEEEEECTTS
T ss_pred             ------------------cCCCcCEEEEEcCCCeEEEE--e--cCEECCCCcc
Confidence                              00235688999999975554  4  5789998873

>4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D*

Probab=98.69  E-value=7e-08  Score=84.36  Aligned_cols=75  Identities=25%  Similarity=0.376  Sum_probs=58.8

Q ss_pred             ceEEEEcCc-eEEEcCCCceEEecCCCCC--CCceeEEecCCCEEEEecCCCceeEeeccCCCCccCCCCcccceeccCC
Q 005206          121 GVLRIINQR-IGLFDGSQNLVWSSNQTKA--TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGF  197 (709)
Q Consensus       121 ~~l~l~~~G-Lvl~d~~g~~vWst~~~~~--~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PtDTlLpg~~l~~~~~tg~  197 (709)
                      -+|.+..|| |||.+. +.+||++|+..+  .+..+.|.++|||||+|. .+.++|.|=                     
T Consensus        21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~-~~~~vWss~---------------------   77 (105)
T 4h3o_A           21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDS-SGRSLWASH---------------------   77 (105)
T ss_dssp             EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECT-TCCEEEECC---------------------
T ss_pred             EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECC-CcEEEEEec---------------------
Confidence            578999999 999986 679999997644  456899999999999996 677899861                     


Q ss_pred             eeEEEEecCCCCCCCCcceEeecCCCCcEEE
Q 005206          198 EWYLTSWKSTDDPSTGDNSFKLDFHGFPEGF  228 (709)
Q Consensus       198 ~~~L~S~~s~~dps~G~~~l~~~~~g~~~~~  228 (709)
                                .....+.|.+.|+++|+..++
T Consensus        78 ----------t~~~~~~~~l~L~ddGNlVly   98 (105)
T 4h3o_A           78 ----------STRGSGNYILILQDDGNVIIY   98 (105)
T ss_dssp             ----------CCCCSSCEEEEECTTSCEEEE
T ss_pred             ----------CCCCCCCEEEEEeCCCeEEEE
Confidence                      111345688999999986554

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1

Probab=98.68  E-value=2e-08  Score=101.41  Aligned_cols=86  Identities=28%  Similarity=0.307  Sum_probs=65.6

Q ss_pred             ceEEEEcCc-eEEEcCCCceEEecCCCCCCCceeEEecCCCEEEEecCCCceeEeeccCCCCccCCCCcccceeccCCee
Q 005206          121 GVLRIINQR-IGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEW  199 (709)
Q Consensus       121 ~~l~l~~~G-Lvl~d~~g~~vWst~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PtDTlLpg~~l~~~~~tg~~~  199 (709)
                      -.|.+..+| |+|.+. +++||.+|+.......++|.++|||||+|. .+.++|+|+++                     
T Consensus        28 f~l~f~~~gnl~ly~~-~~~vW~an~~~~~~~~l~l~~dGnLvl~d~-~~~~vW~s~~~---------------------   84 (236)
T 1dlp_A           28 FRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTA-QNTIRWSSGTK---------------------   84 (236)
T ss_dssp             EEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCT-TTCCSCCCCCC---------------------
T ss_pred             EEEEECCCCcEEEEEC-CEEEEECCCCCCCCeEEEEcCCCcEEEEcC-CCcEEEeCCcc---------------------
Confidence            456666777 888886 789999997655567899999999999996 67899999875                     


Q ss_pred             EEEEecCCCCCCCCcceEeecCCCCcEEEEecCCccccccCCCC
Q 005206          200 YLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWN  243 (709)
Q Consensus       200 ~L~S~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~sg~~~  243 (709)
                                .++|.|.+.|+.+|+..++  ..  .+|.|..+.
T Consensus        85 ----------~~~~~~~~~l~d~Gnlvl~--~~--~~W~S~~~p  114 (236)
T 1dlp_A           85 ----------GSIGNYVLVLQPDRTVTIY--GP--GLWDSGTSN  114 (236)
T ss_dssp             ----------CCSSCCEEEECSSSCEEEE--CS--EEEECSCCC
T ss_pred             ----------ccCCcEEEEEeCCCCEEEe--cC--CEEECCCCC
Confidence                      1235678888888885553  32  788887664

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.50  E-value=2.9e-07  Score=96.26  Aligned_cols=137  Identities=21%  Similarity=0.257  Sum_probs=100.7

Q ss_pred             ceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcC-CCc--eeeEEEEEEeCC---eeEEEEEcc
Q 005206          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRN--LVRLLGCCVEMD---EKMLVYEYM  620 (709)
Q Consensus       547 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~n--Iv~l~g~~~~~~---~~~lV~Ey~  620 (709)
                      .+.++.|.+..||+..    ..+++|+...  ......+.+|.+++..+. +..  +.++++.....+   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            3568999999999863    4578887532  234577899999998883 333  456665544333   348999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD----------------------------------------  660 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------  660 (709)
                      ++..|......     .++..++..++.++++.|..||..                                        
T Consensus        99 ~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            99888654321     256777778888888888888861                                        


Q ss_pred             ---------------CCCceEecCCCCCCEEEcC--CCcEEEEecCCceee
Q 005206          661 ---------------SRFRIIHRDLKASNILLDK--EMTPKISDFGMARIF  694 (709)
Q Consensus       661 ---------------~~~~iiHrDlkp~NILl~~--~~~~KI~DFGla~~l  694 (709)
                                     ....++|+|++|.||++++  ...+.|+||+.+..-
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                           1235899999999999998  566899999998764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.38  E-value=3e-06  Score=88.74  Aligned_cols=137  Identities=20%  Similarity=0.197  Sum_probs=95.2

Q ss_pred             ceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCC---ceeeEEEEEE-eCCeeEEEEEccCC
Q 005206          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR---NLVRLLGCCV-EMDEKMLVYEYMEN  622 (709)
Q Consensus       547 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~---nIv~l~g~~~-~~~~~~lV~Ey~~~  622 (709)
                      .+.++.|....||+.    +..+++|+-.  .......+..|.+++..+.+.   .+.+.+.++. ..+..++||||+++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            357888999999987    5667788742  223456889999999999652   3667777775 34457899999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD------------------------------------------  660 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------  660 (709)
                      ..+......     .++..++..++.++++.|..||+.                                          
T Consensus        98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            888653211     133444444555555555555532                                          


Q ss_pred             ---------------CCCceEecCCCCCCEEEcC---CCc-EEEEecCCceee
Q 005206          661 ---------------SRFRIIHRDLKASNILLDK---EMT-PKISDFGMARIF  694 (709)
Q Consensus       661 ---------------~~~~iiHrDlkp~NILl~~---~~~-~KI~DFGla~~l  694 (709)
                                     ....++|+|++|.|||++.   ++. +.|.||+.+..-
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                           2235799999999999987   355 589999998754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.28  E-value=5.5e-06  Score=84.61  Aligned_cols=137  Identities=18%  Similarity=0.126  Sum_probs=98.2

Q ss_pred             eeecccCce-EEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEEEEccCCCC
Q 005206          548 NKLGQGGFG-IVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYEYMENRS  624 (709)
Q Consensus       548 ~~LG~G~fG-~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  624 (709)
                      +.+..|..| .||+..... +..+.+|+-..   ....++..|...|..+. +--+.++++++.+.+..++|||++++.+
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            356667666 699887654 56788887642   23567889999998884 4457789999999999999999999988


Q ss_pred             HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 005206          625 LDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD--------------------------------------------  660 (709)
Q Consensus       625 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------------  660 (709)
                      +.+.....       ......++.+++..|.-||..                                            
T Consensus       107 ~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          107 AFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             HHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             ccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            76654221       111223455555666666532                                            


Q ss_pred             -----------CCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          661 -----------SRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       661 -----------~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                                 ....++|+|+.+.|||++.+..+-|.||+.+..-
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence                       1123899999999999998877889999998753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.19  E-value=3.7e-06  Score=89.76  Aligned_cols=80  Identities=8%  Similarity=-0.036  Sum_probs=56.6

Q ss_pred             ceee-cccCceEEEEEEEc-------CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcC-C--CceeeEEEEEEeC--
Q 005206          547 YNKL-GQGGFGIVYKGRLL-------EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQ-H--RNLVRLLGCCVEM--  610 (709)
Q Consensus       547 ~~~L-G~G~fG~Vykg~~~-------~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~-H--~nIv~l~g~~~~~--  610 (709)
                      .+.| +.|....+|+....       +++.+++|+.....   ......+..|+.++..+. +  ..+.++++++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 88999999998765       25678888764322   112356788999988884 3  4577888887665  


Q ss_pred             -CeeEEEEEccCCCCHH
Q 005206          611 -DEKMLVYEYMENRSLD  626 (709)
Q Consensus       611 -~~~~lV~Ey~~~gsL~  626 (709)
                       ...++||||+++..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3468999999886653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.92  E-value=4e-05  Score=83.03  Aligned_cols=75  Identities=12%  Similarity=0.180  Sum_probs=51.5

Q ss_pred             ceeecccCceEEEEEEEc-CCcEEEEEEeccCCc-------cchHHHHHHHHHHHhcCC--C-ceeeEEEEEEeCCeeEE
Q 005206          547 YNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG-------QGIEEFKNEVRLIAKLQH--R-NLVRLLGCCVEMDEKML  615 (709)
Q Consensus       547 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-------~~~~~f~~Ei~~l~~l~H--~-nIv~l~g~~~~~~~~~l  615 (709)
                      .+.||.|.++.||++... +++.++||.......       ...+++..|.+++..+.+  + .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            468999999999999765 367899997643211       234567889999888742  3 34466654  4556789


Q ss_pred             EEEccCCC
Q 005206          616 VYEYMENR  623 (709)
Q Consensus       616 V~Ey~~~g  623 (709)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999864

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.90  E-value=5.3e-05  Score=79.79  Aligned_cols=142  Identities=17%  Similarity=0.216  Sum_probs=81.9

Q ss_pred             ceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcC--CCceeeEEE------EEEeCCeeEEEEE
Q 005206          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ--HRNLVRLLG------CCVEMDEKMLVYE  618 (709)
Q Consensus       547 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~--H~nIv~l~g------~~~~~~~~~lV~E  618 (709)
                      .+.|+.|..+.||+....++ .+++|+....    .+++..|..++..|.  .-.+.+++.      +....+..+++||
T Consensus        37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EEECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            34566677899999987554 4888888642    234445555555542  112333332      1234667899999


Q ss_pred             ccCCCCHH-----H---------HHhccCC----C-------CCCCHHHHH-----------------------------
Q 005206          619 YMENRSLD-----S---------VIFDKAR----S-------SILNWQRRF-----------------------------  644 (709)
Q Consensus       619 y~~~gsL~-----~---------~l~~~~~----~-------~~l~~~~~~-----------------------------  644 (709)
                      |+++..+.     .         -++....    .       ..-.|...+                             
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986542     0         1111110    0       112343211                             


Q ss_pred             --HHHHHHHHHHHHHHh----------CCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          645 --NIICGIARGLLYLHQ----------DSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       645 --~i~~~ia~gL~yLH~----------~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                        .+...+..++.+|++          .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence              011223446677763          1234699999999999998888999999998863

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.67  E-value=0.00024  Score=73.34  Aligned_cols=79  Identities=18%  Similarity=0.228  Sum_probs=59.8

Q ss_pred             CcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcC-C--CceeeEEEEEEeCCeeEEEEEc
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-H--RNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H--~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ....++.+|.|..+.||+.++.+|+.+.+|+...........|..|.+.|..|. .  .-+.+++++.    ..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            345567899999999999999999999999876544444566889999999884 2  2355666542    34889999


Q ss_pred             cCCCCH
Q 005206          620 MENRSL  625 (709)
Q Consensus       620 ~~~gsL  625 (709)
                      ++.+..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.62  E-value=0.00036  Score=73.06  Aligned_cols=140  Identities=18%  Similarity=0.145  Sum_probs=94.5

Q ss_pred             CcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcC---CCceeeEEEEEEeCCeeEEEEEccC
Q 005206          545 TDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ---HRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       545 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      ...+.|+.|.+..+|+... +++.+++|+....   ....|..|.+.|..|.   ...+.++++++...+..++||||++
T Consensus        39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            3456899999999999876 4667888876532   3567889999998883   3678899999888888999999999


Q ss_pred             CCCHH--------H---HHhccCC-C------------------CCCCHHHHH---HHHH----------------HHHH
Q 005206          622 NRSLD--------S---VIFDKAR-S------------------SILNWQRRF---NIIC----------------GIAR  652 (709)
Q Consensus       622 ~gsL~--------~---~l~~~~~-~------------------~~l~~~~~~---~i~~----------------~ia~  652 (709)
                      +..+.        .   -|+.... .                  ..-+|...+   ++..                .++.
T Consensus       115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~  194 (312)
T 3jr1_A          115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ  194 (312)
T ss_dssp             CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence            87642        1   1222111 0                  012565432   1111                1111


Q ss_pred             H-HHHHHh-CCCCceEecCCCCCCEEEcCCCcEEEEecC
Q 005206          653 G-LLYLHQ-DSRFRIIHRDLKASNILLDKEMTPKISDFG  689 (709)
Q Consensus       653 g-L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~KI~DFG  689 (709)
                      . ...|.. ..++.++|+|+.+.|++++.++ +.|.||.
T Consensus       195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1 223422 2346799999999999999887 8999984

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.49  E-value=0.00048  Score=75.19  Aligned_cols=74  Identities=9%  Similarity=0.109  Sum_probs=46.7

Q ss_pred             cceeecccCceEEEEEEEcCCcEEEEEEeccC----C---c--cchHHHHHHHHHHH-hcCCCceeeEEEEEEeCCeeEE
Q 005206          546 DYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN----S---G--QGIEEFKNEVRLIA-KLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       546 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~----~---~--~~~~~f~~Ei~~l~-~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      ..+.||.|....||++.. +++.++||.....    .   .  .....+..|+..+. ...+..+.+++.+.  .+..++
T Consensus        38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l  114 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI  114 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred             EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence            346899999999999965 4678899943211    0   1  12233444444332 22335667777765  567799


Q ss_pred             EEEcc-CC
Q 005206          616 VYEYM-EN  622 (709)
Q Consensus       616 V~Ey~-~~  622 (709)
                      ||||+ ++
T Consensus       115 v~e~l~~g  122 (420)
T 2pyw_A          115 GMRYLEPP  122 (420)
T ss_dssp             EECCCCTT
T ss_pred             EEeecCCc
Confidence            99999 76

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.13  E-value=0.0041  Score=64.78  Aligned_cols=159  Identities=12%  Similarity=0.120  Sum_probs=88.9

Q ss_pred             CChHHHHHHhcCcCc-----ceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCc--eeeEE
Q 005206          532 FDFETIVRATDNFTD-----YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN--LVRLL  604 (709)
Q Consensus       532 ~~~~~l~~~t~~f~~-----~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~  604 (709)
                      ++.+++......|..     .+.|+.|....+|+....++ .+++|.....  ...+++..|+.++..+....  +.+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            344555555555543     35577788899999987666 5778877542  12345566777777663212  33333


Q ss_pred             EE------EEeCCeeEEEEEccCCCCHHH----H----------HhccCC----C--CC---CCHHHHHH----------
Q 005206          605 GC------CVEMDEKMLVYEYMENRSLDS----V----------IFDKAR----S--SI---LNWQRRFN----------  645 (709)
Q Consensus       605 g~------~~~~~~~~lV~Ey~~~gsL~~----~----------l~~~~~----~--~~---l~~~~~~~----------  645 (709)
                      ..      ....+..++++||+++..+..    .          ++....    .  ..   ..|...+.          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            21      123456789999999865311    0          111100    0  00   12433111          


Q ss_pred             --HHHHHHHHHHHHHhC----CCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          646 --IICGIARGLLYLHQD----SRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       646 --i~~~ia~gL~yLH~~----~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                        +...+...+.+|++.    .+..++|+|+.+.|||++.+..+.|+||+.+..
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence              011244556666532    234699999999999999876678999998763

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.05  E-value=0.002  Score=66.79  Aligned_cols=138  Identities=12%  Similarity=0.123  Sum_probs=76.3

Q ss_pred             ceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCce-eeEEEEEEeCCeeEEEEEcc-CCCC
Q 005206          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL-VRLLGCCVEMDEKMLVYEYM-ENRS  624 (709)
Q Consensus       547 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~-~~gs  624 (709)
                      .+.|+.|....+|+.     +.+.+|+....... .....+|+.++..+....+ .++++.  +.+..++++||+ ++..
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            578999999999998     55778877543221 2233568887777642222 466654  344568899999 5544


Q ss_pred             HHHH------------------HhccCC--CCCCC-HHHHHHHHH--------------HHHHHHHH----HHh-CCCCc
Q 005206          625 LDSV------------------IFDKAR--SSILN-WQRRFNIIC--------------GIARGLLY----LHQ-DSRFR  664 (709)
Q Consensus       625 L~~~------------------l~~~~~--~~~l~-~~~~~~i~~--------------~ia~gL~y----LH~-~~~~~  664 (709)
                      +...                  ++....  ....+ +.....+..              .+.+.+..    |.. .....
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            4310                  011100  00011 111111111              01111111    111 22345


Q ss_pred             eEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          665 IIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       665 iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ++|+|+.+.||+ ..++.+.|+||..|..
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            899999999999 5667789999998874

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.01  E-value=0.0085  Score=62.50  Aligned_cols=142  Identities=14%  Similarity=0.141  Sum_probs=83.0

Q ss_pred             eeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCC--CceeeEEEE-----EEeCCeeEEEEEcc
Q 005206          548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH--RNLVRLLGC-----CVEMDEKMLVYEYM  620 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~-----~~~~~~~~lV~Ey~  620 (709)
                      +.++ |....||+....+|+.+++|..... ....+++..|..++..+..  -.+++++..     ....+..+++|||+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4576 8888999988777778899988532 1234567778888877742  224455443     22345668899999


Q ss_pred             CCCCHH-----HH---------HhccC------CCCCCCHHHH----HHH---------------HHHHHHHHHHHHh--
Q 005206          621 ENRSLD-----SV---------IFDKA------RSSILNWQRR----FNI---------------ICGIARGLLYLHQ--  659 (709)
Q Consensus       621 ~~gsL~-----~~---------l~~~~------~~~~l~~~~~----~~i---------------~~~ia~gL~yLH~--  659 (709)
                      ++..+.     .+         ++...      .....++...    ..+               ...+...+..+.+  
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            875432     11         11100      0112232211    001               0111122333322  


Q ss_pred             --CCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          660 --DSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       660 --~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                        .....++|+|+++.|||++ + .+.|.||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence              1234589999999999999 4 899999998764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.97  E-value=0.001  Score=72.78  Aligned_cols=73  Identities=18%  Similarity=0.249  Sum_probs=50.2

Q ss_pred             ceeecccCceEEEEEEEcC--------CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCc-eeeEEEEEEeCCeeEEEE
Q 005206          547 YNKLGQGGFGIVYKGRLLE--------GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN-LVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       547 ~~~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~  617 (709)
                      .+.|+.|-...||+....+        ++.+.+|+....  ...+.+..|..++..+...+ ..++++.+.  +  .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence            3578888899999998763        468888887431  11256678999988884333 367777653  2  3899


Q ss_pred             EccCCCCH
Q 005206          618 EYMENRSL  625 (709)
Q Consensus       618 Ey~~~gsL  625 (709)
                      ||+++..|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986443

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.93  E-value=0.0047  Score=64.76  Aligned_cols=142  Identities=15%  Similarity=0.110  Sum_probs=73.4

Q ss_pred             eeecccCceE-EEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcC--CCceeeEEEEEEeCCeeEEEEEccCCCC
Q 005206          548 NKLGQGGFGI-VYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ--HRNLVRLLGCCVEMDEKMLVYEYMENRS  624 (709)
Q Consensus       548 ~~LG~G~fG~-Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~lV~Ey~~~gs  624 (709)
                      +.|+.|.... +|+....+++.+++|......   .+++..|+.++..+.  .-.+.+++.+..  +.-+++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcc
Confidence            4565555544 667765446667666543221   134456677766663  234567777643  23378999997766


Q ss_pred             HHHHHhcc---------------------CC--CCCCCHHHHH-------H-H------------HHHHHHHHHHHH---
Q 005206          625 LDSVIFDK---------------------AR--SSILNWQRRF-------N-I------------ICGIARGLLYLH---  658 (709)
Q Consensus       625 L~~~l~~~---------------------~~--~~~l~~~~~~-------~-i------------~~~ia~gL~yLH---  658 (709)
                      +.+++...                     ..  ...++.....       . +            ...+...+..|.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            65433210                     00  0111111100       0 0            001112223331   


Q ss_pred             hCCCCceEecCCCCCCEEEcCC----CcEEEEecCCceee
Q 005206          659 QDSRFRIIHRDLKASNILLDKE----MTPKISDFGMARIF  694 (709)
Q Consensus       659 ~~~~~~iiHrDlkp~NILl~~~----~~~KI~DFGla~~l  694 (709)
                      ......++|+|+.+.|||++.+    ..+.|.||+.+..-
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            1123469999999999999875    68999999988743

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.84  E-value=0.0056  Score=67.48  Aligned_cols=74  Identities=14%  Similarity=0.230  Sum_probs=48.5

Q ss_pred             ceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCce-eeEEEEEEeCCeeEEEEEccCCCC
Q 005206          547 YNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL-VRLLGCCVEMDEKMLVYEYMENRS  624 (709)
Q Consensus       547 ~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~gs  624 (709)
                      ++.|+.|-...+|+....+ ++.+.+|+....... ...-.+|..++..|...++ .++++.+.  +  .+||||+++..
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            3578889899999998865 477888877433221 1122589999998864444 57777762  2  25999998754


Q ss_pred             H
Q 005206          625 L  625 (709)
Q Consensus       625 L  625 (709)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.80  E-value=0.0021  Score=69.01  Aligned_cols=141  Identities=18%  Similarity=0.207  Sum_probs=83.6

Q ss_pred             eeecccCceEEEEEEEcC--------CcEEEEEEeccCCccchHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEEEE
Q 005206          548 NKLGQGGFGIVYKGRLLE--------GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      +.|..|-...+|+....+        ++.+.+|+.... ......+.+|.+++..|. +.-..++++.+.+    -+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            467778888999988752        467888876332 234566778999998874 3223677776543    29999


Q ss_pred             ccCCCCHHH--------------H---HhccC--CCCCCC--HHHHHHHHHHHH-------------------HHHHHHH
Q 005206          619 YMENRSLDS--------------V---IFDKA--RSSILN--WQRRFNIICGIA-------------------RGLLYLH  658 (709)
Q Consensus       619 y~~~gsL~~--------------~---l~~~~--~~~~l~--~~~~~~i~~~ia-------------------~gL~yLH  658 (709)
                      |+++..|..              .   |+...  -.....  |.+..++..++.                   ..+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            999755421              0   11110  011122  444444443332                   1233332


Q ss_pred             ----hC-CCCceEecCCCCCCEEEcCC----CcEEEEecCCcee
Q 005206          659 ----QD-SRFRIIHRDLKASNILLDKE----MTPKISDFGMARI  693 (709)
Q Consensus       659 ----~~-~~~~iiHrDlkp~NILl~~~----~~~KI~DFGla~~  693 (709)
                          .. ....++|+|+.+.|||++.+    +.+.|+||..|..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                21 23469999999999999877    7899999998874

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.40  E-value=0.004  Score=66.46  Aligned_cols=73  Identities=11%  Similarity=0.131  Sum_probs=44.4

Q ss_pred             eeecccCceEEEEEEEcC---------CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCc-eeeEEEEEEeCCeeEEEE
Q 005206          548 NKLGQGGFGIVYKGRLLE---------GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN-LVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~---------g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~  617 (709)
                      +.|+.|..-.+|+....+         ++.+++|+..... ........|..++..+...+ ..++++..  .  .++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            567888888999998754         2678888764332 22223467888888774333 44676554  2  37899


Q ss_pred             EccCCCCH
Q 005206          618 EYMENRSL  625 (709)
Q Consensus       618 Ey~~~gsL  625 (709)
                      ||+++..+
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.88  E-value=0.047  Score=57.43  Aligned_cols=32  Identities=25%  Similarity=0.482  Sum_probs=28.3

Q ss_pred             CCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          662 RFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       662 ~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ...++|+|+.+.||+++.++.+.|.||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            34699999999999999888899999998774

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.86  E-value=0.29  Score=53.07  Aligned_cols=141  Identities=12%  Similarity=0.172  Sum_probs=84.6

Q ss_pred             ceeecccCceEEEEEEEcC--------CcEEEEEEeccCCccchHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEEE
Q 005206          547 YNKLGQGGFGIVYKGRLLE--------GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       547 ~~~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++.|..|-...+|+....+        ++.+.+++..... .....-.+|..++..+. +.-..++++.+  .  .++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence            4578778889999998763        5778888764332 22223467888888874 32245666533  2  37899


Q ss_pred             EccCCCCHHH-------H----------Hhc--c-----C---CCCCCCHHHHHHHHHH-------------------HH
Q 005206          618 EYMENRSLDS-------V----------IFD--K-----A---RSSILNWQRRFNIICG-------------------IA  651 (709)
Q Consensus       618 Ey~~~gsL~~-------~----------l~~--~-----~---~~~~l~~~~~~~i~~~-------------------ia  651 (709)
                      ||+++..|..       .          |++  .     .   ...+.-|.+..++..+                   +.
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            9999865321       1          111  0     0   1111124443333322                   12


Q ss_pred             HHHHHHHh---------------------CCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          652 RGLLYLHQ---------------------DSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       652 ~gL~yLH~---------------------~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ..+.+|.+                     .....++|+|+.+.||+ +.++.+.|+||..|..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            23333321                     11346899999999999 8888999999998873

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=89.85  E-value=0.62  Score=49.99  Aligned_cols=30  Identities=27%  Similarity=0.393  Sum_probs=25.5

Q ss_pred             ceEecCCCCCCEEE------cCCCcEEEEecCCcee
Q 005206          664 RIIHRDLKASNILL------DKEMTPKISDFGMARI  693 (709)
Q Consensus       664 ~iiHrDlkp~NILl------~~~~~~KI~DFGla~~  693 (709)
                      .++|+|+.+.|||+      +++..++++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4567899999998873

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=86.42  E-value=0.13  Score=36.42  Aligned_cols=25  Identities=40%  Similarity=0.582  Sum_probs=11.8

Q ss_pred             EEehhHHHHHH-HHHHhhhhhhhhcc
Q 005206          462 IGVTVGSAILI-LGLVACFLWRRKTL  486 (709)
Q Consensus       462 i~v~v~~~~li-l~~~~~~~~rrr~~  486 (709)
                      .+++.++++++ +++++++++|||++
T Consensus        14 ~gVVgGv~~v~ii~~~~~~~~RRRr~   39 (44)
T 2l2t_A           14 AGVIGGLFILVIVGLTFAVYVRRKSI   39 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EeehHHHHHHHHHHHHHHHHhhhhhh
Confidence            34444444443 34444555555544

>2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M*

Probab=86.10  E-value=0.6  Score=37.93  Aligned_cols=35  Identities=26%  Similarity=0.476  Sum_probs=29.0

Q ss_pred             ccCCHHHHHHHHhcCCcccceeccccCCCceeEEecc
Q 005206          391 YNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTG  427 (709)
Q Consensus       391 ~~~~~~~C~~~Cl~nCsC~aya~~~~~~g~~C~~w~~  427 (709)
                      ...++++|++.|+.+=.|.||.|+..  ...|+++.+
T Consensus        28 ~~~sl~~Cq~aC~a~~~C~aFTyN~~--s~~CflKs~   62 (82)
T 2ll3_A           28 RASSLSECRARCQAEKECSHYTYNVK--SGLCYPKRG   62 (82)
T ss_dssp             ECSSHHHHHHHHHHCTTEEEEEEETT--TTEEEEEES
T ss_pred             cCCCHHHHHHHhhccCCCCeEEeccC--CCceEcccC
Confidence            34789999999999999999999743  237998765

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=85.45  E-value=0.22  Score=35.28  Aligned_cols=27  Identities=22%  Similarity=0.397  Sum_probs=12.9

Q ss_pred             EEEEehhHHHHHH-HHHHhhhhhhhhcc
Q 005206          460 IIIGVTVGSAILI-LGLVACFLWRRKTL  486 (709)
Q Consensus       460 iii~v~v~~~~li-l~~~~~~~~rrr~~  486 (709)
                      |..+++.++++++ +++++++++|||+.
T Consensus        13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~   40 (44)
T 2ks1_B           13 IATGMVGALLLLLVVALGIGLFMRRRHI   40 (44)
T ss_dssp             STHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred             EEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence            4344444455444 34444555555544

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=80.26  E-value=0.19  Score=55.18  Aligned_cols=59  Identities=8%  Similarity=0.134  Sum_probs=17.3

Q ss_pred             eeecccCceEEEEEEEcC-CcEEEE------EEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEe
Q 005206          548 NKLGQGGFGIVYKGRLLE-GQEIAV------KRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE  609 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~-g~~VAV------K~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~  609 (709)
                      ++||   ||.||+|.+.. ..+|||      |+....  ..+....|.+|..++..++|||+++.+++-..
T Consensus       148 ~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          148 EHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             TTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             ccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            4566   99999999865 367888      766542  23445678999999999999999999887654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	709
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-50
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	9e-48
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-47
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-46
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-46
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-45
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-44
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-44
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-44
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-44
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-43
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-43
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-43
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-43
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	9e-43
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-42
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-42
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-42
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	9e-42
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	7e-41
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-41
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-40
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-40
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-40
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-39
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-39
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-39
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	9e-39
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-38
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-38
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-38
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-37
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-36
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-36
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-36
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-35
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-35
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-35
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-35
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-34
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-34
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-33
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-33
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-33
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-33
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-32
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-32
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-30
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-30
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-29
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-29
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-29
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	7e-29
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-28
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-28
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-28
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-28
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-27
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-26
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-25
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-25
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-19
d1kj1a_	109	b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium	1e-17
d1xd5a_	112	b.78.1.1 (A:) Gastrodianin (antifungal protein) {G	3e-13
d1dlpa2	120	b.78.1.1 (A:116-235) Fetuin-binding protein Scafet	1e-12
d1jpca_	108	b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan	2e-11
d1b2pa_	119	b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill	7e-10
d1dlpa1	115	b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p	6e-08

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 3e-50
 Identities = 52/185 (28%), Positives = 89/185 (48%), Gaps = 16/185 (8%)

Query: 525 DDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEE 584
           DD E+P              T   ++G G FG VYKG+      + +  ++  + Q ++ 
Sbjct: 1   DDWEIPD----------GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA 50

Query: 585 FKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF 644
           FKNEV ++ K +H N++  +G      +  +V ++ E  SL   +            +  
Sbjct: 51  FKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLI 107

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
           +I    A+G+ YLH  S   IIHRDLK++NI L +++T KI DFG+A +          +
Sbjct: 108 DIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 164

Query: 705 RVVGT 709
           ++ G+
Sbjct: 165 QLSGS 169

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 9e-48
 Identities = 47/174 (27%), Positives = 82/174 (47%), Gaps = 9/174 (5%)

Query: 534 FETIVR---ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEV 589
           +E + R     D +    +LG G FG VYK +  E     A K +   S + +E++  E+
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 590 RLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICG 649
            ++A   H N+V+LL      +   ++ E+    ++D+V+ +  R   L   +   +   
Sbjct: 61  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQ 118

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
               L YLH     +IIHRDLKA NIL   +   K++DFG++         +++
Sbjct: 119 TLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 1e-47
 Identities = 44/172 (25%), Positives = 75/172 (43%), Gaps = 11/172 (6%)

Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQH 597
             D+F   ++LG G  G+V+K      G  +A K +       I  +   E++++ +   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             +V   G      E  +  E+M+  SLD V+    R   +  Q    +   + +GL YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
               + +I+HRD+K SNIL++     K+ DFG++               VGT
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGT 166

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  164 bits (417), Expect = 3e-46
 Identities = 54/173 (31%), Positives = 79/173 (45%), Gaps = 16/173 (9%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQG---IEEFKNEVRLIAKLQ 596
              F+D  ++G G FG VY  R +   + +A+K++S +  Q     ++   EVR + KL+
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           H N ++  GC +      LV EY    + D +   K     L       +  G  +GL Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           LH      +IHRD+KA NILL +    K+ DFG A I             VGT
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGT 174

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 6e-46
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 7/168 (4%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           +      +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           RL     + +   ++ EYMEN SL   +        L   +  ++   IA G+ ++ + +
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
               IHRDL+A+NIL+   ++ KI+DFG+AR+   ++           
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFP 173

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  160 bits (406), Expect = 7e-45
 Identities = 52/191 (27%), Positives = 83/191 (43%), Gaps = 19/191 (9%)

Query: 532 FDFETIVRATDNFTDY---------NKLGQGGFGIVYKGRLL----EGQEIAVKRLSRN- 577
           F FE    A   F              +G G FG V  G L         +A+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 578 SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI 637
           + +   +F +E  ++ +  H N++ L G   +    M++ E+MEN SLD   F +     
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD--SFLRQNDGQ 124

Query: 638 LNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               +   ++ GIA G+ YL        +HRDL A NIL++  +  K+SDFG++R    D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 698 QTEQNTKRVVG 708
            ++      +G
Sbjct: 182 TSDPTYTSALG 192

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 1e-44
 Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 7/168 (4%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
              T   ++G G FG+V+ G  L   ++A+K + R      E+F  E  ++ KL H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +L G C+E     LV+E+ME+  L    + + +  +   +    +   +  G+ YL +  
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEA- 120

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
              +IHRDL A N L+ +    K+SDFGM R    DQ   ++      
Sbjct: 121 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFP 165

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  159 bits (402), Expect = 2e-44
 Identities = 51/182 (28%), Positives = 89/182 (48%), Gaps = 8/182 (4%)

Query: 526 DLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEE 584
           D   P +D   + R   + T  +KLG G +G VY+G   +    +AVK L  ++ + +EE
Sbjct: 3   DPSSPNYDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEE 59

Query: 585 FKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF 644
           F  E  ++ +++H NLV+LLG C       ++ E+M   +L   + +  R   ++     
Sbjct: 60  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLL 118

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
            +   I+  + YL +      IHRDL A N L+ +    K++DFG++R+  GD    +  
Sbjct: 119 YMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 175

Query: 705 RV 706
             
Sbjct: 176 AK 177

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 3e-44
 Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 8/170 (4%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHR 598
           +++     +G G +G   K R    G+ +  K L   S      +   +EV L+ +L+H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 599 NLVRLLGCCVEMDEKML--VYEYMENRSLDSVIFDKARSS-ILNWQRRFNIICGIARGLL 655
           N+VR     ++     L  V EY E   L SVI    +    L+ +    ++  +   L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 656 YLHQ--DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
             H+  D    ++HRDLK +N+ LD +   K+ DFG+ARI   D +    
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 4e-44
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 8/170 (4%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRN 599
           +++     LG+G +G V         + +AVK +  + +    E  K E+ +   L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V+  G   E + + L  EY     L   I        +           +  G++YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
                I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (394), Expect = 1e-43
 Identities = 46/159 (28%), Positives = 75/159 (47%), Gaps = 8/159 (5%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
                   +G+G FG V  G    G ++AVK +  ++    + F  E  ++ +L+H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 602 RLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           +LLG  VE    + +V EYM   SL   +  + RS +L           +   + YL  +
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGN 122

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
                +HRDL A N+L+ ++   K+SDFG+ +     Q 
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 158

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 2e-43
 Identities = 43/168 (25%), Positives = 76/168 (45%), Gaps = 7/168 (4%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
            + T   +LG G FG+V  G+     ++A+K +   S    +EF  E +++  L H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +L G C +     ++ EYM N  L + + +         Q+   +   +   + YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK- 119

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             + +HRDL A N L++ +   K+SDFG++R    D+   +       
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 164

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 2e-43
 Identities = 46/176 (26%), Positives = 81/176 (46%), Gaps = 12/176 (6%)

Query: 540 ATDNFTDYN-KLGQGGFGIVYKGRLL---EGQEIAVKRLSRNSGQG-IEEFKNEVRLIAK 594
             DN    + +LG G FG V +G      +  ++A+K L + + +   EE   E +++ +
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65

Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           L +  +VRL+G C + +  MLV E      L   +  K     +       ++  ++ G+
Sbjct: 66  LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGM 122

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR-VVGT 709
            YL + +    +HRDL A N+LL      KISDFG+++  G D +    +      
Sbjct: 123 KYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 4e-43
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 6/166 (3%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           ++     KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +L       +   +V EYM   SL   +  +     L   +  ++   IA G+ Y+ +  
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER-- 131

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
               +HRDL+A+NIL+ + +  K++DFG+AR+   ++         
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 176

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (390), Expect = 9e-43
 Identities = 49/215 (22%), Positives = 86/215 (40%), Gaps = 41/215 (19%)

Query: 523 KTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSR 576
           K   LE P  + E +            +G+G FG V++ R            +AVK L  
Sbjct: 4   KLLSLEYPRNNIEYV----------RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE 53

Query: 577 NSGQGIE-EFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARS 635
            +   ++ +F+ E  L+A+  + N+V+LLG C       L++EYM    L+  +   +  
Sbjct: 54  EASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPH 113

Query: 636 SI---------------------LNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASN 674
           ++                     L+   +  I   +A G+ YL +    + +HRDL   N
Sbjct: 114 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRN 170

Query: 675 ILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
            L+ + M  KI+DFG++R        +        
Sbjct: 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIP 205

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 6e-42
 Identities = 45/196 (22%), Positives = 72/196 (36%), Gaps = 31/196 (15%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNSGQG-IEEFKNEVRLIAK 594
           +N      LG G FG V               ++AVK L   +     E   +E++++ +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 595 L-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK--------------------A 633
           L  H N+V LLG C       L++EY     L + +  K                     
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 634 RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI 693
             ++L ++        +A+G+ +L        +HRDL A N+L+      KI DFG+AR 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 694 FGGDQTEQNTKRVVGT 709
              D            
Sbjct: 214 IMSDSNYVVRGNARLP 229

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 6e-42
 Identities = 48/191 (25%), Positives = 74/191 (38%), Gaps = 26/191 (13%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNSGQG-IEEFKNEVRLIAK 594
           +  +    LG G FG V +              +AVK L  ++     E   +E+++++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 595 L-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI---------------L 638
           L  H N+V LLG C      +++ EY     L + +  K  S I               L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 639 NWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           + +   +    +A+G+ +L        IHRDL A NILL      KI DFG+AR    D 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 699 TEQNTKRVVGT 709
                      
Sbjct: 200 NYVVKGNARLP 210

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 7e-42
 Identities = 46/172 (26%), Positives = 76/172 (44%), Gaps = 17/172 (9%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
            +G+G FG V++G+   G+E+AVK  S    +     + E+     L+H N++  +    
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67

Query: 609 EMDEK----MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD---- 660
           + +       LV +Y E+ SL   +        +  +    +    A GL +LH +    
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 661 -SRFRIIHRDLKASNILLDKEMTPKISDFGMARIF--GGDQTEQNTKRVVGT 709
             +  I HRDLK+ NIL+ K  T  I+D G+A       D  +      VGT
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 9e-42
 Identities = 47/170 (27%), Positives = 87/170 (51%), Gaps = 10/170 (5%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN 599
              +T + K+GQG  G VY    +  GQE+A+++++       E   NE+ ++ + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V  L   +  DE  +V EY+   SL  V+ +          +   +     + L +LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECLQALEFLHS 134

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
               ++IHRD+K+ NILL  + + K++DFG       +Q++++T  +VGT
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 7e-41
 Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 14/172 (8%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           ++F     LG+G FG VY  R  +    +A+K L +          + + EV + + L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            N++RL G   +     L+ EY    ++   +    + S  + QR    I  +A  L Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYC 122

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           H     R+IHRD+K  N+LL      KI+DFG +      +       + GT
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGT 167

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 7e-41
 Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 13/168 (7%)

Query: 548 NKLGQGGFGIVYKGRLLE---GQEIAVKRLSR--NSGQGIEEFKNEVRLIAKLQHRNLVR 602
            +LG G FG V KG        + +AVK L    N     +E   E  ++ +L +  +VR
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           ++G C E +  MLV E  E   L+  +        +  +    ++  ++ G+ YL +   
Sbjct: 73  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES-- 126

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK-RVVGT 709
              +HRDL A N+LL  +   KISDFG+++    D+     +      
Sbjct: 127 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 1e-40
 Identities = 51/179 (28%), Positives = 86/179 (48%), Gaps = 13/179 (7%)

Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLLEGQE-----IAVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  +   E     +A+K L    S +  +E  +E  
Sbjct: 5   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63

Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+      L+ + M    L   + +   +     Q   N    I
Sbjct: 64  VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQI 120

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +     
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 2e-40
 Identities = 49/170 (28%), Positives = 77/170 (45%), Gaps = 16/170 (9%)

Query: 548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLS--RNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
            ++G+G F  VYKG   E   E+A   L   + +    + FK E  ++  LQH N+VR  
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 605 GCCVEMDEK----MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
                  +     +LV E M + +L + +    R  ++  +   +    I +GL +LH  
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 661 SRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           +   IIHRDLK  NI +     + KI D G+A +          K V+GT
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGT 176

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 6e-40
 Identities = 52/181 (28%), Positives = 74/181 (40%), Gaps = 13/181 (7%)

Query: 536 TIVRATDNFTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSR---NSGQGIEEFKNE 588
           T +    +     KLG G FG+V +G       +   +AVK L     +  + +++F  E
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61

Query: 589 VRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC 648
           V  +  L HRNL+RL G  +    KM V E     SL   +       +L    R     
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSR--YAV 118

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            +A G+ YL      R IHRDL A N+LL      KI DFG+ R    +      +    
Sbjct: 119 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175

Query: 709 T 709
            
Sbjct: 176 V 176

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  145 bits (368), Expect = 4e-39
 Identities = 38/170 (22%), Positives = 76/170 (44%), Gaps = 8/170 (4%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           D++  + +LG G FG+V++      G   A K +        E  + E++ ++ L+H  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V L     + +E +++YE+M    L   + D+     ++       +  + +GL ++H++
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHEN 143

Query: 661 SRFRIIHRDLKASNILL--DKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
                +H DLK  NI+    +    K+ DFG+       Q+ + T     
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE 190

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 5e-39
 Identities = 44/170 (25%), Positives = 80/170 (47%), Gaps = 13/170 (7%)

Query: 548 NKLGQGGFGIVYKGRLLE----GQEIAVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVR 602
             +G+G FG VY G LL+        AVK L+R +  G + +F  E  ++    H N++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92

Query: 603 LLGCCVEMDEK-MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           LLG C+  +   ++V  YM++  L + I ++  +  +     F +          +   +
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFLA 147

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGT 709
             + +HRDL A N +LD++ T K++DFG+AR     + +    +      
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 197

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 6e-39
 Identities = 45/174 (25%), Positives = 72/174 (41%), Gaps = 10/174 (5%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAK 594
           +  ++F     LG+G F  V   R L   +E A+K L +        +     E  ++++
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           L H   V+L     + ++      Y +N  L   I         +          I   L
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 121

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            YLH      IIHRDLK  NILL+++M  +I+DFG A++   +  +      VG
Sbjct: 122 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 9e-39
 Identities = 49/186 (26%), Positives = 82/186 (44%), Gaps = 24/186 (12%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEG---QEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-Q 596
           ++    + +G+G FG V K R+ +     + A+KR+    S     +F  E+ ++ KL  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI-------------FDKARSSILNWQRR 643
           H N++ LLG C       L  EY  + +L   +                + +S L+ Q+ 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
            +    +ARG+ YL Q    + IHRDL A NIL+ +    KI+DFG++R     +     
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183

Query: 704 KRVVGT 709
                 
Sbjct: 184 TMGRLP 189

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 2e-38
 Identities = 37/165 (22%), Positives = 76/165 (46%), Gaps = 5/165 (3%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQG-IEEFKNEVRLIAKLQHR 598
              +T+ + +G+G +G+V           +A+K++S    Q   +    E++++ + +H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
           N++ +         + +   Y+    + + ++   ++  L+       +  I RGL Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
                 ++HRDLK SN+LL+     KI DFG+AR+   D      
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  143 bits (362), Expect = 3e-38
 Identities = 40/165 (24%), Positives = 71/165 (43%), Gaps = 8/165 (4%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           D +    +LG G FG+V++      G+    K ++          KNE+ ++ +L H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           + L     +  E +L+ E++    L   I   A    ++     N +     GL ++H  
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH-- 144

Query: 661 SRFRIIHRDLKASNILLDKEMTP--KISDFGMARIFGGDQTEQNT 703
               I+H D+K  NI+ + +     KI DFG+A     D+  + T
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT 188

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  142 bits (360), Expect = 7e-38
 Identities = 40/165 (24%), Positives = 71/165 (43%), Gaps = 13/165 (7%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQ- 596
           ++F+ +  +G+GGFG VY  R  + G+  A+K L +      QG     NE  +++ +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 597 --HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
                +V +       D+   + + M    L   +         +          I  GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGL 120

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
            ++H      +++RDLK +NILLD+    +ISD G+A  F   + 
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 162

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 4e-37
 Identities = 38/173 (21%), Positives = 71/173 (41%), Gaps = 12/173 (6%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQ 596
           +       +G+G FG V++G  +        +A+K     +   + E+F  E   + +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           H ++V+L+G   E +   ++ E      L S +  +  S  L+          ++  L Y
Sbjct: 67  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           L      R +HRD+ A N+L+      K+ DFG++R    D T     +    
Sbjct: 124 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLP 172

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 1e-36
 Identities = 45/182 (24%), Positives = 81/182 (44%), Gaps = 17/182 (9%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRN-SGQGIEEFKNEVRLIAK 594
           +  T   +LGQG FG+VY+G             +A+K ++   S +   EF NE  ++ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIF-------DKARSSILNWQRRFNII 647
               ++VRLLG   +    +++ E M    L S +        +    +  +  +   + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R        +   + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 708 GT 709
             
Sbjct: 197 LP 198

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 1e-36
 Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 11/168 (6%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQE-----IAVKRLSRNSGQG-IEEFKNEVRLIAKL 595
              T    +G G FG VYKG L          +A+K L     +    +F  E  ++ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
            H N++RL G   +    M++ EYMEN +LD   F + +    +  +   ++ GIA G+ 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
           YL        +HRDL A NIL++  +  K+SDFG++R+   D     T
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 2e-36
 Identities = 45/190 (23%), Positives = 73/190 (38%), Gaps = 25/190 (13%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNSGQG-IEEFKNEVRLIAK 594
           D       LG+G FG V +            + +AVK L   +         +E++++  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 595 -LQHRNLVRLLGCCVEMDEK-MLVYEYMENRSLDSVIFDK-------------ARSSILN 639
              H N+V LLG C +     M++ E+ +  +L + +  K                  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 640 WQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
            +        +A+G+ +L      + IHRDL A NILL ++   KI DFG+AR    D  
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 700 EQNTKRVVGT 709
                     
Sbjct: 190 YVRKGDARLP 199

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 1e-35
 Identities = 36/161 (22%), Positives = 69/161 (42%), Gaps = 9/161 (5%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           + +     LG+G FGIV++       +    K + +  G      K E+ ++   +HRN+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNI 63

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           + L      M+E ++++E++    +   I     +  LN +   + +  +   L +LH  
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS- 120

Query: 661 SRFRIIHRDLKASNILLD--KEMTPKISDFGMARIFGGDQT 699
               I H D++  NI+    +  T KI +FG AR       
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  133 bits (336), Expect = 3e-35
 Identities = 43/162 (26%), Positives = 71/162 (43%), Gaps = 10/162 (6%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQH 597
            +F     LG G FG V+  R    G+  A+K L +      + +E   +E  +++ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             ++R+ G   +  +  ++ +Y+E   L S++    R      +     +C      L L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC------LAL 117

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
                  II+RDLK  NILLDK    KI+DFG A+       
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 159

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  132 bits (333), Expect = 3e-35
 Identities = 45/179 (25%), Positives = 76/179 (42%), Gaps = 20/179 (11%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGI---------EEFKNEVRL 591
           +N+     LG+G   +V +       +E AVK +    G            E    EV +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 592 IAKLQ-HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           + K+  H N+++L           LV++ M+   L   + +K     L+ +    I+  +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRAL 119

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
              +  LH   +  I+HRDLK  NILLD +M  K++DFG +      +     + V GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGT 172

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 7e-35
 Identities = 45/170 (26%), Positives = 76/170 (44%), Gaps = 15/170 (8%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
            ++TD   +G G FG+VY+ +L + G+ +A+K++ ++          E++++ KL H N+
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNI 75

Query: 601 VRLLGCCVEMDEKM------LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           VRL        EK       LV +Y+                 L        +  + R L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFGGDQTEQNT 703
            Y+H    F I HRD+K  N+LLD +    K+ DFG A+     +   + 
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  131 bits (329), Expect = 1e-34
 Identities = 43/164 (26%), Positives = 80/164 (48%), Gaps = 8/164 (4%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRN 599
           + +    K+G+G +G+VYK +   G+  A+K  RL +           E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V+L          +LV+E+++      +   +     L      + +  +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
               R++HRDLK  N+L+++E   KI+DFG+AR FG    +   
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 2e-34
 Identities = 47/205 (22%), Positives = 86/205 (41%), Gaps = 28/205 (13%)

Query: 528 ELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE--------GQEIAVKRLSRN-S 578
           ELP      + R  D       LG+G FG V     +           ++AVK L  + +
Sbjct: 1   ELPEDPRWELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 58

Query: 579 GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI 637
            + + +  +E+ ++  + +H+N++ LLG C +     ++ EY    +L   +  +    +
Sbjct: 59  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118

Query: 638 -------------LNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK 684
                        L+ +   +    +ARG+ YL      + IHRDL A N+L+ ++   K
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMK 175

Query: 685 ISDFGMARIFGGDQTEQNTKRVVGT 709
           I+DFG+AR        + T      
Sbjct: 176 IADFGLARDIHHIDYYKKTTNGRLP 200

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  128 bits (324), Expect = 1e-33
 Identities = 41/174 (23%), Positives = 74/174 (42%), Gaps = 14/174 (8%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEE-FKNEVRLIAKLQHR 598
            D +   + LG G F  V         + +A+K +++ + +G E   +NE+ ++ K++H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
           N+V L           L+ + +    L   I +K        +    +I  +   + YLH
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLH 124

Query: 659 QDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
                 I+HRDLK  N+L    D++    ISDFG++++              GT
Sbjct: 125 D---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGT 172

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  127 bits (320), Expect = 2e-33
 Identities = 44/178 (24%), Positives = 76/178 (42%), Gaps = 15/178 (8%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQG---IEEFKNEVRLIAKLQ 596
           +D +     LG GG   V+  R L   +++AVK L  +  +       F+ E +  A L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 597 HRNLVRLLGCCVEMDEK----MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIAR 652
           H  +V +               +V EY++  +L  ++  +     +  +R   +I    +
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ-NTKRVVGT 709
            L + H   +  IIHRD+K +NI++      K+ DFG+AR           T  V+GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 3e-33
 Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 8/165 (4%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R    G+ +A+K  RL   +         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
           N+V+LL      ++  LV+E++          D +  + +      + +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
                R++HRDLK  N+L++ E   K++DFG+AR FG        
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 5e-33
 Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 14/168 (8%)

Query: 548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEE-----FKNEVRLIAKLQHRNLV 601
           + LG+G F  VYK R     Q +A+K++        ++        E++L+ +L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            LL          LV+++ME          K  S +L        +    +GL YLHQ  
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
              I+HRDLK +N+LLD+    K++DFG+A+ FG           V T
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT--HQVVT 163

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 1e-32
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 13/173 (7%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAK-LQ 596
           ++F  +  LG+G FG V+     +  Q  A+K L ++       +E    E R+++   +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           H  L  +       +    V EY+    L   I    +    +  R       I  GL +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           LH      I++RDLK  NILLDK+   KI+DFGM +       + NT    GT
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 166

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 8e-32
 Identities = 45/185 (24%), Positives = 88/185 (47%), Gaps = 19/185 (10%)

Query: 538 VRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQG--IEEFKNEVRLIAK 594
                 +    K+GQG FG V+K R  + GQ++A+K++   + +         E++++  
Sbjct: 6   CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQL 65

Query: 595 LQHRNLVRLLGCCVEMDEKM--------LVYEYMENRSLDSVIFDKARSSILNWQRRFNI 646
           L+H N+V L+  C               LV+++ E+     +     + ++   +R   +
Sbjct: 66  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 125

Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR- 705
           +      L  L+   R +I+HRD+KA+N+L+ ++   K++DFG+AR F   +  Q  +  
Sbjct: 126 L------LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 179

Query: 706 -VVGT 709
             V T
Sbjct: 180 NRVVT 184

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 2e-30
 Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 16/181 (8%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLE--GQEIAVKRLSRNSGQG--IEEFKNEVRLIAK 594
           RA   +    ++G+G +G V+K R L+  G+ +A+KR+   +G+         EV ++  
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 595 L---QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD---KARSSILNWQRRFNIIC 648
           L   +H N+VRL   C            +    +D  +     K     +  +   +++ 
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            + RGL +LH     R++HRDLK  NIL+      K++DFG+ARI+     +     VV 
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVV 177

Query: 709 T 709
           T
Sbjct: 178 T 178

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  119 bits (299), Expect = 5e-30
 Identities = 46/190 (24%), Positives = 74/190 (38%), Gaps = 10/190 (5%)

Query: 514 SSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVK 572
            S +++ A   +D               D F     LG G FG V   +  E G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72

Query: 573 RLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI 629
            L +      + IE   NE R++  +    LV+L     +     +V EY+    + S +
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132

Query: 630 FDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
               R    +          I     YLH      +I+RDLK  N+L+D++   +++DFG
Sbjct: 133 RRIGR---FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG 186

Query: 690 MARIFGGDQT 699
            A+   G   
Sbjct: 187 FAKRVKGRTW 196

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 1e-29
 Identities = 45/172 (26%), Positives = 70/172 (40%), Gaps = 12/172 (6%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQH 597
           ++F     LG+G FG V   R    G+  A+K L +    +   +     E R++   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             L  L       D    V EY     L   +   +R  +   +R       I   L YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           H      +++RD+K  N++LDK+   KI+DFG+ +    D      K   GT
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGT 168

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 1e-29
 Identities = 39/164 (23%), Positives = 77/164 (46%), Gaps = 9/164 (5%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHR 598
             +    K+G+G +G V+K +  E  + +A+K  RL  +          E+ L+ +L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
           N+VRL        +  LV+E+ +                 + +   + +  + +GL + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCH 118

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN 702
                 ++HRDLK  N+L+++    K+++FG+AR FG      +
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (290), Expect = 6e-29
 Identities = 37/163 (22%), Positives = 65/163 (39%), Gaps = 18/163 (11%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCC 607
           LG G  G V +       ++ A+K L         + + EV L  +  Q  ++VR++   
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVY 74

Query: 608 VEMDEK----MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
             +       ++V E ++   L S I D+   +    +    I+  I   + YLH     
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHS---I 130

Query: 664 RIIHRDLKASNILLDKEMTP---KISDFGMARIFGGDQTEQNT 703
            I HRD+K  N+L   +      K++DFG A+      +    
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 173

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 7e-29
 Identities = 42/168 (25%), Positives = 75/168 (44%), Gaps = 7/168 (4%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSR--NSGQGIEEFKNEVRLIAKLQHR 598
             + D   +G G +G V        G ++A+K+L R   S    +    E+RL+  ++H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 599 NLVRLLGCCVEMDEKMLVYE-YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
           N++ LL      +      + Y+    + + +    +   L   R   ++  + +GL Y+
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           H      IIHRDLK  N+ ++++   KI DFG+AR    + T     R
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR 182

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 1e-28
 Identities = 47/179 (26%), Positives = 74/179 (41%), Gaps = 20/179 (11%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSR------NSGQGIEEFKNEVRLIAK 594
           D +    +LG G F +V K R    G + A K + +        G   E+ + EV ++ +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           +QH N++ L        + +L+ E +    L   + +K     L  +     +  I  G+
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGV 126

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMARIFGGDQTEQNTKRVVGT 709
            YLH     +I H DLK  NI+L     P    KI DFG+A            K + GT
Sbjct: 127 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGT 179

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  113 bits (284), Expect = 2e-28
 Identities = 41/182 (22%), Positives = 73/182 (40%), Gaps = 18/182 (9%)

Query: 538 VRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ 596
           +R  + +    K+G G FG +Y G  +  G+E+A+K     +     +   E ++   +Q
Sbjct: 3   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQ 60

Query: 597 HRNLVRLLG-CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
               +  +  C  E D  ++V E +     D        S   + +    +   +   + 
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGPSLED---LFNFCSRKFSLKTVLLLADQMISRIE 117

Query: 656 YLHQDSRFRIIHRDLKASNIL---LDKEMTPKISDFGMARIFGGDQTEQN-----TKRVV 707
           Y+H       IHRD+K  N L     K     I DFG+A+ +   +T Q+      K + 
Sbjct: 118 YIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174

Query: 708 GT 709
           GT
Sbjct: 175 GT 176

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  112 bits (282), Expect = 3e-28
 Identities = 32/172 (18%), Positives = 73/172 (42%), Gaps = 18/172 (10%)

Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           ++G+G FG++++G  L   Q++A+K   R S     + ++E R    L     +  +   
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
            +     ++   +   SL+ ++    R    + +        +   +  +H+     +++
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK---SLVY 124

Query: 668 RDLKASNILLDKEMTP-----KISDFGMARIFGGDQTEQN-----TKRVVGT 709
           RD+K  N L+ +  +       + DFGM + +    T+Q+      K + GT
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 3e-28
 Identities = 39/171 (22%), Positives = 65/171 (38%), Gaps = 19/171 (11%)

Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEE------FKNEVRLIAKLQ--HRN 599
            LG GGFG VY G  +     +A+K + ++      E         EV L+ K+      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           ++RLL      D  +L+ E  E          +  +  L  +   +    +   + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHN 128

Query: 660 DSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFGGDQTEQNTKRVVGT 709
                ++HRD+K  NIL+D      K+ DFG   +      +       GT
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGT 172

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  109 bits (274), Expect = 6e-27
 Identities = 43/205 (20%), Positives = 84/205 (40%), Gaps = 23/205 (11%)

Query: 513 ISSKRDYSADKTDDLELPLFDFETIVRATDNFTDY---NKLGQGGFGIVYKGRLLE-GQE 568
           + S+     D         +D+E+ V    N  DY    KLG+G +  V++   +   ++
Sbjct: 3   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 62

Query: 569 IAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKM--LVYEYMENRSL 625
           + VK L        ++ K E++++  L+   N++ L     +   +   LV+E++ N   
Sbjct: 63  VVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 119

Query: 626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPK 684
             +         L        +  I + L Y H      I+HRD+K  N+++D E    +
Sbjct: 120 KQLY------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLR 170

Query: 685 ISDFGMARIFGGDQTEQNTKRVVGT 709
           + D+G+A  +   Q        V +
Sbjct: 171 LIDWGLAEFYHPGQEYNV---RVAS 192

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 1e-26
 Identities = 42/169 (24%), Positives = 75/169 (44%), Gaps = 15/169 (8%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSR----NSGQGIEEFKNEVRLIA 593
           +NF     LG G +G V+  R +     G+  A+K L +       +  E  + E +++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 594 KLQHR-NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIAR 652
            ++    LV L        +  L+ +Y+    L + +  + R            +  I  
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVL 140

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ 701
            L +LH   +  II+RD+K  NILLD      ++DFG+++ F  D+TE+
Sbjct: 141 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 186

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 1e-25
 Identities = 48/176 (27%), Positives = 80/176 (45%), Gaps = 7/176 (3%)

Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRL 591
           +TI    + + + + +G G +G V      + G  +AVK+LSR   S    +    E+RL
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70

Query: 592 IAKLQHRNLVRLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           +  ++H N++ LL               Y+    + + + +  +   L       +I  I
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
            RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR    + T     R 
Sbjct: 131 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW 183

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 3e-25
 Identities = 46/184 (25%), Positives = 78/184 (42%), Gaps = 21/184 (11%)

Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSR--NSGQGIEEFKNEVRL 591
           ++       + +   +G G  GIV         + +A+K+LSR   +    +    E+ L
Sbjct: 10  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69

Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  + H+N++ LL          E  +  LV E M+      +  +       + +R   
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSY 123

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           ++  +  G+ +LH      IIHRDLK SNI++  + T KI DFG+AR  G          
Sbjct: 124 LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTP 177

Query: 706 VVGT 709
            V T
Sbjct: 178 YVVT 181

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score =  101 bits (251), Expect = 4e-25
 Identities = 30/174 (17%), Positives = 57/174 (32%), Gaps = 28/174 (16%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVK--RLSRNSGQ--------GIEEFKNEVRLIAKLQH 597
             +G+G    V+     +  E  VK  ++   S +        G   F       A+ + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 598 RNLVRLLGCCV----EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           R L +L G  V      +   ++ E +           +     +       ++  I   
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELI--------DAKELYRVRVENPDE--VLDMILEE 115

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
           +   +      I+H DL   N+L+  E    I DF  +   G +   +  +R V
Sbjct: 116 VAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDV 165

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 88.2 bits (217), Expect = 2e-19
 Identities = 29/175 (16%), Positives = 63/175 (36%), Gaps = 18/175 (10%)

Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           KLG G F  V+  + +     +A+K + R      E  ++E++L+ ++   +  +     
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 608 VEMDEKMLVY-------------EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
                K+L +              +         +  K     +       I   +  GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFGGDQTEQNTKRVVG 708
            Y+H+  R  IIH D+K  N+L++       +    +A +      +++    + 
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

 Score = 76.9 bits (189), Expect = 1e-17
 Identities = 21/122 (17%), Positives = 43/122 (35%), Gaps = 16/122 (13%)

Query: 58  DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLA 117
           + LT  + L  G++L           +         + ++  +    T VW +N      
Sbjct: 2   NLLTNGEGLYAGQSLDV-------EPYHFIMQEDCNLVLYDHS----TSVWASNTGILGK 50

Query: 118 NSSGVLRIINQRIGLFDGSQNLVWSSNQTKAT-NPVAQLQDSGNFVLKEAGSDEILWQSF 176
                +   +    ++D     +W+S+  +   N V  LQ+ GN V+        +W + 
Sbjct: 51  KGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIY----GSDIWSTG 106

Query: 177 DY 178
            Y
Sbjct: 107 TY 108

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

 Score = 64.4 bits (156), Expect = 3e-13
 Identities = 19/124 (15%), Positives = 42/124 (33%), Gaps = 13/124 (10%)

Query: 58  DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLA 117
           D L +   L  G +L      +     +  +       + Y N      VW +  +   +
Sbjct: 2   DRLNSGHQLDTGGSLAEGG--YLFIIQNDCNL------VLYDN---NRAVWASGTNGKAS 50

Query: 118 NSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKEAGSDEILWQSFD 177
                ++     + ++ GS+ +  S+   +  N    LQ   N V+    S+  +W +  
Sbjct: 51  GCVLKMQNDGN-LVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIY-DNSNNAIWATHT 108

Query: 178 YPTD 181
              +
Sbjct: 109 NVGN 112

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 63.0 bits (153), Expect = 1e-12
 Identities = 16/92 (17%), Positives = 29/92 (31%), Gaps = 4/92 (4%)

Query: 96  IWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ-RIGLFDGSQNLVWSSNQTKATNPVAQ 154
           I Y       +    +    L  S   L +     + LFD    +  ++   K T   A 
Sbjct: 12  ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAV 71

Query: 155 LQDSGNFVLKEAGSDEILWQSFD--YPTDTLL 184
           LQ +G   +     +  +W S +       + 
Sbjct: 72  LQPNGRMDVLT-NQNIAVWTSGNSRSAGRYVF 102

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

 Score = 59.3 bits (143), Expect = 2e-11
 Identities = 18/122 (14%), Positives = 38/122 (31%), Gaps = 17/122 (13%)

Query: 58  DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLA 117
           + L + + L+ G+ L      F        +   + +             W  N      
Sbjct: 2   NILYSGETLSTGEFLNYGS--FVFIMQEDCNLVLYDVDKPI---------WATNTGGLSR 50

Query: 118 NSSGVLRIINQRIGLFDGSQNLVWSSNQTKAT-NPVAQLQDSGNFVLKEAGSDEILWQSF 176
           +    ++     + +++ S   +W+SN      N V  LQ   N V+         W + 
Sbjct: 51  SCFLSMQTDGNLV-VYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIY----GTDRWATG 105

Query: 177 DY 178
            +
Sbjct: 106 TH 107

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 55.0 bits (132), Expect = 7e-10
 Identities = 23/122 (18%), Positives = 39/122 (31%), Gaps = 19/122 (15%)

Query: 58  DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLA 117
             L AT++L     ++    V+     +  +       + Y N      +W  N      
Sbjct: 15  QILHATESLE----ILFGTHVYRFIMQTDCNL------VLYDN---NNPIWATNTGGLGN 61

Query: 118 NSSGVLRIINQRIGLFDGSQNLVWSSNQT-KATNPVAQLQDSGNFVLKEAGSDEILWQSF 176
               VL+     + +       VW S    KA + V  LQ   N V+      + LW + 
Sbjct: 62  GCRAVLQPDGVLV-VITNENVTVWQSPVAGKAGHYVLVLQPDRNVVI----YGDALWATQ 116

Query: 177 DY 178
             
Sbjct: 117 TV 118

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 49.2 bits (117), Expect = 6e-08
 Identities = 22/82 (26%), Positives = 33/82 (40%), Gaps = 3/82 (3%)

Query: 96  IWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ-RIGLFDGSQNLVWSSNQTKATNPVAQ 154
           I +    + ++    +    L  SS    + +   + LFD     VW+SN   AT   A 
Sbjct: 3   ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAV 61

Query: 155 LQDSGNFVLKEAGSDEILWQSF 176
           LQ  G  V+  A  + I W S 
Sbjct: 62  LQSDGLLVILTA-QNTIRWSSG 82

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	709
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.98
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.97
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.97
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.97
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.97
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.97
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.97
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.97
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.97
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.97
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.97
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.97
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.97
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.97
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.96
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.96
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.96
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.96
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.96
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.96
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.96
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.96
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.96
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.96
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.96
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.96
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.96
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.96
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.96
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.96
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.96
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.95
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.95
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.95
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.95
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.95
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.95
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.95
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.95
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.95
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.95
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.95
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.95
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.95
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.95
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.94
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.94
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.94
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.94
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.94
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.93
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.93
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.93
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.93
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.93
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.93
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.92
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.92
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.91
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.85
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.82
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	99.79
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	99.78
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	99.76
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	99.66
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.54
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	99.44
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.13
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	98.8
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	98.77
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	98.74
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	98.73
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	98.52
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.47
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.87
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.32
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.28
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.0
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.33
d1emoa2	39	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	91.08
d2vj3a1	42	Neurogenic locus notch homolog protein 1, Notch1 {	85.63
d1xkba1	39	Factor X, N-terminal module {Human (Homo sapiens)	83.14
d1emoa1	43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	80.5

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.2e-32  Score=283.86  Aligned_cols=162  Identities=28%  Similarity=0.391  Sum_probs=140.5

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ++|+..++||+|+||+||+|++.. ++.||||++.... .+..++|.+|+.++++++|||||++++++.+.+..+|||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            578899999999999999999864 8999999996543 33456899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCCc
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~~  699 (709)
                      +++|+|.++|...   ..+++.++..++.||+.||+|||+++   ||||||||+||||++++.+||+|||+|+.+..+..
T Consensus        85 ~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          85 CSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            9999999988532   35899999999999999999999998   99999999999999999999999999998865554


Q ss_pred             cccccceecC
Q 005206          700 EQNTKRVVGT  709 (709)
Q Consensus       700 ~~~~~~~~GT  709 (709)
                      ....+.++||
T Consensus       159 ~~~~~~~~GT  168 (271)
T d1nvra_         159 ERLLNKMCGT  168 (271)
T ss_dssp             ECCBCCCCSC
T ss_pred             cccccceeeC
Confidence            4445567776

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=2.2e-32  Score=284.37  Aligned_cols=153  Identities=30%  Similarity=0.507  Sum_probs=138.3

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      .++|...++||+|+||+||+|.+.. ++.||||+++.. ....++|.+|+.++++++|||||+++|+|.+.+..+|||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            4578888999999999999999875 889999999654 34567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      +++|+|.+++.+.. ...+++..++.|+.|||.||+|||+++   ||||||||+||||++++.+||+|||+|+.+..+.
T Consensus        95 ~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          95 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             ccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            99999999996543 346899999999999999999999997   9999999999999999999999999999876543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2e-31  Score=277.55  Aligned_cols=159  Identities=29%  Similarity=0.490  Sum_probs=141.2

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      ++|...++||+|+||+||+|.... |+.||||++........+.+.+|+.++++++|||||++++++.+.+..+|||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            468999999999999999999754 8999999997665556778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCCcc
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~~~  700 (709)
                      ++|+|.+++.+.    .+++.++..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+..+...
T Consensus       100 ~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~  172 (293)
T d1yhwa1         100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (293)
T ss_dssp             TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             CCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence            999999987542    4899999999999999999999998   999999999999999999999999999988654332


Q ss_pred             ccccceecC
Q 005206          701 QNTKRVVGT  709 (709)
Q Consensus       701 ~~~~~~~GT  709 (709)
                        ....+||
T Consensus       173 --~~~~~gt  179 (293)
T d1yhwa1         173 --RSTMVGT  179 (293)
T ss_dssp             --BCCCCSC
T ss_pred             --ccccccC
Confidence              2345565

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6e-32  Score=277.56  Aligned_cols=151  Identities=32%  Similarity=0.572  Sum_probs=131.2

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      ++|+..++||+|+||.||+|.+.+++.||||++... ....++|.+|+.++.+++|||||+++|+|.+.+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            468888999999999999999988899999999653 4456789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      +|+|.+++...  ...+++..++.|+.|||+||+|||+++   |+||||||+||||++++.+||+|||+|+.+....
T Consensus        84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence            99999998653  345899999999999999999999997   9999999999999999999999999999875543

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-31  Score=276.78  Aligned_cols=151  Identities=32%  Similarity=0.558  Sum_probs=134.6

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      ++|...++||+|+||.||+|.+++++.||||++... ....++|.+|+.++.+++|||||+++|++.+ +..+|||||++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~   90 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence            578888999999999999999988899999999654 3456789999999999999999999998754 56799999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      +|+|.+++..... ..++|..++.|+.|||+||.|||+++   |+||||||+||||++++.+||+|||+|+.+....
T Consensus        91 ~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          91 NGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             TCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             CCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence            9999998754332 34899999999999999999999987   9999999999999999999999999999886543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1e-31  Score=279.31  Aligned_cols=150  Identities=29%  Similarity=0.440  Sum_probs=138.0

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      +.|+..++||+|+||+||+|++.. ++.||||++........++|.+|++++++++|||||++++++.+.+..+|||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            468888999999999999999864 8899999998777777889999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ++|+|.+++.+..  ..+++.++..++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+.+..
T Consensus        92 ~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          92 AGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             TTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC
Confidence            9999999986543  35899999999999999999999998   99999999999999999999999999987643

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.9e-32  Score=278.10  Aligned_cols=161  Identities=32%  Similarity=0.524  Sum_probs=131.9

Q ss_pred             hcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      .++|...++||+|+||+||+|++.  ..||||+++..  .....++|.+|+.++.+++|||||+++|++.+ ++.+||||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            357888899999999999999864  46999998654  34567889999999999999999999998754 56899999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      |+++|+|.+++....  ..+++.+++.|+.|||+||+|||+++   ||||||||+||||+.++.+||+|||+|+.+....
T Consensus        84 y~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            999999999996432  35899999999999999999999987   9999999999999999999999999999886554


Q ss_pred             ccccccceecC
Q 005206          699 TEQNTKRVVGT  709 (709)
Q Consensus       699 ~~~~~~~~~GT  709 (709)
                      .......+.||
T Consensus       159 ~~~~~~~~~gt  169 (276)
T d1uwha_         159 GSHQFEQLSGS  169 (276)
T ss_dssp             -------CCCC
T ss_pred             CcccccccccC
Confidence            44444556665

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=6.4e-32  Score=282.52  Aligned_cols=151  Identities=31%  Similarity=0.526  Sum_probs=125.3

Q ss_pred             CcCcceeecccCceEEEEEEEcC-C---cEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-G---QEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g---~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      +|...++||+|+||+||+|++.. +   ..||||++... .....++|.+|+.+|++++|||||+++|+|.+.+..++||
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~  106 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT  106 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence            45566899999999999999854 2   36899998654 3445678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+++|+|.+++...  ...++|.+++.|+.|||+||.|||+++   ||||||||+||||+.++.+||+|||+|+.+...
T Consensus       107 Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         107 EFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             ECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence            999999999988653  335899999999999999999999987   999999999999999999999999999988655


Q ss_pred             C
Q 005206          698 Q  698 (709)
Q Consensus       698 ~  698 (709)
                      .
T Consensus       182 ~  182 (299)
T d1jpaa_         182 T  182 (299)
T ss_dssp             -
T ss_pred             C
Confidence            4

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.2e-31  Score=275.45  Aligned_cols=162  Identities=28%  Similarity=0.414  Sum_probs=138.1

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|+..+.||+|+||+||+|+.. +++.||||++.+.   .....+.+.+|++++++++|||||++++++.+.+..+|||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            46889999999999999999986 4899999999643   2345678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+++|+|.+++....   .+++.....++.||+.||+|||+++   ||||||||+||||++++.+||+|||+|+.+...
T Consensus        88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            9999999999886543   4899999999999999999999998   999999999999999999999999999998665


Q ss_pred             CccccccceecC
Q 005206          698 QTEQNTKRVVGT  709 (709)
Q Consensus       698 ~~~~~~~~~~GT  709 (709)
                      .........+||
T Consensus       162 ~~~~~~~~~~GT  173 (288)
T d1uu3a_         162 SKQARANSFVGT  173 (288)
T ss_dssp             --------CCCC
T ss_pred             CcccccccccCC
Confidence            544445556776

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.1e-31  Score=281.56  Aligned_cols=159  Identities=26%  Similarity=0.371  Sum_probs=138.3

Q ss_pred             hcCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      .++|+..++||+|+||+||+|+... ++.||+|+++... ....+++.+|+.++++++|||||++++++.+.++.+||||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            4679999999999999999999864 8899999997543 3345789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD-SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      |+++|+|.+++.+..   .+++..+..++.||+.||.|||++ +   |+||||||+||||+.++.+||+|||+|+.+.+.
T Consensus        85 y~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence            999999999997543   489999999999999999999974 6   999999999999999999999999999977432


Q ss_pred             CccccccceecC
Q 005206          698 QTEQNTKRVVGT  709 (709)
Q Consensus       698 ~~~~~~~~~~GT  709 (709)
                          ..+.++||
T Consensus       159 ----~~~~~~GT  166 (322)
T d1s9ja_         159 ----MANSFVGT  166 (322)
T ss_dssp             ----TC---CCS
T ss_pred             ----ccccccCC
Confidence                22345666

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.3e-31  Score=269.67  Aligned_cols=150  Identities=29%  Similarity=0.413  Sum_probs=135.5

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...+.||+|+||+||+|+... ++.||||++.+.   .....+++.+|+.++++++|||||++++++.+.+..+|||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            468889999999999999999865 889999998643   2344678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+++|+|.+++....   .+++.....++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.....
T Consensus        86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            9999999999996543   4899999999999999999999998   999999999999999999999999999877543

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.3e-30  Score=266.64  Aligned_cols=151  Identities=28%  Similarity=0.503  Sum_probs=137.5

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      ++|+..++||+|+||+||+|++++++.||||++++. ....++|++|+.++.+++|||||+++|+|.+.+..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            578888999999999999999988889999999754 3456789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      +|+|..++....  ..+++..+.+++.|||+||+|||+++   |+||||||+||||++++.+||+|||+|+.+....
T Consensus        83 ~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          83 NGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             TEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred             CCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence            999999976543  34889999999999999999999997   9999999999999999999999999999876543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.8e-30  Score=274.84  Aligned_cols=166  Identities=28%  Similarity=0.418  Sum_probs=137.4

Q ss_pred             hcCcCcceeecccCceEEEEEEEcCC------cEEEEEEeccC-CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCe
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLLEG------QEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDE  612 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~~g------~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~  612 (709)
                      .++|...++||+|+||+||+|++...      ..||||++... .......|.+|+.++.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            35788889999999999999987542      36999998654 344567899999999998 89999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCC
Q 005206          613 KMLVYEYMENRSLDSVIFDKAR--------------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKA  672 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp  672 (709)
                      .+|||||+++|+|.++|.....                    ...+++..++.|+.||++||+|||+++   ||||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence            9999999999999999975432                    235899999999999999999999997   99999999


Q ss_pred             CCEEEcCCCcEEEEecCCceeeCCCCccccccceecC
Q 005206          673 SNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT  709 (709)
Q Consensus       673 ~NILl~~~~~~KI~DFGla~~l~~~~~~~~~~~~~GT  709 (709)
                      +|||++.++.+||+|||+|+...............||
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt  229 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP  229 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEEC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCC
Confidence            9999999999999999999987655443333344444

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.4e-30  Score=267.53  Aligned_cols=145  Identities=30%  Similarity=0.503  Sum_probs=126.4

Q ss_pred             eeecccCceEEEEEEEcC---CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccCC
Q 005206          548 NKLGQGGFGIVYKGRLLE---GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (709)
Q Consensus       548 ~~LG~G~fG~Vykg~~~~---g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~  622 (709)
                      ++||+|+||+||+|.+.+   ++.||||+++..  .....++|.+|++++++++|||||+++|+|.+ +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            579999999999998754   468999999654  23345789999999999999999999999854 567999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCCc
Q 005206          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (709)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~~  699 (709)
                      |+|.+++.+.   ..+++..++.|+.|||.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+.....
T Consensus        92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~  162 (277)
T d1xbba_          92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  162 (277)
T ss_dssp             EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence            9999998654   34899999999999999999999997   99999999999999999999999999998865543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.1e-30  Score=267.66  Aligned_cols=151  Identities=30%  Similarity=0.530  Sum_probs=130.8

Q ss_pred             cCcCcce-eecccCceEEEEEEEcC---CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          542 DNFTDYN-KLGQGGFGIVYKGRLLE---GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       542 ~~f~~~~-~LG~G~fG~Vykg~~~~---g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      ++|...+ +||+|+||.||+|.+..   +..||||+++... ....++|.+|++++.+++|||||+++|++.+ +..+||
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            4555556 49999999999998743   4579999997653 3446789999999999999999999999864 568999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+++|+|.+++...  ...+++..+..++.|||.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+..
T Consensus        87 mE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence            9999999999998543  235899999999999999999999997   99999999999999999999999999998865


Q ss_pred             CC
Q 005206          697 DQ  698 (709)
Q Consensus       697 ~~  698 (709)
                      ..
T Consensus       162 ~~  163 (285)
T d1u59a_         162 DD  163 (285)
T ss_dssp             CS
T ss_pred             cc
Confidence            54

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.2e-31  Score=271.27  Aligned_cols=166  Identities=30%  Similarity=0.453  Sum_probs=128.0

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeC--CeeEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKMLV  616 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV  616 (709)
                      ++|+..+.||+|+||+||+|+... |+.||||++....  +...+.|.+|++++.+++|||||++++++.+.  +..+||
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            578899999999999999999864 8899999996543  33456799999999999999999999999753  457999


Q ss_pred             EEccCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          617 YEYMENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDS--RFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      |||+++|+|.+++.+.. ....+++..+..++.||+.||.|||+++  ..+||||||||+||||+.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            99999999999986532 2346999999999999999999999864  13599999999999999999999999999998


Q ss_pred             eCCCCccccccceecC
Q 005206          694 FGGDQTEQNTKRVVGT  709 (709)
Q Consensus       694 l~~~~~~~~~~~~~GT  709 (709)
                      +..+...  ....+||
T Consensus       164 ~~~~~~~--~~~~~gt  177 (269)
T d2java1         164 LNHDTSF--AKAFVGT  177 (269)
T ss_dssp             C-------------CC
T ss_pred             cccCCCc--cccCCCC
Confidence            8654322  3345555

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.5e-30  Score=269.91  Aligned_cols=151  Identities=30%  Similarity=0.508  Sum_probs=131.7

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEccC
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~  621 (709)
                      ++|+..+.||+|+||+||+|++++++.||||++... ....++|.+|+.++.+++|||||+++|+|. .++.++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence            568899999999999999999998889999999643 445678999999999999999999999985 466899999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      +|+|..++..... ..++|.+++.|+.|||.||+|||+++   |+||||||+||||++++.+||+|||+|+.+.+..
T Consensus        95 ~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          95 KGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             TCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             CCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            9999998865432 35899999999999999999999997   9999999999999999999999999999875443

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.8e-30  Score=273.10  Aligned_cols=160  Identities=28%  Similarity=0.354  Sum_probs=141.3

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|..++.||+|+||+||+|+.. +++.||||++.+.   .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            57899999999999999999985 4899999999753   2345678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+++|+|.+++.+..   .+++.....++.||+.||+|||+++   ||||||||+||||++++.+||+|||+|+.+...
T Consensus        85 ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            9999999999986643   4889999999999999999999998   999999999999999999999999999977544


Q ss_pred             CccccccceecC
Q 005206          698 QTEQNTKRVVGT  709 (709)
Q Consensus       698 ~~~~~~~~~~GT  709 (709)
                      ..  ....++||
T Consensus       159 ~~--~~~~~~GT  168 (337)
T d1o6la_         159 GA--TMKTFCGT  168 (337)
T ss_dssp             TC--CBCCCEEC
T ss_pred             Cc--ccccceeC
Confidence            32  23456776

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=1.2e-30  Score=273.28  Aligned_cols=167  Identities=27%  Similarity=0.447  Sum_probs=140.3

Q ss_pred             HHhcCcCcceeecccCceEEEEEEEc------CCcEEEEEEeccCCc-cchHHHHHHHHHHHhcCCCceeeEEEEEEeCC
Q 005206          539 RATDNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD  611 (709)
Q Consensus       539 ~~t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~  611 (709)
                      ...++|...++||+|+||+||+|+..      +++.||||++..... +..++|.+|+.++++++||||++++++|.+.+
T Consensus        10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~   89 (301)
T d1lufa_          10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK   89 (301)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence            34578999999999999999999875      247899999975533 34678999999999999999999999999999


Q ss_pred             eeEEEEEccCCCCHHHHHhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC
Q 005206          612 EKMLVYEYMENRSLDSVIFDKAR---------------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDL  670 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDl  670 (709)
                      ..++||||+++|+|.++|.....                     ...+++..++.|+.|||.||+|||+++   ||||||
T Consensus        90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDl  166 (301)
T d1lufa_          90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL  166 (301)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEE
Confidence            99999999999999999964321                     234899999999999999999999997   999999


Q ss_pred             CCCCEEEcCCCcEEEEecCCceeeCCCCccccccceec
Q 005206          671 KASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG  708 (709)
Q Consensus       671 kp~NILl~~~~~~KI~DFGla~~l~~~~~~~~~~~~~G  708 (709)
                      ||+||||+.++.+||+|||+|+.+.+.......+...|
T Consensus       167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~  204 (301)
T d1lufa_         167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAI  204 (301)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCB
T ss_pred             cccceEECCCCcEEEccchhheeccCCccccccCCCCc
Confidence            99999999999999999999998755543333333344

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3e-30  Score=267.68  Aligned_cols=152  Identities=33%  Similarity=0.566  Sum_probs=128.8

Q ss_pred             cCcCcceeecccCceEEEEEEEcCC-----cEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEG-----QEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g-----~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      ..|+..++||+|+||+||+|.+...     ..||||++.... ....++|.+|+.++.+++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4577889999999999999988652     379999996543 3445689999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ||||+.++++.+++.+..  ..++|.+++.++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+.
T Consensus        87 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            999999999998875533  45899999999999999999999997   9999999999999999999999999999876


Q ss_pred             CCC
Q 005206          696 GDQ  698 (709)
Q Consensus       696 ~~~  698 (709)
                      ...
T Consensus       162 ~~~  164 (283)
T d1mqba_         162 DDP  164 (283)
T ss_dssp             ---
T ss_pred             CCC
Confidence            543

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.96  E-value=7.5e-30  Score=272.32  Aligned_cols=152  Identities=24%  Similarity=0.430  Sum_probs=137.3

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      ++|...++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++.+++|||||++++++.+.+..+|||||+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57999999999999999999986 48999999997766566778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC--CCcEEEEecCCceeeCCCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK--EMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~--~~~~KI~DFGla~~l~~~~  698 (709)
                      ++|+|.+++.+.  ...+++..+..|+.||+.||+|||+++   ||||||||+||||+.  ++.+||+|||+|+.+....
T Consensus       106 ~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         106 SGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             CSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             CCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            999999998543  235899999999999999999999998   999999999999964  5789999999999886543

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.6e-30  Score=264.22  Aligned_cols=157  Identities=31%  Similarity=0.413  Sum_probs=131.8

Q ss_pred             CcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEe----CCeeEEEE
Q 005206          545 TDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE----MDEKMLVY  617 (709)
Q Consensus       545 ~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~  617 (709)
                      ...++||+|+||+||+|.+.. ++.||+|++...  .....+.|.+|++++++++|||||++++++.+    ....+|||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            445689999999999999865 789999998654  33446689999999999999999999999875    34579999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc-CCCcEEEEecCCceeeCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD-KEMTPKISDFGMARIFGG  696 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~KI~DFGla~~l~~  696 (709)
                      ||+++|+|.+++.+..   .+++..+..++.||++||+|||+++ .+||||||||+||||+ +++.+||+|||+|+....
T Consensus        92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999996543   4899999999999999999999975 4599999999999996 578999999999987543


Q ss_pred             CCccccccceecC
Q 005206          697 DQTEQNTKRVVGT  709 (709)
Q Consensus       697 ~~~~~~~~~~~GT  709 (709)
                      ..    ...++||
T Consensus       168 ~~----~~~~~GT  176 (270)
T d1t4ha_         168 SF----AKAVIGT  176 (270)
T ss_dssp             TS----BEESCSS
T ss_pred             Cc----cCCcccC
Confidence            32    2345665

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=2.8e-30  Score=270.98  Aligned_cols=149  Identities=34%  Similarity=0.547  Sum_probs=133.2

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCc---cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      +.|+.+++||+|+||+||+|+... ++.||||++.....   ...++|.+|+.++.+++|||||++++++.+.+..+|||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            358889999999999999999764 78999999975432   33467999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ||+++|+|..++...   ..+++.++..++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+....
T Consensus        95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            999999998776443   35899999999999999999999998   99999999999999999999999999997644

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.96  E-value=1.3e-29  Score=270.75  Aligned_cols=152  Identities=26%  Similarity=0.401  Sum_probs=136.9

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      +.|...++||+|+||.||+|... +++.||||++........+.+.+|+.++.+++|||||++++++.+.+..+|||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57899999999999999999985 48999999997665556678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc--CCCcEEEEecCCceeeCCCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD--KEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~--~~~~~KI~DFGla~~l~~~~  698 (709)
                      ++|+|.+++...  ...+++.+...|+.||+.||+|||+++   ||||||||+||||+  .++.+||+|||+|+.+..+.
T Consensus       109 ~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         109 SGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            999998877432  335899999999999999999999998   99999999999998  57899999999999986553

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.96  E-value=1.9e-29  Score=260.56  Aligned_cols=151  Identities=28%  Similarity=0.390  Sum_probs=135.4

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCc---------cchHHHHHHHHHHHhcC-CCceeeEEEEEEeC
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG---------QGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEM  610 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---------~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~  610 (709)
                      ++|...+.||+|+||+||+|+.. +++.||||++.+...         ...+.+.+|+.++.+++ |||||++++++.+.
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            57888999999999999999985 588999999975421         12346889999999997 99999999999999


Q ss_pred             CeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCC
Q 005206          611 DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (709)
Q Consensus       611 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGl  690 (709)
                      +..+|||||+++|+|.++|....   .+++.++..++.||++||+|||+++   |+||||||+||||+.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            99999999999999999996543   4899999999999999999999998   99999999999999999999999999


Q ss_pred             ceeeCCCC
Q 005206          691 ARIFGGDQ  698 (709)
Q Consensus       691 a~~l~~~~  698 (709)
                      |+.+....
T Consensus       157 a~~~~~~~  164 (277)
T d1phka_         157 SCQLDPGE  164 (277)
T ss_dssp             CEECCTTC
T ss_pred             eeEccCCC
Confidence            99886543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.96  E-value=1.1e-29  Score=267.34  Aligned_cols=157  Identities=29%  Similarity=0.411  Sum_probs=138.5

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|...++||+|+||+||+|+... |+.||||++.+.   .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            468889999999999999999854 899999999643   2345678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ||+++|+|..++....   .+++.....++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+...
T Consensus        84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            9999999999886543   3788888899999999999999997   999999999999999999999999999987543


Q ss_pred             CccccccceecC
Q 005206          698 QTEQNTKRVVGT  709 (709)
Q Consensus       698 ~~~~~~~~~~GT  709 (709)
                           ...++||
T Consensus       158 -----~~~~~Gt  164 (316)
T d1fota_         158 -----TYTLCGT  164 (316)
T ss_dssp             -----BCCCCSC
T ss_pred             -----cccccCc
Confidence                 2335665

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=8.9e-30  Score=267.01  Aligned_cols=159  Identities=24%  Similarity=0.353  Sum_probs=122.8

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      +.|...++||+|+||+||+|+... ++.||||++.+.. ....+.+.+|+.++.+++|||||++++++.+.+..+|||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            568899999999999999999864 8899999997543 33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc---CCCcEEEEecCCceeeCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGG  696 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~KI~DFGla~~l~~  696 (709)
                      +++|+|.++|.+.   ..+++.....++.||+.||+|||+++   ||||||||+|||+.   +++.+||+|||+|+....
T Consensus        89 ~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          89 VSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             CCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             cCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            9999999999653   35899999999999999999999998   99999999999995   578999999999997754


Q ss_pred             CCccccccceecC
Q 005206          697 DQTEQNTKRVVGT  709 (709)
Q Consensus       697 ~~~~~~~~~~~GT  709 (709)
                      ...   ....+||
T Consensus       163 ~~~---~~~~~GT  172 (307)
T d1a06a_         163 GSV---LSTACGT  172 (307)
T ss_dssp             -------------
T ss_pred             CCe---eeeeeeC
Confidence            432   2335565

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=5.8e-29  Score=259.23  Aligned_cols=150  Identities=29%  Similarity=0.417  Sum_probs=134.8

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC------ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS------GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  614 (709)
                      +.|...++||+|+||+||+|+.. +|+.||||++.+..      ....+.|.+|+.++++++|||||++++++.+.+..+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            57899999999999999999985 48999999996532      223578999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC----cEEEEecCC
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM----TPKISDFGM  690 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~----~~KI~DFGl  690 (709)
                      |||||+++|+|.+++.+..   .+++..+..++.||+.||+|||+++   |+||||||+|||++.++    .+||+|||+
T Consensus        90 iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence            9999999999999996543   4899999999999999999999998   99999999999998776    599999999


Q ss_pred             ceeeCCC
Q 005206          691 ARIFGGD  697 (709)
Q Consensus       691 a~~l~~~  697 (709)
                      |+.+...
T Consensus       164 a~~~~~~  170 (293)
T d1jksa_         164 AHKIDFG  170 (293)
T ss_dssp             CEECTTS
T ss_pred             hhhcCCC
Confidence            9988544

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.1e-29  Score=265.62  Aligned_cols=162  Identities=30%  Similarity=0.514  Sum_probs=132.4

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-Cc----EEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQ----EIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~----~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  615 (709)
                      .+|+.+++||+|+||+||+|.+.. |+    .||||++... ..+..++|.+|+.++++++|||||+++|+|.+. ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            358889999999999999998754 43    6899998654 345678899999999999999999999999864 5678


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ++||+.+|+|.+++...  ...+++..++.++.|||+||+|||+++   ||||||||+||||+.++.+||+|||+|+.+.
T Consensus        88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            89999999999988654  345899999999999999999999997   9999999999999999999999999999887


Q ss_pred             CCCccccccceecC
Q 005206          696 GDQTEQNTKRVVGT  709 (709)
Q Consensus       696 ~~~~~~~~~~~~GT  709 (709)
                      .......+....||
T Consensus       163 ~~~~~~~~~~~~gt  176 (317)
T d1xkka_         163 AEEKEYHAEGGKVP  176 (317)
T ss_dssp             TTCC--------CC
T ss_pred             cccccccccccccC
Confidence            65554444444554

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.8e-29  Score=263.78  Aligned_cols=168  Identities=27%  Similarity=0.404  Sum_probs=131.6

Q ss_pred             HHhcCcCcceeecccCceEEEEEEEcC------CcEEEEEEeccCC-ccchHHHHHHHHHHHhc-CCCceeeEEEEEEeC
Q 005206          539 RATDNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEM  610 (709)
Q Consensus       539 ~~t~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~  610 (709)
                      ...++|...++||+|+||.||+|++..      ++.||||++.... ....+++.+|+.++.++ +|+|||++++++.+.
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            334678999999999999999998743      3689999997543 34466788899988887 689999999998765


Q ss_pred             C-eeEEEEEccCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEE
Q 005206          611 D-EKMLVYEYMENRSLDSVIFDKAR-------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNIL  676 (709)
Q Consensus       611 ~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NIL  676 (709)
                      + ..++||||+++|+|.++|.....             ...+++.++..++.|||+||.|||+++   ||||||||+|||
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NIL  166 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL  166 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcccee
Confidence            4 57999999999999999975321             235899999999999999999999997   999999999999


Q ss_pred             EcCCCcEEEEecCCceeeCCCCccccccceecC
Q 005206          677 LDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT  709 (709)
Q Consensus       677 l~~~~~~KI~DFGla~~l~~~~~~~~~~~~~GT  709 (709)
                      |++++.+||+|||+|+..............+||
T Consensus       167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt  199 (299)
T d1ywna1         167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLP  199 (299)
T ss_dssp             ECGGGCEEECC------CCSCTTSCCTTSCCCG
T ss_pred             ECCCCcEEEccCcchhhccccccccccCceeeC
Confidence            999999999999999987665554444555665

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.1e-29  Score=266.52  Aligned_cols=165  Identities=27%  Similarity=0.423  Sum_probs=139.9

Q ss_pred             cCcCcceeecccCceEEEEEEEc------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  614 (709)
                      ++|...++||+|+||.||+|.+.      .++.||||+++... .+....|.+|+.++++++|||||+++|+|...+..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            57888899999999999999874      25789999997543 344567999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEe
Q 005206          615 LVYEYMENRSLDSVIFDK-------ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISD  687 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~D  687 (709)
                      +||||+++|+|.+++...       .....+++..+..++.|||+||.|||+++   |+||||||+||||++++++||+|
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence            999999999999998642       12235799999999999999999999987   99999999999999999999999


Q ss_pred             cCCceeeCCCCccccccceecC
Q 005206          688 FGMARIFGGDQTEQNTKRVVGT  709 (709)
Q Consensus       688 FGla~~l~~~~~~~~~~~~~GT  709 (709)
                      ||+|+.+..........+..||
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t  198 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLP  198 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEEC
T ss_pred             cccceeccCCcceeeccceecc
Confidence            9999988655443333333443

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.96  E-value=5.6e-29  Score=265.56  Aligned_cols=149  Identities=28%  Similarity=0.361  Sum_probs=135.7

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++|..+++||+|+||.||+|++. +|+.||||++.+.   .....+.+.+|+.++.+++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999986 4899999998643   2344678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      ||+.+|+|..++.+..   .+++.....|+.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+.+..
T Consensus       121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            9999999999986543   4899999999999999999999998   99999999999999999999999999998854

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.9e-28  Score=258.48  Aligned_cols=150  Identities=23%  Similarity=0.361  Sum_probs=133.7

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~  620 (709)
                      ++|...++||+|+||+||+|.... ++.||||++.... .....+.+|+++|.+++|||||++++++.+.+..||||||+
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            578899999999999999999864 7899999996543 34557889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC--CcEEEEecCCceeeCCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE--MTPKISDFGMARIFGGD  697 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~KI~DFGla~~l~~~  697 (709)
                      ++|+|.+++...  ...+++.+...|+.||+.||+|||+++   |+||||||+|||++.+  ..+||+|||+++.+...
T Consensus        84 ~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          84 SGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            999999999543  235899999999999999999999998   9999999999999854  58999999999987544

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=5e-29  Score=256.93  Aligned_cols=152  Identities=31%  Similarity=0.468  Sum_probs=125.3

Q ss_pred             cCcCcceeecccCceEEEEEEEcC--C--cEEEEEEeccC---CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE--G--QEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~--g--~~VAVK~l~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  614 (709)
                      ++|+..+.||+|+||+||+|++..  +  .+||||++.+.   ..+..++|.+|+.++.+++|||||+++|+|.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            468888999999999999998743  2  37899998654   33446789999999999999999999999965 5678


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      +||||+++|++.+++....  ..+++..++.++.|||.||.|||+++   |+||||||+||||+.++.+||+|||+|+.+
T Consensus        87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            9999999999998876543  34899999999999999999999987   999999999999999999999999999988


Q ss_pred             CCCCc
Q 005206          695 GGDQT  699 (709)
Q Consensus       695 ~~~~~  699 (709)
                      .....
T Consensus       162 ~~~~~  166 (273)
T d1u46a_         162 PQNDD  166 (273)
T ss_dssp             CC-CC
T ss_pred             ccCCC
Confidence            66543

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=8.5e-29  Score=265.57  Aligned_cols=150  Identities=27%  Similarity=0.363  Sum_probs=130.6

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC---ccchHHHHHH---HHHHHhcCCCceeeEEEEEEeCCeeE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNE---VRLIAKLQHRNLVRLLGCCVEMDEKM  614 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~---~~~~~~f~~E---i~~l~~l~H~nIv~l~g~~~~~~~~~  614 (709)
                      ++|...++||+|+||.||+|+... |+.||||++.+..   ......+.+|   +.++..++|||||++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            578999999999999999999865 8999999986431   2223334444   66777788999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceee
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l  694 (709)
                      |||||+++|+|.++|.+..   .+++..+..++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+.+
T Consensus        84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            9999999999999996543   4789999999999999999999998   999999999999999999999999999988


Q ss_pred             CCC
Q 005206          695 GGD  697 (709)
Q Consensus       695 ~~~  697 (709)
                      ...
T Consensus       158 ~~~  160 (364)
T d1omwa3         158 SKK  160 (364)
T ss_dssp             SSS
T ss_pred             CCC
Confidence            654

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.5e-28  Score=259.03  Aligned_cols=160  Identities=29%  Similarity=0.410  Sum_probs=137.6

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC---CccchHHHHHHHHHHH-hcCCCceeeEEEEEEeCCeeEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIA-KLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~---~~~~~~~f~~Ei~~l~-~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      ++|...++||+|+||+||+|+... ++.||||++.+.   .....+.+..|..++. .++|||||++++++.+++..|||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            578889999999999999999865 889999999653   2344567777877765 68999999999999999999999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+++|+|.+++....   .+++.+...++.||+.||+|||+++   ||||||||+|||+++++.+||+|||+|+.+..
T Consensus        82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            99999999999997544   3789999999999999999999998   99999999999999999999999999997754


Q ss_pred             CCccccccceecC
Q 005206          697 DQTEQNTKRVVGT  709 (709)
Q Consensus       697 ~~~~~~~~~~~GT  709 (709)
                      ....  .+..+||
T Consensus       156 ~~~~--~~~~~gt  166 (320)
T d1xjda_         156 GDAK--TNTFCGT  166 (320)
T ss_dssp             TTCC--BCCCCSC
T ss_pred             cccc--ccccCCC
Confidence            4322  3345665

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.1e-28  Score=259.18  Aligned_cols=152  Identities=33%  Similarity=0.553  Sum_probs=131.7

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-Cc--EEEEEEeccC-CccchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCeeEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQ--EIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~--~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      ++|+..++||+|+||+||+|++.+ +.  .||||++... .....++|.+|++++.++ +|||||+++|+|.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            467788999999999999999865 33  5788988654 344567899999999999 799999999999999999999


Q ss_pred             EEccCCCCHHHHHhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcE
Q 005206          617 YEYMENRSLDSVIFDK-------------ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  683 (709)
                      |||+++|+|.++|...             .....+++..+++++.|||.||.|||+++   ||||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999999653             23456999999999999999999999997   9999999999999999999


Q ss_pred             EEEecCCceeeCC
Q 005206          684 KISDFGMARIFGG  696 (709)
Q Consensus       684 KI~DFGla~~l~~  696 (709)
                      ||+|||+|+....
T Consensus       167 kl~DfG~a~~~~~  179 (309)
T d1fvra_         167 KIADFGLSRGQEV  179 (309)
T ss_dssp             EECCTTCEESSCE
T ss_pred             EEccccccccccc
Confidence            9999999987643

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=9.7e-29  Score=258.17  Aligned_cols=151  Identities=28%  Similarity=0.513  Sum_probs=130.1

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ++|+.+++||+|+||+||+|++. +++.||||++....  ....+++.+|++++++++|||||++++++.+.+..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            57999999999999999999985 48999999996442  3346789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      |+.++.+ .++... ....+++..+..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+|+....+
T Consensus        82 ~~~~~~~-~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQDLK-KFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSEEHH-HHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ecCCchh-hhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence            9976544 444332 2345899999999999999999999998   999999999999999999999999999987544

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=8.1e-29  Score=255.47  Aligned_cols=150  Identities=22%  Similarity=0.371  Sum_probs=123.9

Q ss_pred             cCcCcceeecccCceEEEEEEEcC----CcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  616 (709)
                      ++|...+.||+|+||.||+|++..    +..||||++.... ....++|.+|+.++++++|||||+++|++. .+..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            578888999999999999998754    3468999986543 334578999999999999999999999985 4678999


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCC
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~  696 (709)
                      |||+++|+|.+++...  ...+++..++.++.||++||.|||+++   ||||||||+|||+++++.+||+|||+|+.+..
T Consensus        86 ~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          86 MELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccC
Confidence            9999999999987543  345899999999999999999999998   99999999999999999999999999998754


Q ss_pred             C
Q 005206          697 D  697 (709)
Q Consensus       697 ~  697 (709)
                      .
T Consensus       161 ~  161 (273)
T d1mp8a_         161 S  161 (273)
T ss_dssp             -
T ss_pred             C
Confidence            4

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=9.4e-29  Score=259.84  Aligned_cols=166  Identities=28%  Similarity=0.405  Sum_probs=140.6

Q ss_pred             hcCcCcceeecccCceEEEEEEEc------CCcEEEEEEeccCCc-cchHHHHHHHHHHHhc-CCCceeeEEEEEEeCCe
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDE  612 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~  612 (709)
                      .++|...++||+|+||.||+|++.      .++.||||+++.... ....+|.+|+.++.++ +|||||+++|+|.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            357888899999999999999863      356899999976533 3456799999999999 69999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHhccC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEE
Q 005206          613 KMLVYEYMENRSLDSVIFDKA---------------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL  677 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl  677 (709)
                      .+|||||+++|+|.+++....               ....+++..+..++.|||+||+|||+++   ||||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence            999999999999999997543               1235899999999999999999999998   9999999999999


Q ss_pred             cCCCcEEEEecCCceeeCCCCccccccceecC
Q 005206          678 DKEMTPKISDFGMARIFGGDQTEQNTKRVVGT  709 (709)
Q Consensus       678 ~~~~~~KI~DFGla~~l~~~~~~~~~~~~~GT  709 (709)
                      +.++.+||+|||+++.+............+||
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt  210 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLP  210 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEEC
T ss_pred             cccCcccccccchheeccCCCcceEeeecccC
Confidence            99999999999999988655443333344544

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.9e-28  Score=255.94  Aligned_cols=147  Identities=31%  Similarity=0.536  Sum_probs=128.6

Q ss_pred             ceeecccCceEEEEEEEcCC----cEEEEEEeccC-CccchHHHHHHHHHHHhcCCCceeeEEEEEEeC-CeeEEEEEcc
Q 005206          547 YNKLGQGGFGIVYKGRLLEG----QEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-DEKMLVYEYM  620 (709)
Q Consensus       547 ~~~LG~G~fG~Vykg~~~~g----~~VAVK~l~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~lV~Ey~  620 (709)
                      .++||+|+||+||+|++.++    ..||||++++. .....++|.+|++++++++|||||+++|++.+. ...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            36899999999999998652    26899999754 444568899999999999999999999998875 5789999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      ++|+|.+++...  ...+++..+++++.|+|+||.|||+.+   |+||||||+||||++++.+||+|||+++.+....
T Consensus       112 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         112 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             ecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            999999998643  345788999999999999999999997   9999999999999999999999999999876553

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.95  E-value=1.5e-28  Score=255.02  Aligned_cols=150  Identities=27%  Similarity=0.471  Sum_probs=134.5

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ++|..+++||+|+||+||+|++++++.||||++....  ....++|.+|+.+|++++|||||++++++.+.+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5788999999999999999999989999999996542  33467899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      +.++.+..+...   ...+++.....++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|..+...
T Consensus        82 ~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~  153 (286)
T d1ob3a_          82 LDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (286)
T ss_dssp             CSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             ehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence            998777766533   345999999999999999999999987   999999999999999999999999999987544

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.5e-28  Score=256.88  Aligned_cols=147  Identities=32%  Similarity=0.465  Sum_probs=125.4

Q ss_pred             cceeecccCceEEEEEEEcC-CcEEEEEEeccCCc-----cchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEEc
Q 005206          546 DYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG-----QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       546 ~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~-----~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      .+++||+|+||+||+|++.. ++.||||++.....     ...+.+.+|+.++++++|||||++++++.+.+..+|||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            35789999999999999865 89999999965422     1235789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~~  698 (709)
                      ++++++..++.   ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+..+.
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence            99887766553   2345888899999999999999999998   9999999999999999999999999999875543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.95  E-value=5.4e-28  Score=249.74  Aligned_cols=162  Identities=28%  Similarity=0.423  Sum_probs=132.1

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCe----e
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE----K  613 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----~  613 (709)
                      ++|...+.||+|+||.||+|++. +++.||||++++..   ....++|.+|++++.+++|||||++++++...+.    .
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            57999999999999999999985 48999999997542   2335679999999999999999999999987543    7


Q ss_pred             EEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       614 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      +|||||+++++|.+++....   .+++.+...++.||+.||+|||+++   ||||||||+||||+.++..+|+|||+++.
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhh
Confidence            89999999999999886543   4899999999999999999999998   99999999999999999999999999987


Q ss_pred             eCCCCcc-ccccceecC
Q 005206          694 FGGDQTE-QNTKRVVGT  709 (709)
Q Consensus       694 l~~~~~~-~~~~~~~GT  709 (709)
                      +...... ......+||
T Consensus       161 ~~~~~~~~~~~~~~~Gt  177 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGT  177 (277)
T ss_dssp             CC---------------
T ss_pred             hccccccccccccccCc
Confidence            6544322 223334554

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.5e-28  Score=255.08  Aligned_cols=164  Identities=26%  Similarity=0.426  Sum_probs=135.2

Q ss_pred             cCcCcceeecccCceEEEEEEEcC--------CcEEEEEEeccCCc-cchHHHHHHHHHHHhc-CCCceeeEEEEEEeCC
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE--------GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMD  611 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~  611 (709)
                      ++|...++||+|+||.||+|+...        +..||||++++... ....++.+|+..+.++ +|||||+++++|.+.+
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            578888999999999999998643        24799999976543 4567899999999998 8999999999999999


Q ss_pred             eeEEEEEccCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEc
Q 005206          612 EKMLVYEYMENRSLDSVIFDKAR-------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD  678 (709)
Q Consensus       612 ~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~  678 (709)
                      ..++||||+++|+|.++|.....             ...+++.+++.++.|||.||+|||+++   ||||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeec
Confidence            99999999999999999975432             245899999999999999999999998   99999999999999


Q ss_pred             CCCcEEEEecCCceeeCCCCccccccceec
Q 005206          679 KEMTPKISDFGMARIFGGDQTEQNTKRVVG  708 (709)
Q Consensus       679 ~~~~~KI~DFGla~~l~~~~~~~~~~~~~G  708 (709)
                      .++.+||+|||+++..........+...+|
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  199 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRL  199 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCC
T ss_pred             CCCCeEeccchhhccccccccccccccCCC
Confidence            999999999999998866544433333444

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.4e-28  Score=254.50  Aligned_cols=148  Identities=28%  Similarity=0.404  Sum_probs=124.6

Q ss_pred             CcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHH--HHHHHHHhcCCCceeeEEEEEEeCC----eeEEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFK--NEVRLIAKLQHRNLVRLLGCCVEMD----EKMLV  616 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~--~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV  616 (709)
                      .|...++||+|+||.||+|++ +|+.||||++...   ..+++.  .|+..+.+++|||||+++|+|.+.+    ..+||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            466678999999999999997 6889999998543   233444  4555556789999999999998754    57899


Q ss_pred             EEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEecCCCCCCEEEcCCCcEEEEecCCc
Q 005206          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS-----RFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (709)
Q Consensus       617 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiHrDlkp~NILl~~~~~~KI~DFGla  691 (709)
                      |||+++|+|.++|.+.    .++|..++.++.|+|.||+|||+..     ..+||||||||+||||+.++.+||+|||++
T Consensus        80 ~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            9999999999999653    4899999999999999999999741     235999999999999999999999999999


Q ss_pred             eeeCCCC
Q 005206          692 RIFGGDQ  698 (709)
Q Consensus       692 ~~l~~~~  698 (709)
                      +.+....
T Consensus       156 ~~~~~~~  162 (303)
T d1vjya_         156 VRHDSAT  162 (303)
T ss_dssp             EEEETTT
T ss_pred             ccccCCC
Confidence            9886543

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.3e-28  Score=252.27  Aligned_cols=149  Identities=30%  Similarity=0.523  Sum_probs=125.7

Q ss_pred             cCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeC-CeeEEEEEcc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-DEKMLVYEYM  620 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~lV~Ey~  620 (709)
                      ++|+..++||+|+||.||+|++ .|++||||++++.  ...++|.+|++++++++|||||+++|+|.+. +..+|||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            4577788999999999999998 5789999999643  3457899999999999999999999999764 5679999999


Q ss_pred             CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      ++|+|.++|.+... ..++|..++.|+.|||.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          84 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             TTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             CCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC
Confidence            99999999965422 24899999999999999999999987   999999999999999999999999999976543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=3.2e-27  Score=250.37  Aligned_cols=148  Identities=26%  Similarity=0.335  Sum_probs=127.0

Q ss_pred             cCcCcce-eecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhc-CCCceeeEEEEEEe----CCeeE
Q 005206          542 DNFTDYN-KLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVE----MDEKM  614 (709)
Q Consensus       542 ~~f~~~~-~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~----~~~~~  614 (709)
                      ++|.... .||+|+||.||+|++. +++.||||++++     .+.+.+|+.++.++ +|||||++++++.+    ....|
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            5787765 5999999999999985 489999999853     35678899987665 89999999999875    35679


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCcEEEEecCCc
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK---EMTPKISDFGMA  691 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~KI~DFGla  691 (709)
                      |||||+++|+|.++|.+. ....+++.+...|+.||+.||+|||+++   |+||||||+|||++.   ++.+||+|||+|
T Consensus        86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence            999999999999999653 2345899999999999999999999998   999999999999985   467999999999


Q ss_pred             eeeCCCC
Q 005206          692 RIFGGDQ  698 (709)
Q Consensus       692 ~~l~~~~  698 (709)
                      +.+....
T Consensus       162 ~~~~~~~  168 (335)
T d2ozaa1         162 KETTSHN  168 (335)
T ss_dssp             EECCCCC
T ss_pred             eeccCCC
Confidence            9876543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.3e-27  Score=244.44  Aligned_cols=158  Identities=25%  Similarity=0.366  Sum_probs=133.0

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCc------cchHHHHHHHHHHHhcC--CCceeeEEEEEEeCCe
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG------QGIEEFKNEVRLIAKLQ--HRNLVRLLGCCVEMDE  612 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~------~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~  612 (709)
                      ++|...++||+|+||.||+|+.. +++.||||++.+...      ....++.+|+.++++++  |||||++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57889999999999999999986 489999999965321      12345789999999996  9999999999999999


Q ss_pred             eEEEEEccCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCC-CcEEEEecCC
Q 005206          613 KMLVYEYMEN-RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGM  690 (709)
Q Consensus       613 ~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~KI~DFGl  690 (709)
                      .++||||+.+ +++.+++....   .+++..+..++.||+.||+|||+++   |+||||||+|||++.+ +.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence            9999999976 57777775543   4899999999999999999999998   9999999999999854 7999999999


Q ss_pred             ceeeCCCCccccccceecC
Q 005206          691 ARIFGGDQTEQNTKRVVGT  709 (709)
Q Consensus       691 a~~l~~~~~~~~~~~~~GT  709 (709)
                      |+......    .+.++||
T Consensus       158 a~~~~~~~----~~~~~GT  172 (273)
T d1xwsa_         158 GALLKDTV----YTDFDGT  172 (273)
T ss_dssp             CEECCSSC----BCCCCSC
T ss_pred             ceeccccc----ccccccC
Confidence            99764432    2335665

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=4.8e-27  Score=250.83  Aligned_cols=149  Identities=28%  Similarity=0.441  Sum_probs=124.5

Q ss_pred             CcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC------eeEE
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD------EKML  615 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~~l  615 (709)
                      .|+..++||+|+||+||+|++.. ++.||||++.+...    .+.+|+.+|++++|||||++++++....      ..+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            57888999999999999999865 89999999965432    2347999999999999999999986532      4689


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-cEEEEecCCceee
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIF  694 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~KI~DFGla~~l  694 (709)
                      ||||++++.+..+.........+++.++..++.||+.||+|||+++   |+||||||+||||+.++ .+||+|||+|+.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987755444433334456999999999999999999999987   99999999999999775 8999999999988


Q ss_pred             CCCC
Q 005206          695 GGDQ  698 (709)
Q Consensus       695 ~~~~  698 (709)
                      ....
T Consensus       174 ~~~~  177 (350)
T d1q5ka_         174 VRGE  177 (350)
T ss_dssp             CTTS
T ss_pred             cCCc
Confidence            5543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=8.1e-27  Score=242.29  Aligned_cols=150  Identities=25%  Similarity=0.435  Sum_probs=134.8

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCCeeEEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  618 (709)
                      ++|+.+++||+|+||+||+|++. +++.||||+++...  ....+++.+|+.++++++||||+++++++.+.+..++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57899999999999999999985 48899999996442  3446789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeCCC
Q 005206          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (709)
Q Consensus       619 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~~~  697 (709)
                      |+.+++|..++...   ..+++..+..++.|++.||+|||+++   ||||||||+|||++.++.+||+|||+|+.+...
T Consensus        82 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             eccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence            99999988877543   34789999999999999999999997   999999999999999999999999999987654

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=6.2e-27  Score=249.50  Aligned_cols=150  Identities=24%  Similarity=0.432  Sum_probs=127.4

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC----eeEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD----EKML  615 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~l  615 (709)
                      .+|..+++||+|+||+||+|... +++.||||++.+.. ....+++++|+.+|.+++||||+++++++....    ..++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            57999999999999999999875 58999999997543 334678999999999999999999999997643    2355


Q ss_pred             EEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCceeeC
Q 005206          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (709)
Q Consensus       616 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~l~  695 (709)
                      ++||+.+|+|.+++...    .+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+.
T Consensus        88 l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          88 LVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            66777899999998542    4899999999999999999999998   9999999999999999999999999999875


Q ss_pred             CCC
Q 005206          696 GDQ  698 (709)
Q Consensus       696 ~~~  698 (709)
                      ...
T Consensus       161 ~~~  163 (345)
T d1pmea_         161 PDH  163 (345)
T ss_dssp             GGG
T ss_pred             CCC
Confidence            543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.93  E-value=2.1e-26  Score=243.59  Aligned_cols=145  Identities=24%  Similarity=0.428  Sum_probs=127.1

Q ss_pred             cCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcC-CCceeeEEEEEEeC--CeeEEEE
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEM--DEKMLVY  617 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~  617 (709)
                      ++|+.+++||+|+||+||+|+.. +++.||||+++..   ..+++.+|+.+|.+++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            57999999999999999999985 4889999998643   3567899999999995 99999999999854  4589999


Q ss_pred             EccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCC-cEEEEecCCceeeCC
Q 005206          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIFGG  696 (709)
Q Consensus       618 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~KI~DFGla~~l~~  696 (709)
                      ||+++++|..+.      ..+++..+..++.||+.||+|||+++   ||||||||+||||+.++ .+||+|||+|+.+..
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999986543      24899999999999999999999998   99999999999998655 699999999998865


Q ss_pred             CC
Q 005206          697 DQ  698 (709)
Q Consensus       697 ~~  698 (709)
                      ..
T Consensus       183 ~~  184 (328)
T d3bqca1         183 GQ  184 (328)
T ss_dssp             TC
T ss_pred             CC
Confidence            43

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=3.4e-26  Score=240.75  Aligned_cols=151  Identities=28%  Similarity=0.491  Sum_probs=127.4

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeC-------
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-------  610 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-------  610 (709)
                      .++|+.+++||+|+||+||+|++. +++.||||++...  .....+++.+|+.+|++++||||+++++.+...       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            368999999999999999999985 5899999998644  334467899999999999999999999998653       


Q ss_pred             -CeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecC
Q 005206          611 -DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG  689 (709)
Q Consensus       611 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFG  689 (709)
                       ...++||||++++.+..+..   ....++......++.||+.||.|||+++   |+||||||+||||+.++.+||+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence             45789999999887765442   2335888889999999999999999997   9999999999999999999999999


Q ss_pred             CceeeCCC
Q 005206          690 MARIFGGD  697 (709)
Q Consensus       690 la~~l~~~  697 (709)
                      +|+.+...
T Consensus       163 ~~~~~~~~  170 (318)
T d3blha1         163 LARAFSLA  170 (318)
T ss_dssp             TCEECCC-
T ss_pred             eeeecccc
Confidence            99987644

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.7e-26  Score=244.55  Aligned_cols=148  Identities=29%  Similarity=0.480  Sum_probs=123.7

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcCCCceeeEEEEEEeCC------e
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD------E  612 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------~  612 (709)
                      ++|+.+++||+|+||+||+|.+.. ++.||||++.+.  .....+.+.+|+++|++++|||||++++++...+      +
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            689999999999999999999864 899999999754  2334568899999999999999999999998765      4


Q ss_pred             eEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCce
Q 005206          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~  692 (709)
                      .+|||||+ +.+|..++..    ..+++..+..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+|+
T Consensus        98 ~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             CEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccccee
Confidence            69999999 4567766643    24899999999999999999999998   9999999999999999999999999999


Q ss_pred             eeCCC
Q 005206          693 IFGGD  697 (709)
Q Consensus       693 ~l~~~  697 (709)
                      .....
T Consensus       170 ~~~~~  174 (346)
T d1cm8a_         170 QADSE  174 (346)
T ss_dssp             ECCSS
T ss_pred             ccCCc
Confidence            87544

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.6e-26  Score=243.65  Aligned_cols=151  Identities=26%  Similarity=0.376  Sum_probs=133.2

Q ss_pred             cCcCcceeecccCceEEEEEEEc----CCcEEEEEEeccCC----ccchHHHHHHHHHHHhcCC-CceeeEEEEEEeCCe
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQH-RNLVRLLGCCVEMDE  612 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~----~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~  612 (709)
                      ++|...++||+|+||+||+|+..    +|+.||||++.+..    ....+.+.+|+.++.+++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56999999999999999999863    37899999986532    2345678999999999966 899999999999999


Q ss_pred             eEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCce
Q 005206          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~  692 (709)
                      .+++|||+.+|+|.+++....   .+.......++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            999999999999999986554   3678888899999999999999998   9999999999999999999999999999


Q ss_pred             eeCCCC
Q 005206          693 IFGGDQ  698 (709)
Q Consensus       693 ~l~~~~  698 (709)
                      .+....
T Consensus       178 ~~~~~~  183 (322)
T d1vzoa_         178 EFVADE  183 (322)
T ss_dssp             ECCGGG
T ss_pred             hhcccc
Confidence            875443

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.93  E-value=1.4e-25  Score=233.34  Aligned_cols=160  Identities=21%  Similarity=0.342  Sum_probs=134.9

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCC-CceeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH-RNLVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ++|...++||+|+||+||+|++.. ++.||||++....  ..+.+++|++.+..++| +|++.+++++.++...++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            679999999999999999999864 8899999886432  33567889999999965 8999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC-----CCcEEEEecCCceee
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-----EMTPKISDFGMARIF  694 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-----~~~~KI~DFGla~~l  694 (709)
                      + +++|.+++....  ..+++.+...++.|++.||+|||+++   ||||||||+||||+.     ++.+||+|||+|+.+
T Consensus        83 ~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          83 L-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             C-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             c-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            9 689998885533  35899999999999999999999998   999999999999974     578999999999988


Q ss_pred             CCCCcc-----ccccceecC
Q 005206          695 GGDQTE-----QNTKRVVGT  709 (709)
Q Consensus       695 ~~~~~~-----~~~~~~~GT  709 (709)
                      ......     .....++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT  176 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGT  176 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSC
T ss_pred             ccCccccceeecccCceEEc
Confidence            654322     123346676

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=6.4e-26  Score=237.16  Aligned_cols=151  Identities=28%  Similarity=0.457  Sum_probs=125.2

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-C-CcEEEEEEeccC--CccchHHHHHHHHHHHhc---CCCceeeEEEEEEeC---
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-E-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKL---QHRNLVRLLGCCVEM---  610 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~-g~~VAVK~l~~~--~~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~---  610 (709)
                      .++|+.+++||+|+||+||+|++. . ++.||||++...  .......+.+|+.+++.|   +||||+++++++...   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999984 3 567999998643  223344677788877665   899999999998642   


Q ss_pred             --CeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEec
Q 005206          611 --DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDF  688 (709)
Q Consensus       611 --~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DF  688 (709)
                        ...+++|||++++.+......  ....+++.....++.||+.||+|||+++   ||||||||+|||+++++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence              357899999998877654432  3345899999999999999999999998   999999999999999999999999


Q ss_pred             CCceeeCC
Q 005206          689 GMARIFGG  696 (709)
Q Consensus       689 Gla~~l~~  696 (709)
                      |+++....
T Consensus       161 g~~~~~~~  168 (305)
T d1blxa_         161 GLARIYSF  168 (305)
T ss_dssp             CSCCCCCG
T ss_pred             hhhhhhcc
Confidence            99987643

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.92  E-value=7.3e-25  Score=228.52  Aligned_cols=149  Identities=23%  Similarity=0.374  Sum_probs=123.3

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCCccchHHHHHHHHHHHhcCCCc-eeeEEEEEEeCCeeEEEEEc
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN-LVRLLGCCVEMDEKMLVYEY  619 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~Ey  619 (709)
                      ++|+..++||+|+||.||+|++.. ++.||||++....  ..+++..|++++.+++|+| |+.+.++..+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            569999999999999999999854 8899999886543  3356889999999998766 55556666788889999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcC---CCcEEEEecCCceeeCC
Q 005206          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK---EMTPKISDFGMARIFGG  696 (709)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~KI~DFGla~~l~~  696 (709)
                      +. ++|...+...  ...+++..+..++.|++.||+|||+++   ||||||||+|||++.   +..+||+|||+|+.+..
T Consensus        85 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 LG-PSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             CC-CBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             cC-Cchhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            95 5666655432  235899999999999999999999998   999999999999863   56799999999998865


Q ss_pred             CC
Q 005206          697 DQ  698 (709)
Q Consensus       697 ~~  698 (709)
                      ..
T Consensus       159 ~~  160 (299)
T d1ckia_         159 AR  160 (299)
T ss_dssp             TT
T ss_pred             cc
Confidence            44

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.9e-25  Score=237.93  Aligned_cols=149  Identities=29%  Similarity=0.438  Sum_probs=126.1

Q ss_pred             hcCcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeC-----Ce
Q 005206          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-----DE  612 (709)
Q Consensus       541 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~  612 (709)
                      .++|..+++||+|+||+||+|+.. +++.||||++.+..  ....+++.+|+.++++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            467999999999999999999975 58999999997543  23456789999999999999999999998643     33


Q ss_pred             eEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCce
Q 005206          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~  692 (709)
                      .++++||+.+|+|.+++..    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||+|.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            4677888899999999843    24899999999999999999999998   9999999999999999999999999998


Q ss_pred             eeCC
Q 005206          693 IFGG  696 (709)
Q Consensus       693 ~l~~  696 (709)
                      ....
T Consensus       170 ~~~~  173 (348)
T d2gfsa1         170 HTDD  173 (348)
T ss_dssp             CCTG
T ss_pred             ccCc
Confidence            7643

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=8.4e-25  Score=233.73  Aligned_cols=147  Identities=31%  Similarity=0.465  Sum_probs=120.8

Q ss_pred             cCcCcceeecccCceEEEEEEEcC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcCCCceeeEEEEEEeC------Ce
Q 005206          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM------DE  612 (709)
Q Consensus       542 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~  612 (709)
                      ++|..+++||+|+||+||+|.+.. |+.||||++....  ....+++.+|+.++++++|||||++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            579999999999999999999864 8999999997542  33456789999999999999999999999643      57


Q ss_pred             eEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEEecCCce
Q 005206          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (709)
Q Consensus       613 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~  692 (709)
                      .++||||+.++.+. .+.     ..+++.....++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        97 ~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence            89999999766554 332     23789999999999999999999998   9999999999999999999999999999


Q ss_pred             eeCCC
Q 005206          693 IFGGD  697 (709)
Q Consensus       693 ~l~~~  697 (709)
                      .....
T Consensus       168 ~~~~~  172 (355)
T d2b1pa1         168 TAGTS  172 (355)
T ss_dssp             -----
T ss_pred             ccccc
Confidence            77544

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.85  E-value=1.8e-21  Score=188.89  Aligned_cols=135  Identities=20%  Similarity=0.210  Sum_probs=106.8

Q ss_pred             CcceeecccCceEEEEEEEcCCcEEEEEEeccCCc------------------cchHHHHHHHHHHHhcCCCceeeEEEE
Q 005206          545 TDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG------------------QGIEEFKNEVRLIAKLQHRNLVRLLGC  606 (709)
Q Consensus       545 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~------------------~~~~~f~~Ei~~l~~l~H~nIv~l~g~  606 (709)
                      ...++||+|+||.||+|.+.+|++||||+++....                  .....+..|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            34579999999999999998999999998753210                  011234568889999999999998865


Q ss_pred             EEeCCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCCEEEcCCCcEEEE
Q 005206          607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKIS  686 (709)
Q Consensus       607 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~KI~  686 (709)
                      .    ..+++|||+++..+..          ++......++.|++++|.|||+++   |+||||||+|||++++ .++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred             c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence            3    3479999999866532          233345578999999999999998   9999999999999865 58999


Q ss_pred             ecCCceeeCCC
Q 005206          687 DFGMARIFGGD  697 (709)
Q Consensus       687 DFGla~~l~~~  697 (709)
                      |||+|+....+
T Consensus       145 DFG~a~~~~~~  155 (191)
T d1zara2         145 DFPQSVEVGEE  155 (191)
T ss_dssp             CCTTCEETTST
T ss_pred             ECCCcccCCCC
Confidence            99999987544

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.82  E-value=1.4e-20  Score=200.69  Aligned_cols=150  Identities=21%  Similarity=0.288  Sum_probs=121.2

Q ss_pred             CcCcceeecccCceEEEEEEEc-CCcEEEEEEeccCCccchHHHHHHHHHHHhcC-----------CCceeeEEEEEEe-
Q 005206          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-----------HRNLVRLLGCCVE-  609 (709)
Q Consensus       543 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-----------H~nIv~l~g~~~~-  609 (709)
                      +|+.+++||+|+||+||+|+.. +|+.||||++.+. ....+.+.+|+.++.+++           |+||+++++++.. 
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            5889999999999999999985 5899999999643 233567888999888875           5789999988865 


Q ss_pred             -CCeeEEEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCCEEEcCCC------
Q 005206          610 -MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ-DSRFRIIHRDLKASNILLDKEM------  681 (709)
Q Consensus       610 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILl~~~~------  681 (709)
                       ....+++++++..+..............+++..+..++.||+.||+|||+ .+   |+||||||+||||+.++      
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence             35667788877666544444344445568899999999999999999998 55   99999999999998665      


Q ss_pred             cEEEEecCCceeeCC
Q 005206          682 TPKISDFGMARIFGG  696 (709)
Q Consensus       682 ~~KI~DFGla~~l~~  696 (709)
                      .+||+|||.|+....
T Consensus       170 ~~kl~dfg~s~~~~~  184 (362)
T d1q8ya_         170 QIKIADLGNACWYDE  184 (362)
T ss_dssp             EEEECCCTTCEETTB
T ss_pred             eeeEeeccccccccc
Confidence            499999999987644

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=99.79  E-value=2.7e-19  Score=157.64  Aligned_cols=110  Identities=19%  Similarity=0.385  Sum_probs=91.8

Q ss_pred             ccccCCCCCcCCCCEEEecCCeEEEEeeCCCCCCcEEEEEEEeccCCceEEEEcCCCCCCCCCcceEEEEcCc-eEEEcC
Q 005206           57 VDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQR-IGLFDG  135 (709)
Q Consensus        57 ~~~l~~g~~l~~~~~lvS~~g~F~lGFf~~~~~~~~~lgIw~~~~~~~tvVWvANr~~Pv~~~~~~l~l~~~G-Lvl~d~  135 (709)
                      +|+|.+||.|..|++|+|  |.|+|.|...|+     |.++.    ..++||.||++.|..  .+.|.++.+| |+|.|.
T Consensus         1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~~--~~~l~l~~dGnLvl~~~   67 (112)
T d1xd5a_           1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD----NNRAVWASGTNGKAS--GCVLKMQNDGNLVIYSG   67 (112)
T ss_dssp             CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSCS--SEEEEECTTSCEEEEET
T ss_pred             CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc----CCcEEEEccCccCCC--CcEEEEeccccEEEEec
Confidence            489999999999999985  999999987763     44554    468999999998854  4689999999 999997


Q ss_pred             CCceEEecCCCCC-CCceeEEecCCCEEEEecCCCceeEeeccCCCC
Q 005206          136 SQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTD  181 (709)
Q Consensus       136 ~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PtD  181 (709)
                       +..+|++++... ...+|+|+|+|||||++. .+.++|||+.+|+|
T Consensus        68 -~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~-~~~~~W~S~t~~~n  112 (112)
T d1xd5a_          68 -SRAIWASNTNRQNGNYYLILQRDRNVVIYDN-SNNAIWATHTNVGN  112 (112)
T ss_dssp             -TEEEEECCCCCSCCCCEEEECTTSCEEEECT-TSCEEEECCCCCCC
T ss_pred             -CCeEEEEeeccCCCceEEEEcCCCCEEEECC-CCcEEecCCCccCC
Confidence             567787775544 567899999999999986 67899999999986

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=99.78  E-value=1e-18  Score=152.66  Aligned_cols=105  Identities=20%  Similarity=0.330  Sum_probs=88.3

Q ss_pred             cccCCCCCcCCCCEEEecCCeEEEEeeCCCCCCcEEEEEEEeccCCceEEEEcCCCCCCCCCcceEEEEcCc-eEEEcCC
Q 005206           58 DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQR-IGLFDGS  136 (709)
Q Consensus        58 ~~l~~g~~l~~~~~lvS~~g~F~lGFf~~~~~~~~~lgIw~~~~~~~tvVWvANr~~Pv~~~~~~l~l~~~G-Lvl~d~~  136 (709)
                      |+|.+||.|.+|+.|.  +|.|.|+|...++     |.++.    ..++||+||++.|+... +.|.++.+| |+|.|++
T Consensus         2 ~~L~~g~~L~~g~~l~--~g~~~l~~q~dgn-----Lvl~~----~~~~vW~ant~~~~~~~-~~l~l~~dGnLvl~~~~   69 (109)
T d1kj1a_           2 NLLTNGEGLYAGQSLD--VEPYHFIMQEDCN-----LVLYD----HSTSVWASNTGILGKKG-CKAVLQSDGNFVVYDAE   69 (109)
T ss_dssp             CEEETTCEEETTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCCC-CEEEECTTSCEEEECSS
T ss_pred             CCccCCCEEeCCCEEE--eCCEEEEecCCCe-----EEEEe----CCEEEEEeCCCCCCcee-EEEEEcCCceEEEEeCC
Confidence            7899999999999997  4889999976653     43443    46789999999998654 789999999 9999999


Q ss_pred             CceEEecCCCCC-CCceeEEecCCCEEEEecCCCceeEeeccC
Q 005206          137 QNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDY  178 (709)
Q Consensus       137 g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQSFd~  178 (709)
                      |.+||+|+++.. ...+|.|+|+|||||++.    .+|||+.|
T Consensus        70 g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~----~~W~S~t~  108 (109)
T d1kj1a_          70 GRSLWASHSVRGNGNYVLVLQEDGNVVIYGS----DIWSTGTY  108 (109)
T ss_dssp             SCEEEECCCCCCSSCCEEEECTTSCEEEECC----EEEECCCC
T ss_pred             CcEEEEEeeECCCCCEEEEEeCCCcEEEECC----CEecCCCc
Confidence            999999997654 566899999999999963    59999875

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=99.76  E-value=8.4e-19  Score=153.07  Aligned_cols=104  Identities=19%  Similarity=0.266  Sum_probs=88.2

Q ss_pred             cccCCCCCcCCCCEEEecCCeEEEEeeCCCCCCcEEEEEEEeccCCceEEEEcCCCCCCCCCcceEEEEcCc-eEEEcCC
Q 005206           58 DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQR-IGLFDGS  136 (709)
Q Consensus        58 ~~l~~g~~l~~~~~lvS~~g~F~lGFf~~~~~~~~~lgIw~~~~~~~tvVWvANr~~Pv~~~~~~l~l~~~G-Lvl~d~~  136 (709)
                      |+|.+||.|.+|+.|.  +|.|+|.|...|+     |.|+.    ..++||.||++.|..  .+.|.+..+| |+|.|++
T Consensus         2 ~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~~--~~~l~l~~~Gnlvl~~~~   68 (108)
T d1jpca_           2 NILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD----VDKPIWATNTGGLSR--SCFLSMQTDGNLVVYNPS   68 (108)
T ss_dssp             CEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSCS--SCEEEECTTSCEEEECTT
T ss_pred             CCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEe----CCceeeEeCCCCCCC--ccEEEEeccceEEEECCC
Confidence            6899999999999995  6999999988874     55654    357899999998843  4689999999 9999999


Q ss_pred             CceEEecCCCCC-CCceeEEecCCCEEEEecCCCceeEeeccC
Q 005206          137 QNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDY  178 (709)
Q Consensus       137 g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQSFd~  178 (709)
                      |.+||+|++... ...+|+|+|+|||||++.    .+||||+|
T Consensus        69 g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~----~~W~S~t~  107 (108)
T d1jpca_          69 NKPIWASNTGGQNGNYVCILQKDRNVVIYGT----DRWATGTH  107 (108)
T ss_dssp             CCEEEECCCCCSCSCEEEEECTTSCEEEEEC----CCCCCCCC
T ss_pred             ccceEEccccCCCCcEEEEEcCCCCEEEeCC----CcccCCCC
Confidence            999999987654 345789999999999974    48999998

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.66  E-value=7.6e-17  Score=142.91  Aligned_cols=100  Identities=23%  Similarity=0.257  Sum_probs=85.5

Q ss_pred             EEEeccCCceEEEEcCCCCCCCCCcceEEEEcCc-eEEEcCCCceEEecCCCCC-CCceeEEecCCCEEEEecCCCceeE
Q 005206           96 IWYKNIAQRTYVWVANRDDPLANSSGVLRIINQR-IGLFDGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILW  173 (709)
Q Consensus        96 Iw~~~~~~~tvVWvANr~~Pv~~~~~~l~l~~~G-Lvl~d~~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~~lW  173 (709)
                      |||..+++++.+|++|++.|+.....+|.+..|| |+|.+. +.++|++++.+. ....|+|+|+|||||++. .+.++|
T Consensus        12 il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~-~~~~lW   89 (120)
T d1dlpa2          12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTN-QNIAVW   89 (120)
T ss_dssp             ECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEET-TTEEEE
T ss_pred             EEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcC-CCCEEE
Confidence            8999999999999999999999888899999999 999986 678999997765 467899999999999996 678999


Q ss_pred             eeccCCCCccCCCCcccceeccCCeeEEEEecCCCCCCCCcceEeecCCCCcEEE
Q 005206          174 QSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGF  228 (709)
Q Consensus       174 QSFd~PtDTlLpg~~l~~~~~tg~~~~L~S~~s~~dps~G~~~l~~~~~g~~~~~  228 (709)
                      |||.                               +.++|.|.+.|++||+..+|
T Consensus        90 ~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY  113 (120)
T d1dlpa2          90 TSGN-------------------------------SRSAGRYVFVLQPDRNLAIY  113 (120)
T ss_dssp             ECCC-------------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred             EeCC-------------------------------CCCCCcEEEEECCCCcEEEe
Confidence            9973                               24578899999999986554

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.54  E-value=1.5e-15  Score=133.14  Aligned_cols=109  Identities=25%  Similarity=0.252  Sum_probs=92.0

Q ss_pred             EEEeccCCceEEEEcCCCCCCCCCcceEEEEcCc-eEEEcCCCceEEecCCCCCCCceeEEecCCCEEEEecCCCceeEe
Q 005206           96 IWYKNIAQRTYVWVANRDDPLANSSGVLRIINQR-IGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKEAGSDEILWQ  174 (709)
Q Consensus        96 Iw~~~~~~~tvVWvANr~~Pv~~~~~~l~l~~~G-Lvl~d~~g~~vWst~~~~~~~~~a~LldsGNlVl~~~~~~~~lWQ  174 (709)
                      |||.-.++.+..|+.+.+.|+.+...+|.+..|| |||.++ +.++|++++.+..+..|.|+|+|||||++. .+.++||
T Consensus         3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~-~~~~vWs   80 (115)
T d1dlpa1           3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTA-QNTIRWS   80 (115)
T ss_dssp             CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCT-TTCCSCC
T ss_pred             EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEcC-CeeEEEcccCCCCceEEEEeccCCEEEEcc-CCCEEEE
Confidence            6777666778889999999999888899999999 999985 679999998776788999999999999986 6789999


Q ss_pred             eccCCCCccCCCCcccceeccCCeeEEEEecCCCCCCCCcceEeecCCCCcEEEEecCCccccccCC
Q 005206          175 SFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGP  241 (709)
Q Consensus       175 SFd~PtDTlLpg~~l~~~~~tg~~~~L~S~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~sg~  241 (709)
                      |+.                               +.++|.|.|.|++||...+  +  +..+|.+|.
T Consensus        81 S~t-------------------------------~~~~g~y~l~Lq~DGNlvl--Y--~~~~Wssgt  112 (115)
T d1dlpa1          81 SGT-------------------------------KGSIGNYVLVLQPDRTVTI--Y--GPGLWDSGT  112 (115)
T ss_dssp             CCC-------------------------------CCCSSCCEEEECSSSCEEE--E--CSEEEECSC
T ss_pred             cCC-------------------------------CCCCCCEEEEECCCCcEEE--e--CCCeecCCC
Confidence            863                               3467899999999998654  4  347898875

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.44  E-value=3.8e-13  Score=118.37  Aligned_cols=101  Identities=18%  Similarity=0.276  Sum_probs=78.9

Q ss_pred             cccCCCCCcCCCCEEEecCCeEEEEeeCCCCCCcEEEEEEEeccCCceEEEEcCCCCCCCCCcceEEEEcCc-eEEEcCC
Q 005206           58 DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQR-IGLFDGS  136 (709)
Q Consensus        58 ~~l~~g~~l~~~~~lvS~~g~F~lGFf~~~~~~~~~lgIw~~~~~~~tvVWvANr~~Pv~~~~~~l~l~~~G-Lvl~d~~  136 (709)
                      ++|.++|+|    ..++..|.|.|.|...|+     |.+ |.   ..++||.||+..|..  ...|.+..+| |+|.|++
T Consensus        15 ~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVL-y~---~~~~vWssnt~~~~~--~~~l~l~~dGnLvL~d~~   79 (119)
T d1b2pa_          15 QILHATESL----EILFGTHVYRFIMQTDCN-----LVL-YD---NNNPIWATNTGGLGN--GCRAVLQPDGVLVVITNE   79 (119)
T ss_dssp             CEEETTCEE----EEEETTEEEEEEECTTSC-----EEE-EE---TTEEEEECCCTTSCS--SCEEEECTTSCEEEECTT
T ss_pred             CEEeCCCeE----EEecCCceEEEEECCCCc-----EEE-EE---CCeEEEEecCCCCCc--ceEEEEEeCCCEEEECCC
Confidence            345555554    347789999999887764     333 43   367899999987743  4689999999 9999999


Q ss_pred             CceEEecCCCCC-CCceeEEecCCCEEEEecCCCceeEeecc
Q 005206          137 QNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFD  177 (709)
Q Consensus       137 g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQSFd  177 (709)
                      |.+||++++... ...+|+|+|+|||||++.    .+|||-.
T Consensus        80 g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg~----~~W~S~T  117 (119)
T d1b2pa_          80 NVTVWQSPVAGKAGHYVLVLQPDRNVVIYGD----ALWATQT  117 (119)
T ss_dssp             CCEEEECSCCCCSSCEEEEECTTSCEEEEES----EEEECCC
T ss_pred             CcEEEECCCcCCCCceEEEEcCCCCEEEECC----CEeccCC
Confidence            999999997655 355799999999999963    7999954

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.13  E-value=4.7e-11  Score=104.00  Aligned_cols=97  Identities=19%  Similarity=0.274  Sum_probs=73.7

Q ss_pred             CCCcCCCCEEEecCCeEEEEeeCCCCCCcEEEEEEEeccCCceEEEEcCCCCCCCCCcceEEEEcCc-eEEEcCCCceEE
Q 005206           63 TQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQR-IGLFDGSQNLVW  141 (709)
Q Consensus        63 g~~l~~~~~lvS~~g~F~lGFf~~~~~~~~~lgIw~~~~~~~tvVWvANr~~Pv~~~~~~l~l~~~G-Lvl~d~~g~~vW  141 (709)
                      .|.|.+++.|  .+|.|.|.|...|+     |.++.    ...+||.+|...+   ..+.+.+.++| |||.|.++.+||
T Consensus        14 ~~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~----~~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~vW   79 (115)
T d1dlpa1          14 PQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD----SDVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRW   79 (115)
T ss_dssp             CSCCCTTCEE--CSTTEEEEECTTSC-----EEEEE----SSSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCSC
T ss_pred             cceecCCCcE--EcCCEEEEECCCCe-----EEEEc----CCeeEEEcccCCC---CceEEEEeccCCEEEEccCCCEEE
Confidence            4555555555  46779999887764     45543    3567999986542   34789999999 999999999999


Q ss_pred             ecCCCCC-CCceeEEecCCCEEEEecCCCceeEeecc
Q 005206          142 SSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFD  177 (709)
Q Consensus       142 st~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQSFd  177 (709)
                      ++++... ...+++|+++|||||++    ..+|+|-.
T Consensus        80 sS~t~~~~g~y~l~Lq~DGNlvlY~----~~~Wssgt  112 (115)
T d1dlpa1          80 SSGTKGSIGNYVLVLQPDRTVTIYG----PGLWDSGT  112 (115)
T ss_dssp             CCCCCCCSSCCEEEECSSSCEEEEC----SEEEECSC
T ss_pred             EcCCCCCCCCEEEEECCCCcEEEeC----CCeecCCC
Confidence            9987654 45679999999999995    37999843

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=98.80  E-value=9e-09  Score=89.87  Aligned_cols=84  Identities=18%  Similarity=0.228  Sum_probs=65.3

Q ss_pred             ceEEEEcCc-eEEEcCCCceEEecCCCCC-CCceeEEecCCCEEEEecCCCceeEeeccCCCCccCCCCcccceeccCCe
Q 005206          121 GVLRIINQR-IGLFDGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFE  198 (709)
Q Consensus       121 ~~l~l~~~G-Lvl~d~~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PtDTlLpg~~l~~~~~tg~~  198 (709)
                      -.|.+..|| |||.++ +.++|++++.+. ....+.|.++|||||++. .+.++|+|..                     
T Consensus        32 y~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~-~g~~vWsS~t---------------------   88 (119)
T d1b2pa_          32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITN-ENVTVWQSPV---------------------   88 (119)
T ss_dssp             EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT-TCCEEEECSC---------------------
T ss_pred             EEEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECC-CCcEEEECCC---------------------
Confidence            368888999 999986 568999998765 467899999999999996 6778998621                     


Q ss_pred             eEEEEecCCCCCCCCcceEeecCCCCcEEEEecCCccccccCC
Q 005206          199 WYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGP  241 (709)
Q Consensus       199 ~~L~S~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~sg~  241 (709)
                                .-+.|.|.+.|+++|...++    +.+.|.|+.
T Consensus        89 ----------~~~~~~~~l~Lq~DGNlvlY----g~~~W~S~T  117 (119)
T d1b2pa_          89 ----------AGKAGHYVLVLQPDRNVVIY----GDALWATQT  117 (119)
T ss_dssp             ----------CCCSSCEEEEECTTSCEEEE----ESEEEECCC
T ss_pred             ----------cCCCCceEEEEcCCCCEEEE----CCCEeccCC
Confidence                      11456788999999986654    246888764

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=98.77  E-value=5.6e-09  Score=91.42  Aligned_cols=111  Identities=12%  Similarity=0.143  Sum_probs=69.9

Q ss_pred             eEEecCCCEEEEecCCCceeEeeccCCCCccCCCCcccceeccCCeeEEEEecCCCCCCCCcceEeecCCCCcEEEEecC
Q 005206          153 AQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNK  232 (709)
Q Consensus       153 a~LldsGNlVl~~~~~~~~lWQSFd~PtDTlLpg~~l~~~~~tg~~~~L~S~~s~~dps~G~~~l~~~~~g~~~~~~~~~  232 (709)
                      +.+.|+||+||.+.       +|+|.|++||.++|.|.                     .|.|+|.|+.+|..  ++++.
T Consensus         3 ~v~~~~~n~il~~~-------~~~~~~~~~l~~~q~l~---------------------~g~y~L~~q~DGNL--vL~~~   52 (120)
T d1dlpa2           3 VVVANNGNSILYST-------QGNDNHPQTLHATQSLQ---------------------LSPYRLSMETDCNL--VLFDR   52 (120)
T ss_dssp             CCCSSCCCEECCCC---------CCCCCCEECSSCCCB---------------------CSSCEEEEETTTEE--EEEBT
T ss_pred             EEEEeCCCeEEEcC-------CCCCCcccEEcCCCeeE---------------------cCCEEEEEcCCCcE--EEecC
Confidence            45677777777753       67799999999999985                     47899999999975  45677


Q ss_pred             CccccccCCCCCccccccccCccccceeEEEEEcCCceEEEEEEecCCCcEEEEEEccCCcEEEE
Q 005206          233 QERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVSPDGFLQRF  297 (709)
Q Consensus       233 ~~~~~~sg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~Ld~dG~l~~y  297 (709)
                      ...+|.++.-.. .......+.  ..-++.+...++ +..++.........+|++|++||+|++|
T Consensus        53 ~~~vW~s~t~~~-~~~~~~~l~--~~GnLvl~d~~~-~~lW~S~t~~~~~~~~l~Lq~DGnlvlY  113 (120)
T d1dlpa2          53 DDRVWSTNTAGK-GTGCRAVLQ--PNGRMDVLTNQN-IAVWTSGNSRSAGRYVFVLQPDRNLAIY  113 (120)
T ss_dssp             TBCCSCCCCCSS-CSSCEEEEE--TTTEEEEEETTT-EEEEECCCCCSSSCCEEEECSSSCEEEE
T ss_pred             CcEEEEEccccC-CCcEEEEEe--CCeeEEEEcCCC-CEEEEeCCCCCCCcEEEEECCCCcEEEe
Confidence            788998764221 111111121  222333333333 4443322222334568999999999999

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=98.74  E-value=2.4e-08  Score=85.77  Aligned_cols=84  Identities=18%  Similarity=0.325  Sum_probs=64.8

Q ss_pred             ceEEEEcCc-eEEEcCCCceEEecCCCCC-CCceeEEecCCCEEEEecCCCceeEeeccCCCCccCCCCcccceeccCCe
Q 005206          121 GVLRIINQR-IGLFDGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFE  198 (709)
Q Consensus       121 ~~l~l~~~G-Lvl~d~~g~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PtDTlLpg~~l~~~~~tg~~  198 (709)
                      -+|.+..|| |||.+. +.+||++++.+. ....+.|.++|||||++. .+.++|+|                       
T Consensus        21 ~~l~~q~DGNLvly~~-~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~-~g~~vWsS-----------------------   75 (108)
T d1jpca_          21 FVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNP-SNKPIWAS-----------------------   75 (108)
T ss_dssp             EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT-TCCEEEEC-----------------------
T ss_pred             EEEEECCCCeEEEEeC-CceeeEeCCCCCCCccEEEEeccceEEEECC-CccceEEc-----------------------
Confidence            578899999 999985 678999998765 356899999999999986 67889986                       


Q ss_pred             eEEEEecCCCCCCCCcceEeecCCCCcEEEEecCCccccccCC
Q 005206          199 WYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGP  241 (709)
Q Consensus       199 ~~L~S~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~sg~  241 (709)
                              ......+.|.+.|+++|+..++  .  ...|.|+.
T Consensus        76 --------~t~~~~~~~~l~L~ddGNlVly--~--~~~W~S~t  106 (108)
T d1jpca_          76 --------NTGGQNGNYVCILQKDRNVVIY--G--TDRWATGT  106 (108)
T ss_dssp             --------CCCCSCSCEEEEECTTSCEEEE--E--CCCCCCCC
T ss_pred             --------cccCCCCcEEEEEcCCCCEEEe--C--CCcccCCC
Confidence                    1122456788999999986554  3  34777663

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=98.73  E-value=2.7e-08  Score=85.46  Aligned_cols=85  Identities=25%  Similarity=0.365  Sum_probs=64.5

Q ss_pred             ceEEEEcCc-eEEEcCCCceEEecCCCCC--CCceeEEecCCCEEEEecCCCceeEeeccCCCCccCCCCcccceeccCC
Q 005206          121 GVLRIINQR-IGLFDGSQNLVWSSNQTKA--TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGF  197 (709)
Q Consensus       121 ~~l~l~~~G-Lvl~d~~g~~vWst~~~~~--~~~~a~LldsGNlVl~~~~~~~~lWQSFd~PtDTlLpg~~l~~~~~tg~  197 (709)
                      -.|.+..|| |+|.+. +.+||++|+...  .+..+.|.++|||||++. .+.++|+|                      
T Consensus        21 ~~l~~q~dgnLvl~~~-~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~-~g~~vW~s----------------------   76 (109)
T d1kj1a_          21 YHFIMQEDCNLVLYDH-STSVWASNTGILGKKGCKAVLQSDGNFVVYDA-EGRSLWAS----------------------   76 (109)
T ss_dssp             EEEEECTTSCEEEEET-TEEEEECCCCCTTCCCCEEEECTTSCEEEECS-SSCEEEEC----------------------
T ss_pred             EEEEecCCCeEEEEeC-CEEEEEeCCCCCCceeEEEEEcCCceEEEEeC-CCcEEEEE----------------------
Confidence            568888999 999874 678999997644  457799999999999996 67889987                      


Q ss_pred             eeEEEEecCCCCCCCCcceEeecCCCCcEEEEecCCccccccCCC
Q 005206          198 EWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPW  242 (709)
Q Consensus       198 ~~~L~S~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~sg~~  242 (709)
                               ......|.|.+.|+++|+..+  ++  ...|.|+.+
T Consensus        77 ---------~t~~~~~~~~l~L~ddGNlvl--y~--~~~W~S~t~  108 (109)
T d1kj1a_          77 ---------HSVRGNGNYVLVLQEDGNVVI--YG--SDIWSTGTY  108 (109)
T ss_dssp             ---------CCCCCSSCCEEEECTTSCEEE--EC--CEEEECCCC
T ss_pred             ---------eeECCCCCEEEEEeCCCcEEE--EC--CCEecCCCc
Confidence                     111235678899999998655  43  357887653

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=98.52  E-value=1.4e-07  Score=81.39  Aligned_cols=111  Identities=15%  Similarity=0.151  Sum_probs=68.6

Q ss_pred             CCccCCCCcccceeccCCeeEEEEecCCCCCCCCcceEeecCCCCcEEEEecCCccccccCCCCCccccccccCccccce
Q 005206          180 TDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGI  259 (709)
Q Consensus       180 tDTlLpg~~l~~~~~tg~~~~L~S~~s~~dps~G~~~l~~~~~g~~~~~~~~~~~~~~~sg~~~~~~~~~~~~~~~~~~~  259 (709)
                      ||||+|||.|.      .+..|++         |.|+|.|+.||+..  ++....++|.++..+...  + +.+.....-
T Consensus         1 tDtL~~gq~L~------~g~~l~~---------g~~~l~~q~DGNLv--ly~~~~~vW~s~~~~~~~--~-~~l~l~~dG   60 (112)
T d1xd5a_           1 SDRLNSGHQLD------TGGSLAE---------GGYLFIIQNDCNLV--LYDNNRAVWASGTNGKAS--G-CVLKMQNDG   60 (112)
T ss_dssp             CCEEETTEEEC------TTCEEEE---------TTEEEEECTTSCEE--EEETTEEEEECCCTTSCS--S-EEEEECTTS
T ss_pred             CCEecCCCEec------CCCEEEE---------CCEEEEEcCCCCEE--EEcCCcEEEEccCccCCC--C-cEEEEeccc
Confidence            79999999998      5667763         99999999999854  456777899877543211  0 111111111


Q ss_pred             eEEEEEcCCceEEEEEEecCCCcEEEEEEccCCcEEEEEEeCCCCceEEEEcccCCcC
Q 005206          260 NFEFFIDQDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQC  317 (709)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~r~~Ld~dG~l~~y~w~~~~~~W~~~~~~p~~~C  317 (709)
                      .+... +.+ ...+..........++++|+.||+|++|.  .   .....|+...+.|
T Consensus        61 nLvl~-~~~-~~~w~s~t~~~~~~~~l~L~ddGNlvly~--~---~~~~~W~S~t~~~  111 (112)
T d1xd5a_          61 NLVIY-SGS-RAIWASNTNRQNGNYYLILQRDRNVVIYD--N---SNNAIWATHTNVG  111 (112)
T ss_dssp             CEEEE-ETT-EEEEECCCCCSCCCCEEEECTTSCEEEEC--T---TSCEEEECCCCCC
T ss_pred             cEEEE-ecC-CeEEEEeeccCCCceEEEEcCCCCEEEEC--C---CCcEEecCCCccC
Confidence            22222 223 33332222223345799999999999994  1   2346788776665

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.47  E-value=7.1e-07  Score=88.39  Aligned_cols=149  Identities=15%  Similarity=0.082  Sum_probs=103.2

Q ss_pred             HHHHHhcCcCcceeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeE
Q 005206          536 TIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKM  614 (709)
Q Consensus       536 ~l~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~  614 (709)
                      ++....+.|...+..+-++...||+... +++.+.+|+...........+.+|...+..+. +--+.+++.+..+.+..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            4555556776655444444568998864 45667788876554445567888999888774 545678889888889999


Q ss_pred             EEEEccCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 005206          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS---------------------------------  661 (709)
Q Consensus       615 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------  661 (709)
                      +|||++++..+.+.....     .   ....++.++++.|..||+..                                 
T Consensus        87 lv~~~l~G~~~~~~~~~~-----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE-----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC-----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEEeccccccccccccc-----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            999999998876543211     1   11224455555555555321                                 


Q ss_pred             -----------------------CCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          662 -----------------------RFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       662 -----------------------~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                                             ...++|+|+.|.|||++++..+-|.||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                   12379999999999999877778999998874

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.87  E-value=1.9e-05  Score=77.35  Aligned_cols=142  Identities=15%  Similarity=0.123  Sum_probs=87.7

Q ss_pred             eecccCc-eEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcC--CCceeeEEEEEEeCCeeEEEEEccCCCCH
Q 005206          549 KLGQGGF-GIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ--HRNLVRLLGCCVEMDEKMLVYEYMENRSL  625 (709)
Q Consensus       549 ~LG~G~f-G~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL  625 (709)
                      .+..|.. ..||+....++..+.+|.-...   ....+..|...+..+.  ...+.+++++..+.+..++||||+++.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4555554 5899998877877888876433   2345677888887763  34467888888888889999999987655


Q ss_pred             HHH--------------Hhcc---C-CCCCC--CHHHHHHHH--------------------HHHHHHHHHHHhC----C
Q 005206          626 DSV--------------IFDK---A-RSSIL--NWQRRFNII--------------------CGIARGLLYLHQD----S  661 (709)
Q Consensus       626 ~~~--------------l~~~---~-~~~~l--~~~~~~~i~--------------------~~ia~gL~yLH~~----~  661 (709)
                      .+.              +.+-   . ....+  .+.....-.                    ......+..+.+.    .
T Consensus        94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  173 (255)
T d1nd4a_          94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE  173 (255)
T ss_dssp             TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred             ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence            221              1000   0 00000  111110000                    0012223333332    1


Q ss_pred             CCceEecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          662 RFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       662 ~~~iiHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ...++|+|+.|.|||++++..+-|.||+.+..
T Consensus       174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            22489999999999999887788999999875

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.32  E-value=0.00055  Score=71.46  Aligned_cols=76  Identities=14%  Similarity=0.213  Sum_probs=50.5

Q ss_pred             ceeecccCceEEEEEEEcC-CcEEEEEEeccC-------CccchHHHHHHHHHHHhc-CC--CceeeEEEEEEeCCeeEE
Q 005206          547 YNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN-------SGQGIEEFKNEVRLIAKL-QH--RNLVRLLGCCVEMDEKML  615 (709)
Q Consensus       547 ~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~-------~~~~~~~f~~Ei~~l~~l-~H--~nIv~l~g~~~~~~~~~l  615 (709)
                      .+.||.|....||+....+ ++.+.||.-...       -....++...|.+.|..+ .+  ..+.+++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            4579999999999998765 678888864321       112344566788888766 23  346666654  5667789


Q ss_pred             EEEccCCCC
Q 005206          616 VYEYMENRS  624 (709)
Q Consensus       616 V~Ey~~~gs  624 (709)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.28  E-value=0.0079  Score=60.53  Aligned_cols=135  Identities=14%  Similarity=0.150  Sum_probs=77.8

Q ss_pred             eEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCce--eeEE-----EEEEeCCeeEEEEEccCCCCHH--
Q 005206          556 GIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL--VRLL-----GCCVEMDEKMLVYEYMENRSLD--  626 (709)
Q Consensus       556 G~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nI--v~l~-----g~~~~~~~~~lV~Ey~~~gsL~--  626 (709)
                      -.||+++..+|+.+++|..... ....+++..|...+..|....+  +..+     ......+..+.+++++++..+.  
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            4899999999999999987543 3345778889888887743222  1111     1223456678899999764321  


Q ss_pred             ---HH---------Hhc----c--CCCCCCCHHHH-------------------HHHHHHHHHHHHHHHh----CCCCce
Q 005206          627 ---SV---------IFD----K--ARSSILNWQRR-------------------FNIICGIARGLLYLHQ----DSRFRI  665 (709)
Q Consensus       627 ---~~---------l~~----~--~~~~~l~~~~~-------------------~~i~~~ia~gL~yLH~----~~~~~i  665 (709)
                         .+         ++.    .  .....+++...                   -.+...+.+.++.+..    ..+..+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence               11         110    0  00111222111                   1112222233333322    223468


Q ss_pred             EecCCCCCCEEEcCCCcEEEEecCCcee
Q 005206          666 IHRDLKASNILLDKEMTPKISDFGMARI  693 (709)
Q Consensus       666 iHrDlkp~NILl~~~~~~KI~DFGla~~  693 (709)
                      ||+|+.+.|||++++  ..+.||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999754  45899998873

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.00  E-value=0.0068  Score=62.80  Aligned_cols=73  Identities=18%  Similarity=0.220  Sum_probs=49.2

Q ss_pred             ceeecccCceEEEEEEEcCC--------cEEEEEEeccCCccchHHHHHHHHHHHhcC-CCceeeEEEEEEeCCeeEEEE
Q 005206          547 YNKLGQGGFGIVYKGRLLEG--------QEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVY  617 (709)
Q Consensus       547 ~~~LG~G~fG~Vykg~~~~g--------~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~  617 (709)
                      ++.|+-|-.=.+|+....++        +.|.+++.. .. .......+|..+++.+. |.-..++++++.    -.+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEE
Confidence            35788888899999987643        356665553 32 23345568998888884 433457888764    26899


Q ss_pred             EccCCCCH
Q 005206          618 EYMENRSL  625 (709)
Q Consensus       618 Ey~~~gsL  625 (709)
                      ||+++..|
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.33  E-value=0.15  Score=50.15  Aligned_cols=157  Identities=12%  Similarity=0.038  Sum_probs=79.9

Q ss_pred             ChHHHHHHhcCcCcc-----eeecccCceEEEEEEEcCCcEEEEEEeccCCccchHHHHHHHHHHHhcCCCce--eeEEE
Q 005206          533 DFETIVRATDNFTDY-----NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL--VRLLG  605 (709)
Q Consensus       533 ~~~~l~~~t~~f~~~-----~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~~l~~l~H~nI--v~l~g  605 (709)
                      +.+++.....+|...     +.|..|---+.|+.+..+|+ +++|+.....  ..++...|+.++..|.+.++  ...+-
T Consensus         4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~   80 (316)
T d2ppqa1           4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP   80 (316)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence            445666666677543     33556666788999887665 7788775432  23445556666666632221  11110


Q ss_pred             ------EEEeCCeeEEEEEccCCCCHHH--------------HHhcc------CCCCCCC--HH----------------
Q 005206          606 ------CCVEMDEKMLVYEYMENRSLDS--------------VIFDK------ARSSILN--WQ----------------  641 (709)
Q Consensus       606 ------~~~~~~~~~lV~Ey~~~gsL~~--------------~l~~~------~~~~~l~--~~----------------  641 (709)
                            +.........++.++.+.....              .++..      .......  +.                
T Consensus        81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (316)
T d2ppqa1          81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  160 (316)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence                  1222445667777776533211              00000      0000000  00                


Q ss_pred             HHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCCEEEcCCCcEEEEecCCce
Q 005206          642 RRFNIICGIARGLLYLHQD-SRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (709)
Q Consensus       642 ~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~~~~~~KI~DFGla~  692 (709)
                      .....+..+...+.-.+.. -+..+||+|+.+.||+++.+...-|.||+.+.
T Consensus       161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            0011122222222222221 23469999999999999998888999999886

>d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.08  E-value=0.033  Score=35.26  Aligned_cols=32  Identities=38%  Similarity=0.864  Sum_probs=25.7

Q ss_pred             CcCccccCCCCCccccCC-CCCCCCCCCCCccCC
Q 005206          315 DQCDNYGECGPFGICDTN-ASPVCQCMRGFEPKD  347 (709)
Q Consensus       315 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~~~  347 (709)
                      |.|.+-..|| ||.|+.- ..-.|.|-.||+|..
T Consensus         2 dECsignpCG-nGTCtNviGgFec~C~~GFepgp   34 (39)
T d1emoa2           2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP   34 (39)
T ss_dssp             CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred             CccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence            7899999999 5889743 345699999999853

>d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=85.63  E-value=0.088  Score=35.41  Aligned_cols=30  Identities=33%  Similarity=0.802  Sum_probs=23.9

Q ss_pred             CcCcc-ccCCCCCccccCC-CCCCCCCCCCCc
Q 005206          315 DQCDN-YGECGPFGICDTN-ASPVCQCMRGFE  344 (709)
Q Consensus       315 ~~C~~-~~~CG~~g~C~~~-~~~~C~C~~gf~  344 (709)
                      |+|.. ...|..+|.|... ..-.|.|++||+
T Consensus         4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~   35 (42)
T d2vj3a1           4 DECSLGANPCEHAGKCINTLGSFECQCLQGYT   35 (42)
T ss_dssp             CTTTSSSCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred             ccccCCCCCCCCCcEeECCCCCEEeECCCCCc
Confidence            66875 4789999999754 456799999997

>d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor X, N-terminal module
species: Human (Homo sapiens) [TaxId: 9606]

Probab=83.14  E-value=0.24  Score=32.52  Aligned_cols=30  Identities=37%  Similarity=0.921  Sum_probs=22.8

Q ss_pred             CcCccccCCCCCccccCC-CCCCCCCCCCCcc
Q 005206          315 DQCDNYGECGPFGICDTN-ASPVCQCMRGFEP  345 (709)
Q Consensus       315 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~  345 (709)
                      |+|. ...|...|.|... ..-.|.|++||+-
T Consensus         1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~G   31 (39)
T d1xkba1           1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFEG   31 (39)
T ss_dssp             CTTT-TCCCCSSCEECCCSSSCCEECCTTEET
T ss_pred             CcCC-CCCCCCCcEEECCCCCEEEECCCCCCc
Confidence            4565 4678889999754 4578999999973

>d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=80.50  E-value=0.54  Score=31.51  Aligned_cols=31  Identities=26%  Similarity=0.528  Sum_probs=23.6

Q ss_pred             CCcCccccCCCCCccccCC-CCCCCCCCCCCcc
Q 005206          314 KDQCDNYGECGPFGICDTN-ASPVCQCMRGFEP  345 (709)
Q Consensus       314 ~~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~  345 (709)
                      .|+|..+. |+.++.|... ++-.|.|++||+.
T Consensus         5 idEC~~~~-~~~~~~C~Nt~Gsy~C~C~~Gy~~   36 (43)
T d1emoa1           5 MDECKEPD-VCKHGQCINTDGSYRCECPFGYIL   36 (43)
T ss_dssp             CCSSSSTT-SCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred             eeccCCcC-CCCCCEeECCCCCeEeECCCCccc
Confidence            47897654 5578999764 4568999999985